Psyllid ID: psy6191

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-----
Protein Sequence
MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR
Secondary Structure (PSIPRED)
cHHHHHHHHccccccccccEEEEEEcccEEEEEEccccccHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHcccEEEEccccccEEEccccccccccccccccccccccccHHccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHcccccEEEEEEEEEccccEEEEEEEccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEEEEccccccEEEEccccccccccccccccccccccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHcccEEccccccHcHHHHHHHHHcccHcccccHHHHHccccHcccccHHcccccccccccccccHccccHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccHHHEEEcccccEEEccccccEEccccccccc
Coil and Loop (DISEMBL)
MSQEIAIHRSLkhrnvvgfhsffedsKFVYIILELCRKRSMMELYNSacdleemsdpaaqpviwvskwvdysdkygfgyqlnddssgvmfNDLTRMIMLANkntlcgtpnyiapeilnknghsfeVDVWSIGCIMYTllvgkppfetstlKETYSRIKKVEyklpatlkKPAATMIKKMLlldpvqrppvaqllhfeffndycptslpasclmtaprfdsvvpsfnsprrkplmernskrrkaitepeTRFYMKQILEGVSYLHDHKIIHrdlklgnlflsdnfvvkIGDFGLAARIEFDGQRKR
Flexible Loop (DISEMBL)
msqeiaihrslkhrnvvgfhsffedskFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKetysrikkveyklpatlkkPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRfdsvvpsfnsprrkplmernskrrkaitepetrfYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLaariefdgqrkr
Low Complexity Region (SEG)
MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR
Disordered region (IsUnstruct)
******IHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDS****************************TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF******
Disordered Region (DISOPRED)
MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRR**ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA**********
Disordered Region (DISEMBL)
MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR
Disordered Region (DISPRO)
MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE*******
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	305	2.2.26 [Sep-21-2011]
P52304	576	Serine/threonine-protein	yes	N/A	0.747	0.395	0.496	2e-60
Q62673	603	Serine/threonine-protein	yes	N/A	0.763	0.386	0.505	4e-59
Q07832	603	Serine/threonine-protein	yes	N/A	0.750	0.379	0.510	6e-59
P70032	598	Serine/threonine-protein	N/A	N/A	0.8	0.408	0.473	1e-58
P53350	603	Serine/threonine-protein	yes	N/A	0.763	0.386	0.494	1e-58
Q2TA25	602	Serine/threonine-protein	yes	N/A	0.757	0.383	0.478	4e-58
P62205	598	Serine/threonine-protein	yes	N/A	0.803	0.409	0.467	7e-58
P34331	649	Serine/threonine-protein	yes	N/A	0.862	0.405	0.364	5e-46
Q9N2L7	632	Serine/threonine-protein	no	N/A	0.842	0.406	0.386	1e-45
Q86HN7	978	Probable serine/threonine	yes	N/A	0.750	0.234	0.396	3e-39

>sp|P52304|POLO_DROME Serine/threonine-protein kinase polo OS=Drosophila melanogaster GN=polo PE=1 SV=2

 Score =  232 bits (592), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 129/260 (49%), Positives = 161/260 (61%), Gaps = 32/260 (12%)

Query: 2   SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           +QEI IHRSL H N+V FH++FEDS+ +YI+LELC+KRSMMEL+     + E        
Sbjct: 71  AQEITIHRSLNHPNIVKFHNYFEDSQNIYIVLELCKKRSMMELHKRRKSITEFE------ 124

Query: 62  VIWVSKWVDYSDKYGFGYQLNDDS--------SGVMFNDLTRMIM----LAN-------- 101
                ++  Y    G  Y L+D+           +  NDL  + +    LA         
Sbjct: 125 ----CRYYIYQIIQGVKY-LHDNRIIHRDLKLGNLFLNDLLHVKIGDFGLATRIEYEGER 179

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           K TLCGTPNYIAPEIL K GHSFEVD+WSIGC+MYTLLVG+PPFET TLK+TYS+IKK E
Sbjct: 180 KKTLCGTPNYIAPEILTKKGHSFEVDIWSIGCVMYTLLVGQPPFETKTLKDTYSKIKKCE 239

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDS 220
           Y++P+ L+KPAA M+  ML  +P  RP + QLL+FEF      P  LP+SCL  APR  S
Sbjct: 240 YRVPSYLRKPAADMVIAMLQPNPESRPAIGQLLNFEFLKGSKVPMFLPSSCLTMAPRIGS 299

Query: 221 VVPSFNSPRRKPLMERNSKR 240
                +S  RKPLME N  R
Sbjct: 300 NDTIEDSMHRKPLMEMNGIR 319

May play a role in regulating both nuclear and cytoplasmic aspects of the mitotic cycle.
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 1

>sp|Q62673|PLK1_RAT Serine/threonine-protein kinase PLK1 OS=Rattus norvegicus GN=Plk1 PE=2 SV=2

 Score =  228 bits (581), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 127/251 (50%), Positives = 158/251 (62%), Gaps = 18/251 (7%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           MS EI+IHRSL H++VVGFH FFEDS FV+++LELCR+RS++EL+      + +++P A 
Sbjct: 98  MSMEISIHRSLAHQHVVGFHGFFEDSDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 154

Query: 60  ----QPVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
               Q V+         V + D       LN+D   V   D      +      K TLCG
Sbjct: 155 YYLRQIVLGCQYLHRNQVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYEGERKKTLCG 213

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 214 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 273

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   AA++I+KML  DP  RP + +LL+ EFF + Y P  LP +CL   PRF     S +
Sbjct: 274 INPVAASLIQKMLQTDPTARPTIHELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 333

Query: 227 SPRRKPLMERN 237
              RKPL   N
Sbjct: 334 PSNRKPLTVLN 344

Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis. Polo-like kinase proteins acts by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates BORA, BUB1B/BUBR1, CCNB1, CDC25C, CEP55, ECT2, ERCC6L, FBXO5/EMI1, FOXM1, KIF20A/MKLP2, MLF1IP, NEDD1, NINL, NPM1, NUDC, PKMYT1/MYT1, PLK1S1/KIZ, PPP1R12A/MYPT1, PRC1, RACGAP1/CYK4, SGOL1, STAG2/SA2, TEX14, TOPORS, p73/TP73, TPT1 and WEE1. Plays a key role in centrosome functions and the assembly of bipolar spindles by phosphorylating PLK1S1/KIZ, NEDD1 and NINL. NEDD1 phosphorylation promotes subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. Phosphorylation of NINL component of the centrosome leads to NINL dissociation from other centrosomal proteins. Involved in mitosis exit and cytokinesis by phosphorylating CEP55, ECT2, KIF20A/MKLP2, MLF1IP, PRC1 and RACGAP1. Recruited at the central spindle by phosphorylating and docking PRC1 and KIF20A/MKLP2; creates its own docking sites on PRC1 and KIF20A/MKLP2 by mediating phosphorylation of sites subsequently recognized by the POLO box domains. Phosphorylates RACGAP1, thereby creating a docking site for the Rho GTP exchange factor ECT2 that is essential for the cleavage furrow formation. Promotes the central spindle recruitment of ECT2. Plays a central role in G2/M transition of mitotic cell cycle by phosphorylating CCNB1, CDC25C, FOXM1, MLF1IP, PKMYT1/MYT1, PPP1R12A/MYPT1 and WEE1. Part of a regulatory circuit that promotes the activation of CDK1 by phosphorylating the positive regulator CDC25C and inhibiting the negative regulators WEE1 and PKMYT1/MYT1. Also acts by mediating phosphorylation of cyclin-B1 (CCNB1) on centrosomes in prophase. Phosphorylates FOXM1, a key mitotic transcription regulator, leading to enhance FOXM1 transcriptional activity. Involved in kinetochore functions and sister chromatide cohesion by phosphorylating BUB1B/BUBR1, FBXO5/EMI1 and STAG2/SA2. PLK1 is high on non-attached kinetochores suggesting a role of PLK1 in kinetochore attachment or in spindle assembly checkpoint (SAC) regulation. Required for kinetochore localization of BUB1B. Regulates the dissociation of cohesin from chromosomes by phosphorylating cohesin subunits such as STAG2/SA2. Phosphorylates SGOL1: required for spindle pole localization of isoform 3 of SGOL1 and plays a role in regulating its centriole cohesion function. Mediates phosphorylation of FBXO5/EMI1, a negative regulator of the APC/C complex during prophase, leading to FBXO5/EMI1 ubiquitination and degradation by the proteasome. Acts as a negative regulator of p53 family members: phosphorylates TOPORS, leading to inhibit the sumoylation of p53/TP53 and simultaneously enhance the ubiquitination and subsequent degradation of p53/TP53. Phosphorylates the transactivation domain of the transcription factor p73/TP73, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates BORA, and thereby promotes the degradation of BORA. Contributes to the regulation of AURKA function. Also required for recovery after DNA damage checkpoint and entry into mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 1

>sp|Q07832|PLK1_MOUSE Serine/threonine-protein kinase PLK1 OS=Mus musculus GN=Plk1 PE=1 SV=2

 Score =  228 bits (580), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 126/247 (51%), Positives = 157/247 (63%), Gaps = 18/247 (7%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           MS EI+IHRSL H++VVGFH FFEDS FV+++LELCR+RS++EL+      + +++P A 
Sbjct: 98  MSMEISIHRSLAHQHVVGFHDFFEDSDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 154

Query: 60  ----QPVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
               Q V+         V + D       LN+D   V   D      +      K TLCG
Sbjct: 155 YYLRQIVLGCQYLHRNQVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYEGERKKTLCG 213

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 214 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 273

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   AA++I+KML  DP  RP + +LL+ EFF + Y P  LP +CL   PRF     S +
Sbjct: 274 INPVAASLIQKMLQTDPTARPTIHELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 333

Query: 227 SPRRKPL 233
              RKPL
Sbjct: 334 PSSRKPL 340

Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis. Polo-like kinase proteins acts by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates BORA, BUB1B/BUBR1, CCNB1, CDC25C, CEP55, ECT2, ERCC6L, FBXO5/EMI1, FOXM1, KIF20A/MKLP2, MLF1IP, NEDD1, NINL, NPM1, NUDC, PKMYT1/MYT1, PLK1S1/KIZ, PPP1R12A/MYPT1, PRC1, RACGAP1/CYK4, SGOL1, STAG2/SA2, TEX14, TOPORS, p73/TP73, TPT1 and WEE1. Plays a key role in centrosome functions and the assembly of bipolar spindles by phosphorylating PLK1S1/KIZ, NEDD1 and NINL. NEDD1 phosphorylation promotes subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. Phosphorylation of NINL component of the centrosome leads to NINL dissociation from other centrosomal proteins. Involved in mitosis exit and cytokinesis by phosphorylating CEP55, ECT2, KIF20A/MKLP2, MLF1IP, PRC1 and RACGAP1. Recruited at the central spindle by phosphorylating and docking PRC1 and KIF20A/MKLP2; creates its own docking sites on PRC1 and KIF20A/MKLP2 by mediating phosphorylation of sites subsequently recognized by the POLO box domains. Phosphorylates RACGAP1, thereby creating a docking site for the Rho GTP exchange factor ECT2 that is essential for the cleavage furrow formation. Promotes the central spindle recruitment of ECT2. Plays a central role in G2/M transition of mitotic cell cycle by phosphorylating CCNB1, CDC25C, FOXM1, MLF1IP, PKMYT1/MYT1, PPP1R12A/MYPT1 and WEE1. Part of a regulatory circuit that promotes the activation of CDK1 by phosphorylating the positive regulator CDC25C and inhibiting the negative regulators WEE1 and PKMYT1/MYT1. Also acts by mediating phosphorylation of cyclin-B1 (CCNB1) on centrosomes in prophase. Phosphorylates FOXM1, a key mitotic transcription regulator, leading to enhance FOXM1 transcriptional activity. Involved in kinetochore functions and sister chromatide cohesion by phosphorylating BUB1B/BUBR1, FBXO5/EMI1 and STAG2/SA2. PLK1 is high on non-attached kinetochores suggesting a role of PLK1 in kinetochore attachment or in spindle assembly checkpoint (SAC) regulation. Required for kinetochore localization of BUB1B. Regulates the dissociation of cohesin from chromosomes by phosphorylating cohesin subunits such as STAG2/SA2. Phosphorylates SGOL1: required for spindle pole localization of isoform 3 of SGOL1 and plays a role in regulating its centriole cohesion function. Mediates phosphorylation of FBXO5/EMI1, a negative regulator of the APC/C complex during prophase, leading to FBXO5/EMI1 ubiquitination and degradation by the proteasome. Acts as a negative regulator of p53 family members: phosphorylates TOPORS, leading to inhibit the sumoylation of p53/TP53 and simultaneously enhance the ubiquitination and subsequent degradation of p53/TP53. Phosphorylates the transactivation domain of the transcription factor p73/TP73, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates BORA, and thereby promotes the degradation of BORA. Contributes to the regulation of AURKA function. Also required for recovery after DNA damage checkpoint and entry into mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 1

>sp|P70032|PLK1_XENLA Serine/threonine-protein kinase PLK1 OS=Xenopus laevis GN=plk1 PE=1 SV=1

 Score =  226 bits (577), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 124/262 (47%), Positives = 158/262 (60%), Gaps = 18/262 (6%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           M+ EIAI RSL HR+VVGFH FFED+ FVY++LELCR+RS++EL+      + +++P A+
Sbjct: 89  MTMEIAIQRSLDHRHVVGFHGFFEDNDFVYVVLELCRRRSLLELHKRR---KAVTEPEAR 145

Query: 61  PVI---------WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
             +           S  V + D    G    +D   V   D      +      K TLCG
Sbjct: 146 YYLKQTISGCQYLHSNRVIHRD-LKLGNLFLNDEMEVKIGDFGLATKVEYDGERKKTLCG 204

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L K GHSFEVD+WSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 205 TPNYIAPEVLGKKGHSFEVDIWSIGCIMYTLLVGKPPFETSCLKETYMRIKKNEYSIPKH 264

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   AA +I+KML  DP  RP +  LL+ EFF + Y P+ LP +CL   PRF     + +
Sbjct: 265 INPVAAALIQKMLRSDPTSRPTIDDLLNDEFFTSGYIPSRLPTTCLTVPPRFSIAPSTID 324

Query: 227 SPRRKPLMERNSKRRKAITEPE 248
              RKPL   N  +   + E +
Sbjct: 325 QSLRKPLTAINKGQDSPLVEKQ 346

Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis. Polo-like kinase proteins acts by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates cdc25, pkmyt1/myt1, stag2/sa2, tpx2. Plays multiple essential roles during mitosis. Phosphorylates the N-terminal domain of cdc25, which leads to cyclin b-cdc2 activation and mitotic entry. Also required for organization of bipolar spindles, and for exit from mitosis. Involved in kinetochore functions and sister chromatide cohesion by phosphorylating stag2/sa2.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 1

>sp|P53350|PLK1_HUMAN Serine/threonine-protein kinase PLK1 OS=Homo sapiens GN=PLK1 PE=1 SV=1

 Score =  226 bits (577), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 124/251 (49%), Positives = 160/251 (63%), Gaps = 18/251 (7%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct: 98  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 154

Query: 61  ----PVIWVSKW-----VDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                ++   ++     V + D       LN+D   V   D      +      K TLCG
Sbjct: 155 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCG 213

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 214 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 273

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   AA++I+KML  DP  RP + +LL+ EFF + Y P  LP +CL   PRF     S +
Sbjct: 274 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 333

Query: 227 SPRRKPLMERN 237
              RKPL   N
Sbjct: 334 PSNRKPLTVLN 344

Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis. Polo-like kinase proteins acts by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates BORA, BUB1B/BUBR1, CCNB1, CDC25C, CEP55, ECT2, ERCC6L, FBXO5/EMI1, FOXM1, KIF20A/MKLP2, MLF1IP, NEDD1, NINL, NPM1, NUDC, PKMYT1/MYT1, PLK1S1/KIZ, PPP1R12A/MYPT1, PRC1, RACGAP1/CYK4, SGOL1, STAG2/SA2, TEX14, TOPORS, p73/TP73, TPT1 and WEE1. Plays a key role in centrosome functions and the assembly of bipolar spindles by phosphorylating PLK1S1/KIZ, NEDD1 and NINL. NEDD1 phosphorylation promotes subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. Phosphorylation of NINL component of the centrosome leads to NINL dissociation from other centrosomal proteins. Involved in mitosis exit and cytokinesis by phosphorylating CEP55, ECT2, KIF20A/MKLP2, MLF1IP, PRC1 and RACGAP1. Recruited at the central spindle by phosphorylating and docking PRC1 and KIF20A/MKLP2; creates its own docking sites on PRC1 and KIF20A/MKLP2 by mediating phosphorylation of sites subsequently recognized by the POLO box domains. Phosphorylates RACGAP1, thereby creating a docking site for the Rho GTP exchange factor ECT2 that is essential for the cleavage furrow formation. Promotes the central spindle recruitment of ECT2. Plays a central role in G2/M transition of mitotic cell cycle by phosphorylating CCNB1, CDC25C, FOXM1, MLF1IP, PKMYT1/MYT1, PPP1R12A/MYPT1 and WEE1. Part of a regulatory circuit that promotes the activation of CDK1 by phosphorylating the positive regulator CDC25C and inhibiting the negative regulators WEE1 and PKMYT1/MYT1. Also acts by mediating phosphorylation of cyclin-B1 (CCNB1) on centrosomes in prophase. Phosphorylates FOXM1, a key mitotic transcription regulator, leading to enhance FOXM1 transcriptional activity. Involved in kinetochore functions and sister chromatide cohesion by phosphorylating BUB1B/BUBR1, FBXO5/EMI1 and STAG2/SA2. PLK1 is high on non-attached kinetochores suggesting a role of PLK1 in kinetochore attachment or in spindle assembly checkpoint (SAC) regulation. Required for kinetochore localization of BUB1B. Regulates the dissociation of cohesin from chromosomes by phosphorylating cohesin subunits such as STAG2/SA2. Phosphorylates SGOL1: required for spindle pole localization of isoform 3 of SGOL1 and plays a role in regulating its centriole cohesion function. Mediates phosphorylation of FBXO5/EMI1, a negative regulator of the APC/C complex during prophase, leading to FBXO5/EMI1 ubiquitination and degradation by the proteasome. Acts as a negative regulator of p53 family members: phosphorylates TOPORS, leading to inhibit the sumoylation of p53/TP53 and simultaneously enhance the ubiquitination and subsequent degradation of p53/TP53. Phosphorylates the transactivation domain of the transcription factor p73/TP73, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates BORA, and thereby promotes the degradation of BORA. Contributes to the regulation of AURKA function. Also required for recovery after DNA damage checkpoint and entry into mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 1

>sp|Q2TA25|PLK1_BOVIN Serine/threonine-protein kinase PLK1 OS=Bos taurus GN=PLK1 PE=2 SV=2

 Score =  225 bits (573), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 121/253 (47%), Positives = 161/253 (63%), Gaps = 22/253 (8%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct: 96  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 152

Query: 61  PVIWVSKWVDYSDKYGFGYQL--NDDSSGVMFNDLTRMIMLAN-------------KNTL 105
              +  + +    +Y  G ++   D   G +F +    + + +             K TL
Sbjct: 153 ---YYLRQIVLGCQYLHGNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL 209

Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
           CGTPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIK  EY +P
Sbjct: 210 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKNNEYSIP 269

Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPS 224
             +   A+++IKKML  DP  RP + +LL+ EFF + Y P  LP +CL   PRF     S
Sbjct: 270 KHINPVASSLIKKMLQPDPTARPTIHELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSS 329

Query: 225 FNSPRRKPLMERN 237
            +   RKPL   N
Sbjct: 330 LDPSNRKPLTVLN 342

Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis. Polo-like kinase proteins acts by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates BORA, BUB1B/BUBR1, CCNB1, CDC25C, CEP55, ECT2, ERCC6L, FBXO5/EMI1, FOXM1, KIF20A/MKLP2, MLF1IP, NEDD1, NINL, NPM1, NUDC, PKMYT1/MYT1, PLK1S1/KIZ, PPP1R12A/MYPT1, PRC1, RACGAP1/CYK4, SGOL1, STAG2/SA2, TOPORS, TEX14, p73/TP73, TPT1 and WEE1. Plays a key role in centrosome functions and the assembly of bipolar spindles by phosphorylating PLK1S1/KIZ, NEDD1 and NINL. NEDD1 phosphorylation promotes subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. Phosphorylation of NINL component of the centrosome leads to NINL dissociation from other centrosomal proteins. Involved in mitosis exit and cytokinesis by phosphorylating CEP55, ECT2, KIF20A/MKLP2, MLF1IP, PRC1 and RACGAP1. Recruited at the central spindle by phosphorylating and docking PRC1 and KIF20A/MKLP2; creates its own docking sites on PRC1 and KIF20A/MKLP2 by mediating phosphorylation of sites subsequently recognized by the POLO box domains. Phosphorylates RACGAP1, thereby creating a docking site for the Rho GTP exchange factor ECT2 that is essential for the cleavage furrow formation. Promotes the central spindle recruitment of ECT2. Plays a central role in G2/M transition of mitotic cell cycle by phosphorylating CCNB1, CDC25C, FOXM1, MLF1IP, PKMYT1/MYT1, PPP1R12A/MYPT1 and WEE1. Part of a regulatory circuit that promotes the activation of CDK1 by phosphorylating the positive regulator CDC25C and inhibiting the negative regulators WEE1 and PKMYT1/MYT1. Also acts by mediating phosphorylation of cyclin-B1 (CCNB1) on centrosomes in prophase. Phosphorylates FOXM1, a key mitotic transcription regulator, leading to enhance FOXM1 transcriptional activity. Involved in kinetochore functions and sister chromatide cohesion by phosphorylating BUB1B/BUBR1, FBXO5/EMI1 and STAG2/SA2. PLK1 is high on non-attached kinetochores suggesting a role of PLK1 in kinetochore attachment or in spindle assembly checkpoint (SAC) regulation. Required for kinetochore localization of BUB1B. Regulates the dissociation of cohesin from chromosomes by phosphorylating cohesin subunits such as STAG2/SA2. Phosphorylates SGOL1: required for spindle pole localization of isoform 3 of SGOL1 and plays a role in regulating its centriole cohesion function. Mediates phosphorylation of FBXO5/EMI1, a negative regulator of the APC/C complex during prophase, leading to FBXO5/EMI1 ubiquitination and degradation by the proteasome. Acts as a negative regulator of p53 family members: phosphorylates TOPORS, leading to inhibit the sumoylation of p53/TP53 and simultaneously enhance the ubiquitination and subsequent degradation of p53/TP53. Phosphorylates the transactivation domain of the transcription factor p73/TP73, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates BORA, and thereby promotes the degradation of BORA. Contributes to the regulation of AURKA function. Also required for recovery after DNA damage checkpoint and entry into mitosis.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 1

>sp|P62205|PLK1_XENTR Serine/threonine-protein kinase PLK1 OS=Xenopus tropicalis GN=plk1 PE=2 SV=1

 Score =  224 bits (571), Expect = 7e-58,   Method: Compositional matrix adjust.
 Identities = 123/263 (46%), Positives = 158/263 (60%), Gaps = 18/263 (6%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           M+ EIAI RSL HR+VVGFH FFED+ FVY++LELCR+RS++EL+      + +++P A 
Sbjct: 89  MTMEIAIQRSLDHRHVVGFHGFFEDNDFVYVVLELCRRRSLLELHKRR---KAVTEPEAR 145

Query: 60  ----QPVIWV----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
               Q ++      S  V + D    G    +D   V   D      +      K TLCG
Sbjct: 146 YYLKQTILGCQYLHSNRVIHRD-LKLGNLFLNDEMEVKIGDFGLATKVEYDGERKKTLCG 204

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L K GHSFEVD+WSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 205 TPNYIAPEVLGKKGHSFEVDIWSIGCIMYTLLVGKPPFETSCLKETYMRIKKNEYSVPKH 264

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   A  +I+KML  +P  RP +  LL+ EFF   Y P+ LP +CL   PRF     + +
Sbjct: 265 INPMATALIQKMLRSEPTSRPTIDDLLNDEFFTTGYIPSRLPTTCLTVPPRFSIAPSTID 324

Query: 227 SPRRKPLMERNSKRRKAITEPET 249
              RKPL   N  +   + E ++
Sbjct: 325 QSLRKPLTAINKGQDSPLVEKQS 347

Plays multiple essential roles during mitosis. Phosphorylates the N-terminal domain of cdc25, which leads to cyclin b-cdc2 activation and mitotic entry. Also required for organization of bipolar spindles, and for exit from mitosis. Phosphorylates tpx2.

Xenopus tropicalis (taxid: 8364)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 1

>sp|P34331|PLK1_CAEEL Serine/threonine-protein kinase plk-1 OS=Caenorhabditis elegans GN=plk-1 PE=1 SV=3

 Score =  184 bits (468), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 113/310 (36%), Positives = 166/310 (53%), Gaps = 47/310 (15%)

Query: 2   SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ- 60
           ++ I IHR L H N+V   +FFED+  VYI LELC +RS+MEL+      + +++P A+ 
Sbjct: 85  NERILIHRELGHINIVKLFNFFEDNLNVYITLELCARRSLMELHKRR---KAVTEPEARY 141

Query: 61  -------PVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN---KNTLCGTPN 110
                   V+++            G    +D   V   D      +     K TLCGTPN
Sbjct: 142 FTHQIVDGVLYLHDLNIIHRDMKLGNLFLNDDLVVKIGDFGLATTVNGDERKKTLCGTPN 201

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           YIAPE+LNK GHSFEVD+W++GCI+Y LL G+PPFE+ +L+ETYSRI+   Y +P+   +
Sbjct: 202 YIAPEVLNKAGHSFEVDIWAVGCILYILLFGQPPFESKSLEETYSRIRHNNYTIPSIATQ 261

Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRF---------DS 220
           PAA++I+KML  +P +RP   Q+    FF + + PT LP SCL   P+F         ++
Sbjct: 262 PAASLIRKMLDPEPTRRPTAKQVQRDGFFKSGFMPTRLPVSCLTMVPKFGGHETSMMEEN 321

Query: 221 VVP-SFNSPRRKPLMER-------------NSKRRKA--------ITEPETRFYMKQILE 258
           V P   ++  ++PL  R             N+ R +A          EPE   Y+ Q+  
Sbjct: 322 VAPRGVDARSQRPLNGRAGLSALPQHIVSNNADRERAQQQAAEATFREPEDA-YLSQLFH 380

Query: 259 GVSYLHDHKI 268
            V+ L + +I
Sbjct: 381 QVAVLLEQRI 390

Required for oocyte nuclear envelope breakdown before entry of oocyte into spermatheca. In mitotic cells, plays a role in spindle organization and centrosome maturation. In meiotic cells, required for spindle dynamics and probably for spindle attachment to the chromosomes. Zygotic role in the development of the germline and nerve cord.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 1

>sp|Q9N2L7|PLK2_CAEEL Serine/threonine-protein kinase plk-2 OS=Caenorhabditis elegans GN=plk-2 PE=2 SV=1

 Score =  183 bits (464), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 117/303 (38%), Positives = 162/303 (53%), Gaps = 46/303 (15%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           M+QE+ IHR+L+HRNVV  + FFED   VYI LELC +RS+MEL+      + +++P A 
Sbjct: 81  MAQEVQIHRNLQHRNVVKLYHFFEDKSNVYITLELCPRRSLMELHKRR---KAVTEPEAR 137

Query: 60  -------QPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN---KNTLCGTP 109
                  + V+++            G    +D   V   D        N   K TLCGTP
Sbjct: 138 YFTYQIVEGVLYLHNLKIVHRDLKLGNLFLNDELQVKIGDFGLATTCDNDERKKTLCGTP 197

Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           NYIAPE+LNK GHSFEVD+W+IGCI+Y LL G PPFE+ +L+ETYSRIK   Y +P +  
Sbjct: 198 NYIAPEVLNKIGHSFEVDLWAIGCILYILLFGHPPFESKSLEETYSRIKNNNYVIPTSAS 257

Query: 170 KPAATMIKKMLLLDPV--QRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRF-------D 219
             A+ +I+  +LLDPV  +RP    +    FF + + P  LP SCL   P         +
Sbjct: 258 AAASQLIR--VLLDPVPSRRPNARAVCRDHFFKSGFMPARLPVSCLTMVPHLNDDEYAEE 315

Query: 220 SVVPSFNSPRRKP--------------LMERNSKRRK-----AITEPETRFYMKQILEGV 260
           +V PS    +R P              L+ RNS+R++     A  +P T  Y+  +L  V
Sbjct: 316 NVSPSGTIDQRGPHQAGRSGLSAIPAHLVSRNSERQQTHRMEAYRQP-TDCYLSNLLAQV 374

Query: 261 SYL 263
           + L
Sbjct: 375 NDL 377

May be required for cell division and may have a role during G1 or S phase.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 1

>sp|Q86HN7|PLK_DICDI Probable serine/threonine-protein kinase PLK OS=Dictyostelium discoideum GN=PLK PE=3 SV=1

 Score =  162 bits (410), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 99/250 (39%), Positives = 140/250 (56%), Gaps = 21/250 (8%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-A 59
           +  EI IH SL H N+V F   FE+ + VYI+LELC ++++M+++     L E       
Sbjct: 208 LKSEIKIHSSLSHENIVKFEHCFENEENVYILLELCNQKTVMDIHKKRKYLMEYETKYYV 267

Query: 60  QPVIWVSKWVDYSDKYGFGYQLND---DSSGVMFNDL---TRMIMLANKNTLCGTPNYIA 113
             VI   +++  ++      +L +   D+  +   D    T++     K T+CGTPNYIA
Sbjct: 268 YQVIMAVQYLHNNNIIHRDLKLGNLFIDNMRIKLGDFGLSTKVEHGERKKTICGTPNYIA 327

Query: 114 PEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPA 172
           PEIL N NGHS+EVDVWSIG I+YTLL+GKPPFETS +K TY RIK+ +Y  P    +P 
Sbjct: 328 PEILDNSNGHSYEVDVWSIGIILYTLLIGKPPFETSDVKHTYQRIKQNQYSFP---DEPI 384

Query: 173 ATMIKKMLLLD-----PVQRPPVAQLLHFEFFN-DYCPTSLPASCLMTAPRFDSVVPSFN 226
            +   K L++      P QRP + Q+L  +FF     P  LP S L TAP   ++    N
Sbjct: 385 ISHYGKSLIISILNPVPEQRPNLTQILEHDFFTYSPIPKYLPVSSLTTAPSQSTI----N 440

Query: 227 SPRRKPLMER 236
               +PL E+
Sbjct: 441 QNMGRPLSEK 450

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	305
332017215	574	Serine/threonine-protein kinase polo [Ac	0.760	0.404	0.534	1e-61
307182687	544	Serine/threonine-protein kinase polo [Ca	0.767	0.430	0.522	2e-61
328704669	578	PREDICTED: serine/threonine-protein kina	0.813	0.429	0.498	3e-61
193624934	580	PREDICTED: serine/threonine-protein kina	0.803	0.422	0.5	3e-60
312380567	574	hypothetical protein AND_07357 [Anophele	0.773	0.411	0.522	5e-60
291221901	598	PREDICTED: polo-like kinase 1-like [Sacc	0.763	0.389	0.494	1e-59
209946076	369	polo [Drosophila yakuba]	0.747	0.617	0.496	6e-59
195495958	651	GE19659 [Drosophila yakuba] gi|194181591	0.747	0.350	0.496	7e-59
209946078	369	polo [Drosophila simulans] gi|209946082|	0.747	0.617	0.496	8e-59
24667346	576	polo, isoform A [Drosophila melanogaster	0.747	0.395	0.496	1e-58

>gi|332017215|gb|EGI58003.1| Serine/threonine-protein kinase polo [Acromyrmex echinatior]

 Score =  242 bits (618), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 133/249 (53%), Positives = 164/249 (65%), Gaps = 17/249 (6%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYN-----SACDLEEMS 55
           M+QEIAIH+SL HR++VGFH FF+D+K +YIILELCRKRSMMEL+      S C+     
Sbjct: 68  MTQEIAIHQSLNHRHIVGFHGFFDDNKNIYIILELCRKRSMMELHKRRKALSECETRYFM 127

Query: 56  DPAAQPVIWV--SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTP 109
                 V ++  +K +    K G  + LNDD   V   D      L +    K T+CGTP
Sbjct: 128 KQILDGVFYLHQNKIIHRDLKLGNLF-LNDDLQ-VKIGDFGLAAKLVHDGERKKTVCGTP 185

Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           NYIAPE+L K GHS+E D+WSIGCIMYTLLVGKPPFETS+LKETYSRIK+V+YK P  + 
Sbjct: 186 NYIAPEVLTKIGHSYEADIWSIGCIMYTLLVGKPPFETSSLKETYSRIKQVQYKTPQHIS 245

Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFNSP 228
           KPA  M+  ML L+P +RP VA+L+   FF + Y PTSLP SCL  APR D +    N  
Sbjct: 246 KPAMNMVANMLQLNPSKRPSVARLMRDTFFTSGYMPTSLPLSCLTMAPRLDMLESHCN-- 303

Query: 229 RRKPLMERN 237
            R+PL E N
Sbjct: 304 -RRPLGEMN 311

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307182687|gb|EFN69812.1| Serine/threonine-protein kinase polo [Camponotus floridanus]

 Score =  242 bits (617), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 129/247 (52%), Positives = 157/247 (63%), Gaps = 13/247 (5%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYN-----SACDLEEMS 55
           M+QEIAIH++L HR++VGFH FF+DS  +YIILELCRKRSMMEL+      S C+     
Sbjct: 37  MTQEIAIHKTLNHRHIVGFHGFFDDSHNIYIILELCRKRSMMELHKRRKALSECETRYFM 96

Query: 56  DPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNY 111
                 V ++ +          G    +D   V   D      L +    K T+CGTPNY
Sbjct: 97  KQILDGVFYLHQHRIIHRDLKLGNLFLNDELQVKIGDFGLATKLEHDGERKKTVCGTPNY 156

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           IAPE+L K GHS+E DVWSIGCIMYTLLVGKPPFETS+LKETYSRIK+V+YK P  + KP
Sbjct: 157 IAPEVLTKVGHSYEADVWSIGCIMYTLLVGKPPFETSSLKETYSRIKQVQYKTPQHISKP 216

Query: 172 AATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFNSPRR 230
           A  M+  ML L+P +RP VA+L+   FF + Y PTSLP SCL  APR D +    N   R
Sbjct: 217 AMNMVANMLQLNPSRRPSVAKLMKDIFFTSGYMPTSLPLSCLTMAPRLDMLESHCN---R 273

Query: 231 KPLMERN 237
           KPL E N
Sbjct: 274 KPLGEMN 280

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328704669|ref|XP_003242563.1| PREDICTED: serine/threonine-protein kinase polo-like [Acyrthosiphon pisum]

 Score =  241 bits (615), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 130/261 (49%), Positives = 167/261 (63%), Gaps = 13/261 (4%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-----MS 55
           M+QEI IH+ L ++N+V FHSFFED  FVYI+LELCRKRSMMEL+     L E       
Sbjct: 69  MTQEIFIHKVLNNKNIVSFHSFFEDKDFVYIVLELCRKRSMMELHRRRKTLTEPETRYYV 128

Query: 56  DPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML----ANKNTLCGTPNY 111
               Q  +++ +          G    +D   V   DL     +      K TLCGTPNY
Sbjct: 129 QQILQGTLYLHQQNIIHRDLKLGNLFLNDEMEVKIGDLGLAAKIEFVGQRKKTLCGTPNY 188

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           IAPEIL+K GHSFEVDVWSIGCIMYTLLVGKPPFET++LKETY+RI + +Y +P+ L K 
Sbjct: 189 IAPEILSKTGHSFEVDVWSIGCIMYTLLVGKPPFETNSLKETYARITRCDYNIPSHLNKN 248

Query: 172 AATMIKKMLLLDPVQRPPVAQLLHFEFFN-DYCPTSLPASCLMTAPRFDSVVPSFNSPRR 230
           A T+I+KML  DP +RP V+++L  +FF   Y P  LP SCL TAPRFDS+    +   R
Sbjct: 249 ARTLIEKMLQSDPKKRPLVSEILKADFFTIGYMPKKLPPSCLTTAPRFDSINYRESISNR 308

Query: 231 KPLMERNSKR---RKAITEPE 248
           +PL+E NS +    K+ ++P+
Sbjct: 309 RPLIELNSPKPAVNKSASKPQ 329

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|193624934|ref|XP_001949406.1| PREDICTED: serine/threonine-protein kinase polo-like [Acyrthosiphon pisum]

 Score =  238 bits (606), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 132/264 (50%), Positives = 168/264 (63%), Gaps = 19/264 (7%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           M+QEI IH+ LKH N+V FHSFFED+ FVYI+LELCRKRSMMEL+      + +++P  +
Sbjct: 70  MTQEIHIHKMLKHVNIVTFHSFFEDNDFVYIVLELCRKRSMMELHKRR---KTLTEPETR 126

Query: 61  PVIW-VSKWVDYSDKYG-------FGYQLNDDSSGVMFNDLTRMIML----ANKNTLCGT 108
             ++ + +   Y    G        G    +D   V   DL     +      K TLCGT
Sbjct: 127 YYVFQILEGTLYLHNQGIIHRDLKLGNLFLNDEMEVKIGDLGLAARIEYDGQRKKTLCGT 186

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           PNYIAPEIL+K GHSFEVDVWSIGCIMYTLLVGKPPFET++LKETY+RI + +Y LP  L
Sbjct: 187 PNYIAPEILSKTGHSFEVDVWSIGCIMYTLLVGKPPFETNSLKETYARIARCDYSLPPHL 246

Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFNS 227
            K A+++I KML  DP +RP V  ++  +FF   Y P  LPASCL  APRFDS+    + 
Sbjct: 247 NKNASSLINKMLQYDPKKRPCVNDIMKADFFTTGYMPKKLPASCLTMAPRFDSINYRESI 306

Query: 228 PRRKPLMERNSKRR---KAITEPE 248
             R+PL E NS +    K  T+P+
Sbjct: 307 SNRRPLNELNSPKAAIIKVATKPQ 330

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|312380567|gb|EFR26525.1| hypothetical protein AND_07357 [Anopheles darlingi]

 Score =  237 bits (604), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 130/249 (52%), Positives = 159/249 (63%), Gaps = 13/249 (5%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNS---ACDLE---EM 54
           M+QEI IHRSL H+N+VGFHSFF+D   +YI+LELC+KRSMMEL+       D E    M
Sbjct: 72  MTQEITIHRSLNHKNIVGFHSFFDDPLNIYIVLELCKKRSMMELHKRRKFITDYECRYYM 131

Query: 55  SDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCGTPN 110
                       K + + D    G    +D+  V   D      +      K TLCGTPN
Sbjct: 132 HQVMTGVKYLHDKHIIHRD-LKLGNLFLNDNLHVKIGDFGLATKIEFEGERKKTLCGTPN 190

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           YIAPEILNK GHS+EVD+WSIGC+MYTLLVGKPPFET +LK+TYSRI+K EY+LP TL+K
Sbjct: 191 YIAPEILNKKGHSYEVDIWSIGCVMYTLLVGKPPFETKSLKDTYSRIRKCEYRLPPTLRK 250

Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFNSPR 229
            AA MI  ML  DPV+RP + +L  FEF  + + P+SLP SCL  APR D + P+     
Sbjct: 251 SAADMICAMLQSDPVKRPLINKLFEFEFLAHGHIPSSLPISCLTMAPRADQLEPA-ERLN 309

Query: 230 RKPLMERNS 238
           RKPL E N 
Sbjct: 310 RKPLSEMNG 318

Source: Anopheles darlingi

Species: Anopheles darlingi

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|291221901|ref|XP_002730953.1| PREDICTED: polo-like kinase 1-like [Saccoglossus kowalevskii]

 Score =  236 bits (601), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 124/251 (49%), Positives = 161/251 (64%), Gaps = 18/251 (7%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           M+ EIAIHRSL H N+VGFH FFEDS FVY++LELCR+RS+MEL+      + +++P A+
Sbjct: 73  MTMEIAIHRSLIHPNIVGFHGFFEDSNFVYVLLELCRRRSLMELHKRR---KAVTEPEAR 129

Query: 61  --------PVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML----ANKNTLCGT 108
                     I++ K          G    +D   +   D      +      K TLCGT
Sbjct: 130 YFMRQILLATIYIHKEKVIHRDMKLGNLFLNDMMEIKIGDFGLATKIDYEGERKKTLCGT 189

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           PNYIAPE+LNK GHS+EVD+WSIGCI+YTLLVGKPPFET+ LK+TY RIKK EY +P+ +
Sbjct: 190 PNYIAPEVLNKKGHSYEVDMWSIGCILYTLLVGKPPFETTCLKDTYLRIKKNEYYIPSRI 249

Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN-DYCPTSLPASCLMTAPRFDSVVPSFNS 227
             PA ++I+KML  +P++RP + + L  EFF     PT LP SCL TAPRF    P  +S
Sbjct: 250 SAPAKSLIQKMLQSNPIERPSMQEALDDEFFKCGPLPTRLPTSCLTTAPRFSVAQPMASS 309

Query: 228 PRRKPLMERNS 238
             RKPL+E+N 
Sbjct: 310 --RKPLLEKNG 318

Source: Saccoglossus kowalevskii

Species: Saccoglossus kowalevskii

Genus: Saccoglossus

Family: Harrimaniidae

Class: Enteropneusta

Phylum: Hemichordata

Superkingdom: Eukaryota

>gi|209946076|gb|ACI97269.1| polo [Drosophila yakuba]

 Score =  233 bits (595), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 129/260 (49%), Positives = 162/260 (62%), Gaps = 32/260 (12%)

Query: 2   SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           +QEI IHRSL H N+V FHS+FED++ +YI+LELC+KRSMMEL+     + E        
Sbjct: 71  AQEITIHRSLNHPNIVKFHSYFEDAQNIYIVLELCKKRSMMELHKRRKSITE-------- 122

Query: 62  VIWVSKWVDYSDKYGFGYQLNDDS--------SGVMFNDLTRMIM----LAN-------- 101
             +  ++  Y    G  Y L+D+           +  NDL  + +    LA         
Sbjct: 123 --FECRYYIYQIIQGVKY-LHDNRIIHRDLKLGNLFLNDLLHVKIGDFGLATRIEYEGER 179

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           K TLCGTPNYIAPEIL K GHSFEVD+WSIGC+MYTLLVG+PPFET TLK+TYS+IKK E
Sbjct: 180 KKTLCGTPNYIAPEILTKKGHSFEVDIWSIGCVMYTLLVGQPPFETKTLKDTYSKIKKCE 239

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDS 220
           Y++P+ L+KPAA M+  ML  +P  RP + QLL+FEF      P  LP+SCL  APR  S
Sbjct: 240 YRVPSYLRKPAADMVIAMLQPNPESRPAIGQLLNFEFLKGSKVPMFLPSSCLTMAPRIGS 299

Query: 221 VVPSFNSPRRKPLMERNSKR 240
                +S  RKPLME N  R
Sbjct: 300 NDTIEDSMHRKPLMEMNGIR 319

Source: Drosophila yakuba

Species: Drosophila yakuba

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195495958|ref|XP_002095490.1| GE19659 [Drosophila yakuba] gi|194181591|gb|EDW95202.1| GE19659 [Drosophila yakuba]

 Score =  233 bits (594), Expect = 7e-59,   Method: Compositional matrix adjust.
 Identities = 129/260 (49%), Positives = 161/260 (61%), Gaps = 32/260 (12%)

Query: 2   SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           +QEI IHRSL H N+V FHS+FED++ +YI+LELC+KRSMMEL+     + E        
Sbjct: 146 AQEITIHRSLNHPNIVKFHSYFEDAQNIYIVLELCKKRSMMELHKRRKSITEFE------ 199

Query: 62  VIWVSKWVDYSDKYGFGYQLNDDS--------SGVMFNDLTRMIM----LAN-------- 101
                ++  Y    G  Y L+D+           +  NDL  + +    LA         
Sbjct: 200 ----CRYYIYQIIQGVKY-LHDNRIIHRDLKLGNLFLNDLLHVKIGDFGLATRIEYEGER 254

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           K TLCGTPNYIAPEIL K GHSFEVD+WSIGC+MYTLLVG+PPFET TLK+TYS+IKK E
Sbjct: 255 KKTLCGTPNYIAPEILTKKGHSFEVDIWSIGCVMYTLLVGQPPFETKTLKDTYSKIKKCE 314

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDS 220
           Y++P+ L+KPAA M+  ML  +P  RP + QLL+FEF      P  LP+SCL  APR  S
Sbjct: 315 YRVPSYLRKPAADMVIAMLQPNPESRPAIGQLLNFEFLKGSKVPMFLPSSCLTMAPRIGS 374

Query: 221 VVPSFNSPRRKPLMERNSKR 240
                +S  RKPLME N  R
Sbjct: 375 NDTIEDSMHRKPLMEMNGIR 394

Source: Drosophila yakuba

Species: Drosophila yakuba

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|209946078|gb|ACI97270.1| polo [Drosophila simulans] gi|209946082|gb|ACI97272.1| polo [Drosophila melanogaster] gi|209946084|gb|ACI97273.1| polo [Drosophila simulans] gi|209946086|gb|ACI97274.1| polo [Drosophila simulans] gi|209946088|gb|ACI97275.1| polo [Drosophila simulans] gi|209946090|gb|ACI97276.1| polo [Drosophila simulans] gi|209946092|gb|ACI97277.1| polo [Drosophila melanogaster] gi|209946094|gb|ACI97278.1| polo [Drosophila melanogaster] gi|209946096|gb|ACI97279.1| polo [Drosophila melanogaster] gi|209946098|gb|ACI97280.1| polo [Drosophila melanogaster] gi|209946100|gb|ACI97281.1| polo [Drosophila melanogaster] gi|209946102|gb|ACI97282.1| polo [Drosophila melanogaster] gi|209946104|gb|ACI97283.1| polo [Drosophila melanogaster] gi|209946106|gb|ACI97284.1| polo [Drosophila melanogaster] gi|209946108|gb|ACI97285.1| polo [Drosophila melanogaster] gi|209946110|gb|ACI97286.1| polo [Drosophila melanogaster] gi|209946112|gb|ACI97287.1| polo [Drosophila melanogaster] gi|209946114|gb|ACI97288.1| polo [Drosophila melanogaster] gi|209946116|gb|ACI97289.1| polo [Drosophila melanogaster] gi|209946118|gb|ACI97290.1| polo [Drosophila melanogaster] gi|209946120|gb|ACI97291.1| polo [Drosophila melanogaster] gi|209946122|gb|ACI97292.1| polo [Drosophila melanogaster] gi|209946124|gb|ACI97293.1| polo [Drosophila melanogaster] gi|209946126|gb|ACI97294.1| polo [Drosophila melanogaster] gi|209946128|gb|ACI97295.1| polo [Drosophila melanogaster] gi|209946130|gb|ACI97296.1| polo [Drosophila melanogaster] gi|209946132|gb|ACI97297.1| polo [Drosophila melanogaster] gi|209946136|gb|ACI97299.1| polo [Drosophila melanogaster] gi|209946138|gb|ACI97300.1| polo [Drosophila melanogaster] gi|209946140|gb|ACI97301.1| polo [Drosophila melanogaster] gi|209946142|gb|ACI97302.1| polo [Drosophila melanogaster] gi|209946144|gb|ACI97303.1| polo [Drosophila melanogaster] gi|209946146|gb|ACI97304.1| polo [Drosophila melanogaster] gi|209946148|gb|ACI97305.1| polo [Drosophila melanogaster]

 Score =  233 bits (594), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 129/260 (49%), Positives = 162/260 (62%), Gaps = 32/260 (12%)

Query: 2   SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           +QEI IHRSL H N+V FH++FEDS+ +YI+LELC+KRSMMEL+     + E        
Sbjct: 71  AQEITIHRSLNHPNIVKFHNYFEDSQNIYIVLELCKKRSMMELHKRRKSITE-------- 122

Query: 62  VIWVSKWVDYSDKYGFGYQLNDDS--------SGVMFNDLTRMIM----LAN-------- 101
             +  ++  Y    G  Y L+D+           +  NDL  + +    LA         
Sbjct: 123 --FECRYYIYQIIQGVKY-LHDNRIIHRDLKLGNLFLNDLLHVKIGDFGLATRIEYEGER 179

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           K TLCGTPNYIAPEIL K GHSFEVD+WSIGC+MYTLLVG+PPFET TLK+TYS+IKK E
Sbjct: 180 KKTLCGTPNYIAPEILTKKGHSFEVDIWSIGCVMYTLLVGQPPFETKTLKDTYSKIKKCE 239

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDS 220
           Y++P+ L+KPAA M+  ML  +P  RP + QLL+FEF      P  LP+SCL  APR  S
Sbjct: 240 YRVPSYLRKPAADMVIAMLQPNPESRPAIGQLLNFEFLKGSKVPMFLPSSCLTMAPRIGS 299

Query: 221 VVPSFNSPRRKPLMERNSKR 240
                +S  RKPLME N  R
Sbjct: 300 NDTIEDSMHRKPLMEMNGIR 319

Source: Drosophila simulans

Species: Drosophila simulans

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|24667346|ref|NP_524179.2| polo, isoform A [Drosophila melanogaster] gi|62472270|ref|NP_001014592.1| polo, isoform B [Drosophila melanogaster] gi|195348197|ref|XP_002040637.1| GM22270 [Drosophila sechellia] gi|14286167|sp|P52304.2|POLO_DROME RecName: Full=Serine/threonine-protein kinase polo gi|7293666|gb|AAF49036.1| polo, isoform A [Drosophila melanogaster] gi|20151993|gb|AAM11356.1| LD11851p [Drosophila melanogaster] gi|61678452|gb|AAX52738.1| polo, isoform B [Drosophila melanogaster] gi|194122147|gb|EDW44190.1| GM22270 [Drosophila sechellia] gi|220943094|gb|ACL84090.1| polo-PA [synthetic construct]

 Score =  232 bits (592), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 129/260 (49%), Positives = 161/260 (61%), Gaps = 32/260 (12%)

Query: 2   SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           +QEI IHRSL H N+V FH++FEDS+ +YI+LELC+KRSMMEL+     + E        
Sbjct: 71  AQEITIHRSLNHPNIVKFHNYFEDSQNIYIVLELCKKRSMMELHKRRKSITEFE------ 124

Query: 62  VIWVSKWVDYSDKYGFGYQLNDDS--------SGVMFNDLTRMIM----LAN-------- 101
                ++  Y    G  Y L+D+           +  NDL  + +    LA         
Sbjct: 125 ----CRYYIYQIIQGVKY-LHDNRIIHRDLKLGNLFLNDLLHVKIGDFGLATRIEYEGER 179

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           K TLCGTPNYIAPEIL K GHSFEVD+WSIGC+MYTLLVG+PPFET TLK+TYS+IKK E
Sbjct: 180 KKTLCGTPNYIAPEILTKKGHSFEVDIWSIGCVMYTLLVGQPPFETKTLKDTYSKIKKCE 239

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDS 220
           Y++P+ L+KPAA M+  ML  +P  RP + QLL+FEF      P  LP+SCL  APR  S
Sbjct: 240 YRVPSYLRKPAADMVIAMLQPNPESRPAIGQLLNFEFLKGSKVPMFLPSSCLTMAPRIGS 299

Query: 221 VVPSFNSPRRKPLMERNSKR 240
                +S  RKPLME N  R
Sbjct: 300 NDTIEDSMHRKPLMEMNGIR 319

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	305
UNIPROTKB|E2RNE0	551	PLK1 "Uncharacterized protein"	0.786	0.435	0.5	7.5e-57
UNIPROTKB|J9P0Q4	606	PLK1 "Uncharacterized protein"	0.786	0.396	0.5	7.5e-57
FB|FBgn0003124	576	polo "polo" [Drosophila melano	0.836	0.442	0.481	1.2e-56
RGD|3352	603	Plk1 "polo-like kinase 1" [Rat	0.757	0.383	0.517	2e-56
MGI|MGI:97621	603	Plk1 "polo-like kinase 1" [Mus	0.757	0.383	0.517	2.5e-56
UNIPROTKB|P53350	603	PLK1 "Serine/threonine-protein	0.786	0.398	0.5	3.3e-56
UNIPROTKB|P70032	598	plk1 "Serine/threonine-protein	0.793	0.404	0.496	5.3e-56
UNIPROTKB|Q2TA25	602	PLK1 "Serine/threonine-protein	0.786	0.398	0.496	1.4e-55
UNIPROTKB|P62205	598	plk1 "Serine/threonine-protein	0.796	0.406	0.490	1.8e-55
ZFIN|ZDB-GENE-021115-7	595	plk1 "polo-like kinase 1 (Dros	0.767	0.393	0.517	9.9e-55

UNIPROTKB|E2RNE0 PLK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 585 (211.0 bits), Expect = 7.5e-57, P = 7.5e-57
 Identities = 131/262 (50%), Positives = 170/262 (64%)

Query:     1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
             MS EI+IHRSL H+++VGFH FFEDS FV+++LELCR+RS++EL+      + +++P A+
Sbjct:    98 MSMEISIHRSLAHQHIVGFHGFFEDSDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 154

Query:    61 ----PVIWVSKW-----VDYSD-KYGFGYQLNDDSSGVMFND--LTRMIML--ANKNTLC 106
                  ++   ++     V + D K G  + LN+D   V   D  L   +      K TLC
Sbjct:   155 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF-LNEDLE-VKIGDFGLATKVEYDGERKKTLC 212

Query:   107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
             GTPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK +Y +P 
Sbjct:   213 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNDYSIPK 272

Query:   167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCPTSLPASCLMTAPRFDSVVPSF 225
              +   AA++I+KML  DP  RP + +LL+ EFF   Y P  LP +CL  APRF S+ PS 
Sbjct:   273 HINPVAASLIQKMLQTDPAARPTIHELLNDEFFTSGYIPARLPITCLTIAPRF-SIAPSS 331

Query:   226 NSP-RRKPLMERNSKRRKAITE 246
               P  RKPL   N      ++E
Sbjct:   332 LDPSNRKPLTVLNKGTENPMSE 353

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|J9P0Q4 PLK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 585 (211.0 bits), Expect = 7.5e-57, P = 7.5e-57
 Identities = 131/262 (50%), Positives = 170/262 (64%)

Query:     1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
             MS EI+IHRSL H+++VGFH FFEDS FV+++LELCR+RS++EL+      + +++P A+
Sbjct:   101 MSMEISIHRSLAHQHIVGFHGFFEDSDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 157

Query:    61 ----PVIWVSKW-----VDYSD-KYGFGYQLNDDSSGVMFND--LTRMIML--ANKNTLC 106
                  ++   ++     V + D K G  + LN+D   V   D  L   +      K TLC
Sbjct:   158 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF-LNEDLE-VKIGDFGLATKVEYDGERKKTLC 215

Query:   107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
             GTPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK +Y +P 
Sbjct:   216 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNDYSIPK 275

Query:   167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCPTSLPASCLMTAPRFDSVVPSF 225
              +   AA++I+KML  DP  RP + +LL+ EFF   Y P  LP +CL  APRF S+ PS 
Sbjct:   276 HINPVAASLIQKMLQTDPAARPTIHELLNDEFFTSGYIPARLPITCLTIAPRF-SIAPSS 334

Query:   226 NSP-RRKPLMERNSKRRKAITE 246
               P  RKPL   N      ++E
Sbjct:   335 LDPSNRKPLTVLNKGTENPMSE 356

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

FB|FBgn0003124 polo "polo" [Drosophila melanogaster (taxid:7227)]

 Score = 583 (210.3 bits), Expect = 1.2e-56, P = 1.2e-56
 Identities = 132/274 (48%), Positives = 170/274 (62%)

Query:     2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
             +QEI IHRSL H N+V FH++FEDS+ +YI+LELC+KRSMMEL+     + E        
Sbjct:    71 AQEITIHRSLNHPNIVKFHNYFEDSQNIYIVLELCKKRSMMELHKRRKSITEFE--CRYY 128

Query:    62 VIWVSKWVDYSDKYGFGYQLNDDSSGVMF-NDLTRMIM----LAN--------KNTLCGT 108
             +  + + V Y       ++  D   G +F NDL  + +    LA         K TLCGT
Sbjct:   129 IYQIIQGVKYLHDNRIIHR--DLKLGNLFLNDLLHVKIGDFGLATRIEYEGERKKTLCGT 186

Query:   109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
             PNYIAPEIL K GHSFEVD+WSIGC+MYTLLVG+PPFET TLK+TYS+IKK EY++P+ L
Sbjct:   187 PNYIAPEILTKKGHSFEVDIWSIGCVMYTLLVGQPPFETKTLKDTYSKIKKCEYRVPSYL 246

Query:   169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN-DYCPTSLPASCLMTAPRFDSVVPSFNS 227
             +KPAA M+  ML  +P  RP + QLL+FEF      P  LP+SCL  APR  S     +S
Sbjct:   247 RKPAADMVIAMLQPNPESRPAIGQLLNFEFLKGSKVPMFLPSSCLTMAPRIGSNDTIEDS 306

Query:   228 PRRKPLMERNSKRRKAITEPETRFYMKQILEGVS 261
               RKPLME N  R    T  E+ F    + + ++
Sbjct:   307 MHRKPLMEMNGIRPDD-TRLESTFLKANLHDAIT 339

GO:0007140 "male meiosis" evidence=IMP

GO:0007067 "mitosis" evidence=NAS;IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;NAS;IDA

GO:0004672 "protein kinase activity" evidence=NAS;IDA

GO:0000910 "cytokinesis" evidence=TAS

GO:0007060 "male meiosis chromosome segregation" evidence=TAS

GO:0005813 "centrosome" evidence=IDA

GO:0005819 "spindle" evidence=IDA

GO:0035046 "pronuclear migration" evidence=IMP

GO:0007344 "pronuclear fusion" evidence=IMP

GO:0007058 "spindle assembly involved in female meiosis II" evidence=IMP

GO:0007147 "female meiosis II" evidence=IMP

GO:0035044 "sperm aster formation" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IDA;NAS

GO:0008104 "protein localization" evidence=NAS

GO:0030954 "astral microtubule nucleation" evidence=IMP

GO:0000940 "condensed chromosome outer kinetochore" evidence=IDA;NAS

GO:0005737 "cytoplasm" evidence=IDA;NAS

GO:0007049 "cell cycle" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0000776 "kinetochore" evidence=IDA

GO:0000922 "spindle pole" evidence=IDA

GO:0030496 "midbody" evidence=IDA

GO:0006911 "phagocytosis, engulfment" evidence=IMP

GO:0007143 "female meiosis" evidence=IMP

GO:0007052 "mitotic spindle organization" evidence=IMP

GO:0007406 "negative regulation of neuroblast proliferation" evidence=IMP

GO:0051297 "centrosome organization" evidence=IMP

GO:0005814 "centriole" evidence=IDA

GO:0000278 "mitotic cell cycle" evidence=IGI;IMP

GO:0005635 "nuclear envelope" evidence=IDA

GO:0005874 "microtubule" evidence=IDA

GO:0022008 "neurogenesis" evidence=IMP

GO:0035050 "embryonic heart tube development" evidence=IMP

GO:0048600 "oocyte fate commitment" evidence=IMP

RGD|3352 Plk1 "polo-like kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 581 (209.6 bits), Expect = 2.0e-56, P = 2.0e-56
 Identities = 131/253 (51%), Positives = 167/253 (66%)

Query:     1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
             MS EI+IHRSL H++VVGFH FFEDS FV+++LELCR+RS++EL+      + +++P A+
Sbjct:    98 MSMEISIHRSLAHQHVVGFHGFFEDSDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 154

Query:    61 ----PVIWVSKW-----VDYSD-KYGFGYQLNDDSSGVMFNDL---TRMIMLAN-KNTLC 106
                  ++   ++     V + D K G  + LN+D   V   D    T++      K TLC
Sbjct:   155 YYLRQIVLGCQYLHRNQVIHRDLKLGNLF-LNEDLE-VKIGDFGLATKVEYEGERKKTLC 212

Query:   107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
             GTPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P 
Sbjct:   213 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 272

Query:   167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCPTSLPASCLMTAPRFDSVVPSF 225
              +   AA++I+KML  DP  RP + +LL+ EFF   Y P  LP +CL   PRF S+ PS 
Sbjct:   273 HINPVAASLIQKMLQTDPTARPTIHELLNDEFFTSGYIPARLPITCLTIPPRF-SIAPSS 331

Query:   226 NSP-RRKPLMERN 237
               P  RKPL   N
Sbjct:   332 LDPSNRKPLTVLN 344

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISO;ISS

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=ISO;ISS

GO:0000236 "mitotic prometaphase" evidence=IMP

GO:0000776 "kinetochore" evidence=ISO;ISS

GO:0000777 "condensed chromosome kinetochore" evidence=IEA

GO:0000910 "cytokinesis" evidence=ISO;ISS

GO:0000922 "spindle pole" evidence=ISO;IDA

GO:0000942 "condensed nuclear chromosome outer kinetochore" evidence=ISO

GO:0001578 "microtubule bundle formation" evidence=ISO;ISS

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;ISS;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005813 "centrosome" evidence=ISO;ISS

GO:0005819 "spindle" evidence=ISO;ISS

GO:0005876 "spindle microtubule" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO;IGI;ISS

GO:0007067 "mitosis" evidence=ISO;ISS

GO:0007092 "activation of mitotic anaphase-promoting complex activity" evidence=ISO;ISS

GO:0007346 "regulation of mitotic cell cycle" evidence=ISO

GO:0008017 "microtubule binding" evidence=ISO;ISS

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=ISO

GO:0010997 "anaphase-promoting complex binding" evidence=ISO

GO:0016567 "protein ubiquitination" evidence=ISO

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030496 "midbody" evidence=ISO;ISS

GO:0031572 "G2 DNA damage checkpoint" evidence=ISO;ISS

GO:0031648 "protein destabilization" evidence=ISO

GO:0032436 "positive regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=ISO;ISS

GO:0040038 "polar body extrusion after meiotic divisions" evidence=IMP

GO:0043066 "negative regulation of apoptotic process" evidence=ISO;ISS

GO:0043393 "regulation of protein binding" evidence=ISO

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=ISO

GO:0045862 "positive regulation of proteolysis" evidence=ISO

GO:0046677 "response to antibiotic" evidence=IEP

GO:0051233 "spindle midzone" evidence=ISO;IDA

GO:0051297 "centrosome organization" evidence=ISO;ISS

GO:0051443 "positive regulation of ubiquitin-protein ligase activity" evidence=ISO;ISS

GO:0071168 "protein localization to chromatin" evidence=ISO;ISS

GO:0090007 "regulation of mitotic anaphase" evidence=ISO

MGI|MGI:97621 Plk1 "polo-like kinase 1" [Mus musculus (taxid:10090)]

 Score = 580 (209.2 bits), Expect = 2.5e-56, P = 2.5e-56
 Identities = 131/253 (51%), Positives = 167/253 (66%)

Query:     1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
             MS EI+IHRSL H++VVGFH FFEDS FV+++LELCR+RS++EL+      + +++P A+
Sbjct:    98 MSMEISIHRSLAHQHVVGFHDFFEDSDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 154

Query:    61 ----PVIWVSKW-----VDYSD-KYGFGYQLNDDSSGVMFNDL---TRMIMLAN-KNTLC 106
                  ++   ++     V + D K G  + LN+D   V   D    T++      K TLC
Sbjct:   155 YYLRQIVLGCQYLHRNQVIHRDLKLGNLF-LNEDLE-VKIGDFGLATKVEYEGERKKTLC 212

Query:   107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
             GTPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P 
Sbjct:   213 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 272

Query:   167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCPTSLPASCLMTAPRFDSVVPSF 225
              +   AA++I+KML  DP  RP + +LL+ EFF   Y P  LP +CL   PRF S+ PS 
Sbjct:   273 HINPVAASLIQKMLQTDPTARPTIHELLNDEFFTSGYIPARLPITCLTIPPRF-SIAPSS 331

Query:   226 NSPR-RKPLMERN 237
               P  RKPL   N
Sbjct:   332 LDPSSRKPLKVLN 344

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISO

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000236 "mitotic prometaphase" evidence=ISO

GO:0000775 "chromosome, centromeric region" evidence=IEA

GO:0000776 "kinetochore" evidence=ISO

GO:0000910 "cytokinesis" evidence=ISO

GO:0000922 "spindle pole" evidence=ISO

GO:0000942 "condensed nuclear chromosome outer kinetochore" evidence=ISO

GO:0001578 "microtubule bundle formation" evidence=ISO

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005694 "chromosome" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005813 "centrosome" evidence=ISO

GO:0005819 "spindle" evidence=ISO

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005876 "spindle microtubule" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0007049 "cell cycle" evidence=IEA

GO:0007067 "mitosis" evidence=ISO

GO:0007092 "activation of mitotic anaphase-promoting complex activity" evidence=ISO

GO:0007346 "regulation of mitotic cell cycle" evidence=ISO

GO:0008017 "microtubule binding" evidence=ISO

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=ISO

GO:0010997 "anaphase-promoting complex binding" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016567 "protein ubiquitination" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030496 "midbody" evidence=ISO

GO:0031572 "G2 DNA damage checkpoint" evidence=ISO

GO:0031648 "protein destabilization" evidence=ISO

GO:0032436 "positive regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=ISO

GO:0040038 "polar body extrusion after meiotic divisions" evidence=ISO

GO:0043066 "negative regulation of apoptotic process" evidence=ISO

GO:0043393 "regulation of protein binding" evidence=ISO

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=ISO

GO:0045862 "positive regulation of proteolysis" evidence=ISO

GO:0051233 "spindle midzone" evidence=ISO

GO:0051297 "centrosome organization" evidence=ISO

GO:0051301 "cell division" evidence=IEA

GO:0051443 "positive regulation of ubiquitin-protein ligase activity" evidence=ISO

GO:0071168 "protein localization to chromatin" evidence=ISO

GO:0090007 "regulation of mitotic anaphase" evidence=ISO

UNIPROTKB|P53350 PLK1 "Serine/threonine-protein kinase PLK1" [Homo sapiens (taxid:9606)]

 Score = 579 (208.9 bits), Expect = 3.3e-56, P = 3.3e-56
 Identities = 131/262 (50%), Positives = 168/262 (64%)

Query:     1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
             MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct:    98 MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 154

Query:    61 ----PVIWVSKW-----VDYSD-KYGFGYQLNDDSSGVMFND--LTRMIML--ANKNTLC 106
                  ++   ++     V + D K G  + LN+D   V   D  L   +      K TLC
Sbjct:   155 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF-LNEDLE-VKIGDFGLATKVEYDGERKKTLC 212

Query:   107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
             GTPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P 
Sbjct:   213 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 272

Query:   167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCPTSLPASCLMTAPRFDSVVPSF 225
              +   AA++I+KML  DP  RP + +LL+ EFF   Y P  LP +CL   PRF S+ PS 
Sbjct:   273 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRF-SIAPSS 331

Query:   226 NSP-RRKPLMERNSKRRKAITE 246
               P  RKPL   N      + E
Sbjct:   332 LDPSNRKPLTVLNKGLENPLPE 353

GO:0005524 "ATP binding" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0071168 "protein localization to chromatin" evidence=IDA

GO:0032436 "positive regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA;IMP

GO:0051443 "positive regulation of ubiquitin-protein ligase activity" evidence=IMP

GO:0000776 "kinetochore" evidence=IDA

GO:0005813 "centrosome" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0007067 "mitosis" evidence=IMP;IDA

GO:0007346 "regulation of mitotic cell cycle" evidence=IMP

GO:0031648 "protein destabilization" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IDA

GO:0045862 "positive regulation of proteolysis" evidence=IDA

GO:0031572 "G2 DNA damage checkpoint" evidence=IDA

GO:0010997 "anaphase-promoting complex binding" evidence=IPI

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0043066 "negative regulation of apoptotic process" evidence=IMP

GO:0007092 "activation of mitotic anaphase-promoting complex activity" evidence=IDA

GO:0051297 "centrosome organization" evidence=IMP

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IDA;TAS

GO:0000910 "cytokinesis" evidence=IMP;IDA;TAS

GO:0005819 "spindle" evidence=IDA

GO:0001578 "microtubule bundle formation" evidence=IDA

GO:0008017 "microtubule binding" evidence=IDA

GO:0051233 "spindle midzone" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0030496 "midbody" evidence=IDA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0008283 "cell proliferation" evidence=TAS

GO:0000087 "M phase of mitotic cell cycle" evidence=TAS

GO:0000088 "mitotic prophase" evidence=TAS

GO:0000236 "mitotic prometaphase" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007091 "metaphase/anaphase transition of mitotic cell cycle" evidence=TAS

GO:0031145 "anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process" evidence=TAS

GO:0051437 "positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle" evidence=TAS

GO:0051439 "regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle" evidence=TAS

GO:0051726 "regulation of cell cycle" evidence=TAS

GO:0043393 "regulation of protein binding" evidence=IMP

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=IMP

GO:0090007 "regulation of mitotic anaphase" evidence=IMP

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=IMP

GO:0005876 "spindle microtubule" evidence=IDA

GO:0000922 "spindle pole" evidence=IDA

GO:0000942 "condensed nuclear chromosome outer kinetochore" evidence=IDA

UNIPROTKB|P70032 plk1 "Serine/threonine-protein kinase PLK1" [Xenopus laevis (taxid:8355)]

 Score = 577 (208.2 bits), Expect = 5.3e-56, P = 5.3e-56
 Identities = 131/264 (49%), Positives = 167/264 (63%)

Query:     1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
             M+ EIAI RSL HR+VVGFH FFED+ FVY++LELCR+RS++EL+      + +++P A+
Sbjct:    89 MTMEIAIQRSLDHRHVVGFHGFFEDNDFVYVVLELCRRRSLLELHKRR---KAVTEPEAR 145

Query:    61 PVI--------WV-SKWVDYSD-KYGFGYQLNDDSSGVMFND--LTRMIML--ANKNTLC 106
               +        ++ S  V + D K G  + LND+   V   D  L   +      K TLC
Sbjct:   146 YYLKQTISGCQYLHSNRVIHRDLKLGNLF-LNDEME-VKIGDFGLATKVEYDGERKKTLC 203

Query:   107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
             GTPNYIAPE+L K GHSFEVD+WSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P 
Sbjct:   204 GTPNYIAPEVLGKKGHSFEVDIWSIGCIMYTLLVGKPPFETSCLKETYMRIKKNEYSIPK 263

Query:   167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCPTSLPASCLMTAPRFDSVVPS- 224
              +   AA +I+KML  DP  RP +  LL+ EFF   Y P+ LP +CL   PRF S+ PS 
Sbjct:   264 HINPVAAALIQKMLRSDPTSRPTIDDLLNDEFFTSGYIPSRLPTTCLTVPPRF-SIAPST 322

Query:   225 FNSPRRKPLMERNSKRRKAITEPE 248
              +   RKPL   N  +   + E +
Sbjct:   323 IDQSLRKPLTAINKGQDSPLVEKQ 346

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISS;TAS

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=ISS

GO:0000776 "kinetochore" evidence=ISS

GO:0000910 "cytokinesis" evidence=ISS

GO:0001556 "oocyte maturation" evidence=IDA

GO:0001578 "microtubule bundle formation" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISS

GO:0005813 "centrosome" evidence=ISS

GO:0005819 "spindle" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007067 "mitosis" evidence=ISS

GO:0007092 "activation of mitotic anaphase-promoting complex activity" evidence=ISS

GO:0008017 "microtubule binding" evidence=ISS

GO:0019901 "protein kinase binding" evidence=IPI

GO:0030496 "midbody" evidence=ISS

GO:0031572 "G2 DNA damage checkpoint" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0051233 "spindle midzone" evidence=ISS

GO:0051297 "centrosome organization" evidence=ISS

GO:0071168 "protein localization to chromatin" evidence=ISS

UNIPROTKB|Q2TA25 PLK1 "Serine/threonine-protein kinase PLK1" [Bos taurus (taxid:9913)]

 Score = 573 (206.8 bits), Expect = 1.4e-55, P = 1.4e-55
 Identities = 130/262 (49%), Positives = 167/262 (63%)

Query:     1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
             MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct:    96 MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 152

Query:    61 ----PVIWVSKW-----VDYSD-KYGFGYQLNDDSSGVMFND--LTRMIML--ANKNTLC 106
                  ++   ++     V + D K G  + LN+D   V   D  L   +      K TLC
Sbjct:   153 YYLRQIVLGCQYLHGNRVIHRDLKLGNLF-LNEDLE-VKIGDFGLATKVEYDGERKKTLC 210

Query:   107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
             GTPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIK  EY +P 
Sbjct:   211 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKNNEYSIPK 270

Query:   167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCPTSLPASCLMTAPRFDSVVPSF 225
              +   A+++IKKML  DP  RP + +LL+ EFF   Y P  LP +CL   PRF S+ PS 
Sbjct:   271 HINPVASSLIKKMLQPDPTARPTIHELLNDEFFTSGYIPARLPITCLTIPPRF-SIAPSS 329

Query:   226 NSP-RRKPLMERNSKRRKAITE 246
               P  RKPL   N      + E
Sbjct:   330 LDPSNRKPLTVLNKGMENPMPE 351

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0051233 "spindle midzone" evidence=ISS

GO:0005819 "spindle" evidence=ISS

GO:0008017 "microtubule binding" evidence=ISS

GO:0051297 "centrosome organization" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0007092 "activation of mitotic anaphase-promoting complex activity" evidence=ISS

GO:0001578 "microtubule bundle formation" evidence=ISS

GO:0000910 "cytokinesis" evidence=ISS

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=ISS

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISS

GO:0030496 "midbody" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0071168 "protein localization to chromatin" evidence=ISS

GO:0007067 "mitosis" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0005813 "centrosome" evidence=ISS

GO:0051443 "positive regulation of ubiquitin-protein ligase activity" evidence=ISS

GO:0032436 "positive regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=ISS

GO:0031572 "G2 DNA damage checkpoint" evidence=ISS

GO:0000776 "kinetochore" evidence=ISS

GO:0090007 "regulation of mitotic anaphase" evidence=IEA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0043393 "regulation of protein binding" evidence=IEA

GO:0031648 "protein destabilization" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0016567 "protein ubiquitination" evidence=IEA

GO:0010997 "anaphase-promoting complex binding" evidence=IEA

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=IEA

GO:0005876 "spindle microtubule" evidence=IEA

GO:0000942 "condensed nuclear chromosome outer kinetochore" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P62205 plk1 "Serine/threonine-protein kinase PLK1" [Xenopus (Silurana) tropicalis (taxid:8364)]

 Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
 Identities = 130/265 (49%), Positives = 166/265 (62%)

Query:     1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
             M+ EIAI RSL HR+VVGFH FFED+ FVY++LELCR+RS++EL+      + +++P A 
Sbjct:    89 MTMEIAIQRSLDHRHVVGFHGFFEDNDFVYVVLELCRRRSLLELHKRR---KAVTEPEAR 145

Query:    60 ----QPVIWV----SKWVDYSD-KYGFGYQLNDDSSGVMFND--LTRMIML--ANKNTLC 106
                 Q ++      S  V + D K G  + LND+   V   D  L   +      K TLC
Sbjct:   146 YYLKQTILGCQYLHSNRVIHRDLKLGNLF-LNDEME-VKIGDFGLATKVEYDGERKKTLC 203

Query:   107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
             GTPNYIAPE+L K GHSFEVD+WSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P 
Sbjct:   204 GTPNYIAPEVLGKKGHSFEVDIWSIGCIMYTLLVGKPPFETSCLKETYMRIKKNEYSVPK 263

Query:   167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCPTSLPASCLMTAPRFDSVVPS- 224
              +   A  +I+KML  +P  RP +  LL+ EFF   Y P+ LP +CL   PRF S+ PS 
Sbjct:   264 HINPMATALIQKMLRSEPTSRPTIDDLLNDEFFTTGYIPSRLPTTCLTVPPRF-SIAPST 322

Query:   225 FNSPRRKPLMERNSKRRKAITEPET 249
              +   RKPL   N  +   + E ++
Sbjct:   323 IDQSLRKPLTAINKGQDSPLVEKQS 347

GO:0000776 "kinetochore" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0005813 "centrosome" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007067 "mitosis" evidence=ISS

GO:0030496 "midbody" evidence=ISS

GO:0031572 "G2 DNA damage checkpoint" evidence=ISS

GO:0071168 "protein localization to chromatin" evidence=ISS

ZFIN|ZDB-GENE-021115-7 plk1 "polo-like kinase 1 (Drosophila)" [Danio rerio (taxid:7955)]

 Score = 565 (203.9 bits), Expect = 9.9e-55, P = 9.9e-55
 Identities = 130/251 (51%), Positives = 158/251 (62%)

Query:     1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-----MS 55
             MS EIAIH+SL + +VVGFH FFED  FVY++LE+CR+RS++EL+     + E       
Sbjct:    84 MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFM 143

Query:    56 DPAAQPVIWV-SKWVDYSD-KYGFGYQLNDDSSGVMFND--LTRMIML--ANKNTLCGTP 109
                 Q V ++ +  V + D K G  + LNDD   V   D  L   I      K TLCGTP
Sbjct:   144 RQTIQGVQYLHNNRVIHRDLKLGNLF-LNDDMD-VKIGDFGLATKIEFDGERKKTLCGTP 201

Query:   110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
             NYIAPE+L K GHSFEVD+WS+GCI+YTLLVGKPPFETS LKETY RIKK EY +P  + 
Sbjct:   202 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHIN 261

Query:   170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCPTSLPASCLMTAPRFDSVVPSFNSP 228
               A+ +I++ML  DP  RP VA+LL  EFF   Y P  LP SCL   PRF S+ PS   P
Sbjct:   262 PVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPPRF-SIAPSSLDP 320

Query:   229 R--RKPLMERN 237
                RKPL   N
Sbjct:   321 ALLRKPLSSLN 331

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000278 "mitotic cell cycle" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q07832	PLK1_MOUSE	2, ., 7, ., 1, 1, ., 2, 1	0.5101	0.7508	0.3797	yes	N/A
Q62673	PLK1_RAT	2, ., 7, ., 1, 1, ., 2, 1	0.5059	0.7639	0.3864	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	305
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-26
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-23
cd13118	91	cd13118, POLO_box_1, First polo-box domain (PBD) o	6e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-22
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-22
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-19
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-18
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-17
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-16
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-16
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-16
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-15
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-15
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-14
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-14
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-14
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-14
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-14
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-13
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-13
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-13
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-13
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-12
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-12
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-12
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	9e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-11
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-10
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-10
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-09
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-09
pfam00659	64	pfam00659, POLO_box, POLO box duplicated region	1e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-09
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-09
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-08
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-08
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-07
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-07
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-07
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-07
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-06
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-06
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-06
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-06
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-06
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-05
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-05
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-05
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-05
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-05
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-05
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-05
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-05
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-05
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-05
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-05
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-05
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-05
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-05
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-04
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-04
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-04
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-04
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-04
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-04
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-04
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-04
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-04
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	6e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-04
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.001
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	0.001
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.001
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	0.001
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.001
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	0.001
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.001
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	0.002
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.002
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	0.002
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	0.002
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.002
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	0.002
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.002
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	0.002
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.002
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	0.003
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.003
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	0.003
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.003
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	0.003
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.003
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	0.003
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.003
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.003
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	0.003
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.004
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	0.004
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  134 bits (341), Expect = 5e-38
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 40/223 (17%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EI I + LKH N+V  +  FED   +Y+++E C    + +L      L E     A+  
Sbjct: 46  REIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFY 102

Query: 63  IW-VSKWVDYSDKYGFGYQLNDDSSGVMFNDL---------TRMIMLA------------ 100
           +  +   ++Y         L+  S G++  DL            + LA            
Sbjct: 103 LRQILSALEY---------LH--SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE 151

Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS-TLKETYSRIKK 159
              T  GTP Y+APE+L   G+   VD+WS+G I+Y LL GKPPF     L E + +I K
Sbjct: 152 KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 211

Query: 160 VEYKLP---ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
            +   P     +   A  +I+K+L+ DP +R    + L   FF
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  115 bits (291), Expect = 1e-30
 Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 23/216 (10%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI I R L H N+V     FED   +Y+++E C    + +  +    L E     A+ + 
Sbjct: 48  EIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSED---EAKKIA 104

Query: 64  W-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIML--ANKNTLCGTPNY 111
             + + ++Y    G  ++       L D++  V   D  L + ++   ++  T  GTP Y
Sbjct: 105 LQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWY 164

Query: 112 IAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV-------EYK 163
           +APE+L   NG+  +VDVWS+G I+Y LL GKPPF    + +    I+++       +  
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEP 224

Query: 164 LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
             ++  + A  +IKK L  DP +RP   ++L   +F
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-26
 Identities = 39/100 (39%), Positives = 53/100 (53%), Gaps = 3/100 (3%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           NT CGTP Y+APE+L   G+   VD WS+G ++Y +L GKPPF     KE Y +I K   
Sbjct: 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL 210

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR---PPVAQLLHFEFF 199
           + P  L   A  +I  +L  DP +R       ++    FF
Sbjct: 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  103 bits (260), Expect = 3e-26
 Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 52/230 (22%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E+ I + L H N++ ++  FE+   + I++E      + +         +   P  +  
Sbjct: 48  NEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK---KEGKPFPEEQ 104

Query: 63  IWVSKW-------VDY--SDK-----------------------YGFGYQLNDDSSGVMF 90
           I    W       + Y  S K                       +G    L+        
Sbjct: 105 IL--DWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---- 158

Query: 91  NDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL 150
                   LA   T+ GTP Y++PE+     ++++ D+WS+GC++Y L   K PFE   L
Sbjct: 159 --------LAK--TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208

Query: 151 KETYSRIKKVEYK-LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
            E   +I K +Y  +P+        ++  +L  DP +RP +AQ+L   F 
Sbjct: 209 LELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 98.4 bits (246), Expect = 3e-24
 Identities = 28/66 (42%), Positives = 43/66 (65%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K+R  ++E E RFY++QIL  + YLH   I+HRDLK  N+ L ++  VK+ DFGLA +++
Sbjct: 89  KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLD 148

Query: 299 FDGQRK 304
              +  
Sbjct: 149 PGEKLT 154

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.5 bits (241), Expect = 2e-23
 Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 37/229 (16%)

Query: 6   AIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMEL--YNSACDLEEMSDPAAQPV- 62
            + R   H  ++  +  F+D + +Y +LE      +++      + D +     AA+ + 
Sbjct: 54  VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113

Query: 63  -------------------IWVSKWVDYSDK---YGFGYQLNDDSSGVMFN------DLT 94
                              I + K  D   K   +G    L+ +SS           D  
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDK--DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 95  RMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETY 154
                    +  GT  Y++PE+LN+       D+W++GCI+Y +L GKPPF  S    T+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231

Query: 155 SRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP----PVAQLLHFEFF 199
            +I K+EY  P      A  +I+K+L+LDP  R        +L    FF
Sbjct: 232 QKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|240561 cd13118, POLO_box_1, First polo-box domain (PBD) of polo-like kinases Plk1, Plk2, Plk3, and Plk5

 Score = 90.1 bits (224), Expect = 6e-23
 Identities = 26/46 (56%), Positives = 35/46 (76%)

Query: 61  PVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC 106
           P +WVSKWVDYS+KYG GYQL+D S GV+FND T+M++  +   + 
Sbjct: 1   PPVWVSKWVDYSNKYGLGYQLSDGSVGVLFNDSTKMVLSPDGKHVQ 46

The polo-like Ser/Thr kinases (Plk1, Plk2/Snk, Plk3/Prk/Fnk, Plk4/Sak, and the inactive kinase Plk5) play various roles in cytokinesis and mitosis. At their C-terminus, they contain a tandemly repeated polo-box domain (in the case of Plk4, a tandem repeat of cryptic PBDs is found in the middle of the protein followed by a C-terminal single repeat), which appears to be involved in autoinhibition and in mediating the subcellular localization. The latter may be controlled via interactions between the polo-box domain and phospho-peptide motifs. The phosphopeptide binding site is formed at the interface between the two tandemly repeated PBDs. The PBDs of Plk4/Sak appear unique in participating in homodimer interactions, though it is not clear whether and how they interact with phosphopeptides. Length = 91

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 93.8 bits (234), Expect = 2e-22
 Identities = 62/200 (31%), Positives = 91/200 (45%), Gaps = 18/200 (9%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E  I     H  +V  +  F+D K++Y+++E C      EL+    D     +  A+  
Sbjct: 42  SEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG---GELWTILRDRGLFDEYTARFY 98

Query: 63  I-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKN---TLCGTPNY 111
           I  V    +Y    G  Y+       L D +  V   D      L +     T CGTP Y
Sbjct: 99  IACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK--ETYSRIKKVEYKL--PAT 167
           +APEI+   G+ F VD WS+G ++Y LL G+PPF        E Y+ I K   KL  P  
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY 218

Query: 168 LKKPAATMIKKMLLLDPVQR 187
           + K A  +IK++L  +P +R
Sbjct: 219 IDKAAKDLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 93.0 bits (232), Expect = 3e-22
 Identities = 27/60 (45%), Positives = 40/60 (66%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K+   + EP  R Y +QILEG++YLH + I+HRD+K  N+ +  + VVK+ DFG A R+ 
Sbjct: 93  KKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 91.9 bits (229), Expect = 9e-22
 Identities = 39/120 (32%), Positives = 61/120 (50%), Gaps = 5/120 (4%)

Query: 87  GVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE 146
           G++   +           + GTP+YIAPE++   GHS  VD WS+GCI+Y  LVG PPF 
Sbjct: 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202

Query: 147 TSTLKETYSRIKKVEYKLP--ATLKKPAATMIKKMLLLDPVQRP---PVAQLLHFEFFND 201
             T +E +  I   + + P    +   A  +I K+L+ DP +R     + ++ +  FF  
Sbjct: 203 GETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 90.4 bits (225), Expect = 3e-21
 Identities = 29/64 (45%), Positives = 38/64 (59%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R   ++E E +    QIL G+ YLH + IIHRDLK  N+ L +N VVKI DFGLA ++  
Sbjct: 91  RGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK 150

Query: 300 DGQR 303
               
Sbjct: 151 SSSS 154

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 28/216 (12%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            EI I +  KH N+V ++  +     ++I++E C   S+ +L  S    + +++     V
Sbjct: 46  NEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYV 103

Query: 63  IW-VSKWVDYSDKYGFGYQLNDD--SSGVMFND-----------LTRMIMLANKNTLCGT 108
              + K ++Y    G    ++ D  ++ ++                ++     +NT+ GT
Sbjct: 104 CKELLKGLEYLHSNGI---IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGT 160

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           P ++APE++N   + ++ D+WS+G     L  GKPP+           + K+    P  L
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP---PMKALFKIATNGPPGL 217

Query: 169 KKPAAT------MIKKMLLLDPVQRPPVAQLLHFEF 198
           + P          +KK L  +P +RP   QLL   F
Sbjct: 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 7e-20
 Identities = 23/57 (40%), Positives = 37/57 (64%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            KR   ++    +  M Q+L G++Y H H+I+HRDLK  N+ ++ + V+K+ DFGLA
Sbjct: 89  DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 1e-19
 Identities = 26/72 (36%), Positives = 43/72 (59%), Gaps = 3/72 (4%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L++    +    TE + + YMKQ+LEG+ YLH + I+HRD+K  N+ ++++ V+K+ DFG
Sbjct: 89  LLDSPEVK---FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFG 145

Query: 293 LAARIEFDGQRK 304
           LA          
Sbjct: 146 LARPYTKRNSAD 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.0 bits (208), Expect = 6e-19
 Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI I  S+ H N++ +   F D   + I++E        +L  +    ++      +  I
Sbjct: 49  EIRILASVNHPNIISYKEAFLDGNKLCIVMEYA---PFGDLSKAISKRKKKRKLIPEQEI 105

Query: 64  WVSKWVDYSDKYGFGYQL--------NDDSSG---VMFNDLTRM-------IMLAN-KNT 104
           W         +   G Q          D  S    ++ NDL ++       ++  N   T
Sbjct: 106 W-----RIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY-K 163
             GTP+Y+APE+     +S++ D+WS+GC++Y +    PPFE  ++++   ++++ +Y  
Sbjct: 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP 220

Query: 164 LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF 196
           +P    +     I+ ML + P  RP   ++L  
Sbjct: 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 9e-19
 Identities = 56/222 (25%), Positives = 86/222 (38%), Gaps = 40/222 (18%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEM-------- 54
           QEI + ++LKH N+V +    E S  +YIILE     S+ ++        E         
Sbjct: 48  QEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ 107

Query: 55  ---------------SD-PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIM 98
                           D  AA  +      V  +D +G   +LND S             
Sbjct: 108 VLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLAD-FGVATKLNDVSK------------ 154

Query: 99  LANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI- 157
             +  ++ GTP ++APE++  +G S   D+WS+GC +  LL G PP+          RI 
Sbjct: 155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212

Query: 158 KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           +     LP  +       + +    DP  RP   QLL   + 
Sbjct: 213 QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 81.1 bits (201), Expect = 3e-18
 Identities = 30/67 (44%), Positives = 42/67 (62%), Gaps = 4/67 (5%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDF 291
           L++ N  +   ++E E    + QILEG+ YLH + IIHRDLK  N+ L SDN  VK+ DF
Sbjct: 81  LLKENEGK---LSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADF 137

Query: 292 GLAARIE 298
           GL+  + 
Sbjct: 138 GLSKLLT 144

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 81.1 bits (201), Expect = 3e-18
 Identities = 49/227 (21%), Positives = 77/227 (33%), Gaps = 89/227 (39%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNS-ACDLEE-------- 53
           +EI I + L H N+V  +  FED   +Y+++E C   S+ +L       L E        
Sbjct: 40  REIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILL 99

Query: 54  -------------------------MSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGV 88
                                    +     +  +        +D +G    L  D S  
Sbjct: 100 QILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKL--------AD-FGLSKLLTSDKS-- 148

Query: 89  MFNDLTRMIMLANKNTLCGTPNYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFET 147
                          T+ GTP Y+APE+L  K  +S + D+WS+G I+Y L         
Sbjct: 149 ------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------- 187

Query: 148 STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
                                      +I+KML  DP +RP   ++L
Sbjct: 188 ----------------------PELKDLIRKMLQKDPEKRPSAKEIL 212

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 37/85 (43%), Positives = 51/85 (60%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           +T CGT  Y+APEIL ++GH   VD WS+G +MY +L G PPF     K+T  +I K + 
Sbjct: 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL 217

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
            LP  L   A  ++KK+L  +P  R
Sbjct: 218 NLPPYLTPEARDLLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.4 bits (202), Expect = 7e-18
 Identities = 30/84 (35%), Positives = 49/84 (58%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           TLCGTP Y+APEI+   G+   VD W++G ++Y +L G PPF      + Y +I + + +
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR 216

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P+     A  +I+ +L +D  +R
Sbjct: 217 FPSFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 81.1 bits (201), Expect = 7e-18
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 45/224 (20%)

Query: 4   EIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDL-------EEM 54
           E+ I R LKH N+V ++    D  ++ +YI++E          Y    DL       ++ 
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVME----------YCEGGDLAQLIQKCKKE 98

Query: 55  SDPAAQPVIW--VSKWVDYSDKYGFGYQLN---------------DDSSGVMFND--LTR 95
                +  IW  +++ +    +                       D ++ V   D  L +
Sbjct: 99  RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158

Query: 96  MI----MLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK 151
           ++      A   T  GTP Y++PE LN   +  + D+WS+GC++Y L    PPF      
Sbjct: 159 ILGHDSSFAK--TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216

Query: 152 ETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           +  S+IK+ ++ ++P         +IK ML +DP +RP   +LL
Sbjct: 217 QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 9e-18
 Identities = 34/84 (40%), Positives = 51/84 (60%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           TLCGTP Y+APE++   GH+  VD W++G ++Y +LVG PPF        Y +I   + +
Sbjct: 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE 216

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P  L   A  +IKK+L++D  +R
Sbjct: 217 FPRHLDLYAKDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 78.9 bits (195), Expect = 6e-17
 Identities = 30/73 (41%), Positives = 46/73 (63%), Gaps = 2/73 (2%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L E      + + E + + YM+ +L+GV+Y+H + I+HRDLK  NL +S + V+KI DFG
Sbjct: 85  LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFG 144

Query: 293 LAARIEFDGQRKR 305
           L AR+ F  +  R
Sbjct: 145 L-ARL-FSEEEPR 155

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 77.9 bits (193), Expect = 9e-17
 Identities = 23/61 (37%), Positives = 38/61 (62%)

Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +++  K  K   E +   +  Q+   + YLH  KI+HRD+K  N+FL+ N +VK+GDFG+
Sbjct: 90  IKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGI 149

Query: 294 A 294
           +
Sbjct: 150 S 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 33/85 (38%), Positives = 51/85 (60%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           +T CGTP+YIAPEIL+   +   VD W++G ++Y +L G+ PFE     E +  I + E 
Sbjct: 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           + P  L K A +++K  L  +P +R
Sbjct: 214 RYPRWLSKEAKSILKSFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 31/84 (36%), Positives = 44/84 (52%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           TLCGTP Y+APE++   GH   VD W++G ++Y  + G PPF   T    Y +I     K
Sbjct: 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK 233

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P      A  ++K +L  D  +R
Sbjct: 234 FPNWFDGRARDLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 76.1 bits (188), Expect = 4e-16
 Identities = 24/62 (38%), Positives = 40/62 (64%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           +TE +  +  K++L+G+ YLH + IIHRD+K  N+ L+ +  VK+ DFGL+A++     R
Sbjct: 95  LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR 154

Query: 304 KR 305
             
Sbjct: 155 NT 156

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 76.5 bits (189), Expect = 4e-16
 Identities = 29/64 (45%), Positives = 41/64 (64%), Gaps = 3/64 (4%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K LME   +      + E +  M Q+L GV++LHD+ I+HRDLK  NL L++  ++KI D
Sbjct: 93  KSLMETMKQP---FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICD 149

Query: 291 FGLA 294
           FGLA
Sbjct: 150 FGLA 153

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 75.7 bits (187), Expect = 6e-16
 Identities = 30/102 (29%), Positives = 51/102 (50%), Gaps = 7/102 (6%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            ++ GTP ++APE++    +    D+WS+GC +  +  GKPP+  S L    + + K+  
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMAALYKIGS 218

Query: 163 K-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                 +P  L + A   ++K L  DP +RP   +LL   F 
Sbjct: 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 26/54 (48%), Positives = 36/54 (66%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +E + +  M Q+L G+ YLH++ IIHRDLK+ NL L+D   +KI DFGLA    
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 8e-16
 Identities = 43/136 (31%), Positives = 61/136 (44%), Gaps = 6/136 (4%)

Query: 70  DYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVW 129
                      L  D+  V   D  +  + AN  +  GTP+YIAPE+L    +  E D W
Sbjct: 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN--STVGTPDYIAPEVLRGTPYGLECDWW 214

Query: 130 SIGCIMYTLLVGKPPFETSTLKETYSRIK--KVEYKLPATLKKPA-ATMIKKMLLLDPVQ 186
           S+G I+Y +L G PPF + TL+ETY++I   K   + P        A  +   LL DP  
Sbjct: 215 SLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPED 274

Query: 187 R-PPVAQLLHFEFFND 201
           R     ++    FF  
Sbjct: 275 RLGSFEEIKSHPFFKG 290

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 27/57 (47%), Positives = 39/57 (68%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           N++ G+P+Y+APE+L   G+ F VD WS+GC++Y  L G PPF  ST  ET+  +K 
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 1e-15
 Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 6/99 (6%)

Query: 93  LTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE 152
           L+R  +   K    GTP+Y+APE +   G     D WS+GC+++  L G PPF   T   
Sbjct: 143 LSRNGLENKK--FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Query: 153 TYSRIKKVEYKLPATLK----KPAATMIKKMLLLDPVQR 187
            +  I       P  +K      A  +I ++L +DP +R
Sbjct: 201 VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 34/90 (37%), Positives = 52/90 (57%), Gaps = 2/90 (2%)

Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
              N+  GT  YIAPE+++ +GH   VD W++G ++Y +L G  PF+ S   ET+S I K
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILK 246

Query: 160 VEYKLP--ATLKKPAATMIKKMLLLDPVQR 187
            E   P    +   A  +I+K+L+ DP +R
Sbjct: 247 KEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 74.8 bits (182), Expect = 3e-15
 Identities = 63/292 (21%), Positives = 111/292 (38%), Gaps = 44/292 (15%)

Query: 1   MSQEIAIHRSLKH-RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA 59
             +EI I  SL H  N+V  + FF+D   +Y+++E     S+ +L         +S+  A
Sbjct: 44  FLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA 103

Query: 60  QPVIW-VSKWVDY-----------------SDKYGFGYQLND-DSSGVMFNDLTRMIMLA 100
             ++  +   ++Y                  D+ G   +L D   + ++ +  +   + A
Sbjct: 104 LFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163

Query: 101 NKNTLCGTPNYIAPEILNKNGH---SFEVDVWSIGCIMYTLLVGKPPFE----TSTLKET 153
             +T  GTP Y+APE+L        S   D+WS+G  +Y LL G PPFE    +S   +T
Sbjct: 164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223

Query: 154 YSRIKK---------VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY-- 202
              I +         +    P  + K A+ ++KK+L  DP  R   +  L  +       
Sbjct: 224 LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283

Query: 203 ------CPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPE 248
                        S  +      S+    +S     +   + K   +    E
Sbjct: 284 KESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKE 335

Length = 384

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 36/89 (40%), Positives = 53/89 (59%), Gaps = 13/89 (14%)

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GTP+YIAPE+  + G++ E D WS+G IMY +LVG PPF +   +ETY +I  + +K   
Sbjct: 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKI--INWK--E 256

Query: 167 TLKKP--------AATMIKKMLLLDPVQR 187
           TL+ P        A  +IK+ L  +  +R
Sbjct: 257 TLQFPDEVPLSPEAKDLIKR-LCCEAERR 284

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 74.1 bits (182), Expect = 5e-15
 Identities = 31/84 (36%), Positives = 49/84 (58%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           T CGTP+YIAPEIL +  +   VD W++G +MY ++ G+PPFE     + +  I   +  
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL 214

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P  L K A +++K  +  +P +R
Sbjct: 215 YPVWLSKEAVSILKAFMTKNPNKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.5 bits (181), Expect = 6e-15
 Identities = 24/51 (47%), Positives = 39/51 (76%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +TE + + YM Q+LEG++YLH++ I+HRD+K  N+ + +  ++KI DFGLA
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 72.4 bits (178), Expect = 9e-15
 Identities = 27/54 (50%), Positives = 37/54 (68%), Gaps = 2/54 (3%)

Query: 246 EPE--TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
             E   R Y  Q+LEG++YLH H I+HRD+K  N+FL  N V+K+GDFG A ++
Sbjct: 96  LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 72.2 bits (178), Expect = 1e-14
 Identities = 30/71 (42%), Positives = 40/71 (56%), Gaps = 6/71 (8%)

Query: 234 MERN------SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVK 287
           ME N       ++ K  +E   R  + QIL+G++++H H   HRDLK  NL +S   VVK
Sbjct: 80  MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVK 139

Query: 288 IGDFGLAARIE 298
           I DFGLA  I 
Sbjct: 140 IADFGLAREIR 150

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.8 bits (176), Expect = 2e-14
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 28/221 (12%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EIA+H  LKHRN+V +     ++ F  I +E     S+  L  S     + ++    
Sbjct: 52  LHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQT-- 109

Query: 61  PVIWVSKWVDYSDKY------------GFGYQLNDDSSGVMFNDLTRMIMLANKN----T 104
            +I+ +K +    KY            G    +N  S  V  +D      LA  N    T
Sbjct: 110 -IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168

Query: 105 LCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE- 161
             GT  Y+APE+++K   G+    D+WS+GC +  +  GKPPF    L E  + + KV  
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IELGEPQAAMFKVGM 226

Query: 162 YK----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
           +K    +P +L   A   I +    DP +R     LL   F
Sbjct: 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 33/80 (41%), Positives = 49/80 (61%), Gaps = 4/80 (5%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           +L GTPNYIAPE+L + G++   D WS+G I+Y +LVG+PPF   T  ET  ++   E  
Sbjct: 203 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT 262

Query: 164 L----PATLKKPAATMIKKM 179
           L     A L + A+ +I ++
Sbjct: 263 LHIPSQAKLSREASDLILRL 282

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 71.8 bits (177), Expect = 2e-14
 Identities = 25/57 (43%), Positives = 37/57 (64%), Gaps = 2/57 (3%)

Query: 240 RRKAI--TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + K+I  T  + + YM   L G+ YLH + I+HRDLK  NL ++ + V+K+ DFGLA
Sbjct: 93  KDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 71.0 bits (175), Expect = 2e-14
 Identities = 22/56 (39%), Positives = 30/56 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K R  ++  +   +  QI  G+ YL     IHRDL   N  + +N VVKI DFGL+
Sbjct: 94  KNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 149

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.0 bits (174), Expect = 3e-14
 Identities = 28/56 (50%), Positives = 38/56 (67%)

Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           A+TE  TR Y +QILEGV YLH + I+HRD+K  N+       VK+GDFG + R++
Sbjct: 100 ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 32/94 (34%), Positives = 46/94 (48%)

Query: 94  TRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET 153
             M      +T CGTP+YIAPEIL    ++  VD WS G ++Y +L+G+ PF      E 
Sbjct: 145 ENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204

Query: 154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +  I       P  + K A   + K+   DP +R
Sbjct: 205 FDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 3e-14
 Identities = 27/63 (42%), Positives = 47/63 (74%)

Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG 301
           + +TEP+ R+  +Q+LE +++LH HK+IHRDLK GN+ L+ +  VK+ DFG++A+ +   
Sbjct: 98  RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157

Query: 302 QRK 304
           Q++
Sbjct: 158 QKR 160

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 71.1 bits (174), Expect = 4e-14
 Identities = 31/85 (36%), Positives = 50/85 (58%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           NT CGTP Y+APE+L  +G++  VD W++G ++Y +L G PPF    + E Y +I +   
Sbjct: 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL 210

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           + P    + A  ++  +L  DP +R
Sbjct: 211 RFPDGFDRDAKDLLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 32/88 (36%), Positives = 48/88 (54%)

Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A   T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     ++ +  I  
Sbjct: 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210

Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 211 EEIRFPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 6e-14
 Identities = 24/65 (36%), Positives = 36/65 (55%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            +    +E   RFY  +I+  + YLH   II+RDLK  N+ L  +  +K+ DFGLA  + 
Sbjct: 85  SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELS 144

Query: 299 FDGQR 303
            +G R
Sbjct: 145 SEGSR 149

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 70.0 bits (172), Expect = 6e-14
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 5/104 (4%)

Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE--TSTLKETYSRIK 158
              +  GTP Y+APE+L + G+S  VD WS+G   Y  L GK P+   + T+++     +
Sbjct: 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ 214

Query: 159 KV-EYKLPATLKKPAATMIKKMLLLDPVQR--PPVAQLLHFEFF 199
           +  +   PAT    A   I K+L  DP +R    +  L +  +F
Sbjct: 215 ETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 69.9 bits (172), Expect = 6e-14
 Identities = 24/68 (35%), Positives = 34/68 (50%), Gaps = 1/68 (1%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
             R K ++  +   +  QI  G+ YL     IHRDL   N  + +N VVKI DFGL +R 
Sbjct: 94  KNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL-SRD 152

Query: 298 EFDGQRKR 305
            +D    +
Sbjct: 153 LYDDDYYK 160

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.2 bits (172), Expect = 8e-14
 Identities = 29/84 (34%), Positives = 48/84 (57%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           + CGT  Y+APE++N+ GH+   D WS G +M+ +L G  PF+    KET + I K +  
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG 216

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
           +P  L   A ++++ +   +P  R
Sbjct: 217 MPQFLSPEAQSLLRALFKRNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.1 bits (171), Expect = 9e-14
 Identities = 31/88 (35%), Positives = 49/88 (55%)

Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A   T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     ++ +  I  
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209

Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            + K P TL   A +++  +L+ DP +R
Sbjct: 210 EDIKFPRTLSADAKSLLSGLLIKDPNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 1/61 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLH-DHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           K+   I EP   +  +QIL+G+ YLH    IIHRD+K  NL ++    VKI DFG++  +
Sbjct: 91  KKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150

Query: 298 E 298
           E
Sbjct: 151 E 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 32/88 (36%), Positives = 48/88 (54%)

Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A   T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     ++ +  I  
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209

Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 210 EEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 26/61 (42%), Positives = 38/61 (62%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K+  +  EP  R Y +QIL G+ YLHD   +HRD+K  N+ +  N VVK+ DFG+A ++ 
Sbjct: 94  KKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153

Query: 299 F 299
            
Sbjct: 154 E 154

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 31/85 (36%), Positives = 49/85 (57%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           +T CGTP+YIAPEIL    ++F VD WS G ++Y +L+G+ PF      E +  I+    
Sbjct: 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP 213

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
             P  + K +  +++K+   DP +R
Sbjct: 214 HYPRWITKESKDILEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 5/85 (5%)

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL-- 164
           GTP+YIAPEI  + G+  E D WS+G IM+  L+G PPF +    ETY +I      L  
Sbjct: 210 GTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF 269

Query: 165 --PATLKKPAATMIKKMLLLDPVQR 187
                L   A  +I++ L+ +   R
Sbjct: 270 PDDIHLSVEAEDLIRR-LITNAENR 293

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 103 NTLCGTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSR 156
            + CGT  Y+APE++     GH   VD WS+G + + LL G  PF    E ++  E   R
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR 223

Query: 157 IKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           I K +   P T+   A   I+K+L  DP +R
Sbjct: 224 ILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 27/63 (42%), Positives = 41/63 (65%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            R   + EP    Y KQIL+GV+YLH++ ++HRD+K  N+ L  N ++K+ DFG A R+ 
Sbjct: 94  NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153

Query: 299 FDG 301
           + G
Sbjct: 154 WVG 156

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 32/88 (36%), Positives = 47/88 (53%)

Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A   T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I  
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209

Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 210 EEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 31/84 (36%), Positives = 47/84 (55%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           T CGTP+YIAPEI+    +   VD W+ G ++Y +L G+PPF+     E +  I +    
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P +L K A ++ K +L   P +R
Sbjct: 220 YPKSLSKEAVSICKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 23/55 (41%), Positives = 38/55 (69%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R++ + E   + Y+ Q+L+G+++ H H I+HRDLK  NL ++   V+K+ DFGLA
Sbjct: 91  RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLA 145

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 67.9 bits (167), Expect = 3e-13
 Identities = 53/255 (20%), Positives = 86/255 (33%), Gaps = 79/255 (30%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRK--RSMMELYNSACDLEEMSDPAAQP 61
           EI++ + LKH N+V         + +Y++ E C    +  ++          +       
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLI------- 100

Query: 62  VIWVSKWVDYSDKYGFGYQLND-----DSSGVMFNDL-TRMIMLANKNTL---------- 105
                       K    YQL        S  ++  DL  + I++     L          
Sbjct: 101 ------------KS-IMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARA 147

Query: 106 CGTPN-----------YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETST 149
            G P            Y APEIL     +S  VD+WS+GCI   ++ GKP F    E   
Sbjct: 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207

Query: 150 L-----------KETYSRIKKVEYKLPATLKKP--------------AATMIKKMLLLDP 184
           L           +E++  + K+    P   K P                 ++ KML  +P
Sbjct: 208 LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNP 267

Query: 185 VQRPPVAQLLHFEFF 199
            +R    + L   +F
Sbjct: 268 AKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 30/84 (35%), Positives = 47/84 (55%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           T CGTP+YIAPEI+    +   VD W+ G ++Y +L G+PPF+     E +  I +    
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P +L K A ++ K ++   P +R
Sbjct: 220 YPKSLSKEAVSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.2 bits (167), Expect = 3e-13
 Identities = 27/70 (38%), Positives = 43/70 (61%)

Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ++S  R  + E      +K++L+G+ YLH +  IHRD+K GN+ L ++  VKI DFG++A
Sbjct: 91  KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSA 150

Query: 296 RIEFDGQRKR 305
            +   G R R
Sbjct: 151 SLADGGDRTR 160

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET---------Y 154
           T CGTPNYIAPEIL    + F VD W++G +M+ ++ G+ PF+   + +          +
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214

Query: 155 SRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
             I + + ++P +L   A++++K  L  DP +R
Sbjct: 215 QVILEKQIRIPRSLSVKASSVLKGFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 37/220 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           QEIA+   L+H N+V +     +   +YI LEL    S+ +L        E       PV
Sbjct: 51  QEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE-------PV 103

Query: 63  IWVSKWVDYSDKY--GFGYQLND---------------DSSGVM----FNDLTRMIMLAN 101
           I       Y+ +   G  Y L+D               D++GV+    F    +++  + 
Sbjct: 104 I-----RLYTRQILLGLEY-LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157

Query: 102 KNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI--K 158
             +  G+P ++APE++  + G+    D+WS+GC +  +  GKPP+          +I   
Sbjct: 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS 217

Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
           K    +P  L   A   I K L  DP  RP  A+LL   F
Sbjct: 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 67.5 bits (166), Expect = 4e-13
 Identities = 23/64 (35%), Positives = 33/64 (51%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K  + +T  +      QI +G+ YL     +HRDL   N  +++N VVKI DFGL+  I 
Sbjct: 94  KHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIY 153

Query: 299 FDGQ 302
            D  
Sbjct: 154 EDDY 157

Length = 258

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 32/92 (34%), Positives = 51/92 (55%)

Query: 96  MIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
           M+  A   T CGTP+YIAPEIL    ++  VD WS G ++Y +L+G+ PF     +E + 
Sbjct: 147 MLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206

Query: 156 RIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
            I+      P  L + A  ++ K+ + +P +R
Sbjct: 207 SIRMDNPCYPRWLTREAKDILVKLFVREPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 67.4 bits (165), Expect = 5e-13
 Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 29/225 (12%)

Query: 1   MSQEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA 59
           + +E+       H NVV ++ SF    + +++++      S++++  S+     + +   
Sbjct: 46  LRKEVQAMSQCNHPNVVKYYTSFVVGDE-LWLVMPYLSGGSLLDIMKSSYPRGGLDEAII 104

Query: 60  QPVI-WVSKWVDYSDKYGF-------GYQLNDDSSGVMFNDLTRMIMLAN--------KN 103
             V+  V K ++Y    G        G  L  +   V   D      LA+        + 
Sbjct: 105 ATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 104 TLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           T  GTP ++APE++   +G+ F+ D+WS G     L  G  P+  S        +  ++ 
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY--SKYPPMKVLMLTLQN 222

Query: 163 KLP-----ATLKKPAAT---MIKKMLLLDPVQRPPVAQLLHFEFF 199
             P     A  KK + +   MI   L  DP +RP   +LL  +FF
Sbjct: 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.0 bits (166), Expect = 5e-13
 Identities = 30/84 (35%), Positives = 45/84 (53%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           T CGTP+YIAPEIL +  +   VD W++G ++Y +L G  PFE     + +  I   E  
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 214

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P  L + A  ++K  +  +P  R
Sbjct: 215 YPTWLSQDAVDILKAFMTKNPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 66.9 bits (164), Expect = 6e-13
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 51/231 (22%)

Query: 1   MSQEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRS---MMELYNSACDLEEMSD 56
           + +EI+I +      +V ++ S+F+++  ++I++E C   S   +M++ N     EE++ 
Sbjct: 45  IIKEISILKQCDSPYIVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMKITNKTLTEEEIA- 102

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQ----------------LNDDSS------GVMFNDLT 94
                       + Y    G  Y                 LN++        GV      
Sbjct: 103 -----------AILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151

Query: 95  RMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETY 154
            M   A +NT+ GTP ++APE++ + G++ + D+WS+G     +  GKPP+  S +    
Sbjct: 152 TM---AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY--SDIHPM- 205

Query: 155 SRIKKVEYKLPATLKKPA------ATMIKKMLLLDPVQRPPVAQLLHFEFF 199
             I  +  K P TL  P          +KK L+ DP +RP   QLL   F 
Sbjct: 206 RAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 67.2 bits (165), Expect = 7e-13
 Identities = 25/56 (44%), Positives = 34/56 (60%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           ++  ++ E  TRFY  +IL  + YLH   IIHRDLK  N+ L  +  +KI DFG A
Sbjct: 94  RKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTA 149

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 66.9 bits (164), Expect = 7e-13
 Identities = 26/66 (39%), Positives = 40/66 (60%), Gaps = 1/66 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
             K +TE E    + Q L+G+ YLH +K IHRD+K GN+ L++    K+ DFG++ ++  
Sbjct: 92  TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT- 150

Query: 300 DGQRKR 305
           D   KR
Sbjct: 151 DTMAKR 156

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 66.7 bits (163), Expect = 7e-13
 Identities = 46/224 (20%), Positives = 85/224 (37%), Gaps = 54/224 (24%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL---EEMSDPAAQ 60
           EI I   L+H N++ +++ F D   + I +E     ++ +           EEM      
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM------ 102

Query: 61  PVIWV----SKWVDYSDK-------------------------YGFGYQLNDDSSGVMFN 91
            V+W        V Y  K                         +G    L  + S     
Sbjct: 103 -VLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA--- 158

Query: 92  DLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK 151
                       T+ GTP Y++PE+     ++F+ D+W++GC++Y LL  K  F+ +   
Sbjct: 159 -----------ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL 207

Query: 152 ETYSRIKKVEYK-LPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
               +I +  Y  + +       +++  +L  DP +RP   ++L
Sbjct: 208 NLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 5/89 (5%)

Query: 104 TLCGTPNYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSRIK 158
           + CGT  Y+APEI+  K GH   VD WS+G +++ LL G  PF    E +T  E   RI 
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224

Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           K +   P+ +   A  ++ K+L  DP +R
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 67.1 bits (164), Expect = 8e-13
 Identities = 33/109 (30%), Positives = 55/109 (50%), Gaps = 6/109 (5%)

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           +CGTP YIAPE++ + G+   VD W++G I+Y  LVG  PF   T +E + ++   + + 
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Query: 165 PA---TLKKPAATMIKKMLLLDPVQR---PPVAQLLHFEFFNDYCPTSL 207
           P     L   A  +I ++L  +P++R       ++    FF       L
Sbjct: 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 66.3 bits (162), Expect = 1e-12
 Identities = 27/62 (43%), Positives = 38/62 (61%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
            + +  K+RK I E E      Q+L G+  LH+ KI+HRDLK  N+ L  N +VKIGD G
Sbjct: 89  AISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLG 148

Query: 293 LA 294
           ++
Sbjct: 149 IS 150

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 1e-12
 Identities = 27/101 (26%), Positives = 53/101 (52%), Gaps = 8/101 (7%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--- 160
           ++ GTP +++PE+++  G+  + DVWS+GC +  +L  KPP+      E  + I K+   
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF---EAMAAIFKIATQ 222

Query: 161 --EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
               +LP+ +   A   +++  + +  +RP   +LL   F 
Sbjct: 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 24/56 (42%), Positives = 37/56 (66%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K  + +T+   ++++ QIL G+ YLH   +IHRDLK  N+ ++ N  +KI DFGLA
Sbjct: 95  KSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 7/92 (7%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSTLKETYS 155
           +T CGTPNYIAPEIL    + F VD W++G +M+ ++ G+ PF       + +T    + 
Sbjct: 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213

Query: 156 RIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
            I +   ++P  L   A+ ++K  L  DP +R
Sbjct: 214 VILEKPIRIPRFLSVKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 13/126 (10%)

Query: 75  YGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCI 134
           +GF  Q +D  S            L   ++ CGTP Y+APE+  +  +S + D+WS+G I
Sbjct: 213 FGFSKQYSDSVS------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVI 260

Query: 135 MYTLLVGKPPFETSTLKETYSRIKKVEYK-LPATLKKPAATMIKKMLLLDPVQRPPVAQL 193
           +Y LL    PF+  + +E   ++   +Y   P  +      ++  +L  +P  RP   QL
Sbjct: 261 LYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQL 320

Query: 194 LHFEFF 199
           LH EF 
Sbjct: 321 LHTEFL 326

Length = 478

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 65.6 bits (161), Expect = 2e-12
 Identities = 22/65 (33%), Positives = 34/65 (52%)

Query: 230 RKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIG 289
           RK      S  +  ++  +   +  QI +G+ YL   K +HRDL   N  + ++ VVKI 
Sbjct: 88  RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKIS 147

Query: 290 DFGLA 294
           DFGL+
Sbjct: 148 DFGLS 152

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 65.6 bits (160), Expect = 2e-12
 Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 24/209 (11%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E  +   L    ++ ++  F D   + I++E      + +L        +   P  +  +
Sbjct: 49  EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKM-----QRGRPLPEDQV 103

Query: 64  WV-------------SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN----TLC 106
           W              SK + + D       L D    V   DL    +L++      T+ 
Sbjct: 104 WRFFIQILLGLAHLHSKKILHRDIKSLNLFL-DAYDNVKIGDLGVAKLLSDNTNFANTIV 162

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK-LP 165
           GTP Y++PE+     ++ + DVW++G ++Y    GK PF+ +       +I +  +  + 
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS 222

Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
               +  A +I + L  D  QRP   QLL
Sbjct: 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 45/132 (34%), Positives = 65/132 (49%), Gaps = 22/132 (16%)

Query: 165 PATLK--KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVV 222
           P  LK  +   T+I+ MLL + V  P V ++            S   +C M  P + S +
Sbjct: 93  PVVLKIGQKGTTLIEAMLLQN-VNHPSVIRMKDTLV-------SGAITC-MVLPHYSSDL 143

Query: 223 PSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD 282
            ++ + R +PL       +  I E       KQILEG+ YLH  +IIHRD+K  N+F++D
Sbjct: 144 YTYLTKRSRPL----PIDQALIIE-------KQILEGLRYLHAQRIIHRDVKTENIFIND 192

Query: 283 NFVVKIGDFGLA 294
              V IGD G A
Sbjct: 193 VDQVCIGDLGAA 204

Length = 357

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF---------ETSTLKETYS 155
            CGTPNYIAPEIL    + F VD W++G +M+ ++ G+ PF         + +T    + 
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215

Query: 156 RIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
            I + + ++P +L   AA+++K  L  DP +R
Sbjct: 216 VILEKQIRIPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 27/205 (13%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMM-ELYNSACDLEEMSDPAA 59
           MS+   + +++KH  +VG H  F+ +  +Y +L+      +   L    C LE  +   A
Sbjct: 43  MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 102

Query: 60  QPVIWVSKWVDYSDKYGFGYQLN-------------DDSSGVMFND--LTRMIMLAN--K 102
             +         +   G+ + LN             D    ++  D  L +  +  N   
Sbjct: 103 AEI---------ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           +T CGTP Y+APE+L+K  +   VD W +G ++Y +L G PPF +    E Y  I     
Sbjct: 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           +L   +   A  +++ +L  D  +R
Sbjct: 214 QLKPNITNSARHLLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 29/84 (34%), Positives = 45/84 (53%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           T CGTP+YIAPEI+    +   VD W+ G ++Y +L G+ PFE     E +  I +    
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P ++ K A  + K ++   P +R
Sbjct: 220 YPKSMSKEAVAICKGLMTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 34/222 (15%)

Query: 4   EIAIHRSLKHRNVVGFHSF-FEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           E+ +   LKH N+V ++       K VYI +E C   ++ EL      L+E         
Sbjct: 49  EMKVLELLKHPNLVKYYGVEVHREK-VYIFMEYCSGGTLEELLEHGRILDEHV--IRVYT 105

Query: 63  IWVSKWVDYSDKYGFGYQLND--------DSSGVM-FNDLTRMIMLANKNTLC------- 106
           + + + + Y   +G  ++  D        D +GV+   D    + L N  T         
Sbjct: 106 LQLLEGLAYLHSHGIVHR--DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163

Query: 107 -GTPNYIAPEILNKN---GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            GTP Y+APE++      GH    D+WS+GC++  +  GK P+  S L   +  +  V  
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHVGA 221

Query: 163 K----LPATLKKPAATM--IKKMLLLDPVQRPPVAQLLHFEF 198
                +P +L+        + + L  DP +RP  ++LL   F
Sbjct: 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 64.6 bits (157), Expect = 4e-12
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFE-DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           QE  +   LKH N+V +   +E +   +YI++  C      +LY+   + +    P  Q 
Sbjct: 48  QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQV 104

Query: 62  VIW---VSKWVDY-SDKYGFGYQLNDD------SSGVMFNDLTRMIMLANKN----TLCG 107
           V W   ++  + Y  +K+     L         ++ +   DL    +L N+     TL G
Sbjct: 105 VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG 164

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TP Y++PE+ +   ++++ DVW++GC +Y +   K  F    +     RI  +E KLP  
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI--IEGKLPPM 222

Query: 168 LKKPA---ATMIKKMLLLDPVQRPPVAQLLH 195
            K  +     +I  ML   P +RP V  +L 
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 64.6 bits (157), Expect = 4e-12
 Identities = 47/215 (21%), Positives = 92/215 (42%), Gaps = 23/215 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ +   +KH N+V F + F+++  ++I++E C    +M+  N    +    D      
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107

Query: 63  IWVSKWVD-----------------YSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTL 105
           + +S  +                  +  K G   +L D       ND   +       T 
Sbjct: 108 VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL-----AYTC 162

Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK-L 164
            GTP Y++PEI     ++ + D+WS+GC++Y L   K PFE + L +   +I +  +  +
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI 222

Query: 165 PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                +   ++I ++  + P  RP +  +L   F 
Sbjct: 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 25/53 (47%), Positives = 33/53 (62%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
               +EP   FY   ++ G+ YLH++KI++RDLKL NL L     VKI DFGL
Sbjct: 95  TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.3 bits (156), Expect = 6e-12
 Identities = 28/63 (44%), Positives = 44/63 (69%)

Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG 301
           + +TEP+ R   KQ LE ++YLH++KIIHRDLK GN+  + +  +K+ DFG++A+     
Sbjct: 98  RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157

Query: 302 QRK 304
           QR+
Sbjct: 158 QRR 160

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 64.1 bits (156), Expect = 6e-12
 Identities = 48/203 (23%), Positives = 93/203 (45%), Gaps = 12/203 (5%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSAC----DLEEMSDPAA 59
           E  + + L H N++ ++  F + K + I++E     ++ E     C    D + +     
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108

Query: 60  QPVIWV----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN---TLCGTPNYI 112
           Q ++ +    +K + + D       L+     V   D     +L++K+   T+ GTP YI
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYI 168

Query: 113 APEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPA 172
           +PE+     ++ + D+W++GC++Y L   K  FE + L     +I    +   +    P 
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD 228

Query: 173 ATM-IKKMLLLDPVQRPPVAQLL 194
               I  ML LDP +RP ++Q++
Sbjct: 229 LRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 7e-12
 Identities = 21/52 (40%), Positives = 36/52 (69%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           E     Y+ Q+L+G++YLH+  +IHRD+K  N+  + + VVK+ DFG+A ++
Sbjct: 98  ESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKL 149

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 29/56 (51%), Positives = 39/56 (69%)

Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           A+TE  TR Y +QIL+GVSYLH + I+HRD+K  N+       VK+GDFG + RI+
Sbjct: 102 ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 26/61 (42%), Positives = 38/61 (62%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
             + ++    + ++ QIL G+ YLH   I+HRD+K GNL ++ N V+KI DFGLA   E 
Sbjct: 96  SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155

Query: 300 D 300
           D
Sbjct: 156 D 156

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 7e-12
 Identities = 23/57 (40%), Positives = 40/57 (70%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           K+ K + E    + +++ L G++YLH++K+IHRD+K  N+ L+ N  VK+ DFG++A
Sbjct: 105 KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 8e-12
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 1/92 (1%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           T CGTP Y+APEI  +  +S + D++S+G ++Y LL  K PF+   ++E   +     Y 
Sbjct: 204 TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263

Query: 164 -LPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            LP ++      ++  +L  DP +RP  ++LL
Sbjct: 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 29/75 (38%), Positives = 46/75 (61%)

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GTP+YIAPE+  + G++   D WS+G IMY +L+G PPF + T +ETY ++   +  L  
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIF 257

Query: 167 TLKKPAATMIKKMLL 181
             + P +   K ++L
Sbjct: 258 PPEVPISEKAKDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.8 bits (155), Expect = 9e-12
 Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 26/211 (12%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E  +   +KH N+V F   FE    +YI++E C    +M+             P    +
Sbjct: 47  KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIK---LQRGKLFPEDTIL 103

Query: 63  IWVSKWV--------------DYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN----T 104
            W  +                D   K  F  Q    +  V   D     +L +      T
Sbjct: 104 QWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ----NGKVKLGDFGSARLLTSPGAYACT 159

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK- 163
             GTP Y+ PEI     ++ + D+WS+GCI+Y L   K PF+ ++ K    ++ +  YK 
Sbjct: 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219

Query: 164 LPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           LP+       ++IK+M   +P  RP    +L
Sbjct: 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 33/81 (40%), Positives = 49/81 (60%), Gaps = 4/81 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           ++L GTPNYIAPE+L + G++   D WS+G I+Y +LVG+PPF   T  ET  ++   + 
Sbjct: 206 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT 265

Query: 163 KL----PATLKKPAATMIKKM 179
            L     A L   A+ +I K+
Sbjct: 266 SLHIPPQAKLSPEASDLIIKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 28/84 (33%), Positives = 51/84 (60%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           T CGTP ++APE+L +  ++  VD W +G ++Y +LVG+ PF     +E +  I   E +
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR 219

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P  L + A ++++++L  +P +R
Sbjct: 220 YPRFLSREAISIMRRLLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 46/155 (29%), Positives = 67/155 (43%), Gaps = 43/155 (27%)

Query: 157 IKKVEYKLPATLKKPAATMIKKML--------LLDPVQRPPVAQLLHFE-------FFND 201
           +K+VE  LPAT+     +  K M+         L  +    + Q L FE        F +
Sbjct: 31  VKQVE--LPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLE 88

Query: 202 YCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVS 261
           Y P     SCL T  RF+                          E   RF+ +Q+LEG++
Sbjct: 89  YVPGGSIGSCLRTYGRFE--------------------------EQLVRFFTEQVLEGLA 122

Query: 262 YLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR 296
           YLH   I+HRDLK  NL +  + + KI DFG++ +
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 30/95 (31%), Positives = 57/95 (60%), Gaps = 4/95 (4%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS--TLKETYSRIKKVE 161
           +L GTP Y++PE +++NG++F+ D+WS+GC++Y +   + PF      L     +I+K +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD 224

Query: 162 YK-LPAT-LKKPAATMIKKMLLLDPVQRPPVAQLL 194
           Y  LPA    +    ++ + +  DP +RP ++ +L
Sbjct: 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 67/244 (27%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYI------------ILELCRKRSMME------- 43
            EI I +  KH N+V ++  +     +++            I+     R M E       
Sbjct: 64  NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVC 122

Query: 44  ---------LYNSAC---DLEEMSDPAAQPVIWVSK--WVDYSDKYGFGYQLNDDSSGVM 89
                    L++      D++  SD      I +SK   V  +D +GF  QL  + S   
Sbjct: 123 REVLQGLEYLHSQNVIHRDIK--SDN-----ILLSKDGSVKLAD-FGFAAQLTKEKS--- 171

Query: 90  FNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETS 148
                       +N++ GTP ++APE++ +  +  +VD+WS+G +   +  G+PP     
Sbjct: 172 -----------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220

Query: 149 TLKETYSRIKKVEYKLPATLKKPAA------TMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
            L+  +  I     K    LK P          + K L+ DP +RP   +LL   F    
Sbjct: 221 PLRALF-LITT---KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276

Query: 203 CPTS 206
           CP  
Sbjct: 277 CPKE 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 104 TLCGTPNYIAPEIL--NKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSRI 157
           + CGT  Y+AP+I+     GH   VD WS+G +MY LL G  PF    E ++  E   RI
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI 224

Query: 158 KKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
            K E   P  +   A  +I+++L+ DP +R
Sbjct: 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 27/56 (48%), Positives = 38/56 (67%), Gaps = 1/56 (1%)

Query: 246 EPET-RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
            PET +  M+Q+L GV +LH H+I+HRDLK  N+ ++ +  VKI DFGLA    F+
Sbjct: 105 PPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 22/54 (40%), Positives = 37/54 (68%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           + EP+  +  +++L+G+ YLH   +IHRD+K  N+ LS +  VK+ DFG AA++
Sbjct: 113 MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 15/199 (7%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSM-MELYNSACDLEEMSDPAA 59
           M++   + ++LKH  +VG H  F+ ++ +Y +L+      +   L    C LE  +   A
Sbjct: 43  MAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYA 102

Query: 60  QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDL----TRMIMLANKNTLCGT 108
             V   +  + Y       Y+       L D    V+  D       +      +T CGT
Sbjct: 103 AEV---ASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           P Y+APE+L K  +   VD W +G ++Y +L G PPF +  + + Y  I     +LP   
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK 219

Query: 169 KKPAATMIKKMLLLDPVQR 187
              A  ++  +L  D  +R
Sbjct: 220 TVAACDLLVGLLHKDQRRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 34/84 (40%), Positives = 45/84 (53%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           TLCGTP YIAPEIL   GH    D W++G  +Y +LVG PPF  +     Y +I +    
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY 246

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P  L      ++KK+L  D  +R
Sbjct: 247 FPKFLDNNCKHLMKKLLSHDLTKR 270

Length = 340

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 29/84 (34%), Positives = 44/84 (52%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           T CGTP Y+APE+L K  +   VD W +G ++Y +L G PPF +    E Y  I     +
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR 214

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
           L   +   A  +++ +L  D  +R
Sbjct: 215 LKPNISVSARHLLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 25/66 (37%), Positives = 42/66 (63%), Gaps = 4/66 (6%)

Query: 233 LMERNSKR----RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           LME +        + +TE   R+++ Q+L G+ Y+H   +IHRDLK  NL ++++  ++I
Sbjct: 89  LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRI 148

Query: 289 GDFGLA 294
           GDFG+A
Sbjct: 149 GDFGMA 154

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 20/56 (35%), Positives = 35/56 (62%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + E    F ++++L G+ YLH+   IHRD+K  N+ LS+   VK+ DFG++ ++  
Sbjct: 95  LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 31/219 (14%)

Query: 2   SQEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD---- 56
           +QE  +   L H  +V FH SF E   F  II E C  R +       C LEE+      
Sbjct: 50  NQEAQLLSKLDHPAIVKFHASFLERDAFC-IITEYCEGRDL------DCKLEELKHTGKT 102

Query: 57  -PAAQPVIWVSKW---VDYSDKYGFGYQLNDDSSGVMFNDL--------TRMIM----LA 100
               Q   W  +    V Y  +    ++     +  + N+L        +R++M    LA
Sbjct: 103 LSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLA 162

Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
              T  GTP Y++PE L   G+  + D+WS+GCI+Y +      FE         RI + 
Sbjct: 163 T--TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG 220

Query: 161 EY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
               LP T  +   ++++ ML  DP  RP  A++L   F
Sbjct: 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 33/81 (40%), Positives = 49/81 (60%), Gaps = 4/81 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           ++L GTPNYIAPE+L + G++   D WS+G I++ +LVG+PPF   T  ET  ++   E 
Sbjct: 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN 265

Query: 163 KL--PATLK--KPAATMIKKM 179
            L  P  +K    A  +I K+
Sbjct: 266 TLHIPPQVKLSPEAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.4 bits (151), Expect = 2e-11
 Identities = 30/60 (50%), Positives = 40/60 (66%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K   A+TE  TR Y +QILEGVSYLH + I+HRD+K  N+       VK+GDFG + R++
Sbjct: 98  KSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 40/122 (32%), Positives = 55/122 (45%), Gaps = 25/122 (20%)

Query: 73  DKYG------FGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHS--- 123
           DK G      FG  +  D++G++  D           T  GTP+YI+PE+L   G     
Sbjct: 176 DKSGHLKLADFGTCMKMDANGMVRCD-----------TAVGTPDYISPEVLKSQGGDGYY 224

Query: 124 -FEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI--KKVEYKLP--ATLKKPAATMIKK 178
             E D WS+G  +Y +LVG  PF   +L  TYS+I   K     P    + K A  +I  
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICA 284

Query: 179 ML 180
            L
Sbjct: 285 FL 286

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 28/56 (50%), Positives = 39/56 (69%)

Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           A+TE  TR Y +QILEG+SYLH + I+HRD+K  N+       VK+GDFG + R++
Sbjct: 102 ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 29/75 (38%), Positives = 46/75 (61%)

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GTP+YIAPE+  + G++   D WS+G IMY +L+G PPF + T +ETY ++   +  L  
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVF 257

Query: 167 TLKKPAATMIKKMLL 181
             + P +   K ++L
Sbjct: 258 PPEVPISEKAKDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 49/221 (22%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNS----ACDLEEMSDPAA 59
           E+   + L+H++++   +     + VYII EL  K S++    S       +  + D A 
Sbjct: 52  EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111

Query: 60  QPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGT----------- 108
           Q    V++ + Y +               +  DL    +L  ++ +C             
Sbjct: 112 Q----VAEGMAYLE-----------EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156

Query: 109 PNYI-----------APEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSR 156
             Y+           APE  +    S + DVWS G ++Y +   G+ P+      E Y +
Sbjct: 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ 216

Query: 157 IKKVEYKLPATLKKPAATMIKKMLL----LDPVQRPPVAQL 193
           I    Y++P   K P    I K++L     +P  RP    L
Sbjct: 217 ITA-GYRMPCPAKCPQE--IYKIMLECWAAEPEDRPSFKAL 254

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 62.4 bits (151), Expect = 4e-11
 Identities = 25/55 (45%), Positives = 40/55 (72%)

Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR 296
           + +TEP+ +   +Q+LE + YLH  KIIHRDLK GN+ L+ +  +K+ DFG++A+
Sbjct: 105 RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 24/145 (16%)

Query: 69  VDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDV 128
           V  SD +GF  Q++ +              +  + +L GTP ++APE++++  +  EVD+
Sbjct: 154 VKLSD-FGFCAQVSKE--------------VPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198

Query: 129 WSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPA------ATMIKKMLLL 182
           WS+G ++  ++ G+PP+      +   RI+      P  LK          + + +ML+ 
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL---PPKLKNLHKVSPRLRSFLDRMLVR 255

Query: 183 DPVQRPPVAQLLHFEFFNDYCPTSL 207
           DP QR   A+LL+  F     P S 
Sbjct: 256 DPAQRATAAELLNHPFLAKAGPPSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 23/55 (41%), Positives = 35/55 (63%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           +K + E E        L+G++YLH H+ IHRD+K GN+ L++   VK+ DFG A+
Sbjct: 109 KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSAS 163

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 21/48 (43%), Positives = 30/48 (62%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           E   R Y+ +I+  + YLH + IIHRDLK  N+ +  N  +K+ DFGL
Sbjct: 92  EDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGL 139

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 61.8 bits (150), Expect = 5e-11
 Identities = 27/53 (50%), Positives = 38/53 (71%), Gaps = 1/53 (1%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-NFVVKIGDFGLAARI 297
           E    FY KQILEG+ YLHD++I+HRD+K  N+ ++  + VVKI DFG + R+
Sbjct: 107 EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 3/98 (3%)

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP- 165
           GTP+Y+APE+L    H   VD W++G  ++  L G PPF   T ++ +  I   +   P 
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601

Query: 166 --ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
               L   A   I+ +L +DP +R  + +L     F+ 
Sbjct: 602 GEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHG 639

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 61.6 bits (149), Expect = 6e-11
 Identities = 52/239 (21%), Positives = 108/239 (45%), Gaps = 51/239 (21%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYN----------SACD--L 51
           E+ I R  +H+NVV  +  +   + +++++E  +  ++ ++ +          + C+  L
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL 127

Query: 52  EEMSDPAAQPVIW-----------VSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA 100
           + +    +Q VI            +   V  SD +GF  Q++ D              + 
Sbjct: 128 QALCYLHSQGVIHRDIKSDSILLTLDGRVKLSD-FGFCAQISKD--------------VP 172

Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
            + +L GTP ++APE++++  +  EVD+WS+G ++  ++ G+PP+ + +       +K++
Sbjct: 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRL 229

Query: 161 EYKLPATLKKPAAT------MIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLM 213
               P  LK            +++ML  +P +R    +LL   F      T LP  CL+
Sbjct: 230 RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL---LQTGLP-ECLV 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 21/50 (42%), Positives = 35/50 (70%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           T  E +  MK +L G+ Y+H +KI+HRD+K  N+ ++ + ++K+ DFGLA
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 61.0 bits (148), Expect = 9e-11
 Identities = 28/60 (46%), Positives = 39/60 (65%), Gaps = 9/60 (15%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLAARI--------EFDGQ 302
           Y +Q+L G+SYLH+++IIHRD+K  NL + S    ++I DFG AAR+        EF GQ
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 61.7 bits (148), Expect = 1e-10
 Identities = 28/70 (40%), Positives = 38/70 (54%), Gaps = 1/70 (1%)

Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLA 294
           +   R+  ++E E  F + QIL  + YLH   IIHRD+K  N+ L  D  VVK+ DFGLA
Sbjct: 90  KKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149

Query: 295 ARIEFDGQRK 304
             +   G   
Sbjct: 150 KLLPDPGSTS 159

Length = 384

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 60.3 bits (146), Expect = 1e-10
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 15/101 (14%)

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY---- 162
           GTP ++APE++N++G+  + D+WSIGC ++ +  GKPP        +  R+  + Y    
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL------ASMDRLAAMFYIGAH 223

Query: 163 -----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
                +LP +    A   +   L  D  +RP   QLL  +F
Sbjct: 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 25/61 (40%), Positives = 35/61 (57%), Gaps = 4/61 (6%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL----SDNFVVKIGDFGL 293
             +R +I     +  + QIL GV YLH + ++HRDLK  N+ +     +  VVKIGD GL
Sbjct: 99  QAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158

Query: 294 A 294
           A
Sbjct: 159 A 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 23/56 (41%), Positives = 39/56 (69%)

Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           A  E   R +++QIL+G++YLH+  IIHRD+K  N+ + +   +KI DFG++ ++E
Sbjct: 102 AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 20/43 (46%), Positives = 31/43 (72%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y+ Q+L+G++Y H H+++HRDLK  NL +     +K+ DFGLA
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 23/61 (37%), Positives = 36/61 (59%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R+  +TE + +  + QIL G++ LH    +HRDL   N+F++   + KI DFGLA R  +
Sbjct: 112 RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGY 171

Query: 300 D 300
            
Sbjct: 172 P 172

Length = 335

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 7/114 (6%)

Query: 81  LNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT 137
           L DD   V  +DL   + L     +    GTP Y+APE+L    + F VD +++GC +Y 
Sbjct: 127 LLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYE 186

Query: 138 LLVGKPPF----ETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           ++ G+ PF    E    +E   R  ++  + P      A  + + +L  DP +R
Sbjct: 187 MIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 25/204 (12%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           M++   + +++KH  +VG H  F+ ++ +Y +L+        EL+          +P A+
Sbjct: 43  MAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG---ELFFHLQRERSFPEPRAR 99

Query: 61  PVIWVSKWVDYSDKYGFGYQLN-------------DDSSGVMFNDL---TRMIMLANKNT 104
                    + +   G+ + +N             D    V+  D       I  ++  T
Sbjct: 100 FYA-----AEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154

Query: 105 -LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
             CGTP Y+APE++ K  +   VD W +G ++Y +L G PPF    + E Y  I      
Sbjct: 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLV 214

Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
           L       A ++++++L  D  +R
Sbjct: 215 LRPGASLTAWSILEELLEKDRQRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 23/54 (42%), Positives = 33/54 (61%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           R +  +E   RFY  +I+  + YLH   +++RDLKL NL L  +  +KI DFGL
Sbjct: 88  RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 20/57 (35%), Positives = 40/57 (70%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           R  ++E +  +  ++ L+G++YLH+   IHRD+K  N+ L+++  VK+ DFG++A++
Sbjct: 95  RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL 151

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 59.3 bits (143), Expect = 3e-10
 Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 7/114 (6%)

Query: 81  LNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT 137
           L DD   +  +DL   + +    T+    GT  Y+APE++    ++F  D W++GC++Y 
Sbjct: 134 LLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 193

Query: 138 LLVGKPPFETSTLK----ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           ++ G+ PF+    K    E    +K+V+ +        A ++ K +L  DP +R
Sbjct: 194 MIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           E   RFY+  ++    YLH+  II+RDLK  NL L  N  VK+ DFG A +++  GQ+
Sbjct: 92  EYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQK 148

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 23/62 (37%), Positives = 37/62 (59%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L+E        +     R Y+ Q+L+ ++Y H H IIHRD+K  N+ +S++ V+K+ DFG
Sbjct: 86  LLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFG 145

Query: 293 LA 294
            A
Sbjct: 146 FA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 21/53 (39%), Positives = 36/53 (67%)

Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +++   ++++ Q+L G+ Y+H   ++HRDLK  NL L+ N  +KI DFGLA
Sbjct: 103 QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.1 bits (143), Expect = 4e-10
 Identities = 27/59 (45%), Positives = 38/59 (64%), Gaps = 1/59 (1%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRK 304
           EP   FY  QI+ G+ +LH  +II+RDLK  N+ L ++  V+I D GLA  ++ DGQ K
Sbjct: 96  EPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK-DGQSK 153

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.1 bits (143), Expect = 4e-10
 Identities = 31/114 (27%), Positives = 56/114 (49%), Gaps = 7/114 (6%)

Query: 81  LNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT 137
           L DD   +  +DL   + +    T+    GT  Y+APE++    ++F  D W +GC++Y 
Sbjct: 134 LLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYE 193

Query: 138 LLVGKPPFETSTLK----ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           ++ GK PF     K    E   R+K+ + +      + A ++ +++L  DP  R
Sbjct: 194 MIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 29/69 (42%), Positives = 44/69 (63%), Gaps = 5/69 (7%)

Query: 233 LME---RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKI 288
            ME    N   +  ++E   R +M Q+L G+ Y+H   ++HRDLK  N+F++ ++ V+KI
Sbjct: 97  YMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156

Query: 289 GDFGLAARI 297
           GDFGL ARI
Sbjct: 157 GDFGL-ARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 58.7 bits (143), Expect = 5e-10
 Identities = 24/60 (40%), Positives = 35/60 (58%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++     EP  RFY  Q++  + YLH   I++RDLK  NL L  +  +KI DFG A R++
Sbjct: 93  RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 60/247 (24%), Positives = 96/247 (38%), Gaps = 59/247 (23%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS---DPAA- 59
           E+ + R L+H N+V     F     +Y++ E   +R+++EL      LE       P A 
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLLEL------LEASPGGLPPDAV 102

Query: 60  QPVIW-VSKWVDYSDKYGFGYQ------LNDDSSGVM------FNDLTRMIMLANKNTLC 106
           +  IW + + + Y   +   ++      +    SGV+      F    R    +      
Sbjct: 103 RSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV 162

Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFE-TSTLKETYSRIKKV---- 160
            T  Y APE+L  +  +   VDVW+IGCIM  LL G+P F   S + + Y  I+K     
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY-LIQKCLGPL 221

Query: 161 ----------------------------EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQ 192
                                       E + P  +  PA   +K  L +DP +R    +
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281

Query: 193 LLHFEFF 199
           LL   +F
Sbjct: 282 LLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 25/66 (37%), Positives = 40/66 (60%), Gaps = 3/66 (4%)

Query: 232 PLMER---NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
            LM     N  + + +++   +F + QIL G+ Y+H   IIHRDLK  N+ ++++  +KI
Sbjct: 100 HLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 159

Query: 289 GDFGLA 294
            DFGLA
Sbjct: 160 LDFGLA 165

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 23/48 (47%), Positives = 32/48 (66%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           EP  RFY  +I+ G+ +LH+  II+RDLKL N+ L     +KI DFG+
Sbjct: 95  EPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 42/226 (18%)

Query: 3   QEIAIHRSLKHRNVVG-FHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           QEI++ +  +H N+V  F S+    K ++I++E C   S+ ++Y           P ++ 
Sbjct: 49  QEISMLKECRHPNIVAYFGSYLRRDK-LWIVMEYCGGGSLQDIYQVTRG------PLSEL 101

Query: 62  VI-WVS----KWVDY--------SDKYGFGYQLNDDSSGVMFND------LTRMIMLANK 102
            I +V     K + Y         D  G    L +D   V   D      LT  I  A +
Sbjct: 102 QIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATI--AKR 158

Query: 103 NTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIK 158
            +  GTP ++APE+     K G+  + D+W++G     L   +PP F+   ++  +  I 
Sbjct: 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LIS 217

Query: 159 KVEYKLPATLK---KPAATM---IKKMLLLDPVQRPPVAQLLHFEF 198
           K  +  P  LK   K +      IKK L  DP +RP   +LL   F
Sbjct: 218 KSNFP-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 8e-10
 Identities = 56/257 (21%), Positives = 87/257 (33%), Gaps = 82/257 (31%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD---PAAQ 60
           EI + + L H N++     F     +Y++ E        +LY      + + D      +
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD----TDLY------KLIKDRQRGLPE 97

Query: 61  PVIWVSKWVDYSDKYGFGYQLND-----DSSGVMFNDLTRMIMLANKNT---LC------ 106
            +I          K  + YQL        S G++  DL    +L N      L       
Sbjct: 98  SLI----------KS-YLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLAR 146

Query: 107 --GTPN-----------YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE 152
             G+P            Y APE+L    G+S  VD+WS+GCI   LL  +P F   +  +
Sbjct: 147 SFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID 206

Query: 153 TYSRIKKV-----------------------EYKLPATLKK-------PAATMIKKMLLL 182
              +I +                          K    L K        A  ++ +ML  
Sbjct: 207 QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHY 266

Query: 183 DPVQRPPVAQLLHFEFF 199
           DP +R    Q L   +F
Sbjct: 267 DPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 58.0 bits (140), Expect = 9e-10
 Identities = 25/61 (40%), Positives = 40/61 (65%), Gaps = 1/61 (1%)

Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +E      K ++E +   +  Q+L GV Y+H  +I+HRDLK  N+FL +N ++KIGDFG+
Sbjct: 93  LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGV 151

Query: 294 A 294
           +
Sbjct: 152 S 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 58.3 bits (141), Expect = 9e-10
 Identities = 21/68 (30%), Positives = 42/68 (61%), Gaps = 7/68 (10%)

Query: 234 MERNSKR-------RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
           M+++ K+       R A+     + +  Q+L+G+++ H+++++HRDLK  NL ++    +
Sbjct: 80  MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL 139

Query: 287 KIGDFGLA 294
           K+ DFGLA
Sbjct: 140 KLADFGLA 147

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 20/63 (31%), Positives = 36/63 (57%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           ++   +E + +F++ +I+  + YLH   IIHRD+K  N+ L +   V I DF +A ++  
Sbjct: 93  QKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152

Query: 300 DGQ 302
           D  
Sbjct: 153 DTL 155

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 20/43 (46%), Positives = 32/43 (74%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y+ QI+  VSY+H   I+HRD+K  N+FL+   ++K+GDFG++
Sbjct: 106 YLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 25/45 (55%), Positives = 33/45 (73%), Gaps = 1/45 (2%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           RF++ QIL G+++LH  KI+HRD+K  NLFL     VKIGD G+A
Sbjct: 105 RFFI-QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVA 148

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 7/114 (6%)

Query: 81  LNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT 137
           L DD   +  +DL   + +    ++    GT  Y+APE+LN   ++   D W +GC++Y 
Sbjct: 134 LLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYE 193

Query: 138 LLVGKPPF----ETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           ++ G+ PF    E    +E   R+ + E    A   + A ++ K +L  DP QR
Sbjct: 194 MIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 27/100 (27%), Positives = 58/100 (58%), Gaps = 8/100 (8%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF--ETSTLKETYSRIKKV 160
           ++L GTP Y++PE +++NG++F+ D+WS+GC++Y +   + PF  +   L     +I++ 
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC 223

Query: 161 EYKLPATLKKPAATMIKKMLLL----DPVQRPPVAQLLHF 196
           +Y  P    +  +  +++++ +    DP QRP +  +   
Sbjct: 224 DY--PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|144309 pfam00659, POLO_box, POLO box duplicated region

 Score = 53.3 bits (129), Expect = 1e-09
 Identities = 18/45 (40%), Positives = 25/45 (55%), Gaps = 4/45 (8%)

Query: 71  YSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPE 115
           YS KYG GYQL++ +  V FND T++I+      +     YI P 
Sbjct: 1   YSTKYGLGYQLSNGTVQVNFNDHTKIILSPGGKAVT----YIDPN 41

Length = 64

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 35/112 (31%), Positives = 58/112 (51%), Gaps = 11/112 (9%)

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKV 160
           + +L GTP ++APE++++  +  EVD+WS+G ++  ++ G+PP F    LK     +K +
Sbjct: 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMI 228

Query: 161 EYKLPATLKKPAAT------MIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
              LP  LK            + ++L+ DP QR   A+LL   F     P S
Sbjct: 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 26/67 (38%), Positives = 37/67 (55%), Gaps = 5/67 (7%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLH-----DHKIIHRDLKLGNLFLSDNFVVK 287
           L+++  K RK I E      + Q+L  +   H      + ++HRDLK  N+FL  N  VK
Sbjct: 91  LIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK 150

Query: 288 IGDFGLA 294
           +GDFGLA
Sbjct: 151 LGDFGLA 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 24/51 (47%), Positives = 33/51 (64%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + E   R Y+ QIL G+ + H H IIHRD+K  N+ +S + VVK+ DFG A
Sbjct: 97  LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 1/102 (0%)

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKV 160
           +NT  GTP ++APE++ ++ + F+ D+WS+G     L  G+PP  +   ++  +   K  
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS 217

Query: 161 EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
              L     KP    ++  L  DP  RP   +LL  +F   Y
Sbjct: 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 26/51 (50%), Positives = 36/51 (70%)

Query: 248 ETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +TR  MKQ+L  V Y+HD K+IHRD+KL N+FL+ +  + +GDFG A   E
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318

Length = 501

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 20/43 (46%), Positives = 31/43 (72%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y+ QIL+G+ + H  +++HRDLK  NL + +  V+K+ DFGLA
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 3e-09
 Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 8/111 (7%)

Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
            +NT  GTP ++APE++ ++G+  + D+WS+G     L  G+PP            I K 
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN 213

Query: 161 EYKLPATLK-----KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
               P +L+     KP    +   L  DP +RP   +LL  +F      TS
Sbjct: 214 N---PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTS 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 56.4 bits (136), Expect = 3e-09
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +++EIA+ + L+H N+V +     D+  + I LE     S+  L N+    EE      +
Sbjct: 53  LAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVR 109

Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--------LTRMIMLANKN- 103
             +  + K ++Y    G  ++       L D+  G+  +D           +    N   
Sbjct: 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169

Query: 104 -TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI-KKVE 161
            +L G+  ++APE++ +  ++ + D+WS+GC++  +L GK PF   T  +   +I +   
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
            ++P+ +   A   ++K   +D  +RP  A+LL   F
Sbjct: 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 39/124 (31%), Positives = 53/124 (42%), Gaps = 32/124 (25%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--------- 160
           Y APEI LN   ++  VD+WS+GCIM  LL GK  F  S   +   RI  +         
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240

Query: 161 ---------EY--KLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEF 198
                     Y   LP   KK            A  +++KML+LDP +R   A+ L   +
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Query: 199 FNDY 202
             +Y
Sbjct: 301 LAEY 304

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 49/211 (23%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EI + + L H NV+ +++ F +   + I+LEL     +  +       ++      +  
Sbjct: 51  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH---FKKQKRLIPEKT 107

Query: 63  IWV-------------SKWVDYSDKYGFGYQLNDDSSGVM-FNDLTRMIMLANKNT---- 104
           +W              S+ V + D       +   ++GV+   DL      ++K T    
Sbjct: 108 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTAAHS 165

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY-K 163
           L GTP Y++PE +++NG++F+ D+WS+GC++Y +   + PF    +   YS  KK+E   
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCD 224

Query: 164 LPATLKKPAATMIKKMLLL----DPVQRPPV 190
            P       +  +++++ +    DP +RP +
Sbjct: 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 34/104 (32%), Positives = 48/104 (46%), Gaps = 11/104 (10%)

Query: 107 GTPNYIAPEILN------KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK-- 158
           GTP+YIAPE+L       K  +  E D WS+G I Y ++ G+ PF   T  +TY+ I   
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224

Query: 159 KVEYKLPATLK--KPAATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
           +   K P   K       +I+  LL    +R     L    FF+
Sbjct: 225 QRFLKFPEDPKVSSDFLDLIQS-LLCGQKERLGYEGLCCHPFFS 267

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 56.4 bits (137), Expect = 4e-09
 Identities = 34/126 (26%), Positives = 49/126 (38%), Gaps = 36/126 (28%)

Query: 108 TPNYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPF--------------------- 145
           T  Y  PE+L     +  EVD+WS+GCI+  L +GKP F                     
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223

Query: 146 ------------ETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQL 193
                       E    K+ Y R  +  +K    +   A  ++ K+L LDP +R    Q 
Sbjct: 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFK--HLIDPSALDLLDKLLTLDPKKRISADQA 281

Query: 194 LHFEFF 199
           L  E+F
Sbjct: 282 LQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 21/51 (41%), Positives = 35/51 (68%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 97  IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 26/59 (44%), Positives = 33/59 (55%)

Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           K +  P+      QI EG++YL     IHRDL   N+ + +N V KI DFGLA  IE D
Sbjct: 98  KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 22/51 (43%), Positives = 32/51 (62%), Gaps = 1/51 (1%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL   K +HRDL   N  ++++  VKIGDFG+   I E D  RK
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.0 bits (135), Expect = 4e-09
 Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 21/205 (10%)

Query: 7   IHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-- 64
           I   L+H N+V ++  F ++  +YI+++L     + E +NS   L+E      +  IW  
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFTEERIWNI 118

Query: 65  ---VSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIM----LANK-------NTLCGTPN 110
              +   + Y  K       +   + +M  +  ++ +    LA +        ++ GT  
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK-LPATLK 169
           Y  PEI+    +  + DVW+ GCI+Y +   +PPF ++ +    ++I +  Y+ LP  + 
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238

Query: 170 KPAAT-MIKKMLLLDPVQRPPVAQL 193
               T +I   L  D   RP + Q+
Sbjct: 239 SEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 20/45 (44%), Positives = 32/45 (71%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R ++ Q+L G++Y H  +++HRDLK  NL +S+   +K+ DFGLA
Sbjct: 106 RLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 21/95 (22%)

Query: 73  DKYG------FGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNG----H 122
           DK+G      FG  +  D +G++  D           T  GTP+YI+PE+L   G    +
Sbjct: 176 DKHGHLKLADFGTCMKMDETGMVRCD-----------TAVGTPDYISPEVLKSQGGDGYY 224

Query: 123 SFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
             E D WS+G  ++ +LVG  PF   +L  TYS+I
Sbjct: 225 GRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 30/114 (26%), Positives = 58/114 (50%), Gaps = 7/114 (6%)

Query: 81  LNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT 137
           L DD   +  +DL   + +    T+    GT  Y+APE++N   ++F  D W +GC++Y 
Sbjct: 134 LLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYE 193

Query: 138 LLVGKPPF----ETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           ++ G+ PF    E    +E   R+K+ + +      + A ++ + +L  +P +R
Sbjct: 194 MIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.9 bits (134), Expect = 7e-09
 Identities = 26/54 (48%), Positives = 35/54 (64%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           R +  +E  TRFY  +I+  + YLH  KI++RDLKL NL L  +  +KI DFGL
Sbjct: 88  RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.4 bits (133), Expect = 7e-09
 Identities = 49/232 (21%), Positives = 105/232 (45%), Gaps = 29/232 (12%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+ I R   H NVV  ++ +     +++++E     ++ ++       EE     A   +
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ---IATVCL 125

Query: 64  WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIM------------LANKNTLCGTPNY 111
            V + + Y    G  ++ +  S  ++     R+ +            +  + +L GTP +
Sbjct: 126 SVLRALSYLHNQGVIHR-DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK-- 169
           +APE++++  +  EVD+WS+G ++  ++ G+PP+      +   RI+     LP  +K  
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDS 241

Query: 170 -KPAATM---IKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPR 217
            K ++ +   +  ML+ +P QR    +LL     + +   + P SC++   R
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQ----HPFLKLAGPPSCIVPLMR 289

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 31/84 (36%), Positives = 48/84 (57%), Gaps = 10/84 (11%)

Query: 107 GTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI--KK 159
           GTP+YI+PEIL      K  +  E D WS+G  MY +L G+ PF   +L ETY +I   K
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224

Query: 160 VEYKLPAT---LKKPAATMIKKML 180
             ++ PA    + + A  +I++++
Sbjct: 225 ERFQFPAQVTDVSEDAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 26/59 (44%), Positives = 36/59 (61%), Gaps = 4/59 (6%)

Query: 103 NTLCGTPNYIAPEILNKNG----HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
           +T  GTP+YI+PE+L   G    +  E D WS+G  +Y +LVG  PF   +L  TYS+I
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 21/45 (46%), Positives = 31/45 (68%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R+ M Q+L+ + Y+H   +IHRDLK  N+ L+ +  VK+ DFGLA
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA 154

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 54.9 bits (132), Expect = 8e-09
 Identities = 30/120 (25%), Positives = 49/120 (40%), Gaps = 7/120 (5%)

Query: 85  SSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP 144
           ++  +    T       +  L GT  ++APE+L    +    DVWS+GC++  +   KPP
Sbjct: 150 AAARLAAKGTGAGEF--QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Query: 145 FETSTLKETYSRIKKVEY-----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           +         + I K+        +P  L      +  + L L P  RPP  +LL    F
Sbjct: 208 WNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 27/60 (45%), Positives = 35/60 (58%), Gaps = 5/60 (8%)

Query: 103 NTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
           N   GTP+YI+PEIL      K  +  E D WS+G  MY +L G+ PF   +L ETY +I
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 9e-09
 Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 38/226 (16%)

Query: 4   EIAIHRSLKHRNVVGFHS-FFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           EI I    KH N+VG +  +F ++K ++I++E C   ++  +      + E+     +P 
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENK-LWILIEFCDGGALDSI------MLELERGLTEPQ 104

Query: 63  I-WVSKWVDYSDKYGFGYQL--NDDSSGVMFNDLTRMIMLAN-------------KNTLC 106
           I +V + +  +  +   +++   D  +G +   L   + LA+             ++T  
Sbjct: 105 IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI 164

Query: 107 GTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           GTP ++APE++       N + ++ D+WS+G  +  L   +PP           +I K E
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE 224

Query: 162 YKLPATLKKPA------ATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
              P TL +P+         +K  L+ DP  RP  A+LL   F +D
Sbjct: 225 ---PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 56.3 bits (135), Expect = 9e-09
 Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 59/251 (23%)

Query: 4   EIAIHRSLKHRNVVGFHSFF--EDSKFVYIILELCR----KRSMMELYNSACDLEEMSDP 57
           E+ + R LKH+N+V +   F  + ++ +YI++E C      R++ + Y     +EE    
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE---- 117

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQLNDDSSG--VMFNDLT----------RMI--MLANKN 103
               ++ +++ + ++  Y   + L D  +G  V+  DL           R I  + A  N
Sbjct: 118 --HAIVDITRQLLHALAYC--HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173

Query: 104 TL--------------------------CGTPNYIAPEILNKNGHSFE--VDVWSIGCIM 135
            L                           GTP Y +PE+L     S++   D+W++GCI+
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233

Query: 136 YTLLVGKPPF-ETSTLKETYSRIKKVEYKLPATLK-KPAATMIKKMLLLDPVQRPPVAQL 193
           Y L  GK PF + +   +  S +K+    LP   K K    +IK +L L   +RP   Q 
Sbjct: 234 YELCSGKTPFHKANNFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQC 292

Query: 194 LHFEFFNDYCP 204
           L ++   +  P
Sbjct: 293 LGYQIIKNVGP 303

Length = 1021

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 29/64 (45%), Positives = 42/64 (65%), Gaps = 2/64 (3%)

Query: 233 LMER-NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKIGD 290
           LM+R N +R    +E +   +  QI  G+ ++HD KI+HRD+K  N+FLS N  V K+GD
Sbjct: 86  LMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGD 145

Query: 291 FGLA 294
           FG+A
Sbjct: 146 FGIA 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 20/46 (43%), Positives = 30/46 (65%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Q+ EG++YL +   IHRDL   N+ + ++ V K+ DFGLA  I+ D
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 18/62 (29%), Positives = 36/62 (58%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + E +       +L+ +S+LH   +IHRD+K  ++ L+ +  VK+ DFG  A++  +  R
Sbjct: 112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171

Query: 304 KR 305
           ++
Sbjct: 172 RK 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 23/46 (50%), Positives = 32/46 (69%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           + +QI EG++YLH    IHRDL   N+ L ++ +VKIGDFGLA  +
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 11/92 (11%)

Query: 217 RFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRF-----------YMKQILEGVSYLHD 265
           R DSV  S +S     + +++    +   E +  +           Y  Q+  G+ +L  
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS 191

Query: 266 HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
            K IHRDL   N+ LS+N VVKI DFGLA  I
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDI 223

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 20/49 (40%), Positives = 28/49 (57%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           +  QI +G+ YL   + IHRDL   N+ +    +VKI DFGLA  +  D
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 22/48 (45%), Positives = 38/48 (79%)

Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +  ++IL G+S+LH HK+IHRD+K  N+ L++N  VK+ DFG++A+++
Sbjct: 115 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 23/54 (42%), Positives = 33/54 (61%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           R +  TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFGL
Sbjct: 88  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 43/132 (32%), Positives = 57/132 (43%), Gaps = 19/132 (14%)

Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPL 233
           TM++K +L  P  +PP    LH              SC  T  R   V+   N      L
Sbjct: 47  TMVEKRVLALP-GKPPFLTQLH--------------SCFQTMDRLYFVMEYVNG---GDL 88

Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           M    +  K   EP   FY  +I  G+ +LH   II+RDLKL N+ L     +KI DFG+
Sbjct: 89  MYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM 147

Query: 294 AARIEFDGQRKR 305
                F G+  R
Sbjct: 148 CKENIFGGKTTR 159

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 20/55 (36%), Positives = 34/55 (61%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           K+++ I E     Y  Q+   + ++H  +I+HRD+K  N+F++   VVK+GD GL
Sbjct: 98  KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 21/51 (41%), Positives = 34/51 (66%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           I     + +M Q+L+G+++ H H ++HRDLK  NL ++ N  +K+ DFGLA
Sbjct: 96  IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 26/53 (49%), Positives = 37/53 (69%), Gaps = 1/53 (1%)

Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +K+IL+G+ YLH  K IHRD+K  N+ LS+   VK+ DFG+A ++  D Q KR
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKR 158

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 27/83 (32%), Positives = 37/83 (44%), Gaps = 6/83 (7%)

Query: 229 RRKPLMERNSKRRKAITEPETRFY-----MKQILEGVSYLHDHKIIHRDLKLGNLFLSDN 283
            R+P  E  S       E             Q+  G+ +L   K IHRDL   N+ ++++
Sbjct: 109 ARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168

Query: 284 FVVKIGDFGLAARI-EFDGQRKR 305
            V+KI DFGLA  I   D  RK 
Sbjct: 169 HVMKIADFGLARDIHHIDYYRKT 191

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 22/59 (37%), Positives = 36/59 (61%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           +E   + +MKQ+LEG++Y H    +HRD+K  N+ L++   +K+ DFGLA     +  R
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 25/55 (45%), Positives = 37/55 (67%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           +K + E E        L+G++YLH H +IHRD+K GN+ LS+  +VK+GDFG A+
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 53.3 bits (129), Expect = 3e-08
 Identities = 34/120 (28%), Positives = 48/120 (40%), Gaps = 31/120 (25%)

Query: 111 YIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPF----ET---------------STL 150
           Y APEIL ++  +S  VD+W++GCIM  L   +P F    E                   
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223

Query: 151 KETYSRIKKVEYKLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEFF 199
            E Y    K+ ++ P                 A  +IK ML  DP +RP  +Q L   +F
Sbjct: 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 31/111 (27%), Positives = 46/111 (41%), Gaps = 5/111 (4%)

Query: 98  MLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
            L   NT  GT  Y++PE +    +S+  D+WS+G  +    +GK PF        +  +
Sbjct: 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM 212

Query: 158 KKV----EYKLPATLKKP-AATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC 203
           + +       LPA    P     I   L  DP +RP  A+LL   F     
Sbjct: 213 QAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 25/79 (31%), Positives = 39/79 (49%), Gaps = 7/79 (8%)

Query: 226 NSPRRKPLMERNSKR-------RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNL 278
            SPR +  +  ++            ++  E     KQ+  G++YL + K +HRDL   N 
Sbjct: 102 RSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161

Query: 279 FLSDNFVVKIGDFGLAARI 297
            + +N VVKI DFGL+  I
Sbjct: 162 LVGENMVVKIADFGLSRNI 180

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 25/59 (42%), Positives = 36/59 (61%), Gaps = 2/59 (3%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRK 304
           E    FY  QI+ G+ +LH  +I++RDLK  N+ L D+  V+I D GLA  +E  G +K
Sbjct: 94  EARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKK 150

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 39/124 (31%), Positives = 55/124 (44%), Gaps = 32/124 (25%)

Query: 111 YIAPE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV------EY- 162
           Y APE ILN   ++  VD+WS+GCIM  +L GKP F+     +    I KV      E+ 
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240

Query: 163 -------------KLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEF 198
                        KLP   KK            A  +++KML+LD   R   A+ L   +
Sbjct: 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Query: 199 FNDY 202
           F ++
Sbjct: 301 FEEF 304

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 21/45 (46%), Positives = 37/45 (82%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++IL G+++LH HK+IHRD+K  N+ L++N  VK+ DFG++A+++
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 41/129 (31%), Positives = 54/129 (41%), Gaps = 19/129 (14%)

Query: 173 ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKP 232
            TM +K +L      P + QL        YC       C  T  R   V+   N      
Sbjct: 41  CTMTEKRILSLARNHPFLTQL--------YC-------CFQTPDRLFFVMEFVNG---GD 82

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           LM    K R+   E   RFY  +I   + +LHD  II+RDLKL N+ L      K+ DFG
Sbjct: 83  LMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 141

Query: 293 LAARIEFDG 301
           +     F+G
Sbjct: 142 MCKEGIFNG 150

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 24/55 (43%), Positives = 39/55 (70%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + ++E   +F + Q+L+G+ Y+H   IIHRDLK GNL ++++  +KI DFGLA
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 22/45 (48%), Positives = 32/45 (71%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +M Q+L G+SY H  KI+HRDLK  NL +++   +K+ DFGLA
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 21/54 (38%), Positives = 37/54 (68%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           ++E +  +  ++ L+G+ YLH    +HRD+K  N+ L+DN  VK+ DFG++A+I
Sbjct: 103 LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 52.8 bits (126), Expect = 5e-08
 Identities = 26/62 (41%), Positives = 41/62 (66%), Gaps = 1/62 (1%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + E +    +++IL+G+ YLH  K IHRD+K  N+ LS++  VK+ DFG+A ++  D Q 
Sbjct: 98  LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQI 156

Query: 304 KR 305
           KR
Sbjct: 157 KR 158

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.9 bits (127), Expect = 5e-08
 Identities = 22/49 (44%), Positives = 36/49 (73%), Gaps = 1/49 (2%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++++ QIL G+ Y+H   ++HRDLK  N+ +++N  +KI DFGL ARI+
Sbjct: 111 QYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGL-ARIQ 158

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 22/54 (40%), Positives = 38/54 (70%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           ++E +  +  ++ L+G++YLH    +HRD+K  N+ L+DN  VK+ DFG+AA+I
Sbjct: 103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 22/55 (40%), Positives = 32/55 (58%)

Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
            ++E   RFYM ++ E V  LH+   IHRDLK  N  +  +  +K+ DFGL+  I
Sbjct: 97  VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 30/84 (35%), Positives = 50/84 (59%), Gaps = 10/84 (11%)

Query: 107 GTPNYIAPEILN--KNG---HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           GTP+YI+PEIL   ++G   +  E D WS+G  MY +L G+ PF   +L ETY +I   E
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224

Query: 162 --YKLPA---TLKKPAATMIKKML 180
             ++ P+    + + A  +I++++
Sbjct: 225 ERFQFPSHITDVSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 40/132 (30%), Positives = 57/132 (43%), Gaps = 19/132 (14%)

Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPL 233
           TM++K +L     +PP    LH              SC  T  R   V+   N       
Sbjct: 47  TMVEKRVLAL-QDKPPFLTQLH--------------SCFQTVDRLYFVMEYVNGGDLMYH 91

Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +++  K +    EP+  FY  +I  G+ +LH   II+RDLKL N+ L     +KI DFG+
Sbjct: 92  IQQVGKFK----EPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGM 147

Query: 294 AARIEFDGQRKR 305
                 DG   R
Sbjct: 148 CKEHMVDGVTTR 159

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 52.4 bits (126), Expect = 7e-08
 Identities = 20/37 (54%), Positives = 27/37 (72%)

Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           +L+G+SYLH  KIIHRD+K  N+ L+    VK+ DFG
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 23/55 (41%), Positives = 31/55 (56%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +R ++  EP  RFY  +I   + YLH   II+RDLK  N+ L     V + DFGL
Sbjct: 88  QRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.4 bits (126), Expect = 8e-08
 Identities = 22/51 (43%), Positives = 35/51 (68%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +T+   + ++ QIL G+ Y+H   ++HRDLK GNL ++ +  +KI DFGLA
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA 152

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 2/87 (2%)

Query: 103 NTLCGTPNYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           NT CGT  Y+APE+L ++ G++  VD WS+G +++ +  G  PF     ++ Y  I   +
Sbjct: 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213

Query: 162 YKLP-ATLKKPAATMIKKMLLLDPVQR 187
            + P   L       +K +L  +P  R
Sbjct: 214 VRFPKNVLSDEGRQFVKGLLNRNPQHR 240

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 52.2 bits (126), Expect = 9e-08
 Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 33/132 (25%)

Query: 111 YIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFE-TSTL--------------KETY 154
           Y APEIL  +   +  VD+WS+GCI+  +L+GKP F  TSTL               E  
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 155 SRIK-----KVEYKLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEF 198
             IK      +   LP+  +KP           A  ++KK+L+ +P +R    + L   +
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297

Query: 199 FND-YCPTSLPA 209
               + P+  P 
Sbjct: 298 VAQFHNPSDEPV 309

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 52.0 bits (125), Expect = 9e-08
 Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 3/63 (4%)

Query: 233 LMERNSKRRKAITEPETRF--YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           L++R  K         +    Y  QI  G+ YL   + IHRDL   N+ L+ +  VKIGD
Sbjct: 82  LLDRLRKDALGHF-LISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGD 140

Query: 291 FGL 293
           FGL
Sbjct: 141 FGL 143

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 20/49 (40%), Positives = 30/49 (61%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E     Y+ ++   + YLH H IIHRDLK  N+ +S+   +K+ DFGL+
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 22/58 (37%), Positives = 37/58 (63%)

Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N++R     E +   +  QI   + ++HD KI+HRD+K  N+FL+ +  +K+GDFG+A
Sbjct: 91  NAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIA 148

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 22/44 (50%), Positives = 31/44 (70%)

Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+ N  +KI DFGLA
Sbjct: 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 22/70 (31%), Positives = 40/70 (57%), Gaps = 6/70 (8%)

Query: 233 LMERN-----SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVK 287
           LM+ N       R++ + E   + YM Q+L+ + ++H + I HRD+K  N+ + D+ ++K
Sbjct: 81  LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILK 139

Query: 288 IGDFGLAARI 297
           + DFG    I
Sbjct: 140 LADFGSCRGI 149

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 1/44 (2%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +QIL G++YLH   I+HRD+K  NL ++    VKI DFG+ +RI
Sbjct: 175 RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV-SRI 217

Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 24/53 (45%), Positives = 36/53 (67%)

Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 115 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 4/84 (4%)

Query: 210 SCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKII 269
            C  T  R   V+   N      LM +  + RK   EP +RFY  ++   + +LH H +I
Sbjct: 63  CCFQTKDRLFFVMEYVNG---GDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVI 118

Query: 270 HRDLKLGNLFLSDNFVVKIGDFGL 293
           +RDLKL N+ L      K+ DFG+
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 51.4 bits (124), Expect = 2e-07
 Identities = 32/134 (23%), Positives = 55/134 (41%), Gaps = 33/134 (24%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPF------------------------ 145
           Y APE+ L+ + ++  +D+WS+GCI   LL  KP F                        
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231

Query: 146 ETSTLKETYSRIKKVEYKLPATLKK--PAAT-----MIKKMLLLDPVQRPPVAQLLHFEF 198
           +  T ++  + +K +  K    L K  P A+     +++KML+ DP +R    + L   +
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Query: 199 FNDY-CPTSLPASC 211
                 P   P + 
Sbjct: 292 LAQLHDPEDEPVAK 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 50.7 bits (121), Expect = 2e-07
 Identities = 25/66 (37%), Positives = 42/66 (63%), Gaps = 2/66 (3%)

Query: 233 LMER-NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDF 291
           LM++   +R K   E     +  Q+  GV ++H+ +++HRD+K  N+FL+ N  VK+GDF
Sbjct: 85  LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDF 144

Query: 292 GLAARI 297
           G +AR+
Sbjct: 145 G-SARL 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 27/100 (27%), Positives = 52/100 (52%), Gaps = 9/100 (9%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           ++ GTP +++PE+++  G+  + DVWS+GC +  +L  KPP+      E  + I K+  +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY---EAMAAIFKIATQ 224

Query: 164 -----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
                LP+ + + A   +   + ++   RP   +LL   F
Sbjct: 225 PTNPQLPSHISEHARDFLGC-IFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 24/53 (45%), Positives = 37/53 (69%), Gaps = 1/53 (1%)

Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +++IL+G+ YLH  + IHRD+K  N+ LS+   VK+ DFG+A ++  D Q KR
Sbjct: 107 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKR 158

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 1/98 (1%)

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKV 160
           +NT  GTP ++APE++ ++ +  + D+WS+G     L  G+PP  E   +K  +   K  
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN 217

Query: 161 EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
              L     KP    ++  L  +P  RP   +LL  +F
Sbjct: 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 50/216 (23%), Positives = 97/216 (44%), Gaps = 19/216 (8%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYN-----SACDLEEMS 55
           + QEI + +  KH N+V +   +   + ++I +E C   S+ ++Y+     S   +  + 
Sbjct: 53  IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112

Query: 56  DPAAQPVIWV-SKWVDYSDKYGFGYQLND--DSSGVMFNDLTRMI-MLANKNTLCGTPNY 111
               Q + ++ SK   + D  G    L D  D     F    ++   +A + +  GTP +
Sbjct: 113 RETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172

Query: 112 IAPEI--LNKN-GHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKVEYKLPAT 167
           +APE+  + KN G++   D+W++G     L   +PP F+   ++  +  + K  ++ P  
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKSNFQPPKL 231

Query: 168 LKKPAAT-----MIKKMLLLDPVQRPPVAQLLHFEF 198
             K   +      +K  L  +P +RP   +LL   F
Sbjct: 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 21/70 (30%), Positives = 37/70 (52%), Gaps = 1/70 (1%)

Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           R   +   I E      ++++L  + Y+H   +IHRD+K  N+ +++   VK+ DFG+AA
Sbjct: 90  RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAA 149

Query: 296 RIEFDGQRKR 305
            +      KR
Sbjct: 150 LLN-QNSSKR 158

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 16/40 (40%), Positives = 25/40 (62%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q L+ V++ H H  IHRD+K  N+ ++    +K+ DFG A
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 22/45 (48%), Positives = 31/45 (68%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R +M Q+L G++Y+H   I+HRDLK  NL +S    +K+ DFGLA
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 22/45 (48%), Positives = 32/45 (71%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + ++ Q+L G+SY+H   I+HRDLK  NL +SD   +K+ DFGLA
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.0 bits (123), Expect = 2e-07
 Identities = 20/60 (33%), Positives = 35/60 (58%), Gaps = 1/60 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGN-LFLSDNFVVKIGDFGLAARI 297
           K+   ++E E +  ++Q++E ++ LH H IIH D+KL N L+      + + D+GL   I
Sbjct: 101 KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160

Length = 267

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 23/51 (45%), Positives = 37/51 (72%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           ++E + ++ + Q+L G+ Y+H   IIHRDLK GNL ++++  +KI DFGLA
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 21/54 (38%), Positives = 31/54 (57%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           ++   TE ETRFY+ + +  +  +H    IHRD+K  NL L     +K+ DFGL
Sbjct: 94  KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 22/49 (44%), Positives = 31/49 (63%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E   RFY  +I+ G+ +LH   II+RDLKL N+ L  +  +KI DFG+ 
Sbjct: 95  EARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMC 143

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 24/97 (24%), Positives = 48/97 (49%), Gaps = 3/97 (3%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI--KKVE 161
           ++ GTP +++PE+++  G+  + D+WS+GC +  +L  KPP+          +I  +   
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 227

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
             LP  +       +K+ + ++   RP   +LL   F
Sbjct: 228 PVLPPHVSDHCRDFLKR-IFVEAKLRPSADELLRHTF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 54/244 (22%), Positives = 97/244 (39%), Gaps = 53/244 (21%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EI + + L+H N+V     F   K +Y++ E      + +L      L+E      +  
Sbjct: 49  REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR---VRKY 105

Query: 63  IW-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKNTLC----GTPN 110
           ++ + + +++   +   ++       L   S  V   D      LA    +      T  
Sbjct: 106 LFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW 165

Query: 111 YIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPFETST------------------ 149
           Y APE+L    K G +  VD+W++GC++  +L G+P F   +                  
Sbjct: 166 YRAPELLVGDTKYGRA--VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223

Query: 150 LKETYSR--------------IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
            +E + +              I+ +E + P  L      + K+ L +DP  RP  +QLLH
Sbjct: 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Query: 196 FEFF 199
            EFF
Sbjct: 283 HEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 21/217 (9%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEM-----S 55
           + QEI + +  KH N+V +   +     ++I +E C   S+ ++Y+    L E      S
Sbjct: 53  VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVS 112

Query: 56  DPAAQPVIWV-SKWVDYSDKYGFGYQLNDDSSGVMFNDL----TRMIMLANKNTLCGTPN 110
               Q + ++ SK   + D  G    L D+   V   D          +A + +  GTP 
Sbjct: 113 RETLQGLYYLHSKGKMHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPY 171

Query: 111 YIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKVEYKLPA 166
           ++APE+     K G++   D+W++G     L   +PP F+   ++  +  + K  ++ P 
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKSNFQPPK 230

Query: 167 TLKKPAAT-----MIKKMLLLDPVQRPPVAQLLHFEF 198
              K   +      +K  L  +P +RP   +LL   F
Sbjct: 231 LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 25/96 (26%), Positives = 47/96 (48%), Gaps = 1/96 (1%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY- 162
           T  GTP Y++PEI     ++ + D+W++GC++Y +   K  FE   +K    +I +  Y 
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP 219

Query: 163 KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
            + +        ++ ++   +P  RP V  +L   F
Sbjct: 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 50.9 bits (121), Expect = 3e-07
 Identities = 23/55 (41%), Positives = 35/55 (63%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           +K + E E        L+G++YLH H +IHRD+K GN+ L++   VK+ DFG A+
Sbjct: 119 KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS 173

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 21/44 (47%), Positives = 30/44 (68%), Gaps = 1/44 (2%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLA 294
           Y+ QIL G++Y H H+++HRDLK  NL +      +K+ DFGLA
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150

Length = 294

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 23/57 (40%), Positives = 36/57 (63%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +K + E E        L+G++YLH H +IHRD+K GN+ L++   VK+ DFG A++ 
Sbjct: 115 KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 21/57 (36%), Positives = 33/57 (57%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           S+ R  IT  +   +   + EG+ YL +   +HRDL   N+ +S++ V K+ DFGLA
Sbjct: 93  SRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 22/54 (40%), Positives = 33/54 (61%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R+  TE E R Y+ +I+  + +LH   II+RD+KL N+ L     V + DFGL+
Sbjct: 99  REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 21/49 (42%), Positives = 34/49 (69%), Gaps = 1/49 (2%)

Query: 247 PET-RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            ET +  M Q+L G+ +LH H+++HRDLK  N+ ++ +  +K+ DFGLA
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 21/57 (36%), Positives = 29/57 (50%), Gaps = 1/57 (1%)

Query: 239 KRRKAITEPETRFYM-KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + RK     E    M   + E + YL  +  IHRDL   N  + ++ VVK+ DFGLA
Sbjct: 91  RERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 32/124 (25%), Positives = 52/124 (41%), Gaps = 15/124 (12%)

Query: 86  SGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF 145
           SG + N L          T  GT +Y+APE +  N +S + D+WS+G  +  L  G+ P+
Sbjct: 148 SGQLVNSLA--------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Query: 146 --ETSTLKETYSRIKKVEYKLPATL-----KKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
             E       +  ++ +  + P  L            +   L+ DP +RP   +LL   F
Sbjct: 200 PPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259

Query: 199 FNDY 202
              Y
Sbjct: 260 IKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 49.9 bits (120), Expect = 5e-07
 Identities = 27/116 (23%), Positives = 46/116 (39%), Gaps = 27/116 (23%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV---------- 160
           Y APE+L ++ ++  VD+WS+GCI   L   +P F  ++  +   +I  V          
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Query: 161 ----------EYKLPATLKKP-------AATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                         P + K            ++KKML  +P +R    + L   +F
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 29/74 (39%), Positives = 38/74 (51%)

Query: 227 SPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
           S    P  E +   +  +T  +   Y  Q+  G+ +L   K IHRDL   N+ LS+N VV
Sbjct: 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVV 213

Query: 287 KIGDFGLAARIEFD 300
           KI DFGLA  I  D
Sbjct: 214 KICDFGLARDIYKD 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 20/53 (37%), Positives = 36/53 (67%)

Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +++   +F + Q+L G+ Y+H   IIHRDLK  N+ ++++  ++I DFGLA
Sbjct: 113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 25/49 (51%), Positives = 31/49 (63%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+N VVKI DFGLA  I  D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.1 bits (119), Expect = 6e-07
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)

Query: 210 SCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKII 269
           SC  T  R   V+   N      LM    ++RK + E   RFY  +I   ++YLH+  II
Sbjct: 63  SCFQTESRLFFVIEYVNG---GDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGII 118

Query: 270 HRDLKLGNLFLSDNFVVKIGDFGL 293
           +RDLKL N+ L     +K+ D+G+
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 40/128 (31%), Positives = 56/128 (43%), Gaps = 19/128 (14%)

Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPL 233
           TM++K +L     +PP    LH              SC  T  R   V+   N      L
Sbjct: 47  TMVEKRVLALS-GKPPFLTQLH--------------SCFQTMDRLYFVMEYVNG---GDL 88

Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           M +  +  +   EP   FY  +I  G+ +LH   II+RDLKL N+ L     +KI DFG+
Sbjct: 89  MYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM 147

Query: 294 AARIEFDG 301
                +DG
Sbjct: 148 CKENMWDG 155

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 2/62 (3%)

Query: 239 KRRKAITEPETRF--YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR 296
           K +K    PE +   +  QI   + YLH+  I+HRDLK  N+FL+   ++K+GD G+A  
Sbjct: 92  KEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV 151

Query: 297 IE 298
           +E
Sbjct: 152 LE 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 38/124 (30%), Positives = 54/124 (43%), Gaps = 32/124 (25%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL---------------KETY 154
           Y APEI L+   ++  +DVWS+GCI+  LL  KP F+                   +ET 
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234

Query: 155 SRI---KKVEY--KLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEF 198
           SRI   K   Y   LP   KKP           A  +++K+L  DP +R  V + L   +
Sbjct: 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294

Query: 199 FNDY 202
              +
Sbjct: 295 LAIW 298

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 62/232 (26%), Positives = 94/232 (40%), Gaps = 47/232 (20%)

Query: 4   EIAIHRSL-KHRNVVGFHS-FFEDSKFV----YIILELCRKRSMMELYNSACDLEEMSDP 57
           E  I +SL  H NVV F+  F++  K V    +++LELC   S+ EL        +  D 
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD- 126

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQLNDD---------------SSGVMFNDLTRMIMLAN- 101
             + +I    ++ Y    G  +  N+                  GV   D      L + 
Sbjct: 127 --EAMI---SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 102 ---KNTLCGTPNYIAPEIL---NKNGHSFEV--DVWSIGCIMYTLLVGKPP-FETSTLKE 152
              +NT  GTP ++APE++    +  +S++   DVWS+G     L  G PP F+   +K 
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241

Query: 153 TYSRIKKVEYKLPATLKKPA------ATMIKKMLLLDPVQRPPVAQLLHFEF 198
            +    K+    P TL  P          I + L+ D   RP V  LL   F
Sbjct: 242 LF----KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 49.3 bits (117), Expect = 6e-07
 Identities = 22/52 (42%), Positives = 33/52 (63%)

Query: 247 PETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           P+   +  QI EG++Y+     IHRDL+  N+ +S++ + KI DFGLA  IE
Sbjct: 103 PKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 4/84 (4%)

Query: 210 SCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKII 269
           SC  T  R   V+   N      LM    ++RK + E   RFY  +I   +++LH+  II
Sbjct: 63  SCFQTTSRLFLVIEYVNG---GDLMFHMQRQRK-LPEEHARFYAAEICIALNFLHERGII 118

Query: 270 HRDLKLGNLFLSDNFVVKIGDFGL 293
           +RDLKL N+ L  +  +K+ D+G+
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 3/61 (4%)

Query: 247 PETR--FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRK 304
            E R  FY  +I  G+  LH  +I++RDLK  N+ L D   ++I D GLA  I  +G+  
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP-EGETI 158

Query: 305 R 305
           R
Sbjct: 159 R 159

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 49.3 bits (117), Expect = 7e-07
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 13/100 (13%)

Query: 212 LMTAPRFDSVVPSFNSPRRKPL------MERNS-------KRRKAITEPETRFYMKQILE 258
           +M   R D +VP +     +P+      M + S          K +  P+      QI +
Sbjct: 54  IMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113

Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           G++Y+     IHRDL+  N+ + DN V KI DFGLA  IE
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 49.1 bits (117), Expect = 8e-07
 Identities = 20/46 (43%), Positives = 29/46 (63%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           QI EG++++     IHRDL+  N+ +S+    KI DFGLA  IE +
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 49.3 bits (117), Expect = 9e-07
 Identities = 24/55 (43%), Positives = 34/55 (61%), Gaps = 1/55 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHK-IIHRDLKLGNLFLSDNFVVKIGDFGL 293
           R +  +E   RFY  +I+  + YLH  K +++RDLKL NL L  +  +KI DFGL
Sbjct: 88  RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 142

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 49.0 bits (117), Expect = 9e-07
 Identities = 23/108 (21%), Positives = 47/108 (43%), Gaps = 16/108 (14%)

Query: 103 NTLCGTPNYIAPEILN--KNGHSFEVDVWSIGCIMYTLLVGKPP----------FETSTL 150
            ++ G+  ++APE+++    G+S +VD+WS+GC++  +  G+ P          F+    
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227

Query: 151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
           +        +   +   L   A   +     ++P  RP   +LL   F
Sbjct: 228 R----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 7/142 (4%)

Query: 153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH-FEFFNDYCPTSLPASC 211
           +Y+++  VE K   T +  A  +IKK L+ D      V    H FE  +++       SC
Sbjct: 7   SYAKVLLVELK--KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSC 64

Query: 212 LMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHR 271
             T  R   V+   +      LM    ++RK + E   RFY  +I   +++LH+  II+R
Sbjct: 65  FQTESRLFFVIEFVSG---GDLMFHMQRQRK-LPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 272 DLKLGNLFLSDNFVVKIGDFGL 293
           DLKL N+ L     +K+ D+G+
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 1/103 (0%)

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKV 160
           +NT  GTP ++APE++ ++ +  + D+WS+G     L  G+PP  +   ++  +   K  
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN 217

Query: 161 EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC 203
              L     KP    I   L  DP  RP   +LL  +F     
Sbjct: 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 65/280 (23%), Positives = 105/280 (37%), Gaps = 88/280 (31%)

Query: 1   MSQEIAIHRSLKHRNVVG----FHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
             +E+ + + L+H N++     F S  ED   +Y + EL              DL  +  
Sbjct: 56  TYRELKLLKHLRHENIISLSDIFISPLED---IYFVTELL-----------GTDLHRLLT 101

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLND-----DSSGVMFNDLTRMIMLANKN---TLC-- 106
             ++P+    +++ Y     F YQ+        S+GV+  DL    +L N+N    +C  
Sbjct: 102 --SRPL--EKQFIQY-----FLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDF 152

Query: 107 --------------GTPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPF------ 145
                          T  Y APEI L    +  EVD+WS GCI   +L GKP F      
Sbjct: 153 GLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212

Query: 146 ------------------ETSTLKETYSRIKKVEYKLPATLKK-------PAATMIKKML 180
                              T   + T   ++ +  + P    +        A  +++KML
Sbjct: 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272

Query: 181 LLDPVQRPPVAQLLHFEFFNDYC-PTSLPASCLMTAPRFD 219
           + DP +R   A+ L   +   Y  PT  P    +   +FD
Sbjct: 273 VFDPQKRISAAEALAHPYLAPYHDPTDEP----VAEEKFD 308

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 20/42 (47%), Positives = 29/42 (69%)

Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           M+Q L G+ +LH + I+HRDLK  N+ ++    VK+ DFGLA
Sbjct: 114 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 21/57 (36%), Positives = 30/57 (52%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            K R+ +   +   Y  QI +G+ YL   + +HRDL   N+ +     VKIGDFGL 
Sbjct: 99  QKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 28/110 (25%), Positives = 55/110 (50%), Gaps = 3/110 (2%)

Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETY--SR 156
           + ++T+ GTP ++APE++ +  +  +VD+WS+G +   ++ G+PP+   + L+  Y  + 
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229

Query: 157 IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
               E + P  L       + + L +D  +R    +LL   F     P S
Sbjct: 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 49.0 bits (116), Expect = 1e-06
 Identities = 28/110 (25%), Positives = 55/110 (50%), Gaps = 3/110 (2%)

Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETY--SR 156
           + ++T+ GTP ++APE++ +  +  +VD+WS+G +   ++ G+PP+   + L+  Y  + 
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229

Query: 157 IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
               E + P  L       + + L +D  +R    +LL   F     P S
Sbjct: 230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLS 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 48.4 bits (115), Expect = 1e-06
 Identities = 32/115 (27%), Positives = 53/115 (46%), Gaps = 8/115 (6%)

Query: 81  LNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT 137
           L DD      +DL   + L +  T+    GT  Y+APEIL +  +S+ VD +++GC +Y 
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYE 186

Query: 138 LLVGKPPF----ETSTLKETYSRIKKVEYKLP-ATLKKPAATMIKKMLLLDPVQR 187
           ++ G+ PF    E    +E   R  + E K       + +  + +  L   P  R
Sbjct: 187 MVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 22/65 (33%), Positives = 37/65 (56%), Gaps = 2/65 (3%)

Query: 231 KPLMERNSKRR-KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKI 288
           K  M+ N +   + +     + +M Q+L+GV++ H H ++HRDLK  NL +     ++KI
Sbjct: 93  KKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKI 152

Query: 289 GDFGL 293
            D GL
Sbjct: 153 ADLGL 157

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 17/40 (42%), Positives = 25/40 (62%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+  G++YL     IHRDL   N+ + +N + K+ DFGLA
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLA 150

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 22/59 (37%), Positives = 38/59 (64%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           KR + + EP   + + + L G+ +LH +K IHRD+K  N+ L+    VK+ DFG++A++
Sbjct: 116 KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.4 bits (115), Expect = 1e-06
 Identities = 20/45 (44%), Positives = 32/45 (71%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + ++ QIL G++Y H  K++HRDLK  NL +++   +K+ DFGLA
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 19/44 (43%), Positives = 25/44 (56%), Gaps = 1/44 (2%)

Query: 252 YM-KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           YM  QI   + YL     IHRDL   N  + +N +VK+ DFGL+
Sbjct: 108 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 151

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 48.6 bits (115), Expect = 1e-06
 Identities = 28/110 (25%), Positives = 56/110 (50%), Gaps = 3/110 (2%)

Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETY--SR 156
           + ++T+ GTP ++APE++ +  +  +VD+WS+G +   ++ G+PP+   + L+  Y  + 
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

Query: 157 IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
               E + P  L       + + L +D  +R    +LL  +F     P S
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 2e-06
 Identities = 18/45 (40%), Positives = 28/45 (62%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + Y+ +++ GV  LH   IIHRD+K  NL +     +K+ DFGL+
Sbjct: 100 KQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 47.9 bits (115), Expect = 2e-06
 Identities = 39/231 (16%), Positives = 81/231 (35%), Gaps = 60/231 (25%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E +I + L H N+V         + +YI+ E      +++       L +  +      
Sbjct: 50  EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF------LRKHGEK----- 98

Query: 63  IWVSKWVDYSDKYGFGYQLNDDSSGVMF--------NDL-TRMIMLANKNT--------- 104
                 +   D      Q+   + G+ +         DL  R  ++              
Sbjct: 99  ------LTLKDLLQMALQI---AKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149

Query: 105 --LCGTPNY------------IAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETST 149
             +     Y            +APE L     + + DVWS G +++ +  +G+ P+   +
Sbjct: 150 RDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 209

Query: 150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLL----DPVQRPPVAQLLHF 196
            +E    ++   Y+LP     P    + +++L     DP  RP  ++L+  
Sbjct: 210 NEEVLELLED-GYRLPRPENCPDE--LYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 25/64 (39%), Positives = 38/64 (59%), Gaps = 2/64 (3%)

Query: 233 LMERNSKRRKAITEPETRF-YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKIGD 290
           L E   KR  ++ + +T   +  QIL  + ++H   I+HRDLK  N+ L  +  VVKIGD
Sbjct: 86  LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGD 145

Query: 291 FGLA 294
           FG++
Sbjct: 146 FGIS 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 21/57 (36%), Positives = 32/57 (56%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +K  +   E E      Q+L  V ++H   +IHRD+K  N+ L  N +VK+GDFG +
Sbjct: 134 AKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190

Length = 496

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 22/55 (40%), Positives = 30/55 (54%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +R +   EP  RFY  ++   + YLH   II+RDLK  N+ L     V + DFGL
Sbjct: 88  QRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 61/268 (22%), Positives = 94/268 (35%), Gaps = 90/268 (33%)

Query: 4   EIAIHRSLKHRNVVGFHSFF----EDSKFVYIILELCRKRSMMELYNSACDLEEM--SDP 57
           E+ I R  KH N++           D K VY++++L      ME      DL  +  SD 
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL------ME-----SDLHHIIHSD- 101

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQLND-----DSSGVMFNDLTRMIMLANKN--------- 103
             QP+    + + Y     F YQL        S+ V+  DL    +L N++         
Sbjct: 102 --QPL--TEEHIRY-----FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFG 152

Query: 104 ---TLCGTPN--------------YIAPEIL-NKNGHSFEVDVWSIGCI----------- 134
               L  +P               Y APE+L +   ++  +D+WS+GCI           
Sbjct: 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212

Query: 135 ----------MYTLLVGKPPFE---TSTLKETYSRIKKVEYKLPATLKK-------PAAT 174
                     +   ++G P  E             I+ +  K P    K        A  
Sbjct: 213 PGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALD 272

Query: 175 MIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
           ++ +ML  DP +R  V Q L   F   Y
Sbjct: 273 LLSQMLQFDPEERITVEQALQHPFLAQY 300

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 34/125 (27%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFE----------------TSTLKET 153
           Y APEI LN  G++  +D+WS+GCI+  +L  +P F                 T + +E 
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS-QED 233

Query: 154 YSRIKKV---EY--KLPATLKKPAATM-----------IKKMLLLDPVQRPPVAQLLHFE 197
            + I  +    Y   LP   K P   +           + KML  +P +R  V + L   
Sbjct: 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293

Query: 198 FFNDY 202
           +   Y
Sbjct: 294 YLEQY 298

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 19/45 (42%), Positives = 32/45 (71%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + ++ Q+L G++Y H  K++HRDLK  NL +++   +K+ DFGLA
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 20/50 (40%), Positives = 34/50 (68%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +E E RFY  +I+ G+ ++H+  +++RDLK  N+ L ++  V+I D GLA
Sbjct: 95  SEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 22/52 (42%), Positives = 32/52 (61%)

Query: 247 PETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           P+   +  QI EG++++     IHRDL+  N+ +S + V KI DFGLA  IE
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 1/51 (1%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+  K +HRDL   N  ++ +F VKIGDFG+   I E D  RK
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 20/52 (38%), Positives = 30/52 (57%)

Query: 247 PETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           P+      QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 102 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 20/44 (45%), Positives = 29/44 (65%)

Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 20/51 (39%), Positives = 32/51 (62%), Gaps = 1/51 (1%)

Query: 248 ETRFYM-KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           E    + +++LE ++YLH   IIHRD+K  N+FL +     +GDFG A ++
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235

Length = 392

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 20/46 (43%), Positives = 30/46 (65%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           QI +G+SYL + +++HRDL   N+ +     VKI DFGLA  ++ D
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 19/57 (33%), Positives = 34/57 (59%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           ++ R  ++  +   +   + EG+ YL   K++HRDL   N+ +S++ V K+ DFGLA
Sbjct: 91  TRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 22/62 (35%), Positives = 34/62 (54%), Gaps = 3/62 (4%)

Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           RNS R    +     FY  +I+  + YLH  +I++RDLK  N+ L     +K+ DFG A 
Sbjct: 93  RNSGR---FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149

Query: 296 RI 297
           ++
Sbjct: 150 KL 151

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 22/55 (40%), Positives = 31/55 (56%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +R ++  EP  RFY  +I   + YLH   I++RDLK  N+ L     V + DFGL
Sbjct: 88  QRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 20/56 (35%), Positives = 34/56 (60%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K+++ I E     Y  Q+   V ++H  +++HRD+K  N+F++   VVK+GD GL 
Sbjct: 98  KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 19/56 (33%), Positives = 34/56 (60%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K+++ I E     Y  Q+   + ++H  +++HRD+K  N+F++   VVK+GD GL 
Sbjct: 98  KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 26/119 (21%), Positives = 46/119 (38%), Gaps = 30/119 (25%)

Query: 111 YIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--------- 160
           Y APE L  +G +  ++D+W++GC+ + +L   P F  +   +  ++I  V         
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223

Query: 161 ---------EYKLPA-----------TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                     Y  P+                   ++KK+L  DP +R    Q L   +F
Sbjct: 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 20/44 (45%), Positives = 27/44 (61%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           Q+  G++Y+     IHRDL+  N+ + D  V KI DFGLA  IE
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 18/65 (27%), Positives = 34/65 (52%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R+    E   RFY+ +++  +  +H    IHRD+K  N+ +  +  +K+ DFGL  ++  
Sbjct: 94  RKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153

Query: 300 DGQRK 304
              R+
Sbjct: 154 AKDRE 158

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 37/131 (28%), Positives = 54/131 (41%), Gaps = 33/131 (25%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV-----EYKL 164
           Y APE+L     + F VD+WS+GCI   LL GKP F      +   RI ++     E   
Sbjct: 199 YRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNW 258

Query: 165 PATLKKPAAT-----------------------MIKKMLLLDPVQRPPVAQLLHFEFFND 201
           P   K P  T                       +++ +L L+P++R    + L  E+F  
Sbjct: 259 PQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318

Query: 202 Y---C-PTSLP 208
               C P+ LP
Sbjct: 319 DPLPCDPSQLP 329

Length = 335

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 8/115 (6%)

Query: 81  LNDDSSGVMFNDLTRMIMLANKNT----LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY 136
           L D+   V  +DL   + L +  +      GTP ++APE+L    + F VD +++G  +Y
Sbjct: 129 LLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLY 188

Query: 137 TLLVGKPPF----ETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
            ++  + PF    E    KE   RI       P      + +  + +L  DP +R
Sbjct: 189 EMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 20/50 (40%), Positives = 34/50 (68%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +E E RFY  +I+ G+ ++H+  +++RDLK  N+ L ++  V+I D GLA
Sbjct: 95  SEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 19/40 (47%), Positives = 26/40 (65%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L ++F VK+ DFGLA
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLA 145

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 20/46 (43%), Positives = 27/46 (58%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Q+ +G+ +L     IHRD+   N+ L+D  V KI DFGLA  I  D
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 20/47 (42%), Positives = 30/47 (63%)

Query: 247 PETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           P   FY  +I+ G+ +LH   I++RDLKL N+ L  +  +KI DFG+
Sbjct: 96  PRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.8 bits (111), Expect = 5e-06
 Identities = 22/49 (44%), Positives = 28/49 (57%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  QI +G+ YL   + +HRDL   N+ +     VKIGDFGL   IE D
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 20/52 (38%), Positives = 30/52 (57%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           E    FY  +I  G+  LH  +I++RDLK  N+ L D+  ++I D GLA  +
Sbjct: 101 EGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV 152

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 46.4 bits (111), Expect = 7e-06
 Identities = 36/135 (26%), Positives = 56/135 (41%), Gaps = 38/135 (28%)

Query: 108 TPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK----- 159
           T  Y APE+L      G    VD+WS+GCI   LL+  P     +  +   +I +     
Sbjct: 165 TRWYRAPELLFGARHYGVG--VDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222

Query: 160 --------------VEYK-LPATLKK---PAAT-----MIKKMLLLDPVQRPPVAQLLHF 196
                         VE+K  P T  K   PAA+     +++++L L+P +R    Q L  
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282

Query: 197 EFFNDYCPTSLPASC 211
            +F     ++ PA  
Sbjct: 283 PYF-----SNDPAPT 292

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 21/55 (38%), Positives = 30/55 (54%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +R +   EP  RFY  +I   + YLH   I++RDLK  N+ L     + + DFGL
Sbjct: 88  QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.6 bits (110), Expect = 7e-06
 Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 6/66 (9%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL------ 293
           ++  +TE ET+FY+ + +  +  +H    IHRD+K  NL L     VK+ DFGL      
Sbjct: 94  KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153

Query: 294 AARIEF 299
           A R EF
Sbjct: 154 AHRTEF 159

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 18/40 (45%), Positives = 24/40 (60%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI  G+ YL     +HRDL   N  +  + VVKIGDFG++
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 21/56 (37%), Positives = 34/56 (60%), Gaps = 1/56 (1%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +T    +F++ Q+L  + Y+H   + HRDLK  N+  + +  +KI DFGL AR+ F
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVAF 154

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (109), Expect = 8e-06
 Identities = 15/42 (35%), Positives = 29/42 (69%)

Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF 145
           ++ GTP +++PE+++  G+  + DVWS+ C +  +L  KPP+
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.3 bits (110), Expect = 8e-06
 Identities = 18/59 (30%), Positives = 32/59 (54%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           I E   RFY  +++  +  +H    IHRD+K  N+ L  +  +K+ DFG   +++ +G 
Sbjct: 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 46.3 bits (110), Expect = 8e-06
 Identities = 23/63 (36%), Positives = 34/63 (53%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
            KR   +T  +   +  Q+ +G+++L     IHRDL   N+ L+   +VKI DFGLA  I
Sbjct: 132 RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191

Query: 298 EFD 300
             D
Sbjct: 192 MND 194

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.2 bits (109), Expect = 9e-06
 Identities = 64/257 (24%), Positives = 100/257 (38%), Gaps = 72/257 (28%)

Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + +KH NV+G    F      E+   VY++  L     M    N+    +++SD
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-----MGADLNNIVKCQKLSD 117

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNT------------ 104
              Q +I       Y    G  Y     S+G++  DL    +  N++             
Sbjct: 118 EHVQFLI-------YQLLRGLKYI---HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167

Query: 105 -------LCGTPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR 156
                     T  Y APEI LN   ++  VD+WS+GCIM  LL GK  F  +   +   R
Sbjct: 168 ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR 227

Query: 157 IKKVE-YKLPATLKK-------------P-----------------AATMIKKMLLLDPV 185
           I +V     P  LKK             P                 A  +++KML+LD  
Sbjct: 228 IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSD 287

Query: 186 QRPPVAQLLHFEFFNDY 202
           +R   ++ L   +F+ Y
Sbjct: 288 KRISASEALAHPYFSQY 304

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 24/59 (40%), Positives = 33/59 (55%), Gaps = 2/59 (3%)

Query: 241 RKAITEPE--TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           RKA   P    +FY  +++    YLH   II+RDLK  NL L +   VK+ DFG A ++
Sbjct: 110 RKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168

Length = 329

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 23/66 (34%), Positives = 35/66 (53%), Gaps = 6/66 (9%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL------ 293
           ++  ++E  T+FY+ + +  +  +H    IHRD+K  NL L     VK+ DFGL      
Sbjct: 94  KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153

Query: 294 AARIEF 299
           A R EF
Sbjct: 154 AHRTEF 159

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 19/62 (30%), Positives = 36/62 (58%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + E +     + +L+ + YLH   +IHRD+K  ++ L+ +  VK+ DFG  A+I  D  +
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173

Query: 304 KR 305
           ++
Sbjct: 174 RK 175

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 24/61 (39%), Positives = 33/61 (54%), Gaps = 1/61 (1%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           E    FY  +IL G+  LH    ++RDLK  N+ L D   ++I D GLA +I E +  R 
Sbjct: 101 EERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160

Query: 305 R 305
           R
Sbjct: 161 R 161

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 27/67 (40%), Positives = 36/67 (53%), Gaps = 4/67 (5%)

Query: 232 PLMER-NSKRRKAITEPETRFY--MKQILEGVSYLHDHK-IIHRDLKLGNLFLSDNFVVK 287
           PL E  NS + K     E R +    Q++  + YLH  K I+HRDL   N+ L ++  V 
Sbjct: 95  PLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT 154

Query: 288 IGDFGLA 294
           I DFGLA
Sbjct: 155 ITDFGLA 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 20/53 (37%), Positives = 31/53 (58%), Gaps = 1/53 (1%)

Query: 241 RKAITEPETRFYMKQILEGVSYLH-DHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           +  I E         +L+G++YLH  HKIIHRD+K  N+ ++    +K+ DFG
Sbjct: 94  QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFG 146

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 27/73 (36%), Positives = 38/73 (52%), Gaps = 4/73 (5%)

Query: 229 RRKPLMERNSKRRKAITEPETRFYM----KQILEGVSYLHDHKIIHRDLKLGNLFLSDNF 284
           RR P ME +    +   E  T   +     Q+  G+ YL   K IHRDL   N+ +++N 
Sbjct: 115 RRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN 174

Query: 285 VVKIGDFGLAARI 297
           V+KI DFGLA  +
Sbjct: 175 VMKIADFGLARDV 187

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 1/47 (2%)

Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           + EG++YL    +IHRDL   N  + +N VVK+ DFG+  R   D Q
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGM-TRFVLDDQ 154

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 29/117 (24%), Positives = 56/117 (47%), Gaps = 3/117 (2%)

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETY--SRIK 158
           ++T+ GTP ++APE++ +  +  +VD+WS+G +   ++ G+PP+   + L+  Y  +   
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231

Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTA 215
             E + P  L       + + L +D  +R    +LL   F     P S     +  A
Sbjct: 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAAA 288

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 18/40 (45%), Positives = 26/40 (65%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +I  G+ +LH +  IH DL L N  L+ +  VKIGD+GL+
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 19/43 (44%), Positives = 24/43 (55%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           QI  G+ YL  H  +HRDL   N  + +   VKI DFGL+  I
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 20/43 (46%), Positives = 29/43 (67%)

Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           FY  +I+ G+ +LH   II+RDLKL N+ L  +  +KI DFG+
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 14/111 (12%)

Query: 99  LANKNTLCGTPNYIAPEI-----LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET 153
           L  +++  GTP ++APE+     +    + ++ D+WS+G  +  +   +PP         
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 223

Query: 154 YSRIKKVEYKLPATLKKPAA------TMIKKMLLLDPVQRPPVAQLLHFEF 198
             +I K E   P TL +P+         +K  L   P  RP  AQLL   F
Sbjct: 224 LLKIAKSE---PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 52/256 (20%), Positives = 89/256 (34%), Gaps = 77/256 (30%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRK--RSMMELYNSACDLEEMSDPAAQ 60
           +EI++ + LKH N+V  H        + ++ E   K  +  M+ +     L+  +     
Sbjct: 47  REISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTV---- 102

Query: 61  PVIWVSKWVDYSDKYGFGYQLNDDSS-----GVMFNDLTRMIMLANK------------- 102
                        K  F YQL    +      V+  DL    +L NK             
Sbjct: 103 -------------KS-FTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148

Query: 103 ------NTLCG---TPNYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE 152
                 NT      T  Y AP++L     +S  +D+WS+GCIM  ++ G+P F  +  ++
Sbjct: 149 AFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208

Query: 153 TYSRIKKV----------------EYKLPATLKKP-------------AATMIKKMLLLD 183
              +I ++                EYK       P                ++ ++L L+
Sbjct: 209 QLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLN 268

Query: 184 PVQRPPVAQLLHFEFF 199
           P  R      L   +F
Sbjct: 269 PELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 38/124 (30%), Positives = 56/124 (45%), Gaps = 32/124 (25%)

Query: 111 YIAPE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSTLKET----YSRI 157
           Y APE ILN   ++  VD+WS+GCIM  +L GK  F+        T  LK T       +
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239

Query: 158 KKVEYK--------LPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEF 198
           +K+E K        LP   +K            A  +++KML LD  +R    + L   +
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Query: 199 FNDY 202
           F+ +
Sbjct: 300 FDSF 303

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 19/59 (32%), Positives = 36/59 (61%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
              + + E    + +   L G+ +LH+++IIHRD+K  N+ L+    VK+ DFG++A++
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 30/208 (14%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELY----NSACDLEEMSDPA 58
            E  I + L+H  ++  ++     + +YI+ EL +  S++E        A  L ++ D A
Sbjct: 50  AEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA 109

Query: 59  AQPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANKNTLCGTP 109
           AQ    V+  + Y +   + ++       L  +++     D  L R+I         G  
Sbjct: 110 AQ----VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAK 165

Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVE--YK 163
               + APE    N  S + DVWS G ++  ++  G+ P+   T  E    +++V+  Y+
Sbjct: 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---LQQVDQGYR 222

Query: 164 LPATLKKPAATMIKKMLLL---DPVQRP 188
           +P     P   +   ML     DP  RP
Sbjct: 223 MPCPPGCPKE-LYDIMLDCWKEDPDDRP 249

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 52/193 (26%), Positives = 77/193 (39%), Gaps = 31/193 (16%)

Query: 88  VMFNDLTRMIMLANKNTLCGTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLLVGKPPF 145
           V FND    I   +      T  Y APE+     + ++  +D+WSIGCI   +L GKP F
Sbjct: 152 VAFNDTPTAIFWTD---YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Query: 146 E-----------TSTL----KETYSRIK--KVEYKLPATLKKPAATMIKKMLLLDPVQRP 188
                       T  L     ET SR++  K    L +  KK      +K    DP+   
Sbjct: 209 PGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALR 268

Query: 189 PVAQLLHFEFFNDYCPTSLP-ASCLMTAPRFDSVVPSFNSPRRKPL--MERNSKRRKAIT 245
            + +LL F+      P   P A   +  P F  +      P  +P+  +E   +RR+   
Sbjct: 269 LLERLLAFD------PKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTK 322

Query: 246 EPETRFYMKQILE 258
           E       ++ILE
Sbjct: 323 EDVRELIYREILE 335

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 1/52 (1%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I  + Q KR
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKR 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 19/47 (40%), Positives = 32/47 (68%)

Query: 248 ETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + R Y+ Q+++ + + H + I+HRD+K  NL +S N V+K+ DFG A
Sbjct: 101 KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 17/39 (43%), Positives = 27/39 (69%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +I  GV+++H H  +H DL L N FL+ +  VK+GD+G+
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 18/41 (43%), Positives = 25/41 (60%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K + EG++YL   + IHRDL   N  + D   VK+ DFGL+
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 25/78 (32%), Positives = 37/78 (47%), Gaps = 12/78 (15%)

Query: 229 RRKPL------MERNS-----KRRKAITEPETRFYMKQ-ILEGVSYLHDHKIIHRDLKLG 276
           ++KPL      ME        ++R+     +    M Q + EG+ YL  +  IHRDL   
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAAR 129

Query: 277 NLFLSDNFVVKIGDFGLA 294
           N  +S   VVK+ DFG+ 
Sbjct: 130 NCLVSSTGVVKVSDFGMT 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 19/48 (39%), Positives = 29/48 (60%)

Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 17/43 (39%), Positives = 26/43 (60%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +   +  G+ YL   + IHRDL   N+ + +N+V KI DFGL+
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 44.4 bits (105), Expect = 3e-05
 Identities = 21/57 (36%), Positives = 29/57 (50%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           E    FY+ +I   + +LH   II+RDLK  N+ L     VK+ DFGL      +G 
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.4 bits (105), Expect = 3e-05
 Identities = 18/45 (40%), Positives = 29/45 (64%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R Y  + +  + YLH++ I+HRDLK  NL ++    +K+ DFGL+
Sbjct: 104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 21/55 (38%), Positives = 33/55 (60%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +R+   E E + Y  +I+  + +LH   II+RD+KL N+ L  N  V + DFGL+
Sbjct: 98  QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 17/49 (34%), Positives = 29/49 (59%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+   ++YL   + +HRD+   N+ +S    VK+GDFGL+  +E +
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 21/52 (40%), Positives = 32/52 (61%), Gaps = 1/52 (1%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRKR 305
           QI  G+ YL + K++HRDL   N+ +++   +KI DFGL+  + E D   KR
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 44.3 bits (104), Expect = 3e-05
 Identities = 19/51 (37%), Positives = 30/51 (58%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +T+ +     +QI  G+ YL     +HRDL   N  + +N +VKIGDFG++
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 18/43 (41%), Positives = 27/43 (62%)

Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           I  G+ YL +   +HRDL   N+ ++ N V K+ DFGL+ R+E
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 21/55 (38%), Positives = 33/55 (60%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +R   +E E RFY  +I+  + +LH   I++RD+KL N+ L     V + DFGL+
Sbjct: 98  QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 20/44 (45%), Positives = 29/44 (65%)

Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 13/110 (11%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR------ 156
           +T  GT  Y++PE +    ++ + DVWS+G  +  L +GK PF  S + +          
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL 219

Query: 157 ------IKKVEYKLPAT-LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                 +++   +LP++   +     +   LL DP +RP   QL     F
Sbjct: 220 DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 43.8 bits (103), Expect = 4e-05
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 4/86 (4%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           + APE L +   S + DVWS G +++ +   G+ P+    LK+   R++K  YK+ A   
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDG 223

Query: 170 KPAAT--MIKKMLLLDPVQRPPVAQL 193
            P     ++K+   LD   RP   QL
Sbjct: 224 CPPVVYDVMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 18/62 (29%), Positives = 31/62 (50%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K+R+ I   + +    Q+  G++YL     +HRDL   N+ L +    KI DFG++  + 
Sbjct: 87  KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG 146

Query: 299 FD 300
             
Sbjct: 147 AG 148

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 19/40 (47%), Positives = 27/40 (67%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 18/41 (43%), Positives = 29/41 (70%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +L  + YLH+++IIHRD+K  N+F++    V +GDFG A
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.8 bits (103), Expect = 4e-05
 Identities = 20/46 (43%), Positives = 30/46 (65%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           QI +G+SYL + +++HRDL   N+ +     VKI DFGLA  ++ D
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.8 bits (103), Expect = 4e-05
 Identities = 19/62 (30%), Positives = 37/62 (59%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L++   + R ++       +  QI +G+ YL +H+++HR+L   N+ L  + +V+I DFG
Sbjct: 95  LLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFG 154

Query: 293 LA 294
           +A
Sbjct: 155 VA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 19/50 (38%), Positives = 32/50 (64%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           TE + +FY+ ++   + +LH   II+RDLK  N+ L +   +K+ DFGL+
Sbjct: 96  TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 145

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.8 bits (103), Expect = 5e-05
 Identities = 16/49 (32%), Positives = 30/49 (61%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E   +FY+ +++  + +LH + I++RDLK  N+ L     + + DFGL+
Sbjct: 95  EDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLS 143

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 43.5 bits (102), Expect = 5e-05
 Identities = 19/46 (41%), Positives = 26/46 (56%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +M  I  G+ YL     IHRDL   N  L++N  V + DFGL+ +I
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 43.8 bits (103), Expect = 5e-05
 Identities = 18/63 (28%), Positives = 30/63 (47%)

Query: 232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDF 291
           P   +       +T  +   +   +  G+ YL + + IHRDL   N+ + +N   KI DF
Sbjct: 104 PAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADF 163

Query: 292 GLA 294
           GL+
Sbjct: 164 GLS 166

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 43.3 bits (103), Expect = 6e-05
 Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 10/90 (11%)

Query: 113 APEILNKNGHSFEVDVWSIGCIMY---TLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           APE L +   + + DVWS G +++   TL  G+ P+   +  E    +KK  Y+LP    
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTL--GEEPYPGMSNAEVLEYLKK-GYRLPKPPN 228

Query: 170 KPAATMIKKMLL---LDPVQRPPVAQLLHF 196
            P   + K ML     DP  RP  ++L+  
Sbjct: 229 CPPE-LYKLMLQCWAEDPEDRPTFSELVEI 257

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 34/121 (28%), Positives = 51/121 (42%), Gaps = 30/121 (24%)

Query: 111 YIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--------- 160
           Y APEIL  + H S  VD+WS+GCI   ++  KP F   +  +   +I ++         
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228

Query: 161 -------EYK-------------LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
                  +YK             +  TL+     ++ KML LDP +R      L  E+F 
Sbjct: 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288

Query: 201 D 201
           D
Sbjct: 289 D 289

Length = 294

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 4/85 (4%)

Query: 113 APEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEYKL--PATLK 169
           APE L +   S + DVWS G +++ +   G+ P+    LK+    ++K  Y++  P    
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCP 225

Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
                ++K    LDP +RP   QL 
Sbjct: 226 PEVYKVMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 38/218 (17%)

Query: 13  HRNVVGFHSFF--EDSKF---VYIILELCRKRSMMELYNSACDL-EEMSDPAAQPVIW-- 64
           H NVV F+  +  +D K    ++++LELC   S+ +L        E M +P    ++   
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 65  --------VSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYI 112
                   V+K + + D  G    L  +  GV   D      L +    +NT  GTP ++
Sbjct: 134 LMGLQHLHVNKTI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191

Query: 113 APEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEYKLPA 166
           APE++       + +    DVWS+G     L  G PP  +   ++  +    K+    P 
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF----KIPRNPPP 247

Query: 167 TLKKPAA------TMIKKMLLLDPVQRPPVAQLLHFEF 198
           TL +P          I+K L  D  +RP V+ LL   F
Sbjct: 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 43.4 bits (102), Expect = 6e-05
 Identities = 19/46 (41%), Positives = 26/46 (56%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +M  I  G+ YL     IHRDL   N  L++N  V + DFGL+ +I
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 43.3 bits (102), Expect = 6e-05
 Identities = 19/56 (33%), Positives = 33/56 (58%), Gaps = 1/56 (1%)

Query: 244 ITEPETRFYMKQILEGVSYL-HDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           I E   R     +++G+ +L  +H IIHRD+K  N+ ++ N  VK+ DFG++  + 
Sbjct: 99  IPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 20/56 (35%), Positives = 30/56 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K      E E      QI+  +  +H  K++HRDLK  N+FL    ++K+GDFG +
Sbjct: 161 KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS 216

Length = 478

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.1 bits (101), Expect = 8e-05
 Identities = 55/246 (22%), Positives = 97/246 (39%), Gaps = 56/246 (22%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS-----DP 57
           +E+ + R+LK  N+V     F     +Y++ E   +++M+EL      LEEM      + 
Sbjct: 49  RELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV-EKNMLEL------LEEMPNGVPPEK 101

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQ-LNDDSSGVMFNDLTRMIML-----------ANKNTL 105
               +  + K + +  K    ++ +  ++  +  ND+ ++              AN    
Sbjct: 102 VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161

Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
             T  Y +PE+L    +   VD+WS+GCI+  L  G+P F   +  +    I+KV   LP
Sbjct: 162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP 221

Query: 166 AT-------------LKKPAAT-------------------MIKKMLLLDPVQRPPVAQL 193
           A              L+ PA                     ++K +L L+P  R    Q 
Sbjct: 222 AEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281

Query: 194 LHFEFF 199
           L+   F
Sbjct: 282 LNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.1 bits (101), Expect = 8e-05
 Identities = 20/43 (46%), Positives = 28/43 (65%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 42.9 bits (102), Expect = 9e-05
 Identities = 24/88 (27%), Positives = 42/88 (47%), Gaps = 6/88 (6%)

Query: 113 APEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           APE L +   + + DVWS G +++ +  +G+ P+   + +E    +K   Y+LP     P
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN-GYRLPQPPNCP 229

Query: 172 AATMIKKMLL---LDPVQRPPVAQLLHF 196
              +   ML     DP  RP  ++L+  
Sbjct: 230 PE-LYDLMLQCWAEDPEDRPTFSELVEI 256

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 33/143 (23%), Positives = 52/143 (36%), Gaps = 25/143 (17%)

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR-IKKVEYKLP 165
           GTP Y APE L     +   D+++ G I    L G+   + +++ E   + +  V+  LP
Sbjct: 151 GTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP 210

Query: 166 ATLKK-PAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPS 224
             +   P   +++K L  DP QR   A  L   F                A    ++V  
Sbjct: 211 PWIAGHPLGQVLRKALNKDPRQRAASAPALAERF---------------RALELCALVGI 255

Query: 225 FNSPRRKPLMERNSKRRKAITEP 247
                           R+AI  P
Sbjct: 256 LRMGEGAG--------REAIAAP 270

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 9e-05
 Identities = 17/57 (29%), Positives = 30/57 (52%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
             R + +   +     +Q+L  + Y+H   IIHRD+K  N+ ++    + +GDFG A
Sbjct: 251 GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307

Length = 461

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 30/126 (23%), Positives = 48/126 (38%), Gaps = 31/126 (24%)

Query: 106 CGTPNYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV---- 160
             T  Y APE+L     +   VD+W++GCI   LL G P F      E  + + +     
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220

Query: 161 -------------------EYKLPATLKK--PAAT-----MIKKMLLLDPVQRPPVAQLL 194
                                  P  L++  P A+     ++K +L+ DP +R   A+ L
Sbjct: 221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280

Query: 195 HFEFFN 200
              +F 
Sbjct: 281 RHPYFT 286

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 18/50 (36%), Positives = 29/50 (58%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +E  TRFYM + +  +  +H    IHRD+K  N+ +     +K+ DFGL+
Sbjct: 99  SEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 32/120 (26%), Positives = 46/120 (38%), Gaps = 33/120 (27%)

Query: 108 TPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFE----------------TSTL 150
           T  Y APEIL  + H +  VD+WS+GCI   LL  +  F+                T +L
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226

Query: 151 KE-----------TYSRIKK-----VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           +                  K     V Y L +     A  ++ +ML+ DP +R   A  L
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 14/108 (12%)

Query: 102 KNTLCGTPNYIAPEILNKN-----GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR 156
           +NT  GTP ++APE++  +      +    DVWS+G     L  GKPP     +    + 
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--CDMHPMRAL 227

Query: 157 IKKVEYKLPATLKKPAA------TMIKKMLLLDPVQRPPVAQLLHFEF 198
            K      P TLK P          I + L+ +  QRP + +LL   F
Sbjct: 228 FKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 21/60 (35%), Positives = 33/60 (55%), Gaps = 1/60 (1%)

Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           E    FY  ++  G+  L   +I++RDLK  N+ L D   ++I D GLA +I  +G+  R
Sbjct: 101 EQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGETVR 159

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 16/42 (38%), Positives = 29/42 (69%)

Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +L  +SYLH+  +IHRD+K  ++ L+ +  +K+ DFG  A++
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 42/210 (20%), Positives = 87/210 (41%), Gaps = 18/210 (8%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC--RKRSMMELYN---SACDLEEMSDP 57
           +E+   + LKH N + +   +      ++++E C      ++E++       ++  ++  
Sbjct: 70  KEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHG 129

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEI- 116
           A Q + ++            G  L  +   V   D       +  N+  GTP ++APE+ 
Sbjct: 130 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVI 189

Query: 117 --LNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKVEYKLPA-----TL 168
             +++  +  +VDVWS+G     L   KPP F  + +   Y   +     L +     + 
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249

Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
           +      ++K+    P +RP  A+LL  +F
Sbjct: 250 RGFVDYCLQKI----PQERPASAELLRHDF 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 42.4 bits (99), Expect = 1e-04
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 1/52 (1%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I  + Q KR
Sbjct: 122 RECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKR 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 42.2 bits (99), Expect = 1e-04
 Identities = 17/47 (36%), Positives = 26/47 (55%)

Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
            Y  QI  G+ +LH   I++RD+K  N+ L D    ++ D GLA  +
Sbjct: 99  HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 1/52 (1%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I  + Q KR
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKR 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 4/85 (4%)

Query: 107 GTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK---KVEY 162
           GT  Y+APE+L K   +    D +S+GC+++ LL G  PF     K+ +   +    V  
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV 216

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           +LP +      ++++ +L  D  +R
Sbjct: 217 ELPDSFSPELKSLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 19/51 (37%), Positives = 29/51 (56%), Gaps = 3/51 (5%)

Query: 248 ETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV---VKIGDFGLAA 295
           ET   M Q+L+ ++  H+  I+HRDLK  N+ +S   V    K+ DFG+  
Sbjct: 80  ETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 18/40 (45%), Positives = 27/40 (67%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+  G+ YL   + IHRDL   N+ ++++ V+KI DFGLA
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 20/44 (45%), Positives = 29/44 (65%)

Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 18/46 (39%), Positives = 26/46 (56%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +M  I  G+ YL +   IHRDL   N  L ++  V + DFGL+ +I
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 24/56 (42%), Positives = 30/56 (53%), Gaps = 6/56 (10%)

Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSD-----NFVVKIGDFGLAARI-EFDGQRKR 305
           + +G  YL     IHRDL   N  +S+     + VVKIGDFGLA  I + D  RK 
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 20/44 (45%), Positives = 29/44 (65%)

Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 30/122 (24%), Positives = 46/122 (37%), Gaps = 33/122 (27%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKE------------- 152
           Y APE+L     +S  +D+WS+GCI   LL  KP F    E   L +             
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 153 ------TYSRIKKVEYKLPATLKK--PAATM-------IKKMLLLDPVQRPPVAQLLHFE 197
                   ++ K         L+K  PA ++       + ++L  DP +R      L   
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291

Query: 198 FF 199
           +F
Sbjct: 292 YF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 17/50 (34%), Positives = 32/50 (64%)

Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +L+ +S LH   +IHRD+K  ++ L+ +  VK+ DFG  A++  +  R++
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 30/221 (13%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNS----ACDLEEMSDPA 58
           QE  I + L+H  +V  ++   + + +YI+ E   K S+++   S       L ++ D A
Sbjct: 50  QEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109

Query: 59  AQPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANKNTLCGTP 109
           AQ    +++ + Y +   + ++       L  ++      D  L R+I         G  
Sbjct: 110 AQ----IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAK 165

Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVE--YK 163
               + APE  N    + + DVWS G ++  ++  G+ P+   T +E    +++VE  Y+
Sbjct: 166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQVERGYR 222

Query: 164 LPATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
           +P     P     ++ +    DP +RP    L    F  DY
Sbjct: 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYL--QSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 19/47 (40%), Positives = 24/47 (51%), Gaps = 1/47 (2%)

Query: 247 PETRFYM-KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
             T  YM  QI  G+ YL     +HRDL   N  +  N+ +KI DFG
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 6/86 (6%)

Query: 113 APEILNKNGHSFEVDVWSIGCIMY-TLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           APE LN   ++ E DVWS G +++ T  +G  P+   + ++T  RI+   Y++PA    P
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCP 221

Query: 172 AATMIKKMLLL---DPVQRPPVAQLL 194
              + + ML     DP  RP  +++ 
Sbjct: 222 EE-IYRLMLQCWAYDPENRPSFSEIY 246

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 15/104 (14%)

Query: 107 GTPNYIAPE----ILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           G   Y+APE     LN+ G+  + DVWS+G  M  L  G+ P++  + K  + ++K+V  
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD--SWKTPFQQLKQVVE 222

Query: 163 KLPATLKKPAAT-------MIKKMLLLDPVQRPPVAQLLHFEFF 199
           +    L  PA          + K L  +  +RP   +LL   FF
Sbjct: 223 EPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 18/43 (41%), Positives = 25/43 (58%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           QI  G+ YL     +HRDL   N  +  N +VKIGDFG++  +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 17/43 (39%), Positives = 29/43 (67%), Gaps = 1/43 (2%)

Query: 256 ILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           I++ + YL + H +IHRD+K  N+ L  +  VK+ DFG++ R+
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 27/103 (26%), Positives = 43/103 (41%), Gaps = 13/103 (12%)

Query: 111 YIAPEILNKN---GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           Y+APE ++ +   G+    DVWS+G  +Y +  GK P+        + ++ +V    P  
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVKGDPPI 230

Query: 168 LK--------KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
           L               I   L+ D  +RP   +LL   F  DY
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.4 bits (97), Expect = 2e-04
 Identities = 18/40 (45%), Positives = 25/40 (62%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           ++  G+ +LH    IH DL L N  L+ +  VKIGD+GLA
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 18/40 (45%), Positives = 27/40 (67%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL + +++HRDL   N+ +     VKI DFGLA
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 19/59 (32%), Positives = 33/59 (55%)

Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
              +  K ++E   RFY  ++L  + YLH   I++RDLK  N+ L ++  + + DF L+
Sbjct: 92  LQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS 150

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 17/69 (24%), Positives = 35/69 (50%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L+   ++      E   +FY+ +++  +  +H    +HRD+K  N+ +     +K+ DFG
Sbjct: 88  LLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG 147

Query: 293 LAARIEFDG 301
            AAR+  + 
Sbjct: 148 SAARLTANK 156

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 19/64 (29%), Positives = 34/64 (53%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           SK    + E   RFY+ +++  +  +H    +HRD+K  N+ L  N  +++ DFG   ++
Sbjct: 93  SKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152

Query: 298 EFDG 301
             DG
Sbjct: 153 NQDG 156

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 59/257 (22%), Positives = 95/257 (36%), Gaps = 72/257 (28%)

Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + +KH NV+G    F      E+   VY++  L     M    N+    ++++D
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTD 119

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNT------------ 104
              Q +I       Y    G  Y     S+ ++  DL    +  N++             
Sbjct: 120 DHVQFLI-------YQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169

Query: 105 -------LCGTPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR 156
                     T  Y APEI LN   ++  VD+WS+GCIM  LL G+  F  +   +    
Sbjct: 170 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229

Query: 157 IKKVEYKLPATLKKP-------------------------------AATMIKKMLLLDPV 185
           I ++     A L K                                A  +++KML+LD  
Sbjct: 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 289

Query: 186 QRPPVAQLLHFEFFNDY 202
           +R   AQ L   +F  Y
Sbjct: 290 KRITAAQALAHAYFAQY 306

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 8/62 (12%)

Query: 247 PETRFYMKQILE-------GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
            + R  +K++L+       G+ YL     IHRDL   N  + +N V+KI DFG+ +R E 
Sbjct: 86  KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGM-SREEE 144

Query: 300 DG 301
            G
Sbjct: 145 GG 146

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 19/43 (44%), Positives = 24/43 (55%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           QI  G+ YL     +HRDL   N  +    VVKIGDFG++  I
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 18/48 (37%), Positives = 29/48 (60%)

Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL +   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 20/46 (43%), Positives = 27/46 (58%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Q+ +G+S+L     IHRDL   N+ L+   + KI DFGLA  I  D
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.1 bits (96), Expect = 3e-04
 Identities = 23/69 (33%), Positives = 33/69 (47%)

Query: 232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDF 291
           PL +  S ++  IT       M Q+  G+ YL     +HRDL   N+ L +    KI DF
Sbjct: 80  PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDF 139

Query: 292 GLAARIEFD 300
           GL+  +  D
Sbjct: 140 GLSKALGAD 148

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 41.1 bits (96), Expect = 3e-04
 Identities = 18/48 (37%), Positives = 28/48 (58%)

Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N   K+ DFGL+  +E D
Sbjct: 113 LRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 16/40 (40%), Positives = 29/40 (72%), Gaps = 1/40 (2%)

Query: 256 ILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +L G++YL + HKI+HRD+K  N+ ++    +K+ DFG++
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 18/51 (35%), Positives = 30/51 (58%), Gaps = 1/51 (1%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           Y  P+IL     +S ++D+W +GCI Y +  G+P F  ST++E    I ++
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 40.7 bits (95), Expect = 4e-04
 Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 4/85 (4%)

Query: 107 GTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS---RIKKVEY 162
           GT  Y+APE+L K   +    D +S+GC+++ LL G  PF     K+ +        +  
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 216

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           +LP +      ++++ +L  D  +R
Sbjct: 217 ELPDSFSPELRSLLEGLLQRDVNRR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 27/116 (23%), Positives = 46/116 (39%), Gaps = 27/116 (23%)

Query: 84  DSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP 143
           D   + ++ +T          + GTP+Y+APE L     S   D++++G I+Y +L    
Sbjct: 176 DERNICYSSMTIP------GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML---- 225

Query: 144 PFETSTLKETYSRIKKVEYKLPATLKKPA------------ATMIKKMLLLDPVQR 187
                TL   Y R K  +      +  P             + +  K L +DP +R
Sbjct: 226 -----TLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276

Length = 932

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 20/46 (43%), Positives = 29/46 (63%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           QI +G+ YL + +++HRDL   N+ +     VKI DFGLA  +E D
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 1/58 (1%)

Query: 237 NSKRRKAITEPETRFYM-KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           + K  K+  EP    ++  QI  G+ +L  H ++H+DL   N+ + D   VKI D GL
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 17/45 (37%), Positives = 24/45 (53%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            F   QI  G+ YL     +HRDL   N  +  N+ +KI DFG++
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 20/42 (47%), Positives = 28/42 (66%)

Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           M+Q+L G+  LH   I+HRD+K  NL ++ +  VKI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 40.6 bits (95), Expect = 4e-04
 Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 8/79 (10%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETY-SRIKK-VEYKLPATL 168
           Y APE+   +  +   D WS+G I++ LL GK      TL E + S I       +P  +
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGK------TLVECHPSGINTHTTLNIPEWV 201

Query: 169 KKPAATMIKKMLLLDPVQR 187
            + A ++++++L  +P +R
Sbjct: 202 SEEARSLLQQLLQFNPTER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 40.5 bits (94), Expect = 5e-04
 Identities = 27/107 (25%), Positives = 52/107 (48%), Gaps = 7/107 (6%)

Query: 99  LANKNTLCGTPNYIAPEIL--NKN---GHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKE 152
           +  +NT  GTP ++APE++  ++N    + F+ D+WS+G     +  G PP  +   ++ 
Sbjct: 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224

Query: 153 TYSRIKKVEYKLPA-TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
            +   +    +L +    K   + I+  L+ +  QRP   QL+   F
Sbjct: 225 LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 29/171 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+   + L+H N + +   +      ++++E C          SA DL E+     Q V
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEV 115

Query: 63  IWVSKWVDYSDKYGFGYQLN------DDSSG---------VMFNDLTRMIMLANKNTLCG 107
              +  V +    G  Y  +      D  +G         V   D     ++A  N   G
Sbjct: 116 EIAA--VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVG 173

Query: 108 TPNYIAPEI---LNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETY 154
           TP ++APE+   +++  +  +VDVWS+G     L   KPP F  + +   Y
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 1/43 (2%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE 152
           Y  P++L     +S  +D+W +GCI+Y +  G+P F  ST+KE
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 40.5 bits (95), Expect = 5e-04
 Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 4/85 (4%)

Query: 113 APEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVEYKL--PATLK 169
            PE+ + +  S + DVWS G +M+ +   GK P+E  +  E    +    Y+L  P    
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAP 227

Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
               T++       P  RP   +LL
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKKLL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 40.9 bits (95), Expect = 5e-04
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 1/52 (1%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I  + Q KR
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKR 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 15/40 (37%), Positives = 31/40 (77%), Gaps = 1/40 (2%)

Query: 256 ILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           ++EG++YL++ H+I+HRD+K  N+ ++    +K+ DFG++
Sbjct: 112 VVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 18/57 (31%), Positives = 32/57 (56%), Gaps = 3/57 (5%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK---PPFETSTLKETYSR 156
           N+  GT +Y++PE L    +S + D+WS+G  +  L +G+   PP +   L+  + R
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR 216

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 20/62 (32%), Positives = 31/62 (50%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++ K +TE      + Q+  G+ YL +   +HRDL   N+ L      KI DFGL+  + 
Sbjct: 87  QKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146

Query: 299 FD 300
            D
Sbjct: 147 AD 148

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 16/45 (35%), Positives = 27/45 (60%), Gaps = 1/45 (2%)

Query: 102 KNTLCGTPNYIAPE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPF 145
           ++T  GTP ++APE I     +  + D+WS+G  +Y +  G PP+
Sbjct: 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 22/67 (32%), Positives = 33/67 (49%), Gaps = 9/67 (13%)

Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFG 292
           +  +R   I     +  M+QIL  +  LH   I+HRD+K  N+  S+   +F  KI D G
Sbjct: 248 KGLERENKII----QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLG 301

Query: 293 LAARIEF 299
            AA +  
Sbjct: 302 AAADLRV 308

Length = 566

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 25/213 (11%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLE-----EM 54
           EI   R +   N++  + F  D       + +ILE C +  + E+ +   DL      +M
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127

Query: 55  SDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPN---- 110
           +    + +  + K+   +  Y     L   S  V  N   ++I    +  L   P     
Sbjct: 128 AIDCCKGLYNLYKY--TNKPYK---NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182

Query: 111 ---YIAPEILNK--NGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
              Y + ++LN   + ++ + D++S+G +++ +  GK PFE  T KE Y  I      L 
Sbjct: 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK 242

Query: 166 ATLKKPA--ATMIKKMLLLDPVQRPPVAQLLHF 196
             L  P     +++     D ++RP + ++L+ 
Sbjct: 243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275

Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 26/110 (23%), Positives = 51/110 (46%), Gaps = 4/110 (3%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK---PPFETSTLKETYSRIKK 159
           N+  GT +Y++PE L    +S + D+WS+G  +  + +G+   PP +   L+  +    +
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVE 219

Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPA 209
            +     T  +P     + +    P  RPP+A     ++  +  P  LP+
Sbjct: 220 GDPAESETSPRP-RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS 268

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 20/66 (30%), Positives = 37/66 (56%)

Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           ++  +  T +Y +PE++   G  +  D+WS+GCI+Y L  GK  ++T    E    ++K 
Sbjct: 301 SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360

Query: 161 EYKLPA 166
             +LP+
Sbjct: 361 LGRLPS 366

Length = 467

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 40.0 bits (93), Expect = 8e-04
 Identities = 27/107 (25%), Positives = 49/107 (45%), Gaps = 7/107 (6%)

Query: 99  LANKNTLCGTPNYIAPEIL----NKNG-HSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKE 152
           +  +NT  GTP ++APE++    N +  + +  D+WS+G     +  G PP  +   ++ 
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234

Query: 153 TYSRIKKVEYKLPA-TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
            +   +    KL +    K     I+  L+ + + RP   QLL   F
Sbjct: 235 LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 40.1 bits (93), Expect = 8e-04
 Identities = 32/161 (19%), Positives = 69/161 (42%), Gaps = 9/161 (5%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC--RKRSMMELYN---SACDLEEMSDP 57
           +E+   + +KH N + +   +      ++++E C      ++E++       ++  ++  
Sbjct: 74  KEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHG 133

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEI- 116
           A Q + ++            G  L  +   V   D     + +  N+  GTP ++APE+ 
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVI 193

Query: 117 --LNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETY 154
             +++  +  +VDVWS+G     L   KPP F  + +   Y
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 234

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.0 bits (93), Expect = 9e-04
 Identities = 18/64 (28%), Positives = 34/64 (53%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           SK    + E   RFY+ +++  +  +H    +HRD+K  N+ +  N  +++ DFG   ++
Sbjct: 93  SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152

Query: 298 EFDG 301
             DG
Sbjct: 153 MEDG 156

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 9e-04
 Identities = 20/64 (31%), Positives = 34/64 (53%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           SK    + E   RFY+ +++  +  +H    +HRD+K  N+ L  N  +++ DFG   R+
Sbjct: 93  SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152

Query: 298 EFDG 301
             DG
Sbjct: 153 LADG 156

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 31/122 (25%), Positives = 50/122 (40%), Gaps = 32/122 (26%)

Query: 111 YIAPE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-------------------ETSTL 150
           Y APE +LN + ++  +DVWS+GCI   LL  KP F                       L
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233

Query: 151 KETYS-RIKKVEYKLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEF 198
               + + ++    LP T ++            A  +++KML+ DP +R  V + L   +
Sbjct: 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Query: 199 FN 200
             
Sbjct: 294 LA 295

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 22/86 (25%), Positives = 40/86 (46%), Gaps = 4/86 (4%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEYKL--PAT 167
           + APE L     S + DVWS G +++ +   G+ P+   +LKE    ++K  Y++  P  
Sbjct: 163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEG 221

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQL 193
                  ++      +P +RP   +L
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 44/190 (23%), Positives = 87/190 (45%), Gaps = 22/190 (11%)

Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + + H+N++G  + F      E+ + VYI++EL    ++ ++     D E MS 
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQMELDHERMSY 130

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP------- 109
              Q +  +     +    G  ++    S+ V+ +D T  I+        GT        
Sbjct: 131 LLYQMLCGIK----HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186

Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR-IKKVEYKLP 165
               Y APE++   G+   VD+WS+GCIM  ++ G   F  +   + +++ I+++    P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246

Query: 166 ATLKKPAATM 175
             +KK   T+
Sbjct: 247 EFMKKLQPTV 256

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 26/64 (40%), Positives = 37/64 (57%), Gaps = 4/64 (6%)

Query: 241 RKAITEPETRFYMKQILE---GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           RK   E +T+  +K  L+   G++YL     IHRDL   N  + +N V+KI DFG+ +R 
Sbjct: 84  RKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGM-SRQ 142

Query: 298 EFDG 301
           E DG
Sbjct: 143 EDDG 146

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 16/40 (40%), Positives = 23/40 (57%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI  G+ YL     +HRDL   N  + +N  +KI DFG++
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 19/49 (38%), Positives = 27/49 (55%)

Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           +  Q+  G+ +L     +HRDL   N+ L+   +VKI DFGLA  I  D
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 16/40 (40%), Positives = 23/40 (57%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI  G+SYLH   +IH+D+   N  + +   VKI D  L+
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 17/45 (37%), Positives = 26/45 (57%), Gaps = 1/45 (2%)

Query: 251 FYMK-QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            YM  QI  G+ YL     +HRDL   N  + +++ +KI DFG++
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 39.3 bits (91), Expect = 0.001
 Identities = 17/36 (47%), Positives = 24/36 (66%)

Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           G+ YL   + IHRDL   N+ + +N+V KI DFGL+
Sbjct: 124 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 21/122 (17%), Positives = 42/122 (34%), Gaps = 35/122 (28%)

Query: 111 YIAPEIL--NKNGHSFEVDVWSIGCIMYTLLVGKPPFETST------------------- 149
           Y  PE+L   +  ++  VD+W IGC+   +   +P  +  +                   
Sbjct: 192 YRPPELLLGERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEET 250

Query: 150 ------------LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE 197
                       +    +  + +E +    L      ++ K+L LDP +R   +  L   
Sbjct: 251 WPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHP 309

Query: 198 FF 199
           +F
Sbjct: 310 YF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 19/48 (39%), Positives = 27/48 (56%)

Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           FY  QI+    YL    I++RDLK  NL L  +  +K+ DFG A  ++
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182

Length = 340

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 17/36 (47%), Positives = 22/36 (61%), Gaps = 1/36 (2%)

Query: 111 YIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPF 145
           Y APEIL  +   S  VD+WSIGCI   ++  +P F
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 38.9 bits (91), Expect = 0.002
 Identities = 56/255 (21%), Positives = 93/255 (36%), Gaps = 75/255 (29%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EI + + LKH N+V     F   + ++++ E C    + EL  +   + E      + +
Sbjct: 49  REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL---IKKI 105

Query: 63  IW-VSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN---TLC------------ 106
           IW   + V++  K              +  D+    +L  K     LC            
Sbjct: 106 IWQTLQAVNFCHK-----------HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154

Query: 107 -------GTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPFE---------- 146
                   T  Y APE+L    + G    VDVW+IGC+   LL G+P +           
Sbjct: 155 DDYTDYVATRWYRAPELLVGDTQYGPP--VDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212

Query: 147 -TSTLKETYSRIKKV---------------------EYKLPATLKKPAATMIKKMLLLDP 184
              TL +   R +++                     E K P  +  PA + +K  L +DP
Sbjct: 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDP 271

Query: 185 VQRPPVAQLLHFEFF 199
            +R    +LL   +F
Sbjct: 272 TERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 38.9 bits (91), Expect = 0.002
 Identities = 15/35 (42%), Positives = 22/35 (62%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF 145
           Y APE++   G+   VD+WS+GCIM  ++ G   F
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 15/38 (39%), Positives = 24/38 (63%)

Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           + E + YL  +  +HRDL   N+ +S++ V K+ DFGL
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL 148

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 27/106 (25%), Positives = 48/106 (45%), Gaps = 10/106 (9%)

Query: 107 GTPNYIAPEILNKNG------HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           G  +Y+APE +   G      ++ + DVWS+G  +  + +G+ P+   T    ++++  +
Sbjct: 163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222

Query: 161 EY----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                  LP+     A   + K L   P +RP  AQLL   +   Y
Sbjct: 223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 23/80 (28%), Positives = 39/80 (48%), Gaps = 2/80 (2%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMY-TLLVGKPPFETSTLKETYSRIKK-VEYKLPATL 168
           + APE LN   +S E DVWS G +++    +G  P+   + ++T   I++ V    P   
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELC 221

Query: 169 KKPAATMIKKMLLLDPVQRP 188
                 ++++    DP QRP
Sbjct: 222 PDAVYRLMERCWEYDPGQRP 241

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 14/66 (21%), Positives = 28/66 (42%), Gaps = 7/66 (10%)

Query: 232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDF 291
             ++     RK + E   R +++Q+L            H D   GN+ +  +  + + DF
Sbjct: 257 AALKSAGIDRKELAELLVRAFLRQLLR-------DGFFHADPHPGNILVRSDGRIVLLDF 309

Query: 292 GLAARI 297
           G+  R+
Sbjct: 310 GIVGRL 315

Length = 517

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 20/62 (32%), Positives = 29/62 (46%), Gaps = 2/62 (3%)

Query: 234 MER-NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           ME    K  K + E      +++I   V  LH   I+H DL   N+ + D+ +  I DFG
Sbjct: 76  MEYIEGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLI-DFG 134

Query: 293 LA 294
           L 
Sbjct: 135 LG 136

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 16/48 (33%), Positives = 25/48 (52%), Gaps = 6/48 (12%)

Query: 108 TPN-----YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETST 149
           TP      Y APE+L     ++  +D+W++GCI+  LL  KP     +
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 18/54 (33%), Positives = 30/54 (55%), Gaps = 1/54 (1%)

Query: 241 RKAITEPE-TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           R  I E +  RFY+ ++   +  +H    IHRD+K  N+ +  +  +K+ DFGL
Sbjct: 94  RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 14/111 (12%)

Query: 99  LANKNTLCGTPNYIAPEIL-----NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET 153
           +  +++  GTP ++APE++         + ++ DVWS+G  +  +   +PP         
Sbjct: 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216

Query: 154 YSRIKKVEYKLPATLKKPA------ATMIKKMLLLDPVQRPPVAQLLHFEF 198
             +I K E   P TL +P+         +KK L  +   R    QLL   F
Sbjct: 217 LLKIAKSE---PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 17/58 (29%), Positives = 31/58 (53%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG 301
           + E   RFY  +++  +  +H    IHRD+K  N+ L  +  +K+ DFG   ++  +G
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 1/40 (2%)

Query: 256 ILEGVSYLHDH-KIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           I++ + YLH    +IHRD+K  N+ ++ N  VK+ DFG++
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 38.1 bits (89), Expect = 0.003
 Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 1/40 (2%)

Query: 256 ILEGVSYL-HDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            ++ ++YL  + KIIHRD+K  N+ L  N  +K+ DFG++
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 15/43 (34%), Positives = 32/43 (74%), Gaps = 1/43 (2%)

Query: 256 ILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +++G++YL + HKI+HRD+K  N+ ++    +K+ DFG++ ++
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 26/219 (11%)

Query: 1   MSQEIAIHRSLKHRNVVG-FHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA 59
           + QE  +   L H+N++   H   ED +  +++       ++ +L+   C L E ++P A
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNL-KLFLQQCRLGEANNPQA 113

Query: 60  ----QPV---IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANKN 103
               Q V   I ++  + Y  K G  ++       + D+   V   D  L+R +   + +
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173

Query: 104 TLCGTPN----YIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIK 158
            L    N    ++A E L    +S   DVWS G +++ L+ +G+ P+      E  + +K
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233

Query: 159 KVEYKLPATLKKPAA--TMIKKMLLLDPVQRPPVAQLLH 195
              Y+L   +  P     ++     LDP +RP  +QL+ 
Sbjct: 234 D-GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 2/87 (2%)

Query: 218 FDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGN 277
           F +VV  F        M+  ++   A+     + Y  Q+   ++Y+H   I HRDLK  N
Sbjct: 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQN 200

Query: 278 LFLSDN-FVVKIGDFGLAARIEFDGQR 303
           L +  N   +K+ DFG A  +   GQR
Sbjct: 201 LLIDPNTHTLKLCDFGSAKNL-LAGQR 226

Length = 440

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 17/43 (39%), Positives = 24/43 (55%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           QI  G+ YL  H  +H+DL   N+ + +   VKI D GL+  I
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREI 174

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 37.9 bits (88), Expect = 0.004
 Identities = 31/141 (21%), Positives = 53/141 (37%), Gaps = 44/141 (31%)

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL-----VGKPPFET------------ 147
           L GT    APE+L ++ ++ + D+WS G +++ +L     + + P  T            
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Query: 148 ----STLK----------ETYSRIKKVEY----KLPAT---------LKKPAATMIKKML 180
               STLK           +      +EY    + P T         L      ++ KML
Sbjct: 276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKML 335

Query: 181 LLDPVQRPPVAQLLHFEFFND 201
             D   RP   ++L++  F  
Sbjct: 336 TFDAAMRPSAEEILNYPMFAQ 356

Length = 357

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 37.9 bits (88), Expect = 0.004
 Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 13/105 (12%)

Query: 103 NTLCGTPNYIAPEI---LNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIK 158
           N+  GTP ++APE+   +++  +  +VDVWS+G     L   KPP F  + +   Y  I 
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIA 227

Query: 159 KVEYKLPATLKKPA-----ATMIKKMLLLDPVQRPPVAQLLHFEF 198
           + +     TL            +   L   P  RP   +LL   F
Sbjct: 228 QND---SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 37.7 bits (87), Expect = 0.004
 Identities = 25/96 (26%), Positives = 48/96 (50%), Gaps = 5/96 (5%)

Query: 102 KNTLCGTP-NYIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKK 159
           K T+   P  ++A E LN + ++   DVWS G +++ ++ +G  P+   T  E Y ++ +
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226

Query: 160 VEYKL--PATLKKPAATMIKKMLLLDPVQRPPVAQL 193
             Y+L  P         ++++     P +RP  AQ+
Sbjct: 227 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	305
KOG0575|consensus	592		100.0
KOG0588|consensus	786		100.0
KOG0615|consensus	475		100.0
KOG0583|consensus	370		100.0
KOG0598|consensus	357		100.0
KOG0581|consensus	364		100.0
KOG0616|consensus	355		100.0
KOG0033|consensus	355		100.0
KOG0592|consensus	604		100.0
KOG0595|consensus	429		100.0
KOG0611|consensus	668		100.0
KOG0605|consensus	550		100.0
KOG0597|consensus	808		100.0
KOG4717|consensus	864		100.0
KOG0578|consensus	550		100.0
KOG0591|consensus	375		100.0
KOG0610|consensus	459		100.0
KOG0580|consensus	281		100.0
KOG0694|consensus	694		100.0
KOG0032|consensus	382		100.0
KOG0599|consensus	411		100.0
KOG0198|consensus	313		100.0
KOG0582|consensus	516		100.0
KOG0589|consensus	426		100.0
KOG0586|consensus	596		100.0
KOG0585|consensus	576		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0201|consensus	467		100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0593|consensus	396		100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0690|consensus	516		100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0604|consensus	400		100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0661|consensus	538		100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0600|consensus	560		100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0696|consensus	683		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0607|consensus	463		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0192|consensus	362		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0574|consensus	502		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0614|consensus	732		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0612|consensus	1317		100.0
KOG4279|consensus	1226		100.0
KOG0579|consensus	1187		100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4645|consensus	1509		100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0663|consensus	419		100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG4721|consensus	904		100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.98
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.98
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.98
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
PTZ00036	440	glycogen synthase kinase; Provisional	99.98
KOG0660|consensus	359		99.98
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.98
KOG0577|consensus	948		99.98
KOG0603|consensus	612		99.98
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.98
KOG0197|consensus	468		99.98
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
KOG0596|consensus	677		99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
KOG0659|consensus	318		99.97
KOG0603|consensus	612		99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
KOG0658|consensus	364		99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
KOG0608|consensus	1034		99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
KOG0986|consensus	591		99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
KOG1026|consensus	774		99.96
KOG1989|consensus	738		99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
KOG0594|consensus	323		99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.96
KOG0584|consensus	632		99.96
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
KOG0695|consensus	593		99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.96
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.96
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.96
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
KOG1151|consensus	775		99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.96
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.96
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.95
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.95
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.95
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.95
KOG0194|consensus	474		99.95
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
KOG1095|consensus	1025		99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.95
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.95
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.95
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.95
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.95
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.95
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.95
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.95
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.95
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.95
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.95
KOG4236|consensus	888		99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
KOG0587|consensus	953		99.95
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.95
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
KOG0667|consensus	586		99.95
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.94
KOG0666|consensus	438		99.94
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.94
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.94
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.94
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.94
KOG0983|consensus	391		99.94
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.94
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.94
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.94
KOG0662|consensus	292		99.94
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.94
KOG2345|consensus	302		99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
KOG4250|consensus	732		99.93
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.93
KOG1027|consensus	903		99.93
KOG4257|consensus	974		99.93
KOG0576|consensus	829		99.93
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.92
KOG4278|consensus	1157		99.92
KOG0665|consensus	369		99.92
KOG1187|consensus	361		99.92
KOG1094|consensus	807		99.92
KOG0199|consensus	1039		99.91
KOG0669|consensus	376		99.91
KOG0671|consensus	415		99.91
KOG0196|consensus	996		99.9
PHA02882	294	putative serine/threonine kinase; Provisional	99.9
KOG0200|consensus	609		99.89
KOG1006|consensus	361		99.89
KOG0193|consensus	678		99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
KOG0668|consensus	338		99.88
KOG0670|consensus	752		99.88
PLN00181	793	protein SPA1-RELATED; Provisional	99.88
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.87
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.87
KOG0590|consensus	601		99.83
KOG1152|consensus	772		99.83
KOG1025|consensus	1177		99.83
KOG1024|consensus	563		99.83
KOG1035|consensus	1351		99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.8
KOG0590|consensus	601		99.79
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.78
KOG2052|consensus	513		99.75
KOG3653|consensus	534		99.75
KOG1167|consensus	418		99.74
KOG0984|consensus	282		99.73
KOG0195|consensus	448		99.72
KOG0664|consensus	449		99.72
KOG1345|consensus	378		99.63
KOG0606|consensus	1205		99.61
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.61
KOG1290|consensus	590		99.6
KOG1033|consensus	516		99.53
KOG1023|consensus	484		99.52
KOG4158|consensus	598		99.51
KOG0575|consensus	592		99.43
KOG0616|consensus	355		99.39
KOG0606|consensus	1205		99.38
KOG0592|consensus	604		99.37
KOG0600|consensus	560		99.33
KOG0594|consensus	323		99.33
KOG0593|consensus	396		99.32
KOG0598|consensus	357		99.32
KOG0661|consensus	538		99.31
KOG1240|consensus	1431		99.3
KOG1035|consensus	1351		99.25
KOG0599|consensus	411		99.23
KOG0614|consensus	732		99.21
KOG0595|consensus	429		99.2
KOG0694|consensus	694		99.2
KOG0663|consensus	419		99.19
KOG0660|consensus	359		99.18
KOG0658|consensus	364		99.17
KOG0583|consensus	370		99.16
KOG0659|consensus	318		99.13
KOG0581|consensus	364		99.12
KOG0198|consensus	313		99.12
KOG0615|consensus	475		99.11
KOG0605|consensus	550		99.09
KOG0585|consensus	576		99.08
KOG0611|consensus	668		99.07
KOG0588|consensus	786		99.07
KOG0664|consensus	449		99.05
KOG0578|consensus	550		99.03
KOG0591|consensus	375		99.02
KOG0589|consensus	426		99.01
KOG1266|consensus	458		99.01
KOG0662|consensus	292		99.0
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.99
KOG0695|consensus	593		98.98
KOG1164|consensus	322		98.98
PRK09188	365	serine/threonine protein kinase; Provisional	98.97
KOG0986|consensus	591		98.97
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	98.94
KOG0033|consensus	355		98.94
KOG0582|consensus	516		98.92
KOG0197|consensus	468		98.92
KOG0601|consensus	524		98.92
KOG0669|consensus	376		98.92
PRK12274	218	serine/threonine protein kinase; Provisional	98.91
KOG0604|consensus	400		98.9
KOG4236|consensus	888		98.88
KOG0610|consensus	459		98.87
KOG0690|consensus	516		98.86
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	98.86
KOG0192|consensus	362		98.84
KOG0580|consensus	281		98.84
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	98.83
KOG0608|consensus	1034		98.82
PHA02882	294	putative serine/threonine kinase; Provisional	98.82
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	98.81
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	98.81
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	98.81
KOG0666|consensus	438		98.8
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	98.8
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	98.8
KOG0612|consensus	1317		98.79
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	98.79
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	98.79
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	98.78
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	98.78
KOG0597|consensus	808		98.78
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	98.78
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	98.77
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	98.77
PHA03212	391	serine/threonine kinase US3; Provisional	98.76
KOG0667|consensus	586		98.76
KOG0193|consensus	678		98.76
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	98.76
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	98.76
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	98.76
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	98.75
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	98.75
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	98.75
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	98.75
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	98.75
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	98.75
PTZ00263	329	protein kinase A catalytic subunit; Provisional	98.75
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	98.74
PTZ00036	440	glycogen synthase kinase; Provisional	98.74
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	98.74

>KOG0575|consensus

Probab=100.00  E-value=1.1e-49  Score=348.42  Aligned_cols=216  Identities=49%  Similarity=0.883  Sum_probs=190.5

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCce
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGY   79 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   79 (305)
                      +.+||+|+++|+|||||++|++|+|++++|||+|+|+.|+|.+++++...+   .+..++.++ +++.++.|+|+.++.|
T Consensus        65 v~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~l---tEpEary~l~QIv~GlkYLH~~~IiH  141 (592)
T KOG0575|consen   65 VLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPL---TEPEARYFLRQIVEGLKYLHSLGIIH  141 (592)
T ss_pred             HHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCC---CcHHHHHHHHHHHHHHHHHHhcCcee
Confidence            368999999999999999999999999999999999999999999977666   444555444 4578888998777644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      +       +.+...+|+++||+.+..+.    +..|.||||.|+|||++...+++..+||||+|||||.||+|+|||+..
T Consensus       142 RDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  142 RDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             cccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            3       34455789999998776654    346999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc-cccCCCCCCccccccCCCCC
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFD  219 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~  219 (305)
                      +..+++.+|+...+.+|..++.++++||.++|..||.+|||+++++.|+|| +.+.|...|..|....|++.
T Consensus       222 ~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~~  293 (592)
T KOG0575|consen  222 TVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRFG  293 (592)
T ss_pred             hHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcCC
Confidence            999999999999999999999999999999999999999999999999999 56778888888887777664

>KOG0588|consensus

Probab=100.00  E-value=1.3e-45  Score=324.82  Aligned_cols=201  Identities=25%  Similarity=0.492  Sum_probs=178.5

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      ++|||.||+.+.||||++||+++++..++|+|+||++||.|++++..++.+.+  ..+++...++..++.|||.+++.++
T Consensus        59 IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e--~eaa~ff~QIi~gv~yCH~~~icHR  136 (786)
T KOG0588|consen   59 IEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPE--REAAHFFRQILDGVSYCHAFNICHR  136 (786)
T ss_pred             hhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCC--HHHHHHHHHHHHHHHHHhhhcceec
Confidence            47999999999999999999999999999999999999999999999888743  4445555667889999999888764


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.|..++|++.||+-+..-..   ..|.||+|.|.|||++.+..| +.++||||+|||||.||+|+.||++.|
T Consensus       137 DLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN  216 (786)
T KOG0588|consen  137 DLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN  216 (786)
T ss_pred             cCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence                   344556699999986654322   258899999999999998876 678999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      ...++.+++.+.+.+|..++.++++||++||..||.+|+|.+||++|||+..+.
T Consensus       217 ir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  217 IRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence            999999999999999999999999999999999999999999999999998754

>KOG0615|consensus

Probab=100.00  E-value=3.3e-46  Score=312.50  Aligned_cols=198  Identities=28%  Similarity=0.503  Sum_probs=161.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++||++|+|||||+++++|+..++.||||||++||+|++.+-..+.+.   +.....++ ++..++.|+|+.|+.|+
T Consensus       224 ~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~---ed~~K~~f~Qll~avkYLH~~GI~HR  300 (475)
T KOG0615|consen  224 QNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLR---EDLGKLLFKQLLTAVKYLHSQGIIHR  300 (475)
T ss_pred             HHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccc---cchhHHHHHHHHHHHHHHHHcCcccc
Confidence            589999999999999999999999999999999999999999887665553   23334443 45678889998887665


Q ss_pred             ecC--------C--CCCeeEcchhHHHHhcC---CcccccCCCcccccccccCC---CCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 LND--------D--SSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNG---HSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 ~~~--------~--~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~---~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      -..        +  .-.+++.||+.+.....   ..|+||||.|.|||++.+++   ++.++||||+||+||.+++|.+|
T Consensus       301 DiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP  380 (475)
T KOG0615|consen  301 DIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP  380 (475)
T ss_pred             cCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence            221        1  23467888887766533   35899999999999997665   34589999999999999999999


Q ss_pred             CCCCCHHH-HHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         145 FETSTLKE-TYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~~~~~~-~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |.+..... +...|.++.+.+-    ..++.++.+||++||..||++|||++|+|+||||++.
T Consensus       381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            98765444 6778888887653    3588999999999999999999999999999999863

>KOG0583|consensus

Probab=100.00  E-value=1.1e-42  Score=303.52  Aligned_cols=198  Identities=31%  Similarity=0.586  Sum_probs=174.7

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   79 (305)
                      .||+.++++++ |||||++++++.+...+|+|||||.||+|.+.+...+.+.+   ..++.+++ +..++.|+|..|+.|
T Consensus        67 ~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E---~~ar~~F~Qlisav~y~H~~gi~H  143 (370)
T KOG0583|consen   67 KREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKE---DEARKYFRQLISAVAYCHSRGIVH  143 (370)
T ss_pred             HHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCCh---HHHHHHHHHHHHHHHHHHhCCEee
Confidence            48999999999 99999999999999999999999999999999988666643   44555554 578899999888765


Q ss_pred             e-------ecCCC-CCeeEcchhHHHHh----cCCcccccCCCcccccccccCC-C-CccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDS-SGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNG-H-SFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~-~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~-~-~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      +       +.+.. .++++.||+.....    ....+.||||.|+|||++.+.. | +.++||||+||+||.|++|+.||
T Consensus       144 RDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF  223 (370)
T KOG0583|consen  144 RDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPF  223 (370)
T ss_pred             CCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence            4       33444 78999999887765    2346899999999999999876 7 57899999999999999999999


Q ss_pred             CCCCHHHHHHHHhccccCCCCCC-CHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         146 ETSTLKETYSRIKKVEYKLPATL-KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ...+...++..|.++.+.+|..+ +.++++|+++||..||.+|+|+.+++.||||+..
T Consensus       224 ~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  224 DDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            99999999999999999999999 9999999999999999999999999999999963

>KOG0598|consensus

Probab=100.00  E-value=2.2e-42  Score=286.81  Aligned_cols=198  Identities=28%  Similarity=0.460  Sum_probs=170.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   80 (305)
                      ..|..||.+++||+||+|+..||+.+.+|||+||+.||+|.-.+++.+.+.   +..++.++. ++.++.|+|+.|+.++
T Consensus        73 ~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~---E~~arfYlaEi~lAL~~LH~~gIiyR  149 (357)
T KOG0598|consen   73 KAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFS---EDRARFYLAEIVLALGYLHSKGIIYR  149 (357)
T ss_pred             HHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcc---hhHHHHHHHHHHHHHHHHHhCCeeec
Confidence            479999999999999999999999999999999999999999999887763   344444444 4567889998887554


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.....    ....++|||+.|||||++.+.+|+.++|+||+||++|||++|.+||.+.+
T Consensus       150 DlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  150 DLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             cCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence                   4556688999999755432    23467899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCC----CHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRP----PVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~----~~~~~l~~~~~~~~  202 (305)
                      ......+|.+.+ ...|..++.+++++|+++|.+||++|.    .+.++.+||||.+.
T Consensus       230 ~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  230 VKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            999999999988 444555999999999999999999996    68899999999863

>KOG0581|consensus

Probab=100.00  E-value=3.8e-42  Score=285.52  Aligned_cols=199  Identities=23%  Similarity=0.361  Sum_probs=165.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCe-EEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh-hCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKF-VYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK-YGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~-~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~   78 (305)
                      .||++|+++.+||+||++|++|++++. ++|+||||+||+|.+++...+...   +... .....+++++.|+|. .++.
T Consensus       125 ~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~---E~~L~~ia~~VL~GL~YLh~~~~II  201 (364)
T KOG0581|consen  125 LRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIP---EPVLGKIARAVLRGLSYLHEERKII  201 (364)
T ss_pred             HHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCC---HHHHHHHHHHHHHHHHHHhhccCee
Confidence            589999999999999999999999995 999999999999999998765543   2222 223345677888873 5544


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC-
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS-  148 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~-  148 (305)
                      |+       +....+.|+++||+-...+.  -.++++||..|||||.+.+..|+.++||||||+++.||++|+.||... 
T Consensus       202 HRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~  281 (364)
T KOG0581|consen  202 HRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN  281 (364)
T ss_pred             eccCCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC
Confidence            33       33345789999997655543  357899999999999999999999999999999999999999999774 


Q ss_pred             ----CHHHHHHHHhc-cccCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         149 ----TLKETYSRIKK-VEYKLPAT-LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       149 ----~~~~~~~~i~~-~~~~~~~~-~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                          +..+++..|.. ..+.+|.. .|+++++||..||++||.+|+++.|+++|||+++..
T Consensus       282 ~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  282 PPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             CCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence                66788888877 45567776 999999999999999999999999999999998653

>KOG0616|consensus

Probab=100.00  E-value=7.2e-42  Score=275.38  Aligned_cols=197  Identities=25%  Similarity=0.475  Sum_probs=171.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   80 (305)
                      .+|..+|+.+.||++|+|++.|++.+++||||||++||.|..++++.+.+.+   ..++.+. .+..++.|.|+.++.++
T Consensus        92 ~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e---~~arFYAAeivlAleylH~~~iiYR  168 (355)
T KOG0616|consen   92 HNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSE---PHARFYAAEIVLALEYLHSLDIIYR  168 (355)
T ss_pred             hhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCc---hhHHHHHHHHHHHHHHHHhcCeeec
Confidence            4799999999999999999999999999999999999999999998877743   3333333 23556777777665433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                             +.|..+.+++.||+.+..+.. .-|.||||.|+|||++..++|+.++|+|||||++|||+.|.+||.+.+...
T Consensus       169 DLKPENiLlD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~  248 (355)
T KOG0616|consen  169 DLKPENLLLDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ  248 (355)
T ss_pred             cCChHHeeeccCCcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence                   456667888999887766543 358899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND  201 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~  201 (305)
                      ++.+|..+++.+|+.+++++++||+++|+.|-.+|.     ...++..||||+.
T Consensus       249 iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  249 IYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence            999999999999999999999999999999999995     4678999999985

>KOG0033|consensus

Probab=100.00  E-value=7.5e-42  Score=268.72  Aligned_cols=198  Identities=28%  Similarity=0.509  Sum_probs=165.0

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCce
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   79 (305)
                      +.||++|-+.|+|||||+|++.+..+.+.|||+|++.||+|..-+-+..-.   ++..+... -++++++.|+|..++.+
T Consensus        57 l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~y---SEa~aSH~~rQiLeal~yCH~n~IvH  133 (355)
T KOG0033|consen   57 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILEALAYCHSNGIVH  133 (355)
T ss_pred             HHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHhcCcee
Confidence            469999999999999999999999999999999999999997644333111   23333333 34578899999887654


Q ss_pred             e--------ec--CCCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          80 Q--------LN--DDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        80 ~--------~~--~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      +        +.  +.+..+++.||+-++.+.+.   ..++|||.|||||++...+|+.++||||+|||||-++.|.+||.
T Consensus       134 RDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~  213 (355)
T KOG0033|consen  134 RDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  213 (355)
T ss_pred             ccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence            3        22  23456788888766655532   35679999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +.+...++..|+.+.+.+|+    .+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus       214 ~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  214 DEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             CccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            99999999999999887765    68999999999999999999999999999999976

>KOG0592|consensus

Probab=100.00  E-value=3.5e-41  Score=291.13  Aligned_cols=197  Identities=25%  Similarity=0.520  Sum_probs=174.7

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   79 (305)
                      .+|-.+|.+| .||.||+||-.|+|+..+|+|||||++|+|.+++++.+.+.+   ..++.+. .++.+++|.|..|+.|
T Consensus       121 ~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde---~caR~YAAeIldAleylH~~GIIH  197 (604)
T KOG0592|consen  121 TREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDE---TCARFYAAEILDALEYLHSNGIIH  197 (604)
T ss_pred             hHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchH---HHHHHHHHHHHHHHHHHHhcCcee
Confidence            4789999999 899999999999999999999999999999999999887744   3334333 3467889999888766


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC-----------------CcccccCCCcccccccccCCCCccchHHHHHHHH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN-----------------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIM  135 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~-----------------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvil  135 (305)
                      +       |.+....+++.||+.+..+..                 ..+++||..|.+||+|.....++.+|||+||||+
T Consensus       198 RDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCil  277 (604)
T KOG0592|consen  198 RDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCIL  277 (604)
T ss_pred             ccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHH
Confidence            4       456668899999976655421                 1468999999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         136 YTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       136 ye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |+|+.|.+||.+.+..-++++|....+.+|+..++.++|||+++|..||.+|+|++||.+||||..
T Consensus       278 yQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  278 YQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             HHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999975

>KOG0595|consensus

Probab=100.00  E-value=2.4e-40  Score=277.32  Aligned_cols=198  Identities=28%  Similarity=0.507  Sum_probs=162.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCc--
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFG--   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--   78 (305)
                      ..||.||++++|||||+|++++++++++|||||||+||||.+++++.+.+.   +..++.... ++.++.+.|+.++.  
T Consensus        57 ~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~---e~t~r~Fm~QLA~alq~L~~~~IiHR  133 (429)
T KOG0595|consen   57 LSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLP---EATARHFMQQLASALQFLHENNIIHR  133 (429)
T ss_pred             HHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            479999999999999999999999999999999999999999999887664   333333332 34455555555443  


Q ss_pred             ------eeecCC--C---CCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 ------YQLNDD--S---SGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ------~~~~~~--~---~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                            +++...  .   ..+++.||+.+..+.+.   .|.||||.|||||++....|+.|+|+||+|+|+|+|++|++|
T Consensus       134 DLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~P  213 (429)
T KOG0595|consen  134 DLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPP  213 (429)
T ss_pred             cCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCC
Confidence                  333221  1   45678888877766543   588999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccccC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         145 FETSTLKETYSRIKKVEYK---LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |...+..+++..+++....   +|...+++..+++...|+.||..|.+..+-+.|++++..
T Consensus       214 f~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  214 FDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             ccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            9999999999888876543   344677888899999999999999999999999998753

>KOG0611|consensus

Probab=100.00  E-value=3.2e-40  Score=276.41  Aligned_cols=196  Identities=27%  Similarity=0.470  Sum_probs=173.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCce-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFGY-   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-   79 (305)
                      .|||+||+.|+|||||.+|++|++.+.+.|||||..+|+|.+++...+.+   ++..++.++. +..++.|+|+.+..+ 
T Consensus       101 RREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~L---sErEaRhfFRQIvSAVhYCHknrVvHR  177 (668)
T KOG0611|consen  101 RREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSL---SEREARHFFRQIVSAVHYCHKNRVVHR  177 (668)
T ss_pred             HHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccc---cHHHHHHHHHHHHHHHHHHhhccceec
Confidence            69999999999999999999999999999999999999999999988777   4455555554 568899999877644 


Q ss_pred             ------eecCCCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          80 ------QLNDDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        80 ------~~~~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                            ++.|.++++++.||+..+...+.   .|+||+|.|.+||++++..| ++.+|.|||||+||.++.|..||++.+
T Consensus       178 DLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D  257 (668)
T KOG0611|consen  178 DLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD  257 (668)
T ss_pred             ccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence                  35677789999999988877654   58999999999999999987 677999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ...+..+|..+.|.-|. .+.++.-||+.||..||++|.|++++..|-|.+-
T Consensus       258 hk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  258 HKRLVRQISRGAYREPE-TPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHHHHHHhhcccccCCC-CCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            99999999999987765 5667889999999999999999999999999975

>KOG0605|consensus

Probab=100.00  E-value=5.6e-40  Score=283.55  Aligned_cols=196  Identities=31%  Similarity=0.491  Sum_probs=162.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   80 (305)
                      ..|-+||...++|+||+||..|++.+++||||||++|||+..+|.+...+.   +..++.++. .+.++.-.|+.|+.|+
T Consensus       189 ~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~---e~~arfYiaE~vlAI~~iH~~gyIHR  265 (550)
T KOG0605|consen  189 RAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLT---EDWARFYIAETVLAIESIHQLGYIHR  265 (550)
T ss_pred             HHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCc---hHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            358899999999999999999999999999999999999999999887763   444444444 3456677777776553


Q ss_pred             -------ecCCCCCeeEcchhHHHHh---------------------------cC------------------------C
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML---------------------------AN------------------------K  102 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~---------------------------~~------------------------~  102 (305)
                             |.|..+.+++.||+....+                           ..                        .
T Consensus       266 DIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a  345 (550)
T KOG0605|consen  266 DIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLA  345 (550)
T ss_pred             cCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhh
Confidence                   5566788999998532110                           00                        0


Q ss_pred             cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--cCCCC--CCCHHHHHHHHH
Q psy6191         103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE--YKLPA--TLKKPAATMIKK  178 (305)
Q Consensus       103 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~  178 (305)
                      .+.+|||.|||||++.+.+|+..+|+||||||+||||.|.+||.+.++.+++.+|....  +.+|.  ..+.+++|||.+
T Consensus       346 ~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~r  425 (550)
T KOG0605|consen  346 YSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITR  425 (550)
T ss_pred             hcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHH
Confidence            14589999999999999999999999999999999999999999999999999998765  44554  477899999999


Q ss_pred             HhhcCCCCCCC---HhhhhcCccccc
Q psy6191         179 MLLLDPVQRPP---VAQLLHFEFFND  201 (305)
Q Consensus       179 ~l~~dp~~R~~---~~~~l~~~~~~~  201 (305)
                      ||. ||++|..   ++||.+||||+.
T Consensus       426 ll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  426 LLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             Hhc-CHHHhcCcccHHHHhcCCcccc
Confidence            998 9999985   889999999986

>KOG0597|consensus

Probab=100.00  E-value=1.6e-40  Score=288.18  Aligned_cols=197  Identities=26%  Similarity=0.461  Sum_probs=171.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++|+++|+|||||.++++|+++..+|+|.|||.| +|.+++...+.+.   +..++.+ ..++.++.|.|+.++.+.
T Consensus        49 ~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lp---Ee~v~~~a~~LVsaL~yLhs~rilhr  124 (808)
T KOG0597|consen   49 RQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLP---EEQVRAIAYDLVSALYYLHSNRILHR  124 (808)
T ss_pred             HHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCC---HHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            5899999999999999999999999999999999988 9999999887764   3444443 345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+.++.++++||+.+...+..    ..+.|||.|||||++.++.|+..+|+||+||++|||.+|+|||....
T Consensus       125 d~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s  204 (808)
T KOG0597|consen  125 DMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS  204 (808)
T ss_pred             cCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence                   4455678899998766554332    34579999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..++...|......+|...+.++.+|+..+|.+||.+|.|+.+++.|||++..
T Consensus       205 i~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  205 ITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence            99999999999999999999999999999999999999999999999999863

>KOG4717|consensus

Probab=100.00  E-value=3.1e-39  Score=277.57  Aligned_cols=200  Identities=24%  Similarity=0.419  Sum_probs=168.9

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCceee
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGYQL   81 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   81 (305)
                      +|++.|+.++|||||+||++..+...+|||+|+-++|||.+++.+..  +.+.+..++.++ ++..++.|+|+....++-
T Consensus        66 qEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRD  143 (864)
T KOG4717|consen   66 QEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLHVVHRD  143 (864)
T ss_pred             HHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhhhhccc
Confidence            79999999999999999999999999999999999999999986432  112344444444 446778888876654432


Q ss_pred             c--------CCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          82 N--------DDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHS-FEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        82 ~--------~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~-~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                      .        ..-+-|++.||+..+.+..   .+|.||+..|-|||++.+..|+ +++||||||||||.+++|++||+..+
T Consensus       144 LKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN  223 (864)
T KOG4717|consen  144 LKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN  223 (864)
T ss_pred             CCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence            2        2334567788887776543   3589999999999999988875 56999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      ..+++.+|+.++|.+|..++.+|++||..||+.||.+|.+.++|..++|++...+
T Consensus       224 DSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  224 DSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             chhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            9999999999999999999999999999999999999999999999999986544

>KOG0578|consensus

Probab=100.00  E-value=6.2e-40  Score=285.12  Aligned_cols=198  Identities=21%  Similarity=0.372  Sum_probs=161.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      -+|+.+|+.++|||||++++.|--++.+|+||||++||+|.+++....    +.+.....+ ..+.+++.++|..|+.|+
T Consensus       318 lnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~gIiHr  393 (550)
T KOG0578|consen  318 LNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARGIIHR  393 (550)
T ss_pred             HHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcceeee
Confidence            479999999999999999999999999999999999999999876543    223322222 224677888887776654


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +...++.+++.||+....+.    ...+.+|||+|||||++....|++++||||||++..||+-|.+||...+
T Consensus       394 DIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~  473 (550)
T KOG0578|consen  394 DIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN  473 (550)
T ss_pred             ccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC
Confidence                   23345678999997655443    3468999999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHhc-c--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         150 LKETYSRIKK-V--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       150 ~~~~~~~i~~-~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      +...+..|.. +  ....|..+|..+++|+.+||+.|+.+|++|.++|+||||+..+
T Consensus       474 PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  474 PLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             hHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence            7776666643 3  3345678999999999999999999999999999999996543

>KOG0591|consensus

Probab=100.00  E-value=7.7e-40  Score=262.05  Aligned_cols=189  Identities=23%  Similarity=0.460  Sum_probs=147.6

Q ss_pred             hhHHHHHhcCCCCCccceeE-EEEcCC-eEEEEEeccCCCCHHHHHHHhcCCC-CCCCcCchh-HHHHHHHHHHhhh--h
Q psy6191           2 SQEIAIHRSLKHRNVVGFHS-FFEDSK-FVYIILELCRKRSMMELYNSACDLE-EMSDPAAQP-VIWVSKWVDYSDK--Y   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~-~~~~~~-~~ylVmEy~~~g~L~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~--~   75 (305)
                      ..||.+|++|+|||||++++ .|.+++ -+|||||||.+|||.++++....-. .+++...-. ..++..++.++|.  .
T Consensus        66 v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~  145 (375)
T KOG0591|consen   66 VKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP  145 (375)
T ss_pred             HHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc
Confidence            36999999999999999998 454444 4999999999999999987643321 122222222 2233456666664  1


Q ss_pred             C--C-------ceeecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCC
Q psy6191          76 G--F-------GYQLNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        76 ~--~-------~~~~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                      .  +       +....+.++.|+++||+....+.+.    .+++|||.||+||++.+.+|+.++||||+||++|||+.-+
T Consensus       146 r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~  225 (375)
T KOG0591|consen  146 RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQ  225 (375)
T ss_pred             ccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcC
Confidence            1  0       1123344567788888776666554    3678999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhccccC-CC-CCCCHHHHHHHHHHhhcCCCCCCCH
Q psy6191         143 PPFETSTLKETYSRIKKVEYK-LP-ATLKKPAATMIKKMLLLDPVQRPPV  190 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~~~~-~~-~~~~~~~~~li~~~l~~dp~~R~~~  190 (305)
                      +||.+.+..++..+|.++.++ +| ...|.++..+|..|+..||.+||+.
T Consensus       226 ~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  226 SPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            999999999999999999875 66 5688999999999999999999986

>KOG0610|consensus

Probab=100.00  E-value=1.3e-38  Score=267.30  Aligned_cols=199  Identities=28%  Similarity=0.486  Sum_probs=161.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   80 (305)
                      +-|-+||+.++||++++||..|+++++.|+|||||+||||..+.++... ....+..++.+.. ++-++.|+|-.|+.++
T Consensus       125 ~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlGivYR  203 (459)
T KOG0610|consen  125 QTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLGIVYR  203 (459)
T ss_pred             HHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhceeec
Confidence            3588999999999999999999999999999999999999988876533 2345555555444 3456788887776543


Q ss_pred             -------ecCCCCCeeEcchhHHH------------------------------------Hh------------------
Q psy6191          81 -------LNDDSSGVMFNDLTRMI------------------------------------ML------------------   99 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~------------------------------------~~------------------   99 (305)
                             +...++.|++.||....                                    ..                  
T Consensus       204 DLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~  283 (459)
T KOG0610|consen  204 DLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPEL  283 (459)
T ss_pred             cCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhh
Confidence                   22234666666652100                                    00                  


Q ss_pred             ------cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCC--CCCHH
Q psy6191         100 ------ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA--TLKKP  171 (305)
Q Consensus       100 ------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~  171 (305)
                            ...++++||-.|.|||++.+.+++.++|||+|||++|||+.|..||.+.+..+++.+|......+|.  .++..
T Consensus       284 ~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~  363 (459)
T KOG0610|consen  284 VAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSA  363 (459)
T ss_pred             hcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhH
Confidence                  0123678999999999999999999999999999999999999999999999999999988887775  46789


Q ss_pred             HHHHHHHHhhcCCCCCCC----HhhhhcCccccc
Q psy6191         172 AATMIKKMLLLDPVQRPP----VAQLLHFEFFND  201 (305)
Q Consensus       172 ~~~li~~~l~~dp~~R~~----~~~~l~~~~~~~  201 (305)
                      ++|||+++|.+||.+|..    |+||.+||||+.
T Consensus       364 akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g  397 (459)
T KOG0610|consen  364 AKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG  397 (459)
T ss_pred             HHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence            999999999999999998    999999999986

>KOG0580|consensus

Probab=100.00  E-value=2.8e-39  Score=253.17  Aligned_cols=199  Identities=29%  Similarity=0.564  Sum_probs=169.7

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHH--hcCCCCCCCcCchhHHHHHHHHHHhhhhCCc
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNS--ACDLEEMSDPAAQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   78 (305)
                      +.|||+|.+.|+||||.++|++|.++..+||++||+.+|++...+..  ...++  ....+..+.+++.++.|+|...+.
T Consensus        69 lrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~--e~~~a~Yi~q~A~Al~y~h~k~VI  146 (281)
T KOG0580|consen   69 LRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFD--EQRAATYIKQLANALLYCHLKRVI  146 (281)
T ss_pred             hhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccccccc--ccchhHHHHHHHHHHHHhccCCcc
Confidence            46899999999999999999999999999999999999999999873  33332  233344455667888888866544


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHh--cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIML--ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                      ++       +.+..+.+++.||+.++.-  ....|.|||..|.+||++.+..++..+|+|++||..||++.|.+||...+
T Consensus       147 hRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  147 HRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             cCCCCHHHhccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence            33       2334456777777765443  33468999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ..+++.+|.+.+..+|..++.+++|+|.+||.++|.+|.+..|++.|||+..
T Consensus       227 ~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  227 HSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             hHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999999999999999999999999999999864

>KOG0694|consensus

Probab=100.00  E-value=4.9e-39  Score=284.97  Aligned_cols=195  Identities=25%  Similarity=0.454  Sum_probs=163.0

Q ss_pred             hHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   80 (305)
                      .|.+|+.... ||++++|+..|++++++|+||||+.|||+..+.+. ..+   .+..++.+. -+..++.+.|+.|+.++
T Consensus       417 ~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~-~~F---~e~rarfyaAev~l~L~fLH~~~IIYR  492 (694)
T KOG0694|consen  417 CEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT-DVF---SEPRARFYAAEVVLGLQFLHENGIIYR  492 (694)
T ss_pred             HHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEec-ccc---cHHHHHHHHHHHHHHHHHHHhcCceee
Confidence            4777777765 99999999999999999999999999995444332 222   233333332 24567888888887554


Q ss_pred             -------ecCCCCCeeEcchhHHHH----hcCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIM----LANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.|..+.+++.||+....    -...+|+||||.|||||++.+..|+.++|+|||||+|||||.|.+||.+++
T Consensus       493 DlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd  572 (694)
T KOG0694|consen  493 DLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD  572 (694)
T ss_pred             ecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence                   556678999999974432    234679999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      ..+.+..|...++.+|..++.++.++++++|.+||++|..     +++|..||||+.
T Consensus       573 Eee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  573 EEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence            9999999999999999999999999999999999999986     478999999985

>KOG0032|consensus

Probab=100.00  E-value=1.2e-37  Score=271.86  Aligned_cols=197  Identities=31%  Similarity=0.519  Sum_probs=166.1

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++||+++. |||||+++++|++.+.+|+|||+|.||+|.+.+... .   ..+..+.. +.++..++.|+|..|+.|
T Consensus        83 ~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~---~sE~da~~~~~~il~av~~lH~~gvvH  158 (382)
T KOG0032|consen   83 RREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-H---YSERDAAGIIRQILEAVKYLHSLGVVH  158 (382)
T ss_pred             HHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-c---CCHHHHHHHHHHHHHHHHHHHhCCcee
Confidence            58999999999 999999999999999999999999999999988765 1   23333333 344577888999887655


Q ss_pred             e--------ecCC---CCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q--------LNDD---SSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~--------~~~~---~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      +        +...   +..+++.||+.......   ..+.||||.|+|||++....|+..+||||+||++|.|++|.+||
T Consensus       159 rDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF  238 (382)
T KOG0032|consen  159 RDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPF  238 (382)
T ss_pred             ccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCC
Confidence            4        2222   23688889877665543   35789999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         146 ETSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+.+..+.+..|..+.+.++    ..++..++++|+++|..||.+|+|+.++|+|||++..
T Consensus       239 ~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  239 WGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             cCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999889988877554    3578999999999999999999999999999999864

>KOG0599|consensus

Probab=100.00  E-value=2.8e-38  Score=252.25  Aligned_cols=197  Identities=28%  Similarity=0.515  Sum_probs=160.5

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.||+++. |||||+++++|+++.++++|+|+|+.|.|++++.....+.   +...+.+. ++.+++.|.|...+.+
T Consensus        70 ~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlS---EK~tR~iMrqlfegVeylHa~~IVH  146 (411)
T KOG0599|consen   70 RQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLS---EKETRRIMRQLFEGVEYLHARNIVH  146 (411)
T ss_pred             HHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeec---HHHHHHHHHHHHHHHHHHHHhhhhh
Confidence            37999999985 9999999999999999999999999999999999887764   33344443 3345666666544332


Q ss_pred             -------eecCCCCCeeEcchhHHHHhcCC---cccccCCCcccccccc------cCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          80 -------QLNDDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILN------KNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        80 -------~~~~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~------~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                             .+.+++.+|++.||+.+..+...   ...||||+|.|||.+.      ..+|+..+|+||+|||||.++.|.+
T Consensus       147 RDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp  226 (411)
T KOG0599|consen  147 RDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP  226 (411)
T ss_pred             cccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence                   34556688999998866554433   2579999999999874      3458889999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         144 PFETSTLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ||......-.+..|..+++.+..    ..+...+|||.+||+.||.+|+|++|+|.||||..
T Consensus       227 PFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  227 PFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             chhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            99988777777888888876632    47888999999999999999999999999999964

>KOG0198|consensus

Probab=100.00  E-value=1.1e-37  Score=262.35  Aligned_cols=200  Identities=26%  Similarity=0.427  Sum_probs=155.4

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcCC--eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCC
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDSK--FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGF   77 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   77 (305)
                      +++|+.+|++|+|||||++++......  .++|.||||+||+|.+++.+.++  .+.+..++.+. ++++++.|.|..|+
T Consensus        61 l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g~  138 (313)
T KOG0198|consen   61 LEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKGI  138 (313)
T ss_pred             HHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            368999999999999999999754444  79999999999999999988764  23444444433 35677888887665


Q ss_pred             ce-------eecCC-CCCeeEcchhHHHHhcC-------CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhC
Q psy6191          78 GY-------QLNDD-SSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        78 ~~-------~~~~~-~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g  141 (305)
                      .|       .+.+. +..+++.||+.......       ...+.|||.|||||++..+ ..+.++||||+||++.||+||
T Consensus       139 vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg  218 (313)
T KOG0198|consen  139 VHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTG  218 (313)
T ss_pred             eccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCC
Confidence            43       23333 46889999985554331       2357899999999999853 334599999999999999999


Q ss_pred             CCCCCC-CCHHHHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         142 KPPFET-STLKETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       142 ~~Pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+||.. ....+....+...  .+.+|..++.++++||.+|+.+||++||||+++|.|||.+..
T Consensus       219 ~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  219 KPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             CCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence            999987 3444444444333  367888999999999999999999999999999999999753

>KOG0582|consensus

Probab=100.00  E-value=6.7e-37  Score=259.04  Aligned_cols=200  Identities=24%  Similarity=0.403  Sum_probs=156.9

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCc-
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFG-   78 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-   78 (305)
                      +.+|+..|+.++|||||+++..|..+..+|+||.|+.+|++.++++...... +.+..+..++. ++++++|.|+.|.. 
T Consensus        71 l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G~IH  149 (516)
T KOG0582|consen   71 LRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNGHIH  149 (516)
T ss_pred             HHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcCcee
Confidence            3689999999999999999999999999999999999999999998654322 33333333333 46889999977753 


Q ss_pred             ------eeecCCCCCeeEcchhHHHHhc--------CCcccccCCCcccccccc--cCCCCccchHHHHHHHHHHHHhCC
Q psy6191          79 ------YQLNDDSSGVMFNDLTRMIMLA--------NKNTLCGTPNYIAPEILN--KNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        79 ------~~~~~~~~~v~~~d~~~~~~~~--------~~~~~~Gt~~y~aPE~~~--~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                            +++.+.++.|++.||+-...+.        +.++++|||.|||||++.  ..+|+.|+||||||++..||++|.
T Consensus       150 RdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~  229 (516)
T KOG0582|consen  150 RDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGH  229 (516)
T ss_pred             cccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCC
Confidence                  3456667889999985433221        226889999999999964  457999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhccccCCC----------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         143 PPFETSTLKETYSRIKKVEYKLP----------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .||..-.+.+.+-...+..++.+          ...+...+.+|..||++||.+|||++++++|+||+.
T Consensus       230 aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~  298 (516)
T KOG0582|consen  230 APFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK  298 (516)
T ss_pred             CCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence            99998776665444333333211          124567789999999999999999999999999986

>KOG0589|consensus

Probab=100.00  E-value=4.8e-37  Score=265.10  Aligned_cols=201  Identities=24%  Similarity=0.412  Sum_probs=165.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCe-EEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKF-VYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~-~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||.+.+.|+.++. ++||||||+||+|.+.++...+.....+.......+...++.|+|...+-++
T Consensus        51 ~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHR  130 (426)
T KOG0589|consen   51 IQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHR  130 (426)
T ss_pred             HHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence            379999999999999999999998887 9999999999999999987664322122222223334566777775443222


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +....+.|+++||+.+..+...    .+.+|||.||+||++.+.+|+.|+|||||||++|||++-+++|.+.+
T Consensus       131 DlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~  210 (426)
T KOG0589|consen  131 DLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN  210 (426)
T ss_pred             cchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence                   1223467789999887776543    47899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ...+..+|.... .++|...+.+.+.+|+.||..+|..||++.++|.+|.+..+
T Consensus       211 m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  211 MSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             hHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            999999998776 57788899999999999999999999999999999888753

>KOG0586|consensus

Probab=100.00  E-value=2.4e-37  Score=271.27  Aligned_cols=200  Identities=27%  Similarity=0.519  Sum_probs=173.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   80 (305)
                      .||+++|+.|+|||||+++.+.+++..+|+||||+.+|++++++.+.+...+   ..++..+ +...++.|+|+..+.+.
T Consensus       103 ~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e---~~ar~~F~q~vsaveYcH~k~ivHr  179 (596)
T KOG0586|consen  103 GREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKE---KEARAKFRQIVSAVEYCHSKNIVHR  179 (596)
T ss_pred             HHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchh---hhhhhhhHHHHHHHHHHhhcceecc
Confidence            4899999999999999999999999999999999999999999988766543   3344444 45678999998776554


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+...++++.||+..+.+..   ..++||+|.|.|||++.+..| ++.+|+||+||++|.|+.|..||++.+
T Consensus       180 dLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~  259 (596)
T KOG0586|consen  180 DLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN  259 (596)
T ss_pred             ccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence                   334456789999887665432   368999999999999998776 678999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      ..++-.+...+++.+|..++.++.++|+++|.++|.+|+++++++.|.|.+....
T Consensus       260 lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  260 LKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             cccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence            9999889999999999999999999999999999999999999999999986543

>KOG0585|consensus

Probab=100.00  E-value=8.6e-37  Score=260.11  Aligned_cols=198  Identities=26%  Similarity=0.441  Sum_probs=157.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   78 (305)
                      .+||.||++|+|||||+|+++..+  .+.+|||+|||..|.+...   .++..++.+..++.++. +..++.|+|..|+.
T Consensus       156 ~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgii  232 (576)
T KOG0585|consen  156 RREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGII  232 (576)
T ss_pred             HHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCee
Confidence            589999999999999999999986  4689999999999976542   12222234444444443 46678888877664


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC---------CcccccCCCcccccccccC---C-CCccchHHHHHHHHHHH
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN---------KNTLCGTPNYIAPEILNKN---G-HSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~---------~~~~~Gt~~y~aPE~~~~~---~-~~~~~DiwSlGvilye~  138 (305)
                      |+       |.+..+.|++.||+-......         ....+|||.|||||...++   . .+.+.||||+||+||.|
T Consensus       233 HRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCl  312 (576)
T KOG0585|consen  233 HRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCL  312 (576)
T ss_pred             ccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHh
Confidence            43       344457889999875543211         1235899999999987652   2 36789999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHhccccCCCCC--CCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         139 LVGKPPFETSTLKETYSRIKKVEYKLPAT--LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       139 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +.|+.||.+....+++.+|.+....+|..  +...++|||.+||++||.+|+++.++..|||....
T Consensus       313 lfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  313 LFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             hhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            99999999999999999999988888875  68999999999999999999999999999999864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=259.55  Aligned_cols=199  Identities=24%  Similarity=0.449  Sum_probs=164.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++|||||++++++++++.+|+||||+++|+|.+++.....+.+  ......+..+..++.+.|..|+.|. 
T Consensus        49 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~~qi~~~l~~lH~~~i~H~d  126 (291)
T cd05612          49 HNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN--STGLFYASEIVCALEYLHSKEIVYRD  126 (291)
T ss_pred             HHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHHCCeeecC
Confidence            4799999999999999999999999999999999999999999876544321  1112223345678888888776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC-CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET  153 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~  153 (305)
                            +.+..+.+++.||+....... ..+.+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.
T Consensus       127 lkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  206 (291)
T cd05612         127 LKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI  206 (291)
T ss_pred             CCHHHeEECCCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                  233446688888875544332 2356899999999999988899999999999999999999999999888888


Q ss_pred             HHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCcccccc
Q psy6191         154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFNDY  202 (305)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~~  202 (305)
                      ...+......+|...+..++++|++||+.||.+|++     ++++++||||+..
T Consensus       207 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         207 YEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            888888888888889999999999999999999995     9999999999863

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-36  Score=263.32  Aligned_cols=197  Identities=27%  Similarity=0.460  Sum_probs=163.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||+||+|.+.+.....+   .+..+. ....+..++.++|..++.|.
T Consensus        66 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~~ivH~  142 (329)
T PTZ00263         66 AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF---PNDVAKFYHAELVLAFEYLHSKDIIYR  142 (329)
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            47999999999999999999999999999999999999999998765443   222222 22345677888887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                             +.+..+.+++.||+....... ..+.+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+
T Consensus       143 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  222 (329)
T PTZ00263        143 DLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR  222 (329)
T ss_pred             CCCHHHEEECCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH
Confidence                   333446677888865443322 235689999999999998889999999999999999999999999988888


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      .+..+......+|..++..++++|++||+.||.+|++     +++++.||||++
T Consensus       223 ~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        223 IYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            8888888888888889999999999999999999997     799999999986

>KOG0201|consensus

Probab=100.00  E-value=6.6e-38  Score=264.72  Aligned_cols=199  Identities=25%  Similarity=0.385  Sum_probs=154.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCC----
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGF----   77 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----   77 (305)
                      ++||.++.++++|||.++|+.|..+..+|++||||.||++.++++....+.+.  ..+-.+..+..++.|.|..+.    
T Consensus        59 qqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~--~i~~ilre~l~~l~ylH~~~kiHrD  136 (467)
T KOG0201|consen   59 QQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEF--EIAVILREVLKGLDYLHSEKKIHRD  136 (467)
T ss_pred             HHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccc--eeeeehHHHHHHhhhhhhcceeccc
Confidence            58999999999999999999999999999999999999999999876554321  111122234555666664332    


Q ss_pred             ----ceeecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          78 ----GYQLNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        78 ----~~~~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                          +.++... +.+++.||+-...+    ....+++|||.|||||++....|+.++||||||++.|||++|.+|+....
T Consensus       137 IKaanil~s~~-g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h  215 (467)
T KOG0201|consen  137 IKAANILLSES-GDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH  215 (467)
T ss_pred             ccccceeEecc-CcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence                3333333 67888888644433    23479999999999999998899999999999999999999999998876


Q ss_pred             HHHHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         150 LKETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       150 ~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      +...+..|-+ ..+.+....+..+++||..||.+||+.||+|.++|+|+|++..+
T Consensus       216 PmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  216 PMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             cceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            6444333322 23344456788899999999999999999999999999998744

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-36  Score=263.32  Aligned_cols=198  Identities=25%  Similarity=0.421  Sum_probs=163.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++.+|+|||||+||+|.+++.....+.   +... .....+..++.++|+.++.|.
T Consensus        79 ~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~---~~~~~~~~~qi~~aL~~LH~~~ivHr  155 (340)
T PTZ00426         79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP---NDVGCFYAAQIVLIFEYLQSLNIVYR  155 (340)
T ss_pred             HHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence            369999999999999999999999999999999999999999987654432   2222 223345677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                             +.+..+.+++.||+...... ...+.+||+.|||||++.+..++.++||||+||++|||++|.+||.+.+...
T Consensus       156 DLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~  235 (340)
T PTZ00426        156 DLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL  235 (340)
T ss_pred             CCCHHHEEECCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH
Confidence                   23345667888887544322 2346789999999999998889999999999999999999999999988888


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ....+......+|...+..+.++|++||+.||.+|+     +++++++||||+..
T Consensus       236 ~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        236 IYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            888888888888899999999999999999999996     89999999999864

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.2e-36  Score=259.73  Aligned_cols=197  Identities=22%  Similarity=0.397  Sum_probs=163.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|||||||+||+|.+.+.....+   .+..... ...+..++.++|..|+.|.
T Consensus        43 ~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~~L~~lH~~~ivHr  119 (323)
T cd05571          43 LTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF---SEDRARFYGAEIVSALGYLHSCDVVYR  119 (323)
T ss_pred             HHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence            36899999999999999999999999999999999999999988765443   2222222 2345678888888876443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.....    ......+||+.|||||++.+..++.++||||+||++|||++|..||.+.+
T Consensus       120 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  199 (323)
T cd05571         120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             CCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence                   2334466788888754321    11235689999999999998899999999999999999999999999988


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~  201 (305)
                      .......+......+|..++.++.++|++||..||.+|+     ++.++++||||..
T Consensus       200 ~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         200 HEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            888888888778888899999999999999999999999     8999999999976

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=256.39  Aligned_cols=198  Identities=22%  Similarity=0.427  Sum_probs=162.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||+||+|.+++.....+.   ..... ....+..++.++|..++.|.
T Consensus        41 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~qi~~~l~~lH~~~i~Hr  117 (312)
T cd05585          41 LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFD---LSRARFYTAELLCALENLHKFNVIYR  117 (312)
T ss_pred             HHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence            369999999999999999999999999999999999999999987654432   22222 23345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+
T Consensus       118 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~  197 (312)
T cd05585         118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN  197 (312)
T ss_pred             CCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence                   2334456778888654322    11235689999999999998889999999999999999999999999988


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC---CHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP---PVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---~~~~~l~~~~~~~~  202 (305)
                      ..+.+..+......+|...+..+.++|.+||..||.+|+   ++.+++.||||+..
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         198 VNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            888888888888888889999999999999999999997   57899999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0593|consensus

Probab=100.00  E-value=4e-36  Score=243.02  Aligned_cols=199  Identities=25%  Similarity=0.403  Sum_probs=154.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      -|||++|++|+|||+|.|+++|.....+|||+|||+.--|.++-....+..  .+.....++++.+++.++|+.++.++ 
T Consensus        49 lREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~--~~~vk~~l~Q~l~ai~~cHk~n~IHRD  126 (396)
T KOG0593|consen   49 LREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVP--SELVKKYLYQLLKAIHFCHKNNCIHRD  126 (396)
T ss_pred             HHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCC--HHHHHHHHHHHHHHhhhhhhcCeeccc
Confidence            389999999999999999999999999999999999865555543333321  12223344556788999998876543 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcCC----cccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                            +...++.++++||+.+..+...    ..++.|.||.|||++.+ ..|+.++||||+||++.||++|.+-|.+.+
T Consensus       127 IKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S  206 (396)
T KOG0593|consen  127 IKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS  206 (396)
T ss_pred             CChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence                  3334567889999988777633    24678999999998876 679999999999999999999999999988


Q ss_pred             HHHHHHHHhcccc-------------------CCC------------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         150 LKETYSRIKKVEY-------------------KLP------------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       150 ~~~~~~~i~~~~~-------------------~~~------------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      ..+++..|.+...                   .+|            +.++.-+.||+++||.+||++|++.+|++.|++
T Consensus       207 DiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y  286 (396)
T KOG0593|consen  207 DIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY  286 (396)
T ss_pred             hHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence            7776666643211                   111            124456779999999999999999999999999


Q ss_pred             cccc
Q psy6191         199 FNDY  202 (305)
Q Consensus       199 ~~~~  202 (305)
                      |+++
T Consensus       287 Fd~~  290 (396)
T KOG0593|consen  287 FDGF  290 (396)
T ss_pred             HHHH
Confidence            9754

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.5e-35  Score=252.95  Aligned_cols=196  Identities=21%  Similarity=0.393  Sum_probs=162.1

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+++++.++|||||+++++|++++.+|||||||+||+|.+++.....+   .+.... ....+..++.|+|..|+.|. 
T Consensus        44 ~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~~ivH~D  120 (323)
T cd05595          44 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSALEYLHSRDVVYRD  120 (323)
T ss_pred             HHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence            6899999999999999999999999999999999999999888765433   222222 23345778888888776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+.++.+++.||+......    .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus       121 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~  200 (323)
T cd05595         121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  200 (323)
T ss_pred             CCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH
Confidence                  23344678888887544321    12356899999999999988899999999999999999999999998888


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND  201 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~  201 (305)
                      .+....+......+|..+++++.++|.+||..||.+|+     ++.++++|+||..
T Consensus       201 ~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         201 ERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            88888887777788889999999999999999999998     8999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.4e-35  Score=254.67  Aligned_cols=197  Identities=22%  Similarity=0.397  Sum_probs=161.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++|||||++++++++++.+|||||||++|+|.+.+.....+   .+... .....+..++.|+|..++.|.
T Consensus        43 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l---~~~~~~~~~~qi~~aL~~LH~~~ivHr  119 (328)
T cd05593          43 LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVF---SEDRTRFYGAEIVSALDYLHSGKIVYR  119 (328)
T ss_pred             HHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence            36899999999999999999999999999999999999999888654333   22222 223345778888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.....    ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus       120 Dikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  199 (328)
T cd05593         120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (328)
T ss_pred             ccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence                   2334466788888644321    11235689999999999998889999999999999999999999999888


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~  201 (305)
                      ..+....+......+|..++.++.++|++||..||.+|+     ++.++++||||..
T Consensus       200 ~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         200 HEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             HHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            888888887777888899999999999999999999997     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.9e-35  Score=253.55  Aligned_cols=199  Identities=30%  Similarity=0.454  Sum_probs=162.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.+|+.++|||||++++++++++.+|+||||++||+|.+.+.....+.+  ......+..+..++.++|..++.|. 
T Consensus        48 ~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~~qi~~~l~~lH~~~ivH~d  125 (323)
T cd05584          48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFME--DTACFYLSEISLALEHLHQQGIIYRD  125 (323)
T ss_pred             HHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            3699999999999999999999999999999999999999998876544321  1111223345677888888776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+..+.+++.||+.....    ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.
T Consensus       126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~  205 (323)
T cd05584         126 LKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR  205 (323)
T ss_pred             CCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH
Confidence                  2334456778888643211    112346899999999999988899999999999999999999999999888


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ......+......+|..++..+.++|.+||+.||.+|+     ++++++.||||...
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         206 KKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            88888888888888889999999999999999999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-34  Score=250.95  Aligned_cols=197  Identities=23%  Similarity=0.405  Sum_probs=160.2

Q ss_pred             hHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|+.+++.+ +|||||++++++++.+.+|+|||||+||+|.+++.....+.   +.... .+..+..++.++|+.++.|.
T Consensus        44 ~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~---~~~~~~~~~ql~~~L~~lH~~~ivH~  120 (320)
T cd05590          44 TEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEITSALMFLHDKGIIYR  120 (320)
T ss_pred             HHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            577788766 79999999999999999999999999999999887654432   22222 23345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++.....    ......+||+.|||||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus       121 dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  200 (320)
T cd05590         121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN  200 (320)
T ss_pred             CCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence                   2334456778887643321    11235689999999999998889999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH------hhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV------AQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~------~~~l~~~~~~~~  202 (305)
                      ..+....+......+|..++.++.++|++||+.||.+|+++      ++++.||||+..
T Consensus       201 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         201 EDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            88888888888888888899999999999999999999998      899999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0690|consensus

Probab=100.00  E-value=2.9e-35  Score=240.39  Aligned_cols=196  Identities=21%  Similarity=0.387  Sum_probs=164.3

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCce--
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGY--   79 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--   79 (305)
                      -|-++|+..+||++..|...|++.+.+++||||+.||+|.-.+.+...+.   +..++.+- -+..++.|+|..++.+  
T Consensus       217 TE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~Fs---E~RtRFYGaEIvsAL~YLHs~~ivYRD  293 (516)
T KOG0690|consen  217 TENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFS---EDRTRFYGAEIVSALGYLHSRNIVYRD  293 (516)
T ss_pred             hHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhccc---chhhhhhhHHHHHHhhhhhhCCeeeee
Confidence            47789999999999999999999999999999999999998887655442   23332221 1345566777555433  


Q ss_pred             -----eecCCCCCeeEcchhHHHH----hcCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          80 -----QLNDDSSGVMFNDLTRMIM----LANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        80 -----~~~~~~~~v~~~d~~~~~~----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                           ++.|..+.|++.||+...-    -....++||||.|.|||++....|+.++|+|.+||++|||++|+.||.+.+.
T Consensus       294 lKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh  373 (516)
T KOG0690|consen  294 LKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH  373 (516)
T ss_pred             chhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence                 3556678999999964332    2234689999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      ..++..|......+|..++++++.|+..+|.+||.+|..     +.|+.+|+||..
T Consensus       374 ~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  374 EKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             hHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            999999999999999999999999999999999999974     789999999975

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.6e-35  Score=252.18  Aligned_cols=197  Identities=24%  Similarity=0.450  Sum_probs=161.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++.+|+|||||++|+|.+.+.....+   .+... ..+..+..++.|+|..++.|.
T Consensus        46 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l---~~~~~~~~~~qi~~~l~~lH~~~i~H~  122 (318)
T cd05582          46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEEDVKFYLAELALALDHLHSLGIIYR  122 (318)
T ss_pred             HHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            36999999999999999999999999999999999999999988654433   22222 223345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+.++.+++.|++.......    ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus       123 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  202 (318)
T cd05582         123 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD  202 (318)
T ss_pred             CCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence                   233445677888864433211    235689999999999998889999999999999999999999999988


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      ..+....+......+|..++..+.++|++||+.||.+||+     +.+++.||||..
T Consensus       203 ~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         203 RKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            8888888888788888889999999999999999999999     677999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0604|consensus

Probab=100.00  E-value=9.8e-35  Score=234.65  Aligned_cols=201  Identities=23%  Similarity=0.419  Sum_probs=161.1

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   76 (305)
                      .||++++=.. -|||||+++++|++    ...+.+|||.++||+|+..++..+........+++.+-.+..++.|+|+..
T Consensus       102 RrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n  181 (400)
T KOG0604|consen  102 RREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN  181 (400)
T ss_pred             HhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc
Confidence            4788888665 59999999999875    467999999999999999998877643333344444445567788888877


Q ss_pred             CceeecC----------CCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          77 FGYQLND----------DSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        77 ~~~~~~~----------~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      ++++...          .+..+++.||+.+..-.   ...|.|-||+|.|||++..+.|+..+|+||+||++|.|++|.+
T Consensus       182 IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyP  261 (400)
T KOG0604|consen  182 IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP  261 (400)
T ss_pred             hhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCC
Confidence            7665221          23457788887665433   2357899999999999999999999999999999999999999


Q ss_pred             CCCCCC----HHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         144 PFETST----LKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       144 Pf~~~~----~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||....    ....-.+|..+.+.+|.    .+|..++|+|+++|..+|.+|.|+++++.|||++..
T Consensus       262 PFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  262 PFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             cccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            997543    22345678888888875    488899999999999999999999999999999864

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.3e-34  Score=247.20  Aligned_cols=198  Identities=22%  Similarity=0.381  Sum_probs=158.2

Q ss_pred             hHHHHHhc-CCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRS-LKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~-l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.++.. ++||||+++++++++++.+|+|||||+||+|.+.+.....+..  .........+..++.++|..++.|. 
T Consensus        44 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~--~~~~~~~~qi~~~l~~lH~~~ivHrD  121 (316)
T cd05620          44 VEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCGLQFLHSKGIIYRD  121 (316)
T ss_pred             HHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHHCCeEecC
Confidence            56777765 5899999999999999999999999999999998876543321  1112223445778888888776543 


Q ss_pred             ------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+.++.+++.|++.....    ....+.+||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.
T Consensus       122 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~  201 (316)
T cd05620         122 LKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE  201 (316)
T ss_pred             CCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence                  2334456777887643211    122457899999999999988999999999999999999999999999888


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH-hhhhcCcccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV-AQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~-~~~l~~~~~~~~  202 (305)
                      .+....+....+.+|...+.+++++|.+||..||.+|+++ +++++||||+..
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         202 DELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence            8888888777777888899999999999999999999998 588899999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0661|consensus

Probab=100.00  E-value=1.9e-34  Score=245.86  Aligned_cols=199  Identities=24%  Similarity=0.402  Sum_probs=159.4

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCC-eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSK-FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~-~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   78 (305)
                      .||+.-|++|+ |||||+|++++.+.+ .+|+|||||+. +|.++++....+  ..+..++.++ ++.+++.|.|+.|+-
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~--fse~~irnim~QilqGL~hiHk~GfF  132 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRL--FSESDIRNIMYQILQGLAHIHKHGFF  132 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCc--CCHHHHHHHHHHHHHHHHHHHhcCcc
Confidence            48999999999 999999999999888 99999999986 899999876333  3455555554 457899999999986


Q ss_pred             eee-------cCCCCCeeEcchhHHHHhcCC---cccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          79 YQL-------NDDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        79 ~~~-------~~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                      |+.       ......|+++||+.+..+...   ..++-|.||.|||++. ...|+.++||||+|||++|+.+-++-|.|
T Consensus       133 HRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG  212 (538)
T KOG0661|consen  133 HRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG  212 (538)
T ss_pred             cccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence            652       222456788898765544332   3568899999999765 66799999999999999999999999999


Q ss_pred             CCHHHHHHHHhcc-------------------ccCCC-----------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         148 STLKETYSRIKKV-------------------EYKLP-----------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       148 ~~~~~~~~~i~~~-------------------~~~~~-----------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      .+..+++.+|...                   .+.+|           +..+.++.++|.+||..||.+||||.|+++||
T Consensus       213 ~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  213 ASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             CcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            9888777776431                   12232           23567889999999999999999999999999


Q ss_pred             cccccC
Q psy6191         198 FFNDYC  203 (305)
Q Consensus       198 ~~~~~~  203 (305)
                      ||....
T Consensus       293 ffq~~~  298 (538)
T KOG0661|consen  293 FFQVGR  298 (538)
T ss_pred             cccccc
Confidence            998643

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.1e-34  Score=248.50  Aligned_cols=197  Identities=24%  Similarity=0.421  Sum_probs=160.7

Q ss_pred             hHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .|+++++.+ +||||+++++++++++.+|+|||||+||+|.+.+.....+.+  .........+..++.++|..|+.|. 
T Consensus        44 ~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~--~~~~~~~~qi~~aL~~LH~~~ivHrD  121 (321)
T cd05591          44 TEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE--PRSRFYAAEVTLALMFLHRHGVIYRD  121 (321)
T ss_pred             HHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHHCCeeccC
Confidence            578888765 899999999999999999999999999999988876544321  1112223445778888888776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+..+.+++.|++.....    ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.
T Consensus       122 ikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~  201 (321)
T cd05591         122 LKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE  201 (321)
T ss_pred             CCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence                  3334466788888644321    112356799999999999988899999999999999999999999999998


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-------CHhhhhcCccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-------PVAQLLHFEFFND  201 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-------~~~~~l~~~~~~~  201 (305)
                      .+....+......+|..++.++.++|.+||..||.+|+       +++++++||||..
T Consensus       202 ~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         202 DDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            88888888888888888999999999999999999999       8999999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.5e-34  Score=251.32  Aligned_cols=197  Identities=27%  Similarity=0.402  Sum_probs=153.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||+++++++++..+|||||||+||+|.+++.....+   .+..+. .+..+..++.++|+.|+.|.
T Consensus        49 ~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l---~~~~~~~~~~qi~~aL~~lH~~givHr  125 (363)
T cd05628          49 RAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL---TEEETQFYIAETVLAIDSIHQLGFIHR  125 (363)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence            46999999999999999999999999999999999999999998765443   222222 23345678888888776543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---------------------------------------CcccccCCCcccc
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---------------------------------------KNTLCGTPNYIAP  114 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---------------------------------------~~~~~Gt~~y~aP  114 (305)
                             +.+..+.+++.||+....+..                                       ..+.+||+.|+||
T Consensus       126 DlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP  205 (363)
T cd05628         126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAP  205 (363)
T ss_pred             CCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCH
Confidence                   233446678888864322110                                       1246899999999


Q ss_pred             cccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc--ccCCCC--CCCHHHHHHHHHHhhcCCC---CC
Q psy6191         115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--EYKLPA--TLKKPAATMIKKMLLLDPV---QR  187 (305)
Q Consensus       115 E~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~dp~---~R  187 (305)
                      |++.+..++.++||||+||++|||++|++||.+.+..+.+.++...  ...+|.  .++.+++++|.+++. +|.   .|
T Consensus       206 E~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r  284 (363)
T cd05628         206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA  284 (363)
T ss_pred             HHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence            9999888999999999999999999999999998888888877653  233443  468899999999775 444   45


Q ss_pred             CCHhhhhcCcccccc
Q psy6191         188 PPVAQLLHFEFFNDY  202 (305)
Q Consensus       188 ~~~~~~l~~~~~~~~  202 (305)
                      |+++|+++||||+..
T Consensus       285 ~~~~ei~~hp~f~~~  299 (363)
T cd05628         285 PGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCHHHHhCCCCCCCC
Confidence            899999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6e-34  Score=247.78  Aligned_cols=196  Identities=26%  Similarity=0.442  Sum_probs=156.7

Q ss_pred             hHHHH---HhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCc
Q psy6191           3 QEIAI---HRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         3 ~Ei~i---l~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   78 (305)
                      +|+++   ++.++||||+++++++++++.+|+|||||+||+|...+... .+   .+.... ....+..++.+.|..++.
T Consensus        48 ~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~l---~~~~~~~~~~qi~~al~~lH~~~iv  123 (324)
T cd05589          48 CEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-VF---SEPRAVFYAACVVLGLQYLHENKIV  123 (324)
T ss_pred             HHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC-CC---CHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            45444   46778999999999999999999999999999998877542 12   222222 233456778888887764


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                      |.       +.+..+.+++.||+.....    ....+.+||+.|||||++.+..++.++||||+||++|+|++|+.||.+
T Consensus       124 Hrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~  203 (324)
T cd05589         124 YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             ecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence            43       3334466788888643221    112457899999999999988899999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         148 STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      .+..+....+......+|..++..+.++|.+||..||.+||     ++.++++||||++.
T Consensus       204 ~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         204 DDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             CCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            88888888888877888888999999999999999999999     68999999999863

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.2e-34  Score=248.63  Aligned_cols=197  Identities=26%  Similarity=0.478  Sum_probs=155.2

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.+ +|||||++++++++++.+|||||||+||+|.+++.....+   .+..+. ....+..++.++|+.|+.|
T Consensus        43 ~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l---~~~~~~~~~~qi~~~l~~lH~~~ivH  119 (329)
T cd05588          43 QTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKL---PEEHARFYSAEISLALNFLHERGIIY  119 (329)
T ss_pred             HHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3688899888 7999999999999999999999999999999888665443   222222 2334567888888887644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus       120 ~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  199 (329)
T cd05588         120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  199 (329)
T ss_pred             cCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence            3       2334466788888644321    1224578999999999999988999999999999999999999999631


Q ss_pred             ---------CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC------HhhhhcCccccc
Q psy6191         149 ---------TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP------VAQLLHFEFFND  201 (305)
Q Consensus       149 ---------~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~------~~~~l~~~~~~~  201 (305)
                               ........+......+|..++..+.++|++||..||.+|++      ++++++||||..
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         200 GMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             cccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence                     12234455666677788889999999999999999999997      789999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-34  Score=252.10  Aligned_cols=197  Identities=23%  Similarity=0.403  Sum_probs=159.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhh-hCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDK-YGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~   79 (305)
                      .+|+++++.++||||+++++++++++.+|||||||+||+|.+.+.....+   .+.... ....+..++.|+|. .++.|
T Consensus        43 ~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l---~~~~~~~~~~qi~~aL~~lH~~~~ivH  119 (325)
T cd05594          43 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF---SEDRARFYGAEIVSALDYLHSEKNVVY  119 (325)
T ss_pred             HHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence            36889999999999999999999999999999999999999888654433   222222 22345677888886 56543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.||+.....    ....+.+||+.|||||++.+..++.++||||+||++|+|++|..||.+.
T Consensus       120 rDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~  199 (325)
T cd05594         120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  199 (325)
T ss_pred             cCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence            2       2333456778888643321    1123567999999999999888999999999999999999999999998


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccc
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND  201 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~  201 (305)
                      +..+....+......+|...+.++.++|++||+.||.+|+     ++.++++||||..
T Consensus       200 ~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         200 DHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             CHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            8888888887777888889999999999999999999997     8999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.9e-34  Score=246.10  Aligned_cols=198  Identities=23%  Similarity=0.384  Sum_probs=157.9

Q ss_pred             hHHHHHhc-CCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRS-LKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~-l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.+++. ++|||||++++++++++.+|+|||||+||+|.+++.....+..  .........+..++.++|..++.|. 
T Consensus        44 ~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~--~~~~~~~~qi~~al~~LH~~~ivHrd  121 (316)
T cd05619          44 VEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDL--PRATFYAAEIICGLQFLHSKGIVYRD  121 (316)
T ss_pred             HHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence            46777765 5999999999999999999999999999999999876433321  1112223345677888888776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+..+.+++.|++.....    ....+.+||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.
T Consensus       122 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~  201 (316)
T cd05619         122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE  201 (316)
T ss_pred             CCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence                  2234456777887643321    122356799999999999988899999999999999999999999999888


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHh-hhhcCcccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVA-QLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~-~~l~~~~~~~~  202 (305)
                      .+....+......+|...+.+++++|.+||..||.+|+++. +++.||||+..
T Consensus       202 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         202 EELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             HHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence            88888777776777888999999999999999999999996 89999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.6e-34  Score=246.50  Aligned_cols=197  Identities=25%  Similarity=0.433  Sum_probs=159.7

Q ss_pred             hHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|+.+++.+ +||||+++++++++.+.+|+|||||+||+|.+.+.....+   .+... .....++.++.++|+.++.|.
T Consensus        44 ~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l---~~~~~~~~~~qi~~~l~~LH~~~ivH~  120 (318)
T cd05570          44 TEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRF---DEPRARFYAAEIVLGLQFLHERGIIYR  120 (318)
T ss_pred             HHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHhCCeEcc
Confidence            688888877 7999999999999999999999999999999888765433   22222 223345677888887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++.....    ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus       121 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~  200 (318)
T cd05570         121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD  200 (318)
T ss_pred             CCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence                   2334456777787643211    11235689999999999998899999999999999999999999999888


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV-----AQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~-----~~~l~~~~~~~~  202 (305)
                      ..+....+......+|..++.++.++|++||..||.+||++     .+++.||||+..
T Consensus       201 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         201 EDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             HHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            88888888877778888899999999999999999999999     999999999763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.5e-34  Score=243.38  Aligned_cols=195  Identities=23%  Similarity=0.312  Sum_probs=144.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||+++.+..+......+   ..... ..+..+..++.+.|..++.|.
T Consensus        48 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~qi~~~L~~lH~~~i~H~  124 (287)
T cd07848          48 LRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV---PPEKVRSYIYQLIKAIHWCHKNDIVHR  124 (287)
T ss_pred             HHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            47999999999999999999999999999999999998776554332222   22222 223345677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.|++.......     ....+||+.|+|||++.+..++.++||||+||++|||++|++||.+.
T Consensus       125 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             CCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence                   233445678888865443321     22457999999999998888999999999999999999999999876


Q ss_pred             CHHHHHHHHhcccc-------------------CC-------------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         149 TLKETYSRIKKVEY-------------------KL-------------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       149 ~~~~~~~~i~~~~~-------------------~~-------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +..+....+.....                   ..             ...++..+.++|++||+.||.+|||++++++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         205 SEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             CHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            65443332221100                   01             11256778999999999999999999999999


Q ss_pred             ccc
Q psy6191         197 EFF  199 (305)
Q Consensus       197 ~~~  199 (305)
                      |||
T Consensus       285 p~f  287 (287)
T cd07848         285 PAF  287 (287)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.4e-34  Score=242.22  Aligned_cols=200  Identities=20%  Similarity=0.345  Sum_probs=153.1

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.++++++|||||++++++.+++.+|+|||||++|+|.+.+...... ....... .....+..++.++|..++.|. 
T Consensus        49 ~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~d  127 (285)
T cd05631          49 NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQRERIVYRD  127 (285)
T ss_pred             HHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCC
Confidence            6999999999999999999999999999999999999998877543221 1122222 222345677888887775443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK  151 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~  151 (305)
                            +.+..+.+++.||+.......   ....+||+.|||||++.+..++.++||||+||++|+|++|+.||.+.+..
T Consensus       128 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~  207 (285)
T cd05631         128 LKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER  207 (285)
T ss_pred             CCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence                  233445677778765433221   13457999999999999889999999999999999999999999875432


Q ss_pred             ----HHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccccC
Q psy6191         152 ----ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFNDYC  203 (305)
Q Consensus       152 ----~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~~~  203 (305)
                          .....+......++..++..+.+||++||..||.+|++     ++++++||||....
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         208 VKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             hhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence                23333444445667788999999999999999999997     89999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0600|consensus

Probab=100.00  E-value=1.1e-33  Score=242.98  Aligned_cols=198  Identities=25%  Similarity=0.409  Sum_probs=154.4

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCC
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGF   77 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   77 (305)
                      |.|||.||++|+|||||+|.+...+.  ..+|||+|||+. ||.-++....-  .+.+.....+. ++..++.|+|..|+
T Consensus       163 ~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~gv  239 (560)
T KOG0600|consen  163 AIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRGV  239 (560)
T ss_pred             HHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcCe
Confidence            57999999999999999999988776  789999999986 77777654211  12333333343 45678999998776


Q ss_pred             ce-------eecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCC
Q psy6191          78 GY-------QLNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        78 ~~-------~~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .|       +|.+..+.+++.||+.+......     ...+-|.||.|||++.+. .|+.++|+||+||||.||+.|++.
T Consensus       240 lHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI  319 (560)
T KOG0600|consen  240 LHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI  319 (560)
T ss_pred             eeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC
Confidence            44       35566688899999877643322     234679999999988765 599999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc----------cCCC-------------------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETSTLKETYSRIKKVE----------YKLP-------------------ATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~----------~~~~-------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |.+.+..+++..|.+..          ..+|                   ..++..+.+|+..||..||.+|.||.++|+
T Consensus       320 ~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  320 LQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            99999999888875421          1122                   124567789999999999999999999999


Q ss_pred             Cccccc
Q psy6191         196 FEFFND  201 (305)
Q Consensus       196 ~~~~~~  201 (305)
                      ++||+.
T Consensus       400 seyF~t  405 (560)
T KOG0600|consen  400 SEYFTT  405 (560)
T ss_pred             Cccccc
Confidence            999953

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.9e-34  Score=246.95  Aligned_cols=194  Identities=24%  Similarity=0.462  Sum_probs=157.4

Q ss_pred             HHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee----
Q psy6191           6 AIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ----   80 (305)
Q Consensus         6 ~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~----   80 (305)
                      .+++.++|||||++++++++++.+|+|||||+||+|.+++.....+   .+.... ....+..++.++|..|+.|.    
T Consensus        48 ~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~qi~~~l~~lH~~givH~dikp  124 (323)
T cd05575          48 VLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSF---PEPRARFYAAEIASALGYLHSLNIIYRDLKP  124 (323)
T ss_pred             HHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEeCCCCH
Confidence            3568899999999999999999999999999999999988765433   222222 23445778888988776443    


Q ss_pred             ---ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy6191          81 ---LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET  153 (305)
Q Consensus        81 ---~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~  153 (305)
                         +.+..+.+++.||+.....    ......+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+.
T Consensus       125 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  204 (323)
T cd05575         125 ENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM  204 (323)
T ss_pred             HHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH
Confidence               2334466788888644321    112356899999999999988899999999999999999999999999888888


Q ss_pred             HHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hhhhcCcccccc
Q psy6191         154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV----AQLLHFEFFNDY  202 (305)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~----~~~l~~~~~~~~  202 (305)
                      ...+......+++..+..+.++|++||+.||.+|+++    .++++||||...
T Consensus       205 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         205 YDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            8888877777888899999999999999999999987    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0696|consensus

Probab=100.00  E-value=3.9e-34  Score=240.47  Aligned_cols=195  Identities=25%  Similarity=0.433  Sum_probs=158.3

Q ss_pred             HHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCcee-
Q psy6191           4 EIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         4 Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-   80 (305)
                      |-++|... +-|++|+||..|++-+.+|+|||||.||||.-.+++.+.+.+   ..+..+. -++-++-++|..|+.++ 
T Consensus       399 EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKE---p~AvFYAaEiaigLFFLh~kgIiYRD  475 (683)
T KOG0696|consen  399 EKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PVAVFYAAEIAIGLFFLHSKGIIYRD  475 (683)
T ss_pred             hhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCC---chhhhhhHHHHHHhhhhhcCCeeeee
Confidence            55666655 568999999999999999999999999999999998877744   2221111 12233444555554332 


Q ss_pred             ------ecCCCCCeeEcchhH--HHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTR--MIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~--~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+..+.|++.||+-  .++..  ...|+||||.|+|||++..++|+.++|+||+||+||||+.|++||++.+.
T Consensus       476 LKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE  555 (683)
T KOG0696|consen  476 LKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE  555 (683)
T ss_pred             ccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence                  345568899999863  23332  34589999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hhhhcCccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV-----AQLLHFEFFND  201 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~-----~~~l~~~~~~~  201 (305)
                      .++++.|......+|..+|.++.++.+.+|.+.|.+|..+     .++..||||+.
T Consensus       556 ~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  556 DELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            9999999999999999999999999999999999999854     57888999985

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-34  Score=250.87  Aligned_cols=197  Identities=28%  Similarity=0.449  Sum_probs=154.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++.+|||||||+||+|.+++.....+   .+..+.. +..+..++.++|..++.|.
T Consensus        49 ~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l---~~~~~~~~~~qi~~aL~~lH~~~ivH~  125 (364)
T cd05599          49 RAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF---TEEETRFYIAETILAIDSIHKLGYIHR  125 (364)
T ss_pred             HHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            46999999999999999999999999999999999999999998765443   2222322 3345678888888776542


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC------------------------------------------CcccccCCCc
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN------------------------------------------KNTLCGTPNY  111 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~------------------------------------------~~~~~Gt~~y  111 (305)
                             +.+..+.+++.|++....+..                                          ..+.+||+.|
T Consensus       126 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  205 (364)
T cd05599         126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDY  205 (364)
T ss_pred             cCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccc
Confidence                   233445677777754322110                                          1135799999


Q ss_pred             ccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--cCCCC--CCCHHHHHHHHHHhhcCCCCC
Q psy6191         112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE--YKLPA--TLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       112 ~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~l~~dp~~R  187 (305)
                      ||||++.+..++.++||||+||++|||++|.+||.+.+..+....+....  ..+|.  .++..+.++|.+||. +|.+|
T Consensus       206 ~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R  284 (364)
T cd05599         206 IAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERR  284 (364)
T ss_pred             cCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhc
Confidence            99999998889999999999999999999999999988877777665433  23333  468899999999996 99999


Q ss_pred             CC---HhhhhcCcccccc
Q psy6191         188 PP---VAQLLHFEFFNDY  202 (305)
Q Consensus       188 ~~---~~~~l~~~~~~~~  202 (305)
                      ++   +.+++.||||+..
T Consensus       285 ~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         285 LGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCHHHHhcCCCcCCC
Confidence            98   9999999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=246.40  Aligned_cols=198  Identities=27%  Similarity=0.447  Sum_probs=157.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++|||||++++++++++.+|||||||+||+|.+++.....+.   +.... .+..+..++.++|..++.|.
T Consensus        49 ~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~---~~~~~~~~~qi~~~l~~lH~~~ivH~  125 (333)
T cd05600          49 LTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS---EDHARFYMAEMFEAVDALHELGYIHR  125 (333)
T ss_pred             HHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            469999999999999999999999999999999999999999997654432   22222 23345677888887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                             +.+..+.+++.||+...... ...+.+||+.|+|||++.+..++.++||||+||++|||++|.+||.+.+..+
T Consensus       126 dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  205 (333)
T cd05600         126 DLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE  205 (333)
T ss_pred             CCCHHHEEECCCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH
Confidence                   33345667888886544322 2346789999999999998899999999999999999999999999988877


Q ss_pred             HHHHHhccc--cCCCC------CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         153 TYSRIKKVE--YKLPA------TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       153 ~~~~i~~~~--~~~~~------~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ....+....  ...|.      .++.++.++|.+||..+|.+|+++.++++||||.+.
T Consensus       206 ~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         206 TWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            766665422  11122      458899999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.1e-33  Score=237.95  Aligned_cols=192  Identities=22%  Similarity=0.310  Sum_probs=147.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhh-C
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKY-G   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~   76 (305)
                      .+|+.+|++++|||||++++++.+    ..++|+|||||+||+|.+++.....+..  ......+..+..++.+.|.. +
T Consensus        66 ~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~--~~~~~i~~~i~~~l~~lH~~~~  143 (283)
T PHA02988         66 ENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSF--KTKLDMAIDCCKGLYNLYKYTN  143 (283)
T ss_pred             HHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCCh--hHHHHHHHHHHHHHHHHHhcCC
Confidence            489999999999999999999877    4579999999999999999876543321  11122233456677777753 4


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhcC-CcccccCCCccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      ..|.       +.+....+++.|++....+.. .....||+.|+|||++.+  ..++.++|||||||++|||++|+.||.
T Consensus       144 ~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~  223 (283)
T PHA02988        144 KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE  223 (283)
T ss_pred             CCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence            3221       223345677788876554332 234579999999999976  678999999999999999999999999


Q ss_pred             CCCHHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +.+..+....+..  ..+.+|...+..+.+++.+||+.||.+|||+.++++
T Consensus       224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        224 NLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            8888777776643  344555568899999999999999999999999975

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-33  Score=256.41  Aligned_cols=200  Identities=20%  Similarity=0.340  Sum_probs=157.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcC-CCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACD-LEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.++|||||++++++++++.+|||||||+||+|.+++..... ...+.+.... .+..+..++.++|..++.|
T Consensus       113 ~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH  192 (478)
T PTZ00267        113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMH  192 (478)
T ss_pred             HHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEE
Confidence            4699999999999999999999999999999999999999988764321 1111222222 2234567788888777544


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      .       +.+..+.+++.||+.......      ..+.+||+.|||||++.+..++.++||||+||++|+|++|+.||.
T Consensus       193 rDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~  272 (478)
T PTZ00267        193 RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK  272 (478)
T ss_pred             CCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence            3       233445677888865433221      245689999999999998889999999999999999999999999


Q ss_pred             CCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         147 TSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +.+..+....+..... ++|..++.++.++|.+||..||.+||++.+++.|+|++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        273 GPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             CCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            8888777777665543 356678899999999999999999999999999999863

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-33  Score=249.38  Aligned_cols=196  Identities=28%  Similarity=0.446  Sum_probs=155.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++.+|+|||||+||+|.+++.... +   .+.... ....++.++.|+|+.++.|.
T Consensus        91 ~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~-l---~~~~~~~~~~qi~~aL~~LH~~~ivHr  166 (370)
T cd05596          91 WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-I---PEKWARFYTAEVVLALDAIHSMGFIHR  166 (370)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcC-C---CHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            369999999999999999999999999999999999999999886532 2   222222 23345678889988876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccC----CCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKN----GHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~----~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+..+.+++.|++.......     ..+.+||+.|||||++.+.    .++.++||||+||++|||++|++|
T Consensus       167 DLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P  246 (370)
T cd05596         167 DVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  246 (370)
T ss_pred             CCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence                   334456778888875443321     2356899999999998643    378899999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc--cCCCC--CCCHHHHHHHHHHhhcCCCC--CCCHhhhhcCccccc
Q psy6191         145 FETSTLKETYSRIKKVE--YKLPA--TLKKPAATMIKKMLLLDPVQ--RPPVAQLLHFEFFND  201 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~l~~dp~~--R~~~~~~l~~~~~~~  201 (305)
                      |.+.+....+..+....  ..+|.  .++.++.++|.+||..+|.+  |+++++++.||||+.
T Consensus       247 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         247 FYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             cCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            99988887777776533  33444  57899999999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.6e-33  Score=242.85  Aligned_cols=196  Identities=24%  Similarity=0.415  Sum_probs=157.3

Q ss_pred             hHHHHHhc-CCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHRS-LKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~-l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|..++.. .+|||||++++++++++.+|+|||||+||+|.+++.....+.   +.... ....+..++.++|..++.|.
T Consensus        44 ~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~---~~~~~~~~~qi~~al~~LH~~~ivH~  120 (316)
T cd05592          44 VERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD---EARARFYAAEIICGLQFLHKKGIIYR  120 (316)
T ss_pred             HHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            35666654 589999999999999999999999999999999887654432   22222 23345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.....    ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+
T Consensus       121 dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~  200 (316)
T cd05592         121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED  200 (316)
T ss_pred             CCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence                   2334456788888644321    12245689999999999998889999999999999999999999999988


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHh-hhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVA-QLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~-~~l~~~~~~~  201 (305)
                      ..+....+....+.+|...+.++.++|.+||..||.+|+++. +++.||||..
T Consensus       201 ~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         201 EDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence            888888887777778888999999999999999999999864 8889999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0607|consensus

Probab=100.00  E-value=4.6e-34  Score=232.73  Aligned_cols=200  Identities=25%  Similarity=0.438  Sum_probs=158.9

Q ss_pred             hHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCceee
Q psy6191           3 QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQL   81 (305)
Q Consensus         3 ~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (305)
                      ||++++.+++ |+||++|+++|+++..+|||||-+.||.|...+.+...+.+  ..+.+.+--+..+++++|..|+.++-
T Consensus       124 REVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E--~EAs~vvkdia~aLdFlH~kgIAHRD  201 (463)
T KOG0607|consen  124 REVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNE--REASRVVKDIASALDFLHTKGIAHRD  201 (463)
T ss_pred             HHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccH--HHHHHHHHHHHHHHHHHhhcCccccc
Confidence            8999999985 99999999999999999999999999999999987766533  22233333456788999988887763


Q ss_pred             cC----------CCCCeeEcchhH--HHHhc---------CCcccccCCCcccccccc-----cCCCCccchHHHHHHHH
Q psy6191          82 ND----------DSSGVMFNDLTR--MIMLA---------NKNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIM  135 (305)
Q Consensus        82 ~~----------~~~~v~~~d~~~--~~~~~---------~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil  135 (305)
                      ..          .-..|+++||..  ...+.         ...+.||+..|||||++.     ...|+.++|.||||||+
T Consensus       202 lKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIl  281 (463)
T KOG0607|consen  202 LKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVIL  281 (463)
T ss_pred             CCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHH
Confidence            22          123567777631  11111         123679999999999752     33589999999999999


Q ss_pred             HHHHhCCCCCCCCC---------------HHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         136 YTLLVGKPPFETST---------------LKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       136 ye~l~g~~Pf~~~~---------------~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |.||+|.+||.+.-               ...++..|..+.+.+|.    .+|.+++++|+.+|..|+.+|.++.+++.|
T Consensus       282 YImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  282 YIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            99999999997531               34578889999999986    589999999999999999999999999999


Q ss_pred             ccccccCC
Q psy6191         197 EFFNDYCP  204 (305)
Q Consensus       197 ~~~~~~~~  204 (305)
                      ||++...+
T Consensus       362 Pw~~~~~~  369 (463)
T KOG0607|consen  362 PWVQRCAP  369 (463)
T ss_pred             ccccccch
Confidence            99986543

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=250.91  Aligned_cols=197  Identities=25%  Similarity=0.410  Sum_probs=152.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++.+|||||||+||+|.+++.....+   .+..+.. +..++.++.|+|..|+.|.
T Consensus        49 ~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~---~~~~~~~~~~ql~~aL~~LH~~givHr  125 (377)
T cd05629          49 KAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTF---SEDVTRFYMAECVLAIEAVHKLGFIHR  125 (377)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            46999999999999999999999999999999999999999998764433   2222222 3345678888888876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc---------------------------------------------------CC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA---------------------------------------------------NK  102 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~---------------------------------------------------~~  102 (305)
                             +.+..+.+++.||+......                                                   ..
T Consensus       126 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (377)
T cd05629         126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMA  205 (377)
T ss_pred             CCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc
Confidence                   22344567777876332100                                                   00


Q ss_pred             cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc--ccCCCC--CCCHHHHHHHHH
Q psy6191         103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--EYKLPA--TLKKPAATMIKK  178 (305)
Q Consensus       103 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~  178 (305)
                      .+.+||+.|+|||++.+..++.++||||+||++|||++|.+||.+.+..+.+..+...  ...+|.  .++.+++++|.+
T Consensus       206 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~  285 (377)
T cd05629         206 YSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR  285 (377)
T ss_pred             cccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHH
Confidence            1357999999999999888999999999999999999999999988877777666542  233343  478899999999


Q ss_pred             HhhcCCCCC---CCHhhhhcCcccccc
Q psy6191         179 MLLLDPVQR---PPVAQLLHFEFFNDY  202 (305)
Q Consensus       179 ~l~~dp~~R---~~~~~~l~~~~~~~~  202 (305)
                      ||. +|.+|   +++.+++.||||+..
T Consensus       286 lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         286 LIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             Hhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            997 77765   599999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0192|consensus

Probab=100.00  E-value=3.3e-33  Score=242.02  Aligned_cols=192  Identities=21%  Similarity=0.329  Sum_probs=148.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC-eEEEEEeccCCCCHHHHHHHh--cCCCCCCCcCchhHHHHHHHHHHhhhhC-C
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK-FVYIILELCRKRSMMELYNSA--CDLEEMSDPAAQPVIWVSKWVDYSDKYG-F   77 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~-~~ylVmEy~~~g~L~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~   77 (305)
                      .+|+.+|++|+|||||+++|++.+.. .+.|||||+++|+|.+++...  ..+.  ........+.++.++.|+|..+ +
T Consensus        87 ~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~--~~~~l~~aldiArGm~YLH~~~~i  164 (362)
T KOG0192|consen   87 RREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLP--LKVRLRIALDIARGMEYLHSEGPI  164 (362)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCC--HHHHHHHHHHHHHHHHHHhcCCCe
Confidence            58999999999999999999999887 799999999999999999763  2221  1111223334567788888766 3


Q ss_pred             cee-------ecCCC-CCeeEcchhHHHHhc----CCcccccCCCcccccccc--cCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          78 GYQ-------LNDDS-SGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILN--KNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        78 ~~~-------~~~~~-~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~--~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      .|+       +.+.. ..++++||+......    ......||+.|||||++.  ...|+.|+|||||||++|||+||+.
T Consensus       165 IHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~  244 (362)
T KOG0192|consen  165 IHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI  244 (362)
T ss_pred             eecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence            332       22333 377888887553322    223368999999999999  5689999999999999999999999


Q ss_pred             CCCCCCHHHHHHHH--hccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         144 PFETSTLKETYSRI--KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       144 Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||.+....+....+  ....+.+|...++....++.+||..||.+||++.+++.
T Consensus       245 Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  245 PFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            99988775554444  34455667778899999999999999999999999864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.6e-33  Score=242.94  Aligned_cols=198  Identities=21%  Similarity=0.313  Sum_probs=146.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh-CCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY-GFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~   79 (305)
                      .+|++++++++|||||++++++.+++.+|+|||||+||+|.+++.....+.   +... .....+..++.+.|.. ++.|
T Consensus        51 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~i~~~l~~lH~~~~ivH  127 (331)
T cd06649          51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP---EEILGKVSIAVLRGLAYLREKHQIMH  127 (331)
T ss_pred             HHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHhhcCCEEc
Confidence            479999999999999999999999999999999999999999987654332   2111 2223456677777753 2322


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                      .       +.+..+.+++.|++....+.  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus       128 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~  207 (331)
T cd06649         128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA  207 (331)
T ss_pred             CCCChhhEEEcCCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            1       22233557777776443322  22356799999999999988899999999999999999999999976654


Q ss_pred             HHHHHHHhc----------------------------------------------c-ccCCC-CCCCHHHHHHHHHHhhc
Q psy6191         151 KETYSRIKK----------------------------------------------V-EYKLP-ATLKKPAATMIKKMLLL  182 (305)
Q Consensus       151 ~~~~~~i~~----------------------------------------------~-~~~~~-~~~~~~~~~li~~~l~~  182 (305)
                      .+....+..                                              . ....+ ...+.++++||.+||+.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  287 (331)
T cd06649         208 KELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIK  287 (331)
T ss_pred             HHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccC
Confidence            443221110                                              0 00111 13577899999999999


Q ss_pred             CCCCCCCHhhhhcCcccccc
Q psy6191         183 DPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       183 dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||++|||+.++++||||+..
T Consensus       288 ~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         288 NPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             CcccCCCHHHHhcChHHhhc
Confidence            99999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.7e-33  Score=248.84  Aligned_cols=198  Identities=26%  Similarity=0.396  Sum_probs=151.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||+||+|.+++.+...+   .+..... +..+..++.++|..++.|.
T Consensus        49 ~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~---~e~~~~~~~~qi~~aL~~LH~~givHr  125 (381)
T cd05626          49 KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVF---PEVLARFYIAELTLAIESVHKMGFIHR  125 (381)
T ss_pred             HHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            47999999999999999999999999999999999999999998765443   2222222 2345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc---------------------------------------------------CC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA---------------------------------------------------NK  102 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~---------------------------------------------------~~  102 (305)
                             +.+..+.+++.||+....+.                                                   ..
T Consensus       126 DlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (381)
T cd05626         126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLA  205 (381)
T ss_pred             CCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccc
Confidence                   23344567778876321100                                                   01


Q ss_pred             cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc--ccCCCC--CCCHHHHHHHHH
Q psy6191         103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--EYKLPA--TLKKPAATMIKK  178 (305)
Q Consensus       103 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~  178 (305)
                      .+.+||+.|||||++.+..++.++||||+||++|||++|.+||...+..+....+...  ...+|.  .++.+++++|.+
T Consensus       206 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~  285 (381)
T cd05626         206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITK  285 (381)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHH
Confidence            2468999999999999888999999999999999999999999988776665555432  233333  578999999999


Q ss_pred             Hhhc--CCCCCCCHhhhhcCcccccc
Q psy6191         179 MLLL--DPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       179 ~l~~--dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |+..  +|..|+++.++++||||...
T Consensus       286 ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         286 LCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HccCcccccCCCCHHHHhcCcccCCC
Confidence            6654  55559999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-33  Score=250.09  Aligned_cols=197  Identities=28%  Similarity=0.418  Sum_probs=152.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|||||||+||+|.+++.+...+   .+..++. +..+..++.++|..++.|.
T Consensus        49 ~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~---~e~~~~~~~~qi~~al~~lH~~~ivHr  125 (382)
T cd05625          49 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIF---PEDLARFYIAELTCAVESVHKMGFIHR  125 (382)
T ss_pred             HHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            47999999999999999999999999999999999999999998765433   2222222 2345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh---------------------------------------------------cCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML---------------------------------------------------ANK  102 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~---------------------------------------------------~~~  102 (305)
                             +.+..+.+++.||+....+                                                   ...
T Consensus       126 DlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (382)
T cd05625         126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLA  205 (382)
T ss_pred             CCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccc
Confidence                   3334456778887632100                                                   001


Q ss_pred             cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--cCCC--CCCCHHHHHHHHH
Q psy6191         103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE--YKLP--ATLKKPAATMIKK  178 (305)
Q Consensus       103 ~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~~~~li~~  178 (305)
                      .+.+||+.|||||++.+..++.++||||+||++|||++|++||.+.+..+....+....  ...|  ..+++++.++|.+
T Consensus       206 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~  285 (382)
T cd05625         206 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK  285 (382)
T ss_pred             cccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHH
Confidence            24589999999999998889999999999999999999999999888777666655422  2333  3578999999999


Q ss_pred             HhhcCCCCCCC---HhhhhcCcccccc
Q psy6191         179 MLLLDPVQRPP---VAQLLHFEFFNDY  202 (305)
Q Consensus       179 ~l~~dp~~R~~---~~~~l~~~~~~~~  202 (305)
                      |+ .||.+|++   ++++++||||+..
T Consensus       286 l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         286 LC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             Hc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            76 59999997   9999999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.9e-33  Score=241.58  Aligned_cols=196  Identities=23%  Similarity=0.410  Sum_probs=159.2

Q ss_pred             hHHHHHhcCCCC-CccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHRSLKHR-NVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~l~Hp-nIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|+++++.++|| +|+++++++++++.+|+|||||+||+|.+++.....+.   +..+ ..+..+..++.|.|..++.|.
T Consensus        49 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~---~~~~~~~~~qi~~al~~lH~~~ivH~  125 (324)
T cd05587          49 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK---EPHAVFYAAEIAIGLFFLHSKGIIYR  125 (324)
T ss_pred             HHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            688899999765 68899999999999999999999999999887654432   2222 223345678889998876443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.....    ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus       126 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         126 DLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             CCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence                   2334456778888643321    11235689999999999998889999999999999999999999999988


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV-----AQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~-----~~~l~~~~~~~  201 (305)
                      ..+....+......+|..++.++.+++++||..||.+|+++     +++++||||..
T Consensus       206 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         206 EDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            88888888888888888999999999999999999999986     79999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.1e-33  Score=237.57  Aligned_cols=195  Identities=21%  Similarity=0.385  Sum_probs=145.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+||||+++ +|.+++......  ...... ..+..+..++.+.|..++.|.
T Consensus        51 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~  127 (288)
T cd07871          51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNL--MSMHNVKIFMFQLLRGLSYCHKRKILHR  127 (288)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            3799999999999999999999999999999999985 898887654321  111122 223345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.|++......    .....+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.
T Consensus       128 dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             CCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   23344567788876443221    1124578999999998865 56889999999999999999999999887


Q ss_pred             CHHHHHHHHhccc-------------------cCC-----------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         149 TLKETYSRIKKVE-------------------YKL-----------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       149 ~~~~~~~~i~~~~-------------------~~~-----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      +..+....+....                   ..+           ...++.++.+||++||+.||.+|+|++|+++|||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         208 TVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             CHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence            7665544432110                   001           1246778999999999999999999999999999


Q ss_pred             c
Q psy6191         199 F  199 (305)
Q Consensus       199 ~  199 (305)
                      |
T Consensus       288 f  288 (288)
T cd07871         288 F  288 (288)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.8e-33  Score=243.14  Aligned_cols=198  Identities=27%  Similarity=0.486  Sum_probs=153.5

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++.++ +|||||++++++++++.+|+|||||++|+|.+.+.....+   .+.... ....++.++.++|..++.|
T Consensus        43 ~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l---~~~~~~~i~~qi~~~l~~lH~~~ivH  119 (329)
T cd05618          43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---PEEHARFYSAEISLALNYLHERGIIY  119 (329)
T ss_pred             HHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            3678888766 8999999999999999999999999999999887654433   222222 2334567788888877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC-
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET-  147 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~-  147 (305)
                      .       +.+....+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|+|++|+.||.. 
T Consensus       120 ~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  199 (329)
T cd05618         120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  199 (329)
T ss_pred             CCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccC
Confidence            3       2334466788888644321    112356899999999999988899999999999999999999999952 


Q ss_pred             --------CCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC------HhhhhcCcccccc
Q psy6191         148 --------STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP------VAQLLHFEFFNDY  202 (305)
Q Consensus       148 --------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~------~~~~l~~~~~~~~  202 (305)
                              .........+......+|...+..+.++|++||..||.+|++      +.++++||||...
T Consensus       200 ~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         200 GSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             CCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence                    112234455666677788899999999999999999999998      4799999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.3e-33  Score=244.21  Aligned_cols=193  Identities=24%  Similarity=0.450  Sum_probs=156.3

Q ss_pred             HHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee----
Q psy6191           6 AIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ----   80 (305)
Q Consensus         6 ~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~----   80 (305)
                      .+++.++|||||++++++++++.+|+|||||+||+|.+.+.....+   .+.... .+..+..++.++|..|+.|.    
T Consensus        48 ~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~al~~lH~~givH~Dlkp  124 (325)
T cd05604          48 VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSF---PEPRARFYAAEIASALGYLHSINIVYRDLKP  124 (325)
T ss_pred             HHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeeecCCCH
Confidence            3578899999999999999999999999999999999888665433   222222 23345778889998876443    


Q ss_pred             ---ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy6191          81 ---LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET  153 (305)
Q Consensus        81 ---~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~  153 (305)
                         +.+..+.+++.||+.....    ......+||+.|||||++.+..++.++||||+||++|+|++|.+||...+..+.
T Consensus       125 ~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~  204 (325)
T cd05604         125 ENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM  204 (325)
T ss_pred             HHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH
Confidence               3334466788888654321    122356899999999999988899999999999999999999999999888888


Q ss_pred             HHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hhhhcCccccc
Q psy6191         154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV----AQLLHFEFFND  201 (305)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~----~~~l~~~~~~~  201 (305)
                      +..+......+++..+..+.++|++||..||.+||++    .+++.||||..
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         205 YDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             HHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            8888777777777889999999999999999999987    58999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.3e-33  Score=236.15  Aligned_cols=200  Identities=20%  Similarity=0.330  Sum_probs=152.4

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|++++++++|||||++++++.++..+|+|||||+||+|.+.+...... ..+.+... ..+..+..++.+.|+.++.|.
T Consensus        42 ~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  121 (280)
T cd05608          42 VEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR  121 (280)
T ss_pred             HHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            6999999999999999999999999999999999999998877432211 11122222 223345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++....+..    .....||+.|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus       122 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         122 DLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             CCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence                   233445677788865433221    234579999999999998889999999999999999999999997643


Q ss_pred             H----HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         150 L----KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      .    ......+......+|...+..+.+++.+||..||.+|+     +++++++||||+..
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         202 EKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             cchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            2    23333444444556677899999999999999999999     78999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.7e-33  Score=242.91  Aligned_cols=194  Identities=24%  Similarity=0.454  Sum_probs=156.6

Q ss_pred             HHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee---
Q psy6191           5 IAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ---   80 (305)
Q Consensus         5 i~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---   80 (305)
                      ..+++.++|||||++++++++++.+|+|||||+||+|.+++.....+   .+.... ....+..++.++|..|+.|.   
T Consensus        47 ~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~qi~~~L~~lH~~giiHrDlk  123 (325)
T cd05602          47 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF---LEPRARFYAAEIASALGYLHSLNIVYRDLK  123 (325)
T ss_pred             HHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            34578899999999999999999999999999999999988765433   222222 23445778888988876443   


Q ss_pred             ----ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 ----LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 ----~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                          +.+..+.+++.||+.....    ....+.+||+.|||||++.+..++.++||||+||++|+|++|.+||.+.+..+
T Consensus       124 p~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  203 (325)
T cd05602         124 PENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE  203 (325)
T ss_pred             HHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH
Confidence                2234456778888644321    11235689999999999998889999999999999999999999999988888


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHh----hhhcCccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVA----QLLHFEFFND  201 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~----~~l~~~~~~~  201 (305)
                      .+..+......+++.++..+.++|.+||+.||.+|+++.    ++++|+||..
T Consensus       204 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         204 MYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             HHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence            888887777777778999999999999999999999876    7899999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-33  Score=248.25  Aligned_cols=197  Identities=29%  Similarity=0.431  Sum_probs=153.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++.+++|||||++++++++++.+|||||||+||+|.+++.+...+   .+..+.. +..+..++.++|+.|+.|.
T Consensus        49 ~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l---~~~~~~~~~~qi~~~L~~lH~~givHr  125 (360)
T cd05627          49 RAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL---SEEATQFYIAETVLAIDAIHQLGFIHR  125 (360)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence            46999999999999999999999999999999999999999998765443   2222222 2345677888888776543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---------------------------------------CcccccCCCcccc
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---------------------------------------KNTLCGTPNYIAP  114 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---------------------------------------~~~~~Gt~~y~aP  114 (305)
                             +.+..+.+++.|++....+..                                       ..+.+||+.||||
T Consensus       126 DLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  205 (360)
T cd05627         126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP  205 (360)
T ss_pred             CCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCH
Confidence                   233456678888764321100                                       1245899999999


Q ss_pred             cccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--cCCCC--CCCHHHHHHHHHHhhcCCCCCC--
Q psy6191         115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE--YKLPA--TLKKPAATMIKKMLLLDPVQRP--  188 (305)
Q Consensus       115 E~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~l~~dp~~R~--  188 (305)
                      |++.+..++.++||||+||++|||++|++||.+.+..+.+..+....  ..+|.  ..+.+++++|.+++ .||.+|+  
T Consensus       206 E~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  284 (360)
T cd05627         206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS  284 (360)
T ss_pred             HHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCC
Confidence            99999999999999999999999999999999988888777776432  33443  37889999999977 4999998  


Q ss_pred             -CHhhhhcCcccccc
Q psy6191         189 -PVAQLLHFEFFNDY  202 (305)
Q Consensus       189 -~~~~~l~~~~~~~~  202 (305)
                       +++++++||||++.
T Consensus       285 ~~~~ei~~hp~f~~~  299 (360)
T cd05627         285 NGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCHHHHhcCCCCCCC
Confidence             47999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.2e-33  Score=242.21  Aligned_cols=194  Identities=25%  Similarity=0.452  Sum_probs=155.7

Q ss_pred             HHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee---
Q psy6191           5 IAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ---   80 (305)
Q Consensus         5 i~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---   80 (305)
                      ..+++.++|||||++++++++.+.+|+|||||+||+|.+.+.....+   .+.... ....+..++.++|..++.|.   
T Consensus        47 ~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlk  123 (321)
T cd05603          47 NVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCF---LEPRARFYAAEVASAIGYLHSLNIIYRDLK  123 (321)
T ss_pred             HHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence            34688999999999999999999999999999999998887654333   222222 23345678888887776443   


Q ss_pred             ----ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 ----LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 ----~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                          +.+..+.+++.||+.....    ......+||+.|+|||++.+..++.++||||+||++|||++|.+||.+.+...
T Consensus       124 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  203 (321)
T cd05603         124 PENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ  203 (321)
T ss_pred             HHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH
Confidence                2334456778887643321    11235689999999999998889999999999999999999999999988888


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hhhhcCccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV----AQLLHFEFFND  201 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~----~~~l~~~~~~~  201 (305)
                      ....+......+|...+..+.++|.+||+.||.+|+++    .++++|+||.+
T Consensus       204 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         204 MYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             HHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            88888877778888889999999999999999999976    48999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-33  Score=249.04  Aligned_cols=196  Identities=27%  Similarity=0.418  Sum_probs=152.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++++.+|||||||+||+|.+++.....+   .+..+.. +..++.++.++|..++.|.
T Consensus        49 ~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~---~~~~~~~~~~qi~~al~~lH~~~ivHr  125 (376)
T cd05598          49 KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIF---EEDLARFYIAELTCAIESVHKMGFIHR  125 (376)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            47999999999999999999999999999999999999999998765433   2222222 3345678888888776543


Q ss_pred             -------ecCCCCCeeEcchhHHHHh-----------------------------------------------cCCcccc
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML-----------------------------------------------ANKNTLC  106 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~-----------------------------------------------~~~~~~~  106 (305)
                             +.+..+.+++.||+....+                                               ....+.+
T Consensus       126 Dlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (376)
T cd05598         126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLV  205 (376)
T ss_pred             CCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccC
Confidence                   2334456777887642100                                               0012468


Q ss_pred             cCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--cCCC--CCCCHHHHHHHHHHhhc
Q psy6191         107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE--YKLP--ATLKKPAATMIKKMLLL  182 (305)
Q Consensus       107 Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~~~~li~~~l~~  182 (305)
                      ||+.|||||++.+..++.++||||+||++|||++|+.||.+.+..+....+....  ..+|  ..++.++.++|.+|+ .
T Consensus       206 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~  284 (376)
T cd05598         206 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-C  284 (376)
T ss_pred             CCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-c
Confidence            9999999999998899999999999999999999999999888777666654432  2222  357889999999976 5


Q ss_pred             CCCCCC---CHhhhhcCccccc
Q psy6191         183 DPVQRP---PVAQLLHFEFFND  201 (305)
Q Consensus       183 dp~~R~---~~~~~l~~~~~~~  201 (305)
                      +|.+|+   ++.++++||||+.
T Consensus       285 ~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         285 GAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             CHhhcCCCCCHHHHhCCCCcCC
Confidence            999999   9999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-33  Score=236.79  Aligned_cols=199  Identities=21%  Similarity=0.342  Sum_probs=152.8

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.++++++|||||++++++.+++.+|+|||||++|+|.+.+...... .+...... .+..+..++.+.|..++.+. 
T Consensus        49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d  127 (285)
T cd05605          49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLHRERIVYRD  127 (285)
T ss_pred             HHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecC
Confidence            6999999999999999999999999999999999999999887643221 12222222 23345677888888776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK  151 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~  151 (305)
                            +.++.+.+++.|++........   ...+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..
T Consensus       128 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~  207 (285)
T cd05605         128 LKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK  207 (285)
T ss_pred             CCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh
Confidence                  2233456777787654332211   2458999999999998888999999999999999999999999876553


Q ss_pred             HH----HHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         152 ET----YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       152 ~~----~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ..    ...+......++..++..+.+++.+||..||.+||     +++++++||||...
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         208 VKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             hHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            32    23334444556667899999999999999999999     89999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7e-33  Score=241.91  Aligned_cols=198  Identities=25%  Similarity=0.407  Sum_probs=155.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++++ +||||+++++++++++.+|+|||||+||+|.+++.....+   .+.....+ ..+..++.+.|+.++.|
T Consensus        52 ~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~qi~~~l~~lH~~~ivH  128 (332)
T cd05614          52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNF---SEDEVRFYSGEIILALEHLHKLGIVY  128 (332)
T ss_pred             HHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence            3689999999 5999999999999999999999999999999988765443   22222222 34577888888877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      .       +.+.++.+++.||+......     .....+||+.|||||++.+. .++.++||||+||++|||++|..||.
T Consensus       129 rDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~  208 (332)
T cd05614         129 RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT  208 (332)
T ss_pred             cCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence            3       23344678888887543321     12346899999999998765 47889999999999999999999996


Q ss_pred             CC----CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         147 TS----TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~~----~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ..    ........+......+|..++..+.++|.+||..||.+|+     +++++++||||++.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         209 LEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            43    2334445566666777888999999999999999999999     78899999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=246.88  Aligned_cols=197  Identities=27%  Similarity=0.458  Sum_probs=156.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++++++.+|+|||||+||+|.+++.....+   ...... .+..++.++.+.|..|+.|.
T Consensus        49 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l---~~~~~~~i~~qi~~aL~~LH~~giiH~  125 (350)
T cd05573          49 RAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF---PEETARFYIAELVLALDSVHKLGFIHR  125 (350)
T ss_pred             HHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            46999999999999999999999999999999999999999998765333   222222 23345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---------------------------------CcccccCCCcccccccccC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---------------------------------KNTLCGTPNYIAPEILNKN  120 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---------------------------------~~~~~Gt~~y~aPE~~~~~  120 (305)
                             +.+..+.+++.|++.......                                 ....+||+.|+|||++.+.
T Consensus       126 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  205 (350)
T cd05573         126 DIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT  205 (350)
T ss_pred             CCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence                   233446677888764432221                                 2245799999999999988


Q ss_pred             CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--cccCCCCC--CCHHHHHHHHHHhhcCCCCCCC-Hhhhhc
Q psy6191         121 GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK--VEYKLPAT--LKKPAATMIKKMLLLDPVQRPP-VAQLLH  195 (305)
Q Consensus       121 ~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~--~~~~~~~li~~~l~~dp~~R~~-~~~~l~  195 (305)
                      .++.++||||+||++|||++|+.||...+..+....+..  ....+|..  ++.++.++|.+||. ||.+|++ ++++++
T Consensus       206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            999999999999999999999999999887777777765  33344443  58999999999997 9999999 999999


Q ss_pred             Ccccccc
Q psy6191         196 FEFFNDY  202 (305)
Q Consensus       196 ~~~~~~~  202 (305)
                      ||||.+.
T Consensus       285 hp~~~~~  291 (350)
T cd05573         285 HPFFKGI  291 (350)
T ss_pred             CCCcCCC
Confidence            9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0574|consensus

Probab=100.00  E-value=1.7e-34  Score=233.69  Aligned_cols=198  Identities=22%  Similarity=0.367  Sum_probs=149.4

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhC-----
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYG-----   76 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----   76 (305)
                      .||.||++++.|+||++|+.|-....+|||||||-.|++.++++.....  +.+.....++. .++++.|+|...     
T Consensus        77 KEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~--L~E~EIs~iL~~TLKGL~YLH~~~KIHRD  154 (502)
T KOG0574|consen   77 KEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKP--LSEQEISAVLRDTLKGLQYLHDLKKIHRD  154 (502)
T ss_pred             HHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCC--ccHHHHHHHHHHHHhHHHHHHHHHHHHhh
Confidence            6999999999999999999999889999999999999999998754322  22333333332 245566655221     


Q ss_pred             --CceeecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          77 --FGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        77 --~~~~~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                        .+..+....+..++.||+-+-.++    ..+|+.|||.|||||++..-+|+.++||||||++..||..|++||..-.+
T Consensus       155 IKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP  234 (502)
T KOG0574|consen  155 IKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP  234 (502)
T ss_pred             cccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence              122333344667778886555443    45799999999999999999999999999999999999999999987655


Q ss_pred             HHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         151 KETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ......|-...+   .-|..-+++..|+|++||.++|++|.|+.++++|+|++..
T Consensus       235 MRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  235 MRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             cceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            544433322211   1123356678899999999999999999999999999864

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.4e-33  Score=240.51  Aligned_cols=197  Identities=23%  Similarity=0.375  Sum_probs=158.5

Q ss_pred             hHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.++..+ +||||+++++++++++.+|+|||||+||+|.+.+.....+.+  ......+..+..++.+.|..++.|. 
T Consensus        49 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~--~~~~~~~~qi~~aL~~LH~~~ivHrD  126 (323)
T cd05616          49 VEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE--PHAVFYAAEIAIGLFFLHSKGIIYRD  126 (323)
T ss_pred             HHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHHCCEEecC
Confidence            467777766 689999999999999999999999999999998876544321  1112223345677888887775443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+..+.+++.||+.....    ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.
T Consensus       127 lkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~  206 (323)
T cd05616         127 LKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE  206 (323)
T ss_pred             CCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence                  2334456778887644321    122356899999999999998999999999999999999999999999988


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hhhhcCccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV-----AQLLHFEFFND  201 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~-----~~~l~~~~~~~  201 (305)
                      .+....+......+|...+.++.+++.+||+.||.+|++.     .++++||||+.
T Consensus       207 ~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         207 DELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            8888888888888888999999999999999999999984     79999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.8e-33  Score=245.46  Aligned_cols=196  Identities=27%  Similarity=0.433  Sum_probs=152.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++.+|+|||||+||+|.+++... .+   .+.... ....+..++.++|..++.|.
T Consensus        91 ~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~---~~~~~~~~~~qil~aL~~LH~~~IvHr  166 (370)
T cd05621          91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DV---PEKWAKFYTAEVVLALDAIHSMGLIHR  166 (370)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CC---CHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            47999999999999999999999999999999999999999988653 22   222222 22345677888888776543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccC----CCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKN----GHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~----~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+..+.+++.||+......     ...+.+||+.|||||++.+.    .++.++||||+||++|||++|++|
T Consensus       167 DLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~P  246 (370)
T cd05621         167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP  246 (370)
T ss_pred             CCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCC
Confidence                   33445678888887554332     12467899999999998654    378899999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc--cCCCC--CCCHHHHHHHHHHhhcCCCC--CCCHhhhhcCccccc
Q psy6191         145 FETSTLKETYSRIKKVE--YKLPA--TLKKPAATMIKKMLLLDPVQ--RPPVAQLLHFEFFND  201 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~l~~dp~~--R~~~~~~l~~~~~~~  201 (305)
                      |.+.+....+..+....  ..+|.  .++..+++++.+||..++.+  |+++.++++||||+.
T Consensus       247 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         247 FYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             CCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            99988887777776532  34444  46889999999999855544  889999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0614|consensus

Probab=100.00  E-value=3.5e-33  Score=239.82  Aligned_cols=197  Identities=28%  Similarity=0.528  Sum_probs=170.8

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .|-+||-+++.|+||+||..|.++.++||.||-|-||++..+++..+.+++   ..++ .+..+.+++.|+|..++.++ 
T Consensus       469 sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd---~tarF~~acv~EAfeYLH~k~iIYRD  545 (732)
T KOG0614|consen  469 SERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDD---YTARFYVACVLEAFEYLHRKGIIYRD  545 (732)
T ss_pred             hHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCccc---chhhhhHHHHHHHHHHHHhcCceecc
Confidence            588999999999999999999999999999999999999999998887743   2333 34456788999998887654 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK  151 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~  151 (305)
                            +.+..+-.++-||+.+..+..   .-|+||||.|.|||++.+++++.++|.||||+.+||+++|.+||.+.++.
T Consensus       546 LKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm  625 (732)
T KOG0614|consen  546 LKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM  625 (732)
T ss_pred             CChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence                  344456678888888777644   34899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCcccccc
Q psy6191         152 ETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFNDY  202 (305)
Q Consensus       152 ~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~~  202 (305)
                      .+++.|.++  .+.+|..++..+.+||++++..+|.+|..     +.+|.+|.||...
T Consensus       626 ktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  626 KTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             HHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence            999998875  35788999999999999999999999986     8899999999864

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.5e-33  Score=240.81  Aligned_cols=198  Identities=25%  Similarity=0.449  Sum_probs=154.8

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++.++ +||||+++++++++.+.+|+|||||+||+|.+++.....+   .+.... .+..+..++.++|..++.|
T Consensus        43 ~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l---~~~~~~~~~~qi~~al~~lH~~~ivH  119 (327)
T cd05617          43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKL---PEEHARFYAAEICIALNFLHERGIIY  119 (327)
T ss_pred             HHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            3688888887 6999999999999999999999999999999888765433   222222 2334567888888877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|+|++|..||...
T Consensus       120 rDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~  199 (327)
T cd05617         120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII  199 (327)
T ss_pred             cCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence            3       2334466788888654321    1223578999999999999889999999999999999999999999532


Q ss_pred             -------CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH------hhhhcCcccccc
Q psy6191         149 -------TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV------AQLLHFEFFNDY  202 (305)
Q Consensus       149 -------~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~------~~~l~~~~~~~~  202 (305)
                             ........+......+|..++..+.++|.+||..||.+|+++      ++++.||||+..
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         200 TDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             CCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence                   223445556666677888899999999999999999999984      699999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0612|consensus

Probab=100.00  E-value=4.1e-33  Score=258.54  Aligned_cols=196  Identities=24%  Similarity=0.438  Sum_probs=161.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   80 (305)
                      .+|-.||..-+.+-||+|+.+|+|+.++|+||||++||||..++.+...+   ++.-++.++. ++.+++-.|..|+.|+
T Consensus       123 ~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~---pE~~ArFY~aEiVlAldslH~mgyVHR  199 (1317)
T KOG0612|consen  123 REERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRL---PEDWARFYTAEIVLALDSLHSMGYVHR  199 (1317)
T ss_pred             HHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCC---hHHHHHHHHHHHHHHHHHHHhccceec
Confidence            36888999999999999999999999999999999999999999775533   3333333333 3455666666665443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccc----c-CCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILN----K-NGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~----~-~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                             +.|..+.|++.||+....+...     .+.+|||.|++||++.    + +.|+..+|+||+||++|||+.|..
T Consensus       200 DiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T  279 (1317)
T KOG0612|consen  200 DIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET  279 (1317)
T ss_pred             cCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence                   4566789999999988776543     3568999999999984    3 458999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhcc--ccCCC--CCCCHHHHHHHHHHhhcCCCCCCC---HhhhhcCccccc
Q psy6191         144 PFETSTLKETYSRIKKV--EYKLP--ATLKKPAATMIKKMLLLDPVQRPP---VAQLLHFEFFND  201 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~dp~~R~~---~~~~l~~~~~~~  201 (305)
                      ||...+..+++.+|...  .+.+|  ..+|.++++||.+++ -+|..|..   ++++..||||..
T Consensus       280 PFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  280 PFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             cchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence            99999999999999876  56677  568999999999887 57999988   999999999975

>KOG4279|consensus

Probab=100.00  E-value=1.4e-33  Score=250.17  Aligned_cols=199  Identities=26%  Similarity=0.441  Sum_probs=156.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH---HHHHHHHHHhhhhC--
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV---IWVSKWVDYSDKYG--   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~--   76 (305)
                      -+||.++++|+|.|||++.|.+-.++++-|.||-++||+|..+++.+=+.  +.+.....-   -++++++.|.|...  
T Consensus       620 hEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGP--lKDNEstm~fYtkQILeGLkYLHen~IV  697 (1226)
T KOG4279|consen  620 HEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGP--LKDNESTMNFYTKQILEGLKYLHENKIV  697 (1226)
T ss_pred             HHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCC--CccchhHHHHHHHHHHHHhhhhhhccee
Confidence            37999999999999999999999999999999999999999999875332  222222111   23456666666544  


Q ss_pred             ------CceeecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccC--CCCccchHHHHHHHHHHHHhCCCC
Q psy6191          77 ------FGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        77 ------~~~~~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                            -+.+++--++.+++.||+....+.    ...|+.||..|||||++..+  +|+.++|||||||++.||+||+||
T Consensus       698 HRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP  777 (1226)
T KOG4279|consen  698 HRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP  777 (1226)
T ss_pred             eccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence                  344455556677888887665543    35689999999999999754  599999999999999999999999


Q ss_pred             CCC-CCHHHHHHHH--hccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         145 FET-STLKETYSRI--KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~-~~~~~~~~~i--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |.. .++...+.++  -+.-+++|..++.+++++|.+|+..||..||+|.++|..||+...
T Consensus       778 F~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  778 FVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             eeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            964 3344444333  234467788899999999999999999999999999999999764

>KOG0579|consensus

Probab=100.00  E-value=6.9e-33  Score=243.74  Aligned_cols=197  Identities=21%  Similarity=0.360  Sum_probs=151.9

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCce--
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGY--   79 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--   79 (305)
                      -||+||..++||+||+|++.|.-++.+||..|||.||-+..++-..+..  +.+...+.+. ++..++.++|+..+.+  
T Consensus        78 VEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~--LtE~QIqvvc~q~ldALn~LHs~~iIHRD  155 (1187)
T KOG0579|consen   78 VEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRV--LTEDQIQVVCYQVLDALNWLHSQNIIHRD  155 (1187)
T ss_pred             hhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccc--cchHHHHHHHHHHHHHHHHHhhcchhhhh
Confidence            4899999999999999999999999999999999999987766543322  1233333332 2344455555433222  


Q ss_pred             -----eecCCCCCeeEcchhHHHH----hcCCcccccCCCccccccc-----ccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 -----QLNDDSSGVMFNDLTRMIM----LANKNTLCGTPNYIAPEIL-----NKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 -----~~~~~~~~v~~~d~~~~~~----~~~~~~~~Gt~~y~aPE~~-----~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                           .+.--.+.|.+.||+-...    .....++.|||+|||||++     ...+|+.++||||||++|.||+.+.||-
T Consensus       156 LKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH  235 (1187)
T KOG0579|consen  156 LKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH  235 (1187)
T ss_pred             ccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence                 2222235677888864333    3345789999999999986     4667999999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccccC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         146 ETSTLKETYSRIKKVEYK---LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ..-++...+.+|.+..++   -|...+..+.|++++||.+||..||++.++++|||+..
T Consensus       236 helnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  236 HELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             cccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            999998888888776543   35667888999999999999999999999999999985

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.2e-32  Score=232.83  Aligned_cols=199  Identities=20%  Similarity=0.314  Sum_probs=146.7

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|++++++++||||++++++++++..+|+||||++||+|.+.+....... ...... .....+..++.+.|..++.+. 
T Consensus        42 ~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~~~ivH~d  120 (277)
T cd05607          42 LEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHSMDIVYRD  120 (277)
T ss_pred             HHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccC-CCHHHHHHHHHHHHHHHHHHHHCCEEEcc
Confidence            58999999999999999999999999999999999999988875443221 111111 122345677888887776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL-  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~-  150 (305)
                            +.+....+++.|++........   ....||+.|+|||++.+..++.++||||+||++|||++|..||..... 
T Consensus       121 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~  200 (277)
T cd05607         121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK  200 (277)
T ss_pred             CChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch
Confidence                  2233455667777544322211   235799999999999888899999999999999999999999976432 


Q ss_pred             ---HHHHHHHhccccCCC-CCCCHHHHHHHHHHhhcCCCCCCCH----hhhhcCcccccc
Q psy6191         151 ---KETYSRIKKVEYKLP-ATLKKPAATMIKKMLLLDPVQRPPV----AQLLHFEFFNDY  202 (305)
Q Consensus       151 ---~~~~~~i~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~~~----~~~l~~~~~~~~  202 (305)
                         .+....+.......+ ..++.++++++.+||+.||.+||++    ++++.|+||+..
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         201 VAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence               223333333332222 3578899999999999999999999    667899999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4645|consensus

Probab=100.00  E-value=1.3e-34  Score=271.51  Aligned_cols=198  Identities=24%  Similarity=0.414  Sum_probs=158.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|..++..|+|||+|++|++-.+.+.+||.||||+||+|.+++......+++...  ....+.+.++.++|..|+.++ 
T Consensus      1282 ~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~--vyt~qll~gla~LH~~gIVHRD 1359 (1509)
T KOG4645|consen 1282 AEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTR--VYTKQLLEGLAYLHEHGIVHRD 1359 (1509)
T ss_pred             HHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHH--HHHHHHHHHHHHHHhcCceecC
Confidence            58999999999999999999999999999999999999999998866544332221  122344667788887776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcCC--------cccccCCCccccccccc---CCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLANK--------NTLCGTPNYIAPEILNK---NGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~~--------~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                            +.+.++.+++.||+.+..+.+.        +...|||.|||||++.+   ++.+.++||||+|||+.||+||+.
T Consensus      1360 IK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1360 IKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred             CCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence                  3444568889999876654332        35689999999999864   356789999999999999999999


Q ss_pred             CCCC-CCHHHHHHHHh-ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         144 PFET-STLKETYSRIK-KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       144 Pf~~-~~~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ||.. ++...++..+- ...+++|..++.+.+|||.+||+.||.+|.++.|++.|.|-+.
T Consensus      1440 PW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1440 PWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             chhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            9965 45556655553 4567889999999999999999999999999999999998764

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-32  Score=228.80  Aligned_cols=196  Identities=22%  Similarity=0.404  Sum_probs=151.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|++++++++||||+++++++++++.+|+||||++|++|.+.+.....+.+  .........+..++.++|+.++.|. 
T Consensus        52 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~--~~~~~~~~~l~~~l~~lH~~~i~H~d  129 (263)
T cd06625          52 ECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE--TVTRKYTRQILEGVEYLHSNMIVHRD  129 (263)
T ss_pred             HHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCH--HHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            4799999999999999999999999999999999999999998876543321  1111223345677888887775433 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                            +.+....+++.|++.......       .....|++.|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus       130 l~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             CCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence                  223345677777764332111       1345789999999999988899999999999999999999999987


Q ss_pred             CCHHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         148 STLKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       148 ~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      .+.......+..  ....+|...+..+.++|.+||..||.+|||+.+++.|+||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         210 FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             cchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            665554444433  2345667789999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.1e-32  Score=234.11  Aligned_cols=198  Identities=19%  Similarity=0.306  Sum_probs=142.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++..|+|||||. |+|.+.+.....  .+....+ ..+..+..++.+.|+.++.|.
T Consensus        51 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~  127 (303)
T cd07869          51 IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRYILHR  127 (303)
T ss_pred             HHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            379999999999999999999999999999999996 577777654321  1122222 223345778889888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.|++......    .....+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.
T Consensus       128 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   23344667888887543221    1234578999999998865 45788999999999999999999999864


Q ss_pred             C-HHHHHHHHhcc--c-------------------cC--CC---------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         149 T-LKETYSRIKKV--E-------------------YK--LP---------ATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       149 ~-~~~~~~~i~~~--~-------------------~~--~~---------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      . ..+....+...  .                   +.  .|         ...+..+.+|+.+||+.||.+|+|+.|+++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         208 KDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            3 22222222110  0                   00  00         013467889999999999999999999999


Q ss_pred             Ccccccc
Q psy6191         196 FEFFNDY  202 (305)
Q Consensus       196 ~~~~~~~  202 (305)
                      ||||++.
T Consensus       288 h~~f~~~  294 (303)
T cd07869         288 HEYFSDL  294 (303)
T ss_pred             CcccccC
Confidence            9999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0663|consensus

Probab=100.00  E-value=3e-32  Score=223.29  Aligned_cols=198  Identities=22%  Similarity=0.310  Sum_probs=151.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   78 (305)
                      .|||.+|.+++|||||.+.++..-  -+.+|||||||+. ||..++.+...  ......... ..+++.++.|.|+..+.
T Consensus       123 LREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~wil  199 (419)
T KOG0663|consen  123 LREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNWIL  199 (419)
T ss_pred             HHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhceeE
Confidence            489999999999999999998764  4679999999986 88888876541  122222333 34456788888866543


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      |+       +..+.+.++++||+.+......    ...+-|.+|.|||++.+. .|++++|+||+|||+.||+++++-|.
T Consensus       200 HRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~  279 (419)
T KOG0663|consen  200 HRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP  279 (419)
T ss_pred             ecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence            32       3445578889999876654432    455789999999987755 69999999999999999999999999


Q ss_pred             CCCHHHHHHHHhccc-------------------cCCC------------C-CCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         147 TSTLKETYSRIKKVE-------------------YKLP------------A-TLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~-------------------~~~~------------~-~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      +.....++.+|....                   ..++            . .++....+|+.++|.+||.+|.||+|.|
T Consensus       280 G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L  359 (419)
T KOG0663|consen  280 GKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL  359 (419)
T ss_pred             CCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence            988877777764310                   1111            1 1457788999999999999999999999


Q ss_pred             cCcccccc
Q psy6191         195 HFEFFNDY  202 (305)
Q Consensus       195 ~~~~~~~~  202 (305)
                      +|.||.+.
T Consensus       360 ~h~~F~e~  367 (419)
T KOG0663|consen  360 KHEYFRET  367 (419)
T ss_pred             cccccccC
Confidence            99999863

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.4e-33  Score=240.94  Aligned_cols=198  Identities=24%  Similarity=0.406  Sum_probs=152.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++++++.+|||||||+||+|.+++.....  .+.+..... +..+..++.+.|..++.|.
T Consensus        49 ~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~i~H~  126 (330)
T cd05601          49 EEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMGYVHR  126 (330)
T ss_pred             HHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence            4789999999999999999999999999999999999999999876421  112222222 2345677888887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccc------cCCCCccchHHHHHHHHHHHHhCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILN------KNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~------~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                             +.+..+.+++.|++....+...     ...+||+.|+|||++.      ...++.++||||+||++|||++|.
T Consensus       127 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~  206 (330)
T cd05601         127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR  206 (330)
T ss_pred             cCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCC
Confidence                   2334466778888655433221     2347999999999986      455788999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhccc--cCCC--CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         143 PPFETSTLKETYSRIKKVE--YKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .||...+....+..+....  ..+|  ...+.++.++|.+||. ||.+|+++++++.||||...
T Consensus       207 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         207 SPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999888777777665432  2233  3578899999999997 99999999999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4721|consensus

Probab=100.00  E-value=3.2e-33  Score=243.05  Aligned_cols=193  Identities=21%  Similarity=0.349  Sum_probs=145.2

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee--
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ--   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--   80 (305)
                      -+|.-|++|+|||||++.+++...-.++||||||..|-|.++++......  ....++-...++.+..|+|.+.+.++  
T Consensus       161 TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~it--p~llv~Wsk~IA~GM~YLH~hKIIHRDL  238 (904)
T KOG4721|consen  161 TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPIT--PSLLVDWSKGIAGGMNYLHLHKIIHRDL  238 (904)
T ss_pred             hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccC--HHHHHHHHHHhhhhhHHHHHhhHhhhcc
Confidence            57888999999999999999999999999999999999999998653321  11111111112444556665544333  


Q ss_pred             -----ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -----LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -----~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                           +......|++.||+....+.   ..-++|||..|||||++.+.+.+.|+|||||||||+|||||..||.+-+...
T Consensus       239 KSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA  318 (904)
T KOG4721|consen  239 KSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA  318 (904)
T ss_pred             CCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence                 22334567888997655543   3457899999999999999999999999999999999999999997654332


Q ss_pred             HHHHHh--ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         153 TYSRIK--KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       153 ~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      ++--+-  ....+.|...++.++=||+.||.-.|..||++.+++.|-
T Consensus       319 IIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  319 IIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             eEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            211111  123456788888899999999999999999999999883

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.3e-32  Score=241.82  Aligned_cols=197  Identities=27%  Similarity=0.420  Sum_probs=152.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++.+|+|||||+||+|.+++.... +   .+.... ....+..++.+.|..++.|.
T Consensus        91 ~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~-~---~~~~~~~~~~qi~~aL~~LH~~~ivHr  166 (371)
T cd05622          91 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-V---PEKWARFYTAEVVLALDAIHSMGFIHR  166 (371)
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC-C---CHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            378999999999999999999999999999999999999999886532 2   222222 23345677888888776543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccC----CCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKN----GHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~----~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+..+.+++.||+....+.     ...+.+||+.|||||++.+.    .++.++||||+||++|||++|.+|
T Consensus       167 DLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P  246 (371)
T cd05622         167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  246 (371)
T ss_pred             CCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCC
Confidence                   23344667888887554332     12366899999999998654    378899999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc--cCCC--CCCCHHHHHHHHHHhhcCCCC--CCCHhhhhcCcccccc
Q psy6191         145 FETSTLKETYSRIKKVE--YKLP--ATLKKPAATMIKKMLLLDPVQ--RPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~--~~~~--~~~~~~~~~li~~~l~~dp~~--R~~~~~~l~~~~~~~~  202 (305)
                      |.+.+....+..+....  ..+|  ..++..++++|.+||..++.+  |++++++++|+||++.
T Consensus       247 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         247 FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            99988888887776533  2333  358899999999999844433  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.5e-32  Score=236.24  Aligned_cols=198  Identities=21%  Similarity=0.307  Sum_probs=145.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh-CCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY-GFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~   79 (305)
                      .+|++++++++|||||++++++++++.+|+|||||+||+|.+++.....+.   .... .....+..++.|.|.. ++.|
T Consensus        51 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~l~~~l~~lH~~~~ivH  127 (333)
T cd06650          51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTYLREKHKIMH  127 (333)
T ss_pred             HHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence            479999999999999999999999999999999999999999987644331   2221 2223456677777753 3322


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                      .       +.+..+.+++.||+......  .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.
T Consensus       128 ~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~  207 (333)
T cd06650         128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA  207 (333)
T ss_pred             cCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence            1       22334557778876443322  22456899999999999888899999999999999999999999976544


Q ss_pred             HHHHHHH--------------------------------------------hc-cccCCCC-CCCHHHHHHHHHHhhcCC
Q psy6191         151 KETYSRI--------------------------------------------KK-VEYKLPA-TLKKPAATMIKKMLLLDP  184 (305)
Q Consensus       151 ~~~~~~i--------------------------------------------~~-~~~~~~~-~~~~~~~~li~~~l~~dp  184 (305)
                      ......+                                            .. .....+. ..+.++++||.+||++||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P  287 (333)
T cd06650         208 KELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNP  287 (333)
T ss_pred             hHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCc
Confidence            3322111                                            00 0011111 256788999999999999


Q ss_pred             CCCCCHhhhhcCcccccc
Q psy6191         185 VQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       185 ~~R~~~~~~l~~~~~~~~  202 (305)
                      ++|||+.|++.||||+..
T Consensus       288 ~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         288 AERADLKQLMVHAFIKRS  305 (333)
T ss_pred             ccCcCHHHHhhCHHHhcC
Confidence            999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.98  E-value=6.2e-32  Score=234.97  Aligned_cols=196  Identities=23%  Similarity=0.412  Sum_probs=158.1

Q ss_pred             hHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|+.+++.+. ||+|+++++++++++.+|+|||||+||+|.+++.....+.   +... ..+..+..++.++|..|+.|.
T Consensus        49 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~---~~~~~~i~~qi~~al~~lH~~~ivHr  125 (323)
T cd05615          49 VEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFK---EPQAVFYAAEISVGLFFLHRRGIIYR  125 (323)
T ss_pred             HHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            5788888775 5788899999999999999999999999999887654432   2222 223345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+......    .....+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+
T Consensus       126 Dikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (323)
T cd05615         126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED  205 (323)
T ss_pred             CCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence                   33344667888886443221    1235679999999999998889999999999999999999999999988


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      .......+......+|...+.++.+++.+||.+||.+|++     .+++++||||..
T Consensus       206 ~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         206 EDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             HHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence            8888888888888888899999999999999999999997     478999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=5.6e-32  Score=236.72  Aligned_cols=198  Identities=22%  Similarity=0.357  Sum_probs=143.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   75 (305)
                      .+|++++++++|||||++++++...     ..+|+|||||. ++|.+++.....+   ...... .+..+.+++.++|+.
T Consensus        47 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~~~~~i~~qi~~aL~~LH~~  122 (338)
T cd07859          47 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDL---TPEHHQFFLYQLLRALKYIHTA  122 (338)
T ss_pred             HHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccC---CHHHHHHHHHHHHHHHHHHHHC
Confidence            4799999999999999999988643     35899999995 6898888654433   222222 233457888999988


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCccccccccc--CCCCccchHHHHHHHHHHHH
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlGvilye~l  139 (305)
                      ++.|.       +.+..+.+++.||+.......       ....+||+.|+|||++.+  ..++.++||||+||++|||+
T Consensus       123 ~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~  202 (338)
T cd07859         123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL  202 (338)
T ss_pred             CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHH
Confidence            76443       334456678888865432211       124579999999999875  56889999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHhc--------------------------cccCC-----CCCCCHHHHHHHHHHhhcCCCCCC
Q psy6191         140 VGKPPFETSTLKETYSRIKK--------------------------VEYKL-----PATLKKPAATMIKKMLLLDPVQRP  188 (305)
Q Consensus       140 ~g~~Pf~~~~~~~~~~~i~~--------------------------~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~  188 (305)
                      +|++||.+.+.......+..                          .....     .+..+..+.++|.+||..||++||
T Consensus       203 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  282 (338)
T cd07859         203 TGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP  282 (338)
T ss_pred             cCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC
Confidence            99999987654332221110                          00000     023567789999999999999999


Q ss_pred             CHhhhhcCccccccC
Q psy6191         189 PVAQLLHFEFFNDYC  203 (305)
Q Consensus       189 ~~~~~l~~~~~~~~~  203 (305)
                      |++++++||||+...
T Consensus       283 t~~e~l~hp~f~~~~  297 (338)
T cd07859         283 TAEEALADPYFKGLA  297 (338)
T ss_pred             CHHHHhcCchhhhcC
Confidence            999999999998643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.98  E-value=6.5e-32  Score=235.31  Aligned_cols=199  Identities=19%  Similarity=0.287  Sum_probs=138.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++.+++..|+|||||++|+|.+++...... .+..... ..+..+..++.+.|..++.|.
T Consensus        47 ~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiH~  125 (327)
T cd08227          47 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHMGYVHR  125 (327)
T ss_pred             HHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            46999999999999999999999999999999999999999998643211 1122222 223345677888887765432


Q ss_pred             e-------cCCCCCeeEcchhHHHHhcC-----------CcccccCCCccccccccc--CCCCccchHHHHHHHHHHHHh
Q psy6191          81 L-------NDDSSGVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        81 ~-------~~~~~~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlGvilye~l~  140 (305)
                      -       .+..+.+++.|++.......           ....+|+..|+|||++.+  ..++.++||||+||++|||++
T Consensus       126 dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~  205 (327)
T cd08227         126 SVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN  205 (327)
T ss_pred             CCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHH
Confidence            1       11223344444432221111           122357788999999875  458899999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcccc----------------------------------------------CCCCCCCHHHHH
Q psy6191         141 GKPPFETSTLKETYSRIKKVEY----------------------------------------------KLPATLKKPAAT  174 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~~~----------------------------------------------~~~~~~~~~~~~  174 (305)
                      |..||.................                                              +.....++.+.+
T Consensus       206 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (327)
T cd08227         206 GHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH  285 (327)
T ss_pred             CCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHH
Confidence            9999976543332221111100                                              001124567889


Q ss_pred             HHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         175 MIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       175 li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +|.+||+.||.+|||++++++||||+.
T Consensus       286 li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         286 FVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             HHHHHHhhCchhcCCHHHHhcChhhhh
Confidence            999999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=1.2e-31  Score=229.79  Aligned_cols=198  Identities=25%  Similarity=0.454  Sum_probs=159.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+++.+|+||||+++|+|.+++.....+.   .... ..+..+.+++.+.|..++.+.
T Consensus        49 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~---~~~~~~~~~qil~~l~~lH~~~i~H~  125 (290)
T cd05580          49 LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFP---EPVARFYAAQVVLALEYLHSLDIVYR  125 (290)
T ss_pred             HHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            369999999999999999999999999999999999999999987664432   2222 223345677888887765332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                             +.+..+.+++.|++...... .....+||+.|+|||.+.+..++.++||||+|+++|+|++|..||...+...
T Consensus       126 dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  205 (290)
T cd05580         126 DLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ  205 (290)
T ss_pred             CCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                   22333556777775443322 2345679999999999988888899999999999999999999998888777


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ....+......+|...+..++++|.+||..||.+|+     ++++++.||||.+.
T Consensus       206 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         206 IYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence            777777777788888999999999999999999999     89999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.98  E-value=5.8e-32  Score=244.02  Aligned_cols=200  Identities=18%  Similarity=0.341  Sum_probs=144.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--------CeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCch-hHHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--------KFVYIILELCRKRSMMELYNSACDL-EEMSDPAAQ-PVIWVSKWVDY   71 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--------~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~   71 (305)
                      .+|+.+|+.++|||||+++++|...        .++|+|||||++ ++.+++...... ..+...... ....+..++.|
T Consensus       107 ~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~y  185 (440)
T PTZ00036        107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY  185 (440)
T ss_pred             HHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            4799999999999999999987542        358899999986 676665432111 111222222 22345678888


Q ss_pred             hhhhCCcee--------ecCCCCCeeEcchhHHHHhcC---CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHH
Q psy6191          72 SDKYGFGYQ--------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        72 ~~~~~~~~~--------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l  139 (305)
                      +|..++.|+        +...+..+++.||+.+..+..   ..+.+||+.|||||++.+ ..|+.++||||+||++|||+
T Consensus       186 LH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell  265 (440)
T PTZ00036        186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI  265 (440)
T ss_pred             HHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            888776443        222333578888876654322   235679999999998765 46899999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHhcc-----------------cc------------CCCCCCCHHHHHHHHHHhhcCCCCCCCH
Q psy6191         140 VGKPPFETSTLKETYSRIKKV-----------------EY------------KLPATLKKPAATMIKKMLLLDPVQRPPV  190 (305)
Q Consensus       140 ~g~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~  190 (305)
                      +|.+||.+.+..+.+..+...                 ..            .+|...+.++.+||.+||++||.+|+|+
T Consensus       266 tG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta  345 (440)
T PTZ00036        266 LGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP  345 (440)
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH
Confidence            999999987665544443211                 00            1234567889999999999999999999


Q ss_pred             hhhhcCcccccc
Q psy6191         191 AQLLHFEFFNDY  202 (305)
Q Consensus       191 ~~~l~~~~~~~~  202 (305)
                      .|+++||||...
T Consensus       346 ~e~l~hp~f~~~  357 (440)
T PTZ00036        346 IEALADPFFDDL  357 (440)
T ss_pred             HHHhCChhHHhh
Confidence            999999999864

>KOG0660|consensus

Probab=99.98  E-value=3.6e-32  Score=225.32  Aligned_cols=198  Identities=25%  Similarity=0.455  Sum_probs=147.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~   75 (305)
                      .||+.+|+.++|+|||.+.+++..     -+.+|+|+|++ +-||.++++....+   .+..++..+. ++.++.|.|+.
T Consensus        69 lRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L---~d~H~q~f~YQiLrgLKyiHSA  144 (359)
T KOG0660|consen   69 LRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDL---TDDHAQYFLYQILRGLKYIHSA  144 (359)
T ss_pred             HHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccc---cHHHHHHHHHHHHHhcchhhcc
Confidence            489999999999999999999875     35699999999 45888888876544   4445555443 35566666655


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCccccccc-ccCCCCccchHHHHHHHHHHHHhC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~-~~~~~~~~~DiwSlGvilye~l~g  141 (305)
                      ++.++       +....-.++++||+.+.....      .+..+-|.+|.|||++ ....|+.++||||+|||+.||++|
T Consensus       145 nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~g  224 (359)
T KOG0660|consen  145 NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTG  224 (359)
T ss_pred             cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcC
Confidence            54332       222234557777765544321      1345789999999976 466799999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhccc-----------------------cCCC--------CCCCHHHHHHHHHHhhcCCCCCCCH
Q psy6191         142 KPPFETSTLKETYSRIKKVE-----------------------YKLP--------ATLKKPAATMIKKMLLLDPVQRPPV  190 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~~~-----------------------~~~~--------~~~~~~~~~li~~~l~~dp~~R~~~  190 (305)
                      ++-|.|.+...++..|....                       +..|        +..++.+.+|+.+||..||.+|+|+
T Consensus       225 kplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita  304 (359)
T KOG0660|consen  225 KPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA  304 (359)
T ss_pred             CCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH
Confidence            99999887655555443211                       1111        2567889999999999999999999


Q ss_pred             hhhhcCccccccC
Q psy6191         191 AQLLHFEFFNDYC  203 (305)
Q Consensus       191 ~~~l~~~~~~~~~  203 (305)
                      +|+|+|||+..+.
T Consensus       305 ~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  305 EEALAHPYLAPYH  317 (359)
T ss_pred             HHHhcChhhhhhc
Confidence            9999999998753

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.98  E-value=4.1e-32  Score=239.00  Aligned_cols=194  Identities=24%  Similarity=0.331  Sum_probs=143.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++|||||++++++++++.+|+|||||++|+|.+...    .   .+.. ......+..++.|+|..++.|.
T Consensus       120 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~---~~~~~~~i~~qi~~aL~~LH~~~ivHr  192 (353)
T PLN00034        120 CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI----A---DEQFLADVARQILSGIAYLHRRHIVHR  192 (353)
T ss_pred             HHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccccc----C---CHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            479999999999999999999999999999999999999864311    1   1111 1223345677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCccccccccc-----CCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNK-----NGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+....+++.||+....+..    ....+||+.|+|||++..     ...+.++|||||||++|||++|+.|
T Consensus       193 Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~p  272 (353)
T PLN00034        193 DIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP  272 (353)
T ss_pred             CCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCC
Confidence                   233446678888865433221    235689999999998743     2345689999999999999999999


Q ss_pred             CCCCCH---HHHHHHHh-ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         145 FETSTL---KETYSRIK-KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~~~~---~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |.....   ......+. ......+...+.++++||.+||..||++|||+.|+++||||.+.
T Consensus       273 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        273 FGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             CCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            974332   22222222 22334456788999999999999999999999999999999874

>KOG0577|consensus

Probab=99.98  E-value=7.6e-33  Score=241.68  Aligned_cols=197  Identities=21%  Similarity=0.332  Sum_probs=153.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHh-cCCCCCCCcCchhH-HHHHHHHHHhhhhCC--
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSA-CDLEEMSDPAAQPV-IWVSKWVDYSDKYGF--   77 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--   77 (305)
                      ..||+.|++|+|||+|.+.+.|-.+...|||||||-| +-.|++.-. .++   .+.....+ ...++++.|+|+++.  
T Consensus        74 lKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKpl---qEvEIAAi~~gaL~gLaYLHS~~~IH  149 (948)
T KOG0577|consen   74 LKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPL---QEVEIAAITHGALQGLAYLHSHNRIH  149 (948)
T ss_pred             HHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccc---hHHHHHHHHHHHHHHHHHHHHhhHHh
Confidence            4799999999999999999999999999999999975 444444321 222   22222222 223556666664432  


Q ss_pred             -----ceeecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          78 -----GYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        78 -----~~~~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                           +.++..+.+.|++.||+.+.+....++++|||+|||||++.   .+.|+.++||||||+++.|+.-.+||+.+.|
T Consensus       150 RDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN  229 (948)
T KOG0577|consen  150 RDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  229 (948)
T ss_pred             hhccccceEecCCCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence                 33344556889999999999999999999999999999863   5569999999999999999999999999988


Q ss_pred             HHHHHHHHhcc-ccCCCC-CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKV-EYKLPA-TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~-~~~~~~-~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ....+..|... .+.++. .-+..+++||..||++-|..|||.+++++|+|....
T Consensus       230 AMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  230 AMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             HHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence            87777776543 334443 356778999999999999999999999999999753

>KOG0603|consensus

Probab=99.98  E-value=2.9e-32  Score=240.59  Aligned_cols=191  Identities=27%  Similarity=0.440  Sum_probs=149.1

Q ss_pred             hHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .|..++..++ ||.+|+++..|+++..+|++++|..||+|...+.......+.  ......+-.+-.+++.|+.++.++ 
T Consensus        45 ~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~--~~~~~~aelaLald~lh~l~iiyrd  122 (612)
T KOG0603|consen   45 QERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDEL--DVAFYLAELALALDHLHKLGIAYRD  122 (612)
T ss_pred             cHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHH--HHHHHHHHHHHHHhhcchhHHHHhc
Confidence            4778888887 999999999999999999999999999988766543332211  111111122333445554443222 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETY  154 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~  154 (305)
                            +.+..+.++..|++...........|||..|||||+++  ++..++|+||+|+++|||++|..||..    ++.
T Consensus       123 ~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~  196 (612)
T KOG0603|consen  123 YKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTM  196 (612)
T ss_pred             ccccceeecccCccccCCchhhhHhHhhhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHH
Confidence                  33344668889998777766655559999999999998  677899999999999999999999987    777


Q ss_pred             HHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         155 SRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       155 ~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      .+|.+.+...|..++..+++++..++..+|.+|..     +.++++|+||..
T Consensus       197 ~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  197 KRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             HHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence            88988899999999999999999999999999975     468899999864

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2e-32  Score=238.83  Aligned_cols=197  Identities=23%  Similarity=0.392  Sum_probs=154.9

Q ss_pred             hHHHHHhcC---CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCc
Q psy6191           3 QEIAIHRSL---KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         3 ~Ei~il~~l---~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   78 (305)
                      +|..++..+   +|||||++++++++++.+|+|||||++|+|.+.+.....+   .+..+. .+..+..++.|+|..++.
T Consensus        42 ~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~qil~al~~LH~~~iv  118 (330)
T cd05586          42 GERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRF---SEDRAKFYIAELVLALEHLHKYDIV  118 (330)
T ss_pred             HHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            355666655   7999999999999999999999999999999988765443   222222 233457788899988765


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      |.       +.+..+.+++.||+.....    ....+.+||+.|||||++.+. .++.++||||+||++|+|++|..||.
T Consensus       119 HrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~  198 (330)
T cd05586         119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY  198 (330)
T ss_pred             eccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence            43       2234456777887644321    122457899999999998654 58899999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCCCC-CCCHHHHHHHHHHhhcCCCCCC----CHhhhhcCcccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLPA-TLKKPAATMIKKMLLLDPVQRP----PVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~-~~~~~~~~li~~~l~~dp~~R~----~~~~~l~~~~~~~~  202 (305)
                      +.+..+....+......+|. .++.++.++|++||..||.+||    ++.++++||||.+.
T Consensus       199 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         199 AEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            98888888888777666665 4789999999999999999998    68999999999763

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0197|consensus

Probab=99.98  E-value=1e-31  Score=233.14  Aligned_cols=193  Identities=20%  Similarity=0.291  Sum_probs=146.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce--
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY--   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--   79 (305)
                      .+|++||++|+|+|||+|++++..++.+||||||++.|+|.++++....-.-....-.....++.++..|+....+.|  
T Consensus       249 ~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRD  328 (468)
T KOG0197|consen  249 LREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRD  328 (468)
T ss_pred             HHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchh
Confidence            379999999999999999999999899999999999999999998622110000111111223445555554333322  


Q ss_pred             -----eecCCCCCeeEcchhHHHHhcCCcc--cccC---CCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy6191          80 -----QLNDDSSGVMFNDLTRMIMLANKNT--LCGT---PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETS  148 (305)
Q Consensus        80 -----~~~~~~~~v~~~d~~~~~~~~~~~~--~~Gt---~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~  148 (305)
                           .|.++...+++.||+.+....+..-  -.|.   ..|.|||.+....++.|||||||||+|+||+| |+.||.+.
T Consensus       329 LAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m  408 (468)
T KOG0197|consen  329 LAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM  408 (468)
T ss_pred             hhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence                 2444557889999987663332211  1122   35999999999999999999999999999998 99999999


Q ss_pred             CHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         149 TLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       149 ~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      +..+....+.++ ..+-|...+.+..+++..||..+|++|||++.+.
T Consensus       409 sn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  409 SNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            999999888765 3455678999999999999999999999999765

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=1.3e-31  Score=229.07  Aligned_cols=199  Identities=21%  Similarity=0.365  Sum_probs=148.6

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.++++++||||+++++.+.+++.+|+||||++||+|.+++...... ....... ..+..+..++.+.|..++.+. 
T Consensus        49 ~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~iiH~d  127 (285)
T cd05630          49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQERIVYRD  127 (285)
T ss_pred             HHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCC
Confidence            6999999999999999999999999999999999999999888543321 1122112 222345677888887765432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK  151 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~  151 (305)
                            +.+..+.+++.|++........   ...+||+.|+|||++.+..++.++||||+||++|+|++|++||......
T Consensus       128 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~  207 (285)
T cd05630         128 LKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK  207 (285)
T ss_pred             CCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc
Confidence                  2233456777777654332221   2357999999999998888999999999999999999999999864321


Q ss_pred             ---HHHHH-HhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCcccccc
Q psy6191         152 ---ETYSR-IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFNDY  202 (305)
Q Consensus       152 ---~~~~~-i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~~  202 (305)
                         +.... .......++...+.++.+++.+||+.||.+|+|     ++++++||||+..
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         208 IKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             chHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence               11111 122233456678889999999999999999999     8999999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2e-31  Score=236.95  Aligned_cols=197  Identities=20%  Similarity=0.284  Sum_probs=142.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|++++++|+|||||+++++|+.+...|+||||+. ++|.+.+.....+..  .........+..++.|.|..++.|. 
T Consensus       131 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~--~~~~~i~~qi~~aL~ylH~~~IvHrD  207 (391)
T PHA03212        131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAI--CDILAIERSVLRAIQYLHENRIIHRD  207 (391)
T ss_pred             HHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            479999999999999999999999999999999995 688888765543321  1112223345678888888776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                            +.+..+.+++.||+......     .....+||+.|+|||++.+..++.++||||+||++|||++|..||....
T Consensus       208 iKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~  287 (391)
T PHA03212        208 IKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD  287 (391)
T ss_pred             CChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcc
Confidence                  22334567788887543221     1234689999999999998889999999999999999999998875421


Q ss_pred             -------HHHHHHHHh--------------------------ccccCCC---------CCCCHHHHHHHHHHhhcCCCCC
Q psy6191         150 -------LKETYSRIK--------------------------KVEYKLP---------ATLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       150 -------~~~~~~~i~--------------------------~~~~~~~---------~~~~~~~~~li~~~l~~dp~~R  187 (305)
                             ....+..+.                          ......|         ..++.++.++|.+||..||.+|
T Consensus       288 ~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~R  367 (391)
T PHA03212        288 GLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHR  367 (391)
T ss_pred             cccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhC
Confidence                   111111110                          0000001         0234578899999999999999


Q ss_pred             CCHhhhhcCccccc
Q psy6191         188 PPVAQLLHFEFFND  201 (305)
Q Consensus       188 ~~~~~~l~~~~~~~  201 (305)
                      ||+.|+++||||..
T Consensus       368 pta~elL~hp~f~~  381 (391)
T PHA03212        368 PSAEALLDFAAFQD  381 (391)
T ss_pred             CCHHHHhcChhhcc
Confidence            99999999999975

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=2.4e-31  Score=224.43  Aligned_cols=198  Identities=29%  Similarity=0.535  Sum_probs=155.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||++++++++++..+|+||||+++|+|.+++.+...+   ...... .+..+.+++.+.|+.++.+.
T Consensus        41 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l---~~~~~~~~~~~i~~~l~~lH~~~~~h~  117 (262)
T cd05572          41 FSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLF---DEYTARFYIACVVLAFEYLHNRGIIYR  117 (262)
T ss_pred             HHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCC---CHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence            47999999999999999999999999999999999999999998765332   222222 22345677888887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC-
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST-  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~-  149 (305)
                             +.+....+++.|++.......   ....+|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+ 
T Consensus       118 dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  197 (262)
T cd05572         118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE  197 (262)
T ss_pred             CCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC
Confidence                   223345677777765443332   234578999999999988888999999999999999999999998766 


Q ss_pred             -HHHHHHHHh--ccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCcccccc
Q psy6191         150 -LKETYSRIK--KVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFNDY  202 (305)
Q Consensus       150 -~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~~  202 (305)
                       ..+....+.  ......|...+.++.++|.+||..||.+|++     +.|+++||||+++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         198 DPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             CHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence             555555555  3455667677889999999999999999999     9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=3.7e-31  Score=222.41  Aligned_cols=197  Identities=21%  Similarity=0.309  Sum_probs=151.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++..|+||||++|++|.+++...... ...... ...+..+..++.+.|..++.+.
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~~l~~al~~lH~~~i~h~  125 (256)
T cd08529          47 IDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKKILHR  125 (256)
T ss_pred             HHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            36899999999999999999999999999999999999999998764211 112211 1223345677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+....+++.|++....+..    ....+|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+
T Consensus       126 dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             CCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                   222334566677654332221    234579999999999998888999999999999999999999998887


Q ss_pred             HHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ..+....+..... .++...+.++.+++.+||+.+|++||++.++++|||+
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         206 QGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            7666666554433 3444678899999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=6.4e-31  Score=222.24  Aligned_cols=195  Identities=25%  Similarity=0.397  Sum_probs=150.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+++..|+||||++||+|.+++.+...+   ...... .+..+..++.+.|..++.+.
T Consensus        50 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~~l~~lH~~~i~H~  126 (265)
T cd06631          50 QEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL---PEPVFCKYTKQILDGVAYLHNNCVVHR  126 (265)
T ss_pred             HHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            47999999999999999999999999999999999999999998765433   222222 22344567778887665432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                             +.+..+.+++.|++.......          .....||+.|+|||++.+..++.++|+||+||++|+|++|..
T Consensus       127 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~  206 (265)
T cd06631         127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP  206 (265)
T ss_pred             CcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCC
Confidence                   223445677778765443211          124568999999999998889999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhcc---ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         144 PFETSTLKETYSRIKKV---EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ||...+.......+...   ....+...+.++.++|++||..||.+||++.+++.||||
T Consensus       207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         207 PLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99876655443333322   234566788899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=4.6e-31  Score=223.34  Aligned_cols=195  Identities=26%  Similarity=0.461  Sum_probs=150.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++..|+||||+++++|.+++.....+.   .... ..+..+..++.+.|+.++.+.
T Consensus        54 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~---~~~~~~~~~~l~~~l~~lH~~~ivH~  130 (267)
T cd06628          54 AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---ETLVRNFVRQILKGLNYLHNRGIIHR  130 (267)
T ss_pred             HHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCcc---HHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            478999999999999999999999999999999999999999997654432   2222 223345677888887775433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                             +.++...+++.|++......          ......|++.|+|||.+.+..++.++|+||+||++|+|++|..
T Consensus       131 di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~  210 (267)
T cd06628         131 DIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH  210 (267)
T ss_pred             cCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCC
Confidence                   22334556777765332221          1123568999999999988888999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         144 PFETSTLKETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ||...+.......+.. ....+|...+..+.++|++||+.||.+||++.++++||||
T Consensus       211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         211 PFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9987665554444433 3345667788999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=2.2e-31  Score=228.03  Aligned_cols=195  Identities=20%  Similarity=0.324  Sum_probs=142.2

Q ss_pred             hHHHHHhcC---CCCCccceeEEEE-----cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhh
Q psy6191           3 QEIAIHRSL---KHRNVVGFHSFFE-----DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSD   73 (305)
Q Consensus         3 ~Ei~il~~l---~HpnIV~l~~~~~-----~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   73 (305)
                      +|+.+++.+   +|||||++++++.     .+..+|+||||++ |+|.+++...... .+..... ..+..+..++.+.|
T Consensus        50 ~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH  127 (290)
T cd07862          50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLH  127 (290)
T ss_pred             HHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            577777765   6999999999985     3457999999997 5888888653221 1121122 22334567888888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      ..++.|.       +.+..+.+++.|++......   ......||+.|+|||++.+..++.++||||+||++|||++|.+
T Consensus       128 ~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  207 (290)
T cd07862         128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP  207 (290)
T ss_pred             HCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCC
Confidence            8776443       22334567777876443221   1235679999999999988889999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhcccc---------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         144 PFETSTLKETYSRIKKVEY---------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||.+.+..+....+.....                           .+.+.++..+++++.+||+.||++|||+.++++|
T Consensus       208 ~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         208 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             CcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            9998876665555432110                           0112466778899999999999999999999999


Q ss_pred             ccc
Q psy6191         197 EFF  199 (305)
Q Consensus       197 ~~~  199 (305)
                      |||
T Consensus       288 p~f  290 (290)
T cd07862         288 PYF  290 (290)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.3e-31  Score=228.48  Aligned_cols=199  Identities=27%  Similarity=0.491  Sum_probs=153.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++||||+++++.+++++..|+||||+.||+|.+++...... ...+... ..+..+.+++.+.|..++.|.
T Consensus        49 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  127 (316)
T cd05574          49 LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGK-CLSEEVARFYAAEVLLALEYLHLLGIVYR  127 (316)
T ss_pred             HHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCC-ccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            46999999999999999999999999999999999999999988753211 1111111 122345677888887765332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc---------------------------------CCcccccCCCcccccccccC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA---------------------------------NKNTLCGTPNYIAPEILNKN  120 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~---------------------------------~~~~~~Gt~~y~aPE~~~~~  120 (305)
                             +.+.++.+++.|++......                                 ..+...||..|+|||++.+.
T Consensus       128 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  207 (316)
T cd05574         128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD  207 (316)
T ss_pred             CCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC
Confidence                   22334556677765432211                                 11235789999999999888


Q ss_pred             CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCCC--CCHHHHHHHHHHhhcCCCCCCC----Hhhhh
Q psy6191         121 GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT--LKKPAATMIKKMLLLDPVQRPP----VAQLL  194 (305)
Q Consensus       121 ~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R~~----~~~~l  194 (305)
                      .++.++||||+||++|+|++|..||.+.+....+..+......++..  .+..+.++|.+||..||++|||    +++++
T Consensus       208 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll  287 (316)
T cd05574         208 GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK  287 (316)
T ss_pred             CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence            89999999999999999999999999888777777666555555544  6889999999999999999999    99999


Q ss_pred             cCccccc
Q psy6191         195 HFEFFND  201 (305)
Q Consensus       195 ~~~~~~~  201 (305)
                      .||||+.
T Consensus       288 ~~~~~~~  294 (316)
T cd05574         288 QHPFFRG  294 (316)
T ss_pred             cCchhhc
Confidence            9999985

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0596|consensus

Probab=99.97  E-value=1.6e-31  Score=231.73  Aligned_cols=197  Identities=22%  Similarity=0.344  Sum_probs=143.5

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   79 (305)
                      .+||.+|.+|+ |-+||+||||-..++++||||||= .-||..++++.....  .....+.++. .++++...|+.|+.|
T Consensus       407 ~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~--~~~~lk~ywkqML~aV~~IH~~gIVH  483 (677)
T KOG0596|consen  407 RNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSID--PDWFLKFYWKQMLLAVKTIHQHGIVH  483 (677)
T ss_pred             HHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCC--chHHHHHHHHHHHHHHHHHHHhceee
Confidence            47999999996 899999999999999999999984 458989988765432  1112222222 356677777776543


Q ss_pred             eecCC------CCCeeEcchhHHHHhcCC------cccccCCCcccccccccCC-----------CCccchHHHHHHHHH
Q psy6191          80 QLNDD------SSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNG-----------HSFEVDVWSIGCIMY  136 (305)
Q Consensus        80 ~~~~~------~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~-----------~~~~~DiwSlGvily  136 (305)
                      --...      .+.+++.||+-++.+...      .+-|||+.||+||.+....           .+.++||||||||||
T Consensus       484 SDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILY  563 (677)
T KOG0596|consen  484 SDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILY  563 (677)
T ss_pred             cCCCcccEEEEeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHH
Confidence            21111      245677888876654432      3568999999999874332           357899999999999


Q ss_pred             HHHhCCCCCCCC-CHHHHHHHHhcc--ccCCCCCCCH-HHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         137 TLLVGKPPFETS-TLKETYSRIKKV--EYKLPATLKK-PAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       137 e~l~g~~Pf~~~-~~~~~~~~i~~~--~~~~~~~~~~-~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +|+.|++||..- +...-+..|...  ++++|..-+. ++.++++.||..||.+||++.++|+|||+..
T Consensus       564 qMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  564 QMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             HHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            999999999753 234444455443  3355554443 3899999999999999999999999999874

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=3.9e-31  Score=228.52  Aligned_cols=198  Identities=20%  Similarity=0.300  Sum_probs=145.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh-hCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK-YGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~   79 (305)
                      .+|++++++++|||||++++++.+++.+|+||||++||+|.+++.....+   .+... .....+.+++.|.|. .++.+
T Consensus        47 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~l~~lH~~~~i~H  123 (308)
T cd06615          47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PENILGKISIAVLRGLTYLREKHKIMH  123 (308)
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhhCCEEE
Confidence            47999999999999999999999999999999999999999998765333   22222 223345677888885 34322


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                      .       +.+....+++.|++......  ...+.+|++.|+|||.+.+..++.++|+||+||++|+|++|+.||...+.
T Consensus       124 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~  203 (308)
T cd06615         124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA  203 (308)
T ss_pred             CCCChHHEEEecCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence            2       22233456677775433221  13456899999999999888889999999999999999999999976554


Q ss_pred             HHHHHHHhcc-------------------------------------ccCCCC-CCCHHHHHHHHHHhhcCCCCCCCHhh
Q psy6191         151 KETYSRIKKV-------------------------------------EYKLPA-TLKKPAATMIKKMLLLDPVQRPPVAQ  192 (305)
Q Consensus       151 ~~~~~~i~~~-------------------------------------~~~~~~-~~~~~~~~li~~~l~~dp~~R~~~~~  192 (305)
                      ......+...                                     .+..|. ..+.++++++.+||..||++||++.+
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  283 (308)
T cd06615         204 KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE  283 (308)
T ss_pred             hhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence            3332222110                                     011111 25678899999999999999999999


Q ss_pred             hhcCcccccc
Q psy6191         193 LLHFEFFNDY  202 (305)
Q Consensus       193 ~l~~~~~~~~  202 (305)
                      +++||||...
T Consensus       284 ll~~~~~~~~  293 (308)
T cd06615         284 LTKHPFIKRA  293 (308)
T ss_pred             HhcChhhhhc
Confidence            9999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=7.9e-31  Score=225.35  Aligned_cols=199  Identities=20%  Similarity=0.364  Sum_probs=152.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++.+++.+|+||||+++|+|.+++.... +   ..... ..+..+..++.++|+.++.+.
T Consensus        64 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-l---~~~~~~~i~~~l~~al~~LH~~~i~H~  139 (296)
T cd06655          64 INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-M---DEAQIAAVCRECLQALEFLHANQVIHR  139 (296)
T ss_pred             HHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcC-C---CHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            469999999999999999999999999999999999999999876431 2   22222 222334567788887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+.++.+++.|++....+..    ....+|++.|+|||.+.+..++.++||||+||++|+|++|..||.+.+
T Consensus       140 dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             CCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                   223345677777764433222    224578999999999988888999999999999999999999998877


Q ss_pred             HHHHHHHHhcc---ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         150 LKETYSRIKKV---EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       150 ~~~~~~~i~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      ..+....+...   ....|..++..+.++|++||..||.+||++.+++.||||+...+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         220 PLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            65554444322   22345567888999999999999999999999999999986443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-31  Score=231.11  Aligned_cols=199  Identities=24%  Similarity=0.448  Sum_probs=149.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++++++.+|+|||||+||+|.+++......  +.+..+. .+..+..++.++|..++.|.
T Consensus        49 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~  126 (331)
T cd05597          49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYLAEMVLAIDSVHQLGYVHR  126 (331)
T ss_pred             HHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEC
Confidence            36899999999999999999999999999999999999999998753211  1222222 23345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCccccccccc-----CCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNK-----NGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                             +.+..+.+++.||+....+...     ...+||+.|||||++..     ..++.++||||+||++|+|++|+.
T Consensus       127 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~  206 (331)
T cd05597         127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET  206 (331)
T ss_pred             CCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCC
Confidence                   2234456778888654332221     23479999999999863     347889999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccc--cCCC---CCCCHHHHHHHHHHhhcCCCC--CCCHhhhhcCcccccc
Q psy6191         144 PFETSTLKETYSRIKKVE--YKLP---ATLKKPAATMIKKMLLLDPVQ--RPPVAQLLHFEFFNDY  202 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~~~~li~~~l~~dp~~--R~~~~~~l~~~~~~~~  202 (305)
                      ||.+.+..+.+..+....  ..+|   ...+..++++|++||..++.+  |+++.+++.||||+..
T Consensus       207 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         207 PFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            999888777776665432  2333   246889999999998764444  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0659|consensus

Probab=99.97  E-value=2.6e-31  Score=211.52  Aligned_cols=197  Identities=21%  Similarity=0.329  Sum_probs=150.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCce-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGY-   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-   79 (305)
                      .|||..|++++|||||.|+++|-..+.+.||+||++. ||..+++.....  +....... .....+++.|+|...+.| 
T Consensus        49 lREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~--l~pa~iK~y~~m~LkGl~y~H~~~IlHR  125 (318)
T KOG0659|consen   49 LREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNII--LSPADIKSYMLMTLKGLAYCHSKWILHR  125 (318)
T ss_pred             HHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccc--cCHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence            4899999999999999999999999999999999985 788877654322  11111222 233467777777655433 


Q ss_pred             ------eecCCCCCeeEcchhHHHHhcCCc----ccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 ------QLNDDSSGVMFNDLTRMIMLANKN----TLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ------~~~~~~~~v~~~d~~~~~~~~~~~----~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                            ++...++.+++.||+.+......+    ..+-|.+|.|||++-| +.|+..+||||.|||+.||+-|.+-|.+.
T Consensus       126 DlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~  205 (318)
T KOG0659|consen  126 DLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD  205 (318)
T ss_pred             cCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence                  344455778889998766554322    2367999999998764 56999999999999999999999999999


Q ss_pred             CHHHHHHHHhcccc-----C---------------CC--------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         149 TLKETYSRIKKVEY-----K---------------LP--------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       149 ~~~~~~~~i~~~~~-----~---------------~~--------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      +..+++..|...--     .               +|        +..++++.||+.+||.+||.+|+++.|+++|+||+
T Consensus       206 sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~  285 (318)
T KOG0659|consen  206 SDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK  285 (318)
T ss_pred             chHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence            88887777643210     0               11        13456778999999999999999999999999998


Q ss_pred             c
Q psy6191         201 D  201 (305)
Q Consensus       201 ~  201 (305)
                      .
T Consensus       286 ~  286 (318)
T KOG0659|consen  286 S  286 (318)
T ss_pred             c
Confidence            5

>KOG0603|consensus

Probab=99.97  E-value=1.3e-31  Score=236.52  Aligned_cols=194  Identities=24%  Similarity=0.379  Sum_probs=149.4

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce-
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY-   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   79 (305)
                      ++|+.++... +|||||++++++.++..+|+|||++.||.+.+.+......   .....+....++.++.++|..|+.+ 
T Consensus       363 ~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~---~~e~~~w~~~lv~Av~~LH~~gvvhR  439 (612)
T KOG0603|consen  363 QDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEF---CSEASQWAAELVSAVDYLHEQGVVHR  439 (612)
T ss_pred             ccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchh---HHHHHHHHHHHHHHHHHHHhcCeeec
Confidence            3577666554 7999999999999999999999999999888776554322   1112222333466778888766433 


Q ss_pred             -------eecCCCCCeeEcchhHHHHhcCC-cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy6191          80 -------QLNDDSSGVMFNDLTRMIMLANK-NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK  151 (305)
Q Consensus        80 -------~~~~~~~~v~~~d~~~~~~~~~~-~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~  151 (305)
                             ++.+..+.+.+.||+....+... .+.|-|..|.|||++....|+.+||||||||+||+||+|+.||......
T Consensus       440 DLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  440 DLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             CCChhheeecCCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence                   23234455777777765544322 3557789999999999999999999999999999999999999876555


Q ss_pred             -HHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         152 -ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       152 -~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                       ++..++....+.  ..+|.++++||++||+.||.+|+++.+++.|||+.
T Consensus       520 ~ei~~~i~~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  520 IEIHTRIQMPKFS--ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             HHHHHhhcCCccc--cccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence             666666654433  78999999999999999999999999999999993

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5.6e-31  Score=234.79  Aligned_cols=199  Identities=18%  Similarity=0.298  Sum_probs=145.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|++++++++|||||++++++..+..+|+||||+. ++|.+++.....+..  .........+..++.|+|..++.|. 
T Consensus       134 ~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~--~~~~~i~~ql~~aL~~LH~~givHrD  210 (392)
T PHA03207        134 GREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPL--EQAITIQRRLLEALAYLHGRGIIHRD  210 (392)
T ss_pred             HHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCCccccC
Confidence            479999999999999999999999999999999996 688888754433321  1112223345677888888776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                            +.+..+.+++.||+....+..      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       211 lkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             CCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                  333446677888875433221      12457999999999999888999999999999999999999999764


Q ss_pred             CHH---HHHHHHhc----c-------------------------ccCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHh
Q psy6191         149 TLK---ETYSRIKK----V-------------------------EYKLP-----ATLKKPAATMIKKMLLLDPVQRPPVA  191 (305)
Q Consensus       149 ~~~---~~~~~i~~----~-------------------------~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~  191 (305)
                      ...   ..+..+.+    .                         .+..|     ...+.++.++|.+||..||.+|||+.
T Consensus       291 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~  370 (392)
T PHA03207        291 QVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ  370 (392)
T ss_pred             CCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH
Confidence            321   11111110    0                         01111     12356788999999999999999999


Q ss_pred             hhhcCccccccC
Q psy6191         192 QLLHFEFFNDYC  203 (305)
Q Consensus       192 ~~l~~~~~~~~~  203 (305)
                      +++.||||....
T Consensus       371 e~l~~p~f~~~~  382 (392)
T PHA03207        371 DILSLPLFTKEP  382 (392)
T ss_pred             HHhhCchhhccc
Confidence            999999998643

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=6.4e-31  Score=229.52  Aligned_cols=198  Identities=23%  Similarity=0.427  Sum_probs=150.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++..++||||+++++++++++.+|+|||||+||+|.+++.+....  +.+..... +..+..++.+.|..++.|.
T Consensus        49 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~--l~~~~~~~~~~qi~~al~~lH~~~iiHr  126 (332)
T cd05623          49 REERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYLAEMVIAIDSVHQLHYVHR  126 (332)
T ss_pred             HHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            46889999999999999999999999999999999999999998763221  12222222 2335677888887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccc-----cCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                             +.+..+.+++.||+....+..     ....+||+.|||||++.     ...++.++||||+||++|||++|+.
T Consensus       127 Dlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~  206 (332)
T cd05623         127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET  206 (332)
T ss_pred             CCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCC
Confidence                   233456678888875543322     12358999999999885     3457889999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccc--cCCCC---CCCHHHHHHHHHHhhcCCCC--CCCHhhhhcCccccc
Q psy6191         144 PFETSTLKETYSRIKKVE--YKLPA---TLKKPAATMIKKMLLLDPVQ--RPPVAQLLHFEFFND  201 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~--~~~~~---~~~~~~~~li~~~l~~dp~~--R~~~~~~l~~~~~~~  201 (305)
                      ||.+.+..+.+..+....  ..+|.   .++.+++++|++||..++.+  |++++++++||||..
T Consensus       207 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         207 PFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            999988888777775543  22333   46889999999999765544  689999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-30  Score=222.39  Aligned_cols=199  Identities=23%  Similarity=0.357  Sum_probs=150.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.++..+|+||||+++|+|.+++......  +.+... ..+..+..++.+.|..++.+.
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--l~~~~~~~~~~ql~~~l~~lh~~~i~h~  127 (280)
T cd06611          50 MVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLHSHKVIHR  127 (280)
T ss_pred             HHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            36999999999999999999999999999999999999999988654321  122222 223345677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccc-----cCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+..+.+++.|++......    ......||+.|+|||++.     ...++.++|+||+||++|+|++|++|
T Consensus       128 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p  207 (280)
T cd06611         128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP  207 (280)
T ss_pred             CCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence                   22334556667775433221    123457999999999874     33467789999999999999999999


Q ss_pred             CCCCCHHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         145 FETSTLKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |...+..+....+.....   ..|...+.++.++|.+||..||.+||++.++++|||+...
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         208 HHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             cccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            988776666555554422   2345678899999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=8.4e-31  Score=221.76  Aligned_cols=194  Identities=22%  Similarity=0.379  Sum_probs=142.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++.+++.+|+|||||++|+|.+++.....+.   +.... ....+..++.+.|..++.+.
T Consensus        54 ~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---~~~~~~~~~~i~~~l~~lH~~~i~H~  130 (267)
T cd06645          54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS---ESQIAYVSRETLQGLYYLHSKGKMHR  130 (267)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            469999999999999999999999999999999999999999987654432   22222 22334567788887765443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                             +.+....+++.|++....+.    ......||+.|+|||++.   ...++.++|+||+||++|+|++|.+||.
T Consensus       131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~  210 (267)
T cd06645         131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             CCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence                   22334556777776432221    123457999999999874   4457889999999999999999999997


Q ss_pred             CCCHHHHHHHHhccccCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         147 TSTLKETYSRIKKVEYKLP-----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      ..................+     ...+..+.++|.+||..||++||+++++++|||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         211 DLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             cccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            6554333322222222211     135678899999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=1.7e-30  Score=218.54  Aligned_cols=197  Identities=21%  Similarity=0.392  Sum_probs=151.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+++.+|+|||||++|+|.+.+...... ....... ..+..+..++.+.|+.++.+.
T Consensus        47 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  125 (256)
T cd08221          47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ-LFEEEMVLWYLFQIVSAVSYIHKAGILHR  125 (256)
T ss_pred             HHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcccc-CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            47999999999999999999999999999999999999999988764221 1111111 222335667788887665432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+....+++.|++.......    .....||+.|+|||++.+..++.++|+||+||++|+|++|..||...+
T Consensus       126 dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08221         126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN  205 (256)
T ss_pred             CCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence                   122334566777654332211    234679999999999988888899999999999999999999999888


Q ss_pred             HHHHHHHHhccccC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRIKKVEYK-LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ..+....+....+. .+...+.++.+++.+||..||.+||++.++++|+|+
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         206 PLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            87777776655432 234578889999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=221.82  Aligned_cols=198  Identities=25%  Similarity=0.378  Sum_probs=151.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++||||+++++++.++..+|+|+||+++|+|.+++... .+   .... ...+..+..++.+.|..++.+.
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~---~~~~~~~~~~ql~~~l~~lh~~~i~h~  122 (274)
T cd06609          47 QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KL---DETYIAFILREVLLGLEYLHEEGKIHR  122 (274)
T ss_pred             HHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CC---CHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            47999999999999999999999999999999999999999998753 22   2222 2223345667778887765332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+.++.+.+.|++....+.    ......||+.|+|||.+.+..++.++||||+||++|+|++|.+||...+
T Consensus       123 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~  202 (274)
T cd06609         123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH  202 (274)
T ss_pred             CCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence                   22334567777775433322    2235678999999999988889999999999999999999999998776


Q ss_pred             HHHHHHHHhcc-ccCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         150 LKETYSRIKKV-EYKLPAT-LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       150 ~~~~~~~i~~~-~~~~~~~-~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      .......+... ...++.. .+.++.+++.+||..||.+|||++++++||||....
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         203 PMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             hHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            65555444433 2233334 678899999999999999999999999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1e-30  Score=221.37  Aligned_cols=194  Identities=16%  Similarity=0.296  Sum_probs=144.5

Q ss_pred             HHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee-
Q psy6191           4 EIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         4 Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      |+.+...+ +|||||+++++|..++..|+||||+++|+|.+++.....+   .+.. ...+..+.+++.+.|..++.+. 
T Consensus        58 e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l---~~~~~~~~~~qi~~~l~~lH~~~i~H~d  134 (267)
T PHA03390         58 EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKL---SEAEVKKIIRQLVEALNDLHKHNIIHND  134 (267)
T ss_pred             hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence            34444333 7999999999999999999999999999999998765433   2222 2223345677888887775432 


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE-  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~-  152 (305)
                             +...+..+++.|++............||+.|+|||++.+..++.++||||+||++|+|++|..||....... 
T Consensus       135 l~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~  214 (267)
T PHA03390        135 IKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL  214 (267)
T ss_pred             CCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence                   222222577777765544444456679999999999998889999999999999999999999997543322 


Q ss_pred             ---HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-HhhhhcCcccc
Q psy6191         153 ---TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-VAQLLHFEFFN  200 (305)
Q Consensus       153 ---~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-~~~~l~~~~~~  200 (305)
                         ............+...+..+.++|.+||+.||.+|++ ++++++||||.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        215 DLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             hHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence               1222223333455578999999999999999999996 69999999996

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=1.3e-30  Score=219.26  Aligned_cols=197  Identities=21%  Similarity=0.416  Sum_probs=148.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++||||+++++.+.. +..+|+|||||++|+|.+.+...... ...... ...+..+..++.+.|+.++.|
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~i~H  125 (257)
T cd08223          47 EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK-LLPENQVVEWFVQIAMALQYLHEKHILH  125 (257)
T ss_pred             HHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            468999999999999999998874 45789999999999999988653211 111111 222334567778888776543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+....+++.|++......    ...+..|++.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus       126 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  205 (257)
T cd08223         126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK  205 (257)
T ss_pred             cCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            2       22233456666665433221    123457999999999999888999999999999999999999999887


Q ss_pred             CHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +.......+..... ..+...+..+.+++.+||..||.+||++.++++||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         206 DMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            76665555544332 4556788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=1.6e-30  Score=221.89  Aligned_cols=199  Identities=20%  Similarity=0.290  Sum_probs=150.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++||||+++++++..++..|+||||+++|+|.+++.+...  .+.... ......+.+++.+.|+.++.+.
T Consensus        50 ~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~i~H~  127 (282)
T cd06643          50 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENKIIHR  127 (282)
T ss_pred             HHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            3689999999999999999999999999999999999999887754221  112221 2233345677888888775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccc-----cCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+.++.+++.|++......    ......||+.|+|||++.     +..++.++||||+||++|+|++|.+|
T Consensus       128 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p  207 (282)
T cd06643         128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP  207 (282)
T ss_pred             CCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence                   22334556777776443221    123467999999999873     34467899999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc---cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         145 FETSTLKETYSRIKKVE---YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |...+..+....+....   ...|...+.++.++|.+||..||.+||+++++++|||+...
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         208 HHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            98877666655554332   23355678899999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=1.3e-30  Score=219.26  Aligned_cols=197  Identities=20%  Similarity=0.414  Sum_probs=150.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++++++..|+||||+++|+|.+.+....... .... ....+..+..++.+.|..++.+.
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~  125 (256)
T cd08218          47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWFVQICLALKHVHDRKILHR  125 (256)
T ss_pred             HHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            479999999999999999999999999999999999999999886532211 1111 12233445677888887665332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+.+..+++.|++.......    .....|++.|+|||++.+..++.++|+||+||++|+|++|..||...+
T Consensus       126 ~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08218         126 DIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN  205 (256)
T ss_pred             CCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence                   222334566667653322211    123468999999999988888899999999999999999999998887


Q ss_pred             HHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ..+....+..... ..|...+.++.++|.+||..+|.+||++.++++||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         206 MKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            7776665554433 4566788899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=1.4e-30  Score=218.86  Aligned_cols=197  Identities=21%  Similarity=0.363  Sum_probs=150.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++.+..++..|+||||++||+|.+++....... ..+.. ...+..+.+++.+.|..++.+.
T Consensus        47 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~h~  125 (256)
T cd08220          47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTKLILHR  125 (256)
T ss_pred             HHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            479999999999999999999999999999999999999999987643211 12211 2223345677778887665432


Q ss_pred             --------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 --------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 --------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                              +..+...+++.|++.......   .....|++.|+|||.+.+..++.++||||+||++|+|++|..||...+
T Consensus       126 dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  205 (256)
T cd08220         126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN  205 (256)
T ss_pred             CCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence                    222223356666654433221   224578999999999988888999999999999999999999999887


Q ss_pred             HHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      .......+.... ..++...+.++.+++.+||..||.+|||+.++++|||+
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         206 LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             hHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            766665554432 34566788999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=1.9e-30  Score=223.02  Aligned_cols=199  Identities=19%  Similarity=0.340  Sum_probs=149.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.+++.++||||+++++.+.++...|+||||++||+|.+++.... +..  .........+..++.+.|..|+.|. 
T Consensus        65 ~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~--~~~~~i~~ql~~aL~~LH~~gi~H~d  141 (296)
T cd06654          65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDE--GQIAAVCRECLQALEFLHSNQVIHRD  141 (296)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcC-CCH--HHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            368999999999999999999999999999999999999999886432 111  1112223345677888887775432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+.++.+++.|++.......    .....||+.|+|||.+.+..++.++||||+||++|+|++|++||...+.
T Consensus       142 Lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~  221 (296)
T cd06654         142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP  221 (296)
T ss_pred             CCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence                  223345677777764433221    1245799999999999888889999999999999999999999987766


Q ss_pred             HHHHHHHhc-cc--cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         151 KETYSRIKK-VE--YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       151 ~~~~~~i~~-~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      ......+.. ..  ...+..++..+.+++.+||..||++||++.+++.|||+....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         222 LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             HHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            444333322 11  123456788899999999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=1.7e-30  Score=221.22  Aligned_cols=199  Identities=22%  Similarity=0.359  Sum_probs=151.9

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|++++++++||||+++++++++.+..|+||||+++|+|.+.+...... ...+..... +..+..++.+.|..++.+. 
T Consensus        42 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~i~H~d  120 (277)
T cd05577          42 NEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GFPEARAIFYAAQIICGLEHLHQRRIVYRD  120 (277)
T ss_pred             HHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            6899999999999999999999999999999999999999988765421 112222222 2345677888887776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL-  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~-  150 (305)
                            +.+....+++.|++.......   .....|+..|+|||++.+..++.++||||+||++|+|++|+.||..... 
T Consensus       121 i~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  200 (277)
T cd05577         121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK  200 (277)
T ss_pred             CCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc
Confidence                  233445677788765443321   1234688999999999888889999999999999999999999976543 


Q ss_pred             ---HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         151 ---KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ---~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                         ......+.......|...+..+.++|++||+.||.+||     ++.+++.||||++.
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         201 VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             ccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence               23333344444556677899999999999999999999     88889999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=1.6e-30  Score=222.28  Aligned_cols=200  Identities=21%  Similarity=0.326  Sum_probs=152.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++.+|+||||+++|+|.+.+...... .+.... ...+..+..++.+.|..++.+.
T Consensus        48 ~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~iiH~  126 (285)
T cd05632          48 LNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHRENTVYR  126 (285)
T ss_pred             HHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            36999999999999999999999999999999999999999887643321 112222 2223345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                             +.+....+++.|++.......   .....||+.|+|||++.+..++.++|+||+||++|+|++|..||.+...
T Consensus       127 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~  206 (285)
T cd05632         127 DLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE  206 (285)
T ss_pred             CCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                   223335577777764432211   1345799999999999888899999999999999999999999987655


Q ss_pred             HHHH----HHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCcccccc
Q psy6191         151 KETY----SRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~----~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~~  202 (305)
                      ....    ..+......++...+.++.+++.+||..||.+||+     +.+++.|+||+..
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         207 KVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            4332    23333344556678889999999999999999999     8899999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.9e-30  Score=245.97  Aligned_cols=203  Identities=23%  Similarity=0.388  Sum_probs=142.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCch-hHHHHHHHHHHhhhhC-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDL-EEMSDPAAQ-PVIWVSKWVDYSDKYG-   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~-   76 (305)
                      .+|+.++++|+|||||+++++|.+  .+.+|||||||++|+|.+++...... ..+.+..+. .+.+++.++.|+|..+ 
T Consensus        60 ~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~  139 (1021)
T PTZ00266         60 VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD  139 (1021)
T ss_pred             HHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhccc
Confidence            469999999999999999999854  46799999999999999988753211 112222222 2234567788888643 


Q ss_pred             ------Cce--------eecC----------------CCCCeeEcchhHHHHhc---CCcccccCCCccccccccc--CC
Q psy6191          77 ------FGY--------QLND----------------DSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNK--NG  121 (305)
Q Consensus        77 ------~~~--------~~~~----------------~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~--~~  121 (305)
                            +.|        ++..                ....+++.||+....+.   .....+||+.|+|||++.+  ..
T Consensus       140 ~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~  219 (1021)
T PTZ00266        140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKS  219 (1021)
T ss_pred             ccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCC
Confidence                  211        1110                01124455554332221   1134579999999999854  45


Q ss_pred             CCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCC-CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         122 HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP-ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       122 ~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      ++.++|||||||+||||++|..||...+............+.+| ...+.++.+||..||..+|.+||++.|+|.|+|+.
T Consensus       220 ~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        220 YDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             CCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            88999999999999999999999986654443333322223333 34688899999999999999999999999999998


Q ss_pred             ccCC
Q psy6191         201 DYCP  204 (305)
Q Consensus       201 ~~~~  204 (305)
                      ...+
T Consensus       300 ~i~~  303 (1021)
T PTZ00266        300 NVGP  303 (1021)
T ss_pred             hcCC
Confidence            6543

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=1.7e-30  Score=224.63  Aligned_cols=198  Identities=19%  Similarity=0.394  Sum_probs=145.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+||||+++ +|.+.+......  +....... ...+..++.+.|..++.|.
T Consensus        52 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~qi~~aL~~lH~~~ivH~  128 (309)
T cd07872          52 IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNI--MSMHNVKIFLYQILRGLAYCHRRKVLHR  128 (309)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            3799999999999999999999999999999999985 788877544321  12222222 2345677888888775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.|++......    ......||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.
T Consensus       129 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             CCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   23344567778876543221    1224568999999998865 45788999999999999999999999887


Q ss_pred             CHHHHHHHHhcc-------------------ccCCC-----------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         149 TLKETYSRIKKV-------------------EYKLP-----------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       149 ~~~~~~~~i~~~-------------------~~~~~-----------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      +..+....+...                   ....|           ..++.+++++|.+||..||.+|+|+.|+++|||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  288 (309)
T cd07872         209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY  288 (309)
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence            654443332210                   01111           246778899999999999999999999999999


Q ss_pred             cccc
Q psy6191         199 FNDY  202 (305)
Q Consensus       199 ~~~~  202 (305)
                      |+..
T Consensus       289 ~~~~  292 (309)
T cd07872         289 FRSL  292 (309)
T ss_pred             hhhc
Confidence            9864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=2.7e-30  Score=222.98  Aligned_cols=198  Identities=24%  Similarity=0.381  Sum_probs=151.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++||||+++++.+.+++.+|+||||++||+|.+++.....+   .+.... .+..+..++.+.|..++.+.
T Consensus        49 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~---~~~~~~~~~~~i~~~l~~lH~~~i~H~  125 (305)
T cd05609          49 FVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGAL---PVDMARMYFAETVLALEYLHNYGIVHR  125 (305)
T ss_pred             HHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            37999999999999999999999999999999999999999998765433   222222 22334567788887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHh-------------------cCCcccccCCCcccccccccCCCCccchHHHHHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML-------------------ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCI  134 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~-------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvi  134 (305)
                             +.+..+.+++.|++.....                   .......|++.|+|||.+.+..++.++|+||+||+
T Consensus       126 dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~v  205 (305)
T cd05609         126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGII  205 (305)
T ss_pred             CCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHH
Confidence                   2233455667776533210                   00123468899999999988889999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHhccccCCCC---CCCHHHHHHHHHHhhcCCCCCCC---HhhhhcCcccccc
Q psy6191         135 MYTLLVGKPPFETSTLKETYSRIKKVEYKLPA---TLKKPAATMIKKMLLLDPVQRPP---VAQLLHFEFFNDY  202 (305)
Q Consensus       135 lye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~dp~~R~~---~~~~l~~~~~~~~  202 (305)
                      +|||++|..||.+.+..+....+.......|.   ..+.++.++|.+||..||.+||+   +.+++.||||...
T Consensus       206 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         206 LYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            99999999999988877777766655433333   46788999999999999999998   7899999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=1.8e-30  Score=218.20  Aligned_cols=196  Identities=22%  Similarity=0.368  Sum_probs=148.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.++..+|+||||+++++|.+++......  ...... ..+..+..++.++|..++.+.
T Consensus        46 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~--l~~~~~~~~~~~l~~~l~~lh~~~i~H~  123 (256)
T cd06612          46 IKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLHSNKKIHR  123 (256)
T ss_pred             HHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccC--CCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            57999999999999999999999999999999999999999998653321  111111 223345667788887665432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++.......    .....|++.|+|||++.+..++.++||||+||++|+|++|+.||...+
T Consensus       124 dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~  203 (256)
T cd06612         124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH  203 (256)
T ss_pred             CCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence                   222344567777765444322    223468999999999988889999999999999999999999998766


Q ss_pred             HHHHHHHHhccc---cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRIKKVE---YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      .......+....   ...+...+..+.++|.+||+.||.+|||+.+++.||||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         204 PMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            555443333221   22344567889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=1.5e-30  Score=230.01  Aligned_cols=195  Identities=20%  Similarity=0.337  Sum_probs=141.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+.+++.++||||+++++++...      ..+|+||||+++ +|.+.+...  +   ..... ..+.++..++.+.|.
T Consensus        71 ~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~---~~~~~~~~~~qi~~aL~~LH~  144 (364)
T cd07875          71 YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--L---DHERMSYLLYQMLCGIKHLHS  144 (364)
T ss_pred             HHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHhc--C---CHHHHHHHHHHHHHHHHHHhh
Confidence            3799999999999999999988643      458999999976 566666432  1   11111 223345677888887


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .++.|.       +.+....+++.||+.......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.|
T Consensus       145 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p  224 (364)
T cd07875         145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL  224 (364)
T ss_pred             CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCC
Confidence            775443       233345677888865543222   2345799999999999988899999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc----------------------cC--------------C------CCCCCHHHHHHHHHHhhc
Q psy6191         145 FETSTLKETYSRIKKVE----------------------YK--------------L------PATLKKPAATMIKKMLLL  182 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~----------------------~~--------------~------~~~~~~~~~~li~~~l~~  182 (305)
                      |.+.+..+.+..+....                      +.              .      +...+..++++|.+||+.
T Consensus       225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  304 (364)
T cd07875         225 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI  304 (364)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCc
Confidence            98877655544432110                      00              0      011245688999999999


Q ss_pred             CCCCCCCHhhhhcCcccccc
Q psy6191         183 DPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       183 dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||.+|||+.++++||||+.+
T Consensus       305 dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         305 DASKRISVDEALQHPYINVW  324 (364)
T ss_pred             CcccCCCHHHHhcCcccccc
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=7.9e-31  Score=228.82  Aligned_cols=198  Identities=21%  Similarity=0.422  Sum_probs=150.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++++++.+|||||||+||+|.+++......  +.+..... +..+..++.+.|..++.|.
T Consensus        49 ~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~--l~~~~~~~~~~qi~~~L~~lH~~~iiHr  126 (331)
T cd05624          49 REERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYIAEMVLAIHSIHQLHYVHR  126 (331)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            46889999999999999999999999999999999999999998763211  12222222 2345677888887776543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCccccccccc-----CCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNK-----NGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                             +.+..+.+++.||+.......     ....+||+.|||||++.+     +.++.++||||+||++|+|++|+.
T Consensus       127 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~  206 (331)
T cd05624         127 DIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET  206 (331)
T ss_pred             cCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCC
Confidence                   233445678888875433222     123579999999999865     457889999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccc--cCCCC---CCCHHHHHHHHHHhhcCCCC--CCCHhhhhcCccccc
Q psy6191         144 PFETSTLKETYSRIKKVE--YKLPA---TLKKPAATMIKKMLLLDPVQ--RPPVAQLLHFEFFND  201 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~--~~~~~---~~~~~~~~li~~~l~~dp~~--R~~~~~~l~~~~~~~  201 (305)
                      ||...+..+.+..+....  +.+|.   .++.+++++|.+||..++.+  |++++++++|+||..
T Consensus       207 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         207 PFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            999888877777765533  33343   35789999999999876554  468999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=2.1e-30  Score=222.25  Aligned_cols=200  Identities=20%  Similarity=0.296  Sum_probs=147.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++..++..|+||||++||+|..++.+....  +.... ...+..+..++.+.|..++.+.
T Consensus        57 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~  134 (292)
T cd06644          57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHSMKIIHR  134 (292)
T ss_pred             HHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhcCCeeec
Confidence            36899999999999999999999999999999999999998877543211  12221 2223345677788887665432


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccc-----cCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+.++.+++.|++.....    .......|++.|+|||++.     ...++.++||||+||++|+|++|.+|
T Consensus       135 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p  214 (292)
T cd06644         135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP  214 (292)
T ss_pred             CCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence                   2233455777777643221    1123456899999999884     33467789999999999999999999


Q ss_pred             CCCCCHHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         145 FETSTLKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      |...+..+....+.....   ..+...+.++.++|.+||..||++||+++++++||||....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         215 HHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             CccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            987766655555443322   23456778899999999999999999999999999997543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=3.3e-30  Score=217.86  Aligned_cols=198  Identities=23%  Similarity=0.379  Sum_probs=149.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++.+++++..|+||||++|++|.+++..........+... ..+..+..++.+.|..|+.+.
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~  126 (267)
T cd06610          47 RKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR  126 (267)
T ss_pred             HHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            5799999999999999999999999999999999999999999876432111122222 223345677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC--------cccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK--------NTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~--------~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.++...+++.|++....+...        ...+|++.|+|||++... .++.++|+||+||++|+|++|..|
T Consensus       127 ~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p  206 (267)
T cd06610         127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP  206 (267)
T ss_pred             CCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCC
Confidence                   2233456777787655443321        345799999999998766 688999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhcccc-CCC-----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         145 FETSTLKETYSRIKKVEY-KLP-----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~-~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      |...+..+....+..... .++     ..++....+++.+||..||++||++.+++.||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         207 YSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            988766555544433321 121     2456788999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-30  Score=217.35  Aligned_cols=194  Identities=24%  Similarity=0.373  Sum_probs=147.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHh-cCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSA-CDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++||||+++++++.+++.+|+||||+++++|.+++... ..+   .+... ..+..+..++.+.|..++.+
T Consensus        48 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l---~~~~~~~~~~ql~~~l~~lh~~~i~h  124 (262)
T cd06613          48 QQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL---SELQIAYVCRETLKGLAYLHETGKIH  124 (262)
T ss_pred             HHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCC---CHHHHHHHHHHHHHHHHHHHhCCcee
Confidence            47999999999999999999999999999999999999999988764 222   22222 22333567788888777544


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccC---CCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKN---GHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~---~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .       +.+..+.+++.|++......    ......|+..|+|||++.+.   .++.++|+||+||++|+|++|.+||
T Consensus       125 ~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~  204 (262)
T cd06613         125 RDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM  204 (262)
T ss_pred             cCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence            3       22344567778876443322    22356789999999998766   7888999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccccC-----CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         146 ETSTLKETYSRIKKVEYK-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      ...+..+....+....+.     .+...+.++.+++++||..||.+|||+.+++.|+|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         205 FDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             CCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            887665554444433222     12234677899999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=2.9e-30  Score=217.05  Aligned_cols=197  Identities=22%  Similarity=0.420  Sum_probs=148.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++.++++...|+||||+++++|.+++...... ...+. ....+..+.+++.+.|..++.+.
T Consensus        47 ~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~H~  125 (257)
T cd08225          47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV-LFSEDQILSWFVQISLGLKHIHDRKILHR  125 (257)
T ss_pred             HHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            47999999999999999999999999999999999999999988654321 11111 12223345677788887665332


Q ss_pred             --------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +.+.+..+++.|++........    ....|++.|+|||.+.+..++.++|+||+||++|+|++|..||...
T Consensus       126 dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         126 DIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             cCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                    2222233466676544333221    2346899999999998888899999999999999999999999887


Q ss_pred             CHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +..+....+.... ...++..+.++.++|.+||..+|++|||+.+++.||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         206 NLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             cHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            7666555444332 23445678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=2e-30  Score=221.88  Aligned_cols=195  Identities=19%  Similarity=0.306  Sum_probs=141.1

Q ss_pred             hHHHHHhcC---CCCCccceeEEEEc-----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhh
Q psy6191           3 QEIAIHRSL---KHRNVVGFHSFFED-----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSD   73 (305)
Q Consensus         3 ~Ei~il~~l---~HpnIV~l~~~~~~-----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   73 (305)
                      +|+++++.+   +||||+++++++.+     ...+|+||||+.+ +|.+++...... .+..... ..+..+..++.+.|
T Consensus        48 ~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH  125 (288)
T cd07863          48 REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPP-GLPAETIKDLMRQFLRGLDFLH  125 (288)
T ss_pred             HHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            578877766   79999999999865     3568999999985 888887653221 1222222 22334567888888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      ..|+.|.       +.+..+.+++.|++.......   .....||+.|+|||++.+..++.++||||+||++|+|++|.+
T Consensus       126 ~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~  205 (288)
T cd07863         126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP  205 (288)
T ss_pred             hCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCc
Confidence            8775442       223445677788765443322   234578999999999988889999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccc-----------c----------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         144 PFETSTLKETYSRIKKVE-----------Y----------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~-----------~----------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||.+.+.......+....           .                ...+.++..+.++|.+||+.||.+|||+.+++.|
T Consensus       206 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         206 LFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            998876655444432210           0                0112456778999999999999999999999999


Q ss_pred             ccc
Q psy6191         197 EFF  199 (305)
Q Consensus       197 ~~~  199 (305)
                      |||
T Consensus       286 p~f  288 (288)
T cd07863         286 PFF  288 (288)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=3.7e-30  Score=218.39  Aligned_cols=197  Identities=21%  Similarity=0.337  Sum_probs=144.1

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   73 (305)
                      .+|+.+++++ +||||+++++++.+.      ..+|+|||||++|+|.+++...... .+.+... ..+..+..++.++|
T Consensus        50 ~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~-~l~~~~~~~~~~qi~~~l~~LH  128 (272)
T cd06637          50 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLSHLH  128 (272)
T ss_pred             HHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            4789999998 799999999998753      5699999999999999998763221 1122212 22334567788888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccc-----cCCCCccchHHHHHHHHHH
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye  137 (305)
                      ..++.+.       +.+....+++.|++.....    ....+..||+.|+|||++.     +..++.++||||+||++||
T Consensus       129 ~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e  208 (272)
T cd06637         129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE  208 (272)
T ss_pred             HCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence            7775432       2334456778887654322    1234567999999999885     3357889999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhccc--cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         138 LLVGKPPFETSTLKETYSRIKKVE--YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      |++|..||...........+....  ...+...+..+.+++.+||..||.+|||+.+++.||||
T Consensus       209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         209 MAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            999999997765544443333221  11233567889999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=3.6e-30  Score=221.81  Aligned_cols=197  Identities=20%  Similarity=0.386  Sum_probs=144.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++..|+||||++ ++|.+.+......  ....... ....+.+++.+.|..++.+.
T Consensus        52 ~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~qi~~aL~~lH~~~i~H~  128 (301)
T cd07873          52 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNS--INMHNVKLFLFQLLRGLNYCHRRKVLHR  128 (301)
T ss_pred             HHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            369999999999999999999999999999999997 5888877653221  1122222 22345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.|++.......    .....||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.
T Consensus       129 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             CCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   233345677788765433211    1234679999999987654 5788999999999999999999999887


Q ss_pred             CHHHHHHHHhcc-------------------ccCCC-----------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         149 TLKETYSRIKKV-------------------EYKLP-----------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       149 ~~~~~~~~i~~~-------------------~~~~~-----------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      +..+....+...                   ....|           ..+++.++++|.+||..||.+|||++++++|||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~  288 (301)
T cd07873         209 TVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY  288 (301)
T ss_pred             CHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            765544332210                   01111           246778899999999999999999999999999


Q ss_pred             ccc
Q psy6191         199 FND  201 (305)
Q Consensus       199 ~~~  201 (305)
                      |..
T Consensus       289 f~~  291 (301)
T cd07873         289 FHC  291 (301)
T ss_pred             ccc
Confidence            975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.1e-30  Score=216.68  Aligned_cols=194  Identities=23%  Similarity=0.372  Sum_probs=148.6

Q ss_pred             HHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee------
Q psy6191           7 IHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ------   80 (305)
Q Consensus         7 il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------   80 (305)
                      +.+..+||||+++++++++++.+|+||||++||+|.+++.....+.+  ......+..+.+++.+.|..++.+.      
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~n  127 (260)
T cd05611          50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE--DWAKQYIAEVVLGVEDLHQRGIIHRDIKPEN  127 (260)
T ss_pred             HhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            34566899999999999999999999999999999999876543321  1122233445677888887765432      


Q ss_pred             -ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy6191          81 -LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK  159 (305)
Q Consensus        81 -~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~  159 (305)
                       +.+....+++.|++............|++.|+|||.+.+..++.++||||+|+++|+|++|.+||...+..+....+..
T Consensus       128 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  207 (260)
T cd05611         128 LLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS  207 (260)
T ss_pred             eEECCCCcEEEeecccceeccccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence             2233455677777644443334567899999999999888889999999999999999999999998887777666654


Q ss_pred             cccCC----CCCCCHHHHHHHHHHhhcCCCCCCCH---hhhhcCcccccc
Q psy6191         160 VEYKL----PATLKKPAATMIKKMLLLDPVQRPPV---AQLLHFEFFNDY  202 (305)
Q Consensus       160 ~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~---~~~l~~~~~~~~  202 (305)
                      .....    +...+..+.+++.+||..||++||++   +|++.||||++.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence            43322    23568899999999999999999955   799999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=4.1e-30  Score=226.84  Aligned_cols=195  Identities=19%  Similarity=0.335  Sum_probs=140.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+.+++.++|||||++++++...+      .+|+||||+++ ++.+.+...  +   ..... ..+..+..++.++|.
T Consensus        68 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~---~~~~~~~~~~qi~~~L~~LH~  141 (359)
T cd07876          68 YRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHME--L---DHERMSYLLYQMLCGIKHLHS  141 (359)
T ss_pred             HHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhcc--C---CHHHHHHHHHHHHHHHHHHHh
Confidence            37999999999999999999987543      58999999986 455555321  1   11222 223345778888888


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .|+.|.       +.+.++.+++.||+.......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.|
T Consensus       142 ~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p  221 (359)
T cd07876         142 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVI  221 (359)
T ss_pred             CCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence            776543       233446677888865432211   2345799999999999988899999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhc----------------------cccCC--------------------CCCCCHHHHHHHHHHhhc
Q psy6191         145 FETSTLKETYSRIKK----------------------VEYKL--------------------PATLKKPAATMIKKMLLL  182 (305)
Q Consensus       145 f~~~~~~~~~~~i~~----------------------~~~~~--------------------~~~~~~~~~~li~~~l~~  182 (305)
                      |.+.+....+..+..                      .....                    +...+..+++||.+||..
T Consensus       222 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  301 (359)
T cd07876         222 FQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI  301 (359)
T ss_pred             CCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhcc
Confidence            987664433222111                      00000                    112356789999999999


Q ss_pred             CCCCCCCHhhhhcCcccccc
Q psy6191         183 DPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       183 dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||.+|||+.|+++|||++.+
T Consensus       302 dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         302 DPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             CcccCCCHHHHhcCchhhhh
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=2.5e-30  Score=235.66  Aligned_cols=198  Identities=19%  Similarity=0.333  Sum_probs=138.6

Q ss_pred             hHHHHHhcCCCC------CccceeEEEEcC-CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           3 QEIAIHRSLKHR------NVVGFHSFFEDS-KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         3 ~Ei~il~~l~Hp------nIV~l~~~~~~~-~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      +|+.++++++|+      +|++++++|+++ ..+|||||++ |++|.+++.....+.   .... ..+..+..++.|+|.
T Consensus       174 ~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~---~~~~~~i~~qi~~aL~yLH~  249 (467)
T PTZ00284        174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFS---HRHLAQIIFQTGVALDYFHT  249 (467)
T ss_pred             HHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHh
Confidence            577888777554      589999999865 5799999998 778888886654332   2222 233445677888885


Q ss_pred             -hCCcee--------ecCCCC---------------CeeEcchhHHHHh-cCCcccccCCCcccccccccCCCCccchHH
Q psy6191          75 -YGFGYQ--------LNDDSS---------------GVMFNDLTRMIML-ANKNTLCGTPNYIAPEILNKNGHSFEVDVW  129 (305)
Q Consensus        75 -~~~~~~--------~~~~~~---------------~v~~~d~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~Diw  129 (305)
                       .|+.|.        +.....               .+++.||+..... ......+||+.|||||++.+..|+.++|||
T Consensus       250 ~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw  329 (467)
T PTZ00284        250 ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMW  329 (467)
T ss_pred             cCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHH
Confidence             465432        211111               2566676643221 122457899999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCC------------------------------------------C
Q psy6191         130 SIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA------------------------------------------T  167 (305)
Q Consensus       130 SlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------------------------~  167 (305)
                      |+||++|||++|++||.+.+..+....+......+|.                                          .
T Consensus       330 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (467)
T PTZ00284        330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI  409 (467)
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhh
Confidence            9999999999999999887765544333221111000                                          0


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       168 ~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      .+..+.|||.+||++||.+|+|++|+|+||||....+
T Consensus       410 ~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        410 RDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             chHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence            1244679999999999999999999999999987544

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=1.9e-30  Score=219.55  Aligned_cols=197  Identities=20%  Similarity=0.357  Sum_probs=148.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++|||||++++++.+++..|+||||++|++|.+++.....+.+  ......+..+..++.++|+.++.+. 
T Consensus        51 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~ql~~al~~LH~~~i~H~~  128 (268)
T cd06630          51 RKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--AVIINYTEQLLRGLSYLHENQIIHRD  128 (268)
T ss_pred             HHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCH--HHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            4799999999999999999999999999999999999999999876543321  1112223445677888888776442 


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC--------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                             +...+..+++.|++.......        .+...||..|+|||++.+..++.++|+||+||++|+|++|..||
T Consensus       129 i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  208 (268)
T cd06630         129 VKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW  208 (268)
T ss_pred             CCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence                   222223467777754332221        12457899999999998888899999999999999999999999


Q ss_pred             CCCCHHHHHH---HH--hccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         146 ETSTLKETYS---RI--KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       146 ~~~~~~~~~~---~i--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      ...+......   .+  .......|...+.++.+++.+||..||.+||++.++++||||.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         209 NAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            7544322222   21  1223445667888999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=1.1e-30  Score=219.96  Aligned_cols=196  Identities=24%  Similarity=0.385  Sum_probs=152.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|++++++++||||+++++.++++..+|+||||++|++|.+.+.....+.+  ......+..+.+++.+.|..++.+. 
T Consensus        48 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~--~~~~~~~~~i~~~l~~lh~~~i~h~d  125 (258)
T cd05578          48 LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE--EQVKFWICEIVLALEYLHSKGIIHRD  125 (258)
T ss_pred             HHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCH--HHHHHHHHHHHHHHHHHHhCCeeccC
Confidence            4799999999999999999999999999999999999999999876533321  1122233445677888887765432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC--
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST--  149 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~--  149 (305)
                            +.+....+++.|++.......   .....|+..|+|||++.+..++.++|+||+|+++|+|++|..||...+  
T Consensus       126 l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  205 (258)
T cd05578         126 IKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT  205 (258)
T ss_pred             CCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence                  223345667777764443322   234678999999999988888999999999999999999999998766  


Q ss_pred             -HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH--hhhhcCccc
Q psy6191         150 -LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV--AQLLHFEFF  199 (305)
Q Consensus       150 -~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~--~~~l~~~~~  199 (305)
                       ...............|...+..+.++|.+||..||.+|+++  .+++.||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         206 IRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence             34444444435566777888999999999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=3e-30  Score=216.95  Aligned_cols=194  Identities=25%  Similarity=0.424  Sum_probs=148.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++++++.+|+||||+++|+|.+.+....... .... ....+..+..++.+.|+.++.+.
T Consensus        46 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~i~~al~~lH~~~i~H~  124 (255)
T cd08219          46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEKRVLHR  124 (255)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence            468999999999999999999999999999999999999999876432211 1111 12223445677888887765443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+.++.+++.|++.......    .....|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus       125 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  204 (255)
T cd08219         125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS  204 (255)
T ss_pred             CCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence                   223345566777765433322    124579999999999988889999999999999999999999999888


Q ss_pred             HHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         150 LKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       150 ~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .......+..... .+|...+..+.++|.+||..||.+||++.++++-
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         205 WKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            7776666655443 3566788899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=5.1e-30  Score=222.45  Aligned_cols=197  Identities=21%  Similarity=0.372  Sum_probs=136.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCC------CCCCcCch-hHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLE------EMSDPAAQ-PVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~~~   72 (305)
                      .+|++++++++|||||++++++.+  +..+|+||||+.+ +|.+++.......      .+...... .+.++..++.|+
T Consensus        46 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L  124 (317)
T cd07868          46 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL  124 (317)
T ss_pred             HHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH
Confidence            479999999999999999999854  5679999999864 7888775432111      11111122 233456788888


Q ss_pred             hhhCCcee--------ec---CCCCCeeEcchhHHHHhc-------CCcccccCCCccccccccc-CCCCccchHHHHHH
Q psy6191          73 DKYGFGYQ--------LN---DDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGC  133 (305)
Q Consensus        73 ~~~~~~~~--------~~---~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGv  133 (305)
                      |..++.|.        +.   +....+++.||+......       .....+||+.|+|||++.+ ..++.++||||+||
T Consensus       125 H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  204 (317)
T cd07868         125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC  204 (317)
T ss_pred             HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHH
Confidence            87775443        21   233467788886553322       1235689999999998876 45899999999999


Q ss_pred             HHHHHHhCCCCCCCCCH---------HHHHHHHhcc----------------------------ccC----------CCC
Q psy6191         134 IMYTLLVGKPPFETSTL---------KETYSRIKKV----------------------------EYK----------LPA  166 (305)
Q Consensus       134 ilye~l~g~~Pf~~~~~---------~~~~~~i~~~----------------------------~~~----------~~~  166 (305)
                      ++|+|++|++||.....         ......+...                            ...          ...
T Consensus       205 il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (317)
T cd07868         205 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV  284 (317)
T ss_pred             HHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCC
Confidence            99999999999965321         0111111000                            000          001


Q ss_pred             CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       167 ~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ..+..+.++|.+||+.||.+|+|++|+++||||
T Consensus       285 ~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         285 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            234568899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=1.6e-30  Score=230.47  Aligned_cols=197  Identities=22%  Similarity=0.327  Sum_probs=145.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC-----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK-----FVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   75 (305)
                      .+|+.+++.++|||||++++++++++     .+|+||||+. ++|.+.+.....+   ...... .+..+..++.+.|..
T Consensus        47 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l---~~~~~~~~~~qi~~aL~~LH~~  122 (372)
T cd07853          47 FRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPL---SSDHVKVFLYQILRGLKYLHSA  122 (372)
T ss_pred             HHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHHhC
Confidence            47999999999999999999998877     8999999997 5787777544332   222222 233456788888887


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~  142 (305)
                      ++.|.       +.+....+++.||+.......     .....||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus       123 ~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  202 (372)
T cd07853         123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR  202 (372)
T ss_pred             CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCC
Confidence            76443       233445677888764432211     1234689999999998764 4789999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhcc-----------------------c---------cCCCCCCCHHHHHHHHHHhhcCCCCCCCH
Q psy6191         143 PPFETSTLKETYSRIKKV-----------------------E---------YKLPATLKKPAATMIKKMLLLDPVQRPPV  190 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~-----------------------~---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~  190 (305)
                      +||.+.+.......+...                       .         +.+....+.++.+||.+||+.||.+|||+
T Consensus       203 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  282 (372)
T cd07853         203 ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA  282 (372)
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH
Confidence            999887765544433210                       0         01223457788999999999999999999


Q ss_pred             hhhhcCcccccc
Q psy6191         191 AQLLHFEFFNDY  202 (305)
Q Consensus       191 ~~~l~~~~~~~~  202 (305)
                      .++++||||...
T Consensus       283 ~e~l~hp~~~~~  294 (372)
T cd07853         283 ADALAHPYLDEG  294 (372)
T ss_pred             HHHhcCHhhCCC
Confidence            999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.6e-30  Score=235.18  Aligned_cols=201  Identities=23%  Similarity=0.356  Sum_probs=155.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC--------eEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK--------FVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDY   71 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~--------~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~   71 (305)
                      .+|+.++..++|||||++++.+...+        .+|+||||+++|+|.+++...... ..+.+... ..+..+..++.|
T Consensus        79 ~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~  158 (496)
T PTZ00283         79 QAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH  158 (496)
T ss_pred             HHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence            46899999999999999998876432        479999999999999988653221 11222222 223345678888


Q ss_pred             hhhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          72 SDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        72 ~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      .|..++.|.       +.+....+++.||+......      ...+.+||+.|||||++.+..++.++||||+||++|||
T Consensus       159 lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeL  238 (496)
T PTZ00283        159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYEL  238 (496)
T ss_pred             HHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence            887775443       23344667888887543221      12457899999999999988899999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         139 LVGKPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       139 l~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ++|+.||.+.+..+....+..... .+|...+.++.+++.+||..||.+||++.++++|||+...
T Consensus       239 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        239 LTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             HHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            999999999888777776655433 4677889999999999999999999999999999998753

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=6.4e-30  Score=218.36  Aligned_cols=197  Identities=21%  Similarity=0.310  Sum_probs=141.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++++++.+|+||||++ |+|.+++........+...... .+..+.+++.+.|..++.+.
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~  125 (285)
T cd07861          47 IREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR  125 (285)
T ss_pred             HHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            469999999999999999999999999999999998 5888887653321122222222 23445778888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.|++.......    .....|++.|+|||++.+. .++.++||||+||++|+|++|++||.+.
T Consensus       126 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             CCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                   223345677777764432211    1234678999999988654 5788999999999999999999999876


Q ss_pred             CHHHHHHHHhcc------------------c-----------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKV------------------E-----------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~------------------~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +.......+...                  .           ......++.++.++|++||..||.+|||+.+++.||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         206 SEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             CHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            543322211000                  0           00122467888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=5.7e-30  Score=218.90  Aligned_cols=202  Identities=23%  Similarity=0.331  Sum_probs=147.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhh-hCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDK-YGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~   79 (305)
                      .+|+.++++++|||||++++++..++.+|+|||||+|++|.+++........+.+.... ....+.+++.+.|. .++.|
T Consensus        47 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H  126 (286)
T cd06622          47 IMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH  126 (286)
T ss_pred             HHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEee
Confidence            36999999999999999999999999999999999999999888753211111222222 22234566777774 34432


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh--cCCcccccCCCcccccccccCC------CCccchHHHHHHHHHHHHhCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML--ANKNTLCGTPNYIAPEILNKNG------HSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~------~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .       +.+..+.+++.|++....+  ....+.+|++.|+|||++.+..      ++.++||||+||++|+|++|..|
T Consensus       127 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p  206 (286)
T cd06622         127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP  206 (286)
T ss_pred             CCCCHHHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCC
Confidence            2       2223456777777644332  1223457899999999985433      47889999999999999999999


Q ss_pred             CCCCCHHHHHHH---Hhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         145 FETSTLKETYSR---IKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       145 f~~~~~~~~~~~---i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      |...+.......   +.. ....+|...+.++.++|.+||..||.+||++++++.||||....
T Consensus       207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         207 YPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             CCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            977655443332   222 23455667889999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=3.7e-30  Score=219.09  Aligned_cols=196  Identities=23%  Similarity=0.336  Sum_probs=148.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++..|+||||++||+|.+++... .+   ..... ..+..+..++.+.|+.++.+.
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~l---~~~~~~~~~~~l~~~l~~lh~~~ivH~  125 (277)
T cd06640          50 QQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-PF---DEFQIATMLKEILKGLDYLHSEKKIHR  125 (277)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHhCCccCc
Confidence            47999999999999999999999999999999999999999988642 22   12111 222334566777777665332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++.......    .....||..|+|||++.+...+.++|+||+||++|||++|.+||...+
T Consensus       126 dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06640         126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH  205 (277)
T ss_pred             CCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence                   223334566777754433222    223468899999999988888999999999999999999999998776


Q ss_pred             HHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         150 LKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .......+... ...++...+.++.+++.+||..||.+||++.+++.|+|+..
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06640         206 PMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK  258 (277)
T ss_pred             hHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence            66554444322 23344456788899999999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=5.2e-30  Score=218.71  Aligned_cols=197  Identities=20%  Similarity=0.322  Sum_probs=142.8

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEE------cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFE------DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~------~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   73 (305)
                      .+|+.+++++ +||||+++++++.      ....+|+|||||++|+|.+++...... ...+... ..+..+..++.++|
T Consensus        60 ~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH  138 (282)
T cd06636          60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHLH  138 (282)
T ss_pred             HHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            4688888888 7999999999985      356899999999999999988653221 1122111 22234567788888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccc-----cCCCCccchHHHHHHHHHH
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye  137 (305)
                      ..++.+.       +.+..+.+++.|++......    .....+||+.|+|||++.     ...++.++||||+||++||
T Consensus       139 ~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~e  218 (282)
T cd06636         139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE  218 (282)
T ss_pred             HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHH
Confidence            7775433       22334567778876543321    234567999999999875     3457889999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhcccc-C-CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         138 LLVGKPPFETSTLKETYSRIKKVEY-K-LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      |++|..||......+....+..... . .+...+..+.++|++||..||.+||++.+++.||||
T Consensus       219 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         219 MAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            9999999977655444433332211 1 123467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=4.8e-30  Score=219.18  Aligned_cols=195  Identities=24%  Similarity=0.388  Sum_probs=142.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||++++++++++..+|+||||+++++|..+......+   .... ...+..+..++.+.|..++.+.
T Consensus        48 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~ql~~~l~~LH~~~i~H~  124 (286)
T cd07847          48 LREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV---PEHLIKKIIWQTLQAVNFCHKHNCIHR  124 (286)
T ss_pred             HHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCC---CHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            46999999999999999999999999999999999999888776543322   2222 2233345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC----cccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.|++....+...    ....|+..|+|||++.+ ..++.++||||+||++|+|++|.+||.+.
T Consensus       125 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~  204 (286)
T cd07847         125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK  204 (286)
T ss_pred             CCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence                   2233345677777654433222    24568899999999865 45788999999999999999999999876


Q ss_pred             CHHHHHHHHhcc---------------------ccCC----------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         149 TLKETYSRIKKV---------------------EYKL----------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       149 ~~~~~~~~i~~~---------------------~~~~----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      +..+....+...                     ..+.          -..++..+.+++.+||..||++||++.+++.||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         205 SDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             ChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence            654433322110                     0000          023567789999999999999999999999999


Q ss_pred             cc
Q psy6191         198 FF  199 (305)
Q Consensus       198 ~~  199 (305)
                      ||
T Consensus       285 ~f  286 (286)
T cd07847         285 YF  286 (286)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5.6e-30  Score=230.85  Aligned_cols=197  Identities=18%  Similarity=0.295  Sum_probs=140.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++|+|||||++++++..++..|+||||+. |+|.+++.....  .+.... ......+..++.|+|..|+.|.
T Consensus       208 ~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~gIvHr  284 (461)
T PHA03211        208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEGIIHR  284 (461)
T ss_pred             HHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEEC
Confidence            479999999999999999999999999999999995 688887754321  112222 2223345677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+....+++.||+....+..      ....+||+.|||||++.+..++.++|||||||++|||++|..|+..
T Consensus       285 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~  364 (461)
T PHA03211        285 DIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS  364 (461)
T ss_pred             cCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence                   233445677788765432211      1245799999999999988899999999999999999998766533


Q ss_pred             CC--------HHHHHHHHhcccc---CCC-------------------------------CCCCHHHHHHHHHHhhcCCC
Q psy6191         148 ST--------LKETYSRIKKVEY---KLP-------------------------------ATLKKPAATMIKKMLLLDPV  185 (305)
Q Consensus       148 ~~--------~~~~~~~i~~~~~---~~~-------------------------------~~~~~~~~~li~~~l~~dp~  185 (305)
                      ..        ...+...+.....   .++                               ..++.++.+||.+||+.||.
T Consensus       365 ~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~  444 (461)
T PHA03211        365 ASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGA  444 (461)
T ss_pred             CCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChh
Confidence            21        1222222222111   011                               02345788999999999999


Q ss_pred             CCCCHhhhhcCccccc
Q psy6191         186 QRPPVAQLLHFEFFND  201 (305)
Q Consensus       186 ~R~~~~~~l~~~~~~~  201 (305)
                      +|||+.|+|+||||+.
T Consensus       445 ~RPsa~elL~hp~f~~  460 (461)
T PHA03211        445 RRPSAAELLRLPLFQS  460 (461)
T ss_pred             hCcCHHHHhhCcccCC
Confidence            9999999999999974

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=4.1e-30  Score=220.48  Aligned_cols=198  Identities=21%  Similarity=0.396  Sum_probs=150.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.+++.++||||+++++.+..++..|+||||+++++|.+++... .+..  ......+..+..++.+.|..++.+. 
T Consensus        67 ~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~--~~~~~~~~qi~~~l~~LH~~~ivH~d  143 (292)
T cd06658          67 FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNE--EQIATVCLSVLRALSYLHNQGVIHRD  143 (292)
T ss_pred             HHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC-CCCH--HHHHHHHHHHHHHHHHHHHCCEeecC
Confidence            47999999999999999999999999999999999999999987542 2211  1122223345677888887765332 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+..+.+++.|++......    .....+||+.|+|||++.+..++.++|+||+||++|||++|..||...+.
T Consensus       144 lkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  223 (292)
T cd06658         144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP  223 (292)
T ss_pred             CCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                  22334567778876543321    22345799999999999888889999999999999999999999988776


Q ss_pred             HHHHHHHhccc---cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         151 KETYSRIKKVE---YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ......+....   .......+..+.+++.+||..||.+|||++++++||||...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         224 LQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            66555443321   11223467789999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=6e-30  Score=223.05  Aligned_cols=199  Identities=19%  Similarity=0.317  Sum_probs=139.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||+++++|++++..|+||||+.+|++.+++.+.... .+.+... ..+..+..++.|+|+.++.|.
T Consensus        47 ~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivHr  125 (328)
T cd08226          47 QNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNGYIHR  125 (328)
T ss_pred             HHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            57899999999999999999999999999999999999999988764321 1122222 223345677888887765433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----------CcccccCCCcccccccccC--CCCccchHHHHHHHHHHHHh
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlGvilye~l~  140 (305)
                             +.+..+.+++.|++.......           .....++..|||||++.+.  .++.++||||+||++|+|++
T Consensus       126 Dlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~  205 (328)
T cd08226         126 NIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT  205 (328)
T ss_pred             CCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh
Confidence                   112223444455432221111           0112356779999998764  47889999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhccccC-----------------------------------------------CCCCCCHHHH
Q psy6191         141 GKPPFETSTLKETYSRIKKVEYK-----------------------------------------------LPATLKKPAA  173 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~~~~-----------------------------------------------~~~~~~~~~~  173 (305)
                      |.+||......+...........                                               .+...+..+.
T Consensus       206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (328)
T cd08226         206 GRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ  285 (328)
T ss_pred             CCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHH
Confidence            99999876544433322211110                                               0112455688


Q ss_pred             HHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         174 TMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       174 ~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +|+++||+.||.+|||+.++++||||+.
T Consensus       286 ~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         286 NLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             HHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence            9999999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=1.2e-29  Score=216.78  Aligned_cols=199  Identities=22%  Similarity=0.393  Sum_probs=152.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.+++.++|||||++++++..++..|+||||++|++|.+++.. ..+.  .......+..+..++.+.|..++.+. 
T Consensus        64 ~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~--~~~~~~~~~ql~~~l~~lH~~~i~H~d  140 (285)
T cd06648          64 FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMN--EEQIATVCLAVLKALSFLHAQGVIHRD  140 (285)
T ss_pred             HHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCC--HHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            3699999999999999999999999999999999999999998875 2221  11112233445677788887775433 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+....+++.|++.......    .....|++.|+|||.+.+..++.++||||+||++|+|++|..||...+.
T Consensus       141 l~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~  220 (285)
T cd06648         141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP  220 (285)
T ss_pred             CChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH
Confidence                  223345567777764332221    2345799999999999888899999999999999999999999988877


Q ss_pred             HHHHHHHhccccCC---CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         151 KETYSRIKKVEYKL---PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       151 ~~~~~~i~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      .+....+.......   +...+..+.+++.+||..||.+||++.++++|+|++...
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         221 LQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence            76666665543221   223678899999999999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=4.6e-30  Score=217.23  Aligned_cols=194  Identities=22%  Similarity=0.350  Sum_probs=143.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++.+|+||||+++|+|.+++.....+   .+... .....+..++.+.|..++.+.
T Consensus        54 ~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~qi~~~l~~lH~~~i~H~  130 (267)
T cd06646          54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPL---SELQIAYVCRETLQGLAYLHSKGKMHR  130 (267)
T ss_pred             HHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            47999999999999999999999999999999999999999988654333   11111 222334667788887765443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                             +.+....+++.|++......    ......|++.|+|||.+.   ...++.++|+||+||++|||++|..||.
T Consensus       131 dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~  210 (267)
T cd06646         131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             CCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence                   22334557777876543321    123467999999999874   3446789999999999999999999997


Q ss_pred             CCCHHHHHHHHhccccCC-----CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         147 TSTLKETYSRIKKVEYKL-----PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      ..+..+....+....+..     +...+..+.++|++||..||++|||++++++|+|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         211 DLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            655443333332222221     1245788999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=8.9e-30  Score=216.88  Aligned_cols=196  Identities=19%  Similarity=0.269  Sum_probs=147.4

Q ss_pred             HHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee---
Q psy6191           5 IAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ---   80 (305)
Q Consensus         5 i~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---   80 (305)
                      +.+++..+||||+++++++.+++.+|+||||++||+|.+++.....+   ....+ ..+..+..++.++|+.++.+.   
T Consensus        48 ~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l---~~~~~~~~~~ql~~~l~~lH~~~i~H~di~  124 (278)
T cd05606          48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEAEMRFYAAEIILGLEHMHNRFVVYRDLK  124 (278)
T ss_pred             HHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCEEcCCCC
Confidence            34555678999999999999999999999999999999888654332   22222 223345677888887765332   


Q ss_pred             ----ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC---CH
Q psy6191          81 ----LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETS---TL  150 (305)
Q Consensus        81 ----~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~---~~  150 (305)
                          +.+....+++.|++....+.  ...+.+||+.|+|||++.++ .++.++||||+||++|+|++|+.||...   ..
T Consensus       125 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~  204 (278)
T cd05606         125 PANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK  204 (278)
T ss_pred             HHHEEECCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch
Confidence                22333456677776443222  22356899999999998744 6889999999999999999999999765   33


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccccC
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDYC  203 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~~  203 (305)
                      ......+......+|...+..+.+++.+||..||.+|+     ++.++++||||++..
T Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         205 HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            33334444455667777899999999999999999999     999999999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=4.4e-30  Score=220.86  Aligned_cols=199  Identities=20%  Similarity=0.350  Sum_probs=149.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++..++..|+||||++||+|.+++.... +   ... ....+..+..++.+.|..++.|.
T Consensus        64 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~---~~~~~~~~~~~l~~~L~~LH~~~i~H~  139 (297)
T cd06656          64 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-M---DEGQIAAVCRECLQALDFLHSNQVIHR  139 (297)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC-C---CHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            468999999999999999999999999999999999999999886432 1   111 11222334567888887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+.++.+++.|++.......    .....|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+
T Consensus       140 dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~  219 (297)
T cd06656         140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (297)
T ss_pred             CCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   233445677788764433221    224578999999999988888999999999999999999999998766


Q ss_pred             HHHHHHHHhc-c--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         150 LKETYSRIKK-V--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       150 ~~~~~~~i~~-~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      .......+.. .  ....|...+...++++.+||..||.+||++.+++.||||....+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         220 PLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             cchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            5433222221 1  11234567788999999999999999999999999999986433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=4.7e-30  Score=226.13  Aligned_cols=194  Identities=19%  Similarity=0.333  Sum_probs=140.6

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      +|+.+++.++|||||++++++...      ..+|+|||||++ ++.+.+...  +   ..... ..+..+..++.++|..
T Consensus        65 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l---~~~~~~~~~~qi~~aL~~LH~~  138 (355)
T cd07874          65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME--L---DHERMSYLLYQMLCGIKHLHSA  138 (355)
T ss_pred             HHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhhc--C---CHHHHHHHHHHHHHHHHHHHhC
Confidence            699999999999999999998654      358999999976 566655432  1   11111 2233456788888887


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      |+.|.       +.+....+++.||+.......   ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||
T Consensus       139 givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  218 (355)
T cd07874         139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_pred             CcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            76543       223345677888875543222   23467999999999999888999999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcc----------------------c-----cC---------------CCCCCCHHHHHHHHHHhhcC
Q psy6191         146 ETSTLKETYSRIKKV----------------------E-----YK---------------LPATLKKPAATMIKKMLLLD  183 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~----------------------~-----~~---------------~~~~~~~~~~~li~~~l~~d  183 (305)
                      .+.+..+.+..+...                      .     ..               .+...+..++++|.+||..|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d  298 (355)
T cd07874         219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID  298 (355)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCC
Confidence            887654433221110                      0     00               01123456789999999999


Q ss_pred             CCCCCCHhhhhcCcccccc
Q psy6191         184 PVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       184 p~~R~~~~~~l~~~~~~~~  202 (305)
                      |.+|||+.|+++||||+.+
T Consensus       299 P~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         299 PAKRISVDEALQHPYINVW  317 (355)
T ss_pred             chhcCCHHHHhcCcchhcc
Confidence            9999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.2e-30  Score=217.04  Aligned_cols=198  Identities=24%  Similarity=0.351  Sum_probs=142.3

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCch-hHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDL-EEMSDPAAQ-PVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~   72 (305)
                      .+|+.+++++ +||||+++++++.+..      .+|+||||+++++|.+++...... ..+...... .+..+..++.+.
T Consensus        50 ~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l  129 (275)
T cd06608          50 KEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL  129 (275)
T ss_pred             HHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            4799999998 7999999999997644      599999999999999988654311 111222222 223356778888


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCccccccccc-----CCCCccchHHHHHHHHH
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNK-----NGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlGvily  136 (305)
                      |..++.+.       +.+..+.+++.|++.....    .......||+.|+|||++..     ..++.++||||+||++|
T Consensus       130 H~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~  209 (275)
T cd06608         130 HENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAI  209 (275)
T ss_pred             hcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHH
Confidence            87775442       2223455667777543221    11234578999999998753     24677899999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         137 TLLVGKPPFETSTLKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       137 e~l~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +|++|.+||...+.......+.....   ..+...+..++++|.+||..||.+|||+.++++|||+
T Consensus       210 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         210 ELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            99999999987655554444443321   1122356788999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0658|consensus

Probab=99.97  E-value=1.9e-30  Score=215.45  Aligned_cols=200  Identities=23%  Similarity=0.408  Sum_probs=151.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCchhHHH-HHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDL-EEMSDPAAQPVIW-VSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~   74 (305)
                      .+|+.+|+.++|||||+|.-+|...     -++.+||||++. +|.+.++.-... ..+.....+.+.+ +..++.|.|.
T Consensus        65 nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~  143 (364)
T KOG0658|consen   65 NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS  143 (364)
T ss_pred             cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence            4899999999999999999988642     257789999986 788887742111 2234444444444 4567778877


Q ss_pred             hCCcee--------ecCCCCCeeEcchhHHHHhcCC---cccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCC
Q psy6191          75 YGFGYQ--------LNDDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        75 ~~~~~~--------~~~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~  142 (305)
                      .|+.|+        ++.+.+.++++||+.+..+...   .+.--|..|.|||++.+ ..|+.+.||||.|||+.||+-|+
T Consensus       144 ~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~  223 (364)
T KOG0658|consen  144 HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ  223 (364)
T ss_pred             cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC
Confidence            776543        4445567889999888776432   35567999999998765 56999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhcc------------c-----cC------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhh
Q psy6191         143 PPFETSTLKETYSRIKKV------------E-----YK------------LPATLKKPAATMIKKMLLLDPVQRPPVAQL  193 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~------------~-----~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~  193 (305)
                      +-|.+.+...++..|.+.            .     ..            +....++++.+|+.++|+++|.+|.++.|+
T Consensus       224 plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~  303 (364)
T KOG0658|consen  224 PLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA  303 (364)
T ss_pred             cccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH
Confidence            999998877666555321            0     11            123467889999999999999999999999


Q ss_pred             hcCcccccc
Q psy6191         194 LHFEFFNDY  202 (305)
Q Consensus       194 l~~~~~~~~  202 (305)
                      +.||||+..
T Consensus       304 l~h~fFdel  312 (364)
T KOG0658|consen  304 LAHPFFDEL  312 (364)
T ss_pred             hcchhhHHh
Confidence            999999863

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=8.8e-30  Score=215.49  Aligned_cols=196  Identities=22%  Similarity=0.404  Sum_probs=145.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++||||+++++++.+  +..+|+||||+++++|.+.+.....+..  .........+..++.+.|..++.|
T Consensus        52 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~--~~~~~~~~qi~~~l~~LH~~~i~H  129 (266)
T cd06651          52 ECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE--SVTRKYTRQILEGMSYLHSNMIVH  129 (266)
T ss_pred             HHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHhCCeee
Confidence            469999999999999999999876  4689999999999999998876443321  111122334567788888776543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .       +.+....+++.|++....+..       .....||..|+|||.+.+..++.++||||+||++|||++|+.||
T Consensus       130 ~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf  209 (266)
T cd06651         130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW  209 (266)
T ss_pred             CCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence            2       223345577777754332211       12346899999999998888899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         146 ETSTLKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       146 ~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      ...+..+....+..  ..+.+|...+..+++++ +||..||.+||+++++++||||+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         210 AEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             cccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            87665544433322  23445667788899999 56778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=5.9e-30  Score=215.93  Aligned_cols=197  Identities=27%  Similarity=0.463  Sum_probs=156.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++.+++++..|+||||+++|+|.+++.+...+   ..... ..+..+.+++.+.|..++.|.
T Consensus        41 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~qi~~~L~~lH~~~i~H~  117 (265)
T cd05579          41 LTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSL---DEDVARIYIAEIVLALEYLHSNGIIHR  117 (265)
T ss_pred             HHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHcCeecC
Confidence            46899999999999999999999999999999999999999998765432   22222 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g  141 (305)
                             +.+..+.+++.|++......            .....+|++.|+|||.+....++.++|+||+|+++|++++|
T Consensus       118 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g  197 (265)
T cd05579         118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG  197 (265)
T ss_pred             CCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence                   23344567777775433221            12245788999999999888888999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhccccCCCCCC--CHHHHHHHHHHhhcCCCCCCCH---hhhhcCccccc
Q psy6191         142 KPPFETSTLKETYSRIKKVEYKLPATL--KKPAATMIKKMLLLDPVQRPPV---AQLLHFEFFND  201 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~li~~~l~~dp~~R~~~---~~~l~~~~~~~  201 (305)
                      ..||...+..+....+.......|...  +..+.+++.+||+.||.+|||+   .++++||||++
T Consensus       198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         198 IPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             CCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            999998888887777776666666554  8899999999999999999999   99999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0608|consensus

Probab=99.97  E-value=1.3e-30  Score=229.28  Aligned_cols=197  Identities=28%  Similarity=0.386  Sum_probs=156.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHH-HHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVS-KWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   80 (305)
                      ..|-+||.+-+.+-||+||..|+|++.+|+||||++|||+..++-+.+-++   +..++.++..+ -+++..|+.|+.++
T Consensus       677 KAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFe---E~LARFYIAEltcAiesVHkmGFIHR  753 (1034)
T KOG0608|consen  677 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFE---EDLARFYIAELTCAIESVHKMGFIHR  753 (1034)
T ss_pred             hhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCH---HHHHHHHHHHHHHHHHHHHhccceec
Confidence            358899999999999999999999999999999999999999988776653   33445555443 35777777777554


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----------------------------------------------CCccccc
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----------------------------------------------NKNTLCG  107 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----------------------------------------------~~~~~~G  107 (305)
                             |.|..+.|++.||+....+-                                              .....+|
T Consensus       754 DiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvg  833 (1034)
T KOG0608|consen  754 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVG  833 (1034)
T ss_pred             ccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcC
Confidence                   44556788888885322110                                              0124589


Q ss_pred             CCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc----cCCCCCCCHHHHHHHHHHhhcC
Q psy6191         108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE----YKLPATLKKPAATMIKKMLLLD  183 (305)
Q Consensus       108 t~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~li~~~l~~d  183 (305)
                      |+.|+|||++...+|+..||+||.|||||||+.|++||...+..++..++.+..    +.....++.++.++|.+++ .+
T Consensus       834 t~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~s  912 (1034)
T KOG0608|consen  834 TPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CS  912 (1034)
T ss_pred             CCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cC
Confidence            999999999999999999999999999999999999999988888777766543    2334579999999999876 57


Q ss_pred             CCCCCC---HhhhhcCcccccc
Q psy6191         184 PVQRPP---VAQLLHFEFFNDY  202 (305)
Q Consensus       184 p~~R~~---~~~~l~~~~~~~~  202 (305)
                      ++.|..   ++|+..||||+..
T Consensus       913 ad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  913 ADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             hhhhhcccchhhhhcCcccccc
Confidence            888874   6789999999863

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=5.4e-30  Score=224.26  Aligned_cols=194  Identities=17%  Similarity=0.291  Sum_probs=140.6

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcC-CeEEEEEeccCCCCHHHHHHHhcCCC-C-------------------------
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDS-KFVYIILELCRKRSMMELYNSACDLE-E-------------------------   53 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~-~~~ylVmEy~~~g~L~~~~~~~~~~~-~-------------------------   53 (305)
                      .+|+.+++++ +|||||++++++.+. +.+|+|||||++|+|.+++....... .                         
T Consensus        58 ~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (338)
T cd05102          58 MSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRI  137 (338)
T ss_pred             HHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccc
Confidence            4799999999 899999999988764 46999999999999999887532100 0                         


Q ss_pred             ---------------------------------CCC-cCchhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcc
Q psy6191          54 ---------------------------------MSD-PAAQPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND   92 (305)
Q Consensus        54 ---------------------------------~~~-~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d   92 (305)
                                                       +.. ........++.++.|.|..++.|.       +.+....+++.|
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~D  217 (338)
T cd05102         138 EAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD  217 (338)
T ss_pred             ccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEee
Confidence                                             000 001122345677888888775443       223345677788


Q ss_pred             hhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHhc-cccC
Q psy6191          93 LTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETY-SRIKK-VEYK  163 (305)
Q Consensus        93 ~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~~~~-~~i~~-~~~~  163 (305)
                      |+......      ..++..||+.|||||++.+..++.++||||+||++|||++ |..||.+....+.+ ..+.. ....
T Consensus       218 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~  297 (338)
T cd05102         218 FGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR  297 (338)
T ss_pred             cccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC
Confidence            86543321      1223456788999999988889999999999999999997 99999875543332 33332 2334


Q ss_pred             CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         164 LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       164 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .|...+..+.+++.+||..||.+|||+.++++
T Consensus       298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         298 APENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            56678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=8.1e-30  Score=219.19  Aligned_cols=196  Identities=21%  Similarity=0.397  Sum_probs=151.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++..++..|+||||+++|+|.+++... .+   .... ...+..+..++.+.|..++.+.
T Consensus        66 ~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~---~~~~~~~~~~qi~~~L~~LH~~~ivH~  141 (297)
T cd06659          66 FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RL---NEEQIATVCESVLQALCYLHSQGVIHR  141 (297)
T ss_pred             HHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc-CC---CHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            47999999999999999999999999999999999999999877542 11   1111 1223345677888887765332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++......    .....+|++.|+|||++.+..++.++||||+||++|||++|..||...+
T Consensus       142 dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  221 (297)
T cd06659         142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS  221 (297)
T ss_pred             CCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                   22344567788887554332    1235679999999999988889999999999999999999999998877


Q ss_pred             HHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ..+....+.....   ..+...+..+.++|++||+.||.+||++.++++||||..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~  276 (297)
T cd06659         222 PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ  276 (297)
T ss_pred             HHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence            6666655544322   223356788999999999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=1.2e-29  Score=213.27  Aligned_cols=195  Identities=26%  Similarity=0.429  Sum_probs=148.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++.++..+|+||||+++++|.+++.+...+.   .... .....+.+++.+.|..++.+.
T Consensus        50 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---~~~~~~~~~~i~~~l~~lH~~~i~H~  126 (258)
T cd06632          50 EQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP---EPVIRLYTRQILLGLEYLHDRNTVHR  126 (258)
T ss_pred             HHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            479999999999999999999999999999999999999999987654321   1111 122335677788887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+....+++.|++.......   .....|++.|+|||.+.... ++.++|+||+||++|+|++|+.||....
T Consensus       127 dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             CCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence                   222345667777754332221   23567999999999987666 8899999999999999999999998766


Q ss_pred             HHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      .......+..  ....+|...+..+.+++.+||..||.+||++.+++.|||+
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         207 GVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            5444444333  2234566788999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=1.2e-29  Score=214.51  Aligned_cols=196  Identities=22%  Similarity=0.398  Sum_probs=145.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++||||+++++++.+  ...+|+||||++||+|.+++.+...+.+  .........+..++.+.|..++.+
T Consensus        52 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~l~~~l~~lH~~~i~H  129 (265)
T cd06652          52 ECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE--NVTRKYTRQILEGVSYLHSNMIVH  129 (265)
T ss_pred             HHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHhCCEec
Confidence            469999999999999999999876  3579999999999999998875433321  111222334566778888776533


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc-------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .       +.+....+++.|++....+.       ......||..|+|||.+.+..++.++||||+||++|+|++|+.||
T Consensus       130 ~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~  209 (265)
T cd06652         130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW  209 (265)
T ss_pred             CCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCC
Confidence            2       22334556777775433211       123457999999999998888899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         146 ETSTLKETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      ...+.......+...  ....|...+..+.++|++|+. +|.+||+++++++|||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         210 AEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            876555544444322  233456678889999999994 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=8.5e-30  Score=217.53  Aligned_cols=196  Identities=20%  Similarity=0.305  Sum_probs=140.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++..|+||||+. ++|.+++...... .+.... ...+..+..++.+.|..++.+.
T Consensus        47 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~i~H~  124 (284)
T cd07860          47 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLS-GIPLPLIKSYLFQLLQGLAFCHSHRVLHR  124 (284)
T ss_pred             HHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            469999999999999999999999999999999996 5788877643211 111111 1223345677888887765332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.|++....+..    .....|++.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.
T Consensus       125 ~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             CCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                   223345677777765433221    12345789999999886544 688899999999999999999999876


Q ss_pred             CHHHHHHHHhccc------------------c-----------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKVE------------------Y-----------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~~------------------~-----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +......++....                  .           ...+.++.+++++|.+||..||.+|||+++++.||||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         205 SEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             CHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            6544332221100                  0           0112467788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1.3e-29  Score=214.59  Aligned_cols=198  Identities=27%  Similarity=0.404  Sum_probs=144.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+||||+++++|.+.+............. ......+..++.+.|..++.+.
T Consensus        53 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~  132 (268)
T cd06624          53 HEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR  132 (268)
T ss_pred             HHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            479999999999999999999999999999999999999999887542210001111 1122345677888887765432


Q ss_pred             --------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC--CCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 --------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 --------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                              +..+...+++.|++.......    .....|++.|+|||++.+.  .++.++|+||+||++|+|++|++||.
T Consensus       133 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~  212 (268)
T cd06624         133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI  212 (268)
T ss_pred             CCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence                    222234566777754432211    1234689999999998654  37889999999999999999999997


Q ss_pred             CCCHH-HHHHH--HhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         147 TSTLK-ETYSR--IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       147 ~~~~~-~~~~~--i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ..... .....  .......+|...+.++++++.+||..+|.+|||+.+++.||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         213 ELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             cccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            54322 11111  1223345667788999999999999999999999999999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=1e-29  Score=217.13  Aligned_cols=196  Identities=21%  Similarity=0.309  Sum_probs=143.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.++...|+||||+ +++|.+++......  ....... .+..+..++.+.|..++.|.
T Consensus        47 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~  123 (286)
T cd07832          47 LREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERP--LPEAQVKSYMRMLLKGVAYMHANGIMHR  123 (286)
T ss_pred             HHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            47999999999999999999999999999999999 99999988653311  1222222 22345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+..+.+++.|++.......     .....||..|+|||++.+. .++.++||||+||++|+|++|.+||.+
T Consensus       124 dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             CcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence                   222345567777764443322     2245789999999988654 468899999999999999999999987


Q ss_pred             CCHHHHHHHHhccc-------------------cC-----------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         148 STLKETYSRIKKVE-------------------YK-----------LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       148 ~~~~~~~~~i~~~~-------------------~~-----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      .+..+.+..+....                   ..           ..+..+..+.++|.+||..||.+|||++++++||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         204 ENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             CCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            76555443332110                   00           0123467888999999999999999999999999


Q ss_pred             ccc
Q psy6191         198 FFN  200 (305)
Q Consensus       198 ~~~  200 (305)
                      ||.
T Consensus       284 ~~~  286 (286)
T cd07832         284 YFT  286 (286)
T ss_pred             CcC
Confidence            984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=4.1e-30  Score=222.73  Aligned_cols=200  Identities=23%  Similarity=0.339  Sum_probs=141.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|++||||++|+|.+++...... .+.+.. ...+..+.+++.++|..++.+.
T Consensus        47 ~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~ivH~  125 (314)
T cd08216          47 QQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSKGFIHR  125 (314)
T ss_pred             HHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            57999999999999999999999999999999999999999998754221 112222 2223345678888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-----------CCcccccCCCcccccccccC--CCCccchHHHHHHHHHHHHh
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-----------NKNTLCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-----------~~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlGvilye~l~  140 (305)
                             +.+..+.+++.|++......           ......++..|+|||++.+.  .++.++||||+||++|||++
T Consensus       126 dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~  205 (314)
T cd08216         126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN  205 (314)
T ss_pred             CCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh
Confidence                   12223445555554332111           11234678899999998753  58889999999999999999


Q ss_pred             CCCCCCCCCHHHH-HHHHhccc---------------------------------cCCCCCCCHHHHHHHHHHhhcCCCC
Q psy6191         141 GKPPFETSTLKET-YSRIKKVE---------------------------------YKLPATLKKPAATMIKKMLLLDPVQ  186 (305)
Q Consensus       141 g~~Pf~~~~~~~~-~~~i~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~dp~~  186 (305)
                      |..||........ ...+....                                 ...+..++.++.+++.+||..||++
T Consensus       206 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  285 (314)
T cd08216         206 GHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPES  285 (314)
T ss_pred             CCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCc
Confidence            9999986543332 22221100                                 0001123456789999999999999


Q ss_pred             CCCHhhhhcCcccccc
Q psy6191         187 RPPVAQLLHFEFFNDY  202 (305)
Q Consensus       187 R~~~~~~l~~~~~~~~  202 (305)
                      |||+.++++||||+..
T Consensus       286 Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         286 RPSASQLLNHSFFKQC  301 (314)
T ss_pred             CcCHHHHhcCchHhhh
Confidence            9999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1.6e-29  Score=216.20  Aligned_cols=201  Identities=23%  Similarity=0.426  Sum_probs=152.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhc-CCCCCCCcC-chhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSAC-DLEEMSDPA-AQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++||||+++++++..++..|+||||++|++|.+++.... .+   .... ...+..+..++.+.|+.|+.+
T Consensus        63 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l---~~~~~~~i~~~i~~~L~~lH~~gi~H  139 (286)
T cd06614          63 INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRM---NEPQIAYVCREVLQGLEYLHSQNVIH  139 (286)
T ss_pred             HHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCC---CHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            479999999999999999999999999999999999999999998754 22   2222 222334567788888777544


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.|++.......    .....|++.|+|||++.+..++.++|+||+||++|+|++|..||...
T Consensus       140 ~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~  219 (286)
T cd06614         140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE  219 (286)
T ss_pred             CCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence            3       122334566677754433222    13456889999999998888899999999999999999999999887


Q ss_pred             CHHHHHHHHhcccc-CC--CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCCC
Q psy6191         149 TLKETYSRIKKVEY-KL--PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPT  205 (305)
Q Consensus       149 ~~~~~~~~i~~~~~-~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~~  205 (305)
                      +.......+..... ..  +...+..+.++|.+||+.||.+||++.+++.|+||...+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  279 (286)
T cd06614         220 PPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK  279 (286)
T ss_pred             CHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence            66555444433221 11  22367889999999999999999999999999999875543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=1.3e-29  Score=216.39  Aligned_cols=195  Identities=15%  Similarity=0.233  Sum_probs=147.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC-------------CCCcC-chhHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-------------MSDPA-AQPVIWVSK   67 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~-------------~~~~~-~~~~~~~~~   67 (305)
                      .+|+.++++++||||+++++++.+.+..|+||||+++|+|.+++.......+             +.... ...+..+..
T Consensus        56 ~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  135 (283)
T cd05048          56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA  135 (283)
T ss_pred             HHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHH
Confidence            4799999999999999999999999999999999999999999876432211             00001 122334567


Q ss_pred             HHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHH
Q psy6191          68 WVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCI  134 (305)
Q Consensus        68 ~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvi  134 (305)
                      ++.++|..++.|.       +.+....+++.|++.......      .....+|+.|+|||.+.+..++.++||||+||+
T Consensus       136 al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~i  215 (283)
T cd05048         136 GMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV  215 (283)
T ss_pred             HHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHH
Confidence            7888887775443       222334566677654322111      123467889999999988889999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         135 MYTLLV-GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       135 lye~l~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +|||++ |..||.+.+..+....+.... ...|...+.++.+++.+||..||.+||++.+++++
T Consensus       216 l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         216 LWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999998 999999888877777765443 34466788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.2e-29  Score=213.83  Aligned_cols=191  Identities=15%  Similarity=0.210  Sum_probs=140.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++.+++..|+|||||++|+|.+++......  +.... ......+..++.|.|+.++.|.
T Consensus        47 ~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~iiH~  124 (258)
T cd05078          47 FEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL--INISWKLEVAKQLAWALHFLEDKGLTHG  124 (258)
T ss_pred             HHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            36889999999999999999999999999999999999999998754321  11111 1223445677888888775443


Q ss_pred             ecC--------CCC-------CeeEcchhHHHHhcCCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhC-CC
Q psy6191          81 LND--------DSS-------GVMFNDLTRMIMLANKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVG-KP  143 (305)
Q Consensus        81 ~~~--------~~~-------~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g-~~  143 (305)
                      -..        ++.       .+++.|++............||+.|+|||++.+ ..++.++||||+||++|+|++| .+
T Consensus       125 dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~  204 (258)
T cd05078         125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK  204 (258)
T ss_pred             CCccceEEEecccccccCCCceEEecccccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            111        111       134455544333334445689999999999876 4578899999999999999998 57


Q ss_pred             CCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         144 PFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||...+...... +......+|...+.++.+++.+||+.||.+|||++++++
T Consensus       205 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  255 (258)
T cd05078         205 PLSALDSQKKLQ-FYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIR  255 (258)
T ss_pred             ChhhccHHHHHH-HHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            776655544332 233345667777888999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=2.1e-29  Score=215.94  Aligned_cols=199  Identities=26%  Similarity=0.344  Sum_probs=143.8

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~   73 (305)
                      .+|+.+++++ +||||+++++++.+.     +..|+||||++||+|.++++..... ....+... ..+..+..++.+.|
T Consensus        66 ~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH  145 (291)
T cd06639          66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH  145 (291)
T ss_pred             HHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4689999998 899999999998754     4689999999999999988643211 11122222 22334567788888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccC-----CCCccchHHHHHHHHHH
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKN-----GHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DiwSlGvilye  137 (305)
                      ..++.+.       +.+....+++.|++......    .....+|++.|+|||++...     .++.++||||+||++||
T Consensus       146 ~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~e  225 (291)
T cd06639         146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE  225 (291)
T ss_pred             hCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHH
Confidence            7765432       22334557777776544322    12345789999999998543     25789999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         138 LLVGKPPFETSTLKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      |++|++||...+..+....+.....   ..+...+..+.++|.+||..||++||++.++++||||+
T Consensus       226 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         226 LGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            9999999987766555444433321   22445667889999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.97  E-value=1.4e-29  Score=214.37  Aligned_cols=192  Identities=14%  Similarity=0.203  Sum_probs=141.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+||||||+++|+|.+++.....  .+.... ......+..++.+.|+.++.|.
T Consensus        54 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~iiH~  131 (266)
T cd05064          54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMGYVHK  131 (266)
T ss_pred             HHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            4799999999999999999999999999999999999999998865321  112211 1223345677888887765332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+.+..+++.|++.......     .....+|+.|+|||++.+..++.++||||+||++||+++ |..||.+
T Consensus       132 dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~  211 (266)
T cd05064         132 GLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             cccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence                   112223445555542221111     112345678999999988889999999999999999775 9999998


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ..+.|...+..+.+++.+||+.||.+||+++++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         212 MSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            8777766666543 33456678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=1.2e-29  Score=216.20  Aligned_cols=194  Identities=20%  Similarity=0.268  Sum_probs=144.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+||||+++|+|.....    +   .+.. ...+..+..++.+.|+.++.+.
T Consensus        47 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~---~~~~~~~~~~qi~~~l~~lH~~~i~H~  119 (279)
T cd06619          47 MSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRK----I---PEHVLGRIAVAVVKGLTYLWSLKILHR  119 (279)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhhc----C---CHHHHHHHHHHHHHHHHHHHHCCEeeC
Confidence            369999999999999999999999999999999999999865421    1   1111 1223345677888888776442


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL-  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~-  150 (305)
                             +.+..+.+++.|++....+.  .....+||+.|+|||++.+..++.++|+||+||++|+|++|..||..... 
T Consensus       120 dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~  199 (279)
T cd06619         120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN  199 (279)
T ss_pred             CCCHHHEEECCCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccc
Confidence                   23344567778876543322  23456899999999999988899999999999999999999999965221 


Q ss_pred             ------HHHHHHHhcc-ccCC-CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         151 ------KETYSRIKKV-EYKL-PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ------~~~~~~i~~~-~~~~-~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                            .+....+... .... ....+.++.+++.+||..||.+||++++++.||||...
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         200 QGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             ccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence                  1222222211 1122 23467889999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=4.3e-30  Score=218.69  Aligned_cols=197  Identities=24%  Similarity=0.365  Sum_probs=147.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+|||||++|+|.+++... .+   .+... ..+..+..++.+.|..++.+.
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~---~~~~~~~~~~~i~~~l~~lH~~~ivH~  125 (277)
T cd06642          50 QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-PL---EETYIATILREILKGLDYLHSERKIHR  125 (277)
T ss_pred             HHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC-CC---CHHHHHHHHHHHHHHHHHHhcCCeecc
Confidence            57999999999999999999999999999999999999999887532 11   22211 222334667788887665432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++....+..    .....|+..|+|||.+.+..++.++|+||+||++|||++|+.||....
T Consensus       126 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06642         126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH  205 (277)
T ss_pred             CCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence                   122334566667654433222    123568999999999988888999999999999999999999998765


Q ss_pred             HHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .......+... ...++...+.++.++|.+||..+|.+||++.++++|||+...
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         206 PMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             hhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            55544433322 223444577889999999999999999999999999999754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=7.1e-30  Score=218.03  Aligned_cols=195  Identities=19%  Similarity=0.347  Sum_probs=139.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++.+|+|||||++ +|.+.+......  +..... ..+..+.+++.+.|..++.+.
T Consensus        47 ~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~~i~H~  123 (284)
T cd07839          47 LREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSHNVLHR  123 (284)
T ss_pred             hHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            3699999999999999999999999999999999974 777776543211  122222 223345678888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCC-CC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPF-ET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf-~~  147 (305)
                             +.+..+.+++.|++.......    .....||+.|+|||++.+. .++.++||||+||++|+|++|..|| .+
T Consensus       124 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~  203 (284)
T cd07839         124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  203 (284)
T ss_pred             CCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence                   223345677888765543221    1234678999999988664 4788999999999999999998875 44


Q ss_pred             CCHHHHHHHHhcc----------------c----c---------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         148 STLKETYSRIKKV----------------E----Y---------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       148 ~~~~~~~~~i~~~----------------~----~---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      .+..+.+..+...                .    .         ...+.++.+++++|.+||..||.+|||+++++.|||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         204 NDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             CCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence            4433333322110                0    0         011246788899999999999999999999999999


Q ss_pred             c
Q psy6191         199 F  199 (305)
Q Consensus       199 ~  199 (305)
                      |
T Consensus       284 f  284 (284)
T cd07839         284 F  284 (284)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0986|consensus

Probab=99.97  E-value=2.5e-30  Score=219.65  Aligned_cols=198  Identities=20%  Similarity=0.316  Sum_probs=153.2

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCC----
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGF----   77 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----   77 (305)
                      +|-.|+.+++.|+||.|-.+|++.+.+++||..|.||||.-.+-+.+.. ...+..+..+.. +.-++.|.|...+    
T Consensus       234 nEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~-gF~e~ra~FYAAEi~cGLehlH~~~iVYRD  312 (591)
T KOG0986|consen  234 NEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNP-GFDEQRARFYAAEIICGLEHLHRRRIVYRD  312 (591)
T ss_pred             HHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCC-CCchHHHHHHHHHHHhhHHHHHhcceeecc
Confidence            6889999999999999999999999999999999999998777655531 112222222211 1223445553332    


Q ss_pred             ----ceeecCCCCCeeEcchhHHHHhcCCc---ccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC-
Q psy6191          78 ----GYQLNDDSSGVMFNDLTRMIMLANKN---TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST-  149 (305)
Q Consensus        78 ----~~~~~~~~~~v~~~d~~~~~~~~~~~---~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~-  149 (305)
                          |+ +.|+.++|.+.|++.+..+....   .-+||.+|||||++.++.|+.++|+||+||++|||+.|+.||.... 
T Consensus       313 LKPeNI-LLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  313 LKPENI-LLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             CChhhe-eeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence                33 34445788888887665544332   3389999999999999999999999999999999999999997543 


Q ss_pred             ---HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCcccccc
Q psy6191         150 ---LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFNDY  202 (305)
Q Consensus       150 ---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~~  202 (305)
                         ..+.-.++......+|..+|++++++.+.+|.+||.+|..     ++++.+||||++.
T Consensus       392 Kvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  392 KVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             hhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence               3356667777778889999999999999999999999984     6789999999873

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=1.3e-29  Score=214.23  Aligned_cols=199  Identities=23%  Similarity=0.359  Sum_probs=148.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhh-hCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDK-YGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~   79 (305)
                      .+|++++++++||||+++++++.+++..|+||||+++++|.+++.....  ...... ...+..+..++.+.|. .++.+
T Consensus        47 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~i~H  124 (265)
T cd06605          47 LRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG--RIPERILGKIAVAVLKGLTYLHEKHKIIH  124 (265)
T ss_pred             HHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHcCCCCeec
Confidence            4799999999999999999999999999999999999999999876421  111111 1223345677788887 66533


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC--CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC--
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS--  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~--  148 (305)
                      .       +.+..+.+++.|++.......  .....|++.|+|||.+.+..++.++||||+||++|+|++|..||...  
T Consensus       125 ~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  204 (265)
T cd06605         125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND  204 (265)
T ss_pred             CCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Confidence            2       223345677777754332211  12367999999999998888999999999999999999999999754  


Q ss_pred             ---CHHHHHHHHhcc-ccCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         149 ---TLKETYSRIKKV-EYKLPAT-LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ---~~~~~~~~i~~~-~~~~~~~-~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                         ...+....+... ....+.. .+.++.++|.+||..||.+|||+.+++.||||+.+
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         205 PPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             ccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence               233333333322 2233444 78889999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=2.9e-29  Score=211.73  Aligned_cols=198  Identities=26%  Similarity=0.451  Sum_probs=149.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhh----
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSD----   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~----   73 (305)
                      .+|++++++++||||+++++++.+  +..+|+||||+++|+|.+++...... ..+..... ..+..+.+++.+.|    
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~  126 (265)
T cd08217          47 VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD  126 (265)
T ss_pred             HHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcc
Confidence            368999999999999999998764  45789999999999999998754211 11122222 22233566777887    


Q ss_pred             -hhCCcee-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhC
Q psy6191          74 -KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        74 -~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g  141 (305)
                       +.++.+.       +.+..+.+++.|++.......    ..+..|++.|+|||++.+..++.++|+||+||++|+|++|
T Consensus       127 ~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g  206 (265)
T cd08217         127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL  206 (265)
T ss_pred             ccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHC
Confidence             5444332       223345667777765444332    2245799999999999888889999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         142 KPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ..||...+..+....+..... .+|...+..+.+++.+||..||.+||++.++++|||+
T Consensus       207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         207 SPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             CCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999998876666666655443 4566788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=9.4e-30  Score=223.20  Aligned_cols=195  Identities=26%  Similarity=0.415  Sum_probs=141.7

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhh
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKY   75 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   75 (305)
                      +|+.++++++|||||++++++.+.      ...|++||++ +++|.+++... .+   ...... .+.++..++.|+|..
T Consensus        63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~-~l---~~~~~~~i~~qi~~aL~~LH~~  137 (343)
T cd07878          63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ-KL---SDEHVQFLIYQLLRGLKYIHSA  137 (343)
T ss_pred             HHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHHC
Confidence            699999999999999999988643      4589999998 78888876532 22   222222 233456788888887


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhc-CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      ++.|.       +.+....+++.||+...... ...+.+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus       138 ~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  217 (343)
T cd07878         138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP  217 (343)
T ss_pred             CeecccCChhhEEECCCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            76443       22334567777876544322 2235689999999999876 568899999999999999999999998


Q ss_pred             CCCHHHHHHHHhccc-----------------------cCCC--------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKVE-----------------------YKLP--------ATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~-----------------------~~~~--------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +.+..+....+....                       ...+        ...++.+.+||.+||..||.+|||+.|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            766544433332110                       0001        124556789999999999999999999999


Q ss_pred             Ccccccc
Q psy6191         196 FEFFNDY  202 (305)
Q Consensus       196 ~~~~~~~  202 (305)
                      ||||...
T Consensus       298 hp~~~~~  304 (343)
T cd07878         298 HPYFSQY  304 (343)
T ss_pred             Ccchhcc
Confidence            9999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.2e-29  Score=223.48  Aligned_cols=197  Identities=18%  Similarity=0.290  Sum_probs=137.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+||||+. |+|.+++......  +..... ..+..+..++.|.|..++.|.
T Consensus       105 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivHr  181 (357)
T PHA03209        105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRP--LPIDQALIIEKQILEGLRYLHAQRIIHR  181 (357)
T ss_pred             HHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            369999999999999999999999999999999996 5788877543221  122222 223345677888887775442


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P-f~~~~  149 (305)
                             +.+....+++.||+......   ...+..||+.|+|||++.+..++.++||||+||++|||+++..| |....
T Consensus       182 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~  261 (357)
T PHA03209        182 DVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP  261 (357)
T ss_pred             CCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCC
Confidence                   22334567778876543221   12346799999999999988899999999999999999986544 44321


Q ss_pred             HH---------HHHHHH-hcc---ccCCC------------------------------CCCCHHHHHHHHHHhhcCCCC
Q psy6191         150 LK---------ETYSRI-KKV---EYKLP------------------------------ATLKKPAATMIKKMLLLDPVQ  186 (305)
Q Consensus       150 ~~---------~~~~~i-~~~---~~~~~------------------------------~~~~~~~~~li~~~l~~dp~~  186 (305)
                      ..         ..+..+ ...   ...+|                              ...+.++.++|.+||+.||.+
T Consensus       262 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~  341 (357)
T PHA03209        262 STPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAM  341 (357)
T ss_pred             CcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCccc
Confidence            10         011111 100   00111                              123556778999999999999


Q ss_pred             CCCHhhhhcCccccc
Q psy6191         187 RPPVAQLLHFEFFND  201 (305)
Q Consensus       187 R~~~~~~l~~~~~~~  201 (305)
                      |||+.|+++||||++
T Consensus       342 Rpta~e~l~hp~f~~  356 (357)
T PHA03209        342 RPSAEEILNYPMFAQ  356 (357)
T ss_pred             CcCHHHHhcCchhcc
Confidence            999999999999974

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-29  Score=212.18  Aligned_cols=196  Identities=29%  Similarity=0.500  Sum_probs=155.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++||||+++++.+++++.+|+||||+++++|.+++.....+.+  ......+..+.+++.+.|+.++.+. 
T Consensus        41 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~--~~~~~~~~qi~~~l~~lh~~~~~H~~  118 (250)
T cd05123          41 LTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARFYAAEIVLALEYLHSLGIIYRD  118 (250)
T ss_pred             HHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCCceecC
Confidence            4689999999999999999999999999999999999999999876543321  1112223345677788887665432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+....+++.|++.......    .....|+..|+|||.+.+...+.++|+||+|+++|++++|..||...+.
T Consensus       119 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~  198 (250)
T cd05123         119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR  198 (250)
T ss_pred             CCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence                  222334566666654433221    2345789999999999888888899999999999999999999988877


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH---hhhhcCccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV---AQLLHFEFF  199 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~---~~~l~~~~~  199 (305)
                      .+....+......+|...+....+++++||..||.+||++   ++++.||||
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         199 KEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            7777777767777888889999999999999999999999   999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=2.8e-29  Score=214.49  Aligned_cols=197  Identities=21%  Similarity=0.336  Sum_probs=142.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhh-hCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDK-YGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~   79 (305)
                      .+|+++++.++||||+++++++.+...+|+||||+++|+|.+++.....+   ....... ...+..++.+.|. .++.+
T Consensus        51 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~i~~~l~~LH~~~~i~H  127 (284)
T cd06620          51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPI---PVEILGKIAVAVVEGLTYLYNVHRIMH  127 (284)
T ss_pred             HHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCC---CHHHHHHHHHHHHHHHHHHHHhcCeec
Confidence            47999999999999999999999999999999999999999988764332   1112212 2233455666664 33322


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh--cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML--ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                      .       +.+.+..+++.|++.....  ......+||..|+|||++.+..++.++||||+||++|+|++|..||...+.
T Consensus       128 ~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             cCCCHHHEEECCCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence            1       2233455677777543222  122356899999999999888889999999999999999999999986543


Q ss_pred             H-----------HHHHHHhcc-ccCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         151 K-----------ETYSRIKKV-EYKLPAT-LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       151 ~-----------~~~~~i~~~-~~~~~~~-~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .           +....+... ...++.. .+..+.+++.+||..||.+|||+.++++|+||..
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         208 DDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             hhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            1           222222221 2223332 6678999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=1.9e-29  Score=214.76  Aligned_cols=197  Identities=23%  Similarity=0.354  Sum_probs=149.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+||||+++|+|.+++... .+   .... ...+..+..++.+.|..++.+.
T Consensus        50 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~-~~---~~~~~~~~~~~l~~~l~~lh~~~i~h~  125 (277)
T cd06641          50 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PL---DETQIATILREILKGLDYLHSEKKIHR  125 (277)
T ss_pred             HHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHccCCeecC
Confidence            47999999999999999999999999999999999999999988642 11   1111 1222334566777777665432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++....+..    .....|+..|+|||.+.+...+.++|+||+||++|+|++|..||...+
T Consensus       126 dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  205 (277)
T cd06641         126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH  205 (277)
T ss_pred             CCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence                   222334566667654322211    234578999999999988888889999999999999999999998776


Q ss_pred             HHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .......+... ...++...+.++.+++.+||..||.+||++.++++||||...
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         206 PMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             hHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            65555544333 233455678899999999999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG1026|consensus

Probab=99.96  E-value=1e-29  Score=231.23  Aligned_cols=194  Identities=16%  Similarity=0.290  Sum_probs=149.7

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCC----C----cCc----hhHHHHHHH
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS----D----PAA----QPVIWVSKW   68 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~----~----~~~----~~~~~~~~~   68 (305)
                      +.||+++|..|+|||||+|+|++..++.+|||+|||..|||.+++..........    +    ...    ....+++.+
T Consensus       536 F~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaG  615 (774)
T KOG1026|consen  536 FRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAG  615 (774)
T ss_pred             HHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHH
Confidence            3699999999999999999999999999999999999999999998765432211    1    111    112233455


Q ss_pred             HHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcCCc--cccc----CCCcccccccccCCCCccchHHHHHHHH
Q psy6191          69 VDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKN--TLCG----TPNYIAPEILNKNGHSFEVDVWSIGCIM  135 (305)
Q Consensus        69 ~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~~~--~~~G----t~~y~aPE~~~~~~~~~~~DiwSlGvil  135 (305)
                      ..|+....+.|+       +......|++.||+.........  .+-|    -..||+||.+..+.++++|||||+||+|
T Consensus       616 M~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvL  695 (774)
T KOG1026|consen  616 MEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVL  695 (774)
T ss_pred             HHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhh
Confidence            566554444333       23344678888887554432221  1111    2469999999999999999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         136 YTLLV-GKPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       136 ye~l~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      +|+++ |..||.+-+..+.+..|..+.. ..|...+.+..+|+..||..+|.+||++.||-
T Consensus       696 WEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  696 WEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             hhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            99998 9999999999999999987654 56788999999999999999999999999984

>KOG1989|consensus

Probab=99.96  E-value=3.1e-30  Score=235.36  Aligned_cols=189  Identities=23%  Similarity=0.379  Sum_probs=139.5

Q ss_pred             hhHHHHHhcCC-CCCccceeEE-EEc------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSF-FED------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~-~~~------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~   72 (305)
                      .+||++|++|+ |||||.|+|. ...      .-.++|.||||+||.|.++++....-. +.+..+.. +..+.+++.++
T Consensus        82 ~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~m  160 (738)
T KOG1989|consen   82 KREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAM  160 (738)
T ss_pred             HHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHH
Confidence            58999999998 9999999993 321      236899999999999999998654332 23333333 33345666655


Q ss_pred             hhhC--C--------ceeecCCCCCeeEcchhHHHH--hcC-----------CcccccCCCccccccc---ccCCCCccc
Q psy6191          73 DKYG--F--------GYQLNDDSSGVMFNDLTRMIM--LAN-----------KNTLCGTPNYIAPEIL---NKNGHSFEV  126 (305)
Q Consensus        73 ~~~~--~--------~~~~~~~~~~v~~~d~~~~~~--~~~-----------~~~~~Gt~~y~aPE~~---~~~~~~~~~  126 (305)
                      |...  +        ++ |....+.++++||+.+.-  ...           .-.-.-||.|.|||++   .+...+.|+
T Consensus       161 H~~~pPiIHRDLKiENv-Lls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKs  239 (738)
T KOG1989|consen  161 HYLKPPIIHRDLKIENV-LLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKS  239 (738)
T ss_pred             hcCCCccchhhhhhhhe-EEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchh
Confidence            5332  2        33 333446789999864321  110           0012358999999987   466789999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCC--CCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         127 DVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       127 DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |||||||+||-|+....||+....    ..|.++.|.+|+  ..+..+.+||+.||+.||.+||++.|++.+
T Consensus       240 DIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  240 DIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             HHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            999999999999999999987633    347788888886  588899999999999999999999998753

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=3.3e-29  Score=214.84  Aligned_cols=198  Identities=21%  Similarity=0.369  Sum_probs=148.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++.+++..|+||||+++++|.+++... .+   ... ....+..+..++.++|..|+.+.
T Consensus        65 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~---~~~~~~~~~~ql~~~l~~lH~~givH~  140 (292)
T cd06657          65 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RM---NEEQIAAVCLAVLKALSVLHAQGVIHR  140 (292)
T ss_pred             HHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            46999999999999999999999999999999999999999877532 11   111 12223345667788887765332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++......    .....+||+.|+|||.+.+..++.++|+||+||++|+|++|.+||.+.+
T Consensus       141 dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~  220 (292)
T cd06657         141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  220 (292)
T ss_pred             CCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                   22333456777776433221    1234578999999999988788899999999999999999999998876


Q ss_pred             HHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         150 LKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       150 ~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      ..+....+.....   ......+..+.+++.+||..||.+||++.+++.||||.+..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         221 PLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            6655444433211   12234678899999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=3.1e-29  Score=216.57  Aligned_cols=197  Identities=19%  Similarity=0.299  Sum_probs=146.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++.+++..|+||||+. |++.+++......  +..... ..+..+..++.+.|..++.+.
T Consensus        63 ~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~--l~~~~~~~~~~ql~~~L~~LH~~~i~H~  139 (307)
T cd06607          63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP--LQEVEIAAICHGALQGLAYLHSHERIHR  139 (307)
T ss_pred             HHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccC--CCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            479999999999999999999999999999999997 5676766532211  122221 122335677888887765433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                             +.+..+.+++.|++.........+..|++.|+|||++.   ...++.++||||+||++|||++|.+||.+.+.
T Consensus       140 dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~  219 (307)
T cd06607         140 DIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (307)
T ss_pred             CCCcccEEECCCCCEEEeecCcceecCCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence                   22334556777776555444455678999999999874   35578899999999999999999999988776


Q ss_pred             HHHHHHHhcc-ccCC-CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         151 KETYSRIKKV-EYKL-PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       151 ~~~~~~i~~~-~~~~-~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ......+... .... +...+..+.++|.+||..||.+||++.+++.|||+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         220 MSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            6554444332 2222 2235678899999999999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=4.2e-29  Score=213.69  Aligned_cols=200  Identities=24%  Similarity=0.301  Sum_probs=143.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcC-chhHHHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDL-EEMSDPA-AQPVIWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~   77 (305)
                      .+|++++++++|||||++++++.+  .+.+|+||||++||+|.+++...... ..+.... ...+..+..++.+.|..++
T Consensus        47 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i  126 (287)
T cd06621          47 LRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI  126 (287)
T ss_pred             HHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            479999999999999999999865  44799999999999999887643221 1111111 1223345677888887775


Q ss_pred             cee-------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          78 GYQ-------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        78 ~~~-------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .+.       +.+....+++.|++......  ......|+..|+|||.+.+..++.++||||+||++|+|++|..||...
T Consensus       127 ~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccCCCCHHHEEEecCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            443       22334556777775433221  123456899999999998888999999999999999999999999765


Q ss_pred             -----CHHHHHHHHhccc-cCCCC------CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         149 -----TLKETYSRIKKVE-YKLPA------TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       149 -----~~~~~~~~i~~~~-~~~~~------~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                           ...+....+.... ..++.      ..+..+.++|.+||..||.+|||+.|++.||||..
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~  271 (287)
T cd06621         207 GEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA  271 (287)
T ss_pred             cCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence                 2233333333211 11111      23467899999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=3.9e-29  Score=215.67  Aligned_cols=193  Identities=15%  Similarity=0.197  Sum_probs=141.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCC-----------------cCchhHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-----------------PAAQPVIW   64 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~-----------------~~~~~~~~   64 (305)
                      .+|++++++++|||||++++++.+++..|+|||||++|+|.+++...........                 ........
T Consensus        67 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  146 (304)
T cd05096          67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQ  146 (304)
T ss_pred             HHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHH
Confidence            4799999999999999999999999999999999999999998865422111000                 00122334


Q ss_pred             HHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHH
Q psy6191          65 VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSI  131 (305)
Q Consensus        65 ~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSl  131 (305)
                      +..++.++|..++.|.       +.+....+++.||+....+..      .+...+|+.|||||++.+..++.++||||+
T Consensus       147 i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  226 (304)
T cd05096         147 IASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF  226 (304)
T ss_pred             HHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHH
Confidence            5677888888776443       223345677888865433211      223456889999999988889999999999


Q ss_pred             HHHHHHHHh--CCCCCCCCCHHHHHHHHhc--------cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         132 GCIMYTLLV--GKPPFETSTLKETYSRIKK--------VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       132 Gvilye~l~--g~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      ||++|||++  |..||...+..+....+..        .....|+..+..+.+++.+||..||.+|||+.++.
T Consensus       227 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         227 GVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             HHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            999999986  6688887665554433321        11223456778899999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=4e-29  Score=210.21  Aligned_cols=192  Identities=20%  Similarity=0.280  Sum_probs=144.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++.+|+||||+++|+|.+++.....  .+.... ......+..++.+.|+.++.+.
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  124 (256)
T cd05114          47 IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSFIHR  124 (256)
T ss_pred             HHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            4699999999999999999999999999999999999999998865322  112221 1222345677888887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.|++........     ....++..|+|||++.+..++.++||||+||++|+|++ |++||..
T Consensus       125 dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~  204 (256)
T cd05114         125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK  204 (256)
T ss_pred             ccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence                   1223344566666543322111     12235568999999988889999999999999999999 9999998


Q ss_pred             CCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+.... ...|...+..+.+++.+||..||.+||+++++++
T Consensus       205 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         205 KSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            88777777776543 2345567788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0594|consensus

Probab=99.96  E-value=4e-29  Score=207.60  Aligned_cols=200  Identities=21%  Similarity=0.358  Sum_probs=153.8

Q ss_pred             hhHHHHHhcCCCCC-ccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCC-CCCCCc-CchhHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRN-VVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDL-EEMSDP-AAQPVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~Hpn-IV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~   72 (305)
                      .|||.++++|+|+| ||+|++++.+++      .+|||+||++. ||.+++...... ..+... ......++..+++++
T Consensus        58 iREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~  136 (323)
T KOG0594|consen   58 IREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL  136 (323)
T ss_pred             hHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            48999999999999 999999999887      89999999975 888888765422 111111 222234557889999


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHh
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~  140 (305)
                      |..++.|+       +.+.++.+++.||+.+....    .....++|.+|.|||++.+. .|++.+||||+|||++||++
T Consensus       137 H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~  216 (323)
T KOG0594|consen  137 HSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT  216 (323)
T ss_pred             HhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh
Confidence            98876543       34456788999997665543    12356799999999998766 79999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcc------------------ccCCCC------------CCCHHHHHHHHHHhhcCCCCCCCH
Q psy6191         141 GKPPFETSTLKETYSRIKKV------------------EYKLPA------------TLKKPAATMIKKMLLLDPVQRPPV  190 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~------------------~~~~~~------------~~~~~~~~li~~~l~~dp~~R~~~  190 (305)
                      +++-|.+.+..++..+|...                  ...+|.            ..+.+..+++.+||+.+|.+|.|+
T Consensus       217 ~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa  296 (323)
T KOG0594|consen  217 RRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA  296 (323)
T ss_pred             CCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH
Confidence            99999998887777666431                  001111            122477899999999999999999


Q ss_pred             hhhhcCcccccc
Q psy6191         191 AQLLHFEFFNDY  202 (305)
Q Consensus       191 ~~~l~~~~~~~~  202 (305)
                      ..++.||||...
T Consensus       297 ~~al~h~yf~~~  308 (323)
T KOG0594|consen  297 KGALTHPYFSEL  308 (323)
T ss_pred             HHHhcChhhccc
Confidence            999999999864

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=2.2e-29  Score=218.42  Aligned_cols=197  Identities=22%  Similarity=0.368  Sum_probs=134.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE--cCCeEEEEEeccCCCCHHHHHHHhcCCC------CCCCcCc-hhHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE--DSKFVYIILELCRKRSMMELYNSACDLE------EMSDPAA-QPVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~--~~~~~ylVmEy~~~g~L~~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~   72 (305)
                      .+|++++++++|||||++++++.  ++..+|+||||+.+ +|.+++.......      .+..... ..+..+..++.+.
T Consensus        46 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l  124 (317)
T cd07867          46 CREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL  124 (317)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999985  46789999999875 7777765322111      0111111 2223456778888


Q ss_pred             hhhCCcee--------ec---CCCCCeeEcchhHHHHhc-------CCcccccCCCccccccccc-CCCCccchHHHHHH
Q psy6191          73 DKYGFGYQ--------LN---DDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGC  133 (305)
Q Consensus        73 ~~~~~~~~--------~~---~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGv  133 (305)
                      |..++.|.        +.   +....+++.|++......       .....+||+.|+|||++.+ ..++.++||||+||
T Consensus       125 H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~  204 (317)
T cd07867         125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC  204 (317)
T ss_pred             HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHH
Confidence            87775432        21   223457778876544322       1234578999999999876 45789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHH---------HHHHHHh---------------c-------------ccc----------CCCC
Q psy6191         134 IMYTLLVGKPPFETSTLK---------ETYSRIK---------------K-------------VEY----------KLPA  166 (305)
Q Consensus       134 ilye~l~g~~Pf~~~~~~---------~~~~~i~---------------~-------------~~~----------~~~~  166 (305)
                      ++|||++|.+||......         .....+.               .             ...          ....
T Consensus       205 il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (317)
T cd07867         205 IFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKV  284 (317)
T ss_pred             HHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccC
Confidence            999999999999753211         0000000               0             000          0011


Q ss_pred             CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       167 ~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ..+..+.++|.+||+.||.+|||++|+++||||
T Consensus       285 ~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         285 KPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            234567899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.96  E-value=4.5e-29  Score=210.77  Aligned_cols=193  Identities=20%  Similarity=0.320  Sum_probs=145.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++..++.+|+||||+++|+|.+++...... ...... ...+..+.+++.+.|..++.+.
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~  128 (263)
T cd05052          50 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFIHR  128 (263)
T ss_pred             HHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            36999999999999999999999999999999999999999988653221 111111 1223345677888887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+..+.+++.|++........     ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus       129 dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  208 (263)
T cd05052         129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  208 (263)
T ss_pred             ccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence                   2223345666776544332211     12234668999999988889999999999999999998 9999998


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ....|...+..+.+++.+||..||++||++.++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         209 IDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            8877776666543 44556778899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0584|consensus

Probab=99.96  E-value=1.8e-29  Score=222.34  Aligned_cols=196  Identities=21%  Similarity=0.329  Sum_probs=153.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC--eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhC--
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK--FVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYG--   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~--~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--   76 (305)
                      ..|+.+|+.|+|||||++|+++.+..  .+.+|.|++..|+|.++.++.....   -.+... .-++++++.|+|...  
T Consensus        89 ~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn---~kaik~W~RQILkGL~yLHs~~PP  165 (632)
T KOG0584|consen   89 YSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVN---IKAIKSWCRQILKGLVYLHSQDPP  165 (632)
T ss_pred             HHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCC---HHHHHHHHHHHHHHhhhhhcCCCC
Confidence            47999999999999999999998755  4999999999999999998765432   111111 112456676666322  


Q ss_pred             C--------ceeecCCCCCeeEcchhHHHHhcC--CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          77 F--------GYQLNDDSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        77 ~--------~~~~~~~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      +        ++.++...+.|+++|++.+.....  ...+.|||.|||||++. ..|+..+||||||.++.||+|+..||.
T Consensus       166 IIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  166 IIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             ccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence            2        344555667889999887766432  34578999999999998 678999999999999999999999996


Q ss_pred             C-CCHHHHHHHHhccccC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         147 T-STLKETYSRIKKVEYK--LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      . .+..+++.++..+..+  +...-++++++||.+||.. ...|+|+.|+|.||||+..
T Consensus       245 EC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  245 ECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             hhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            5 6777888888766432  2234578899999999998 9999999999999999864

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.96  E-value=1.3e-29  Score=216.53  Aligned_cols=196  Identities=26%  Similarity=0.403  Sum_probs=142.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+++++.++||||+++++++.+++..|+||||++++++.++......+..  ......+..+.+++.+.|+.++.+. 
T Consensus        48 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~--~~~~~~~~~i~~~l~~LH~~~i~h~~  125 (286)
T cd07846          48 MREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDE--SRVRKYLFQILRGIEFCHSHNIIHRD  125 (286)
T ss_pred             HHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCH--HHHHHHHHHHHHHHHHHHHCCccccC
Confidence            3799999999999999999999999999999999999998887654332211  1112223345677888887775432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC----CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                            +.+..+.+++.|++....+..    .....|+..|+|||++.+ ..++.++||||+||++|||++|++||...+
T Consensus       126 l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~  205 (286)
T cd07846         126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS  205 (286)
T ss_pred             CCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence                  223345567777754332211    123568999999998865 347889999999999999999999998766


Q ss_pred             HHHHHHHHhcccc-------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         150 LKETYSRIKKVEY-------------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       150 ~~~~~~~i~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      ..+....+.....                               ..++.++..+.+++.+||..||.+||++.++++|+|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         206 DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             hHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence            5443333221000                               012346778999999999999999999999999999


Q ss_pred             c
Q psy6191         199 F  199 (305)
Q Consensus       199 ~  199 (305)
                      |
T Consensus       286 ~  286 (286)
T cd07846         286 F  286 (286)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=4.6e-29  Score=211.69  Aligned_cols=195  Identities=21%  Similarity=0.366  Sum_probs=142.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++...+.+|+||||+++|+|.+++.....+.   ...... ...+..++.+.|..++.+.
T Consensus        56 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~---~~~~~~~~~qi~~~l~~lH~~~i~H~  132 (272)
T cd06629          56 RSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE---EQLVRFFTEQVLEGLAYLHSKGILHR  132 (272)
T ss_pred             HHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCC---HHHHHHHHHHHHHHHHHHhhCCeeec
Confidence            369999999999999999999999999999999999999999987654332   222222 2334566777777664332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCC--CCccchHHHHHHHHHHHHhCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNG--HSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~--~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                             +.+.+..+++.|++......+      .....|+..|+|||.+....  ++.++|+||+|+++|+|++|..||
T Consensus       133 dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  212 (272)
T cd06629         133 DLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW  212 (272)
T ss_pred             CCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence                   222334556666653332211      12356899999999987654  788999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcc--ccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         146 ETSTLKETYSRIKKV--EYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~--~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ...+..+....+...  ...++.    .++..+.++|.+||..||.+|||++++++|||+
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         213 SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            766554433332211  222222    357889999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.96  E-value=3.9e-29  Score=213.00  Aligned_cols=194  Identities=17%  Similarity=0.220  Sum_probs=145.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-----------CCCCcCc-hhHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-----------EMSDPAA-QPVIWVSKWV   69 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-----------~~~~~~~-~~~~~~~~~~   69 (305)
                      .+|+++++.++||||+++++++.++...|+||||+++|+|.+++.......           .+..... ..+..+..++
T Consensus        56 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l  135 (280)
T cd05049          56 EREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM  135 (280)
T ss_pred             HHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHH
Confidence            479999999999999999999999999999999999999999987643210           0011111 1122345667


Q ss_pred             HHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHH
Q psy6191          70 DYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        70 ~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvily  136 (305)
                      .+.|..++.+.       +.+....+++.|++......      ..+...+++.|+|||++.+..++.++||||+||++|
T Consensus       136 ~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  215 (280)
T cd05049         136 VYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW  215 (280)
T ss_pred             HHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence            77787665432       22233456666765433211      122345678899999999888999999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         137 TLLV-GKPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       137 e~l~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||++ |..||...+..+....+..... ..+...+..+.+++.+||..||.+||++.|++.
T Consensus       216 e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         216 EIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9998 9999988777777666665443 334568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=1.7e-29  Score=215.02  Aligned_cols=196  Identities=28%  Similarity=0.499  Sum_probs=156.1

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++ ||||+++++++.+++..|+||||+++|+|.+++.....+..  .........+..++.++|..++.+.
T Consensus        49 ~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~--~~~~~i~~ql~~~l~~Lh~~~~~H~  126 (280)
T cd05581          49 KIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE--KCTRFYAAEILLALEYLHSKGIIHR  126 (280)
T ss_pred             HHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHHCCeeec
Confidence            46889999998 99999999999999999999999999999999876543311  1122223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------------------------CCcccccCCCcccccccccCCCCccchHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------------------------NKNTLCGTPNYIAPEILNKNGHSFEVDVW  129 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------------------------~~~~~~Gt~~y~aPE~~~~~~~~~~~Diw  129 (305)
                             +.+..+.+++.|++......                        ......|++.|+|||++....++.++|+|
T Consensus       127 dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~  206 (280)
T cd05581         127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLW  206 (280)
T ss_pred             CCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHH
Confidence                   22334567777775433221                        11245689999999998888888999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hhhhcCccc
Q psy6191         130 SIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV----AQLLHFEFF  199 (305)
Q Consensus       130 SlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~----~~~l~~~~~  199 (305)
                      |+||+++++++|+.||...+....+..+......+|...+....++|.+||..||.+||++    +++++||||
T Consensus       207 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         207 ALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            9999999999999999988877777777777778888899999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=5.1e-29  Score=212.35  Aligned_cols=193  Identities=19%  Similarity=0.277  Sum_probs=142.0

Q ss_pred             HHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee-----
Q psy6191           7 IHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ-----   80 (305)
Q Consensus         7 il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-----   80 (305)
                      ++...+||||+++++++.+++..|+||||++||+|.+++.....+   ...... ....+..++.+.|..++.+.     
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l---~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~  126 (279)
T cd05633          50 LVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF---SEKEMRFYATEIILGLEHMHNRFVVYRDLKPA  126 (279)
T ss_pred             HHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHH
Confidence            334458999999999999999999999999999999888654433   222222 22345677888887765433     


Q ss_pred             --ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCC---HHH
Q psy6191          81 --LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPFETST---LKE  152 (305)
Q Consensus        81 --~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~---~~~  152 (305)
                        +.+....+++.|++......  ......||+.|+|||.+. +..++.++||||+||++|+|++|..||....   ...
T Consensus       127 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  206 (279)
T cd05633         127 NILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE  206 (279)
T ss_pred             HEEECCCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH
Confidence              22334556677776443221  122357999999999886 4568899999999999999999999997532   222


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ...........+|...+.++.++|.+||..||.+|+     ++.++++||||+..
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         207 IDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             HHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            222223334556778899999999999999999999     69999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=8.1e-29  Score=214.55  Aligned_cols=198  Identities=20%  Similarity=0.314  Sum_probs=145.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++|||||++++++.++...|+|||||. |++.+.+......  +...... .+..+..++.++|..|+.+.
T Consensus        69 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~--l~~~~~~~~~~qi~~al~~LH~~gi~H~  145 (313)
T cd06633          69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHNMIHR  145 (313)
T ss_pred             HHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            468999999999999999999999999999999996 5777776543221  1221111 22335667788887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                             +.+..+.+++.|++........+...|+..|+|||++.   ...++.++||||+||++|+|++|.+||...+.
T Consensus       146 dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~  225 (313)
T cd06633         146 DIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  225 (313)
T ss_pred             CCChhhEEECCCCCEEEeecCCCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence                   22233456667765444333445678999999999874   35578899999999999999999999988766


Q ss_pred             HHHHHHHhcccc-CC-CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         151 KETYSRIKKVEY-KL-PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~~-~~-~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ......+..... .. ....+...++++.+||+.+|.+||++.+++.||||...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         226 MSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            555544433222 11 22456778999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=5e-30  Score=215.91  Aligned_cols=195  Identities=32%  Similarity=0.531  Sum_probs=146.8

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee--
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ--   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--   80 (305)
                      +|+.++++++||||+++++++.++..+|+|||||++++|.+++.....+..  ......+..+.+++.+.|..++.|.  
T Consensus        47 ~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~--~~~~~~~~qi~~~L~~Lh~~~i~H~di  124 (260)
T PF00069_consen   47 REIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSE--EEILKIAYQILEALAYLHSKGIVHRDI  124 (260)
T ss_dssp             HHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBH--HHHHHHHHHHHHHHHHHHHTTEEESSB
T ss_pred             hhhhccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence            489999999999999999999999999999999999999999984444321  1112233445677888887765443  


Q ss_pred             -----ecCCCCCeeEcchhHHHH----hcCCcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -----LNDDSSGVMFNDLTRMIM----LANKNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -----~~~~~~~v~~~d~~~~~~----~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                           +.+..+.+++.|++....    .......+||+.|+|||++. +..++.++||||+|+++|+|++|..||...+.
T Consensus       125 kp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~  204 (260)
T PF00069_consen  125 KPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS  204 (260)
T ss_dssp             SGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence                 233456677888876542    12234567999999999998 77889999999999999999999999998732


Q ss_pred             ---HHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         151 ---KETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       151 ---~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                         ..............+    ...+..+.++|.+||..||.+||++.++++||||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  205 DDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence               223333222211111    1223789999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.96  E-value=9e-29  Score=211.75  Aligned_cols=194  Identities=15%  Similarity=0.226  Sum_probs=145.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC----------CCCcCc-hhHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE----------MSDPAA-QPVIWVSKWVD   70 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~----------~~~~~~-~~~~~~~~~~~   70 (305)
                      .+|+.++++++|||||++++++.+.+.+|+||||+++|+|.+++........          +..... ..+..+..++.
T Consensus        55 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~  134 (288)
T cd05093          55 HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMV  134 (288)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHH
Confidence            4799999999999999999999999999999999999999999875432100          111111 12233567788


Q ss_pred             HhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHH
Q psy6191          71 YSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        71 ~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  137 (305)
                      +.|..|+.+.       +.+....+++.|++.......      .+...|++.|+|||++.+..++.++|||||||++|+
T Consensus       135 ~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~  214 (288)
T cd05093         135 YLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE  214 (288)
T ss_pred             HHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence            8887775443       222334566677654432211      123346788999999998889999999999999999


Q ss_pred             HHh-CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         138 LLV-GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       138 ~l~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |++ |.+||...+..+....+.... ...+...+.++.+++.+||+.||.+|||+.+++.
T Consensus       215 l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         215 IFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            998 999998887777766666554 3445567889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=3.7e-29  Score=213.90  Aligned_cols=195  Identities=26%  Similarity=0.400  Sum_probs=143.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+++..|+||||++++.+..+..+...+   .... ...+..+..++.++|..++.+.
T Consensus        48 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~i~~~l~~LH~~~i~H~  124 (288)
T cd07833          48 LREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGL---PPDAVRSYIWQLLQAIAYCHSHNIIHR  124 (288)
T ss_pred             HHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            47999999999999999999999999999999999987776655443222   2211 1223345677888887665332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+....+++.|++.......     .....|++.|+|||++.+. .++.++||||+|+++|+|++|.+||.+
T Consensus       125 dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             CCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                   233456677888765443222     2246789999999998877 788999999999999999999999987


Q ss_pred             CCHHHHHHHHhccc--------------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKVE--------------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~~--------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+....                                ..++..++.++.++|++||..||.+|||++++++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         205 DSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            65443322221100                                0122334788999999999999999999999999


Q ss_pred             Cccc
Q psy6191         196 FEFF  199 (305)
Q Consensus       196 ~~~~  199 (305)
                      ||||
T Consensus       285 ~~~f  288 (288)
T cd07833         285 HPYF  288 (288)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=5.6e-29  Score=212.72  Aligned_cols=198  Identities=26%  Similarity=0.367  Sum_probs=140.8

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEE-----cCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCch-hHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFE-----DSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAAQ-PVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~-----~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~   73 (305)
                      .+|+.+++++ +||||+++++++.     ++..+|+||||++||+|.+++...... ..+.+.... .+..+..++.+.|
T Consensus        62 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH  141 (286)
T cd06638          62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH  141 (286)
T ss_pred             HHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH
Confidence            3688999999 7999999999873     456799999999999999987643211 111111111 2233467788888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCccccccccc-----CCCCccchHHHHHHHHHH
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNK-----NGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilye  137 (305)
                      ..++.+.       +.+....+++.|++......    ......||+.|+|||++..     ..++.++||||+||++||
T Consensus       142 ~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~e  221 (286)
T cd06638         142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE  221 (286)
T ss_pred             hCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHH
Confidence            7765433       22233456777776433221    1234579999999998753     347889999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhccc---cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         138 LLVGKPPFETSTLKETYSRIKKVE---YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      |++|+.||...+.......+....   ...|...+..+.+++.+||..||.+|||+.++++|+||
T Consensus       222 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         222 LGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            999999998766544433332221   12234467789999999999999999999999999996

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0695|consensus

Probab=99.96  E-value=1.3e-29  Score=208.33  Aligned_cols=196  Identities=25%  Similarity=0.458  Sum_probs=154.5

Q ss_pred             hHHHHHhc-CCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHRS-LKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~-l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   80 (305)
                      .|-.+..+ -+||++|.|+..|+++..+++|.||++||+|.-.+++...+.   +..++.+.. +..++.+.|..|+.++
T Consensus       299 tek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklp---eeharfys~ei~lal~flh~rgiiyr  375 (593)
T KOG0695|consen  299 TEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHARFYSAEICLALNFLHERGIIYR  375 (593)
T ss_pred             hhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCc---HHHhhhhhHHHHHHHHHHhhcCeeee
Confidence            34555544 479999999999999999999999999999988887766553   333433322 2334666676665433


Q ss_pred             -------ecCCCCCeeEcchhHHHH----hcCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC--
Q psy6191          81 -------LNDDSSGVMFNDLTRMIM----LANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET--  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~----~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~--  147 (305)
                             +.|..+.+++.|++-...    -...+|+||||.|+|||++.+..|+.++|+|+|||+++||+.|+.||+-  
T Consensus       376 dlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  376 DLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             eccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence                   455667888888864332    1234689999999999999999999999999999999999999999952  


Q ss_pred             ------CCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC------HhhhhcCccccc
Q psy6191         148 ------STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP------VAQLLHFEFFND  201 (305)
Q Consensus       148 ------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~------~~~~l~~~~~~~  201 (305)
                            .+..-+++.|......+|..+|-.+..+++..|.+||.+|..      ..++..|+||+.
T Consensus       456 m~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  456 MDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             CCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence                  233446777888889999999999999999999999999974      578899999974

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=1.2e-28  Score=208.03  Aligned_cols=195  Identities=24%  Similarity=0.456  Sum_probs=146.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+.+.+|+|+||+++++|.+++.....+   ...... .+..+..++.+.|+.++.+.
T Consensus        47 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~i~~~i~~~l~~lh~~~i~H~  123 (264)
T cd06626          47 ADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRIL---DEHVIRVYTLQLLEGLAYLHSHGIVHR  123 (264)
T ss_pred             HHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCC---ChHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            47999999999999999999999999999999999999999998764332   222222 23345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC--------cccccCCCcccccccccCC---CCccchHHHHHHHHHHHHhCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK--------NTLCGTPNYIAPEILNKNG---HSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~--------~~~~Gt~~y~aPE~~~~~~---~~~~~DiwSlGvilye~l~g~  142 (305)
                             +.+....+++.|++........        ....|++.|+|||++.+..   ++.++||||+||++|+|++|+
T Consensus       124 dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~  203 (264)
T cd06626         124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK  203 (264)
T ss_pred             CCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCC
Confidence                   2233456777777644433221        1356889999999987665   788999999999999999999


Q ss_pred             CCCCCCC-HHHHHHHHhc-cccCCCCCC--CHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         143 PPFETST-LKETYSRIKK-VEYKLPATL--KKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       143 ~Pf~~~~-~~~~~~~i~~-~~~~~~~~~--~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      .||.... .......+.. ....+|...  +..+.++|.+||+.||.+|||+.+++.|||+
T Consensus       204 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         204 RPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9997653 3333222322 233444444  7889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=3.4e-29  Score=214.91  Aligned_cols=198  Identities=19%  Similarity=0.329  Sum_probs=147.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++..++..|+||||+++|+|.+++.+.. +   ..... .....+..++.+.|+.++.+.
T Consensus        64 ~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-l---~~~~~~~i~~~l~~al~~LH~~gi~H~  139 (293)
T cd06647          64 INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-M---DEGQIAAVCRECLQALEFLHSNQVIHR  139 (293)
T ss_pred             HHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC-C---CHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            368999999999999999999999999999999999999999886532 1   11111 222334567788887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++.......    .....|++.|+|||.+.+..++.++|+||+||++|++++|+.||...+
T Consensus       140 dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~  219 (293)
T cd06647         140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (293)
T ss_pred             cCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                   122334566667653332211    224578999999999988888999999999999999999999998766


Q ss_pred             HHHHHHHHhc-ccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         150 LKETYSRIKK-VEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       150 ~~~~~~~i~~-~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      ..+....+.. ...  ..+..++...+++|++||..||.+||++.+++.|+||....
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         220 PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             hhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            5444332221 111  22334677899999999999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=1.1e-28  Score=207.24  Aligned_cols=198  Identities=23%  Similarity=0.406  Sum_probs=151.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCc-CchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDP-AAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++|||++++++.+.++...|+||||+++++|.+.+...... ...... ....+..+.+++.+.|..|+.+
T Consensus        47 ~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H  126 (258)
T cd08215          47 LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILH  126 (258)
T ss_pred             HHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            47899999999999999999999999999999999999999988764210 111111 1222334567788888776543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.|++.......    ....+|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       127 ~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             ccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence            3       222345666677654433222    13457899999999998888899999999999999999999999887


Q ss_pred             CHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +..+....+... ...+|...+..+.+++.+||..||++|||+.+++.||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         207 NLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            766666555443 334566788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=3.5e-29  Score=221.72  Aligned_cols=194  Identities=19%  Similarity=0.281  Sum_probs=139.5

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC----------------------------
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE----------------------------   52 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~----------------------------   52 (305)
                      .+|+++++.+ +|||||++++++.+.+.+|+|||||++|+|.+++.......                            
T Consensus        89 ~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (374)
T cd05106          89 MSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIR  168 (374)
T ss_pred             HHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccc
Confidence            4799999999 89999999999999999999999999999999886432100                            


Q ss_pred             ---------------------------------------CCCCc-CchhHHHHHHHHHHhhhhCCcee-------ecCCC
Q psy6191          53 ---------------------------------------EMSDP-AAQPVIWVSKWVDYSDKYGFGYQ-------LNDDS   85 (305)
Q Consensus        53 ---------------------------------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~   85 (305)
                                                             .+... .......+..++.|+|..++.|.       +.++.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~  248 (374)
T cd05106         169 SDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG  248 (374)
T ss_pred             ccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC
Confidence                                                   00000 01112335677888887775443       22233


Q ss_pred             CCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q psy6191          86 SGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIK  158 (305)
Q Consensus        86 ~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~~~~~~i~  158 (305)
                      ..+++.||+.......      .++..+++.|||||++.+..++.++||||+||++|||++ |+.||.............
T Consensus       249 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~  328 (374)
T cd05106         249 RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV  328 (374)
T ss_pred             CeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH
Confidence            4566777764432211      112335567999999988889999999999999999997 999998765443333332


Q ss_pred             cc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         159 KV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       159 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ..  ....|...+.++.+++.+||+.||.+|||+.++.+
T Consensus       329 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22  33445567899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=8.2e-29  Score=212.60  Aligned_cols=199  Identities=23%  Similarity=0.350  Sum_probs=141.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.++...|+||||++ ++|.+.+....... ...... ..+..+..++.+.|..++.+.
T Consensus        49 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~i~H~  126 (294)
T PLN00009         49 IREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFA-KNPRLIKTYLYQILRGIAYCHSHRVLHR  126 (294)
T ss_pred             HHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCC-cCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            369999999999999999999999999999999996 57877765433221 111111 222345677888887765332


Q ss_pred             --------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 --------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 --------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                              +...+..+++.|++.......    .....|++.|+|||.+.+. .++.++||||+||++|+|++|.+||..
T Consensus       127 dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             CCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                    222233466677764432211    1234678999999988654 578899999999999999999999987


Q ss_pred             CCHHHHHHHHhcc---------------------ccC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         148 STLKETYSRIKKV---------------------EYK--------LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       148 ~~~~~~~~~i~~~---------------------~~~--------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      .+..+...++...                     ...        ..+..+..+.++|.+||..||.+||++.+++.|||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~  286 (294)
T PLN00009        207 DSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY  286 (294)
T ss_pred             CCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence            6654443332110                     000        11346778899999999999999999999999999


Q ss_pred             cccc
Q psy6191         199 FNDY  202 (305)
Q Consensus       199 ~~~~  202 (305)
                      |.+.
T Consensus       287 ~~~~  290 (294)
T PLN00009        287 FKDL  290 (294)
T ss_pred             HhHH
Confidence            9864

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=6e-29  Score=209.97  Aligned_cols=191  Identities=16%  Similarity=0.230  Sum_probs=137.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++.++...|+||||+++|+|..++......  .... .......+..++.|.|+.++.|.
T Consensus        52 ~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~  129 (262)
T cd05077          52 FETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV--LTTPWKFKVAKQLASALSYLEDKDLVHG  129 (262)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHhhhCCeECC
Confidence            36789999999999999999999999999999999999998887643221  1111 12233445778888887775443


Q ss_pred             ecCCCCC---------------eeEcchhHHHHhcCCcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHH-hCCC
Q psy6191          81 LNDDSSG---------------VMFNDLTRMIMLANKNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLL-VGKP  143 (305)
Q Consensus        81 ~~~~~~~---------------v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l-~g~~  143 (305)
                      -.. ..+               +++.|++............||+.|||||.+. +..++.++||||+||++|||+ .|..
T Consensus       130 dlk-p~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~  208 (262)
T cd05077         130 NVC-TKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI  208 (262)
T ss_pred             CCC-cccEEEecCCccCCCCceeEeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            111 111               4445554433333334557899999999886 566889999999999999998 5899


Q ss_pred             CCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         144 PFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||......+... ............+.++.+++.+||..||.+||++.+++++
T Consensus       209 p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         209 PLKDKTLAEKER-FYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCCcchhHHHH-HHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            998765544322 2223333334456788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=1.1e-28  Score=208.15  Aligned_cols=193  Identities=18%  Similarity=0.276  Sum_probs=142.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++..|+||||+++|+|.+++....... ..... ......+..++.+.|..++.+.
T Consensus        49 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~l~~~l~~LH~~~i~H~  127 (261)
T cd05072          49 LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGK-VLLPKLIDFSAQIAEGMAYIERKNYIHR  127 (261)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            469999999999999999999999999999999999999999886542211 11111 1122345667778887665332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.|++........     ....++..|+|||.+.+..++.++||||+||++|+|++ |..||..
T Consensus       128 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~  207 (261)
T cd05072         128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG  207 (261)
T ss_pred             ccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence                   2223345566676544332211     12345678999999988888999999999999999998 9999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.......+... ..+.+...+.++.+++.+||..||++||+++++.+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         208 MSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            7776666665543 22334457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=1.2e-28  Score=209.68  Aligned_cols=195  Identities=14%  Similarity=0.212  Sum_probs=145.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCC----Cc----CchhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS----DP----AAQPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~----~~----~~~~~~~~~~~~~~~~   73 (305)
                      .+|+.+++.++|||||++++++.++...|+||||+++|+|.+++.......+..    ..    .......+.+++.+.|
T Consensus        57 ~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH  136 (277)
T cd05062          57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN  136 (277)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999999999999999999999999999986533211100    00    1112233567788888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~  140 (305)
                      ..++.+.       +.+....+++.|++.......      .....+++.|||||++.+..++.++|||||||++|||++
T Consensus       137 ~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  216 (277)
T cd05062         137 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT  216 (277)
T ss_pred             HCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHc
Confidence            7765432       223345566777764332211      112356788999999988889999999999999999999


Q ss_pred             -CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         141 -GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       141 -g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                       |..||.+.+..+....+.... ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       217 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         217 LAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             789998887776666554433 34566778889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=1.2e-28  Score=210.35  Aligned_cols=195  Identities=15%  Similarity=0.238  Sum_probs=145.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC--------------CCCcC-chhHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE--------------MSDPA-AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~--------------~~~~~-~~~~~~~~   66 (305)
                      .+|++++++++|||||++++++.+++..|+||||+++|+|.+++........              ..... ...+..+.
T Consensus        55 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~  134 (283)
T cd05090          55 QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIA  134 (283)
T ss_pred             HHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHH
Confidence            4799999999999999999999999999999999999999998864321100              00000 11223346


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.|.|..++.|.       +.+....+++.|++.......      .....++..|+|||.+.+..++.++||||+||
T Consensus       135 ~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  214 (283)
T cd05090         135 AGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGV  214 (283)
T ss_pred             HHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHH
Confidence            67788887765332       223345577778765433211      22345677899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++|||++ |.+||.+.+..+....+.... ...|...+..+.+++.+||+.||++||++.+++++
T Consensus       215 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         215 VLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            9999998 999998877666665554433 34566788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=1.7e-28  Score=212.90  Aligned_cols=197  Identities=20%  Similarity=0.310  Sum_probs=146.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+||||+.| ++.+.+......  +.... ...+..+..++.++|..++.|.
T Consensus        73 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~--l~~~~~~~i~~~i~~~l~~lH~~~i~H~  149 (317)
T cd06635          73 IKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHNMIHR  149 (317)
T ss_pred             HHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            3689999999999999999999999999999999975 777776543221  11111 1223345677888887775433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                             +.+..+.+++.|++............|++.|+|||.+.   .+.++.++||||+||++|+|++|.+||...+.
T Consensus       150 dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  229 (317)
T cd06635         150 DIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  229 (317)
T ss_pred             CCCcccEEECCCCCEEEecCCCccccCCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence                   22233556777776554444455678999999999873   45678899999999999999999999988766


Q ss_pred             HHHHHHHhcccc-CC-CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         151 KETYSRIKKVEY-KL-PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       151 ~~~~~~i~~~~~-~~-~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ......+..... .. +...+..+++++.+||+.+|.+||++.++++|+|+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         230 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             HHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            655555543322 22 2346778999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=1.2e-28  Score=213.03  Aligned_cols=197  Identities=20%  Similarity=0.367  Sum_probs=142.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|+.++++++||||+++++++.+.  +.+|+||||+.+ +|.+++.....  .+.... ...+..+.+++.+.|..++.
T Consensus        54 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~  130 (309)
T cd07845          54 LREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT--PFSESQVKCLMLQLLRGLQYLHENFII  130 (309)
T ss_pred             hHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3699999999999999999999765  579999999975 78888765321  112222 12233456778888887754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      |.       +.+..+.+++.|++.......    .....+++.|+|||++.+ ..++.++||||+||++|+|++|.+||.
T Consensus       131 H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~  210 (309)
T cd07845         131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP  210 (309)
T ss_pred             cCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence            43       223345677777764433221    122346888999998865 457899999999999999999999999


Q ss_pred             CCCHHHHHHHHhcc-------------------ccCCC-----------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         147 TSTLKETYSRIKKV-------------------EYKLP-----------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-------------------~~~~~-----------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +.+..+....+...                   .+..+           ...+..+.++|.+||..||.+|||+.++++|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             CCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            88777665544321                   01111           1247788999999999999999999999999


Q ss_pred             ccccc
Q psy6191         197 EFFND  201 (305)
Q Consensus       197 ~~~~~  201 (305)
                      |||.+
T Consensus       291 ~~f~~  295 (309)
T cd07845         291 SYFKE  295 (309)
T ss_pred             hhhcc
Confidence            99985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.96  E-value=1e-28  Score=207.86  Aligned_cols=195  Identities=19%  Similarity=0.297  Sum_probs=149.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC------CCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL------EEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+++++.++||||+++++++.++..+|+||||+++|+|.+++......      ....+... ..+..+.+++.+.|.
T Consensus        44 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  123 (262)
T cd00192          44 LKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS  123 (262)
T ss_pred             HHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc
Confidence            47999999999999999999999999999999999999999998765211      11122222 223334677888887


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-  140 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-  140 (305)
                      .++.+.       +.+....+++.|++.......      .....+++.|+|||.+....++.++||||+||++|+|++ 
T Consensus       124 ~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  203 (262)
T cd00192         124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL  203 (262)
T ss_pred             CCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhc
Confidence            765443       223335677777765443322      234568899999999988889999999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         141 GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |..||...+..+....+... ....|...+.++.+++.+||..||.+|||+.+++++
T Consensus       204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         204 GATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            69999988777777666543 345567788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=1.5e-28  Score=209.48  Aligned_cols=193  Identities=22%  Similarity=0.353  Sum_probs=139.4

Q ss_pred             hHHHHHhcCC-CCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCc
Q psy6191           3 QEIAIHRSLK-HRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         3 ~Ei~il~~l~-HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   78 (305)
                      +|+.+++++. ||||+++++++.++  +.+|+||||++ |++.+.+.....  .+.... ...+..+..++.+.|..++.
T Consensus        46 ~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~i~  122 (282)
T cd07831          46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHRNGIF  122 (282)
T ss_pred             HHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            6888999885 99999999999988  89999999997 477777754321  112222 22334456778888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                      +.       +.+. ..+++.|++....+..   .....||+.|+|||.+. +..++.++||||+||++|||++|.+||.+
T Consensus       123 H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~  201 (282)
T cd07831         123 HRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG  201 (282)
T ss_pred             ecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence            43       2223 5667777764433322   12456899999999765 45578899999999999999999999988


Q ss_pred             CCHHHHHHHHhcc------------------ccCCC-----------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         148 STLKETYSRIKKV------------------EYKLP-----------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       148 ~~~~~~~~~i~~~------------------~~~~~-----------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      .+..+....+...                  .+.+|           ...+..+.++|.+||..||++||+++++++|||
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         202 TNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             CCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            7665543333210                  11111           245688999999999999999999999999999


Q ss_pred             c
Q psy6191         199 F  199 (305)
Q Consensus       199 ~  199 (305)
                      |
T Consensus       282 ~  282 (282)
T cd07831         282 F  282 (282)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=1.4e-28  Score=207.63  Aligned_cols=198  Identities=26%  Similarity=0.345  Sum_probs=150.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhh-hCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDK-YGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~   80 (305)
                      .+|+.++++++||||+++++++..++.+|+||||+++++|.+++.....+.+  ......+..+..++.+.|. .++.+.
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~--~~~~~~~~~l~~~l~~lh~~~~~~H~  124 (264)
T cd06623          47 LRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE--PVLAYIARQILKGLDYLHTKRHIIHR  124 (264)
T ss_pred             HHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHhccCCCccC
Confidence            4789999999999999999999999999999999999999999876533311  1112223345677888887 765442


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC-
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS-  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~-  148 (305)
                             +.+....+++.|++........    ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||... 
T Consensus       125 ~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             CCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence                   2233455667776544332211    2456899999999998888899999999999999999999999776 


Q ss_pred             --CHHHHHHHHhcc-ccCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         149 --TLKETYSRIKKV-EYKLPAT-LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       149 --~~~~~~~~i~~~-~~~~~~~-~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                        +..+....+... ....+.. .+..+.++|.+||..+|.+||++.++++|||+..
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         205 QPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             ccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence              344444444432 2334445 7888999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.96  E-value=1.4e-28  Score=210.96  Aligned_cols=194  Identities=16%  Similarity=0.225  Sum_probs=145.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-------------CCCCCcC-chhHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-------------EEMSDPA-AQPVIWVSK   67 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~   67 (305)
                      .+|++++++++||||+++++++.+.+..|+||||+++|+|.+++......             ..+.... ...+..+..
T Consensus        55 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~  134 (291)
T cd05094          55 QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIAS  134 (291)
T ss_pred             HHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHH
Confidence            47999999999999999999999999999999999999999998754310             0011111 112233466


Q ss_pred             HHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHH
Q psy6191          68 WVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCI  134 (305)
Q Consensus        68 ~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvi  134 (305)
                      ++.+.|..++.+.       +.+.+..+++.|++.......      .....|++.|+|||.+.+..++.++||||+||+
T Consensus       135 al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  214 (291)
T cd05094         135 GMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI  214 (291)
T ss_pred             HHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHH
Confidence            7788887775443       223334566677754432211      123457889999999988889999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         135 MYTLLV-GKPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       135 lye~l~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +|||++ |.+||...+..+....+..... ..+...+..+.+++.+||+.||.+||++.++++
T Consensus       215 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         215 LWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            999998 9999988777776666655433 334557888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=6.5e-29  Score=206.65  Aligned_cols=190  Identities=17%  Similarity=0.277  Sum_probs=140.1

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|...+....||||+++++++++++..|+||||++||+|.+++.....+   ..... .....+..++.++|+.++.+. 
T Consensus        34 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l---~~~~~~~~~~ql~~~l~~lH~~~i~H~d  110 (237)
T cd05576          34 RERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNI---PEECVKRWAAEMVVALDALHREGIVCRD  110 (237)
T ss_pred             hHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCC---CHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence            4556666678999999999999999999999999999999988765433   22222 222345677888887765432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC-CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET  153 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~  153 (305)
                            +.+..+.+.+.|++....... .....++..|+|||.+.+..++.++|+||+||++|||++|..||........
T Consensus       111 lkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~  190 (237)
T cd05576         111 LNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN  190 (237)
T ss_pred             CCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc
Confidence                  222334556666654333222 1244578889999999888889999999999999999999999865432110


Q ss_pred             HHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hhhhcCccc
Q psy6191         154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV-----AQLLHFEFF  199 (305)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~-----~~~l~~~~~  199 (305)
                          ......+|...+..++++|.+||+.||.+|+++     ++++.||||
T Consensus       191 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         191 ----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence                112234677789999999999999999999986     899999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=2e-28  Score=208.97  Aligned_cols=197  Identities=19%  Similarity=0.325  Sum_probs=141.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++++++..||||||+++ +|.+++........+...... .+..+..++.+.|..++.+.
T Consensus        46 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~  124 (284)
T cd07836          46 IREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR  124 (284)
T ss_pred             HHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            3699999999999999999999999999999999985 888887654321112222222 23345677788887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+....+++.|++.......    .....||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.
T Consensus       125 dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         125 DLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             CCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   223345677777765433221    134568999999998765 45788999999999999999999999877


Q ss_pred             CHHHHHHHHhcc------------------ccC-----------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKV------------------EYK-----------LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~------------------~~~-----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +..+....+...                  ...           +.+..+..+++++.+||+.||.+||++.++++||||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         205 NNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             CcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            655444333210                  000           112356778899999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.96  E-value=1.6e-28  Score=210.41  Aligned_cols=194  Identities=20%  Similarity=0.378  Sum_probs=138.3

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|++++++++||||+++++++++++..|+||||+.+ +|.+++.....  ......... +..+.+++.+.|..++.+. 
T Consensus        52 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~i~H~d  128 (291)
T cd07844          52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRRVLHRD  128 (291)
T ss_pred             HHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            699999999999999999999999999999999985 89888765322  112222222 3345778888887775433 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc----CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                            +.+..+.+++.|++......    ......+++.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+
T Consensus       129 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         129 LKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             CCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence                  22344567778876443211    1123357889999998865 457889999999999999999999997655


Q ss_pred             -HHHHHHHHhcc-------------------ccCC-----------CCCCC--HHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         150 -LKETYSRIKKV-------------------EYKL-----------PATLK--KPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       150 -~~~~~~~i~~~-------------------~~~~-----------~~~~~--~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                       ..+....+...                   ....           ...++  .++.+++.+||..||.+|||+.+++.|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         209 DVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence             22222211100                   0000           01233  678899999999999999999999999


Q ss_pred             ccc
Q psy6191         197 EFF  199 (305)
Q Consensus       197 ~~~  199 (305)
                      |||
T Consensus       289 ~~f  291 (291)
T cd07844         289 PYF  291 (291)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.96  E-value=2.6e-28  Score=208.91  Aligned_cols=200  Identities=14%  Similarity=0.232  Sum_probs=148.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCC----CCcC----chhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEM----SDPA----AQPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~~   73 (305)
                      .+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++.........    ....    ......+..++.++|
T Consensus        57 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH  136 (288)
T cd05061          57 LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN  136 (288)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            36889999999999999999999999999999999999999999764321110    0111    112234567788888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~  140 (305)
                      +.++.+.       +.+....+++.|++.......      .....++..|+|||.+.+..++.++|+||+||++|||++
T Consensus       137 ~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~  216 (288)
T cd05061         137 AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS  216 (288)
T ss_pred             hCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHh
Confidence            7776443       222345566777754332111      122345778999999988889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc------Cccccc
Q psy6191         141 -GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH------FEFFND  201 (305)
Q Consensus       141 -g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~------~~~~~~  201 (305)
                       |.+||.+.+..+....+... ....+...+..+.+++.+||..||.+|||+.++++      ||||++
T Consensus       217 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         217 LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence             79999887776666555433 33455667888999999999999999999999976      777764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.96  E-value=1.4e-28  Score=207.09  Aligned_cols=193  Identities=19%  Similarity=0.248  Sum_probs=144.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++.+|+||||+++|+|.+++.....  ..... ....+..+..++.+.|..++.+.
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  124 (256)
T cd05113          47 IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQFIHR  124 (256)
T ss_pred             HHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            4799999999999999999999999999999999999999998865322  11221 12233445677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCc-----ccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKN-----TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~-----~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+.+..+++.|++.........     ...|+..|+|||.+.+..++.++||||+||++|+|++ |..||..
T Consensus       125 dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~  204 (256)
T cd05113         125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER  204 (256)
T ss_pred             ccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence                   22333456777775443221111     1234567999999988889999999999999999998 9999988


Q ss_pred             CCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+..... ..+...+..+.+++.+||..||.+||++.+++.+
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         205 FNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            777666666655432 3355678889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=1.3e-28  Score=209.32  Aligned_cols=190  Identities=16%  Similarity=0.183  Sum_probs=137.3

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCC-cCchhHHHHHHHHHHhhhhCCceee
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQPVIWVSKWVDYSDKYGFGYQL   81 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~   81 (305)
                      +|+.++++++|||||++++++.++...|+|||||++|+|..++......  ... ........+..++.|.|..++.|.-
T Consensus        65 ~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiH~d  142 (274)
T cd05076          65 ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR--VPVAWKITVAQQLASALSYLEDKNLVHGN  142 (274)
T ss_pred             HHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHcCCccCCC
Confidence            6888999999999999999999999999999999999998888653221  111 1222334456788888877754431


Q ss_pred             cCCCCC---------------eeEcchhHHHHhcCCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHH-hCCCC
Q psy6191          82 NDDSSG---------------VMFNDLTRMIMLANKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLL-VGKPP  144 (305)
Q Consensus        82 ~~~~~~---------------v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l-~g~~P  144 (305)
                      .. ..+               +++.|++............|++.|+|||.+.+ ..++.++||||+||++|||+ +|..|
T Consensus       143 lk-p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  221 (274)
T cd05076         143 VC-AKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP  221 (274)
T ss_pred             CC-cccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            11 122               34445443322222234468899999998865 56889999999999999985 69999


Q ss_pred             CCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         145 FETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |...+..+..... ......|...+..+.++|.+||..||.+|||+.+++++
T Consensus       222 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         222 LKERTPSEKERFY-EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ccccChHHHHHHH-HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            9876655443322 22334555667789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.96  E-value=8.7e-29  Score=213.40  Aligned_cols=195  Identities=19%  Similarity=0.299  Sum_probs=144.6

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC-------------CCCcC-chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-------------MSDPA-AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~-------------~~~~~-~~~~~~~~   66 (305)
                      .+|+.+++++ +|||||++++++++++.+|+||||+++|+|.+++........             +.... ...+..+.
T Consensus        55 ~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  134 (303)
T cd05088          55 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA  134 (303)
T ss_pred             HHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHH
Confidence            3699999999 899999999999999999999999999999999876543211             01111 11223456


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHh---cCCcccccCCCcccccccccCCCCccchHHHHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIML---ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvily  136 (305)
                      .++.+.|+.|+.|.       +.+....+++.|++.....   .......+++.|+|||++.+..++.++||||+||++|
T Consensus       135 ~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  214 (303)
T cd05088         135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  214 (303)
T ss_pred             HHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence            77888888776443       2233345667776533211   1111223466799999998888899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         137 TLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       137 e~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||++ |.+||.+.+..+....+... ....|...+.++.+++.+||..||.+||++++++..
T Consensus       215 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         215 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9998 99999887777766655443 233455678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.96  E-value=2.1e-28  Score=206.06  Aligned_cols=191  Identities=19%  Similarity=0.218  Sum_probs=143.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.+++.++||||++++++++. +..|+||||+++|+|.+++.....+.+  ......+..+..++.+.|+.++.+. 
T Consensus        44 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~i~~qi~~al~~lH~~~i~H~d  120 (257)
T cd05116          44 LREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTE--KNITELVHQVSMGMKYLEETNFVHRD  120 (257)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCCEeecc
Confidence            468999999999999999998764 567999999999999999875433221  1112223345677888887775432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcCC-------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLANK-------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~~-------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                            +.+....+++.|++........       ....+++.|+|||.+....++.++||||+||++|||++ |.+||.
T Consensus       121 lkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  200 (257)
T cd05116         121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK  200 (257)
T ss_pred             cchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence                  1223344667777644332221       12234678999999988888999999999999999998 999999


Q ss_pred             CCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +.+..+....+.... +..|...+.++.++|.+||+.||++||+++++..
T Consensus       201 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         201 GMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            887777777776543 4567778999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=2.2e-28  Score=213.84  Aligned_cols=198  Identities=21%  Similarity=0.382  Sum_probs=144.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|++++++++|||||++++++..++..|+||||+. |+|.+++.....+..  ......+..+..++.+.|..++.|. 
T Consensus        68 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~--~~~~~~~~ql~~aL~~LH~~~i~H~d  144 (335)
T PTZ00024         68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTE--SQVKCILLQILNGLNVLHKWYFMHRD  144 (335)
T ss_pred             HHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            369999999999999999999999999999999997 589888865433321  1111223345677888887776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc------------------CCcccccCCCcccccccccC-CCCccchHHHHHHHH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA------------------NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIM  135 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~------------------~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvil  135 (305)
                            +.+....+++.|++......                  ......||+.|+|||++.+. .++.++||||+||++
T Consensus       145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l  224 (335)
T PTZ00024        145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF  224 (335)
T ss_pred             ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence                  22334566777775443222                  01133578899999988654 468899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHhcccc---------------------C-------CCCCCCHHHHHHHHHHhhcCCCCC
Q psy6191         136 YTLLVGKPPFETSTLKETYSRIKKVEY---------------------K-------LPATLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       136 ye~l~g~~Pf~~~~~~~~~~~i~~~~~---------------------~-------~~~~~~~~~~~li~~~l~~dp~~R  187 (305)
                      |+|++|.+||.+.+..+....+.....                     .       .....+..+.++|.+||..||.+|
T Consensus       225 ~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  304 (335)
T PTZ00024        225 AELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER  304 (335)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence            999999999988776655444322100                     0       012346778899999999999999


Q ss_pred             CCHhhhhcCcccccc
Q psy6191         188 PPVAQLLHFEFFNDY  202 (305)
Q Consensus       188 ~~~~~~l~~~~~~~~  202 (305)
                      ||+++++.||||+..
T Consensus       305 ~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        305 ISAKEALKHEYFKSD  319 (335)
T ss_pred             cCHHHHhcCcccCCC
Confidence            999999999999864

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.96  E-value=1.5e-28  Score=206.14  Aligned_cols=192  Identities=20%  Similarity=0.280  Sum_probs=140.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+++..|+||||+++|+|.+++......  +.... ...+..+..++.+.|..++.|.
T Consensus        41 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~i~H~  118 (252)
T cd05084          41 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKHCIHR  118 (252)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            47999999999999999999999999999999999999999998653321  11111 1223344677788887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+....+++.|++......+.      ....++..|+|||.+.+..++.++||||+||++|||++ |.+||.
T Consensus       119 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~  198 (252)
T cd05084         119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA  198 (252)
T ss_pred             ccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence                   2233345667776543321111      01122456999999988889999999999999999998 999998


Q ss_pred             CCCHHHHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ..+.......+.. .....|...+..+.+++.+||+.||++|||+.++++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         199 NLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7766555554433 234556677889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=1.6e-28  Score=211.60  Aligned_cols=193  Identities=19%  Similarity=0.272  Sum_probs=141.5

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++++++ +|||||++++++...+.+|+||||+++|+|.+++...... ....... .....+..++.+.|..++.+
T Consensus        86 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~ivH  164 (302)
T cd05055          86 MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-FLTLEDLLSFSYQVAKGMAFLASKNCIH  164 (302)
T ss_pred             HHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeh
Confidence            4699999999 7999999999999999999999999999999998653221 1111111 12223456677888766433


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                      .       +.+....+++.|++....+..      .+...+++.|+|||.+.+..++.++||||+||++|||++ |..||
T Consensus       165 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~  244 (302)
T cd05055         165 RDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY  244 (302)
T ss_pred             hhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCc
Confidence            2       223344566777765443221      123346788999999988889999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+..+.+......  ....+...+..+.+++.+||..||++|||+.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         245 PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            887665544333322  22334567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=2.4e-28  Score=209.33  Aligned_cols=198  Identities=25%  Similarity=0.420  Sum_probs=150.2

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++++++ +||||++++++++.+..+|+||||+++|+|.+++.....+   .......++ .+..++.+.|+.++.+
T Consensus        52 ~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l---~~~~~~~~~~qi~~al~~lH~~~i~H  128 (290)
T cd05613          52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF---KEQEVQIYSGEIVLALEHLHKLGIIY  128 (290)
T ss_pred             HHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            3699999999 5999999999999999999999999999999998765433   222222222 4567788888777543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccC--CCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .       +.+..+.+++.|++.......     ....+|+..|+|||.+.+.  .++.++||||+||++|+|++|..||
T Consensus       129 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~  208 (290)
T cd05613         129 RDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF  208 (290)
T ss_pred             cCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCC
Confidence            2       233345677777754332211     1245799999999998643  4678899999999999999999999


Q ss_pred             CCCC----HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         146 ETST----LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ...+    ..+....+......+|...+..+.+++.+||..||.+|+     ++++++.||||+..
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         209 TVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             CcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            6432    233444455555566777889999999999999999997     89999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=1.9e-28  Score=206.65  Aligned_cols=193  Identities=19%  Similarity=0.303  Sum_probs=144.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++.+.+..|+||||+++|+|.+++...... ....... ..+..+..++.+.|+.++.+.
T Consensus        50 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~al~~lH~~~i~h~  128 (261)
T cd05148          50 QKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQNSIHR  128 (261)
T ss_pred             HHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            47999999999999999999999999999999999999999998753221 1111111 222345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~  148 (305)
                             +.+....+++.|++........    ....+++.|+|||.+.+..++.++||||+||++|+|++ |+.||...
T Consensus       129 dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~  208 (261)
T cd05148         129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM  208 (261)
T ss_pred             ccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence                   1222345566676544332211    12345678999999988889999999999999999998 89999888


Q ss_pred             CHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         149 TLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       149 ~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +..+.+..+... ..+.+...+..+.+++.+||..||.+|||+.++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         209 NNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            777776666543 33455678889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=6.9e-29  Score=220.03  Aligned_cols=195  Identities=19%  Similarity=0.257  Sum_probs=139.2

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC---------------------------
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE---------------------------   53 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~---------------------------   53 (305)
                      .+|+++++.+ +|||||++++++.+++..|+|||||+||+|.+++........                           
T Consensus        86 ~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  165 (375)
T cd05104          86 MSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSL  165 (375)
T ss_pred             HHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhh
Confidence            4799999999 899999999999999999999999999999998865321000                           


Q ss_pred             ---------------------------------------------CCCc-CchhHHHHHHHHHHhhhhCCcee-------
Q psy6191          54 ---------------------------------------------MSDP-AAQPVIWVSKWVDYSDKYGFGYQ-------   80 (305)
Q Consensus        54 ---------------------------------------------~~~~-~~~~~~~~~~~~~~~~~~~~~~~-------   80 (305)
                                                                   +... .......+..++.+.|..++.|.       
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  245 (375)
T cd05104         166 NEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI  245 (375)
T ss_pred             hhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhE
Confidence                                                         0000 00112234567888887765432       


Q ss_pred             ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH-
Q psy6191          81 LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKE-  152 (305)
Q Consensus        81 ~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~~-  152 (305)
                      +.+....+++.||+.......      .++..++..|+|||++.+..++.++||||+||++|||++ |..||....... 
T Consensus       246 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~  325 (375)
T cd05104         246 LLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK  325 (375)
T ss_pred             EEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH
Confidence            222334566677764432211      122345677999999998889999999999999999998 899998755433 


Q ss_pred             HHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         153 TYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       153 ~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ....+... ....|...+.++++++.+||..||.+|||+.++++.
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         326 FYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            33333322 223455678899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.2e-28  Score=225.80  Aligned_cols=200  Identities=18%  Similarity=0.236  Sum_probs=138.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcC-CCCC-C-CcCchhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACD-LEEM-S-DPAAQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~-~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|+.+|++++|||||++++++++++..|+|||++. ++|.+++..... .... . ......+.++..++.|+|..++.
T Consensus       211 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIi  289 (501)
T PHA03210        211 ENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLI  289 (501)
T ss_pred             HHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            479999999999999999999999999999999986 467666543211 0000 0 01112233456778888887764


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC-C
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-F  145 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P-f  145 (305)
                      |.       +.+..+.+++.||+....+..     ..+.+||+.|+|||++.+..++.++||||+||++|||++|..+ |
T Consensus       290 HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             cCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            42       233445678888875543322     1246899999999999988999999999999999999998754 4


Q ss_pred             CCC--CHHHHHHH-Hhcc---ccCCC----------------------------CCCCHHHHHHHHHHhhcCCCCCCCHh
Q psy6191         146 ETS--TLKETYSR-IKKV---EYKLP----------------------------ATLKKPAATMIKKMLLLDPVQRPPVA  191 (305)
Q Consensus       146 ~~~--~~~~~~~~-i~~~---~~~~~----------------------------~~~~~~~~~li~~~l~~dp~~R~~~~  191 (305)
                      ...  +....+.. +...   ...+|                            ..++.++.++|.+||..||.+|||+.
T Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~  449 (501)
T PHA03210        370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA  449 (501)
T ss_pred             cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence            322  12121111 1100   00000                            12345667889999999999999999


Q ss_pred             hhhcCcccccc
Q psy6191         192 QLLHFEFFNDY  202 (305)
Q Consensus       192 ~~l~~~~~~~~  202 (305)
                      |++.||||...
T Consensus       450 elL~hp~f~~~  460 (501)
T PHA03210        450 ELLALPLFSAE  460 (501)
T ss_pred             HHhhChhhhcC
Confidence            99999999753

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=2.7e-28  Score=210.79  Aligned_cols=197  Identities=20%  Similarity=0.296  Sum_probs=144.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++||||+++++++.++...|+||||+. |++.+++......  +...... .+..+..++.+.|..++.+.
T Consensus        63 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~--l~~~~~~~~~~~l~~~l~~LH~~~i~H~  139 (308)
T cd06634          63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHR  139 (308)
T ss_pred             HHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            369999999999999999999999999999999997 5777776543211  1222222 22334567778887665332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                             +.+.++.+++.|++............||+.|+|||.+.   ...++.++||||+||++|+|++|..||...+.
T Consensus       140 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  219 (308)
T cd06634         140 DVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (308)
T ss_pred             CCCHHhEEECCCCcEEECCcccceeecCcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence                   22334556777776554444455678999999999874   34578899999999999999999999987665


Q ss_pred             HHHHHHHhcccc-C-CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         151 KETYSRIKKVEY-K-LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       151 ~~~~~~i~~~~~-~-~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .+....+..... . .+...+..+.++|++||..+|.+||+++++++|+|+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             HHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            544443433222 2 13357788999999999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.7e-28  Score=205.25  Aligned_cols=193  Identities=18%  Similarity=0.279  Sum_probs=144.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+.+..|+||||++|++|.+++.....  ...... ...+..+.+++.+.|+.++.+.
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  124 (256)
T cd05059          47 IEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNGFIHR  124 (256)
T ss_pred             HHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            3699999999999999999999999999999999999999998865322  111111 1222345677788887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCc--c---cccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKN--T---LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~--~---~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+.++.+++.|++......+..  .   ..++..|+|||.+.+..++.++||||+||++|+|++ |.+||..
T Consensus       125 dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  204 (256)
T cd05059         125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER  204 (256)
T ss_pred             cccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence                   22334557777776433222211  1   123457999999988889999999999999999999 8999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+... ....|...+..+.+++.+||..+|++|||+.++++.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         205 FSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            7777666666543 334566688999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=2.8e-28  Score=204.80  Aligned_cols=196  Identities=26%  Similarity=0.412  Sum_probs=149.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++||||+++++.+.+.  +.+|+||||+++++|.+++.....+..  ......+..+..++.+.|+.++.+
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~~~l~~~l~~lh~~~~~h  124 (260)
T cd06606          47 EREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--PVIRKYTRQILEGLAYLHSNGIVH  124 (260)
T ss_pred             HHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHHCCccc
Confidence            5799999999999999999999988  899999999999999999876542211  111222334567788888776543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      .       +.+....+++.|++.......      .....|+..|+|||.+.+..++.++||||+|+++|+|++|..||.
T Consensus       125 ~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  204 (260)
T cd06606         125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS  204 (260)
T ss_pred             cCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            2       222345667777654332221      234578999999999988888999999999999999999999998


Q ss_pred             CCC-HHHHHHHHh--ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         147 TST-LKETYSRIK--KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       147 ~~~-~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ... .......+.  .....+|...+....++|.+||..||.+||++.+++.||||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         205 ELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            765 333333333  23345667788999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.6e-28  Score=208.87  Aligned_cols=197  Identities=21%  Similarity=0.362  Sum_probs=146.0

Q ss_pred             hhHHHHHhcCC---CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLK---HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~---HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   77 (305)
                      .+|+.++++++   ||||+++++++.++...|+||||++|++|.+++... .+   .... ...+..+..++.+.|..++
T Consensus        47 ~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l---~~~~~~~i~~~i~~~l~~lh~~~i  122 (277)
T cd06917          47 QREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-PI---AEKYISVIIREVLVALKYIHKVGV  122 (277)
T ss_pred             HHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc-CC---CHHHHHHHHHHHHHHHHHHHhCCc
Confidence            46899999997   999999999999999999999999999999988643 22   2111 1222334667788887775


Q ss_pred             cee-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          78 GYQ-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        78 ~~~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .+.       +.+..+.+++.|++.......    .....|++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||
T Consensus       123 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~  202 (277)
T cd06917         123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY  202 (277)
T ss_pred             ccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCC
Confidence            443       223345677777764433221    234579999999998864 45688999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccc-cCCCC-CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         146 ETSTLKETYSRIKKVE-YKLPA-TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-~~~~~-~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+.+.......+.... ..++. ..+.++.+++.+||..||.+||++.+++.|+|+...
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         203 SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             CCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            8876655443333221 22233 267789999999999999999999999999999753

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.3e-28  Score=207.94  Aligned_cols=194  Identities=15%  Similarity=0.225  Sum_probs=147.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCC-------CC-cCchhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEM-------SD-PAAQPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~-------~~-~~~~~~~~~~~~~~~~~   73 (305)
                      .+|+.+++.++||||+++++++.++...|+||||+++|+|.+++.......+.       .. .....+..+..++.+.|
T Consensus        57 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH  136 (277)
T cd05032          57 LNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA  136 (277)
T ss_pred             HHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            37899999999999999999999999999999999999999998754322110       11 11112234567788888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~  140 (305)
                      ..++.+.       +.+..+.+++.|++....+..      .....||..|+|||.+.+..++.++|||||||++||+++
T Consensus       137 ~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  216 (277)
T cd05032         137 AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT  216 (277)
T ss_pred             hCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhc
Confidence            7765443       223345677778764432211      234467889999999988889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         141 -GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       141 -g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                       |..||.+.+..+....+... ....|...+.++.+++.+||+.+|.+|||+.+++.
T Consensus       217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         217 LAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             cCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             99999888777766666543 34556778899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.96  E-value=2.6e-28  Score=208.06  Aligned_cols=194  Identities=16%  Similarity=0.238  Sum_probs=143.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC------------CCCCcCc-hhHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE------------EMSDPAA-QPVIWVSKW   68 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~------------~~~~~~~-~~~~~~~~~   68 (305)
                      .+|+++++.++||||+++++++.+++..|+||||+++|+|.+++.......            .+..... ..+..+..+
T Consensus        55 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a  134 (280)
T cd05092          55 QREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASG  134 (280)
T ss_pred             HHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHH
Confidence            479999999999999999999999999999999999999999987543210            0011111 112234567


Q ss_pred             HHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHH
Q psy6191          69 VDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIM  135 (305)
Q Consensus        69 ~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvil  135 (305)
                      +.+.|+.++.+.       +.++...+++.|++.......      .....+++.|+|||.+.+..++.++|||||||++
T Consensus       135 l~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  214 (280)
T cd05092         135 MVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL  214 (280)
T ss_pred             HHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHH
Confidence            788887765432       222334566677654322111      1233457889999999888899999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         136 YTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       136 ye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |||++ |.+||...+..+....+... ....|...+..+.+++.+||+.||.+||++.++++
T Consensus       215 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         215 WEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            99998 99999877766665555443 33455678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=2e-28  Score=208.91  Aligned_cols=196  Identities=22%  Similarity=0.349  Sum_probs=139.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+||||++ ++|.+++..... ....... ......+.+++.+.|..++.+.
T Consensus        46 ~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~  123 (283)
T cd07835          46 IREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHRVLHR  123 (283)
T ss_pred             HHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence            369999999999999999999999999999999995 689888865432 1111211 1223345677888887665332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+....+++.|++......    ......|++.|+|||++.+. .++.++||||+||++|+|++|.+||...
T Consensus       124 dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         124 DLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   22234566677765443221    11233578999999987654 5788999999999999999999999876


Q ss_pred             CHHHHHHHHhcc-------------------------c----cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKV-------------------------E----YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~-------------------------~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +.......+...                         .    ....+.++..+.++|.+||+.||.+|||+++++.||||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         204 SEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             CHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            654332222110                         0    01123466789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=1.1e-28  Score=207.99  Aligned_cols=197  Identities=26%  Similarity=0.412  Sum_probs=147.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++||||+++++++.+....|+||||+++++|.+++...... ..+.+... ..+..+..++.+.|..++.+
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h  129 (260)
T cd08222          50 NQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILH  129 (260)
T ss_pred             HHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence            36889999999999999999999999999999999999999887642211 11122211 22334567788888777543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+ .+.+++.|++.......    .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       130 ~~l~~~nili~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~  208 (260)
T cd08222         130 RDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ  208 (260)
T ss_pred             cCCChhheEee-cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            2       111 23456666653332211    23456899999999988888889999999999999999999999877


Q ss_pred             CHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +.......+... .+..+...+.++.++|.+||..||++||++.++++||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         209 NFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             cHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            766665555433 234455678899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.3e-28  Score=203.33  Aligned_cols=195  Identities=27%  Similarity=0.446  Sum_probs=148.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+++..|+||||+++++|.+++.....+   ..... ..+..+..++.+.|..|+.+.
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l---~~~~~~~~~~~i~~~l~~lH~~~i~H~  123 (254)
T cd06627          47 MQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF---PESLVAVYVYQVLQGLAYLHEQGVIHR  123 (254)
T ss_pred             HHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCC---CHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence            47999999999999999999999999999999999999999998765333   22221 223334566777777765443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++........    ....|+..|+|||.+.+..++.++||||+|+++|+|++|..||...+
T Consensus       124 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~  203 (254)
T cd06627         124 DIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN  203 (254)
T ss_pred             CCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence                   1222345666666544332221    23578999999999987778899999999999999999999998766


Q ss_pred             HHHHHHHH-hccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRI-KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      .......+ ......+|...+..+.+++.+||..+|++|||+.+++.||||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         204 PMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            54443333 334445667788999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=2.5e-28  Score=209.44  Aligned_cols=195  Identities=23%  Similarity=0.331  Sum_probs=141.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|+.++++++||||+++++++..+  +.+|+||||+++ +|.+++.....  .+.... ......+.+++.+.|..++.
T Consensus        52 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~  128 (293)
T cd07843          52 LREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNWIL  128 (293)
T ss_pred             HHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3699999999999999999999877  899999999985 89888865432  112222 22334456788888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      +.       +.+....+++.|++.......    .....|++.|+|||++.+. .++.++||||+||++|+|++|.+||.
T Consensus       129 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~  208 (293)
T cd07843         129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP  208 (293)
T ss_pred             eccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence            43       223345667777754332222    1234688999999988654 46889999999999999999999998


Q ss_pred             CCCHHHHHHHHhcc-------------------------------ccCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         147 TSTLKETYSRIKKV-------------------------------EYKLPAT-LKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-------------------------------~~~~~~~-~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      ..+......++...                               ...++.. ++..+.++|++||+.||++|||+.|++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell  288 (293)
T cd07843         209 GKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL  288 (293)
T ss_pred             CCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence            77655444333210                               0112222 577889999999999999999999999


Q ss_pred             cCccc
Q psy6191         195 HFEFF  199 (305)
Q Consensus       195 ~~~~~  199 (305)
                      .||||
T Consensus       289 ~~~~f  293 (293)
T cd07843         289 KHPYF  293 (293)
T ss_pred             cCCCC
Confidence            99997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG1151|consensus

Probab=99.96  E-value=8.6e-29  Score=210.12  Aligned_cols=199  Identities=24%  Similarity=0.392  Sum_probs=149.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE-cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhh------
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE-DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSD------   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~-~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------   73 (305)
                      .||.+|.+.|+||-||++|++|. +.+.++-|+|||+|.||.-+++.....   ++..++. +.+++.++.|+.      
T Consensus       515 cREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklm---SEKEARSIiMQiVnAL~YLNEikpPI  591 (775)
T KOG1151|consen  515 CREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLM---SEKEARSIIMQIVNALKYLNEIKPPI  591 (775)
T ss_pred             HHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhh---hHHHHHHHHHHHHHHHHHHhccCCCe
Confidence            58999999999999999999996 567899999999999999888765443   3444443 445667776665      


Q ss_pred             -----hhCCceeecCC--CCCeeEcchhHHHHhcCC-----------cccccCCCcccccccc-c---CCCCccchHHHH
Q psy6191          74 -----KYGFGYQLNDD--SSGVMFNDLTRMIMLANK-----------NTLCGTPNYIAPEILN-K---NGHSFEVDVWSI  131 (305)
Q Consensus        74 -----~~~~~~~~~~~--~~~v~~~d~~~~~~~~~~-----------~~~~Gt~~y~aPE~~~-~---~~~~~~~DiwSl  131 (305)
                           +.| ++++.+.  .+.|++.||+...+..+.           ....||.||.+||.+. +   ...+.++||||+
T Consensus       592 IHYDLKPg-NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv  670 (775)
T KOG1151|consen  592 IHYDLKPG-NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV  670 (775)
T ss_pred             eeeccCCc-cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence                 223 3333332  456888999877765432           2457999999999763 2   246889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHH-HH--HHH-hccccCCC--CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         132 GCIMYTLLVGKPPFETSTLKE-TY--SRI-KKVEYKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       132 Gvilye~l~g~~Pf~~~~~~~-~~--~~i-~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      |||+|.++.|+.||...-... ++  ..| +.....+|  +.+++++++||++||++--+.|....++..||+|..+..
T Consensus       671 GVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r  749 (775)
T KOG1151|consen  671 GVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR  749 (775)
T ss_pred             ehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence            999999999999997643222 21  122 22333444  579999999999999999999999999999999987543

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=3.4e-28  Score=204.59  Aligned_cols=193  Identities=22%  Similarity=0.326  Sum_probs=144.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEE-EcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFF-EDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~-~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++||||+++++++ .+++..|+||||+++|+|.+++...... ...... ......+..++.+.|..++.+
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H  125 (256)
T cd05082          47 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANNFVH  125 (256)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            4799999999999999999975 4567899999999999999998754321 111111 222334567788888777544


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~  150 (305)
                      .       +.+....+++.|++...... ...+..++..|+|||++.+..++.++||||+||++|+|++ |+.||...+.
T Consensus       126 ~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~  205 (256)
T cd05082         126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  205 (256)
T ss_pred             cccchheEEEcCCCcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence            2       22334556677776443221 1234456778999999988889999999999999999997 9999998887


Q ss_pred             HHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         151 KETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       151 ~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+....+... ....+...+....+++.+||..||.+|||+.++++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         206 KDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            7776666543 33445667889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=2.3e-28  Score=215.23  Aligned_cols=194  Identities=20%  Similarity=0.339  Sum_probs=140.2

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      +|+.++++++|||||+++++|...      ...|+|||||.+ +|.+.+...  +   ..... ..+..+..++.++|..
T Consensus        64 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l---~~~~~~~~~~ql~~aL~~LH~~  137 (353)
T cd07850          64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--L---DHERMSYLLYQMLCGIKHLHSA  137 (353)
T ss_pred             HHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--C---CHHHHHHHHHHHHHHHHHHHhC
Confidence            699999999999999999998754      357999999965 787776533  2   22222 2233456778888877


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      |+.+.       +.+..+.+++.|++.......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||
T Consensus       138 gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf  217 (353)
T cd07850         138 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF  217 (353)
T ss_pred             CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence            75443       233445677778765443222   13456899999999999888999999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccc----------------------c--------------CC-------CCCCCHHHHHHHHHHhhc
Q psy6191         146 ETSTLKETYSRIKKVE----------------------Y--------------KL-------PATLKKPAATMIKKMLLL  182 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~----------------------~--------------~~-------~~~~~~~~~~li~~~l~~  182 (305)
                      ...+....+..+....                      .              .+       +...+..++++|.+||+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  297 (353)
T cd07850         218 PGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI  297 (353)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCC
Confidence            8766544333321100                      0              00       112345678999999999


Q ss_pred             CCCCCCCHhhhhcCcccccc
Q psy6191         183 DPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       183 dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||.+|||+.|++.||||+.+
T Consensus       298 dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         298 DPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             ChhhCcCHHHHhcChhHhhc
Confidence            99999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=3.3e-28  Score=210.25  Aligned_cols=194  Identities=22%  Similarity=0.336  Sum_probs=136.3

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCC--------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhh
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSK--------FVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSD   73 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~--------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   73 (305)
                      +|++++++++|||||++++++.+..        ..|+|||||.+ +|.+.+.....  ...... ...+..+..++.+.|
T Consensus        60 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH  136 (310)
T cd07865          60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIH  136 (310)
T ss_pred             HHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH
Confidence            6999999999999999999987654        46999999975 78777754321  112222 222334567788888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhcC--------CcccccCCCcccccccccC-CCCccchHHHHHHHHHH
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye  137 (305)
                      ..++.+.       +.+..+.+++.|++.......        .....|++.|+|||++.+. .++.++||||+||++|+
T Consensus       137 ~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~e  216 (310)
T cd07865         137 RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAE  216 (310)
T ss_pred             HCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHH
Confidence            7775442       223345677777764433211        1234678899999987654 47889999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhcccc-------------------CCC-------------CCCCHHHHHHHHHHhhcCCC
Q psy6191         138 LLVGKPPFETSTLKETYSRIKKVEY-------------------KLP-------------ATLKKPAATMIKKMLLLDPV  185 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~~~~~i~~~~~-------------------~~~-------------~~~~~~~~~li~~~l~~dp~  185 (305)
                      |++|++||.+.+.......+.....                   .+|             ...+..+.++|.+||..||.
T Consensus       217 l~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~  296 (310)
T cd07865         217 MWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA  296 (310)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChh
Confidence            9999999987765443332222100                   011             11245678999999999999


Q ss_pred             CCCCHhhhhcCccc
Q psy6191         186 QRPPVAQLLHFEFF  199 (305)
Q Consensus       186 ~R~~~~~~l~~~~~  199 (305)
                      +|||++++++||||
T Consensus       297 ~R~t~~e~l~h~~f  310 (310)
T cd07865         297 KRIDADTALNHDFF  310 (310)
T ss_pred             hccCHHHHhcCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.96  E-value=4.6e-28  Score=208.29  Aligned_cols=195  Identities=19%  Similarity=0.292  Sum_probs=143.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC-------------CCCcC-chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-------------MSDPA-AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~-------------~~~~~-~~~~~~~~   66 (305)
                      .+|+.+++++ +|||||++++++.+.+.+|+||||+++|+|.+++........             +.... ...+..+.
T Consensus        50 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  129 (297)
T cd05089          50 AGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA  129 (297)
T ss_pred             HHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHH
Confidence            4699999999 799999999999999999999999999999999865432110             00011 11223346


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvily  136 (305)
                      .++.++|+.++.|.       +.+....+++.|++......   ......++..|+|||++.+..++.++|||||||++|
T Consensus       130 ~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~  209 (297)
T cd05089         130 TGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW  209 (297)
T ss_pred             HHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence            77888887775443       22233455666765432111   111122345799999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         137 TLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       137 e~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||++ |..||.+.+..+....+... ....|...+..+.+++.+||..||.+||+++++++.
T Consensus       210 el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         210 EIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9997 99999988877776666543 234566788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.96  E-value=4.8e-28  Score=206.11  Aligned_cols=195  Identities=17%  Similarity=0.203  Sum_probs=142.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCC-CcC----chhHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS-DPA----AQPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~   76 (305)
                      .+|+.++++++|||||++++++.+.+..|+||||++||+|.+++.......... ...    .+.+..+..++.+.|..+
T Consensus        57 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  136 (277)
T cd05036          57 LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH  136 (277)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            368999999999999999999999999999999999999999987654321111 111    122334567778888776


Q ss_pred             Ccee--------ecCC--CCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh
Q psy6191          77 FGYQ--------LNDD--SSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        77 ~~~~--------~~~~--~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~  140 (305)
                      +.|.        +.+.  ...+++.|++....+..      .....+++.|+|||++.+..++.++||||+||++|||++
T Consensus       137 ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  216 (277)
T cd05036         137 FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS  216 (277)
T ss_pred             EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence            5432        1111  11245556553332211      112233567999999988889999999999999999997


Q ss_pred             -CCCCCCCCCHHHHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         141 -GKPPFETSTLKETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       141 -g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                       |..||.+.+..+....+.. .....|...+..+.+++.+||+.||++||++.++++|
T Consensus       217 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         217 LGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             9999998777666555543 2345567788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=4.3e-28  Score=204.48  Aligned_cols=192  Identities=18%  Similarity=0.298  Sum_probs=141.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++. .+..|+||||+++|+|.+++...... ...... ......+..++.+.|+.++.+.
T Consensus        49 ~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~al~~lH~~~i~H~  126 (260)
T cd05069          49 LQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIERMNYIHR  126 (260)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            47999999999999999999875 45689999999999999998753221 111111 1223345677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.++...+++.|++........     ....++..|+|||.+.+..++.++||||+||++|+|++ |.+||.+
T Consensus       127 dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  206 (260)
T cd05069         127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             ccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   2223344666676644322111     12345678999999988889999999999999999999 9999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ....+...+..+.+++++||..||.+||+++++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         207 MVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             CCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            7777666665543 23445667889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.9e-28  Score=203.29  Aligned_cols=195  Identities=22%  Similarity=0.391  Sum_probs=146.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++||||+++++++.+.  +.+|+||||+++++|.+.+.....+.+  .........+..++.+.|..++.+
T Consensus        52 ~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~i~~al~~LH~~~i~H  129 (264)
T cd06653          52 ECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE--NVTRRYTRQILQGVSYLHSNMIVH  129 (264)
T ss_pred             HHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHhCCEec
Confidence            4799999999999999999998764  569999999999999998875433311  111122334567788888777543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc-------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .       +.+.+..+++.|++......       ......||..|+|||.+.+..++.++|+||+||++|+|++|++||
T Consensus       130 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  209 (264)
T cd06653         130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW  209 (264)
T ss_pred             CCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            2       22334556777775443221       112456899999999998888899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         146 ETSTLKETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ...+..+....+...  ...+|..++..+.++|.+||+ +|.+||++.+++.|||.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         210 AEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            877655554444332  234677889999999999998 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=5.4e-28  Score=203.37  Aligned_cols=192  Identities=19%  Similarity=0.269  Sum_probs=143.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+ ...|+||||+++|+|.+.+..... ........ .....+..++.+.|..++.+.
T Consensus        44 ~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~  121 (257)
T cd05040          44 LKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHR  121 (257)
T ss_pred             HHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            479999999999999999999988 899999999999999999876432 11111111 122345677888887776443


Q ss_pred             e-------cCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 L-------NDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 ~-------~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                      -       .+..+.+++.|++....+..       .....|+..|+|||.+.+..++.++||||+||++|+|++ |..||
T Consensus       122 di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  201 (257)
T cd05040         122 DLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW  201 (257)
T ss_pred             ccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence            2       22234566777754433221       123457889999999988889999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+..+....+...  ....|...+....+++.+||..+|.+||++.++++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         202 AGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            887777666555432  22344567788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=6.6e-28  Score=203.97  Aligned_cols=193  Identities=16%  Similarity=0.223  Sum_probs=145.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++..|+||||+++|+|.+++.....  .+.... ...+..+..++.++|+.++.+.
T Consensus        53 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~  130 (266)
T cd05033          53 LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNYVHR  130 (266)
T ss_pred             HHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            3699999999999999999999999999999999999999998865322  111111 1223345677788887765442


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+....+++.|++........      ....+++.|+|||.+.+..++.++||||+||++|+|++ |..||.
T Consensus       131 di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~  210 (266)
T cd05033         131 DLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             CCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence                   2233455677777655443211      12235678999999988889999999999999999998 999998


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .....+....+... ..+.+...+..+.+++.+||+.||++||++.+++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         211 DMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            77766666666543 234455678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=4.6e-29  Score=210.31  Aligned_cols=192  Identities=24%  Similarity=0.398  Sum_probs=140.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHh--cCCCCCCCcCchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSA--CDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++|||||++++++.+.+..++|||||++|+|.+++...  ..+.  .......+..+..++.|.|+.++.|
T Consensus        49 ~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~--~~~~~~i~~~i~~~l~~Lh~~~iiH  126 (259)
T PF07714_consen   49 LNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLS--EQQRLSIAIQIAEALSYLHSNNIIH  126 (259)
T ss_dssp             HHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSB--HHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             eeccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccc
Confidence            47999999999999999999999888899999999999999999876  2221  1112223344577888888776433


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                      .       +.+....+++.|++......      ......+...|+|||.+.+..++.++||||||+++||+++ |+.||
T Consensus       127 ~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~  206 (259)
T PF07714_consen  127 GNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPF  206 (259)
T ss_dssp             ST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            1       23334567777775443331      1123356778999999988889999999999999999999 78999


Q ss_pred             CCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+..+....+.... ...|...+....++|.+||..||.+||++.++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  207 SDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             TTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             cccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9888877777765443 3445568899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=5.6e-28  Score=203.84  Aligned_cols=193  Identities=19%  Similarity=0.292  Sum_probs=142.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++..++.+|+||||+++|+|.+++...... ...... ...+..+..++.+.|+.++.+.
T Consensus        49 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  127 (261)
T cd05068          49 LAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQNYIHR  127 (261)
T ss_pred             HHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            47999999999999999999999999999999999999999998654311 111111 2222334677788887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC--ccccc---CCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK--NTLCG---TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~--~~~~G---t~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+..+.+++.|++........  ....|   +..|+|||.+.+..++.++||||+||++|||++ |+.||.+
T Consensus       128 dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  207 (261)
T cd05068         128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG  207 (261)
T ss_pred             cCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence                   2223345667776533222111  11123   357999999988889999999999999999999 9999998


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.......+... ....+...+..+.+++.+||..||.+||++.++..
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         208 MTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            8777766666443 23345567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=2.8e-28  Score=209.60  Aligned_cols=197  Identities=19%  Similarity=0.307  Sum_probs=142.5

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|++++++++|||||++++++.+++..|+||||+ +|+|.+++.....  .+.... ...+..+.+++.+.|..++.+. 
T Consensus        51 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i~H~d  127 (298)
T cd07841          51 REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSI--VLTPADIKSYMLMTLRGLEYLHSNWILHRD  127 (298)
T ss_pred             HHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Confidence            6899999999999999999999999999999999 9999999875431  112222 2233445778888888775443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC----CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                            +.+..+.+++.|++.......    .....+++.|+|||.+.+ ..++.++||||+||++|+|++|.+||.+.+
T Consensus       128 l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~  207 (298)
T cd07841         128 LKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS  207 (298)
T ss_pred             CChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence                  222334566666653332211    123357889999998854 457889999999999999999999998766


Q ss_pred             HHHHHHHHhccc-----------------------cC-----CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         150 LKETYSRIKKVE-----------------------YK-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~-----------------------~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ..+....+....                       ..     .....+..+.++|.+||..||.+|||+.+++.|+||.+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         208 DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             cHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence            544443332110                       00     01234677889999999999999999999999999986


Q ss_pred             c
Q psy6191         202 Y  202 (305)
Q Consensus       202 ~  202 (305)
                      .
T Consensus       288 ~  288 (298)
T cd07841         288 D  288 (298)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=1.5e-28  Score=214.78  Aligned_cols=198  Identities=22%  Similarity=0.345  Sum_probs=142.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   76 (305)
                      .+|+.++++++|||||+++++++.    ...+|+||||+. |+|.+.+.....+   ..... ..+..+..++.++|..+
T Consensus        52 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~i~~qi~~aL~~LH~~~  127 (334)
T cd07855          52 LRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPL---TEEHIRYFLYQLLRGLKYIHSAN  127 (334)
T ss_pred             HHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCC---CHHHHHHHHHHHHHHHHHHHHCC
Confidence            369999999999999999998863    457999999996 6888887654332   22222 22334567788888777


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhcC--------CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHh
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~  140 (305)
                      +.+.       +.+....+++.|++.......        ....+||..|+|||++.+ ..++.++||||+||++|+|++
T Consensus       128 ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~  207 (334)
T cd07855         128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG  207 (334)
T ss_pred             eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc
Confidence            5442       233445677777764433211        124579999999998765 458899999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcc--------------------------ccCC-----CCCCCHHHHHHHHHHhhcCCCCCCC
Q psy6191         141 GKPPFETSTLKETYSRIKKV--------------------------EYKL-----PATLKKPAATMIKKMLLLDPVQRPP  189 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~--------------------------~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~  189 (305)
                      |++||.+.+.......+...                          ....     .+..+.++.++|.+||+.||.+||+
T Consensus       208 g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt  287 (334)
T cd07855         208 RRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT  287 (334)
T ss_pred             CCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC
Confidence            99999876544332221110                          0001     1345788999999999999999999


Q ss_pred             HhhhhcCccccccC
Q psy6191         190 VAQLLHFEFFNDYC  203 (305)
Q Consensus       190 ~~~~l~~~~~~~~~  203 (305)
                      +.+++.||||....
T Consensus       288 ~~~~l~~~~~~~~~  301 (334)
T cd07855         288 VEQALQHPFLAQYH  301 (334)
T ss_pred             HHHHHhChhhhhcc
Confidence            99999999998653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.96  E-value=6.8e-28  Score=201.92  Aligned_cols=192  Identities=18%  Similarity=0.255  Sum_probs=141.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+.+..|+||||+++|+|.+++......  ..... ......+..++.+.|..++.|.
T Consensus        40 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~H~  117 (250)
T cd05085          40 LSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLESKNCIHR  117 (250)
T ss_pred             HHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            36999999999999999999999999999999999999999988643221  11111 2222334566777787665332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.|++.......     .....+++.|+|||++.+..++.++||||+||++|++++ |..||..
T Consensus       118 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~  197 (250)
T cd05085         118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG  197 (250)
T ss_pred             ccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence                   122334566667654332111     112244677999999988888999999999999999998 9999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.......+... ....+...+..+.+++.+||..||++||++.++.+
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         198 MTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            7776665555443 23445668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=3.5e-28  Score=216.53  Aligned_cols=194  Identities=20%  Similarity=0.274  Sum_probs=138.6

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC--C-------------------------
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE--E-------------------------   53 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~--~-------------------------   53 (305)
                      .+|++++++++ |||||++++++++.+.+|||||||++|+|.+++.......  .                         
T Consensus        88 ~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (400)
T cd05105          88 MSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYV  167 (400)
T ss_pred             HHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchh
Confidence            47999999996 9999999999999999999999999999999886532100  0                         


Q ss_pred             ------------------------------------------------------------------CCCc-CchhHHHHH
Q psy6191          54 ------------------------------------------------------------------MSDP-AAQPVIWVS   66 (305)
Q Consensus        54 ------------------------------------------------------------------~~~~-~~~~~~~~~   66 (305)
                                                                                        +... .......+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~  247 (400)
T cd05105         168 ILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVA  247 (400)
T ss_pred             hhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHH
Confidence                                                                              0000 001122345


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.+.|..++.+.       +.+....+++.|++......      ......|++.|||||++.+..++.++||||+||
T Consensus       248 ~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGv  327 (400)
T cd05105         248 RGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI  327 (400)
T ss_pred             HHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHH
Confidence            67788887665332       22233456677776443221      122345778899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHH-HHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         134 IMYTLLV-GKPPFETSTLKET-YSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~-~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++|||++ |..||........ ...+... ....+...+..+.+++.+||..||.+||++.++.+
T Consensus       328 il~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         328 LLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            9999997 9999987544333 3333322 23445678889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=6e-28  Score=201.93  Aligned_cols=195  Identities=26%  Similarity=0.429  Sum_probs=145.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++..+...|+||||++|++|.+++.....  ....... ..+..+..++.+.|..++.+.
T Consensus        45 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~h~  122 (253)
T cd05122          45 INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLEYLHSNGIIHR  122 (253)
T ss_pred             HHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHhhcCCEecC
Confidence            4799999999999999999999999999999999999999998866421  1111111 222334566777776654332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                             +.+.++.+++.|++.......   .....|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus       123 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  202 (253)
T cd05122         123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP  202 (253)
T ss_pred             CCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch
Confidence                   222345567777754443322   2456789999999999888889999999999999999999999987755


Q ss_pred             HHHHHHHhc-cccCCCCC--CCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         151 KETYSRIKK-VEYKLPAT--LKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       151 ~~~~~~i~~-~~~~~~~~--~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      ......+.. .....+..  .+..+.++|.+||..||.+|||+.++++|||
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         203 MKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            444333332 22222322  3788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=6.2e-28  Score=203.44  Aligned_cols=192  Identities=15%  Similarity=0.278  Sum_probs=141.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++. ++..|+||||+++|+|.+++....... ...... ..+..+..++.+.|..++.+.
T Consensus        49 ~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~-~~~~~~~~i~~~i~~al~~LH~~~i~H~  126 (260)
T cd05067          49 LAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNYIHR  126 (260)
T ss_pred             HHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCeecc
Confidence            47999999999999999999874 467999999999999999886543221 111111 222345677888887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+.+..+.+.|++......     ......++..|+|||++....++.++||||+||++|||++ |++||.+
T Consensus       127 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  206 (260)
T cd05067         127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG  206 (260)
T ss_pred             cccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence                   22233456666765443222     1122346678999999988889999999999999999998 9999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ....+...+.+..+++.+||..||++||+++++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         207 MTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            7776666555443 23445667889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=3.9e-28  Score=205.90  Aligned_cols=194  Identities=20%  Similarity=0.305  Sum_probs=141.4

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC-------------CCCcC-chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-------------MSDPA-AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~-------------~~~~~-~~~~~~~~   66 (305)
                      .+|+++++++ +|||||++++++...+.+|+||||+++|+|.+++........             +.... ...+..+.
T Consensus        43 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~  122 (270)
T cd05047          43 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA  122 (270)
T ss_pred             HHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHH
Confidence            3699999999 899999999999999999999999999999999875432110             01111 12223346


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHh---cCCcccccCCCcccccccccCCCCccchHHHHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIML---ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvily  136 (305)
                      .++.+.|+.++.|.       +.+....+++.|++.....   .......+++.|+|||++....++.++|||||||++|
T Consensus       123 ~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~  202 (270)
T cd05047         123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  202 (270)
T ss_pred             HHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence            77888887765442       1222344556666533211   0111223456799999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         137 TLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       137 e~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||++ |..||.+.+..+....+... ....+...+.+..+++.+||..||.+|||+.+++.
T Consensus       203 el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         203 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            9997 99999887777666655443 23445567888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.96  E-value=6.6e-28  Score=208.94  Aligned_cols=194  Identities=17%  Similarity=0.309  Sum_probs=144.8

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC--------CCCcC------chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE--------MSDPA------AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~--------~~~~~------~~~~~~~~   66 (305)
                      .+|+++++++ +|||||++++++.+++.+|+||||+++|+|.+++........        .....      ......+.
T Consensus        65 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  144 (314)
T cd05099          65 ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVA  144 (314)
T ss_pred             HHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHH
Confidence            3699999999 699999999999999999999999999999999876432100        00000      11223456


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.+.|+.|+.+.       +.+..+.+++.|++.......      .....+++.|||||++.+..++.++||||+||
T Consensus       145 ~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  224 (314)
T cd05099         145 RGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI  224 (314)
T ss_pred             HHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHH
Confidence            77888887776442       223345577777765433211      11123456899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++|+|++ |..||.+.+..+.+..+.... ...|...+.+..+++.+||..||.+|||+.+++.
T Consensus       225 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         225 LMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999999 899999888777777665543 3445667889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=1.1e-27  Score=205.06  Aligned_cols=194  Identities=16%  Similarity=0.201  Sum_probs=143.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCC-------------------Cc-Cchh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS-------------------DP-AAQP   61 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~-------------------~~-~~~~   61 (305)
                      .+|+.++++++|||||++++++.+++..|+||||+++|+|.+++..........                   .. ....
T Consensus        56 ~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  135 (288)
T cd05050          56 QREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCI  135 (288)
T ss_pred             HHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHH
Confidence            469999999999999999999999999999999999999999987543211100                   00 0122


Q ss_pred             HHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchH
Q psy6191          62 VIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDV  128 (305)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~Di  128 (305)
                      +..+..++.+.|..++.+.       +.+....+++.|++.......      .....+++.|+|||.+.+..++.++||
T Consensus       136 ~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  215 (288)
T cd05050         136 AKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDV  215 (288)
T ss_pred             HHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence            2334566778887665432       222334566677754332111      122345677999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         129 WSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       129 wSlGvilye~l~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||+||++|||++ |..||.+.+..+....+..... ..|...+.++.+++.+||+.||.+|||+.|+++
T Consensus       216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            999999999997 8899988877777776665443 345667889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=7.6e-28  Score=203.82  Aligned_cols=194  Identities=19%  Similarity=0.268  Sum_probs=142.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC----CCCCc-CchhHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE----EMSDP-AAQPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~~   76 (305)
                      .+|+.+++.++|||||++++++.+++..|+||||+++|+|.+++.......    ..... ....+..+..++.+.|..+
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (269)
T cd05044          47 LKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH  126 (269)
T ss_pred             HHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            478999999999999999999999999999999999999999987543211    01111 1112234456677888766


Q ss_pred             Ccee-------ecCCCC-----CeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          77 FGYQ-------LNDDSS-----GVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        77 ~~~~-------~~~~~~-----~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      +.+.       +.+...     .+++.|++......      ..+...++..|+|||.+.+..++.++|||||||++|+|
T Consensus       127 i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el  206 (269)
T cd05044         127 FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEI  206 (269)
T ss_pred             cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHH
Confidence            5332       111112     46666765432211      11233567889999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         139 LV-GKPPFETSTLKETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       139 l~-g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++ |..||...+..+....+.. ..+..+...+..+.+++.+||..+|.+||++.++++
T Consensus       207 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         207 LTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            98 9999988776666655543 234556678889999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=6.8e-28  Score=208.20  Aligned_cols=195  Identities=18%  Similarity=0.283  Sum_probs=144.9

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-------------CCCCc-CchhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-------------EMSDP-AAQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-------------~~~~~-~~~~~~~~~   66 (305)
                      .+|+++++.+ +|||||++++++.+++..|+|||||++|+|.+++.......             .+... ....+..+.
T Consensus        71 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  150 (307)
T cd05098          71 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVA  150 (307)
T ss_pred             HHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHH
Confidence            3689999999 79999999999999999999999999999999997643211             00100 111233446


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.+.|..++.+.       +.+....+++.|++.......      .....+++.|||||++.+..++.++||||+||
T Consensus       151 ~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~  230 (307)
T cd05098         151 RGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV  230 (307)
T ss_pred             HHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHH
Confidence            77888887776442       223335567777764432211      11123457899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++|||++ |..||.+.+..+....+.... ...|...+.++.+++.+||..+|.+|||+.+++++
T Consensus       231 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         231 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            9999998 899998887777666655443 35566788899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.96  E-value=7.4e-28  Score=202.72  Aligned_cols=191  Identities=19%  Similarity=0.244  Sum_probs=140.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||+++++++. +..|+||||+++|+|.+++.....  ..... .......+..++.+.|..++.+.
T Consensus        43 ~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  119 (257)
T cd05115          43 MREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKNFVHR  119 (257)
T ss_pred             HHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCeeec
Confidence            479999999999999999998864 578999999999999998864321  11111 12223445677888887765433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.|++........       ....+++.|+|||.+....++.++|||||||++|++++ |..||
T Consensus       120 dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  199 (257)
T cd05115         120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY  199 (257)
T ss_pred             ccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                   1223344566676544322111       11123578999999988888999999999999999996 99999


Q ss_pred             CCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+..+....+... ....|...+.++.+++.+||..||++||++.++.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         200 KKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            888777766655543 34556778899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.95  E-value=7.9e-28  Score=206.52  Aligned_cols=198  Identities=20%  Similarity=0.246  Sum_probs=139.1

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCe-----EEEEEeccCCCCHHHHHHHhcCC--CCCCCcCc-hhHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKF-----VYIILELCRKRSMMELYNSACDL--EEMSDPAA-QPVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~-----~ylVmEy~~~g~L~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~   72 (305)
                      .+|+.+++.+. |||||++++++...+.     .|+|||||++ +|.+++......  ..+.+... ..+..+.+++.+.
T Consensus        48 ~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L  126 (295)
T cd07837          48 LREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC  126 (295)
T ss_pred             HHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            46999999995 6999999999987666     8999999986 788887653221  11122222 2233456778888


Q ss_pred             hhhCCcee--------ecCCCCCeeEcchhHHHHhcC----CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHH
Q psy6191          73 DKYGFGYQ--------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        73 ~~~~~~~~--------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l  139 (305)
                      |..++.+.        +....+.+++.|++.......    .....+++.|+|||++.+ ..++.++||||+||++|+|+
T Consensus       127 H~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~  206 (295)
T cd07837         127 HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS  206 (295)
T ss_pred             HHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHH
Confidence            87775443        222245567777754332211    122357899999998764 45788999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHhccc--------------------cC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHh
Q psy6191         140 VGKPPFETSTLKETYSRIKKVE--------------------YK--------LPATLKKPAATMIKKMLLLDPVQRPPVA  191 (305)
Q Consensus       140 ~g~~Pf~~~~~~~~~~~i~~~~--------------------~~--------~~~~~~~~~~~li~~~l~~dp~~R~~~~  191 (305)
                      +|.+||.+.+..+....+....                    ..        ..+..+..+.++|.+||..||.+||++.
T Consensus       207 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~  286 (295)
T cd07837         207 RKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK  286 (295)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHH
Confidence            9999998776554433322100                    00        0024677899999999999999999999


Q ss_pred             hhhcCcccc
Q psy6191         192 QLLHFEFFN  200 (305)
Q Consensus       192 ~~l~~~~~~  200 (305)
                      +++.||||+
T Consensus       287 eil~~~~~~  295 (295)
T cd07837         287 AALTHPYFD  295 (295)
T ss_pred             HHhcCCCcC
Confidence            999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=1.6e-27  Score=203.47  Aligned_cols=194  Identities=15%  Similarity=0.230  Sum_probs=145.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC-------------CCCc-CchhHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-------------MSDP-AAQPVIWVSK   67 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~-------------~~~~-~~~~~~~~~~   67 (305)
                      .+|+.+++.++|||||++++++++.+..++++||+.+++|.+++........             +... ....+..+..
T Consensus        56 ~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~  135 (283)
T cd05091          56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAA  135 (283)
T ss_pred             HHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence            4689999999999999999999999999999999999999998864321110             0000 0112234567


Q ss_pred             HHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHH
Q psy6191          68 WVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCI  134 (305)
Q Consensus        68 ~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvi  134 (305)
                      ++.+.|..++.|.       +..+...+++.|++....+.      ..+...+|+.|+|||.+.+..++.++||||+||+
T Consensus       136 aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~  215 (283)
T cd05091         136 GMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVV  215 (283)
T ss_pred             HHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHH
Confidence            7888887775433       22233457777776433221      1123456789999999988889999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         135 MYTLLV-GKPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       135 lye~l~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +|||++ |..||.+.+..+....+..... ..|...+....+++.+||+.||.+||++.+++.
T Consensus       216 l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         216 LWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            999998 8999998888777777766543 346678888999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.95  E-value=1.4e-27  Score=204.55  Aligned_cols=194  Identities=13%  Similarity=0.219  Sum_probs=144.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC---------------------CCCcC-c
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE---------------------MSDPA-A   59 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~---------------------~~~~~-~   59 (305)
                      .+|+.+++.++|||||++++.+..++..|+||||+.+|+|.+++........                     +.... .
T Consensus        51 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  130 (290)
T cd05045          51 LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLI  130 (290)
T ss_pred             HHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHH
Confidence            4699999999999999999999999999999999999999998865322110                     00000 1


Q ss_pred             hhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccc
Q psy6191          60 QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEV  126 (305)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~  126 (305)
                      ..+..+..++.+.|+.++.|.       +.++...+++.|++.......      .....++..|+|||.+.+..++.++
T Consensus       131 ~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~  210 (290)
T cd05045         131 SFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS  210 (290)
T ss_pred             HHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHh
Confidence            112234566777776665332       223345567777764432211      1233567889999998888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         127 DVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       127 DiwSlGvilye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||||+||++|||++ |..||.+.+..+....+... ....|...+.++.+++.+||+.||.+||++.++++
T Consensus       211 Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         211 DVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999998 99999988877766655432 33446678889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=5.6e-28  Score=206.79  Aligned_cols=198  Identities=23%  Similarity=0.395  Sum_probs=147.3

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++++ +||||+++++.++++..+|+||||+++|+|.+.+.....+   ..... ..+..+.+++.+.|..++.+
T Consensus        52 ~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~ql~~~l~~lH~~~~~H  128 (288)
T cd05583          52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF---TESEVRVYIAEIVLALDHLHQLGIIY  128 (288)
T ss_pred             HHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCc---CHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            3689999999 6999999999999999999999999999999988654332   11111 22334567788888776543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCC--CCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNG--HSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~--~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .       +.+....+++.|++....+..     ....+|++.|+|||.+.+..  .+.++|+||+|+++|+|++|..||
T Consensus       129 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~  208 (288)
T cd05583         129 RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF  208 (288)
T ss_pred             cCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCc
Confidence            2       223345567777754332211     12357899999999987654  678999999999999999999999


Q ss_pred             CCCC----HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC---HhhhhcCcccccc
Q psy6191         146 ETST----LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP---VAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~---~~~~l~~~~~~~~  202 (305)
                      ...+    ..+....+.......|...+..+.++|.+||+.||++|||   +.++++||||+..
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         209 TVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             ccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            6432    2333344445556677778899999999999999999998   5677999999763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=9.1e-28  Score=202.09  Aligned_cols=191  Identities=16%  Similarity=0.227  Sum_probs=140.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++|||||+++++++. +..|+||||+++|+|.+++.....+.+  ......+..+..++.+.|..++.+. 
T Consensus        44 ~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~qi~~~l~~lh~~~i~H~d  120 (257)
T cd05060          44 LREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPV--SDLKELAHQVAMGMAYLESKHFVHRD  120 (257)
T ss_pred             HHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCH--HHHHHHHHHHHHHHHHHhhcCeeccC
Confidence            468999999999999999998764 568999999999999999876543311  1112233345667778877664332 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcCCc-------ccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLANKN-------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~~~-------~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                            +.+....+++.|++.........       ...|+..|+|||.+.+..++.++||||+||++|+|++ |.+||.
T Consensus       121 i~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~  200 (257)
T cd05060         121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG  200 (257)
T ss_pred             cccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence                  22334556677775443322111       1123467999999988889999999999999999998 999998


Q ss_pred             CCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ..+..+....+.... ...|...+..+.++|.+||..||.+||++.+++.
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         201 EMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             cCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            877766666554443 3455667889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.95  E-value=9e-28  Score=206.00  Aligned_cols=195  Identities=15%  Similarity=0.279  Sum_probs=145.1

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCC-------------CCcC-chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEM-------------SDPA-AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~-------------~~~~-~~~~~~~~   66 (305)
                      .+|+.+++++ +||||+++++++.+++.+|+||||+++|+|.+++.........             .... ...+..+.
T Consensus        63 ~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  142 (293)
T cd05053          63 VSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVA  142 (293)
T ss_pred             HHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHH
Confidence            3699999999 8999999999999999999999999999999998754321110             0000 11223446


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.+.|..++.|.       +.+..+.+++.|++....+..      .....++..|+|||.+.+..++.++||||+||
T Consensus       143 ~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  222 (293)
T cd05053         143 RGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV  222 (293)
T ss_pred             HHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhh
Confidence            67888887775443       223345567778764433221      11223567899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++|||++ |..||.+.+..+....+... ....|...+..+.+++.+||..||.+|||+.+++++
T Consensus       223 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         223 LLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            9999997 99999988777766655443 234556678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.95  E-value=6.7e-28  Score=208.90  Aligned_cols=197  Identities=24%  Similarity=0.353  Sum_probs=137.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCC--CCCCcCch-hHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLE--EMSDPAAQ-PVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~   76 (305)
                      .+|+.++++++|||||++++++.+.  +.+|+||||+++ ++.+++.......  .+.+.... .+.++..++.+.|..+
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  128 (316)
T cd07842          50 CREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW  128 (316)
T ss_pred             HHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4699999999999999999999988  889999999975 6777665432211  11222222 2334567888888777


Q ss_pred             Ccee-------ecCC----CCCeeEcchhHHHHhc-------CCcccccCCCccccccccc-CCCCccchHHHHHHHHHH
Q psy6191          77 FGYQ-------LNDD----SSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        77 ~~~~-------~~~~----~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye  137 (305)
                      +.+.       +.+.    .+.+++.|++......       .....+||+.|+|||++.+ ..++.++||||+||++|+
T Consensus       129 i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~  208 (316)
T cd07842         129 VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAE  208 (316)
T ss_pred             EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHH
Confidence            5442       2222    4557777776433221       1234578999999998765 457889999999999999


Q ss_pred             HHhCCCCCCCCCHHH---------HHHHHh--------------------------ccccCCC-----------CCCCHH
Q psy6191         138 LLVGKPPFETSTLKE---------TYSRIK--------------------------KVEYKLP-----------ATLKKP  171 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~---------~~~~i~--------------------------~~~~~~~-----------~~~~~~  171 (305)
                      |++|++||.+.+...         ....+.                          ......+           ...+..
T Consensus       209 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (316)
T cd07842         209 LLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ  288 (316)
T ss_pred             HHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHH
Confidence            999999997644321         000000                          0000111           145567


Q ss_pred             HHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         172 AATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       172 ~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +.+++.+||..||.+|||+.+++.||||
T Consensus       289 ~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         289 GFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            8899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.95  E-value=9.5e-28  Score=202.32  Aligned_cols=191  Identities=18%  Similarity=0.305  Sum_probs=139.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+ ...|+||||+++|+|.+++..... ........ ..+..+..++.+.|+.++.+.
T Consensus        49 ~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~  126 (260)
T cd05070          49 LEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMNYIHR  126 (260)
T ss_pred             HHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            479999999999999999998854 568999999999999998865321 11121111 222345677888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.|++....+...     ....|+..|+|||.+.+..++.++|||||||++|+|++ |.+||.+
T Consensus       127 di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~  206 (260)
T cd05070         127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             CCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence                   1122334556666543322111     12235667999999988888999999999999999999 8999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .+..+....+... ..+.+...+..+.+++.+||..||.+|||+.++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         207 MNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             CCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            7777766666543 3445666788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0194|consensus

Probab=99.95  E-value=1e-28  Score=217.33  Aligned_cols=192  Identities=23%  Similarity=0.337  Sum_probs=146.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcC-CCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACD-LEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      -+|.++|++++|||||++||+...+..+|||||+|.||+|.++++.... +.  ........+..+.++.|+|+.++.|+
T Consensus       209 m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~--~~ek~~~~~~AA~Gl~YLh~k~~IHR  286 (474)
T KOG0194|consen  209 MKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLP--TLEKLRFCYDAARGLEYLHSKNCIHR  286 (474)
T ss_pred             HHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCC--HHHHHHHHHHHHhHHHHHHHCCCcch
Confidence            4799999999999999999999999999999999999999999987653 21  11122233445677888887765443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---Ccccc-cCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLC-GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~-Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~  148 (305)
                             |...+..+++.||+....-..   ....+ --..|+|||.+....|+.++||||+||++||+.+ |..||.+.
T Consensus       287 DIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~  366 (474)
T KOG0194|consen  287 DIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM  366 (474)
T ss_pred             hHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence                   223334568888875332110   00011 1246999999998899999999999999999998 89999999


Q ss_pred             CHHHHHHHHhcccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         149 TLKETYSRIKKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       149 ~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +..+....|....+  +.|...+.....++.+|+..||++|+++.++.+
T Consensus       367 ~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  367 KNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            99998888854444  445567778889999999999999999998864

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.95  E-value=1.2e-27  Score=202.10  Aligned_cols=192  Identities=16%  Similarity=0.281  Sum_probs=139.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+ +..|+||||+++|+|.+++...... ...... ......+..++.+.|..++.+.
T Consensus        49 ~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~  126 (262)
T cd05071          49 LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVERMNYVHR  126 (262)
T ss_pred             HHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhcccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            479999999999999999998754 5689999999999999998753211 111111 1222344677788887775443


Q ss_pred             e-------cCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 L-------NDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 ~-------~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                      -       .+....+++.|++........     ....|+..|+|||++.+..++.++||||+||++|+|++ |..||.+
T Consensus       127 dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~  206 (262)
T cd05071         127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  206 (262)
T ss_pred             ccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            1       122344566676544322111     12346678999999988889999999999999999999 8999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ....+...+..+.+++.+||+.||++||++.+++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         207 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             CChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            7777766665443 23345567888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=1.4e-27  Score=200.59  Aligned_cols=198  Identities=22%  Similarity=0.404  Sum_probs=150.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++||||+++++++.++...|+||||+++++|.+++...... ........ ..+..+..++.+.|..|+.+
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h  126 (256)
T cd08530          47 VNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILH  126 (256)
T ss_pred             HHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence            36899999999999999999999999999999999999999988653211 11111111 22334567777888776533


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC--CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                      .       +.+.+..+++.|++.......  .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus       127 ~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~  206 (256)
T cd08530         127 RDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM  206 (256)
T ss_pred             CCCCcceEEEecCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            2       222345566777754443322  2234689999999999888889999999999999999999999998887


Q ss_pred             HHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         151 KETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       151 ~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      .+....+....+ ..+...+.++++++.+||..+|.+||++.++++||++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         207 QDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            766655554433 3455678889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=5.1e-28  Score=212.17  Aligned_cols=197  Identities=25%  Similarity=0.390  Sum_probs=143.9

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCe------EEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhh
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKF------VYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKY   75 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~------~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   75 (305)
                      +|+.++++++||||+++++++..++.      +|+||||+ +++|.+++... .+   ...... .+..+.+++.+.|..
T Consensus        63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~l---~~~~~~~~~~ql~~aL~~LH~~  137 (343)
T cd07851          63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ-KL---SDDHIQFLVYQILRGLKYIHSA  137 (343)
T ss_pred             HHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHHC
Confidence            69999999999999999998876655      99999998 67998887642 11   222222 233456778888877


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhc-CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      |+.+.       +.+.++.+++.|++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.
T Consensus       138 gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~  217 (343)
T cd07851         138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP  217 (343)
T ss_pred             CeecCCCCHHHeEECCCCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            75433       22334557777776544322 2235578999999998765 367889999999999999999999998


Q ss_pred             CCCHHHHHHHHhcccc-------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKVEY-------------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +.+..+....+.....                               ......+..+.++|.+||..||.+|||+.+++.
T Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            7766554444322110                               011235788999999999999999999999999


Q ss_pred             CccccccCC
Q psy6191         196 FEFFNDYCP  204 (305)
Q Consensus       196 ~~~~~~~~~  204 (305)
                      ||||..+..
T Consensus       298 h~~~~~~~~  306 (343)
T cd07851         298 HPYLAEYHD  306 (343)
T ss_pred             CCCccccCC
Confidence            999986533

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=3.9e-28  Score=211.80  Aligned_cols=198  Identities=23%  Similarity=0.343  Sum_probs=146.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC-----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK-----FVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|+.+++.++||||+++++++.+.+     .+|+||||+++ +|.+++.....+   ..... ..+..+..++.+.|..
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~l---~~~~~~~i~~~l~~~l~~LH~~  122 (330)
T cd07834          47 LREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPL---TDDHIQYFLYQILRGLKYLHSA  122 (330)
T ss_pred             HHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCCCC---CHHHHHHHHHHHHHHHHHHHhC
Confidence            47999999999999999999998875     89999999984 788877654322   22222 2333456778888877


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHh
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~  140 (305)
                      |+.+.       +.+....+++.|++.......       .....||+.|+|||++.+. .++.++|+||+||++|+|++
T Consensus       123 gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~  202 (330)
T cd07834         123 NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT  202 (330)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHc
Confidence            75432       233345677777754433221       2235689999999999877 78999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhccccC-------------------------------CCCCCCHHHHHHHHHHhhcCCCCCCC
Q psy6191         141 GKPPFETSTLKETYSRIKKVEYK-------------------------------LPATLKKPAATMIKKMLLLDPVQRPP  189 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~dp~~R~~  189 (305)
                      |.+||.+.+..+....+......                               ..+..+..+.++|.+||+.||.+||+
T Consensus       203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt  282 (330)
T cd07834         203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT  282 (330)
T ss_pred             CCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC
Confidence            99999887766554444321100                               11235678899999999999999999


Q ss_pred             HhhhhcCccccccC
Q psy6191         190 VAQLLHFEFFNDYC  203 (305)
Q Consensus       190 ~~~~l~~~~~~~~~  203 (305)
                      +++++.||||+...
T Consensus       283 ~~~ll~~~~~~~~~  296 (330)
T cd07834         283 ADEALAHPYLAQLH  296 (330)
T ss_pred             HHHHHhCccHHhhc
Confidence            99999999998643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=1.3e-27  Score=202.16  Aligned_cols=194  Identities=21%  Similarity=0.415  Sum_probs=142.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.++||||+++++++.+++..|+||||++||+|.+++...... ....+... ..+..+.+++.+.|..++.+
T Consensus        50 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H  129 (267)
T cd08229          50 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH  129 (267)
T ss_pred             HHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            46999999999999999999999999999999999999999988643211 11111111 22234567788888776543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.|++........    ...+|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.
T Consensus       130 ~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            2       2234456777787654433221    2457999999999998888999999999999999999999999765


Q ss_pred             CH--HHHHHHHhccccC-C-CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         149 TL--KETYSRIKKVEYK-L-PATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       149 ~~--~~~~~~i~~~~~~-~-~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ..  .+....+....+. . +...+..+.+++.+||..||.+|||+.++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         210 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             cchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            43  2333444333221 2 2347788999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=2.3e-27  Score=201.05  Aligned_cols=193  Identities=19%  Similarity=0.257  Sum_probs=135.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCC--CCcC-chhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEM--SDPA-AQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|+.++++++|||||++++++.+...+|+||||+++|+|.+++.........  .... ......+..++.++|..++.
T Consensus        43 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~  122 (269)
T cd05087          43 LEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI  122 (269)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            46999999999999999999999999999999999999999998754322111  1111 12233456778888877653


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccC-------CCCccchHHHHHHHHHHH
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKN-------GHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~-------~~~~~~DiwSlGvilye~  138 (305)
                      +.       +.+.+..+++.|++......      .....+|++.|+|||++.+.       .++.++||||+||++|||
T Consensus       123 H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el  202 (269)
T cd05087         123 HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL  202 (269)
T ss_pred             ccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHH
Confidence            32       22334557777776443211      12345688899999998642       357899999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHH-HhccccC-----CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         139 LV-GKPPFETSTLKETYSR-IKKVEYK-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       139 l~-g~~Pf~~~~~~~~~~~-i~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++ |..||...+..+.... +......     +....+....+++.+|+ .||++|||+++++.
T Consensus       203 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         203 FELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             HhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            96 9999987665554332 2222121     12245677889999998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1095|consensus

Probab=99.95  E-value=1.1e-27  Score=225.20  Aligned_cols=194  Identities=18%  Similarity=0.259  Sum_probs=152.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCC-CCcCch----hHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEM-SDPAAQ----PVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~   76 (305)
                      .+|..+|+.++|||||+++|+.-+....+|+||||+||||..+++....-... ......    ..+.++++..|+....
T Consensus       743 l~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~  822 (1025)
T KOG1095|consen  743 LKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH  822 (1025)
T ss_pred             HHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC
Confidence            47999999999999999999999999999999999999999999875322111 111111    1233466777777666


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhcCCcc----cccC--CCcccccccccCCCCccchHHHHHHHHHHHHh-CC
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLANKNT----LCGT--PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GK  142 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~~~~~----~~Gt--~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~  142 (305)
                      +.|+       +.+....|++.||+.+..+.+...    -.+.  ..|||||.+....++.|+|||||||+|||++| |.
T Consensus       823 fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~  902 (1025)
T KOG1095|consen  823 FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGA  902 (1025)
T ss_pred             CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCC
Confidence            5443       334458899999987765433221    1122  35999999999999999999999999999998 99


Q ss_pred             CCCCCCCHHHHHH-HHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         143 PPFETSTLKETYS-RIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       143 ~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .||.+.+..+.+. -...++.+.|...+....+++..||..+|++||++..+++
T Consensus       903 ~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  903 TPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            9999998888877 4455677778889999999999999999999999999887

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=3e-27  Score=203.92  Aligned_cols=195  Identities=19%  Similarity=0.288  Sum_probs=146.1

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCC--------CCc------CchhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEM--------SDP------AAQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~--------~~~------~~~~~~~~~   66 (305)
                      .+|+.+++.+ +||||+++++++..++.+|+||||+++|+|.+++.........        ...      ....+..+.
T Consensus        68 ~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~  147 (304)
T cd05101          68 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVA  147 (304)
T ss_pred             HHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHH
Confidence            4799999999 8999999999999999999999999999999998764322110        000      011123456


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.|+|..|+.|.       +.+..+.+++.|++.......      .....+++.|+|||++.+..++.++||||+||
T Consensus       148 ~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  227 (304)
T cd05101         148 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV  227 (304)
T ss_pred             HHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHH
Confidence            77888888776443       122334566677754432211      12234677899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++|+|++ |..||.+.+..+....+.... ...|...+..+.+++.+||..+|.+|||+.++++.
T Consensus       228 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         228 LMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            9999998 889999888888777665432 23455678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=3.3e-27  Score=199.96  Aligned_cols=193  Identities=14%  Similarity=0.181  Sum_probs=137.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-CCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-EMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.++|||||++++.+.+....|+|||||++|+|.+++....... ....... .....+..++.+.|+.++.+
T Consensus        43 ~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H  122 (268)
T cd05086          43 LQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLH  122 (268)
T ss_pred             HHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            468899999999999999999999999999999999999999987643221 1111111 12233567788888776543


Q ss_pred             e-------ecCCCCCeeEcchhHHHH------hcCCcccccCCCcccccccccC-------CCCccchHHHHHHHHHHHH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIM------LANKNTLCGTPNYIAPEILNKN-------GHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~------~~~~~~~~Gt~~y~aPE~~~~~-------~~~~~~DiwSlGvilye~l  139 (305)
                      .       +.+....+++.|++....      .......+|++.|+|||++...       .++.++||||+||++|||+
T Consensus       123 ~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~  202 (268)
T cd05086         123 SDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF  202 (268)
T ss_pred             cCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHH
Confidence            2       223334567777764321      1223456789999999987532       3467899999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHhcc-c-----cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         140 V-GKPPFETSTLKETYSRIKKV-E-----YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       140 ~-g~~Pf~~~~~~~~~~~i~~~-~-----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      + |.+||...+..+.+..+... .     ..++...+....+++..|+ .||.+||+++++++
T Consensus       203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         203 ENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             hCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7 57899877766655544322 1     2233456778889999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.95  E-value=1.4e-27  Score=225.68  Aligned_cols=194  Identities=22%  Similarity=0.249  Sum_probs=138.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc---------CchhHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP---------AAQPVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~   72 (305)
                      .+|++++++++|||||++++++.+++..|+|||||+||+|.+++.+..........         ....+..+.+++.+.
T Consensus        50 lrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL  129 (932)
T PRK13184         50 LREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV  129 (932)
T ss_pred             HHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999999999999999999999999998753211111110         011223456778888


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHh----------------------cCCcccccCCCcccccccccCCCC
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIML----------------------ANKNTLCGTPNYIAPEILNKNGHS  123 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~----------------------~~~~~~~Gt~~y~aPE~~~~~~~~  123 (305)
                      |..|+.|.       +.+..+.+++.|++.....                      ...+..+||+.|||||++.+..++
T Consensus       130 Hs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S  209 (932)
T PRK13184        130 HSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS  209 (932)
T ss_pred             HHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC
Confidence            87776543       2233355667777543322                      011245799999999999988899


Q ss_pred             ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-cC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         124 FEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE-YK--LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       124 ~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~-~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .++||||+||++|||++|+.||...+............ ..  ....++..+.+++.+||..||.+|++..+.+.
T Consensus       210 ~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        210 ESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             cHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999998755443322211111 11  11356788999999999999999987665443

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=5.3e-28  Score=206.16  Aligned_cols=195  Identities=22%  Similarity=0.363  Sum_probs=141.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++.+|+||||+++ ++.+.+.....  .+..... .....+.+++.+.|..++.+.
T Consensus        46 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~  122 (283)
T cd05118          46 LREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSHGILHR  122 (283)
T ss_pred             HHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            4799999999999999999999999999999999975 88887765321  1122222 223345677888887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+.+..+++.|++........    ....|+..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.
T Consensus       123 dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  202 (283)
T cd05118         123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK  202 (283)
T ss_pred             CcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence                   2233455667776543322221    124588899999998766 6888999999999999999999999877


Q ss_pred             CHHHHHHHHhccc-------------------cC-----------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         149 TLKETYSRIKKVE-------------------YK-----------LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       149 ~~~~~~~~i~~~~-------------------~~-----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      +..+....+....                   ..           ..+..+.++.++|.+||..||.+||++.+++.|||
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~  282 (283)
T cd05118         203 SEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY  282 (283)
T ss_pred             CHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence            6554443332110                   00           11235678899999999999999999999999999


Q ss_pred             c
Q psy6191         199 F  199 (305)
Q Consensus       199 ~  199 (305)
                      |
T Consensus       283 ~  283 (283)
T cd05118         283 F  283 (283)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=2.2e-27  Score=203.44  Aligned_cols=194  Identities=19%  Similarity=0.266  Sum_probs=135.3

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.+++.++||||+++++++.+++..|+||||+. +++.+.+.....  ....... .....+..++.+.|..++.+. 
T Consensus        52 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~d  128 (291)
T cd07870          52 REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQHILHRD  128 (291)
T ss_pred             HHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            69999999999999999999999999999999996 677666543211  1111111 223345677888887775443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                            +.+..+.+++.|++......    ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+
T Consensus       129 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         129 LKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             CChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence                  22334567777876443221    12334689999999998754 57889999999999999999999997654


Q ss_pred             HH-HHHHHHhcc------------------c-----cCCCC---------CCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         150 LK-ETYSRIKKV------------------E-----YKLPA---------TLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       150 ~~-~~~~~i~~~------------------~-----~~~~~---------~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .. +.+..+...                  .     ...+.         ..+.++.+++.+||+.||.+|||+.|++.|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         209 DVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            32 222221100                  0     00000         124578899999999999999999999999


Q ss_pred             ccc
Q psy6191         197 EFF  199 (305)
Q Consensus       197 ~~~  199 (305)
                      |||
T Consensus       289 ~~~  291 (291)
T cd07870         289 PYF  291 (291)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.1e-27  Score=199.04  Aligned_cols=192  Identities=19%  Similarity=0.280  Sum_probs=141.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+....|+||||++|++|.+++.....  ...... ......+.+++.+.|..++.+.
T Consensus        40 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~i~h~  117 (251)
T cd05041          40 LQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKNCIHR  117 (251)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEehh
Confidence            4799999999999999999999999999999999999999998865322  111111 1222234566777776664332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+....+++.|++.......      .....++..|+|||.+.+..++.++||||+||++|+|++ |..||.
T Consensus       118 di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~  197 (251)
T cd05041         118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP  197 (251)
T ss_pred             hcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence                   223334566677654432221      112234567999999988889999999999999999999 899998


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ..+.......+... ....|...+....+++.+||..+|.+|||+.++++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         198 GMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             cCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            87766655555432 23445677889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.95  E-value=2.2e-27  Score=199.53  Aligned_cols=193  Identities=17%  Similarity=0.267  Sum_probs=142.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++++....|+||||+++|+|.+++......  +..... .....+..++.+.|..++.+.
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~h~  124 (256)
T cd05112          47 IEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLESSNVIHR  124 (256)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccC--CCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            46999999999999999999999999999999999999999988653221  122211 222334566777777665433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+.+..+++.|++.......     .....++..|+|||.+.++.++.++||||+||++|||++ |..||..
T Consensus       125 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  204 (256)
T cd05112         125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN  204 (256)
T ss_pred             ccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence                   222334456666653322111     112235678999999988889999999999999999998 9999998


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+... ....|...+..+.+++.+||..+|.+|||+.++++.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         205 RSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            8777776666543 223355678899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=8.1e-28  Score=210.41  Aligned_cols=196  Identities=25%  Similarity=0.371  Sum_probs=141.0

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhC
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   76 (305)
                      +|+.+++.++||||+++++++...     ..+|+||||+. ++|.+++.....+   .+... ..+..+..++.+.|..+
T Consensus        53 ~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l---~~~~~~~i~~qi~~aL~~LH~~~  128 (337)
T cd07858          53 REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTL---SDDHCQYFLYQLLRGLKYIHSAN  128 (337)
T ss_pred             HHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHHhCC
Confidence            699999999999999999988754     35899999996 6888887654333   22222 22334567788888776


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhcCC----cccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.+.       +.+....+++.|++........    ....||..|+|||.+.. ..++.++||||+||++|+|++|++|
T Consensus       129 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  208 (337)
T cd07858         129 VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL  208 (337)
T ss_pred             EecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCC
Confidence            5332       2233456777887654433221    34578999999998764 4688999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhcc------------------------c----c---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhh
Q psy6191         145 FETSTLKETYSRIKKV------------------------E----Y---KLPATLKKPAATMIKKMLLLDPVQRPPVAQL  193 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~------------------------~----~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~  193 (305)
                      |.+.+.......+...                        .    .   ...+..+..+.++|++||+.||++|||++++
T Consensus       209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el  288 (337)
T cd07858         209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA  288 (337)
T ss_pred             CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence            9876543322222100                        0    0   0123467888999999999999999999999


Q ss_pred             hcCcccccc
Q psy6191         194 LHFEFFNDY  202 (305)
Q Consensus       194 l~~~~~~~~  202 (305)
                      ++||||...
T Consensus       289 l~h~~~~~~  297 (337)
T cd07858         289 LAHPYLASL  297 (337)
T ss_pred             HcCcchhhh
Confidence            999999764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.95  E-value=2.4e-27  Score=200.77  Aligned_cols=192  Identities=16%  Similarity=0.236  Sum_probs=141.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+.+..|+||||+++|+|.+++.....  .+.... ...+..+..++.+.|..++.+.
T Consensus        54 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~~i~H~  131 (268)
T cd05063          54 LSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMNYVHR  131 (268)
T ss_pred             HHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            4689999999999999999999999999999999999999998865321  111111 2223345667788887765433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC--c-----ccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK--N-----TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~--~-----~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+.+..+++.|++........  .     ...+++.|+|||++.+..++.++||||+||++|||++ |..||
T Consensus       132 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~  211 (268)
T cd05063         132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY  211 (268)
T ss_pred             ccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence                   2223345666676543322111  1     1123456999999988888999999999999999997 99999


Q ss_pred             CCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+..+....+... ..+.+...+..+.+++.+||..||.+||++.++++
T Consensus       212 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         212 WDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            887777776666543 22333456788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.95  E-value=2.7e-27  Score=200.23  Aligned_cols=194  Identities=22%  Similarity=0.414  Sum_probs=140.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++++.++||||+++++++.+.+..|+||||+++|+|.+++...... ....+... ..+..+..++.+.|..++.+
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H  129 (267)
T cd08228          50 VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH  129 (267)
T ss_pred             HHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeC
Confidence            46999999999999999999999999999999999999999888643211 11121111 22334567788888776544


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+.+.|++.......    .....|++.|+|||.+.+..++.++|+||+||++|||++|..||...
T Consensus       130 ~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            2       223334566777754332211    22457999999999998888899999999999999999999999754


Q ss_pred             C--HHHHHHHHhcccc-CC-CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         149 T--LKETYSRIKKVEY-KL-PATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       149 ~--~~~~~~~i~~~~~-~~-~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .  .......+..... +. +...+....+++.+||..||.+||++.++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         210 KMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             cccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence            3  2344444443322 12 2246678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=3.4e-27  Score=206.47  Aligned_cols=196  Identities=23%  Similarity=0.362  Sum_probs=140.7

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   77 (305)
                      .+|+.+++++ +||||+++++++...  ...|+||||++ ++|.+++... .+   ..... ..+..+..++.+.|..++
T Consensus        54 ~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~---~~~~~~~i~~qi~~~L~~LH~~~i  128 (337)
T cd07852          54 FREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-IL---EDVHKRYIMYQLLKALKYIHSGNV  128 (337)
T ss_pred             hHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3699999999 999999999998653  47899999998 5888887653 22   11111 123345677888887776


Q ss_pred             cee-------ecCCCCCeeEcchhHHHHhcC---------CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHh
Q psy6191          78 GYQ-------LNDDSSGVMFNDLTRMIMLAN---------KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        78 ~~~-------~~~~~~~v~~~d~~~~~~~~~---------~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~  140 (305)
                      .+.       +.+..+.+++.|++.......         .....||+.|+|||++.+ ..++.++||||+||++|+|++
T Consensus       129 ~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t  208 (337)
T cd07852         129 IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL  208 (337)
T ss_pred             ecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh
Confidence            443       233445677778764443221         123568999999998754 457889999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhccc---------------------------c----CCCCCCCHHHHHHHHHHhhcCCCCCCC
Q psy6191         141 GKPPFETSTLKETYSRIKKVE---------------------------Y----KLPATLKKPAATMIKKMLLLDPVQRPP  189 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~~---------------------------~----~~~~~~~~~~~~li~~~l~~dp~~R~~  189 (305)
                      |++||.+....+....+....                           .    ...+..+.++.++|.+||+.||++|||
T Consensus       209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps  288 (337)
T cd07852         209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT  288 (337)
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC
Confidence            999998765443322221110                           0    011235778899999999999999999


Q ss_pred             HhhhhcCcccccc
Q psy6191         190 VAQLLHFEFFNDY  202 (305)
Q Consensus       190 ~~~~l~~~~~~~~  202 (305)
                      +.++++|||++..
T Consensus       289 ~~~il~~~~~~~~  301 (337)
T cd07852         289 AEEALEHPYVAQF  301 (337)
T ss_pred             HHHHhhChhhhhh
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=1.9e-27  Score=201.24  Aligned_cols=192  Identities=17%  Similarity=0.232  Sum_probs=141.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++.+|+||||+++|+|.+++......  ..... ...+..+..++.+.|..++.+.
T Consensus        53 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~i~h~  130 (267)
T cd05066          53 LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIASGMKYLSDMGYVHR  130 (267)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCEeeh
Confidence            46899999999999999999999999999999999999999998654211  11111 1222345677788887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.|++........       ....++..|+|||.+.+..++.++|+||+||++|++++ |..||
T Consensus       131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~  210 (267)
T cd05066         131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  210 (267)
T ss_pred             hhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence                   2223344666776544332211       11223567999999988889999999999999999886 99999


Q ss_pred             CCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+..+....+... ..+.+...+..+.+++.+||+.+|.+||++.++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         211 WEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            887766666655543 22334456788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.5e-27  Score=209.08  Aligned_cols=198  Identities=25%  Similarity=0.377  Sum_probs=143.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   74 (305)
                      .+|++++++++|||||+++++++.+.      ..|+||||+ |++|.+++... .+   ...... ....+..++.+.|.
T Consensus        62 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~l---~~~~~~~i~~qi~~al~~LH~  136 (343)
T cd07880          62 YRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE-KL---SEDRIQFLVYQMLKGLKYIHA  136 (343)
T ss_pred             HHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHh
Confidence            36999999999999999999998654      469999999 77898887542 22   222222 23345677888888


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC-CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .|+.+.       +.+....+++.|++....... .....||+.|+|||.+.+ ..++.++|+||+||++|+|++|.+||
T Consensus       137 ~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  216 (343)
T cd07880         137 AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF  216 (343)
T ss_pred             CCeecCCCCHHHEEEcCCCCEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            776443       223345577777765443222 234578999999998865 45788999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcccc-------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         146 ETSTLKETYSRIKKVEY-------------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .+.+.......+.+...                               ......+..+.++|.+||..||.+|||+.+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         217 KGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence            87765444333322111                               01134667789999999999999999999999


Q ss_pred             cCccccccCC
Q psy6191         195 HFEFFNDYCP  204 (305)
Q Consensus       195 ~~~~~~~~~~  204 (305)
                      .||||+....
T Consensus       297 ~~~~~~~~~~  306 (343)
T cd07880         297 AHPYFEEFHD  306 (343)
T ss_pred             cCccHhhhcC
Confidence            9999986533

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.8e-27  Score=198.92  Aligned_cols=193  Identities=21%  Similarity=0.310  Sum_probs=143.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++..|+||||+++|+|.+++...... ...... ...+..+..++.+.|..++.|.
T Consensus        48 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~  126 (256)
T cd05039          48 LAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEKNFVHR  126 (256)
T ss_pred             HHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccch
Confidence            46999999999999999999999999999999999999999998754311 111111 1223345667788887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLK  151 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~  151 (305)
                             +.+....+++.|++........ ....++..|+|||.+....++.++||||+||++|+|++ |..||...+..
T Consensus       127 di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  206 (256)
T cd05039         127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  206 (256)
T ss_pred             hcccceEEEeCCCCEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence                   2223345566666543322111 12334567999999988888999999999999999997 99999888777


Q ss_pred             HHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         152 ETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       152 ~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +....+... ....|...+..+.++|.+||..+|.+||++.+++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         207 DVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            766655443 33455667889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.95  E-value=2.3e-27  Score=200.98  Aligned_cols=193  Identities=18%  Similarity=0.262  Sum_probs=136.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC-C-CCc-CchhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-M-SDP-AAQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~-~-~~~-~~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|+.+++.++||||+++++++.+...+|+||||+++|+|.+++........ . ... .......+..++.+.|+.++.
T Consensus        43 ~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  122 (269)
T cd05042          43 LQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI  122 (269)
T ss_pred             HHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEe
Confidence            3699999999999999999999999999999999999999999876432211 0 111 112233456778888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCccccccccc-------CCCCccchHHHHHHHHHHH
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNK-------NGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DiwSlGvilye~  138 (305)
                      |.       +.+.+..+++.|++......      ......+++.|+|||++..       ..++.++||||+||++|||
T Consensus       123 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el  202 (269)
T cd05042         123 HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL  202 (269)
T ss_pred             cccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHH
Confidence            33       22334567777876443211      1223456778999998743       3467799999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHH-hccccC-----CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         139 LV-GKPPFETSTLKETYSRI-KKVEYK-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       139 l~-g~~Pf~~~~~~~~~~~i-~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++ |.+||......+....+ ......     .+...+....+++..|+ .||.+|||++++++
T Consensus       203 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         203 FTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            99 88999877655554443 222222     23356777888999888 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.3e-27  Score=199.96  Aligned_cols=193  Identities=18%  Similarity=0.310  Sum_probs=142.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.++...|+||||+++|+|.+++...... .+..... ..+..+..++.+.|..++.+.
T Consensus        49 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~-~~~~~~~~~~~~~i~~al~~lh~~~i~h~  127 (261)
T cd05034          49 LQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLESRNYIHR  127 (261)
T ss_pred             HHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            47999999999999999999999999999999999999999998653211 1111111 122234567778887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.|++....+..     .....++..|+|||.+.+..++.++|+||+||++|+|++ |+.||.+
T Consensus       128 di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  207 (261)
T cd05034         128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG  207 (261)
T ss_pred             CcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence                   222335566667653322211     112234678999999988889999999999999999998 9999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.......+... ....|...+.++.+++.+||..||.+||+++++.+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         208 MTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            7777666666543 23445567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.95  E-value=2.6e-27  Score=199.64  Aligned_cols=192  Identities=17%  Similarity=0.289  Sum_probs=140.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+ ...|+||||+++|+|.+++....... ...... ..+..+..++.+.|..++.+.
T Consensus        49 ~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~l~~aL~~lH~~~i~H~  126 (260)
T cd05073          49 LAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNYIHR  126 (260)
T ss_pred             HHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccc-cCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            479999999999999999999988 78999999999999999987642211 111111 122345667778887765443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.|++....+...     ....|+..|+|||++....++.++|+||+||++|++++ |.+||.+
T Consensus       127 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~  206 (260)
T cd05073         127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG  206 (260)
T ss_pred             ccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence                   2223345666776543322211     12235677999999988888999999999999999998 9999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.......+... ....+...+.++.+++.+||..||++||++.+++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         207 MSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            7766665555443 22344567889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=1.6e-27  Score=208.36  Aligned_cols=195  Identities=17%  Similarity=0.271  Sum_probs=140.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCCC---------------------------
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDLE---------------------------   52 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~~---------------------------   52 (305)
                      .+|+.+++++ +|||||++++++.. +..+|+||||+++|+|.+++.......                           
T Consensus        58 ~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (337)
T cd05054          58 MTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVS  137 (337)
T ss_pred             HHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCC
Confidence            3699999999 89999999998765 567999999999999999886432100                           


Q ss_pred             -------------------------------CCCCc-CchhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcch
Q psy6191          53 -------------------------------EMSDP-AAQPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDL   93 (305)
Q Consensus        53 -------------------------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~   93 (305)
                                                     .+... ....+..++.++.|+|..++.|.       +.+....+++.||
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~Df  217 (337)
T cd05054         138 SSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDF  217 (337)
T ss_pred             ccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEecc
Confidence                                           00000 01112345677888887775432       2233455777887


Q ss_pred             hHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHhcc-ccCC
Q psy6191          94 TRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETY-SRIKKV-EYKL  164 (305)
Q Consensus        94 ~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~~~~-~~i~~~-~~~~  164 (305)
                      +....+.      ..++..|+..|||||++.+..++.++||||+||++|||++ |..||.+....+.+ ..+... ....
T Consensus       218 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  297 (337)
T cd05054         218 GLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA  297 (337)
T ss_pred             ccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC
Confidence            7554332      1223456788999999998899999999999999999998 99999875543333 222222 2334


Q ss_pred             CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         165 PATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       165 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |...+.++.+++.+||+.+|++||++.++++|
T Consensus       298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55678889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=2.1e-27  Score=203.98  Aligned_cols=194  Identities=14%  Similarity=0.168  Sum_probs=141.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC--------CCCCcCc-hhHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE--------EMSDPAA-QPVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~--------~~~~~~~-~~~~~~~~~~~~~   72 (305)
                      .+|++++++++|||||++++++.+++..|+||||+++++|.+++.......        ....... ..+..+..++.+.
T Consensus        67 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L  146 (296)
T cd05051          67 LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL  146 (296)
T ss_pred             HHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            369999999999999999999999999999999999999999987643211        1111111 1223356778888


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHH
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l  139 (305)
                      |..++.|.       +.+....+++.|++....+.      ...+..+|+.|||||.+.+..++.++||||+||++|||+
T Consensus       147 H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  226 (296)
T cd05051         147 ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL  226 (296)
T ss_pred             HHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHH
Confidence            87775443       12223455666765433221      123445778999999998888999999999999999999


Q ss_pred             h--CCCCCCCCCHHHHHHHHhcc--------ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         140 V--GKPPFETSTLKETYSRIKKV--------EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       140 ~--g~~Pf~~~~~~~~~~~i~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +  |..||...+..+.+..+...        ....+...+.++.+++.+||+.||.+|||+.+++.
T Consensus       227 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         227 TLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            8  78899877666655544322        12234456788999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.95  E-value=2e-27  Score=203.32  Aligned_cols=200  Identities=21%  Similarity=0.310  Sum_probs=137.8

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhc--CCCCCCCcC-chhHHHHHHHHHHhhh-hC
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSAC--DLEEMSDPA-AQPVIWVSKWVDYSDK-YG   76 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~-~~   76 (305)
                      .+|+.++.++. |||||++++++.++...|+||||+.+ ++.++.....  ....+.... ......+..++.|.|. .+
T Consensus        50 ~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~  128 (288)
T cd06616          50 LMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK  128 (288)
T ss_pred             HHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence            46899999986 99999999999999999999999874 5554432210  001111111 2223344566777764 35


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccC---CCCccchHHHHHHHHHHHHhCCC
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKN---GHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~---~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      +.|.       +.+..+.+++.|++....+..   .....||+.|+|||++.+.   .++.++||||+||++|+|++|++
T Consensus       129 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  208 (288)
T cd06616         129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF  208 (288)
T ss_pred             eeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCC
Confidence            4332       222335577778765543322   1244689999999998765   68899999999999999999999


Q ss_pred             CCCCCCH-HHHHHHHhccc-cCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         144 PFETSTL-KETYSRIKKVE-YKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       144 Pf~~~~~-~~~~~~i~~~~-~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||...+. .+....+.... +.++    ...+.++.+|+.+||..||.+|||+++++.||||.+.
T Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         209 PYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             CchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            9976542 22222222221 1222    2367889999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.95  E-value=2.8e-27  Score=201.80  Aligned_cols=199  Identities=23%  Similarity=0.338  Sum_probs=139.1

Q ss_pred             hHHHH-HhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhh-CCc
Q psy6191           3 QEIAI-HRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKY-GFG   78 (305)
Q Consensus         3 ~Ei~i-l~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~-~~~   78 (305)
                      +|+.+ ++.++|||||++++++.+++.+|+||||++ |+|.+++...... ....+... ..+..+..++.+.|+. ++.
T Consensus        48 ~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~  126 (283)
T cd06617          48 MDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVI  126 (283)
T ss_pred             HHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Confidence            35554 677899999999999999999999999997 6788877653221 11122222 2233456777888864 543


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCccccccccc----CCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNK----NGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~----~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.       +.+....+++.|++.......   .....||..|+|||++.+    ..++.++|+||+||++|+|++|+.|
T Consensus       127 h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  206 (283)
T cd06617         127 HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP  206 (283)
T ss_pred             cCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence            22       223345677778765433222   123568999999998864    4468899999999999999999999


Q ss_pred             CCCC-CHHHHHHHH-hccccCCC-CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         145 FETS-TLKETYSRI-KKVEYKLP-ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~~-~~~~~~~~i-~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |... +..+....+ ......+| ...+.++.++|.+||..||.+||++.++++||||...
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         207 YDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             CCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            9753 222322222 22223333 2467889999999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.95  E-value=4.3e-27  Score=198.48  Aligned_cols=192  Identities=17%  Similarity=0.233  Sum_probs=139.6

Q ss_pred             hHHHHHhcCCCCCccceeEEEE-cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFE-DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~-~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.+++.++|||||++++++. .++..|+||||+.+|+|.+++........ ..........+.+++.+.|..++.+. 
T Consensus        45 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~lH~~~i~H~d  123 (262)
T cd05058          45 KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPT-VKDLIGFGLQVAKGMEYLASKKFVHRD  123 (262)
T ss_pred             HHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCC-HHHHHHHHHHHHHHHHHHHhCCccccc
Confidence            6899999999999999999765 46678999999999999999865322110 01111222345677888887765442 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC--------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                            +.+....+++.|++.......        .....+++.|+|||.+.+..++.++||||+||++|||++ |.+||
T Consensus       124 lk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  203 (262)
T cd05058         124 LAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  203 (262)
T ss_pred             cCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence                  223345567777764432211        123356778999999988889999999999999999999 57788


Q ss_pred             CCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+..+....+.... ...+...+..+.+++.+||..||++||++.+++.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         204 PDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             CCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            7777666655554432 3345557888999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.95  E-value=3.5e-27  Score=205.52  Aligned_cols=197  Identities=24%  Similarity=0.408  Sum_probs=140.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++|||||+++++|.. +...|+||||+ +++|.++++.. .+   ..... ..+..+..++.+.|..++.+
T Consensus        57 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~---~~~~~~~~~~ql~~aL~~LH~~~iiH  131 (328)
T cd07856          57 YRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR-PL---EKQFIQYFLYQILRGLKYVHSAGVVH  131 (328)
T ss_pred             HHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            369999999999999999999876 56899999998 56888877532 11   11111 12334567788888777544


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC-CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                      .       +.+....+++.|++....... ..+..|++.|+|||.+.+ ..++.++||||+||++|+|++|++||...+.
T Consensus       132 ~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~  211 (328)
T cd07856         132 RDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH  211 (328)
T ss_pred             CCCCHHHEeECCCCCEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            3       223345577777765433221 234578999999998765 5688999999999999999999999987654


Q ss_pred             HHHHHHHhc------------------------c--ccCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         151 KETYSRIKK------------------------V--EYKLP-----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       151 ~~~~~~i~~------------------------~--~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ......+..                        .  ....|     ...+..+.++|.+||+.||++|||+++++.|||+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         212 VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             HHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence            322211110                        0  00111     2456789999999999999999999999999999


Q ss_pred             cccC
Q psy6191         200 NDYC  203 (305)
Q Consensus       200 ~~~~  203 (305)
                      ....
T Consensus       292 ~~~~  295 (328)
T cd07856         292 APYH  295 (328)
T ss_pred             cccc
Confidence            7543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=1.4e-27  Score=209.40  Aligned_cols=196  Identities=22%  Similarity=0.333  Sum_probs=138.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--------------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--------------KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--------------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~   66 (305)
                      .+|++++++++||||+++++++...              ...|+||||++ ++|.+.+... .+   .+.... ....+.
T Consensus        50 ~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~l---~~~~~~~~~~qi~  124 (342)
T cd07854          50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-PL---SEEHARLFMYQLL  124 (342)
T ss_pred             HHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC-CC---CHHHHHHHHHHHH
Confidence            4699999999999999999877654              36899999997 5888776532 12   222222 233456


Q ss_pred             HHHHHhhhhCCcee--------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCccccccccc-CCCCccchHHH
Q psy6191          67 KWVDYSDKYGFGYQ--------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNK-NGHSFEVDVWS  130 (305)
Q Consensus        67 ~~~~~~~~~~~~~~--------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwS  130 (305)
                      +++.++|..|+.+.        +...+..+++.|++....+..       .....||..|+|||++.+ ..++.++||||
T Consensus       125 ~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwS  204 (342)
T cd07854         125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA  204 (342)
T ss_pred             HHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHH
Confidence            77888887776443        222333456677754432211       122368899999998654 56788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-------------------------c-----CCCCCCCHHHHHHHHHHh
Q psy6191         131 IGCIMYTLLVGKPPFETSTLKETYSRIKKVE-------------------------Y-----KLPATLKKPAATMIKKML  180 (305)
Q Consensus       131 lGvilye~l~g~~Pf~~~~~~~~~~~i~~~~-------------------------~-----~~~~~~~~~~~~li~~~l  180 (305)
                      +||++|+|++|+.||.+.+..+....+....                         .     .+.+.++.++.++|.+||
T Consensus       205 lGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  284 (342)
T cd07854         205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQIL  284 (342)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHh
Confidence            9999999999999998766544433322110                         0     011246778899999999


Q ss_pred             hcCCCCCCCHhhhhcCcccccc
Q psy6191         181 LLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       181 ~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +.||.+|||+.+++.||||+..
T Consensus       285 ~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         285 TFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CCCchhccCHHHHhCCCccccc
Confidence            9999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=2.9e-27  Score=203.21  Aligned_cols=194  Identities=14%  Similarity=0.175  Sum_probs=139.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCC--------Cc-CchhHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS--------DP-AAQPVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~   72 (305)
                      .+|++++++++||||+++++++.+++..|+||||+++|+|.+++..........        .. .......+..++.+.
T Consensus        67 ~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l  146 (296)
T cd05095          67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL  146 (296)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            479999999999999999999999999999999999999999987643221100        00 111123345778888


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHH
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l  139 (305)
                      |..++.+.       +.+....+++.|++....+..      .++..+++.|+|||...++.++.++||||+||++|||+
T Consensus       147 H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~  226 (296)
T cd05095         147 SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL  226 (296)
T ss_pred             HHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHH
Confidence            87775433       222334566777765433211      12334567899999888888999999999999999999


Q ss_pred             h--CCCCCCCCCHHHHHHHHh--------ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         140 V--GKPPFETSTLKETYSRIK--------KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       140 ~--g~~Pf~~~~~~~~~~~i~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +  |..||...+..+......        ....+.|...+..+.+++.+||+.||.+||++.++.+
T Consensus       227 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         227 TLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8  789998766554433221        1112334557788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=1.5e-27  Score=208.58  Aligned_cols=196  Identities=24%  Similarity=0.392  Sum_probs=138.2

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhC
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   76 (305)
                      +|+.++++++|||||++++++...     ..+|+||||+.+ ++.+++... .+   .+... ..+..+.+++.+.|..+
T Consensus        52 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~l---~~~~~~~i~~ql~~aL~~LH~~~  126 (336)
T cd07849          52 REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HL---SNDHIQYFLYQILRGLKYIHSAN  126 (336)
T ss_pred             HHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHhCC
Confidence            699999999999999999987654     358999999975 787776532 12   22222 22334567788888777


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhC
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g  141 (305)
                      +.|.       +.+....+++.|++.......       ....+||+.|+|||.+.+ ..++.++||||+||++|+|++|
T Consensus       127 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G  206 (336)
T cd07849         127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN  206 (336)
T ss_pred             eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            5443       223345567777764332211       123578999999998654 5688899999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhc---------------c-----------ccC-----CCCCCCHHHHHHHHHHhhcCCCCCCCH
Q psy6191         142 KPPFETSTLKETYSRIKK---------------V-----------EYK-----LPATLKKPAATMIKKMLLLDPVQRPPV  190 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~---------------~-----------~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~  190 (305)
                      ++||.+.+.......+..               .           ...     ..+..+.++.++|.+||..||.+|||+
T Consensus       207 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  286 (336)
T cd07849         207 RPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV  286 (336)
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH
Confidence            999987654332221110               0           000     012356778999999999999999999


Q ss_pred             hhhhcCccccccC
Q psy6191         191 AQLLHFEFFNDYC  203 (305)
Q Consensus       191 ~~~l~~~~~~~~~  203 (305)
                      .+++.||||+...
T Consensus       287 ~e~l~hp~~~~~~  299 (336)
T cd07849         287 EEALAHPYLEQYH  299 (336)
T ss_pred             HHHhcCccccccC
Confidence            9999999998653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=1.9e-27  Score=202.85  Aligned_cols=195  Identities=26%  Similarity=0.398  Sum_probs=139.6

Q ss_pred             hHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|+..+++++ ||||+++++++++++..|+||||+ +|+|.+.+...... .+.... ...+..+...+.+.|..++.+.
T Consensus        46 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~  123 (283)
T cd07830          46 REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK-PFSESVIRSIIYQILQGLAHIHKHGFFHR  123 (283)
T ss_pred             HHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccc-cCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            6889999999 999999999999999999999999 88999888654311 111111 2223345667788887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+....+++.|++.......   .....||..|+|||++. ...++.++|+||+||++++|++|.+||...+
T Consensus       124 dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~  203 (283)
T cd07830         124 DLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS  203 (283)
T ss_pred             CCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence                   223345566677654433222   12456899999999875 4457889999999999999999999998766


Q ss_pred             HHHHHHHHhcc-------------------ccCC-----------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRIKKV-------------------EYKL-----------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i~~~-------------------~~~~-----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ..+....+...                   ...+           ....+..+.++|++||+.||.+|||+.|++.||||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         204 EIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            54443332210                   0000           11235778999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.9e-27  Score=202.32  Aligned_cols=194  Identities=13%  Similarity=0.190  Sum_probs=138.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC------CCCcC----chhHHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE------MSDPA----AQPVIWVSKWVDY   71 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~------~~~~~----~~~~~~~~~~~~~   71 (305)
                      .+|++++++++||||+++++++..++..|+|||||++|+|.+++........      .....    ...+..+..++.+
T Consensus        65 ~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  144 (295)
T cd05097          65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKY  144 (295)
T ss_pred             HHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHH
Confidence            4699999999999999999999999999999999999999998865321100      00011    1122334667788


Q ss_pred             hhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          72 SDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        72 ~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      .|..++.+.       +.+....+++.|++....+..      .+...+++.|+|||++.+..++.++|||||||++|+|
T Consensus       145 lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el  224 (295)
T cd05097         145 LASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM  224 (295)
T ss_pred             HHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHH
Confidence            887765432       122334566677654432211      1223457789999999888899999999999999999


Q ss_pred             Hh--CCCCCCCCCHHHHHHHHhc--------cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         139 LV--GKPPFETSTLKETYSRIKK--------VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       139 l~--g~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++  |..||...+..+....+..        .....+...+..+.+++.+||+.||.+||+++++++
T Consensus       225 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         225 FTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            88  6789987665554433321        112234457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.95  E-value=2.8e-27  Score=201.05  Aligned_cols=195  Identities=18%  Similarity=0.297  Sum_probs=141.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC------CCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE------EMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|++++++++|||||++++++.+.+..|+||||+++|+|.+++.......      ....... ..+..+..++.+.|+
T Consensus        56 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~  135 (275)
T cd05046          56 RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN  135 (275)
T ss_pred             HHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh
Confidence            479999999999999999999999999999999999999999987543111      1111111 122335677888887


Q ss_pred             hCCceeec-------CCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-C
Q psy6191          75 YGFGYQLN-------DDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-G  141 (305)
Q Consensus        75 ~~~~~~~~-------~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g  141 (305)
                      .++.|.-.       +..+.+++.|++......     ......+++.|+|||.+.+..++.++||||+||++|+|++ |
T Consensus       136 ~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~  215 (275)
T cd05046         136 ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG  215 (275)
T ss_pred             cCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence            77544321       122334444443222111     1123456788999999888888899999999999999998 8


Q ss_pred             CCCCCCCCHHHHHHHHhcccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         142 KPPFETSTLKETYSRIKKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ..||...+.......+.....  ..+...+..+.+++.+||..||.+||++.+++..
T Consensus       216 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         216 ELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            899987766666666654433  3345678899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.95  E-value=4.2e-27  Score=197.71  Aligned_cols=192  Identities=20%  Similarity=0.293  Sum_probs=140.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++..+ ..|+||||+++|+|.+++...... ...... ...+..+..++.+.|+.|+.+.
T Consensus        47 ~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~~~H~  124 (254)
T cd05083          47 LEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESKKLVHR  124 (254)
T ss_pred             HHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            4799999999999999999998765 479999999999999998754321 111111 1223345677888887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLK  151 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~  151 (305)
                             +.+....+++.|++....... .....++..|+|||.+.+..++.++|+||+||++|+|++ |++||...+..
T Consensus       125 dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  204 (254)
T cd05083         125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK  204 (254)
T ss_pred             ccCcceEEEcCCCcEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence                   122234566777754432211 122334678999999988889999999999999999998 99999988777


Q ss_pred             HHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         152 ETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       152 ~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +....+... ....+...+..+.+++.+||..+|.+||++++++.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         205 EVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            666655443 23344567888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.95  E-value=4.7e-27  Score=197.48  Aligned_cols=193  Identities=19%  Similarity=0.301  Sum_probs=143.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++++.+++..|+||||+++++|.+++....... ..... ...+..+..++.+.|..++.+.
T Consensus        49 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~~~h~  127 (258)
T smart00219       49 LREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESKNFIHR  127 (258)
T ss_pred             HHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhcc-CCHHHHHHHHHHHHHHHHHHhcCCeeec
Confidence            479999999999999999999999999999999999999999986543210 11111 1222334667778887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+..+.+++.|++........     ....|++.|+|||.+.+..++.++||||+||++|+|++ |.+||..
T Consensus       128 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             ccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence                   2223345666776543322211     01236789999999988888999999999999999998 8999988


Q ss_pred             CCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.......+.... ...+...+.++.+++.+||..||.+|||+.++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      208 MSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            77777766665443 3445567889999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG4236|consensus

Probab=99.95  E-value=9.9e-29  Score=213.58  Aligned_cols=198  Identities=24%  Similarity=0.469  Sum_probs=149.4

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCC--
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGF--   77 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--   77 (305)
                      |..|++||++++||.||.|--.|++.+.+++|||-+.| |+.+.+-... ...+.+...+.++ +++-++.|+|..++  
T Consensus       610 lR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~knIvH  687 (888)
T KOG4236|consen  610 LRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKNIVH  687 (888)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcceee
Confidence            46899999999999999999999999999999999865 6666553321 1122333333222 23334455554333  


Q ss_pred             ------ceeecCCC--CCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          78 ------GYQLNDDS--SGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        78 ------~~~~~~~~--~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                            +.++.+.+  ..++++||+.+.++..+   .+++|||.|.|||++..++|..+-|+||+|||+|.-++|..||.
T Consensus       688 CDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  688 CDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             ccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence                  44444432  35788888776665443   47899999999999999999999999999999999999999996


Q ss_pred             CCCHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ...  ++-.+|.+..+-+|+    .++.++.|||..+|+..-.+|.|.++.+.|||++++
T Consensus       768 EdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  768 EDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             Ccc--chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            542  333445555555554    588999999999999999999999999999999875

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=3.6e-27  Score=206.06  Aligned_cols=195  Identities=17%  Similarity=0.296  Sum_probs=145.5

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC--------CCCCcC------chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE--------EMSDPA------AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~--------~~~~~~------~~~~~~~~   66 (305)
                      .+|+++++++ +|||||++++++..++.+|+||||+++|+|.+++.......        ...+..      ......+.
T Consensus        65 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  144 (334)
T cd05100          65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVA  144 (334)
T ss_pred             HHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHH
Confidence            4799999999 79999999999999999999999999999999987643210        001111      11233456


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.+.|..|+.|.       +.+....+++.|++.......      .....+++.|||||++.+..++.++||||+||
T Consensus       145 ~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  224 (334)
T cd05100         145 RGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV  224 (334)
T ss_pred             HHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHH
Confidence            77888887775443       222334566777754332211      11223456799999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++|||++ |..||.+.+..+....+... ....|...+..+.+++.+||..+|.+||++.+++.+
T Consensus       225 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         225 LLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            9999998 89999988877777666543 234556678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0587|consensus

Probab=99.95  E-value=7e-28  Score=219.05  Aligned_cols=198  Identities=22%  Similarity=0.371  Sum_probs=143.6

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEc-----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhh-
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFED-----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSD-   73 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~-----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-   73 (305)
                      +-|.+|++.+ +|||++++|++|..     ++.+|||||||.||+.-|+++...+. .+.+.....++. ...++.|+| 
T Consensus        63 E~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~-rl~E~~IaYI~re~lrgl~HLH~  141 (953)
T KOG0587|consen   63 ELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGN-RLKEEWIAYILREILRGLAHLHN  141 (953)
T ss_pred             HHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhccc-chhhHHHHHHHHHHHHHHHHHhh
Confidence            3567788776 69999999999863     57899999999999999999876532 223332222222 133444444 


Q ss_pred             -------hhCCceeecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccC-----CCCccchHHHHHHHHHH
Q psy6191          74 -------KYGFGYQLNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKN-----GHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        74 -------~~~~~~~~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DiwSlGvilye  137 (305)
                             -.|.++++. .+..|++.||+-...+    .+.+|..|||.|||||++...     .|+..+|+||||++..|
T Consensus       142 nkviHRDikG~NiLLT-~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIE  220 (953)
T KOG0587|consen  142 NKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIE  220 (953)
T ss_pred             cceeeecccCceEEEe-ccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeeh
Confidence                   334344333 3477888888755443    456799999999999998532     36788999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhccc-cCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         138 LLVGKPPFETSTLKETYSRIKKVE-YKL--PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~~~~~i~~~~-~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |.-|.+|+.+.-+...+-.|-... +.+  |..-+..+.++|..||.+|-.+||+..+++.|||++.
T Consensus       221 ladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  221 MAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            999999998876665544443221 111  2234567789999999999999999999999999974

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=5.8e-27  Score=198.08  Aligned_cols=194  Identities=23%  Similarity=0.442  Sum_probs=140.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-CCCCcC-chhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-EMSDPA-AQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++||||+++++++.+++..|+||||+++|+|.+++....... ...... ...+..+.+++.+.|..|+.+
T Consensus        50 ~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  129 (267)
T cd08224          50 LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMH  129 (267)
T ss_pred             HHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            479999999999999999999999999999999999999999886431110 011111 122233466777888766533


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.|++....+..    .....|++.|+|||.+.+..++.++|+||+||++|+|++|..||...
T Consensus       130 ~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            2       223344566667654332221    12457899999999998888999999999999999999999999654


Q ss_pred             C--HHHHHHHHhcccc-CCCC-CCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         149 T--LKETYSRIKKVEY-KLPA-TLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       149 ~--~~~~~~~i~~~~~-~~~~-~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .  ..+....+..... +.|. ..+.+..++|.+||..+|.+|||+.++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         210 KMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             CccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3  2333334433222 2333 57778999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=3.4e-27  Score=201.61  Aligned_cols=195  Identities=21%  Similarity=0.344  Sum_probs=140.1

Q ss_pred             hHHHHHhcC---CCCCccceeEEEEcCCe-----EEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhh
Q psy6191           3 QEIAIHRSL---KHRNVVGFHSFFEDSKF-----VYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSD   73 (305)
Q Consensus         3 ~Ei~il~~l---~HpnIV~l~~~~~~~~~-----~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   73 (305)
                      +|+.+++++   +||||+++++++.+.+.     +|+||||+.+ +|.+++...... .+.... ...+..+.+++.+.|
T Consensus        47 ~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~-~l~~~~~~~~~~~i~~al~~LH  124 (287)
T cd07838          47 REIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKP-GLPPETIKDLMRQLLRGVDFLH  124 (287)
T ss_pred             HHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            577777665   69999999999998877     9999999985 788877653321 112222 222334567788888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      ..++.+.       +.+....+++.|++.......   .....|++.|+|||++.+..++.++||||+||++|+|++|.+
T Consensus       125 ~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~  204 (287)
T cd07838         125 SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRP  204 (287)
T ss_pred             HCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCC
Confidence            7765432       223335677777764433221   123458899999999988889999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccc-----cC-----------CC-----------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         144 PFETSTLKETYSRIKKVE-----YK-----------LP-----------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~-----~~-----------~~-----------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||.+.+..+...++....     ..           ++           +.++..+.++|.+||+.||.+||++.+++.|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         205 LFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            998877666555443210     00           00           1234667899999999999999999999999


Q ss_pred             ccc
Q psy6191         197 EFF  199 (305)
Q Consensus       197 ~~~  199 (305)
                      |||
T Consensus       285 ~~~  287 (287)
T cd07838         285 PYF  287 (287)
T ss_pred             cCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=5.5e-27  Score=197.32  Aligned_cols=190  Identities=15%  Similarity=0.202  Sum_probs=136.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.. ...|+||||+++|+|.+++......  +.... ......+..++.+.|..++.|.
T Consensus        49 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~H~  125 (259)
T cd05037          49 FETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNN--VSLHWKLDVAKQLASALHYLEDKKLVHG  125 (259)
T ss_pred             HHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHhhCCeecc
Confidence            478999999999999999999988 7789999999999999998764421  11111 1222345677888887665332


Q ss_pred             --------ecCCC------CCeeEcchhHHHHhcCCcccccCCCcccccccccC--CCCccchHHHHHHHHHHHHh-CCC
Q psy6191          81 --------LNDDS------SGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLV-GKP  143 (305)
Q Consensus        81 --------~~~~~------~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlGvilye~l~-g~~  143 (305)
                              +....      ..+++.|++............|+..|+|||++.+.  .++.++||||+||++|+|++ |..
T Consensus       126 dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~  205 (259)
T cd05037         126 NVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE  205 (259)
T ss_pred             cCccceEEEecCccccCCceeEEeCCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCC
Confidence                    22111      13667777655444444455688899999998876  68899999999999999999 688


Q ss_pred             CCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         144 PFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||...+..+...... .....|......+.+++.+||..||.+|||+.++++
T Consensus       206 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         206 PLSTLSSSEKERFYQ-DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CcccCCchhHHHHHh-cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            887665433322222 222233334478899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=3.9e-27  Score=209.74  Aligned_cols=195  Identities=21%  Similarity=0.279  Sum_probs=140.9

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC---------C------------------
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE---------E------------------   53 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~---------~------------------   53 (305)
                      .+|+.+|.++. |||||++++++.+++.+|+|||||++|+|.+++.......         .                  
T Consensus        88 ~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (401)
T cd05107          88 MSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSH  167 (401)
T ss_pred             HHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccc
Confidence            36999999998 9999999999999999999999999999999986532100         0                  


Q ss_pred             --------------------------------------------------------------------CCCc-CchhHHH
Q psy6191          54 --------------------------------------------------------------------MSDP-AAQPVIW   64 (305)
Q Consensus        54 --------------------------------------------------------------------~~~~-~~~~~~~   64 (305)
                                                                                          +... .......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  247 (401)
T cd05107         168 VSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQ  247 (401)
T ss_pred             hhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHH
Confidence                                                                                0000 0001123


Q ss_pred             HHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHH
Q psy6191          65 VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSI  131 (305)
Q Consensus        65 ~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSl  131 (305)
                      +..++.+.|..++.+.       +.+....+++.|++......      ...+.+||+.|||||.+.+..++.++||||+
T Consensus       248 i~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  327 (401)
T cd05107         248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF  327 (401)
T ss_pred             HHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHH
Confidence            4567788887765443       22233456667776443221      1234567889999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHH-HHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         132 GCIMYTLLV-GKPPFETSTLKETY-SRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       132 Gvilye~l~-g~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||++|||++ |..||......+.. ..+... ....|...+..+.+++.+||..||.+||++.++++.
T Consensus       328 Gvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         328 GILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999998 89999875544443 333322 234566788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=4.8e-27  Score=200.58  Aligned_cols=195  Identities=24%  Similarity=0.378  Sum_probs=140.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++||||+++++++.++  +..|+||||+++ +|.+++.....  .+..... ..+..+..++.+.|..++.
T Consensus        46 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~i~~al~~LH~~~~~  122 (287)
T cd07840          46 IREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEV--KFTESQIKCYMKQLLEGLQYLHSNGIL  122 (287)
T ss_pred             HHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            3699999999999999999999988  899999999985 88888765421  1122222 2233456778888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      +.       +.+....+++.|++........     ....++..|+|||.+.+ ..++.++||||+||++|||++|..||
T Consensus       123 h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~  202 (287)
T cd07840         123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF  202 (287)
T ss_pred             eccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCC
Confidence            43       2233456777777644433221     23457889999997764 45788999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcccc-----------------------C--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         146 ETSTLKETYSRIKKVEY-----------------------K--------LPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~-----------------------~--------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      ...+.......+.....                       .        +....+..+.+++++||..||.+||++.+++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l  282 (287)
T cd07840         203 QGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL  282 (287)
T ss_pred             CCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            88776554443322100                       0        0011267788999999999999999999999


Q ss_pred             cCccc
Q psy6191         195 HFEFF  199 (305)
Q Consensus       195 ~~~~~  199 (305)
                      .||||
T Consensus       283 ~~~~~  287 (287)
T cd07840         283 QHEYF  287 (287)
T ss_pred             hCcCC
Confidence            99997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.2e-26  Score=196.81  Aligned_cols=195  Identities=16%  Similarity=0.217  Sum_probs=142.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCe------EEEEEeccCCCCHHHHHHHhcCC---CCCCCcCc-hhHHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKF------VYIILELCRKRSMMELYNSACDL---EEMSDPAA-QPVIWVSKWVDY   71 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~------~ylVmEy~~~g~L~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~   71 (305)
                      .+|+.+++.++|||||++++++.+...      .|+||||+++|+|.+++......   ..+..... ..+..+..++.+
T Consensus        49 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~  128 (273)
T cd05035          49 LSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY  128 (273)
T ss_pred             HHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHH
Confidence            368999999999999999998765544      89999999999999988543211   11111111 123345677888


Q ss_pred             hhhhCCcee-------ecCCCCCeeEcchhHHHHhcCC------cccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          72 SDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        72 ~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      .|+.++.+.       +.+....+++.|++........      ....++..|+|||.+.+..++.++||||+||++|||
T Consensus       129 lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el  208 (273)
T cd05035         129 LSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI  208 (273)
T ss_pred             HHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHH
Confidence            887765332       2223345677777644322111      122456789999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         139 LV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       139 l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++ |.+||.+.+..+....+... ....|...+..+.+++.+||+.||.+|||+.+++++
T Consensus       209 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         209 ATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99 99999887777766665543 345567788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.95  E-value=5.7e-27  Score=198.56  Aligned_cols=192  Identities=16%  Similarity=0.246  Sum_probs=140.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.++...|+||||+++|+|.+++......  ..... ......+..++.+.|..|+.+.
T Consensus        53 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~~l~~al~~lH~~g~~H~  130 (269)
T cd05065          53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ--FTVIQLVGMLRGIAAGMKYLSEMNYVHR  130 (269)
T ss_pred             HHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCC--CCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            46999999999999999999999999999999999999999988654221  11111 1222334577788887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-------cccc--cCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-------NTLC--GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKP  143 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-------~~~~--Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~  143 (305)
                             +.+....+++.|++........       ....  ++..|+|||.+.+..++.++||||+||++|||++ |..
T Consensus       131 dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~  210 (269)
T cd05065         131 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER  210 (269)
T ss_pred             ccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC
Confidence                   2223345566676543222111       0111  2457999999988889999999999999999886 999


Q ss_pred             CCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         144 PFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||...+..+....+... ..+.+...+..+.+++.+||..||.+||++.+++.
T Consensus       211 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         211 PYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99887776666665432 23344567788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.95  E-value=6e-27  Score=201.73  Aligned_cols=195  Identities=24%  Similarity=0.371  Sum_probs=137.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC----------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK----------FVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVD   70 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~----------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~   70 (305)
                      .+|++++++++||||+++++++.+..          .+|+||||+++ ++.+.+....  ..+..... ..+..+..++.
T Consensus        54 ~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~  130 (302)
T cd07864          54 IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLN  130 (302)
T ss_pred             HHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHH
Confidence            46999999999999999999987755          89999999986 6666655421  11122222 22234567788


Q ss_pred             HhhhhCCcee-------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCccccccccc-CCCCccchHHHHHHHHHH
Q psy6191          71 YSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        71 ~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye  137 (305)
                      ++|..++.+.       +.+....+++.|++........     ....+++.|+|||.+.+ ..++.++||||+||++|+
T Consensus       131 ~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~e  210 (302)
T cd07864         131 YCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE  210 (302)
T ss_pred             HHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHH
Confidence            8887765432       2233456777777644432211     12356888999998764 357889999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhcccc------------------------------CCCCCCCHHHHHHHHHHhhcCCCCC
Q psy6191         138 LLVGKPPFETSTLKETYSRIKKVEY------------------------------KLPATLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~~~~~i~~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~R  187 (305)
                      |++|++||...+..+....+.....                              .....++..+.++|.+||..||.+|
T Consensus       211 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  290 (302)
T cd07864         211 LFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR  290 (302)
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhC
Confidence            9999999987765554433322100                              0012357788999999999999999


Q ss_pred             CCHhhhhcCccc
Q psy6191         188 PPVAQLLHFEFF  199 (305)
Q Consensus       188 ~~~~~~l~~~~~  199 (305)
                      |++.+++.||||
T Consensus       291 p~~~~il~~~~~  302 (302)
T cd07864         291 CTAEEALNSPWL  302 (302)
T ss_pred             CCHHHHhcCCCC
Confidence            999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=2e-26  Score=195.40  Aligned_cols=195  Identities=17%  Similarity=0.224  Sum_probs=142.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCC---CCCCCcCc-hhHHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDL---EEMSDPAA-QPVIWVSKWVDY   71 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~   71 (305)
                      .+|+++++.++|||||++++++...      ...++||||+++|+|.+.+.....-   ..+..... .....+..++.+
T Consensus        48 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  127 (272)
T cd05075          48 LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEY  127 (272)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHH
Confidence            4689999999999999999976432      3579999999999998877432111   00111111 222335677888


Q ss_pred             hhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          72 SDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        72 ~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      .|..++.|.       +.+....+++.|++.......      .....+++.|+|||.+.+..++.++||||+||++|||
T Consensus       128 lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el  207 (272)
T cd05075         128 LSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI  207 (272)
T ss_pred             HHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHH
Confidence            887775443       223345677788765443221      1223467789999999988899999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         139 LV-GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       139 l~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++ |.+||.+.+..+....+.... ...+...+..+.++|.+||+.||.+|||+.++++.
T Consensus       208 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         208 ATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             HcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99 899998877777666665543 24456778889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=5.4e-27  Score=203.41  Aligned_cols=192  Identities=17%  Similarity=0.216  Sum_probs=141.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++..+ ..++|+||+++|+|.+.+......  .... .......+..++.|.|..++.|.
T Consensus        57 ~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~--~~~~~~~~~~~qi~~~L~~LH~~~iiH~  133 (316)
T cd05108          57 LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEERRLVHR  133 (316)
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcccc--CCHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence            4689999999999999999998775 578999999999999988754221  1111 11223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+....+++.|++........      ....+|..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       134 dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~  213 (316)
T cd05108         134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  213 (316)
T ss_pred             ccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence                   2233456777787655433211      12234678999999998889999999999999999997 999998


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +.+..+....+... ..+.|...+.+..+++.+||..||.+||++.+++.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         214 GIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            87665554433322 234455678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.95  E-value=7.6e-27  Score=197.90  Aligned_cols=191  Identities=20%  Similarity=0.296  Sum_probs=139.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++ ...|+||||+++|+|.+++......  ....... .+..+..++.+.|..++.+.
T Consensus        55 ~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~~~H~  131 (270)
T cd05056          55 LQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS--LDLASLILYSYQLSTALAYLESKRFVHR  131 (270)
T ss_pred             HHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCC--CCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            469999999999999999999876 4578999999999999998754321  1222111 22345677788887664332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.|++........     ....+++.|+|||.+....++.++||||+||++|||++ |..||.+
T Consensus       132 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~  211 (270)
T cd05056         132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG  211 (270)
T ss_pred             ccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence                   2223345666666543222111     12234568999999988889999999999999999986 9999988


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ....|...+..+.+++.+|+..+|.+|||+.+++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         212 VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8776666665543 33556678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=1.1e-26  Score=197.87  Aligned_cols=190  Identities=17%  Similarity=0.208  Sum_probs=139.6

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.++++++|||||++++++. +...|+||||+++|+|.+++......  +.... ......+..++.+.|..++.|. 
T Consensus        58 ~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiH~d  134 (279)
T cd05111          58 DHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHRMVHRN  134 (279)
T ss_pred             HHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHHCCEeccc
Confidence            5677889999999999999875 45688999999999999998754321  11111 2223345677888887775432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                            +.+....+++.|++.......      .....|+..|+|||.+.+..++.++||||+||++|||++ |..||.+
T Consensus       135 lkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  214 (279)
T cd05111         135 LAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG  214 (279)
T ss_pred             cCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence                  223345567778765433211      123457788999999988889999999999999999998 9999988


Q ss_pred             CCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ....+....+.... ...+...+.+..+++.+||..||++|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         215 MRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            77666555454433 2334456678899999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=4.8e-27  Score=200.16  Aligned_cols=194  Identities=22%  Similarity=0.360  Sum_probs=140.9

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.++++++||||+++++++.+.+..|+||||++ ++|.+++.+...  .+.... ...+..+..++.+.|..++.+. 
T Consensus        47 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~  123 (282)
T cd07829          47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPG--PLSPNLIKSIMYQLLRGLAYCHSHRILHRD  123 (282)
T ss_pred             HHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            68999999999999999999999999999999998 589998876421  112222 2223345677888887775442 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                            +.+....+++.|++.......    .....++..|+|||.+.+. .++.++|+||+||++|||++|.+||.+.+
T Consensus       124 l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         124 LKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             CChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence                  222345566777654433221    1234567889999998766 78899999999999999999999998876


Q ss_pred             HHHHHHHHhcc------------------ccCC-----------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRIKKV------------------EYKL-----------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i~~~------------------~~~~-----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ..+....+...                  ...+           -+..+..+.++|++||..||.+||++.+++.||||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         204 EIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            55443333210                  0000           11246788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=6.8e-27  Score=205.18  Aligned_cols=196  Identities=23%  Similarity=0.375  Sum_probs=140.1

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhh
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKY   75 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   75 (305)
                      +|+.++++++|||||++++++...      ...|+|+|++ |++|.+++... .+   ...... .+..+..++.+.|..
T Consensus        65 ~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l---~~~~~~~i~~qi~~aL~~LH~~  139 (345)
T cd07877          65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KL---TDDHVQFLIYQILRGLKYIHSA  139 (345)
T ss_pred             HHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHHC
Confidence            699999999999999999998643      4588999987 78898877532 22   222222 233456788888887


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcC-CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      ++.+.       +.+..+.+++.|++....... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|++||.
T Consensus       140 ~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  219 (345)
T cd07877         140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  219 (345)
T ss_pred             CeeecCCChHHEEEcCCCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            76443       223345567777764433222 234578999999998765 467889999999999999999999998


Q ss_pred             CCCHHHHHHHHhccc-----------------------cCC--------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKVE-----------------------YKL--------PATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~-----------------------~~~--------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ..+.......+....                       ...        ....+..+.++|.+||..||.+|+++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         220 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            765544333221100                       000        1134677899999999999999999999999


Q ss_pred             CccccccC
Q psy6191         196 FEFFNDYC  203 (305)
Q Consensus       196 ~~~~~~~~  203 (305)
                      ||||....
T Consensus       300 h~~f~~~~  307 (345)
T cd07877         300 HAYFAQYH  307 (345)
T ss_pred             ChhhhhcC
Confidence            99998643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=5.3e-27  Score=205.67  Aligned_cols=197  Identities=22%  Similarity=0.349  Sum_probs=138.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|++++++++||||+++++++....      ..|+||||+.+ ++.++...  .+   ..... ..+..+..++.+.|.
T Consensus        62 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~---~~~~~~~~~~qi~~aL~~LH~  135 (342)
T cd07879          62 YRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGH--PL---SEDKVQYLVYQMLCGLKYIHS  135 (342)
T ss_pred             HHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHcC--CC---CHHHHHHHHHHHHHHHHHHHH
Confidence            37999999999999999999987643      46999999974 66655421  11   11111 223345677888887


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhc-CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .++.|.       +.+..+.+++.|++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||
T Consensus       136 ~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf  215 (342)
T cd07879         136 AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF  215 (342)
T ss_pred             CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCC
Confidence            775432       22334567777775433221 1234578999999999865 45888999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccc-----------------------cCC--------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         146 ETSTLKETYSRIKKVE-----------------------YKL--------PATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-----------------------~~~--------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .+.+....+..+....                       ...        .+..+..+.++|.+||+.||.+||++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l  295 (342)
T cd07879         216 KGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL  295 (342)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            8876544433322100                       000        123567789999999999999999999999


Q ss_pred             cCccccccCC
Q psy6191         195 HFEFFNDYCP  204 (305)
Q Consensus       195 ~~~~~~~~~~  204 (305)
                      .||||....+
T Consensus       296 ~h~~f~~~~~  305 (342)
T cd07879         296 EHPYFDSFRD  305 (342)
T ss_pred             cCcchhhccc
Confidence            9999987543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0667|consensus

Probab=99.95  E-value=1.6e-27  Score=211.46  Aligned_cols=197  Identities=25%  Similarity=0.344  Sum_probs=139.9

Q ss_pred             hHHHHHhcCC-CC-----CccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhh
Q psy6191           3 QEIAIHRSLK-HR-----NVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKY   75 (305)
Q Consensus         3 ~Ei~il~~l~-Hp-----nIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   75 (305)
                      .||.||..|+ |-     |||+++|+|...+++|||+|+++ -+|.++++...... ++-...+.+. +++.++..++..
T Consensus       231 ~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l  308 (586)
T KOG0667|consen  231 IEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHEL  308 (586)
T ss_pred             HHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhC
Confidence            5999999997 42     89999999999999999999986 48999998654322 2222222222 234455444433


Q ss_pred             CC--------ceeecC-CCCCeeEcchhHHHHhcC-CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          76 GF--------GYQLND-DSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        76 ~~--------~~~~~~-~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      ++        |+++.+ ....|++.||+.+-.... .-+.+-|..|.|||++.+..|+.+.||||||||++||.+|.+-|
T Consensus       309 ~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  309 GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             CeeeccCChhheeeccCCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence            32        333332 223455666654433211 12566789999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcccc----------------------------------------------------CCCCC------
Q psy6191         146 ETSTLKETYSRIKKVEY----------------------------------------------------KLPAT------  167 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~----------------------------------------------------~~~~~------  167 (305)
                      .+.+..+++..|....-                                                    ..|..      
T Consensus       389 pG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~  468 (586)
T KOG0667|consen  389 PGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLES  468 (586)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccch
Confidence            99988887777642100                                                    01100      


Q ss_pred             -----CCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         168 -----LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       168 -----~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                           -.....|+|++||..||.+|+|..|+|+|||++.
T Consensus       469 ~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  469 GLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG  507 (586)
T ss_pred             hcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence                 0123469999999999999999999999999984

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=1.6e-26  Score=197.21  Aligned_cols=190  Identities=19%  Similarity=0.249  Sum_probs=134.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++||||+++++++..  +..+|+||||+++|+|.+++.... +   .... ...+..+.+++.+.|..++.
T Consensus        54 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-l---~~~~~~~i~~~l~~~l~~lH~~~i~  129 (283)
T cd05080          54 KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-L---NLAQLLLFAQQICEGMAYLHSQHYI  129 (283)
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcC-C---CHHHHHHHHHHHHHHHHHHHHCCee
Confidence            479999999999999999998765  457999999999999999886531 2   2211 22233456778888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.       +.+....+++.|++.......       .....++..|+|||.+.+..++.++||||+||++|||++|..|
T Consensus       130 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p  209 (283)
T cd05080         130 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS  209 (283)
T ss_pred             ccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCC
Confidence            32       222334566777764433221       1123456779999999888889999999999999999999999


Q ss_pred             CCCCCHH--HH-------------HHHHh-ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETSTLK--ET-------------YSRIK-KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~~~~--~~-------------~~~i~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |......  +.             ...+. ....+.|...+..+.+++.+||..||++|||+++++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         210 KQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            8653211  00             00010 1112335567789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.3e-26  Score=195.93  Aligned_cols=191  Identities=18%  Similarity=0.236  Sum_probs=142.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+ ...|+||||+++|+|.+++......  +... .......+..++.+.|..++.+.
T Consensus        57 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~i~H~  133 (279)
T cd05057          57 LDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKRLVHR  133 (279)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCEEec
Confidence            479999999999999999999987 7899999999999999988754321  1111 12223345677888887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCc------ccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKN------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~------~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+....+++.|++....+....      ...++..|+|||.+....++.++|+||+||++||+++ |..||.
T Consensus       134 di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  213 (279)
T cd05057         134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE  213 (279)
T ss_pred             ccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence                   22233456677776443322111      1223567999999988888999999999999999998 999999


Q ss_pred             CCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +.+..+....+.... ...|...+..+.+++.+||..||.+||++.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         214 GIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            887777666665432 3445667788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0666|consensus

Probab=99.94  E-value=4.8e-27  Score=191.22  Aligned_cols=200  Identities=26%  Similarity=0.441  Sum_probs=140.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCCC--CCCCcCchhHHH-HHHHHHHhhh---
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDLE--EMSDPAAQPVIW-VSKWVDYSDK---   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~---   74 (305)
                      .|||.++++|+|||||.|..+|-+ +..+||++||++. ||.++++-.....  .++......++| +++++.|+|.   
T Consensus        75 cREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWv  153 (438)
T KOG0666|consen   75 CREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWV  153 (438)
T ss_pred             HHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhhe
Confidence            599999999999999999999977 8899999999986 8888876443221  122222233333 3555666653   


Q ss_pred             -----hCCceeecCC---CCCeeEcchhHHHHh-------cCCcccccCCCcccccccccC-CCCccchHHHHHHHHHHH
Q psy6191          75 -----YGFGYQLNDD---SSGVMFNDLTRMIML-------ANKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        75 -----~~~~~~~~~~---~~~v~~~d~~~~~~~-------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~  138 (305)
                           ...++++..+   .+.|++.|++...+.       .+.+.++-|.+|.|||++.+. .|+.++||||+|||+.||
T Consensus       154 lHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaEl  233 (438)
T KOG0666|consen  154 LHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAEL  233 (438)
T ss_pred             eeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHH
Confidence                 2223333322   356888998766553       234567789999999988765 589999999999999999


Q ss_pred             HhCCCCCCCCCH---------HHHHHHHhccc-------c----CCCC--------------------------CCCHHH
Q psy6191         139 LVGKPPFETSTL---------KETYSRIKKVE-------Y----KLPA--------------------------TLKKPA  172 (305)
Q Consensus       139 l~g~~Pf~~~~~---------~~~~~~i~~~~-------~----~~~~--------------------------~~~~~~  172 (305)
                      ++-.+-|.+...         ...+.+|....       +    .+|.                          .-++.+
T Consensus       234 Ltl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a  313 (438)
T KOG0666|consen  234 LTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSA  313 (438)
T ss_pred             HccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchH
Confidence            999999976421         12223332110       0    0110                          123347


Q ss_pred             HHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         173 ATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       173 ~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+|+.+||.+||.+|+|++++|+|+||+..
T Consensus       314 ~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  314 LDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             HHHHHHHhccCchhhccHHHHhcccccccC
Confidence            799999999999999999999999999853

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.94  E-value=3.8e-26  Score=193.45  Aligned_cols=194  Identities=22%  Similarity=0.397  Sum_probs=138.9

Q ss_pred             hHHHHHh-cCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcC-chhHHHHHHHHHHhhh-hCCc
Q psy6191           3 QEIAIHR-SLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPA-AQPVIWVSKWVDYSDK-YGFG   78 (305)
Q Consensus         3 ~Ei~il~-~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~-~~~~   78 (305)
                      +|+.+++ .++||||+++++++.+++..|+||||++|++|.+++...... ..+.... ...+..+..++.+.|. .++.
T Consensus        57 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~  136 (269)
T cd08528          57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIV  136 (269)
T ss_pred             HHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCcee
Confidence            5777776 489999999999999999999999999999999987542211 1111111 1222334566777764 3332


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      +.       +.+....+++.|++.......   .....|+..|+|||.+.+..++.++|+||+||++|+|++|.+||...
T Consensus       137 H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~  216 (269)
T cd08528         137 HRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST  216 (269)
T ss_pred             ecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence            21       222334566667654433222   13457899999999998888899999999999999999999999887


Q ss_pred             CHHHHHHHHhccccC-CCC-CCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         149 TLKETYSRIKKVEYK-LPA-TLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~-~~~-~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +.......+...... .+. ..+..+.+++.+||+.||.+||++.|+..+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         217 NMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            766655555444332 122 467889999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.94  E-value=2.3e-26  Score=197.66  Aligned_cols=197  Identities=21%  Similarity=0.336  Sum_probs=138.4

Q ss_pred             hHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhh-hCCce
Q psy6191           3 QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDK-YGFGY   79 (305)
Q Consensus         3 ~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~   79 (305)
                      +|+.++.++ .||||+++++++.++..+|+||||+. +++.+++.....  .+.... ...+..+.+++.++|. .++.|
T Consensus        62 ~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~i~H  138 (296)
T cd06618          62 MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHGVIH  138 (296)
T ss_pred             HHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEec
Confidence            466666666 49999999999999999999999985 477776654322  111111 2234445677888885 45433


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCC----CCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNG----HSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~----~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .       +.+....+++.|++....+.+.   ....|++.|+|||.+.+..    ++.++||||+||++|+|++|+.||
T Consensus       139 ~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  218 (296)
T cd06618         139 RDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY  218 (296)
T ss_pred             CCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCC
Confidence            2       2234456777887654433221   2335788999999987553    788999999999999999999999


Q ss_pred             CCCCH-HHHHHHHhccc-cCCCC--CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         146 ETSTL-KETYSRIKKVE-YKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~~~~-~~~~~~i~~~~-~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..... .+....+.... ...+.  ..+.++.+++.+||..||.+||++++++.|+|+...
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         219 KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            76332 33333333222 22222  367889999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=2.6e-26  Score=200.54  Aligned_cols=197  Identities=21%  Similarity=0.307  Sum_probs=139.4

Q ss_pred             hHHHHHhcC-CCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhC
Q psy6191           3 QEIAIHRSL-KHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         3 ~Ei~il~~l-~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   76 (305)
                      +|+++++++ +|||||+++++...    ...+|++|||+. ++|.+.+.....+   .... ...+..+..++.+.|..|
T Consensus        50 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~g  125 (332)
T cd07857          50 RELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPL---TDAHFQSFIYQILCGLKYIHSAN  125 (332)
T ss_pred             HHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHHhCC
Confidence            699999999 59999999997542    356899999986 5888887654333   2222 222344567888888877


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhc--------CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHh
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLA--------NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~--------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~  140 (305)
                      +.+.       +.+..+.+++.|++....+.        .....+||+.|+|||.+.+ ..++.++||||+||++|+|++
T Consensus       126 ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~  205 (332)
T cd07857         126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG  205 (332)
T ss_pred             cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            6443       22334557777776443221        1134579999999998765 468899999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcc-------------------------c---cC---CCCCCCHHHHHHHHHHhhcCCCCCCC
Q psy6191         141 GKPPFETSTLKETYSRIKKV-------------------------E---YK---LPATLKKPAATMIKKMLLLDPVQRPP  189 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~-------------------------~---~~---~~~~~~~~~~~li~~~l~~dp~~R~~  189 (305)
                      |.+||.+.+.......+...                         .   ..   ..+..+..+.+++.+||..||.+|||
T Consensus       206 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t  285 (332)
T cd07857         206 RKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS  285 (332)
T ss_pred             CCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC
Confidence            99999876543332221110                         0   00   11235678899999999999999999


Q ss_pred             HhhhhcCccccccC
Q psy6191         190 VAQLLHFEFFNDYC  203 (305)
Q Consensus       190 ~~~~l~~~~~~~~~  203 (305)
                      +.+++.|||++.+.
T Consensus       286 ~~~ll~~~~~~~~~  299 (332)
T cd07857         286 VEEALEHPYLAIWH  299 (332)
T ss_pred             HHHHhcChhhhhhc
Confidence            99999999998654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.94  E-value=2.2e-26  Score=217.22  Aligned_cols=98  Identities=31%  Similarity=0.628  Sum_probs=86.0

Q ss_pred             cccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCC---CCCHHHHHHHHHHhh
Q psy6191         105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA---TLKKPAATMIKKMLL  181 (305)
Q Consensus       105 ~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~l~  181 (305)
                      ++||+.|||||++.+..++.++||||+||++|||++|++||.+.+..+.+..+....+.+|.   .++..+.+++.+||.
T Consensus       540 ~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~  619 (669)
T cd05610         540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLT  619 (669)
T ss_pred             eeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence            36899999999999888999999999999999999999999998888888777665544443   467788999999999


Q ss_pred             cCCCCCCCHhhhhcCcccccc
Q psy6191         182 LDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       182 ~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .||.+||++.++++||||...
T Consensus       620 ~dP~~R~ta~e~l~h~~~~~~  640 (669)
T cd05610         620 MDPTKRAGLKELKQHPLFHGV  640 (669)
T ss_pred             cChhHCcCHHHHHhCHhhcCC
Confidence            999999999999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.94  E-value=1.7e-26  Score=199.66  Aligned_cols=195  Identities=21%  Similarity=0.337  Sum_probs=134.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   72 (305)
                      .+|++++++++||||+++++++.+        ...+|+||||+.+ ++.+.+.....  .+...... .+..+.+++.+.
T Consensus        55 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~l~~al~~l  131 (311)
T cd07866          55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSV--KLTESQIKCYMLQLLEGINYL  131 (311)
T ss_pred             HHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHH
Confidence            479999999999999999998754        3457999999875 56666543211  12222222 223456778888


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHhcC---------------CcccccCCCcccccccccC-CCCccchHH
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN---------------KNTLCGTPNYIAPEILNKN-GHSFEVDVW  129 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~---------------~~~~~Gt~~y~aPE~~~~~-~~~~~~Diw  129 (305)
                      |..++.+.       +.+....+++.|++.......               .....||+.|+|||++.+. .++.++|||
T Consensus       132 H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~  211 (311)
T cd07866         132 HENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIW  211 (311)
T ss_pred             HhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhH
Confidence            87775432       223334566777654332211               1234578999999987654 578899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-----------------------cCCC-------CCCCHHHHHHHHHH
Q psy6191         130 SIGCIMYTLLVGKPPFETSTLKETYSRIKKVE-----------------------YKLP-------ATLKKPAATMIKKM  179 (305)
Q Consensus       130 SlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~-----------------------~~~~-------~~~~~~~~~li~~~  179 (305)
                      |+||++|+|++|++||.+.+.......+....                       ...+       ...+..+.++|.+|
T Consensus       212 slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  291 (311)
T cd07866         212 GIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKL  291 (311)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHH
Confidence            99999999999999998876654443332100                       0000       12345678999999


Q ss_pred             hhcCCCCCCCHhhhhcCccc
Q psy6191         180 LLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       180 l~~dp~~R~~~~~~l~~~~~  199 (305)
                      |..||.+|||+.+++.||||
T Consensus       292 l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         292 LSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             cccCcccCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=3.7e-26  Score=194.68  Aligned_cols=194  Identities=19%  Similarity=0.229  Sum_probs=139.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCC-----CCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDL-----EEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+.++++++||||+++++++.. +...|+++||+++|+|.+++......     ..+..... ..+..+..++.|.|+
T Consensus        56 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  135 (280)
T cd05043          56 LQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK  135 (280)
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            479999999999999999998665 57899999999999999988654221     11111111 222345677888887


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-  140 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-  140 (305)
                      .++.+.       +.+....+++.|++....+..      .....|+..|+|||++.+..++.++||||+||++||+++ 
T Consensus       136 ~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~  215 (280)
T cd05043         136 RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL  215 (280)
T ss_pred             CCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence            765332       112234455556544322211      112345678999999988889999999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         141 GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |++||...+..+....+... .+..+...+.++.+++.+||..||++|||+.++++
T Consensus       216 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         216 GQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99999887777766555443 22334456788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.94  E-value=3.1e-26  Score=190.27  Aligned_cols=195  Identities=33%  Similarity=0.563  Sum_probs=148.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++||||+++++.+.++...++||||+++++|.+++.....+   .... ...+..+..++.+.|+.++.+.
T Consensus        35 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~l~~~l~~lh~~~i~h~  111 (244)
T smart00220       35 LREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRL---SEDEARFYARQILSALEYLHSNGIIHR  111 (244)
T ss_pred             HHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCC---CHHHHHHHHHHHHHHHHHHHHcCeecC
Confidence            57999999999999999999999999999999999999999988754321   1111 1222234566777777665432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC-CC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET-ST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~-~~  149 (305)
                             +.+..+.+++.|++.......   .....|++.|++||.+.+..++.++||||+|+++|++++|..||.. .+
T Consensus       112 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~  191 (244)
T smart00220      112 DLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ  191 (244)
T ss_pred             CcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence                   222335667777755443322   2456789999999999888888899999999999999999999987 55


Q ss_pred             HHHHHHHHhccccCCCCC---CCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         150 LKETYSRIKKVEYKLPAT---LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~---~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      .......+.......+..   .+.++.+++.+||..||.+||++.++++||||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      192 LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            555555555444433322   77889999999999999999999999999996

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0983|consensus

Probab=99.94  E-value=4.2e-27  Score=188.45  Aligned_cols=199  Identities=21%  Similarity=0.317  Sum_probs=142.7

Q ss_pred             HHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhh-hhCCc--
Q psy6191           4 EIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSD-KYGFG--   78 (305)
Q Consensus         4 Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~--   78 (305)
                      .++++... +.|.||+-+|+|.++..++|.||.+.. -+..++++....  .++..+.. .....+++.|+. ++++.  
T Consensus       140 Dldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~p--iPE~ilGk~tva~v~AL~YLKeKH~viHR  216 (391)
T KOG0983|consen  140 DLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGP--IPERILGKMTVAIVKALYYLKEKHGVIHR  216 (391)
T ss_pred             hhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCC--chHHhhhhhHHHHHHHHHHHHHhcceeec
Confidence            34444443 479999999999999999999999742 334455443321  12222211 122345555543 33332  


Q ss_pred             -----eeecCCCCCeeEcchhHHHHhcCC---cccccCCCccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          79 -----YQLNDDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNK---NGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        79 -----~~~~~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                           .++.|..++|+++||+-.-.+.+.   ....|.+.|||||.+.-   ..|+-.+|||||||+++|++||+.||.+
T Consensus       217 DvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~  296 (391)
T KOG0983|consen  217 DVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG  296 (391)
T ss_pred             ccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence                 335667789999999765544432   34579999999999853   3588999999999999999999999987


Q ss_pred             -CCHHHHHHHHhcccc-CCCC--CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCCC
Q psy6191         148 -STLKETYSRIKKVEY-KLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPT  205 (305)
Q Consensus       148 -~~~~~~~~~i~~~~~-~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~~  205 (305)
                       .+..+.+.+|.+..+ .+|.  .+|+..++|+..||.+|+.+||.-.++|+|||+..+.+.
T Consensus       297 c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a  358 (391)
T KOG0983|consen  297 CKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA  358 (391)
T ss_pred             CCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence             456677777776443 2332  378999999999999999999999999999999887554

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=4.4e-26  Score=194.73  Aligned_cols=193  Identities=19%  Similarity=0.283  Sum_probs=135.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++||||+++++++.+.  ...|+||||++||+|.+++......  ..... ...+..+..++.+.|+.|+.
T Consensus        54 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~i~~~i~~aL~~lH~~gi~  131 (284)
T cd05079          54 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSRQYV  131 (284)
T ss_pred             HHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4799999999999999999998875  6799999999999999988653211  11111 22233456778888877764


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      |.       +.+.++.+++.|++....+..       .....|+..|+|||++.+..++.++||||+||++|+|++++.|
T Consensus       132 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~  211 (284)
T cd05079         132 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS  211 (284)
T ss_pred             ecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCC
Confidence            43       222334566677654332211       1245677889999999888889999999999999999998776


Q ss_pred             CCCCC---------------HHHHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         145 FETST---------------LKETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       145 f~~~~---------------~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +....               .......+.. ...+.+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         212 ESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            53211               0111111111 1223455678899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.94  E-value=7e-27  Score=230.67  Aligned_cols=181  Identities=20%  Similarity=0.278  Sum_probs=125.7

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCceeec
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLN   82 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (305)
                      +|++++++++|||||++++++.+++..|+|||||++|+|.++++.   +.  .......+..++.++.|.|...      
T Consensus       732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~--~~~~~~i~~~ia~~L~yLH~~~------  800 (968)
T PLN00113        732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LS--WERRRKIAIGIAKALRFLHCRC------  800 (968)
T ss_pred             HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CC--HHHHHHHHHHHHHHHHHhccCC------
Confidence            579999999999999999999999999999999999999999853   11  0111223334567777777321      


Q ss_pred             CCCCCeeEcchhHHHHhcC-----------------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          83 DDSSGVMFNDLTRMIMLAN-----------------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        83 ~~~~~v~~~d~~~~~~~~~-----------------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                        +.+++|+|+++.+++.+                 ..+..||+.|||||++.+..++.++||||+||++|||++|+.||
T Consensus       801 --~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~  878 (968)
T PLN00113        801 --SPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA  878 (968)
T ss_pred             --CCCeecCCCCHHhEEECCCCceEEEeccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence              23455555544443221                 12346789999999999888999999999999999999999999


Q ss_pred             CCCC-----HHHHHHHHh-c------cccCCCCC------CCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         146 ETST-----LKETYSRIK-K------VEYKLPAT------LKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       146 ~~~~-----~~~~~~~i~-~------~~~~~~~~------~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ....     ..+...... .      ..+.++..      ...+..+++.+||+.||++|||+.|+++.
T Consensus       879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        879 DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            5421     111111000 0      00111111      11245688999999999999999999864

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.94  E-value=5.6e-26  Score=193.52  Aligned_cols=191  Identities=15%  Similarity=0.219  Sum_probs=141.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCC-cCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++||||+++++++.+ ...+++|||+++|+|.+++.....  .+.. ........+..++.+.|+.++.|.
T Consensus        57 ~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~iiH~  133 (279)
T cd05109          57 LDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVRLVHR  133 (279)
T ss_pred             HHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            478999999999999999999876 457899999999999998865321  1111 122233455777888887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.++.+.+++.|++........      ....+++.|+|||.+.+..++.++||||+||++|||++ |.+||.
T Consensus       134 dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  213 (279)
T cd05109         134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD  213 (279)
T ss_pred             ccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence                   2233355777787644332211      11234678999999988889999999999999999998 999998


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ..........+... ....+...+.++.+++.+||..||++||++.+++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         214 GIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            77666655555443 23445567889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0662|consensus

Probab=99.94  E-value=1.3e-26  Score=174.97  Aligned_cols=200  Identities=22%  Similarity=0.400  Sum_probs=144.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCc--
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFG--   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--   78 (305)
                      .|||.++++|+|.|||+++++...++.+-+|+|||.. +|..++....+.  +....+ ...+++..++.++|....-  
T Consensus        49 lreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~--~d~~~~rsfmlqllrgl~fchshnvlhr  125 (292)
T KOG0662|consen   49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGD--LDPEIVRSFMLQLLRGLGFCHSHNVLHR  125 (292)
T ss_pred             HHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCc--CCHHHHHHHHHHHHhhhhhhhhhhhhhc
Confidence            3899999999999999999999999999999999975 666666543221  111112 2233445566666544321  


Q ss_pred             -----eeecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCC-CCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          79 -----YQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        79 -----~~~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                           .++...++.+++.||+....+.-    -+..+-|.+|.+|.++-+.. |+++.|+||.|||+.|+.. |++-|.+
T Consensus       126 dlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg  205 (292)
T KOG0662|consen  126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_pred             cCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence                 12333446778888876554321    23446799999999987664 8999999999999999986 8888999


Q ss_pred             CCHHHHHHHHhccc--------------------cCCCC---------CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         148 STLKETYSRIKKVE--------------------YKLPA---------TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       148 ~~~~~~~~~i~~~~--------------------~~~~~---------~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      .+..++..+|....                    +.+|.         .++...+|++.++|..+|.+|++++++++|||
T Consensus       206 ~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpy  285 (292)
T KOG0662|consen  206 NDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPY  285 (292)
T ss_pred             CcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcc
Confidence            88888777774310                    01111         23345689999999999999999999999999


Q ss_pred             ccccCC
Q psy6191         199 FNDYCP  204 (305)
Q Consensus       199 ~~~~~~  204 (305)
                      |.+.++
T Consensus       286 f~d~s~  291 (292)
T KOG0662|consen  286 FSDFSP  291 (292)
T ss_pred             ccccCC
Confidence            987543

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.94  E-value=6.8e-26  Score=195.36  Aligned_cols=192  Identities=16%  Similarity=0.236  Sum_probs=139.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++... ..++||||+++|+|.+++......  .... .......+..++.+.|..++.|.
T Consensus        57 ~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~--~~~~~~~~~~~qi~~~L~~LH~~~ivH~  133 (303)
T cd05110          57 MDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEERRLVHR  133 (303)
T ss_pred             HHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence            3689999999999999999998764 478999999999999988654321  1111 12223345677888887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+....+++.|++.......      .....++..|+|||.+.+..++.++||||+||++|||++ |..||.
T Consensus       134 dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~  213 (303)
T cd05110         134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD  213 (303)
T ss_pred             ccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence                   222345567777765443221      122345778999999988889999999999999999997 999998


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +....+....+... .+..+...+..+.+++.+||..||++||++.++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         214 GIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            76655544444332 233445577889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG2345|consensus

Probab=99.93  E-value=5e-27  Score=185.41  Aligned_cols=195  Identities=22%  Similarity=0.344  Sum_probs=132.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCCC-CCCCcCchh-HHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDLE-EMSDPAAQP-VIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~   74 (305)
                      .|||+..++++||||++++++...+     ...||++.|...|+|.+.+....... .+++..... ...+.+++.+.|.
T Consensus        66 ~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~  145 (302)
T KOG2345|consen   66 LREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE  145 (302)
T ss_pred             HHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc
Confidence            3899999999999999999875433     45999999999999999987654332 222222111 1224566777776


Q ss_pred             hC--Ccee-------ecCCCCCeeEcchhHHHHh-------------cCCcccccCCCcccccccccCC---CCccchHH
Q psy6191          75 YG--FGYQ-------LNDDSSGVMFNDLTRMIML-------------ANKNTLCGTPNYIAPEILNKNG---HSFEVDVW  129 (305)
Q Consensus        75 ~~--~~~~-------~~~~~~~v~~~d~~~~~~~-------------~~~~~~~Gt~~y~aPE~~~~~~---~~~~~Diw  129 (305)
                      ++  +.|.       +..+++..++.|++.....             .+...--.|..|.|||++.-+.   .+.++|||
T Consensus       146 ~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIW  225 (302)
T KOG2345|consen  146 KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIW  225 (302)
T ss_pred             cCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchh
Confidence            55  2222       1222344555566533211             0011123588999999986443   58899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccccCCCC--CCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         130 SIGCIMYTLLVGKPPFETSTLK--ETYSRIKKVEYKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       130 SlGvilye~l~g~~Pf~~~~~~--~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||||+||+|+.|..||+..-..  .+...+.++.+.+|.  ..++...++|+.||+.||.+||++.+++.+
T Consensus       226 SLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  226 SLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             hhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            9999999999999999642111  111123444555553  478889999999999999999999999863

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=8.8e-26  Score=197.99  Aligned_cols=195  Identities=18%  Similarity=0.267  Sum_probs=137.4

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCCCC------------------CCC-----
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDLEE------------------MSD-----   56 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~~~------------------~~~-----   56 (305)
                      .+|+.+++++ +|||||++++++.. +..+|+|||||++|+|.+++........                  ..+     
T Consensus        58 ~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (343)
T cd05103          58 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRR  137 (343)
T ss_pred             HHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhh
Confidence            3799999999 68999999998765 4578999999999999999865321000                  000     


Q ss_pred             --------------------------------------cC----chhHHHHHHHHHHhhhhCCcee-------ecCCCCC
Q psy6191          57 --------------------------------------PA----AQPVIWVSKWVDYSDKYGFGYQ-------LNDDSSG   87 (305)
Q Consensus        57 --------------------------------------~~----~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~   87 (305)
                                                            ..    ......+..++.+.|+.++.|.       +.+....
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~  217 (343)
T cd05103         138 LDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV  217 (343)
T ss_pred             ccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc
Confidence                                                  00    0112234667888887775432       2233455


Q ss_pred             eeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhc
Q psy6191          88 VMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKE-TYSRIKK  159 (305)
Q Consensus        88 v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~~-~~~~i~~  159 (305)
                      +++.|++......      ..++..+++.|+|||++.+..++.++||||+||++|+|++ |..||......+ ....+..
T Consensus       218 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  297 (343)
T cd05103         218 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE  297 (343)
T ss_pred             EEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc
Confidence            6777776443321      1123345678999999988889999999999999999997 999997654332 2222222


Q ss_pred             -cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         160 -VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       160 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                       .....|...+++..+++.+||+.||.+||++.++++|
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         298 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             2334456678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=2.2e-25  Score=190.34  Aligned_cols=192  Identities=19%  Similarity=0.270  Sum_probs=133.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++|||||++++++..  ...+|+||||+++|+|.+++......  +.... ...+..+..++.+.|..|+.
T Consensus        53 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--l~~~~~~~~~~~l~~aL~~LH~~~i~  130 (284)
T cd05081          53 EREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGSKRYV  130 (284)
T ss_pred             HHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcC--CCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            479999999999999999998754  45799999999999999998653211  11111 22233456778888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcCCc-------ccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLANKN-------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~~~-------~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.       +.+....+++.|++.........       ...++..|+|||++.+..++.++||||+||++|||++|..|
T Consensus       131 H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~  210 (284)
T cd05081         131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK  210 (284)
T ss_pred             eccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence            42       22333456777776544332211       11234569999999888899999999999999999999877


Q ss_pred             CCCCCHH----------------HHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETSTLK----------------ETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~~~~----------------~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +......                .....+.. .....+...+..+.+++.+||..||++|||+.+++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         211 SCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             CCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6433211                01111111 122334567788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG4250|consensus

Probab=99.93  E-value=3e-26  Score=204.61  Aligned_cols=187  Identities=22%  Similarity=0.330  Sum_probs=128.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~   74 (305)
                      .+|+++|++|+|||||+++++-++..      ...+|||||.||||...+++......+++.+...++ .+..++.|+|.
T Consensus        59 ~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE  138 (732)
T KOG4250|consen   59 CREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE  138 (732)
T ss_pred             HHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58999999999999999999876544      468999999999999999765433333333222222 23466777777


Q ss_pred             hCCceeecCCC-----------CCeeEcchhHHHHhcCC---cccccCCCccccccccc-CCCCccchHHHHHHHHHHHH
Q psy6191          75 YGFGYQLNDDS-----------SGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        75 ~~~~~~~~~~~-----------~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l  139 (305)
                      .|+.|+.....           ...++.|++-+..+.+.   .+++||+.|.+||++.. +.|+..+|.||+||++|+++
T Consensus       139 n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ca  218 (732)
T KOG4250|consen  139 NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECA  218 (732)
T ss_pred             cCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHh
Confidence            77655533221           12345666655444332   46789999999999984 78999999999999999999


Q ss_pred             hCCCCCCC----CCHHHHHHHHhcc---------------------ccCCCCCCCHHH----HHHHHHHhhcCCCCCC
Q psy6191         140 VGKPPFET----STLKETYSRIKKV---------------------EYKLPATLKKPA----ATMIKKMLLLDPVQRP  188 (305)
Q Consensus       140 ~g~~Pf~~----~~~~~~~~~i~~~---------------------~~~~~~~~~~~~----~~li~~~l~~dp~~R~  188 (305)
                      ||..||..    .+..+....+...                     ..++|..++...    ..++..+|..||.+|.
T Consensus       219 TG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  219 TGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            99999953    2222333333211                     122334445443    3577888999999998

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=2.2e-25  Score=190.07  Aligned_cols=192  Identities=21%  Similarity=0.287  Sum_probs=136.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|+++++.++||||+++++++..  +...|+||||+++|+|.+++......  .... ....+..+..++.+.|..++.
T Consensus        54 ~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~l~~aL~~lH~~~i~  131 (284)
T cd05038          54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGSQRYI  131 (284)
T ss_pred             HHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccc--cCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            579999999999999999999887  66899999999999999998654311  1111 122233456778888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcCC-------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLANK-------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~~-------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.       +.+....+++.|++........       ....++..|+|||.+.+..++.++||||+||++|||++|..|
T Consensus       132 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p  211 (284)
T cd05038         132 HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP  211 (284)
T ss_pred             cCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCC
Confidence            32       2223355677777655443311       122345679999999888889999999999999999999999


Q ss_pred             CCCCCHHH---------------HHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETSTLKE---------------TYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~~~~~---------------~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |.......               ....+.. .....+...+.+..+++.+||..||.+|||+.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         212 SQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            86542211               1111111 122334456678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1027|consensus

Probab=99.93  E-value=2.9e-26  Score=207.69  Aligned_cols=197  Identities=28%  Similarity=0.403  Sum_probs=145.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHh-cCCCCCCCcCch-hHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSA-CDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   78 (305)
                      .|||.+|+.- +|||||++|+.-+++++.||.+|+|.. +|.+++... ............ .+.+..+++.|+|+.++.
T Consensus       550 ~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iV  628 (903)
T KOG1027|consen  550 QREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIV  628 (903)
T ss_pred             HHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccc
Confidence            5899999988 599999999999999999999999976 899998874 111111111222 222345778888887765


Q ss_pred             eeecC------------CCCCeeEcchhHHHHhc-------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHH
Q psy6191          79 YQLND------------DSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        79 ~~~~~------------~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l  139 (305)
                      |+-..            ....+++.||+....+.       ...+..||-+|+|||++....-+.++||+|+||++|..+
T Consensus       629 HRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvl  708 (903)
T KOG1027|consen  629 HRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVL  708 (903)
T ss_pred             cccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEe
Confidence            54221            12335667776554432       234667999999999999888888999999999999888


Q ss_pred             hC-CCCCCCCCHHHHHHHHhccccCCC---CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         140 VG-KPPFETSTLKETYSRIKKVEYKLP---ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       140 ~g-~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +| ..||...-  +...+|.+..+.+-   +....++.|||.+|+..||..||+|.++|.||+|=+
T Consensus       709 tgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  709 TGGSHPFGDSL--ERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             cCCccCCCchH--HhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            85 89997543  33345666555432   223338999999999999999999999999999843

>KOG4257|consensus

Probab=99.93  E-value=2e-25  Score=196.51  Aligned_cols=190  Identities=19%  Similarity=0.301  Sum_probs=141.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      ..|..+|++++|||||+|+|++.+ ..+|||||+|+-|.|..+++.....-  ..... ....++..++.|.++..+.|+
T Consensus       439 lqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL--~l~tL~ly~~Qi~talaYLeSkrfVHR  515 (974)
T KOG4257|consen  439 LQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSL--PLRTLTLYCYQICTALAYLESKRFVHR  515 (974)
T ss_pred             HHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccc--hHHHHHHHHHHHHHHHHHHHhhchhhh
Confidence            368999999999999999999976 57999999999999999998654321  11111 111223344555554433222


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCccc---cc--CCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKNTL---CG--TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~~~---~G--t~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.....=|+++||+....+.+..-+   .|  -.-|||||-++-+.++.++|||-|||+++|++. |.-||.+
T Consensus       516 DIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg  595 (974)
T KOG4257|consen  516 DIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG  595 (974)
T ss_pred             hhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence                   3333456889999877666554322   22  235999999999999999999999999999876 9999998


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      -...+..-.|.++ +.+.|+..++.+..++.+||.+||.+||.+.++.
T Consensus       596 vkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  596 VKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            7666665556554 4577889999999999999999999999987763

>KOG0576|consensus

Probab=99.93  E-value=3.6e-26  Score=202.43  Aligned_cols=197  Identities=23%  Similarity=0.409  Sum_probs=147.1

Q ss_pred             ChhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhh-----
Q psy6191           1 MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDK-----   74 (305)
Q Consensus         1 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----   74 (305)
                      +++||-+++..+|||||-|++.|-..+.+||+||||.||+|.+...-.+.+.+.   ....+-. ..+++.|+|.     
T Consensus        59 iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tgplsel---qiayvcRetl~gl~ylhs~gk~h  135 (829)
T KOG0576|consen   59 IQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLKYLHSQGKIH  135 (829)
T ss_pred             cccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhH---HHHHHHhhhhccchhhhcCCccc
Confidence            368999999999999999999999999999999999999999876554444321   1111111 1344555554     


Q ss_pred             ---hCCceeecCCCCCeeEcchhHHHH----hcCCcccccCCCccccccc---ccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          75 ---YGFGYQLNDDSSGVMFNDLTRMIM----LANKNTLCGTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        75 ---~~~~~~~~~~~~~v~~~d~~~~~~----~~~~~~~~Gt~~y~aPE~~---~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                         .|-+.++. +.+.+++.||+-...    +....++.|||+|||||+-   ..+.|...+|||++|++..|+..-++|
T Consensus       136 RdiKGanillt-d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp  214 (829)
T KOG0576|consen  136 RDIKGANILLT-DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP  214 (829)
T ss_pred             ccccccceeec-ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence               44344333 347788888864433    3345678999999999975   355789999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccccCCCC-----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         145 FETSTLKETYSRIKKVEYKLPA-----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ....-+........+..+..|.     .-++.+-+|++.+|.++|.+||+++.+|.|||...
T Consensus       215 lfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  215 LFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             ccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            8776666655555555555443     24456779999999999999999999999999864

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.92  E-value=2.2e-24  Score=183.01  Aligned_cols=194  Identities=18%  Similarity=0.231  Sum_probs=139.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCCC---CCCCc-CchhHHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDLE---EMSDP-AAQPVIWVSKWVDY   71 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~   71 (305)
                      .+|++++++++|||||++++++...+      ..++++||+++|+|.+++.......   .+... ....+..+..++.|
T Consensus        49 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~  128 (273)
T cd05074          49 LREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEY  128 (273)
T ss_pred             HHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            36899999999999999999886532      3589999999999988764321110   11111 12223345677888


Q ss_pred             hhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          72 SDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        72 ~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      .|..++.+.       +.+....+++.|++.......      .....+++.|++||.+.+..++.++||||+||++|+|
T Consensus       129 lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el  208 (273)
T cd05074         129 LSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI  208 (273)
T ss_pred             HHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHH
Confidence            887775432       223345566777754332211      1233456789999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         139 LV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       139 l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++ |.+||.+.+..+....+... ....+...+..+.+++.+||..+|.+|||+.+++.
T Consensus       209 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         209 MTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             hhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99 89999888776666655443 23445567789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4278|consensus

Probab=99.92  E-value=1.1e-24  Score=192.11  Aligned_cols=192  Identities=20%  Similarity=0.340  Sum_probs=143.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      ..|..+|+.++|||+|+|++++..+-.+|||.|||..|+|.++++.... .+...... ...-++..+..|+.+..+.++
T Consensus       311 LkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkknFIHR  389 (1157)
T KOG4278|consen  311 LKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKNFIHR  389 (1157)
T ss_pred             HHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence            4699999999999999999999999999999999999999999976432 22111111 001122344455544433332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC--cccccC---CCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK--NTLCGT---PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~--~~~~Gt---~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +......|+..||+........  ....|.   .-|.|||-+..+.++.|+|||+|||+|+|+.| |-.||.+
T Consensus       390 DLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG  469 (1157)
T KOG4278|consen  390 DLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG  469 (1157)
T ss_pred             hhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence                   2334467888999876654322  122332   45999999999999999999999999999998 9999999


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      -+..+.+..+.++ ...-|...++...+|++.||+.+|..||++.++.
T Consensus       470 idlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  470 IDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             ccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            9888877766543 3345778899999999999999999999998874

>KOG0665|consensus

Probab=99.92  E-value=2.4e-25  Score=181.87  Aligned_cols=195  Identities=21%  Similarity=0.326  Sum_probs=138.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~   74 (305)
                      .||..+|..++|+|||+++.+|.-.      ..+|+||||+.. +|.+.+....+     +.....++ +..-++.|.|.
T Consensus        63 ~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~elD-----H~tis~i~yq~~~~ik~lhs  136 (369)
T KOG0665|consen   63 YRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILMELD-----HETISYILYQMLCGIKHLHS  136 (369)
T ss_pred             hhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHHhcc-----hHHHHHHHHHHHHHHHHHHh
Confidence            4899999999999999999998633      458999999974 77777663322     22233333 33456778887


Q ss_pred             hCCceeecCCCC-------CeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          75 YGFGYQLNDDSS-------GVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        75 ~~~~~~~~~~~~-------~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .|+.++-...++       .+++.||+.+..-.   ..+..+.|..|.|||++.+..|...+||||+||++.||++|..-
T Consensus       137 ~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vl  216 (369)
T KOG0665|consen  137 AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVL  216 (369)
T ss_pred             cceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEE
Confidence            777666322222       23455554433211   12346789999999999988899999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc---------------------------cC----CC-----C------CCCHHHHHHHHHHhhc
Q psy6191         145 FETSTLKETYSRIKKVE---------------------------YK----LP-----A------TLKKPAATMIKKMLLL  182 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~---------------------------~~----~~-----~------~~~~~~~~li~~~l~~  182 (305)
                      |.+.+....+.++....                           ..    +|     .      .-..-+++++.+||..
T Consensus       217 f~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi  296 (369)
T KOG0665|consen  217 FPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVI  296 (369)
T ss_pred             ecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhcc
Confidence            98877655554442110                           00    11     0      1123478999999999


Q ss_pred             CCCCCCCHhhhhcCcccccc
Q psy6191         183 DPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       183 dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||++|.+++++|+|||++-+
T Consensus       297 ~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  297 DPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             ChhhcccHHHHhcCCeeeee
Confidence            99999999999999999843

>KOG1187|consensus

Probab=99.92  E-value=1e-24  Score=190.37  Aligned_cols=193  Identities=19%  Similarity=0.271  Sum_probs=127.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC-eEEEEEeccCCCCHHHHHHHhcCCCCC-CCcCchhHHHHHHHHHHhhhhC---
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK-FVYIILELCRKRSMMELYNSACDLEEM-SDPAAQPVIWVSKWVDYSDKYG---   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~-~~ylVmEy~~~g~L~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---   76 (305)
                      .+|+.++.+++|||+|+|+||+.+.+ ...||+||+++|+|.+.+...... .+ ........+.+++++.|+|...   
T Consensus       119 ~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~  197 (361)
T KOG1187|consen  119 LNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPP  197 (361)
T ss_pred             HHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCC
Confidence            57999999999999999999999988 599999999999999988654321 11 1112233344567777777432   


Q ss_pred             Cce-------eecCCCCCeeEcchhHHHHhcC-Cc---cc-ccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          77 FGY-------QLNDDSSGVMFNDLTRMIMLAN-KN---TL-CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        77 ~~~-------~~~~~~~~v~~~d~~~~~~~~~-~~---~~-~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.|       .+.|.....++.||+.+..... ..   +. .||.+|+|||.+..+..+.++|||||||+|.|+++|+.|
T Consensus       198 iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~  277 (361)
T KOG1187|consen  198 IIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKA  277 (361)
T ss_pred             EecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcc
Confidence            111       1222233444445543322211 11   11 799999999999888899999999999999999999998


Q ss_pred             CCCCC------HHHHH-HHHhcc------ccCCC-CCCC--HH---HHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETST------LKETY-SRIKKV------EYKLP-ATLK--KP---AATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~~------~~~~~-~~i~~~------~~~~~-~~~~--~~---~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+...      ..+.. ..+...      .+.+. ...+  ..   ...+..+|++.+|..||++.|+.+
T Consensus       278 ~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  278 VDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            87532      11111 111111      11222 1222  22   345678899999999999999753

>KOG1094|consensus

Probab=99.92  E-value=6.8e-25  Score=191.88  Aligned_cols=194  Identities=16%  Similarity=0.194  Sum_probs=140.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce--
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY--   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--   79 (305)
                      .+||++|.+|+|||||+|++++..++.+++||||+++|||.+++..............+...++..++.|+....+.|  
T Consensus       583 ~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd  662 (807)
T KOG1094|consen  583 LKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRD  662 (807)
T ss_pred             HHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhcc
Confidence            479999999999999999999999999999999999999999987653222111122222233344555554433322  


Q ss_pred             -----eecCCCCCeeEcchhHHHHhcCC------cccccCCCcccccccccCCCCccchHHHHHHHHHHHH--hCCCCCC
Q psy6191          80 -----QLNDDSSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL--VGKPPFE  146 (305)
Q Consensus        80 -----~~~~~~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l--~g~~Pf~  146 (305)
                           -+.+....+++.|++-..-+...      +..+=-..|||||.+..+.++.++|+|++||++||++  +...||.
T Consensus       663 ~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~  742 (807)
T KOG1094|consen  663 LATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS  742 (807)
T ss_pred             ccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence                 24556678888888644322211      1223346799999988889999999999999999975  5789998


Q ss_pred             CCCHHHHHHHHhcc--------ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKV--------EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ..+..+...+....        -...|+..+..+.+++.+||..|-.+||+++++..
T Consensus       743 ~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  743 QLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             hhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            77666555443221        12346667888999999999999999999999853

>KOG0199|consensus

Probab=99.91  E-value=9.2e-25  Score=194.59  Aligned_cols=197  Identities=17%  Similarity=0.218  Sum_probs=146.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHH--------HHHHHhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVS--------KWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~   73 (305)
                      .||+.+|-+|+|||+|+|||+..+ ..+.||||+|+.|+|.+-+.....-.-+...-.....+++        +.++|+|
T Consensus       159 lrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRD  237 (1039)
T KOG0199|consen  159 LREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRD  237 (1039)
T ss_pred             HHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence            589999999999999999999888 7899999999999999988762111000011111112222        3345555


Q ss_pred             hhCCceeecCCCCCeeEcchhHHHHhcCCcc-cc------cCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          74 KYGFGYQLNDDSSGVMFNDLTRMIMLANKNT-LC------GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        74 ~~~~~~~~~~~~~~v~~~d~~~~~~~~~~~~-~~------Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                      ...-|+++.. ..-|+++||+....+..... ++      --..|.|||.++...++.++|+|++||+++||++ |..||
T Consensus       238 LAARNlllas-prtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW  316 (1039)
T KOG0199|consen  238 LAARNLLLAS-PRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW  316 (1039)
T ss_pred             hhhhhheecc-cceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence            4444555554 57899999986655433221 11      1236999999999999999999999999999998 89999


Q ss_pred             CCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         146 ETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      .+.+...++.+|..++ .+-|...+.++.++++.||..+|+.|||+..|...-+..
T Consensus       317 ~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  317 VGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             CCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            9999999988887443 344667889999999999999999999999886544443

>KOG0669|consensus

Probab=99.91  E-value=1.2e-24  Score=172.56  Aligned_cols=197  Identities=22%  Similarity=0.344  Sum_probs=135.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~   72 (305)
                      .|||.++..|+|+|||.+++++.+        ...+||||.+|+. ||..++.+..-  .++-...+.+.. +.+++.+.
T Consensus        64 lreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~i  140 (376)
T KOG0669|consen   64 LREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYI  140 (376)
T ss_pred             HHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHH
Confidence            389999999999999999987653        3459999999986 67777644311  111112222222 22333333


Q ss_pred             hhhCC-------ceeecCCCCCeeEcchhHHHHhcCCc--------ccccCCCccccccccc-CCCCccchHHHHHHHHH
Q psy6191          73 DKYGF-------GYQLNDDSSGVMFNDLTRMIMLANKN--------TLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        73 ~~~~~-------~~~~~~~~~~v~~~d~~~~~~~~~~~--------~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvily  136 (305)
                      |...+       ...+.+..+.+++.||+....++...        .-+-|.+|..||.+.+ +.|+++.|||..|||+.
T Consensus       141 Hr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCima  220 (376)
T KOG0669|consen  141 HRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMA  220 (376)
T ss_pred             HHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHH
Confidence            32221       22344445788899998664432221        1234899999997764 56999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhccc----------------------cCCCC-------------CCCHHHHHHHHHHhh
Q psy6191         137 TLLVGKPPFETSTLKETYSRIKKVE----------------------YKLPA-------------TLKKPAATMIKKMLL  181 (305)
Q Consensus       137 e~l~g~~Pf~~~~~~~~~~~i~~~~----------------------~~~~~-------------~~~~~~~~li~~~l~  181 (305)
                      ||.+|.+-|++.+...++..|....                      .++|.             .-++++.+|+.++|.
T Consensus       221 eMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~  300 (376)
T KOG0669|consen  221 EMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLK  300 (376)
T ss_pred             HHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhc
Confidence            9999999999988877766653210                      01111             123467899999999


Q ss_pred             cCCCCCCCHhhhhcCccccc
Q psy6191         182 LDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       182 ~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .||.+|+.+++++.|.||..
T Consensus       301 ~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  301 LDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCcccCcchHhhhchhhhhc
Confidence            99999999999999999974

>KOG0671|consensus

Probab=99.91  E-value=6e-25  Score=183.48  Aligned_cols=198  Identities=22%  Similarity=0.344  Sum_probs=134.5

Q ss_pred             hHHHHHhcCCC--CC----ccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhh
Q psy6191           3 QEIAIHRSLKH--RN----VVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKY   75 (305)
Q Consensus         3 ~Ei~il~~l~H--pn----IV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   75 (305)
                      -||++++++.+  ||    +|++.+||.-.++++||+|.+ |-++.+.+........ +-...+.+. ++.+.+.++|+.
T Consensus       134 iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~f-pi~~ir~m~~QL~~sv~fLh~~  211 (415)
T KOG0671|consen  134 IEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPF-PIDHIRHMGYQLLESVAFLHDL  211 (415)
T ss_pred             HHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCcccc-chHHHHHHHHHHHHHHHHHHhc
Confidence            38899999942  43    899999999999999999987 4578888765433211 222222222 335667777766


Q ss_pred             CCcee--------ecC-------------------CCCCeeEcchhHHHHh-cCCcccccCCCcccccccccCCCCccch
Q psy6191          76 GFGYQ--------LND-------------------DSSGVMFNDLTRMIML-ANKNTLCGTPNYIAPEILNKNGHSFEVD  127 (305)
Q Consensus        76 ~~~~~--------~~~-------------------~~~~v~~~d~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~D  127 (305)
                      ++.+.        +.+                   .+..|.+.||+.+... ....+++-|..|.|||++.+-+++.++|
T Consensus       212 kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCD  291 (415)
T KOG0671|consen  212 KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCD  291 (415)
T ss_pred             ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccC
Confidence            54321        110                   1223444454443321 1224678999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcc------------------ccCCCCC-------------------
Q psy6191         128 VWSIGCIMYTLLVGKPPFETSTLKE---TYSRIKKV------------------EYKLPAT-------------------  167 (305)
Q Consensus       128 iwSlGvilye~l~g~~Pf~~~~~~~---~~~~i~~~------------------~~~~~~~-------------------  167 (305)
                      |||+||||+|+.+|..-|+..+..+   .+++|...                  ...+|..                   
T Consensus       292 vWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~  371 (415)
T KOG0671|consen  292 VWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKY  371 (415)
T ss_pred             ceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHH
Confidence            9999999999999999998876555   33333220                  1111110                   


Q ss_pred             ---CC---HHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         168 ---LK---KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       168 ---~~---~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                         .+   .++.|||++||..||.+|+|+.|+|.||||+..
T Consensus       372 ~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  372 MLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             hccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence               01   135699999999999999999999999999853

>KOG0196|consensus

Probab=99.90  E-value=2.7e-24  Score=193.68  Aligned_cols=191  Identities=19%  Similarity=0.285  Sum_probs=137.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      ..|..||.+.+|||||+|.|+......+.||.|||++|+|..+++...+-  ..-...- .+--+..+..|+.+.+..|+
T Consensus       678 L~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~YVHR  755 (996)
T KOG0196|consen  678 LSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMNYVHR  755 (996)
T ss_pred             hhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcCchhh
Confidence            46999999999999999999999999999999999999999998764321  0100000 01112233334433332221


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCc-ccc----c--CCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKN-TLC----G--TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~-~~~----G--t~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             |.+.+-..+..||+....+.+.. +..    |  -..|.|||.+..+.++.++||||+||+|+|.++ |..||
T Consensus       756 DLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  756 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             hhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence                   22222345677776554443221 111    1  146999999999999999999999999999665 99999


Q ss_pred             CCCCHHHHHHHHhccccCCCC--CCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKVEYKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+.++.++.|..+ +.+|+  ..+..+.+|+..||++|-.+||.+.||..
T Consensus       836 WdmSNQdVIkaIe~g-yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  836 WDMSNQDVIKAIEQG-YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             cccchHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            999999999888764 55555  45667789999999999999999999976

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.90  E-value=6.2e-23  Score=176.16  Aligned_cols=186  Identities=15%  Similarity=0.124  Sum_probs=128.4

Q ss_pred             HHHhcCCCCCccceeEEEEcCC----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           6 AIHRSLKHRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         6 ~il~~l~HpnIV~l~~~~~~~~----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      ..+..++|+||+++++.+....    ..|++||++.. ++.+.+.......+  .........+..++.+.|..++.|+ 
T Consensus        75 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~i~~qi~~~l~~lH~~~iiHrD  151 (294)
T PHA02882         75 KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNK--KLIKNIMKDMLTTLEYIHEHGISHGD  151 (294)
T ss_pred             HHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCH--HHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            4456789999999999766543    56889998754 55565544321110  1111233445677888887765433 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc-----------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA-----------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~-----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                            +.+....+++.||+.+....           ......||+.|+|||+..+..++.++||||+||++|||++|.+
T Consensus       152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~  231 (294)
T PHA02882        152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL  231 (294)
T ss_pred             CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence                  22334567788886543221           1234579999999999999899999999999999999999999


Q ss_pred             CCCCCCHH---------HHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         144 PFETSTLK---------ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       144 Pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||.+.+..         +....+......+ ...+..+.++++.|+..+|.+||+.+++++
T Consensus       232 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        232 PWKGFGHNGNLIHAAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             CCCccccchHHHHHhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            99765321         1223333333333 345788999999999999999999999874

>KOG0200|consensus

Probab=99.89  E-value=6.9e-23  Score=190.95  Aligned_cols=193  Identities=18%  Similarity=0.301  Sum_probs=139.7

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhc---CCCCC---C-C---cCc----hhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSAC---DLEEM---S-D---PAA----QPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~---~~~~~---~-~---~~~----~~~~~~~   66 (305)
                      ..|+++|+.+ +|||||.+.+++.+++.+++|+|||..|+|.++++...   ....-   . +   ...    ....+++
T Consensus       349 ~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa  428 (609)
T KOG0200|consen  349 MSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIA  428 (609)
T ss_pred             HHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHH
Confidence            4799999998 69999999999999999999999999999999998766   11000   0 0   000    1112234


Q ss_pred             HHHHHhh--------hhCCceeecCCCCCeeEcchhHHHHhcCCcc-----cccCCC--cccccccccCCCCccchHHHH
Q psy6191          67 KWVDYSD--------KYGFGYQLNDDSSGVMFNDLTRMIMLANKNT-----LCGTPN--YIAPEILNKNGHSFEVDVWSI  131 (305)
Q Consensus        67 ~~~~~~~--------~~~~~~~~~~~~~~v~~~d~~~~~~~~~~~~-----~~Gt~~--y~aPE~~~~~~~~~~~DiwSl  131 (305)
                      .+..+..        ..+-+.+ ...+..+++.||+......+...     -.||..  |||||.+....|+.++||||+
T Consensus       429 ~GMe~L~~~~~vHRDLAaRNVL-i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSf  507 (609)
T KOG0200|consen  429 NGMEYLASVPCVHRDLAARNVL-ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSF  507 (609)
T ss_pred             HHHHHHhhCCccchhhhhhhEE-ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHH
Confidence            4444433        2222333 33346778888876653322211     122333  999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCC-HHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         132 GCIMYTLLV-GKPPFETST-LKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       132 Gvilye~l~-g~~Pf~~~~-~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||+|||+++ |..||.+-. ..+.+..+..+. ...|...+.+..++++.||..+|++||++.++..
T Consensus       508 GI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  508 GILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            999999998 899998754 555666666553 3567788999999999999999999999998863

>KOG1006|consensus

Probab=99.89  E-value=4.4e-24  Score=170.55  Aligned_cols=199  Identities=21%  Similarity=0.317  Sum_probs=136.6

Q ss_pred             hHHH-HHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC--CCCCCcCchhH-HHHHHH---------H
Q psy6191           3 QEIA-IHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL--EEMSDPAAQPV-IWVSKW---------V   69 (305)
Q Consensus         3 ~Ei~-il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~--~~~~~~~~~~~-~~~~~~---------~   69 (305)
                      .|.+ +|+.-+.||||++||..-.++..||.||+++- +|..+.+.....  .++++.....+ .....+         +
T Consensus       111 ~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lki  189 (361)
T KOG1006|consen  111 MEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKI  189 (361)
T ss_pred             HHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhh
Confidence            3443 45666899999999999999999999999964 565554432111  11111111110 011122         3


Q ss_pred             HHhhhhCCceeecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccc--cCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          70 DYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILN--KNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~--~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .|++-..-++ +.+..+.|+++||+-.-.+.+   ...-.|...|||||.+.  +.+|+-++|+||||++|||++||..|
T Consensus       190 IHRDvKPSNI-Lldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fP  268 (361)
T KOG1006|consen  190 IHRDVKPSNI-LLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFP  268 (361)
T ss_pred             hhccCChhhe-EEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCC
Confidence            4444333244 445558899999975544432   23346899999999986  34589999999999999999999999


Q ss_pred             CCCC-CHHHHHHHHhccccCC---CC---CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         145 FETS-TLKETYSRIKKVEYKL---PA---TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       145 f~~~-~~~~~~~~i~~~~~~~---~~---~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      +.+- +..++...+..+.++.   +.   ..+.....+|.-||.+|-..||.-.+++++||++.+.
T Consensus       269 yr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  269 YRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             cchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            9774 3445555555554332   11   3677889999999999999999999999999998753

>KOG0193|consensus

Probab=99.89  E-value=1.3e-23  Score=184.76  Aligned_cols=192  Identities=19%  Similarity=0.302  Sum_probs=138.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++-+|-||+=+.|++..+.. -||.-+|+|-+|..++.-....-++. ......-++.++++|+|..++.|+ 
T Consensus       436 KnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~-~~idIAqQiaqGM~YLHAK~IIHrD  513 (678)
T KOG0193|consen  436 KNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMN-TTIDIAQQIAQGMDYLHAKNIIHRD  513 (678)
T ss_pred             HHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHH-HHHHHHHHHHHhhhhhhhhhhhhhh
Confidence            589999999999999999999988877 89999999999999875432110000 011112234677777776665433 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                            +.+++..|+++||+....-.      ......|...|||||++.   ..+|+..+||||||||+|||++|..||
T Consensus       514 LKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy  593 (678)
T KOG0193|consen  514 LKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY  593 (678)
T ss_pred             ccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence                  22333778888887543211      113456888999999985   346899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccccC-----CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKVEYK-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+...++-++..+...     .-...+.+.++|+..||.+++++||.+.+||.
T Consensus       594 si~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  594 SIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            976666655444444211     11234457889999999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=3.8e-23  Score=163.99  Aligned_cols=156  Identities=10%  Similarity=0.067  Sum_probs=102.3

Q ss_pred             CCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhC--CceeecCCCCCeeEcchhHHHHhcCCcccccCCCccccc
Q psy6191          39 RSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYG--FGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPE  115 (305)
Q Consensus        39 g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE  115 (305)
                      |+|.+++......  +.+..+. .+..+..++.|.|..+  -++.+ +....++.  ++..... ......||+.|||||
T Consensus         1 GsL~~~l~~~~~~--l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~-~~~~~~~~--fG~~~~~-~~~~~~g~~~y~aPE   74 (176)
T smart00750        1 VSLADILEVRGRP--LNEEEIWAVCLQCLRALRELHRQAKSGNILL-TWDGLLKL--DGSVAFK-TPEQSRVDPYFMAPE   74 (176)
T ss_pred             CcHHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcCCcccEeE-cCccceee--ccceEee-ccccCCCcccccChH
Confidence            7888988754321  2232232 2344567888888654  13322 22233333  3322211 122347999999999


Q ss_pred             ccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccccCC-------CCCCCH--HHHHHHHHHhhcCCC
Q psy6191         116 ILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK-ETYSRIKKVEYKL-------PATLKK--PAATMIKKMLLLDPV  185 (305)
Q Consensus       116 ~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~-~~~~~i~~~~~~~-------~~~~~~--~~~~li~~~l~~dp~  185 (305)
                      ++.+..++.++||||+||++|||++|+.||...... .....+.......       +...+.  .+.+++.+||..||.
T Consensus        75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~  154 (176)
T smart00750       75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQ  154 (176)
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccc
Confidence            999999999999999999999999999999765332 2222222211111       112233  588999999999999


Q ss_pred             CCCCHhhhhcCcccc
Q psy6191         186 QRPPVAQLLHFEFFN  200 (305)
Q Consensus       186 ~R~~~~~~l~~~~~~  200 (305)
                      +||++.+++.|+|+.
T Consensus       155 ~Rp~~~~ll~~~~~~  169 (176)
T smart00750      155 RREAANHYLAHCRAL  169 (176)
T ss_pred             cccCHHHHHHHHHHH
Confidence            999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0668|consensus

Probab=99.88  E-value=1.1e-22  Score=159.45  Aligned_cols=194  Identities=20%  Similarity=0.324  Sum_probs=137.7

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   77 (305)
                      .|||.||+.|. |||||+|+++..+.  ...-||+||+++-|..++...-+.      ...+.++ .+++++++||+.|+
T Consensus        80 kREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d------~dIryY~~elLkALdyCHS~GI  153 (338)
T KOG0668|consen   80 KREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTD------YDIRYYIYELLKALDYCHSMGI  153 (338)
T ss_pred             HHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhch------hhHHHHHHHHHHHHhHHHhcCc
Confidence            69999999998 99999999999874  568899999999998887754433      3344443 35788999999887


Q ss_pred             ceeecCC--------CCCeeEcchhHHHHhcC---CcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          78 GYQLNDD--------SSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        78 ~~~~~~~--------~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .++-...        ...+.+.|-+.+..-..   -+.-+.+..|--||++. -+.|+.+-|+||+||++..|+..+.||
T Consensus       154 mHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF  233 (338)
T KOG0668|consen  154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF  233 (338)
T ss_pred             ccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence            6542221        11222223232222111   12346788999999875 566899999999999999999999888


Q ss_pred             C-CCCHHHHHHHHhc-------------cccCCCC------------------------CCCHHHHHHHHHHhhcCCCCC
Q psy6191         146 E-TSTLKETYSRIKK-------------VEYKLPA------------------------TLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       146 ~-~~~~~~~~~~i~~-------------~~~~~~~------------------------~~~~~~~~li~~~l~~dp~~R  187 (305)
                      . +.+..+++.+|.+             -...+++                        -.++++.||+.++|..|-.+|
T Consensus       234 FhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeR  313 (338)
T KOG0668|consen  234 FHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQER  313 (338)
T ss_pred             cCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccc
Confidence            5 3333333333321             1111111                        145789999999999999999


Q ss_pred             CCHhhhhcCccccc
Q psy6191         188 PPVAQLLHFEFFND  201 (305)
Q Consensus       188 ~~~~~~l~~~~~~~  201 (305)
                      +||.|++.||||..
T Consensus       314 lTakEam~HpyF~~  327 (338)
T KOG0668|consen  314 LTAKEAMAHPYFAP  327 (338)
T ss_pred             cchHHHhcCchHHH
Confidence            99999999999974

>KOG0670|consensus

Probab=99.88  E-value=1e-23  Score=182.39  Aligned_cols=199  Identities=20%  Similarity=0.306  Sum_probs=141.0

Q ss_pred             hhHHHHHhcCCC------CCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHH-HHHHHH---
Q psy6191           2 SQEIAIHRSLKH------RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWV-SKWVDY---   71 (305)
Q Consensus         2 ~~Ei~il~~l~H------pnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---   71 (305)
                      .+|++||++|+-      -++|+|+..|...++++||+|-+. -+|.++++..+.-..+.-.+.+.+.++ ..++.+   
T Consensus       476 l~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~  554 (752)
T KOG0670|consen  476 LKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK  554 (752)
T ss_pred             hHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh
Confidence            379999999952      389999999999999999999875 578899987665433333333333222 112222   


Q ss_pred             -----hhhhCCceeecCCCCCeeEcchhHHHHhcCCc--ccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          72 -----SDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN--TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        72 -----~~~~~~~~~~~~~~~~v~~~d~~~~~~~~~~~--~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                           ++...-+++++.....++++||+.+.......  .+.-+..|.|||++.+-.|+.+.|+||+||+|||+.||+.-
T Consensus       555 c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl  634 (752)
T KOG0670|consen  555 CGVLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL  634 (752)
T ss_pred             cCeeecccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence                 22222245555556667888887665443321  23456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccccCCCC-----------------------------------------------------CCC--
Q psy6191         145 FETSTLKETYSRIKKVEYKLPA-----------------------------------------------------TLK--  169 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~~-----------------------------------------------------~~~--  169 (305)
                      |.+.+....+...+.....+|.                                                     .++  
T Consensus       635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de  714 (752)
T KOG0670|consen  635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE  714 (752)
T ss_pred             cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence            9988766554433222111110                                                     011  


Q ss_pred             -----HHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         170 -----KPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       170 -----~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                           ..+++|+.+||..||++|.|..|+|.||||..
T Consensus       715 q~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  715 QPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             hHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                 13569999999999999999999999999963

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.88  E-value=3.2e-23  Score=200.02  Aligned_cols=189  Identities=16%  Similarity=0.159  Sum_probs=125.1

Q ss_pred             HhcCCC-CCccceeEEE-------EcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCc
Q psy6191           8 HRSLKH-RNVVGFHSFF-------EDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         8 l~~l~H-pnIV~l~~~~-------~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   78 (305)
                      .+.++| +||++++++|       .....++.+|||+ +++|.+++.....  .+....+.. +.++..++.|+|..|+.
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~gIv  102 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR--SVDAFECFHVFRQIVEIVNAAHSQGIV  102 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc--cccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            456788 7999999998       3345788899987 5699999864311  122222322 33457889999987765


Q ss_pred             eeecCC--------------------------CCCeeEcchhHHHHhc--------------------CCcccccCCCcc
Q psy6191          79 YQLNDD--------------------------SSGVMFNDLTRMIMLA--------------------NKNTLCGTPNYI  112 (305)
Q Consensus        79 ~~~~~~--------------------------~~~v~~~d~~~~~~~~--------------------~~~~~~Gt~~y~  112 (305)
                      |+-...                          ...+++.||+......                    .....+||++||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            442211                          1122333443221100                    011246899999


Q ss_pred             cccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHh
Q psy6191         113 APEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVA  191 (305)
Q Consensus       113 aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~  191 (305)
                      |||++.+..|+.++|||||||+||||++|.+||....  .....+..... ..+........+++.+||..||.+||++.
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence            9999998889999999999999999999999986432  12222221111 11111244567899999999999999999


Q ss_pred             hhhcCccccc
Q psy6191         192 QLLHFEFFND  201 (305)
Q Consensus       192 ~~l~~~~~~~  201 (305)
                      |+++||||..
T Consensus       261 eil~h~~~~~  270 (793)
T PLN00181        261 ELLQSEFINE  270 (793)
T ss_pred             HHhhchhhhh
Confidence            9999999975

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.87  E-value=4.4e-22  Score=183.92  Aligned_cols=180  Identities=14%  Similarity=0.152  Sum_probs=113.6

Q ss_pred             EcCCeEEEEEeccCCCCHHHHHHHhcCCC-----------CCCCc------Cc-hhHHHHHHHHHHhhhhCCcee-----
Q psy6191          24 EDSKFVYIILELCRKRSMMELYNSACDLE-----------EMSDP------AA-QPVIWVSKWVDYSDKYGFGYQ-----   80 (305)
Q Consensus        24 ~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-----------~~~~~------~~-~~~~~~~~~~~~~~~~~~~~~-----   80 (305)
                      .++...||||||+.+|+|.+++.......           .....      .. .....+..++.|.|..++.|+     
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            45678999999999999999886532110           00000      00 112234567888887775443     


Q ss_pred             ---ecCCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccC----------------------CCCccchHHH
Q psy6191          81 ---LNDDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKN----------------------GHSFEVDVWS  130 (305)
Q Consensus        81 ---~~~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~----------------------~~~~~~DiwS  130 (305)
                         +..+...+++.||+.+..+.     ...+++||+.|||||.+...                      .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence               33334567888887654321     12457899999999965322                      1334569999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHhccccC-------CCC--------------CCCHHHHHHHHHHhhcCCCCCCC
Q psy6191         131 IGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK-------LPA--------------TLKKPAATMIKKMLLLDPVQRPP  189 (305)
Q Consensus       131 lGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~-------~~~--------------~~~~~~~~li~~~l~~dp~~R~~  189 (305)
                      +||+||||+++..|+... .......+......       .+.              ..+....+||.+||++||.+|||
T Consensus       365 lGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t  443 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS  443 (566)
T ss_pred             HHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence            999999999987765432 11111111111100       011              11223458999999999999999


Q ss_pred             HhhhhcCccccccCC
Q psy6191         190 VAQLLHFEFFNDYCP  204 (305)
Q Consensus       190 ~~~~l~~~~~~~~~~  204 (305)
                      +.++|+||||+....
T Consensus       444 a~e~L~Hpff~~~~~  458 (566)
T PLN03225        444 AKAALAHPYFDREGL  458 (566)
T ss_pred             HHHHhCCcCcCCCCc
Confidence            999999999987544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.9e-21  Score=175.80  Aligned_cols=199  Identities=15%  Similarity=0.182  Sum_probs=125.2

Q ss_pred             hHHHHHhcCCCCCc-----cceeEEEEc--------CCeEEEEEeccCCCCHHHHHHHhcC-CC-----------CC---
Q psy6191           3 QEIAIHRSLKHRNV-----VGFHSFFED--------SKFVYIILELCRKRSMMELYNSACD-LE-----------EM---   54 (305)
Q Consensus         3 ~Ei~il~~l~HpnI-----V~l~~~~~~--------~~~~ylVmEy~~~g~L~~~~~~~~~-~~-----------~~---   54 (305)
                      .|+.++.+++|.|+     +++++++..        ++..||||||+++|+|.+++..... ..           ..   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            36677777776654     677777653        3568999999999999998875321 00           00   


Q ss_pred             -CCc-----Cc-hhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC---Ccc--cccCCCccccc
Q psy6191          55 -SDP-----AA-QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNT--LCGTPNYIAPE  115 (305)
Q Consensus        55 -~~~-----~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~--~~Gt~~y~aPE  115 (305)
                       ...     .. .....+..++.+.|..++.|.       +.+....+++.||+.......   ...  ..+|+.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence             000     01 112234566778887665332       222334567777764432211   112  23489999999


Q ss_pred             ccccCC--------------------C--CccchHHHHHHHHHHHHhCCC-CCCCCCH-----------HHHHHHHhccc
Q psy6191         116 ILNKNG--------------------H--SFEVDVWSIGCIMYTLLVGKP-PFETSTL-----------KETYSRIKKVE  161 (305)
Q Consensus       116 ~~~~~~--------------------~--~~~~DiwSlGvilye~l~g~~-Pf~~~~~-----------~~~~~~i~~~~  161 (305)
                      ++....                    |  ..++||||+||++|+|++|.. ||.....           ...+..+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            875322                    1  124799999999999999975 7754211           11122222233


Q ss_pred             cCCC--CCCCHHHHHHHHHHhhcCC---CCCCCHhhhhcCccccc
Q psy6191         162 YKLP--ATLKKPAATMIKKMLLLDP---VQRPPVAQLLHFEFFND  201 (305)
Q Consensus       162 ~~~~--~~~~~~~~~li~~~l~~dp---~~R~~~~~~l~~~~~~~  201 (305)
                      +.++  ...++.++||+.+||..+|   .+|+|++|+|+||||..
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            3332  3578889999999999876   68999999999999963

>KOG0590|consensus

Probab=99.83  E-value=4.8e-21  Score=176.80  Aligned_cols=296  Identities=25%  Similarity=0.378  Sum_probs=195.2

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHH-HHhcCCCCCCCcCchhHHH-HHHHHHHhh-hhCC
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELY-NSACDLEEMSDPAAQPVIW-VSKWVDYSD-KYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~   77 (305)
                      ..|..+-+.+. |+|++++++...+.+..|+++||+.||++.+.+ ....  .......++.++. ....+.+.| ..+.
T Consensus        68 ~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~~  145 (601)
T KOG0590|consen   68 DTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENGV  145 (601)
T ss_pred             CccccccccccccccccccCCccCCCcccccccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccccc
Confidence            35777778887 999999999999999999999999999998877 3322  1122333333332 233455555 3333


Q ss_pred             cee-------ecCCCC-CeeEcchhHHHHhcC-C------ccccc-CCCcccccccccC-CCCccchHHHHHHHHHHHHh
Q psy6191          78 GYQ-------LNDDSS-GVMFNDLTRMIMLAN-K------NTLCG-TPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        78 ~~~-------~~~~~~-~v~~~d~~~~~~~~~-~------~~~~G-t~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~  140 (305)
                      .+.       +.+.++ .+++.|++.+..... .      ...|| |+.|+|||...+. ..+...|+||+|+++..+++
T Consensus       146 ~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~  225 (601)
T KOG0590|consen  146 THRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT  225 (601)
T ss_pred             ccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc
Confidence            222       233334 677778766655444 2      24589 9999999998874 56788999999999999999


Q ss_pred             CCCCCCCCCHHHH--HHHHhcc---ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc-cCC----------
Q psy6191         141 GKPPFETSTLKET--YSRIKKV---EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND-YCP----------  204 (305)
Q Consensus       141 g~~Pf~~~~~~~~--~~~i~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~-~~~----------  204 (305)
                      |..|+........  ...+...   .......++....+++.+++..+|..|.+.+++..++|+.. ...          
T Consensus       226 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~  305 (601)
T KOG0590|consen  226 GELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADS  305 (601)
T ss_pred             CCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccccccccccccccccc
Confidence            9999976443221  1111111   23344567888899999999999999999999999999987 100          


Q ss_pred             CCCCcccc------------ccCCCCC-----------CCCCC--C---------------------------CCCCCcc
Q psy6191         205 TSLPASCL------------MTAPRFD-----------SVVPS--F---------------------------NSPRRKP  232 (305)
Q Consensus       205 ~~~~~~~~------------~~~~~~~-----------~~~~~--~---------------------------~~~~~~~  232 (305)
                      ........            .....+.           ...+.  +                           ..+...+
T Consensus       306 ~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e  385 (601)
T KOG0590|consen  306 LTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIE  385 (601)
T ss_pred             cccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhh
Confidence            00000000            0000000           00000  0                           0000000


Q ss_pred             -------------chhh-------cccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecc
Q psy6191         233 -------------LMER-------NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG  292 (305)
Q Consensus       233 -------------l~~r-------~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg  292 (305)
                                   .|+.       .....+.+...++.+++.|++.|+.|+|..|+.|||+|++|+++...+.+|++|||
T Consensus       386 ~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  386 TLDIVQEIDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             hHHHHhhcccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecC
Confidence                         0000       00011256777888999999999999999999999999999999999999999999


Q ss_pred             cceecCc
Q psy6191         293 LAARIEF  299 (305)
Q Consensus       293 ~a~~~~~  299 (305)
                      .+.....
T Consensus       466 ~~~vf~~  472 (601)
T KOG0590|consen  466 AASVFRY  472 (601)
T ss_pred             cceeecc
Confidence            9865543

>KOG1152|consensus

Probab=99.83  E-value=1.6e-21  Score=170.71  Aligned_cols=142  Identities=23%  Similarity=0.404  Sum_probs=112.7

Q ss_pred             hHHHHHhcCC---CCCccceeEEEEcCCeEEEEEecc-CCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCC
Q psy6191           3 QEIAIHRSLK---HRNVVGFHSFFEDSKFVYIILELC-RKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGF   77 (305)
Q Consensus         3 ~Ei~il~~l~---HpnIV~l~~~~~~~~~~ylVmEy~-~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~   77 (305)
                      .||+||..|+   ||||+|++++|++++++||+||-- +|-||++++..+...   .+..+..++. +..++.|+|+.|+
T Consensus       615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m---~E~eAk~IFkQV~agi~hlh~~~i  691 (772)
T KOG1152|consen  615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRM---DEPEAKLIFKQVVAGIKHLHDQGI  691 (772)
T ss_pred             hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCcc---chHHHHHHHHHHHhccccccccCc
Confidence            5999999998   999999999999999999999975 456888888765443   5555555554 4567889999988


Q ss_pred             ceeecCC-------CCCeeEcchhHHHH--hcCCcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          78 GYQLNDD-------SSGVMFNDLTRMIM--LANKNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        78 ~~~~~~~-------~~~v~~~d~~~~~~--~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                      .++-..+       .+-+++.||+.+..  .+...+++||..|.|||++.+..| +...|||++|++||.++....||.+
T Consensus       692 vhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  692 VHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eecccccccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            7664332       34456777766543  344568999999999999998887 6679999999999999999999864

>KOG1025|consensus

Probab=99.83  E-value=7.2e-21  Score=172.64  Aligned_cols=191  Identities=18%  Similarity=0.237  Sum_probs=144.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|.-+|.+|+|||+++|++++..+. +.||++|+++|.|.++++...+.-. .........++++++.|.+.....|+ 
T Consensus       746 LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~ig-sq~lLnw~~QIAkgM~YLe~qrlVHrd  823 (1177)
T KOG1025|consen  746 LDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIG-SQDLLNWCYQIAKGMKYLEEQRLVHRD  823 (1177)
T ss_pred             HHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhcccc-HHHHHHHHHHHHHHHHHHHhcchhhhh
Confidence            47889999999999999999998876 9999999999999999876432100 00011112234566666664443222 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcCCcccc------cCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLANKNTLC------GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~~~~~~------Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                            +....+.+++.||+....+.......      --+.|||=|.+....|+.++||||+||+++|++| |..|+++
T Consensus       824 LaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g  903 (1177)
T KOG1025|consen  824 LAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG  903 (1177)
T ss_pred             hhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence                  33445778889998777664432211      1345899999999999999999999999999998 9999999


Q ss_pred             CCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         148 STLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       148 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      ....++-..+.++. ...|+..+-+...++.+||..|+..||+++++-
T Consensus       904 i~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  904 IPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             CCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence            98888776665543 456778888999999999999999999998873

>KOG1024|consensus

Probab=99.83  E-value=3e-19  Score=150.13  Aligned_cols=194  Identities=18%  Similarity=0.185  Sum_probs=140.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEE-EcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh------HHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFF-EDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP------VIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~-~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~   74 (305)
                      ..|--++..+.|||+..+.++. ++....+.++.+..-|+|...+......+.........      ..++..++.|.|.
T Consensus       335 L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~  414 (563)
T KOG1024|consen  335 LQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN  414 (563)
T ss_pred             HHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh
Confidence            4577788889999999999985 55677888899999999999887544322111111111      1233566888888


Q ss_pred             hCCceee-------cCCCCCeeEcchhHHHHhcCCccc-cc-----CCCcccccccccCCCCccchHHHHHHHHHHHHh-
Q psy6191          75 YGFGYQL-------NDDSSGVMFNDLTRMIMLANKNTL-CG-----TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-  140 (305)
Q Consensus        75 ~~~~~~~-------~~~~~~v~~~d~~~~~~~~~~~~~-~G-----t~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-  140 (305)
                      +|+.+..       .++.-.|++.|......+-...-. .|     -..|||||.+....|+.++|+|||||+|+||+| 
T Consensus       415 ~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtl  494 (563)
T KOG1024|consen  415 HGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTL  494 (563)
T ss_pred             cCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhc
Confidence            8765432       223344555554322222111111 12     236999999999999999999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         141 GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |+.|+..-++.+....++++ +...|.+.++++..++..||..+|++||+.+|+..
T Consensus       495 g~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  495 GKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            99999999999988887765 34557789999999999999999999999999854

>KOG1035|consensus

Probab=99.82  E-value=2.7e-20  Score=175.21  Aligned_cols=171  Identities=24%  Similarity=0.394  Sum_probs=121.8

Q ss_pred             CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHh
Q psy6191          27 KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIML   99 (305)
Q Consensus        27 ~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~   99 (305)
                      ..+||-||||+.-.+.+++.+..... ..+..-+..-.++.++.|.|+.|+.|+       ..+....|+++||+.+...
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~  747 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL  747 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhh
Confidence            46899999999988888876543321 112222222335778888888776443       3345678999998644331


Q ss_pred             ----------------------cCCcccccCCCcccccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCC-HHHH
Q psy6191         100 ----------------------ANKNTLCGTPNYIAPEILNKNG---HSFEVDVWSIGCIMYTLLVGKPPFETST-LKET  153 (305)
Q Consensus       100 ----------------------~~~~~~~Gt~~y~aPE~~~~~~---~~~~~DiwSlGvilye~l~g~~Pf~~~~-~~~~  153 (305)
                                            .+.++.+||..|+|||++.+..   |+.|+|+|||||||+||+.   ||.... ....
T Consensus       748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i  824 (1351)
T KOG1035|consen  748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI  824 (1351)
T ss_pred             hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH
Confidence                                  0123568999999999997654   9999999999999999974   676543 3345


Q ss_pred             HHHHhccccCCCCCC----CHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         154 YSRIKKVEYKLPATL----KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       154 ~~~i~~~~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +..++++..+.|..+    -+..+.+|+.||+.||.+||||.|+|.+.|+-.
T Consensus       825 L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  825 LTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             HHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            566666666555222    234578999999999999999999999999863

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.80  E-value=7.1e-19  Score=142.48  Aligned_cols=163  Identities=30%  Similarity=0.534  Sum_probs=121.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++|++|+++++++......|+||||++|++|.+++.....  ...... ...+..+.+.+.+.|..++.+.
T Consensus        39 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~H~  116 (215)
T cd00180          39 LREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLHSNGIIHR  116 (215)
T ss_pred             HHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            5899999999999999999999999999999999999999999875420  111111 1222334566777776665332


Q ss_pred             -------ecCC-CCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDD-SSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~-~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+. ...+.+.|++.......    .....++..|++||.+... .++.++|+||+|+++++|         
T Consensus       117 dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------  187 (215)
T cd00180         117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------  187 (215)
T ss_pred             CCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence                   1112 34555555543332221    2234588899999999876 788899999999999999         


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         148 STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                                            ....+++.+|+..||.+||++.++++++
T Consensus       188 ----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                  6778999999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0590|consensus

Probab=99.79  E-value=5.3e-21  Score=176.52  Aligned_cols=196  Identities=22%  Similarity=0.347  Sum_probs=141.5

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCceeec
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLN   82 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (305)
                      .|..+-..++||||+.....+++....+-+||||++ ||..++.....+.  .......+-++..++.|.|+.|+.++-.
T Consensus       370 sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~--~~e~~c~fKqL~~Gv~y~h~~Giahrdl  446 (601)
T KOG0590|consen  370 SEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLT--PLEADCFFKQLLRGVKYLHSMGLAHRDL  446 (601)
T ss_pred             hheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccc--hhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence            355666789999999998888887777777999999 9999887653332  1222233344567889999988776533


Q ss_pred             C-------CCCCeeEcchhHHHHh--------cCCcccccCCCcccccccccCCCCc-cchHHHHHHHHHHHHhCCCCCC
Q psy6191          83 D-------DSSGVMFNDLTRMIML--------ANKNTLCGTPNYIAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        83 ~-------~~~~v~~~d~~~~~~~--------~~~~~~~Gt~~y~aPE~~~~~~~~~-~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      .       ..+.+++.||+....+        .....++|+..|+|||++.+..|++ .+||||.||+++.|.+|+.||.
T Consensus       447 K~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk  526 (601)
T KOG0590|consen  447 KLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK  526 (601)
T ss_pred             ccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence            2       2235666777543321        1224679999999999999888765 5999999999999999999996


Q ss_pred             CCCHHHHH-H--------HHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         147 TSTLKETY-S--------RIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       147 ~~~~~~~~-~--------~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .....+.. .        ++..+...+-..++...+.+|.+||+.||.+|.|+++|++.+|++.
T Consensus       527 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  527 VAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS  590 (601)
T ss_pred             cccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence            54332211 1        1111112222346778899999999999999999999999999985

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.78  E-value=1.4e-18  Score=142.76  Aligned_cols=159  Identities=27%  Similarity=0.422  Sum_probs=113.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++.+++++||||+++++++......|+|+||+++++|.+++......  ...... .....+...+.+.|..++.+.
T Consensus        45 ~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~  122 (225)
T smart00221       45 LREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLGIVHR  122 (225)
T ss_pred             HHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            47999999999999999999999999999999999999999998764321  111111 112223455666666654332


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCccccccc-ccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~-~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+....+++.|++........     ...+|+..|++||.+ ....++.++|+||+|+++|+|++|+.||..
T Consensus       123 di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      123 DLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                   1223356667776544333222     456789999999998 666678899999999999999999999977


Q ss_pred             -CC-HHHHHHHHhcccc
Q psy6191         148 -ST-LKETYSRIKKVEY  162 (305)
Q Consensus       148 -~~-~~~~~~~i~~~~~  162 (305)
                       .+ ..+....+....+
T Consensus       203 ~~~~~~~~~~~~~~~~~  219 (225)
T smart00221      203 EGEFTSLLSDVWSFGVP  219 (225)
T ss_pred             cchhHHHHHHHHhcCCc
Confidence             34 4466666666553

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG2052|consensus

Probab=99.75  E-value=2.8e-18  Score=146.39  Aligned_cols=186  Identities=19%  Similarity=0.374  Sum_probs=117.2

Q ss_pred             hHHHHHh--cCCCCCccceeEEEEcC----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhC
Q psy6191           3 QEIAIHR--SLKHRNVVGFHSFFEDS----KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         3 ~Ei~il~--~l~HpnIV~l~~~~~~~----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   76 (305)
                      ||-+|-+  .|+|+||..+++.=..+    ..+|||.||-+.|+|.|++++. .+.  .+.........+.++.|+|---
T Consensus       252 rEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-tv~--~~~ml~LalS~AsGLaHLH~eI  328 (513)
T KOG2052|consen  252 RETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-TVT--TEGMLKLALSIASGLAHLHMEI  328 (513)
T ss_pred             hHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc-cCC--HHHHHHHHHHHhhhHHHHHHHH
Confidence            4555554  57999999999875433    2599999999999999999862 221  1112222233456677776211


Q ss_pred             CceeecCCCCCeeEcchhHHHHhc--------------------------CCcccccCCCcccccccccCCC-----Cc-
Q psy6191          77 FGYQLNDDSSGVMFNDLTRMIMLA--------------------------NKNTLCGTPNYIAPEILNKNGH-----SF-  124 (305)
Q Consensus        77 ~~~~~~~~~~~v~~~d~~~~~~~~--------------------------~~~~~~Gt~~y~aPE~~~~~~~-----~~-  124 (305)
                      ++-+   ..+.+.|+|++..+++.                          ..+.-+||-.|||||++...-.     +. 
T Consensus       329 ~GTq---gKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk  405 (513)
T KOG2052|consen  329 VGTQ---GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYK  405 (513)
T ss_pred             hcCC---CCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhh
Confidence            1111   23445555554444332                          2245689999999999865431     22 


Q ss_pred             cchHHHHHHHHHHHHh-----C-----CCCCCC----CCHHHHHHHH---hccccCCCCC-CCHH----HHHHHHHHhhc
Q psy6191         125 EVDVWSIGCIMYTLLV-----G-----KPPFET----STLKETYSRI---KKVEYKLPAT-LKKP----AATMIKKMLLL  182 (305)
Q Consensus       125 ~~DiwSlGvilye~l~-----g-----~~Pf~~----~~~~~~~~~i---~~~~~~~~~~-~~~~----~~~li~~~l~~  182 (305)
                      .+||||||.|++|++-     |     ++||.+    +...+.+..+   .+..+.+|.. .+.+    ...+++.||..
T Consensus       406 ~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~  485 (513)
T KOG2052|consen  406 RADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYA  485 (513)
T ss_pred             HHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcC
Confidence            4999999999999863     2     578854    2223333332   3344445543 2322    35789999999


Q ss_pred             CCCCCCCHhhhh
Q psy6191         183 DPVQRPPVAQLL  194 (305)
Q Consensus       183 dp~~R~~~~~~l  194 (305)
                      ||..|.|+-.+.
T Consensus       486 Np~aRltALriK  497 (513)
T KOG2052|consen  486 NPAARLTALRIK  497 (513)
T ss_pred             CchhhhHHHHHH
Confidence            999999987764

>KOG3653|consensus

Probab=99.75  E-value=3e-18  Score=147.18  Aligned_cols=186  Identities=18%  Similarity=0.235  Sum_probs=118.3

Q ss_pred             hHHHHHh--cCCCCCccceeEEEEcCC----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhC
Q psy6191           3 QEIAIHR--SLKHRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         3 ~Ei~il~--~l~HpnIV~l~~~~~~~~----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   76 (305)
                      .|-+|.+  .++|+||++++++-+...    .+|||+||.+.|+|.+++.....-   -....+....+.+++.|+|.--
T Consensus       251 ~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntis---w~~~cria~SmarGLa~LHee~  327 (534)
T KOG3653|consen  251 NEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANTIS---WNSLCRIAESMARGLAHLHEEL  327 (534)
T ss_pred             hHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcccc---HHHHHHHHHHHHHHHHHhcccC
Confidence            3444544  579999999999877655    899999999999999999754210   0112223334567777777321


Q ss_pred             CceeecCCCCCeeEcchhHHHHhcCC------------------------cccccCCCcccccccccCCC-C-----ccc
Q psy6191          77 FGYQLNDDSSGVMFNDLTRMIMLANK------------------------NTLCGTPNYIAPEILNKNGH-S-----FEV  126 (305)
Q Consensus        77 ~~~~~~~~~~~v~~~d~~~~~~~~~~------------------------~~~~Gt~~y~aPE~~~~~~~-~-----~~~  126 (305)
                       . .-......|.|+|++..+++...                        ..-+||..|||||++.+... .     .+.
T Consensus       328 -p-~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~  405 (534)
T KOG3653|consen  328 -P-RGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRI  405 (534)
T ss_pred             -C-cCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHH
Confidence             0 11223455666666555443211                        13579999999999976542 1     258


Q ss_pred             hHHHHHHHHHHHHhCCCC------------CCC-----CCHHHHHHHH--hccccCCCCCC-----CHHHHHHHHHHhhc
Q psy6191         127 DVWSIGCIMYTLLVGKPP------------FET-----STLKETYSRI--KKVEYKLPATL-----KKPAATMIKKMLLL  182 (305)
Q Consensus       127 DiwSlGvilye~l~g~~P------------f~~-----~~~~~~~~~i--~~~~~~~~~~~-----~~~~~~li~~~l~~  182 (305)
                      ||||+|.||+||++...-            |+.     .+..+....+  ++.++.+|..-     -.-+++.+..||..
T Consensus       406 DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDh  485 (534)
T KOG3653|consen  406 DVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDH  485 (534)
T ss_pred             HHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCC
Confidence            999999999999875432            321     1222222222  34455555421     13457889999999


Q ss_pred             CCCCCCCHhhh
Q psy6191         183 DPVQRPPVAQL  193 (305)
Q Consensus       183 dp~~R~~~~~~  193 (305)
                      ||+.|.|+.=+
T Consensus       486 DaeARLTA~Cv  496 (534)
T KOG3653|consen  486 DAEARLTAGCV  496 (534)
T ss_pred             chhhhhhhHHH
Confidence            99999997643

>KOG1167|consensus

Probab=99.74  E-value=2.2e-18  Score=146.11  Aligned_cols=195  Identities=22%  Similarity=0.331  Sum_probs=130.2

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH-HHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   79 (305)
                      ..|+++|..+- +-||+++.+.+..++.+.+||||.+.-+..+++.... +     ...+.+++ +.+++.+.|+.|+.+
T Consensus        82 ~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~l~-~-----~~i~~Yl~~ll~Al~~~h~~GIvH  155 (418)
T KOG1167|consen   82 LNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRSLS-L-----AEIRWYLRNLLKALAHLHKNGIVH  155 (418)
T ss_pred             HHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhcCC-H-----HHHHHHHHHHHHHhhhhhccCccc
Confidence            57999999985 8999999999999999999999999988888765432 1     11222333 356677777777655


Q ss_pred             eecCC--------CCCeeEcchhHHHH-----------------hcC-C------------------------------c
Q psy6191          80 QLNDD--------SSGVMFNDLTRMIM-----------------LAN-K------------------------------N  103 (305)
Q Consensus        80 ~~~~~--------~~~v~~~d~~~~~~-----------------~~~-~------------------------------~  103 (305)
                      +-...        .+.-.+.||+.+..                 ... .                              .
T Consensus       156 RDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~a  235 (418)
T KOG1167|consen  156 RDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERA  235 (418)
T ss_pred             cCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceec
Confidence            42221        22223445532220                 000 0                              0


Q ss_pred             ccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH---------hc-----cc------
Q psy6191         104 TLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETSTL-KETYSRI---------KK-----VE------  161 (305)
Q Consensus       104 ~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~-~~~~~~i---------~~-----~~------  161 (305)
                      ...|||+|.|||++.. ..-++++||||.|||+.-+++++.||..... ......|         .+     +.      
T Consensus       236 nrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k  315 (418)
T KOG1167|consen  236 NRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK  315 (418)
T ss_pred             ccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc
Confidence            1259999999998764 4568899999999999999999999964321 0000000         00     00      


Q ss_pred             cC-------------C------------------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         162 YK-------------L------------------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       162 ~~-------------~------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      -.             +                  ....+..+.+|+.+||..||.+|.|++++|+||||++.
T Consensus       316 sn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  316 SNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             ccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence            00             0                  00123357799999999999999999999999999853

>KOG0984|consensus

Probab=99.73  E-value=9.2e-18  Score=129.92  Aligned_cols=156  Identities=22%  Similarity=0.304  Sum_probs=102.4

Q ss_pred             hHHHHH-hcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-CCCCcCchh-HHHHHHHHHHh-------
Q psy6191           3 QEIAIH-RSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-EMSDPAAQP-VIWVSKWVDYS-------   72 (305)
Q Consensus         3 ~Ei~il-~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~-------   72 (305)
                      +|+++. +....|++|.+|+.+.++..+||.||.++. +|..+........ .+++..... ...+..++.|+       
T Consensus        93 ~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vI  171 (282)
T KOG0984|consen   93 MDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVI  171 (282)
T ss_pred             HhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhh
Confidence            566554 455799999999999999999999999864 5554443322111 112222111 12233333333       


Q ss_pred             --hhhCCceeecCCCCCeeEcchhHHHHhcCC--cc-cccCCCcccccccc----cCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          73 --DKYGFGYQLNDDSSGVMFNDLTRMIMLANK--NT-LCGTPNYIAPEILN----KNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        73 --~~~~~~~~~~~~~~~v~~~d~~~~~~~~~~--~~-~~Gt~~y~aPE~~~----~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                        +-..-+. +.+..+.|+.+||+-.-.+.+.  .+ -.|.-.|||||.+.    ...|+-++||||||+++.||++++.
T Consensus       172 HRDvKPsNi-LIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~  250 (282)
T KOG0984|consen  172 HRDVKPSNI-LINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF  250 (282)
T ss_pred             hccCCcceE-EEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc
Confidence              3222233 3344478899998765554432  12 45888999999875    3368999999999999999999999


Q ss_pred             CCCC-CCHHHHHHHHhcc
Q psy6191         144 PFET-STLKETYSRIKKV  160 (305)
Q Consensus       144 Pf~~-~~~~~~~~~i~~~  160 (305)
                      ||.. .++.+++..+...
T Consensus       251 PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  251 PYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             cccccCCHHHHHHHHhcC
Confidence            9975 5667776666543

>KOG0195|consensus

Probab=99.72  E-value=1.1e-17  Score=134.81  Aligned_cols=192  Identities=17%  Similarity=0.282  Sum_probs=133.8

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce-ee
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY-QL   81 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~   81 (305)
                      +|.-.++-..||||..+++.+...-.+.++..|++-|+|+.++.......--...+.+..+-+..+..+.|...-.+ ..
T Consensus       236 eefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~  315 (448)
T KOG0195|consen  236 EEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRF  315 (448)
T ss_pred             hhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhh
Confidence            45566777899999999999999999999999999999999987654432111122222333455666666543111 11


Q ss_pred             cCCCCCeeEc-chhHHHHhcCCc------ccccCCCcccccccccCCCC---ccchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy6191          82 NDDSSGVMFN-DLTRMIMLANKN------TLCGTPNYIAPEILNKNGHS---FEVDVWSIGCIMYTLLVGKPPFETSTLK  151 (305)
Q Consensus        82 ~~~~~~v~~~-d~~~~~~~~~~~------~~~Gt~~y~aPE~~~~~~~~---~~~DiwSlGvilye~l~g~~Pf~~~~~~  151 (305)
                      .-.+..|++. |++......+..      .-.-+|.||+||.+..++.+   .++|+|||.++++|+.|...||..-++.
T Consensus       316 ~lns~hvmidedltarismad~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm  395 (448)
T KOG0195|consen  316 YLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM  395 (448)
T ss_pred             hcccceEEecchhhhheecccceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence            1123344433 232222122111      12347899999999766543   4799999999999999999999887776


Q ss_pred             HHHHHH--hccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         152 ETYSRI--KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       152 ~~~~~i--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      +.--+|  ......+|+.++.....|++-|+..||.+||.++.+.
T Consensus       396 ecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  396 ECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             hhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            654444  3445678999999999999999999999999988764

>KOG0664|consensus

Probab=99.72  E-value=1e-18  Score=140.69  Aligned_cols=195  Identities=23%  Similarity=0.346  Sum_probs=135.2

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCC-----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhC
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSK-----FVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYG   76 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~-----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   76 (305)
                      ||+.++...+|.||....+..+-.+     .+|+|.|++.. ||..++-....+   ...... .+.+++.++.|.|..+
T Consensus       101 re~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~L---s~DHvKVFlYQILRGLKYLHsA~  176 (449)
T KOG0664|consen  101 REIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQAL---TPDHVKVFVYQILRGLKYLHTAN  176 (449)
T ss_pred             HHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCCC---CcchhhhhHHHHHhhhHHHhhcc
Confidence            7999999999999999999877543     48899998864 555555443333   222222 2344567778887665


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCC
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      +-++       +...+-.++++||+......     .....+-|-+|.|||++.+. .|+.++||||+|||+.|++-.+.
T Consensus       177 ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrI  256 (449)
T KOG0664|consen  177 ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKI  256 (449)
T ss_pred             hhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhh
Confidence            4332       22223345677876443211     11233568899999998765 58999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhcc-----------------------ccCCCC-----------CCCHHHHHHHHHHhhcCCCCCCC
Q psy6191         144 PFETSTLKETYSRIKKV-----------------------EYKLPA-----------TLKKPAATMIKKMLLLDPVQRPP  189 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~-----------------------~~~~~~-----------~~~~~~~~li~~~l~~dp~~R~~  189 (305)
                      -|+..++.+.+..|...                       ....|.           ....++.+++.++|..||.+|.+
T Consensus       257 LFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris  336 (449)
T KOG0664|consen  257 LFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS  336 (449)
T ss_pred             hhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc
Confidence            99988877666555321                       111111           22335678889999999999999


Q ss_pred             HhhhhcCccccc
Q psy6191         190 VAQLLHFEFFND  201 (305)
Q Consensus       190 ~~~~l~~~~~~~  201 (305)
                      .++.+.|++...
T Consensus       337 ~~~A~~~~~~~e  348 (449)
T KOG0664|consen  337 VEEALQHRYLEE  348 (449)
T ss_pred             Hhhhcccccccc
Confidence            999999999865

>KOG1345|consensus

Probab=99.63  E-value=1.6e-16  Score=127.97  Aligned_cols=185  Identities=17%  Similarity=0.258  Sum_probs=118.6

Q ss_pred             CCCCccceeEE-EEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCcee--------e
Q psy6191          12 KHRNVVGFHSF-FEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGYQ--------L   81 (305)
Q Consensus        12 ~HpnIV~l~~~-~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--------~   81 (305)
                      .|.|||.-|++ |++.+.+.++||||+-|||.+-+...    .+.+.....+. +++.++.+.|+..+.++        +
T Consensus        79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLi  154 (378)
T KOG1345|consen   79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILI  154 (378)
T ss_pred             cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEE
Confidence            48999998875 89999999999999999998765432    11222333333 34566777776554333        1


Q ss_pred             -cCCCCCeeEcchhHHHHhcCC-cccccCCCcccccccc---cCC--CCccchHHHHHHHHHHHHhCCCCCCCCC-----
Q psy6191          82 -NDDSSGVMFNDLTRMIMLANK-NTLCGTPNYIAPEILN---KNG--HSFEVDVWSIGCIMYTLLVGKPPFETST-----  149 (305)
Q Consensus        82 -~~~~~~v~~~d~~~~~~~~~~-~~~~Gt~~y~aPE~~~---~~~--~~~~~DiwSlGvilye~l~g~~Pf~~~~-----  149 (305)
                       ..+-..|+++||+.....+.. ...--+..|-+||+..   .+.  ..+.+|+|.||+++|.+++|.+||+...     
T Consensus       155 f~~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~  234 (378)
T KOG1345|consen  155 FDADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP  234 (378)
T ss_pred             ecCCccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch
Confidence             112235667777644321111 0111345699999753   222  3678999999999999999999998542     


Q ss_pred             HHHHHHHHhccccCCCC---CCCHHHHHHHHHHhhcCCCCC---CCHhhhhcCcccc
Q psy6191         150 LKETYSRIKKVEYKLPA---TLKKPAATMIKKMLLLDPVQR---PPVAQLLHFEFFN  200 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~dp~~R---~~~~~~l~~~~~~  200 (305)
                      ..+..+-........|.   .+++.+..+.++-|..++..|   .++..-....|..
T Consensus       235 Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  235 YWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             HHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            22222222233334443   477888999999999999999   5555555566664

>KOG0606|consensus

Probab=99.61  E-value=1.2e-15  Score=142.73  Aligned_cols=136  Identities=27%  Similarity=0.477  Sum_probs=107.1

Q ss_pred             HHHHHhhhhCCceeecC-------CCCCeeEcchhHHHHhc-------------------CCcccccCCCcccccccccC
Q psy6191          67 KWVDYSDKYGFGYQLND-------DSSGVMFNDLTRMIMLA-------------------NKNTLCGTPNYIAPEILNKN  120 (305)
Q Consensus        67 ~~~~~~~~~~~~~~~~~-------~~~~v~~~d~~~~~~~~-------------------~~~~~~Gt~~y~aPE~~~~~  120 (305)
                      ..+.|.|.+|+.+.-..       .-+.+++.||+...+..                   ....+||||.|+|||++..+
T Consensus       154 la~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq  233 (1205)
T KOG0606|consen  154 LAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ  233 (1205)
T ss_pred             HHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh
Confidence            44667777765443221       12456677775443311                   01356999999999999999


Q ss_pred             CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCCC---CCHHHHHHHHHHhhcCCCCCC---CHhhhh
Q psy6191         121 GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT---LKKPAATMIKKMLLLDPVQRP---PVAQLL  194 (305)
Q Consensus       121 ~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~li~~~l~~dp~~R~---~~~~~l  194 (305)
                      +|+..+|||++|+|+||.+.|..||+++++.+++..+......+|..   ...+++++|.++|+.+|..|.   .+-++.
T Consensus       234 gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk  313 (1205)
T KOG0606|consen  234 GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVK  313 (1205)
T ss_pred             ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhh
Confidence            99999999999999999999999999999999998887777777653   678899999999999999995   466888


Q ss_pred             cCcccccc
Q psy6191         195 HFEFFNDY  202 (305)
Q Consensus       195 ~~~~~~~~  202 (305)
                      +|+||...
T Consensus       314 ~h~ff~~L  321 (1205)
T KOG0606|consen  314 QHGFFQLL  321 (1205)
T ss_pred             hccceeec
Confidence            99999863

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.61  E-value=2.6e-14  Score=123.56  Aligned_cols=200  Identities=30%  Similarity=0.440  Sum_probs=139.6

Q ss_pred             hhHHHHHhcCCCC-CccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHR-NVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~Hp-nIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.+.|+ ||+++++.+......|+|+||+.++++.+++.............. .....+...+.+.|..++.+
T Consensus        45 ~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~h  124 (384)
T COG0515          45 LREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH  124 (384)
T ss_pred             HHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            5789999999988 799999999888889999999999999977665421101111111 12223344556777666433


Q ss_pred             e-------ecCCCC-CeeEcchhHHHHhc----------CCcccccCCCccccccccc---CCCCccchHHHHHHHHHHH
Q psy6191          80 Q-------LNDDSS-GVMFNDLTRMIMLA----------NKNTLCGTPNYIAPEILNK---NGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        80 ~-------~~~~~~-~v~~~d~~~~~~~~----------~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlGvilye~  138 (305)
                      +       +.+... .+.+.|++....+.          .....+||+.|+|||.+.+   ..++...|+||+|++++++
T Consensus       125 rd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~  204 (384)
T COG0515         125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL  204 (384)
T ss_pred             cCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHH
Confidence            2       122223 46777776543221          2356789999999999987   5788899999999999999


Q ss_pred             HhCCCCCCCCCH----HHHHHHHhccccC-CCCCCC--------HHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         139 LVGKPPFETSTL----KETYSRIKKVEYK-LPATLK--------KPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       139 l~g~~Pf~~~~~----~~~~~~i~~~~~~-~~~~~~--------~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ++|..||.....    ......+...... ......        ....+++.+++..+|..|.+..+...+++...
T Consensus       205 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         205 LTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             HhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            999999877653    4444444433322 211111        46789999999999999999999888866653

>KOG1290|consensus

Probab=99.60  E-value=7.5e-16  Score=133.08  Aligned_cols=96  Identities=29%  Similarity=0.496  Sum_probs=72.2

Q ss_pred             cCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhc------------c--------
Q psy6191         107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST------LKETYSRIKK------------V--------  160 (305)
Q Consensus       107 Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~------~~~~~~~i~~------------~--------  160 (305)
                      -|..|.|||++.+.+|++.+||||++|++|||+||..-|+..+      ....+..|..            +        
T Consensus       413 QTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFn  492 (590)
T KOG1290|consen  413 QTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFN  492 (590)
T ss_pred             hhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhc
Confidence            5889999999999999999999999999999999999885421      1111111111            1        


Q ss_pred             ----------------------ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         161 ----------------------EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       161 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                                            .|.++..-..++.+|+.-||+.+|++|+||.++++|||+++.
T Consensus       493 r~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~  556 (590)
T KOG1290|consen  493 RRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPV  556 (590)
T ss_pred             cccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCC
Confidence                                  111222222345689999999999999999999999999863

>KOG1033|consensus

Probab=99.53  E-value=4e-15  Score=130.16  Aligned_cols=169  Identities=21%  Similarity=0.287  Sum_probs=107.5

Q ss_pred             CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHH-----HHHHHhhhhCCceeecCCCCCeeEcchhHHHHhc
Q psy6191          27 KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVS-----KWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA  100 (305)
Q Consensus        27 ~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~v~~~d~~~~~~~~  100 (305)
                      .++||.|++|+.++|.+++.....-++.........+ +..     ++..|.+..+.++...++ ..+++.||+......
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts~~  407 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTSQD  407 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccc-hhhhhhhhhheeecc
Confidence            3699999999999999999765544332211111111 112     233355544434443333 356667775433221


Q ss_pred             ----------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccccCCCCC-C
Q psy6191         101 ----------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVEYKLPAT-L  168 (305)
Q Consensus       101 ----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~  168 (305)
                                +...-+||.+||+||.+.++.|+.++||||||++|||++. =..+|..   ..++..+..+.++.-.. -
T Consensus       408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~~d  484 (516)
T KOG1033|consen  408 KDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFLQD  484 (516)
T ss_pred             cCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHhhc
Confidence                      2235579999999999999999999999999999999987 3333321   22333444444321111 2


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       169 ~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      .+...+|+.++|.+.|.+||++.+.-.|.|.
T Consensus       485 ~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  485 YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2345689999999999999987776666664

>KOG1023|consensus

Probab=99.52  E-value=4.4e-14  Score=125.54  Aligned_cols=184  Identities=22%  Similarity=0.303  Sum_probs=122.3

Q ss_pred             HhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH---HHHHHHHHHhhhhCCcee----
Q psy6191           8 HRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV---IWVSKWVDYSDKYGFGYQ----   80 (305)
Q Consensus         8 l~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~----   80 (305)
                      |+.+.|.|+.+++|...++..+++|-+||..|+|.|.+....    +........   --+.+++.|.|...+.+.    
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence            578999999999999999999999999999999999987621    111111111   113456777775444322    


Q ss_pred             ----ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCC-------CCccchHHHHHHHHHHHHhCCC
Q psy6191          81 ----LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNG-------HSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 ----~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~-------~~~~~DiwSlGvilye~l~g~~  143 (305)
                          +.+..-.+++.|++.......      .....-...|.|||++....       -+.++||||+|+++||+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence                112223455666654443321      11111234699999987642       2556999999999999999999


Q ss_pred             CCCCC----CHHHHHHHHhc-cccCCCC------CCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         144 PFETS----TLKETYSRIKK-VEYKLPA------TLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       144 Pf~~~----~~~~~~~~i~~-~~~~~~~------~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||...    +..+....+.+ ....+.+      ...++...+++.||..+|..||+++++..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            99753    23456666665 2222212      23345778999999999999999998753

>KOG4158|consensus

Probab=99.51  E-value=3.6e-14  Score=120.28  Aligned_cols=176  Identities=20%  Similarity=0.264  Sum_probs=115.1

Q ss_pred             CCCCccceeEEEEcC---------------------------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHH
Q psy6191          12 KHRNVVGFHSFFEDS---------------------------KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW   64 (305)
Q Consensus        12 ~HpnIV~l~~~~~~~---------------------------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~   64 (305)
                      +|||||++.++|.++                           ..+|+||.-.+. +|.+++-....-   .....-.+.+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s---~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRS---YRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCc---hHHHHHHHHH
Confidence            799999999887643                           458999977654 677776432111   1112223345


Q ss_pred             HHHHHHHhhhhCCceeecCCC-----------CCeeEcchhHHHHh----------cCCcccccCCCcccccccccCC--
Q psy6191          65 VSKWVDYSDKYGFGYQLNDDS-----------SGVMFNDLTRMIML----------ANKNTLCGTPNYIAPEILNKNG--  121 (305)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~-----------~~v~~~d~~~~~~~----------~~~~~~~Gt~~y~aPE~~~~~~--  121 (305)
                      .++++.|.+++|+.++.....           .-+++.||+....-          +..-..-|...-||||+....+  
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            578899999988776532221           22345555432110          0111234777899999975332  


Q ss_pred             ----CCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHh
Q psy6191         122 ----HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR--IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVA  191 (305)
Q Consensus       122 ----~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  191 (305)
                          .-.++|.|+.|.+-||++....||.+.....+-.+  -....+.+|..+++.+++++..+|+.||.+|++..
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                12479999999999999999999987432211111  11233567788999999999999999999999854

>KOG0575|consensus

Probab=99.43  E-value=1.7e-13  Score=121.70  Aligned_cols=73  Identities=64%  Similarity=1.105  Sum_probs=65.4

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccccCC
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRK  304 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~~~  304 (305)
                      ..+++.. ++++.++|+++++++.||+.|+.|||+++|+|||+|..|+|++.+..+||+|||+|.++...+.++
T Consensus       103 ~sL~el~-Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen  103 GSLMELL-KRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             ccHHHHH-HhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            3455444 578899999999999999999999999999999999999999999999999999999999776554

>KOG0616|consensus

Probab=99.39  E-value=5.1e-13  Score=109.10  Aligned_cols=70  Identities=39%  Similarity=0.575  Sum_probs=61.4

Q ss_pred             CCccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       229 ~~~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+....+ +.++++++.+++|.+||+.+++|+|++++++||+||+||+++..|.+|+.|||+|+.+..
T Consensus       127 ~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  127 PGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             CCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            3445555443 456799999999999999999999999999999999999999999999999999998763

>KOG0606|consensus

Probab=99.38  E-value=1.2e-12  Score=123.02  Aligned_cols=190  Identities=22%  Similarity=0.280  Sum_probs=132.1

Q ss_pred             CCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhhCCcee-------ec
Q psy6191          11 LKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKYGFGYQ-------LN   82 (305)
Q Consensus        11 l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-------~~   82 (305)
                      ..||.+|+....+.....+||||+|+.||+|...+++.....   ...++..+ ...+...+.+.....+.       +.
T Consensus       861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~s---aepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~  937 (1205)
T KOG0606|consen  861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLS---AEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI  937 (1205)
T ss_pred             CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcc---cccccchhHHHHhhhhccccchhhcccccccchhh
Confidence            356888887777777788999999999999999887765332   22222222 22222222221100000       00


Q ss_pred             CCCCCeeEcchh----------------HHH--------------Hh-----cCCcccccCCCcccccccccCCCCccch
Q psy6191          83 DDSSGVMFNDLT----------------RMI--------------ML-----ANKNTLCGTPNYIAPEILNKNGHSFEVD  127 (305)
Q Consensus        83 ~~~~~v~~~d~~----------------~~~--------------~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~D  127 (305)
                      ...+.....++.                ..+              .+     .......||+.|.|||.+.+...+..+|
T Consensus       938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen  938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred             cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence            000111111110                000              00     1123568999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCC---CCCHHHHHHHHHHhhcCCCCCCCHh---hhhcCccccc
Q psy6191         128 VWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA---TLKKPAATMIKKMLLLDPVQRPPVA---QLLHFEFFND  201 (305)
Q Consensus       128 iwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~dp~~R~~~~---~~l~~~~~~~  201 (305)
                      +|+.|++++|.++|.+||........+.+|.+....+|.   ..+..+++++.++|..+|.+|..+.   ++-.|+||++
T Consensus      1018 ~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred             hhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence            999999999999999999999999999999888777664   4778899999999999999999877   8889999987


Q ss_pred             cC
Q psy6191         202 YC  203 (305)
Q Consensus       202 ~~  203 (305)
                      ..
T Consensus      1098 ~~ 1099 (1205)
T KOG0606|consen 1098 VD 1099 (1205)
T ss_pred             CC
Confidence            43

>KOG0592|consensus

Probab=99.37  E-value=6.8e-13  Score=116.44  Aligned_cols=75  Identities=35%  Similarity=0.544  Sum_probs=64.3

Q ss_pred             CCCCCCccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         225 FNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       225 ~~~~~~~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +..-..+.+.... ++.++|.+.++++|.+||+.+++|+|++||||||+||+|||++.++.++|.|||-|+.+...
T Consensus       153 Le~A~nGdll~~i-~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  153 LEYAPNGDLLDLI-KKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEecCCCcHHHHH-HHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            3334455565544 45588999999999999999999999999999999999999999999999999999988643

>KOG0600|consensus

Probab=99.33  E-value=1.9e-12  Score=112.82  Aligned_cols=61  Identities=44%  Similarity=0.744  Sum_probs=56.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      .-.|+++++++|+.|++.|+.|||.+|++|||+|.+|||+++.|.+||+|||+|+.....+
T Consensus       212 ~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  212 GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            4458999999999999999999999999999999999999999999999999999776555

>KOG0594|consensus

Probab=99.33  E-value=1.7e-12  Score=108.77  Aligned_cols=57  Identities=40%  Similarity=0.734  Sum_probs=53.1

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..++...++.++.|++.|+.|||+++++|||+||.|+++++.+.+|++|||+|+...
T Consensus       115 ~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen  115 QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            456778899999999999999999999999999999999999999999999998665

>KOG0593|consensus

Probab=99.32  E-value=1.6e-12  Score=106.65  Aligned_cols=61  Identities=30%  Similarity=0.561  Sum_probs=56.5

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .....+++..++.+++|++.++.|||+++++|||+||+||+++..+.+|+||||||+.+..
T Consensus        93 ~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   93 RYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             hccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            3445688899999999999999999999999999999999999999999999999999874

>KOG0598|consensus

Probab=99.32  E-value=2.1e-12  Score=108.59  Aligned_cols=63  Identities=38%  Similarity=0.628  Sum_probs=57.8

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcccc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ  302 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~  302 (305)
                      +.+.++|..+++|+++|+.+++|||+.||+|||+||+|||++..|.++++|||+|+.....+.
T Consensus       118 ~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  118 REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            456699999999999999999999999999999999999999999999999999987665544

>KOG0661|consensus

Probab=99.31  E-value=2.6e-12  Score=111.12  Aligned_cols=67  Identities=39%  Similarity=0.604  Sum_probs=60.3

Q ss_pred             cccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccccC
Q psy6191         237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR  303 (305)
Q Consensus       237 ~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~~  303 (305)
                      ...++..|++..++.++.||+.|+.|+|.+|.+|||+||+|||+.....+||+|||+||-+.....+
T Consensus       100 mK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen  100 MKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             HhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence            3344667999999999999999999999999999999999999999999999999999988765543

>KOG1240|consensus

Probab=99.30  E-value=4.2e-13  Score=126.42  Aligned_cols=184  Identities=20%  Similarity=0.271  Sum_probs=112.1

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCceee
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQL   81 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   81 (305)
                      +|++ .+.++|||++.+.-+.++++..|||=+|... +|.|.+...-.+.   ..+. -..+++..++..+|..|+.|--
T Consensus        71 ~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~---~iEKkWiaFQLL~al~qcH~~gVcHGD  145 (1431)
T KOG1240|consen   71 EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLV---LIEKKWIAFQLLKALSQCHKLGVCHGD  145 (1431)
T ss_pred             HHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHH---HHHHHHHHHHHHHHHHHHHHcCccccc
Confidence            4555 6677999999999999999999999999865 5666554322221   1111 1234456778888877765432


Q ss_pred             cCCCCCee--------EcchhHHHH--hc-----CCcccccC----CCcccccccccCC-----------CCccchHHHH
Q psy6191          82 NDDSSGVM--------FNDLTRMIM--LA-----NKNTLCGT----PNYIAPEILNKNG-----------HSFEVDVWSI  131 (305)
Q Consensus        82 ~~~~~~v~--------~~d~~~~~~--~~-----~~~~~~Gt----~~y~aPE~~~~~~-----------~~~~~DiwSl  131 (305)
                      .. ..+|.        +.||.....  +.     +.+-+..|    ..|+|||.+....           .+++.||+|+
T Consensus       146 IK-sENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~  224 (1431)
T KOG1240|consen  146 IK-SENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSA  224 (1431)
T ss_pred             cc-cceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhh
Confidence            21 12222        234322211  00     00111122    3599999874321           3568999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHhccccCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         132 GCIMYTLLV-GKPPFETSTLKETYSRIKKVEYKLP-----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       132 Gvilye~l~-g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||+++|+++ |++||.-+   +++. -+.+.-..|     .--+...+++|..|++.||.+|.+|++.|+.
T Consensus       225 GCViaELf~Eg~PlF~LS---QL~a-Yr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  225 GCVIAELFLEGRPLFTLS---QLLA-YRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHHHHHHHhcCCCcccHH---HHHh-HhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            999999987 89999532   1111 011100000     1123467899999999999999999999874

>KOG1035|consensus

Probab=99.25  E-value=1.5e-10  Score=110.48  Aligned_cols=186  Identities=18%  Similarity=0.200  Sum_probs=100.4

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCe----EEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCC
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKF----VYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGF   77 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~----~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   77 (305)
                      -|+..+..+.|+|+++++.|--.+..    +++.-|||.+-++...+.......   -...+.. .....++.+.|....
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~---~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIP---LETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccC---HHHHHHHHHHHhhhHHHHHHhcc
Confidence            35667788899999999998655433    344558899888888877654431   1111111 112344555553322


Q ss_pred             ceeecCC----------CCCeeEc--chhHHHHhcCC---cccccCCCcccccccccCCCCcc--chHHHHHHHHHHHHh
Q psy6191          78 GYQLNDD----------SSGVMFN--DLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFE--VDVWSIGCIMYTLLV  140 (305)
Q Consensus        78 ~~~~~~~----------~~~v~~~--d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~--~DiwSlGvilye~l~  140 (305)
                      .+.....          ...+...  ++.....+.+.   ....-+..+-|||....+.++.+  .|+|.+|.....+..
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~  387 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ  387 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence            2211110          0011111  11111101110   01123456778888776665544  699999999999888


Q ss_pred             CCCCCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         141 GKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      |..+-...   .....+      ++........+.+.+|+.-++++|+++.+++.|+|.+
T Consensus       388 ~~~i~~~~---~~~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~  438 (1351)
T KOG1035|consen  388 GEDISEKS---AVPVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLR  438 (1351)
T ss_pred             cCcccccc---cchhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence            76543221   111111      1111111456677778877788888888888777664

>KOG0599|consensus

Probab=99.23  E-value=7.3e-12  Score=101.44  Aligned_cols=77  Identities=42%  Similarity=0.698  Sum_probs=65.5

Q ss_pred             CCCCCCccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcccc
Q psy6191         225 FNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ  302 (305)
Q Consensus       225 ~~~~~~~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~  302 (305)
                      |...+++.++.... ..-.+++.+++.++.|+..|++|+|.++++|||+||+||+++.+..++++|||+|.++..+.+
T Consensus       102 Fdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek  178 (411)
T KOG0599|consen  102 FDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK  178 (411)
T ss_pred             hhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchh
Confidence            34445555665553 345689999999999999999999999999999999999999999999999999999986654

>KOG0614|consensus

Probab=99.21  E-value=1e-11  Score=108.44  Aligned_cols=64  Identities=38%  Similarity=0.586  Sum_probs=60.2

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccccC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR  303 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~~  303 (305)
                      ++++|.+..+++|+++++.+.+|+|++++|+||+||+|++++..|.+|+.|||+|+++..++++
T Consensus       513 dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  513 DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            4678999999999999999999999999999999999999999999999999999999877654

>KOG0595|consensus

Probab=99.20  E-value=2.1e-11  Score=103.83  Aligned_cols=63  Identities=40%  Similarity=0.686  Sum_probs=56.0

Q ss_pred             ccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC------CceEEeecccceecCcc
Q psy6191         238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN------FVVKIGDFGLAARIEFD  300 (305)
Q Consensus       238 ~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~------~~~k~~dfg~a~~~~~~  300 (305)
                      .++++.+++..++.++.|++.|++++|.++++|||+||.|||++..      -.+||+|||+|+.+...
T Consensus       100 i~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen  100 IRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            3445579999999999999999999999999999999999999875      46899999999988643

>KOG0694|consensus

Probab=99.20  E-value=1.7e-11  Score=110.55  Aligned_cols=63  Identities=41%  Similarity=0.685  Sum_probs=57.2

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcccc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ  302 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~  302 (305)
                      ....++++.+++|.++++.||+|+|.+|||+||+|.+|||++..|.+||+|||+++.--..|.
T Consensus       461 ~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  461 HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            345699999999999999999999999999999999999999999999999999986654443

>KOG0663|consensus

Probab=99.19  E-value=2.3e-11  Score=101.14  Aligned_cols=58  Identities=43%  Similarity=0.619  Sum_probs=55.3

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+|...++++++-|++.|+.|+|.+.++|||+|++|+|++..|.+|++|||+|+....
T Consensus       172 q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  172 QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            5689999999999999999999999999999999999999999999999999998764

>KOG0660|consensus

Probab=99.18  E-value=1.9e-11  Score=102.58  Aligned_cols=62  Identities=39%  Similarity=0.718  Sum_probs=57.2

Q ss_pred             ccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       238 ~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+.+..+++..+++++.|++.|+.|+|+.+++|||+||+|+++..+..+|++|||+|+.+..
T Consensus       116 ik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  116 IKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             HHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence            34455599999999999999999999999999999999999999999999999999998864

>KOG0658|consensus

Probab=99.17  E-value=2.9e-11  Score=101.66  Aligned_cols=62  Identities=35%  Similarity=0.564  Sum_probs=56.3

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CceEEeecccceecCcccc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKIGDFGLAARIEFDGQ  302 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~-~~~k~~dfg~a~~~~~~~~  302 (305)
                      +..++.-+++.|++|+..|+.|+|++|++|||+||.|+|++.. +.+|++|||.|+.+..+..
T Consensus       119 ~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  119 NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            4567888999999999999999999999999999999999965 8999999999999986654

>KOG0583|consensus

Probab=99.16  E-value=4.5e-11  Score=105.07  Aligned_cols=66  Identities=36%  Similarity=0.596  Sum_probs=60.7

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CceEEeecccceec
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKIGDFGLAARI  297 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~-~~~k~~dfg~a~~~  297 (305)
                      ..+.+.... .+.+.|.+++.++.|++.|+.|||++|++|||+||+|++++.. +.+|++|||+++..
T Consensus       105 GdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen  105 GDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             ccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            556666665 7789999999999999999999999999999999999999999 99999999999877

>KOG0659|consensus

Probab=99.13  E-value=1.1e-10  Score=94.30  Aligned_cols=64  Identities=34%  Similarity=0.532  Sum_probs=57.7

Q ss_pred             hhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         235 ERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       235 ~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .....+...++..+++.|+.+++.|+.|||++.++|||+||.|+++++++.+|++|||+|+.+.
T Consensus        89 ~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   89 VVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             HHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence            3334455668899999999999999999999999999999999999999999999999999775

>KOG0581|consensus

Probab=99.12  E-value=5.6e-11  Score=100.12  Aligned_cols=61  Identities=41%  Similarity=0.616  Sum_probs=56.0

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~-~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+.++|.....++.+++.|+.|||. ++++|||+||+|+|+.+.|.+|++|||+++.+.+.
T Consensus       171 ~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  171 RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            34669999999999999999999995 99999999999999999999999999999887654

>KOG0198|consensus

Probab=99.12  E-value=9.9e-11  Score=99.42  Aligned_cols=56  Identities=48%  Similarity=0.804  Sum_probs=53.7

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCceEEeecccceecC
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-NFVVKIGDFGLAARIE  298 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~-~~~~k~~dfg~a~~~~  298 (305)
                      .++++.++.|.+|++.|+.|+|++|++|+|+|++|||++. ++.+|++|||+|+.+.
T Consensus       113 ~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen  113 KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            6999999999999999999999999999999999999999 7999999999998776

>KOG0615|consensus

Probab=99.11  E-value=8e-11  Score=100.43  Aligned_cols=70  Identities=37%  Similarity=0.579  Sum_probs=59.8

Q ss_pred             CCCccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC---CceEEeecccceecC
Q psy6191         228 PRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN---FVVKIGDFGLAARIE  298 (305)
Q Consensus       228 ~~~~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~---~~~k~~dfg~a~~~~  298 (305)
                      ...+.++.+.. ..+.+.+...+.++.|++.++.|+|+.|++|||+||+|||+..+   ..+|++|||+|+...
T Consensus       258 v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g  330 (475)
T KOG0615|consen  258 VEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG  330 (475)
T ss_pred             ecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence            34456666654 34568888899999999999999999999999999999999876   689999999998875

>KOG0605|consensus

Probab=99.09  E-value=1.1e-10  Score=102.64  Aligned_cols=67  Identities=30%  Similarity=0.531  Sum_probs=58.6

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +++.-.. +.+.+++.++++|+++.+.+++-+|.+|+||||+||+|+|++..|++|++|||+++-+..
T Consensus       227 D~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  227 DMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             cHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            3444333 456799999999999999999999999999999999999999999999999999976544

>KOG0585|consensus

Probab=99.08  E-value=1.6e-10  Score=100.37  Aligned_cols=54  Identities=43%  Similarity=0.776  Sum_probs=51.7

Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       244 l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      +.+.+++.|+..++.||+|||.+|++|||+||+|+|++..+.+||+|||++...
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~  260 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEF  260 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeec
Confidence            788999999999999999999999999999999999999999999999998755

>KOG0611|consensus

Probab=99.07  E-value=1.3e-10  Score=99.19  Aligned_cols=65  Identities=38%  Similarity=0.705  Sum_probs=57.4

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      .+... ..+++.+++.+++.+++||..++.|||.++++|||+|.+|||++.++.+||+|||++...
T Consensus       139 eLYDY-iSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  139 ELYDY-ISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             cHHHH-HHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence            34433 346678999999999999999999999999999999999999999999999999997543

>KOG0588|consensus

Probab=99.07  E-value=1.2e-10  Score=104.95  Aligned_cols=57  Identities=46%  Similarity=0.736  Sum_probs=53.5

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeeccccee
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR  296 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~  296 (305)
                      +++++++.++..+++||+.|+.|||+.+++|||+||+|++++..+.+||+|||+|..
T Consensus       105 ~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL  161 (786)
T KOG0588|consen  105 RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL  161 (786)
T ss_pred             hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec
Confidence            467899999999999999999999999999999999999999888899999999863

>KOG0664|consensus

Probab=99.05  E-value=1.7e-10  Score=93.67  Aligned_cols=61  Identities=41%  Similarity=0.739  Sum_probs=55.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcccc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ  302 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~  302 (305)
                      ..++.+.++-+++||+.|+.|+|+.+++|||+||.|+++.++..+|++|||+|+....+..
T Consensus       151 Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  151 QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            4577888999999999999999999999999999999999999999999999998775543

>KOG0578|consensus

Probab=99.03  E-value=4.4e-10  Score=99.54  Aligned_cols=59  Identities=37%  Similarity=0.623  Sum_probs=56.3

Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcccc
Q psy6191         244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ  302 (305)
Q Consensus       244 l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~  302 (305)
                      +.|.++..+|.+++.||.|||.+|++|||+|.+||++..++.+|+.|||||+++.....
T Consensus       366 ~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  366 MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            77999999999999999999999999999999999999999999999999999987764

>KOG0591|consensus

Probab=99.02  E-value=3.3e-10  Score=92.35  Aligned_cols=114  Identities=27%  Similarity=0.450  Sum_probs=80.7

Q ss_pred             HHHHHHHhhcCCCCCCCHhhhhcCccccccCCCCCCccccccCCCCCCCCCCCCCCCCccchhhcccccccCChHHHHHH
Q psy6191         173 ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFY  252 (305)
Q Consensus       173 ~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~r~~~~~~~l~~~~~~~~  252 (305)
                      .++++.+=...--+.|++-+-..|.|..+...  +..           +...-......-++++..+.+..++|..+-.+
T Consensus        63 q~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev--lni-----------vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~  129 (375)
T KOG0591|consen   63 QDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV--LNI-----------VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKY  129 (375)
T ss_pred             HHHHHHHHHHHhcCCchHHHHHHHhhhccchh--hHH-----------HHHhhcccCHHHHHHHHHhccccCchHHHHHH
Confidence            34555443333345577777666666543210  000           00111222334467777777888999999999


Q ss_pred             HHHHHHHHHHHHh--CC--ceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         253 MKQILEGVSYLHD--HK--IIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       253 ~~qi~~~l~~~h~--~~--~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +.|++.++..||.  ..  ++|||+||.||+++.+|.+|+.|||+++.++.
T Consensus       130 f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s  180 (375)
T KOG0591|consen  130 FVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS  180 (375)
T ss_pred             HHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence            9999999999999  44  99999999999999999999999999998864

>KOG0589|consensus

Probab=99.01  E-value=1.4e-10  Score=101.38  Aligned_cols=60  Identities=40%  Similarity=0.670  Sum_probs=56.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +..+++..+..|+.|++.++.|||.+.|+|||+|+.|||+++++.+++.|||+|+.+...
T Consensus       100 ~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen  100 GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            367899999999999999999999999999999999999999999999999999988654

>KOG1266|consensus

Probab=99.01  E-value=1.5e-10  Score=96.39  Aligned_cols=191  Identities=18%  Similarity=0.185  Sum_probs=110.6

Q ss_pred             HhcCCCCCccceeEEEEcCC-----eEEEEEeccCCCCHHHHHHHhcCCCC-CCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           8 HRSLKHRNVVGFHSFFEDSK-----FVYIILELCRKRSMMELYNSACDLEE-MSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         8 l~~l~HpnIV~l~~~~~~~~-----~~ylVmEy~~~g~L~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +-++.|.|||++|.|+.+.+     .+-++.||++.|++.+.+++...... +....- +..-++..++.|+|.+.--..
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            34567999999999987654     47888999999999998876432210 000000 001123455666664431110


Q ss_pred             ---------ecCCCCCeeEcchhH-----HHHh---cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 ---------LNDDSSGVMFNDLTR-----MIML---ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 ---------~~~~~~~v~~~d~~~-----~~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                               ..-.++-|+++-..+     ....   .......|-++|.|||.=.....+.++|||++|....+|..|..
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence                     011112222211100     0000   01122346789999998666666778999999999999998875


Q ss_pred             C-CCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         144 P-FETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       144 P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      - -.+....+.-..|.+.-+.+   -+.--++++.+||+-.|..||++.+++.||.+-.
T Consensus       281 q~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  281 QSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             ccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            4 22222212112222221111   1122357899999999999999999999997643

>KOG0662|consensus

Probab=99.00  E-value=3.6e-10  Score=86.29  Aligned_cols=64  Identities=33%  Similarity=0.545  Sum_probs=55.8

Q ss_pred             hhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         235 ERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       235 ~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +....-.+.+..+.++.++-|++.|+.|||+++++|||+||.|+++..++.+|++|||+|+-+.
T Consensus        89 kyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   89 KYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             HHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            3333445567778888999999999999999999999999999999999999999999998654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.99  E-value=1.9e-10  Score=96.42  Aligned_cols=154  Identities=18%  Similarity=0.357  Sum_probs=82.0

Q ss_pred             EEEEEeccCCCCHHHHHHHhcCCCCCC---CcCchhH--HHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHH
Q psy6191          29 VYIILELCRKRSMMELYNSACDLEEMS---DPAAQPV--IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRM   96 (305)
Q Consensus        29 ~ylVmEy~~~g~L~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~   96 (305)
                      .+++|.-+ .+||.+++..........   ...++..  .+..+.+.+.|..|+.|.       +.+.++.+.++||...
T Consensus       114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~  192 (288)
T PF14531_consen  114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL  192 (288)
T ss_dssp             EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred             hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence            36677766 468877754321111110   0111111  122455667776665331       3334577778887543


Q ss_pred             HHhcCCcc-cccCCCcccccccccC--------CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCCC
Q psy6191          97 IMLANKNT-LCGTPNYIAPEILNKN--------GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT  167 (305)
Q Consensus        97 ~~~~~~~~-~~Gt~~y~aPE~~~~~--------~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  167 (305)
                      ........ ...+..|.+||.....        .++.+.|.|+||+++|.|.+|+.||...........    .+..-..
T Consensus       193 ~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~~C~~  268 (288)
T PF14531_consen  193 VRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFSRCRD  268 (288)
T ss_dssp             EETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGTTSS-
T ss_pred             eecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cchhcCC
Confidence            32222111 2345779999976432        367889999999999999999999986543222110    1111126


Q ss_pred             CCHHHHHHHHHHhhcCCCCC
Q psy6191         168 LKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       168 ~~~~~~~li~~~l~~dp~~R  187 (305)
                      +++..++||.++|+.||.+|
T Consensus       269 ~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  269 MPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             --HHHHHHHHHHT-SSGGGS
T ss_pred             cCHHHHHHHHHHccCCcccC
Confidence            88899999999999999987

>KOG0695|consensus

Probab=98.98  E-value=5.5e-10  Score=93.19  Aligned_cols=96  Identities=30%  Similarity=0.460  Sum_probs=78.8

Q ss_pred             hhhhcCccccccCCCCCCccccccCCCCCCCCCCCCCCCCccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCcee
Q psy6191         191 AQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIH  270 (305)
Q Consensus       191 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~  270 (305)
                      +++-+|||+-.      ..+|..+..+...++...+.......|++.+    .++++.+++|.++|+.++.|+|.+|+++
T Consensus       305 e~asn~pflvg------lhscfqtesrlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rgiiy  374 (593)
T KOG0695|consen  305 EQASNNPFLVG------LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERGIIY  374 (593)
T ss_pred             HhccCCCeEEe------hhhhhcccceEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcCeee
Confidence            34445666543      4577778877777777777666666666554    4999999999999999999999999999


Q ss_pred             cCCCCCcEEecCCCceEEeeccccee
Q psy6191         271 RDLKLGNLFLSDNFVVKIGDFGLAAR  296 (305)
Q Consensus       271 ~~l~~~~~l~~~~~~~k~~dfg~a~~  296 (305)
                      ||+|..|++++..+.+|+.|+|+++-
T Consensus       375 rdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  375 RDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             eeccccceEEccCCceeecccchhhc
Confidence            99999999999999999999999864

>KOG1164|consensus

Probab=98.98  E-value=1.1e-08  Score=88.84  Aligned_cols=192  Identities=16%  Similarity=0.165  Sum_probs=127.3

Q ss_pred             hhHHHHHhcCCC----CCccceeEEE-EcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKH----RNVVGFHSFF-EDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~H----pnIV~l~~~~-~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   75 (305)
                      ..|+.+++.+..    +++.++++.+ .++.+-||||+++ |.+|.++..... ....+.. ..+..++....+.+.|..
T Consensus        64 ~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~  141 (322)
T KOG1164|consen   64 KIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK  141 (322)
T ss_pred             hhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc
Confidence            468899999873    5899999999 5888999999987 779999876544 2222222 223334456677788877


Q ss_pred             CCcee--------ecCCC----CCeeEcchhHHH--Hh---------cC---CcccccCCCcccccccccCCCCccchHH
Q psy6191          76 GFGYQ--------LNDDS----SGVMFNDLTRMI--ML---------AN---KNTLCGTPNYIAPEILNKNGHSFEVDVW  129 (305)
Q Consensus        76 ~~~~~--------~~~~~----~~v~~~d~~~~~--~~---------~~---~~~~~Gt~~y~aPE~~~~~~~~~~~Diw  129 (305)
                      |+.|+        +....    ..+.+.||+...  ..         ..   ...+.||..|+++..-.+...+.+.|+|
T Consensus       142 G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDle  221 (322)
T KOG1164|consen  142 GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLE  221 (322)
T ss_pred             CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhh
Confidence            76554        22221    346677775443  11         00   1235599999999999888899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHH---HHHHHHhccccC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         130 SIGCIMYTLLVGKPPFETSTLK---ETYSRIKKVEYK--LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       130 SlGvilye~l~g~~Pf~~~~~~---~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |++-++.++..|..||.+....   ..+.........  .....+....++...+-..+...+|.-..+..
T Consensus       222 s~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  222 SLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             hHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            9999999999999999765432   222222111111  12234455666666666678888888776644

>PRK09188 serine/threonine protein kinase; Provisional

Probab=98.97  E-value=9.2e-10  Score=96.17  Aligned_cols=115  Identities=10%  Similarity=0.051  Sum_probs=73.4

Q ss_pred             hhHHHHHhcCCCCCccc-eeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVG-FHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~-l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||. ++++    +..|||||||+|++|... .   ..     ........+.+++.++|..|+.|.
T Consensus        69 ~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~---~~-----~~~~~~~~i~~aL~~lH~~gIiHr  135 (365)
T PRK09188         69 AREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLA-R---PH-----GDPAWFRSAHRALRDLHRAGITHN  135 (365)
T ss_pred             HHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHHh-C---cc-----chHHHHHHHHHHHHHHHHCCCeeC
Confidence            58999999999999995 5542    458999999999999632 1   00     011223334577778887665443


Q ss_pred             ec--------CCCCCeeEcchhHHHHhc------------CCcccccCCCcccccccccCC------CCccchHH
Q psy6191          81 LN--------DDSSGVMFNDLTRMIMLA------------NKNTLCGTPNYIAPEILNKNG------HSFEVDVW  129 (305)
Q Consensus        81 ~~--------~~~~~v~~~d~~~~~~~~------------~~~~~~Gt~~y~aPE~~~~~~------~~~~~Diw  129 (305)
                      -.        +....+++.||+.+..+.            +-.+.+||+.|+|||++....      .+..+|-|
T Consensus       136 DL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        136 DLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            22        233456777876443221            113567999999999986432      23346777

>KOG0986|consensus

Probab=98.97  E-value=8.8e-10  Score=95.32  Aligned_cols=60  Identities=38%  Similarity=0.601  Sum_probs=56.2

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      ..+++.++.+|.++|+.|++.+|..+|++||+||+|||++..|+++|+|+|+|.-+...+
T Consensus       282 ~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  282 PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            469999999999999999999999999999999999999999999999999998876544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=98.94  E-value=3.7e-10  Score=91.91  Aligned_cols=117  Identities=9%  Similarity=0.124  Sum_probs=71.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--------KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   73 (305)
                      ++|+..+.++.||+|....+++.+.        ...||||||++|.+|.++...       .+   .....+...+...|
T Consensus        83 e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~-------~~---~~~~~i~~~l~~lH  152 (232)
T PRK10359         83 ENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEI-------SE---DVKAKIKASIESLH  152 (232)
T ss_pred             HHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhhc-------cH---HHHHHHHHHHHHHH
Confidence            5899999999999999999987744        358999999999999876321       11   11223345555666


Q ss_pred             hhCCcee--------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          74 KYGFGYQ--------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        74 ~~~~~~~--------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      ..|+.|.        +..+ + +.+.|++........        .....++..+.|+.++|+|||||++...
T Consensus       153 ~~gi~H~Dikp~Nili~~~-g-i~liDfg~~~~~~e~--------~a~d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        153 QHGMVSGDPHKGNFIVSKN-G-LRIIDLSGKRCTAQR--------KAKDRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             HcCCccCCCChHHEEEeCC-C-EEEEECCCcccccch--------hhHHHHHHHhHhcccccccceeEeehHH
Confidence            5554332        2211 1 444554332211100        0011134455577899999999987543

>KOG0033|consensus

Probab=98.94  E-value=1.2e-09  Score=87.42  Aligned_cols=57  Identities=40%  Similarity=0.697  Sum_probs=51.7

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~---~~~~k~~dfg~a~~~~  298 (305)
                      .-++|..+.-|++||++++.|||.++++|||+||.|+++.+   ...+|++|||+|..+.
T Consensus       105 ~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen  105 EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            45788889999999999999999999999999999999953   4579999999999887

>KOG0582|consensus

Probab=98.92  E-value=2.1e-09  Score=92.84  Aligned_cols=70  Identities=29%  Similarity=0.572  Sum_probs=60.3

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccccC
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR  303 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~~  303 (305)
                      .+++...+  ..+.|..+..++++++.|+.|+|.+|.||||+|+.|||++.+|.+|++|||++..+...|.+
T Consensus       113 dIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  113 DIIKTYYP--DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             HHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            34444433  34889999999999999999999999999999999999999999999999998877766643

>KOG0197|consensus

Probab=98.92  E-value=1.4e-09  Score=95.71  Aligned_cols=61  Identities=39%  Similarity=0.618  Sum_probs=55.4

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+..+..++...++.||+.|+.||.+++.|||||.+.|||++.+..+||+|||+|+.+..+
T Consensus       296 ~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  296 EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            4556788899999999999999999999999999999999999999999999999955443

>KOG0601|consensus

Probab=98.92  E-value=2.3e-09  Score=96.05  Aligned_cols=225  Identities=21%  Similarity=0.310  Sum_probs=122.9

Q ss_pred             hHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHH-HH----HHHHhhhhC
Q psy6191           3 QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWV-SK----WVDYSDKYG   76 (305)
Q Consensus         3 ~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~   76 (305)
                      +|..-.+.++ |+|.|+.+..++..+.+|+-+|+|. .+|.++....+...  .+......+.. ..    ++.+.|...
T Consensus       166 ~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~--p~~~l~~~~~~~~~~~~~al~~~hs~~  242 (524)
T KOG0601|consen  166 REFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFL--PDNLLWNSLRDWLSRDVTALSHLHSNN  242 (524)
T ss_pred             chhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccC--CchhhhhHHhhhhhcccccccccCCCc
Confidence            4555555664 9999999999999999999999996 56766655544421  22222222111 11    222222111


Q ss_pred             Cc--------eeecCCCCCeeEcchhHHHHhcCC---------cccccCCCcccccccccCCCCccchHHHHHHHHHHHH
Q psy6191          77 FG--------YQLNDDSSGVMFNDLTRMIMLANK---------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        77 ~~--------~~~~~~~~~v~~~d~~~~~~~~~~---------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l  139 (305)
                      +.        +....+.......|+.....+.+.         ...-|..-|++||.+++. ++.+.||+|+|.+..+..
T Consensus       243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~  321 (524)
T KOG0601|consen  243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAI  321 (524)
T ss_pred             ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhH
Confidence            10        000011012222232221111111         011466789999998754 678899999999999988


Q ss_pred             hCCCCCCCC--CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCCCCCCccccccCCC
Q psy6191         140 VGKPPFETS--TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPR  217 (305)
Q Consensus       140 ~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  217 (305)
                      +|..++...  +......... ....+-...+......+..++..+|..|++++                          
T Consensus       322 l~~~~~~~g~~~~W~~~r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q--------------------------  374 (524)
T KOG0601|consen  322 LGSHLPSVGKNSSWSQLRQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQ--------------------------  374 (524)
T ss_pred             hhcccccCCCCCCcccccccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHH--------------------------
Confidence            887665433  1111111100 00011112333333345555555555554444                          


Q ss_pred             CCCCCCCCCCCCCccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CceEEeeccccee
Q psy6191         218 FDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKIGDFGLAAR  296 (305)
Q Consensus       218 ~~~~~~~~~~~~~~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~-~~~k~~dfg~a~~  296 (305)
                                                            ++.++.++|....+|+|++|.||++.++ ...++.|||.+..
T Consensus       375 --------------------------------------~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  375 --------------------------------------ILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             --------------------------------------HHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence                                                  4445555556667788999999988875 6677788877653

>KOG0669|consensus

Probab=98.92  E-value=1.3e-09  Score=87.61  Aligned_cols=61  Identities=33%  Similarity=0.645  Sum_probs=55.7

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ....++..+++.++.++.+|+.|+|++.++|||+|+.|++++.++.++++|||+|+.++..
T Consensus       117 ~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~  177 (376)
T KOG0669|consen  117 RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTS  177 (376)
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence            3445888999999999999999999999999999999999999999999999999877644

>PRK12274 serine/threonine protein kinase; Provisional

Probab=98.91  E-value=5.9e-09  Score=83.32  Aligned_cols=135  Identities=8%  Similarity=-0.021  Sum_probs=85.8

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++|+ |++|++++++    +..|+||||+.|.+|.+.....         .......+...+.+.|..|+.|.
T Consensus        49 ~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~~---------~~~~~~qi~~~L~~lH~~GIvHr  115 (218)
T PRK12274         49 RREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPRG---------DLAYFRAARRLLQQLHRCGVAHN  115 (218)
T ss_pred             HHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhhh---------hHHHHHHHHHHHHHHHHCcCccC
Confidence            58999999995 5889999986    3479999999999987543210         01112223344555665554332


Q ss_pred             e--------cCCCCCeeEcchhHHHHhcCCc-----------------ccccCCCcccccccccC-CCC-ccchHHHHHH
Q psy6191          81 L--------NDDSSGVMFNDLTRMIMLANKN-----------------TLCGTPNYIAPEILNKN-GHS-FEVDVWSIGC  133 (305)
Q Consensus        81 ~--------~~~~~~v~~~d~~~~~~~~~~~-----------------~~~Gt~~y~aPE~~~~~-~~~-~~~DiwSlGv  133 (305)
                      -        .+..+.+++.||+.+......+                 ...+++.|++|+.-.-- ..+ ...++.+.|.
T Consensus       116 DL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~  195 (218)
T PRK12274        116 DLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGK  195 (218)
T ss_pred             CCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence            1        2223456777775443221111                 11368899999853311 122 4678999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q psy6191         134 IMYTLLVGKPPFETST  149 (305)
Q Consensus       134 ilye~l~g~~Pf~~~~  149 (305)
                      -+|.++|+..|+.+++
T Consensus       196 ~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        196 PVYRFVTRRVLHWEDN  211 (218)
T ss_pred             hHHHHHhccCCccccC
Confidence            9999999999987654

>KOG0604|consensus

Probab=98.90  E-value=1.6e-09  Score=89.17  Aligned_cols=69  Identities=42%  Similarity=0.544  Sum_probs=57.9

Q ss_pred             Cccchhhcccc-cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCceEEeecccceecC
Q psy6191         230 RKPLMERNSKR-RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIE  298 (305)
Q Consensus       230 ~~~l~~r~~~~-~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~---~~~~k~~dfg~a~~~~  298 (305)
                      .+.++.|...+ ...++|.++..++.||..++.|||+.++.|||+||+|+|...   +..+|++|||||+.-.
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            34566555433 346999999999999999999999999999999999999964   4578999999998654

>KOG4236|consensus

Probab=98.88  E-value=2.2e-09  Score=94.66  Aligned_cols=68  Identities=37%  Similarity=0.478  Sum_probs=59.4

Q ss_pred             hcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC---CceEEeecccceecCccccC
Q psy6191         236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN---FVVKIGDFGLAARIEFDGQR  303 (305)
Q Consensus       236 r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~---~~~k~~dfg~a~~~~~~~~~  303 (305)
                      ..+.+++.+++..+++++.||+.++.|+|-.+++|+|+||+|+++.+.   -.+|++|||+|+.+....-+
T Consensus       653 ILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  653 ILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            446678889999999999999999999999999999999999999754   47899999999998755443

>KOG0610|consensus

Probab=98.87  E-value=3.3e-09  Score=90.81  Aligned_cols=59  Identities=32%  Similarity=0.557  Sum_probs=54.3

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      +..+.+++..+++|+++++.+|+|||..|+|+||+||+|||+..+|.+.+.||-++.+.
T Consensus       171 Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  171 QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            34566999999999999999999999999999999999999999999999999887554

>KOG0690|consensus

Probab=98.86  E-value=1.8e-09  Score=89.89  Aligned_cols=55  Identities=44%  Similarity=0.747  Sum_probs=52.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccce
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA  295 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~  295 (305)
                      ...++++.+++|-++|+.++.|+|++++++||+|.+|++++++|.+|+.|||+++
T Consensus       262 er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  262 ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch
Confidence            3458999999999999999999999999999999999999999999999999986

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=98.86  E-value=3.8e-09  Score=93.48  Aligned_cols=58  Identities=36%  Similarity=0.658  Sum_probs=54.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+.+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+.
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          95 KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            4568899999999999999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0192|consensus

Probab=98.84  E-value=5.7e-09  Score=91.23  Aligned_cols=60  Identities=33%  Similarity=0.496  Sum_probs=55.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEecCCC-ceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHK-IIHRDLKLGNLFLSDNF-VVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~-~~~~~l~~~~~l~~~~~-~~k~~dfg~a~~~~~  299 (305)
                      +...++......++-+|+.|+.|+|+++ +||||+|+.|+|++... .+||+|||+++....
T Consensus       135 ~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  135 RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            3567889999999999999999999999 99999999999999997 999999999987664

>KOG0580|consensus

Probab=98.84  E-value=2.4e-09  Score=85.38  Aligned_cols=59  Identities=36%  Similarity=0.560  Sum_probs=53.8

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +...+.+..+..|..|++.++.|||..+|+|||+||+|+|++..+.+|++|||.+..-.
T Consensus       117 ~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  117 RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            34558889999999999999999999999999999999999999999999999976554

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=98.83  E-value=6.1e-09  Score=90.66  Aligned_cols=57  Identities=39%  Similarity=0.666  Sum_probs=53.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+..
T Consensus        89 ~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          89 ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            456889999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0608|consensus

Probab=98.82  E-value=5.7e-09  Score=93.92  Aligned_cols=71  Identities=25%  Similarity=0.447  Sum_probs=59.8

Q ss_pred             CCccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       229 ~~~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++|.-.. +.+-|.|.-+++|++++.+++++.|.-|.||||+||+|||++.+|.+|+.|||++.=+..+
T Consensus       712 PGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  712 PGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             CCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence            3445555443 3456888899999999999999999999999999999999999999999999998755443

>PHA02882 putative serine/threonine kinase; Provisional

Probab=98.82  E-value=7.8e-09  Score=88.73  Aligned_cols=55  Identities=29%  Similarity=0.451  Sum_probs=50.9

Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       244 l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .++..+..++.|++.|+.|+|..+++|||+||+||+++..+.++++|||+|+.+.
T Consensus       123 ~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~  177 (294)
T PHA02882        123 KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI  177 (294)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence            4677788899999999999999999999999999999999999999999998764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=98.81  E-value=7.6e-09  Score=90.36  Aligned_cols=58  Identities=36%  Similarity=0.576  Sum_probs=53.5

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.++.|+|.++++|+|+||+||+++.++.++++|||+++.+.
T Consensus        99 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          99 RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            3458899999999999999999999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=98.81  E-value=9.2e-09  Score=89.84  Aligned_cols=59  Identities=27%  Similarity=0.540  Sum_probs=54.5

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++..+..++.|++.++.|+|.++++|+|+||.||+++.++.++++|||+|..+..
T Consensus        96 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          96 EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            45688999999999999999999999999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=98.81  E-value=7.5e-09  Score=91.81  Aligned_cols=57  Identities=26%  Similarity=0.537  Sum_probs=53.1

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.|+.|+|+++++|||+||+||+++..+.+|++|||+|+.+..
T Consensus       138 ~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         138 DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            478889999999999999999999999999999999999999999999999987643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0666|consensus

Probab=98.80  E-value=5.4e-09  Score=86.53  Aligned_cols=56  Identities=38%  Similarity=0.595  Sum_probs=51.3

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC----CceEEeecccceecC
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN----FVVKIGDFGLAARIE  298 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~----~~~k~~dfg~a~~~~  298 (305)
                      .++..-++.+++|++.|+.|+|++=++|||+||.||++..+    |.+||+|||+|+.+.
T Consensus       128 ~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~  187 (438)
T KOG0666|consen  128 QLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFN  187 (438)
T ss_pred             cCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhh
Confidence            46777888999999999999999999999999999999877    899999999998764

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=98.80  E-value=8.1e-09  Score=90.13  Aligned_cols=58  Identities=28%  Similarity=0.504  Sum_probs=53.4

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      +.+.+++..+..++.|++.++.|+|.++++|+|+||.||+++.++.++++|||+++..
T Consensus        89 ~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          89 KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            3456889999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=98.80  E-value=1e-08  Score=89.47  Aligned_cols=60  Identities=27%  Similarity=0.532  Sum_probs=55.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++..+..++.|++.++.|+|+++++|+|++|.||+++..+.+|++|||+|+.+...
T Consensus        96 ~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          96 EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            356899999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0612|consensus

Probab=98.79  E-value=7.7e-09  Score=98.52  Aligned_cols=73  Identities=30%  Similarity=0.473  Sum_probs=64.0

Q ss_pred             CCccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcccc
Q psy6191         229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ  302 (305)
Q Consensus       229 ~~~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~~  302 (305)
                      ..++++.-.++.. .+++..+++|++.++.++.-+|+-|.||||+||+|+|++..|++|++|||.|-++..+|.
T Consensus       158 pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  158 PGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             cCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            3455665555544 799999999999999999999999999999999999999999999999999988876664

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=98.79  E-value=1.1e-08  Score=89.35  Aligned_cols=59  Identities=25%  Similarity=0.536  Sum_probs=54.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++..+..++.|++.++.|+|+++++|+|+||.||+++.++.+|++|||+|+.+..
T Consensus        96 ~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          96 EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            45688899999999999999999999999999999999999999999999999876643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=98.79  E-value=9.2e-09  Score=88.64  Aligned_cols=59  Identities=37%  Similarity=0.657  Sum_probs=53.6

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+.+++.++..++.|++.|+.|+|+++++|+|+||+||+++..+.+|++|||+|+...
T Consensus        96 ~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          96 HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            34568888999999999999999999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=98.78  E-value=1.2e-08  Score=89.28  Aligned_cols=58  Identities=43%  Similarity=0.622  Sum_probs=53.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...++..+...++.|++.|+.|+|+++++|+|+||.||+++.++.+|++|||+|+.+.
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~  225 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY  225 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccc
Confidence            3458888999999999999999999999999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=98.78  E-value=1.1e-08  Score=89.28  Aligned_cols=59  Identities=24%  Similarity=0.514  Sum_probs=54.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++..+..++.|++.++.|+|.++++|||+||+||+++.++.++++|||+|..+..
T Consensus        96 ~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          96 EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            45688889999999999999999999999999999999999999999999999876643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0597|consensus

Probab=98.78  E-value=7.4e-09  Score=92.07  Aligned_cols=58  Identities=31%  Similarity=0.567  Sum_probs=54.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+.++|+.++.+..+++.++.|+|+++++|||+||.||++..++.+|++|||+|+...
T Consensus        94 d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   94 DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence            3569999999999999999999999999999999999999999999999999998654

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=98.78  E-value=1.2e-08  Score=90.55  Aligned_cols=57  Identities=28%  Similarity=0.529  Sum_probs=53.1

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++..+..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+..
T Consensus       138 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         138 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            478888999999999999999999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=98.77  E-value=1.2e-08  Score=88.98  Aligned_cols=57  Identities=35%  Similarity=0.627  Sum_probs=52.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      ...+.+.++..++.|++.|+.|+|++|++|+|+||.||+++.++.++++|||+|+..
T Consensus        90 ~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          90 ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            345788899999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=98.77  E-value=1.1e-08  Score=87.61  Aligned_cols=58  Identities=38%  Similarity=0.651  Sum_probs=52.7

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+++...
T Consensus        97 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          97 GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            3446788899999999999999999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PHA03212 serine/threonine kinase US3; Provisional

Probab=98.76  E-value=1.4e-08  Score=90.74  Aligned_cols=56  Identities=34%  Similarity=0.566  Sum_probs=52.1

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      ..++..++..++.|++.|+.|+|+++++|||+||+||+++..+.++++|||+|+..
T Consensus       177 ~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        177 RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            45788899999999999999999999999999999999999999999999998643

>KOG0667|consensus

Probab=98.76  E-value=1e-08  Score=92.47  Aligned_cols=108  Identities=26%  Similarity=0.436  Sum_probs=77.7

Q ss_pred             HHHHHHhhcCCCCCCCHhhhhcCccccccCCCCCCccccccCCCCCCCCCCCCCCCCccchhhcccccccCChHHHHHHH
Q psy6191         174 TMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYM  253 (305)
Q Consensus       174 ~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~r~~~~~~~l~~~~~~~~~  253 (305)
                      .+|..+-+.||+.-..+-.++.+-.|+.+       .|+.         -.+-......+++.+.  ...++...++.++
T Consensus       234 ~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H-------lciV---------fELL~~NLYellK~n~--f~Glsl~~ir~~~  295 (586)
T KOG0667|consen  234 RILELLNKHDPDDKYNIVRMLDYFYFRNH-------LCIV---------FELLSTNLYELLKNNK--FRGLSLPLVRKFA  295 (586)
T ss_pred             HHHHHHhccCCCCCeeEEEeeeccccccc-------eeee---------ehhhhhhHHHHHHhcC--CCCCCHHHHHHHH
Confidence            45666666889888888877777666653       1221         1111111223343332  2348899999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCcEEecC--CCceEEeecccceecCc
Q psy6191         254 KQILEGVSYLHDHKIIHRDLKLGNLFLSD--NFVVKIGDFGLAARIEF  299 (305)
Q Consensus       254 ~qi~~~l~~~h~~~~~~~~l~~~~~l~~~--~~~~k~~dfg~a~~~~~  299 (305)
                      .|++.+|.+||..++||+||||+|||+..  ...+||+|||.|.....
T Consensus       296 ~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  296 QQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             HHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            99999999999999999999999999974  45899999999876653

>KOG0193|consensus

Probab=98.76  E-value=7.1e-09  Score=92.73  Aligned_cols=56  Identities=46%  Similarity=0.739  Sum_probs=51.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccce
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA  295 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~  295 (305)
                      ....|...+...+..|++.|+.|||+.+|||||+|.-|||+.+++++||.|||+|.
T Consensus       481 ~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  481 QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence            34557888999999999999999999999999999999999999999999999974

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=98.76  E-value=1.1e-08  Score=90.39  Aligned_cols=58  Identities=33%  Similarity=0.626  Sum_probs=53.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++..+..++.|++.++.|+|++|++|+|+||+||+++..+.++++|||+|+.+.
T Consensus        95 ~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          95 KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            4568899999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=98.76  E-value=1.4e-08  Score=88.39  Aligned_cols=58  Identities=38%  Similarity=0.645  Sum_probs=53.4

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      +...+++.++..++.|++.++.|+|++|++|+|+||.||+++.++.++++|||+++..
T Consensus        89 ~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          89 RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            3456889999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=98.76  E-value=1.3e-08  Score=88.74  Aligned_cols=57  Identities=44%  Similarity=0.698  Sum_probs=52.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      ...+++.++..++.|++.|+.|+|.++++|+|+||+||+++.++.+|++|||+++..
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          89 ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            345889999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=98.75  E-value=1.4e-08  Score=90.58  Aligned_cols=56  Identities=30%  Similarity=0.548  Sum_probs=52.3

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      +.+++..++.++.|++.++.|+|.++++|||+||+||+++.++.+|++|||+|+.+
T Consensus        96 ~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          96 GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            45888999999999999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=98.75  E-value=1.3e-08  Score=90.04  Aligned_cols=58  Identities=36%  Similarity=0.654  Sum_probs=54.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+.+++..+..++.|++.|+.|+|.++++|+|+||+||+++.++.++++|||+++.+.
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          95 KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            3468999999999999999999999999999999999999999999999999988664

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=98.75  E-value=2.1e-08  Score=87.30  Aligned_cols=57  Identities=39%  Similarity=0.679  Sum_probs=52.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~-~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      ...+++.++..++.|++.|+.|+|+ .+++|+|+||+||+++.++.+|++|||+|+..
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          89 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            3468899999999999999999997 79999999999999999999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=98.75  E-value=1.4e-08  Score=88.14  Aligned_cols=58  Identities=38%  Similarity=0.651  Sum_probs=53.5

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.|+.|+|.++++|+|++|.||+++.++.+|++|||+|+...
T Consensus        90 ~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          90 SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            4468899999999999999999999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=98.75  E-value=1.5e-08  Score=88.13  Aligned_cols=57  Identities=39%  Similarity=0.635  Sum_probs=52.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      ...+++..+..++.|++.|+.|+|.+|++|+|++|.||+++.++.+|++|||+++..
T Consensus        90 ~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          90 ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            456889999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=98.75  E-value=1.6e-08  Score=89.75  Aligned_cols=57  Identities=30%  Similarity=0.551  Sum_probs=53.1

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++..+..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||++..+..
T Consensus       138 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         138 DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            478889999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=98.75  E-value=1.6e-08  Score=88.24  Aligned_cols=59  Identities=34%  Similarity=0.556  Sum_probs=54.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+.+++..+..++.|++.++.|+|+++++|+|+||.||+++.++.+|++|||+++.+..
T Consensus       112 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263        112 AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            34678889999999999999999999999999999999999999999999999987643

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=98.74  E-value=1.5e-08  Score=88.80  Aligned_cols=58  Identities=34%  Similarity=0.522  Sum_probs=53.9

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+.+++..+..++.|++.++.|+|..+++|+|+||.||+++.++.++++|||+|+.+.
T Consensus       125 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        125 NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            3468899999999999999999999999999999999999999999999999998764

>PTZ00036 glycogen synthase kinase; Provisional

Probab=98.74  E-value=1.3e-08  Score=92.26  Aligned_cols=61  Identities=31%  Similarity=0.488  Sum_probs=53.8

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-ceEEeecccceecCc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF-VVKIGDFGLAARIEF  299 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~-~~k~~dfg~a~~~~~  299 (305)
                      .....+++..+..++.|++.|+.|||+++++|||+||+||+++..+ .+|++|||+|+.+..
T Consensus       162 ~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        162 RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            3445688999999999999999999999999999999999998654 799999999987643

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=98.74  E-value=1.7e-08  Score=88.52  Aligned_cols=58  Identities=34%  Similarity=0.658  Sum_probs=53.8

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|+|.++++|+|++|.||+++.++.+|++|||+|+.+..
T Consensus       113 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878         113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            4588999999999999999999999999999999999999999999999999887643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	305
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-59
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-23
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-59
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-23
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-59
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-23
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-59
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-23
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-59
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-23
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-58
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-23
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-56
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-25
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-55
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-25
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-55
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-25
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-55
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-25
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-28
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-23
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-23
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-04
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-22
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-04
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-22
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-04
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-22
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-04
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-22
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-04
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-22
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-04
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-04
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-22
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-04
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-22
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-04
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-22
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-04
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-22
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-04
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-04
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-04
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-04
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-04
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-22
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-04
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-22
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-04
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-22
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-04
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-22
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-04
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-22
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-04
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-22
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-04
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-22
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-04
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-21
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-04
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-21
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-04
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-21
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-04
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-21
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-04
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-21
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-04
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-21
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-04
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-20
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-04
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-20
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-05
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-17
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-17
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-17
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-17
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-17
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-17
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
1q4k_B	259	The Polo-Box Domain Of Plk1 In Complex With A Phosp		5e-16
2ogq_A	239	Molecular And Structural Basis Of Plk1 Substrate Re		5e-16
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-16
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-05
1umw_A	237	Structure Of A Human Plk1 Polo-Box DomainPHOSPHOPEP		6e-16
4h5x_B	240	Human Plk1-Pbd With A Glycerol Bound At The Phophop		6e-16
3fvh_A	237	Polo-Like Kinase 1 Polo Box Domain In Complex With		6e-16
3c5l_A	221	Polo-Like Kinase 1 Polo Box Domain In Complex With		6e-16
3hih_A	223	Structure Of Human Plk1-pbd With Glycerol And Sulfa		6e-16
3p2w_A	232	Unliganded Form Of Polo-Like Kinase I Polo-Box Doma		7e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-04
3soa_A	444	Full-Length Human Camkii Length = 444		2e-15
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-15
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-15
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-14
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-14
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-14
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-13
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-04
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-04
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-04
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-05
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-05
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-05
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-04
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-05
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-05
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-05
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-05
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-05
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-05
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		8e-05
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-04
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-04
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-04
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-04
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-04
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-04
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-04
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-04
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-04
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-04
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-04
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-04
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-04
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-04
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-04
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-04
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-04
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-04
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-04
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-04
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-04
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-04
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-04
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-04
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-04
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-04
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-04
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-04
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		8e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-04
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		9e-04
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		9e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-04
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-04

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  226 bits (577), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 124/251 (49%), Positives = 160/251 (63%), Gaps = 18/251 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct: 68  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 124
Query: 61  ----PVIWVSKW-----VDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                ++   ++     V + D       LN+D   V   D      +      K TLCG
Sbjct: 125 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCG 183
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 184 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 243
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   AA++I+KML  DP  RP + +LL+ EFF + Y P  LP +CL   PRF     S +
Sbjct: 244 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 303
Query: 227 SPRRKPLMERN 237
              RKPL   N
Sbjct: 304 PSNRKPLTVLN 314

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 47/77 (61%), Positives = 66/77 (85%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R+Y++QI+ G  YLH +++IHRDLKLGNLFL+++  VKI
Sbjct: 104 RRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 162
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA ++E+DG+RK+
Sbjct: 163 GDFGLATKVEYDGERKK 179

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  226 bits (576), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 124/251 (49%), Positives = 160/251 (63%), Gaps = 18/251 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 120
Query: 61  ----PVIWVSKW-----VDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                ++   ++     V + D       LN+D   V   D      +      K TLCG
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCG 179
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 239
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   AA++I+KML  DP  RP + +LL+ EFF + Y P  LP +CL   PRF     S +
Sbjct: 240 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 299
Query: 227 SPRRKPLMERN 237
              RKPL   N
Sbjct: 300 PSNRKPLTVLN 310

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 47/77 (61%), Positives = 66/77 (85%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R+Y++QI+ G  YLH +++IHRDLKLGNLFL+++  VKI
Sbjct: 100 RRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 158
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA ++E+DG+RK+
Sbjct: 159 GDFGLATKVEYDGERKK 175

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  224 bits (571), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 123/251 (49%), Positives = 159/251 (63%), Gaps = 18/251 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct: 86  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 142
Query: 61  ----PVIWVSKW-----VDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                ++   ++     V + D       LN+D   V   D      +      K  LCG
Sbjct: 143 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCG 201
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 202 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 261
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   AA++I+KML  DP  RP + +LL+ EFF + Y P  LP +CL   PRF     S +
Sbjct: 262 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 321
Query: 227 SPRRKPLMERN 237
              RKPL   N
Sbjct: 322 PSNRKPLTVLN 332

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 47/77 (61%), Positives = 66/77 (85%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R+Y++QI+ G  YLH +++IHRDLKLGNLFL+++  VKI
Sbjct: 122 RRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 180
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA ++E+DG+RK+
Sbjct: 181 GDFGLATKVEYDGERKK 197

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  224 bits (571), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 123/251 (49%), Positives = 159/251 (63%), Gaps = 18/251 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 144
Query: 61  ----PVIWVSKW-----VDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                ++   ++     V + D       LN+D   V   D      +      K  LCG
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCG 203
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 263
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   AA++I+KML  DP  RP + +LL+ EFF + Y P  LP +CL   PRF     S +
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 323
Query: 227 SPRRKPLMERN 237
              RKPL   N
Sbjct: 324 PSNRKPLTVLN 334

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 47/77 (61%), Positives = 66/77 (85%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R+Y++QI+ G  YLH +++IHRDLKLGNLFL+++  VKI
Sbjct: 124 RRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 182
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA ++E+DG+RK+
Sbjct: 183 GDFGLATKVEYDGERKK 199

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  224 bits (570), Expect = 7e-59,   Method: Compositional matrix adjust.
 Identities = 123/251 (49%), Positives = 159/251 (63%), Gaps = 18/251 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 120
Query: 61  ----PVIWVSKW-----VDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                ++   ++     V + D       LN+D   V   D      +      K TLCG
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCG 179
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 239
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPSFN 226
           +   AA++I+KML  DP  RP + +LL+ EFF + Y P  LP +CL   P F     S +
Sbjct: 240 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPXFSIAPSSLD 299
Query: 227 SPRRKPLMERN 237
              RKPL   N
Sbjct: 300 PSNRKPLTVLN 310

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 47/77 (61%), Positives = 66/77 (85%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R+Y++QI+ G  YLH +++IHRDLKLGNLFL+++  VKI
Sbjct: 100 RRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 158
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA ++E+DG+RK+
Sbjct: 159 GDFGLATKVEYDGERKK 175

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  220 bits (560), Expect = 9e-58,   Method: Compositional matrix adjust.
 Identities = 120/238 (50%), Positives = 156/238 (65%), Gaps = 19/238 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL+      + +++P A+
Sbjct: 62  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEAR 118
Query: 61  ----PVIWVSKW-----VDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                ++   ++     V + D       LN+D   V   D      +      K  LCG
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCG 177
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRFDSVVPS 224
           +   AA++I+KML  DP  RP + +LL+ EFF + Y P  LP +CL   PRF S+ PS
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRF-SIAPS 294

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 47/77 (61%), Positives = 66/77 (85%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R+Y++QI+ G  YLH +++IHRDLKLGNLFL+++  VKI
Sbjct: 98  RRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 156
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA ++E+DG+RK+
Sbjct: 157 GDFGLATKVEYDGERKK 173

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  213 bits (543), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 118/232 (50%), Positives = 149/232 (64%), Gaps = 18/232 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           MS EIAIH+SL + +VVGFH FFED  FVY++LE+CR+RS++EL+      + +++P A 
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRR---KAVTEPEAR 145
Query: 60  -------QPVIWV-SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                  Q V ++ +  V + D       LNDD   V   D      +      K TLCG
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD-VKIGDFGLATKIEFDGERKKTLCG 204
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L K GHSFEVD+WS+GCI+YTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRF 218
           +   A+ +I++ML  DP  RP VA+LL  EFF + Y P  LP SCL   PRF
Sbjct: 265 INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPPRF 316

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 50/77 (64%), Positives = 68/77 (88%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R++M+Q ++GV YLH++++IHRDLKLGNLFL+D+  VKI
Sbjct: 125 RRRSLLELH-KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKI 183
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA +IEFDG+RK+
Sbjct: 184 GDFGLATKIEFDGERKK 200

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  211 bits (537), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 117/232 (50%), Positives = 148/232 (63%), Gaps = 18/232 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           MS EIAIH+SL + +VVGFH FFED  FVY++LE+CR+RS++EL+      + +++P A 
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRR---KAVTEPEAR 145
Query: 60  -------QPVIWV-SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                  Q V ++ +  V + D       LNDD   V   D      +      K  LCG
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD-VKIGDFGLATKIEFDGERKKXLCG 204
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L K GHSFEVD+WS+GCI+YTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRF 218
           +   A+ +I++ML  DP  RP VA+LL  EFF + Y P  LP SCL   PRF
Sbjct: 265 INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPPRF 316

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 50/77 (64%), Positives = 68/77 (88%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R++M+Q ++GV YLH++++IHRDLKLGNLFL+D+  VKI
Sbjct: 125 RRRSLLELH-KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKI 183
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA +IEFDG+RK+
Sbjct: 184 GDFGLATKIEFDGERKK 200

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  211 bits (537), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 117/232 (50%), Positives = 148/232 (63%), Gaps = 18/232 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           MS EIAIH+SL + +VVGFH FFED  FVY++LE+CR+RS++EL+      + +++P A 
Sbjct: 73  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRR---KAVTEPEAR 129
Query: 60  -------QPVIWV-SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                  Q V ++ +  V + D       LNDD   V   D      +      K  LCG
Sbjct: 130 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD-VKIGDFGLATKIEFDGERKKDLCG 188
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L K GHSFEVD+WS+GCI+YTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 189 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 248
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRF 218
           +   A+ +I++ML  DP  RP VA+LL  EFF + Y P  LP SCL   PRF
Sbjct: 249 INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPPRF 300

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 50/77 (64%), Positives = 68/77 (88%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R++M+Q ++GV YLH++++IHRDLKLGNLFL+D+  VKI
Sbjct: 109 RRRSLLELH-KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKI 167
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA +IEFDG+RK+
Sbjct: 168 GDFGLATKIEFDGERKK 184

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  211 bits (537), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 117/232 (50%), Positives = 148/232 (63%), Gaps = 18/232 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           MS EIAIH+SL + +VVGFH FFED  FVY++LE+CR+RS++EL+      + +++P A 
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRR---KAVTEPEAR 145
Query: 60  -------QPVIWV-SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA----NKNTLCG 107
                  Q V ++ +  V + D       LNDD   V   D      +      K  LCG
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD-VKIGDFGLATKIEFDGERKKDLCG 204
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPAT 167
           TPNYIAPE+L K GHSFEVD+WS+GCI+YTLLVGKPPFETS LKETY RIKK EY +P  
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF-NDYCPTSLPASCLMTAPRF 218
           +   A+ +I++ML  DP  RP VA+LL  EFF + Y P  LP SCL   PRF
Sbjct: 265 INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPPRF 316

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 50/77 (64%), Positives = 68/77 (88%), Gaps = 1/77 (1%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           RR+ L+E + KRRKA+TEPE R++M+Q ++GV YLH++++IHRDLKLGNLFL+D+  VKI
Sbjct: 125 RRRSLLELH-KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKI 183
Query: 289 GDFGLAARIEFDGQRKR 305
           GDFGLA +IEFDG+RK+
Sbjct: 184 GDFGLATKIEFDGERKK 200

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 116/222 (52%), Gaps = 34/222 (15%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  E+ IH  LKH +++  +++FEDS +VY++LE+C    M     +   ++  S+  A+
Sbjct: 58  VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEAR 115
Query: 61  PVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN----------------- 103
             +       +    G  Y     S G++  DLT   +L  +N                 
Sbjct: 116 HFM-------HQIITGMLYL---HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165
Query: 104 -----TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK 158
                TLCGTPNYI+PEI  ++ H  E DVWS+GC+ YTLL+G+PPF+T T+K T +++ 
Sbjct: 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225
Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
             +Y++P+ L   A  +I ++L  +P  R  ++ +L   F +
Sbjct: 226 LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 33/67 (49%), Positives = 43/67 (64%), Gaps = 1/67 (1%)
Query: 234 MERNSKRR-KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           M R  K R K  +E E R +M QI+ G+ YLH H I+HRDL L NL L+ N  +KI DFG
Sbjct: 98  MNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157
Query: 293 LAARIEF 299
           LA +++ 
Sbjct: 158 LATQLKM 164

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 21/229 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE------M 54
           + +EI I   L H N++  +++F D + +Y+ILE   +  + +    +C  +E      M
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM 129
Query: 55  SDPAAQPVIWVSKWVDYSD--------KYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC 106
            + A   +    K V + D              ++ D    V    L R        T+C
Sbjct: 130 EELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR-------KTMC 182
Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GT +Y+ PE++    H+ +VD+W IG + Y LLVG PPFE+++  ETY RI KV+ K PA
Sbjct: 183 GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPA 242
Query: 167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTA 215
           ++   A  +I K+L  +P +R P+AQ+    +        LP S L + 
Sbjct: 243 SVPTGAQDLISKLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQSV 291

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 115/222 (51%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + ++TLCGT 
Sbjct: 116 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRDTLCGTL 171
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 231
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 232 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 271

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 98  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 113/222 (50%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 120 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE +    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 235
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 236 EGARDLISRLLKHNPSQRPXLREVLEHPWIT--ANSSKPSNC 275

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 15/221 (6%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANKNTLCGTPN 110
            E+++  +      SK V + D       L       + N   +     + + TLCGT +
Sbjct: 117 TELANALS---YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLD 173
Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + +
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 233
Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
            A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 234 GARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 272

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 18/49 (36%), Positives = 28/49 (57%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI +FG +
Sbjct: 109 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS 157

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 114/222 (51%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 72  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 131
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 132 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 187
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 247
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 248 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 287

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 124 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 172

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 114/222 (51%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 118 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 173
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 233
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 273

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 100 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 114/222 (51%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 115 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 170
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 230
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 270

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 97  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 114/222 (51%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 120 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 235
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 236 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 275

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 114/222 (51%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 120 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 235
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 236 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 275

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 114/222 (51%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 141 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 196
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 256
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 257 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 296

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 133 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 114/222 (51%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + ++ LCGT 
Sbjct: 141 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRDDLCGTL 196
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 256
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 257 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 296

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 123 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANKNTLCGTPN 110
            E+++  +      SK V + D       L       + N   +     + + TLCGT +
Sbjct: 118 TELANALS---YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLD 174
Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + +
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 171 PAATMIKKMLLLDPVQRPPVAQLL 194
            A  +I ++L  +P QRP + ++L
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVL 258

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 19/59 (32%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI +FG +
Sbjct: 100 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS 158

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 107/205 (52%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 54  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 113
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 114 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 169
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 229
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 230 EGARDLISRLLKHNPSQRPMLREVL 254

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 96  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 154

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 107/205 (52%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 52  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 111
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 112 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 167
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 227
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 228 EGARDLISRLLKHNPSQRPMLREVL 252

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/57 (35%), Positives = 30/57 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG
Sbjct: 94  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 150

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 107/205 (52%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 118 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 173
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 233
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 100 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 107/205 (52%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 118
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + + TLCGT 
Sbjct: 119 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTL 174
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 234
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 235 EGARDLISRLLKHNPSQRPMLREVL 259

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/57 (35%), Positives = 30/57 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG
Sbjct: 101 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 157

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 115 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTELCGTL 170
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 230
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 270

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 97  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 116 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTL 171
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 231
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 232 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 271

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 98  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 115 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTL 170
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 230
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 270

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 97  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 120 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTL 175
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 235
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 236 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 275

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 102 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 117 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRXXLCGTL 172
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 232
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 233 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 272

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 99  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 118 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRAALCGTL 173
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 233
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 273

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/57 (35%), Positives = 30/57 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG
Sbjct: 100 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 115 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTL 170
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 230
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 270

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/57 (35%), Positives = 30/57 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG
Sbjct: 97  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + ++ LCGT 
Sbjct: 118 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRDDLCGTL 173
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 233
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 100 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 115 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTXLCGTL 170
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 230
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 97  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 115 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRAALCGTL 170
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 230
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/57 (35%), Positives = 30/57 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG
Sbjct: 97  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 115 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRXXLCGTL 170
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 230
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 97  RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 118 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRXXLCGTL 173
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 233
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 100 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F DS  VY+ILE           +K S  +   +A  +
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  LCGT 
Sbjct: 115 TELANALS---YCHSKKVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRAALCGTL 170
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T ++TY RI +VE+  P  + 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVT 230
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +P QRP + ++L
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/57 (36%), Positives = 30/57 (52%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           R  ++     E  T  Y+ ++   +SY H  K+IHRD+K  NL L     +KI DFG
Sbjct: 97  RELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 112/222 (50%), Gaps = 17/222 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L   +  +   D    +    + +  L GT 
Sbjct: 120 TELANALS---YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRXXLXGTL 175
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + 
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 235
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           + A  +I ++L  +P QRP + ++L   +      +S P++C
Sbjct: 236 EGARDLISRLLKHNPSQRPMLREVLEHPWIT--ANSSKPSNC 275

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 52  EEMSDPAAQPVIWVSKWVDYSD------KYGFGYQLNDDSSGVMFNDLTRMIMLANKNTL 105
            E+++  +      SK V + D        G   +L     G   +  +     + + TL
Sbjct: 116 TELANALS---YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPS-----SRRTTL 167
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
            GT +Y+ PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P
Sbjct: 168 SGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 227
Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
             + + A  +I ++L  +P QRP + ++L
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L  +   +   D    +    + ++TLCGT 
Sbjct: 119 TELANALS---YCHSKRVIHRDIKPENLLLGSNGE-LKIADFGWSVHAPSSRRDTLCGTL 174
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVG PPFE  T +ETY RI +VE+  P  + 
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVT 234
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +  QR  +A++L
Sbjct: 235 EGARDLISRLLKHNASQRLTLAEVL 259

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 20/50 (40%), Positives = 29/50 (58%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L  N  +KI DFG + 
Sbjct: 111 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSV 160

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +E+ I   L+H N++  + +F D+  VY+ILE           +K S  +   +A  +
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML--ANKNTLCGTP 109
            E+++  +      SK V + D       L  +   +   D    +    + + TLCGT 
Sbjct: 119 TELANALS---YCHSKRVIHRDIKPENLLLGSNGE-LKIADFGWSVHAPSSRRTTLCGTL 174
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +Y+ PE++    H  +VD+WS+G + Y  LVG PPFE  T +ETY RI +VE+  P  + 
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVT 234
Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL 194
           + A  +I ++L  +  QR  +A++L
Sbjct: 235 EGARDLISRLLKHNASQRLTLAEVL 259

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 20/50 (40%), Positives = 29/50 (58%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           E  T  Y+ ++   +SY H  ++IHRD+K  NL L  N  +KI DFG + 
Sbjct: 111 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSV 160

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EIA+ R +KH N+V     +E    +Y++++L    S  EL++   +    ++  A 
Sbjct: 67  IENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLV---SGGELFDRIVEKGFYTEKDAS 123
Query: 61  PVI-WVSKWVDYSDKYGFG----------YQLNDDSSGVMFNDLTRMIMLANKN---TLC 106
            +I  V   V Y  + G            Y   D+ S +M +D     M    +   T C
Sbjct: 124 TLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTAC 183
Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GTP Y+APE+L +  +S  VD WSIG I Y LL G PPF      + + +I K EY+  +
Sbjct: 184 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDS 243
Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQ 192
                +   A   I+ ++  DP +R    Q
Sbjct: 244 PYWDDISDSAKDFIRNLMEKDPNKRYTCEQ 273

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +EI I   L+H N++  +++F D K +Y++LE           +K    +   SA  +
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 121
Query: 52  EEMSDP----AAQPVIWVS-KWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC 106
           EE++D       + VI    K  +    Y    ++ D    V    L R  M       C
Sbjct: 122 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM-------C 174
Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GT +Y+ PE++    H  +VD+W  G + Y  LVG PPF++ +  ET+ RI  V+ K P 
Sbjct: 175 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 234
Query: 167 TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            L   +  +I K+L   P QR P+  ++
Sbjct: 235 FLSDGSKDLISKLLRYHPPQRLPLKGVM 262

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC---------RKRSMMELYNSACDL 51
           + +EI I   L+H N++  +++F D K +Y++LE           +K    +   SA  +
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 52  EEMSDP----AAQPVIWVS-KWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC 106
           EE++D       + VI    K  +    Y    ++ D    V    L R  M       C
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM-------C 173
Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GT +Y+ PE++    H  +VD+W  G + Y  LVG PPF++ +  ET+ RI  V+ K P 
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233
Query: 167 TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            L   +  +I K+L   P QR P+  ++
Sbjct: 234 FLSDGSKDLISKLLRYHPPQRLPLKGVM 261

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 28/259 (10%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA--Q 60
           +E+ I + L H N+V      E  K +Y+++E      + +   +   ++E    A   Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 61  PVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANK-NTLCGTPNYIAP 114
            V  V     K++ + D       L+ D +  + +   +      NK +T CG+P Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 115 EILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           E+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  +     
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFN------DYCPTSLPASCLMTAPRFDSVVPSFNS 227
            ++KK L+L+P +R  + Q++   + N      +  P   P             +P +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVAP-------------LPDYKD 288
Query: 228 PRRKPLMERNSKRRKAITE 246
           PRR  LM      R+ I +
Sbjct: 289 PRRTELMVSMGYTREEIQD 307

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/56 (41%), Positives = 30/56 (53%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + E E R   +QI+  V Y H   I+HRDLK  NL L  +  +KI DFG +    F
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF 165

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EIA+ + +KH N+V     +E +   Y++++L    S  EL++   +    ++  A 
Sbjct: 53  LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV---SGGELFDRILERGVYTEKDAS 109
Query: 61  PVIW-VSKWVDYSDKYGFG----------YQLNDDSSGVMFND--LTRMIMLANKNTLCG 107
            VI  V   V Y  + G            Y   +++S +M  D  L++M      +T CG
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG 169
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA- 166
           TP Y+APE+L +  +S  VD WSIG I Y LL G PPF   T  + + +IK+  Y+  + 
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP 229
Query: 167 ---TLKKPAATMIKKMLLLDPVQR 187
               + + A   I  +L  DP +R
Sbjct: 230 FWDDISESAKDFICHLLEKDPNER 253

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/65 (38%), Positives = 38/65 (58%), Gaps = 4/65 (6%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAAR 296
            R   TE +    ++Q+L  V YLH++ I+HRDLK  NL      +N  + I DFGL ++
Sbjct: 99  ERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL-SK 157
Query: 297 IEFDG 301
           +E +G
Sbjct: 158 MEQNG 162

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 28/259 (10%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA--Q 60
           +E+ I + L H N+V      E  K +Y+++E      + +   +   ++E    A   Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 61  PVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANK-NTLCGTPNYIAP 114
            V  V     K++ + D       L+ D +  + +   +      NK +T CG+P Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 115 EILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           E+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  +     
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFN------DYCPTSLPASCLMTAPRFDSVVPSFNS 227
            ++KK L+L+P +R  + Q++   + N      +  P   P             +P +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEP-------------LPDYKD 288
Query: 228 PRRKPLMERNSKRRKAITE 246
           PRR  LM      R+ I +
Sbjct: 289 PRRTELMVSMGYTREEIQD 307

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/56 (41%), Positives = 30/56 (53%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + E E R   +QI+  V Y H   I+HRDLK  NL L  +  +KI DFG +    F
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF 165

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 28/259 (10%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA--Q 60
           +E+ I + L H N+V      E  K +Y+++E      + +   +   ++E    A   Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 61  PVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANK-NTLCGTPNYIAP 114
            V  V     K++ + D       L+ D +  + +   +      NK +T CG+P Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 115 EILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           E+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  +     
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFN------DYCPTSLPASCLMTAPRFDSVVPSFNS 227
            ++KK L+L+P +R  + Q++   + N      +  P   P             +P +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEP-------------LPDYKD 288
Query: 228 PRRKPLMERNSKRRKAITE 246
           PRR  LM      R+ I +
Sbjct: 289 PRRTELMVSMGYTREEIQD 307

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/56 (41%), Positives = 30/56 (53%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + E E R   +QI+  V Y H   I+HRDLK  NL L  +  +KI DFG +    F
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF 165

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 28/259 (10%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA--Q 60
           +E+ I + L H N+V      E  K +Y+++E      + +   +   ++E    A   Q
Sbjct: 55  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ 114
Query: 61  PVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANK-NTLCGTPNYIAP 114
            V  V     K++ + D       L+ D +  + +   +      NK +T CG+P Y AP
Sbjct: 115 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 174
Query: 115 EILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           E+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  +     
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 234
Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFN------DYCPTSLPASCLMTAPRFDSVVPSFNS 227
            ++KK L+L+P +R  + Q++   + N      +  P   P             +P +  
Sbjct: 235 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEP-------------LPDYKD 281
Query: 228 PRRKPLMERNSKRRKAITE 246
           PRR  LM      R+ I +
Sbjct: 282 PRRTELMVSMGYTREEIQD 300

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/56 (41%), Positives = 30/56 (53%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + E E R   +QI+  V Y H   I+HRDLK  NL L  +  +KI DFG +    F
Sbjct: 103 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF 158

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           M  EIA+   +KH N+V     +E    +Y+I++L    S  EL++   +    ++  A 
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV---SGGELFDRIVEKGFYTERDAS 119
Query: 61  PVIW-VSKWVDYSDKYG-----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTL 105
            +I+ V   V Y    G             Y L++DS  +M +D  L++M    +  +T 
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPGSVLSTA 178
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
           CGTP Y+APE+L +  +S  VD WSIG I Y LL G PPF      + + +I K EY+  
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 238
Query: 166 A----TLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
           +     +   A   I+ ++  DP +R    Q L 
Sbjct: 239 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 32/53 (60%), Gaps = 3/53 (5%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLF---LSDNFVVKIGDFGLA 294
           TE +    + Q+L+ V YLHD  I+HRDLK  NL    L ++  + I DFGL+
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           M  EIA+   +KH N+V     +E    +Y+I++L    S  EL++   +    ++  A 
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV---SGGELFDRIVEKGFYTERDAS 119
Query: 61  PVIW-VSKWVDYSDKYG-----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTL 105
            +I+ V   V Y    G             Y L++DS  +M +D  L++M    +  +T 
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPGSVLSTA 178
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
           CGTP Y+APE+L +  +S  VD WSIG I Y LL G PPF      + + +I K EY+  
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 238
Query: 166 A----TLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
           +     +   A   I+ ++  DP +R    Q L 
Sbjct: 239 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 32/53 (60%), Gaps = 3/53 (5%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLF---LSDNFVVKIGDFGLA 294
           TE +    + Q+L+ V YLHD  I+HRDLK  NL    L ++  + I DFGL+
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           M  EIA+   +KH N+V     +E    +Y+I++L    S  EL++   +    ++  A 
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV---SGGELFDRIVEKGFYTERDAS 119
Query: 61  PVIW-VSKWVDYSDKYG-----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTL 105
            +I+ V   V Y    G             Y L++DS  +M +D  L++M    +  +T 
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPGSVLSTA 178
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
           CGTP Y+APE+L +  +S  VD WSIG I Y LL G PPF      + + +I K EY+  
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 238
Query: 166 A----TLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
           +     +   A   I+ ++  DP +R    Q L 
Sbjct: 239 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 32/53 (60%), Gaps = 3/53 (5%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLF---LSDNFVVKIGDFGLA 294
           TE +    + Q+L+ V YLHD  I+HRDLK  NL    L ++  + I DFGL+
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           M  EIA+   +KH N+V     +E    +Y+I++L    S  EL++   +    ++  A 
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV---SGGELFDRIVEKGFYTERDAS 119
Query: 61  PVIW-VSKWVDYSDKYG-----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTL 105
            +I+ V   V Y    G             Y L++DS  +M +D  L++M    +  +T 
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPGSVLSTA 178
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
           CGTP Y+APE+L +  +S  VD WSIG I Y LL G PPF      + + +I K EY+  
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 238
Query: 166 A----TLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
           +     +   A   I+ ++  DP +R    Q L 
Sbjct: 239 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 32/53 (60%), Gaps = 3/53 (5%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLF---LSDNFVVKIGDFGLA 294
           TE +    + Q+L+ V YLHD  I+HRDLK  NL    L ++  + I DFGL+
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS-DPAA 59
           + +E+ I R ++H N++  H  FE+   V +ILEL    S  EL++   + E ++ D A 
Sbjct: 55  IEREVNILREIRHPNIITLHDIFENKTDVVLILELV---SGGELFDFLAEKESLTEDEAT 111
Query: 60  QPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNT--------------- 104
           Q +  +   V Y       +          F+     IML +KN                
Sbjct: 112 QFLKQILDGVHYLHSKRIAH----------FDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 105 ---------LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                    + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET +
Sbjct: 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221
Query: 156 RIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            I  V Y       +   + A   I+++L+ DP +R  +AQ L
Sbjct: 222 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/62 (45%), Positives = 41/62 (66%), Gaps = 4/62 (6%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAAR 296
           ++++TE E   ++KQIL+GV YLH  +I H DLK  N+ L D  V    +K+ DFG+A +
Sbjct: 102 KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 297 IE 298
           IE
Sbjct: 162 IE 163

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS-DPAA 59
           + +E+ I R ++H N++  H  FE+   V +ILEL    S  EL++   + E ++ D A 
Sbjct: 76  IEREVNILREIRHPNIITLHDIFENKTDVVLILELV---SGGELFDFLAEKESLTEDEAT 132
Query: 60  QPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNT--------------- 104
           Q +  +   V Y       +          F+     IML +KN                
Sbjct: 133 QFLKQILDGVHYLHSKRIAH----------FDLKPENIMLLDKNVPNPRIKLIDFGIAHK 182
Query: 105 ---------LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                    + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET +
Sbjct: 183 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 242
Query: 156 RIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            I  V Y       +   + A   I+++L+ DP +R  +AQ L
Sbjct: 243 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSL 285

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/62 (45%), Positives = 41/62 (66%), Gaps = 4/62 (6%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAAR 296
           ++++TE E   ++KQIL+GV YLH  +I H DLK  N+ L D  V    +K+ DFG+A +
Sbjct: 123 KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 182
Query: 297 IE 298
           IE
Sbjct: 183 IE 184

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 115/259 (44%), Gaps = 28/259 (10%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA--Q 60
           +E+ I + L H N+V      E  K +Y+++E      + +   +   ++E    A   Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 61  PVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANK-NTLCGTPNYIAP 114
            V  V     K++ + D       L+ D +  + +   +      NK +  CG+P Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAP 181
Query: 115 EILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           E+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  +     
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFN------DYCPTSLPASCLMTAPRFDSVVPSFNS 227
            ++KK L+L+P +R  + Q++   + N      +  P   P             +P +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEP-------------LPDYKD 288
Query: 228 PRRKPLMERNSKRRKAITE 246
           PRR  LM      R+ I +
Sbjct: 289 PRRTELMVSMGYTREEIQD 307

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/56 (41%), Positives = 30/56 (53%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + E E R   +QI+  V Y H   I+HRDLK  NL L  +  +KI DFG +    F
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF 165

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 114/259 (44%), Gaps = 28/259 (10%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA--Q 60
           +E+ I + L H N+V      E  K +Y+++E      + +   +   ++E    A   Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 61  PVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANK-NTLCGTPNYIAP 114
            V  V     K++ + D       L+ D +  + +   +      NK +  CG P Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAP 181
Query: 115 EILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           E+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  +     
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241
Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFN------DYCPTSLPASCLMTAPRFDSVVPSFNS 227
            ++KK L+L+P +R  + Q++   + N      +  P   P             +P +  
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEP-------------LPDYKD 288
Query: 228 PRRKPLMERNSKRRKAITE 246
           PRR  LM      R+ I +
Sbjct: 289 PRRTELMVSMGYTREEIQD 307

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/56 (41%), Positives = 30/56 (53%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + E E R   +QI+  V Y H   I+HRDLK  NL L  +  +KI DFG +    F
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF 165

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS-DPAA 59
           + +E+ I R ++H N++  H  FE+   V +ILEL    S  EL++   + E ++ D A 
Sbjct: 62  IEREVNILREIRHPNIITLHDIFENKTDVVLILELV---SGGELFDFLAEKESLTEDEAT 118
Query: 60  QPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNT--------------- 104
           Q +  +   V Y       +          F+     IML +KN                
Sbjct: 119 QFLKQILDGVHYLHSKRIAH----------FDLKPENIMLLDKNVPNPRIKLIDFGIAHK 168
Query: 105 ---------LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                    + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET +
Sbjct: 169 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 228
Query: 156 RIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            I  V Y       +   + A   I+++L+ DP +R  +AQ L
Sbjct: 229 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSL 271

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/62 (45%), Positives = 41/62 (66%), Gaps = 4/62 (6%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAAR 296
           ++++TE E   ++KQIL+GV YLH  +I H DLK  N+ L D  V    +K+ DFG+A +
Sbjct: 109 KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 168
Query: 297 IE 298
           IE
Sbjct: 169 IE 170

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 81  LNDDSSGVMFNDLTRMIMLANKN---TLCGTPNYIAPEILNKNGHSF-EVDVWSIGCIMY 136
           L DD+  V   D     ++ + N   T CG+PNY APE++N   ++  EVDVWS G ++Y
Sbjct: 140 LLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLY 199
Query: 137 TLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF 196
            +LVG+ PF+   +   + ++    Y +P  L   A ++I++M++ DP+QR  + ++   
Sbjct: 200 VMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259
Query: 197 EFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQI 256
            +FN   P  L     +     DS + S        L E        I E        ++
Sbjct: 260 PWFNVNLPDYLRPMEEVQGSYADSRIVS-------KLGEAMGFSEDYIVEALRSDENNEV 312
Query: 257 LEGVSYLHDHKIIHRDLK 274
            E  + LH++++I   L+
Sbjct: 313 KEAYNLLHENQVIQEKLE 330

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 29/54 (53%), Positives = 37/54 (68%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +K +TE E R + +QI+  + Y H HKI+HRDLK  NL L DN  VKI DFGL+
Sbjct: 102 KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ I + L H N+V      E  K +Y+I+E     S  E+++       M +  A+  
Sbjct: 60  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA---SGGEVFDYLVAHGRMKEKEARSK 116
Query: 63  I-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDL---TRMIMLANKNTLCGTPNY 111
              +   V Y  +    ++       L D    +   D        +    +T CG+P Y
Sbjct: 117 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPY 176
Query: 112 IAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
            APE+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  +  
Sbjct: 177 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 236
Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               ++K+ L+L+P++R  + Q++   + N
Sbjct: 237 DCENLLKRFLVLNPIKRGTLEQIMKDRWIN 266

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 32/59 (54%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           + E E R   +QI+  V Y H  +I+HRDLK  NL L  +  +KI DFG +      G+
Sbjct: 108 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 166

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI+  R L+H +++  +   +    + +++E        EL++     ++MS+  A+
Sbjct: 51  IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEAR 106
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKN---TLCGTP 109
                +   V+Y  ++   ++       L D+   V   D     ++ + N   T CG+P
Sbjct: 107 RFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP 166
Query: 110 NYIAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           NY APE+++   ++  EVDVWS G I+Y +L  + PF+  ++   +  I    Y LP  L
Sbjct: 167 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFL 226
Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSL 207
              AA +IK+ML+++P+ R  + +++  ++F    P  L
Sbjct: 227 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYL 265

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/62 (48%), Positives = 40/62 (64%), Gaps = 1/62 (1%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +R  ++E E R + +QI+  V Y H HKI+HRDLK  NL L ++  VKI DFGL + I  
Sbjct: 96  QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMT 154
Query: 300 DG 301
           DG
Sbjct: 155 DG 156

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI+  R L+H +++  +   +    + +++E        EL++     ++MS+  A+
Sbjct: 55  IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEAR 110
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKN---TLCGTP 109
                +   V+Y  ++   ++       L D+   V   D     ++ + N   T CG+P
Sbjct: 111 RFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP 170
Query: 110 NYIAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           NY APE+++   ++  EVDVWS G I+Y +L  + PF+  ++   +  I    Y LP  L
Sbjct: 171 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFL 230
Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSL 207
              AA +IK+ML+++P+ R  + +++  ++F    P  L
Sbjct: 231 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYL 269

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/63 (47%), Positives = 40/63 (63%), Gaps = 1/63 (1%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +R  ++E E R + +QI+  V Y H HKI+HRDLK  NL L ++  VKI DFGL + I  
Sbjct: 100 QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMT 158
Query: 300 DGQ 302
           DG 
Sbjct: 159 DGN 161

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI+  R L+H +++  +   +    + +++E        EL++     ++MS+  A+
Sbjct: 61  IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEAR 116
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKN---TLCGTP 109
                +   V+Y  ++   ++       L D+   V   D     ++ + N   T CG+P
Sbjct: 117 RFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP 176
Query: 110 NYIAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           NY APE+++   ++  EVDVWS G I+Y +L  + PF+  ++   +  I    Y LP  L
Sbjct: 177 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFL 236
Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSL 207
              AA +IK+ML+++P+ R  + +++  ++F    P  L
Sbjct: 237 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYL 275

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/63 (47%), Positives = 40/63 (63%), Gaps = 1/63 (1%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +R  ++E E R + +QI+  V Y H HKI+HRDLK  NL L ++  VKI DFGL + I  
Sbjct: 106 QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMT 164
Query: 300 DGQ 302
           DG 
Sbjct: 165 DGN 167

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI+  R L+H +++  +   +    + +++E        EL++     ++MS+  A+
Sbjct: 60  IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEAR 115
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKN---TLCGTP 109
                +   V+Y  ++   ++       L D+   V   D     ++ + N   T CG+P
Sbjct: 116 RFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP 175
Query: 110 NYIAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           NY APE+++   ++  EVDVWS G I+Y +L  + PF+  ++   +  I    Y LP  L
Sbjct: 176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFL 235
Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSL 207
              AA +IK+ML+++P+ R  + +++  ++F    P  L
Sbjct: 236 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYL 274

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/63 (47%), Positives = 40/63 (63%), Gaps = 1/63 (1%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +R  ++E E R + +QI+  V Y H HKI+HRDLK  NL L ++  VKI DFGL + I  
Sbjct: 105 QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMT 163
Query: 300 DGQ 302
           DG 
Sbjct: 164 DGN 166

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 108/249 (43%), Gaps = 26/249 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E  I R LKH N+V  H    +  F Y++ +L    +  EL+      E  S+  A 
Sbjct: 50  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLV---TGGELFEDIVAREYYSEADAS 106
Query: 61  PVIW-VSKWVDYSDKYGFGYQ--------LNDDSSG--VMFNDLTRMIMLANKNT----L 105
             I  + + V++    G  ++        L   S G  V   D    I +          
Sbjct: 107 HCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGF 166
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
            GTP Y++PE+L K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   Y  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 226
Query: 166 A----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSV 221
           +    T+   A  +I KML ++P +R   ++ L   +    C  S  AS +      D  
Sbjct: 227 SPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI---CQRSTVASMMHRQETVD-C 282
Query: 222 VPSFNSPRR 230
           +  FN+ R+
Sbjct: 283 LKKFNARRK 291

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/65 (41%), Positives = 39/65 (60%), Gaps = 3/65 (4%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARI 297
           R+  +E +    ++QILE V++ H + I+HRDLK  NL L   S    VK+ DFGLA  +
Sbjct: 97  REYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV 156
Query: 298 EFDGQ 302
           + D Q
Sbjct: 157 QGDQQ 161

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 108/249 (43%), Gaps = 26/249 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E  I R LKH N+V  H    +  F Y++ +L    +  EL+      E  S+  A 
Sbjct: 50  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLV---TGGELFEDIVAREYYSEADAS 106
Query: 61  PVIW-VSKWVDYSDKYGFGYQ--------LNDDSSG--VMFNDLTRMIMLANKNT----L 105
             I  + + V++    G  ++        L   S G  V   D    I +          
Sbjct: 107 HCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGF 166
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
            GTP Y++PE+L K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   Y  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 226
Query: 166 A----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSV 221
           +    T+   A  +I KML ++P +R   ++ L   +    C  S  AS +      D  
Sbjct: 227 SPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI---CQRSTVASMMHRQETVD-C 282
Query: 222 VPSFNSPRR 230
           +  FN+ R+
Sbjct: 283 LKKFNARRK 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/65 (41%), Positives = 39/65 (60%), Gaps = 3/65 (4%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARI 297
           R+  +E +    ++QILE V++ H + I+HRDLK  NL L   S    VK+ DFGLA  +
Sbjct: 97  REYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV 156
Query: 298 EFDGQ 302
           + D Q
Sbjct: 157 QGDQQ 161

>pdb|1Q4K|B Chain B, The Polo-Box Domain Of Plk1 In Complex With A Phospho- Peptide Length = 259

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 37/67 (55%), Positives = 47/67 (70%), Gaps = 5/67 (7%)
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC----- 106
           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L      
Sbjct: 54  EEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERD 113
Query: 107 GTPNYIA 113
           GT +Y+ 
Sbjct: 114 GTESYLT 120

>pdb|2OGQ|A Chain A, Molecular And Structural Basis Of Plk1 Substrate Recognition: Implications In Centrosomal Localization Length = 239

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 37/67 (55%), Positives = 47/67 (70%), Gaps = 5/67 (7%)
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC----- 106
           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L      
Sbjct: 34  EEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERD 93
Query: 107 GTPNYIA 113
           GT +Y+ 
Sbjct: 94  GTESYLT 100

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 109/248 (43%), Gaps = 25/248 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E  I R L+H N+V  H   ++  F Y++ +L    +  EL+      E  S+  A 
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV---TGGELFEDIVAREFYSEADAS 131
Query: 61  PVIW-VSKWVDYSDKYGFGYQ--------LNDDSSG--VMFNDLTRMIMLANKNT---LC 106
             I  + + + Y    G  ++        L   + G  V   D    I + +        
Sbjct: 132 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 191
Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GTP Y++PE+L K+ +S  VD+W+ G I+Y LLVG PPF        Y++IK   Y  P+
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251
Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVV 222
               T+   A ++I  ML ++P +R    Q L   +    C     AS +      D  +
Sbjct: 252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI---CNRERVASAIHRQDTVD-CL 307
Query: 223 PSFNSPRR 230
             FN+ R+
Sbjct: 308 KKFNARRK 315

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARI 297
           R+  +E +    ++QILE ++Y H + I+HR+LK  NL L+       VK+ DFGLA  +
Sbjct: 122 REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181

>pdb|1UMW|A Chain A, Structure Of A Human Plk1 Polo-Box DomainPHOSPHOPEPTIDE Complex Length = 237

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 37/67 (55%), Positives = 47/67 (70%), Gaps = 5/67 (7%)
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC----- 106
           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L      
Sbjct: 32  EEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERD 91
Query: 107 GTPNYIA 113
           GT +Y+ 
Sbjct: 92  GTESYLT 98

>pdb|4H5X|B Chain B, Human Plk1-Pbd With A Glycerol Bound At The Phophopeptide Binding Site Length = 240

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 37/67 (55%), Positives = 47/67 (70%), Gaps = 5/67 (7%)
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC----- 106
           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L      
Sbjct: 35  EEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERD 94
Query: 107 GTPNYIA 113
           GT +Y+ 
Sbjct: 95  GTESYLT 101

>pdb|3FVH|A Chain A, Polo-Like Kinase 1 Polo Box Domain In Complex With Ac-Lhspta-Nh2 Peptide Length = 237

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 37/67 (55%), Positives = 47/67 (70%), Gaps = 5/67 (7%)
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC----- 106
           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L      
Sbjct: 32  EEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERD 91
Query: 107 GTPNYIA 113
           GT +Y+ 
Sbjct: 92  GTESYLT 98

>pdb|3C5L|A Chain A, Polo-Like Kinase 1 Polo Box Domain In Complex With Pphspt Peptide Length = 221

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 37/67 (55%), Positives = 47/67 (70%), Gaps = 5/67 (7%)
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC----- 106
           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L      
Sbjct: 26  EEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERD 85
Query: 107 GTPNYIA 113
           GT +Y+ 
Sbjct: 86  GTESYLT 92

>pdb|3HIH|A Chain A, Structure Of Human Plk1-pbd With Glycerol And Sulfate In The Phophopeptide Binding Site Length = 223

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 37/67 (55%), Positives = 47/67 (70%), Gaps = 5/67 (7%)
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC----- 106
           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L      
Sbjct: 28  EEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERD 87
Query: 107 GTPNYIA 113
           GT +Y+ 
Sbjct: 88  GTESYLT 94

>pdb|3P2W|A Chain A, Unliganded Form Of Polo-Like Kinase I Polo-Box Domain Length = 232

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 37/67 (55%), Positives = 47/67 (70%), Gaps = 5/67 (7%)
Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC----- 106
           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L      
Sbjct: 36  EEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERD 95
Query: 107 GTPNYIA 113
           GT +Y+ 
Sbjct: 96  GTESYLT 102

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E  I R L+H N+V  H   ++  F Y++ +L    +  EL+      E  S+  A 
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV---TGGELFEDIVAREFYSEADAS 108
Query: 61  PVIW-VSKWVDYSDKYGFGYQ--------LNDDSSG--VMFNDLTRMIMLANKNT---LC 106
             I  + + + Y    G  ++        L   + G  V   D    I + +        
Sbjct: 109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 168
Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GTP Y++PE+L K+ +S  VD+W+ G I+Y LLVG PPF        Y++IK   Y  P+
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228
Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
               T+   A ++I  ML ++P +R    Q L
Sbjct: 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 260

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARI 297
           R+  +E +    ++QILE ++Y H + I+HR+LK  NL L+       VK+ DFGLA  +
Sbjct: 99  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E  I R L+H N+V  H   ++  F Y++ +L    +  EL+      E  S+  A 
Sbjct: 51  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV---TGGELFEDIVAREFYSEADAS 107
Query: 61  PVIW-VSKWVDYSDKYGFGYQ--------LNDDSSG--VMFNDLTRMIMLANKNT---LC 106
             I  + + + Y    G  ++        L   + G  V   D    I + +        
Sbjct: 108 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 167
Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GTP Y++PE+L K+ +S  VD+W+ G I+Y LLVG PPF        Y++IK   Y  P+
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 227
Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
               T+   A ++I  ML ++P +R    Q L
Sbjct: 228 PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 259

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARI 297
           R+  +E +    ++QILE ++Y H + I+HR+LK  NL L+       VK+ DFGLA  +
Sbjct: 98  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 157

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E  I R L+H N+V  H   ++  F Y++ +L    +  EL+      E  S+  A 
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV---TGGELFEDIVAREFYSEADAS 108
Query: 61  PVIW-VSKWVDYSDKYGFGYQ--------LNDDSSG--VMFNDLTRMIMLANKNT---LC 106
             I  + + + Y    G  ++        L   + G  V   D    I + +        
Sbjct: 109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 168
Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GTP Y++PE+L K+ +S  VD+W+ G I+Y LLVG PPF        Y++IK   Y  P+
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228
Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
               T+   A ++I  ML ++P +R    Q L
Sbjct: 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 260

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARI 297
           R+  +E +    ++QILE ++Y H + I+HR+LK  NL L+       VK+ DFGLA  +
Sbjct: 99  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ I + L H N+V      E  K +Y+I+E     S  E+++       M +  A+  
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA---SGGEVFDYLVAHGRMKEKEARSK 119
Query: 63  I-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDL---TRMIMLANKNTLCGTPNY 111
              +   V Y  +    ++       L D    +   D        +    +  CG P Y
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 112 IAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
            APE+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  +  
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               ++K+ L+L+P++R  + Q++   + N
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 32/59 (54%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           + E E R   +QI+  V Y H  +I+HRDLK  NL L  +  +KI DFG +      G+
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 101/246 (41%), Gaps = 20/246 (8%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMME-----LYNSACDLEEMS 55
           + +E  I R LKH N+V  H    +  F Y++ +L     + E      Y S  D     
Sbjct: 50  LEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI 109
Query: 56  DPAAQPVIWVSKW-VDYSDKYGFGYQLNDDSSG--VMFNDLTRMIMLANKNT----LCGT 108
               + V+   +  V + D       L     G  V   D    I +           GT
Sbjct: 110 QQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
           P Y++PE+L K  +   VD+W+ G I+Y LLVG PPF      + Y +IK   Y  P+  
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPE 229
Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPS 224
             T+   A  +I +ML ++P +R    + L   +    C  S  AS +M        +  
Sbjct: 230 WDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV---CQRSTVAS-MMHRQETVECLKK 285
Query: 225 FNSPRR 230
           FN+ R+
Sbjct: 286 FNARRK 291

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/65 (38%), Positives = 37/65 (56%), Gaps = 3/65 (4%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARI 297
           R+  +E +    ++QILE V + H   ++HRDLK  NL L+       VK+ DFGLA  +
Sbjct: 97  REYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEV 156
Query: 298 EFDGQ 302
           + D Q
Sbjct: 157 QGDQQ 161

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 2   SQEIAIH-RSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           ++EI I  R  +H N++     ++D K+VY++ EL +     EL +     +  S+  A 
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG---ELLDKILRQKFFSEREAS 119
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSG----VMFNDLTRMIMLANKNTL--- 105
            V++ ++K V+Y    G  ++       L  D SG    +   D      L  +N L   
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 106 -CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS---TLKETYSRIKKVE 161
            C T N++APE+L + G+    D+WS+G ++YT+L G  PF      T +E  +RI   +
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
Query: 162 YKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           + L      ++   A  ++ KML +DP QR   A +L
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACD---------- 50
           +  EI + +SL H N++     FED   +YI++E C    ++E   SA            
Sbjct: 67  IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 51  LEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDS--SGVMFNDLTRMIML---ANKNTL 105
            E M         + S+ V + D         D S  S +   D     +     +    
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
            GT  Y+APE+  ++  +F+ D+WS G +MY LL G  PF  ++L+E     +K  YK P
Sbjct: 187 AGTALYMAPEVFKRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---QKATYKEP 242
Query: 166 ------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                   L   A  ++K+ML  DP +RP  AQ+LH E+F
Sbjct: 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 40/74 (54%), Gaps = 6/74 (8%)
Query: 233 LMER---NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVV 286
           L+ER      R KA++E      MKQ++  ++Y H   ++H+DLK  N+   D   +  +
Sbjct: 107 LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI 166
Query: 287 KIGDFGLAARIEFD 300
           KI DFGLA   + D
Sbjct: 167 KIIDFGLAELFKSD 180

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 125/282 (44%), Gaps = 39/282 (13%)
Query: 2   SQEIAIH-RSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           S+EI I  R  +H N++     ++D K VY++ EL R     EL +     +  S+  A 
Sbjct: 68  SEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGG---ELLDKILRQKFFSEREAS 124
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSG----VMFNDLTRMIMLANKNTL--- 105
            V+  + K V+Y    G  ++       L  D SG    +   D      L  +N L   
Sbjct: 125 FVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 106 -CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE---TSTLKETYSRIKKVE 161
            C T N++APE+L + G+    D+WS+G ++YT+L G  PF    + T +E  +RI   +
Sbjct: 185 PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 162 YKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCL----- 212
           + L      T+ + A  ++ KML +DP QR    Q+L   +        LP S L     
Sbjct: 245 FTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ--KDKLPQSQLSHQDL 302
Query: 213 -----MTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPET 249
                  A  + ++  S  +P+ KP+      +R+    P T
Sbjct: 303 QLVKGAMAATYSALNSSKPTPQLKPIESSILAQRRVRKLPST 344

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 4/62 (6%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF----VVKIGDFGLAA 295
           R+K  +E E  F +  I + V YLH   ++HRDLK  N+   D       ++I DFG A 
Sbjct: 114 RQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK 173
Query: 296 RI 297
           ++
Sbjct: 174 QL 175

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 29/283 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E  I R LKH N+V  H    +    Y+I +L    +  EL+      E  S+  A 
Sbjct: 57  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV---TGGELFEDIVAREYYSEADAS 113
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-LNDDS---------SGVMFNDLTRMIMLANKNT----L 105
             I  + + V +  + G  ++ L  ++         + V   D    I +  +       
Sbjct: 114 HCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
            GTP Y++PE+L K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   Y  P
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 233
Query: 166 A----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSV 221
           +    T+   A  +I KML ++P +R   A+ L   + +     S  ASC+      D  
Sbjct: 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH---RSTVASCMHRQETVD-C 289
Query: 222 VPSFNSPRR---KPLMERNSKRRKAITEPETRFYMKQILEGVS 261
           +  FN+ R+     L    + R  ++ + E     +Q++E +S
Sbjct: 290 LKKFNARRKLKGAILTVMLATRNFSVRKQEIIKVTEQLIEAIS 332

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 37/65 (56%), Gaps = 3/65 (4%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF---VVKIGDFGLAARI 297
           R+  +E +    ++QILE V + H   ++HR+LK  NL L+       VK+ DFGLA  +
Sbjct: 104 REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163
Query: 298 EFDGQ 302
           E + Q
Sbjct: 164 EGEQQ 168

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 103/246 (41%), Gaps = 20/246 (8%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMME-----LYNSACDLEEMS 55
           + +E  I R LKH N+V  H    +    Y+I +L     + E      Y S  D     
Sbjct: 68  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 127
Query: 56  DPAAQPVIWVSKW-VDYSDKYGFGYQLNDDSSG--VMFNDLTRMIMLANKNT----LCGT 108
               + V+   +  V + D       L     G  V   D    I +  +        GT
Sbjct: 128 QQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 187
Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
           P Y++PE+L K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   Y  P+  
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 247
Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPS 224
             T+   A  +I KML ++P +R   A+ L   + +     S  ASC+      D  +  
Sbjct: 248 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH---RSTVASCMHRQETVD-CLKK 303
Query: 225 FNSPRR 230
           FN+ R+
Sbjct: 304 FNARRK 309

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/65 (38%), Positives = 37/65 (56%), Gaps = 3/65 (4%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF---VVKIGDFGLAARI 297
           R+  +E +    ++QILE V + H   ++HRDLK  NL L+       VK+ DFGLA  +
Sbjct: 115 REYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEV 174
Query: 298 EFDGQ 302
           E + Q
Sbjct: 175 EGEQQ 179

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           QEI I +SL H N++  +  FED+  +Y+++ELC    + E         E SD AA+ +
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE-SD-AARIM 112
Query: 63  IWVSKWVDYSDKYGFGYQ---------LNDDSSG----VMFNDLTRMIMLANKNTLCGTP 109
             V   V Y  K    ++         L D        + F    R        T  GTP
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA--- 166
            Y++P++L +  +  E D WS G +MY LL G PPF   T  E   +I++  +  P    
Sbjct: 173 YYVSPQVL-EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDW 231
Query: 167 -TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
             +   A ++I+++L   P QR    Q L  E+F     +S
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 22/147 (14%)
Query: 155 SRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
           +RI++   K+P    +      +++ ++  +  P + +L  +E F D     L       
Sbjct: 33  TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL--YETFEDNTDIYLVMELCTG 90
Query: 215 APRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLK 274
              F+ VV                  ++   E +    MK +L  V+Y H   + HRDLK
Sbjct: 91  GELFERVV-----------------HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 275 LGN-LFLSD--NFVVKIGDFGLAARIE 298
             N LFL+D  +  +K+ DFGLAAR +
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFK 160

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           QEI I +SL H N++  +  FED+  +Y+++ELC    + E         E SD AA+ +
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE-SD-AARIM 129
Query: 63  IWVSKWVDYSDKYGFGYQ---------LNDDSSG----VMFNDLTRMIMLANKNTLCGTP 109
             V   V Y  K    ++         L D        + F    R        T  GTP
Sbjct: 130 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 189
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA--- 166
            Y++P++L +  +  E D WS G +MY LL G PPF   T  E   +I++  +  P    
Sbjct: 190 YYVSPQVL-EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDW 248
Query: 167 -TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
             +   A ++I+++L   P QR    Q L  E+F     +S
Sbjct: 249 LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 289

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 22/147 (14%)
Query: 155 SRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
           +RI++   K+P    +      +++ ++  +  P + +L  +E F D     L       
Sbjct: 50  TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL--YETFEDNTDIYLVMELCTG 107
Query: 215 APRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLK 274
              F+ VV                  ++   E +    MK +L  V+Y H   + HRDLK
Sbjct: 108 GELFERVV-----------------HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 150
Query: 275 LGN-LFLSD--NFVVKIGDFGLAARIE 298
             N LFL+D  +  +K+ DFGLAAR +
Sbjct: 151 PENFLFLTDSPDSPLKLIDFGLAARFK 177

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 109/249 (43%), Gaps = 26/249 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E  I R LKH N+V  H    +  F Y++ +L    +  EL+      E  S+  A 
Sbjct: 77  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLV---TGGELFEDIVAREYYSEADAS 133
Query: 61  PVI-WVSKWVDYSDKYGFGYQ--------LNDDSSG--VMFNDLTRMIMLANKNT----L 105
             I  + + V++  ++   ++        L     G  V   D    I +  +       
Sbjct: 134 HCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGF 193
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
            GTP Y++PE+L K+ +   VD+W+ G I+Y LLVG PPF      + Y +IK   Y  P
Sbjct: 194 AGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFP 253
Query: 166 A----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSV 221
           +    T+   A  +I +ML ++P +R    Q L   +    C  S  AS +M        
Sbjct: 254 SPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWV---CQRSTVAS-MMHRQETVEC 309
Query: 222 VPSFNSPRR 230
           +  FN+ R+
Sbjct: 310 LRKFNARRK 318

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/67 (41%), Positives = 41/67 (61%), Gaps = 5/67 (7%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARI 297
           R+  +E +    + QILE V+++H H I+HRDLK  NL L+       VK+ DFGLA  I
Sbjct: 124 REYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--I 181
Query: 298 EFDGQRK 304
           E  G+++
Sbjct: 182 EVQGEQQ 188

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   SQEIAIH-RSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           S+EI I  R  +H N++     ++D K VY++ EL R     EL +     +  S+  A 
Sbjct: 68  SEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGG---ELLDKILRQKFFSEREAS 124
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSG----VMFNDLTRMIMLANKNTL--- 105
            V+  + K V+Y    G  ++       L  D SG    +   D      L  +N L   
Sbjct: 125 FVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 106 -CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE---TSTLKETYSRIKKVE 161
            C T N++APE+L + G+    D+WS+G ++YT+L G  PF    + T +E  +RI   +
Sbjct: 185 PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 162 YKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
           + L      T+ + A  ++ KML +DP QR    Q+L 
Sbjct: 245 FTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQ 282

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 4/62 (6%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF----VVKIGDFGLAA 295
           R+K  +E E  F +  I + V YLH   ++HRDLK  N+   D       ++I DFG A 
Sbjct: 114 RQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK 173
Query: 296 RI 297
           ++
Sbjct: 174 QL 175

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA--Q 60
           +E+ I + L H N+V      E  K +Y++ E      + +   +    +E    A   Q
Sbjct: 62  REVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ 121
Query: 61  PVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANK-NTLCGTPNYIAP 114
            V  V     K++ + D       L+ D +  + +   +      NK +  CG P Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAP 181
Query: 115 EILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           E+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P        
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCE 241
Query: 174 TMIKKMLLLDPVQRPPVAQL 193
            ++KK L+L+P +R  + Q+
Sbjct: 242 NLLKKFLILNPSKRGTLEQI 261

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 29/54 (53%)
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           E E R   +QI+  V Y H   I+HRDLK  NL L  +  +KI DFG +    F
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTF 165

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+A+ + L H N++  + FFED +  Y+++E C K    EL++      + ++  A  +
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME-CYKGG--ELFDEIIHRMKFNEVDAAVI 141
Query: 63  I-WVSKWVDYSDKYGFGY----------QLNDDSSGVMFNDLTRMIMLANKNTL---CGT 108
           I  V   V Y  K+   +          +  +  + +   D     +  N+  +    GT
Sbjct: 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201
Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
             YIAPE+L K  +  + DVWSIG I++ LL G PPF   T +E   +++K +Y   +  
Sbjct: 202 AYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE 260
Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP 204
              + + A  +IK+ML  D  +R    Q L   +  + C 
Sbjct: 261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 24/135 (17%)
Query: 173 ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKP 232
           + +++++ +L  +  P + +L  ++FF D     L   C      FD ++          
Sbjct: 81  SKLLEEVAVLKLLDHPNIMKL--YDFFEDKRNYYLVMECYKGGELFDEII---------- 128
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIG 289
                   R    E +    +KQ+L GV+YLH H I+HRDLK  NL L     + ++KI 
Sbjct: 129 -------HRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181
Query: 290 DFGLAARIEFDGQRK 304
           DFGL+A   F+ Q+K
Sbjct: 182 DFGLSAV--FENQKK 194

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 61/105 (58%), Gaps = 1/105 (0%)
Query: 104 TLCGTPNYIAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           T CG+PNY APE+++   ++  EVD+WS G I+Y LL G  PF+   +   + +I+   +
Sbjct: 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF 228
Query: 163 KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSL 207
            +P  L +  AT++  ML +DP++R  +  +   E+F    P+ L
Sbjct: 229 YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 30/51 (58%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + E E R   +QIL  V Y H H ++HRDLK  N+ L  +   KI DFGL+
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 36/85 (42%), Positives = 52/85 (61%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           +T CGT  Y+APEIL ++GH+  VD WS+G +MY +L G PPF     K+T  +I K + 
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238
Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
            LP  L + A  ++KK+L  +   R
Sbjct: 239 NLPPYLTQEARDLLKKLLKRNAASR 263

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 23/63 (36%), Positives = 32/63 (50%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     E    FY+ +I   + +LH   II+RDLK  N+ L+    VK+ DFGL     
Sbjct: 113 EREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172
Query: 299 FDG 301
            DG
Sbjct: 173 HDG 175

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 51/268 (19%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I R + H NV+  H  +E+   V +ILEL    S  EL++     E +S+  A 
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELV---SGGELFDFLAQKESLSEEEAT 118
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN---------------- 103
             I  +   V+Y       +          F+     IML +KN                
Sbjct: 119 SFIKQILDGVNYLHTKKIAH----------FDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 104 --------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                    + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 156 RIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
            I  V Y       +   + A   I+K+L+ +  +R  + + L         P   P   
Sbjct: 229 NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH-------PWITPVDN 281
Query: 212 LMTAPRFDSVVPSFNSPRRKPLMERNSK 239
                R +SVV   N   RK  + R SK
Sbjct: 282 QQAMVRRESVVNLENF--RKQYVRRRSK 307

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/66 (45%), Positives = 44/66 (66%), Gaps = 5/66 (7%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
           ++++++E E   ++KQIL+GV+YLH  KI H DLK  N+ L D  +    +K+ DFGLA 
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 296 RIEFDG 301
            IE DG
Sbjct: 168 EIE-DG 172

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 108/268 (40%), Gaps = 51/268 (19%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I R + H NV+  H  +E+   V +ILEL    S  EL++     E +S+  A 
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELV---SGGELFDFLAQKESLSEEEAT 118
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN---------------- 103
             I  +   V+Y       +          F+     IML +KN                
Sbjct: 119 SFIKQILDGVNYLHTKKIAH----------FDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 104 --------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                    + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 156 RIKKVEYKLPATL----KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
            I  V Y           + A   I+K+L+ +  +R  + + L         P   P   
Sbjct: 229 NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH-------PWITPVDN 281
Query: 212 LMTAPRFDSVVPSFNSPRRKPLMERNSK 239
                R +SVV   N   RK  + R SK
Sbjct: 282 QQAMVRRESVVNLENF--RKQYVRRRSK 307

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/66 (45%), Positives = 44/66 (66%), Gaps = 5/66 (7%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
           ++++++E E   ++KQIL+GV+YLH  KI H DLK  N+ L D  +    +K+ DFGLA 
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 296 RIEFDG 301
            IE DG
Sbjct: 168 EIE-DG 172

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 1/103 (0%)
Query: 106 CGTPNYIAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           CG+PNY APE+++   ++  EVD+WS G I+Y LL G  PF+   +   + +I+   + +
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI 230
Query: 165 PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSL 207
           P  L +  AT++  ML +DP++R  +  +   E+F    P+ L
Sbjct: 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 30/51 (58%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + E E R   +QIL  V Y H H ++HRDLK  N+ L  +   KI DFGL+
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSAC----DLEEMSD 56
           + +EIA+H+ LKH+N+V +   F ++ F+ I +E     S+  L  S      D E+   
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 57  PAAQPVIWVSKWVD-----YSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN----TLCG 107
              + ++   K++      + D  G    +N  S  +  +D      LA  N    T  G
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG 185
Query: 108 TPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIK--KVEY 162
           T  Y+APEI++K   G+    D+WS+GC +  +  GKPPF E    +    ++   KV  
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245
Query: 163 KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           ++P ++   A   I K    DP +R     LL  EF 
Sbjct: 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 26/54 (48%), Positives = 38/54 (70%), Gaps = 1/54 (1%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-NFVVKIGDFGLAARI 297
            E    FY KQILEG+ YLHD++I+HRD+K  N+ ++  + V+KI DFG + R+
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSAC----DLEEMSD 56
           + +EIA+H+ LKH+N+V +   F ++ F+ I +E     S+  L  S      D E+   
Sbjct: 52  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 111
Query: 57  PAAQPVIWVSKWVD-----YSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN----TLCG 107
              + ++   K++      + D  G    +N  S  +  +D      LA  N    T  G
Sbjct: 112 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG 171
Query: 108 TPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIK--KVEY 162
           T  Y+APEI++K   G+    D+WS+GC +  +  GKPPF E    +    ++   KV  
Sbjct: 172 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 231
Query: 163 KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           ++P ++   A   I K    DP +R     LL  EF 
Sbjct: 232 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 26/54 (48%), Positives = 38/54 (70%), Gaps = 1/54 (1%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-NFVVKIGDFGLAARI 297
            E    FY KQILEG+ YLHD++I+HRD+K  N+ ++  + V+KI DFG + R+
Sbjct: 106 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 159

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 2   SQEIAIH-RSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           ++EI I  R  +H N++     ++D K+VY++ EL +     EL +     +  S+  A 
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKG---GELLDKILRQKFFSEREAS 119
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSG----VMFNDLTRMIMLANKNTL--- 105
            V++ ++K V+Y    G  ++       L  D SG    +   D      L  +N L   
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT 179
Query: 106 -CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS---TLKETYSRIKKVE 161
            C T N++APE+L + G+    D+WS+G ++YT L G  PF      T +E  +RI   +
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGK 239
Query: 162 YKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           + L      ++   A  ++ K L +DP QR   A +L
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVL 276

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 106/242 (43%), Gaps = 30/242 (12%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           + +EI  HRSL+H N+V F         + I++E     S  EL+   C+    S+  A 
Sbjct: 62  VKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA---SGGELFERICNAGRFSEDEAR 118
Query: 60  ---QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSG-----VMFNDLTRMIMLANKNT 104
              Q +I     V Y+      ++       L D S         F      ++ +   +
Sbjct: 119 FFFQQLI---SGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKS 175
Query: 105 LCGTPNYIAPEILNKNGHSFEV-DVWSIGCIMYTLLVGKPPFET----STLKETYSRIKK 159
             GTP YIAPE+L K  +  +V DVWS G  +Y +LVG  PFE        ++T  RI  
Sbjct: 176 AVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 160 VEYKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPR 217
           V+Y +P    +      +I ++ + DP +R  + ++ + E+F    P  L     MT  +
Sbjct: 236 VQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTT-Q 294
Query: 218 FD 219
           FD
Sbjct: 295 FD 296

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 2/50 (4%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGDFG 292
           +E E RF+ +Q++ GVSY H  ++ HRDLKL N  L  +    +KI DFG
Sbjct: 113 SEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFG 162

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 42/223 (18%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I R + H NV+  H  +E+   V +ILEL    S  EL++     E +S+  A 
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELV---SGGELFDFLAQKESLSEEEAT 118
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN---------------- 103
             I  +   V+Y       +          F+     IML +KN                
Sbjct: 119 SFIKQILDGVNYLHTKKIAH----------FDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 104 --------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                    + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 156 RIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            I  V Y       +   + A   I+K+L+ +  +R  + + L
Sbjct: 229 NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/66 (45%), Positives = 44/66 (66%), Gaps = 5/66 (7%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
           ++++++E E   ++KQIL+GV+YLH  KI H DLK  N+ L D  +    +K+ DFGLA 
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 296 RIEFDG 301
            IE DG
Sbjct: 168 EIE-DG 172

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 35/85 (41%), Positives = 51/85 (60%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           +  CGT  Y+APEIL ++GH+  VD WS+G +MY +L G PPF     K+T  +I K + 
Sbjct: 179 HXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238
Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
            LP  L + A  ++KK+L  +   R
Sbjct: 239 NLPPYLTQEARDLLKKLLKRNAASR 263

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 23/63 (36%), Positives = 32/63 (50%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     E    FY+ +I   + +LH   II+RDLK  N+ L+    VK+ DFGL     
Sbjct: 113 EREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172
Query: 299 FDG 301
            DG
Sbjct: 173 HDG 175

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I R + H NV+  H  +E+   V +ILEL    S  EL++     E +S+  A 
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELV---SGGELFDFLAQKESLSEEEAT 118
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN---------------- 103
             I  +   V+Y       +          F+     IML +KN                
Sbjct: 119 SFIKQILDGVNYLHTKKIAH----------FDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 104 --------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                    + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 156 RIKKVEYKLPATL----KKPAATMIKKMLLLDPVQRPPVAQLL 194
            I  V Y           + A   I+K+L+ +  +R  + + L
Sbjct: 229 NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEAL 271

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/66 (45%), Positives = 44/66 (66%), Gaps = 5/66 (7%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
           ++++++E E   ++KQIL+GV+YLH  KI H DLK  N+ L D  +    +K+ DFGLA 
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 296 RIEFDG 301
            IE DG
Sbjct: 168 EIE-DG 172

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I R + H NV+  H  +E+   V +ILEL    S  EL++     E +S+  A 
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELV---SGGELFDFLAQKESLSEEEAT 118
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN---------------- 103
             I  +   V+Y       +          F+     IML +KN                
Sbjct: 119 SFIKQILDGVNYLHTKKIAH----------FDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 104 --------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                    + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 156 RIKKVEYKLPATL----KKPAATMIKKMLLLDPVQRPPVAQLL 194
            I  V Y           + A   I+K+L+ +  +R  + + L
Sbjct: 229 NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEAL 271

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/66 (45%), Positives = 44/66 (66%), Gaps = 5/66 (7%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
           ++++++E E   ++KQIL+GV+YLH  KI H DLK  N+ L D  +    +K+ DFGLA 
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 296 RIEFDG 301
            IE DG
Sbjct: 168 EIE-DG 172

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/68 (45%), Positives = 43/68 (63%), Gaps = 4/68 (5%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAAR 296
           ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA +
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 297 IEFDGQRK 304
           I+F  + K
Sbjct: 168 IDFGNEFK 175

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 167 KIDFGNEFK 175

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 167 KIDFGNEFK 175

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 167 KIDFGNEFK 175

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/68 (45%), Positives = 43/68 (63%), Gaps = 4/68 (5%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAAR 296
           ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA +
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 297 IEFDGQRK 304
           I+F  + K
Sbjct: 168 IDFGNEFK 175

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/68 (45%), Positives = 43/68 (63%), Gaps = 4/68 (5%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAAR 296
           ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA +
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 297 IEFDGQRK 304
           I+F  + K
Sbjct: 168 IDFGNEFK 175

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 9/207 (4%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA--Q 60
           +E+ I + L H N+V      E  K +Y+++E      + +   +   ++E    A   Q
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 61  PVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANK-NTLCGTPNYIAP 114
            V  V     K++ + D       L+ D +  + +   +    + NK +T CG+P Y AP
Sbjct: 123 IVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAP 182
Query: 115 EILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           E+     +   EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  +     
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 242
Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
            ++KK+L+L+P++R  + Q++   + N
Sbjct: 243 NLLKKLLVLNPIKRGSLEQIMKDRWMN 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + E E R   +QI+  V Y H   I+HRDLK  NL L  +  +KI DFG +
Sbjct: 111 MKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFS 161

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 167 KIDFGNEFK 175

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 167 KIDFGNEFK 175

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 116
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 117 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 106 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 166 KIDFGNEFK 174

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 116
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 117 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 106 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 166 KIDFGNEFK 174

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 167 KIDFGNEFK 175

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 167 KIDFGNEFK 175

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/68 (45%), Positives = 43/68 (63%), Gaps = 4/68 (5%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAAR 296
           ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA +
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 297 IEFDGQRK 304
           I+F  + K
Sbjct: 168 IDFGNEFK 175

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 105/256 (41%), Gaps = 59/256 (23%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I R + H N++  H  +E+   V +ILEL    S  EL++     E +S+  A 
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELV---SGGELFDFLAQKESLSEEEAT 118
Query: 61  PVI-WVSKWVDYS------------------DK-----------YGFGYQLNDDSSGVMF 90
             I  +   V+Y                   DK           +G  +++ D   GV F
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEF 175
Query: 91  NDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL 150
            ++             GTP ++APEI+N      E D+WSIG I Y LL G  PF   T 
Sbjct: 176 KNI------------FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223
Query: 151 KETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
           +ET + I  V Y       +   + A   I+K+L+ +  +R  + + L         P  
Sbjct: 224 QETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH-------PWI 276
Query: 207 LPASCLMTAPRFDSVV 222
            P        R +SVV
Sbjct: 277 TPVDTQQAMVRRESVV 292

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/66 (45%), Positives = 44/66 (66%), Gaps = 5/66 (7%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
           ++++++E E   ++KQIL+GV+YLH  KI H DLK  N+ L D  +    +K+ DFGLA 
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 296 RIEFDG 301
            IE DG
Sbjct: 168 EIE-DG 172

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 30/242 (12%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           + +EI  HRSL+H N+V F         + I++E     S  EL+   C+    S+  A 
Sbjct: 62  VKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA---SGGELFERICNAGRFSEDEAR 118
Query: 60  ---QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSG-----VMFNDLTRMIMLANKNT 104
              Q +I     V Y       ++       L D S         F      ++ +   +
Sbjct: 119 FFFQQLI---SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKS 175
Query: 105 LCGTPNYIAPEILNKNGHSFEV-DVWSIGCIMYTLLVGKPPFET----STLKETYSRIKK 159
             GTP YIAPE+L K  +  +V DVWS G  +Y +LVG  PFE        ++T  RI  
Sbjct: 176 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 160 VEYKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPR 217
           V+Y +P    +      +I ++ + DP +R  + ++ + E+F    P  L     MT  +
Sbjct: 236 VQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTT-Q 294
Query: 218 FD 219
           FD
Sbjct: 295 FD 296

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 22/50 (44%), Positives = 31/50 (62%), Gaps = 2/50 (4%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGDFG 292
           +E E RF+ +Q++ GVSY H  ++ HRDLKL N  L  +    +KI  FG
Sbjct: 113 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFG 162

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 30/242 (12%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           + +EI  HRSL+H N+V F         + I++E     S  EL+   C+    S+  A 
Sbjct: 62  VKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA---SGGELFERICNAGRFSEDEAR 118
Query: 60  ---QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSG-----VMFNDLTRMIMLANKNT 104
              Q +I     V Y       ++       L D S         F      ++ +   +
Sbjct: 119 FFFQQLI---SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 175
Query: 105 LCGTPNYIAPEILNKNGHSFEV-DVWSIGCIMYTLLVGKPPFET----STLKETYSRIKK 159
             GTP YIAPE+L K  +  +V DVWS G  +Y +LVG  PFE        ++T  RI  
Sbjct: 176 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 160 VEYKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPR 217
           V+Y +P    +      +I ++ + DP +R  + ++ + E+F    P  L     MT  +
Sbjct: 236 VQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTT-Q 294
Query: 218 FD 219
           FD
Sbjct: 295 FD 296

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 2/50 (4%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGDFG 292
           +E E RF+ +Q++ GVSY H  ++ HRDLKL N  L  +    +KI DFG
Sbjct: 113 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 162

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 104/242 (42%), Gaps = 30/242 (12%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           + +EI  HRSL+H N+V F         + I++E     S  EL+   C+    S+  A 
Sbjct: 62  VKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA---SGGELFERICNAGRFSEDEAR 118
Query: 60  ---QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSG-----VMFNDLTRMIMLANKNT 104
              Q +I     V Y       ++       L D S         F      ++ +    
Sbjct: 119 FFFQQLI---SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKD 175
Query: 105 LCGTPNYIAPEILNKNGHSFEV-DVWSIGCIMYTLLVGKPPFET----STLKETYSRIKK 159
             GTP YIAPE+L K  +  +V DVWS G  +Y +LVG  PFE        ++T  RI  
Sbjct: 176 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 160 VEYKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPR 217
           V+Y +P    +      +I ++ + DP +R  + ++ + E+F    P  L     MT  +
Sbjct: 236 VQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTT-Q 294
Query: 218 FD 219
           FD
Sbjct: 295 FD 296

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 22/50 (44%), Positives = 31/50 (62%), Gaps = 2/50 (4%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGDFG 292
           +E E RF+ +Q++ GVSY H  ++ HRDLKL N  L  +    +KI  FG
Sbjct: 113 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFG 162

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 50/88 (56%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N+  GT  Y++PE+L +   S   D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 189 ARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 248
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 59/123 (47%), Gaps = 13/123 (10%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 192 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 251
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFD 219
           +EY  PA     A  +++K+L+LD  +R      L  E    Y P       L   P F+
Sbjct: 252 LEYDFPAAFFPKARDLVEKLLVLDATKR------LGCEEMEGYGP-------LKAHPFFE 298
Query: 220 SVV 222
           SV 
Sbjct: 299 SVT 301

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 137 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 193

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+A+ + L H N++  + FFED +  Y+++E+ R     EL++     ++ S+  A  ++
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG---ELFDEIILRQKFSEVDAAVIM 127
Query: 64  -WVSKWVDYSDKYGFGYQ--------LNDDSSGVMFN----DLTRMIMLANK-NTLCGTP 109
             V     Y  K+   ++        L   S   +       L+    +  K     GT 
Sbjct: 128 KQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTA 187
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP---- 165
            YIAPE+L K  +  + DVWS G I+Y LL G PPF   T +E   R++K ++       
Sbjct: 188 YYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDW 246
Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC 203
             +   A  ++K ML  +P +R    + L+  +   +C
Sbjct: 247 TQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKFC 284

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 22/152 (14%)
Query: 156 RIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTA 215
           R  K+  K   T    +  ++ ++ +L  +  P + +L  +EFF D     L        
Sbjct: 49  RAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL--YEFFEDKRNYYLVMEVYRGG 106
Query: 216 PRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKL 275
             FD ++                  R+  +E +    MKQ+L G +YLH H I+HRDLK 
Sbjct: 107 ELFDEII-----------------LRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKP 149
Query: 276 GNLFL---SDNFVVKIGDFGLAARIEFDGQRK 304
            NL L   S + ++KI DFGL+A  E  G+ K
Sbjct: 150 ENLLLESKSRDALIKIVDFGLSAHFEVGGKMK 181

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 102/237 (43%), Gaps = 29/237 (12%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA- 59
           + +EI  HRSL+H N+V F         + I++E     S  EL+   C+    S+  A 
Sbjct: 61  VKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA---SGGELFERICNAGRFSEDEAR 117
Query: 60  ---QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSG-----VMFNDLTRMIMLANKNT 104
              Q +I     V Y       ++       L D S         F      ++ +   +
Sbjct: 118 FFFQQLI---SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 174
Query: 105 LCGTPNYIAPEILNKNGHSFEV-DVWSIGCIMYTLLVGKPPFET----STLKETYSRIKK 159
             GTP YIAPE+L K  +  +V DVWS G  +Y +LVG  PFE        ++T  RI  
Sbjct: 175 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 234
Query: 160 VEYKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
           V+Y +P    +      +I ++ + DP +R  + ++ + E+F    P  L     MT
Sbjct: 235 VQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMT 291

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 2/50 (4%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGDFG 292
           +E E RF+ +Q++ GVSY H  ++ HRDLKL N  L  +    +KI DFG
Sbjct: 112 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 161

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+A+ + L H N++  + FFED +  Y+++E+ R     EL++     ++ S+  A  ++
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG---ELFDEIILRQKFSEVDAAVIM 110
Query: 64  -WVSKWVDYSDKYGFGYQ--------LNDDSSGVMFN----DLTRMIMLANK-NTLCGTP 109
             V     Y  K+   ++        L   S   +       L+    +  K     GT 
Sbjct: 111 KQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTA 170
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP---- 165
            YIAPE+L K  +  + DVWS G I+Y LL G PPF   T +E   R++K ++       
Sbjct: 171 YYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDW 229
Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP 204
             +   A  ++K ML  +P +R    + L+  +   +C 
Sbjct: 230 TQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKFCS 268

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 156 RIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTA 215
           R  K+  K   T    +  ++ ++ +L  +  P + +L  +EFF D     L        
Sbjct: 32  RAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL--YEFFEDKRNYYLVMEVYRGG 89
Query: 216 PRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKL 275
             FD ++                  R+  +E +    MKQ+L G +YLH H I+HRDLK 
Sbjct: 90  ELFDEIIL-----------------RQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKP 132
Query: 276 GNLFL---SDNFVVKIGDFGLAARIEFDGQRKR 305
            NL L   S + ++KI DFGL+A  E  G+ K 
Sbjct: 133 ENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 165

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 48/84 (57%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           + CGT  Y+APE++N+ GHS   D WS G +M+ +L G  PF+    KET + I K +  
Sbjct: 189 SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG 248
Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
           +P  L   A ++++ +   +P  R
Sbjct: 249 MPQFLSTEAQSLLRALFKRNPANR 272

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 20/50 (40%), Positives = 33/50 (66%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           TE + +FY+ ++  G+ +LH   II+RDLK  N+ L +   +K+ DFGL+
Sbjct: 128 TEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 177

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E++I + ++H NV+  H  +E+   V +I EL    +  EL++   + E +++  A 
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILIGELV---AGGELFDFLAEKESLTEEEAT 117
Query: 61  PVI-WVSKWVDYSDKYGFGYQLNDDSSGVMFND--------------LTRMIMLANK-NT 104
             +  +   V Y       +  +     +M  D              L   I   N+   
Sbjct: 118 EFLKQILNGVYYLHSLQIAH-FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                +     A   I+++L+ DP +R  +   L 
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/69 (44%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIGDFGLAA 295
            ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI DFGLA 
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 296 RIEFDGQRK 304
           +I+F  + K
Sbjct: 167 KIDFGNEFK 175

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 47/88 (53%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A   T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I  
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 220 EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/62 (40%), Positives = 35/62 (56%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R +  TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFGL      
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 300 DG 301
           DG
Sbjct: 158 DG 159

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 47/88 (53%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A   T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I  
Sbjct: 163 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 222
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 223 EEIRFPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/62 (40%), Positives = 35/62 (56%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R +  TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFGL      
Sbjct: 101 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 160
Query: 300 DG 301
           DG
Sbjct: 161 DG 162

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 47/88 (53%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A   T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I  
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 220 EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/62 (40%), Positives = 35/62 (56%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R +  TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFGL      
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 300 DG 301
           DG
Sbjct: 158 DG 159

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A   T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     ++ +  I  
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 364 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 1/63 (1%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHK-IIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           R +  +E   RFY  +I+  + YLH  K +++RDLKL NL L  +  +KI DFGL     
Sbjct: 241 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300
Query: 299 FDG 301
            DG
Sbjct: 301 KDG 303

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A   T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     ++ +  I  
Sbjct: 307 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 366
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 367 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 1/63 (1%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHK-IIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           R +  +E   RFY  +I+  + YLH  K +++RDLKL NL L  +  +KI DFGL     
Sbjct: 244 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 303
Query: 299 FDG 301
            DG
Sbjct: 304 KDG 306

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 59/123 (47%), Gaps = 13/123 (10%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        +++I K
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK 248
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFD 219
           +EY  P      A  +++K+L+LD  +R      L  E    Y P       L   P F+
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKR------LGCEEMEGYGP-------LKAHPFFE 295
Query: 220 SVV 222
           SV 
Sbjct: 296 SVT 298

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 49/88 (55%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N+  GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 186 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 245
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 246 LEYDFPEKFFPKARDLVEKLLVLDATKR 273

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 131 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 187

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 59/123 (47%), Gaps = 13/123 (10%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        +++I K
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK 248
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFD 219
           +EY  P      A  +++K+L+LD  +R      L  E    Y P       L   P F+
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKR------LGCEEMEGYGP-------LKAHPFFE 295
Query: 220 SVV 222
           SV 
Sbjct: 296 SVT 298

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 49/88 (55%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N+  GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 190 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 249
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 250 LEYDFPEKFFPKARDLVEKLLVLDATKR 277

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 135 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 191

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF---------ETSTLKET 153
           +T CGTPNYIAPEIL    + F VD W++G +M+ ++ G+ PF         + +T    
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270
Query: 154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +  I + + ++P +L   AA+++K  L  DP +R
Sbjct: 271 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 210 SCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKII 269
           SC  T  R   V+   N      LM    ++RK + E   RFY  +I   ++YLH+  II
Sbjct: 120 SCFQTESRLFFVIEYVNG---GDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGII 175
Query: 270 HRDLKLGNLFLSDNFVVKIGDFGL 293
           +RDLKL N+ L     +K+ D+G+
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGM 199

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 53/95 (55%)
Query: 96  MIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
           M+  A  N  CGTP+YIAPEIL    ++  VD WS G ++Y +L+G+ PF     +E + 
Sbjct: 170 MLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 229
Query: 156 RIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV 190
            I+      P  L+K A  ++ K+ + +P +R  V
Sbjct: 230 SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 264

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           FY  +I+ G+ +LH   I++RDLKL N+ L  +  +KI DFG+ 
Sbjct: 123 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 166

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 186 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 245
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 246 LEYDFPEKFFPKARDLVEKLLVLDATKR 273

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 131 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 187

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 187 ARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 171 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 230
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 231 LEYDFPEKFFPKARDLVEKLLVLDATKR 258

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 116 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 172

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 53/95 (55%)
Query: 96  MIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
           M+  A  N  CGTP+YIAPEIL    ++  VD WS G ++Y +L+G+ PF     +E + 
Sbjct: 169 MLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
Query: 156 RIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV 190
            I+      P  L+K A  ++ K+ + +P +R  V
Sbjct: 229 SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 263

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           FY  +I+ G+ +LH   I++RDLKL N+ L  +  +KI DFG+ 
Sbjct: 122 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI   +  +H +++  +        +++++E     S  EL++  C    + +  ++
Sbjct: 63  IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV---SGGELFDYICKNGRLDEKESR 119
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKNTL---CGTP 109
            +   +   VDY  ++   ++       L D        D     M+++   L   CG+P
Sbjct: 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSP 179
Query: 110 NYIAPEILNKNGHSF-EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           NY APE+++   ++  EVD+WS G I+Y LL G  PF+   +   + +I    +  P  L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239
Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSL 207
                +++K ML +DP++R  +  +   E+F    P  L
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYL 278

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 24/51 (47%), Positives = 32/51 (62%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + E E+R   +QIL GV Y H H ++HRDLK  N+ L  +   KI DFGL+
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 187 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 194 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 253
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 254 LEYDFPEKFFPKARDLVEKLLVLDATKR 281

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 139 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 195

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 248
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 187 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 165 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 225 LEYDFPEKFFPKARDLVEKLLVLDATKR 252

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A     CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I  
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 220 EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/62 (40%), Positives = 35/62 (56%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R +  TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFGL      
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 300 DG 301
           DG
Sbjct: 158 DG 159

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 248
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 187 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATKR 274

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A     CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I  
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 224
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 225 EEIRFPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/62 (40%), Positives = 35/62 (56%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R +  TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFGL      
Sbjct: 103 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 162
Query: 300 DG 301
           DG
Sbjct: 163 DG 164

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 164 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 223
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 224 LEYDFPEKFFPKARDLVEKLLVLDATKR 251

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 109 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 165

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 48/84 (57%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           + CGT  Y+APE++N+ GH+   D WS G +M+ +L G  PF+    KET + I K +  
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG 244
Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
           +P  L   A ++++ +   +P  R
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/50 (38%), Positives = 32/50 (64%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           TE + +FY+ ++   + +LH   II+RDLK  N+ L +   +K+ DFGL+
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 48/84 (57%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           + CGT  Y+APE++N+ GH+   D WS G +M+ +L G  PF+    KET + I K +  
Sbjct: 186 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG 245
Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
           +P  L   A ++++ +   +P  R
Sbjct: 246 MPQFLSPEAQSLLRMLFKRNPANR 269

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/50 (38%), Positives = 32/50 (64%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           TE + +FY+ ++   + +LH   II+RDLK  N+ L +   +K+ DFGL+
Sbjct: 125 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 174

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 248
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKR 276

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 134 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A     CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I  
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 220 EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/62 (40%), Positives = 35/62 (56%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R +  TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFGL      
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 300 DG 301
           DG
Sbjct: 158 DG 159

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 166 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 225
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 226 LEYDFPEKFFPKARDLVEKLLVLDATKR 253

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 111 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 167

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A     CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I  
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 220 EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/62 (40%), Positives = 35/62 (56%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R +  TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFGL      
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 300 DG 301
           DG
Sbjct: 158 DG 159

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 190 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 249
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 250 LEYDFPEKFFPKARDLVEKLLVLDATKR 277

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 135 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 191

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 48/88 (54%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A  N   GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K
Sbjct: 167 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 226
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +EY  P      A  +++K+L+LD  +R
Sbjct: 227 LEYDFPEKFFPKARDLVEKLLVLDATKR 254

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 36/57 (63%)
Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  + ++ R
Sbjct: 112 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 168

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A     CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     ++ +  I  
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 224
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 225 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 1/63 (1%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHK-IIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           R +  +E   RFY  +I+  + YLH  K +++RDLKL NL L  +  +KI DFGL     
Sbjct: 102 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 161
Query: 299 FDG 301
            DG
Sbjct: 162 KDG 164

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A     CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     ++ +  I  
Sbjct: 164 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 223
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 224 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 1/63 (1%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHK-IIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           R +  +E   RFY  +I+  + YLH  K +++RDLKL NL L  +  +KI DFGL     
Sbjct: 101 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 160
Query: 299 FDG 301
            DG
Sbjct: 161 KDG 163

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 48/84 (57%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           + CGT  Y+APE++N+ GH+   D WS G +M+ +L G  PF+    KET + I K +  
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG 244
Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
           +P  L   A ++++ +   +P  R
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/50 (38%), Positives = 32/50 (64%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           TE + +FY+ ++   + +LH   II+RDLK  N+ L +   +K+ DFGL+
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           A     CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     ++ +  I  
Sbjct: 166 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 225
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E + P TL   A +++  +L  DP QR
Sbjct: 226 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 1/63 (1%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHK-IIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           R +  +E   RFY  +I+  + YLH  K +++RDLKL NL L  +  +KI DFGL     
Sbjct: 103 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 162
Query: 299 FDG 301
            DG
Sbjct: 163 KDG 165

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 99/239 (41%), Gaps = 50/239 (20%)
Query: 1   MSQEIAIHRSLKHRNVVGFHS--FFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA 58
           + +EI + R L+H+NV+      + E+ + +Y+++E C            C ++EM D  
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC-----------VCGMQEMLDSV 101
Query: 59  AQPVIWVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDLT-RMIMLANKNTL------- 105
            +      K       +G+  QL D      S G++  D+    ++L    TL       
Sbjct: 102 PE------KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGV 155
Query: 106 ------------C----GTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLLVGKPPFET 147
                       C    G+P +  PEI N       F+VD+WS G  +Y +  G  PFE 
Sbjct: 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
Query: 148 STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
             + + +  I K  Y +P     P + ++K ML  +P +R  + Q+    +F    P +
Sbjct: 216 DNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 22/55 (40%), Positives = 32/55 (58%), Gaps = 7/55 (12%)
Query: 247 PETRF-------YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           PE RF       Y  Q+++G+ YLH   I+H+D+K GNL L+    +KI   G+A
Sbjct: 102 PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 15/199 (7%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMM-ELYNSACDLEEMSDPAA 59
           MS+   + +++KH  +VG H  F+ +  +Y +L+      +   L    C LE  +   A
Sbjct: 86  MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 145
Query: 60  QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDL----TRMIMLANKNTLCGT 108
             +   +  + Y       Y+       L D    ++  D       +   +  +T CGT
Sbjct: 146 AEI---ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGT 202
Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
           P Y+APE+L+K  +   VD W +G ++Y +L G PPF +    E Y  I     +L   +
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI 262
Query: 169 KKPAATMIKKMLLLDPVQR 187
              A  +++ +L  D  +R
Sbjct: 263 TNSARHLLEGLLQKDRTKR 281

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 21/55 (38%), Positives = 30/55 (54%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +R +   EP  RFY  +I   + YLH   I++RDLK  N+ L     + + DFGL
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 185

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 23/227 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI  HRSL+H N+V F         + II+E     S  ELY   C+    S+  A+
Sbjct: 63  VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA---SGGELYERICNAGRFSEDEAR 119
Query: 61  PVIW-VSKWVDYSDKYGFGYQ-------LNDDSSG-----VMFNDLTRMIMLANKNTLCG 107
                +   V Y       ++       L D S         F      ++ +   +  G
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 108 TPNYIAPEILNKNGHSFEV-DVWSIGCIMYTLLVGKPPFET----STLKETYSRIKKVEY 162
           TP YIAPE+L +  +  ++ DVWS G  +Y +LVG  PFE        ++T  RI  V+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 163 KLPATLK--KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSL 207
            +P  ++       +I ++ + DP  R  + ++    +F    P  L
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADL 286

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/50 (50%), Positives = 32/50 (64%), Gaps = 2/50 (4%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGDFG 292
           +E E RF+ +Q+L GVSY H  +I HRDLKL N  L  +    +KI DFG
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG 163

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 42/229 (18%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            EI++ +SL H N++     FED K+ Y++ E      + E   +    +E    AA  +
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC--DAANIM 152
Query: 63  IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLT-RMIMLANKNTLC--------------- 106
             +   + Y  K+            ++  D+    I+L NKN+L                
Sbjct: 153 KQILSGICYLHKHN-----------IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 107 --------GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK 158
                   GT  YIAPE+L K  ++ + DVWS G IMY LL G PPF     ++   +++
Sbjct: 202 DYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC 203
           K +Y         +   A  +IK ML  D  +R    + L+  +   Y 
Sbjct: 261 KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 34/58 (58%), Gaps = 3/58 (5%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN---FVVKIGDFGLAA 295
           R    E +    MKQIL G+ YLH H I+HRD+K  N+ L +      +KI DFGL++
Sbjct: 140 RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF---------ETSTLKET 153
           +  CGTPNYIAPEIL    + F VD W++G +M+ ++ G+ PF         + +T    
Sbjct: 164 SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 223
Query: 154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +  I + + ++P +L   AA+++K  L  DP +R
Sbjct: 224 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 257

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 210 SCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKII 269
           SC  T  R   V+   N      LM    ++RK + E   RFY  +I   ++YLH+  II
Sbjct: 73  SCFQTESRLFFVIEYVNG---GDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGII 128
Query: 270 HRDLKLGNLFLSDNFVVKIGDFGL 293
           +RDLKL N+ L     +K+ D+G+
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGM 152

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF---------ETSTLKET 153
           +  CGTPNYIAPEIL    + F VD W++G +M+ ++ G+ PF         + +T    
Sbjct: 168 SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227
Query: 154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +  I + + ++P +L   AA+++K  L  DP +R
Sbjct: 228 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 210 SCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKII 269
           SC  T  R   V+   N      LM    ++RK + E   RFY  +I   ++YLH+  II
Sbjct: 77  SCFQTESRLFFVIEYVNG---GDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGII 132
Query: 270 HRDLKLGNLFLSDNFVVKIGDFGL 293
           +RDLKL N+ L     +K+ D+G+
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGM 156

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF---------ETSTLKET 153
           +  CGTPNYIAPEIL    + F VD W++G +M+ ++ G+ PF         + +T    
Sbjct: 179 SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 238
Query: 154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +  I + + ++P ++   AA+++K  L  DP +R
Sbjct: 239 FQVILEKQIRIPRSMSVKAASVLKSFLNKDPKER 272

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 210 SCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKII 269
           SC  T  R   V+   N      LM    ++RK + E   RFY  +I   ++YLH+  II
Sbjct: 88  SCFQTESRLFFVIEYVNG---GDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGII 143
Query: 270 HRDLKLGNLFLSDNFVVKIGDFGL 293
           +RDLKL N+ L     +K+ D+G+
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGM 167

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 69/122 (56%), Gaps = 13/122 (10%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET-------STLKETYSR 156
           T C T +Y APE+LN+NG+    D+WS+G I+YT+L G+ PF++       ++  E   +
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK 227
Query: 157 IKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCL 212
           IKK ++         + + A  +I+ +L +DP +R  ++ L + E+  D   + L ++ L
Sbjct: 228 IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD--GSQLSSNPL 285
Query: 213 MT 214
           MT
Sbjct: 286 MT 287

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/65 (41%), Positives = 41/65 (63%), Gaps = 4/65 (6%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIG 289
           L ER  K++K  +E E  + M++++  VS++HD  ++HRDLK  NL  +   DN  +KI 
Sbjct: 93  LFER-IKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKII 151
Query: 290 DFGLA 294
           DFG A
Sbjct: 152 DFGFA 156

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
            CGTP+YIAPEI+    +   VD W+ G ++Y +L G+PPF+     E +  I +     
Sbjct: 180 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY 239
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P +L K A ++ K ++   P +R
Sbjct: 240 PKSLSKEAVSICKGLMTKHPAKR 262

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 58/135 (42%), Gaps = 23/135 (17%)
Query: 173 ATMIKK--MLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRR 230
            TM++K  + LLD   +PP    LH              SC  T  R   V+   N    
Sbjct: 65  CTMVEKRVLALLD---KPPFLTQLH--------------SCFQTVDRLYFVMEYVNGGDL 107
Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
              +++  K      EP+  FY  +I  G+ +LH   II+RDLKL N+ L     +KI D
Sbjct: 108 MYHIQQVGK----FKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIAD 163
Query: 291 FGLAARIEFDGQRKR 305
           FG+      DG   R
Sbjct: 164 FGMCKEHMMDGVTTR 178

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPA 58
           +  E+ + R LKH N+V ++    D  +  +YI++E C    +  +        +  D  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 59  ------AQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----------- 101
                  Q  + + +    SD  G      D     +F D  + + L +           
Sbjct: 112 FVLRVMTQLTLALKECHRRSDG-GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 102 --KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
               T  GTP Y++PE +N+  ++ + D+WS+GC++Y L    PPF   + KE   +I++
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 160 VEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
            ++ ++P         +I +ML L    RP V ++L 
Sbjct: 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 37/73 (50%), Gaps = 5/73 (6%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLH-----DHKIIHRDLKLGNLFLSDNFVVK 287
           ++ + +K R+ + E      M Q+   +   H      H ++HRDLK  N+FL     VK
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156
Query: 288 IGDFGLAARIEFD 300
           +GDFGLA  +  D
Sbjct: 157 LGDFGLARILNHD 169

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 47/83 (56%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP+YIAPE+++   ++  +D WS G ++Y +L G  PF  S   +TY +I   E + 
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF 222
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P    +    ++ +++  D  QR
Sbjct: 223 PPFFNEDVKDLLSRLITRDLSQR 245

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 21/59 (35%), Positives = 32/59 (54%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           ++ +    P  +FY  ++   + YLH   II+RDLK  N+ L  N  +KI DFG A  +
Sbjct: 98  RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EI I + L H  ++   +FF D++  YI+LEL       EL++     + + +   +
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK 123
Query: 61  PVIW-VSKWVDYSDKYGFGYQ----------LNDDSSGVMFNDLTRMIMLANKN---TLC 106
              + +   V Y  + G  ++            ++   +   D     +L   +   TLC
Sbjct: 124 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 183
Query: 107 GTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEY 162
           GTP Y+APE+L      G++  VD WS+G I++  L G PPF E  T      +I   +Y
Sbjct: 184 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 243
Query: 163 ----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
               ++ A + + A  ++KK+L++DP  R    + L   +  D
Sbjct: 244 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 34/54 (62%), Gaps = 3/54 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFG 292
           K + E   + Y  Q+L  V YLH++ IIHRDLK  N+ LS   ++ ++KI DFG
Sbjct: 115 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 168

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EI I + L H  ++   +FF D++  YI+LEL       EL++     + + +   +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK 117
Query: 61  PVIW-VSKWVDYSDKYGFGYQ----------LNDDSSGVMFNDLTRMIMLANKN---TLC 106
              + +   V Y  + G  ++            ++   +   D     +L   +   TLC
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 107 GTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEY 162
           GTP Y+APE+L      G++  VD WS+G I++  L G PPF E  T      +I   +Y
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 163 ----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
               ++ A + + A  ++KK+L++DP  R    + L   +  D
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 34/54 (62%), Gaps = 3/54 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFG 292
           K + E   + Y  Q+L  V YLH++ IIHRDLK  N+ LS   ++ ++KI DFG
Sbjct: 109 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EI I + L H  ++   +FF D++  YI+LEL       EL++     + + +   +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK 117
Query: 61  PVIW-VSKWVDYSDKYGFGYQ----------LNDDSSGVMFNDLTRMIMLANKN---TLC 106
              + +   V Y  + G  ++            ++   +   D     +L   +   TLC
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 107 GTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEY 162
           GTP Y+APE+L      G++  VD WS+G I++  L G PPF E  T      +I   +Y
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 163 ----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
               ++ A + + A  ++KK+L++DP  R    + L   +  D
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 34/54 (62%), Gaps = 3/54 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFG 292
           K + E   + Y  Q+L  V YLH++ IIHRDLK  N+ LS   ++ ++KI DFG
Sbjct: 109 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EI I + L H  ++   +FF D++  YI+LEL       EL++     + + +   +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK 117
Query: 61  PVIW-VSKWVDYSDKYGFGYQ----------LNDDSSGVMFNDLTRMIMLANKN---TLC 106
              + +   V Y  + G  ++            ++   +   D     +L   +   TLC
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 107 GTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEY 162
           GTP Y+APE+L      G++  VD WS+G I++  L G PPF E  T      +I   +Y
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 163 ----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
               ++ A + + A  ++KK+L++DP  R    + L   +  D
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 34/54 (62%), Gaps = 3/54 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFG 292
           K + E   + Y  Q+L  V YLH++ IIHRDLK  N+ LS   ++ ++KI DFG
Sbjct: 109 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EI I + L H  ++   +FF D++  YI+LEL       EL++     + + +   +
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK 116
Query: 61  PVIW-VSKWVDYSDKYGFGYQ----------LNDDSSGVMFNDLTRMIMLANKN---TLC 106
              + +   V Y  + G  ++            ++   +   D     +L   +   TLC
Sbjct: 117 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 176
Query: 107 GTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEY 162
           GTP Y+APE+L      G++  VD WS+G I++  L G PPF E  T      +I   +Y
Sbjct: 177 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 236
Query: 163 ----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
               ++ A + + A  ++KK+L++DP  R    + L   +  D
Sbjct: 237 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 34/54 (62%), Gaps = 3/54 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFG 292
           K + E   + Y  Q+L  V YLH++ IIHRDLK  N+ LS   ++ ++KI DFG
Sbjct: 108 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 161

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EI I + L H  ++   +FF D++  YI+LEL       EL++     + + +   +
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK 256
Query: 61  PVIW-VSKWVDYSDKYGFGYQ----------LNDDSSGVMFNDLTRMIMLANKN---TLC 106
              + +   V Y  + G  ++            ++   +   D     +L   +   TLC
Sbjct: 257 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 316
Query: 107 GTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEY 162
           GTP Y+APE+L      G++  VD WS+G I++  L G PPF E  T      +I   +Y
Sbjct: 317 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 376
Query: 163 ----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
               ++ A + + A  ++KK+L++DP  R    + L   +  D
Sbjct: 377 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 142 KPPFETSTLKETYSRI-KKVEYKL-PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           K  FE  T K+   RI  K ++ +  A    PA  +  ++ +L  +  P + ++ +F   
Sbjct: 166 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 225
Query: 200 NDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEG 259
            DY    +    +     FD VV +                 K + E   + Y  Q+L  
Sbjct: 226 EDY---YIVLELMEGGELFDKVVGN-----------------KRLKEATCKLYFYQMLLA 265
Query: 260 VSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFG 292
           V YLH++ IIHRDLK  N+ LS   ++ ++KI DFG
Sbjct: 266 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 301

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EI I + L H  ++   +FF D++  YI+LEL       EL++     + + +   +
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK 242
Query: 61  PVIW-VSKWVDYSDKYGFGYQ----------LNDDSSGVMFNDLTRMIMLANKN---TLC 106
              + +   V Y  + G  ++            ++   +   D     +L   +   TLC
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302
Query: 107 GTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEY 162
           GTP Y+APE+L      G++  VD WS+G I++  L G PPF E  T      +I   +Y
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 163 ----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
               ++ A + + A  ++KK+L++DP  R    + L   +  D
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 142 KPPFETSTLKETYSRI-KKVEYKL-PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           K  FE  T K+   RI  K ++ +  A    PA  +  ++ +L  +  P + ++ +F   
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211
Query: 200 NDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEG 259
            DY    +    +     FD VV +                 K + E   + Y  Q+L  
Sbjct: 212 EDY---YIVLELMEGGELFDKVVGN-----------------KRLKEATCKLYFYQMLLA 251
Query: 260 VSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFG 292
           V YLH++ IIHRDLK  N+ LS   ++ ++KI DFG
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 45/84 (53%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           T CGTP+YIAPEIL +  +   VD W++G ++Y +L G  PFE     + +  I   E  
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 242
Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P  L + A  ++K  +  +P  R
Sbjct: 243 YPTWLHEDATGILKSFMTKNPTMR 266

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 40/84 (47%), Gaps = 4/84 (4%)
Query: 211 CLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIH 270
           C  T  R   V+   N      LM    K R+   E   RFY  +I+  + +LHD  II+
Sbjct: 92  CFQTPDRLFFVMEFVNG---GDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIY 147
Query: 271 RDLKLGNLFLSDNFVVKIGDFGLA 294
           RDLKL N+ L      K+ DFG+ 
Sbjct: 148 RDLKLDNVLLDHEGHCKLADFGMC 171

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 106/260 (40%), Gaps = 50/260 (19%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQP 61
           +E+ + + L H N++      EDS   YI+ EL    +  EL++     +  S+  AA+ 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELY---TGGELFDEIIKRKRFSEHDAARI 126
Query: 62  VIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLT-RMIMLANKNTLC-------------- 106
           +  V   + Y  K+            ++  DL    I+L +K   C              
Sbjct: 127 IKQVFSGITYMHKHN-----------IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 107 ---------GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
                    GT  YIAPE+L +  +  + DVWS G I+Y LL G PPF     K  Y  +
Sbjct: 176 QNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDIL 231
Query: 158 KKVE-----YKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPAS 210
           K+VE     + LP   T+   A  +I+KML   P  R    Q L   +   Y   +   S
Sbjct: 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTIS 291
Query: 211 CLMTAPRFDSVVPSFNSPRR 230
            L +     + +  F + ++
Sbjct: 292 DLPSLESAMTNIRQFQAEKK 311

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 29/165 (17%)
Query: 139 LVGKPPFETSTLKETYSRIKKVEYKLPATLK-----KPAATMIKKMLLLDPVQRPPVAQL 193
           ++GK  F    + +   RI + EY +    K     K  +T+++++ LL  +  P + +L
Sbjct: 29  MLGKGSF--GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 194 LHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYM 253
             FE   D     +          FD ++                 +RK  +E +    +
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEII-----------------KRKRFSEHDAARII 127
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAA 295
           KQ+  G++Y+H H I+HRDLK  N+ L     +  +KI DFGL+ 
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETY----SRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF ++T +        RI+
Sbjct: 168 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 227
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y  P    + + + A  +I+ +L  DP +R  + Q ++  + N      +P + L T
Sbjct: 228 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ--SMVVPQTPLHT 285
Query: 215 A 215
           A
Sbjct: 286 A 286

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/56 (39%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    M+ I   + +LH H I HRD+K  NL  +    + V+K+ DFG A
Sbjct: 104 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 159

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETY----SRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF ++T +        RI+
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y  P    + + + A  +I+ +L  DP +R  + Q ++  + N      +P + L T
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ--SMVVPQTPLHT 304
Query: 215 A 215
           A
Sbjct: 305 A 305

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/56 (39%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    M+ I   + +LH H I HRD+K  NL  +    + V+K+ DFG A
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPA 58
           +  E+ + R LKH N+V ++    D  +  +YI++E C    +  +        +  D  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 59  ------AQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----------- 101
                  Q  + + +    SD  G      D     +F D  + + L +           
Sbjct: 112 FVLRVMTQLTLALKECHRRSDG-GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 102 --KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
                  GTP Y++PE +N+  ++ + D+WS+GC++Y L    PPF   + KE   +I++
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 160 VEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
            ++ ++P         +I +ML L    RP V ++L 
Sbjct: 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 37/73 (50%), Gaps = 5/73 (6%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLH-----DHKIIHRDLKLGNLFLSDNFVVK 287
           ++ + +K R+ + E      M Q+   +   H      H ++HRDLK  N+FL     VK
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156
Query: 288 IGDFGLAARIEFD 300
           +GDFGLA  +  D
Sbjct: 157 LGDFGLARILNHD 169

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 21/220 (9%)
Query: 3   QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP---- 57
           +E+ I R +  H N++     +E + F +++ +L +K  + +       L E        
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 58  AAQPVIWVSKWVD--YSDKYGFGYQLNDDSSGVMFNDLTRMIML---ANKNTLCGTPNYI 112
           A   VI     ++  + D       L+DD + +   D      L       ++CGTP+Y+
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLRSVCGTPSYL 190
Query: 113 APEIL------NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           APEI+      N  G+  EVD+WS G IMYTLL G PPF           I    Y+  +
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                       ++ + L++ P +R    + L   FF  Y
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 22/56 (39%), Positives = 36/56 (64%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            ++E ETR  M+ +LE +  LH   I+HRDLK  N+ L D+  +K+ DFG + +++
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 50/232 (21%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQP 61
           +E+ + + L H N++      EDS   YI+ EL    +  EL++     +  S+  AA+ 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGEL---YTGGELFDEIIKRKRFSEHDAARI 126
Query: 62  VIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLT-RMIMLANKNTLC-------------- 106
           +  V   + Y  K+            ++  DL    I+L +K   C              
Sbjct: 127 IKQVFSGITYMHKHN-----------IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 107 ---------GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
                    GT  YIAPE+L +  +  + DVWS G I+Y LL G PPF     K  Y  +
Sbjct: 176 QNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDIL 231
Query: 158 KKVE-----YKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
           K+VE     + LP   T+   A  +I+KML   P  R    Q L   +   Y
Sbjct: 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 29/165 (17%)
Query: 139 LVGKPPFETSTLKETYSRIKKVEYKLPATLK-----KPAATMIKKMLLLDPVQRPPVAQL 193
           ++GK  F    + +   RI + EY +    K     K  +T+++++ LL  +  P + +L
Sbjct: 29  MLGKGSF--GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 194 LHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYM 253
             FE   D     +          FD ++                 +RK  +E +    +
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEII-----------------KRKRFSEHDAARII 127
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAA 295
           KQ+  G++Y+H H I+HRDLK  N+ L     +  +KI DFGL+ 
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 21/220 (9%)
Query: 3   QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP---- 57
           +E+ I R +  H N++     +E + F +++ +L +K  + +       L E        
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 58  AAQPVIWVSKWVD--YSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYI 112
           A   VI     ++  + D       L+DD + +   D      L     L   CGTP+Y+
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYL 190
Query: 113 APEIL------NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           APEI+      N  G+  EVD+WS G IMYTLL G PPF           I    Y+  +
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                       ++ + L++ P +R    + L   FF  Y
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 22/56 (39%), Positives = 36/56 (64%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            ++E ETR  M+ +LE +  LH   I+HRDLK  N+ L D+  +K+ DFG + +++
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPA 58
           +  E+ + R LKH N+V ++    D  +  +YI++E C    +  +        +  D  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 59  ------AQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----------- 101
                  Q  + + +    SD  G      D     +F D  + + L +           
Sbjct: 112 FVLRVMTQLTLALKECHRRSDG-GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE 170
Query: 102 --KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
                  GTP Y++PE +N+  ++ + D+WS+GC++Y L    PPF   + KE   +I++
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 160 VEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
            ++ ++P         +I +ML L    RP V ++L 
Sbjct: 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 37/73 (50%), Gaps = 5/73 (6%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLH-----DHKIIHRDLKLGNLFLSDNFVVK 287
           ++ + +K R+ + E      M Q+   +   H      H ++HRDLK  N+FL     VK
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156
Query: 288 IGDFGLAARIEFD 300
           +GDFGLA  +  D
Sbjct: 157 LGDFGLARILNHD 169

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 50/232 (21%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQP 61
           +E+ + + L H N++      EDS   YI+ EL    +  EL++     +  S+  AA+ 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGEL---YTGGELFDEIIKRKRFSEHDAARI 126
Query: 62  VIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLT-RMIMLANKNTLC-------------- 106
           +  V   + Y  K+            ++  DL    I+L +K   C              
Sbjct: 127 IKQVFSGITYMHKHN-----------IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 107 ---------GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
                    GT  YIAPE+L +  +  + DVWS G I+Y LL G PPF     K  Y  +
Sbjct: 176 QNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDIL 231
Query: 158 KKVE-----YKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
           K+VE     + LP   T+   A  +I+KML   P  R    Q L   +   Y
Sbjct: 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 29/165 (17%)
Query: 139 LVGKPPFETSTLKETYSRIKKVEYKLPATLK-----KPAATMIKKMLLLDPVQRPPVAQL 193
           ++GK  F    + +   RI + EY +    K     K  +T+++++ LL  +  P + +L
Sbjct: 29  MLGKGSF--GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 194 LHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYM 253
             FE   D     +          FD ++                 +RK  +E +    +
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEII-----------------KRKRFSEHDAARII 127
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAA 295
           KQ+  G++Y+H H I+HRDLK  N+ L     +  +KI DFGL+ 
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           TLCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + +
Sbjct: 183 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 242
Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P+        +++ +L +D  +R
Sbjct: 243 FPSHFSSDLKDLLRNLLQVDLTKR 266

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 119 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 178

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           TLCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + +
Sbjct: 218 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 277
Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P+        +++ +L +D  +R
Sbjct: 278 FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 154 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 213

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
           TLCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + +
Sbjct: 198 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 257
Query: 164 LPATLKKPAATMIKKMLLLDPVQR 187
            P+        +++ +L +D  +R
Sbjct: 258 FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 19/219 (8%)
Query: 3   QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-----MSD 56
           +E+ I R +  H N++     +E + F +++ +L +K  + +       L E     +  
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 118
Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIA 113
              + +  + K             L DD   +   D      L     L   CGTP+Y+A
Sbjct: 119 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 178
Query: 114 PEIL------NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA- 166
           PEI+      N  G+  EVD+WS G IMYTLL G PPF           I    Y+  + 
Sbjct: 179 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 238
Query: 167 ---TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                      ++ + L++ P +R    + L   FF  Y
Sbjct: 239 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 22/56 (39%), Positives = 36/56 (64%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            ++E ETR  M+ +LE +  LH   I+HRDLK  N+ L D+  +K+ DFG + +++
Sbjct: 107 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 162

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQPV 62
           EI +   L H N++     FE    + ++LEL    +  EL++   +    S+  AA  V
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELV---TGGELFDRIVEKGYYSERDAADAV 154
Query: 63  IWVSKWVDYSDKYGFG----------YQLNDDSSGVMFNDLTRMIMLANK---NTLCGTP 109
             + + V Y  + G            Y      + +   D     ++ ++    T+CGTP
Sbjct: 155 KQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP 214
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE-TYSRIKKVEYKLPA-- 166
            Y APEIL    +  EVD+WS+G I Y LL G  PF      +  + RI   EY   +  
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274
Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
              +   A  +++K+++LDP +R    Q L 
Sbjct: 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 34/49 (69%), Gaps = 3/49 (6%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIE 298
           +KQILE V+YLH++ I+HRDLK  NL  +    +  +KI DFGL+  +E
Sbjct: 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQP 61
           +E+ + + L H N++  + FFED  + Y++ E+    +  EL++     +  S+  AA+ 
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY---TGGELFDEIISRKRFSEVDAARI 154
Query: 62  VIWVSKWVDYSDKYGFGYQ--------LNDDSSG-----VMFNDLTRMIMLANKNTLCGT 108
           +  V   + Y  K    ++        L   S       + F   T            GT
Sbjct: 155 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 214
Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE-----YK 163
             YIAPE+L+   +  + DVWS G I+Y LL G PPF  +     Y  +KKVE     ++
Sbjct: 215 AYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFE 270
Query: 164 LPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSV 221
           LP    + + A  +I+KML   P  R      L  E+   Y    +        P  D+ 
Sbjct: 271 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV----PSLDNA 326
Query: 222 V 222
           +
Sbjct: 327 I 327

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 22/143 (15%)
Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRF 218
           KV  K     K    ++++++ LL  +  P + +L  +EFF D     L          F
Sbjct: 80  KVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL--YEFFEDKGYFYLVGEVYTGGELF 137
Query: 219 DSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNL 278
           D ++                  RK  +E +    ++Q+L G++Y+H +KI+HRDLK  NL
Sbjct: 138 DEIIS-----------------RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 180
Query: 279 FL---SDNFVVKIGDFGLAARIE 298
            L   S +  ++I DFGL+   E
Sbjct: 181 LLESKSKDANIRIIDFGLSTHFE 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQP 61
           +E+ + + L H N++  + FFED  + Y++ E+    +  EL++     +  S+  AA+ 
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY---TGGELFDEIISRKRFSEVDAARI 155
Query: 62  VIWVSKWVDYSDKYGFGYQ--------LNDDSSG-----VMFNDLTRMIMLANKNTLCGT 108
           +  V   + Y  K    ++        L   S       + F   T            GT
Sbjct: 156 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 215
Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE-----YK 163
             YIAPE+L+   +  + DVWS G I+Y LL G PPF  +     Y  +KKVE     ++
Sbjct: 216 AYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFE 271
Query: 164 LPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSV 221
           LP    + + A  +I+KML   P  R      L  E+   Y    +        P  D+ 
Sbjct: 272 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV----PSLDNA 327
Query: 222 V 222
           +
Sbjct: 328 I 328

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 22/143 (15%)
Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRF 218
           KV  K     K    ++++++ LL  +  P + +L  +EFF D     L          F
Sbjct: 81  KVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL--YEFFEDKGYFYLVGEVYTGGELF 138
Query: 219 DSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNL 278
           D ++                  RK  +E +    ++Q+L G++Y+H +KI+HRDLK  NL
Sbjct: 139 DEIIS-----------------RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 181
Query: 279 FL---SDNFVVKIGDFGLAARIE 298
            L   S +  ++I DFGL+   E
Sbjct: 182 LLESKSKDANIRIIDFGLSTHFE 204

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQP 61
           +E+ + + L H N++  + FFED  + Y++ E+    +  EL++     +  S+  AA+ 
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY---TGGELFDEIISRKRFSEVDAARI 131
Query: 62  VIWVSKWVDYSDKYGFGYQ--------LNDDSSG-----VMFNDLTRMIMLANKNTLCGT 108
           +  V   + Y  K    ++        L   S       + F   T            GT
Sbjct: 132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 191
Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE-----YK 163
             YIAPE+L+   +  + DVWS G I+Y LL G PPF  +     Y  +KKVE     ++
Sbjct: 192 AYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFE 247
Query: 164 LPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSV 221
           LP    + + A  +I+KML   P  R      L  E+   Y    +        P  D+ 
Sbjct: 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV----PSLDNA 303
Query: 222 V 222
           +
Sbjct: 304 I 304

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 22/143 (15%)
Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRF 218
           KV  K     K    ++++++ LL  +  P + +L  +EFF D     L          F
Sbjct: 57  KVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL--YEFFEDKGYFYLVGEVYTGGELF 114
Query: 219 DSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNL 278
           D ++                  RK  +E +    ++Q+L G++Y+H +KI+HRDLK  NL
Sbjct: 115 DEIIS-----------------RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 157
Query: 279 FL---SDNFVVKIGDFGLAARIE 298
            L   S +  ++I DFGL+   E
Sbjct: 158 LLESKSKDANIRIIDFGLSTHFE 180

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 44/83 (53%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
            CGTP+YIAPEI+    +   VD W+ G ++Y +L G+ PFE     E +  I +     
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P ++ K A  + K ++   P +R
Sbjct: 241 PKSMSKEAVAICKGLMTKHPGKR 263

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 55/129 (42%), Gaps = 19/129 (14%)
Query: 173 ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKP 232
            TM++K +L  P  +PP    LH              SC  T  R   V+   N      
Sbjct: 66  CTMVEKRVLALP-GKPPFLTQLH--------------SCFQTMDRLYFVMEYVNGGDLMY 110
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
            +++  +      EP   FY  +I  G+ +L    II+RDLKL N+ L     +KI DFG
Sbjct: 111 HIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166
Query: 293 LAARIEFDG 301
           +     +DG
Sbjct: 167 MCKENIWDG 175

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 44/83 (53%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
            CGTP+YIAPEI+    +   VD W+ G ++Y +L G+ PFE     E +  I +     
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 561
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P ++ K A  + K ++   P +R
Sbjct: 562 PKSMSKEAVAICKGLMTKHPGKR 584

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 55/129 (42%), Gaps = 19/129 (14%)
Query: 173 ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKP 232
            TM++K +L  P  +PP    LH              SC  T  R   V+   N      
Sbjct: 387 CTMVEKRVLALP-GKPPFLTQLH--------------SCFQTMDRLYFVMEYVNGGDLMY 431
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
            +++  +      EP   FY  +I  G+ +L    II+RDLKL N+ L     +KI DFG
Sbjct: 432 HIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 293 LAARIEFDG 301
           +     +DG
Sbjct: 488 MCKENIWDG 496

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQP 61
           +E+ + + L H N++  + FFED  + Y++ E+    +  EL++     +  S+  AA+ 
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY---TGGELFDEIISRKRFSEVDAARI 137
Query: 62  VIWVSKWVDYSDKYGFGYQ--------LNDDSSG-----VMFNDLTRMIMLANKNTLCGT 108
           +  V   + Y  K    ++        L   S       + F   T            GT
Sbjct: 138 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 197
Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY--KLPA 166
             YIAPE+L+   +  + DVWS G I+Y LL G PPF  +   +   +++K +Y  +LP 
Sbjct: 198 AYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 256
Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
              + + A  +I+KML   P  R      L  E+   Y
Sbjct: 257 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 294

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 22/143 (15%)
Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRF 218
           KV  K     K    ++++++ LL  +  P + +L  +EFF D     L          F
Sbjct: 63  KVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL--YEFFEDKGYFYLVGEVYTGGELF 120
Query: 219 DSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNL 278
           D ++                  RK  +E +    ++Q+L G++Y+H +KI+HRDLK  NL
Sbjct: 121 DEIIS-----------------RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 163
Query: 279 FL---SDNFVVKIGDFGLAARIE 298
            L   S +  ++I DFGL+   E
Sbjct: 164 LLESKSKDANIRIIDFGLSTHFE 186

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/240 (22%), Positives = 113/240 (47%), Gaps = 53/240 (22%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYN----------SACD--L 51
           E+ I R  +H NVV  +  +   + +++++E  +  ++ ++ +          + C+  L
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL 151
Query: 52  EEMSDPAAQPVI-----------WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLA 100
           + ++   AQ VI            +   V  SD +GF  Q++ D              + 
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSD-FGFCAQISKD--------------VP 196
Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK-- 158
            +  L GTP ++APE+++++ ++ EVD+WS+G ++  ++ G+PP+ + +  +   R++  
Sbjct: 197 KRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 256
Query: 159 -----KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLM 213
                K  +K+   L+      +++ML+ DP +R    +LL   F      T LP  CL+
Sbjct: 257 PPPKLKNSHKVSPVLRD----FLERMLVRDPQERATAQELLDHPFL---LQTGLP-ECLV 308

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/62 (30%), Positives = 37/62 (59%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + E +     + +L+ ++YLH   +IHRD+K  ++ L+ +  VK+ DFG  A+I  D  +
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197
Query: 304 KR 305
           ++
Sbjct: 198 RK 199

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 13  HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW-VSKWVDY 71
           H +++     +E S F++++ +L RK    EL++   +   +S+   + ++  + + V +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRK---GELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 72  SDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKN- 120
                  ++       L DD+  +  +D      L        LCGTP Y+APEIL  + 
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSM 275
Query: 121 -----GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA----TLKKP 171
                G+  EVD+W+ G I++TLL G PPF           I + +Y+  +         
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSST 335
Query: 172 AATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
              +I ++L +DP  R    Q L   FF 
Sbjct: 336 VKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 26/56 (46%), Positives = 39/56 (69%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           A++E ETR  M+ +LE VS+LH + I+HRDLK  N+ L DN  +++ DFG +  +E
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 49/88 (55%), Gaps = 6/88 (6%)
Query: 106 CGTPNYIAPEIL--NKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSRIKK 159
           CGT  Y+AP+I+    +GH   VD WS+G +MY LL G  PF    E ++  E   RI K
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQR 187
            E   P  +   A  +I+++L+ DP +R
Sbjct: 281 SEPPYPQEMSALAKDLIQRLLMKDPKKR 308

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 22/55 (40%), Positives = 35/55 (63%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +R+  TE E + Y+ +I+  + +LH   II+RD+KL N+ L  N  V + DFGL+
Sbjct: 152 QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 29/52 (55%), Positives = 37/52 (71%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +QI +GV Y+H  K+IHRDLK  N+FL D   VKIGDFGL   ++ DG+R R
Sbjct: 143 EQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 194

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 32/241 (13%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQP 61
           +E+ + + L H N+   + FFED  + Y++ E+    +  EL++     +  S+  AA+ 
Sbjct: 75  REVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVY---TGGELFDEIISRKRFSEVDAARI 131
Query: 62  VIWVSKWVDYSDKYGFGYQ--------LNDDSSG-----VMFNDLTRMIMLANKNTLCGT 108
           +  V   + Y  K    ++        L   S       + F   T            GT
Sbjct: 132 IRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGT 191
Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE-----YK 163
             YIAPE+L+   +  + DVWS G I+Y LL G PPF  +     Y  +KKVE     ++
Sbjct: 192 AYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFE 247
Query: 164 LPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSV 221
           LP    + + A  +I+K L   P  R      L  E+   Y    +     +  P  D+ 
Sbjct: 248 LPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQIS----VDVPSLDNA 303
Query: 222 V 222
           +
Sbjct: 304 I 304

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 22/143 (15%)
Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRF 218
           KV  K     K    ++++++ LL  +  P + +L  +EFF D     L          F
Sbjct: 57  KVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL--YEFFEDKGYFYLVGEVYTGGELF 114
Query: 219 DSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNL 278
           D ++                  RK  +E +    ++Q+L G++Y H +KI+HRDLK  NL
Sbjct: 115 DEIIS-----------------RKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENL 157
Query: 279 FL---SDNFVVKIGDFGLAARIE 298
            L   S +  ++I DFGL+   E
Sbjct: 158 LLESKSKDANIRIIDFGLSTHFE 180

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 191 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 250
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 251 PSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 126 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 185

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 191 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 250
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 251 PSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 126 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 185

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL----EEMSDPA 58
           +E+A+  ++KH N+V +   FE++  +YI+++ C    + +  N+   +    +++ D  
Sbjct: 72  REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 59  AQPVIWVSKWVD----YSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC----GTPN 110
            Q  + +    D    + D       L  D + V   D     +L +   L     GTP 
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGT-VQLGDFGIARVLNSTVELARACIGTPY 190
Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           Y++PEI     ++ + D+W++GC++Y L   K  FE  ++K    +I    +  P +L  
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHY 249
Query: 171 P--AATMIKKMLLLDPVQRPPVAQLLHFEF----FNDYCPTSLPAS--CLMTAPRFDSVV 222
                +++ ++   +P  RP V  +L   F       +    L A   CL T  +F S  
Sbjct: 250 SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQ- 308
Query: 223 PSFNSPRRKPLMERNSKR---RKAITEPETRF 251
                P ++P   +NS      + IT+P  ++
Sbjct: 309 ---PIPAKRPASGQNSISVMPAQKITKPAAKY 337

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 21/58 (36%), Positives = 37/58 (63%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N+++     E +   +  QI   + ++HD KI+HRD+K  N+FL+ +  V++GDFG+A
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK 192

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK 192

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK 192

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK 192

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 278
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 279 PSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 154 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 213

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 185 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 244
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 245 PSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 35/60 (58%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL + +   +++ DFG A R++
Sbjct: 120 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK 179

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK 192

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 192

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 193

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK 193

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 193

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 35/60 (58%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFGLA R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK 192

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 133 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 192

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 193 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 252
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 253 PSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 128 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 187

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 278
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 279 PSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 154 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 213

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 193

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFG A R++
Sbjct: 134 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 193

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 33/60 (55%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R     EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 134 RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 25/60 (41%), Positives = 35/60 (58%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +K+ DFGLA R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK 192

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 9/127 (7%)
Query: 83  DDSSGVMFNDLTRMIMLANKNTLCG----TPNYIAPEILNKNGHSFEVDVWSIGCIMYTL 138
           ++S+ V   D    I L     + G    TP+++APE++ +  +   VDVW  G I++ L
Sbjct: 167 ENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFIL 226
Query: 139 LVGKPPFETSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           L G  PF   T +  +  I K +YK+     + + + A  ++++ML+LDP +R  V + L
Sbjct: 227 LSGCLPF-YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285
Query: 195 HFEFFND 201
           +  +  +
Sbjct: 286 NHPWLKE 292

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 26/60 (43%), Positives = 39/60 (65%), Gaps = 3/60 (5%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAARIEFDG 301
           +E     YM+QILE + Y HD+ IIHRD+K  N+ L+   ++  VK+GDFG+A ++   G
Sbjct: 128 SEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG 187

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 50  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 106
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 107 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 99  GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158
Query: 303 RK 304
            +
Sbjct: 159 ER 160

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 108
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 303 RK 304
            +
Sbjct: 161 ER 162

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 108
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 303 RK 304
            +
Sbjct: 161 ER 162

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 108
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 303 RK 304
            +
Sbjct: 161 ER 162

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 108
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 303 RK 304
            +
Sbjct: 161 ER 162

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 108
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 303 RK 304
            +
Sbjct: 161 ER 162

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+ I R  +H NVV  ++ +     +++++E     ++ ++       EE        V+
Sbjct: 121 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL 180
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAP 114
                  ++ V + D       L  D   V  +D      ++     +  L GTP ++AP
Sbjct: 181 QALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 239
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKVEYKLPATLKK--- 170
           E++++  +  EVD+WS+G ++  ++ G+PP F    LK     +K +   LP  LK    
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMIRDNLPPRLKNLHK 295
Query: 171 --PA-ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCL 212
             P+    + ++L+ DP QR   A+LL   F     P   PAS +
Sbjct: 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP---PASIV 337

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/50 (34%), Positives = 32/50 (64%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +L+ +S LH   +IHRD+K  ++ L+ +  VK+ DFG  A++  +  R++
Sbjct: 179 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+ I R  +H NVV  ++ +     +++++E     ++ ++       EE        V+
Sbjct: 78  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL 137
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAP 114
                  ++ V + D       L  D   V  +D      ++     +  L GTP ++AP
Sbjct: 138 QALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 196
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKVEYKLPATLK---- 169
           E++++  +  EVD+WS+G ++  ++ G+PP F    LK     +K +   LP  LK    
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMIRDNLPPRLKNLHK 252
Query: 170 -KPA-ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCL 212
             P+    + ++L+ DP QR   A+LL   F     P   PAS +
Sbjct: 253 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP---PASIV 294

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/50 (34%), Positives = 32/50 (64%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +L+ +S LH   +IHRD+K  ++ L+ +  VK+ DFG  A++  +  R++
Sbjct: 136 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 185

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 108
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 303 RK 304
            +
Sbjct: 161 ER 162

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+ I R  +H NVV  ++ +     +++++E     ++ ++       EE        V+
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL 257
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAP 114
                  ++ V + D       L  D   V  +D      ++     +  L GTP ++AP
Sbjct: 258 QALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 316
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKVEYKLPATLKK--- 170
           E++++  +  EVD+WS+G ++  ++ G+PP F    LK     +K +   LP  LK    
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMIRDNLPPRLKNLHK 372
Query: 171 --PA-ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCL 212
             P+    + ++L+ DP QR   A+LL   F     P   PAS +
Sbjct: 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP---PASIV 414

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/50 (34%), Positives = 32/50 (64%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +L+ +S LH   +IHRD+K  ++ L+ +  VK+ DFG  A++  +  R++
Sbjct: 256 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+ I R  +H NVV  ++ +     +++++E     ++ ++       EE        V+
Sbjct: 76  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL 135
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAP 114
                  ++ V + D       L  D   V  +D      ++     +  L GTP ++AP
Sbjct: 136 QALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 194
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKVEYKLPATLK---- 169
           E++++  +  EVD+WS+G ++  ++ G+PP F    LK     +K +   LP  LK    
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMIRDNLPPRLKNLHK 250
Query: 170 -KPA-ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCL 212
             P+    + ++L+ DP QR   A+LL   F     P   PAS +
Sbjct: 251 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP---PASIV 292

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/50 (34%), Positives = 32/50 (64%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +L+ +S LH   +IHRD+K  ++ L+ +  VK+ DFG  A++  +  R++
Sbjct: 134 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 183

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 44/79 (55%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLD 183
           P+        +++ +L +D
Sbjct: 258 PSHFSSDLKDLLRNLLQVD 276

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+ I R  +H NVV  ++ +     +++++E     ++ ++       EE        V+
Sbjct: 71  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL 130
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAP 114
                  ++ V + D       L  D   V  +D      ++     +  L GTP ++AP
Sbjct: 131 QALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 189
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKVEYKLPATLK---- 169
           E++++  +  EVD+WS+G ++  ++ G+PP F    LK     +K +   LP  LK    
Sbjct: 190 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMIRDNLPPRLKNLHK 245
Query: 170 -KPA-ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCL 212
             P+    + ++L+ DP QR   A+LL   F     P   PAS +
Sbjct: 246 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP---PASIV 287

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 17/50 (34%), Positives = 32/50 (64%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +L+ +S LH   +IHRD+K  ++ L+ +  VK+ DFG  A++  +  R++
Sbjct: 129 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 178

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+ I R  +H NVV  ++ +     +++++E     ++ ++       EE        V+
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL 126
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAP 114
                  ++ V + D       L  D   V  +D      ++     +  L GTP ++AP
Sbjct: 127 QALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 185
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKVEYKLPATLKK--- 170
           E++++  +  EVD+WS+G ++  ++ G+PP F    LK     +K +   LP  LK    
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMIRDNLPPRLKNLHK 241
Query: 171 --PA-ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCL 212
             P+    + ++L+ DP QR   A+LL   F     P   PAS +
Sbjct: 242 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP---PASIV 283

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 17/50 (34%), Positives = 32/50 (64%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +L+ +S LH   +IHRD+K  ++ L+ +  VK+ DFG  A++  +  R++
Sbjct: 125 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 212 LMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHR 271
           ++  P  D +   F    + P+ME  +   K ++E + RFY + +++G+ YLH  KIIHR
Sbjct: 104 VLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHR 161
Query: 272 DLKLGNLFLSDNFVVKIGDFGLAARIEFDG 301
           D+K  NL + ++  +KI DFG++   EF G
Sbjct: 162 DIKPSNLLVGEDGHIKIADFGVSN--EFKG 189

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 45/83 (54%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP Y+AP I+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 183 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 242
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 243 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 300
Query: 215 A 215
           +
Sbjct: 301 S 301

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 118 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 173

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 177 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 236
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 237 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 294
Query: 215 A 215
           +
Sbjct: 295 S 295

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 181 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 240
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 241 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 298
Query: 215 A 215
           +
Sbjct: 299 S 299

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 116 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 171

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I+  L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 52  IKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 108
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N +C
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 303 RK 304
            +
Sbjct: 161 ER 162

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 17/130 (13%)
Query: 76  GFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIM 135
           GFG  +    SG++                 GTP+++APE++ +  +   VDVW  G I+
Sbjct: 178 GFGVAIQLGESGLV------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 225
Query: 136 YTLLVGKPPFETSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVA 191
           + LL G  PF   T +  +  I K +YK+     + + + A  ++++ML+LDP +R  V 
Sbjct: 226 FILLSGCLPF-YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVY 284
Query: 192 QLLHFEFFND 201
           + L+  +  +
Sbjct: 285 EALNHPWLKE 294

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 37/60 (61%), Gaps = 3/60 (5%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAARIEFDG 301
           +E     YM+QILE + Y HD+ IIHRD+K   + L+   ++  VK+G FG+A ++   G
Sbjct: 130 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 189

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 28/52 (53%), Positives = 37/52 (71%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +QI +GV Y+H  K+I+RDLK  N+FL D   VKIGDFGL   ++ DG+R R
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR 180

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 338
Query: 215 A 215
           +
Sbjct: 339 S 339

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 227 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 286
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 287 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 344
Query: 215 A 215
           +
Sbjct: 345 S 345

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 162 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 217

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 176 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 235
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 236 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 293
Query: 215 A 215
           +
Sbjct: 294 S 294

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 111 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 166

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 182 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 241
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 242 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 299
Query: 215 A 215
           +
Sbjct: 300 S 300

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 117 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 172

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 191 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 250
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 251 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 308
Query: 215 A 215
           +
Sbjct: 309 S 309

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 126 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 181

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 177 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 236
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 237 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 294
Query: 215 A 215
           +
Sbjct: 295 S 295

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+
Sbjct: 175 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 234
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T
Sbjct: 235 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHT 292
Query: 215 A 215
           +
Sbjct: 293 S 293

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 165

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 17/130 (13%)
Query: 76  GFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIM 135
           GFG  +    SG++                 GTP+++APE++ +  +   VDVW  G I+
Sbjct: 176 GFGVAIQLGESGLV------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
Query: 136 YTLLVGKPPFETSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVA 191
           + LL G  PF   T +  +  I K +YK+     + + + A  ++++ML+LDP +R  V 
Sbjct: 224 FILLSGCLPF-YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVY 282
Query: 192 QLLHFEFFND 201
           + L+  +  +
Sbjct: 283 EALNHPWLKE 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 37/60 (61%), Gaps = 3/60 (5%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAARIEFDG 301
           +E     YM+QILE + Y HD+ IIHRD+K   + L+   ++  VK+G FG+A ++   G
Sbjct: 128 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 60/118 (50%), Gaps = 10/118 (8%)
Query: 106 CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIKKVE 161
           C TP Y+APE+L    +    D+WS+G IMY LL G PPF +    +      +RI+  +
Sbjct: 178 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 237
Query: 162 YKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTA 215
           Y+ P    + + +    +I+ +L  +P QR  + + ++  +      T +P + L T+
Sbjct: 238 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ--STKVPQTPLHTS 293

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 165

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GTP Y+APEILN +  +   D+W+IG I Y LL    PF     +ETY  I +V    
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252
Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPV------AQLLHFEFFNDYCPTSLPAS 210
                +++ + A   I+ +L+ +P +RP        + L  ++F N + P    +S
Sbjct: 253 SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSS 308

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%), Gaps = 3/57 (5%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF---VVKIGDFGLAARI 297
           ++E +    +KQILEGV YLH + I+H DLK  N+ LS  +    +KI DFG++ +I
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 45/83 (54%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           LCGTP  +APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 45/83 (54%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           L GTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 26/64 (40%), Positives = 43/64 (67%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
            + +TE + +   KQ L+ ++YLHD+KIIHRDLK GN+  + +  +K+ DFG++A+    
Sbjct: 129 ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 188
Query: 301 GQRK 304
            QR+
Sbjct: 189 IQRR 192

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 26/64 (40%), Positives = 43/64 (67%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
            + +TE + +   KQ L+ ++YLHD+KIIHRDLK GN+  + +  +K+ DFG++A+    
Sbjct: 129 ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRX 188
Query: 301 GQRK 304
            QR+
Sbjct: 189 IQRR 192

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 26/64 (40%), Positives = 43/64 (67%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
            + +TE + +   KQ L+ ++YLHD+KIIHRDLK GN+  + +  +K+ DFG++A+    
Sbjct: 129 ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRX 188
Query: 301 GQRK 304
            QR+
Sbjct: 189 IQRR 192

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 34/241 (14%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-EMS-DPAAQ 60
           +EI     L+H  +V  H  FED   + +I E     S  EL+    D   +MS D A +
Sbjct: 97  KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM---SGGELFEKVADEHNKMSEDEAVE 153
Query: 61  PVIWVSKWVDYSDKYGFGYQLNDDSSGVMFN----------DLTRMIMLANKNTL---CG 107
            +  V K + +  +  +   L+     +MF           D      L  K ++    G
Sbjct: 154 YMRQVCKGLCHMHENNY-VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 212
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP-- 165
           T  + APE+       +  D+WS+G + Y LL G  PF      ET   +K  ++ +   
Sbjct: 213 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 272
Query: 166 --ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVP 223
             + + +     I+K+LL DP  R  + Q L         P   P +    AP  DS +P
Sbjct: 273 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH-------PWLTPGN----APGRDSQIP 321
Query: 224 S 224
           S
Sbjct: 322 S 322

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 29/200 (14%)
Query: 28  FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYG---------- 76
           ++YI ++LCRK ++ +  N  C +EE        + + +++ V++    G          
Sbjct: 89  YLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSN 148
Query: 77  -------------FGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHS 123
                        FG     D        LT M   A      GT  Y++PE ++ N +S
Sbjct: 149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208
Query: 124 FEVDVWSIGCIMYTLLVGKPPFETSTLK-ETYSRIKKVEYKLPATLKKPAA-TMIKKMLL 181
            +VD++S+G I++ LL    PF T   +  T + ++ +++    T K P    M++ ML 
Sbjct: 209 HKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLS 265
Query: 182 LDPVQRPPVAQLLHFEFFND 201
             P++RP    ++    F D
Sbjct: 266 PSPMERPEAINIIENAVFED 285

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 22/50 (44%), Positives = 33/50 (66%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRK 304
           QI E V +LH   ++HRDLK  N+F + + VVK+GDFGL   ++ D + +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 56/114 (49%), Gaps = 7/114 (6%)
Query: 81  LNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT 137
           L DD   +  +DL   + +    T+    GT  Y+APE++    ++F  D W++GC++Y 
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
Query: 138 LLVGKPPFETSTLK----ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           ++ G+ PF+    K    E    +K+V  +        A ++  ++L  DP +R
Sbjct: 378 MIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 22/53 (41%), Positives = 32/53 (60%), Gaps = 2/53 (3%)
Query: 247 PETR--FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           PE R  FY  +I  G+  LH  +I++RDLK  N+ L D+  ++I D GLA  +
Sbjct: 284 PEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 56/114 (49%), Gaps = 7/114 (6%)
Query: 81  LNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT 137
           L DD   +  +DL   + +    T+    GT  Y+APE++    ++F  D W++GC++Y 
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
Query: 138 LLVGKPPFETSTLK----ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           ++ G+ PF+    K    E    +K+V  +        A ++  ++L  DP +R
Sbjct: 378 MIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 22/53 (41%), Positives = 32/53 (60%), Gaps = 2/53 (3%)
Query: 247 PETR--FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           PE R  FY  +I  G+  LH  +I++RDLK  N+ L D+  ++I D GLA  +
Sbjct: 284 PEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 34/241 (14%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-EMS-DPAAQ 60
           +EI     L+H  +V  H  FED   + +I E     S  EL+    D   +MS D A +
Sbjct: 203 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM---SGGELFEKVADEHNKMSEDEAVE 259
Query: 61  PVIWVSKWVDYSDKYGFGYQLNDDSSGVMFN----------DLTRMIMLANKNTL---CG 107
            +  V K + +  +  +   L+     +MF           D      L  K ++    G
Sbjct: 260 YMRQVCKGLCHMHENNY-VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 318
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP-- 165
           T  + APE+       +  D+WS+G + Y LL G  PF      ET   +K  ++ +   
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 378
Query: 166 --ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVP 223
             + + +     I+K+LL DP  R  + Q L         P   P +    AP  DS +P
Sbjct: 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH-------PWLTPGN----APGRDSQIP 427
Query: 224 S 224
           S
Sbjct: 428 S 428

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 20/68 (29%), Positives = 40/68 (58%), Gaps = 2/68 (2%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD--NFVVKIGD 290
           L E+ +     ++E E   YM+Q+ +G+ ++H++  +H DLK  N+  +   +  +K+ D
Sbjct: 241 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 300
Query: 291 FGLAARIE 298
           FGL A ++
Sbjct: 301 FGLTAHLD 308

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/225 (21%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           E+ I R   H NVV  +S +     +++++E     ++ ++       EE     A   +
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ---IATVCL 148
Query: 64  WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIM------------LANKNTLCGTPNY 111
            V + + Y    G  ++ +  S  ++     R+ +            +  +  L GTP +
Sbjct: 149 SVLRALSYLHNQGVIHR-DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYW 207
Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           +APE++++  +  EVD+WS+G ++  ++ G+PP+      +   RI+         L K 
Sbjct: 208 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKV 267
Query: 172 AATM---IKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLM 213
           ++ +   +  ML+ +P QR    +LL   F       + P SC++
Sbjct: 268 SSVLRGFLDLMLVREPSQRATAQELLGHPFLK----LAGPPSCIV 308

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 16/42 (38%), Positives = 29/42 (69%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +L  +SYLH+  +IHRD+K  ++ L+ +  +K+ DFG  A++
Sbjct: 150 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 191

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 45/83 (54%)
Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           L GTP Y+APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + + 
Sbjct: 198 LXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 165 PATLKKPAATMIKKMLLLDPVQR 187
           P+        +++ +L +D  +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 26/59 (44%), Positives = 36/59 (61%), Gaps = 4/59 (6%)
Query: 103 NTLCGTPNYIAPEILNKNG----HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
           +T  GTP+YI+PE+L   G    +  E D WS+G  +Y +LVG  PF   +L  TYS+I
Sbjct: 232 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 290

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 26/59 (44%), Positives = 36/59 (61%), Gaps = 4/59 (6%)
Query: 103 NTLCGTPNYIAPEILNKNG----HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
           +T  GTP+YI+PE+L   G    +  E D WS+G  +Y +LVG  PF   +L  TYS+I
Sbjct: 232 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 290

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 26/59 (44%), Positives = 36/59 (61%), Gaps = 4/59 (6%)
Query: 103 NTLCGTPNYIAPEILNKNG----HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
           +T  GTP+YI+PE+L   G    +  E D WS+G  +Y +LVG  PF   +L  TYS+I
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 58/121 (47%), Gaps = 10/121 (8%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLKETYSRIK 158
            T C TP Y+APE+L    +    D WS+G I Y LL G PPF +    +      +RI+
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIR 280
Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y+ P    + + +    +I+ +L  +P QR  + +  +  +      T +P + L T
Sbjct: 281 XGQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQ--STKVPQTPLHT 338
Query: 215 A 215
           +
Sbjct: 339 S 339

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/56 (41%), Positives = 30/56 (53%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E     K I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 156 QAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 26/59 (44%), Positives = 39/59 (66%), Gaps = 1/59 (1%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLA 294
           N   +  + E   R +M Q+L G+ Y+H   ++HRDLK  NLF+ +++ V+KIGDFGLA
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 38/53 (71%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T    R+++ Q+L G+ Y+H  ++IHRDLK  NL +++N  +KIGDFG+A
Sbjct: 154 QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 38/53 (71%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T    R+++ Q+L G+ Y+H  ++IHRDLK  NL +++N  +KIGDFG+A
Sbjct: 153 QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 42/186 (22%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCR-------------------KRSMME 43
           +EI + + L H NV+ +++ F +   + I+LEL                     +R++ +
Sbjct: 81  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 44  LYNSACD-LEEMS-------DPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTR 95
            +   C  LE M        D     V   +  V          +L D   G  F+  T 
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---------VKLGDLGLGRFFSSKT- 190
Query: 96  MIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                  ++L GTP Y++PE +++NG++F+ D+WS+GC++Y +   + PF    +   YS
Sbjct: 191 ----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYS 245
Query: 156 RIKKVE 161
             KK+E
Sbjct: 246 LCKKIE 251

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/56 (33%), Positives = 34/56 (60%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K+++ I E     Y  Q+   + ++H  +++HRD+K  N+F++   VVK+GD GL 
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 26/51 (50%), Positives = 34/51 (66%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +T    + YM   L+G+ YLH H I+HRDLK  NL L +N V+K+ DFGLA
Sbjct: 109 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 159

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 10/131 (7%)
Query: 81  LNDDSSGVMFNDLTRMIMLANKN---TLCGTPNYIAPEILNKN---GHSFEVDVWSIGCI 134
           L D+   V   D     ML  +    T+ GT  Y+APE+ +     G+SF VD WS+G  
Sbjct: 147 LLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206
Query: 135 MYTLLVGKPPFE---TSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR-PPV 190
            Y LL G+ P+    +++ KE     +      P+   +   +++KK+L  +P QR   +
Sbjct: 207 AYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQL 266
Query: 191 AQLLHFEFFND 201
           + + +F + ND
Sbjct: 267 SDVQNFPYMND 277

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 52  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 108
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N + 
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 168
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 303 RK 304
            +
Sbjct: 161 ER 162

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 125 ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 179

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 37/55 (67%), Gaps = 7/55 (12%)
Query: 248 ETRFYMKQILE-------GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F MK++++       G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 102 ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 156

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 37/55 (67%), Gaps = 7/55 (12%)
Query: 248 ETRFYMKQILE-------GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F MK++++       G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 114 ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 37/55 (67%), Gaps = 7/55 (12%)
Query: 248 ETRFYMKQILE-------GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F MK++++       G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 114 ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 180

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 180

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 118 ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 172

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +EI I++ L H NVV F+    +    Y+ LE C   S  EL++       M +P AQ
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC---SGGELFDRIEPDIGMPEPDAQ 107
Query: 61  PVI-WVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK----NTLC 106
                +   V Y    G  ++       L D+   +  +D  L  +    N+    N + 
Sbjct: 108 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKL 164
           GT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS  K+ +  L
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 227
Query: 165 PATLKKPAA--TMIKKMLLLDPVQRPPVAQLLHFEFFN 200
               K  +A   ++ K+L+ +P  R  +  +    ++N
Sbjct: 228 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
            + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 303 RK 304
            +
Sbjct: 160 ER 161

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 100 ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 154

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 103 ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 157

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 74/145 (51%), Gaps = 20/145 (13%)
Query: 151 KETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPA 209
           K++  RI  ++  +L A  +   +T I+++ LL  +  P +  L+               
Sbjct: 41  KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID-------------- 86
Query: 210 SCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKII 269
             ++ + R  ++V  F     K +++ N   +  + + + + Y+ Q+L GV++ H H+I+
Sbjct: 87  --VIHSERCLTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 270 HRDLKLGNLFLSDNFVVKIGDFGLA 294
           HRDLK  NL ++ +  +K+ DFGLA
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLA 166

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 25/55 (45%), Positives = 37/55 (67%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           +K + E E        L+G++YLH H +IHRD+K GN+ LS+  +VK+GDFG A+
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 202

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 103 ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 157

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 21/55 (38%), Positives = 40/55 (72%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR 296
           + +TEP+ +   +Q+LE +++LH  +IIHRDLK GN+ ++    +++ DFG++A+
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 98  ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 98  ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 21/55 (38%), Positives = 40/55 (72%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR 296
           + +TEP+ +   +Q+LE +++LH  +IIHRDLK GN+ ++    +++ DFG++A+
Sbjct: 104 RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 158

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/55 (50%), Positives = 35/55 (63%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFGLA 
Sbjct: 98  ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 74/145 (51%), Gaps = 20/145 (13%)
Query: 151 KETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPA 209
           K++  RI  ++  +L A  +   +T I+++ LL  +  P +  L+               
Sbjct: 41  KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID-------------- 86
Query: 210 SCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKII 269
             ++ + R  ++V  F     K +++ N   +  + + + + Y+ Q+L GV++ H H+I+
Sbjct: 87  --VIHSERCLTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 270 HRDLKLGNLFLSDNFVVKIGDFGLA 294
           HRDLK  NL ++ +  +K+ DFGLA
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLA 166

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 103 NTLCGTPNYIAPEILNKNG----HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK 158
           +T  GTP+YI+PE+L   G    +  E D WS+G  ++ +LVG  PF   +L  TYS+I 
Sbjct: 233 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292
Query: 159 KVEYKL----PATLKKPAATMIKKMLLLDPVQ--RPPVAQLLHFEFFND 201
             +  L     A + K A  +I   L    V+  R  V ++    FF +
Sbjct: 293 DHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 341

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 4/100 (4%)
Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP- 165
           GTP ++APE++N +  SF  D+WS+G I Y LL G  PF      ET + I    + L  
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
Query: 166 ---ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                + + A   I K+L+ +   R   ++ L   + +D+
Sbjct: 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/55 (45%), Positives = 34/55 (61%), Gaps = 2/55 (3%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL--SDNFVVKIGDFGLAAR 296
           +TE +T  +MKQI EG+ ++H   I+H DLK  N+     D   +KI DFGLA R
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 25/55 (45%), Positives = 37/55 (67%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           +K + E E        L+G++YLH H +IHRD+K GN+ LS+  +VK+GDFG A+
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/55 (49%), Positives = 34/55 (61%), Gaps = 7/55 (12%)
Query: 248 ETRFYM-------KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           ET+F M       +Q  +G+ YLH   IIHRD+K  N+FL +   VKIGDFGLA 
Sbjct: 126 ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT 180

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 22/48 (45%), Positives = 38/48 (79%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +  ++IL G+S+LH HK+IHRD+K  N+ L++N  VK+ DFG++A+++
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 25/44 (56%), Positives = 33/44 (75%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +QILE +SY+H   IIHRDLK  N+F+ ++  VKIGDFGLA  +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 25/44 (56%), Positives = 33/44 (75%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +QILE +SY+H   IIHRDLK  N+F+ ++  VKIGDFGLA  +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/243 (21%), Positives = 96/243 (39%), Gaps = 47/243 (19%)
Query: 7   IHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVS 66
           +++   ++N++    FFED    Y++ E  +  S++          E    A++ V  V+
Sbjct: 64  LYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNERE--ASRVVRDVA 121
Query: 67  KWVDYSDKYGFGYQL---------------------NDDSSGVMFNDLTRMIMLANKNTL 105
             +D+    G  ++                       D  SG+  N+    I      T 
Sbjct: 122 AALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTP 181
Query: 106 CGTPNYIAPEILN--KNGHSF---EVDVWSIGCIMYTLLVGKPPFETSTLKET------- 153
           CG+  Y+APE++    +  +F     D+WS+G ++Y +L G PPF      +        
Sbjct: 182 CGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEV 241
Query: 154 --------YSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
                   +  I++ +Y+ P    A +   A  +I K+L+ D  QR   AQ+L   +   
Sbjct: 242 CRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301
Query: 202 YCP 204
             P
Sbjct: 302 QAP 304

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 10/84 (11%)
Query: 107 GTPNYIAPEIL-----NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI--KK 159
           GTP+YI+PEIL      K  +  E D WS+G  MY +L G+ PF   +L ETY +I   K
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297
Query: 160 VEYKLPAT---LKKPAATMIKKML 180
             ++ P     + + A  +I++++
Sbjct: 298 ERFQFPTQVTDVSENAKDLIRRLI 321

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 14  RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYS 72
           +N VG         ++YI ++LCRK ++ +  N  C LE+        + I +++ V++ 
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 73  DKYG-----------------------FGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP 109
              G                       FG     D        LT M   A      GT 
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTK 240
Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK-ETYSRIKKVEYKLPATL 168
            Y++PE ++ N +S +VD++S+G I++ LL     F T   +    + ++ +++ L  T 
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVRNLKFPLLFTQ 297
Query: 169 KKPAA-TMIKKMLLLDPVQRPPVAQLLHFEFFND 201
           K P    M++ ML   P +RP    ++    F +
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 22/50 (44%), Positives = 33/50 (66%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRK 304
           QI E V +LH   ++HRDLK  N+F + + VVK+GDFGL   ++ D + +
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 43/75 (57%)
Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K ++ +   +   + E      ++++LEG+ YLH +  IHRD+K GN+ L ++  V+I D
Sbjct: 100 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD 159
Query: 291 FGLAARIEFDGQRKR 305
           FG++A +   G   R
Sbjct: 160 FGVSAFLATGGDITR 174

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 43/75 (57%)
Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K ++ +   +   + E      ++++LEG+ YLH +  IHRD+K GN+ L ++  V+I D
Sbjct: 105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD 164
Query: 291 FGLAARIEFDGQRKR 305
           FG++A +   G   R
Sbjct: 165 FGVSAFLATGGDITR 179

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 26/62 (41%), Positives = 38/62 (61%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           R+   R +I   +   + +QI EG++YLH    IHRDL   N+ L ++ +VKIGDFGLA 
Sbjct: 123 RDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182
Query: 296 RI 297
            +
Sbjct: 183 AV 184

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 9/106 (8%)
Query: 99  LANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK 158
           +A +N + GTP ++APE++ + G++   D+WS+G     +  GKPP+           I 
Sbjct: 179 MAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI---HPMRAIF 235
Query: 159 KVEYKLPATLKKPA------ATMIKKMLLLDPVQRPPVAQLLHFEF 198
            +    P T +KP          +K+ L+  P QR    QLL   F
Sbjct: 236 MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 23/58 (39%), Positives = 36/58 (62%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           R K +TE E    ++  L+G+ YLH  + IHRD+K GN+ L+     K+ DFG+A ++
Sbjct: 118 RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 26/62 (41%), Positives = 41/62 (66%), Gaps = 1/62 (1%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + E +    +++IL+G+ YLH  K IHRD+K  N+ LS++  VK+ DFG+A ++  D Q 
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQI 179
Query: 304 KR 305
           KR
Sbjct: 180 KR 181

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 26/62 (41%), Positives = 41/62 (66%), Gaps = 1/62 (1%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + E +    +++IL+G+ YLH  K IHRD+K  N+ LS++  VK+ DFG+A ++  D Q 
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQI 174
Query: 304 KR 305
           KR
Sbjct: 175 KR 176

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 26/53 (49%), Positives = 37/53 (69%), Gaps = 1/53 (1%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +K+IL+G+ YLH  K IHRD+K  N+ LS+   VK+ DFG+A ++  D Q KR
Sbjct: 126 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKR 177

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 26/62 (41%), Positives = 41/62 (66%), Gaps = 1/62 (1%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + E +    +++IL+G+ YLH  K IHRD+K  N+ LS++  VK+ DFG+A ++  D Q 
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQI 159
Query: 304 KR 305
           KR
Sbjct: 160 KR 161

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 26/62 (41%), Positives = 41/62 (66%), Gaps = 1/62 (1%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + E +    +++IL+G+ YLH  K IHRD+K  N+ LS++  VK+ DFG+A ++  D Q 
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQI 159
Query: 304 KR 305
           KR
Sbjct: 160 KR 161

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 23/116 (19%)
Query: 75  YGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN--KNG---HSFEVDVW 129
           +G   ++NDD +                +   GTP+YI+PEIL   ++G   +  E D W
Sbjct: 219 FGSCLKMNDDGT-------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 265
Query: 130 SIGCIMYTLLVGKPPFETSTLKETYSRIKKVE--YKLPA---TLKKPAATMIKKML 180
           S+G  MY +L G+ PF   +L ETY +I   E  ++ P+    + + A  +I++++
Sbjct: 266 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 321

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 19/64 (29%), Positives = 34/64 (53%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           SK    + E   RFY+ +++  +  +H    +HRD+K  N+ L  N  +++ DFG   ++
Sbjct: 166 SKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKM 225
Query: 298 EFDG 301
             DG
Sbjct: 226 NDDG 229

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 23/116 (19%)
Query: 75  YGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN--KNG---HSFEVDVW 129
           +G   ++NDD +                +   GTP+YI+PEIL   ++G   +  E D W
Sbjct: 235 FGSCLKMNDDGT-------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 281
Query: 130 SIGCIMYTLLVGKPPFETSTLKETYSRIKKVE--YKLPA---TLKKPAATMIKKML 180
           S+G  MY +L G+ PF   +L ETY +I   E  ++ P+    + + A  +I++++
Sbjct: 282 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 337

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 19/64 (29%), Positives = 34/64 (53%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           SK    + E   RFY+ +++  +  +H    +HRD+K  N+ L  N  +++ DFG   ++
Sbjct: 182 SKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKM 241
Query: 298 EFDG 301
             DG
Sbjct: 242 NDDG 245

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 16/111 (14%)
Query: 207 LPASCLMTAPRFDSVVPSFNSPRRKP-------LMERNS-----KRRKAITEPETRFYMK 254
           L A   +T+PR   +VP + + R  P       L+E  S     K +  + E    +Y+ 
Sbjct: 117 LMACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG 173
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLAARIEFDGQRK 304
           Q LEG+ YLH  +I+H D+K  N+ L SD     + DFG A  ++ DG  K
Sbjct: 174 QALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGK 224

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 24/45 (53%), Positives = 33/45 (73%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
            +QILE +SY+H   IIHR+LK  N+F+ ++  VKIGDFGLA  +
Sbjct: 122 FRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNV 166

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 16/111 (14%)
Query: 207 LPASCLMTAPRFDSVVPSFNSPRRKP-------LMERNS-----KRRKAITEPETRFYMK 254
           L A   +T+PR   +VP + + R  P       L+E  S     K +  + E    +Y+ 
Sbjct: 136 LMACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG 192
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLAARIEFDGQRK 304
           Q LEG+ YLH  +I+H D+K  N+ L SD     + DFG A  ++ DG  K
Sbjct: 193 QALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGK 243

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 97/255 (38%), Gaps = 66/255 (25%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EI + + LKH+N+V  H      K + ++ E C +   ++ Y  +C+ +        P 
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD--LKKYFDSCNGD------LDPE 101
Query: 63  IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPN------------ 110
           I  S         GF +  N     V+  DL    +L N+N      N            
Sbjct: 102 IVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156
Query: 111 ----------YIAPEIL-NKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIK 158
                     Y  P++L     +S  +D+WS GCI   L   G+P F  + + +   RI 
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
Query: 159 KV----------------EYK----LPAT---------LKKPAATMIKKMLLLDPVQRPP 189
           ++                +YK     PAT         L      +++ +L  +PVQR  
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 190 VAQLLHFEFFNDYCP 204
             + L   +F+D+CP
Sbjct: 277 AEEALQHPYFSDFCP 291

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/50 (38%), Positives = 34/50 (68%), Gaps = 1/50 (2%)
Query: 246 EPE-TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +PE  + ++ Q+L+G+ + H   ++HRDLK  NL ++ N  +K+ +FGLA
Sbjct: 99  DPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 22/52 (42%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+S+ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 1/104 (0%)
Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKK 159
            +N   GTP ++APE++ ++ + F+ D+WS+G     L  G+PP  +   ++  +   K 
Sbjct: 172 KRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN 231
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC 203
               L     KP    ++  L  DP  RP   +LL  +F   Y 
Sbjct: 232 SPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 275

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 37/53 (69%), Gaps = 1/53 (1%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           +++IL+G+ YLH  + IHRD+K  N+ LS+   VK+ DFG+A ++  D Q KR
Sbjct: 122 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKR 173

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/62 (40%), Positives = 38/62 (61%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           R+   R +I   +   + +QI EG++YLH    IHR+L   N+ L ++ +VKIGDFGLA 
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165
Query: 296 RI 297
            +
Sbjct: 166 AV 167

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 115 NIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA 172

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/62 (43%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
              EP   FY  QI+ G+ +LH   II+RDLK  N+ L D+  V+I D GLA  ++  GQ
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK-AGQ 343
Query: 303 RK 304
            K
Sbjct: 344 TK 345

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 25/62 (40%), Positives = 38/62 (61%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           R+   R +I   +   + +QI EG++YLH    IHR+L   N+ L ++ +VKIGDFGLA 
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165
Query: 296 RI 297
            +
Sbjct: 166 AV 167

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/62 (43%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
              EP   FY  QI+ G+ +LH   II+RDLK  N+ L D+  V+I D GLA  ++  GQ
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK-AGQ 343
Query: 303 RK 304
            K
Sbjct: 344 TK 345

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/62 (43%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
              EP   FY  QI+ G+ +LH   II+RDLK  N+ L D+  V+I D GLA  ++  GQ
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK-AGQ 343
Query: 303 RK 304
            K
Sbjct: 344 TK 345

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/62 (43%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
              EP   FY  QI+ G+ +LH   II+RDLK  N+ L D+  V+I D GLA  ++  GQ
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK-AGQ 343
Query: 303 RK 304
            K
Sbjct: 344 TK 345

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 106 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 157

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 102 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 102 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 101 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 115 NIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 101 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 106 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 157

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 100 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 103 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 154

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 15/175 (8%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYN-SACDLEEMSDPAA 59
           + +EI+I    +HRN++  H  FE  + + +I E      + E  N SA +L E      
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE--REIV 105
Query: 60  QPVIWVSKWVDYSDKYGFG----------YQLNDDSSG--VMFNDLTRMIMLANKNTLCG 107
             V  V + + +   +  G          YQ    S+   + F    ++    N   L  
Sbjct: 106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165
Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            P Y APE+   +  S   D+WS+G ++Y LL G  PF   T ++    I   EY
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 102 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 101 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 98  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 98  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 102 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA 153

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 102 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 98  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 102 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 98  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 100 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 103 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 154

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 98  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 98  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 100 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA 151

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 100 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 101 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA 152

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 100 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA 151

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 35/52 (67%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA
Sbjct: 99  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA 150

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 16/111 (14%)
Query: 207 LPASCLMTAPRFDSVVPSFNSPRRKP-------LMERNS-----KRRKAITEPETRFYMK 254
           L A   +++PR   +VP + + R  P       L+E  S     K+   + E    +Y+ 
Sbjct: 115 LVACAGLSSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 171
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLAARIEFDGQRK 304
           Q LEG+ YLH  +I+H D+K  N+ L SD     + DFG A  ++ DG  K
Sbjct: 172 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 222

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 16/111 (14%)
Query: 207 LPASCLMTAPRFDSVVPSFNSPRRKP-------LMERNS-----KRRKAITEPETRFYMK 254
           L A   +++PR   +VP + + R  P       L+E  S     K+   + E    +Y+ 
Sbjct: 117 LVACAGLSSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 173
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLAARIEFDGQRK 304
           Q LEG+ YLH  +I+H D+K  N+ L SD     + DFG A  ++ DG  K
Sbjct: 174 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 16/111 (14%)
Query: 207 LPASCLMTAPRFDSVVPSFNSPRRKP-------LMERNS-----KRRKAITEPETRFYMK 254
           L A   +++PR   +VP + + R  P       L+E  S     K+   + E    +Y+ 
Sbjct: 101 LVACAGLSSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 157
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLAARIEFDGQRK 304
           Q LEG+ YLH  +I+H D+K  N+ L SD     + DFG A  ++ DG  K
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 102/248 (41%), Gaps = 54/248 (21%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + LKH NV+G    F      ED   VY++  L     M    N+    + +SD
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL-----MGADLNNIVKCQALSD 130
Query: 57  PAAQPVIW-VSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML---------ANKNTLC 106
              Q +++ + + + Y    G  ++ +   S V  N+ + + +L                
Sbjct: 131 EHVQFLVYQLLRGLKYIHSAGIIHR-DLKPSNVAVNEDSELRILDFGLARQADEEMTGYV 189
Query: 107 GTPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV----- 160
            T  Y APEI LN   ++  VD+WS+GCIM  LL GK  F  S   +   RI +V     
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS 249
Query: 161 ---------EY------KLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLL 194
                    E+       LP   +K            A  ++ +ML+LD  QR   A+ L
Sbjct: 250 PEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEAL 309
Query: 195 HFEFFNDY 202
              +F+ Y
Sbjct: 310 AHAYFSQY 317

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/53 (39%), Positives = 37/53 (69%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +A+++   +F + Q+L G+ Y+H   IIHRDLK  N+ ++++  ++I DFGLA
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA 178

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA 177

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA 177

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA 183

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 149 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 201

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 39/221 (17%)
Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNS-ACDLEEMSDPAA 59
           +  EI+I   L H  ++  H  FED   + +ILE     S  EL++  A +  +MS+   
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL---SGGELFDRIAAEDYKMSE--- 148
Query: 60  QPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNT--------------- 104
                 ++ ++Y  +   G +   + S V  +     IM   K                 
Sbjct: 149 ------AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202
Query: 105 -------LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
                     T  + APEI+++    F  D+W+IG + Y LL G  PF      ET   +
Sbjct: 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262
Query: 158 KKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           K+ +++      +++   A   IK +L  +P +R  V   L
Sbjct: 263 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/70 (35%), Positives = 39/70 (55%), Gaps = 2/70 (2%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGD 290
           L +R +     ++E E   YM+Q  EG+ ++H+H I+H D+K  N+         VKI D
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194
Query: 291 FGLAARIEFD 300
           FGLA ++  D
Sbjct: 195 FGLATKLNPD 204

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 102/248 (41%), Gaps = 54/248 (21%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + LKH NV+G    F      ED   VY++  L     M    N+    + +SD
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL-----MGADLNNIVKSQALSD 130
Query: 57  PAAQPVIW-VSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML---------ANKNTLC 106
              Q +++ + + + Y    G  ++ +   S V  N+ + + +L                
Sbjct: 131 EHVQFLVYQLLRGLKYIHSAGIIHR-DLKPSNVAVNEDSELRILDFGLARQADEEMTGYV 189
Query: 107 GTPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV----- 160
            T  Y APEI LN   ++  VD+WS+GCIM  LL GK  F  S   +   RI +V     
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS 249
Query: 161 ---------EY------KLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLL 194
                    E+       LP   +K            A  ++ +ML+LD  QR   A+ L
Sbjct: 250 PEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEAL 309
Query: 195 HFEFFNDY 202
              +F+ Y
Sbjct: 310 AHAYFSQY 317

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 39/58 (67%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + +A+++   +F + Q+L G+ Y+H   IIHRDLK  N+ ++++  ++I DFGLA
Sbjct: 121 NIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA 178

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 100/247 (40%), Gaps = 52/247 (21%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + LKH NV+G    F      ED   VY++  L     M    N+    + +SD
Sbjct: 68  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL-----MGADLNNIVKCQALSD 122
Query: 57  PAAQPVIW-VSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIM---LANK-----NTLCG 107
              Q +++ + + + Y    G  ++    S+  +  D    I+   LA +          
Sbjct: 123 EHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVA 182
Query: 108 TPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE----- 161
           T  Y APEI LN   ++  VD+WS+GCIM  LL GK  F  S   +   RI +V      
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSP 242
Query: 162 ---------------YKLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLH 195
                            LP   +K            A  ++ +ML+LD  QR   A+ L 
Sbjct: 243 EVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALA 302
Query: 196 FEFFNDY 202
             +F+ Y
Sbjct: 303 HAYFSQY 309

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/53 (39%), Positives = 37/53 (69%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +A+++   +F + Q+L G+ Y+H   IIHRDLK  N+ ++++  ++I DFGLA
Sbjct: 118 QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 170

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 174

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 177

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 178

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 177

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 130 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 182

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 119 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 171

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 117 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 174

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 184

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 112 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 169

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA 174

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 184

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 99/248 (39%), Gaps = 48/248 (19%)
Query: 7   IHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVS 66
           +++   HRNV+    FFE+    Y++ E  R  S++   +      E+   A+  V  V+
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE--ASVVVQDVA 121
Query: 67  KWVDYSDKYGFGY--------------QLN-------DDSSGVMFNDLTRMIMLANKNTL 105
             +D+    G  +              Q++       D  SG+  N     I      T 
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 106 CGTPNYIAPEILNKNGHSFEV-----DVWSIGCIMYTLLVGKPPFETSTLKET------- 153
           CG+  Y+APE++        +     D+WS+G I+Y LL G PPF      +        
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 154 --------YSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
                   +  I++ +Y+ P    A +   A  +I K+L+ D  QR   AQ+L   +   
Sbjct: 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301
Query: 202 YCP-TSLP 208
             P  +LP
Sbjct: 302 CAPENTLP 309

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 112 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 169

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 143 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 195

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 192

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 184

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 172

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 174

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 135 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 192

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 183

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 138 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 195

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA 178

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 192

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 139 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 191

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 113 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 170

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 134 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 191

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 178

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 24/53 (45%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 178

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 24/55 (43%), Positives = 38/55 (69%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + + E   +F + Q+L+G+ Y+H   IIHRDLK GNL ++++  +KI DFGLA
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 24/51 (47%), Positives = 35/51 (68%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 65/124 (52%), Gaps = 18/124 (14%)
Query: 172 AATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRK 231
           A    +++LLL  +Q   V  LL  + F        PAS L     F  V+P   +  +K
Sbjct: 85  AKRAYRELLLLKHMQHENVIGLL--DVFT-------PASSLRNFYDFYLVMPFMQTDLQK 135
Query: 232 PL-MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
            + ME         +E + ++ + Q+L+G+ Y+H   ++HRDLK GNL ++++  +KI D
Sbjct: 136 IMGME--------FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILD 187
Query: 291 FGLA 294
           FGLA
Sbjct: 188 FGLA 191

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 91/215 (42%), Gaps = 13/215 (6%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI + R  K+ N+V +   +     +++++E     S+ ++    C  E       +  +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAP 114
                  S  V + D       L  D S V   D      +    + ++T+ GTP ++AP
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETY--SRIKKVEYKLPATLKKP 171
           E++ +  +  +VD+WS+G +   ++ G+PP+   + L+  Y  +     E + P  L   
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 172 AATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
               + + L +D  +R    +LL  +F     P S
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 17/44 (38%), Positives = 30/44 (68%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 25/101 (24%)
Query: 202 YCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVS 261
           Y      ASCL   P      P  + P+R+ +   +++                   G++
Sbjct: 108 YMANGSVASCLRERPESQ---PPLDWPKRQRIALGSAR-------------------GLA 145
Query: 262 YLHDH---KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           YLHDH   KIIHRD+K  N+ L + F   +GDFGLA  +++
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 20/45 (44%), Positives = 35/45 (77%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++  Q+L+G+++ H++KI+HRDLK  NL ++    +K+GDFGLA
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 36/62 (58%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           R+   R  +   +   + +QI EG++YLH    IHR L   N+ L ++ +VKIGDFGLA 
Sbjct: 101 RDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 160
Query: 296 RI 297
            +
Sbjct: 161 AV 162

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 64/123 (52%), Gaps = 16/123 (13%)
Query: 172 AATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRK 231
           A    +++LLL  +Q   V  LL  + F        PAS L     F  V+P   +  +K
Sbjct: 67  AKRAYRELLLLKHMQHENVIGLL--DVFT-------PASSLRNFYDFYLVMPFMQTDLQK 117
Query: 232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDF 291
            +  +        +E + ++ + Q+L+G+ Y+H   ++HRDLK GNL ++++  +KI DF
Sbjct: 118 IMGLK-------FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF 170
Query: 292 GLA 294
           GLA
Sbjct: 171 GLA 173

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 36/62 (58%)
Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           R+   R  +   +   + +QI EG++YLH    IHR L   N+ L ++ +VKIGDFGLA 
Sbjct: 100 RDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 159
Query: 296 RI 297
            +
Sbjct: 160 AV 161

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 25/101 (24%)
Query: 202 YCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVS 261
           Y      ASCL   P      P  + P+R+ +   +++                   G++
Sbjct: 116 YMANGSVASCLRERPESQ---PPLDWPKRQRIALGSAR-------------------GLA 153
Query: 262 YLHDH---KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           YLHDH   KIIHRD+K  N+ L + F   +GDFGLA  +++
Sbjct: 154 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 194

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 37/57 (64%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGL
Sbjct: 115 NIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGL 171

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 21/50 (42%), Positives = 35/50 (70%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           T  E +  M+ +L G+ Y+H +KI+HRD+K  N+ ++ + V+K+ DFGLA
Sbjct: 123 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 21/50 (42%), Positives = 35/50 (70%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           T  E +  M+ +L G+ Y+H +KI+HRD+K  N+ ++ + V+K+ DFGLA
Sbjct: 123 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 21/50 (42%), Positives = 35/50 (70%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           T  E +  M+ +L G+ Y+H +KI+HRD+K  N+ ++ + V+K+ DFGLA
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 21/50 (42%), Positives = 35/50 (70%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           T  E +  M+ +L G+ Y+H +KI+HRD+K  N+ ++ + V+K+ DFGLA
Sbjct: 123 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 36/53 (67%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI D+GLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLA 172

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 97/255 (38%), Gaps = 66/255 (25%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EI + + LKH+N+V  H      K + ++ E C +   ++ Y  +C+ +        P 
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD--LKKYFDSCNGD------LDPE 101
Query: 63  IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNT-----------LCGTPN- 110
           I  S         GF +  N     V+  DL    +L N+N              G P  
Sbjct: 102 IVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156
Query: 111 ----------YIAPEIL-NKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIK 158
                     Y  P++L     +S  +D+WS GCI   L    +P F  + + +   RI 
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIF 216
Query: 159 KV----------------EYK----LPAT---------LKKPAATMIKKMLLLDPVQRPP 189
           ++                +YK     PAT         L      +++ +L  +PVQR  
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 190 VAQLLHFEFFNDYCP 204
             + L   +F+D+CP
Sbjct: 277 AEEALQHPYFSDFCP 291

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 20/50 (40%), Positives = 34/50 (68%), Gaps = 1/50 (2%)
Query: 246 EPE-TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +PE  + ++ Q+L+G+ + H   ++HRDLK  NL ++ N  +K+ DFGLA
Sbjct: 99  DPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLA 148

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 108 TPNYIAPEILNKNGHSF---EVDVWSIGCIMYTLLVGKPPFETSTLK-ETYSRIKKVEYK 163
           T +Y APE+ +   H       DVWS+GC++Y ++ G+ P++    K ++ +   + +  
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 164 LPATLKKPAA--TMIKKMLLLDPVQRPPVAQLL 194
           +P + +  +A   ++  M+ +DP QRP +  LL
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLL 298

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 166

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 168

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 162

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 165

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 169

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 170

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 166

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 161

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 33/51 (64%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           Y+ QI+ G+ + H H IIHRD+K  N+ +S + VVK+ DFG A  +   G+
Sbjct: 129 YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 19/42 (45%), Positives = 31/42 (73%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           M Q+L G+ +LH H+++HRDLK  N+ ++ +  +K+ DFGLA
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 19/42 (45%), Positives = 31/42 (73%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           M Q+L G+ +LH H+++HRDLK  N+ ++ +  +K+ DFGLA
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%)
Query: 230 RKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIG 289
           R  L +    +R  I+    +++M  IL G+  LH+  ++HRDL  GN+ L+DN  + I 
Sbjct: 117 RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176
Query: 290 DFGLAARIEFDGQR 303
           DF LA     D  +
Sbjct: 177 DFNLAREDTADANK 190

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 19/42 (45%), Positives = 31/42 (73%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           M Q+L G+ +LH H+++HRDLK  N+ ++ +  +K+ DFGLA
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  IE
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 155

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%)
Query: 230 RKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIG 289
           R  L +    +R  I+    +++M  IL G+  LH+  ++HRDL  GN+ L+DN  + I 
Sbjct: 117 RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176
Query: 290 DFGLAARIEFDGQR 303
           DF LA     D  +
Sbjct: 177 DFNLAREDTADANK 190

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +Q+  G++YL + K +HRDL   N  + +N VVKI DFGL+  I
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 36/139 (25%)
Query: 75  YGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFE--------- 125
           +G   Q+  D++ V+            K++  GT NY+ PE +     S E         
Sbjct: 198 FGIANQMQPDTTSVV------------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 126 --VDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--------EYKLPATLKKPAATM 175
              DVWS+GCI+Y +  GK PF+     +  ++I K+        E + P   +K    +
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 176 IKKMLLLDPVQRPPVAQLL 194
           +K  L  DP QR  + +LL
Sbjct: 301 LKCCLKRDPKQRISIPELL 319

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 205
Query: 299 FD 300
            D
Sbjct: 206 PD 207

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 48/248 (19%)
Query: 7   IHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVS 66
           +++   HRNV+    FFE+    Y++ E  R  S++   +      E+   A+  V  V+
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE--ASVVVQDVA 121
Query: 67  KWVDYSDKYGFGYQ-LNDDS--------------------SGVMFNDLTRMIMLANKNTL 105
             +D+    G  ++ L  ++                    SG+  N     I      T 
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTP 181
Query: 106 CGTPNYIAPEILNKNGHSFEV-----DVWSIGCIMYTLLVGKPPFETSTLKET------- 153
           CG+  Y+APE++        +     D+WS+G I+Y LL G PPF      +        
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 154 --------YSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
                   +  I++ +Y+ P    A +   A  +I K+L+ D  QR   AQ+L   +   
Sbjct: 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301
Query: 202 YCP-TSLP 208
             P  +LP
Sbjct: 302 CAPENTLP 309

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 36/59 (61%)
Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           R   + EP   +  +Q++  V YL    IIHRD+K  N+ ++++F +K+ DFG AA +E
Sbjct: 123 RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 103 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 161
Query: 299 FD 300
            D
Sbjct: 162 PD 163

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI + R  K+ N+V +   +     +++++E     S+ ++    C  E       +  +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAP 114
                  S  V + D       L  D S V   D      +    + ++ + GTP ++AP
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 185
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETY--SRIKKVEYKLPATLKKP 171
           E++ +  +  +VD+WS+G +   ++ G+PP+   + L+  Y  +     E + P  L   
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 172 AATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
               + + L +D  +R    +LL  +F     P S
Sbjct: 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 17/44 (38%), Positives = 30/44 (68%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 177
Query: 299 FD 300
            D
Sbjct: 178 PD 179

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 100 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 158
Query: 299 FD 300
            D
Sbjct: 159 PD 160

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 99  KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 157
Query: 299 FD 300
            D
Sbjct: 158 PD 159

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 177
Query: 299 FD 300
            D
Sbjct: 178 PD 179

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 36/139 (25%)
Query: 75  YGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFE--------- 125
           +G   Q+  D++ V+            K++  GT NY+ PE +     S E         
Sbjct: 198 FGIANQMQPDTTSVV------------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 126 --VDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--------EYKLPATLKKPAATM 175
              DVWS+GCI+Y +  GK PF+     +  ++I K+        E + P   +K    +
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 176 IKKMLLLDPVQRPPVAQLL 194
           +K  L  DP QR  + +LL
Sbjct: 301 LKCCLKRDPKQRISIPELL 319

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 205
Query: 299 FD 300
            D
Sbjct: 206 PD 207

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/47 (44%), Positives = 30/47 (63%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +  QI EG++++     IHRDL+  N+ +S + V KI DFGLA  IE
Sbjct: 116 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 162

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 205
Query: 299 FD 300
            D
Sbjct: 206 PD 207

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/57 (45%), Positives = 34/57 (59%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           ++ IT  +   Y  Q+  G+ +L   K IHRDL   N+ LS+N VVKI DFGLA  I
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++Y+     IHRDL+  N+ +S++ + KI DFGLA  IE
Sbjct: 118 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 161

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++Y+     IHRDL+  N+ +S++ + KI DFGLA  IE
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 160

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 31/43 (72%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           ++ Q+L G++Y HD +++HRDLK  NL ++    +KI DFGLA
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/110 (24%), Positives = 56/110 (50%), Gaps = 3/110 (2%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETY--SR 156
           + ++T+ GTP ++APE++ +  +  +VD+WS+G +   ++ G+PP+   + L+  Y  + 
Sbjct: 172 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 231
Query: 157 IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
               E + P  L       + + L +D  +R    +L+  +F     P S
Sbjct: 232 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLS 281

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 16/44 (36%), Positives = 30/44 (68%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           ++ L+ + +LH +++IHR++K  N+ L  +  VK+ DFG  A+I
Sbjct: 124 RECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQI 167

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI + R  K+ N+V +   +     +++++E     S+ ++    C  E       +  +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAP 114
                  S  V + D       L  D S V   D      +    + ++ + GTP ++AP
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSEMVGTPYWMAP 185
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETY--SRIKKVEYKLPATLKKP 171
           E++ +  +  +VD+WS+G +   ++ G+PP+   + L+  Y  +     E + P  L   
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 172 AATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
               + + L +D  +R    +LL  +F     P S
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 17/44 (38%), Positives = 30/44 (68%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 31/43 (72%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           ++ Q+L G++Y HD +++HRDLK  NL ++    +KI DFGLA
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 31/43 (72%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           ++ Q+L G++Y HD +++HRDLK  NL ++    +KI DFGLA
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 21/47 (44%), Positives = 30/47 (63%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +  QI EG++++     IHRDL+  N+ +S + V KI DFGLA  IE
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 24/58 (41%), Positives = 37/58 (63%)
Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI  FGLA
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLA 172

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 17/109 (15%)
Query: 202 YCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSK----------------RRKAIT 245
           YC  +L    ++ A R ++++   N   R P +E+                   + + ++
Sbjct: 66  YCQRTLREIKILLAFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS 124
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
                +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 125 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 173

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 35/53 (66%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI D GLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLA 172

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLA 171

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLA 171

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 17/109 (15%)
Query: 202 YCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSK----------------RRKAIT 245
           YC  +L    ++ A R ++++   N   R P +E+                   + + ++
Sbjct: 66  YCQRTLREIKILLAFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS 124
Query: 246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
                +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 125 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLA 173

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLA 171

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/215 (20%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI + R  K+ N+V +   +     +++++E     S+ ++    C  E       +  +
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 64  WV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAP 114
                  S  V + D       L  D S V   D      +    + ++ + GTP ++AP
Sbjct: 128 QALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 186
Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETY--SRIKKVEYKLPATLKKP 171
           E++ +  +  +VD+WS+G +   ++ G+PP+   + L+  Y  +     E + P  L   
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 246
Query: 172 AATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
               + + L +D  +R    +L+  +F     P S
Sbjct: 247 FRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLS 281

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 17/44 (38%), Positives = 30/44 (68%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I
Sbjct: 124 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 167

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 27/42 (64%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           Y  Q+ EG+ YL   + IHRDL   NL L+   +VKIGDFGL
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 161

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/43 (44%), Positives = 30/43 (69%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +  QIL+G+ + HD +I+HRD+K  N+ +  N  +KI DFG+A
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLA 175

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 27/42 (64%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           Y  Q+ EG+ YL   + IHRDL   NL L+   +VKIGDFGL
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLA 175

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 20/42 (47%), Positives = 29/42 (69%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           M+Q L G+ +LH + I+HRDLK  N+ ++    VK+ DFGLA
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 35/53 (66%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI D GLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLA 172

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 162

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 162

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 20/42 (47%), Positives = 29/42 (69%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           M+Q L G+ +LH + I+HRDLK  N+ ++    VK+ DFGLA
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 171

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 154

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 158

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 155

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLA 191

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 27/42 (64%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           Y  Q+ EG+ YL   + IHRDL   NL L+   +VKIGDFGL
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 20/42 (47%), Positives = 29/42 (69%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           M+Q L G+ +LH + I+HRDLK  N+ ++    VK+ DFGLA
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+   I E D  RK
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 20/42 (47%), Positives = 29/42 (69%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           M+Q L G+ +LH + I+HRDLK  N+ ++    VK+ DFGLA
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 173

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 156

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 35/53 (66%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI D GLA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLA 172

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 133 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 176

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 134 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 177

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 125 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 168

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 126 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 169

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 27/42 (64%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           Y  Q+ EG+ YL   + IHRDL   NL L+   +VKIGDFGL
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 157

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 126 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 169

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI EG++++ +   IHR+L+  N+ +SD    KI DFGLA  IE
Sbjct: 113 QIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIE 156

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 191

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 27/42 (64%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           Y  Q+ EG+ YL   + IHRDL   NL L+   +VKIGDFGL
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 157

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 133 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 176

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 136 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 179

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 21/44 (47%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 171

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 27/42 (64%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           Y  Q+ EG+ YL   + IHRDL   NL L+   +VKIGDFGL
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 161

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 22/42 (52%), Positives = 27/42 (64%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           Y  Q+ EG+ YL   + IHRDL   NL L+   +VKIGDFGL
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 157

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 35/53 (66%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DF LA
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLA 172

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  IE
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 30/44 (68%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +++ QIL G+ Y+H   ++HRDLK  NL ++    +KI DFGLA
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLA 191

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+  K +HRDL   N  ++ +F VKIGDFG+   I E D  RK
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+  K +HRDL   N  ++ +F VKIGDFG+   I E D  RK
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 185

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+  K +HRDL   N  ++ +F VKIGDFG+   I E D  RK
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 7/108 (6%)
Query: 99  LANKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETY 154
            + ++ + GT  +IAPE+L+   K   ++ VD++S GC+ Y ++  G  PF  S  ++  
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239
Query: 155 SRIKKVEYKLPATLKKP---AATMIKKMLLLDPVQRPPVAQLLHFEFF 199
             +           K     A  +I+KM+ +DP +RP    +L   FF
Sbjct: 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 135 RRPPGMEXSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 192 ENNVMKIADFGLARDI 207

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/45 (42%), Positives = 32/45 (71%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + ++ Q+L G++Y H  K++HRDLK  NL +++   +K+ DFGLA
Sbjct: 103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/68 (38%), Positives = 34/68 (50%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L E   K +  I   +   Y  QI +G+ YL   + +HRDL   N+ +     VKIGDFG
Sbjct: 112 LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171
Query: 293 LAARIEFD 300
           L   IE D
Sbjct: 172 LTKAIETD 179

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/68 (38%), Positives = 34/68 (50%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L E   K +  I   +   Y  QI +G+ YL   + +HRDL   N+ +     VKIGDFG
Sbjct: 100 LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 159
Query: 293 LAARIEFD 300
           L   IE D
Sbjct: 160 LTKAIETD 167

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 22/68 (32%), Positives = 41/68 (60%)
Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           + +T+  T +Y APE++ + G S   DVWSIGCI++   VG   F+T   +E  + ++++
Sbjct: 209 HHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERI 268
Query: 161 EYKLPATL 168
              +P+ +
Sbjct: 269 LGPIPSRM 276

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 21/57 (36%), Positives = 35/57 (61%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + +++   ++++ Q L  V  LH   +IHRDLK  NL ++ N  +K+ DFGLA  I+
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 21/57 (36%), Positives = 35/57 (61%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + +++   ++++ Q L  V  LH   +IHRDLK  NL ++ N  +K+ DFGLA  I+
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 2/104 (1%)
Query: 93  LTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE-TSTLK 151
           L R      K +  G   ++APE++  +  S   DVWS G +++ LL G+ PF     L 
Sbjct: 162 LAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221
Query: 152 ETYS-RIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
             Y   + K+   +P+T  +P A +++     DP  RP    +L
Sbjct: 222 VAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 127 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 183
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 184 ENNVMKIADFGLARDI 199

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 21/57 (36%), Positives = 35/57 (61%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + +++   ++++ Q L  V  LH   +IHRDLK  NL ++ N  +K+ DFGLA  I+
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/50 (38%), Positives = 34/50 (68%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +E + RFY  +I+ G+ ++H+  +++RDLK  N+ L ++  V+I D GLA
Sbjct: 290 SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 135 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 192 ENNVMKIADFGLARDI 207

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 124 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 180
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 181 ENNVMKIADFGLARDI 196

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 33/57 (57%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           +TE   +  +  +L G  ++H+  IIHRDLK  N  L+ +  VKI DFGLA  I  D
Sbjct: 128 LTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSD 184

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/50 (38%), Positives = 34/50 (68%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +E + RFY  +I+ G+ ++H+  +++RDLK  N+ L ++  V+I D GLA
Sbjct: 289 SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 338

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 181 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 238 ENNVMKIADFGLARDI 253

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/51 (37%), Positives = 34/51 (66%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           +E + RFY  +I+ G+ ++H+  +++RDLK  N+ L ++  V+I D GLA 
Sbjct: 290 SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/51 (37%), Positives = 34/51 (66%)
Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
           +E + RFY  +I+ G+ ++H+  +++RDLK  N+ L ++  V+I D GLA 
Sbjct: 290 SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 27/44 (61%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL   N+ + +N V K+ DFGLA  IE
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIE 165

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 122 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT 178
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 179 ENNVMKIADFGLARDI 194

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 135 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 192 ENNVMKIADFGLARDI 207

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 135 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 192 ENNVMKIADFGLARDI 207

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 135 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 192 ENNVMKIADFGLARDI 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/43 (44%), Positives = 28/43 (65%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +  QI EG++++     IHRDL+  N+ +S + V KI DFGLA
Sbjct: 283 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 325

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 135 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 192 ENNVMKIADFGLARDI 207

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 135 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 192 ENNVMKIADFGLARDI 207

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 72/172 (41%), Gaps = 28/172 (16%)
Query: 14  RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWV---D 70
           R +   H  F+D  ++Y+++E      ++ L +   +      PA     ++++ V   D
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE----RIPAEMARFYLAEIVMAID 176
Query: 71  YSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKNTL-----CGTPNYIAPEILN 118
              + G+ ++       L D    +   D    + L    T+      GTP+Y++PEIL 
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 119 KNGHSF-------EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYK 163
             G          E D W++G   Y +  G+ PF   +  ETY +I  V YK
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI--VHYK 286

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/56 (37%), Positives = 34/56 (60%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +TE   +  +  +L GV Y+H   I+HRDLK  N  ++ +  VK+ DFGLA  +++
Sbjct: 153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 135 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 282 DNFVVKIGDFGLAARI 297
           +N V+KI DFGLA  I
Sbjct: 192 ENNVMKIADFGLARDI 207

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/66 (36%), Positives = 39/66 (59%), Gaps = 4/66 (6%)
Query: 104 TLCGTPNYIAPEILNKNGHSF--EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI--KK 159
           T  GTP ++APE+LN    S+  + D WS G +++ LL+G  PF      +T S++  KK
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292
Query: 160 VEYKLP 165
           + ++ P
Sbjct: 293 LCFENP 298

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 27/44 (61%), Gaps = 2/44 (4%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDN--FVVKIGDFGLA 294
           M+QI   + YLH+  I HRD+K  N   S N  F +K+ DFGL+
Sbjct: 174 MRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLS 217

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/76 (31%), Positives = 40/76 (52%)
Query: 225 FNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF 284
            N  RRK   + + +  + +   +   +  Q+ +G+++L     IHRD+   N+ L++  
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 189
Query: 285 VVKIGDFGLAARIEFD 300
           V KIGDFGLA  I  D
Sbjct: 190 VAKIGDFGLARDIMND 205

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/244 (21%), Positives = 96/244 (39%), Gaps = 49/244 (20%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EI + + LKH N+V     F   + ++++ E C    + EL      + E      + +
Sbjct: 51  REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEH---LVKSI 107
Query: 63  IWVS-KWVDYSDKYGFGYQ-LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKN 120
            W + + V++  K+   ++ +  ++  +  + + ++        L G  +Y   E+  + 
Sbjct: 108 TWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW 167
Query: 121 GHSFE-----------VDVWSIGCIMYTLLVGKPPFET-----------STLKETYSRIK 158
             S E           VDVW+IGC+   LL G P +              TL +   R +
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227
Query: 159 KV---------------------EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE 197
           +V                     E K P  +  PA  ++K  L +DP +R    QLLH  
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFP-NISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
Query: 198 FFND 201
           +F +
Sbjct: 287 YFEN 290

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 33/57 (57%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            + ++ + E   +    Q L+ V++ H H  IHRD+K  N+ ++ + V+K+ DFG A
Sbjct: 93  DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA 149

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 18/44 (40%), Positives = 27/44 (61%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           QI  G++Y+     +HRDL+  N+ + +N V K+ DFGL   IE
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIE 332

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+  K +HRDL   N  ++ +F VKIGDFG+   I E D  RK
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 32/49 (65%), Gaps = 3/49 (6%)
Query: 250 RFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSD-NFVVKIGDFGLAA 295
           R + +QIL+G+ +LH     IIHRDLK  N+F++     VKIGD GLA 
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 27/43 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL + K +HRDL   N  L ++F VK+ DFGLA  I
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+  K +HRDL   N  ++ +F VKIGDFG+   I E D  RK
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 187

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/76 (31%), Positives = 40/76 (52%)
Query: 225 FNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF 284
            N  RRK   + + +  + +   +   +  Q+ +G+++L     IHRD+   N+ L++  
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 197
Query: 285 VVKIGDFGLAARIEFD 300
           V KIGDFGLA  I  D
Sbjct: 198 VAKIGDFGLARDIMND 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/216 (20%), Positives = 89/216 (41%), Gaps = 32/216 (14%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+AI + L+H N+V F         + I+ E   + S+  L + +   E++ +     +
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 63  IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN---TLC------------- 106
                   Y    G  Y L++ +  ++  DL    +L +K     +C             
Sbjct: 143 A-------YDVAKGMNY-LHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL 194
Query: 107 ------GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI--K 158
                 GTP ++APE+L     + + DV+S G I++ L   + P+      +  + +  K
Sbjct: 195 XSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254
Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
               ++P  L    A +I+     +P +RP  A ++
Sbjct: 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 2/41 (4%)
Query: 256 ILEGVSYLHDHK--IIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + +G++YLH+    I+HRDLK  NL +   + VK+ DFGL+
Sbjct: 146 VAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 186

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 22/44 (50%), Positives = 29/44 (65%)
Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           G+ YLH   IIHRD+K  N+ L +NFV KI DFG++ +    GQ
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQ 194

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 39/76 (51%), Gaps = 10/76 (13%)
Query: 229 RRKPLMERNSKRRKAITEPETRFYMK-------QILEGVSYLHDHKIIHRDLKLGNLFLS 281
           RR P ME +    +    PE +   K       Q+  G+ YL   K IHRDL   N+ ++
Sbjct: 135 RRPPGMEYSYDINRV---PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191
Query: 282 DNFVVKIGDFGLAARI 297
           +N V++I DFGLA  I
Sbjct: 192 ENNVMRIADFGLARDI 207

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 19/43 (44%), Positives = 29/43 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +I +G++YL+  K +HRDL   N  ++ +F VKIGDFG+   I
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGLA  +E D
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDD 200

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 229 RRKPLMERNSKRRKAITEPETR---FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV 285
           R+  ++E +     A +   TR    +  Q+ +G+++L     IHRD+   N+ L++  V
Sbjct: 143 RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202
Query: 286 VKIGDFGLAARIEFD 300
            KIGDFGLA  I  D
Sbjct: 203 AKIGDFGLARDIMND 217

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + + H+N++G  + F      E+ + VYI++EL    ++ ++     D E MS 
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY 130
Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP------- 109
              Q +  +     +    G  ++    S+ V+ +D T  I+        GT        
Sbjct: 131 LLYQMLCGIK----HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEV 186
Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR-IKKVEYKLP 165
               Y APE++   G+   VD+WS+GCIM  ++  K  F      + +++ I+++    P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 166 ATLKKPAATM 175
           A +KK   T+
Sbjct: 247 AFMKKLQPTV 256

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 238

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 203

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/46 (50%), Positives = 29/46 (63%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 250

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/46 (50%), Positives = 29/46 (63%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 248

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 20/38 (52%), Positives = 27/38 (71%)
Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR 296
           G+ YLH   IIHRD+K  N+ L +NFV KI DFG++ +
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + + H+N++G  + F      E+ + VYI++EL    ++ ++     D E MS 
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY 130
Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP------- 109
              Q ++ +     +    G  ++    S+ V+ +D T  I+        GT        
Sbjct: 131 LLYQMLVGIK----HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV 186
Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
               Y APE++   G+   VD+WS+GCIM  ++ G   F  +   + ++++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA 173

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/36 (50%), Positives = 26/36 (72%)
Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           G+++LH++  IHRD+K  N+ L + F  KI DFGLA
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 48/208 (23%)
Query: 2   SQEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMS 55
           ++E+ I R +KH NVV   +FF      +D  F+ ++LE   +     +Y ++    ++ 
Sbjct: 80  NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLK 135
Query: 56  DPAAQPVIWVSKW-------VDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN 101
                P++ +  +       + Y    G  ++       L D  SGV+     ++I   +
Sbjct: 136 Q--TMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL-----KLIDFGS 188
Query: 102 KNTL-CGTPN--------YIAPE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK 151
              L  G PN        Y APE I     ++  +D+WS GC+M  L+ G+P F   +  
Sbjct: 189 AKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI 248
Query: 152 ETYSRIKKVEYKLPATLKKPAATMIKKM 179
           +    I KV       L  P+   IK M
Sbjct: 249 DQLVEIIKV-------LGTPSREQIKTM 269

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 123 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 166

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/229 (21%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 13  HRNVVGFHSFFEDSKFVYIILELC---------------RKRSMMELYNSACDLEEMSDP 57
           H NV+ ++      +F+YI LELC                   + + YN    L +++  
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 58  AA---------QPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLT--------RMIMLA 100
            A         + +   +  V  S ++    Q   ++  ++ +D          +     
Sbjct: 146 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 101 NKNTLCGTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLV-GKPPF------ETSTL 150
           N N   GT  + APE+L    K   +  +D++S+GC+ Y +L  GK PF      E++ +
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           +  +S + +++     +L   A  +I +M+  DP++RP   ++L    F
Sbjct: 266 RGIFS-LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 13/59 (22%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLS-------------DNFVVKIGDFGLAARIE 298
           ++QI  GV++LH  KIIHRDLK  N+ +S             +N  + I DFGL  +++
Sbjct: 139 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/36 (50%), Positives = 26/36 (72%)
Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           G+++LH++  IHRD+K  N+ L + F  KI DFGLA
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/215 (20%), Positives = 86/215 (40%), Gaps = 30/215 (13%)
Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+AI + L+H N+V F         + I+ E   + S+  L + +   E++ +     +
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 63  IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTL----------------- 105
                   Y    G  Y  N +   V  N  +  +++  K T+                 
Sbjct: 143 A-------YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
Query: 106 ----CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI--KK 159
                GTP ++APE+L     + + DV+S G I++ L   + P+      +  + +  K 
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC 255
Query: 160 VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
              ++P  L    A +I+     +P +RP  A ++
Sbjct: 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/229 (21%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 13  HRNVVGFHSFFEDSKFVYIILELC---------------RKRSMMELYNSACDLEEMSDP 57
           H NV+ ++      +F+YI LELC                   + + YN    L +++  
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 58  AA---------QPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLT--------RMIMLA 100
            A         + +   +  V  S ++    Q   ++  ++ +D          +     
Sbjct: 146 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 101 NKNTLCGTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLV-GKPPF------ETSTL 150
           N N   GT  + APE+L    K   +  +D++S+GC+ Y +L  GK PF      E++ +
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           +  +S + +++     +L   A  +I +M+  DP++RP   ++L    F
Sbjct: 266 RGIFS-LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 13/59 (22%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLS-------------DNFVVKIGDFGLAARIE 298
           ++QI  GV++LH  KIIHRDLK  N+ +S             +N  + I DFGL  +++
Sbjct: 139 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 95  RMIMLANKNTLCGTPNYIAPEILNKNGH---SFEVDVWSIGCIMYTLLVGKPPFETSTLK 151
           R  ++  + T   TP Y  PEI++   +     + D+W++GCI+Y L   + PFE     
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--- 256
Query: 152 ETYSRIKKVEYKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
               RI   +Y +P   T      ++I+ ML ++P +R  +A+++H
Sbjct: 257 -AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVH 301

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 4/49 (8%)
Query: 251 FYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           FY  Q    V ++H  K  IIHRDLK+ NL LS+   +K+ DFG A  I
Sbjct: 142 FY--QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKD 197

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/68 (33%), Positives = 38/68 (55%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L++   + R  +   +   +  QI +G+SYL D +++HRDL   N+ +     VKI DFG
Sbjct: 105 LLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFG 164
Query: 293 LAARIEFD 300
           LA  ++ D
Sbjct: 165 LARLLDID 172

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/51 (37%), Positives = 30/51 (58%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +T+ +     +QI  G+ YL     +HRDL   N  + +N +VKIGDFG++
Sbjct: 125 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 175

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 22/54 (40%), Positives = 33/54 (61%)
Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +TE   +  +  +L G +++H+  IIHRDLK  N  L+ +  VK+ DFGLA  I
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/49 (48%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA  I  D
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKD 197

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/36 (50%), Positives = 26/36 (72%)
Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           G+++LH++  IHRD+K  N+ L + F  KI DFGLA
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 174

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 22/48 (45%), Positives = 32/48 (66%), Gaps = 5/48 (10%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFL-----SDNFVVKIGDFGLA 294
           ++ Q++ GV++ H  + +HRDLK  NL L     S+  V+KIGDFGLA
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/36 (50%), Positives = 26/36 (72%)
Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           G+++LH++  IHRD+K  N+ L + F  KI DFGLA
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 171

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           +  Q+ +G+++L     IHRD+   N+ L++  V KIGDFGLA  I  D
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           +  Q+ +G+++L     IHRD+   N+ L++  V KIGDFGLA  I  D
Sbjct: 171 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 3/65 (4%)
Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +ERN    K +T      Y  QI + ++YL     +HRD+ + N+ ++    VK+GDFGL
Sbjct: 115 LERNKNSLKVLT---LVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 171
Query: 294 AARIE 298
           +  IE
Sbjct: 172 SRYIE 176

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 3/65 (4%)
Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +ERN    K +T      Y  QI + ++YL     +HRD+ + N+ ++    VK+GDFGL
Sbjct: 99  LERNKNSLKVLT---LVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 155
Query: 294 AARIE 298
           +  IE
Sbjct: 156 SRYIE 160

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 124 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           +  Q+ +G+++L     IHRD+   N+ L++  V KIGDFGLA  I  D
Sbjct: 163 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + + H+N++G  + F      E+ + VYI++EL    ++ ++     D E MS 
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY 130
Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP------- 109
              Q +  +     +    G  ++    S+ V+ +D T  I+        GT        
Sbjct: 131 LLYQMLCGIK----HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEV 186
Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR-IKKVEYKLP 165
               Y APE++   G+   VD+WS+GCIM  ++ G   F  +   + +++ I+++    P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 166 ATLKKPAATM 175
             +KK   T+
Sbjct: 247 EFMKKLQPTV 256

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 153 LRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 3/65 (4%)
Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +ERN    K +T      Y  QI + ++YL     +HRD+ + N+ ++    VK+GDFGL
Sbjct: 103 LERNKNSLKVLT---LVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159
Query: 294 AARIE 298
           +  IE
Sbjct: 160 SRYIE 164

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 124 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 36/65 (55%)
Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           + +TL  T +Y APE++   G S   DVWSIGCI+    +G   F T   KE  + ++++
Sbjct: 190 HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 161 EYKLP 165
              LP
Sbjct: 250 LGPLP 254

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 141 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 188

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + + H+N++G  + F      E+ + VYI++EL    ++ ++     D E MS 
Sbjct: 74  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY 132
Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP------- 109
              Q +  +     +    G  ++    S+ V+ +D T  I+        GT        
Sbjct: 133 LLYQMLCGIK----HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFV 188
Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR-IKKVEYKLP 165
               Y APE++   G+   VD+WS+GCIM  ++ G   F  +   + +++ I+++    P
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 248
Query: 166 ATLKKPAATM 175
             +KK   T+
Sbjct: 249 EFMKKLQPTV 258

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 132 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 175

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 153 LRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 15/114 (13%)
Query: 100 ANKNTLCGTPNYIAPEILNKNGH-------SFEVDVWSIGCIMYTLLV-GKPPF------ 145
            N N   GT  + APE+L ++ +       +  +D++S+GC+ Y +L  GK PF      
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 146 ETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           E++ ++  +S + +++     +L   A  +I +M+  DP++RP   ++L    F
Sbjct: 247 ESNIIRGIFS-LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 13/59 (22%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLS-------------DNFVVKIGDFGLAARIE 298
           ++QI  GV++LH  KIIHRDLK  N+ +S             +N  + I DFGL  +++
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 20/50 (40%), Positives = 27/50 (54%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
            Y  QI +G+ YL   + +HRDL   N+ +     VKI DFGLA  +  D
Sbjct: 115 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 164

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 59/113 (52%), Gaps = 15/113 (13%)
Query: 101 NKNTLCGTPNYIAPEILNKNGH-------SFEVDVWSIGCIMYTLLV-GKPPF------E 146
           N N   GT  + APE+L ++ +       +  +D++S+GC+ Y +L  GK PF      E
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 147 TSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           ++ ++  +S + +++     +L   A  +I +M+  DP++RP   ++L    F
Sbjct: 248 SNIIRGIFS-LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 13/59 (22%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLS-------------DNFVVKIGDFGLAARIE 298
           ++QI  GV++LH  KIIHRDLK  N+ +S             +N  + I DFGL  +++
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + + H+N++G  + F      E+ + VYI++EL    ++ ++     D E MS 
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY 130
Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP------- 109
              Q +  +     +    G  ++    S+ V+ +D T  I+        GT        
Sbjct: 131 LLYQMLCGIK----HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR-IKKVEYKLP 165
               Y APE++   G+   VD+WS+GCIM  ++ G   F  +   + +++ I+++    P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 166 ATLKKPAATM 175
             +KK   T+
Sbjct: 247 EFMKKLQPTV 256

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + + H+N++G  + F      E+ + VYI++EL    ++ ++     D E MS 
Sbjct: 73  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY 131
Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP------- 109
              Q +  +     +    G  ++    S+ V+ +D T  I+        GT        
Sbjct: 132 LLYQMLCGIK----HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187
Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR-IKKVEYKLP 165
               Y APE++   G+   VD+WS+GCIM  ++ G   F  +   + +++ I+++    P
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247
Query: 166 ATLKKPAATM 175
             +KK   T+
Sbjct: 248 EFMKKLQPTV 257

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 21/62 (33%), Positives = 30/62 (48%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + R  +       Y  QI +G+ YL   + +HRDL   N+ +     VKI DFGLA  + 
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178
Query: 299 FD 300
            D
Sbjct: 179 LD 180

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 151 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 198

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA 173

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA 173

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 21/62 (33%), Positives = 30/62 (48%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + R  +       Y  QI +G+ YL   + +HRDL   N+ +     VKI DFGLA  + 
Sbjct: 106 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 165
Query: 299 FD 300
            D
Sbjct: 166 LD 167

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 21/62 (33%), Positives = 30/62 (48%)
Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + R  +       Y  QI +G+ YL   + +HRDL   N+ +     VKI DFGLA  + 
Sbjct: 107 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 166
Query: 299 FD 300
            D
Sbjct: 167 LD 168

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/57 (35%), Positives = 31/57 (54%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +A+  P       Q+  G++Y+     IHRDL+  N+ + +  + KI DFGLA  IE
Sbjct: 100 RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIE 156

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 33/51 (64%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+  K +HR+L   N  ++ +F VKIGDFG+   I E D  RK
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 33/51 (64%), Gaps = 1/51 (1%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFDGQRK 304
           +I +G++YL+  K +HR+L   N  ++ +F VKIGDFG+   I E D  RK
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 189

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 16/42 (38%), Positives = 26/42 (61%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF 145
            + GT  Y++PE    +      DV+S+GC++Y +L G+PPF
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
           +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 28/48 (58%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL   +E D
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 16/42 (38%), Positives = 26/42 (61%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF 145
            + GT  Y++PE    +      DV+S+GC++Y +L G+PPF
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 16/42 (38%), Positives = 26/42 (61%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF 145
            + GT  Y++PE    +      DV+S+GC++Y +L G+PPF
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  IE D
Sbjct: 151 LRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 16/42 (38%), Positives = 26/42 (61%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF 145
            + GT  Y++PE    +      DV+S+GC++Y +L G+PPF
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 18/57 (31%), Positives = 32/57 (56%), Gaps = 1/57 (1%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKK 159
            + GT  Y++PE    +      DV+S+GC++Y +L G+PPF   S +   Y  +++
Sbjct: 195 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 251

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 16/42 (38%), Positives = 26/42 (61%)
Query: 104 TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF 145
            + GT  Y++PE    +      DV+S+GC++Y +L G+PPF
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 151 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 193

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 150 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 192

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 147 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 189

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 135 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 178

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 167

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 128 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 171

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 167

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 129 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 172

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 167

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 78/171 (45%), Gaps = 21/171 (12%)
Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + + H+N++G  + F      E+ + VYI++EL    ++ ++     D E MS 
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY 130
Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP------- 109
              Q +  +     +    G  ++    S+ V+ +D T  I+        GT        
Sbjct: 131 LLYQMLCGIK----HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 110 ---NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
               Y APE++   G+   VD+WS+GCIM  ++ G   F  +   + ++++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           Q+  G+ YL   K IHRDL   N+ ++++ V+KI DFGLA  I
Sbjct: 199 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA 173

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 107 GTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
           GT  Y  PE ++++  H+    VWS+G ++Y ++ G  PFE          I + E   P
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFP 253
Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           A +      +I++ L   P  RP + ++L
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFGL+  +E
Sbjct: 143 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 190

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA 173

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFGL+  +E
Sbjct: 112 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 130 LRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 29/44 (65%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFGL+  +E
Sbjct: 118 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 165

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFGL+  +E
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 162

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFGL+  +E
Sbjct: 117 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 164

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFGL+  +E
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 162

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFGL+  +E
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 160 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 199

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 140 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 179

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 133 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 172

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFGL+  +E
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 162

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 141 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 138 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 140 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 179

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 141 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 159 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 198

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           + EG++YL +  +IHRDL   N  + +N V+K+ DFG+  R   D Q
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQ 157

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 25/40 (62%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ YL   K +HRDL   N  L + F VK+ DFGLA
Sbjct: 139 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 178

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 153 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/40 (50%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI EG++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 122 QIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 161

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 161 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 141 LRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 163 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/62 (38%), Positives = 33/62 (53%)
Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L E   K ++ I   +   Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFG
Sbjct: 103 LREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 162
Query: 293 LA 294
           L 
Sbjct: 163 LT 164

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFGL+  +E
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFG++  +E D
Sbjct: 137 LRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 204 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 118 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 160

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 164

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 164

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 117 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 159

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 123 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 165

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 130 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 124 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 166

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 126 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 168

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 125 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 167

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/43 (39%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +   +  G+ YL   + IHRDL   N+ + +N+V KI DFGL+
Sbjct: 137 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 179

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 137 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 138 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/43 (39%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +   +  G+ YL   + IHRDL   N+ + +N+V KI DFGL+
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAAR 296
           S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A +
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 297 I 297
           +
Sbjct: 173 L 173

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 144 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAAR 296
           S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A +
Sbjct: 114 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 173
Query: 297 I 297
           +
Sbjct: 174 L 174

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAAR 296
           S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A +
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 297 I 297
           +
Sbjct: 173 L 173

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAAR 296
           S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A +
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 297 I 297
           +
Sbjct: 173 L 173

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 133 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAAR 296
           S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A +
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 297 I 297
           +
Sbjct: 173 L 173

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/53 (35%), Positives = 29/53 (54%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           + A+  P+    + QI  G+ YL  H ++H+DL   N+ + D   VKI D GL
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 191

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAAR 296
           S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A +
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 297 I 297
           +
Sbjct: 173 L 173

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAAR 296
           S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A +
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 297 I 297
           +
Sbjct: 173 L 173

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFG++  +E D
Sbjct: 122 LRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 169

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
           + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A ++
Sbjct: 137 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAAR 296
           S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A +
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 297 I 297
           +
Sbjct: 173 L 173

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAAR 296
           S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DFG A +
Sbjct: 117 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 176
Query: 297 I 297
           +
Sbjct: 177 L 177

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 179

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL 
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 179

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFG++  +E D
Sbjct: 116 LRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 163

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/53 (35%), Positives = 29/53 (54%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           + A+  P+    + QI  G+ YL  H ++H+DL   N+ + D   VKI D GL
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + K I  G++YLH   IIHRDL   N  + +N  V + DFGLA
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA 155

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           + EG++YL +  +IHRDL   N  + +N V+K+ DFG+  R   D Q
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQ 158

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI---EFD 300
           Q+ +G+ +L   K +HRDL   N  L + F VK+ DFGLA  +   EFD
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           + EG++YL +  +IHRDL   N  + +N V+K+ DFG+  R   D Q
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQ 155

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           + EG++YL +  +IHRDL   N  + +N V+K+ DFG+  R   D Q
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQ 160

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 256 ILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQ 302
           + EG++YL +  +IHRDL   N  + +N V+K+ DFG+  R   D Q
Sbjct: 112 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQ 157

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 39/65 (60%), Gaps = 1/65 (1%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFD 300
           +A+T  +   +  QI +G+ YL + K++HRDL   N+ +++   +KI DFGL+  + E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 301 GQRKR 305
              KR
Sbjct: 205 SXVKR 209

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI---EFD 300
           Q+ +G+ +L   K +HRDL   N  L + F VK+ DFGLA  +   EFD
Sbjct: 142 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 190

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI---EFD 300
           Q+ +G+ +L   K +HRDL   N  L + F VK+ DFGLA  +   EFD
Sbjct: 141 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 189

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI---EFD 300
           Q+ +G+ +L   K +HRDL   N  L + F VK+ DFGLA  +   EFD
Sbjct: 139 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 187

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI---EFD 300
           Q+ +G+ +L   K +HRDL   N  L + F VK+ DFGLA  +   EFD
Sbjct: 146 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 194

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/54 (37%), Positives = 28/54 (51%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R+ +T     +   QI   + YL     IHRDL   N  + +N VVK+ DFGL+
Sbjct: 124 REEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLS 177

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI---EFD 300
           Q+ +G+ +L   K +HRDL   N  L + F VK+ DFGLA  +   EFD
Sbjct: 141 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 189

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI---EFD 300
           Q+ +G+ +L   K +HRDL   N  L + F VK+ DFGLA  +   EFD
Sbjct: 142 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFD 190

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL +   +HRDL   N+ ++ N V K+ DFGL+  +E D
Sbjct: 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/65 (33%), Positives = 36/65 (55%), Gaps = 2/65 (3%)
Query: 239 KRRKAITEPETRFYM-KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           + ++ +   ET   M   + EG++YL +  +IHRDL   N  + +N V+K+ DFG+  R 
Sbjct: 114 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRF 172
Query: 298 EFDGQ 302
             D Q
Sbjct: 173 VLDDQ 177

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/46 (43%), Positives = 29/46 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           QI +G+ YL + +++HRDL   N+ +     VKI DFGLA  +E D
Sbjct: 148 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 193

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/57 (35%), Positives = 32/57 (56%), Gaps = 3/57 (5%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK---PPFETSTLKETYSR 156
           N+  GT +Y+APE L    +S + D+WS+G  +  L VG+   PP +   L+  + R
Sbjct: 171 NSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGR 227

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/55 (36%), Positives = 34/55 (61%), Gaps = 1/55 (1%)
Query: 241 RKAITEP-ETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R  I EP   ++ + Q+++ + YLH   ++HRD+K  N+ L+    VK+ DFGL+
Sbjct: 102 RANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS 156

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 159 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 198

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 35/65 (53%)
Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           + +TL    +Y APE++   G S   DVWSIGCI+    +G   F T   KE  + ++++
Sbjct: 190 HHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 161 EYKLP 165
              LP
Sbjct: 250 LGPLP 254

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/46 (47%), Positives = 31/46 (67%), Gaps = 1/46 (2%)
Query: 248 ETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +TR   ++I++G+ YLH   I+H+DLK  N+F  DN  V I DFGL
Sbjct: 131 KTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGL 175

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 28/46 (60%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Q+ +G+++L     IHRDL   N+ L+   + KI DFGLA  I+ D
Sbjct: 176 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKND 221

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 39/65 (60%), Gaps = 1/65 (1%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFD 300
           +A+T  +   +  QI +G+ YL + K++HRDL   N+ +++   +KI DFGL+  + E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 301 GQRKR 305
              KR
Sbjct: 205 SYVKR 209

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 135 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 174

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 18/59 (30%), Positives = 32/59 (54%)
Query: 243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG 301
           ++ E +   Y++  L  +++LH   ++H D+K  N+FL      K+GDFGL   +   G
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 18/40 (45%), Positives = 24/40 (60%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI  G+ YL     +HRDL   N  +  N +VKIGDFG++
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 171

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 165

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 129 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 168

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 166

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 171

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/46 (43%), Positives = 29/46 (63%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           QI +G+ YL + +++HRDL   N+ +     VKI DFGLA  +E D
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 170

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 165

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 166

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 171

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 150 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 189

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 20/55 (36%), Positives = 37/55 (67%), Gaps = 1/55 (1%)
Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLA 294
           R+ +T+ + RFYM +IL+ + Y H   I+HRD+K  N+ +  ++  +++ D+GLA
Sbjct: 125 RQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 131 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 170

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           QI +G++YL D +++HRDL   N+ +     VKI DFGLA
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ +  G+ YL D   +HRDL   N+ +  N V K+ DFGL+  +E D
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ +  G+ YL D   +HRDL   N+ +  N V K+ DFGL+  +E D
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 52/105 (49%), Gaps = 10/105 (9%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           N+  GT +Y++PE L    +S + D+WS+G  +  + VG+ P  + +   + +  + ++Y
Sbjct: 180 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGS--GSMAIFELLDY 237
Query: 163 -------KLPATL-KKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                  KLP+ +        + K L+ +P +R  + QL+   F 
Sbjct: 238 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 282

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 28/46 (60%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Q+ +G+++L     IHRDL   N+ L+   + KI DFGLA  I+ D
Sbjct: 169 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 214

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 28/46 (60%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Q+ +G+++L     IHRDL   N+ L+   + KI DFGLA  I+ D
Sbjct: 176 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 221

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 17/46 (36%), Positives = 28/46 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++ I  G+ YL +   +HRDL   N+ ++ N V K+ DFGL+  +E
Sbjct: 122 LRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 167

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 28/46 (60%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Q+ +G+++L     IHRDL   N+ L+   + KI DFGLA  I+ D
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 28/46 (60%)
Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           Q+ +G+++L     IHRDL   N+ L+   + KI DFGLA  I+ D
Sbjct: 171 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 216

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 16/43 (37%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +   +  G+ YL   + IHR+L   N+ + +N+V KI DFGL+
Sbjct: 144 FAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLS 186

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 19/43 (44%), Positives = 26/43 (60%)
Query: 252 YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Y  QI +G+ YL   + IHR+L   N+ + +   VKIGDFGL 
Sbjct: 120 YTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLT 162

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 17/46 (36%), Positives = 28/46 (60%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++ I  G+ YL +   +HRDL   N+ ++ N V K+ DFGL+  +E
Sbjct: 124 LRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 169

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 46/99 (46%), Gaps = 2/99 (2%)
Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI-KKVE 161
           N   GT +Y++PE L    +S + D+WS+G  +  + VG+ P     + E    I  +  
Sbjct: 164 NEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPP 223
Query: 162 YKLP-ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
            KLP A         + K L+ +P +R  + QL+   F 
Sbjct: 224 PKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 262

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 18/71 (25%), Positives = 36/71 (50%), Gaps = 1/71 (1%)
Query: 99  LANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK 158
           L       GT  Y APE  +++  ++  D++++ C++Y  L G PP++   L    + I 
Sbjct: 189 LTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVXGAHIN 248
Query: 159 KVEYKLPATLK 169
           +     P+T++
Sbjct: 249 QA-IPRPSTVR 258

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 17/48 (35%), Positives = 28/48 (58%)
Query: 251 FYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            Y  Q+   ++YL   + +HRD+   N+ +S    VK+GDFGL+  +E
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME 162

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K + E + YL   + +HRDL   N  ++D  VVK+ DFGL+
Sbjct: 111 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 151

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K + E + YL   + +HRDL   N  ++D  VVK+ DFGL+
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K + E + YL   + +HRDL   N  ++D  VVK+ DFGL+
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K + E + YL   + +HRDL   N  ++D  VVK+ DFGL+
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K + E + YL   + +HRDL   N  ++D  VVK+ DFGL+
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 152

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 20/68 (29%), Positives = 37/68 (54%)
Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           +  T+  T +Y  PE++ + G +   DVWSIGCI++    G   F+T   +E    ++K+
Sbjct: 204 HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 263
Query: 161 EYKLPATL 168
              +P+ +
Sbjct: 264 LGPIPSHM 271

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K + E + YL   + +HRDL   N  ++D  VVK+ DFGL+
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 152

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/68 (29%), Positives = 37/68 (54%)
Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           +  T+  T +Y  PE++ + G +   DVWSIGCI++    G   F+T   +E    ++K+
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 254
Query: 161 EYKLPATL 168
              +P+ +
Sbjct: 255 LGPIPSHM 262

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/68 (29%), Positives = 37/68 (54%)
Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           +  T+  T +Y  PE++ + G +   DVWSIGCI++    G   F+T   +E    ++K+
Sbjct: 227 HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 286
Query: 161 EYKLPATL 168
              +P+ +
Sbjct: 287 LGPIPSHM 294

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/65 (33%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI-EFD 300
           +A+T  +   +  QI +G+ YL +  ++HRDL   N+ +++   +KI DFGL+  + E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 301 GQRKR 305
              KR
Sbjct: 205 SXVKR 209

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           ++ I  G+ YL D   +HR L   N+ ++ N V K+ DFGL+  +E D
Sbjct: 115 LRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDD 162

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K + E + YL   + +HRDL   N  ++D  VVK+ DFGL+
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 158

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	305
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-64
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-60
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-14
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-56
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-14
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-48
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-18
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-46
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-17
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-39
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-15
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-38
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-38
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-37
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-37
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-37
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-15
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-37
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-36
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-15
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-36
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-36
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-15
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-36
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-36
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-35
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-35
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-35
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-35
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-34
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-14
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-34
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-34
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-34
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-34
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-34
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-14
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-34
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-14
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-18
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-32
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-18
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-22
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-31
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-17
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-21
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-30
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-30
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-30
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-30
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-30
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-29
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-29
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-29
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-16
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-28
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-28
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-28
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-17
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-16
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-17
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-18
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-06
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-07
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-07
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-12
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-24
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-23
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-11
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-12
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-23
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-23
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-23
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-22
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-11
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-10
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-12
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-21
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-12
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-21
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-12
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-21
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-19
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-06
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-21
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-17
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-20
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-18
1q4k_B	259	Serine/threonine-protein kinase PLK; six-stranded	3e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-13
3p34_A	232	Serine/threonine-protein kinase PLK1; phosphoprote	9e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-08
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-18
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-08
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-07
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-10
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-09
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-09
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-05
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-16
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-08
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-14
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-16
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-10
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-08
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-15
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-06
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-09
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-14
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-10
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-14
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-12
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-14
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-12
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-14
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-09
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-14
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-09
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-13
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-06
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-13
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-06
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-13
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-07
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-13
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-06
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-05
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-10
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-10
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-12
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-10
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-12
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-11
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-12
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-11
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-05
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-08
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-11
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-11
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-11
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-10
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-11
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-10
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-10
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-11
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-08
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-11
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-07
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-11
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-08
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-11
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-11
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-11
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-11
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-04
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-11
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-06
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-11
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-08
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-11
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-11
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-11
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-11
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-10
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-10
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-10
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-10
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-10
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-10
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-10
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-04
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-10
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-06
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-10
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-04
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-10
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-10
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-10
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-10
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-10
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-10
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-04
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-10
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-10
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-10
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-10
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-10
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-10
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-10
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-05
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-10
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-10
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-10
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-10
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-10
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-09
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-09
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-09
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-09
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-09
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-09
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-09
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-06
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-07
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-04
1mby_A	88	SAK, serine/threonine kinase; POLO domain, strand	8e-04

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  201 bits (515), Expect = 6e-64
 Identities = 65/235 (27%), Positives = 112/235 (47%), Gaps = 44/235 (18%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  E+ IH  LKH +++  +++FEDS +VY++LE+C    M     +    +  S+  A+
Sbjct: 58  VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEAR 115

Query: 61  PVIW-VSKWVDY--------------------------SDKYGFGYQLNDDSSGVMFNDL 93
             +  +   + Y                          +D   FG      ++ +     
Sbjct: 116 HFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIAD---FGL-----ATQLKMPHE 167

Query: 94  TRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET 153
                     TLCGTPNYI+PEI  ++ H  E DVWS+GC+ YTLL+G+PPF+T T+K T
Sbjct: 168 KHY-------TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220

Query: 154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLP 208
            +++   +Y++P+ L   A  +I ++L  +P  R  ++ +L   F +    T   
Sbjct: 221 LNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSK 275

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  113 bits (284), Expect = 1e-29
 Identities = 30/73 (41%), Positives = 43/73 (58%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           +      R K  +E E R +M QI+ G+ YLH H I+HRDL L NL L+ N  +KI DFG
Sbjct: 98  MNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157

Query: 293 LAARIEFDGQRKR 305
           LA +++   ++  
Sbjct: 158 LATQLKMPHEKHY 170

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  194 bits (494), Expect = 3e-60
 Identities = 84/137 (61%), Positives = 96/137 (70%), Gaps = 1/137 (0%)

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           K  LCGTPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK E
Sbjct: 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN-DYCPTSLPASCLMTAPRFDS 220
           Y +P  +   AA++I+KML  DP  RP + +LL+ EFF   Y P  LP +CL   PRF  
Sbjct: 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI 317

Query: 221 VVPSFNSPRRKPLMERN 237
              S +   RKPL   N
Sbjct: 318 APSSLDPSNRKPLTVLN 334

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (297), Expect = 4e-31
 Identities = 43/67 (64%), Positives = 59/67 (88%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           KRRKA+TEPE R+Y++QI+ G  YLH +++IHRDLKLGNLFL+++  VKIGDFGLA ++E
Sbjct: 133 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192

Query: 299 FDGQRKR 305
           +DG+RK+
Sbjct: 193 YDGERKK 199

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 70.0 bits (172), Expect = 6e-14
 Identities = 30/44 (68%), Positives = 40/44 (90%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMEL 44
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL 131

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  183 bits (466), Expect = 2e-56
 Identities = 81/124 (65%), Positives = 93/124 (75%), Gaps = 2/124 (1%)

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           K  LCGTPNYIAPE+L+K GHSFEVDVWSIGCIMYTLLVGKPPFETS LKETY RIKK E
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 231

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN-DYCPTSLPASCLMTAPRFDS 220
           Y +P  +   AA++I+KML  DP  RP + +LL+ EFF   Y P  LP +CL   PRF S
Sbjct: 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRF-S 290

Query: 221 VVPS 224
           + PS
Sbjct: 291 IAPS 294

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  117 bits (296), Expect = 2e-31
 Identities = 43/67 (64%), Positives = 59/67 (88%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           KRRKA+TEPE R+Y++QI+ G  YLH +++IHRDLKLGNLFL+++  VKIGDFGLA ++E
Sbjct: 107 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166

Query: 299 FDGQRKR 305
           +DG+RK+
Sbjct: 167 YDGERKK 173

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 69.9 bits (172), Expect = 6e-14
 Identities = 30/44 (68%), Positives = 40/44 (90%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMEL 44
           MS EI+IHRSL H++VVGFH FFED+ FV+++LELCR+RS++EL
Sbjct: 62  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL 105

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  160 bits (408), Expect = 5e-48
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 13/218 (5%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ I   L+H N++  + +F D+  VY+ILE         +Y     L +  +      
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG---TVYRELQKLSKFDEQRTATY 114

Query: 63  IW-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANKNTLCGTPNYI 112
           I  ++  + Y       ++       L   +  +   D   +     + +  LCGT +Y+
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL 174

Query: 113 APEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPA 172
            PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + + A
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234

Query: 173 ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPAS 210
             +I ++L  +P QRP + ++L   +            
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ 272

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 81.1 bits (201), Expect = 5e-18
 Identities = 19/62 (30%), Positives = 30/62 (48%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +    
Sbjct: 101 QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160

Query: 299 FD 300
             
Sbjct: 161 SS 162

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  155 bits (395), Expect = 6e-46
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 13/215 (6%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI I   L+H N++  +++F D K +Y++LE   +    ELY          +  +   +
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRG---ELYKELQKHGRFDEQRSATFM 120

Query: 64  W-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANKNTLCGTPNYIA 113
             ++  + Y  +    ++       L      +   D   +       + T+CGT +Y+ 
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLP 180

Query: 114 PEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           PE++    H  +VD+W  G + Y  LVG PPF++ +  ET+ RI  V+ K P  L   + 
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240

Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLP 208
            +I K+L   P QR P+  ++   +        LP
Sbjct: 241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 77.6 bits (192), Expect = 9e-17
 Identities = 17/60 (28%), Positives = 32/60 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++     E  +  +M+++ + + Y H+ K+IHRD+K  NL +     +KI DFG +    
Sbjct: 106 QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  142 bits (361), Expect = 8e-41
 Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 52/252 (20%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFED------------SKFVYIILELCRKRSMMELYNSA 48
           + +E+     L+H  +V + + + +              ++YI ++LCRK ++ +  N  
Sbjct: 50  VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR 109

Query: 49  CDLEEMSDPAAQPVIWVSKW-------VDYS-----------------DKYG------FG 78
           C +EE        V             V++                            FG
Sbjct: 110 CTIEERERS----VCL--HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163

Query: 79  YQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL 138
                D        LT M   A      GT  Y++PE ++ N +S +VD++S+G I++ L
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

Query: 139 LVGKPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE 197
           L   P         T + ++ +++  L          M++ ML   P++RP    ++   
Sbjct: 224 LY--PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281

Query: 198 FFND-YCPTSLP 208
            F D   P    
Sbjct: 282 VFEDLDFPGKTV 293

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 96.3 bits (240), Expect = 2e-23
 Identities = 26/70 (37%), Positives = 37/70 (52%), Gaps = 3/70 (4%)

Query: 239 KRRKAITEPETRF---YMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
             R  I E E         QI E V +LH   ++HRDLK  N+F + + VVK+GDFGL  
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166

Query: 296 RIEFDGQRKR 305
            ++ D + + 
Sbjct: 167 AMDQDEEEQT 176

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  139 bits (353), Expect = 1e-39
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            EIA+ + +KH N+V     +E +   Y++++L       EL++   +    ++  A  V
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG---ELFDRILERGVYTEKDASLV 111

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANKNTLCGTP 109
           I  V   V Y  + G            Y   +++S +M  D  L++M      +T CGTP
Sbjct: 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP 171

Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA--- 166
            Y+APE+L +  +S  VD WSIG I Y LL G PPF   T  + + +IK+  Y+  +   
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW 231

Query: 167 -TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
             + + A   I  +L  DP +R    + L
Sbjct: 232 DDISESAKDFICHLLEKDPNERYTCEKAL 260

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 22/57 (38%), Positives = 33/57 (57%), Gaps = 3/57 (5%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARIE 298
           TE +    ++Q+L  V YLH++ I+HRDLK  NL      +N  + I DFGL+   +
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  136 bits (345), Expect = 1e-38
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 21/210 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E  I R L+H N+V  H   ++  F Y++ +L       EL+      E  S+  A   
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG---ELFEDIVAREFYSEADASHC 110

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCGT 108
           I  + + + Y    G                   + V   D  L   +  +   +   GT
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
           P Y++PE+L K+ +S  VD+W+ G I+Y LLVG PPF        Y++IK   Y  P+  
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 230

Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
             T+   A ++I  ML ++P +R    Q L
Sbjct: 231 WDTVTPEAKSLIDSMLTVNPKKRITADQAL 260

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 76.4 bits (189), Expect = 3e-16
 Identities = 24/66 (36%), Positives = 38/66 (57%), Gaps = 4/66 (6%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARI 297
           R+  +E +    ++QILE ++Y H + I+HR+LK  NL L   +    VK+ DFGLA  +
Sbjct: 99  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158

Query: 298 EFDGQR 303
             D + 
Sbjct: 159 N-DSEA 163

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  135 bits (341), Expect = 4e-38
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 22/224 (9%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
             QEI I +SL H N++  +  FED+  +Y+++ELC   +  EL+          +  A 
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC---TGGELFERVVHKRVFRESDAA 109

Query: 61  PVIW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLC 106
            ++  V   V Y  K            F +  +   S +   D  L           T  
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GTP Y++P++L    +  E D WS G +MY LL G PPF   T  E   +I++  +  P 
Sbjct: 170 GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE 228

Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
                +   A ++I+++L   P QR    Q L  E+F     +S
Sbjct: 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 74.2 bits (183), Expect = 1e-15
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 4/66 (6%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARI 297
           ++   E +    MK +L  V+Y H   + HRDLK  N      S +  +K+ DFGLAAR 
Sbjct: 100 KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159

Query: 298 EFDGQR 303
           +  G+ 
Sbjct: 160 K-PGKM 164

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  135 bits (342), Expect = 1e-37
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 54/282 (19%)

Query: 3   QEIAI-HRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           +EI I  R  +H N++     ++D K+VY++ EL +     EL +     +  S+  A  
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG---ELLDKILRQKFFSEREASA 120

Query: 62  VIW-VSKWVDY------------------SDKYGFGYQLNDDSSGVMFND--LTRMIMLA 100
           V++ ++K V+Y                   D+       + +   +   D    + +   
Sbjct: 121 VLFTITKTVEYLHAQGVVHRDLKPSNILYVDE-------SGNPESIRICDFGFAKQLRAE 173

Query: 101 NK--NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF---ETSTLKETYS 155
           N    T C T N++APE+L + G+    D+WS+G ++YT+L G  PF      T +E  +
Sbjct: 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233

Query: 156 RIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASC 211
           RI   ++ L      ++   A  ++ KML +DP QR   A +L   +   +    LP   
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW--DQLPQYQ 291

Query: 212 LMTA-------PRFDSVVPSFNSPRRKPLME----RNSKRRK 242
           L              +   + N  +   L        ++RR 
Sbjct: 292 LNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRG 333

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 20/67 (29%), Positives = 33/67 (49%), Gaps = 4/67 (5%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS----DNFVVKIGDFGLAA 295
           R+K  +E E    +  I + V YLH   ++HRDLK  N+       +   ++I DFG A 
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 296 RIEFDGQ 302
           ++  +  
Sbjct: 169 QLRAENG 175

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  135 bits (341), Expect = 3e-37
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 21/210 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E  I R L+H N+V  H   ++  F Y++ +L       EL+      E  S+  A   
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG---GELFEDIVAREFYSEADASHC 133

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCGT 108
           I  + + + Y    G                   + V   D  L   +  +   +   GT
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 193

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
           P Y++PE+L K+ +S  VD+W+ G I+Y LLVG PPF        Y++IK   Y  P+  
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 253

Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
             T+   A ++I  ML ++P +R    Q L
Sbjct: 254 WDTVTPEAKSLIDSMLTVNPKKRITADQAL 283

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 24/67 (35%), Positives = 38/67 (56%), Gaps = 4/67 (5%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAAR 296
            R+  +E +    ++QILE ++Y H + I+HR+LK  NL L   +    VK+ DFGLA  
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 297 IEFDGQR 303
           +  D + 
Sbjct: 181 VN-DSEA 186

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  132 bits (335), Expect = 4e-37
 Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 22/212 (10%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           + +E+ + + L H N++      EDS   YI+ EL    +  EL++     +  S+  A 
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY---TGGELFDEIIKRKRFSEHDAA 124

Query: 61  PVIW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLC 106
            +I  V   + Y  K+              +  +    +   D  L+       K     
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA 166
           GT  YIAPE+L    +  + DVWS G I+Y LL G PPF      +   R++  +Y    
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243

Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
               T+   A  +I+KML   P  R    Q L
Sbjct: 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 23/61 (37%), Positives = 36/61 (59%), Gaps = 3/61 (4%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARI 297
           RK  +E +    +KQ+  G++Y+H H I+HRDLK  N+ L     +  +KI DFGL+   
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 298 E 298
           +
Sbjct: 175 Q 175

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  135 bits (343), Expect = 6e-37
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 22/211 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E  I R LKH N+V  H    +    Y+I +L       EL+      E  S+  A   
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG---ELFEDIVAREYYSEADASHC 115

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK--NTLCG 107
           I  + + V +  + G                   + V   D  L   +    +      G
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA- 166
           TP Y++PE+L K+ +   VD+W+ G I+Y LLVG PPF        Y +IK   Y  P+ 
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP 235

Query: 167 ---TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
              T+   A  +I KML ++P +R   A+ L
Sbjct: 236 EWDTVTPEAKDLINKMLTINPSKRITAAEAL 266

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 3/67 (4%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAAR 296
            R+  +E +    ++QILE V + H   ++HR+LK  NL L        VK+ DFGLA  
Sbjct: 103 AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162

Query: 297 IEFDGQR 303
           +E + Q 
Sbjct: 163 VEGEQQA 169

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  131 bits (331), Expect = 2e-36
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 25/215 (11%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELY----NSACDLEEMSD 56
           +  EI + +SL H N++     FED   +YI++E C      EL     ++    + +S+
Sbjct: 67  IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC---EGGELLERIVSAQARGKALSE 123

Query: 57  PAAQPVIW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK- 102
                ++  +   + Y                 +Q     S +   D  L  +       
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
               GT  Y+APE+  ++  +F+ D+WS G +MY LL G  PF  ++L+E   +    E 
Sbjct: 184 TNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

Query: 163 KL---PATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
                   L   A  ++K+ML  DP +RP  AQ+L
Sbjct: 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 73.8 bits (182), Expect = 2e-15
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 7/77 (9%)

Query: 233 LMER---NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVV 286
           L+ER      R KA++E      MKQ++  ++Y H   ++H+DLK  N+     S +  +
Sbjct: 107 LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI 166

Query: 287 KIGDFGLAARIEFDGQR 303
           KI DFGLA   +   + 
Sbjct: 167 KIIDFGLAELFK-SDEH 182

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  132 bits (334), Expect = 2e-36
 Identities = 50/276 (18%), Positives = 100/276 (36%), Gaps = 46/276 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+A+  ++KH N+V +   FE++  +YI+++ C    + +  N+            +  
Sbjct: 72  REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK-----GVLFQEDQ 126

Query: 63  IWVSKWVDYSDKYGFGYQLND-----DSSGVMFNDL-TRMIMLANKNTL----------- 105
           I    W           Q+           ++  D+ ++ I L    T+           
Sbjct: 127 IL--DWF---------VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

Query: 106 ----------CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
                      GTP Y++PEI     ++ + D+W++GC++Y L   K  FE  ++K    
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

Query: 156 RIKKVEYK-LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
           +I    +  +         +++ ++   +P  RP V  +L   F        L     + 
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQ--LI 293

Query: 215 APRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETR 250
           A  F     S    +  P     S +      P  +
Sbjct: 294 AEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQK 329

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 21/58 (36%), Positives = 37/58 (63%)

Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           N+++     E +   +  QI   + ++HD KI+HRD+K  N+FL+ +  V++GDFG+A
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  132 bits (333), Expect = 2e-36
 Identities = 62/272 (22%), Positives = 117/272 (43%), Gaps = 32/272 (11%)

Query: 1   MSQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA 59
             +EI   +  + H N+V  H  F D    ++++EL       EL+      +  S+  A
Sbjct: 52  TQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG---ELFERIKKKKHFSETEA 108

Query: 60  QPVI-WVSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK--NT 104
             ++  +   V +    G            +   +D+  +   D    R+    N+   T
Sbjct: 109 SYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSTLKETYSRI 157
            C T +Y APE+LN+NG+    D+WS+G I+YT+L G+ PF         ++  E   +I
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228

Query: 158 KKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLM 213
           KK ++         + + A  +I+ +L +DP +R  ++ L + E+  D   + L ++ LM
Sbjct: 229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG--SQLSSNPLM 286

Query: 214 TAPRFDSVVPSFNSPRRKPLMERNSKRRKAIT 245
           T     S   + ++  +      N  +R+   
Sbjct: 287 TPDILGSSGAAVHTCVKATFHAFNKYKREGFC 318

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 3/67 (4%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAAR 296
           ++K  +E E  + M++++  VS++HD  ++HRDLK  NL     +DN  +KI DFG A  
Sbjct: 99  KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158

Query: 297 IEFDGQR 303
              D Q 
Sbjct: 159 KPPDNQP 165

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  132 bits (334), Expect = 2e-36
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 24/212 (11%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            EI +   L H N++     FE    + ++LEL       EL++   +    S+  A   
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG---ELFDRIVEKGYYSERDAADA 153

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCGT 108
           +  + + V Y  + G            Y      + +   D  L++++       T+CGT
Sbjct: 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGT 213

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF--ETSTLKETYSRIKKVEYKLPA 166
           P Y APEIL    +  EVD+WS+G I Y LL G  PF  E    +  + RI   EY   +
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-QFMFRRILNCEYYFIS 272

Query: 167 ----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
                +   A  +++K+++LDP +R    Q L
Sbjct: 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 25/57 (43%), Positives = 37/57 (64%), Gaps = 3/57 (5%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARIE 298
           +E +    +KQILE V+YLH++ I+HRDLK  NL     + +  +KI DFGL+  +E
Sbjct: 146 SERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  130 bits (330), Expect = 3e-36
 Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 31/233 (13%)

Query: 1   MSQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA 59
             +E+ I R +  H N++     +E + F +++ +L +K    EL++   +   +S+   
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG---ELFDYLTEKVTLSEKET 126

Query: 60  QPVIW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTL 105
           + ++  + + +    K                L DD   +   D   +  +    K   +
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENI---LLDDDMNIKLTDFGFSCQLDPGEKLREV 183

Query: 106 CGTPNYIAPEIL------NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           CGTP+Y+APEI+      N  G+  EVD+WS G IMYTLL G PPF           I  
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243

Query: 160 VEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLP 208
             Y+  +            ++ + L++ P +R    + L   FF  Y    + 
Sbjct: 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 82.3 bits (204), Expect = 2e-18
 Identities = 22/59 (37%), Positives = 37/59 (62%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            +  ++E ETR  M+ +LE +  LH   I+HRDLK  N+ L D+  +K+ DFG + +++
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  130 bits (330), Expect = 7e-36
 Identities = 45/220 (20%), Positives = 91/220 (41%), Gaps = 37/220 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC----------RKRSMMELYNSACDLE 52
           +E +I   LKH ++V     +     +Y++ E            ++     +Y+     E
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS-----E 129

Query: 53  EMSDPAAQPVIWVSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLA 100
            +   A+  +  + + + Y                     ++S+ V      +   +  +
Sbjct: 130 AV---ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186

Query: 101 NK--NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK 158
                   GTP+++APE++ +  +   VDVW  G I++ LL G  PF   T +  +  I 
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGII 245

Query: 159 KVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           K +YK+       + + A  ++++ML+LDP +R  V + L
Sbjct: 246 KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 24/62 (38%), Positives = 36/62 (58%), Gaps = 3/62 (4%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARIEFDG 301
           +E     YM+QILE + Y HD+ IIHRD+K   + L    ++  VK+G FG+A ++   G
Sbjct: 128 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187

Query: 302 QR 303
             
Sbjct: 188 LV 189

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  128 bits (323), Expect = 2e-35
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 36/218 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ I R ++H N++  H  FE+   V +ILEL    S  EL++   + E +++  A   
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELV---SGGELFDFLAEKESLTEDEATQF 113

Query: 63  IW-VSKWVDY------------------SDKYGFGYQLNDDSSGVMFND--LTRMIMLAN 101
           +  +   V Y                   DK       N  +  +   D  +   I   N
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDK-------NVPNPRIKLIDFGIAHKIEAGN 166

Query: 102 K-NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           +   + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + I  V
Sbjct: 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226

Query: 161 EYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            Y           + A   I+++L+ DP +R  +AQ L
Sbjct: 227 NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 79.5 bits (197), Expect = 2e-17
 Identities = 27/62 (43%), Positives = 40/62 (64%), Gaps = 4/62 (6%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL----SDNFVVKIGDFGLAAR 296
           ++++TE E   ++KQIL+GV YLH  +I H DLK  N+ L      N  +K+ DFG+A +
Sbjct: 102 KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161

Query: 297 IE 298
           IE
Sbjct: 162 IE 163

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  129 bits (325), Expect = 3e-35
 Identities = 43/261 (16%), Positives = 85/261 (32%), Gaps = 61/261 (23%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCR------------KRSMMELYNSACD 50
            E+ + + L H N+   +  +ED +++ +++ELC               S  +       
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136

Query: 51  LEEMSDPAAQPVIWVSKWVDYSDKYGFGY----------QL------------------- 81
            +    P             + +   F            Q+                   
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196

Query: 82  ------NDDSSGVMFND--LTRMIMLANK------NTLCGTPNYIAPEILNKNGHS--FE 125
                  + S  +   D  L++     N        T  GTP ++APE+LN    S   +
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256

Query: 126 VDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLL 181
            D WS G +++ LL+G  PF      +T S++   +          L   A  ++  +L 
Sbjct: 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN 316

Query: 182 LDPVQRPPVAQLLHFEFFNDY 202
            +  +R    + L   + + +
Sbjct: 317 RNVDERFDAMRALQHPWISQF 337

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 20/98 (20%), Positives = 34/98 (34%), Gaps = 2/98 (2%)

Query: 203 CPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSY 262
             ++   +  +   +               +            E      M+QI   + Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 263 LHDHKIIHRDLKLGNLFLS--DNFVVKIGDFGLAARIE 298
           LH+  I HRD+K  N   S   +F +K+ DFGL+    
Sbjct: 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY 221

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  129 bits (325), Expect = 6e-35
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 22/211 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E++I R + H N++  H  +E+   V +ILEL    S  EL++     E +S+  A   
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELV---SGGELFDFLAQKESLSEEEATSF 120

Query: 63  IW-VSKWVDYSDKYG-----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCG 107
           I  +   V+Y                     N     +   D  L   I    +   + G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA- 166
           TP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + I  V Y     
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240

Query: 167 ---TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
                 + A   I+K+L+ +  +R  + + L
Sbjct: 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 78.9 bits (195), Expect = 8e-17
 Identities = 27/62 (43%), Positives = 39/62 (62%), Gaps = 4/62 (6%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL----SDNFVVKIGDFGLAAR 296
           +++++E E   ++KQIL+GV+YLH  KI H DLK  N+ L         +K+ DFGLA  
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168

Query: 297 IE 298
           IE
Sbjct: 169 IE 170

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  127 bits (322), Expect = 8e-35
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 22/211 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E++I R + H NV+  H  +E+   V +ILEL    S  EL++     E +S+  A   
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELV---SGGELFDFLAQKESLSEEEATSF 120

Query: 63  IW-VSKWVDYSDKYGFG-----------YQLNDDSSGVMFND--LTRMIMLANK-NTLCG 107
           I  +   V+Y                     N     +   D  L   I    +   + G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA- 166
           TP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + I  V Y     
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240

Query: 167 ---TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
                 + A   I+K+L+ +  +R  + + L
Sbjct: 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEAL 271

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.0 bits (198), Expect = 2e-17
 Identities = 27/63 (42%), Positives = 40/63 (63%), Gaps = 4/63 (6%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL----SDNFVVKIGDFGLAA 295
           ++++++E E   ++KQIL+GV+YLH  KI H DLK  N+ L         +K+ DFGLA 
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

Query: 296 RIE 298
            IE
Sbjct: 168 EIE 170

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  129 bits (327), Expect = 2e-34
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 22/211 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ + + L H N++  + FFED  + Y++ E+    +  EL++     +  S+  A  +
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY---TGGELFDEIISRKRFSEVDAARI 131

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCGT 108
           I  V   + Y  K               +     + +   D  L+     + K     GT
Sbjct: 132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 191

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
             YIAPE+L+   +  + DVWS G I+Y LL G PPF  +   +   +++K +Y      
Sbjct: 192 AYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 250

Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
              + + A  +I+KML   P  R      L 
Sbjct: 251 WKKVSESAKDLIRKMLTYVPSMRISARDALD 281

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 24/63 (38%), Positives = 38/63 (60%), Gaps = 3/63 (4%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGN-LFLS--DNFVVKIGDFGLAARI 297
           RK  +E +    ++Q+L G++Y+H +KI+HRDLK  N L  S   +  ++I DFGL+   
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179

Query: 298 EFD 300
           E  
Sbjct: 180 EAS 182

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  125 bits (316), Expect = 2e-34
 Identities = 48/232 (20%), Positives = 94/232 (40%), Gaps = 43/232 (18%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
            E+ + R LKH N+V ++    D  +  +YI++E C    +  +        +      +
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG---TKERQYLDE 110

Query: 61  PVIWVSKW-------VDYSDKYGFGYQLNDDSSGVMFNDL-TRMIMLANKN--------- 103
             +   +        +         ++ +D    V+  DL    + L  K          
Sbjct: 111 EFVL--RVMTQLTLALKEC------HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162

Query: 104 ------------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK 151
                       T  GTP Y++PE +N+  ++ + D+WS+GC++Y L    PPF   + K
Sbjct: 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222

Query: 152 ETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
           E   +I++ ++ ++P         +I +ML L    RP V ++L      ++
Sbjct: 223 ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 78.1 bits (193), Expect = 7e-17
 Identities = 23/67 (34%), Positives = 35/67 (52%), Gaps = 5/67 (7%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHD-----HKIIHRDLKLGNLFLSDNFVVK 287
           ++ + +K R+ + E      M Q+   +   H      H ++HRDLK  N+FL     VK
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156

Query: 288 IGDFGLA 294
           +GDFGLA
Sbjct: 157 LGDFGLA 163

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  126 bits (318), Expect = 2e-34
 Identities = 60/260 (23%), Positives = 108/260 (41%), Gaps = 30/260 (11%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            EI I + L H  ++   +FF+  +  YI+LEL       EL++     + + +   +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGG---ELFDKVVGNKRLKEATCKLY 119

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCGT 108
            + +   V Y  + G                ++   +   D   ++++   +   TLCGT
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 109 PNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEYKL 164
           P Y+APE+L      G++  VD WS+G I++  L G PPF E  T      +I   +Y  
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239

Query: 165 P----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDS 220
                A + + A  ++KK+L++DP  R    + L   +  D          L++     +
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD-LLSEENEST 298

Query: 221 VVPSFNSPRRKPLMERNSKR 240
            +P   +   +P   R   R
Sbjct: 299 ALPQVLA---QPSTSRKRPR 315

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 79.6 bits (197), Expect = 3e-17
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 3/62 (4%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAAR 296
             K + E   + Y  Q+L  V YLH++ IIHRDLK  N+ L    ++ ++KI DFG +  
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166

Query: 297 IE 298
           + 
Sbjct: 167 LG 168

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  126 bits (318), Expect = 3e-34
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 36/218 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E++I + ++H NV+  H  +E+   V +ILEL    +  EL++   + E +++  A   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119

Query: 63  IW-VSKWVDY------------------SDKYGFGYQLNDDSSGVMFND--LTRMIMLAN 101
           +  +   V Y                   D+       N     +   D  L   I   N
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDR-------NVPKPRIKIIDFGLAHKIDFGN 172

Query: 102 K-NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
           +   + GTP ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

Query: 161 EYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            Y+            A   I+++L+ DP +R  +   L
Sbjct: 233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 27/62 (43%), Positives = 38/62 (61%), Gaps = 4/62 (6%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS----DNFVVKIGDFGLAAR 296
           ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L         +KI DFGLA +
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167

Query: 297 IE 298
           I+
Sbjct: 168 ID 169

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  129 bits (325), Expect = 4e-34
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            EI++ +SL H N++     FED K+ Y++ E        EL+    +  +  +  A  +
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY---EGGELFEQIINRHKFDECDAANI 151

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCGT 108
           +  +   + Y  K+              +  +    +   D  L+       K     GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
             YIAPE+L K  ++ + DVWS G IMY LL G PPF     ++   +++K +Y      
Sbjct: 212 AYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270

Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
              +   A  +IK ML  D  +R    + L
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTAEEAL 300

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 26/63 (41%), Positives = 34/63 (53%), Gaps = 3/63 (4%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGN-LFLS--DNFVVKIGDFGLAARI 297
           R    E +    MKQIL G+ YLH H I+HRD+K  N L  +      +KI DFGL++  
Sbjct: 140 RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 298 EFD 300
             D
Sbjct: 200 SKD 202

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  127 bits (321), Expect = 5e-34
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 26/224 (11%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +  EI I + L H  ++   +FF+     YI+LEL       EL++     + + +   +
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG---ELFDKVVGNKRLKEATCK 242

Query: 61  PVIW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLC 106
              + +   V Y  + G                ++   +   D   ++++   +   TLC
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302

Query: 107 GTPNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEY 162
           GTP Y+APE+L      G++  VD WS+G I++  L G PPF E  T      +I   +Y
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362

Query: 163 KLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                  A + + A  ++KK+L++DP  R    + L   +  D 
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 3/62 (4%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAAR 296
             K + E   + Y  Q+L  V YLH++ IIHRDLK  N+ L    ++ ++KI DFG +  
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291

Query: 297 IE 298
           + 
Sbjct: 292 LG 293

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  128 bits (323), Expect = 6e-34
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+A+ + L H N++  + FFED +  Y+++E        EL++      + ++  A  +
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY---KGGELFDEIIHRMKFNEVDAAVI 141

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCGT 108
           I  V   V Y  K+              +  +  + +   D  L+ +     K     GT
Sbjct: 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
             YIAPE+L K  +  + DVWSIG I++ LL G PPF   T +E   +++K +Y   +  
Sbjct: 202 AYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE 260

Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
              + + A  +IK+ML  D  +R    Q L 
Sbjct: 261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 28/63 (44%), Positives = 37/63 (58%), Gaps = 3/63 (4%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGN-LFLS--DNFVVKIGDFGLAARI 297
           R    E +    +KQ+L GV+YLH H I+HRDLK  N L  S   + ++KI DFGL+A  
Sbjct: 130 RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189

Query: 298 EFD 300
           E  
Sbjct: 190 ENQ 192

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  127 bits (322), Expect = 9e-34
 Identities = 57/226 (25%), Positives = 89/226 (39%), Gaps = 22/226 (9%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ + + L H N++      EDS   YI+ EL    +  EL++     +  S+  A  +
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELY---TGGELFDEIIKRKRFSEHDAARI 126

Query: 63  IW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCGT 108
           I  V   + Y  K+              +  +    +   D  L+       K     GT
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
             YIAPE+L    +  + DVWS G I+Y LL G PPF      +   R++  +Y      
Sbjct: 187 AYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPAS 210
             T+   A  +I+KML   P  R    Q L   +   Y   +   S
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTIS 291

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 24/63 (38%), Positives = 37/63 (58%), Gaps = 3/63 (4%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGN-LFLS--DNFVVKIGDFGLAARI 297
           RK  +E +    +KQ+  G++Y+H H I+HRDLK  N L  S   +  +KI DFGL+   
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 298 EFD 300
           + +
Sbjct: 175 QQN 177

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  124 bits (314), Expect = 1e-33
 Identities = 43/261 (16%), Positives = 71/261 (27%), Gaps = 72/261 (27%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E+ I   +K+   +       +   VYII E         +         +       +
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEND---SILKFDEYFFVLDKNYTCFI 148

Query: 63  -IWVSKW--------VDYS------------------DKYG------FGYQLNDDSSGVM 89
            I V K           Y                   DK G      FG       S  M
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE------SEYM 202

Query: 90  FNDLTRMIMLANKNTLCGTPNYIAPEILNKNG--HSFEVDVWSIGCIMYTLLVGKPPFET 147
            +   +           GT  ++ PE  +     +  +VD+WS+G  +Y +     PF  
Sbjct: 203 VDKKIK--------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

Query: 148 -STLKETYSRIKKVEYKLPATLKKP-------------------AATMIKKMLLLDPVQR 187
             +L E ++ I+    + P                             +K  L  +P +R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314

Query: 188 PPVAQLLHFEFFNDYCPTSLP 208
                 L  E+  D     L 
Sbjct: 315 ITSEDALKHEWLADTNIEDLR 335

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 82.5 bits (204), Expect = 4e-18
 Identities = 22/81 (27%), Positives = 38/81 (46%), Gaps = 4/81 (4%)

Query: 225 FNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHK-IIHRDLKLGNLFLSDN 283
                   ++++N      I     +  +K +L   SY+H+ K I HRD+K  N+ +  N
Sbjct: 131 LKFDEYFFVLDKNYTCF--IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188

Query: 284 FVVKIGDFGLAARIEFDGQRK 304
             VK+ DFG +  +  D + K
Sbjct: 189 GRVKLSDFGESEYMV-DKKIK 208

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  121 bits (305), Expect = 9e-33
 Identities = 44/240 (18%), Positives = 81/240 (33%), Gaps = 64/240 (26%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSM-------MELYNSACDLEEM- 54
           +E+     L H N+V ++  ++   +          RS        ME +     LE+  
Sbjct: 53  REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQME-FCDKGTLEQWI 111

Query: 55  ----SDPAAQPVIWVSKW-------VDYS-----------------DKYG------FGYQ 80
                +   + +    +        VDY                            FG  
Sbjct: 112 EKRRGEKLDKVLAL--ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFG-- 167

Query: 81  LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL- 139
                   + ND  R           GT  Y++PE ++   +  EVD++++G I+  LL 
Sbjct: 168 ----LVTSLKNDGKR-------TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

Query: 140 VGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           V    FETS     ++ ++     +     K   T+++K+L   P  RP  +++L     
Sbjct: 217 VCDTAFETSKF---FTDLRD--GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 97.7 bits (244), Expect = 6e-24
 Identities = 29/69 (42%), Positives = 42/69 (60%)

Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR 296
             +R + + +       +QI +GV Y+H  K+I+RDLK  N+FL D   VKIGDFGL   
Sbjct: 112 EKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 297 IEFDGQRKR 305
           ++ DG+R R
Sbjct: 172 LKNDGKRTR 180

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  121 bits (305), Expect = 1e-32
 Identities = 49/242 (20%), Positives = 96/242 (39%), Gaps = 59/242 (24%)

Query: 3   QEIAIHRSLKHRN--VVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
            EIA    L+  +  ++  + +    +++Y+++E        +L +     + +     +
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI----DLNSWLKKKKSIDPWERK 130

Query: 61  PVIW--VSKWVDY--------SD-------------K---YGFGYQLNDDSSGVMFNDLT 94
              W  + + V          SD             K   +G   Q+  D++ V+     
Sbjct: 131 -SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVV----- 184

Query: 95  RMIMLANKNTLCGTPNYIAPEIL-----------NKNGHSFEVDVWSIGCIMYTLLVGKP 143
                  K++  GT NY+ PE +           +K+  S + DVWS+GCI+Y +  GK 
Sbjct: 185 -------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

Query: 144 PFE--TSTLKETYSRIK-KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
           PF+   + + + ++ I    E + P   +K    ++K  L  DP QR  + +LL   +  
Sbjct: 238 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

Query: 201 DY 202
             
Sbjct: 298 IQ 299

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 93.1 bits (232), Expect = 4e-22
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 177

Query: 299 FD 300
            D
Sbjct: 178 PD 179

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  122 bits (308), Expect = 2e-32
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 31/217 (14%)

Query: 3   QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           +E  I R +  H +++     +E S F++++ +L RK    EL++   +   +S+   + 
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG---ELFDYLTEKVALSEKETRS 204

Query: 62  VIW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK-NTLCG 107
           ++  + + V +                   L DD+  +  +D   +  +    K   LCG
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENI---LLDDNMQIRLSDFGFSCHLEPGEKLRELCG 261

Query: 108 TPNYIAPEILNKN------GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           TP Y+APEIL  +      G+  EVD+W+ G I++TLL G PPF           I + +
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321

Query: 162 YKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           Y+  +            +I ++L +DP  R    Q L
Sbjct: 322 YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQAL 358

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 81.7 bits (202), Expect = 8e-18
 Identities = 27/64 (42%), Positives = 43/64 (67%), Gaps = 1/64 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
            + A++E ETR  M+ +LE VS+LH + I+HRDLK  N+ L DN  +++ DFG +  +E 
Sbjct: 193 EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE- 251

Query: 300 DGQR 303
            G++
Sbjct: 252 PGEK 255

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  121 bits (305), Expect = 3e-32
 Identities = 53/290 (18%), Positives = 98/290 (33%), Gaps = 61/290 (21%)

Query: 3   QEIAIHRSLKH--RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
            EIA    L+     ++  + +    +++Y+++E        +L +     + +     +
Sbjct: 56  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI----DLNSWLKKKKSIDPWERK 111

Query: 61  PVIW--VSKWVDY--------SD-------------K---YGFGYQLNDDSSGVMFNDLT 94
              W  + + V          SD             K   +G   Q+  D++ V+     
Sbjct: 112 -SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVV----- 165

Query: 95  RMIMLANKNTLCGTPNYIAPEIL-----------NKNGHSFEVDVWSIGCIMYTLLVGKP 143
                  K++  GT NY+ PE +           +K+  S + DVWS+GCI+Y +  GK 
Sbjct: 166 -------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

Query: 144 PFETST-LKETYSRI--KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
           PF+           I     E + P   +K    ++K  L  DP QR  + +LL   +  
Sbjct: 219 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

Query: 201 DYCP--TSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPE 248
                   +              +   NSP       +      +  E  
Sbjct: 279 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESH 328

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 92.8 bits (231), Expect = 9e-22
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 100 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 158

Query: 299 FD 300
            D
Sbjct: 159 PD 160

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  118 bits (298), Expect = 1e-31
 Identities = 39/248 (15%), Positives = 87/248 (35%), Gaps = 60/248 (24%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFED-------------SKFVYIILELCRKRSMMELYNSAC 49
            E+ +  SL H+ VV +++ + +                ++I +E C   ++ +L     
Sbjct: 51  SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL----- 105

Query: 50  DLEEMSDPAAQPVIWVSKW-------VDY-----------------SDKYG------FG- 78
            +   +    +   W  +        + Y                  D+        FG 
Sbjct: 106 -IHSENLNQQRDEYW--RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162

Query: 79  -YQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMY 136
              ++     +  +         N  +  GT  Y+A E+L+  GH + ++D++S+G I +
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222

Query: 137 TLLVGKPPFETSTLKETYSRIKKVEYKLPATL----KKPAATMIKKMLLLDPVQRPPVAQ 192
            ++   P            +++ V  + P        K    +I+ ++  DP +RP    
Sbjct: 223 EMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGART 280

Query: 193 LLHFEFFN 200
           LL+  +  
Sbjct: 281 LLNSGWLP 288

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 93.2 bits (232), Expect = 4e-22
 Identities = 27/73 (36%), Positives = 37/73 (50%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L +            E     +QILE +SY+H   IIHRDLK  N+F+ ++  VKIGDFG
Sbjct: 102 LYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161

Query: 293 LAARIEFDGQRKR 305
           LA  +       +
Sbjct: 162 LAKNVHRSLDILK 174

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  119 bits (299), Expect = 1e-31
 Identities = 51/233 (21%), Positives = 87/233 (37%), Gaps = 41/233 (17%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
            S +I        +N VG         ++YI ++LCRK ++ +  N  C LE+       
Sbjct: 108 PSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE----H 163

Query: 61  PVIWVSKW-------VDY-------------------SD---KYG-FGYQLNDDSSGVMF 90
            V             V++                    D   K G FG     D      
Sbjct: 164 GVCL--HIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

Query: 91  NDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL 150
             LT M   A      GT  Y++PE ++ N +S +VD++S+G I++ LL     F T   
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQME 278

Query: 151 K-ETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
           +    + ++ +++  L          M++ ML   P +RP    ++    F +
Sbjct: 279 RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.9 bits (241), Expect = 3e-23
 Identities = 25/70 (35%), Positives = 39/70 (55%), Gaps = 3/70 (4%)

Query: 239 KRRKAITEPET---RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
            RR ++ + E         QI E V +LH   ++HRDLK  N+F + + VVK+GDFGL  
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 212

Query: 296 RIEFDGQRKR 305
            ++ D + + 
Sbjct: 213 AMDQDEEEQT 222

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  122 bits (307), Expect = 2e-31
 Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 21/210 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNS-ACDLEEMSDPAAQP 61
           +EI     L+H  +V  H  FED   + +I E     S  EL+   A +  +MS+  A  
Sbjct: 203 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM---SGGELFEKVADEHNKMSEDEAVE 259

Query: 62  VIW-VSKWVDYSDKYGFGYQ---------LNDDSSGVMFND--LTRMIMLANK-NTLCGT 108
            +  V K + +  +  + +              S+ +   D  LT  +          GT
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 319

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-- 166
             + APE+       +  D+WS+G + Y LL G  PF      ET   +K  ++ +    
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 379

Query: 167 --TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
              + +     I+K+LL DP  R  + Q L
Sbjct: 380 FSGISEDGKDFIRKLLLADPNTRMTIHQAL 409

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.9 bits (197), Expect = 7e-17
 Identities = 20/68 (29%), Positives = 40/68 (58%), Gaps = 2/68 (2%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGD 290
           L E+ +     ++E E   YM+Q+ +G+ ++H++  +H DLK  N+  +   +  +K+ D
Sbjct: 241 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 300

Query: 291 FGLAARIE 298
           FGL A ++
Sbjct: 301 FGLTAHLD 308

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  119 bits (299), Expect = 3e-31
 Identities = 55/301 (18%), Positives = 103/301 (34%), Gaps = 67/301 (22%)

Query: 3   QEIAIHRSLKH--RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
            EIA    L+     ++  + +    +++Y+++E        +L +     + +     +
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI----DLNSWLKKKKSIDPWERK 158

Query: 61  PVIW--VSKWVDY--------SD-------------K---YGFGYQLNDDSSGVMFNDLT 94
              W  + + V          SD             K   +G   Q+  D++ V+     
Sbjct: 159 -SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVV----- 212

Query: 95  RMIMLANKNTLCGTPNYIAPEIL-----------NKNGHSFEVDVWSIGCIMYTLLVGKP 143
                  K++  G  NY+ PE +           +K+  S + DVWS+GCI+Y +  GK 
Sbjct: 213 -------KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

Query: 144 PFETSTLKETYSRIKKV-----EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
           PF    +    S++  +     E + P   +K    ++K  L  DP QR  + +LL   +
Sbjct: 266 PF--QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

Query: 199 FNDYCPTSLPASCLMTAPRFDSVV---PSFNSPRRKPLMERNSKRRKAITEPETRFYMKQ 255
                   +      T      V+      NSP       +      +  E       K 
Sbjct: 324 VQIQ-THPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKT 382

Query: 256 I 256
            
Sbjct: 383 F 383

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 92.2 bits (229), Expect = 2e-21
 Identities = 24/62 (38%), Positives = 39/62 (62%), Gaps = 1/62 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K++K+I   E + Y K +LE V  +H H I+H DLK  N  + D  ++K+ DFG+A +++
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 205

Query: 299 FD 300
            D
Sbjct: 206 PD 207

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  119 bits (301), Expect = 4e-31
 Identities = 47/239 (19%), Positives = 85/239 (35%), Gaps = 49/239 (20%)

Query: 1   MSQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA 59
             +E+ + R   +H NV+ +    +D +F YI +ELC   ++ E            +P  
Sbjct: 64  ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPIT 122

Query: 60  ------------------------QPVIWVSKWVDYSDKY-----GFGYQLNDDSSGVMF 90
                                     ++          K      G   +L         
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH---- 178

Query: 91  NDLTRMIMLANKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLV-GKPPFE 146
                    + ++ + GT  +IAPE+L+   K   ++ VD++S GC+ Y ++  G  PF 
Sbjct: 179 -------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231

Query: 147 TSTLKETYSRIKKVEYKLPATLKKP---AATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
            S  ++    +           K     A  +I+KM+ +DP +RP    +L   FF   
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 76.7 bits (189), Expect = 7e-16
 Identities = 21/73 (28%), Positives = 33/73 (45%), Gaps = 5/73 (6%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-----NFVVK 287
           L E   ++  A    E    ++Q   G+++LH   I+HRDLK  N+ +S           
Sbjct: 104 LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAM 163

Query: 288 IGDFGLAARIEFD 300
           I DFGL  ++   
Sbjct: 164 ISDFGLCKKLAVG 176

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  117 bits (294), Expect = 1e-30
 Identities = 51/241 (21%), Positives = 97/241 (40%), Gaps = 33/241 (13%)

Query: 3   QEIAIH-RSLKHRNVVGFHSFFEDS----KFVYIILELCRKRSMMELYN--SACDLEEMS 55
           QE+  H ++    ++V     +E+     + + II+E        EL++       +  +
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG---GELFSRIQERGDQAFT 126

Query: 56  DPAAQPVIW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLANK 102
           +  A  ++  +   + +   +             Y   +  + +   D    +       
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSRIK 158
            T C TP Y+APE+L    +    D+WS+G IMY LL G PPF      +       RI+
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246

Query: 159 KVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
             +Y  P    + + + A  +I+ +L  DP +R  + Q ++  + N      +P + L T
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS--MVVPQTPLHT 304

Query: 215 A 215
           A
Sbjct: 305 A 305

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 72.8 bits (179), Expect = 8e-15
 Identities = 22/64 (34%), Positives = 31/64 (48%), Gaps = 3/64 (4%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLA 294
            +  +A TE E    M+ I   + +LH H I HRD+K  NL       + V+K+ DFG A
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178

Query: 295 ARIE 298
               
Sbjct: 179 KETT 182

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  116 bits (292), Expect = 2e-30
 Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 17/230 (7%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ I + L H N+V      E  K +Y+I+E        E+++       M +  A+  
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG---EVFDYLVAHGRMKEKEARSK 119

Query: 63  IW--VSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK-NTLCGTPN 110
               VS  V Y  +    ++       L D    +   D   +    +  K +  CG P 
Sbjct: 120 FRQIVSA-VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP 178

Query: 111 YIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           Y APE+         EVDVWS+G I+YTL+ G  PF+   LKE   R+ + +Y++P  + 
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238

Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFD 219
                ++K+ L+L+P++R  + Q++   + N           +       
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDIS 288

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 75.8 bits (187), Expect = 6e-16
 Identities = 23/58 (39%), Positives = 31/58 (53%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG 301
           + E E R   +QI+  V Y H  +I+HRDLK  NL L  +  +KI DFG +      G
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  114 bits (288), Expect = 3e-30
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 17/217 (7%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI   +  +H +++  +         ++++E        EL++  C    + +  A+ + 
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG---ELFDYICKHGRVEEMEARRLF 117

Query: 64  W--VSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK-NTLCGTPNY 111
              +S  VDY  ++   ++       L D        D  L+ M+       T CG+PNY
Sbjct: 118 QQILSA-VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNY 176

Query: 112 IAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
            APE+++       EVD+WS G I+Y LL G  PF+   +   + +I+   + +P  L +
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNR 236

Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSL 207
             AT++  ML +DP++R  +  +   E+F    P+ L
Sbjct: 237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 75.3 bits (186), Expect = 7e-16
 Identities = 23/62 (37%), Positives = 32/62 (51%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +   + E E R   +QIL  V Y H H ++HRDLK  N+ L  +   KI DFGL+  +  
Sbjct: 104 KHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163

Query: 300 DG 301
             
Sbjct: 164 GE 165

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  116 bits (292), Expect = 5e-30
 Identities = 54/290 (18%), Positives = 112/290 (38%), Gaps = 49/290 (16%)

Query: 3   QEIAIH-RSLKHRNVVGFHSFFEDS----KFVYIILELCR--------KRSMMELYNSAC 49
           +E+ +H R+ +  ++V     +E+     K + I++E           +    + +    
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT--- 159

Query: 50  DLEEMSDPAAQPVIWVSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMI 97
             E     A++ +  + + + Y                 Y     ++ +   D    +  
Sbjct: 160 --ERE---ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214

Query: 98  MLANK-NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKE 152
              N   T C TP Y+APE+L    +    D+WS+G IMY LL G PPF      +    
Sbjct: 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 274

Query: 153 TYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLP 208
             +RI+  +Y+ P      + +    +I+ +L  +P QR  + + ++  +      T +P
Sbjct: 275 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS--TKVP 332

Query: 209 ASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILE 258
            + L T+      V   +  R + + E  +     +     +  +K+I +
Sbjct: 333 QTPLHTS-----RVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIED 377

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 24/64 (37%), Positives = 32/64 (50%), Gaps = 3/64 (4%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLA 294
            +  +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 152 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211

Query: 295 ARIE 298
               
Sbjct: 212 KETT 215

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  114 bits (287), Expect = 6e-30
 Identities = 56/256 (21%), Positives = 95/256 (37%), Gaps = 51/256 (19%)

Query: 1   MSQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA 59
           + +E+ +    + HRNV+    FFE+    Y++ E  R      + +        ++  A
Sbjct: 57  VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG---SILSHIHKRRHFNELEA 113

Query: 60  QPVIW-VSKWVDYSDKYG----------FGYQLNDDSSGVM-----------FNDLTRMI 97
             V+  V+  +D+    G             +  +  S V             N     I
Sbjct: 114 SVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173

Query: 98  MLANKNTLCGTPNYIAPEILNKNGHSF-----EVDVWSIGCIMYTLLVGKPPF------- 145
                 T CG+  Y+APE++              D+WS+G I+Y LL G PPF       
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

Query: 146 --------ETSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQL 193
                     +     +  I++ +Y+ P    A +   A  +I K+L+ D  QR   AQ+
Sbjct: 234 CGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293

Query: 194 LHFEFFNDYCP-TSLP 208
           L   +     P  +LP
Sbjct: 294 LQHPWVQGCAPENTLP 309

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 20/68 (29%), Positives = 33/68 (48%), Gaps = 3/68 (4%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAAR 296
           +R+   E E    ++ +   + +LH+  I HRDLK  N+     +    VKI DF L + 
Sbjct: 104 KRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163

Query: 297 IEFDGQRK 304
           I+ +G   
Sbjct: 164 IKLNGDCS 171

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (289), Expect = 2e-29
 Identities = 52/251 (20%), Positives = 100/251 (39%), Gaps = 52/251 (20%)

Query: 1   MSQEIAI-HRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMEL----YNSACDLEEMS 55
              EI +   S  H NV+ ++      +F+YI LELC   ++ +L      S  +L+   
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQK 113

Query: 56  DPAAQPVIW-VSKWVDY--------------------SDKYGFGYQLNDDSSGVMFND-- 92
           +     ++  ++  V +                    S ++    Q   ++  ++ +D  
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 93  LTRMI------MLANKNTLCGTPNYIAPEILNKNGH-------SFEVDVWSIGCIMYTLL 139
           L + +         N N   GT  + APE+L ++ +       +  +D++S+GC+ Y +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 140 V-GKPPFETSTLKETYSRIKKVEYKLPA-------TLKKPAATMIKKMLLLDPVQRPPVA 191
             GK PF         S I +  + L         +L   A  +I +M+  DP++RP   
Sbjct: 234 SKGKHPFGDKY--SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291

Query: 192 QLLHFEFFNDY 202
           ++L    F   
Sbjct: 292 KVLRHPLFWPK 302

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 24/76 (31%), Positives = 36/76 (47%), Gaps = 13/76 (17%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-------------DNF 284
            +  K   E      ++QI  GV++LH  KIIHRDLK  N+ +S             +N 
Sbjct: 106 DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165

Query: 285 VVKIGDFGLAARIEFD 300
            + I DFGL  +++  
Sbjct: 166 RILISDFGLCKKLDSG 181

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  113 bits (284), Expect = 3e-29
 Identities = 55/232 (23%), Positives = 110/232 (47%), Gaps = 18/232 (7%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI+  + L+H +++  +        + +++E        EL++   + + M++   +   
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGG----ELFDYIVEKKRMTEDEGRRFF 114

Query: 64  W--VSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK-NTLCGTPNY 111
              +   ++Y  ++   ++       L DD+  V   D  L+ ++   N   T CG+PNY
Sbjct: 115 QQIICA-IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNY 173

Query: 112 IAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
            APE++N       EVDVWS G ++Y +LVG+ PF+   +   + ++    Y +P  L  
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP 233

Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVV 222
            A ++I++M++ DP+QR  + ++    +FN   P  L     +     DS +
Sbjct: 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRI 285

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 29/62 (46%), Positives = 38/62 (61%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
            +K +TE E R + +QI+  + Y H HKI+HRDLK  NL L DN  VKI DFGL+  +  
Sbjct: 101 EKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160

Query: 300 DG 301
             
Sbjct: 161 GN 162

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  112 bits (281), Expect = 6e-29
 Identities = 57/246 (23%), Positives = 97/246 (39%), Gaps = 43/246 (17%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI I++ L H NVV F+    +    Y+ LE C      EL++       M +P AQ   
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG---ELFDRIEPDIGMPEPDAQRFF 111

Query: 64  W--VSKWVDYS-----------------DKYG------FGYQLNDDSSGVMFNDLTRMIM 98
              ++  V Y                  D+        FG          +F    R  +
Sbjct: 112 HQLMAG-VVYLHGIGITHRDIKPENLLLDERDNLKISDFGL-------ATVFRYNNRERL 163

Query: 99  LANKNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFE-TSTLKETYSR 156
           L   N +CGT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS 
Sbjct: 164 L---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

Query: 157 IKKVEYKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMT 214
            K+ +  L     +      ++ K+L+ +P  R  +  +    ++N           + +
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 280

Query: 215 APRFDS 220
               +S
Sbjct: 281 GGVSES 286

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 76.2 bits (188), Expect = 5e-16
 Identities = 23/61 (37%), Positives = 36/61 (59%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ + 
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161

Query: 304 K 304
           +
Sbjct: 162 R 162

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  111 bits (280), Expect = 7e-29
 Identities = 39/221 (17%), Positives = 63/221 (28%), Gaps = 41/221 (18%)

Query: 3   QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E+  H  + +H   V     +E+   +Y+  ELC              L E        
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPE-------A 157

Query: 62  VIW-----VSKWVDY-----------------SDKYGFGYQLNDDSSGVMFNDLTRMIML 99
            +W         + +                     G   +L D      F  L  +   
Sbjct: 158 QVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGD------FGLLVELGTA 210

Query: 100 ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP-PFETSTLKETYSRIK 158
                  G P Y+APE+L    +    DV+S+G  +  +      P      ++      
Sbjct: 211 GAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL 269

Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
             E    A L     +++  ML  DP  R     LL     
Sbjct: 270 PPE--FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 87.8 bits (218), Expect = 4e-20
 Identities = 19/72 (26%), Positives = 35/72 (48%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L +       ++ E +   Y++  L  +++LH   ++H D+K  N+FL      K+GDFG
Sbjct: 143 LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFG 202

Query: 293 LAARIEFDGQRK 304
           L   +   G  +
Sbjct: 203 LLVELGTAGAGE 214

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  110 bits (277), Expect = 1e-28
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 43/226 (19%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI I++ L H NVV F+    +    Y+ LE C      EL++       M +P AQ   
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG---ELFDRIEPDIGMPEPDAQRFF 111

Query: 64  W--VSKWVDYS-----------------DKYG------FGYQLNDDSSGVMFNDLTRMIM 98
              ++  V Y                  D+        FG          +F    R  +
Sbjct: 112 HQLMAG-VVYLHGIGITHRDIKPENLLLDERDNLKISDFGL-------ATVFRYNNRERL 163

Query: 99  LANKNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFE-TSTLKETYSR 156
           L   N +CGT  Y+APE+L +   H+  VDVWS G ++  +L G+ P++  S   + YS 
Sbjct: 164 L---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

Query: 157 IKKVEYKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
            K+ +  L     +      ++ K+L+ +P  R  +  +    ++N
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.1 bits (188), Expect = 3e-16
 Identities = 23/61 (37%), Positives = 36/61 (59%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    ++ + 
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161

Query: 304 K 304
           +
Sbjct: 162 R 162

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  113 bits (284), Expect = 1e-28
 Identities = 52/233 (22%), Positives = 99/233 (42%), Gaps = 18/233 (7%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI   +  +H +++  +        +++++E        EL++  C    + +  ++ + 
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG---ELFDYICKNGRLDEKESRRLF 122

Query: 64  W--VSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANK-NTLCGTPNY 111
              +S  VDY  ++   ++       L D        D  L+ M+       T CG+PNY
Sbjct: 123 QQILSG-VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNY 181

Query: 112 IAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
            APE+++       EVD+WS G I+Y LL G  PF+   +   + +I    +  P  L  
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNP 241

Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFFN-DYCPTSLPASCLMTAPRFDSVV 222
              +++K ML +DP++R  +  +   E+F  D      P     ++   D   
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEA 294

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 73.7 bits (181), Expect = 6e-15
 Identities = 24/62 (38%), Positives = 34/62 (54%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +   + E E+R   +QIL GV Y H H ++HRDLK  N+ L  +   KI DFGL+  +  
Sbjct: 109 KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168

Query: 300 DG 301
             
Sbjct: 169 GE 170

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  110 bits (277), Expect = 3e-28
 Identities = 60/239 (25%), Positives = 89/239 (37%), Gaps = 51/239 (21%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI  HRSL+H N+V F         + II+E        ELY   C+    S+  A+   
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG---ELYERICNAGRFSEDEARFFF 122

Query: 64  W--VSKWVDYSDKYG-------------------------FGYQLNDDSSGVMFNDLTRM 96
              +S  V Y                              FGY     S   + +   + 
Sbjct: 123 QQLLSG-VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPK- 175

Query: 97  IMLANKNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFE----TSTLK 151
                  +  GTP YIAPE+L +        DVWS G  +Y +LVG  PFE        +
Sbjct: 176 -------STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228

Query: 152 ETYSRIKKVEYKLPAT--LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLP 208
           +T  RI  V+Y +P    +      +I ++ + DP  R  + ++    +F    P  L 
Sbjct: 229 KTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLM 287

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 73.2 bits (180), Expect = 7e-15
 Identities = 27/67 (40%), Positives = 35/67 (52%), Gaps = 2/67 (2%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGDFGLAARI 297
                +E E RF+ +Q+L GVSY H  +I HRDLKL N  L  +    +KI DFG +   
Sbjct: 109 NAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168

Query: 298 EFDGQRK 304
               Q K
Sbjct: 169 VLHSQPK 175

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  109 bits (275), Expect = 5e-28
 Identities = 52/263 (19%), Positives = 90/263 (34%), Gaps = 50/263 (19%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            EIAI   ++H N++     FE+  F  +++E     S ++L+        + +P A  +
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHG--SGLDLFAFIDRHPRLDEPLASYI 135

Query: 63  IW--VSKWVDYSDKYG-----------------------FGYQLNDDSSGVMFNDLTRMI 97
               VS  V Y                            FG        G +F       
Sbjct: 136 FRQLVSA-VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFY------ 187

Query: 98  MLANKNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR 156
                 T CGT  Y APE+L  N     E+++WS+G  +YTL+  + PF           
Sbjct: 188 ------TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEE 235

Query: 157 IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAP 216
             +     P  + K   +++  +L   P +R  + +L+   +     P +L         
Sbjct: 236 TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ--PVNLADYTWEEVF 293

Query: 217 RFDSVVPSFNSPRRKPLMERNSK 239
           R +       S     +  R+  
Sbjct: 294 RVNKPESGVLSAASLEMGNRSLS 316

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.5 bits (199), Expect = 1e-17
 Identities = 22/62 (35%), Positives = 36/62 (58%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R   + EP   +  +Q++  V YL    IIHRD+K  N+ ++++F +K+ DFG AA +E 
Sbjct: 123 RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182

Query: 300 DG 301
             
Sbjct: 183 GK 184

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (268), Expect = 3e-27
 Identities = 32/230 (13%), Positives = 78/230 (33%), Gaps = 40/230 (17%)

Query: 3   QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           +E+  H  L +H +VV + S + +   + I  E C   S+ +  +    +        + 
Sbjct: 59  REVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK---EA 115

Query: 62  VIWV-------------------------------SKWVDYSDKYGFGYQLNDDSSGVMF 90
            +                                 +   + + + G       +      
Sbjct: 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175

Query: 91  NDLTRMIMLANKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETST 149
            DL  +  +++     G   ++A E+L +N  H  + D++++   +      +P      
Sbjct: 176 GDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--- 232

Query: 150 LKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
             + +  I++    ++P  L +    ++K M+  DP +RP    L+    
Sbjct: 233 NGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 20/84 (23%), Positives = 33/84 (39%), Gaps = 19/84 (22%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN--------- 283
            +  N +      E E +  + Q+  G+ Y+H   ++H D+K  N+F+S           
Sbjct: 101 AISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160

Query: 284 ----------FVVKIGDFGLAARI 297
                      + KIGD G   RI
Sbjct: 161 GDEDDWASNKVMFKIGDLGHVTRI 184

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  107 bits (268), Expect = 3e-27
 Identities = 40/249 (16%), Positives = 78/249 (31%), Gaps = 54/249 (21%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPA 58
             +E  + + L H+N+V   +  E+  ++   +I+E C   S+  +     +   + +  
Sbjct: 54  QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113

Query: 59  AQPVIW-VSKWVDYSDKYGF-----------GYQLNDDSSGVMFND--LTRMIMLANK-N 103
              V+  V   +++  + G                 D  S     D    R +    +  
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

Query: 104 TLCGTPNYIAPEIL--------NKNGHSFEVDVWSIGCIMYTLLVGKPPFETS----TLK 151
           +L GT  Y+ P++         ++  +   VD+WSIG   Y    G  PF         K
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 152 ETYSRIKKVEY-------------------------KLPATLKKPAATMIKKMLLLDPVQ 186
           E   +I   +                           L   L+     ++  +L  D  +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293

Query: 187 RPPVAQLLH 195
                Q   
Sbjct: 294 CWGFDQFFA 302

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 84.0 bits (208), Expect = 8e-19
 Identities = 19/70 (27%), Positives = 35/70 (50%), Gaps = 4/70 (5%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS----DNFVVKIGDFGLA 294
                + E E    ++ ++ G+++L ++ I+HR++K GN+          V K+ DFG A
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

Query: 295 ARIEFDGQRK 304
             +E D Q  
Sbjct: 164 RELEDDEQFV 173

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  106 bits (267), Expect = 5e-27
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 2/107 (1%)

Query: 104 TLCGTPNYIAPEILN--KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           T  G+P +  PEI N       F+VD+WS G  +Y +  G  PFE   + + +  I K  
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS 229

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLP 208
           Y +P     P + ++K ML  +P +R  + Q+    +F    P +  
Sbjct: 230 YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEA 276

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.8 bits (195), Expect = 5e-17
 Identities = 19/58 (32%), Positives = 31/58 (53%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            K     +   Y  Q+++G+ YLH   I+H+D+K GNL L+    +KI   G+A  + 
Sbjct: 103 EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  106 bits (267), Expect = 1e-26
 Identities = 40/250 (16%), Positives = 78/250 (31%), Gaps = 54/250 (21%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPA 58
             +E  + + L H+N+V   +  E+  ++   +I+E C   S+  +     +   + +  
Sbjct: 54  QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113

Query: 59  AQPVIW-VSKWVDYSDKYGF-----------GYQLNDDSSGVMFND--LTRMIMLANK-N 103
              V+  V   +++  + G                 D  S     D    R +    +  
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

Query: 104 TLCGTPNYIAPEIL--------NKNGHSFEVDVWSIGCIMYTLLVGKPPFET----STLK 151
           +L GT  Y+ P++         ++  +   VD+WSIG   Y    G  PF         K
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 152 ETYSRIKKVEY-------------------------KLPATLKKPAATMIKKMLLLDPVQ 186
           E   +I   +                           L   L+     ++  +L  D  +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293

Query: 187 RPPVAQLLHF 196
                Q    
Sbjct: 294 CWGFDQFFAE 303

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 19/70 (27%), Positives = 35/70 (50%), Gaps = 4/70 (5%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS----DNFVVKIGDFGLA 294
                + E E    ++ ++ G+++L ++ I+HR++K GN+          V K+ DFG A
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

Query: 295 ARIEFDGQRK 304
             +E D Q  
Sbjct: 164 RELEDDEQFV 173

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  105 bits (263), Expect = 2e-26
 Identities = 36/231 (15%), Positives = 84/231 (36%), Gaps = 44/231 (19%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKF----VYIILELCRKRSMMELYNSACDLEEMSDPA 58
           +E  +HR   H N++   ++    +      +++L   ++ ++         L++  +  
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER---LKDKGNFL 131

Query: 59  AQPVIW-----VSKWVDY-----------------SDKYG------FGYQLNDDSSGVMF 90
            +  I      + + ++                      G       G            
Sbjct: 132 TEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191

Query: 91  NDLTRMIMLANKNTLCGTPNYIAPEILNKNGH---SFEVDVWSIGCIMYTLLVGKPPFET 147
                +   A +     T +Y APE+ +   H       DVWS+GC++Y ++ G+ P++ 
Sbjct: 192 RQALTLQDWAAQRC---TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

Query: 148 STLK-ETYSRIKKVEYKLPATLK--KPAATMIKKMLLLDPVQRPPVAQLLH 195
              K ++ +   + +  +P + +       ++  M+ +DP QRP +  LL 
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 89.7 bits (223), Expect = 8e-21
 Identities = 21/75 (28%), Positives = 33/75 (44%), Gaps = 2/75 (2%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
            +ER   +   +TE +  + +  I  G+  +H     HRDLK  N+ L D     + D G
Sbjct: 120 EIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179

Query: 293 LA--ARIEFDGQRKR 305
               A I  +G R+ 
Sbjct: 180 SMNQACIHVEGSRQA 194

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  104 bits (261), Expect = 3e-26
 Identities = 29/85 (34%), Positives = 48/85 (56%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           N+  GT  Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K+EY
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 249

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
             P      A  +++K+L+LD  +R
Sbjct: 250 DFPEKFFPKARDLVEKLLVLDATKR 274

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 24/67 (35%), Positives = 40/67 (59%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++  +  E  TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  + 
Sbjct: 122 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181

Query: 299 FDGQRKR 305
            + ++ R
Sbjct: 182 PESKQAR 188

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  103 bits (258), Expect = 1e-25
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 4/96 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
             + GTP Y+APEILN +  +   D+W+IG I Y LL    PF     +ETY  I +V  
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250

Query: 163 KLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
                  +++ + A   I+ +L+ +P +RP     L
Sbjct: 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 78.4 bits (194), Expect = 8e-17
 Identities = 24/64 (37%), Positives = 37/64 (57%), Gaps = 3/64 (4%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLA 294
            +  + ++E +    +KQILEGV YLH + I+H DLK  N+ L        +KI DFG++
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181

Query: 295 ARIE 298
            +I 
Sbjct: 182 RKIG 185

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 46.5 bits (111), Expect = 5e-06
 Identities = 10/35 (28%), Positives = 17/35 (48%), Gaps = 1/35 (2%)

Query: 3   QEIAIHRSLKHR-NVVGFHSFFEDSKFVYIILELC 36
            EIA+    K    V+  H  +E++  + +ILE  
Sbjct: 77  HEIAVLELAKSCPRVINLHEVYENTSEIILILEYA 111

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (253), Expect = 5e-25
 Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 4/96 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
             L   P Y APE+   +  S   D+WS+G ++Y LL G  PF   T ++    I   EY
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220

Query: 163 KLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
                    +   A   + ++L+ +   R   ++ L
Sbjct: 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 78.8 bits (195), Expect = 6e-17
 Identities = 19/68 (27%), Positives = 35/68 (51%), Gaps = 2/68 (2%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGD 290
           + ER +     + E E   Y+ Q+ E + +LH H I H D++  N+      +  +KI +
Sbjct: 88  IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIE 147

Query: 291 FGLAARIE 298
           FG A +++
Sbjct: 148 FGQARQLK 155

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 11/34 (32%), Positives = 19/34 (55%)

Query: 3  QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC 36
          +EI+I    +HRN++  H  FE  + + +I E  
Sbjct: 50 KEISILNIARHRNILHLHESFESMEELVMIFEFI 83

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  103 bits (259), Expect = 5e-25
 Identities = 38/244 (15%), Positives = 73/244 (29%), Gaps = 44/244 (18%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFV------YIILELCRKRSMMELYNSACDLEEM 54
              EI I + L H NVV      +  + +       + +E C    + +  N   +   +
Sbjct: 59  WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118

Query: 55  SDPAAQPVIW-VSKWVDYSDKYG----------FGYQLNDDSSGVMFND--LTRMIMLAN 101
            +   + ++  +S  + Y  +               Q           D    + +    
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 102 K-NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
                 GT  Y+APE+L +  ++  VD WS G + +  + G  PF  +     +    + 
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 161 EY------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF 196
           +                          L   L       ++ ML+    QR    Q  + 
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298

Query: 197 EFFN 200
             F 
Sbjct: 299 GCFQ 302

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 20/63 (31%), Positives = 31/63 (49%), Gaps = 3/63 (4%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAA 295
           +    + E   R  +  I   + YLH+++IIHRDLK  N+ L       + KI D G A 
Sbjct: 113 ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172

Query: 296 RIE 298
            ++
Sbjct: 173 ELD 175

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (255), Expect = 6e-25
 Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 4/96 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
                T  + APEI+++    F  D+W+IG + Y LL G  PF      ET   +K+ ++
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267

Query: 163 KLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           +       ++   A   IK +L  +P +R  V   L
Sbjct: 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 24/68 (35%), Positives = 38/68 (55%), Gaps = 2/68 (2%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGD 290
           L +R +     ++E E   YM+Q  EG+ ++H+H I+H D+K  N+         VKI D
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194

Query: 291 FGLAARIE 298
           FGLA ++ 
Sbjct: 195 FGLATKLN 202

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 12/34 (35%), Positives = 17/34 (50%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC 36
            EI+I   L H  ++  H  FED   + +ILE  
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  100 bits (250), Expect = 2e-24
 Identities = 28/221 (12%), Positives = 63/221 (28%), Gaps = 31/221 (14%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE--MSDPA 58
            +Q +   +       + F+S         ++ EL    +++   N   +  E  M    
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 59  AQPVIW-VSKWVDY------------------SDKYGFGYQLNDDSSGVMFNDLTR---M 96
                  +   ++                    + +      +D S+G+   DL +   M
Sbjct: 174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 97  IMLANKNTL---CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET 153
            +          C T  +   E+L+    ++++D + +   +Y +L G      +   E 
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293

Query: 154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
                           +        ML +      P   LL
Sbjct: 294 KPEGLFRRLPHLDMWNE----FFHVMLNIPDCHHLPSLDLL 330

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 64.6 bits (157), Expect = 6e-12
 Identities = 14/73 (19%), Positives = 30/73 (41%), Gaps = 11/73 (15%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV------- 285
           +    +   K + +     +  ++L  +  +HD +IIH D+K  N  L + F+       
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217

Query: 286 ----VKIGDFGLA 294
               + + D G +
Sbjct: 218 LSAGLALIDLGQS 230

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  100 bits (251), Expect = 2e-24
 Identities = 17/141 (12%), Positives = 40/141 (28%), Gaps = 15/141 (10%)

Query: 81  LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEIL-----------NKNGHSFEVDVW 129
           + D   GV       ++    +     +  +  PE+             +   +F  D W
Sbjct: 238 VLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297

Query: 130 SIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP 189
           ++G ++Y +     P            I +    +P  ++     +++  L      R  
Sbjct: 298 ALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRA----LLEGFLRYPKEDRLL 353

Query: 190 VAQLLHFEFFNDYCPTSLPAS 210
             Q +    +         A 
Sbjct: 354 PLQAMETPEYEQLRTELSAAL 374

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 11/64 (17%), Positives = 27/64 (42%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           ++  +S   K++          Q++  ++ LH + ++H  L+  ++ L     V +  F 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 293 LAAR 296
              R
Sbjct: 252 HLVR 255

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  100 bits (251), Expect = 2e-24
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 4/96 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
               GTP ++APE++N +  SF  D+WS+G I Y LL G  PF      ET + I    +
Sbjct: 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305

Query: 163 KLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
            L       + + A   I K+L+ +   R   ++ L
Sbjct: 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEAL 341

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 27/68 (39%), Positives = 38/68 (55%), Gaps = 2/68 (2%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGD 290
           L +R       +TE +T  +MKQI EG+ ++H   I+H DLK  N+     D   +KI D
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID 232

Query: 291 FGLAARIE 298
           FGLA R +
Sbjct: 233 FGLARRYK 240

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 8/34 (23%), Positives = 17/34 (50%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC 36
            EI++   L H N++  +  FE    + +++E  
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 99.5 bits (249), Expect = 2e-24
 Identities = 36/85 (42%), Positives = 52/85 (61%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           +T CGT  Y+APEIL ++GH+  VD WS+G +MY +L G PPF     K+T  +I K + 
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
            LP  L + A  ++KK+L  +   R
Sbjct: 239 NLPPYLTQEARDLLKKLLKRNAASR 263

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 64.5 bits (158), Expect = 4e-12
 Identities = 21/62 (33%), Positives = 31/62 (50%), Gaps = 1/62 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L  +  +      E    FY+ +I   + +LH   II+RDLK  N+ L+    VK+ DFG
Sbjct: 108 LFMQLEREGI-FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166

Query: 293 LA 294
           L 
Sbjct: 167 LC 168

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 98.8 bits (247), Expect = 5e-24
 Identities = 29/85 (34%), Positives = 48/85 (56%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            + CGT  Y+APE++N+ GH+   D WS G +M+ +L G  PF+    KET + I K + 
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL 243

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
            +P  L   A ++++ +   +P  R
Sbjct: 244 GMPQFLSPEAQSLLRMLFKRNPANR 268

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 64.5 bits (158), Expect = 4e-12
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 1/62 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L  R SK     TE + +FY+ ++   + +LH   II+RDLK  N+ L +   +K+ DFG
Sbjct: 113 LFTRLSKEVM-FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171

Query: 293 LA 294
           L+
Sbjct: 172 LS 173

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 30/85 (35%), Positives = 45/85 (52%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            T CGTP+YIAPEIL +  +   VD W++G ++Y +L G  PFE     + +  I   E 
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 241

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
             P  L + A  ++K  +  +P  R
Sbjct: 242 VYPTWLHEDATGILKSFMTKNPTMR 266

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 21/56 (37%), Positives = 32/56 (57%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           ++ +   E   RFY  +I+  + +LHD  II+RDLKL N+ L      K+ DFG+ 
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 97.0 bits (242), Expect = 1e-23
 Identities = 26/103 (25%), Positives = 49/103 (47%), Gaps = 5/103 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSF---EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK 159
           +   GTP ++APE L++    F    +DVW++G  +Y  + G+ PF    +   +S+IK 
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS 254

Query: 160 VEYKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
              + P    + +    +I +ML  +P  R  V ++    +  
Sbjct: 255 QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.9 bits (203), Expect = 3e-18
 Identities = 25/67 (37%), Positives = 44/67 (65%), Gaps = 2/67 (2%)

Query: 232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDF 291
           P+ME  + +   ++E + RFY + +++G+ YLH  KIIHRD+K  NL + ++  +KI DF
Sbjct: 124 PVMEVPTLKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 292 GLAARIE 298
           G++   +
Sbjct: 182 GVSNEFK 188

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 31/85 (36%), Positives = 46/85 (54%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I   E 
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           + P TL   A +++  +L  DP QR
Sbjct: 223 RFPRTLSPEAKSLLAGLLKKDPKQR 247

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 64.5 bits (158), Expect = 5e-12
 Identities = 25/62 (40%), Positives = 35/62 (56%), Gaps = 1/62 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L    S+ R   TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFG
Sbjct: 92  LFFHLSRERV-FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150

Query: 293 LA 294
           L 
Sbjct: 151 LC 152

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 97.5 bits (243), Expect = 2e-23
 Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 43/232 (18%)

Query: 3   QEIAIHRSLK-HRNVVGFHSFF-------EDSKFVYIILELCRKRSMMELYNSACDLEEM 54
           QE+   + L  H N+V F S         +  +  +++L    K  ++E          +
Sbjct: 74  QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133

Query: 55  SDPAAQPVIW-VSKWVDY-------------------SDKYG------FGYQLNDDSSGV 88
           S      + +   + V +                       G      FG          
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193

Query: 89  MFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGH---SFEVDVWSIGCIMYTLLVGKPPF 145
                 R  ++  + T   TP Y  PEI++   +     + D+W++GCI+Y L   + PF
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

Query: 146 ETSTLKETYSRIKKVEYKLPATLKKPAA--TMIKKMLLLDPVQRPPVAQLLH 195
           E         RI   +Y +P    +     ++I+ ML ++P +R  +A+++H
Sbjct: 254 EDGAKL----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVH 301

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 80.2 bits (198), Expect = 2e-17
 Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 2/61 (3%)

Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSDNFVVKIGDFGLA 294
             + R  ++         Q    V ++H  K  IIHRDLK+ NL LS+   +K+ DFG A
Sbjct: 126 KMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

Query: 295 A 295
            
Sbjct: 186 T 186

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 29/85 (34%), Positives = 45/85 (52%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            T CGTP+YIAPEI+    +   VD W+ G ++Y +L G+ PFE     E +  I +   
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
             P ++ K A  + K ++   P +R
Sbjct: 239 AYPKSMSKEAVAICKGLMTKHPGKR 263

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 1/62 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           LM    +  +   EP   FY  +I  G+ +L    II+RDLKL N+ L     +KI DFG
Sbjct: 108 LMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166

Query: 293 LA 294
           + 
Sbjct: 167 MC 168

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 96.8 bits (242), Expect = 2e-23
 Identities = 29/85 (34%), Positives = 48/85 (56%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            TLCGTP+YIAPE+++   ++  +D WS G ++Y +L G  PF  S   +TY +I   E 
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 220

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           + P    +    ++ +++  D  QR
Sbjct: 221 RFPPFFNEDVKDLLSRLITRDLSQR 245

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.9 bits (154), Expect = 1e-11
 Identities = 21/60 (35%), Positives = 32/60 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++ +    P  +FY  ++   + YLH   II+RDLK  N+ L  N  +KI DFG A  + 
Sbjct: 98  RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 96.6 bits (241), Expect = 2e-23
 Identities = 31/122 (25%), Positives = 52/122 (42%), Gaps = 8/122 (6%)

Query: 104 TLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
              GT  Y  PE ++++  H+    VWS+G ++Y ++ G  PFE          I + E 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAEL 250

Query: 163 KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN-DYCPTSLPASCLMTAPRFDSV 221
             PA +      +I++ L   P  RP + ++L   +         L  S    AP   S+
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSL 310

Query: 222 VP 223
           +P
Sbjct: 311 LP 312

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 14/57 (24%), Positives = 28/57 (49%), Gaps = 1/57 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLAA 295
            +  + E  +R +  Q++  + + H   ++HRD+K  N+ +       K+ DFG  A
Sbjct: 132 EKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 96.5 bits (241), Expect = 4e-23
 Identities = 32/85 (37%), Positives = 50/85 (58%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           NT CGTP+YIAPEIL    ++  VD WS G ++Y +L+G+ PF     +E +  I+    
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
             P  L+K A  ++ K+ + +P +R
Sbjct: 236 FYPRWLEKEAKDLLVKLFVREPEKR 260

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 22/62 (35%), Positives = 32/62 (51%), Gaps = 1/62 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           LM       K        FY  +I+ G+ +LH   I++RDLKL N+ L  +  +KI DFG
Sbjct: 105 LMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 293 LA 294
           + 
Sbjct: 164 MC 165

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 26/85 (30%), Positives = 46/85 (54%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            TLCGTP  +APEI+   G++  VD W++G ++Y +  G PPF      + Y +I   + 
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           + P+        +++ +L +D  +R
Sbjct: 256 RFPSHFSSDLKDLLRNLLQVDLTKR 280

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 23/60 (38%), Positives = 34/60 (56%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 96.6 bits (241), Expect = 5e-23
 Identities = 29/85 (34%), Positives = 46/85 (54%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           +T CGTP Y+APE+L+K  +   VD W +G ++Y +L G PPF +    E Y  I     
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 256

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           +L   +   A  +++ +L  D  +R
Sbjct: 257 QLKPNITNSARHLLEGLLQKDRTKR 281

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 22/62 (35%), Positives = 30/62 (48%), Gaps = 1/62 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L     + R    EP  RFY  +I   + YLH   I++RDLK  N+ L     + + DFG
Sbjct: 126 LFYHLQRERC-FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184

Query: 293 LA 294
           L 
Sbjct: 185 LC 186

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 94.7 bits (236), Expect = 1e-22
 Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 7/102 (6%)

Query: 104 TLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
              GT  Y  PE +  +  H     VWS+G ++Y ++ G  PFE          I + + 
Sbjct: 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQV 260

Query: 163 KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP 204
                +      +I+  L L P  RP   ++ +  +  D   
Sbjct: 261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.1 bits (185), Expect = 1e-15
 Identities = 19/57 (33%), Positives = 32/57 (56%), Gaps = 1/57 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLAA 295
            R A+ E   R +  Q+LE V + H+  ++HRD+K  N+ +  +   +K+ DFG  A
Sbjct: 142 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 29/85 (34%), Positives = 45/85 (52%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            T CGTP+YIAPEI+    +   VD W+ G ++Y +L G+ PFE     E +  I +   
Sbjct: 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 559

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
             P ++ K A  + K ++   P +R
Sbjct: 560 AYPKSMSKEAVAICKGLMTKHPGKR 584

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 1/62 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           LM    +  +   EP   FY  +I  G+ +L    II+RDLKL N+ L     +KI DFG
Sbjct: 429 LMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487

Query: 293 LA 294
           + 
Sbjct: 488 MC 489

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 92.8 bits (231), Expect = 4e-22
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 36/223 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EIA+H+ LKH+N+V +   F ++ F+ I +E     S+  L  S     + ++      
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-- 125

Query: 63  IWVSKWVDYSDKYGFGY---------------QLNDDSSGVM----FNDLTRMI-MLANK 102
            +  + ++     G  Y                L +  SGV+    F    R+  +    
Sbjct: 126 FYTKQILE-----GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180

Query: 103 NTLCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS---RI 157
            T  GT  Y+APEI++K   G+    D+WS+GC +  +  GKPPF    L E  +   ++
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF--YELGEPQAAMFKV 238

Query: 158 KKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
              +   ++P ++   A   I K    DP +R     LL  EF
Sbjct: 239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 80.0 bits (198), Expect = 2e-17
 Identities = 26/56 (46%), Positives = 38/56 (67%), Gaps = 1/56 (1%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLAARIE 298
             E    FY KQILEG+ YLHD++I+HRD+K  N+ + + + V+KI DFG + R+ 
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 94.8 bits (236), Expect = 4e-22
 Identities = 31/85 (36%), Positives = 47/85 (55%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
            T CGTP Y+APE+L  N +   VD W +G +MY ++ G+ PF     ++ +  I   E 
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 366

Query: 163 KLPATLKKPAATMIKKMLLLDPVQR 187
           + P TL   A +++  +L  DP QR
Sbjct: 367 RFPRTLGPEAKSLLSGLLKKDPKQR 391

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 2/63 (3%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHK-IIHRDLKLGNLFLSDNFVVKIGDF 291
           L    S+ R   +E   RFY  +I+  + YLH  K +++RDLKL NL L  +  +KI DF
Sbjct: 235 LFFHLSRERV-FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293

Query: 292 GLA 294
           GL 
Sbjct: 294 GLC 296

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 103 NTLCGTPNYIAPEILNKN---GHSFEVDVWSIGCIMYTLLVGKPPFE---TSTLKETYSR 156
            T+ GT  Y+APE+ +     G+SF VD WS+G   Y LL G+ P+    +++ KE    
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231

Query: 157 IKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
            +      P+   +   +++KK+L  +P QR
Sbjct: 232 FETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 17/62 (27%), Positives = 35/62 (56%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++     E   + ++ +++  + YL + +IIHRD+K  N+ L ++  V I DF +AA + 
Sbjct: 107 QQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166

Query: 299 FD 300
            +
Sbjct: 167 RE 168

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 93.6 bits (232), Expect = 8e-22
 Identities = 18/128 (14%), Positives = 32/128 (25%), Gaps = 9/128 (7%)

Query: 103 NTLCGTPNYIAPEILNKNGH-----SFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
                 P   A  +L    H     +F  D W++G  +Y +     P            I
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329

Query: 158 KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPR 217
            +    +P     P   +++  L      R    Q +    +         A  L     
Sbjct: 330 FRSCKNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDG 385

Query: 218 FDSVVPSF 225
             +     
Sbjct: 386 EPTREGGA 393

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 11/65 (16%), Positives = 27/65 (41%)

Query: 232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDF 291
            ++  +S   K++          Q++  ++ LH + ++H  L+  ++ L     V +  F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255

Query: 292 GLAAR 296
               R
Sbjct: 256 EHLVR 260

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 4/89 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSRIK 158
               GTP ++APE+L    + F VD +++G  +Y ++  + PF    E    KE   R+ 
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406

Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +     P      +    + +L  DP +R
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKR 435

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 24/70 (34%), Positives = 36/70 (51%)

Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           +    +      EP   FY  QI+ G+ +LH   II+RDLK  N+ L D+  V+I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335

Query: 294 AARIEFDGQR 303
           A  ++    +
Sbjct: 336 AVELKAGQTK 345

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL---------KET 153
           +T CGTPNYIAPEIL    + F VD W++G +M+ ++ G+ PF+                
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227

Query: 154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +  I + + ++P +L   AA+++K  L  DP +R
Sbjct: 228 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 63.8 bits (156), Expect = 9e-12
 Identities = 21/56 (37%), Positives = 35/56 (62%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +R++ + E   RFY  +I   ++YLH+  II+RDLKL N+ L     +K+ D+G+ 
Sbjct: 102 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 23/89 (25%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSRIK 158
               GT  Y+APE++    ++F  D W++GC++Y ++ G+ PF    +    +E    +K
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402

Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +V  +        A ++  ++L  DP +R
Sbjct: 403 EVPEEYSERFSPQARSLCSQLLCKDPAER 431

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 65.2 bits (159), Expect = 4e-12
 Identities = 20/61 (32%), Positives = 31/61 (50%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
            +    E    FY  +I  G+  LH  +I++RDLK  N+ L D+  ++I D GLA  +  
Sbjct: 279 GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338

Query: 300 D 300
            
Sbjct: 339 G 339

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 91.2 bits (227), Expect = 3e-21
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 103 NTLCGTPNYIAPEIL--NKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSR 156
              CGT  Y+AP+I+    +GH   VD WS+G +MY LL G  PF    E ++  E   R
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277

Query: 157 IKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           I K E   P  +   A  +I+++L+ DP +R
Sbjct: 278 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 1/62 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L    S+R +  TE E + Y+ +I+  + +LH   II+RD+KL N+ L  N  V + DFG
Sbjct: 146 LFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204

Query: 293 LA 294
           L+
Sbjct: 205 LS 206

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL---------KET 153
           +T CGTPNYIAPEIL    + F VD W++G +M+ ++ G+ PF+                
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270

Query: 154 YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR 187
           +  I + + ++P +L   AA+++K  L  DP +R
Sbjct: 271 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 64.3 bits (157), Expect = 8e-12
 Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 1/62 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           LM    ++RK + E   RFY  +I   ++YLH+  II+RDLKL N+ L     +K+ D+G
Sbjct: 140 LMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 293 LA 294
           + 
Sbjct: 199 MC 200

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.6 bits (230), Expect = 4e-21
 Identities = 24/89 (26%), Positives = 42/89 (47%), Gaps = 4/89 (4%)

Query: 103 NTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETSTLK---ETYSRIK 158
           +   GT  Y+APE+L K   +    D +S+GC+++ LL G  PF     K   E      
Sbjct: 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

Query: 159 KVEYKLPATLKKPAATMIKKMLLLDPVQR 187
            +  +LP +      ++++ +L  D  +R
Sbjct: 408 TMAVELPDSFSPELRSLLEGLLQRDVNRR 436

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 19/56 (33%), Positives = 35/56 (62%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            +    +E + RFY  +I+ G+ ++H+  +++RDLK  N+ L ++  V+I D GLA
Sbjct: 284 SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 89.7 bits (223), Expect = 6e-21
 Identities = 28/96 (29%), Positives = 56/96 (58%), Gaps = 4/96 (4%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF--ETSTLKETYSRIKKV 160
           ++L GTP Y++PE +++NG++F+ D+WS+GC++Y +   + PF  +   L     +I++ 
Sbjct: 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 253

Query: 161 EYK-LPAT-LKKPAATMIKKMLLLDPVQRPPVAQLL 194
           +Y  LP+    +    ++   +  DP +RP V  + 
Sbjct: 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVY 289

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 84.7 bits (210), Expect = 4e-19
 Identities = 19/62 (30%), Positives = 37/62 (59%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           +++   K+++ I E     Y  Q+   + ++H  +++HRD+K  N+F++   VVK+GD G
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 181

Query: 293 LA 294
           L 
Sbjct: 182 LG 183

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 46.9 bits (112), Expect = 3e-06
 Identities = 11/34 (32%), Positives = 21/34 (61%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC 36
           +EI + + L H NV+ +++ F +   + I+LEL 
Sbjct: 81  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 114

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 90.1 bits (223), Expect = 9e-21
 Identities = 19/114 (16%), Positives = 36/114 (31%), Gaps = 11/114 (9%)

Query: 100 ANKNTLCGTPNYIAPEILNKNG--HSFEVDVWSIGCIMYTLLVGKPPFE--TSTLKETYS 155
                      Y   E LN +    +  ++ W +G  +Y +     PF   T  +K ++ 
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305

Query: 156 RIK-------KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
           R          + +     L     T+I + L  D  +R    + +    F   
Sbjct: 306 RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 9/65 (13%), Positives = 22/65 (33%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
            ++     R             Q++   + L    ++H      NLF+  +  + +GD  
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239

Query: 293 LAARI 297
              ++
Sbjct: 240 ALWKV 244

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 88.6 bits (220), Expect = 2e-20
 Identities = 41/235 (17%), Positives = 71/235 (30%), Gaps = 58/235 (24%)

Query: 2   SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            +E+     L    +V  +    +  +V I +EL    S+ +L      L E        
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE-------D 150

Query: 62  VIWV--------------------------------SKWVDYSDKYGFGY--QLNDDSSG 87
                                                      D   FG+   L  D  G
Sbjct: 151 RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCD---FGHALCLQPDGLG 207

Query: 88  VMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-E 146
                      L   + + GT  ++APE++       +VD+WS  C+M  +L G  P+ +
Sbjct: 208 KS---------LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258

Query: 147 TSTLKETYSRI---KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
                    +I        ++P +     A  I++ L  +PV R    +L     
Sbjct: 259 YFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 82.5 bits (204), Expect = 4e-18
 Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 1/67 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKIGDFGLAARI 297
           K+   + E    +Y+ Q LEG+ YLH  +I+H D+K  N+ LS +     + DFG A  +
Sbjct: 142 KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

Query: 298 EFDGQRK 304
           + DG  K
Sbjct: 202 QPDGLGK 208

>1q4k_B Serine/threonine-protein kinase PLK; six-stranded anti-parallel beta sheet with one alpha helix, transferase; HET: TPO; 2.30A {Homo sapiens} SCOP: d.223.1.2 d.223.1.2 Length = 259

 Score = 87.2 bits (215), Expect = 3e-20
 Identities = 35/73 (47%), Positives = 45/73 (61%)

Query: 34  ELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDL 93
           +L    +           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND 
Sbjct: 36  QLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDS 95

Query: 94  TRMIMLANKNTLC 106
           TR+I+  + ++L 
Sbjct: 96  TRLILYNDGDSLQ 108

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.7 bits (220), Expect = 5e-20
 Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 9/94 (9%)

Query: 103 NTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
           +   GTP+YI+PEIL      K  +  E D WS+G  MY +L G+ PF   +L ETY +I
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

Query: 158 --KKVEYKLPATLKK--PAATMIKKMLLLDPVQR 187
              K  ++ P  +      A  + + L+     R
Sbjct: 294 MNHKERFQFPTQVTDVSENAKDLIRRLICSREHR 327

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 19/72 (26%), Positives = 37/72 (51%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L+   SK    + E   RFY+ +++  +  +H    +HRD+K  N+ +  N  +++ DFG
Sbjct: 161 LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 220

Query: 293 LAARIEFDGQRK 304
              ++  DG  +
Sbjct: 221 SCLKLMEDGTVQ 232

>3p34_A Serine/threonine-protein kinase PLK1; phosphoprotein binding domain, PLK1, kinase, transferase; HET: TPO; 1.40A {Homo sapiens} PDB: 3p2z_A* 3p2w_A* 3p35_A* 3p36_A* 3p37_A* 3q1i_A* 2ogq_A 2ojs_A* 2ojx_A 3bzi_A* 3mhn_A* 3mhq_A 3mq8_B* 4dfw_A* 1q4o_A* 1umw_A* 3hik_A* 3rq7_A* 3fvh_A* 3hih_A ... Length = 232

 Score = 85.2 bits (210), Expect = 9e-20
 Identities = 34/55 (61%), Positives = 42/55 (76%)

Query: 52  EEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLC 106
           EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L 
Sbjct: 36  EEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQ 90

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 34/93 (36%), Positives = 46/93 (49%), Gaps = 9/93 (9%)

Query: 103 NTLCGTPNYIAPEILNKNG----HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI- 157
           +T  GTP+YI+PE+L   G    +  E D WS+G  +Y +LVG  PF   +L  TYS+I 
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

Query: 158 -KKVEYKLPAT--LKKPAATMIKKMLLLDPVQR 187
             K     P    + K A  +I    L D   R
Sbjct: 287 NHKNSLTFPDDNDISKEAKNLICA-FLTDREVR 318

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 67.4 bits (165), Expect = 6e-13
 Identities = 17/63 (26%), Positives = 31/63 (49%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
               + E   RFY  +++  +  +H    IHRD+K  N+ L  +  +K+ DFG   ++  
Sbjct: 161 SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220

Query: 300 DGQ 302
           +G 
Sbjct: 221 EGM 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 11/96 (11%)

Query: 103 NTLCGTPNYIAPEILNKNG-------HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
               GTP+Y++PEIL   G       +  E D W++G   Y +  G+ PF   +  ETY 
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280

Query: 156 RI--KKVEYKLPATLKK--PAATMIKKMLLLDPVQR 187
           +I   K    LP   +     A    + LL  P  R
Sbjct: 281 KIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETR 316

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 67.4 bits (165), Expect = 7e-13
 Identities = 20/72 (27%), Positives = 36/72 (50%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L+   SK  + I     RFY+ +I+  +  +H    +HRD+K  N+ L     +++ DFG
Sbjct: 148 LLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207

Query: 293 LAARIEFDGQRK 304
              ++  DG  +
Sbjct: 208 SCLKLRADGTVR 219

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 82.6 bits (205), Expect = 3e-18
 Identities = 28/64 (43%), Positives = 40/64 (62%), Gaps = 3/64 (4%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           + +++ NS     +T    + YM   L+G+ YLH H I+HRDLK  NL L +N V+K+ D
Sbjct: 99  EVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLAD 155

Query: 291 FGLA 294
           FGLA
Sbjct: 156 FGLA 159

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 34/162 (20%), Positives = 60/162 (37%), Gaps = 36/162 (22%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--------- 160
           Y APE+L     +   VD+W++GCI+  LL+  P     +  +  +RI +          
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237

Query: 161 -------EYKL-----PATLKK--PAAT-----MIKKMLLLDPVQRPPVAQLLHFEFFND 201
                  +Y          L     AA      +I+ + L +P  R    Q L  ++F++
Sbjct: 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

Query: 202 YCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKA 243
             P   P   L   PR +       + + +       KR++ 
Sbjct: 298 R-PGPTPGCQL---PRPN---CPVETLKEQSNPALAIKRKRT 332

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 81.6 bits (202), Expect = 4e-18
 Identities = 35/236 (14%), Positives = 79/236 (33%), Gaps = 54/236 (22%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDS----KFVYIILELCRKRSMMELYNSACDLEEMSD 56
             +E  + + L+H N+V F+  +E +    K + ++ EL    ++         ++    
Sbjct: 72  FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV- 130

Query: 57  PAAQPVIWVSKWV-------DYSDKYGFGYQLNDDSSGVMFNDLT--------------- 94
                   +  W         +         L+  +  ++  DL                
Sbjct: 131 --------LRSWCRQILKGLQF---------LHTRTPPIIHRDLKCDNIFITGPTGSVKI 173

Query: 95  ------RMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ET 147
                  +   +    + GTP ++APE+  +  +   VDV++ G  M  +   + P+ E 
Sbjct: 174 GDLGLATLKRASFAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSEC 232

Query: 148 STLKETYSRI--KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
               + Y R+                   +I+  +  +  +R  +  LL+  FF +
Sbjct: 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 78.5 bits (194), Expect = 5e-17
 Identities = 27/68 (39%), Positives = 37/68 (54%), Gaps = 3/68 (4%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLS-DNFVVKIGDFGLAA 295
           KR K +     R + +QIL+G+ +LH     IIHRDLK  N+F++     VKIGD GLA 
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180

Query: 296 RIEFDGQR 303
                  +
Sbjct: 181 LKRASFAK 188

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.9 bits (203), Expect = 4e-18
 Identities = 20/64 (31%), Positives = 34/64 (53%), Gaps = 2/64 (3%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           +  ++        +     +  M+Q L G+ +LH + I+HRDLK  N+ ++    VK+ D
Sbjct: 106 RTYLD--KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163

Query: 291 FGLA 294
           FGLA
Sbjct: 164 FGLA 167

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 57.2 bits (139), Expect = 1e-09
 Identities = 24/121 (19%), Positives = 46/121 (38%), Gaps = 27/121 (22%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV---------- 160
           Y APE+L ++ ++  VD+WS+GCI   +   KP F  ++  +   +I  +          
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244

Query: 161 ------EYKLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC 203
                     P    +P            A ++ +ML  +P +R    + L   + +   
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304

Query: 204 P 204
            
Sbjct: 305 G 305

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.4 bits (202), Expect = 6e-18
 Identities = 22/64 (34%), Positives = 41/64 (64%), Gaps = 3/64 (4%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K +++     +  + + + + Y+ Q+L GV++ H H+I+HRDLK  NL ++ +  +K+ D
Sbjct: 106 KKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLAD 162

Query: 291 FGLA 294
           FGLA
Sbjct: 163 FGLA 166

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 29/126 (23%), Positives = 44/126 (34%), Gaps = 33/126 (26%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--------- 160
           Y AP++L     +S  VD+WSIGCI   ++ GKP F   T  +   +I  +         
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244

Query: 161 -------EYKLPATLKKPAATMIK---------------KMLLLDPVQRPPVAQLLHFEF 198
                   +K   T +                        ML  DP +R      ++  +
Sbjct: 245 PQVQELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

Query: 199 FNDYCP 204
           F D  P
Sbjct: 304 FKDLDP 309

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 81.0 bits (201), Expect = 8e-18
 Identities = 23/64 (35%), Positives = 39/64 (60%), Gaps = 2/64 (3%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K  M+  +     I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ D
Sbjct: 89  KKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLAD 146

Query: 291 FGLA 294
           FGLA
Sbjct: 147 FGLA 150

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.6 bits (200), Expect = 1e-17
 Identities = 22/64 (34%), Positives = 37/64 (57%), Gaps = 3/64 (4%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K L++        +     + ++ Q+L G++Y HD +++HRDLK  NL ++    +KI D
Sbjct: 87  KKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIAD 143

Query: 291 FGLA 294
           FGLA
Sbjct: 144 FGLA 147

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 56.8 bits (138), Expect = 1e-09
 Identities = 51/255 (20%), Positives = 88/255 (34%), Gaps = 75/255 (29%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI+I + LKH N+V  +      K + ++ E               DL+++ D     + 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-----------DQDLKKLLDVCEGGL- 97

Query: 64  WVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDL-TRMIMLANKNTL----------CG 107
                 +      F  QL +         V+  DL  + +++  +  L           G
Sbjct: 98  ------ESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151

Query: 108 TPN-----------YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
            P            Y AP++L     +S  +D+WS+GCI   ++ G P F   +  +   
Sbjct: 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211

Query: 156 RIKKV----------------EYKL------PATLKK--PAAT-----MIKKMLLLDPVQ 186
           RI ++                +Y        P   +            ++ KML LDP Q
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271

Query: 187 RPPVAQLLHFEFFND 201
           R    Q L   +F +
Sbjct: 272 RITAKQALEHAYFKE 286

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 19/64 (29%), Positives = 35/64 (54%), Gaps = 2/64 (3%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
              ++        +     +  M Q+L G+ +LH H+++HRDLK  N+ ++ +  +K+ D
Sbjct: 106 TTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163

Query: 291 FGLA 294
           FGLA
Sbjct: 164 FGLA 167

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 55.7 bits (135), Expect = 4e-09
 Identities = 26/131 (19%), Positives = 44/131 (33%), Gaps = 28/131 (21%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV---------- 160
           Y APE+L ++ ++  VD+WS+GCI   +   KP F  S+  +   +I  V          
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244

Query: 161 ------EYKLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC 203
                      +   +P              ++ K L  +P +R      L   +F D  
Sbjct: 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL- 303

Query: 204 PTSLPASCLMT 214
                      
Sbjct: 304 ERCKENLDSHL 314

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 80.3 bits (199), Expect = 1e-17
 Identities = 18/64 (28%), Positives = 34/64 (53%), Gaps = 3/64 (4%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K   +        +     + ++ Q+L+G+ + H   ++HRDLK  NL ++ N  +K+ +
Sbjct: 88  KKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLAN 144

Query: 291 FGLA 294
           FGLA
Sbjct: 145 FGLA 148

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 51.4 bits (124), Expect = 1e-07
 Identities = 29/125 (23%), Positives = 50/125 (40%), Gaps = 31/125 (24%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKV-------- 160
           Y  P++L     +S  +D+WS GCI   L   G+P F  + + +   RI ++        
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 161 --------------EYKLPATLKK--PAAT-----MIKKMLLLDPVQRPPVAQLLHFEFF 199
                          Y    +L    P        +++ +L  +PVQR    + L   +F
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

Query: 200 NDYCP 204
           +D+CP
Sbjct: 287 SDFCP 291

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 80.7 bits (200), Expect = 1e-17
 Identities = 19/64 (29%), Positives = 35/64 (54%), Gaps = 3/64 (4%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
              ++R    ++ + E   +    Q L+ V++ H H  IHRD+K  N+ ++ + V+K+ D
Sbjct: 89  LHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCD 145

Query: 291 FGLA 294
           FG A
Sbjct: 146 FGFA 149

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 57.6 bits (140), Expect = 9e-10
 Identities = 32/133 (24%), Positives = 51/133 (38%), Gaps = 34/133 (25%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPF------------------------ 145
           Y +PE+L     +   VDVW+IGC+   LL G P +                        
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227

Query: 146 -ETSTLKETYSRIKKVEYKLPATLKK--PAAT-----MIKKMLLLDPVQRPPVAQLLHFE 197
              ST +  +S +K  + +    L+   P  +     ++K  L +DP +R    QLLH  
Sbjct: 228 QVFSTNQY-FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286

Query: 198 FFNDYCPTSLPAS 210
           +F +       A 
Sbjct: 287 YFENIREIEDLAK 299

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 22/64 (34%), Positives = 38/64 (59%), Gaps = 3/64 (4%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
             L+     +    T  E +  M+ +L G+ Y+H +KI+HRD+K  N+ ++ + V+K+ D
Sbjct: 111 AGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167

Query: 291 FGLA 294
           FGLA
Sbjct: 168 FGLA 171

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 34/162 (20%), Positives = 58/162 (35%), Gaps = 40/162 (24%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKP--------------------P----- 144
           Y  PE+L  +  +   +D+W  GCIM  +    P                          
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253

Query: 145 --------FETSTLKETYSRIKKVEYKLPATLKKPAA-TMIKKMLLLDPVQRPPVAQLLH 195
                   +E   L +   R  KV+ +L A ++ P A  +I K+L+LDP QR      L+
Sbjct: 254 PNVDNYELYEKLELVKGQKR--KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311

Query: 196 FEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERN 237
            +FF    P       +++          + +P R+     +
Sbjct: 312 HDFFWSD-PMPSDLKGMLSTHLTSM--FEYLAPPRRKHHHHH 350

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.3 bits (199), Expect = 2e-17
 Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 3/64 (4%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
              +E        +     + Y+ QI+ G+ + H H IIHRD+K  N+ +S + VVK+ D
Sbjct: 111 LDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCD 167

Query: 291 FGLA 294
           FG A
Sbjct: 168 FGFA 171

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 51/257 (19%), Positives = 95/257 (36%), Gaps = 77/257 (29%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI + + L+H N+V      +  K  Y++ E       ++       + +  +     + 
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF------VD-----HTILDDLELFPNGL- 121

Query: 64  WVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDLTRMIMLANKNT---LC--------G 107
                 DY     + +Q+ +      S  ++  D+    +L +++    LC         
Sbjct: 122 ------DYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

Query: 108 TPN-----------YIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETS------- 148
            P            Y APE+L  +      VDVW+IGC++  + +G+P F          
Sbjct: 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY 235

Query: 149 -------TLKET----------YSRIKKVEYKLPATLKK--PAAT-----MIKKMLLLDP 184
                   L             ++ ++  E K    L++  P  +     + KK L +DP
Sbjct: 236 HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDP 295

Query: 185 VQRPPVAQLLHFEFFND 201
            +RP  A+LLH +FF  
Sbjct: 296 DKRPFCAELLHHDFFQM 312

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.9 bits (198), Expect = 2e-17
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 2/66 (3%)

Query: 231 KPLMERNSKR--RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           K  M+  +     + +     +++  Q+L+G+++ H++KI+HRDLK  NL ++    +K+
Sbjct: 90  KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKL 149

Query: 289 GDFGLA 294
           GDFGLA
Sbjct: 150 GDFGLA 155

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 47/269 (17%), Positives = 91/269 (33%), Gaps = 75/269 (27%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI 63
           EI++ + LKH N+V  +        + ++ E               DL++  D  ++ V 
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-----------DNDLKKYMD--SRTVG 99

Query: 64  WVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDL-TRMIMLANKNTL----------CG 107
              + ++ +    F +QL         + ++  DL  + +++  +  L           G
Sbjct: 100 NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

Query: 108 TPN-----------YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS 155
            P            Y AP++L     +S  +D+WS GCI+  ++ GKP F  +  +E   
Sbjct: 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK 219

Query: 156 RI----------------------------------KKVEYKLPATLKKPAATMIKKMLL 181
            I                                  + ++      L       +  +L 
Sbjct: 220 LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279

Query: 182 LDPVQRPPVAQLLHFEFFNDYCPTSLPAS 210
           L+P  R    Q LH  +F +Y   +    
Sbjct: 280 LNPDMRLSAKQALHHPWFAEYYHHASMGG 308

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 21/64 (32%), Positives = 36/64 (56%), Gaps = 3/64 (4%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K  ++        I     + ++ Q+L G++Y H  K++HRDLK  NL +++   +K+ D
Sbjct: 87  KQYLDDCGNI---INMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLAD 143

Query: 291 FGLA 294
           FGLA
Sbjct: 144 FGLA 147

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 58.0 bits (141), Expect = 6e-10
 Identities = 31/163 (19%), Positives = 53/163 (32%), Gaps = 37/163 (22%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--------- 160
           Y  P+IL     +S ++D+W +GCI Y +  G+P F  ST++E    I ++         
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225

Query: 161 ----------EYKLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                      Y  P    +             A ++ K+L  +   R      +   FF
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

Query: 200 NDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRK 242
                  L        P   S+        +K    R++    
Sbjct: 286 LS-----LGERI-HKLPDTTSIFALKEIQLQKEASLRSAHHHH 322

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 78.1 bits (193), Expect = 9e-17
 Identities = 24/91 (26%), Positives = 42/91 (46%), Gaps = 9/91 (9%)

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSRIKKVEYKLPA- 166
            A E   +  +    D+WS+G IMY LL G PPF      +      +RI+  +Y+ P  
Sbjct: 166 FAKETTGEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224

Query: 167 ---TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
               + +    +I+ +L  +P QR  + + +
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 255

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.3 bits (178), Expect = 9e-15
 Identities = 24/60 (40%), Positives = 31/60 (51%), Gaps = 3/60 (5%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLA 294
            +  +A TE E    MK I E + YLH   I HRD+K  NL       N ++K+ DFG A
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 43.4 bits (103), Expect = 4e-05
 Identities = 7/40 (17%), Positives = 19/40 (47%), Gaps = 5/40 (12%)

Query: 3  QEIAI-HRSLKHRNVVGFHSFFEDS----KFVYIILELCR 37
          +E+ +  R+ +  ++V     +E+     K + I++E   
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 75.8 bits (187), Expect = 6e-16
 Identities = 50/251 (19%), Positives = 89/251 (35%), Gaps = 59/251 (23%)

Query: 3   QEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRSMMELYNSAC-DLEEMSDPAAQ 60
           +EI       H N+V ++ SF    + ++++++L    S++++        E  S    +
Sbjct: 62  KEIQAMSQCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 61  PVIW-----VSKWVDYSDKYG-----------------------FGYQLNDDSSGVMFND 92
             I      V + ++Y  K G                       FG       S  +   
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV------SAFLATG 174

Query: 93  LTRMIMLANKNTLCGTPNYIAPE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPF------ 145
                    + T  GTP ++APE +    G+ F+ D+WS G     L  G  P+      
Sbjct: 175 GDITRN-KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233

Query: 146 ---------ETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF 196
                    +  +L+      + ++ K   + +K    MI   L  DP +RP  A+LL  
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLK-KYGKSFRK----MISLCLQKDPEKRPTAAELLRH 288

Query: 197 EFFNDYCPTSL 207
           +FF        
Sbjct: 289 KFFQKAKNKEF 299

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 72.0 bits (177), Expect = 1e-14
 Identities = 24/75 (32%), Positives = 43/75 (57%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K ++ +   +   + E      ++++LEG+ YLH +  IHRD+K GN+ L ++  V+I D
Sbjct: 105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD 164

Query: 291 FGLAARIEFDGQRKR 305
           FG++A +   G   R
Sbjct: 165 FGVSAFLATGGDITR 179

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 75.4 bits (186), Expect = 6e-16
 Identities = 26/68 (38%), Positives = 33/68 (48%), Gaps = 6/68 (8%)

Query: 233 LMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
             E +S               +     +Q   G+ YLH   IIHRDLK  N+FL ++  V
Sbjct: 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTV 159

Query: 287 KIGDFGLA 294
           KIGDFGLA
Sbjct: 160 KIGDFGLA 167

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 52.3 bits (126), Expect = 5e-08
 Identities = 35/229 (15%), Positives = 76/229 (33%), Gaps = 54/229 (23%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMEL---YNSACDLEEMSDPAA 59
            E+ + R  +H N++ F  +    +   I+ + C   S+        +  +++++ D A 
Sbjct: 69  NEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 60  Q-----------PVI--------------WVSKWVDYSDKYGFGYQLNDDSSGVMFNDLT 94
           Q            +I                 K  D      FG       +        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD------FGL------ATEKSRWSG 175

Query: 95  RMIMLANKNTLCGTPNYIAPEILNKNGH---SFEVDVWSIGCIMYTLLVGKPPFETSTLK 151
                       G+  ++APE++        SF+ DV++ G ++Y L+ G+ P+     +
Sbjct: 176 SHQFEQL----SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

Query: 152 ETYSRIKKVEYKLPATLKKPA------ATMIKKMLLLDPVQRPPVAQLL 194
           +    +       P   K  +        ++ + L     +RP   ++L
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 76.4 bits (188), Expect = 8e-16
 Identities = 20/64 (31%), Positives = 33/64 (51%), Gaps = 4/64 (6%)

Query: 235 ERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF----VVKIGD 290
            + +K+   +     +  + QIL+G+ YLH + ++HRDLK  N+ +         VKI D
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175

Query: 291 FGLA 294
            G A
Sbjct: 176 MGFA 179

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 49.8 bits (119), Expect = 4e-07
 Identities = 34/188 (18%), Positives = 61/188 (32%), Gaps = 53/188 (28%)

Query: 111 YIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPF------------------------ 145
           Y APE+L    H +  +D+W+IGCI   LL  +P F                        
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260

Query: 146 ----------------ETSTLKETYSRIKKVEYKLPATLKKP-------AATMIKKMLLL 182
                           E STL + + R       L   ++K        A  +++K+L +
Sbjct: 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 320

Query: 183 DPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRK 242
           DP++R    Q +   +F +    +         P      P       +   ++  K+ +
Sbjct: 321 DPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPY-----PKREFLTEEEPDDKGDKKNQ 375

Query: 243 AITEPETR 250
              +    
Sbjct: 376 QQQQGNNH 383

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 25/69 (36%), Positives = 40/69 (57%), Gaps = 9/69 (13%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF-----V 285
           K  M++N      ++    + ++ Q++ GV++ H  + +HRDLK  NL LS +      V
Sbjct: 120 KKYMDKNPD----VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175

Query: 286 VKIGDFGLA 294
           +KIGDFGLA
Sbjct: 176 LKIGDFGLA 184

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 58.0 bits (141), Expect = 6e-10
 Identities = 30/122 (24%), Positives = 46/122 (37%), Gaps = 31/122 (25%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--------- 160
           Y  PEIL     +S  VD+WSI CI   +L+  P F   +  +   +I +V         
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262

Query: 161 -------EYK--------------LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                  ++K              L A L      ++  ML +DPV+R      L   +F
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

Query: 200 ND 201
           + 
Sbjct: 323 SH 324

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 73.6 bits (181), Expect = 4e-15
 Identities = 24/66 (36%), Positives = 43/66 (65%), Gaps = 1/66 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +   + E    +  ++IL G+S+LH HK+IHRD+K  N+ L++N  VK+ DFG++A+++ 
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD- 180

Query: 300 DGQRKR 305
               +R
Sbjct: 181 RTVGRR 186

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 52.0 bits (125), Expect = 6e-08
 Identities = 29/134 (21%), Positives = 50/134 (37%), Gaps = 31/134 (23%)

Query: 99  LANKNTLCGTPNYIAPEIL-----NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKET 153
           +  +NT  GTP ++APE++         + F+ D+WS+G     +  G PP         
Sbjct: 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP--------- 233

Query: 154 YSRIK--KVEYKLPATLKKPAATM------------IKKMLLLDPVQRPPVAQLLHFEFF 199
              +   +  + +P   + PA  +            I+  L+ +  QRP   QL+   F 
Sbjct: 234 LCDMHPMRALFLIP---RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

Query: 200 NDYCPTSLPASCLM 213
            D          L 
Sbjct: 291 RDQPNERQVRIQLK 304

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 73.2 bits (180), Expect = 5e-15
 Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 7/68 (10%)

Query: 233 LMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
           L +  +        +  +   +TR   ++I++G+ YLH   I+H+DLK  N+F  DN  V
Sbjct: 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKV 168

Query: 287 KIGDFGLA 294
            I DFGL 
Sbjct: 169 VITDFGLF 176

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 21/103 (20%), Positives = 42/103 (40%), Gaps = 17/103 (16%)

Query: 106 CGTPNYIAPEIL---------NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSR 156
            G   ++APEI+         +K   S   DV+++G I Y L   + PF+T   +     
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--- 251

Query: 157 IKKVEYKL-----PATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           I ++   +        + K  + ++      +  +RP   +L+
Sbjct: 252 IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 72.2 bits (177), Expect = 1e-14
 Identities = 13/62 (20%), Positives = 30/62 (48%)

Query: 244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQR 303
           + E    + ++ +L+ + Y+H    +HR +K  ++ +S +  V +        +   GQR
Sbjct: 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184

Query: 304 KR 305
           +R
Sbjct: 185 QR 186

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 38/285 (13%), Positives = 78/285 (27%), Gaps = 96/285 (33%)

Query: 3   QEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRSMMELYNSACD--LEEMSDPAA 59
            E+ + +   H N+V +  +F  D++ ++++       S  +L  +     + E      
Sbjct: 75  GELHVSKLFNHPNIVPYRATFIADNE-LWVVTSFMAYGSAKDLICTHFMDGMNE------ 127

Query: 60  QPVI-WVSKWV----DY--SDKY---------------------GFGY--QLNDDSSGVM 89
              I ++ + V    DY     Y                     G      +        
Sbjct: 128 -LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ--- 183

Query: 90  FNDLTRMIMLANKNTLCGTPNYIAPEIL--NKNGHSFEVDVWSIGCIMYTLLVGKPPF-- 145
                + ++            +++PE+L  N  G+  + D++S+G     L  G  PF  
Sbjct: 184 ----RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239

Query: 146 --------------------------------------------ETSTLKETYSRIKKVE 161
                                                         +T     S      
Sbjct: 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299

Query: 162 YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
           +    T        +++ L  +P  RP  + LL+  FF      +
Sbjct: 300 HPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 344

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 26/66 (39%), Positives = 41/66 (62%), Gaps = 1/66 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
               + E +    +++IL+G+ YLH  K IHRD+K  N+ LS++  VK+ DFG+A ++  
Sbjct: 112 EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-T 170

Query: 300 DGQRKR 305
           D Q KR
Sbjct: 171 DTQIKR 176

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 58.9 bits (143), Expect = 3e-10
 Identities = 29/103 (28%), Positives = 48/103 (46%), Gaps = 1/103 (0%)

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRIKKV 160
           +NT  GTP ++APE++ ++ +  + D+WS+G     L  G+PP  E   +K  +   K  
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN 235

Query: 161 EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC 203
              L     KP    ++  L  +P  RP   +LL  +F     
Sbjct: 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 23/67 (34%), Positives = 44/67 (65%), Gaps = 1/67 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +  + +TEP+ +   +Q+LE +++LH  +IIHRDLK GN+ ++    +++ DFG++A+  
Sbjct: 109 ELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168

Query: 299 FDGQRKR 305
               +KR
Sbjct: 169 -KTLQKR 174

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 55.0 bits (133), Expect = 6e-09
 Identities = 30/120 (25%), Positives = 54/120 (45%), Gaps = 16/120 (13%)

Query: 99  LANKNTLCGTPNYIAPEI-----LNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKE 152
           L  +++  GTP ++APE+     +    + ++ D+WS+G  +  +   +PP  E + ++ 
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230

Query: 153 TYSRIKKVEYKLPATLKKPAA------TMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
              +I K +   P TL  P+         +K  L  +P  RP  AQLL   F +      
Sbjct: 231 LL-KIAKSD---PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 21/65 (32%), Positives = 34/65 (52%), Gaps = 1/65 (1%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIG 289
                  +K ++ +     + YM Q+L  ++Y+H   I HRD+K  NL L   + V+K+ 
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184

Query: 290 DFGLA 294
           DFG A
Sbjct: 185 DFGSA 189

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 64.7 bits (158), Expect = 5e-12
 Identities = 60/264 (22%), Positives = 97/264 (36%), Gaps = 82/264 (31%)

Query: 4   EIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMME--LYNSACDLEEMS 55
           E+ I R +KH NVV   +FF      +D  F+ ++LE       +   +Y ++    ++ 
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY------VPETVYRASRHYAKLK 135

Query: 56  DPAAQPVIWVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDLTRMIMLANKNT----LC 106
                 +I          K  + YQL        S G+   D+    +L +  +    L 
Sbjct: 136 QTMPMLLI----------KL-YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184

Query: 107 ----------GTPN--YI------APE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-- 145
                     G PN  YI      APE I     ++  +D+WS GC+M  L+ G+P F  
Sbjct: 185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244

Query: 146 --ETSTLKE--------TYSRIKKV-----EYKLPATLKKP------------AATMIKK 178
                 L E        +  +IK +     E+K P     P            A  +I +
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISR 304

Query: 179 MLLLDPVQRPPVAQLLHFEFFNDY 202
           +L   P  R    + L   FF++ 
Sbjct: 305 LLEYTPSARLTAIEALCHPFFDEL 328

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 20/61 (32%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSDNFVVKIGDFGL 293
             S  R+ + E         + +G++YLH+    I+HR+LK  NL +   + VK+ DFGL
Sbjct: 126 HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185

Query: 294 A 294
           +
Sbjct: 186 S 186

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 58.5 bits (142), Expect = 5e-10
 Identities = 45/230 (19%), Positives = 83/230 (36%), Gaps = 58/230 (25%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS------- 55
           +E+AI + L+H N+V F         + I+ E   + S+  L + +   E++        
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142

Query: 56  --DPA---------AQPVI--------------WVSKWVDYSDKYGFGYQLNDDSSGVMF 90
             D A           P++              +  K  D      FG       S +  
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD------FGL------SRLKA 190

Query: 91  NDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL 150
           +            +  GTP ++APE+L     + + DV+S G I++ L   + P+     
Sbjct: 191 STFLSS------KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN--- 241

Query: 151 KETYSRIKKVEYK-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                 +  V +K     +P  L    A +I+     +P +RP  A ++ 
Sbjct: 242 LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 21/65 (32%), Positives = 34/65 (52%), Gaps = 1/65 (1%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIG 289
             +    S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ 
Sbjct: 140 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 199

Query: 290 DFGLA 294
           DFG A
Sbjct: 200 DFGSA 204

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 64.0 bits (156), Expect = 9e-12
 Identities = 61/282 (21%), Positives = 98/282 (34%), Gaps = 83/282 (29%)

Query: 4   EIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMME--LYNSACDLEEMS 55
           E+ I R L H N+V    FF      +D  ++ ++L+       +   +Y  A       
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY------VPETVYRVARHYSRAK 150

Query: 56  DPAAQPVIWVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDLTRMIMLANKNT----LC 106
                  +          K  + YQL        S G+   D+    +L + +T    LC
Sbjct: 151 QTLPVIYV----------KL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 199

Query: 107 ----------GTPN--YI------APE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-- 145
                     G PN  YI      APE I     ++  +DVWS GC++  LL+G+P F  
Sbjct: 200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259

Query: 146 --ETSTLKE--------TYSRIKKV-----EYKLPATLKKP------------AATMIKK 178
                 L E        T  +I+++     E+K P     P            A  +  +
Sbjct: 260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319

Query: 179 MLLLDPVQRPPVAQLLHFEFFNDY-CPTSLPASCLMTAPRFD 219
           +L   P  R    +     FF++   P     +   T   F+
Sbjct: 320 LLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFN 361

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 70.9 bits (174), Expect = 4e-14
 Identities = 25/58 (43%), Positives = 38/58 (65%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
            +K + E E        L+G++YLH H +IHRD+K GN+ LS+  +VK+GDFG A+ +
Sbjct: 147 HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 55.5 bits (134), Expect = 6e-09
 Identities = 30/117 (25%), Positives = 48/117 (41%), Gaps = 13/117 (11%)

Query: 99  LANKNTLCGTPNYIAPEI---LNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETY 154
           +A  N+  GTP ++APE+   +++  +  +VDVWS+G     L   KPP F  + +   Y
Sbjct: 204 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 263

Query: 155 SRIKKVEYKLPATLKKPAATM-----IKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
             I +        L+    +      +   L   P  RP    LL   F     P +
Sbjct: 264 -HIAQ---NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 70.5 bits (173), Expect = 4e-14
 Identities = 26/66 (39%), Positives = 39/66 (59%), Gaps = 1/66 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           R K +TE E    ++  L+G+ YLH  + IHRD+K GN+ L+     K+ DFG+A ++  
Sbjct: 118 RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT- 176

Query: 300 DGQRKR 305
           D   KR
Sbjct: 177 DTMAKR 182

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 61.2 bits (149), Expect = 5e-11
 Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 11/115 (9%)

Query: 99  LANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETYSRI 157
           +A +NT+ GTP ++APE++ + G++   D+WS+G     +  GKPP  +   ++  +  I
Sbjct: 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MI 237

Query: 158 KKVEYKLPATLKKPAA------TMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
                  P T +KP          +K+ L+  P QR    QLL   F       S
Sbjct: 238 PT---NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 69.6 bits (171), Expect = 7e-14
 Identities = 46/238 (19%), Positives = 91/238 (38%), Gaps = 57/238 (23%)

Query: 3   QEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELC---------RKRSMMELYNSACDLE 52
            EI + R  K+ N+V +  S+    +  ++++E            +  M E   +A   E
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE 124

Query: 53  EMS-------------DPAAQPVIWVS----KWVDYSDKYGFGYQLNDDSSGVMFNDLTR 95
            +              D  +  ++       K  D+    GF  Q+  +           
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF----GFCAQITPE----------- 169

Query: 96  MIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKETY 154
               + ++T+ GTP ++APE++ +  +  +VD+WS+G +   ++ G+PP    + L+  Y
Sbjct: 170 ---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226

Query: 155 SRIKKVEYKLPATLKKPAA------TMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
             I          L+ P          + + L +D  +R    +LL  +F     P S
Sbjct: 227 -LIAT---NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 69.3 bits (170), Expect = 8e-14
 Identities = 21/66 (31%), Positives = 36/66 (54%), Gaps = 1/66 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
               + E +     ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I  
Sbjct: 109 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT- 167

Query: 300 DGQRKR 305
             Q KR
Sbjct: 168 PEQSKR 173

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 69.7 bits (171), Expect = 9e-14
 Identities = 20/66 (30%), Positives = 36/66 (54%), Gaps = 1/66 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
            +  + E +     + +L+ ++YLH   +IHRD+K  ++ L+ +  VK+ DFG  A+I  
Sbjct: 134 SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS- 192

Query: 300 DGQRKR 305
               KR
Sbjct: 193 KDVPKR 198

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 48/239 (20%), Positives = 101/239 (42%), Gaps = 59/239 (24%)

Query: 3   QEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E+ I R  +H NVV  + S+    + +++++E  +  ++ ++ +       +++     
Sbjct: 91  NEVVIMRDYQHFNVVEMYKSYLVGEE-LWVLMEFLQGGALTDIVSQVR----LNEEQIAT 145

Query: 62  VIW-VSKWVDY--------------------------SDKYGFGYQLNDDSSGVMFNDLT 94
           V   V + + Y                          SD +GF  Q++ D          
Sbjct: 146 VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSD-FGFCAQISKD---------- 194

Query: 95  RMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP-FETSTLKET 153
               +  + +L GTP ++APE+++++ ++ EVD+WS+G ++  ++ G+PP F  S ++  
Sbjct: 195 ----VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250

Query: 154 YSRIKKVEYKLPATLKKPAA------TMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
             R++      P  LK            +++ML+ DP +R    +LL   F        
Sbjct: 251 K-RLRD---SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 1/63 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDF 291
           +++   +  ++I       Y+ Q+   V ++H   I HRD+K  NL + S +  +K+ DF
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 292 GLA 294
           G A
Sbjct: 187 GSA 189

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 55.9 bits (135), Expect = 5e-09
 Identities = 27/122 (22%), Positives = 49/122 (40%), Gaps = 30/122 (24%)

Query: 111 YIAPE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE-TSTL--------------KETY 154
           Y APE +L    ++  +D+WSIGC+   L++GKP F   +++              KE  
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266

Query: 155 SRI--KKVEYKLPATLKKPAATM------------IKKMLLLDPVQRPPVAQLLHFEFFN 200
            R+     E + P    K    +            ++++L  +P  R    + +   FF+
Sbjct: 267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326

Query: 201 DY 202
             
Sbjct: 327 HL 328

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 19/56 (33%), Positives = 33/56 (58%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +    ++      +  QIL+G+ + HD +I+HRD+K  N+ +  N  +KI DFG+A
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 46.5 bits (111), Expect = 4e-06
 Identities = 26/104 (25%), Positives = 44/104 (42%), Gaps = 9/104 (8%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE-TSTLKETYSRIKKVE 161
           N + GT  Y +PE           D++SIG ++Y +LVG+PPF   + +      I+   
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229

Query: 162 YKLPATLKK--PAA--TMIKKMLLLDPVQRPPVAQLLHFEFFND 201
             +   ++K  P +   +I +    D   R    Q    E  +D
Sbjct: 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ----EMKDD 269

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 67.7 bits (166), Expect = 4e-13
 Identities = 16/56 (28%), Positives = 28/56 (50%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
                +T       +    + +++ H + IIHRD+K  N+ +S    VK+ DFG+A
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 46.5 bits (111), Expect = 4e-06
 Identities = 27/107 (25%), Positives = 43/107 (40%), Gaps = 16/107 (14%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST--------LKETY 154
             + GT  Y++PE    +      DV+S+GC++Y +L G+PPF   +        ++E  
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236

Query: 155 SRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
                    L A L      ++ K L  +P  R   A     E   D
Sbjct: 237 IPPSARHEGLSADLDA----VVLKALAKNPENRYQTAA----EMRAD 275

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 67.4 bits (165), Expect = 5e-13
 Identities = 24/76 (31%), Positives = 35/76 (46%), Gaps = 7/76 (9%)

Query: 233 LMERNS-----KRRKAITEPETRFYM-KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
            ++  +     K   +      R    K I  G++YLH   IIHRDL   N  + +N  V
Sbjct: 88  YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNV 147

Query: 287 KIGDFGLAARIEFDGQ 302
            + DFGL AR+  D +
Sbjct: 148 VVADFGL-ARLMVDEK 162

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 39/228 (17%), Positives = 75/228 (32%), Gaps = 39/228 (17%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELC-------------RKRSMMELYNS 47
             +E+ + R L+H NV+ F       K +  I E                +    +  + 
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF 113

Query: 48  ACD-------LEEMS----DPAAQPVI----WVSKWVDYSDKYGFGY--QLNDDSSGVMF 90
           A D       L  M+    D  +   +          D      FG    + D+ +    
Sbjct: 114 AKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVAD------FGLARLMVDEKTQPEG 167

Query: 91  NDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST- 149
               +      + T+ G P ++APE++N   +  +VDV+S G ++  ++           
Sbjct: 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227

Query: 150 LKETYSRIKKVEYKLPATLKKPAA--TMIKKMLLLDPVQRPPVAQLLH 195
               +    +           P +   +  +   LDP +RP   +L H
Sbjct: 228 RTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 68.0 bits (166), Expect = 6e-13
 Identities = 18/58 (31%), Positives = 33/58 (56%), Gaps = 1/58 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           + + +   E   Y+ +IL  +SYLH   +++ DLK  N+ L++   +K+ D G  +RI
Sbjct: 175 KGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI 231

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 37/201 (18%), Positives = 71/201 (35%), Gaps = 36/201 (17%)

Query: 10  SLKHRNVVGFHSFFED-----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIW 64
            + H ++V   +F E          YI++E    +S+         + E      +    
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLE---- 190

Query: 65  VSKWVDYSDKYGFGYQLND--------DSSGVMFNDL---TRMIMLANKNTLCGTPNYIA 113
           +   + Y    G  Y  ND            +   DL   +R+    +   L GTP + A
Sbjct: 191 ILPALSYLHSIGLVY--NDLKPENIMLTEEQLKLIDLGAVSRI---NSFGYLYGTPGFQA 245

Query: 114 PEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           PEI+ + G +   D++++G  +  L +  P      +                 LK   +
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED--------DPVLKTYDS 296

Query: 174 --TMIKKMLLLDPVQRPPVAQ 192
              ++++ +  DP QR   A+
Sbjct: 297 YGRLLRRAIDPDPRQRFTTAE 317

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 66.9 bits (164), Expect = 7e-13
 Identities = 23/65 (35%), Positives = 43/65 (66%), Gaps = 2/65 (3%)

Query: 232 PLMERNSKR--RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIG 289
           P M+ + ++      +E + ++ + Q+L+G+ Y+H   ++HRDLK GNL ++++  +KI 
Sbjct: 109 PFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168

Query: 290 DFGLA 294
           DFGLA
Sbjct: 169 DFGLA 173

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 57/261 (21%), Positives = 97/261 (37%), Gaps = 83/261 (31%)

Query: 4   EIAIHRSLKHRNVVG----FHSFFEDSKF--VYIILELCRKRSMMELYNSACDLEEMSDP 57
           E+ + + ++H NV+G    F        F   Y+++        M+      DL++    
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF------MQ-----TDLQK---- 117

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDLTRMIMLANKN---TLC--- 106
               ++   K+ +   +Y   YQ+        S+GV+  DL    +  N++    +    
Sbjct: 118 ----IMG-LKFSEEKIQY-LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171

Query: 107 -------------GTPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFE-TSTL- 150
                         T  Y APE+ L+   ++  VD+WS+GCIM  +L GK  F+    L 
Sbjct: 172 LARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231

Query: 151 -------------KETYSRI-----KKVEYKLPATLKKPAATM-----------IKKMLL 181
                         E   ++     K     LP T +K    +           ++KML 
Sbjct: 232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLE 291

Query: 182 LDPVQRPPVAQLLHFEFFNDY 202
           LD  +R   AQ L   FF  +
Sbjct: 292 LDVDKRLTAAQALTHPFFEPF 312

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 19/54 (35%), Positives = 36/54 (66%), Gaps = 1/54 (1%)

Query: 242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLA 294
           + +T+ + RFYM +IL+ + Y H   I+HRD+K  N+ +  ++  +++ D+GLA
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 19/131 (14%), Positives = 42/131 (32%), Gaps = 39/131 (29%)

Query: 111 YIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPF--------------------ETST 149
           +  PE+L +   + + +D+WS+GC++ +++  K PF                    +   
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255

Query: 150 LKETYSRIKKVEYK--LPATLKKPAATMI----------------KKMLLLDPVQRPPVA 191
             + Y+      +   L    +K     +                 K+L  D   R    
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315

Query: 192 QLLHFEFFNDY 202
           + +   +F   
Sbjct: 316 EAMEHPYFYTV 326

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 21/56 (37%), Positives = 32/56 (57%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +    +TE   +  +  +L GV Y+H   I+HRDLK  N  ++ +  VK+ DFGLA
Sbjct: 148 RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 42.9 bits (101), Expect = 7e-05
 Identities = 29/155 (18%), Positives = 47/155 (30%), Gaps = 63/155 (40%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIM-----------YTLLVGKPPFE-TSTL------- 150
           Y APE+ L +  ++  +DVWSIGCI                   P F  +S         
Sbjct: 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQK 308

Query: 151 ---------------------------KETYSRIKKVEYK-----LPATLKKPAATM--- 175
                                      +E    ++K + K      P       A     
Sbjct: 309 AGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368

Query: 176 --------IKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                   +K+ML+ +P +R  + + L   FF + 
Sbjct: 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 24/68 (35%), Positives = 37/68 (54%), Gaps = 5/68 (7%)

Query: 232 PLMERN-----SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
            LM  +       +R  I+    +++M  IL G+  LH+  ++HRDL  GN+ L+DN  +
Sbjct: 114 ELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173

Query: 287 KIGDFGLA 294
            I DF LA
Sbjct: 174 TICDFNLA 181

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 53/276 (19%), Positives = 81/276 (29%), Gaps = 89/276 (32%)

Query: 4   EIAIHRSLKHRNVVGFHSFF-----EDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA 58
           EI +     H N++G    F          +Y++ EL      M       DL +     
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL------MR-----TDLAQ----- 122

Query: 59  AQPVIWVSKWVDYSD---KYGFGYQLNDD-----SSGVMFNDLTRMIMLANKN------- 103
              VI   + +  S    +Y F Y +         +GV+  DL    +L   N       
Sbjct: 123 ---VI-HDQRIVISPQHIQY-FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177

Query: 104 -----TLCGTPN---------YIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFE-T 147
                      N         Y APE+ +   G +  VD+WS GC+M  +   K  F  +
Sbjct: 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237

Query: 148 STL--------------KETYSRIKK------VEYKLPATLKKP-----------AATMI 176
           +                 E             +   L     +            A  +I
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297

Query: 177 KKMLLLDPVQRPPVAQLLHFEFFNDY-CPTSLPASC 211
            KML  +P +R    Q L   +F     P  L    
Sbjct: 298 AKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL 333

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 2/65 (3%)

Query: 232 PLMERNSKR--RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIG 289
            LM+ N  +  +  +      + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI 
Sbjct: 110 ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169

Query: 290 DFGLA 294
           DFGLA
Sbjct: 170 DFGLA 174

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 49/273 (17%), Positives = 92/273 (33%), Gaps = 95/273 (34%)

Query: 4   EIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSDP 57
           E+ + + + H+N++G  + F      E+ + VYI++EL      M+      +L +    
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL------MD-----ANLCQ---- 118

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDLTRMIMLANKN---TLC--- 106
               VI   +       Y   YQ+        S+G++  DL    ++   +    +    
Sbjct: 119 ----VIQ-MELDHERMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 172

Query: 107 ---------------GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF------ 145
                           T  Y APE++   G+   VD+WS+GCIM  ++ G   F      
Sbjct: 173 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232

Query: 146 -------------ETSTLKETYSRIKKVEYKLPATLKKP--------------------- 171
                            +K+    ++      P                           
Sbjct: 233 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 292

Query: 172 --AATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
             A  ++ KML++D  +R  V + L   + N +
Sbjct: 293 SQARDLLSKMLVIDASKRISVDEALQHPYINVW 325

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 24/55 (43%), Positives = 38/55 (69%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           + + + E   +F + Q+L+G+ Y+H   IIHRDLK GNL ++++  +KI DFGLA
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 58/281 (20%), Positives = 101/281 (35%), Gaps = 92/281 (32%)

Query: 4   EIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSDP 57
           E+ + + ++H NV+G    F      +D    Y+++        M       DL +    
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF------MG-----TDLGK---- 118

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDLTRMIMLANKNTLC------ 106
               ++   K  +   ++   YQ+        ++G++  DL    +  N++  C      
Sbjct: 119 ----LMKHEKLGEDRIQF-LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--CELKILD 171

Query: 107 ---------------GTPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFE-TST 149
                           T  Y APE+ LN   ++  VD+WS+GCIM  ++ GK  F+ +  
Sbjct: 172 FGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231

Query: 150 L--------------KETYSRIKKVEYK-----LPATLKKP-----------AATMIKKM 179
           L               E   R++  E K     LP   KK            A  +++KM
Sbjct: 232 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 291

Query: 180 LLLDPVQRPPVAQLLHFEFFNDY-CPTSLPASCLMTAPRFD 219
           L+LD  QR    + L   +F         P        ++D
Sbjct: 292 LVLDAEQRVTAGEALAHPYFESLHDTEDEP-----QVQKYD 327

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 64.3 bits (157), Expect = 5e-12
 Identities = 24/62 (38%), Positives = 32/62 (51%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K +  I   +   Y  QI +G+ YL   + +HRDL   N+ +     VKIGDFGL   IE
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177

Query: 299 FD 300
            D
Sbjct: 178 TD 179

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 64.6 bits (158), Expect = 5e-12
 Identities = 24/66 (36%), Positives = 37/66 (56%), Gaps = 3/66 (4%)

Query: 232 PLME---RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
            LME       + + ++     +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI
Sbjct: 110 DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 169

Query: 289 GDFGLA 294
            DFGLA
Sbjct: 170 CDFGLA 175

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 34/124 (27%), Positives = 52/124 (41%), Gaps = 32/124 (25%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFE-TSTL--------------KETY 154
           Y APEI LN  G++  +D+WS+GCI+  +L  +P F     L              +E  
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256

Query: 155 SRIKKVEYK-----LPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEF 198
           + I  ++ +     LP   K P           A  ++ KML  +P +R  V Q L   +
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 199 FNDY 202
              Y
Sbjct: 317 LEQY 320

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 64.2 bits (157), Expect = 6e-12
 Identities = 16/65 (24%), Positives = 32/65 (49%), Gaps = 1/65 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDF 291
             ++   + + I E         I++ + +LH    +IHRD+K  N+ ++    VK+ DF
Sbjct: 95  FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154

Query: 292 GLAAR 296
           G++  
Sbjct: 155 GISGY 159

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 58.0 bits (141), Expect = 6e-10
 Identities = 26/110 (23%), Positives = 48/110 (43%), Gaps = 11/110 (10%)

Query: 102 KNTLCGTPNYIAPE----ILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
           K+   G   Y+APE     LN+ G+S + D+WS+G  M  L + + P+   +    + ++
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQL 223

Query: 158 KKVEYKLPATLK-----KPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
           K+V  +    L              + L  +  +RP   +L+   FF  +
Sbjct: 224 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 2/65 (3%)

Query: 232 PLMERNSKR--RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIG 289
            LM+ N  +  +  +      + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI 
Sbjct: 147 ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206

Query: 290 DFGLA 294
           DFGLA
Sbjct: 207 DFGLA 211

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 59.1 bits (143), Expect = 4e-10
 Identities = 30/152 (19%), Positives = 50/152 (32%), Gaps = 46/152 (30%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-------------------ETSTLK 151
           Y APE++   G+   VD+WS+GCIM  ++  K  F                       +K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288

Query: 152 ETYSRIKKVEYKLPATLKKP-----------------------AATMIKKMLLLDPVQRP 188
           +    ++      P                             A  ++ KML++DP +R 
Sbjct: 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348

Query: 189 PVAQLLHFEFFNDY-CPTSLPASCLMTAPRFD 219
            V   L   + N +  P  + A        +D
Sbjct: 349 SVDDALQHPYINVWYDPAEVEAPP---PQIYD 377

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 63.9 bits (156), Expect = 7e-12
 Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 4/63 (6%)

Query: 236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHK---IIHRDLKLGNLFLSDNF-VVKIGDF 291
             ++     T      +  Q  +GV+YLH  +   +IHRDLK  NL L     V+KI DF
Sbjct: 91  HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150

Query: 292 GLA 294
           G A
Sbjct: 151 GTA 153

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 61.6 bits (150), Expect = 4e-11
 Identities = 48/247 (19%), Positives = 91/247 (36%), Gaps = 48/247 (19%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E+     + H N+V  +    +   V +++E     S+  + + A  L   +  AA  +
Sbjct: 50  VELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYT--AAHAM 105

Query: 63  IW---VSKWVDYSDKYGFGYQL-NDDSSGVMFNDL-TRMIMLANKNTLC----------- 106
            W    S+ V Y         L +     ++  DL    ++L    T+            
Sbjct: 106 SWCLQCSQGVAY---------LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156

Query: 107 --------GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK 158
                   G+  ++APE+   + +S + DV+S G I++ ++  + PF+   +     RI 
Sbjct: 157 QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIM 214

Query: 159 KVEYK-----LPATLKKPAATMIKKMLLLDPVQRPP----VAQLLHFEFFNDYCPTSLPA 209
              +      L   L KP  +++ +    DP QRP     V  + H   +       L  
Sbjct: 215 WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274

Query: 210 SCLMTAP 216
            C  + P
Sbjct: 275 PCQHSLP 281

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 63.8 bits (156), Expect = 7e-12
 Identities = 23/62 (37%), Positives = 33/62 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K ++ I   +   Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL   + 
Sbjct: 106 KHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165

Query: 299 FD 300
            D
Sbjct: 166 QD 167

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 18/61 (29%), Positives = 36/61 (59%), Gaps = 1/61 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           K+   I E         +++G++YL + HKI+HRD+K  N+ ++    +K+ DFG++ ++
Sbjct: 123 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182

Query: 298 E 298
            
Sbjct: 183 I 183

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 58.7 bits (142), Expect = 4e-10
 Identities = 26/106 (24%), Positives = 43/106 (40%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY 162
           N+  GT +Y++PE L    +S + D+WS+G  +  + VG+ P      KE          
Sbjct: 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247

Query: 163 KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLP 208
              A       T  + +       RPP+A     ++  +  P  LP
Sbjct: 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 27/66 (40%), Positives = 40/66 (60%), Gaps = 3/66 (4%)

Query: 232 PLME---RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
            LM     N  + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173

Query: 289 GDFGLA 294
            DFGLA
Sbjct: 174 LDFGLA 179

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 63/279 (22%), Positives = 98/279 (35%), Gaps = 88/279 (31%)

Query: 4   EIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSDP 57
           E+ + + +KH NV+G    F      E+   VY++  L      M       DL      
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL------MG-----ADLNN---- 122

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDLTRMIMLANKN---TLC--- 106
               ++   K  D   ++   YQ+        S+ ++  DL    +  N++    +    
Sbjct: 123 ----IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 177

Query: 107 -------------GTPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFE-TSTL- 150
                         T  Y APEI LN   ++  VD+WS+GCIM  LL G+  F  T  + 
Sbjct: 178 LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237

Query: 151 -------------KETYSRI-----KKVEYKLPATLKKPAATM-----------IKKMLL 181
                         E   +I     +     L    K   A +           ++KML+
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297

Query: 182 LDPVQRPPVAQLLHFEFFNDY-CPTSLPASCLMTAPRFD 219
           LD  +R   AQ L   +F  Y  P   P      A  +D
Sbjct: 298 LDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYD 331

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 22/56 (39%), Positives = 33/56 (58%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           K    +TE   +  +  +L G +++H+  IIHRDLK  N  L+ +  VK+ DFGLA
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 28/152 (18%), Positives = 50/152 (32%), Gaps = 60/152 (39%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIMYTLL------------------------------ 139
           Y APE+ L +  ++  +D+WS GCI   LL                              
Sbjct: 217 YRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRN 276

Query: 140 -------------------VGKPPFET-STLKETYSR--IKKVEYKLPATLKK--PAAT- 174
                              +G P  +    + +      IK   ++ P  LK+  P+ + 
Sbjct: 277 SKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336

Query: 175 ----MIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
               +++ ML  +P +R  + Q L   +  D 
Sbjct: 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDV 368

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 15/65 (23%), Positives = 30/65 (46%), Gaps = 3/65 (4%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHD--HKIIHRDLKLGNLFL-SDNFVVKIG 289
                 +R+ A      + ++ Q++  +  LH     + HRD+K  N+ +   +  +K+ 
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174

Query: 290 DFGLA 294
           DFG A
Sbjct: 175 DFGSA 179

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 49/274 (17%), Positives = 88/274 (32%), Gaps = 94/274 (34%)

Query: 3   QEIAIHRSLKHRNVVGFHSFF-------EDSKFVYIILELCRKRSMMELYNSACDLEEMS 55
           Q +     L H N+V   S+F           ++ +++E       +        L    
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY------VP-----DTLHRCC 116

Query: 56  DPAAQ-----PVIWVSKWVDYSDKYGFGYQL-------NDDSSGVMFNDLTRMIMLANKN 103
               +     P I +        K  F +QL       +  S  V   D+    +L N+ 
Sbjct: 117 RNYYRRQVAPPPILI--------KV-FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167

Query: 104 T----LC----------GTPN--YI------APE-ILNKNGHSFEVDVWSIGCIMYTLLV 140
                LC            PN  YI      APE I     ++  VD+WS+GCI   +++
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227

Query: 141 GKPPFE-TSTL--------------KETYSRIK--KVEYKLPATLKKP------------ 171
           G+P F   ++               +E   ++     +  L  +   P            
Sbjct: 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKD 287

Query: 172 ---AATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
              A  ++  +L   P +R    + L   +F++ 
Sbjct: 288 AKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 25/61 (40%), Positives = 36/61 (59%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
            R +I   +   + +QI EG++YLH    IHRDL   N+ L ++ +VKIGDFGLA  +  
Sbjct: 127 PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

Query: 300 D 300
            
Sbjct: 187 G 187

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 63.2 bits (154), Expect = 1e-11
 Identities = 23/62 (37%), Positives = 33/62 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K ++ I   +   Y  QI +G+ YL   + IHRDL   N+ + +   VKIGDFGL   + 
Sbjct: 137 KHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196

Query: 299 FD 300
            D
Sbjct: 197 QD 198

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 63.2 bits (154), Expect = 1e-11
 Identities = 18/61 (29%), Positives = 33/61 (54%), Gaps = 1/61 (1%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR 296
            + +  I E         I++ + YL + H +IHRD+K  N+ L +   +K+ DFG++ R
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174

Query: 297 I 297
           +
Sbjct: 175 L 175

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 58.1 bits (141), Expect = 5e-10
 Identities = 44/244 (18%), Positives = 77/244 (31%), Gaps = 61/244 (25%)

Query: 3   QEIAI-HRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
            ++ +  +S     +V    +F  ++  V+I          MEL  +  +  +       
Sbjct: 72  MDLDVVLKSHDCPYIVQCFGTFITNTD-VFIA---------MELMGTCAEKLKKRMQGPI 121

Query: 61  PVIWVSKWVDYSDKYGFGYQLNDDS---------------------------SGVMFNDL 93
           P   + K +  +      Y L +                             SG + +D 
Sbjct: 122 PERILGK-MTVAIVKALYY-LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179

Query: 94  TRMIMLANKNTLCGTPNYIAPEIL-----NKNGHSFEVDVWSIGCIMYTLLVGKPPFETS 148
                   K+   G   Y+APE +      K  +    DVWS+G  +  L  G+ P+   
Sbjct: 180 A-------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--K 230

Query: 149 TLKETYSRIKKVEYKLPATLKKPAA------TMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
             K  +  + KV  + P  L           + +K  L  D  +RP   +LL   F   Y
Sbjct: 231 NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290

Query: 203 CPTS 206
               
Sbjct: 291 ETLE 294

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 20/55 (36%), Positives = 33/55 (60%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
             + +++   ++++ Q L  V  LH   +IHRDLK  NL ++ N  +K+ DFGLA
Sbjct: 105 STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 32/143 (22%), Positives = 49/143 (34%), Gaps = 34/143 (23%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFE----------------TSTLKET 153
           Y APE+ L    +S  +DVWS GCI+  L + +P F                 T      
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247

Query: 154 YSRIKKVEYK-----LPATLKKPAATM-----------IKKMLLLDPVQRPPVAQLLHFE 197
              I+    +     LP     P   M           +++ML+ DP +R    + L   
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307

Query: 198 FFNDY-CPTSLPASCLMTAPRFD 219
           +   Y  P   P    +    F+
Sbjct: 308 YLQTYHDPNDEPEGEPIPPSFFE 330

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 21/62 (33%), Positives = 30/62 (48%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + R  +       Y  QI +G+ YL   + +HRDL   N+ +     VKI DFGLA  + 
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178

Query: 299 FD 300
            D
Sbjct: 179 LD 180

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 25/56 (44%), Positives = 38/56 (67%), Gaps = 1/56 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDFGLA 294
            +  + E   R +M Q+L G+ Y+H   ++HRDLK  NLF+ +++ V+KIGDFGLA
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 24/123 (19%), Positives = 42/123 (34%), Gaps = 31/123 (25%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPF-------------------ETSTL 150
           Y +P + L+ N ++  +D+W+ GCI   +L GK  F                        
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249

Query: 151 KETYSRIKKVEYKLPATLKKP-----------AATMIKKMLLLDPVQRPPVAQLLHFEFF 199
           +E  S I            KP           A   ++++L   P+ R    + L   + 
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

Query: 200 NDY 202
           + Y
Sbjct: 310 SIY 312

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 19/64 (29%), Positives = 28/64 (43%), Gaps = 1/64 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
                +        +     G+ YL     IHRDL   N  +++  V+KI DFG+ +R E
Sbjct: 205 TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM-SREE 263

Query: 299 FDGQ 302
            DG 
Sbjct: 264 ADGV 267

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 18/63 (28%), Positives = 30/63 (47%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
              R+ ++     +   QI   + YL     IHR+L   N  + +N +VK+ DFGL+  +
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368

Query: 298 EFD 300
             D
Sbjct: 369 TGD 371

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 17/55 (30%), Positives = 32/55 (58%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           R   +     ++ + Q+++ + YLH   ++HRD+K  N+ L+    VK+ DFGL+
Sbjct: 102 RANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS 156

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 29/140 (20%), Positives = 48/140 (34%), Gaps = 48/140 (34%)

Query: 111 YIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFE-TSTL--------------KETY 154
           Y APEI L    ++  +D+WS+GCI+  +L GKP F  +ST+               E  
Sbjct: 196 YRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDV 255

Query: 155 SRIKKVEYK-----LPATLKKPAATM---------------------------IKKMLLL 182
             I+    K     L   ++   +                             + K+L  
Sbjct: 256 ESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315

Query: 183 DPVQRPPVAQLLHFEFFNDY 202
           +P +R      L   F + +
Sbjct: 316 NPNKRISANDALKHPFVSIF 335

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 61.9 bits (151), Expect = 3e-11
 Identities = 6/59 (10%), Positives = 22/59 (37%), Gaps = 2/59 (3%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSDNFVVKIGDFGLA 294
                 + + +   +   +  G+++LH  +  I    L   ++ + ++   +I    + 
Sbjct: 102 EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 38/223 (17%), Positives = 77/223 (34%), Gaps = 45/223 (20%)

Query: 3   QEIAIHRSLKHRNVVGFH--SFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           +E    R   H NV+          +    +I       S   LYN   +        +Q
Sbjct: 56  EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS---LYNVLHEGTNFVVDQSQ 112

Query: 61  PVIW---VSKWVDYSDKYGFGYQLNDDSSGVMFNDL-TRMIMLANKNTL----------- 105
            V +   +++ + +         L+     +  + L +R +M+    T            
Sbjct: 113 AVKFALDMARGMAF---------LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163

Query: 106 -----CGTPNYIAPEILNK---NGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
                   P ++APE L K   + +    D+WS   +++ L+  + PF   +  E     
Sbjct: 164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---G 220

Query: 158 KKVEYK-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
            KV  +     +P  +    + ++K  +  DP +RP    ++ 
Sbjct: 221 MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 1/68 (1%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIG 289
           K      S     I E          ++ +++L +  KIIHRD+K  N+ L  +  +K+ 
Sbjct: 109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 168

Query: 290 DFGLAARI 297
           DFG++ ++
Sbjct: 169 DFGISGQL 176

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 16/114 (14%)

Query: 102 KNTLCGTPNYIAPEIL----NKNGHSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSR 156
           K    G   Y+APE +    ++ G+    DVWS+G  +Y L  G+ P+   +++ +  ++
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ 241

Query: 157 IKKVEYKLPATLKKPAAT--------MIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
           + K +   P  L               +   L  D  +RP   +LL   F   Y
Sbjct: 242 VVKGD---PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 61.9 bits (151), Expect = 3e-11
 Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 6/69 (8%)

Query: 232 PLMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV 285
           P M            ++  T  +   +  Q+  G+ YL + K +HRDL   N  L ++F 
Sbjct: 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT 162

Query: 286 VKIGDFGLA 294
           VK+ DFGLA
Sbjct: 163 VKVADFGLA 171

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 61.9 bits (151), Expect = 3e-11
 Identities = 19/68 (27%), Positives = 30/68 (44%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
              R+ ++     +   QI   + YL     IHRDL   N  + +N +VK+ DFGL+  +
Sbjct: 102 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161

Query: 298 EFDGQRKR 305
             D     
Sbjct: 162 TGDTYTAH 169

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 61.9 bits (151), Expect = 4e-11
 Identities = 20/62 (32%), Positives = 33/62 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + +  I       +  QI +G++YL D +++HRDL   N+ +     VKI DFGLA  + 
Sbjct: 109 EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

Query: 299 FD 300
            +
Sbjct: 169 AE 170

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 61.1 bits (149), Expect = 6e-11
 Identities = 15/56 (26%), Positives = 27/56 (48%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           +R+  +  P     ++QI   +   H     HRD+K  N+ +S +    + DFG+A
Sbjct: 126 RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA 181

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 47.2 bits (113), Expect = 2e-06
 Identities = 14/48 (29%), Positives = 28/48 (58%)

Query: 103 NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL 150
               GT  Y+APE  +++  ++  D++++ C++Y  L G PP++   L
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 60.8 bits (148), Expect = 7e-11
 Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 7/63 (11%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLS-----DNFVVKIGDF 291
            +   I        M  I  G+ Y+ +    I+HRDL+  N+FL           K+ DF
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 292 GLA 294
           GL+
Sbjct: 174 GLS 176

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 52.7 bits (127), Expect = 3e-08
 Identities = 22/99 (22%), Positives = 43/99 (43%), Gaps = 8/99 (8%)

Query: 104 TLCGTPNYIAPEILNKNGHSF--EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
            L G   ++APE +     S+  + D +S   I+YT+L G+ PF+  +  +    I  + 
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFINMIR 243

Query: 162 YK-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
            +     +P         +I+     DP +RP  + ++ 
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 60.8 bits (148), Expect = 7e-11
 Identities = 19/62 (30%), Positives = 33/62 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + R A+       +  QI +G+ YL +H ++HR+L   N+ L     V++ DFG+A  + 
Sbjct: 107 QHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166

Query: 299 FD 300
            D
Sbjct: 167 PD 168

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 60.7 bits (148), Expect = 7e-11
 Identities = 22/69 (31%), Positives = 31/69 (44%), Gaps = 6/69 (8%)

Query: 232 PLMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV 285
           P M+               T  +   +  Q+ +G+ YL   K +HRDL   N  L + F 
Sbjct: 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT 166

Query: 286 VKIGDFGLA 294
           VK+ DFGLA
Sbjct: 167 VKVADFGLA 175

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 60.8 bits (148), Expect = 8e-11
 Identities = 18/60 (30%), Positives = 27/60 (45%)

Query: 235 ERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            R  +    +       +M  I  G+ YL     IHRDL   N  L+++  V + DFGL+
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 60.8 bits (148), Expect = 9e-11
 Identities = 20/69 (28%), Positives = 29/69 (42%)

Query: 226 NSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV 285
           + P  K L          +   +      Q+  G+ YL     +HRDL   N  +    V
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196

Query: 286 VKIGDFGLA 294
           VKIGDFG++
Sbjct: 197 VKIGDFGMS 205

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 17/57 (29%), Positives = 29/57 (50%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           S+ R  +       +   + E + YL  +  +HRDL   N+ +S++ V K+ DFGL 
Sbjct: 280 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 16/67 (23%), Positives = 24/67 (35%), Gaps = 8/67 (11%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDH--------KIIHRDLKLGNLFLSDNFVVKIGDF 291
           +   +            + G+ +LH           I HRDLK  N+ +  N    I D 
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186

Query: 292 GLAARIE 298
           GLA +  
Sbjct: 187 GLAVKFI 193

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 30/189 (15%), Positives = 52/189 (27%), Gaps = 58/189 (30%)

Query: 3   QEIAIHRSLKHRNVVGF----HSFFEDSKFVYIILELC-----------RKRSMMELYNS 47
            EI     ++H N++GF             +Y+I +                    +   
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKL 139

Query: 48  ACDL--------EEMSDPAAQPVI---------------WVSKWVDYSDKYGFGYQLNDD 84
           A            E+     +P I                     D       G      
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD------LGL----- 188

Query: 85  SSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN-----KNGHSFE-VDVWSIGCIMYTL 138
              V F   T  + +   NT  GT  Y+ PE+L+      +  S+   D++S G I++ +
Sbjct: 189 --AVKFISDTNEVDIPP-NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

Query: 139 LVGKPPFET 147
                    
Sbjct: 246 ARRCVSGGI 254

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 60.3 bits (147), Expect = 1e-10
 Identities = 18/36 (50%), Positives = 26/36 (72%)

Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           G+++LH++  IHRD+K  N+ L + F  KI DFGLA
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 59.9 bits (146), Expect = 1e-10
 Identities = 20/72 (27%), Positives = 34/72 (47%), Gaps = 6/72 (8%)

Query: 233 LMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
           L            R+ ++       Y  Q+   ++YL   + +HRD+   N+ +S N  V
Sbjct: 96  LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 155

Query: 287 KIGDFGLAARIE 298
           K+GDFGL+  +E
Sbjct: 156 KLGDFGLSRYME 167

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 20/62 (32%), Positives = 33/62 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + +  I       +  QI +G++YL D +++HRDL   N+ +     VKI DFGLA  + 
Sbjct: 109 EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

Query: 299 FD 300
            +
Sbjct: 169 AE 170

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 60.0 bits (146), Expect = 1e-10
 Identities = 17/62 (27%), Positives = 30/62 (48%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++ + + +      + Q+  G+ YL +   +HRDL   N+ L      KI DFGL+  + 
Sbjct: 109 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168

Query: 299 FD 300
            D
Sbjct: 169 AD 170

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 23/69 (33%), Positives = 38/69 (55%), Gaps = 3/69 (4%)

Query: 229 RRKPLMERNSKRRKAITEPETRFYMK---QILEGVSYLHDHKIIHRDLKLGNLFLSDNFV 285
           R+  ++E +     A +   TR  +    Q+ +G+++L     IHRD+   N+ L++  V
Sbjct: 143 RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202

Query: 286 VKIGDFGLA 294
            KIGDFGLA
Sbjct: 203 AKIGDFGLA 211

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 21/63 (33%), Positives = 34/63 (53%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
            +  K +  P+      QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  I
Sbjct: 271 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330

Query: 298 EFD 300
           E +
Sbjct: 331 EDN 333

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 8/100 (8%)

Query: 113 APEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           APE       + + DVWS G ++  L   G+ P+     +E   ++++  Y++P   + P
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECP 407

Query: 172 AATMIKKMLL---LDPVQRPPVAQLLHFEFFNDYCPTSLP 208
            + +   M      +P +RP    L    F  DY  ++ P
Sbjct: 408 ES-LHDLMCQCWRKEPEERPTFEYL--QAFLEDYFTSTEP 444

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 17/71 (23%), Positives = 25/71 (35%), Gaps = 8/71 (11%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHD--------HKIIHRDLKLGNLFLSDNFVVKIGDF 291
           +   +        +  I  G+++LH           I HRDLK  N+ +  N    I D 
Sbjct: 98  QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157

Query: 292 GLAARIEFDGQ 302
           GLA        
Sbjct: 158 GLAVMHSQSTN 168

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 41/253 (16%), Positives = 72/253 (28%), Gaps = 79/253 (31%)

Query: 3   QEIAIHRSLKHRNVVGF----HSFFEDSKFVYIILELC-----------RKRSMMELYNS 47
            E+     L+H N++GF     +    S  +++I                    +     
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI 110

Query: 48  ACDL--------EEMSDPAAQPVI---------------WVSKWVDYSDKYGFGYQLNDD 84
              +         E+     +P I                     D       G  +   
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD------LGLAVMHS 164

Query: 85  SSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN-----KNGHSFE-VDVWSIGCIMYTL 138
            S           +    N   GT  Y+APE+L+         S++ VD+W+ G +++ +
Sbjct: 165 QSTNQ--------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

Query: 139 LVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPV----QRPPVAQLL 194
                                 +YK P     P     + M  +  V    QRP +    
Sbjct: 217 ARRMVSNGIVE-----------DYKPPFYDVVPNDPSFEDMRKV--VCVDQQRPNIPN-- 261

Query: 195 HFEFFNDYCPTSL 207
              +F+D   TSL
Sbjct: 262 --RWFSDPTLTSL 272

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 21/63 (33%), Positives = 34/63 (53%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
            +  K +  P+      QI  G++Y+     +HRDL+  N+ + +N V K+ DFGLA  I
Sbjct: 354 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413

Query: 298 EFD 300
           E +
Sbjct: 414 EDN 416

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 23/98 (23%), Positives = 43/98 (43%), Gaps = 8/98 (8%)

Query: 113 APEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           APE       + + DVWS G ++  L   G+ P+     +E   ++++  Y++P   + P
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECP 490

Query: 172 AATMIKKMLL---LDPVQRPPVAQLLHFEFFNDYCPTS 206
            + +   M      +P +RP    L    F  DY  ++
Sbjct: 491 ES-LHDLMCQCWRKEPEERPTFEYL--QAFLEDYFTST 525

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 41/219 (18%), Positives = 80/219 (36%), Gaps = 33/219 (15%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMME-LYNSACDLEEMSDPAAQP 61
           QE  +   LKH N++           + +++E  R   +   L       + + + A Q 
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ- 113

Query: 62  VIWVSKWVDY--SDKYGF----------------GYQLNDDSSGVMFND--LTRMIMLAN 101
              +++ ++Y   +                        +  +  +   D  L R      
Sbjct: 114 ---IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVE 161
           K +  G   ++APE++  +  S   DVWS G +++ LL G+ PF      +  +    V 
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG---IDGLAVAYGVA 227

Query: 162 YK-----LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                  +P+T  +P A +++     DP  RP    +L 
Sbjct: 228 MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 25/66 (37%), Positives = 32/66 (48%), Gaps = 11/66 (16%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHK---IIHRDLKLGNLFLS--------DNFVVKI 288
             K I       +  QI  G++YLHD     IIHRDLK  N+ +          N ++KI
Sbjct: 98  SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157

Query: 289 GDFGLA 294
            DFGLA
Sbjct: 158 TDFGLA 163

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 23/63 (36%), Positives = 34/63 (53%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           S        P+   +  QI EG++++     IHRDL+  N+ +S + V KI DFGLA  I
Sbjct: 275 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334

Query: 298 EFD 300
           E +
Sbjct: 335 EDN 337

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 59.8 bits (145), Expect = 2e-10
 Identities = 21/69 (30%), Positives = 31/69 (44%), Gaps = 6/69 (8%)

Query: 232 PLMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV 285
           P M+               T  +   +  Q+ +G+ +L   K +HRDL   N  L + F 
Sbjct: 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT 230

Query: 286 VKIGDFGLA 294
           VK+ DFGLA
Sbjct: 231 VKVADFGLA 239

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 59.5 bits (145), Expect = 2e-10
 Identities = 22/40 (55%), Positives = 28/40 (70%), Gaps = 3/40 (7%)

Query: 258 EGVSYLHDH---KIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            G++YLHDH   KIIHRD+K  N+ L + F   +GDFGLA
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 59.1 bits (144), Expect = 2e-10
 Identities = 17/57 (29%), Positives = 29/57 (50%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           S+ R  +       +   + E + YL  +  +HRDL   N+ +S++ V K+ DFGL 
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 20/60 (33%), Positives = 27/60 (45%)

Query: 235 ERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
            R     K I       +M  I  G+ YL +   +HRDL   N  L D+  V + DFGL+
Sbjct: 135 SRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 59.1 bits (144), Expect = 2e-10
 Identities = 22/63 (34%), Positives = 34/63 (53%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +     +T  +      QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  I
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159

Query: 298 EFD 300
           E +
Sbjct: 160 EDN 162

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 20/72 (27%), Positives = 37/72 (51%)

Query: 223 PSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD 282
               S   +     +    +A+T  +   +  QI +G+ YL + K++HRDL   N+ +++
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE 185

Query: 283 NFVVKIGDFGLA 294
              +KI DFGL+
Sbjct: 186 GRKMKISDFGLS 197

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 23/62 (37%), Positives = 31/62 (50%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K +          Y  Q+ EG+ YL   + IHRDL   NL L+   +VKIGDFGL   + 
Sbjct: 113 KHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172

Query: 299 FD 300
            +
Sbjct: 173 QN 174

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 39.9 bits (94), Expect = 5e-04
 Identities = 24/102 (23%), Positives = 37/102 (36%), Gaps = 9/102 (8%)

Query: 113 APEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           APE L     S   D W  G  ++ +   G+ P+      +   +I K   +LP     P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251

Query: 172 AAT-MIKKML---LLDPVQRPPVAQLLHFEFFNDYCPTSLPA 209
                +  M+      P  RP    L   +F  +  PT + A
Sbjct: 252 QDIYNV--MVQCWAHKPEDRPTFVALR--DFLLEAQPTDMRA 289

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 20/72 (27%), Positives = 34/72 (47%), Gaps = 6/72 (8%)

Query: 233 LMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
           L            R+ ++       Y  Q+   ++YL   + +HRD+   N+ +S N  V
Sbjct: 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530

Query: 287 KIGDFGLAARIE 298
           K+GDFGL+  +E
Sbjct: 531 KLGDFGLSRYME 542

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 58.8 bits (143), Expect = 3e-10
 Identities = 19/62 (30%), Positives = 30/62 (48%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            +R+ I        + Q+  G+ YL +   +HRDL   N+ L +    KI DFGL+  + 
Sbjct: 102 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161

Query: 299 FD 300
            D
Sbjct: 162 AD 163

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 33/125 (26%), Positives = 48/125 (38%), Gaps = 11/125 (8%)

Query: 187 RPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNS-------- 238
           R                   + A  +    R DS+  S +S     + E++         
Sbjct: 122 RNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181

Query: 239 ---KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
                +  +T      Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVKI DFGLA 
Sbjct: 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 296 RIEFD 300
            I  D
Sbjct: 242 DIYKD 246

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 58.7 bits (143), Expect = 3e-10
 Identities = 17/74 (22%), Positives = 30/74 (40%), Gaps = 6/74 (8%)

Query: 233 LMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
            +             K +   +       + EG+++L  H+ IHRDL   N  +  +  V
Sbjct: 84  YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCV 143

Query: 287 KIGDFGLAARIEFD 300
           K+ DFG+   +  D
Sbjct: 144 KVSDFGMTRYVLDD 157

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 20/73 (27%), Positives = 32/73 (43%), Gaps = 10/73 (13%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDH----------KIIHRDLKLGNLFLSDNFVVKIG 289
           +   ++  E     + +  G++YLH+            I HRD+K  N+ L +N    I 
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173

Query: 290 DFGLAARIEFDGQ 302
           DFGLA + E    
Sbjct: 174 DFGLALKFEAGKS 186

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 58.0 bits (141), Expect = 6e-10
 Identities = 19/72 (26%), Positives = 34/72 (47%), Gaps = 6/72 (8%)

Query: 233 LMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
           L           + + ++       Y  QI + ++YL     +HRD+ + N+ ++    V
Sbjct: 93  LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECV 152

Query: 287 KIGDFGLAARIE 298
           K+GDFGL+  IE
Sbjct: 153 KLGDFGLSRYIE 164

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 58.4 bits (142), Expect = 6e-10
 Identities = 23/67 (34%), Positives = 32/67 (47%)

Query: 228 PRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVK 287
                 +      +  +T      Y  Q+ +G+ +L   K IHRDL   N+ LS+  VVK
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 188

Query: 288 IGDFGLA 294
           I DFGLA
Sbjct: 189 ICDFGLA 195

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 18/62 (29%), Positives = 30/62 (48%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            +R+ I        + Q+  G+ YL +   +HR+L   N+ L +    KI DFGL+  + 
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487

Query: 299 FD 300
            D
Sbjct: 488 AD 489

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 58.2 bits (141), Expect = 7e-10
 Identities = 19/67 (28%), Positives = 26/67 (38%), Gaps = 8/67 (11%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDH--------KIIHRDLKLGNLFLSDNFVVKIGDF 291
            R  +T             G+++LH           I HRDLK  N+ +  N    I D 
Sbjct: 132 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191

Query: 292 GLAARIE 298
           GLA R +
Sbjct: 192 GLAVRHD 198

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 43.2 bits (102), Expect = 5e-05
 Identities = 38/236 (16%), Positives = 74/236 (31%), Gaps = 75/236 (31%)

Query: 3   QEIAIHRSLKHRNVVGF----HSFFEDSKFVYIILELC-----------RKRSMMELYNS 47
            EI     L+H N++GF    +        ++++ +                ++  +   
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL 144

Query: 48  ACDL--------EEMSDPAAQPVI---------------WVSKWVDYSDKYGFGYQLNDD 84
           A            E+     +P I                     D       G      
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD------LGL----- 193

Query: 85  SSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN-----KNGHSFE-VDVWSIGCIMYTL 138
              V  +  T  I +A  N   GT  Y+APE+L+     K+  SF+  D++++G + + +
Sbjct: 194 --AVRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

Query: 139 LVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPV----QRPPV 190
                                 +Y+LP     P+   +++M  +  V     RP +
Sbjct: 251 ARRCSIGGIHE-----------DYQLPYYDLVPSDPSVEEMRKV--VCEQKLRPNI 293

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 20/66 (30%), Positives = 35/66 (53%)

Query: 229 RRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKI 288
           R       N+      +  +      +I +G++YL+ +K +HRDL   N  ++++F VKI
Sbjct: 120 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179

Query: 289 GDFGLA 294
           GDFG+ 
Sbjct: 180 GDFGMT 185

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 22/72 (30%), Positives = 35/72 (48%)

Query: 223 PSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD 282
            S +          +S     ++  E     +Q+  G++YL + K +HRDL   N  + +
Sbjct: 150 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE 209

Query: 283 NFVVKIGDFGLA 294
           N VVKI DFGL+
Sbjct: 210 NMVVKIADFGLS 221

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 58.0 bits (141), Expect = 7e-10
 Identities = 17/40 (42%), Positives = 25/40 (62%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+++L     IHRDL   N+ L+   + KI DFGLA
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 57.6 bits (140), Expect = 8e-10
 Identities = 20/74 (27%), Positives = 31/74 (41%), Gaps = 6/74 (8%)

Query: 233 LMERNS------KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
            M          + R      +     K + E + YL   + +HRDL   N  ++D  VV
Sbjct: 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 159

Query: 287 KIGDFGLAARIEFD 300
           K+ DFGL+  +  D
Sbjct: 160 KVSDFGLSRYVLDD 173

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 58.1 bits (141), Expect = 8e-10
 Identities = 23/67 (34%), Positives = 35/67 (52%)

Query: 228 PRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVK 287
           P  +   + N    + +T  +      Q+  G+ YL   K IHRDL   N+ +++N V+K
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197

Query: 288 IGDFGLA 294
           I DFGLA
Sbjct: 198 IADFGLA 204

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 58.1 bits (141), Expect = 8e-10
 Identities = 19/62 (30%), Positives = 30/62 (48%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
                 T  +    ++ +  G+ YL D   +HRDL   N+ +  N V K+ DFGL+  +E
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202

Query: 299 FD 300
            D
Sbjct: 203 DD 204

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 57.2 bits (139), Expect = 1e-09
 Identities = 18/67 (26%), Positives = 30/67 (44%)

Query: 228 PRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVK 287
                +  +  + +  +   +      QI  G+ YL     +HRDL   N  +  N +VK
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 173

Query: 288 IGDFGLA 294
           IGDFG++
Sbjct: 174 IGDFGMS 180

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 57.6 bits (140), Expect = 1e-09
 Identities = 20/36 (55%), Positives = 26/36 (72%)

Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           G+ YLH   IIHRD+K  N+ L +NFV KI DFG++
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 56.8 bits (138), Expect = 1e-09
 Identities = 18/62 (29%), Positives = 30/62 (48%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            +R              + EG++YL +  +IHRDL   N  + +N V+K+ DFG+   + 
Sbjct: 96  TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155

Query: 299 FD 300
            D
Sbjct: 156 DD 157

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 21/62 (33%), Positives = 31/62 (50%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           K     T  +    ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFGL   +E
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198

Query: 299 FD 300
            D
Sbjct: 199 DD 200

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 23/67 (34%), Positives = 35/67 (52%)

Query: 228 PRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVK 287
           P  +   + N    + +T  +      Q+  G+ YL   K IHRDL   N+ +++N V+K
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243

Query: 288 IGDFGLA 294
           I DFGLA
Sbjct: 244 IADFGLA 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 20/67 (29%), Positives = 34/67 (50%)

Query: 228 PRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVK 287
           P  +     +    + ++  +      Q+  G+ YL   K IHRDL   N+ ++++ V+K
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 231

Query: 288 IGDFGLA 294
           I DFGLA
Sbjct: 232 IADFGLA 238

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 56.4 bits (137), Expect = 2e-09
 Identities = 22/70 (31%), Positives = 33/70 (47%), Gaps = 1/70 (1%)

Query: 226 NSPRRKPLMERNSKRRKAITEPETRFYM-KQILEGVSYLHDHKIIHRDLKLGNLFLSDNF 284
            SP        + +  K+  EP    ++  QI  G+ YL  H ++H+DL   N+ + D  
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 165

Query: 285 VVKIGDFGLA 294
            VKI D GL 
Sbjct: 166 NVKISDLGLF 175

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 18/67 (26%), Positives = 31/67 (46%)

Query: 228 PRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVK 287
               P     +     ++  +   +   +  G+ YL   + IHRDL   N+ + +N+V K
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182

Query: 288 IGDFGLA 294
           I DFGL+
Sbjct: 183 IADFGLS 189

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 56.4 bits (136), Expect = 3e-09
 Identities = 17/78 (21%), Positives = 27/78 (34%), Gaps = 13/78 (16%)

Query: 234 MERNS----KRRKAITEPETRFYMKQILEGVSYLHD---------HKIIHRDLKLGNLFL 280
               S              +      +  G++YLH            I HRDL   N+ +
Sbjct: 94  YPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV 153

Query: 281 SDNFVVKIGDFGLAARIE 298
            ++    I DFGL+ R+ 
Sbjct: 154 KNDGTCVISDFGLSMRLT 171

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 17/60 (28%), Positives = 32/60 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++    +  +    ++ I  G+ YL +   +HRDL   N+ ++ N V K+ DFGL+  +E
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 6e-09
 Identities = 25/141 (17%), Positives = 42/141 (29%), Gaps = 48/141 (34%)

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS------------ 155
           T  Y + E+L  +G++   D+WS  C+ + L  G   FE  + +E               
Sbjct: 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315

Query: 156 -------------------------RIKKV-----------EYKLPATLKKPAATMIKKM 179
                                     I K+           +Y+            +  M
Sbjct: 316 GKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPM 375

Query: 180 LLLDPVQRPPVAQLLHFEFFN 200
           L L P +R   A+ L   + N
Sbjct: 376 LELIPEKRATAAECLRHPWLN 396

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.8 bits (111), Expect = 5e-06
 Identities = 16/52 (30%), Positives = 31/52 (59%), Gaps = 3/52 (5%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDH-KIIHRDLKLGNLFLSDN 283
            + +++ +   +  P  +  ++Q+L+G+ YLH   +IIH D+K  N+ LS N
Sbjct: 134 WIIKSNYQG--LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 55.0 bits (133), Expect = 7e-09
 Identities = 17/40 (42%), Positives = 25/40 (62%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           Q+ +G+ +L     +HRDL   N+ ++   VVKI DFGLA
Sbjct: 180 QVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 23/195 (11%), Positives = 58/195 (29%), Gaps = 35/195 (17%)

Query: 10  SLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP--AAQPVIWVSK 67
            +    V              ++ E  R  S+ E+       +    P  A + +  ++ 
Sbjct: 87  RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEV------ADTSPSPVGAIRAMQSLAA 140

Query: 68  WVDYSDKYGFGYQLNDDSSGVMFNDLTRM-IMLANKNTL-CGTPNYIAPEILNKNGHSFE 125
             D + +           +GV  +      + ++    +    P  +          + +
Sbjct: 141 AADAAHR-----------AGVALSIDHPSRVRVSIDGDVVLAYPATMPDA-------NPQ 182

Query: 126 VDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP-------ATLKKPAATMIKK 178
            D+  IG  +Y LLV + P   + ++   +  ++     P         +    + +  +
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242

Query: 179 MLLLDPVQRPPVAQL 193
            +  D   R     L
Sbjct: 243 SVQGDGGIRSASTLL 257

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 4/49 (8%), Positives = 11/49 (22%)

Query: 247 PETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAA 295
                 M+ +       H   +         + +S +  V +       
Sbjct: 129 VGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 51.5 bits (124), Expect = 9e-08
 Identities = 10/68 (14%), Positives = 27/68 (39%), Gaps = 8/68 (11%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDL--------KLGNLFLSDNFVVKIGD 290
           K +  I         KQ+   + +L ++ +IH ++        +  +    +   +K+ D
Sbjct: 105 KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164

Query: 291 FGLAARIE 298
            G++  + 
Sbjct: 165 PGISITVL 172

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 18/45 (40%), Positives = 24/45 (53%), Gaps = 3/45 (6%)

Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLA 294
            + I  G  YL ++  IHRD+   N  L+      V KIGDFG+A
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 18/45 (40%), Positives = 24/45 (53%), Gaps = 3/45 (6%)

Query: 253 MKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLA 294
            + I  G  YL ++  IHRD+   N  L+      V KIGDFG+A
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 19/57 (33%), Positives = 30/57 (52%), Gaps = 5/57 (8%)

Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN--FVVKIGDFGLAARIEFDGQR 303
            R +   IL+ +  LH ++IIH DLK  N+ L       +K+ DFG +    ++ QR
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQR 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 27/131 (20%), Positives = 47/131 (35%), Gaps = 23/131 (17%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           Y APE++    +   +D+WS+GCI+  LL G P        +  + + ++       L  
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-------LGM 317

Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRR 230
           P+  ++              ++     F +       P  C +T     SVV +    RR
Sbjct: 318 PSQKLLDA------------SKRAK-NFVSSKG---YPRYCTVTTLSDGSVVLNGGRSRR 361

Query: 231 KPLMERNSKRR 241
             L      R 
Sbjct: 362 GKLRGPPESRE 372

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 31/144 (21%), Positives = 52/144 (36%), Gaps = 44/144 (30%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL-- 168
           Y  PE++ + G +   DVWSIGCI++    G   F+T   +E    ++K+   +P+ +  
Sbjct: 205 YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264

Query: 169 ----------------------------KKPAAT--------------MIKKMLLLDPVQ 186
                                        KP  +              ++++ML  DP Q
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324

Query: 187 RPPVAQLLHFEFFNDYCPTSLPAS 210
           R  +A+ L   FF    P      
Sbjct: 325 RITLAEALLHPFFAGLTPEERSFH 348

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 15/74 (20%), Positives = 29/74 (39%), Gaps = 22/74 (29%)

Query: 249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV-------------------VKIG 289
            R    Q+   + +LH++++ H DLK  N+   ++                     +++ 
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 290 DFGLAARIEFDGQR 303
           DFG A    FD + 
Sbjct: 185 DFGSAT---FDHEH 195

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 24/147 (16%), Positives = 38/147 (25%), Gaps = 48/147 (32%)

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS------------ 155
           T  Y +PE+L         D+WS  C+++ L+ G   FE                     
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257

Query: 156 ------------------------------RIKKVEYKLPATLKKPAATM------IKKM 179
                                         +   +E  L    K            +  M
Sbjct: 258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317

Query: 180 LLLDPVQRPPVAQLLHFEFFNDYCPTS 206
           L LDP +R     L++  +  D     
Sbjct: 318 LQLDPRKRADAGGLVNHPWLKDTLGME 344

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 48.9 bits (117), Expect = 8e-07
 Identities = 20/69 (28%), Positives = 31/69 (44%), Gaps = 9/69 (13%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDH-KIIHRDLKLGNLFLSD------NFV 285
           L+++   R   I     +   KQ+L G+ Y+H    IIH D+K  N+ +           
Sbjct: 119 LIKKYEHRG--IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176

Query: 286 VKIGDFGLA 294
           +KI D G A
Sbjct: 177 IKIADLGNA 185

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.3 bits (118), Expect = 6e-07
 Identities = 18/68 (26%), Positives = 35/68 (51%), Gaps = 7/68 (10%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           Y +PE+L    +   +D+WS+GCI+  +  G+P F  +   +  ++I +V       L  
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-------LGI 276

Query: 171 PAATMIKK 178
           P A ++ +
Sbjct: 277 PPAHILDQ 284

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 17/50 (34%), Positives = 26/50 (52%), Gaps = 4/50 (8%)

Query: 249 TRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFL--SDNFVVKIGDFGLA 294
           TR + +Q+   + +L   +  IIH DLK  N+ L       +KI DFG +
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 25/135 (18%), Positives = 40/135 (29%), Gaps = 46/135 (34%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV---------- 160
           Y APE++   G     D+WS GC++  L  G   F T    E  + ++ +          
Sbjct: 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284

Query: 161 ---------------------------EYKLPATLKKPAATM---------IKKMLLLDP 184
                                                P   +         +  +L +DP
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344

Query: 185 VQRPPVAQLLHFEFF 199
             RP  A+LL  +F 
Sbjct: 345 TLRPSPAELLKHKFL 359

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 15/56 (26%), Positives = 23/56 (41%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           + Y  +IL+ ++YL    + H DLK  N+ L D +  K              Q  R
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 31/134 (23%), Positives = 48/134 (35%), Gaps = 44/134 (32%)

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           Y APE++   G S   DVWSIGCI+    +G   F T   KE  + ++++   LP  + +
Sbjct: 200 YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259

Query: 171 PAAT--------------------------------------------MIKKMLLLDPVQ 186
                                                           +I+KML  DP +
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319

Query: 187 RPPVAQLLHFEFFN 200
           R  + + L   FF+
Sbjct: 320 RITLREALKHPFFD 333

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 20/73 (27%), Positives = 32/73 (43%), Gaps = 22/73 (30%)

Query: 250 RFYMKQILEGVSYLHDHKIIHRDLKLGN-LFLSDNFV------------------VKIGD 290
           R    QI + V++LH +K+ H DLK  N LF+  ++                   +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 291 FGLAARIEFDGQR 303
           FG A    +D + 
Sbjct: 181 FGSAT---YDDEH 190

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 11/45 (24%), Positives = 26/45 (57%), Gaps = 2/45 (4%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFL--SDNFVVKIGDFGLAAR 296
            ++L+ + +LH+++ +H ++   N+F+   D   V +  +G A R
Sbjct: 166 CRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 42.4 bits (100), Expect = 9e-05
 Identities = 14/44 (31%), Positives = 28/44 (63%), Gaps = 2/44 (4%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFL--SDNFVVKIGDFGLAAR 296
           ++L+ + Y+H+++ +H D+K  NL L   +   V + D+GL+ R
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 17/44 (38%), Positives = 29/44 (65%), Gaps = 2/44 (4%)

Query: 255 QILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGDFGLAAR 296
           +IL+ + Y+H+H+ +H D+K  NL L+  +   V + D+GLA R
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 13/54 (24%), Positives = 23/54 (42%), Gaps = 17/54 (31%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIG-----------DFGLAAR 296
            Q++  + Y+H   +I+RD+K       +NF++              DF LA  
Sbjct: 112 IQLISRMEYVHSKNLIYRDVK------PENFLIGRPGNKTQQVIHIIDFALAKE 159

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 41.0 bits (95), Expect = 3e-04
 Identities = 11/61 (18%), Positives = 21/61 (34%), Gaps = 1/61 (1%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           R K  +    +  + Q+   ++      +  HRDL  GN+ L    + K+          
Sbjct: 154 RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213

Query: 299 F 299
            
Sbjct: 214 I 214

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 40.4 bits (95), Expect = 3e-04
 Identities = 16/46 (34%), Positives = 24/46 (52%), Gaps = 3/46 (6%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAAR 296
            Q++  + Y+H    IHRD+K  N  +       +V I DFGLA +
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 40.4 bits (95), Expect = 4e-04
 Identities = 14/54 (25%), Positives = 24/54 (44%), Gaps = 17/54 (31%)

Query: 254 KQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIG-----------DFGLAAR 296
           KQ+L  V  +H+  +++RD+K       DNF++              DFG+   
Sbjct: 113 KQMLARVQSIHEKSLVYRDIK------PDNFLIGRPNSKNANMIYVVDFGMVKF 160

>1mby_A SAK, serine/threonine kinase; POLO domain, strand exchange, transferase; 2.00A {Mus musculus} SCOP: d.223.1.1 Length = 88

 Score = 36.9 bits (85), Expect = 8e-04
 Identities = 10/36 (27%), Positives = 19/36 (52%)

Query: 75  YGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPN 110
            G+  QL   +  V FND ++++M A  +++  T  
Sbjct: 14  VGWATQLTSGAVWVQFNDGSQLVMQAGVSSISYTSP 49

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	305
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.98
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.98
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.98
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.98
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.98
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.98
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.98
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.98
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.98
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.98
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.98
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.95
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.95
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.95
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.95
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.95
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.94
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.93
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.91
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.88
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.62
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.41
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.37
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.37
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.35
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.35
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.33
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.33
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.27
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.27
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.25
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.25
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.23
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.23
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.22
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.21
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.21
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.14
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.01
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	98.99
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	98.98
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	98.96
3rp9_A	458	Mitogen-activated protein kinase; structural genom	98.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	98.94
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	98.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	98.93
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	98.93
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	98.93
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	98.93
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	98.92
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	98.91
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	98.91
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	98.91
3o0g_A	292	Cell division protein kinase 5; kinase activator c	98.91
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	98.91
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	98.9
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	98.89
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	98.89
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	98.89
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	98.89
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	98.89
3niz_A	311	Rhodanese family protein; structural genomics, str	98.88
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	98.87
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	98.87
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	98.86
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	98.86
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	98.86
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	98.86
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	98.86
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	98.85
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	98.85
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	98.85
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	98.85
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	98.85
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	98.84
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	98.84
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	98.84
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	98.84
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	98.83
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	98.83
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	98.83
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	98.83
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	98.83
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	98.83
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	98.82
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	98.82
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	98.81
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	98.81
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	98.81
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	98.81
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	98.81
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	98.81
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	98.81
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	98.81
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	98.81
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	98.8
3pls_A	298	Macrophage-stimulating protein receptor; protein k	98.8
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	98.8
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	98.8
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	98.8
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	98.8
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	98.8
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	98.8
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	98.8
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	98.79
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	98.79
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	98.79
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	98.79
3q4u_A	301	Activin receptor type-1; structural genomics conso	98.79
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	98.78
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	98.78
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	98.78
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	98.78
3ork_A	311	Serine/threonine protein kinase; structural genomi	98.78
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	98.77
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	98.77
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	98.77
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	98.77
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	98.77
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	98.77
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	98.76
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	98.76
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	98.76
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	98.76
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	98.76
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	98.76
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	98.76
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	98.76
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	98.75
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	98.75
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	98.75
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	98.75
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	98.75
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	98.75
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	98.75
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	98.74
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	98.74
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	98.74
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	98.74
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	98.74
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	98.74
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	98.74
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	98.74
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	98.74
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	98.74
3soc_A	322	Activin receptor type-2A; structural genomics cons	98.73
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	98.73
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	98.73
3fme_A	290	Dual specificity mitogen-activated protein kinase;	98.73
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	98.73
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	98.73
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	98.73
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	98.73
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	98.73
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	98.73
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	98.72
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	98.72
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	98.72
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	98.72
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	98.72
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	98.72
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	98.72
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	98.72
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	98.72
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	98.72
2a19_B	284	Interferon-induced, double-stranded RNA-activated	98.72
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	98.71
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	98.71
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	98.71
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	98.71
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	98.71
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	98.71
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	98.71
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	98.71
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	98.7
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	98.7
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	98.69
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	98.69
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	98.68
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	98.68
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	98.68
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	98.68
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	98.68
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	98.68
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	98.68
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	98.68
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	98.68
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	98.68
3an0_A	340	Dual specificity mitogen-activated protein kinase;	98.68
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	98.68
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	98.68
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	98.67
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	98.67
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	98.67
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	98.67
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	98.67
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	98.67
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	98.67
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	98.67
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	98.67
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	98.67
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	98.66
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	98.66
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	98.66
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	98.66
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	98.66
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	98.66
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	98.66
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	98.66
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	98.65
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	98.65
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	98.65
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	98.65
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	98.65
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	98.64
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	98.64
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	98.64
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	98.64
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	98.64
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	98.64
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	98.64
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	98.63
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	98.63
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	98.63
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	98.63
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	98.63
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	98.63
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	98.62
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	98.62
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	98.62
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	98.62
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	98.62
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	98.62
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	98.61
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	98.61
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	98.61
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	98.6
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	98.6
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	98.59
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	98.59
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	98.59
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	98.59
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	98.59
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	98.59
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	98.58
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	98.57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	98.57
3bhy_A	283	Death-associated protein kinase 3; death associate	98.57
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	98.56
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	98.55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	98.55
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	98.55
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	98.54
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	98.54
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	98.54
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	98.54
3aln_A	327	Dual specificity mitogen-activated protein kinase;	98.53
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	98.53
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	98.52
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	98.5
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	98.5
2dyl_A	318	Dual specificity mitogen-activated protein kinase	98.49
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	98.49
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	98.49
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	98.49
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	98.49

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.4e-50  Score=343.16  Aligned_cols=198  Identities=23%  Similarity=0.463  Sum_probs=171.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++|+|||||+++++|++++.+|||||||+||+|.+++.+.+.+   .+..+..+ .++..++.|+|..++.|+
T Consensus        80 ~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l---~e~~~~~~~~qi~~al~ylH~~~IiHR  156 (311)
T 4aw0_A           80 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF---DETCTRFYTAEIVSALEYLHGKGIIHR  156 (311)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            58999999999999999999999999999999999999999999877655   33333333 345788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+..+.+++.||+.+..+.      ...++||||.|||||++.+..|+.++||||+||++|||++|++||.+
T Consensus       157 DlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~  236 (311)
T 4aw0_A          157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  236 (311)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                   33455788999998665432      23578999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhh------hhcCcccccc
Q psy6191         148 STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQ------LLHFEFFNDY  202 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~------~l~~~~~~~~  202 (305)
                      .+..+++.+|.+..+.+|..+++++++||.+||++||.+|+|++|      +++||||++.
T Consensus       237 ~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          237 GNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             SSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            999999999999999999999999999999999999999999998      4789999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-48  Score=337.48  Aligned_cols=198  Identities=20%  Similarity=0.367  Sum_probs=165.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++|++++.+|||||||+||+|.+++.+. .+   .+..+.. +.+++.++.|+|..++.|+
T Consensus       119 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~l---~e~~~~~~~~qi~~aL~ylH~~~IiHR  194 (346)
T 4fih_A          119 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RM---NEEQIAAVCLAVLQALSVLHAQGVIHR  194 (346)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS-CC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC-CC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            58999999999999999999999999999999999999999998753 22   3333333 3445788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.+..+..    ..+.|||+.|||||++.+..|+.++||||+||++|||++|++||.+.+
T Consensus       195 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  274 (346)
T 4fih_A          195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  274 (346)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence                   334557889999987654322    357899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         150 LKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       150 ~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      ..+.+..|.....   ..+..+++++++||.+||++||.+|||++|+++||||+...
T Consensus       275 ~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          275 PLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9888888865432   23346899999999999999999999999999999998643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.9e-49  Score=335.02  Aligned_cols=198  Identities=24%  Similarity=0.443  Sum_probs=167.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++|++++.+|||||||+||+|.+++.+...+   .+..+..+ .++..++.|+|+.++.|+
T Consensus        74 ~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l---~e~~~~~~~~qi~~aL~ylH~~~IiHR  150 (304)
T 3ubd_A           74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEEDVKFYLAELALALDHLHSLGIIYR  150 (304)
T ss_dssp             ----CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCC---CHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            47999999999999999999999999999999999999999999877654   33333333 345788999998887553


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.+...    ....+.|||+.|||||++.+..|+.++||||+||++|||++|++||.+.+
T Consensus       151 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~  230 (304)
T 3ubd_A          151 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD  230 (304)
T ss_dssp             SCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence                   3444567899999755332    22357899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~~  202 (305)
                      ..+++.+|.+..+.+|..+++++++||.+||++||.+|||     ++|+++||||++.
T Consensus       231 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          231 RKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999999999999999999999999999999998     4799999999853

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.2e-49  Score=339.39  Aligned_cols=200  Identities=20%  Similarity=0.396  Sum_probs=166.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++|+|||||+++++|++++.+|||||||+||+|.+++....... ..+..+ ..+.++..++.|+|+.|+.|+
T Consensus        71 ~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~-~~e~~~~~~~~qi~~aL~ylH~~~IiHR  149 (350)
T 4b9d_A           71 RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDRKILHR  149 (350)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCC-CCHHHHHHHHHHHHHHHHHHHHTTCEET
T ss_pred             HHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            589999999999999999999999999999999999999999997643321 122222 233456788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.+..+..    ..+.|||+.|||||++.+..|+.++||||+||++|||++|++||.+.+
T Consensus       150 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~  229 (350)
T 4b9d_A          150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS  229 (350)
T ss_dssp             TCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence                   334456789999975543221    246789999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..+++.+|....+ +++..++.++++||.+||++||.+|||++|+++||||+..
T Consensus       230 ~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          230 MKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999888877665 4567899999999999999999999999999999999753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-48  Score=326.94  Aligned_cols=196  Identities=25%  Similarity=0.483  Sum_probs=160.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++|++++.+||||||| +|+|.+++.+...+   .+..+..+ .++..++.|+|+.++.|+
T Consensus        61 ~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l---~e~~~~~~~~qi~~al~ylH~~~IiHR  136 (275)
T 3hyh_A           61 EREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKM---SEQEARRFFQQIISAVEYCHRHKIVHR  136 (275)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSC---CHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            58999999999999999999999999999999999 68999999876554   33333333 345788999998887554


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.+.....   ..+.|||+.|||||++.+..| +.++||||+||++|||++|++||.+.+
T Consensus       137 DiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~  216 (275)
T 3hyh_A          137 DLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES  216 (275)
T ss_dssp             CCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence                   334456788999976544322   346899999999999988775 679999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ..+++..+....+.+|..+++++++||.+||++||++|||++|+++||||+.
T Consensus       217 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          217 IPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999999999999999999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=338.70  Aligned_cols=198  Identities=20%  Similarity=0.371  Sum_probs=165.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++|+|||||+++++|++++.+|||||||+||+|.+++... .+   .+..+.. +..++.++.|+|..|+.|+
T Consensus       196 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~-~l---~e~~~~~~~~qil~aL~ylH~~~IiHR  271 (423)
T 4fie_A          196 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RM---NEEQIAAVCLAVLQALSVLHAQGVIHR  271 (423)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS-CC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc-CC---CHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            58999999999999999999999999999999999999999998753 22   3333333 3445788999998886553


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.+..+.    ...+.|||+.|||||++.+..|+.++|||||||++|||++|++||.+.+
T Consensus       272 DiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  351 (423)
T 4fie_A          272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  351 (423)
T ss_dssp             CCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence                   33445678999998665432    2357899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccc---cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         150 LKETYSRIKKVE---YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       150 ~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      ..+.+..|....   ...+..++.++++||.+||++||.+|+|++|+|+||||+...
T Consensus       352 ~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          352 PLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            988888886543   233457899999999999999999999999999999998643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1e-46  Score=319.20  Aligned_cols=196  Identities=17%  Similarity=0.279  Sum_probs=155.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   76 (305)
                      .+|+++|++|+|||||+++++|++    ++.+|||||||+||+|.+++.+...+.   +..+. ....++.++.|+|..+
T Consensus        73 ~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~---~~~~~~~~~qi~~aL~ylH~~~  149 (290)
T 3fpq_A           73 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK---IKVLRSWCRQILKGLQFLHTRT  149 (290)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHTSS
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHHCC
Confidence            589999999999999999999976    457999999999999999998765542   22222 2335678888998776


Q ss_pred             --Cce--------eecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          77 --FGY--------QLNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        77 --~~~--------~~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                        +.|        ++.+..+.+++.||+.+....  ...+.||||.|||||++.+ .|+.++||||+||++|||++|++|
T Consensus       150 ~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~P  228 (290)
T 3fpq_A          150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP  228 (290)
T ss_dssp             SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence              533        333345678999998765432  2357899999999999875 589999999999999999999999


Q ss_pred             CCCC-CHHHHHHHHhcccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         145 FETS-TLKETYSRIKKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       145 f~~~-~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |.+. +.......+.....  .++...++++++||.+||++||.+|||++|+++||||++
T Consensus       229 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          229 YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             TTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            9764 45555666655432  345567889999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-46  Score=323.55  Aligned_cols=198  Identities=21%  Similarity=0.292  Sum_probs=161.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++|+|||||+++++|++++.+|||||||+||+|.+++++...+   .+..+.. +.++..++.|+|..++.|+
T Consensus        98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l---~e~~~~~~~~qi~~aL~ylH~~~IiHR  174 (336)
T 4g3f_A           98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL---PEDRALYYLGQALEGLEYLHTRRILHG  174 (336)
T ss_dssp             THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            47999999999999999999999999999999999999999999877654   3333333 3445788999998776443


Q ss_pred             --------ecCCCCCeeEcchhHHHHhc---------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 --------LNDDSSGVMFNDLTRMIMLA---------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 --------~~~~~~~v~~~d~~~~~~~~---------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                              +..++..+++.||+.+..+.         ..+++|||+.|||||++.+..|+.++||||+||++|||++|++
T Consensus       175 DlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~  254 (336)
T 4g3f_A          175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH  254 (336)
T ss_dssp             CCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence                    33333358999997543321         2345799999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhh-------------hcCcccccc
Q psy6191         144 PFETSTLKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQL-------------LHFEFFNDY  202 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~-------------l~~~~~~~~  202 (305)
                      ||.+.+..++..+|....+   .+|+.+++.++++|.+||++||.+|||+.|+             ++|||+..+
T Consensus       255 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          255 PWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             SSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             CCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            9998877777777766543   3577899999999999999999999999997             568888754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.1e-43  Score=321.84  Aligned_cols=196  Identities=18%  Similarity=0.255  Sum_probs=163.9

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+.+++.++|||||+++++|++++.+|||||||+||+|.+++.+.+.+   .+..++.+ ..++.++.|+|..|+.|+ 
T Consensus       241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l---~E~~a~~y~~qIl~aL~yLH~~gIiHRD  317 (689)
T 3v5w_A          241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEHMHNRFVVYRD  317 (689)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCC---CHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred             HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            3467888999999999999999999999999999999999999887655   33334333 345788999998886553 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC--CcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCC---
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPFETS---  148 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~g~~Pf~~~---  148 (305)
                            +.+..+.+++.||+.+..+..  ..+.||||.|||||++. +..|+.++||||+||++|||++|++||.+.   
T Consensus       318 LKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~  397 (689)
T 3v5w_A          318 LKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  397 (689)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred             CchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                  344567889999987654432  35789999999999996 457999999999999999999999999763   


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      +..+....+....+.+|..+++++++||.+||++||.+|++     ++|+++||||++
T Consensus       398 ~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          398 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            44566677777888899999999999999999999999998     799999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=307.51  Aligned_cols=197  Identities=20%  Similarity=0.310  Sum_probs=155.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   74 (305)
                      .+|+++|++|+|||||++++++++      .+.+|||||||+ |+|.+++.....+   .+..++.+ .+++.++.|+|.
T Consensus       101 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l---~~~~~~~~~~qil~al~ylH~  176 (398)
T 4b99_A          101 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPL---TLEHVRYFLYQLLRGLKYMHS  176 (398)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCC---CHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHH
Confidence            479999999999999999999764      367999999996 6799988765443   33333333 345788999998


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHh--------cCCcccccCCCcccccccccC-CCCccchHHHHHHHHHHH
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIML--------ANKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~--------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~  138 (305)
                      .|+.|+       +.+..+.+++.||+.+..+        ....+.|||+.|||||++.+. +|+.++||||+||++|||
T Consensus       177 ~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~el  256 (398)
T 4b99_A          177 AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM  256 (398)
T ss_dssp             TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred             CcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHH
Confidence            887554       3344567888898755332        123468999999999998764 579999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHhccccCC-------------------------------CCCCCHHHHHHHHHHhhcCCCCC
Q psy6191         139 LVGKPPFETSTLKETYSRIKKVEYKL-------------------------------PATLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       139 l~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~dp~~R  187 (305)
                      ++|++||.+.+..+++..|.......                               .+.++.++.+||.+||++||.+|
T Consensus       257 l~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R  336 (398)
T 4b99_A          257 LARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSAR  336 (398)
T ss_dssp             HHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTS
T ss_pred             HHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHC
Confidence            99999999999888877775422111                               12468899999999999999999


Q ss_pred             CCHhhhhcCcccccc
Q psy6191         188 PPVAQLLHFEFFNDY  202 (305)
Q Consensus       188 ~~~~~~l~~~~~~~~  202 (305)
                      +|++|+|+||||+..
T Consensus       337 ~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          337 ISAAAALRHPFLAKY  351 (398)
T ss_dssp             CCHHHHTTSGGGTTT
T ss_pred             cCHHHHhcCHhhCcC
Confidence            999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-42  Score=321.29  Aligned_cols=199  Identities=24%  Similarity=0.389  Sum_probs=164.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|+.|+|||||+|+++|++++.+|||||||+||+|.+++.....  .+.+..+.. +.+++.++.|+|..++.|+
T Consensus       202 ~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHR  279 (573)
T 3uto_A          202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHL  279 (573)
T ss_dssp             HHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            5899999999999999999999999999999999999999998854321  122223333 3345788999998876443


Q ss_pred             --------ecC-CCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LND-DSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~~-~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +.. ..+.+++.||+.+..+...   .+.|||+.|||||++.+..|+.++||||+||++|||++|.+||.+.
T Consensus       280 DlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~  359 (573)
T 3uto_A          280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  359 (573)
T ss_dssp             CCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             cCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                    322 2356888898765544322   3679999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +..+++..|....+.++    ..++.++++||.+||++||.+|||++|+|+||||+..
T Consensus       360 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          360 NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             SHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            99999999988776654    4589999999999999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.4e-43  Score=297.45  Aligned_cols=198  Identities=23%  Similarity=0.448  Sum_probs=146.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------------FVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKW   68 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~   68 (305)
                      .+|+++|++|+|||||+++++|++.+            ++|||||||+||+|.+++.......+.....+ ....++.++
T Consensus        51 ~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~a  130 (299)
T 4g31_A           51 MREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA  130 (299)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHH
Confidence            48999999999999999999997654            48999999999999999987665543322222 233456788


Q ss_pred             HHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc----------------CCcccccCCCcccccccccCCCCcc
Q psy6191          69 VDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA----------------NKNTLCGTPNYIAPEILNKNGHSFE  125 (305)
Q Consensus        69 ~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~----------------~~~~~~Gt~~y~aPE~~~~~~~~~~  125 (305)
                      +.|+|..++.|+       +.+..+.+++.||+.+..+.                ...+.|||+.|||||++.+..|+.+
T Consensus       131 l~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~  210 (299)
T 4g31_A          131 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK  210 (299)
T ss_dssp             HHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTH
T ss_pred             HHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH
Confidence            999998887554       33445678999997543321                1235689999999999999999999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccccC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         126 VDVWSIGCIMYTLLVGKPPFETSTL-KETYSRIKKVEYK-LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       126 ~DiwSlGvilye~l~g~~Pf~~~~~-~~~~~~i~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +||||+||++|||++   ||.+... ......+....++ .+...++.+.+||.+||++||.+|||+.|+++||||++.
T Consensus       211 ~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          211 VDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999996   8865422 2333344433221 112355677899999999999999999999999999853

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.7e-42  Score=293.91  Aligned_cols=198  Identities=15%  Similarity=0.240  Sum_probs=159.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcC----------CCCCCCcC-chhHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACD----------LEEMSDPA-AQPVIWVSKWVD   70 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~----------~~~~~~~~-~~~~~~~~~~~~   70 (305)
                      .+|+++|++|+|||||++++++.+++.+|||||||+||+|.+++.....          ...+.... ......++.++.
T Consensus        63 ~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~  142 (299)
T 4asz_A           63 HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMV  142 (299)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHH
Confidence            5899999999999999999999999999999999999999999976431          11122222 222344578899


Q ss_pred             HhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHH
Q psy6191          71 YSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        71 ~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  137 (305)
                      |+|..++.|+       +.+.+..+++.||+.+.....      ....+||+.|||||++.++.|+.++|||||||++||
T Consensus       143 yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~E  222 (299)
T 4asz_A          143 YLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE  222 (299)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             HHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHH
Confidence            9998776543       334456788999986654322      234579999999999999999999999999999999


Q ss_pred             HHh-CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         138 LLV-GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       138 ~l~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |+| |+.||.+.+..+....+..+. .+.|...+.++.+|+.+||+.||.+|||+.++.  +|+..
T Consensus       223 llt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          223 IFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             HHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            998 999999999888888887654 466788999999999999999999999999994  56653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-41  Score=297.77  Aligned_cols=194  Identities=24%  Similarity=0.350  Sum_probs=146.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++|+.+ +|||||+++++|++++++|||||||+||+|.++++.   +   .+..++.+ .++..++.|+|+.|+.|
T Consensus        67 ~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~---l---~~~~~~~~~~qll~al~ylH~~gIiH  140 (361)
T 4f9c_A           67 AAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS---L---SFQEVREYMLNLFKALKRIHQFGIVH  140 (361)
T ss_dssp             HHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT---C---CHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC---C---CHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            4899999998 699999999999999999999999999999998842   2   33333333 34578899999887654


Q ss_pred             e--------ecCCCCCeeEcchhHHHHhc--------------------------------CCcccccCCCccccccccc
Q psy6191          80 Q--------LNDDSSGVMFNDLTRMIMLA--------------------------------NKNTLCGTPNYIAPEILNK  119 (305)
Q Consensus        80 ~--------~~~~~~~v~~~d~~~~~~~~--------------------------------~~~~~~Gt~~y~aPE~~~~  119 (305)
                      +        +..+.+.+++.||+.+....                                ...+.|||+.|||||++.+
T Consensus       141 RDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~  220 (361)
T 4f9c_A          141 RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK  220 (361)
T ss_dssp             SCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred             CcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence            3        33333567888886442110                                1134689999999999876


Q ss_pred             C-CCCccchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhc--------------------------------------
Q psy6191         120 N-GHSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKK--------------------------------------  159 (305)
Q Consensus       120 ~-~~~~~~DiwSlGvilye~l~g~~Pf~~-~~~~~~~~~i~~--------------------------------------  159 (305)
                      . .|+.++||||+||++|||++|++||.. .+..+.+..|..                                      
T Consensus       221 ~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  300 (361)
T 4f9c_A          221 CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRG  300 (361)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-
T ss_pred             CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcc
Confidence            5 589999999999999999999999964 344343333321                                      


Q ss_pred             ccc----------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         160 VEY----------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       160 ~~~----------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ...                .....++++++|||++||++||.+|+|++|+|+||||++
T Consensus       301 ~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          301 MDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             ---------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             ccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            000                112357889999999999999999999999999999985

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=292.82  Aligned_cols=195  Identities=16%  Similarity=0.231  Sum_probs=153.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC------------CCCc-CchhHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE------------MSDP-AAQPVIWVSKW   68 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~------------~~~~-~~~~~~~~~~~   68 (305)
                      .+|+++|++|+|||||++++++.+++.+|||||||+||+|.+++........            +... .......++.+
T Consensus        91 ~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g  170 (329)
T 4aoj_A           91 QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG  170 (329)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHH
Confidence            5899999999999999999999999999999999999999999976432111            1111 11223345788


Q ss_pred             HHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHH
Q psy6191          69 VDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIM  135 (305)
Q Consensus        69 ~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvil  135 (305)
                      +.|+|..++.|+       +.+....+++.||+.+..+..      .++.+||+.|||||++.+..|+.++|||||||++
T Consensus       171 l~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl  250 (329)
T 4aoj_A          171 MVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL  250 (329)
T ss_dssp             HHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHH
Confidence            899998776443       334456788999976544321      2356899999999999999999999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         136 YTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       136 ye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |||+| |+.||.+.+..+....+... .++.|...++++.+|+.+||+.||.+|||+.|++++
T Consensus       251 ~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          251 WEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            99999 99999998888888777654 456788899999999999999999999999999753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.8e-41  Score=286.90  Aligned_cols=195  Identities=16%  Similarity=0.227  Sum_probs=156.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC-------------CCC-cCchhHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-------------MSD-PAAQPVIWVSK   67 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~-------------~~~-~~~~~~~~~~~   67 (305)
                      .+|+.+|++|+|||||++++++.+++.+|||||||++|+|.+++........             +.. ........++.
T Consensus        77 ~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~  156 (308)
T 4gt4_A           77 RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA  156 (308)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHH
Confidence            5799999999999999999999999999999999999999999975432111             011 11123345678


Q ss_pred             HHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHH
Q psy6191          68 WVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCI  134 (305)
Q Consensus        68 ~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvi  134 (305)
                      ++.|+|..++.|+       +.+....+++.||+.+..+.      ..++.+||+.|||||++.++.|+.++|||||||+
T Consensus       157 gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvv  236 (308)
T 4gt4_A          157 GMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV  236 (308)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHH
Confidence            8999998776443       33444678888987543321      1345689999999999999999999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         135 MYTLLV-GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       135 lye~l~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||||+| |+.||.+.+..+....+.... .+.|...+..+.+|+.+||..||.+|||+.|++++
T Consensus       237 l~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          237 LWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999998 899999999888888887654 45677899999999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=287.43  Aligned_cols=192  Identities=18%  Similarity=0.271  Sum_probs=141.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+ +.+|||||||+||+|.+++......  +... .......++.++.|+|..++.|+
T Consensus        80 ~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~--l~~~~~~~i~~qia~gL~yLH~~~IiHR  156 (307)
T 3omv_A           80 RNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETK--FQMFQLIDIARQTAQGMDYLHAKNIIHR  156 (307)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCC--CCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            589999999999999999998754 5689999999999999998654221  1222 22233456788999998876553


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------CCcccccCCCccccccccc---CCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNK---NGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+.+..+++.||+.+....      ...+.+||+.|||||++.+   ..|+.++|||||||+||||+||+.|
T Consensus       157 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~P  236 (307)
T 3omv_A          157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP  236 (307)
T ss_dssp             CCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCC
Confidence                   23334567888887543221      2246799999999999864   3589999999999999999999999


Q ss_pred             CCCCCHHHHH-HHHhccc--c---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         145 FETSTLKETY-SRIKKVE--Y---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       145 f~~~~~~~~~-~~i~~~~--~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |.+.+..... ..+....  +   ..+...+.++.+|+.+||+.||.+|||+.|++++
T Consensus       237 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          237 YSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             TTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             CCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9876554433 3333321  1   2345678899999999999999999999987643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-38  Score=275.98  Aligned_cols=198  Identities=26%  Similarity=0.489  Sum_probs=167.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|+.++|||||++++++++++.+|+|||||+||+|.+++.....+   .+..+.. +..+..++.|+|..++.|.
T Consensus        62 ~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l---~~~~~~~~~~qi~~al~~lH~~~ivHr  138 (328)
T 3fe3_A           62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRM---KEKEARSKFRQIVSAVQYCHQKRIVHR  138 (328)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCC---CHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence            47999999999999999999999999999999999999999999776544   2222222 3345778889998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+....+++.||+.......   ..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+
T Consensus       139 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  218 (328)
T 3fe3_A          139 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN  218 (328)
T ss_dssp             CCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence                   334456788889876544322   246789999999999987776 478999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..+....+....+.+|...+.++.++|++||..||.+|||++|+++||||+..
T Consensus       219 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          219 LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence            99999999888889999999999999999999999999999999999999854

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.5e-38  Score=273.54  Aligned_cols=197  Identities=22%  Similarity=0.393  Sum_probs=166.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++|||||++++++++++.+|+|||||+||+|.+++.....+   .+..+.. ...+..++.|+|..|+.|.
T Consensus        53 ~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~~ivHr  129 (337)
T 1o6l_A           53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSALEYLHSRDVVYR  129 (337)
T ss_dssp             HHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCC---CHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            47999999999999999999999999999999999999999998776443   2222222 2345678889998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|||++|.+||.+.+
T Consensus       130 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  209 (337)
T 1o6l_A          130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence                   3344567888888754321    12346799999999999999899999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~  201 (305)
                      ..+....+......+|..++.++.++|.+||..||.+|+     +++++++||||..
T Consensus       210 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          210 HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            888888888888888999999999999999999999999     8999999999975

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.1e-38  Score=278.07  Aligned_cols=197  Identities=27%  Similarity=0.453  Sum_probs=161.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||++++++++++.+|||||||+||+|.+++.....+   .+..+ ..+..+..++.|+|..|+.|.
T Consensus        63 ~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l---~~~~~~~i~~qi~~aL~~LH~~givHr  139 (361)
T 2yab_A           63 EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILDGVNYLHTKKIAHF  139 (361)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCC---BHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            47999999999999999999999999999999999999999998654333   22222 223345678889988776442


Q ss_pred             --------ecCCCC---CeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 --------LNDDSS---GVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 --------~~~~~~---~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                              +.+...   .+++.||+.......   ..+.+||+.|+|||++.+..++.++||||+||++|+|++|.+||.
T Consensus       140 Dlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~  219 (361)
T 2yab_A          140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  219 (361)
T ss_dssp             CCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             CCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence                    322221   578888875543322   246789999999999998899999999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +.+..+.+..+....+.++    ..++..+++||.+||..||.+|||+.|+++||||+.
T Consensus       220 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          220 GDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            9999999888888776665    468899999999999999999999999999999984

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.9e-39  Score=281.14  Aligned_cols=195  Identities=18%  Similarity=0.250  Sum_probs=151.1

Q ss_pred             hhHHHHHhcCCC-CCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCCC-------------CCCCc-CchhHHHH
Q psy6191           2 SQEIAIHRSLKH-RNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDLE-------------EMSDP-AAQPVIWV   65 (305)
Q Consensus         2 ~~Ei~il~~l~H-pnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~~-------------~~~~~-~~~~~~~~   65 (305)
                      .+|+++|++++| ||||++++++.+ ++.+|||||||++|+|.++++......             .+... .......+
T Consensus       115 ~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  194 (353)
T 4ase_A          115 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV  194 (353)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHH
Confidence            479999999965 999999999865 567999999999999999997643210             01111 11223346


Q ss_pred             HHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHH
Q psy6191          66 SKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIG  132 (305)
Q Consensus        66 ~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG  132 (305)
                      +.++.|+|..++.|+       +.+....+++.||+.+..+..      .++.+||+.|||||++.++.|+.++||||||
T Consensus       195 a~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~G  274 (353)
T 4ase_A          195 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG  274 (353)
T ss_dssp             HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehH
Confidence            788889998776543       334456788999987654322      2356899999999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCHHH-HHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         133 CIMYTLLV-GKPPFETSTLKE-TYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       133 vilye~l~-g~~Pf~~~~~~~-~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |++|||+| |++||.+.+..+ ....+.. ..+..|...++++.+++.+||+.||.+|||+.|+++|
T Consensus       275 v~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          275 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            99999998 999998865443 3444443 3456788899999999999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-38  Score=273.02  Aligned_cols=197  Identities=22%  Similarity=0.452  Sum_probs=165.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++.+|+|||||+||+|.+++.....+   .+..+.. +..+..++.++|..|+.|.
T Consensus        54 ~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~~ivHr  130 (318)
T 1fot_A           54 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYLHSKDIIYR  130 (318)
T ss_dssp             HHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSC---CHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             HHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            46999999999999999999999999999999999999999999875443   2222222 2345678888887775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                             +.+..+.+++.||+...... ...+.+||+.|+|||++.+..++.++||||+||++|||++|.+||.+.+..+
T Consensus       131 Dlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  210 (318)
T 1fot_A          131 DLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK  210 (318)
T ss_dssp             CCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CCChheEEEcCCCCEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence                   33345677888886544332 2346799999999999999899999999999999999999999999999888


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND  201 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~  201 (305)
                      .+..+......+|..++.++.++|.+||..||.+|+     +++++++||||++
T Consensus       211 ~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          211 TYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            888898888888999999999999999999999999     8999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=276.94  Aligned_cols=197  Identities=23%  Similarity=0.393  Sum_probs=162.8

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++++.+ +|||||++++++++++.+|||||||+||+|.+++.....+   .+..+.. +..+..++.|+|..|+.|
T Consensus        71 ~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~givH  147 (353)
T 3txo_A           71 MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF---DEARARFYAAEIISALMFLHDKGIIY  147 (353)
T ss_dssp             HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            3689999988 7999999999999999999999999999999999876544   2222222 334567888999887654


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.||+.....    ....+.|||+.|+|||++.+..|+.++||||+||++|||++|++||.+.
T Consensus       148 rDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          148 RDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence            3       3344567888888754321    1234679999999999999888999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH------hhhhcCccccc
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV------AQLLHFEFFND  201 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~------~~~l~~~~~~~  201 (305)
                      +..+.+..|......+|..++.++.++|++||.+||.+|+++      +++++||||+.
T Consensus       228 ~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          228 NEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             SHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             CHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            999999999998889999999999999999999999999998      89999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.8e-38  Score=273.18  Aligned_cols=198  Identities=24%  Similarity=0.397  Sum_probs=166.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.+ +|||||++++++++++.+|+|||||+||+|.+++.....+.   ...+. .+..+..++.|+|..|+.|
T Consensus        65 ~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~---~~~~~~~~~qi~~aL~~LH~~~ivH  141 (345)
T 1xjd_A           65 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD---LSRATFYAAEIILGLQFLHSKGIVY  141 (345)
T ss_dssp             HHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3688888876 99999999999999999999999999999999998765442   22222 2334567888999887654


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|||++|.+||.+.
T Consensus       142 rDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (345)
T 1xjd_A          142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  221 (345)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence            3       3344567888888754322    2235679999999999999989999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHh-hhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVA-QLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~-~~l~~~~~~~~  202 (305)
                      +..+.+..+......+|..++.++.++|.+||..||.+||++. ++++||||+..
T Consensus       222 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          222 DEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             SHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             CHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            9999999998888888999999999999999999999999998 99999999863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-37  Score=272.04  Aligned_cols=197  Identities=22%  Similarity=0.409  Sum_probs=166.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++.++|||||++++++++++.+|||||||+||+|.+++.....+   .+..... +..+..++.++|..|+.|.
T Consensus        89 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~~ivHr  165 (350)
T 1rdq_E           89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLHSLDLIYR  165 (350)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            46999999999999999999999999999999999999999999876544   2222222 3345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                             +.+..+.+++.||+...... ...+.+||+.|+|||++.+..++.++||||+||++|||++|.+||.+.+..+
T Consensus       166 Dlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  245 (350)
T 1rdq_E          166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ  245 (350)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cCccceEEECCCCCEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH
Confidence                   23344667888887554332 2346799999999999998899999999999999999999999999999999


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      .+..+......+|..++.++.++|.+||..||.+||+     ++++++||||+.
T Consensus       246 ~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            9999988888899999999999999999999999998     999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=279.92  Aligned_cols=197  Identities=29%  Similarity=0.469  Sum_probs=162.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++..|+|||||+||+|.+.+.....+   .+..+ ..+..+..++.|+|+.|+.|.
T Consensus        58 ~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~---~e~~~~~i~~qil~aL~~lH~~givHr  134 (444)
T 3soa_A           58 EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY---SEADASHCIQQILEAVLHCHQMGVVHR  134 (444)
T ss_dssp             HHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCC---CHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            58999999999999999999999999999999999999999998765443   22222 223345778899998876543


Q ss_pred             --------ecC--CCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 --------LND--DSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 --------~~~--~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                              +..  ....+++.||+.......    ....+||+.|+|||++.+..|+.++||||+||++|+|++|.+||.
T Consensus       135 DlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~  214 (444)
T 3soa_A          135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW  214 (444)
T ss_dssp             CCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence                    221  234577888875543322    235689999999999998889999999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +.+..+....+....+.+|.    .+++++.++|.+||..||.+|||+.|+++||||+.
T Consensus       215 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          215 DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             CSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             CccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            99998888888877665553    57899999999999999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.4e-37  Score=269.54  Aligned_cols=197  Identities=23%  Similarity=0.382  Sum_probs=165.8

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.+ +|||||++++++++++.+|||||||+||+|.+++.....+   .+..+. .+..+..++.|+|..|+.|
T Consensus        68 ~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~givH  144 (353)
T 2i0e_A           68 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF---KEPHAVFYAAEIAIGLFFLQSKGIIY  144 (353)
T ss_dssp             HHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            3688999988 8999999999999999999999999999999999876544   222222 2334567888999887654


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|||++|++||.+.
T Consensus       145 rDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  224 (353)
T 2i0e_A          145 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  224 (353)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence            3       3344567888888754431    1235679999999999999989999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      +..+.+..|....+.+|..++.++.++|.+||..||.+|++     ++++++||||+.
T Consensus       225 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          225 DEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             SHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            99999999988888899999999999999999999999995     699999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.5e-37  Score=273.80  Aligned_cols=198  Identities=27%  Similarity=0.482  Sum_probs=161.4

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++++ +|||||+++++|++++.+|||||||+||+|.+++.....+   .+..+..+ ..++.++.++|+.++.+
T Consensus       100 ~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l---~~~~~~~~~~qi~~aL~~LH~~givH  176 (396)
T 4dc2_A          100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---PEEHARFYSAEISLALNYLHERGIIY  176 (396)
T ss_dssp             HHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            4688999876 8999999999999999999999999999999999876544   22333333 34567888999887654


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.||+.....    ....+.|||+.|+|||++.+..|+.++||||+||++|||++|++||...
T Consensus       177 rDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             ccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            3       3344567888898755321    2235789999999999999999999999999999999999999999632


Q ss_pred             ---------CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH------hhhhcCcccccc
Q psy6191         149 ---------TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV------AQLLHFEFFNDY  202 (305)
Q Consensus       149 ---------~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~------~~~l~~~~~~~~  202 (305)
                               ........+....+.+|..++.++++||++||+.||.+|+++      +|+++||||+..
T Consensus       257 ~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          257 GSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             ccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence                     234466777778888999999999999999999999999985      799999999863

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.1e-37  Score=267.90  Aligned_cols=198  Identities=27%  Similarity=0.485  Sum_probs=161.1

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++++ +|||||++++++++++.+|+|||||+||+|.+++.....+   .+..+.. +..+..++.++|..++.|
T Consensus        57 ~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l---~~~~~~~~~~qi~~aL~~LH~~~ivH  133 (345)
T 3a8x_A           57 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---PEEHARFYSAEISLALNYLHERGIIY  133 (345)
T ss_dssp             HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            4689999887 8999999999999999999999999999999999876443   2222222 234567888999887654


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC-
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET-  147 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~-  147 (305)
                      .       +.+..+.+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|||++|++||.. 
T Consensus       134 rDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  213 (345)
T 3a8x_A          134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  213 (345)
T ss_dssp             CCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred             cCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence            3       3344567888998765431    123467999999999999998999999999999999999999999975 


Q ss_pred             --------CCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH------hhhhcCcccccc
Q psy6191         148 --------STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV------AQLLHFEFFNDY  202 (305)
Q Consensus       148 --------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~------~~~l~~~~~~~~  202 (305)
                              .+.......+......+|..++..++++|.+||..||.+||++      +++++||||+..
T Consensus       214 ~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          214 GSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             TC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             ccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence                    3344566677777788899999999999999999999999996      799999999853

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.7e-37  Score=266.44  Aligned_cols=198  Identities=27%  Similarity=0.431  Sum_probs=162.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|||||||+||+|.+++.....+.   +... ..+..+..++.++|..|+.|.
T Consensus        69 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~qi~~al~~lH~~~ivH~  145 (327)
T 3a62_A           69 KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM---EDTACFYLAEISMALGHLHQKGIIYR  145 (327)
T ss_dssp             --HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCC---HHHHHHHHHHHHHHHHHHHhCCEEcc
Confidence            479999999999999999999999999999999999999999997654432   2222 223345678889998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus       146 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  225 (327)
T 3a62_A          146 DLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN  225 (327)
T ss_dssp             CCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence                   2334456788888644321    12345789999999999998889999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ..+....+......+|..++.++.++|.+||..||.+||     ++.++++||||+..
T Consensus       226 ~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          226 RKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            888888888888888999999999999999999999999     88999999999853

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.3e-38  Score=272.01  Aligned_cols=197  Identities=23%  Similarity=0.467  Sum_probs=161.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++.+|+||||| +|+|.+++.....+   .+.... .+..+..++.++|..|+.+.
T Consensus        57 ~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l---~~~~~~~i~~qi~~aL~~LH~~givH~  132 (336)
T 3h4j_B           57 EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRM---TEDEGRRFFQQIICAIEYCHRHKIVHR  132 (336)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSC---CHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            48999999999999999999999999999999999 78999988766544   222222 23345678889998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+....+++.||+.......   ..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+
T Consensus       133 Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~  212 (336)
T 3h4j_B          133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF  212 (336)
T ss_dssp             CCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred             CCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence                   233446788888875544322   246789999999999988775 789999999999999999999998877


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .......+....+.+|..+++++.++|++||..||.+|||++|+++||||+..
T Consensus       213 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          213 IPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             STTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            66666666666777888899999999999999999999999999999999854

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.8e-37  Score=271.34  Aligned_cols=197  Identities=28%  Similarity=0.506  Sum_probs=160.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++..|+|||||+||+|.+.+.....+   .+... ..+..+..++.|+|..++.|.
T Consensus        76 ~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~---~~~~~~~~~~qi~~al~~lH~~~ivH~  152 (362)
T 2bdw_A           76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESIAYCHSNGIVHR  152 (362)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCC---CHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            47999999999999999999999999999999999999999988654332   22222 223345778899998876543


Q ss_pred             --------ecCC--CCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 --------LNDD--SSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 --------~~~~--~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                              +...  ...+++.||+.......   ....+||+.|+|||++.+..++.++||||+||++|+|++|.+||.+
T Consensus       153 Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~  232 (362)
T 2bdw_A          153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  232 (362)
T ss_dssp             CCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                    2221  23478888875543322   2356899999999999988899999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         148 STLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .+..+....+....+.+|.    .++.++.++|.+||..||.+|||+.++++||||..
T Consensus       233 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          233 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            9988888888777666553    47899999999999999999999999999999974

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-37  Score=264.89  Aligned_cols=197  Identities=26%  Similarity=0.466  Sum_probs=158.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||+||+|.+++.....+   ..... ..+..+..++.++|..++.|.
T Consensus        62 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~qi~~al~~lH~~~ivH~  138 (326)
T 2y0a_A           62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYYLHSLQIAHF  138 (326)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCC---BHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCc---CHHHHHHHHHHHHHHHHHHHHCCeEcC
Confidence            47999999999999999999999999999999999999999998654332   22222 223345678888888775442


Q ss_pred             --------ecCCC---CCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 --------LNDDS---SGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 --------~~~~~---~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                              +....   ..+++.||+......   .....+||+.|+|||++.+..++.++||||+||++|+|++|..||.
T Consensus       139 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  218 (326)
T 2y0a_A          139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  218 (326)
T ss_dssp             CCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             CCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence                    22221   157888887554332   2245689999999999998889999999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +.+..+....+....+.++    ...+..+.++|.+||..||.+|||+.++++||||+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             CSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             CCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            9888888777776655544    467889999999999999999999999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.5e-37  Score=261.03  Aligned_cols=197  Identities=19%  Similarity=0.349  Sum_probs=156.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||+||+|.+++.... +   .+... ..+..+..++.++|..|+.|.
T Consensus        65 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~---~~~~~~~~~~qi~~~l~~lH~~~i~H~  140 (297)
T 3fxz_A           65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-M---DEGQIAAVCRECLQALEFLHSNQVIHR  140 (297)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC-C---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC-C---CHHHHHHHHHHHHHHHHHHHhCCceeC
Confidence            479999999999999999999999999999999999999999987642 1   22222 223345678888888775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+......    ...+.+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+
T Consensus       141 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  220 (297)
T 3fxz_A          141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (297)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   23344677888887543322    2245689999999999999999999999999999999999999999887


Q ss_pred             HHHHHHHHhcc---ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKV---EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .......+...   ....|..++..+.++|.+||..||.+|||+.|+++||||+..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          221 PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            76655544322   234456788999999999999999999999999999999853

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.7e-36  Score=263.38  Aligned_cols=197  Identities=24%  Similarity=0.435  Sum_probs=159.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|+.++|||||+++++|++++.+|+|||||.||+|.+++.....+   .+..+.. +..+..++.|+|..|+.|.
T Consensus        63 ~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l---~~~~~~~~~~qi~~aL~~LH~~givHr  139 (384)
T 4fr4_A           63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHF---KEETVKLFICELVMALDYLQNQRIIHR  139 (384)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            47999999999999999999999999999999999999999999865443   2222222 3345678889998776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc---CCcccccCCCccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNK---NGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+..+.+++.||+......   ...+.+||+.|+|||++.+   ..|+.++||||+||++|||++|+.||..
T Consensus       140 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~  219 (384)
T 4fr4_A          140 DMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI  219 (384)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence                   33445678888887654332   2346799999999999863   4588999999999999999999999974


Q ss_pred             ---CCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-HhhhhcCccccc
Q psy6191         148 ---STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-VAQLLHFEFFND  201 (305)
Q Consensus       148 ---~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-~~~~l~~~~~~~  201 (305)
                         ....+....+......+|...+..+.++|.+||..||.+||+ ++++++||||++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          220 RSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             CTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             CCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence               345566666777777888899999999999999999999998 899999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.5e-37  Score=272.50  Aligned_cols=197  Identities=28%  Similarity=0.451  Sum_probs=159.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||+++++|++++.+|||||||+||+|.+++... .+   .+..+.. ...+..++.|+|..|+.|.
T Consensus       117 ~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~---~e~~~~~~~~qi~~aL~~LH~~givHr  192 (410)
T 3v8s_A          117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DV---PEKWARFYTAEVVLALDAIHSMGFIHR  192 (410)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC-CC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC-CC---CHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            47999999999999999999999999999999999999999998753 22   2222222 3345678889998776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCC----CCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNG----HSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~----~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+..+.+++.||+.......     ..+.+||+.|||||++.+..    |+.++||||+||++|||++|++|
T Consensus       193 DLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P  272 (410)
T 3v8s_A          193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  272 (410)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence                   334556788888876543322     34779999999999987655    78899999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc--cCCC--CCCCHHHHHHHHHHhhcCCCC--CCCHhhhhcCcccccc
Q psy6191         145 FETSTLKETYSRIKKVE--YKLP--ATLKKPAATMIKKMLLLDPVQ--RPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~--~~~~--~~~~~~~~~li~~~l~~dp~~--R~~~~~~l~~~~~~~~  202 (305)
                      |.+.+..+.+..|....  ..+|  ..++.++++||.+||..+|.+  |++++|+++||||+..
T Consensus       273 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          273 FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             TCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             CCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            99999988888886542  3344  468999999999999999988  9999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-36  Score=268.12  Aligned_cols=196  Identities=24%  Similarity=0.445  Sum_probs=161.3

Q ss_pred             hHHHH-HhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAI-HRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~i-l~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|..+ ++.++|||||++++++++++.+|||||||+||+|.+++.+...+.   +..+.. +..+..++.|+|..|+.|.
T Consensus        87 ~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~---~~~~~~~~~qi~~aL~~LH~~givHr  163 (373)
T 2r5t_A           87 SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL---EPRARFYAAEIASALGYLHSLNIVYR  163 (373)
T ss_dssp             ----CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHHCCceec
Confidence            45555 578999999999999999999999999999999999998765442   222222 3345678889998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+......    ...+.|||+.|+|||++.+..++.++||||+||++|||++|.+||.+.+
T Consensus       164 Dlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  243 (373)
T 2r5t_A          164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  243 (373)
T ss_dssp             CCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred             CCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence                   33445678889987554322    2356799999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV----AQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~----~~~l~~~~~~~  201 (305)
                      ..+.+..|......+|..++..++++|.+||+.||.+|+++    .++++||||+.
T Consensus       244 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          244 TAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            99999999888888889999999999999999999999987    58999999985

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.8e-37  Score=278.06  Aligned_cols=198  Identities=23%  Similarity=0.438  Sum_probs=164.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++.+|||||||+||+|.+++.....+   .+..+. .+..+..++.|+|..++.|.
T Consensus        64 ~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l---~~~~~~~i~~qi~~aL~~LH~~givHr  140 (476)
T 2y94_A           64 RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRL---DEKESRRLFQQILSGVDYCHRHMVVHR  140 (476)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSC---CHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCCCcc
Confidence            48999999999999999999999999999999999999999988654333   222222 23345778889988775442


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+....+++.||+.......   ..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+
T Consensus       141 DLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~  220 (476)
T 2y94_A          141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH  220 (476)
T ss_dssp             CCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence                   333456788888875543322   246789999999999987765 789999999999999999999999988


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .......+....+..|..++.++.++|++||..||.+|||+.++++||||+..
T Consensus       221 ~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          221 VPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             SHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            88888889888888888999999999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-37  Score=267.88  Aligned_cols=198  Identities=23%  Similarity=0.383  Sum_probs=160.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++.+|+|||||+||+|.+.+.....  .+.+... ..+..+..++.|+|..|+.|.
T Consensus        49 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~givH~  126 (321)
T 1tki_A           49 KKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHNIGHF  126 (321)
T ss_dssp             HHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcC
Confidence            5899999999999999999999999999999999999999998864321  1122222 223345778889988776443


Q ss_pred             --------ecC-CCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LND-DSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~~-~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +.. ....+++.||+........   ...+||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.
T Consensus       127 Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  206 (321)
T 1tki_A          127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             CCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence                    222 1456788888755433222   3467999999999999888899999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +..+....+....+.++    ..++.++.++|.+||..||.+|||+.|+++||||+.
T Consensus       207 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          207 TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             CHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            98888888887766655    368899999999999999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.3e-37  Score=267.02  Aligned_cols=198  Identities=28%  Similarity=0.501  Sum_probs=157.4

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++.++ +|||||++++++++++.+|+|||||+||+|.+.+.....+   .+..+ ..+..+..++.|+|..|+.|
T Consensus        63 ~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~---~~~~~~~~~~qi~~al~~lH~~givH  139 (342)
T 2qr7_A           63 TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF---SEREASAVLFTITKTVEYLHAQGVVH  139 (342)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTC---CHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence            4799999887 7999999999999999999999999999999998765433   22222 22334567888888877643


Q ss_pred             e--------ecCCCC---CeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          80 Q--------LNDDSS---GVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        80 ~--------~~~~~~---~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .        +.+.++   .+++.||+.......    ..+.+||+.|+|||++.+..|+.++||||+||++|+|++|.+|
T Consensus       140 rDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  219 (342)
T 2qr7_A          140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP  219 (342)
T ss_dssp             SCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCC
Confidence            2        222222   378888875543322    2467899999999999888889999999999999999999999


Q ss_pred             CCC---CCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         145 FET---STLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~---~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |.+   .+..+....+....+.++    ..++.++++||++||..||.+|||+.++++||||.++
T Consensus       220 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          220 FANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             SCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             CCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            986   456677777777666544    4689999999999999999999999999999999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-36  Score=273.61  Aligned_cols=198  Identities=23%  Similarity=0.396  Sum_probs=161.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhh-hCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDK-YGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~   79 (305)
                      .+|+.++++++|||||++++++++++.+|||||||+||+|.+++.....+   ....... +..++.++.|+|. .|+.|
T Consensus       196 ~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~~giiH  272 (446)
T 4ejn_A          196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF---SEDRARFYGAEIVSALDYLHSEKNVVY  272 (446)
T ss_dssp             -----CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCC---CHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHhhcCCEEE
Confidence            46899999999999999999999999999999999999999998776543   2222222 3345678888886 66644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.||+.....    ....+.+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       273 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             CCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            3       3334467888888754321    1234678999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      +.......+......+|..++.++.+||.+||..||.+||     +++|+++||||+..
T Consensus       353 ~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          353 DHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             SHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            9988888888888888999999999999999999999999     99999999999863

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.7e-36  Score=264.14  Aligned_cols=199  Identities=24%  Similarity=0.426  Sum_probs=154.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-CCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-EMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++|||||++++++++++.+|||||||+||+|.+.+....... ...+..+ ..+..+..++.|+|..++.|
T Consensus        74 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH  153 (351)
T 3c0i_A           74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH  153 (351)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            489999999999999999999999999999999999999988776543211 1122222 22334577888998877544


Q ss_pred             e--------ecCC--CCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q--------LNDD--SSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~--------~~~~--~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .        +...  ...+++.||+.......    ....+||+.|+|||++.+..++.++||||+||++|+|++|.+||
T Consensus       154 rDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  233 (351)
T 3c0i_A          154 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF  233 (351)
T ss_dssp             SCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCC
Confidence            2        2221  22377888865543322    23568999999999999888999999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         146 ETSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .+. ..+....+....+..+    ..++.++.++|.+||..||.+|||+.++++||||+.
T Consensus       234 ~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          234 YGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             CSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            875 3455566665555444    468899999999999999999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.8e-36  Score=267.63  Aligned_cols=201  Identities=18%  Similarity=0.274  Sum_probs=148.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||++|+|.+++...... .+.+..... +..+..++.|+|..++.|.
T Consensus        74 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHr  152 (389)
T 3gni_B           74 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHMGYVHR  152 (389)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            47999999999999999999999999999999999999999998764211 122222222 3345678889998776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-----------CCcccccCCCccccccccc--CCCCccchHHHHHHHHHHHHh
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-----------NKNTLCGTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-----------~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlGvilye~l~  140 (305)
                             +.+..+.+++.||+......           .....+||+.|+|||++.+  ..++.++||||+||++|||++
T Consensus       153 Dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~  232 (389)
T 3gni_B          153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN  232 (389)
T ss_dssp             CCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH
Confidence                   23344567777876433211           1123589999999999987  578999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhccc----------------------------------------------cCCCCCCCHHHHH
Q psy6191         141 GKPPFETSTLKETYSRIKKVE----------------------------------------------YKLPATLKKPAAT  174 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~~----------------------------------------------~~~~~~~~~~~~~  174 (305)
                      |++||.+.+.......+....                                              ...+..++..+.+
T Consensus       233 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  312 (389)
T 3gni_B          233 GHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH  312 (389)
T ss_dssp             SSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHH
Confidence            999998765444333222111                                              1134457888999


Q ss_pred             HHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         175 MIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       175 li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      ||.+||+.||.+|||+.|+++||||+...
T Consensus       313 li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          313 FVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             HHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence            99999999999999999999999998643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-35  Score=261.34  Aligned_cols=199  Identities=28%  Similarity=0.448  Sum_probs=147.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||+||+|.+++.....+   ...... .+..+..++.|+|..|+.|.
T Consensus        64 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~ql~~~L~~LH~~~ivH~  140 (361)
T 3uc3_A           64 QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF---SEDEARFFFQQLLSGVSYCHSMQICHR  140 (361)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTCCSC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            48999999999999999999999999999999999999999998766544   222222 23345678889998876443


Q ss_pred             -------ecCCCC--CeeEcchhHHHH---hcCCcccccCCCcccccccccCCCCcc-chHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSS--GVMFNDLTRMIM---LANKNTLCGTPNYIAPEILNKNGHSFE-VDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~--~v~~~d~~~~~~---~~~~~~~~Gt~~y~aPE~~~~~~~~~~-~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+.+.  .+++.||+....   .......+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+
T Consensus       141 Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (361)
T 3uc3_A          141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED  220 (361)
T ss_dssp             CCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred             CCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence                   222222  388888864332   122345689999999999987777555 8999999999999999999987


Q ss_pred             CC----HHHHHHHHhccccCCCC--CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         148 ST----LKETYSRIKKVEYKLPA--TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       148 ~~----~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      .+    .......+....+.+|.  .++..+.+||.+||..||.+|||+.|+++||||....
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          221 PEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             ---CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             CccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            43    34555556555555554  5789999999999999999999999999999997643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.2e-36  Score=268.69  Aligned_cols=198  Identities=22%  Similarity=0.419  Sum_probs=158.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHh-cCCCCCCCcCchh-HHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSA-CDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.++|||||+++++|++++.+|||||||+||+|.+++... ..+   .+..+.. +..+..++.|+|..++.|
T Consensus       122 ~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l---~e~~~~~~~~qi~~aL~~LH~~giiH  198 (437)
T 4aw2_A          122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL---PEEMARFYLAEMVIAIDSVHQLHYVH  198 (437)
T ss_dssp             HHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCC---CHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCC---CHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            47999999999999999999999999999999999999999999763 222   2222322 234567788888877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccc-----cCCCCccchHHHHHHHHHHHHhCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                      .       +.+..+.+++.||+.......     ..+.+||+.|||||++.     ...|+.++||||+||++|||++|+
T Consensus       199 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~  278 (437)
T 4aw2_A          199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE  278 (437)
T ss_dssp             CCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred             cccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence            2       334456788888875533222     23468999999999986     456899999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhcc--ccCCCC---CCCHHHHHHHHHHhhcCCCC--CCCHhhhhcCcccccc
Q psy6191         143 PPFETSTLKETYSRIKKV--EYKLPA---TLKKPAATMIKKMLLLDPVQ--RPPVAQLLHFEFFNDY  202 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~--~~~~~~---~~~~~~~~li~~~l~~dp~~--R~~~~~~l~~~~~~~~  202 (305)
                      +||.+.+..+.+..|...  .+.+|.   .++.++++||++||..+|.+  |++++|+++||||+..
T Consensus       279 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          279 TPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             CTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             CCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            999999988888887653  244454   48999999999999988888  9999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.4e-36  Score=276.51  Aligned_cols=199  Identities=20%  Similarity=0.348  Sum_probs=160.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++++.+|||||||+||+|.+++...... ...+..+.. +..+..++.|+|..|+.|.
T Consensus       232 ~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~-~l~e~~~~~i~~qIl~aL~yLH~~gIvHr  310 (576)
T 2acx_A          232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLEDLHRERIVYR  310 (576)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence            47999999999999999999999999999999999999999988754321 122222222 2345678889998776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC-
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST-  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~-  149 (305)
                             +.+..+.+++.||+.......   ..+.+||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+ 
T Consensus       311 DLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~  390 (576)
T 2acx_A          311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK  390 (576)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred             CCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence                   334456788888876544322   235689999999999998889999999999999999999999998753 


Q ss_pred             ---HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccc
Q psy6191         150 ---LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND  201 (305)
Q Consensus       150 ---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~  201 (305)
                         ..+....+......+|..++.++++||.+||..||.+|+     +++|+++||||+.
T Consensus       391 ~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          391 KIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             CCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             chhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence               455666677777778888999999999999999999999     7899999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.3e-35  Score=258.15  Aligned_cols=213  Identities=52%  Similarity=0.865  Sum_probs=169.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||++++|.+++.....+.+  ......+..+..++.++|..++.|. 
T Consensus        89 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~i~~qi~~aL~~LH~~~ivH~d  166 (335)
T 2owb_A           89 SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEARYYLRQIVLGCQYLHRNRVIHRD  166 (335)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCH--HHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCH--HHHHHHHHHHHHHHHHHHHCCCEecC
Confidence            4799999999999999999999999999999999999999999876544321  1112223345678888888775432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+....+++.||+......    .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.
T Consensus       167 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  246 (335)
T 2owb_A          167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL  246 (335)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH
Confidence                  23344567888886544322    22356899999999999988899999999999999999999999999888


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC-CCCCCccccccCC
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC-PTSLPASCLMTAP  216 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~  216 (305)
                      .+....+....+.+|...+..+.++|.+||..||.+|||+.|+++|+||.... +...+..+....|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~~~~~~~~~  313 (335)
T 2owb_A          247 KETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPP  313 (335)
T ss_dssp             HHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCC
T ss_pred             HHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccCCcccccCCC
Confidence            88888888878888889999999999999999999999999999999997642 3333333333333

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.6e-36  Score=254.05  Aligned_cols=200  Identities=25%  Similarity=0.489  Sum_probs=164.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+|||||++|+|.+++.....+   ..... ..+..+..++.+.|..++.|.
T Consensus        62 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~~l~~lH~~~i~H~  138 (284)
T 2vgo_A           62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF---DEQRSATFMEELADALHYCHERKVIHR  138 (284)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             HHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            47999999999999999999999999999999999999999998775443   22222 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK  151 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~  151 (305)
                             +.+..+.+++.||+......  .....+||+.|+|||++.+..++.++||||+||++|+|++|..||...+..
T Consensus       139 dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  218 (284)
T 2vgo_A          139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT  218 (284)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             CCCHHHEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence                   23344567788876443221  234568999999999999888999999999999999999999999998888


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         152 ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      +....+......+|...+..+.++|.+||..||.+|||++++++||||+....
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          219 ETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            88888888888888899999999999999999999999999999999986543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.8e-35  Score=251.41  Aligned_cols=199  Identities=52%  Similarity=0.855  Sum_probs=163.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||++|+|.+++.....+.+  ......+..+..++.+.|..|+.|. 
T Consensus        63 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~i~~qi~~~l~~lH~~~i~H~d  140 (294)
T 2rku_A           63 SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEARYYLRQIVLGCQYLHRNRVIHRD  140 (294)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCH--HHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCCccccC
Confidence            4799999999999999999999999999999999999999999876544321  1112223345678888888775442 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+....+++.|++......    .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.
T Consensus       141 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  220 (294)
T 2rku_A          141 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL  220 (294)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                  23344567788886543322    22346799999999999988899999999999999999999999999988


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+....+......+|...+..+.++|.+||..||.+|||++++++||||+..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          221 KETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence            8888888888888888999999999999999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-35  Score=272.30  Aligned_cols=199  Identities=26%  Similarity=0.434  Sum_probs=161.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|||||||+||+|.+.+.....+.   +..+ ..+..+..++.|+|..++.|.
T Consensus        94 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~---~~~~~~i~~qi~~~l~~lH~~~ivH~  170 (504)
T 3q5i_A           94 YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD---ECDAANIMKQILSGICYLHKHNIVHR  170 (504)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCC---HHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            479999999999999999999999999999999999999999887765442   2222 233445678889988775432


Q ss_pred             --------ecCCC--CCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 --------LNDDS--SGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 --------~~~~~--~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                              +...+  ..+++.||+.......   ....+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+
T Consensus       171 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  249 (504)
T 3q5i_A          171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG  249 (504)
T ss_dssp             CCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence                    22222  2477888875543322   245689999999999874 588999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         148 STLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      .+..+....+....+.++    ..++.++++||++||..||.+|||++|+++||||+....
T Consensus       250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          250 QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            999999888888776555    568999999999999999999999999999999987543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1e-35  Score=280.45  Aligned_cols=198  Identities=23%  Similarity=0.384  Sum_probs=167.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++..+ +|||||+++++|++.+.+|||||||+||+|.+++.....+.   +..+. .+..++.++.|+|..++.|
T Consensus       389 ~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~---~~~~~~~~~qi~~aL~~LH~~gIiH  465 (674)
T 3pfq_A          389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAVFYAAEIAIGLFFLQSKGIIY  465 (674)
T ss_dssp             HHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHHTSEEC
T ss_pred             HHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            3688999887 79999999999999999999999999999999998765442   22222 2334567889999887644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      +       +.+..+.+++.||+.....    ....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.
T Consensus       466 rDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             CCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence            3       3344467888888754321    2235689999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV-----AQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~-----~~~l~~~~~~~~  202 (305)
                      +..+++..|....+.+|..++.++.+||++||++||.+|+++     +++++||||+..
T Consensus       546 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          546 DEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             SHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             CHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            999999999999999999999999999999999999999997     999999999863

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=265.97  Aligned_cols=199  Identities=21%  Similarity=0.318  Sum_probs=158.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++++.+|||||||+||+|.+.+......  +.+... ..+..+..++.++|..++.|.
T Consensus       134 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~  211 (373)
T 2x4f_A          134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQMYILHL  211 (373)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            58999999999999999999999999999999999999999988653211  122112 223345678888887775432


Q ss_pred             --------ec-CCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LN-DDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~-~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +. +....+++.||+.......   ....+||+.|+|||++.+..++.++||||+||++|||++|..||.+.
T Consensus       212 Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  291 (373)
T 2x4f_A          212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD  291 (373)
T ss_dssp             CCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence                    22 3334577778765433221   23457999999999999888999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +..+....+....+.++    ..++.++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       292 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          292 NDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            88888888776655444    3578999999999999999999999999999999863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-36  Score=263.82  Aligned_cols=199  Identities=23%  Similarity=0.364  Sum_probs=158.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++++.+|+|||||+||+|.+++.....  .+.+... ..+..+..++.++|..|+.|.
T Consensus        96 ~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHr  173 (387)
T 1kob_A           96 KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHSIVHL  173 (387)
T ss_dssp             HHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            4799999999999999999999999999999999999999998754321  1122222 223345678888887775432


Q ss_pred             --------ecC-CCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LND-DSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~~-~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +.. ....+++.||+........   ...+||+.|+|||++.+..++.++||||+||++|||++|..||.+.
T Consensus       174 Dlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  253 (387)
T 1kob_A          174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE  253 (387)
T ss_dssp             CCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             ccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence                    222 2345888888755433222   3458999999999999888999999999999999999999999998


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +..+....+....+.++    ..++.++.++|.+||..||.+|||+.++++||||+..
T Consensus       254 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          254 DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence            88888877776655443    3578999999999999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9e-36  Score=252.60  Aligned_cols=199  Identities=27%  Similarity=0.547  Sum_probs=161.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+||||+++|+|.+.+.....+   ..... ..+..+..++.++|..|+.|.
T Consensus        57 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~qi~~~l~~LH~~~i~H~  133 (279)
T 3fdn_A           57 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF---DEQRTATYITELANALSYCHSKRVIHR  133 (279)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHTTTCEEC
T ss_pred             HHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            47999999999999999999999999999999999999999998766443   22222 223345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh--cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML--ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK  151 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~  151 (305)
                             +.+..+.+++.||+.....  ......+||+.|+|||++.+..++.++||||+||++|+|++|..||...+..
T Consensus       134 dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  213 (279)
T 3fdn_A          134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ  213 (279)
T ss_dssp             CCCGGGEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             cCChHhEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence                   2334456777777533221  1123568999999999999888999999999999999999999999999988


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         152 ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      +....+......+|...+..+.++|.+||..||.+|||+.|+++||||+...
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          214 ETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            8888888888888889999999999999999999999999999999998643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=264.73  Aligned_cols=198  Identities=22%  Similarity=0.425  Sum_probs=157.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||+++++|++++.+|||||||+||+|.+++.+...  .+.+..+.. +..+..++.|+|..++.|.
T Consensus       109 ~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~giiHr  186 (412)
T 2vd5_A          109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLGYVHR  186 (412)
T ss_dssp             HHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            4799999999999999999999999999999999999999999976532  112222222 3345678889988776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccc-------cCCCCccchHHHHHHHHHHHHhC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILN-------KNGHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~-------~~~~~~~~DiwSlGvilye~l~g  141 (305)
                             +.+..+.+++.||+.......     ..+.+||+.|||||++.       ...|+.++||||+||++|||++|
T Consensus       187 DLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG  266 (412)
T 2vd5_A          187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG  266 (412)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred             ccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence                   334456788888875543322     23569999999999987       35689999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhccc--cCCC---CCCCHHHHHHHHHHhhcCCCCC---CCHhhhhcCcccccc
Q psy6191         142 KPPFETSTLKETYSRIKKVE--YKLP---ATLKKPAATMIKKMLLLDPVQR---PPVAQLLHFEFFNDY  202 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~~~~li~~~l~~dp~~R---~~~~~~l~~~~~~~~  202 (305)
                      ++||.+.+..+.+.+|....  ..+|   ..++.++++||++||. +|.+|   ++++++++||||+..
T Consensus       267 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          267 QTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             SCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            99999999888888876532  3333   5789999999999999 99998   589999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-35  Score=256.86  Aligned_cols=198  Identities=26%  Similarity=0.434  Sum_probs=138.8

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++++. |||||++++++++++..|||||||+||+|.+++.....+   .+.... .+..+..++.++|..++.|
T Consensus        53 ~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~qi~~~l~~LH~~~ivH  129 (325)
T 3kn6_A           53 QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSHMHDVGVVH  129 (325)
T ss_dssp             HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCC---CHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCCee
Confidence            47999999997 999999999999999999999999999999999875443   222222 2334567888888777543


Q ss_pred             e--------ecCCC--CCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q--------LNDDS--SGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~--------~~~~~--~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .        +...+  ..+++.||+......    ...+.+||+.|+|||++.+..++.++||||+||++|+|++|..||
T Consensus       130 ~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  209 (325)
T 3kn6_A          130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF  209 (325)
T ss_dssp             CCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence            2        22211  146777776443221    124568999999999999999999999999999999999999999


Q ss_pred             CCCC-------HHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         146 ETST-------LKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~~~-------~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+.+       ..+....+....+.++.    .++.++++||.+||..||.+|||+.++++||||++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          210 QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             C-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             CCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            7643       35666777776665553    578999999999999999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-35  Score=271.00  Aligned_cols=199  Identities=26%  Similarity=0.435  Sum_probs=162.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||.||+|.+.+.....+.+  ......+..+..++.|+|..++.|. 
T Consensus        74 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~i~~qi~~~l~~lH~~~ivH~D  151 (484)
T 3nyv_A           74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE--VDAARIIRQVLSGITYMHKNKIVHRD  151 (484)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBH--HHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence            4799999999999999999999999999999999999999998876544321  1112233345678889998876443 


Q ss_pred             -------ec--CCCCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LN--DDSSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~--~~~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.  .....+++.||+........   ...+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.
T Consensus       152 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  230 (484)
T 3nyv_A          152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA  230 (484)
T ss_dssp             CCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence                   22  23456888898876654332   34589999999999876 5899999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      +..+....+....+.++    ..++..+++||++||+.||.+|||+.|+++||||+...
T Consensus       231 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          231 NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             SHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             CHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            99888888877665443    35789999999999999999999999999999998643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.2e-35  Score=269.20  Aligned_cols=199  Identities=26%  Similarity=0.420  Sum_probs=159.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++.+|+|||||+||+|.+.+.....+   .+..+ ..+..+..++.|+|..|+.|.
T Consensus        69 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~i~~qi~~al~~lH~~~ivH~  145 (486)
T 3mwu_A           69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFSGITYMHKHNIVHR  145 (486)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            47999999999999999999999999999999999999999988766544   22222 233345678889998876443


Q ss_pred             --------ec--CCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 --------LN--DDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 --------~~--~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                              +.  +....+++.||+.......   ....+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+
T Consensus       146 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  224 (486)
T 3mwu_A          146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (486)
T ss_dssp             CCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                    22  1234577888875543322   235689999999999976 489999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         148 STLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      .+..+....+....+.++    ..++.+++++|.+||..||.+|||+.++++||||+....
T Consensus       225 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          225 KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             SSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             CCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            998888888877655443    357899999999999999999999999999999987543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.9e-35  Score=270.15  Aligned_cols=198  Identities=28%  Similarity=0.447  Sum_probs=158.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||+||+|.+.+.....+.+  ......+..+..++.|+|..|+.|. 
T Consensus        84 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~--~~~~~i~~qi~~~l~~lH~~~ivH~D  161 (494)
T 3lij_A           84 LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE--VDAAVIIKQVLSGVTYLHKHNIVHRD  161 (494)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCH--HHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCH--HHHHHHHHHHHHHHHHHHHCCceecc
Confidence            4799999999999999999999999999999999999999998876654421  1112233345678889998775432 


Q ss_pred             -------ecCC--CCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDD--SSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~--~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +...  ...+++.||+.......   ....+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.
T Consensus       162 lkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  240 (494)
T 3lij_A          162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQ  240 (494)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence                   2221  23477888875433222   245689999999999864 5889999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +..+....+....+.++    ..++..++++|++||+.||.+|||+.++++||||+..
T Consensus       241 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          241 TDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             SHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             CHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            99888888877766554    3578999999999999999999999999999999763

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.8e-35  Score=252.21  Aligned_cols=202  Identities=19%  Similarity=0.295  Sum_probs=153.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC---CCCCcCchh-HHHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE---EMSDPAAQP-VIWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~   77 (305)
                      .+|++++++++|||||++++++++++.+|||||||+ |+|.+++.......   ......... ...+..++.++|..|+
T Consensus        51 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i  129 (317)
T 2pmi_A           51 IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI  129 (317)
T ss_dssp             HHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            479999999999999999999999999999999998 59999887653211   112222222 2245778889888775


Q ss_pred             cee-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          78 GYQ-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        78 ~~~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .+.       +.+..+.+++.||+......    .....+||+.|+|||++.+ ..++.++||||+||++|||++|++||
T Consensus       130 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  209 (317)
T 2pmi_A          130 LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF  209 (317)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            442       23344677888887544322    1235689999999999876 46899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccc----------------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHh
Q psy6191         146 ETSTLKETYSRIKKVE----------------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVA  191 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~----------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  191 (305)
                      .+.+..+....+....                                  ...+...+.++.+||.+||+.||.+|||+.
T Consensus       210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  289 (317)
T 2pmi_A          210 PGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK  289 (317)
T ss_dssp             CCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHH
Confidence            9988777665553210                                  011224678899999999999999999999


Q ss_pred             hhhcCccccccCC
Q psy6191         192 QLLHFEFFNDYCP  204 (305)
Q Consensus       192 ~~l~~~~~~~~~~  204 (305)
                      |+++||||++...
T Consensus       290 e~l~hp~f~~~~~  302 (317)
T 2pmi_A          290 QALHHPWFAEYYH  302 (317)
T ss_dssp             HHTTSGGGGGGCC
T ss_pred             HHhCChhhhcccc
Confidence            9999999987543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.9e-35  Score=270.75  Aligned_cols=200  Identities=21%  Similarity=0.324  Sum_probs=161.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCchh-HHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAAQP-VIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++|||||++++++++++.+|||||||+||+|.+++...... ..+.+..+.. +..+..++.|+|..|+.|
T Consensus       233 ~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvH  312 (543)
T 3c4z_A          233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY  312 (543)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcc
Confidence            36999999999999999999999999999999999999999998754321 1122222222 234567888998877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.||+....+..    ..+.+||+.|||||++.+..|+.++||||+||++|||++|++||.+.
T Consensus       313 rDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             cCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            3       334456788888876543322    23469999999999999989999999999999999999999999875


Q ss_pred             ----CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         149 ----TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       149 ----~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                          +..+....+......+|..++..+.++|.+||..||.+||+     ++++++||||+.
T Consensus       393 ~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          393 GEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             TCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             ccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence                34666777777777888899999999999999999999996     488999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-35  Score=255.01  Aligned_cols=198  Identities=27%  Similarity=0.458  Sum_probs=158.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||+||+|.+++.....+.+  ......+..+..++.++|..++.|. 
T Consensus        63 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~i~~qi~~aL~~lH~~~ivH~d  140 (321)
T 2a2a_A           63 EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--EEATSFIKQILDGVNYLHTKKIAHFD  140 (321)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEH--HHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            4799999999999999999999999999999999999999999876433211  1112223345677888887775432 


Q ss_pred             -------ecCCCC---CeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSS---GVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~---~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.++..   .+++.||+.......   ....+||+.|+|||++.+..++.++||||+||++|+|++|..||.+
T Consensus       141 ikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  220 (321)
T 2a2a_A          141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (321)
T ss_dssp             CSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence                   222221   578888865543322   2356799999999999988899999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         148 STLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .+..+....+....+.++    ...+..+.++|.+||..||.+|||+.++++||||+.
T Consensus       221 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          221 DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             CCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            888888888877665554    467889999999999999999999999999999974

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=258.13  Aligned_cols=198  Identities=27%  Similarity=0.437  Sum_probs=147.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++.+|+|||||+||+|.+++.....+   ..... ..+..+..++.++|..++.|.
T Consensus        96 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~qi~~~L~~LH~~~ivH~  172 (349)
T 2w4o_A           96 RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY---SERDAADAVKQILEAVAYLHENGIVHR  172 (349)
T ss_dssp             ---CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSC---CHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            47999999999999999999999999999999999999999988654332   22222 223345678888888776442


Q ss_pred             --------ec--CCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 --------LN--DDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 --------~~--~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                              +.  +....+++.||+.......   ..+.+||+.|+|||++.+..++.++||||+||++|||++|..||..
T Consensus       173 Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  252 (349)
T 2w4o_A          173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD  252 (349)
T ss_dssp             CCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence                    22  1246688888876544322   2356899999999999988899999999999999999999999977


Q ss_pred             CCHHH-HHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         148 STLKE-TYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       148 ~~~~~-~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+... ....+....+..+    ..++.++.++|.+||..||.+|||+.|+++||||+..
T Consensus       253 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          253 ERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             TTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             CcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            55443 5566665544332    4578899999999999999999999999999999853

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.1e-35  Score=248.93  Aligned_cols=197  Identities=29%  Similarity=0.473  Sum_probs=158.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+|||||++|+|.+++.....+.   .... ..+..+..++.+.|..++.|.
T Consensus        54 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---~~~~~~i~~~i~~~l~~lH~~~i~H~  130 (277)
T 3f3z_A           54 KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR---ESDAARIMKDVLSAVAYCHKLNVAHR  130 (277)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCC---HHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            479999999999999999999999999999999999999999887654432   2222 223345677888887775432


Q ss_pred             -------ec---CCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LN---DDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~---~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.   +....+++.||+......   ...+.+||+.|+|||++.+. ++.++||||+||++|+|++|..||..
T Consensus       131 dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~  209 (277)
T 3f3z_A          131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA  209 (277)
T ss_dssp             CCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence                   21   334567778876543322   22356899999999998765 88999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         148 STLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+..+....+......+|.    ..+..+.++|.+||..||.+|||+.++++||||++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          210 PTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            8888888888777766664    688999999999999999999999999999999753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4e-36  Score=257.20  Aligned_cols=190  Identities=14%  Similarity=0.218  Sum_probs=128.2

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCC----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhh---
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKY---   75 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---   75 (305)
                      +|+..+.+++|||||++++++.+++    .+|||||||+||+|.++++... +.  .+........+..++.|.|..   
T Consensus        46 ~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-l~--~~~~~~i~~~ia~gl~ylH~~~~~  122 (303)
T 3hmm_A           46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VT--VEGMIKLALSTASGLAHLHMEIVG  122 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-BC--HHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred             HHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC-CC--HHHHHHHHHHHHHHHHHHHHhhhh
Confidence            5677778899999999999998654    6899999999999999997642 11  112223344567788888854   


Q ss_pred             -----CCcee-------ecCCCCCeeEcchhHHHHhcC--------CcccccCCCcccccccccC------CCCccchHH
Q psy6191          76 -----GFGYQ-------LNDDSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNKN------GHSFEVDVW  129 (305)
Q Consensus        76 -----~~~~~-------~~~~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~~------~~~~~~Diw  129 (305)
                           ++.|+       +.+....+++.||+.+.....        ..+.+||+.|||||++.+.      .|+.++|||
T Consensus       123 ~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVw  202 (303)
T 3hmm_A          123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY  202 (303)
T ss_dssp             TTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred             ccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhh
Confidence                 32221       233345667777764332211        1245899999999998754      367799999


Q ss_pred             HHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHhcc--ccCCCCCC-----CHHHHHHHHHHhhcCCCCC
Q psy6191         130 SIGCIMYTLLVGKPPFETS---------------TLKETYSRIKKV--EYKLPATL-----KKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       130 SlGvilye~l~g~~Pf~~~---------------~~~~~~~~i~~~--~~~~~~~~-----~~~~~~li~~~l~~dp~~R  187 (305)
                      ||||+||||+||.+||...               ...+....+...  .+.+|...     ...+.+|+.+||..||.+|
T Consensus       203 S~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~R  282 (303)
T 3hmm_A          203 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR  282 (303)
T ss_dssp             HHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGS
T ss_pred             hHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHC
Confidence            9999999999998776421               122333333322  22333322     1356789999999999999


Q ss_pred             CCHhhhhc
Q psy6191         188 PPVAQLLH  195 (305)
Q Consensus       188 ~~~~~~l~  195 (305)
                      ||+.|+++
T Consensus       283 Pt~~ei~~  290 (303)
T 3hmm_A          283 LTALRIKK  290 (303)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHHH
Confidence            99999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=253.49  Aligned_cols=195  Identities=24%  Similarity=0.406  Sum_probs=150.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++|||||++++++.+  ++.+|+|||||++|+|.+++..    ..+...... .+..+..++.++|..++.
T Consensus        84 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iv  159 (298)
T 2zv2_A           84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQKII  159 (298)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            379999999999999999999987  6789999999999998765321    111222222 223356778888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCC---CCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNG---HSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~---~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      |.       +.+..+.+++.||+........    ...+||+.|+|||++.+..   ++.++||||+||++|+|++|+.|
T Consensus       160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            32       2334456788888755433221    3468999999999997654   37789999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccccCCC--CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         145 FETSTLKETYSRIKKVEYKLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      |.+.+.......+......+|  ..++..+.++|.+||..||.+|||+.|+++||||+
T Consensus       240 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          240 FMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             SCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             CCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            999888777777766555444  46889999999999999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.3e-35  Score=247.89  Aligned_cols=198  Identities=28%  Similarity=0.498  Sum_probs=158.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+|||||+||+|.+.+.....+   ..... ..+..+..++.+.|..++.|.
T Consensus        53 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~i~~~l~~lH~~~i~H~  129 (284)
T 3kk8_A           53 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESIAYCHSNGIVHR  129 (284)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCcCcC
Confidence            47999999999999999999999999999999999999999988765443   22222 223345677888887775432


Q ss_pred             --------ecCC--CCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 --------LNDD--SSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 --------~~~~--~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                              +..+  ...+++.||+.......   ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+
T Consensus       130 dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  209 (284)
T 3kk8_A          130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  209 (284)
T ss_dssp             CCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence                    2211  12377788765533322   2346899999999999988899999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         148 STLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+..+....+.......|    ...++.+.++|.+||..||.+|||+.|+++||||+..
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          210 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             CchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            988888877776655544    3578899999999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.3e-35  Score=252.37  Aligned_cols=200  Identities=20%  Similarity=0.346  Sum_probs=148.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++.+|+|||||++ +|.+.+.....  .+.+..... +..+..++.++|..|+.|.
T Consensus        67 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  143 (311)
T 3niz_A           67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHRILHR  143 (311)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            4799999999999999999999999999999999985 78887764322  112222222 3345678889988776442


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.||+......    .....+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.
T Consensus       144 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  223 (311)
T 3niz_A          144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV  223 (311)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence                   23344667888887554322    1234579999999999876 56899999999999999999999999876


Q ss_pred             CHHHHHHHHhcccc------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         149 TLKETYSRIKKVEY------------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       149 ~~~~~~~~i~~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      +..+....+.....                              ...+..+.++.+||.+||+.||.+|||++|+++|||
T Consensus       224 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  303 (311)
T 3niz_A          224 TDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY  303 (311)
T ss_dssp             STTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             ChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence            65554444322100                              011246778999999999999999999999999999


Q ss_pred             ccccCC
Q psy6191         199 FNDYCP  204 (305)
Q Consensus       199 ~~~~~~  204 (305)
                      |++..+
T Consensus       304 f~~~~~  309 (311)
T 3niz_A          304 FKDLDP  309 (311)
T ss_dssp             GTTSCT
T ss_pred             cccCCc
Confidence            987543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.3e-35  Score=252.16  Aligned_cols=198  Identities=27%  Similarity=0.451  Sum_probs=148.8

Q ss_pred             hhHHHHHhc-CCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRS-LKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~-l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++ ++|||||++++++++++.+|+|||||+||+|.+++.....+   ...... .+..+..++.++|..++.|
T Consensus        58 ~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~qi~~~l~~lH~~~ivH  134 (316)
T 2ac3_A           58 FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALDFLHNKGIAH  134 (316)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCC---CHHHHHHHHHHHHHHHHHHHhCCcee
Confidence            479999988 47999999999999999999999999999999999876443   222222 2334567888998887644


Q ss_pred             e-------ecCCCC---CeeEcchhHHHHh-----------cCCcccccCCCccccccccc-----CCCCccchHHHHHH
Q psy6191          80 Q-------LNDDSS---GVMFNDLTRMIML-----------ANKNTLCGTPNYIAPEILNK-----NGHSFEVDVWSIGC  133 (305)
Q Consensus        80 ~-------~~~~~~---~v~~~d~~~~~~~-----------~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DiwSlGv  133 (305)
                      .       +.+..+   .+++.||+.....           ....+.+||+.|+|||++.+     ..++.++||||+||
T Consensus       135 ~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~  214 (316)
T 2ac3_A          135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV  214 (316)
T ss_dssp             CCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHH
T ss_pred             CCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHH
Confidence            3       122222   2788887532211           11234579999999999875     45788999999999


Q ss_pred             HHHHHHhCCCCCCCCC---------------HHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         134 IMYTLLVGKPPFETST---------------LKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       134 ilye~l~g~~Pf~~~~---------------~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      ++|+|++|+.||.+.+               .......+....+.+|    ..++..++++|.+||..||.+|||+.|++
T Consensus       215 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          215 ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             HHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence            9999999999998754               2344556666666655    35788999999999999999999999999


Q ss_pred             cCcccccc
Q psy6191         195 HFEFFNDY  202 (305)
Q Consensus       195 ~~~~~~~~  202 (305)
                      +||||+..
T Consensus       295 ~hp~~~~~  302 (316)
T 2ac3_A          295 QHPWVQGC  302 (316)
T ss_dssp             HSTTCC--
T ss_pred             cChhhcCC
Confidence            99999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-34  Score=246.32  Aligned_cols=197  Identities=22%  Similarity=0.340  Sum_probs=149.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++.+|+||||+++ +|.+++.....  .+..... ..+..+..++.++|..|+.|.
T Consensus        48 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  124 (288)
T 1ob3_A           48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHR  124 (288)
T ss_dssp             HHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            4799999999999999999999999999999999986 89888865321  1122222 223345778889998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.||+.......    ....+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.
T Consensus       125 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             CCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   334456788999987655432    2345799999999998754 5899999999999999999999999988


Q ss_pred             CHHHHHHHHhcccc-----------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKVEY-----------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +..+....+.....                             .....++.++.++|.+||..||.+|||++|+++||||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             CHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence            77666555432100                             0123478889999999999999999999999999999


Q ss_pred             cc
Q psy6191         200 ND  201 (305)
Q Consensus       200 ~~  201 (305)
                      ++
T Consensus       285 ~~  286 (288)
T 1ob3_A          285 KE  286 (288)
T ss_dssp             GC
T ss_pred             hh
Confidence            75

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.2e-35  Score=249.06  Aligned_cols=199  Identities=22%  Similarity=0.422  Sum_probs=146.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHH-hcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNS-ACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++|||||++++++++++.+|||||||++ ++.+.+.. ...+   .+.... .+..+..++.+.|+.|+.|
T Consensus        49 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l---~~~~~~~~~~ql~~~l~~lH~~~ivH  124 (292)
T 3o0g_A           49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCHSRNVLH  124 (292)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCC---CHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCC---CHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            4799999999999999999999999999999999986 55555543 2222   222222 2334567888998877544


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCC-CCccchHHHHHHHHHHHHhCCCC-CC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPP-FE  146 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlGvilye~l~g~~P-f~  146 (305)
                      .       +.+..+.+++.||+......    .....+||+.|+|||++.+.. ++.++||||+||++|+|++|..| |.
T Consensus       125 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             CCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence            2       23344677888887554332    223568999999999987665 89999999999999999988776 55


Q ss_pred             CCCHHHHHHHHhccc-----------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         147 TSTLKETYSRIKKVE-----------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      +.+..+....+....                             ....+..+..+++||.+||+.||.+|||++|+++||
T Consensus       205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  284 (292)
T 3o0g_A          205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence            566555555543210                             011234678899999999999999999999999999


Q ss_pred             cccccCC
Q psy6191         198 FFNDYCP  204 (305)
Q Consensus       198 ~~~~~~~  204 (305)
                      ||++.++
T Consensus       285 ~f~~~~p  291 (292)
T 3o0g_A          285 YFSDFCP  291 (292)
T ss_dssp             GGTTC--
T ss_pred             ccccCCC
Confidence            9997653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.1e-35  Score=245.89  Aligned_cols=199  Identities=24%  Similarity=0.452  Sum_probs=155.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.+++.++||||+++++++.+++..|+|||||++|+|.+++.....+.+  ......+..+..++.+.|..++.|. 
T Consensus        59 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~qi~~~l~~lH~~~i~H~d  136 (276)
T 2h6d_A           59 KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE--MEARRLFQQILSAVDYCHRHMVVHRD  136 (276)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCH--HHHHHHHHHHHHHHHHHHHHCSSCCC
T ss_pred             HHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCH--HHHHHHHHHHHHHHHHHHHCCCccCC
Confidence            4799999999999999999999999999999999999999999976544321  1112223345677888888776443 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                            +.+....+++.|++.......   ....+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.
T Consensus       137 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  216 (276)
T 2h6d_A          137 LKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV  216 (276)
T ss_dssp             CCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence                  233445678888875544322   134579999999999987765 6899999999999999999999999888


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         151 KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ......+......+|...+..+.++|.+||..||.+|||+.++++||||++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          217 PTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            8888888877777888899999999999999999999999999999999853

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.5e-35  Score=252.75  Aligned_cols=196  Identities=21%  Similarity=0.391  Sum_probs=155.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+|||||+||+|.+++... .+   ..... ..+..+..++.++|..++.|.
T Consensus        90 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~l---~~~~~~~i~~qi~~~L~~LH~~~ivH~  165 (321)
T 2c30_A           90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-RL---NEEQIATVCEAVLQALAYLHAQGVIHR  165 (321)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-CC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-CC---CHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            47999999999999999999999999999999999999999987542 11   22222 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+......    .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus       166 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~  245 (321)
T 2c30_A          166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS  245 (321)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                   23344667888887543322    2245689999999999998889999999999999999999999999888


Q ss_pred             HHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ..+....+.....   ..+...+..+.++|.+||..||.+|||+.++++||||..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          246 PVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             HHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence            8777766654432   223357888999999999999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-35  Score=255.54  Aligned_cols=198  Identities=24%  Similarity=0.450  Sum_probs=150.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+++.++|||||++++++++++..|+|||||+||+|.+++.....+   ..... ..+..+..++.++|..|+.+.
T Consensus        53 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~qi~~aL~~LH~~givH~  129 (323)
T 3tki_A           53 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM---PEPDAQRFFHQLMAGVVYLHGIGITHR  129 (323)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBC---CHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            48999999999999999999999999999999999999999887544332   22222 223345678888888775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                             +.+..+.+++.||+......      .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.
T Consensus       130 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  209 (323)
T 3tki_A          130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD  209 (323)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             ccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence                   33344678888887554321      1235789999999999987664 778999999999999999999998


Q ss_pred             CCCHH-HHHHHHhccccCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         147 TSTLK-ETYSRIKKVEYKL--PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~~~~~-~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..+.. .............  ...++..+.+||.+||..||.+|||+.|+++||||+..
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          210 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             SSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            75543 2222222222222  24688999999999999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-34  Score=248.84  Aligned_cols=198  Identities=28%  Similarity=0.484  Sum_probs=158.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++++++..|+|||||+||+|.+++.....+   ..... ..+..+..++.+.|..++.|.
T Consensus        54 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~~l~~lH~~~i~H~  130 (304)
T 2jam_A           54 ENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY---TEKDASLVIQQVLSAVKYLHENGIVHR  130 (304)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCC---CHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            47999999999999999999999999999999999999999998765443   22222 223345677888888776443


Q ss_pred             --------ec--CCCCCeeEcchhHHHHhcC--CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LN--DDSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~--~~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +.  +....+++.|++.......  ....+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.
T Consensus       131 dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  210 (304)
T 2jam_A          131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE  210 (304)
T ss_dssp             SCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                    21  3345677777764432211  23457999999999999888999999999999999999999999998


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +..+....+....+.++    ..++..+.++|.+||..||.+|||+.++++||||+..
T Consensus       211 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          211 TESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             CHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             CHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            88888777776554433    4678999999999999999999999999999999853

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=249.89  Aligned_cols=199  Identities=33%  Similarity=0.645  Sum_probs=134.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++..|+|||||++|+|.+++.....  .+..... ..+..+..++.++|..++.|.
T Consensus        59 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  136 (278)
T 3cok_A           59 QNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHGILHR  136 (278)
T ss_dssp             HHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            4799999999999999999999999999999999999999999875421  1122222 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+....+++.|++......    .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+
T Consensus       137 dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  216 (278)
T 3cok_A          137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT  216 (278)
T ss_dssp             SCCGGGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             CCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence                   23344567788876443221    1235679999999999998889999999999999999999999998877


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..+....+....+..|...+.++.++|.+||..||.+|||++++++||||...
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          217 VKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             CC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            66666666666677788899999999999999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.4e-34  Score=249.63  Aligned_cols=197  Identities=21%  Similarity=0.310  Sum_probs=147.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|||||||+| +|.+++.....+   ..... ..+..+..++.++|..++.|.
T Consensus        81 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~---~~~~~~~i~~ql~~~l~~LH~~~ivH~  156 (329)
T 3gbz_A           81 IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDV---SMRVIKSFLYQLINGVNFCHSRRCLHR  156 (329)
T ss_dssp             HHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTC---CHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCC---CHHHHHHHHHHHHHHHHHHHhCCEECC
Confidence            4899999999999999999999999999999999985 999998765443   22222 223345778889998776442


Q ss_pred             --------ec----CCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCC
Q psy6191          81 --------LN----DDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        81 --------~~----~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~  143 (305)
                              +.    +....+++.||+......    .....+||+.|+|||++.+. .++.++||||+||++|+|++|.+
T Consensus       157 Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  236 (329)
T 3gbz_A          157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP  236 (329)
T ss_dssp             CCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence                    22    222347888988765543    22356789999999998764 58999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccccC------------------C------------CCCCCHHHHHHHHHHhhcCCCCCCCHhhh
Q psy6191         144 PFETSTLKETYSRIKKVEYK------------------L------------PATLKKPAATMIKKMLLLDPVQRPPVAQL  193 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~------------------~------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~  193 (305)
                      ||.+.+..+....+......                  +            +...+.++.+||.+||..||.+|||+.|+
T Consensus       237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  316 (329)
T 3gbz_A          237 LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA  316 (329)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence            99988877666555321100                  0            01167889999999999999999999999


Q ss_pred             hcCcccccc
Q psy6191         194 LHFEFFNDY  202 (305)
Q Consensus       194 l~~~~~~~~  202 (305)
                      ++||||+..
T Consensus       317 l~hp~f~~~  325 (329)
T 3gbz_A          317 LEHPYFSHN  325 (329)
T ss_dssp             HTSGGGSSS
T ss_pred             hCCcccCCC
Confidence            999999863

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.7e-35  Score=263.29  Aligned_cols=200  Identities=22%  Similarity=0.423  Sum_probs=145.7

Q ss_pred             hhHHHHH-hcCCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIH-RSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il-~~l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|+.++ +..+|||||+++++|++    ++.+|||||||+||+|.+++...... .+.+..+ ..+..+..++.|+|..
T Consensus       102 ~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~  180 (400)
T 1nxk_A          102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSI  180 (400)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4788887 55689999999999886    67899999999999999998754321 1122222 2233456788899887


Q ss_pred             CCcee--------ecCC--CCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCC
Q psy6191          76 GFGYQ--------LNDD--SSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        76 ~~~~~--------~~~~--~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                      ++.|.        +...  ...+++.||+......   ...+.+||+.|+|||++.+..|+.++||||+||++|||++|+
T Consensus       181 ~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  260 (400)
T 1nxk_A          181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY  260 (400)
T ss_dssp             TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSS
T ss_pred             CccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCC
Confidence            75432        2221  4568888887543322   124678999999999999889999999999999999999999


Q ss_pred             CCCCCCCHHH----HHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         143 PPFETSTLKE----TYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       143 ~Pf~~~~~~~----~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .||.+.+...    ....+....+.+|    ..++.++.+||++||..||.+|||+.++++||||...
T Consensus       261 ~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          261 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             CSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            9997654321    3344544444444    4588999999999999999999999999999999753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-34  Score=245.40  Aligned_cols=199  Identities=28%  Similarity=0.479  Sum_probs=150.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++|||||++++++.+.+..|+|||||++|+|.+.+...... ..+..... ..+..+..++.++|..++.+
T Consensus        68 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH  147 (285)
T 3is5_A           68 EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH  147 (285)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEE
Confidence            47999999999999999999999999999999999999999988643211 11122222 22334567888888877644


Q ss_pred             e--------ec--CCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          80 Q--------LN--DDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        80 ~--------~~--~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      .        +.  +....+++.||+......   .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||.
T Consensus       148 ~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~  226 (285)
T 3is5_A          148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT  226 (285)
T ss_dssp             CCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence            2        22  123457788876443221   224568999999999986 457899999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCCC---CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLP---ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +.+..+....+.......+   ...++.+.++|.+||..||.+|||+.|+++||||+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          227 GTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            9888777666654443332   247889999999999999999999999999999974

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.7e-35  Score=255.02  Aligned_cols=202  Identities=20%  Similarity=0.369  Sum_probs=151.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-----------------------------
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-----------------------------   52 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-----------------------------   52 (305)
                      .+|++++++++|||||++++++++++.+|+|||||+||+|.+++.......                             
T Consensus        76 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (345)
T 3hko_A           76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH  155 (345)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC-
T ss_pred             HHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccc
Confidence            479999999999999999999999999999999999999999874211000                             


Q ss_pred             CC--------CCc-CchhHHHHHHHHHHhhhhCCcee--------ecCC-CCCeeEcchhHHHHhcC--------Ccccc
Q psy6191          53 EM--------SDP-AAQPVIWVSKWVDYSDKYGFGYQ--------LNDD-SSGVMFNDLTRMIMLAN--------KNTLC  106 (305)
Q Consensus        53 ~~--------~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~v~~~d~~~~~~~~~--------~~~~~  106 (305)
                      ..        .+. ....+..+..++.++|..++.+.        +..+ ...+++.||+.......        ....+
T Consensus       156 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  235 (345)
T 3hko_A          156 GFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA  235 (345)
T ss_dssp             -CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------C
T ss_pred             cccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccC
Confidence            00        000 00122345677888887775332        2222 22688888865432211        23567


Q ss_pred             cCCCccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCC----CCCHHHHHHHHHHh
Q psy6191         107 GTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA----TLKKPAATMIKKML  180 (305)
Q Consensus       107 Gt~~y~aPE~~~~--~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l  180 (305)
                      ||+.|+|||++.+  ..++.++||||+||++|||++|+.||.+.+..+....+......++.    .++..+.++|.+||
T Consensus       236 gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  315 (345)
T 3hko_A          236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLL  315 (345)
T ss_dssp             CCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHS
T ss_pred             CCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHc
Confidence            9999999999865  56889999999999999999999999998888777777655443332    37889999999999


Q ss_pred             hcCCCCCCCHhhhhcCccccccC
Q psy6191         181 LLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       181 ~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      ..||.+||++.++++||||+...
T Consensus       316 ~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          316 NRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             CSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             CCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999999998643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-34  Score=257.51  Aligned_cols=196  Identities=24%  Similarity=0.342  Sum_probs=148.5

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCC--eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSK--FVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~--~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   77 (305)
                      .+|+.+++++. |||||++++++..++  .+|||||||+ |+|.+++... .+   ....... +..++.++.|+|..|+
T Consensus        56 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~---~~~~~~~i~~qi~~~L~~LH~~~i  130 (388)
T 3oz6_A           56 FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN-IL---EPVHKQYVVYQLIKVIKYLHSGGL  130 (388)
T ss_dssp             HHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT-CC---CHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC-CC---CHHHHHHHHHHHHHHHHHHHhCCE
Confidence            37999999997 999999999998544  7999999998 5898888753 22   2222222 2345778899998776


Q ss_pred             cee-------ecCCCCCeeEcchhHHHHhc-------------------------CCcccccCCCccccccccc-CCCCc
Q psy6191          78 GYQ-------LNDDSSGVMFNDLTRMIMLA-------------------------NKNTLCGTPNYIAPEILNK-NGHSF  124 (305)
Q Consensus        78 ~~~-------~~~~~~~v~~~d~~~~~~~~-------------------------~~~~~~Gt~~y~aPE~~~~-~~~~~  124 (305)
                      .|.       +.+....+++.||+......                         .....+||+.|+|||++.+ ..|+.
T Consensus       131 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  210 (388)
T 3oz6_A          131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTK  210 (388)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCT
T ss_pred             EeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCC
Confidence            443       33344678888887543221                         1234689999999999876 67899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccc------------------------------------------
Q psy6191         125 EVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY------------------------------------------  162 (305)
Q Consensus       125 ~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~------------------------------------------  162 (305)
                      ++||||+||++|||++|++||.+.+....+..+.....                                          
T Consensus       211 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (388)
T 3oz6_A          211 GIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN  290 (388)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhh
Confidence            99999999999999999999999887776665542110                                          


Q ss_pred             -----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         163 -----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       163 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                           ..+...+.++.+||.+||+.||.+|||++|+++||||+..
T Consensus       291 ~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             HHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred             hcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence                 0112568899999999999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.4e-34  Score=252.78  Aligned_cols=198  Identities=20%  Similarity=0.296  Sum_probs=154.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|||||||. |+|.+++......  +..... ..+..+..++.++|..++.|.
T Consensus       102 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~  178 (348)
T 1u5q_A          102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHR  178 (348)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            479999999999999999999999999999999998 5788877543211  122222 223345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                             +.+..+.+++.||+...........+||+.|+|||++.   ...++.++||||+||++|||++|++||.+.+.
T Consensus       179 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  258 (348)
T 1u5q_A          179 DVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  258 (348)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             CCCHHHEEECCCCCEEEeeccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                   22344567888887665555566789999999999884   55688999999999999999999999998877


Q ss_pred             HHHHHHHhcccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         151 KETYSRIKKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ......+.....  ..+...+..+.++|.+||..||.+|||++++++|||+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          259 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            666555544332  2234678899999999999999999999999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.1e-34  Score=252.35  Aligned_cols=196  Identities=28%  Similarity=0.492  Sum_probs=155.5

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++++ +|||||+++++++..+..|+|||||+||+|.+++.....+   ...... .+..+..++.++|..|+.|
T Consensus       147 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l---~~~~~~~i~~qi~~~L~~LH~~gi~H  223 (365)
T 2y7j_A          147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL---SEKETRSIMRSLLEAVSFLHANNIVH  223 (365)
T ss_dssp             HHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            4799999998 8999999999999999999999999999999998765443   222222 2334567788888777533


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc---CCcccccCCCccccccccc------CCCCccchHHHHHHHHHHHHhCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNK------NGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~------~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      .       +.+..+.+++.||+....+.   .....+||+.|+|||++.+      ..++.++|||||||++|+|++|..
T Consensus       224 ~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~  303 (365)
T 2y7j_A          224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP  303 (365)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence            2       23344667888887543322   2245689999999999853      357889999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         144 PFETSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      ||.+.+.......+....+.++    ...+..+.++|.+||..||.+|||+.++++||||+
T Consensus       304 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          304 PFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             SSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            9999888777777766655443    36788899999999999999999999999999996

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=249.05  Aligned_cols=199  Identities=19%  Similarity=0.348  Sum_probs=147.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++.+|+|||||+ |+|.+++......  ....... .+..+..++.++|..|+.+.
T Consensus        48 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~  124 (324)
T 3mtl_A           48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNI--INMHNVKLFLFQLLRGLAYCHRQKVLHR  124 (324)
T ss_dssp             CCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             HHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            379999999999999999999999999999999998 5888888764321  1222222 23345678888888775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.||+.....    ......+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.
T Consensus       125 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             SCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   2333456778887643221    11234579999999999876 56899999999999999999999999998


Q ss_pred             CHHHHHHHHhcccc------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         149 TLKETYSRIKKVEY------------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       149 ~~~~~~~~i~~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      +..+....+.....                              ..+..++.++.+||.+||+.||.+|||++|+++|||
T Consensus       205 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  284 (324)
T 3mtl_A          205 TVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF  284 (324)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             CHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence            87776655533110                              011246788899999999999999999999999999


Q ss_pred             ccccC
Q psy6191         199 FNDYC  203 (305)
Q Consensus       199 ~~~~~  203 (305)
                      |....
T Consensus       285 f~~~~  289 (324)
T 3mtl_A          285 FLSLG  289 (324)
T ss_dssp             GGGGC
T ss_pred             hhhcc
Confidence            98653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-33  Score=240.83  Aligned_cols=196  Identities=17%  Similarity=0.280  Sum_probs=149.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   76 (305)
                      .+|+.++++++|||||++++++++    +..+|+|||||++|+|.+++.....+.   .... .....+..++.++|..+
T Consensus        73 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~qi~~~l~~lH~~~  149 (290)
T 1t4h_A           73 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK---IKVLRSWCRQILKGLQFLHTRT  149 (290)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHTSS
T ss_pred             HHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCC---HHHHHHHHHHHHHHHHHHHcCC
Confidence            479999999999999999999876    467999999999999999998754432   2112 22334567788888777


Q ss_pred             --Cce--------eecCCCCCeeEcchhHHHHhcC--CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          77 --FGY--------QLNDDSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        77 --~~~--------~~~~~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                        +.|        .+......+++.||+.......  ....+||+.|+|||++.+ .++.++||||+||++|+|++|+.|
T Consensus       150 ~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p  228 (290)
T 1t4h_A          150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP  228 (290)
T ss_dssp             SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCC
Confidence              533        2333456788888876543322  235679999999998874 488999999999999999999999


Q ss_pred             CCCCC-HHHHHHHHhccc--cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         145 FETST-LKETYSRIKKVE--YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       145 f~~~~-~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |.... .......+....  ..++...++.+.++|.+||..||.+|||+.++++||||++
T Consensus       229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          229 YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             TTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            98744 444444444332  2334567788999999999999999999999999999975

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.7e-35  Score=262.96  Aligned_cols=195  Identities=19%  Similarity=0.341  Sum_probs=143.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   74 (305)
                      .+|+.+|+.++|||||++++++.+.      +.+|||||||+++ +.+.+...     +.+.... .+.+++.++.|+|.
T Consensus       109 ~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~~~-----l~~~~~~~~~~qil~aL~~lH~  182 (464)
T 3ttj_A          109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQME-----LDHERMSYLLYQMLCGIKHLHS  182 (464)
T ss_dssp             HHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHTSC-----CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHH
Confidence            4899999999999999999999765      4679999999875 55555321     1222222 23345778899998


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .|+.|.       +.+....+++.||+.......   ....+||+.|+|||++.+..|+.++||||+||++|||++|++|
T Consensus       183 ~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p  262 (464)
T 3ttj_A          183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL  262 (464)
T ss_dssp             TTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCC
Confidence            876543       333446788888875544332   2457899999999999998999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccccC-------------------------------CCCC-----------CCHHHHHHHHHHhhc
Q psy6191         145 FETSTLKETYSRIKKVEYK-------------------------------LPAT-----------LKKPAATMIKKMLLL  182 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~-------------------------------~~~~-----------~~~~~~~li~~~l~~  182 (305)
                      |.+.+..+.+..|......                               +|..           .+.++.+||.+||..
T Consensus       263 F~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~  342 (464)
T 3ttj_A          263 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI  342 (464)
T ss_dssp             SCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCC
Confidence            9998877766655331100                               0000           045689999999999


Q ss_pred             CCCCCCCHhhhhcCcccccc
Q psy6191         183 DPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       183 dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||.+|||++|+++||||+.+
T Consensus       343 dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          343 DPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             STTTSCCHHHHHTSTTTGGG
T ss_pred             ChhhCCCHHHHhcChhhhhc
Confidence            99999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=250.10  Aligned_cols=191  Identities=22%  Similarity=0.357  Sum_probs=150.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCC-CHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKR-SMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g-~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++|||||++++++++++.+|+||||+.+| +|.+++.....+   ...... .+..+..++.++|..++.+
T Consensus        77 ~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l---~~~~~~~i~~qi~~~L~~LH~~~ivH  153 (335)
T 3dls_A           77 TLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL---DEPLASYIFRQLVSAVGYLRLKDIIH  153 (335)
T ss_dssp             EHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCC---CHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeEE
Confidence            36999999999999999999999999999999999777 999998765433   222222 2334567888888777543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+....+++.||+.......   ..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...
T Consensus       154 ~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  233 (335)
T 3dls_A          154 RDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL  233 (335)
T ss_dssp             SCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred             eccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence            2       233446678888875543322   235689999999999987765 88999999999999999999999763


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .      .........|...+.++.++|.+||..||.+|||+.++++||||+.
T Consensus       234 ~------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          234 E------ETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             G------GGTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             H------HHHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence            2      2233344556778999999999999999999999999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3e-34  Score=251.92  Aligned_cols=197  Identities=23%  Similarity=0.376  Sum_probs=149.7

Q ss_pred             hhHHHHHhcCC-----CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLK-----HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~-----HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|+.+++.+.     |||||++++++.+.+.+||||||| +|+|.+++...... .+..... ..+..+..++.++|..
T Consensus        79 ~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~  156 (360)
T 3llt_A           79 KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKM  156 (360)
T ss_dssp             HHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            36899999986     999999999999999999999999 99999998765321 1122222 2233456788888877


Q ss_pred             CCcee--------ecC------------------------CCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCC
Q psy6191          76 GFGYQ--------LND------------------------DSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGH  122 (305)
Q Consensus        76 ~~~~~--------~~~------------------------~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~  122 (305)
                      |+.|.        +..                        ....+++.||+...... .....+||+.|+|||++.+..+
T Consensus       157 ~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~  236 (360)
T 3llt_A          157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW  236 (360)
T ss_dssp             TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCC
T ss_pred             CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCC
Confidence            75432        221                        14567778876554322 2346789999999999999899


Q ss_pred             CccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCC------------------------------------
Q psy6191         123 SFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA------------------------------------  166 (305)
Q Consensus       123 ~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------------------  166 (305)
                      +.++||||+||++|+|++|++||.+.+..+....+......+|.                                    
T Consensus       237 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  316 (360)
T 3llt_A          237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH  316 (360)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHH
T ss_pred             CCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhh
Confidence            99999999999999999999999988777666555433222221                                    


Q ss_pred             ----------CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         167 ----------TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       167 ----------~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                                ..+..+.+||.+||+.||.+|||+.|+++||||+
T Consensus       317 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             hhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence                      1235667999999999999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.8e-34  Score=242.96  Aligned_cols=198  Identities=29%  Similarity=0.487  Sum_probs=155.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+||||+++|+|.+++.....+   ..... ..+..+..++.++|..++.|.
T Consensus        56 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~l~~lH~~~i~H~  132 (283)
T 3bhy_A           56 EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TEDEATQFLKQILDGVHYLHSKRIAHF  132 (283)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            47999999999999999999999999999999999999999999765443   22222 223345677888887775432


Q ss_pred             --------ecCCC---CCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 --------LNDDS---SGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 --------~~~~~---~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                              +..+.   ..+++.|++......   .....+||+.|+|||++.+..++.++||||+||++|+|++|..||.
T Consensus       133 dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  212 (283)
T 3bhy_A          133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  212 (283)
T ss_dssp             CCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence                    22221   157788876443221   1234579999999999998889999999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +.+..+....+.......+    ...+..+.++|.+||..||.+|||+.++++||||+..
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          213 GETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             CSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             CcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            9888888777766655443    4678899999999999999999999999999999753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-34  Score=246.61  Aligned_cols=198  Identities=25%  Similarity=0.398  Sum_probs=146.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++++++..|+|||||++++|.+++.....+   ....... ...+..++.+.|..|+.|.
T Consensus        50 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~---~~~~~~~i~~~l~~~l~~lH~~~ivH~  126 (311)
T 4agu_A           50 LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGV---PEHLVKSITWQTLQAVNFCHKHNCIHR  126 (311)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCC---CHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            47999999999999999999999999999999999999999887654333   2222222 2345678888888775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.|++......    .....+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.
T Consensus       127 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  206 (311)
T 4agu_A          127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK  206 (311)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                   23344567788876543322    1235589999999999875 56899999999999999999999999988


Q ss_pred             CHHHHHHHHhccc-------------------cCCC------------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         149 TLKETYSRIKKVE-------------------YKLP------------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       149 ~~~~~~~~i~~~~-------------------~~~~------------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      +..+....+....                   ...|            +..+.++.++|.+||..||.+|||++|+++||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  286 (311)
T 4agu_A          207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP  286 (311)
T ss_dssp             SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred             CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence            7766554443210                   0011            35678899999999999999999999999999


Q ss_pred             ccccc
Q psy6191         198 FFNDY  202 (305)
Q Consensus       198 ~~~~~  202 (305)
                      ||++.
T Consensus       287 ~f~~~  291 (311)
T 4agu_A          287 YFENI  291 (311)
T ss_dssp             GGTTC
T ss_pred             HHHhc
Confidence            99864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7e-34  Score=243.88  Aligned_cols=201  Identities=25%  Similarity=0.437  Sum_probs=154.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE--cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE--DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~--~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|+.++++++|||||++++++.  +++.+|+|||||++| |.+++...... ....... ..+..+..++.++|..++.
T Consensus        54 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~i~  131 (305)
T 2wtk_C           54 KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYLHSQGIV  131 (305)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTC-SCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCccc-ccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            47999999999999999999984  456899999999987 77776653221 1122122 2233456788888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCC--CCccchHHHHHHHHHHHHhCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNG--HSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~--~~~~~DiwSlGvilye~l~g~~  143 (305)
                      |.       +.+..+.+++.|++.......      .....||+.|+|||++.+..  ++.++||||+||++|+|++|..
T Consensus       132 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~  211 (305)
T 2wtk_C          132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY  211 (305)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             ecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCC
Confidence            32       223345677777765433211      12457999999999987643  4779999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         144 PFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      ||.+.+..+....+....+.+|...+..+.++|.+||..||.+|||+.++++||||+...+
T Consensus       212 p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          212 PFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            9999998888888888888888899999999999999999999999999999999986543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-33  Score=248.33  Aligned_cols=198  Identities=22%  Similarity=0.309  Sum_probs=149.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh-CCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY-GFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~   79 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||+||+|.+++.....+.   .... .....+..++.++|.. |+.|
T Consensus        79 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~i~~~i~~~l~~lh~~~~i~H  155 (360)
T 3eqc_A           79 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTYLREKHKIMH  155 (360)
T ss_dssp             HHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             HHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCC---HHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            489999999999999999999999999999999999999999998764432   2222 2233456777888764 6543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh--cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML--ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                      .       +.+..+.+++.||+.....  ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.
T Consensus       156 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  235 (360)
T 3eqc_A          156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  235 (360)
T ss_dssp             SCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred             CCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            2       3334467888888644322  233467899999999999998999999999999999999999999987665


Q ss_pred             HHHHHHH------------------------------------------hcc-ccCCC-CCCCHHHHHHHHHHhhcCCCC
Q psy6191         151 KETYSRI------------------------------------------KKV-EYKLP-ATLKKPAATMIKKMLLLDPVQ  186 (305)
Q Consensus       151 ~~~~~~i------------------------------------------~~~-~~~~~-~~~~~~~~~li~~~l~~dp~~  186 (305)
                      .+....+                                          ... ....+ ...+.++.+||.+||..||.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  315 (360)
T 3eqc_A          236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE  315 (360)
T ss_dssp             HHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTT
T ss_pred             HHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhh
Confidence            4432211                                          111 11111 246788999999999999999


Q ss_pred             CCCHhhhhcCcccccc
Q psy6191         187 RPPVAQLLHFEFFNDY  202 (305)
Q Consensus       187 R~~~~~~l~~~~~~~~  202 (305)
                      |||++|+++||||+..
T Consensus       316 Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          316 RADLKQLMVHAFIKRS  331 (360)
T ss_dssp             SCCHHHHHTSHHHHHH
T ss_pred             CCCHHHHhhChHhhcc
Confidence            9999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-34  Score=244.19  Aligned_cols=199  Identities=20%  Similarity=0.297  Sum_probs=149.3

Q ss_pred             hhHHHHHhcCC---CCCccceeEEEEcCC-----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLK---HRNVVGFHSFFEDSK-----FVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~---HpnIV~l~~~~~~~~-----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   72 (305)
                      .+|++++++++   |||||++++++.+..     .+|+||||+. |+|.+++...... .+...... .+..+..++.++
T Consensus        59 ~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~l  136 (308)
T 3g33_A           59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFL  136 (308)
T ss_dssp             HHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHH
Confidence            37888887775   999999999998765     5899999998 5999998764321 12222222 233456788899


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCC
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                      |..++.|.       +.+....+++.||+......   .....+||+.|+|||++.+..++.++||||+||++|+|++|+
T Consensus       137 H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  216 (308)
T 3g33_A          137 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK  216 (308)
T ss_dssp             HHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSS
T ss_pred             HHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCC
Confidence            98876543       22334567788887554332   224568999999999999888999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhccccC---------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         143 PPFETSTLKETYSRIKKVEYK---------------------------LPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +||.+.+..+....+......                           ..+.++..+.+||.+||+.||.+|||+.|+++
T Consensus       217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          217 PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            999998887776665431100                           11346788999999999999999999999999


Q ss_pred             Ccccccc
Q psy6191         196 FEFFNDY  202 (305)
Q Consensus       196 ~~~~~~~  202 (305)
                      ||||+..
T Consensus       297 h~~~~~~  303 (308)
T 3g33_A          297 HSYLHKD  303 (308)
T ss_dssp             STTC---
T ss_pred             CccccCC
Confidence            9999863

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-33  Score=245.41  Aligned_cols=198  Identities=18%  Similarity=0.293  Sum_probs=152.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||++ +|.+++.....  ....... ..+..+..++.++|..++.|.
T Consensus        60 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  136 (346)
T 1ua2_A           60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHWILHR  136 (346)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCCEECC
Confidence            3799999999999999999999999999999999986 78887754321  1122222 233345678889998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.||+.......    ....+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.
T Consensus       137 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          137 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             CCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence                   333456788899886654432    2356899999999998654 5899999999999999999999999998


Q ss_pred             CHHHHHHHHhcccc-----CC-----------------------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         149 TLKETYSRIKKVEY-----KL-----------------------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       149 ~~~~~~~~i~~~~~-----~~-----------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      +..+.+..+.....     .+                       ....+.++.+||.+||..||.+|||+.|+++||||+
T Consensus       217 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~  296 (346)
T 1ua2_A          217 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  296 (346)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence            87776666543110     00                       134568899999999999999999999999999998


Q ss_pred             cc
Q psy6191         201 DY  202 (305)
Q Consensus       201 ~~  202 (305)
                      ..
T Consensus       297 ~~  298 (346)
T 1ua2_A          297 NR  298 (346)
T ss_dssp             SS
T ss_pred             cC
Confidence            64

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6e-34  Score=244.93  Aligned_cols=200  Identities=22%  Similarity=0.343  Sum_probs=150.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhC--Cc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYG--FG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~   78 (305)
                      .+|++++++++|||||++++++.+++.+|+|||||++|+|.+++........+..... .....+..++.++|..+  +.
T Consensus        82 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~iv  161 (309)
T 3p86_A           82 LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV  161 (309)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCC
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEE
Confidence            4799999999999999999999999999999999999999999875432111122222 22334567888888877  54


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                      +.       +.+....+++.||+......    .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+
T Consensus       162 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~  241 (309)
T 3p86_A          162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN  241 (309)
T ss_dssp             CTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             CCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            32       33444678888887554322    22456899999999999999899999999999999999999999999


Q ss_pred             CCHHHHHHHH--hccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc--Cccccc
Q psy6191         148 STLKETYSRI--KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH--FEFFND  201 (305)
Q Consensus       148 ~~~~~~~~~i--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~--~~~~~~  201 (305)
                      .+..+....+  ......+|..++..+.++|.+||..||.+|||+.++++  .++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          242 LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            8887776655  33455677889999999999999999999999999987  455543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.1e-34  Score=251.79  Aligned_cols=201  Identities=23%  Similarity=0.355  Sum_probs=146.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~   74 (305)
                      .+|+++|+.++|||||++++++...+      ++|+|||||+++.+..+.........+....... +..+..++.|+|.
T Consensus        80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~  159 (394)
T 4e7w_A           80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS  159 (394)
T ss_dssp             CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999996543      4899999999764443332221111222222222 2345678889888


Q ss_pred             hCCcee--------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCC
Q psy6191          75 YGFGYQ--------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        75 ~~~~~~--------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~  142 (305)
                      .|+.|.        +......+++.||+......   .....+||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus       160 ~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  239 (394)
T 4e7w_A          160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ  239 (394)
T ss_dssp             TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            775432        33244667888887554321   22356899999999998654 5899999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhcc-----------------cc------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhh
Q psy6191         143 PPFETSTLKETYSRIKKV-----------------EY------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQL  193 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~  193 (305)
                      +||.+.+..+....+.+.                 ..            .++...+.++.+||.+||+.||.+|||+.|+
T Consensus       240 ~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (394)
T 4e7w_A          240 PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA  319 (394)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH
Confidence            999998876665554321                 00            1234578899999999999999999999999


Q ss_pred             hcCcccccc
Q psy6191         194 LHFEFFNDY  202 (305)
Q Consensus       194 l~~~~~~~~  202 (305)
                      ++||||+..
T Consensus       320 l~hp~f~~~  328 (394)
T 4e7w_A          320 LCHPFFDEL  328 (394)
T ss_dssp             HTSGGGSTT
T ss_pred             hcChhhhhh
Confidence            999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-34  Score=250.09  Aligned_cols=197  Identities=23%  Similarity=0.360  Sum_probs=151.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~   74 (305)
                      .+|++++++++|||||++++++..++      .+|+||||+ +++|.+++... .+   .+..... +..+..++.++|.
T Consensus        72 ~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~l---~~~~~~~~~~qi~~~L~~LH~  146 (367)
T 1cm8_A           72 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-KL---GEDRIQFLVYQMLKGLRYIHA  146 (367)
T ss_dssp             HHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC-CC---CHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999998763      469999999 88999998752 22   2222222 3345678889988


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC-CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .|+.|.       +.+....+++.||+....... ....+||+.|+|||++.+ ..++.++||||+||++|||++|++||
T Consensus       147 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  226 (367)
T 1cm8_A          147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF  226 (367)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCccccCcCHHHEEEcCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence            775442       233445678888875543322 345689999999999876 67899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcccc-------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         146 ETSTLKETYSRIKKVEY-------------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .+.+..+.+..+.....                               .+....++.+.+||.+||..||.+|||+++++
T Consensus       227 ~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l  306 (367)
T 1cm8_A          227 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL  306 (367)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHh
Confidence            98887666555532111                               12245688999999999999999999999999


Q ss_pred             cCccccccC
Q psy6191         195 HFEFFNDYC  203 (305)
Q Consensus       195 ~~~~~~~~~  203 (305)
                      +||||+...
T Consensus       307 ~hp~f~~~~  315 (367)
T 1cm8_A          307 AHPYFESLH  315 (367)
T ss_dssp             HSGGGTTTC
T ss_pred             cChHHHhhc
Confidence            999998643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5e-34  Score=247.41  Aligned_cols=201  Identities=24%  Similarity=0.397  Sum_probs=153.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++++ +|||||++++++++++.+|+|||||+||+|.+++..... ..+..... ..+..+..++.++|..|+.+
T Consensus        76 ~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~givH  154 (327)
T 3lm5_A           76 LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNNIVH  154 (327)
T ss_dssp             HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            4799999998 469999999999999999999999999999888743211 11122112 22334567788888777533


Q ss_pred             e--------ecC--CCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          80 Q--------LND--DSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        80 ~--------~~~--~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      .        +..  ....+++.||+.......   ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.
T Consensus       155 ~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  234 (327)
T 3lm5_A          155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV  234 (327)
T ss_dssp             SCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            2        222  135678888865443222   235689999999999998899999999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         147 TSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      +.+..+....+.......+    ...+..+.++|.+||..||.+|||++++++||||+...
T Consensus       235 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          235 GEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             CSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             CCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            9888887776665444333    45788999999999999999999999999999998653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-33  Score=246.37  Aligned_cols=198  Identities=25%  Similarity=0.423  Sum_probs=155.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++++++ +|||||++++++++++.+|||||||++|+|.+++.....+   ....... +..+..++.|+|..++.|
T Consensus       106 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~aL~~LH~~~ivH  182 (355)
T 1vzo_A          106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF---TEHEVQIYVGEIVLALEHLHKLGIIY  182 (355)
T ss_dssp             CCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCC---CHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4799999999 6999999999999999999999999999999999875443   2222222 234577888998877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh-----cCCcccccCCCccccccccc--CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML-----ANKNTLCGTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .       +.+....+++.||+.....     ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||
T Consensus       183 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf  262 (355)
T 1vzo_A          183 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF  262 (355)
T ss_dssp             CCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            3       3334467888888643221     12235689999999999875  34788999999999999999999999


Q ss_pred             CCC----CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         146 ETS----TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ...    ........+......+|..++..+.++|.+||..||.+||     +++++++||||...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          263 TVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             SCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             ccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            743    3445555566666777888999999999999999999999     99999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-33  Score=239.71  Aligned_cols=201  Identities=22%  Similarity=0.436  Sum_probs=155.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE--cCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhhC-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE--DSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKYG-   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~--~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~-   76 (305)
                      .+|+.++++++|||||++++++.  +++.+|+|||||++|+|.+++...... ..+..... ..+..+..++.++|..+ 
T Consensus        53 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  132 (279)
T 2w5a_A           53 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD  132 (279)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccC
Confidence            47999999999999999999874  467899999999999999998764321 11122212 22334567788888776 


Q ss_pred             ----Ccee-------ecCCCCCeeEcchhHHHHhcCC----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhC
Q psy6191          77 ----FGYQ-------LNDDSSGVMFNDLTRMIMLANK----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        77 ----~~~~-------~~~~~~~v~~~d~~~~~~~~~~----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g  141 (305)
                          +.+.       +.+....+++.|++........    ...+||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus       133 ~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  212 (279)
T 2w5a_A          133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL  212 (279)
T ss_dssp             -----CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence                4332       2334466888888766544322    245799999999999988899999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         142 KPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..||...+..+....+..... .+|...+.++.++|.+||..||.+|||+.++++|+|+...
T Consensus       213 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          213 MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             CCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            999999888777777765544 5667889999999999999999999999999999999754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.6e-33  Score=238.47  Aligned_cols=198  Identities=19%  Similarity=0.313  Sum_probs=151.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||++|+|.+++......  +..... ..+..+..++.+.|..|+.|.
T Consensus        64 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~  141 (302)
T 2j7t_A           64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKRIIHR  141 (302)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence            47999999999999999999999999999999999999999988653221  122222 223345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHH----hcCCcccccCCCccccccc-----ccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIM----LANKNTLCGTPNYIAPEIL-----NKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~----~~~~~~~~Gt~~y~aPE~~-----~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+..+.+++.||+....    .......+||+.|+|||++     .+..++.++||||+||++|+|++|..|
T Consensus       142 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  221 (302)
T 2j7t_A          142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP  221 (302)
T ss_dssp             CCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence                   233446788888875432    2234567899999999988     456788999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         145 FETSTLKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |...+.......+.....   ..+...+..+.++|.+||..||.+|||+.++++||||+.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          222 HHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             TTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             CccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence            998887776665554432   234567889999999999999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.3e-34  Score=246.10  Aligned_cols=197  Identities=25%  Similarity=0.366  Sum_probs=148.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||++++|.++......+   ..... ..+..+..++.++|..|+.|.
T Consensus        72 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~qi~~~l~~LH~~~ivH~  148 (331)
T 4aaa_A           72 MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGL---DYQVVQKYLFQIINGIGFCHSHNIIHR  148 (331)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCC---CHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCC---CHHHHHHHHHHHHHHHHHHHHCCEEcc
Confidence            37999999999999999999999999999999999999998876544332   22222 223345678888888776442


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.||+.......    ....+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.
T Consensus       149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (331)
T 4aaa_A          149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD  228 (331)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                   333446788888875543221    2356799999999998765 6899999999999999999999999988


Q ss_pred             CHHHHHHHHhccc-------------------cCC------------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         149 TLKETYSRIKKVE-------------------YKL------------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       149 ~~~~~~~~i~~~~-------------------~~~------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      +..+....+....                   ...            .+.++..+.+||.+||..||.+|||+.|+++||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            7666554432110                   011            124678899999999999999999999999999


Q ss_pred             cccc
Q psy6191         198 FFND  201 (305)
Q Consensus       198 ~~~~  201 (305)
                      ||+.
T Consensus       309 ~f~~  312 (331)
T 4aaa_A          309 FFQM  312 (331)
T ss_dssp             HHHG
T ss_pred             hhcc
Confidence            9974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.4e-34  Score=255.76  Aligned_cols=196  Identities=28%  Similarity=0.501  Sum_probs=141.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++++. +..|+|||||++|+|.+.+.....+   .+.... .+..+..++.|+|..++.|.
T Consensus       188 ~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~i~~qi~~~l~~LH~~~ivHr  263 (419)
T 3i6u_A          188 ETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRL---KEATCKLYFYQMLLAVQYLHENGIIHR  263 (419)
T ss_dssp             HHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCC---CHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCC---CHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            479999999999999999999865 4589999999999998877543332   222222 23345678888888776443


Q ss_pred             --------ecC--CCCCeeEcchhHHHHhcC---CcccccCCCccccccccc---CCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 --------LND--DSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNK---NGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 --------~~~--~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                              +..  ....+++.||+.......   ..+.+||+.|+|||++.+   ..++.++||||+||++|+|++|.+|
T Consensus       264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p  343 (419)
T 3i6u_A          264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP  343 (419)
T ss_dssp             CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence                    221  123478888875544322   246789999999999853   5678899999999999999999999


Q ss_pred             CCCCCHH-HHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         145 FETSTLK-ETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       145 f~~~~~~-~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |...... .....+....+.++    ..++..+.++|.+||+.||.+|||++|+++||||++
T Consensus       344 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          344 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             SCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            9764332 33344444444332    357899999999999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.3e-34  Score=250.45  Aligned_cols=200  Identities=20%  Similarity=0.317  Sum_probs=153.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-----CCCCcCc-hhHHHHHHHHHHhhh-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-----EMSDPAA-QPVIWVSKWVDYSDK-   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~~-   74 (305)
                      .+|++++++++|||||++++++.+++.+|+|||||++|+|.+++.....+.     ....... ..+..+..++.++|. 
T Consensus        91 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  170 (348)
T 2pml_X           91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE  170 (348)
T ss_dssp             HHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc
Confidence            479999999999999999999999999999999999999988732211111     1111111 222345677888887 


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccC-CCCc-cchHHHHHHHHHHHHhCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKN-GHSF-EVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~-~~~~-~~DiwSlGvilye~l~g~~  143 (305)
                      .|+.|.       +.+....+++.|++......  .....+||+.|+|||++.+. .++. ++||||+||++|+|++|..
T Consensus       171 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~  250 (348)
T 2pml_X          171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV  250 (348)
T ss_dssp             SCEECCCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCEeecCCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence            765432       22334567777776543322  22456799999999999877 5666 8999999999999999999


Q ss_pred             CCCCCCH-HHHHHHHhccccCCC-------------------CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         144 PFETSTL-KETYSRIKKVEYKLP-------------------ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       144 Pf~~~~~-~~~~~~i~~~~~~~~-------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ||...+. .+....+......+|                   ...+..+.++|.+||..||.+|||+.++++||||++
T Consensus       251 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             SSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            9988766 677777777766666                   568899999999999999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-33  Score=240.66  Aligned_cols=198  Identities=26%  Similarity=0.500  Sum_probs=156.1

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++++++. |||||++++++++++..|+|||||++|+|.+++.....+.   .... ..+..+..++.++|..|+.|
T Consensus        71 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~qi~~~l~~lH~~~i~H  147 (298)
T 1phk_A           71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS---EKETRKIMRALLEVICALHKLNIVH  147 (298)
T ss_dssp             HHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCC---HHHHHHHHHHHHHHHHHHHHCCccc
Confidence            47999999995 9999999999999999999999999999999998754432   2222 22334567788888877543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccc------cCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILN------KNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~------~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      .       +.+....+++.|++......   .....+||+.|+|||++.      ...++.++||||+||++|+|++|..
T Consensus       148 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  227 (298)
T 1phk_A          148 RDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP  227 (298)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCC
Confidence            2       23344567788876543322   223567999999999884      4457889999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         144 PFETSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||.+.+.......+....+.++    ...+..+.++|.+||..||.+|||+.++++||||++.
T Consensus       228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          228 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             SSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            9999888777777766555443    3578899999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-34  Score=249.35  Aligned_cols=199  Identities=18%  Similarity=0.293  Sum_probs=149.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   77 (305)
                      .+|+.++++++|||||++++++++..    ..|+|||||+||+|.+++.....+.+  ......+..+..++.+.|..++
T Consensus        60 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~--~~~~~~~~qi~~~l~~lH~~~i  137 (311)
T 3ork_A           60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP--KRAIEVIADACQALNFSHQNGI  137 (311)
T ss_dssp             HHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCH--HHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCCC
Confidence            47999999999999999999988654    35999999999999999986654321  1122223345678888888776


Q ss_pred             cee-------ecCCCCCeeEcchhHHHHhc-------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          78 GYQ-------LNDDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        78 ~~~-------~~~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      .|.       +.+..+.+++.||+......       .....+||+.|+|||++.+..++.++||||+||++|+|++|+.
T Consensus       138 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~  217 (311)
T 3ork_A          138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP  217 (311)
T ss_dssp             CCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence            443       22334667888886443321       2234679999999999998899999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccccCC----CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         144 PFETSTLKETYSRIKKVEYKL----PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||.+.+..+....+.......    +..++.++.++|.+||..||.+||++.+++.|+|++..
T Consensus       218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          218 PFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             SCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            999988777655554433322    24588999999999999999999999999999999753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.2e-33  Score=238.48  Aligned_cols=197  Identities=17%  Similarity=0.294  Sum_probs=148.3

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|+.++.++ +|||||++++++.+++.+|+|||||+||+|.+++...... ..+..... ..+..+..++.++|..++.
T Consensus        58 ~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv  137 (289)
T 1x8b_A           58 LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV  137 (289)
T ss_dssp             HHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            3688889888 9999999999999999999999999999999998764221 11122222 2233456788888887754


Q ss_pred             ee--------ecC------------------CCCCeeEcchhHHHHhcCCcccccCCCcccccccccC-CCCccchHHHH
Q psy6191          79 YQ--------LND------------------DSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKN-GHSFEVDVWSI  131 (305)
Q Consensus        79 ~~--------~~~------------------~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSl  131 (305)
                      |.        +..                  ....+++.|++...........+||+.|+|||++.+. .++.++||||+
T Consensus       138 H~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl  217 (289)
T 1x8b_A          138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFAL  217 (289)
T ss_dssp             CSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred             ecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHH
Confidence            32        211                  2224667777655555555567899999999998766 56789999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         132 GCIMYTLLVGKPPFETSTLKETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       132 Gvilye~l~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ||++|+|++|.+|+......   ..+.. ....+|...+..+.++|.+||..||.+|||+.++++||||..
T Consensus       218 G~il~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          218 ALTVVCAAGAEPLPRNGDQW---HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             HHHHHHHTTCCCCCSSSHHH---HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             HHHHHHHhcCCCCCcchhHH---HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence            99999999999887655332   22332 334567789999999999999999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-33  Score=256.20  Aligned_cols=198  Identities=24%  Similarity=0.347  Sum_probs=139.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   75 (305)
                      .+|+.+|++++|||||++++++..     .+.+||||||+. |+|.+++.....+   .+..+.. +..++.++.|+|..
T Consensus       100 ~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l---~~~~~~~~~~qi~~aL~~LH~~  175 (458)
T 3rp9_A          100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYL---TELHIKTLLYNLLVGVKYVHSA  175 (458)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCC---CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCC---CHHHHHHHHHHHHHHHHHHHhC
Confidence            479999999999999999999943     367999999985 7899988764433   2222333 33457888999988


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhc-------------------------------CCcccccCCCccccccc
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLA-------------------------------NKNTLCGTPNYIAPEIL  117 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~-------------------------------~~~~~~Gt~~y~aPE~~  117 (305)
                      ++.|.       +.+....+++.||+......                               .....+||++|+|||++
T Consensus       176 ~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  255 (458)
T 3rp9_A          176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI  255 (458)
T ss_dssp             TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred             CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence            76543       33445678888887543221                               12346899999999976


Q ss_pred             -ccCCCCccchHHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHHhccc----
Q psy6191         118 -NKNGHSFEVDVWSIGCIMYTLLV-----------GKPPFETSTL--------------------KETYSRIKKVE----  161 (305)
Q Consensus       118 -~~~~~~~~~DiwSlGvilye~l~-----------g~~Pf~~~~~--------------------~~~~~~i~~~~----  161 (305)
                       .+..|+.++||||+||++|||++           |+++|.+.+.                    ...+..|....    
T Consensus       256 ~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~  335 (458)
T 3rp9_A          256 LLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS  335 (458)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC
T ss_pred             hCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC
Confidence             56679999999999999999998           7778866431                    11111111000    


Q ss_pred             ---------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         162 ---------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       162 ---------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                                                 ....+..+.++.+||++||..||.+|||++|+++||||+...
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          336 EEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             HHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence                                       001134588999999999999999999999999999998753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-33  Score=248.57  Aligned_cols=199  Identities=21%  Similarity=0.370  Sum_probs=148.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--------------------------------------CCeEEEEEeccCCCCHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--------------------------------------SKFVYIILELCRKRSMME   43 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--------------------------------------~~~~ylVmEy~~~g~L~~   43 (305)
                      .+|+++|+.++|||||+++++|.+                                      +.++|+|||||+ |+|.+
T Consensus        48 ~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~  126 (383)
T 3eb0_A           48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHK  126 (383)
T ss_dssp             CHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHH
T ss_pred             HHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHH
Confidence            489999999999999999999843                                      445999999998 48877


Q ss_pred             HHHHhcCC-CCCCCcCch-hHHHHHHHHHHhhhhCCcee--------ecCCCCCeeEcchhHHHHhc---CCcccccCCC
Q psy6191          44 LYNSACDL-EEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ--------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPN  110 (305)
Q Consensus        44 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~  110 (305)
                      .+...... ..+...... ....+..++.|+|..|+.|.        +......+++.||+......   .....+||+.
T Consensus       127 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~  206 (383)
T 3eb0_A          127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF  206 (383)
T ss_dssp             HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSS
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCC
Confidence            76542111 111222222 23345678889988775432        22234567888887554322   2235689999


Q ss_pred             cccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------------c-----------
Q psy6191         111 YIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV-----------------E-----------  161 (305)
Q Consensus       111 y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~-----------------~-----------  161 (305)
                      |+|||++.+. .++.++||||+||++|||++|++||.+.+..+....+...                 .           
T Consensus       207 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  286 (383)
T 3eb0_A          207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW  286 (383)
T ss_dssp             CCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH
T ss_pred             ccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH
Confidence            9999988764 4899999999999999999999999998877666555321                 0           


Q ss_pred             -cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         162 -YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       162 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                       ..+|...+.++.+||.+||..||.+|||+.|+++||||+.
T Consensus       287 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          287 RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             HhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence             0134567888999999999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.4e-33  Score=237.74  Aligned_cols=198  Identities=27%  Similarity=0.428  Sum_probs=156.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|++++++++|||||++++++.+++..|+||||+++|+|.+.+.....+.+  ......+..+..++.++|..|+.+. 
T Consensus        69 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~i~~qi~~~l~~LH~~~i~H~d  146 (287)
T 2wei_A           69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITYMHKHNIVHRD  146 (287)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCH--HHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             HHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCCeeccC
Confidence            4799999999999999999999999999999999999999998876544321  1112223345677888887776432 


Q ss_pred             -------ecCC--CCCeeEcchhHHHHhcCC---cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDD--SSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~--~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +...  ...+++.|++........   ....||+.|+|||++.+. ++.++||||+||++|+|++|..||.+.
T Consensus       147 l~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (287)
T 2wei_A          147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGK  225 (287)
T ss_dssp             CCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence                   2221  235788888765543322   345699999999998764 889999999999999999999999998


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +..+....+....+..+    ..++.++.++|.+||..||.+|||+.++++||||+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          226 NEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             SHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            88887777766554433    4578999999999999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.2e-34  Score=247.90  Aligned_cols=198  Identities=21%  Similarity=0.408  Sum_probs=145.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------------------------------------------------------
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------------------------------------------------------   27 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------------------------------------------------------   27 (305)
                      .+|+++|++++|||||++++++.+..                                                      
T Consensus        52 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  131 (332)
T 3qd2_B           52 MREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS  131 (332)
T ss_dssp             HHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCC
Confidence            47999999999999999999986543                                                      


Q ss_pred             ---eEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHH
Q psy6191          28 ---FVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRM   96 (305)
Q Consensus        28 ---~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~   96 (305)
                         ++|+|||||+||+|.+++............ ....+..+..++.++|..++.|.       +.+....+++.||+..
T Consensus       132 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  211 (332)
T 3qd2_B          132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV  211 (332)
T ss_dssp             CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcc
Confidence               389999999999999999876554332211 12233445778888888775432       2334467788888654


Q ss_pred             HHhc----------------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q psy6191          97 IMLA----------------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV  160 (305)
Q Consensus        97 ~~~~----------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~  160 (305)
                      ....                .....+||+.|+|||++.+..++.++||||+||++|||++|..|+...  ......+...
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~  289 (332)
T 3qd2_B          212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNL  289 (332)
T ss_dssp             EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTT
T ss_pred             cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhcc
Confidence            3221                123467999999999999889999999999999999999998776321  2222333332


Q ss_pred             ccC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         161 EYK-LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       161 ~~~-~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ..+ .+...++.+.++|.+||..||.+|||+.|+++||||++
T Consensus       290 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          290 KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            211 11245677899999999999999999999999999974

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.3e-33  Score=238.51  Aligned_cols=201  Identities=27%  Similarity=0.408  Sum_probs=151.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY-   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-   79 (305)
                      .+|+.+++.++|||||++++++.+++..|+|||||++|+|.+++............... ....+..++.++|..++.| 
T Consensus        67 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  146 (295)
T 2clq_A           67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR  146 (295)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEcc
Confidence            47999999999999999999999999999999999999999998765322111111111 1234567788888777543 


Q ss_pred             -------eecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccC--CCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          80 -------QLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        80 -------~~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                             .+....+.+++.|++.......    .....||+.|+|||++.+.  .++.++||||+||++|+|++|+.||.
T Consensus       147 dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  226 (295)
T 2clq_A          147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY  226 (295)
T ss_dssp             CCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred             CCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence                   2333246778888865433221    2456899999999998764  37889999999999999999999997


Q ss_pred             CCCHH-HHHH--HHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         147 TSTLK-ETYS--RIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~~~~~-~~~~--~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..+.. ....  ........+|...+.++.++|.+||..||.+|||+.++++||||+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          227 ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             GGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             CCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            64322 2211  12234456677899999999999999999999999999999999853

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.9e-33  Score=244.85  Aligned_cols=198  Identities=21%  Similarity=0.310  Sum_probs=147.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   72 (305)
                      .+|++++++++|||||++++++.+        ++.+|+|||||++ +|.+.+.....  ........ .+..+..++.++
T Consensus        64 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~L  140 (351)
T 3mi9_A           64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYI  140 (351)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHH
Confidence            379999999999999999999987        4579999999986 77776654321  11222222 233456788888


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHhc--------CCcccccCCCccccccccc-CCCCccchHHHHHHHHH
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA--------NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~--------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvily  136 (305)
                      |..|+.|.       +.+..+.+++.||+......        .....+||+.|+|||++.+ ..++.++||||+||++|
T Consensus       141 H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~  220 (351)
T 3mi9_A          141 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA  220 (351)
T ss_dssp             HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHH
T ss_pred             HHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHH
Confidence            88775442       23344677888887543321        1234679999999998875 45899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhccccCCCCC--------------------------------CCHHHHHHHHHHhhcCC
Q psy6191         137 TLLVGKPPFETSTLKETYSRIKKVEYKLPAT--------------------------------LKKPAATMIKKMLLLDP  184 (305)
Q Consensus       137 e~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------~~~~~~~li~~~l~~dp  184 (305)
                      +|++|.+||.+.+.......+.......+..                                .++.+.+||.+||+.||
T Consensus       221 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  300 (351)
T 3mi9_A          221 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP  300 (351)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSG
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCCh
Confidence            9999999999988777766654422222211                                25678899999999999


Q ss_pred             CCCCCHhhhhcCcccccc
Q psy6191         185 VQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       185 ~~R~~~~~~l~~~~~~~~  202 (305)
                      .+|||++|+++||||...
T Consensus       301 ~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          301 AQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             GGSCCHHHHHTSGGGGSS
T ss_pred             hhCCCHHHHhCCCCcCCC
Confidence            999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.4e-33  Score=237.04  Aligned_cols=198  Identities=24%  Similarity=0.444  Sum_probs=148.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++..|+|||||++|+|.+++.....+   ..... ..+..+..++.+.|..|+.|.
T Consensus        53 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~l~~lH~~~i~H~  129 (276)
T 2yex_A           53 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM---PEPDAQRFFHQLMAGVVYLHGIGITHR  129 (276)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBC---CHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCC---CHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            47999999999999999999999999999999999999998877543222   21111 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                             +.+..+.+++.|++......      .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.
T Consensus       130 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  209 (276)
T 2yex_A          130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD  209 (276)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCS
T ss_pred             CCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Confidence                   22344567788876543221      1245689999999999987664 778999999999999999999998


Q ss_pred             CCCHH-HHHHHHhcccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         147 TSTLK-ETYSRIKKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~~~~~-~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..+.. .....+.....  ..+...+..+.++|.+||..||.+|||+.++++||||+..
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          210 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             CSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            75432 22233332222  2224688999999999999999999999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.7e-33  Score=250.72  Aligned_cols=200  Identities=21%  Similarity=0.383  Sum_probs=145.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc------CCeEEEEEeccCCCCHHHHHHHhcC-CCCCCCcCchh-HHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED------SKFVYIILELCRKRSMMELYNSACD-LEEMSDPAAQP-VIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~------~~~~ylVmEy~~~g~L~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~   73 (305)
                      .+|+++|++++|||||+++++|..      ..++|+||||+++ ++.+++..... ...+....... +..+..++.|+|
T Consensus        95 ~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  173 (420)
T 1j1b_A           95 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH  173 (420)
T ss_dssp             CHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            479999999999999999999853      2357899999986 56665543211 11122222222 334567888998


Q ss_pred             hhCCcee--------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhC
Q psy6191          74 KYGFGYQ--------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        74 ~~~~~~~--------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g  141 (305)
                      ..++.|.        +..+...+++.||+....+.   .....+||+.|+|||++.+. .|+.++||||+||++|||++|
T Consensus       174 ~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G  253 (420)
T 1j1b_A          174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG  253 (420)
T ss_dssp             TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhC
Confidence            8775432        33233456788887554322   22356899999999998754 789999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcc-----------------ccC------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhh
Q psy6191         142 KPPFETSTLKETYSRIKKV-----------------EYK------------LPATLKKPAATMIKKMLLLDPVQRPPVAQ  192 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~  192 (305)
                      ++||.+.+..+.+..+.+.                 .+.            ++...+.++.+||.+||..||.+|||+.|
T Consensus       254 ~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e  333 (420)
T 1j1b_A          254 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE  333 (420)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHH
Confidence            9999988766655544321                 111            23456889999999999999999999999


Q ss_pred             hhcCcccccc
Q psy6191         193 LLHFEFFNDY  202 (305)
Q Consensus       193 ~l~~~~~~~~  202 (305)
                      +++||||+..
T Consensus       334 ~l~hp~f~~~  343 (420)
T 1j1b_A          334 ACAHSFFDEL  343 (420)
T ss_dssp             HHTSGGGGGG
T ss_pred             HhCCHhhccc
Confidence            9999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.7e-33  Score=251.37  Aligned_cols=201  Identities=21%  Similarity=0.241  Sum_probs=147.4

Q ss_pred             hhHHHHHhcC------CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSL------KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l------~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+++++.+      +|||||++++++...+.+|||||||. |+|.+++...... .+..... ..+..++.++.|+|.
T Consensus       141 ~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~  218 (429)
T 3kvw_A          141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHK  218 (429)
T ss_dssp             HHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            3688888876      67899999999999999999999996 6899988764321 1122222 223345678888887


Q ss_pred             hCCcee-------ecCCCC--CeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          75 YGFGYQ-------LNDDSS--GVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        75 ~~~~~~-------~~~~~~--~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .++.|.       +.+..+  .+++.||+...... ...+.+||+.|+|||++.+..++.++||||+||++|||++|.+|
T Consensus       219 ~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p  298 (429)
T 3kvw_A          219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL  298 (429)
T ss_dssp             HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCeecCCCCHHHeEEccCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCC
Confidence            775432       222222  27888887543322 23467899999999999988999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccccC-----------------------------------------------------------CC
Q psy6191         145 FETSTLKETYSRIKKVEYK-----------------------------------------------------------LP  165 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~-----------------------------------------------------------~~  165 (305)
                      |.+.+..+.+..+......                                                           ++
T Consensus       299 f~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  378 (429)
T 3kvw_A          299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK  378 (429)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcc
Confidence            9998876665544321000                                                           11


Q ss_pred             CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         166 ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       166 ~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                      ...++.+.+||++||+.||.+|||++|+++||||++..+
T Consensus       379 ~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          379 GCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP  417 (429)
T ss_dssp             TCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred             ccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCC
Confidence            123677899999999999999999999999999987543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-33  Score=239.55  Aligned_cols=199  Identities=21%  Similarity=0.340  Sum_probs=154.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++.+|+|||||++|+|.+++......  +..... ..+..+..++.++|..|+.|.
T Consensus        72 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~i~H~  149 (314)
T 3com_A           72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLHFMRKIHR  149 (314)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCC--CCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence            47999999999999999999999999999999999999999998643211  122222 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++......    ......||+.|+|||++.+..++.++||||+||++|+|++|..||...+
T Consensus       150 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  229 (314)
T 3com_A          150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH  229 (314)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence                   23344567788876543322    2245689999999999998889999999999999999999999999877


Q ss_pred             HHHHHHHHhccc---cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         150 LKETYSRIKKVE---YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       150 ~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .......+....   ...+...+..+.++|.+||..||.+|||+.++++||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          230 PMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             hHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            665554443322   22345678899999999999999999999999999999853

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.3e-33  Score=238.01  Aligned_cols=201  Identities=23%  Similarity=0.384  Sum_probs=143.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-----CCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-----EEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|+.++++++|||||++++++.+++..|+|||||+||+|.+++......     ..+..... ..+..+..++.++|..
T Consensus        61 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  140 (303)
T 2vwi_A           61 LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN  140 (303)
T ss_dssp             -----CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            47999999999999999999999999999999999999999998753211     11111111 2223456778888887


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcC---------CcccccCCCccccccccc-CCCCccchHHHHHHHHHHH
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLAN---------KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~---------~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~  138 (305)
                      |+.|.       +.+..+.+++.|++.......         ....+||+.|+|||++.+ ..++.++||||+||++|+|
T Consensus       141 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  220 (303)
T 2vwi_A          141 GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL  220 (303)
T ss_dssp             TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHH
T ss_pred             CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHH
Confidence            76443       233446788889876654321         234679999999999875 5688999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHhcccc----------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         139 LVGKPPFETSTLKETYSRIKKVEY----------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       139 l~g~~Pf~~~~~~~~~~~i~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ++|+.||...+.............          ......+.++.++|.+||..||.+|||+.++++||||+..
T Consensus       221 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          221 ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             HHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             HhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence            999999988765544433322211          1224567889999999999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-33  Score=243.02  Aligned_cols=199  Identities=15%  Similarity=0.185  Sum_probs=158.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCC----CCcC-chhHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEM----SDPA-AQPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~   76 (305)
                      .+|+.++++++|||||++++++.+++..|+|||||+||+|.+++.........    .... ...+..+..++.++|..+
T Consensus       122 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  201 (367)
T 3l9p_A          122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH  201 (367)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            47999999999999999999999999999999999999999999876432211    1111 122334567888888877


Q ss_pred             Ccee-------ecC---CCCCeeEcchhHHHHh------cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh
Q psy6191          77 FGYQ-------LND---DSSGVMFNDLTRMIML------ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        77 ~~~~-------~~~---~~~~v~~~d~~~~~~~------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~  140 (305)
                      +.|.       +.+   ....+++.||+.....      ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       202 ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt  281 (367)
T 3l9p_A          202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS  281 (367)
T ss_dssp             CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence            6443       222   2234889999766543      22345678999999999988889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         141 -GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       141 -g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                       |.+||.+.+..+....+.... ...|...+..+.+++.+||+.||.+|||+.+++++.+.-
T Consensus       282 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          282 LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             999999998888877776543 455677899999999999999999999999999987654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-33  Score=248.28  Aligned_cols=195  Identities=21%  Similarity=0.355  Sum_probs=141.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+.+++.++|||||++++++.+.+      .+|+|||||++ +|.+.+...  +   ..... ..+..+..++.++|.
T Consensus        72 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~---~~~~~~~i~~qi~~al~~lH~  145 (371)
T 2xrw_A           72 YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--L---DHERMSYLLYQMLCGIKHLHS  145 (371)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHSC--C---CHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhhc--c---CHHHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999998765      79999999985 687777522  1   22222 223345678888888


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .|+.|.       +.+..+.+++.||+.......   ....+||+.|+|||++.+..++.++||||+||++|+|++|+.|
T Consensus       146 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  225 (371)
T 2xrw_A          146 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL  225 (371)
T ss_dssp             TTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            776443       333446788888875544322   2356899999999999988899999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccccC------------------------------------CCCC------CCHHHHHHHHHHhhc
Q psy6191         145 FETSTLKETYSRIKKVEYK------------------------------------LPAT------LKKPAATMIKKMLLL  182 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~------------------------------------~~~~------~~~~~~~li~~~l~~  182 (305)
                      |.+.+..+.+..+......                                    +|..      .+..+++||.+||..
T Consensus       226 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  305 (371)
T 2xrw_A          226 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI  305 (371)
T ss_dssp             SCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcC
Confidence            9998877766655432110                                    0000      145688999999999


Q ss_pred             CCCCCCCHhhhhcCcccccc
Q psy6191         183 DPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       183 dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||.+|||++|+++||||+.+
T Consensus       306 dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          306 DASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             SGGGSCCHHHHHHSHHHHTT
T ss_pred             ChhhCCCHHHHhCCcchhhh
Confidence            99999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-33  Score=249.02  Aligned_cols=200  Identities=21%  Similarity=0.340  Sum_probs=139.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE--cCCeEEEEEeccCCCCHHHHHHHhcCCC------CCCCcCch-hHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE--DSKFVYIILELCRKRSMMELYNSACDLE------EMSDPAAQ-PVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~--~~~~~ylVmEy~~~g~L~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~~~   72 (305)
                      .+|+.+|++++|||||++++++.  ++..+|||||||.+ +|.+++.......      .+....+. .+..++.++.|+
T Consensus        66 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L  144 (405)
T 3rgf_A           66 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL  144 (405)
T ss_dssp             HHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999995  47799999999975 7888775432110      11222222 233457788999


Q ss_pred             hhhCCcee--------ec---CCCCCeeEcchhHHHHh-------cCCcccccCCCccccccccc-CCCCccchHHHHHH
Q psy6191          73 DKYGFGYQ--------LN---DDSSGVMFNDLTRMIML-------ANKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGC  133 (305)
Q Consensus        73 ~~~~~~~~--------~~---~~~~~v~~~d~~~~~~~-------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGv  133 (305)
                      |..++.|.        +.   +....+++.||+.....       ......+||+.|+|||++.+ ..++.++||||+||
T Consensus       145 H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~  224 (405)
T 3rgf_A          145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC  224 (405)
T ss_dssp             HHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHH
T ss_pred             HhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHH
Confidence            98876443        31   33457888888754332       22345789999999999876 45899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHH---------HHHHHHhcccc-C-------------------------------------CCC
Q psy6191         134 IMYTLLVGKPPFETSTLK---------ETYSRIKKVEY-K-------------------------------------LPA  166 (305)
Q Consensus       134 ilye~l~g~~Pf~~~~~~---------~~~~~i~~~~~-~-------------------------------------~~~  166 (305)
                      ++|+|++|++||.+.+..         +.+..+..... +                                     ...
T Consensus       225 il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (405)
T 3rgf_A          225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV  304 (405)
T ss_dssp             HHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTC
T ss_pred             HHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCC
Confidence            999999999999765431         22222211000 0                                     001


Q ss_pred             CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       167 ~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..+..+.+||.+||..||.+|||++|+++||||+..
T Consensus       305 ~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED  340 (405)
T ss_dssp             CTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence            126678999999999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.1e-33  Score=249.36  Aligned_cols=199  Identities=20%  Similarity=0.322  Sum_probs=141.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   75 (305)
                      .+|+.+|++++|||||++++++...     +.+|||||||. |+|.+++.....+   .+..... +..++.++.|+|..
T Consensus        73 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l---~~~~~~~i~~qil~aL~~LH~~  148 (432)
T 3n9x_A           73 LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFL---TEEHIKTILYNLLLGENFIHES  148 (432)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCC---CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCC---CHHHHHHHHHHHHHHHHHHHHC
Confidence            4899999999999999999999876     67999999987 5999998764333   2222322 33457788899987


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhc--------------------------CCcccccCCCccccccc-ccCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLA--------------------------NKNTLCGTPNYIAPEIL-NKNG  121 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~--------------------------~~~~~~Gt~~y~aPE~~-~~~~  121 (305)
                      |+.|.       +.+....+++.||+......                          ...+.+||++|+|||++ ....
T Consensus       149 givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~  228 (432)
T 3n9x_A          149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN  228 (432)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSC
T ss_pred             CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCC
Confidence            76442       33344678888886433211                          12467899999999986 5667


Q ss_pred             CCccchHHHHHHHHHHHHhC-----------CCCCCCCCH-----------------HHHHHHH----------------
Q psy6191         122 HSFEVDVWSIGCIMYTLLVG-----------KPPFETSTL-----------------KETYSRI----------------  157 (305)
Q Consensus       122 ~~~~~DiwSlGvilye~l~g-----------~~Pf~~~~~-----------------~~~~~~i----------------  157 (305)
                      |+.++||||+||++|||++|           .++|.+.+.                 ...+..|                
T Consensus       229 ~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~  308 (432)
T 3n9x_A          229 YTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN  308 (432)
T ss_dssp             CCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhcc
Confidence            99999999999999999984           444544321                 1111111                


Q ss_pred             --------hccccCC-------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccCC
Q psy6191         158 --------KKVEYKL-------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP  204 (305)
Q Consensus       158 --------~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~~  204 (305)
                              .......       .+..++++.+||++||..||.+|||++|+++||||+....
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             CHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence                    1111111       1357899999999999999999999999999999987543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5e-33  Score=244.65  Aligned_cols=196  Identities=23%  Similarity=0.371  Sum_probs=139.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS------KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   74 (305)
                      .+|+.++++++|||||++++++...      ..+|+||||+ +++|.+++... .   +...... .+..+..++.++|.
T Consensus        76 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~---l~~~~~~~i~~qi~~aL~~LH~  150 (367)
T 2fst_X           76 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-K---LTDDHVQFLIYQILRGLKYIHS  150 (367)
T ss_dssp             HHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C-C---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHH
Confidence            3799999999999999999999764      6689999999 78998887642 2   2222222 23345678889998


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC-CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .|+.|.       +.+....+++.||+....... ....+||+.|+|||++.+ ..++.++||||+||++|||++|++||
T Consensus       151 ~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  230 (367)
T 2fst_X          151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  230 (367)
T ss_dssp             TTCCCCCCCGGGEEECTTCCEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCeeeCCCCHhhEEECCCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            876443       333446788889876544322 345689999999999876 67899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcccc-----------------------C--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         146 ETSTLKETYSRIKKVEY-----------------------K--------LPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~-----------------------~--------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .+.+.......+.....                       .        .....++.+.+||.+||..||.+|||+.|++
T Consensus       231 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L  310 (367)
T 2fst_X          231 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL  310 (367)
T ss_dssp             CCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence            99887666555432100                       0        0124578899999999999999999999999


Q ss_pred             cCcccccc
Q psy6191         195 HFEFFNDY  202 (305)
Q Consensus       195 ~~~~~~~~  202 (305)
                      +||||+..
T Consensus       311 ~hp~~~~~  318 (367)
T 2fst_X          311 AHAYFAQY  318 (367)
T ss_dssp             TSGGGTTT
T ss_pred             cChhhhhc
Confidence            99999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-33  Score=240.24  Aligned_cols=199  Identities=21%  Similarity=0.341  Sum_probs=146.9

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEc------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFED------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   73 (305)
                      .+|+.+++++ +||||+++++++.+      ++.+|+|||||++|+|.+++...... .+..... ..+..+..++.++|
T Consensus        68 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH  146 (326)
T 2x7f_A           68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLSHLH  146 (326)
T ss_dssp             HHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            4799999998 89999999999987      56899999999999999998764211 1122222 22334567888888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccc-----cCCCCccchHHHHHHHHHH
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye  137 (305)
                      ..|+.|.       +.+....+++.||+......    .....+||+.|+|||++.     +..++.++||||+||++|+
T Consensus       147 ~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~  226 (326)
T 2x7f_A          147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE  226 (326)
T ss_dssp             HTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred             HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence            8776443       23344668888886543322    234568999999999986     4568899999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhcccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         138 LLVGKPPFETSTLKETYSRIKKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |++|..||.+.+.......+.....  ..+...+..+.++|.+||..||.+||++.++++||||++
T Consensus       227 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          227 MAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             HHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             HHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence            9999999988877666555543322  123467899999999999999999999999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-32  Score=235.59  Aligned_cols=196  Identities=19%  Similarity=0.268  Sum_probs=147.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||+||+|.+++.....+.   .... .....+..++.+.|..|+.|.
T Consensus        59 ~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~---~~~~~~~~~qi~~~l~~lH~~~i~H~  135 (294)
T 4eqm_A           59 EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLS---VDTAINFTNQILDGIKHAHDMRIVHR  135 (294)
T ss_dssp             HHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCC---HHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            479999999999999999999999999999999999999999998765432   2222 223345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh-----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML-----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.||+.....     ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus       136 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  215 (294)
T 4eqm_A          136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE  215 (294)
T ss_dssp             CCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             CCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence                   2334466788888644322     1234568999999999999988999999999999999999999999988


Q ss_pred             CHHHHHHHHhcccc-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         149 TLKETYSRIKKVEY-----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       149 ~~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      +.............     ..+..++..+.++|.+||..||.+||+..+.+.++|..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          216 TAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             CHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             ChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            87665444433221     23456889999999999999999999666555566543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-32  Score=232.22  Aligned_cols=193  Identities=16%  Similarity=0.253  Sum_probs=152.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+|||||++|+|.+++......  ...... .....+..++.+.|..++.|.
T Consensus        53 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~i~H~  130 (269)
T 4hcu_A           53 IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHR  130 (269)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcc--cCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            47999999999999999999999999999999999999999998654321  111111 222345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh-----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML-----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.....     .......||+.|+|||++.+..++.++||||+||++|+|++ |..||..
T Consensus       131 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~  210 (269)
T 4hcu_A          131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  210 (269)
T ss_dssp             CCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence                   2233356777888655432     22334567889999999998889999999999999999999 9999999


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+... ....|...+..+.+++.+||..||.+|||+.+++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          211 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            8888887777654 345566789999999999999999999999999865

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.5e-33  Score=237.73  Aligned_cols=196  Identities=23%  Similarity=0.337  Sum_probs=155.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++||||+++++++.+++.+|+|||||++|+|.+++... .+   ..... ..+..+..++.++|..|+.|.
T Consensus        68 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~---~~~~~~~~~~qi~~~l~~lH~~~i~H~  143 (303)
T 3a7i_A           68 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PL---DETQIATILREILKGLDYLHSEKKIHR  143 (303)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS-CC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC-CC---CHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            57999999999999999999999999999999999999999988542 11   22112 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.|++......    .....+||+.|+|||++.+..++.++||||+||++|+|++|..||...+
T Consensus       144 dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  223 (303)
T 3a7i_A          144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH  223 (303)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence                   22344567788876543322    2245689999999999998889999999999999999999999999887


Q ss_pred             HHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         150 LKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .......+... ...++...+..+.++|.+||..||.+|||+.++++||||..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          224 PMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             HHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             HHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            77665555433 33456678999999999999999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.6e-33  Score=240.78  Aligned_cols=196  Identities=28%  Similarity=0.498  Sum_probs=145.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++ .|+|||||++|+|.+++.....+   ..... ..+..+..++.++|..++.|.
T Consensus        63 ~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~qi~~~l~~lH~~~ivH~  138 (322)
T 2ycf_A           63 ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRL---KEATCKLYFYQMLLAVQYLHENGIIHR  138 (322)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCC---CHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            47999999999999999999998765 89999999999999988654332   22222 223345678888887775432


Q ss_pred             --------ecCC--CCCeeEcchhHHHHhcCC---cccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 --------LNDD--SSGVMFNDLTRMIMLANK---NTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 --------~~~~--~~~v~~~d~~~~~~~~~~---~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                              +...  ...+++.||+........   ...+||+.|+|||++.   ...++.++||||+||++|+|++|..|
T Consensus       139 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  218 (322)
T 2ycf_A          139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP  218 (322)
T ss_dssp             CCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence                    2221  123777787654332221   2457999999999873   45688999999999999999999999


Q ss_pred             CCCCCHH-HHHHHHhccccCC----CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         145 FETSTLK-ETYSRIKKVEYKL----PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       145 f~~~~~~-~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |...... .....+.......    +...+..+.++|.+||..||.+|||+.++++||||++
T Consensus       219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          219 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             SCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             CcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            9764332 2333344333332    2457889999999999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-32  Score=245.51  Aligned_cols=198  Identities=23%  Similarity=0.386  Sum_probs=140.9

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++++++ +|||||++++++++++.+|||||||. |+|.+++....... ........+..+..++.|+|..++.|.
T Consensus        65 ~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~-~~~~~~~i~~qi~~aL~~LH~~~ivHr  142 (432)
T 3p23_A           65 DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAH-LGLEPITLLQQTTSGLAHLHSLNIVHR  142 (432)
T ss_dssp             HHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCC-CSSCHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCc-cchhHHHHHHHHHHHHHHHHHCcCEeC
Confidence            5899999999 79999999999999999999999997 59999987543211 111122334456788999998876553


Q ss_pred             ecCC------------CCCeeEcchhHHHHh-------cCCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHH
Q psy6191          81 LNDD------------SSGVMFNDLTRMIML-------ANKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        81 ~~~~------------~~~v~~~d~~~~~~~-------~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~  138 (305)
                      -...            ...+++.||+.....       ....+.+||+.|+|||++.   ...++.++||||+||++|||
T Consensus       143 DlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~el  222 (432)
T 3p23_A          143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV  222 (432)
T ss_dssp             CCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHH
Confidence            2111            113457777643322       1234568999999999997   34577899999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHhccccCC---CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         139 LV-GKPPFETSTLKETYSRIKKVEYKL---PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       139 l~-g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ++ |..||...........+.......   +...+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       223 lt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             HcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            99 999997665444333332222211   1123445789999999999999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.5e-33  Score=245.91  Aligned_cols=196  Identities=21%  Similarity=0.336  Sum_probs=148.1

Q ss_pred             hhHHHHHhcCC--CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK--HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~--HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++|++++  |||||++++++.+++.+||||| |.+|+|.+++.....+..  ......+..++.++.|+|..++.|
T Consensus       102 ~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~--~~~~~i~~qi~~aL~~lH~~~ivH  178 (390)
T 2zmd_A          102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIHQHGIVH  178 (390)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCH--HHHHHHHHHHHHHHHHHHTTTCCC
T ss_pred             HHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCCeee
Confidence            47999999996  5999999999999999999999 678999999987543311  112223344577888999877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCccccccccc-----------CCCCccchHHHHHHHH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNK-----------NGHSFEVDVWSIGCIM  135 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil  135 (305)
                      .       +.+ .+.+++.||+......      ...+.+||+.|+|||++.+           ..++.++|||||||++
T Consensus       179 rDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil  257 (390)
T 2zmd_A          179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL  257 (390)
T ss_dssp             CCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHH
T ss_pred             cCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHH
Confidence            3       122 3567888886543221      1245689999999999864           3588899999999999


Q ss_pred             HHHHhCCCCCCCCC-HHHHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         136 YTLLVGKPPFETST-LKETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       136 ye~l~g~~Pf~~~~-~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |||++|++||.... ....+..+...  ...+|...+.++.++|.+||..||.+|||+.|+++||||..
T Consensus       258 ~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~  326 (390)
T 2zmd_A          258 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  326 (390)
T ss_dssp             HHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence            99999999998753 33444444433  33456677889999999999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.4e-33  Score=243.91  Aligned_cols=196  Identities=23%  Similarity=0.386  Sum_probs=147.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|++++++++|||||++++++...     ..+|+||||+. |+|.+++.... +   ..... ..+..+..++.++|..
T Consensus        73 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~-~---~~~~~~~i~~qi~~aL~~LH~~  147 (364)
T 3qyz_A           73 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQH-L---SNDHICYFLYQILRGLKYIHSA  147 (364)
T ss_dssp             HHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHCC-C---CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhCC-C---CHHHHHHHHHHHHHHHHHHHHC
Confidence            4799999999999999999999765     47999999998 48999886532 2   22222 2233456788888887


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHh
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~  140 (305)
                      |+.|.       +.+....+++.||+.......       ....+||+.|+|||++. +..++.++||||+||++|+|++
T Consensus       148 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  227 (364)
T 3qyz_A          148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS  227 (364)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH
Confidence            75432       233445678888865433211       23458999999999865 4558999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcccc-------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCC
Q psy6191         141 GKPPFETSTLKETYSRIKKVEY-------------------------------KLPATLKKPAATMIKKMLLLDPVQRPP  189 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~  189 (305)
                      |++||.+.+..+....+.....                               ..++..+.++.+||.+||..||.+|||
T Consensus       228 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  307 (364)
T 3qyz_A          228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE  307 (364)
T ss_dssp             SSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC
Confidence            9999998776655554432100                               012356888999999999999999999


Q ss_pred             HhhhhcCcccccc
Q psy6191         190 VAQLLHFEFFNDY  202 (305)
Q Consensus       190 ~~~~l~~~~~~~~  202 (305)
                      +.|+++||||+..
T Consensus       308 ~~e~l~hp~~~~~  320 (364)
T 3qyz_A          308 VEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHTSGGGTTT
T ss_pred             HHHHhcCcchhhc
Confidence            9999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.98  E-value=9.8e-33  Score=243.16  Aligned_cols=195  Identities=19%  Similarity=0.296  Sum_probs=152.2

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-------------CCCCcC-chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-------------EMSDPA-AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-------------~~~~~~-~~~~~~~~   66 (305)
                      .+|+++|+++ +|||||++++++.+++.+|+|||||+||+|.+++.......             .+.... ......+.
T Consensus       134 ~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  213 (370)
T 2psq_A          134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA  213 (370)
T ss_dssp             HHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHH
Confidence            4799999999 89999999999999999999999999999999998654210             001111 11233456


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.|+|..++.|.       +.+..+.+++.||+.......      .....||+.|+|||++.+..++.++|||||||
T Consensus       214 ~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~  293 (370)
T 2psq_A          214 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV  293 (370)
T ss_dssp             HHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHH
Confidence            78888887775432       233446788888875433221      22346789999999999889999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++|||++ |..||.+.+..+....+... ....|...+..+.++|.+||..||.+||++.|++++
T Consensus       294 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          294 LMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999 99999988877777666554 345677889999999999999999999999999863

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.98  E-value=8.2e-33  Score=241.32  Aligned_cols=196  Identities=21%  Similarity=0.330  Sum_probs=145.4

Q ss_pred             hhHHHHHhcCCC--CCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKH--RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~H--pnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|+.++++++|  ||||++++++.+++.+||||| +.+|+|.+++.....+.   .... ..+..+..++.++|..++.
T Consensus        55 ~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~---~~~~~~i~~qi~~al~~lH~~~ii  130 (343)
T 3dbq_A           55 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSID---PWERKSYWKNMLEAVHTIHQHGIV  130 (343)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSCCCC---HHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHhCCee
Confidence            479999999987  999999999999999999999 57889999998754432   2222 2233457788899988765


Q ss_pred             eeecC------CCCCeeEcchhHHHHhc------CCcccccCCCccccccccc-----------CCCCccchHHHHHHHH
Q psy6191          79 YQLND------DSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNK-----------NGHSFEVDVWSIGCIM  135 (305)
Q Consensus        79 ~~~~~------~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil  135 (305)
                      |.-..      ..+.+++.||+......      ...+.+||+.|+|||++.+           ..++.++||||+||++
T Consensus       131 HrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il  210 (343)
T 3dbq_A          131 HSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL  210 (343)
T ss_dssp             CCCCCGGGEEEETTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred             cCCCCcceEEEECCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence            43111      12457777876443221      1235689999999999864           5688899999999999


Q ss_pred             HHHHhCCCCCCCCC-HHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         136 YTLLVGKPPFETST-LKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       136 ye~l~g~~Pf~~~~-~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |+|++|+.||.... .......+..  ....+|...+..+.++|.+||..||.+|||+.|+++||||+.
T Consensus       211 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          211 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             HHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            99999999998643 2233333332  334566777889999999999999999999999999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.98  E-value=6.4e-32  Score=233.79  Aligned_cols=199  Identities=20%  Similarity=0.324  Sum_probs=150.6

Q ss_pred             hHHHHHhcC---CCCCccceeEEEE-----cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhh
Q psy6191           3 QEIAIHRSL---KHRNVVGFHSFFE-----DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSD   73 (305)
Q Consensus         3 ~Ei~il~~l---~HpnIV~l~~~~~-----~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   73 (305)
                      +|+.+++.+   +|||||++++++.     +...+|+||||++ |+|.+++...... .+..... ..+..+..++.++|
T Consensus        60 ~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH  137 (326)
T 1blx_A           60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLH  137 (326)
T ss_dssp             HHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            688888776   8999999999997     5678999999998 6999998764321 1122222 22334567888999


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      ..|+.|.       +.+..+.+++.||+......   .....+||+.|+|||++.+..++.++||||+||++|+|++|++
T Consensus       138 ~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  217 (326)
T 1blx_A          138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP  217 (326)
T ss_dssp             HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             HCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence            8876543       23344567788876443221   1235689999999999998889999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccc---------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         144 PFETSTLKETYSRIKKVE---------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||.+.+.......+....                           ..++..++..+.++|.+||..||.+|||+.++++|
T Consensus       218 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            999888776665553210                           01234578889999999999999999999999999


Q ss_pred             ccccccC
Q psy6191         197 EFFNDYC  203 (305)
Q Consensus       197 ~~~~~~~  203 (305)
                      |||++..
T Consensus       298 p~~~~~~  304 (326)
T 1blx_A          298 PYFQDLE  304 (326)
T ss_dssp             GGGTTCC
T ss_pred             ccccccc
Confidence            9998643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.98  E-value=3.4e-33  Score=237.75  Aligned_cols=192  Identities=13%  Similarity=0.181  Sum_probs=144.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+|||||+||+|.+++......  ...... .....+..++.++|..++.|.
T Consensus        60 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivH~  137 (289)
T 4fvq_A           60 FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLAAAMHFLEENTLIHG  137 (289)
T ss_dssp             HHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGG--CCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCC--CCHHHHHHHHHHHHHHHHHHhhCCeECC
Confidence            47999999999999999999999999999999999999999999765321  111111 223345678888888776443


Q ss_pred             e-------cCCCCC--------eeEcchhHHHHhcCCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhC-CC
Q psy6191          81 L-------NDDSSG--------VMFNDLTRMIMLANKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVG-KP  143 (305)
Q Consensus        81 ~-------~~~~~~--------v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g-~~  143 (305)
                      -       .+....        +++.|++............||+.|+|||++.+ ..++.++||||+||++|+|++| .+
T Consensus       138 Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~  217 (289)
T 4fvq_A          138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK  217 (289)
T ss_dssp             CCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CcCcceEEEecCCcccccccceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence            1       111122        66777765444334445679999999999987 6789999999999999999995 55


Q ss_pred             CCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         144 PFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||...+...... .......+|...+.++.++|.+||..||.+|||+.+++++
T Consensus       218 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          218 PLSALDSQRKLQ-FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TTTTSCHHHHHH-HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CccccchHHHHH-HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            665555544433 3334556677788899999999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.98  E-value=1.3e-32  Score=241.65  Aligned_cols=198  Identities=24%  Similarity=0.352  Sum_probs=142.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   75 (305)
                      .+|++++++++|||||++++++.+     ...+|+|||||+ |+|.+.+.....  ........ .+..+..++.++|..
T Consensus        77 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~  153 (362)
T 3pg1_A           77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--VISPQHIQYFMYHILLGLHVLHEA  153 (362)
T ss_dssp             HHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            479999999999999999999853     347999999998 588887764321  11222222 233456788899888


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhc---CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      ++.|.       +.+..+.+++.||+......   .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.|
T Consensus       154 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  233 (362)
T 3pg1_A          154 GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL  233 (362)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence            76543       23345678888887554321   2345689999999999876 6789999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc------------------------c--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhh
Q psy6191         145 FETSTLKETYSRIKKVE------------------------Y--------KLPATLKKPAATMIKKMLLLDPVQRPPVAQ  192 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~------------------------~--------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  192 (305)
                      |.+.+..+....+....                        .        ..++..++.+.+||.+||..||.+|||+.|
T Consensus       234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  313 (362)
T 3pg1_A          234 FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ  313 (362)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence            99888766655543210                        0        112346788999999999999999999999


Q ss_pred             hhcCcccccc
Q psy6191         193 LLHFEFFNDY  202 (305)
Q Consensus       193 ~l~~~~~~~~  202 (305)
                      +++||||+..
T Consensus       314 ll~hp~f~~~  323 (362)
T 3pg1_A          314 ALRHPYFESL  323 (362)
T ss_dssp             HHTSGGGTTT
T ss_pred             HHcCchhhhc
Confidence            9999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.98  E-value=1.4e-32  Score=231.59  Aligned_cols=192  Identities=14%  Similarity=0.241  Sum_probs=142.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhC--
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYG--   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--   76 (305)
                      .+|+.++++++|||||++++++.++  +..|+|||||++|+|.+++...... .+.... ......+..++.++|..+  
T Consensus        55 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~~~  133 (271)
T 3kmu_A           55 NEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHTLEPL  133 (271)
T ss_dssp             HHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSC-CCCHHHHHHHHHHHHHHHHHHTTSSSC
T ss_pred             HHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccC-CCCHHHHHHHHHHHHHHHHHHhcCCCc
Confidence            4799999999999999999999987  7899999999999999999764321 112211 222334567888888776  


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccccCCCCc---cchHHHHHHHHHHHHhCCCCCC
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSF---EVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~---~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      +.|.       +.+....+++.|++.... ......+||+.|+|||++.+..++.   ++||||+||++|||++|+.||.
T Consensus       134 i~H~dikp~Nil~~~~~~~~l~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  212 (271)
T 3kmu_A          134 IPRHALNSRSVMIDEDMTARISMADVKFS-FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA  212 (271)
T ss_dssp             CTTCCCSGGGEEECTTSCEEEEGGGSCCT-TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred             eecCCCccceEEEcCCcceeEEeccceee-ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            4332       112223333333322111 1234567999999999998765444   7999999999999999999999


Q ss_pred             CCCHHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +.+..+....+..  .....|...+..+.++|.+||..||.+|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          213 DLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8887776555543  244567789999999999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.98  E-value=9.9e-33  Score=239.85  Aligned_cols=199  Identities=24%  Similarity=0.358  Sum_probs=147.3

Q ss_pred             hhHHHHHhcCCCCC------ccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRN------VVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~Hpn------IV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   74 (305)
                      .+|+++++.++|+|      ||++++++++++.+|+||||| +|+|.+++....... ..... ...+..+..++.++|.
T Consensus        59 ~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-~~~~~~~~~~~qi~~~l~~lH~  136 (339)
T 1z57_A           59 RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP-FRLDHIRKMAYQICKSVNFLHS  136 (339)
T ss_dssp             HHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCC-CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCC-CcHHHHHHHHHHHHHHHHHHHH
Confidence            47899999887765      999999999999999999999 899999987654221 12211 2233445678889888


Q ss_pred             hCCcee--------ecCC------------------CCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccch
Q psy6191          75 YGFGYQ--------LNDD------------------SSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVD  127 (305)
Q Consensus        75 ~~~~~~--------~~~~------------------~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~D  127 (305)
                      .++.|.        +...                  ...+++.||+...... ...+.+||+.|+|||++.+..++.++|
T Consensus       137 ~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  216 (339)
T 1z57_A          137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCD  216 (339)
T ss_dssp             TTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHH
T ss_pred             CCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchh
Confidence            775433        2111                  2346777776443322 234568999999999999888999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCC------------------------------------------
Q psy6191         128 VWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP------------------------------------------  165 (305)
Q Consensus       128 iwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------------------  165 (305)
                      |||+||++|||++|..||...+..+....+......+|                                          
T Consensus       217 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
T 1z57_A          217 VWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML  296 (339)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCS
T ss_pred             hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcc
Confidence            99999999999999999998877665444432211111                                          


Q ss_pred             --CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         166 --ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       166 --~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                        ...+..+.+||.+||..||.+|||+.|+++||||+..
T Consensus       297 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred             cchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence              1123567899999999999999999999999999853

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.98  E-value=2.5e-32  Score=236.13  Aligned_cols=205  Identities=16%  Similarity=0.201  Sum_probs=145.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeE------EEEEeccCCCCHHHHHHHhcCCC---CCCCcCc-hhHHHHHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFV------YIILELCRKRSMMELYNSACDLE---EMSDPAA-QPVIWVSKWVDY   71 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~------ylVmEy~~~g~L~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~   71 (305)
                      .+|++++++++|||||++++++.+.+..      |+|||||++|+|.+++.......   .+..... ..+..+..++.+
T Consensus        73 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~  152 (323)
T 3qup_A           73 LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY  152 (323)
T ss_dssp             HHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHH
Confidence            4799999999999999999999887665      99999999999999986543211   1121111 223345678888


Q ss_pred             hhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          72 SDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        72 ~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      +|..|+.|.       +.+....+++.||+.......      .....||+.|+|||++.+..++.++||||+||++|+|
T Consensus       153 LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  232 (323)
T 3qup_A          153 LSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI  232 (323)
T ss_dssp             HHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             HHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHH
Confidence            888776443       233446788888875543221      1234578899999999988999999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCC-------HhhhhcCccccccCCCC
Q psy6191         139 LV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPP-------VAQLLHFEFFNDYCPTS  206 (305)
Q Consensus       139 l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~-------~~~~l~~~~~~~~~~~~  206 (305)
                      ++ |.+||.+.+..+....+... ....+...+..+.++|.+||..||.+|||       +++++.|+|+......+
T Consensus       233 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          233 MTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             HTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred             HhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence            99 99999988877776666544 34567788999999999999999999999       67778899998654443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.98  E-value=3.1e-32  Score=237.41  Aligned_cols=194  Identities=15%  Similarity=0.199  Sum_probs=151.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC---------------------CCCCcCc-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE---------------------EMSDPAA-   59 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~---------------------~~~~~~~-   59 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||++|+|.+++.......                     .+..... 
T Consensus        98 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  177 (343)
T 1luf_A           98 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL  177 (343)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHH
T ss_pred             HHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHH
Confidence            579999999999999999999999999999999999999999997642210                     0111111 


Q ss_pred             hhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccc
Q psy6191          60 QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEV  126 (305)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~  126 (305)
                      ..+..+..++.++|..++.|.       +.+....+++.||+......      ......||+.|+|||++.+..++.++
T Consensus       178 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  257 (343)
T 1luf_A          178 CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES  257 (343)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCccc
Confidence            122345678889998876443       22334567788887554432      12345789999999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         127 DVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       127 DiwSlGvilye~l~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||||+||++|+|++ |..||.+.+..+....+..... ..|...+..+.++|.+||..||.+|||+.++++
T Consensus       258 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          258 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            99999999999999 9999999888887777765543 566788999999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.98  E-value=3.5e-32  Score=239.81  Aligned_cols=195  Identities=24%  Similarity=0.376  Sum_probs=146.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeE------EEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFV------YIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~------ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+.+++.++|||||++++++.+.+..      |+|||||. |+|.+.+...     ...... ..+..+..++.++|.
T Consensus        89 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~  162 (371)
T 4exu_A           89 YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGME-----FSEEKIQYLVYQMLKGLKYIHS  162 (371)
T ss_dssp             HHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTSC-----CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHH
Confidence            4799999999999999999999987765      99999998 5787765321     122222 223345678888888


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhc-CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .|+.+.       +.+....+++.||+...... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||
T Consensus       163 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  242 (371)
T 4exu_A          163 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF  242 (371)
T ss_dssp             TTCCCSCCCGGGEEECTTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCcCCCcCHHHeEECCCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence            776443       33344668888887554332 2345689999999999876 67899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhcccc-------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         146 ETSTLKETYSRIKKVEY-------------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .+.+..+....+.....                               ..++..+..+.+||.+||+.||.+|||+.|++
T Consensus       243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  322 (371)
T 4exu_A          243 KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL  322 (371)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             CCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence            98887666555432110                               11235688999999999999999999999999


Q ss_pred             cCcccccc
Q psy6191         195 HFEFFNDY  202 (305)
Q Consensus       195 ~~~~~~~~  202 (305)
                      +||||+..
T Consensus       323 ~hp~f~~~  330 (371)
T 4exu_A          323 THPFFEPF  330 (371)
T ss_dssp             TSGGGTTT
T ss_pred             cCcccccC
Confidence            99999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.98  E-value=1.6e-32  Score=237.73  Aligned_cols=192  Identities=18%  Similarity=0.254  Sum_probs=148.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|||||||+||+|.+++......  ...... ..+..+..++.++|..++.|.
T Consensus        98 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivH~  175 (325)
T 3kul_A           98 LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYLSDLGYVHR  175 (325)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTC--SCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence            47999999999999999999999999999999999999999998653211  121111 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+.......       .....||+.|+|||++.+..++.++||||+||++|+|++ |..||
T Consensus       176 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~  255 (325)
T 3kul_A          176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY  255 (325)
T ss_dssp             CCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence                   233445677888764432211       122356788999999998889999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.+..+....+... ....|...+..+.++|.+||..||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          256 WNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            998888877776554 44566788999999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=3.4e-32  Score=238.13  Aligned_cols=197  Identities=22%  Similarity=0.334  Sum_probs=146.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|++++++++|||||++++++..+     ...|+||||+. |+|.+++... .+   ..... ..+..+..++.++|..
T Consensus        57 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~---~~~~~~~~~~qi~~~L~~LH~~  131 (353)
T 2b9h_A           57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ-ML---SDDHIQYFIYQTLRAVKVLHGS  131 (353)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC-CC---CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc-CC---CHHHHHHHHHHHHHHHHHHHHC
Confidence            3799999999999999999988764     78999999998 5899888753 11   22222 2233456788888887


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhc--------------CCcccccCCCccccccccc-CCCCccchHHHHHH
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLA--------------NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGC  133 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~--------------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGv  133 (305)
                      |+.|.       +.+....+++.||+......              .....+||+.|+|||++.+ ..++.++||||+||
T Consensus       132 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~  211 (353)
T 2b9h_A          132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGC  211 (353)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHH
T ss_pred             CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHH
Confidence            75432       23344567888886433211              1124589999999998754 67899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHhccc------------------------c--------CCCCCCCHHHHHHHHHHhh
Q psy6191         134 IMYTLLVGKPPFETSTLKETYSRIKKVE------------------------Y--------KLPATLKKPAATMIKKMLL  181 (305)
Q Consensus       134 ilye~l~g~~Pf~~~~~~~~~~~i~~~~------------------------~--------~~~~~~~~~~~~li~~~l~  181 (305)
                      ++|+|++|++||.+.+..+....+....                        .        ..++..+..+.++|.+||.
T Consensus       212 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  291 (353)
T 2b9h_A          212 ILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV  291 (353)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSC
T ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcC
Confidence            9999999999999887665544332100                        0        0123578889999999999


Q ss_pred             cCCCCCCCHhhhhcCccccccC
Q psy6191         182 LDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       182 ~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                      .||.+|||+.++++||||+...
T Consensus       292 ~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          292 FDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             SSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cCcccCCCHHHHhcCccccccC
Confidence            9999999999999999998643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=3e-32  Score=236.36  Aligned_cols=195  Identities=19%  Similarity=0.350  Sum_probs=144.2

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   77 (305)
                      .+|+.++++++ |||||++++++.+  ....|+|||||++|+|.+++..   +   ..... ..+..+..++.++|..|+
T Consensus        78 ~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~---~~~~~~~~~~qi~~~l~~lH~~~i  151 (330)
T 3nsz_A           78 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---L---TDYDIRFYMYEILKALDYCHSMGI  151 (330)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---C---CHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---C---CHHHHHHHHHHHHHHHHHHHhCCe
Confidence            58999999997 9999999999998  6789999999999999988743   1   22222 223345678888888775


Q ss_pred             cee--------ecCCCCCeeEcchhHHHHhc---CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          78 GYQ--------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        78 ~~~--------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .|.        +..+...+++.||+......   .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||
T Consensus       152 vH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~  231 (330)
T 3nsz_A          152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF  231 (330)
T ss_dssp             ECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             eeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence            432        33233367788887554322   2245689999999999876 66899999999999999999999999


Q ss_pred             CCC-CHHHHHHHH-------------hccccC------------------------CCCCCCHHHHHHHHHHhhcCCCCC
Q psy6191         146 ETS-TLKETYSRI-------------KKVEYK------------------------LPATLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       146 ~~~-~~~~~~~~i-------------~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~R  187 (305)
                      ... +..+....+             ......                        .+..++.++.+||.+||..||.+|
T Consensus       232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  311 (330)
T 3nsz_A          232 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR  311 (330)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGS
T ss_pred             ccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccC
Confidence            543 222222211             111111                        112278899999999999999999


Q ss_pred             CCHhhhhcCcccccc
Q psy6191         188 PPVAQLLHFEFFNDY  202 (305)
Q Consensus       188 ~~~~~~l~~~~~~~~  202 (305)
                      ||++|+++||||+..
T Consensus       312 pta~e~l~hp~f~~~  326 (330)
T 3nsz_A          312 LTAREAMEHPYFYTV  326 (330)
T ss_dssp             CCHHHHHTSGGGTTC
T ss_pred             CCHHHHhcCccHhhh
Confidence            999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=9.9e-33  Score=238.37  Aligned_cols=197  Identities=20%  Similarity=0.282  Sum_probs=141.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC--eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK--FVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~--~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++|||||++++++.+.+  .+|||||||+||+|.+++........+...... .+..+..++.++|..++.
T Consensus        55 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv  134 (319)
T 4euu_A           55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV  134 (319)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            37999999999999999999998765  889999999999999999765432212222222 233456788888877754


Q ss_pred             ee--------e-c--CCCCCeeEcchhHHHHhcC---CcccccCCCcccccccc--------cCCCCccchHHHHHHHHH
Q psy6191          79 YQ--------L-N--DDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILN--------KNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        79 ~~--------~-~--~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~--------~~~~~~~~DiwSlGvily  136 (305)
                      +.        + .  +....+++.||+.......   ..+.+||+.|+|||++.        +..++.++||||+||++|
T Consensus       135 H~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~  214 (319)
T 4euu_A          135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY  214 (319)
T ss_dssp             CSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHH
Confidence            32        1 0  2223466778765543322   23567999999999886        467889999999999999


Q ss_pred             HHHhCCCCCCCCC----HHHHHHHHhcccc-------------------CCC------CCCCHHHHHHHHHHhhcCCCCC
Q psy6191         137 TLLVGKPPFETST----LKETYSRIKKVEY-------------------KLP------ATLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       137 e~l~g~~Pf~~~~----~~~~~~~i~~~~~-------------------~~~------~~~~~~~~~li~~~l~~dp~~R  187 (305)
                      ||++|+.||...+    ..+....+....+                   .+|      ..++..+.++|++||+.||++|
T Consensus       215 el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R  294 (319)
T 4euu_A          215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC  294 (319)
T ss_dssp             HHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTS
T ss_pred             HHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhh
Confidence            9999999996432    2334444433221                   111      1233467889999999999999


Q ss_pred             CCHhhhhcCcc
Q psy6191         188 PPVAQLLHFEF  198 (305)
Q Consensus       188 ~~~~~~l~~~~  198 (305)
                      ||++|+++||-
T Consensus       295 ~s~~ell~h~~  305 (319)
T 4euu_A          295 WGFDQFFAETS  305 (319)
T ss_dssp             CCHHHHHHHHH
T ss_pred             ccHHHhhhccH
Confidence            99999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=1e-31  Score=235.67  Aligned_cols=199  Identities=18%  Similarity=0.247  Sum_probs=140.0

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCe-------EEEEEeccCCCCHHHHHHHh-cCCCCCCCcCch-hHHHHHHHHHHhh
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKF-------VYIILELCRKRSMMELYNSA-CDLEEMSDPAAQ-PVIWVSKWVDYSD   73 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~-------~ylVmEy~~~g~L~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~   73 (305)
                      +|+..++.++|||||++++++.+.+.       +|+|||||+++ |.+.+... ............ .+..+..++.+.|
T Consensus        68 ~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH  146 (360)
T 3e3p_A           68 QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH  146 (360)
T ss_dssp             HHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence            46667788899999999999976443       89999999974 44443321 111111221122 2233466777777


Q ss_pred             --hhCCce--------eecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccC-CCCccchHHHHHHHHHHHH
Q psy6191          74 --KYGFGY--------QLNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        74 --~~~~~~--------~~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l  139 (305)
                        ..++.|        ++....+.+++.||+.......   ....+||+.|+|||++.+. .++.++||||+||++|+|+
T Consensus       147 ~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell  226 (360)
T 3e3p_A          147 LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM  226 (360)
T ss_dssp             STTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence              666543        2332245677788765543322   2356799999999998654 4899999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHhcccc--------------------------------CCCCCCCHHHHHHHHHHhhcCCCCC
Q psy6191         140 VGKPPFETSTLKETYSRIKKVEY--------------------------------KLPATLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       140 ~g~~Pf~~~~~~~~~~~i~~~~~--------------------------------~~~~~~~~~~~~li~~~l~~dp~~R  187 (305)
                      +|++||.+.+.......+.....                                ..+...+.++.+||.+||+.||.+|
T Consensus       227 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  306 (360)
T 3e3p_A          227 LGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER  306 (360)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGS
T ss_pred             hCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcccc
Confidence            99999999887766655532100                                1112245788999999999999999


Q ss_pred             CCHhhhhcCcccccc
Q psy6191         188 PPVAQLLHFEFFNDY  202 (305)
Q Consensus       188 ~~~~~~l~~~~~~~~  202 (305)
                      ||+.|+++||||+..
T Consensus       307 pt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          307 MKPYEALCHPYFDEL  321 (360)
T ss_dssp             CCHHHHTTSGGGGGG
T ss_pred             CCHHHHhcCcccccc
Confidence            999999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=2.8e-32  Score=234.73  Aligned_cols=192  Identities=17%  Similarity=0.221  Sum_probs=138.5

Q ss_pred             hHHHHHh-cCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIHR-SLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~-~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|+..+. ..+|||||++++++++++.+||||||| +|+|.+.+......  +..... ..+..+..++.++|..++.+.
T Consensus       105 ~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~  181 (311)
T 3p1a_A          105 AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS--LPEAQVWGYLRDTLLALAHLHSQGLVHL  181 (311)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            3444444 449999999999999999999999999 67898887665321  122222 223345678888887765432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                             +.+....+++.||+......   .....+||+.|+|||++.+ .++.++||||+||++|||++|..||.+...
T Consensus       182 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~  260 (311)
T 3p1a_A          182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG  260 (311)
T ss_dssp             CCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH
T ss_pred             CCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence                   22334567777776433221   1234579999999999876 689999999999999999999777765432


Q ss_pred             HHHHHHHhccc--cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         151 KETYSRIKKVE--YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       151 ~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .   ..+....  ..++..++.++.++|.+||+.||.+|||+.|+++||||+.
T Consensus       261 ~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          261 W---QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             H---HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             H---HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            2   2233221  2234568899999999999999999999999999999974

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=8.2e-32  Score=228.59  Aligned_cols=193  Identities=19%  Similarity=0.234  Sum_probs=152.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++.+|+|||||++|+|.+++......  ...... ..+..+..++.++|+.++.|.
T Consensus        67 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~  144 (283)
T 3gen_A           67 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQFLHR  144 (283)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGC--CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            47999999999999999999999999999999999999999998753211  122222 223345677888888776442


Q ss_pred             -------ecCCCCCeeEcchhHHHHh-----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML-----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.....     .......||+.|+|||++.+..++.++||||+||++|+|++ |+.||..
T Consensus       145 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~  224 (283)
T 3gen_A          145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER  224 (283)
T ss_dssp             SCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence                   3334467888888755432     22234567889999999998889999999999999999998 9999999


Q ss_pred             CCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+.... ...|...+..+.++|.+||..||.+|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          225 FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            88887777776543 34566788999999999999999999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=8.8e-33  Score=243.65  Aligned_cols=193  Identities=12%  Similarity=0.103  Sum_probs=132.2

Q ss_pred             HHHHhcCCCCCcccee-------EEEEcC-----------------CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-
Q psy6191           5 IAIHRSLKHRNVVGFH-------SFFEDS-----------------KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-   59 (305)
Q Consensus         5 i~il~~l~HpnIV~l~-------~~~~~~-----------------~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-   59 (305)
                      +.+++. +|||||+++       +++..+                 ..+|||||||+ |+|.+++.......  ..... 
T Consensus       116 ~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~--~~~~~~  191 (371)
T 3q60_A          116 AARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVY--VFRGDE  191 (371)
T ss_dssp             HHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSC--CCCHHH
T ss_pred             HHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcccc--chhhhh
Confidence            455666 799988765       666544                 33899999999 89999997653321  11111 


Q ss_pred             -----hhH-HHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcCCc-ccccCCCccccccccc--CCCC
Q psy6191          60 -----QPV-IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKN-TLCGTPNYIAPEILNK--NGHS  123 (305)
Q Consensus        60 -----~~~-~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~~~-~~~Gt~~y~aPE~~~~--~~~~  123 (305)
                           ..+ ..+..++.|+|..++.|.       +.+..+.+++.||+......... ...||+.|+|||++.+  ..++
T Consensus       192 ~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  271 (371)
T 3q60_A          192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFT  271 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECC
T ss_pred             hhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcC
Confidence                 122 456788899998775432       33344678888887665444333 5578899999999987  6789


Q ss_pred             ccchHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HhccccCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         124 FEVDVWSIGCIMYTLLVGKPPFETSTLKET--YSR-----IKKVEYKL--PATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       124 ~~~DiwSlGvilye~l~g~~Pf~~~~~~~~--~~~-----i~~~~~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .++||||+||++|||++|+.||.+.+....  +..     .....+.+  +..++..+.++|.+||..||.+|||+.+++
T Consensus       272 ~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  351 (371)
T 3q60_A          272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM  351 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            999999999999999999999987643211  100     01112222  246889999999999999999999999999


Q ss_pred             cCccccc
Q psy6191         195 HFEFFND  201 (305)
Q Consensus       195 ~~~~~~~  201 (305)
                      +||||+.
T Consensus       352 ~hp~f~~  358 (371)
T 3q60_A          352 ETPEFLQ  358 (371)
T ss_dssp             TSHHHHH
T ss_pred             cCHHHHH
Confidence            9999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=3.9e-32  Score=234.34  Aligned_cols=196  Identities=20%  Similarity=0.324  Sum_probs=146.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE--------------cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE--------------DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~--------------~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~   66 (305)
                      .+|++++++++|||||++++++.              +.+.+|+||||++ |+|.+++... .+   ..... ..+..+.
T Consensus        56 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~---~~~~~~~~~~qi~  130 (320)
T 2i6l_A           56 LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG-PL---LEEHARLFMYQLL  130 (320)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC-CC---CHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcC-Cc---cHHHHHHHHHHHH
Confidence            47999999999999999999884              4478999999998 6999988542 11   22222 2233456


Q ss_pred             HHHHHhhhhCCcee--------ecCCCCCeeEcchhHHHHh-------cCCcccccCCCccccccccc-CCCCccchHHH
Q psy6191          67 KWVDYSDKYGFGYQ--------LNDDSSGVMFNDLTRMIML-------ANKNTLCGTPNYIAPEILNK-NGHSFEVDVWS  130 (305)
Q Consensus        67 ~~~~~~~~~~~~~~--------~~~~~~~v~~~d~~~~~~~-------~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwS  130 (305)
                      .++.++|..|+.|.        +...+..+++.||+.....       .......||+.|+|||++.+ ..++.++||||
T Consensus       131 ~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  210 (320)
T 2i6l_A          131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA  210 (320)
T ss_dssp             HHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHH
T ss_pred             HHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHh
Confidence            78888888776443        2223346777787644322       12234568999999998765 67899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHhcccc------------------------------CCCCCCCHHHHHHHHHHh
Q psy6191         131 IGCIMYTLLVGKPPFETSTLKETYSRIKKVEY------------------------------KLPATLKKPAATMIKKML  180 (305)
Q Consensus       131 lGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~------------------------------~~~~~~~~~~~~li~~~l  180 (305)
                      +||++|||++|+.||.+.+..+....+.....                              ..+..++.++.++|.+||
T Consensus       211 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  290 (320)
T 2i6l_A          211 AGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL  290 (320)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTS
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHc
Confidence            99999999999999998887666555432211                              012457889999999999


Q ss_pred             hcCCCCCCCHhhhhcCcccccc
Q psy6191         181 LLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       181 ~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..||.+|||++++++||||+..
T Consensus       291 ~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          291 TFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             CSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CCCccccCCHHHHhCCcccccc
Confidence            9999999999999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=2.6e-33  Score=247.52  Aligned_cols=194  Identities=13%  Similarity=0.250  Sum_probs=142.1

Q ss_pred             hhHH---HHHhcCCCCCcccee-------EEEEcCCe-----------------EEEEEeccCCCCHHHHHHHhcCCCCC
Q psy6191           2 SQEI---AIHRSLKHRNVVGFH-------SFFEDSKF-----------------VYIILELCRKRSMMELYNSACDLEEM   54 (305)
Q Consensus         2 ~~Ei---~il~~l~HpnIV~l~-------~~~~~~~~-----------------~ylVmEy~~~g~L~~~~~~~~~~~~~   54 (305)
                      .+|+   +++++++|||||+++       +++++++.                 .||||||| +|+|.+++.....+.+.
T Consensus       121 ~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~  199 (377)
T 3byv_A          121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSST  199 (377)
T ss_dssp             HHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTT
T ss_pred             HHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccc
Confidence            4788   556667899999999       88877653                 89999999 68999999875443220


Q ss_pred             C----CcCc-hhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC-CcccccCCCcccccccccC-
Q psy6191          55 S----DPAA-QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNKN-  120 (305)
Q Consensus        55 ~----~~~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~-  120 (305)
                      .    .... ..+..+..++.|+|..++.|.       +.+..+.+++.||+....... ..+.+| +.|+|||++.+. 
T Consensus       200 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~  278 (377)
T 3byv_A          200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRA  278 (377)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHT
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccc
Confidence            0    0111 233445778889988775432       233446788888875543222 245678 999999999877 


Q ss_pred             ----------CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCH
Q psy6191         121 ----------GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPV  190 (305)
Q Consensus       121 ----------~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  190 (305)
                                .++.++|||||||++|||++|+.||.+.+.......+.    ..+..++.++.++|.+||..||.+|||+
T Consensus       279 ~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             STHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             cccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence                      79999999999999999999999998765443333232    2345788999999999999999999999


Q ss_pred             hhhhcCccccc
Q psy6191         191 AQLLHFEFFND  201 (305)
Q Consensus       191 ~~~l~~~~~~~  201 (305)
                      .++++||||+.
T Consensus       355 ~e~l~hp~f~~  365 (377)
T 3byv_A          355 LQAMETPEYEQ  365 (377)
T ss_dssp             HHHHTSHHHHH
T ss_pred             HHHhhChHHHH
Confidence            99999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=9.1e-32  Score=233.13  Aligned_cols=199  Identities=15%  Similarity=0.188  Sum_probs=156.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC----CCCc-CchhHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE----MSDP-AAQPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~   76 (305)
                      .+|+.++++++|||||++++++.+++..|+|||||+||+|.+++........    +... ....+..+..++.++|..+
T Consensus        81 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~  160 (327)
T 2yfx_A           81 LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH  160 (327)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence            4799999999999999999999999999999999999999999987543211    1111 1122334567788888877


Q ss_pred             Ccee--------ecC--CCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh
Q psy6191          77 FGYQ--------LND--DSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        77 ~~~~--------~~~--~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~  140 (305)
                      +.|.        +..  ....+++.||+......      ......||+.|+|||++.+..++.++||||+||++|+|++
T Consensus       161 i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  240 (327)
T 2yfx_A          161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS  240 (327)
T ss_dssp             CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHc
Confidence            6442        221  23357888987665432      2234578999999999988889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         141 -GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       141 -g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                       |..||...+..+....+... ....+...+..+.++|.+||..||.+||++.+++++.|.-
T Consensus       241 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          241 LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence             99999988887777666554 3455677899999999999999999999999999987764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=8.8e-32  Score=241.90  Aligned_cols=197  Identities=24%  Similarity=0.409  Sum_probs=138.4

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCC----C-cCchhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMS----D-PAAQPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~   75 (305)
                      .+|+.+++++ +|||||++++++++++.+|||||||. |+|.+++..........    . .....+..++.++.|+|..
T Consensus        56 ~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  134 (434)
T 2rio_A           56 LMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL  134 (434)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC
Confidence            4799999876 89999999999999999999999996 69999997654322110    1 1122344567888999987


Q ss_pred             CCcee--------ecC------------CCCCeeEcchhHHHHhcC--------CcccccCCCccccccccc-------C
Q psy6191          76 GFGYQ--------LND------------DSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNK-------N  120 (305)
Q Consensus        76 ~~~~~--------~~~------------~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~-------~  120 (305)
                      ++.|.        +..            ....+++.||+.......        ....+||+.|+|||++.+       .
T Consensus       135 ~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  214 (434)
T 2rio_A          135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKR  214 (434)
T ss_dssp             TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCC
T ss_pred             CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccccccc
Confidence            75443        221            123567777764432211        234689999999999865       5


Q ss_pred             CCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccccCCCC-------CCCHHHHHHHHHHhhcCCCCCCCHhh
Q psy6191         121 GHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVEYKLPA-------TLKKPAATMIKKMLLLDPVQRPPVAQ  192 (305)
Q Consensus       121 ~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~~~~~~i~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~R~~~~~  192 (305)
                      .++.++||||+||++|||++ |..||......+.  .+.......+.       .++.++.++|.+||..||.+|||+.+
T Consensus       215 ~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (434)
T 2rio_A          215 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK  292 (434)
T ss_dssp             CCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence            68899999999999999999 9999976544332  23222222221       23467899999999999999999999


Q ss_pred             hhcCccccc
Q psy6191         193 LLHFEFFND  201 (305)
Q Consensus       193 ~l~~~~~~~  201 (305)
                      +++||||..
T Consensus       293 il~hp~f~~  301 (434)
T 2rio_A          293 VLRHPLFWP  301 (434)
T ss_dssp             HHTSGGGSC
T ss_pred             HHhCCccCC
Confidence            999999964

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=1.2e-31  Score=228.17  Aligned_cols=198  Identities=20%  Similarity=0.291  Sum_probs=138.9

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhh-CCce
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKY-GFGY   79 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~   79 (305)
                      +|...++.++|||||++++++.+++..|+|||||+| +|.+++...... ..+..... ..+..+..++.+.|.. |+.|
T Consensus        55 ~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H  133 (290)
T 3fme_A           55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH  133 (290)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCC
T ss_pred             HHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec
Confidence            445568889999999999999999999999999985 887777542111 11222222 2233456788888876 7644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCccccccc----ccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEIL----NKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~----~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .       +.+....+++.||+.......   ....+||+.|+|||++    .+..++.++||||+||++|+|++|+.||
T Consensus       134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  213 (290)
T 3fme_A          134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY  213 (290)
T ss_dssp             CCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred             CCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            3       233446788888876543322   2345799999999996    4566889999999999999999999999


Q ss_pred             CC-CCHHHHHH-HHhccccCCC-CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         146 ET-STLKETYS-RIKKVEYKLP-ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       146 ~~-~~~~~~~~-~i~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .. ........ .+.......+ ...+.++.++|.+||..||.+|||+.|+++||||+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          214 DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             CCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             cccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            86 33333333 3333333333 368899999999999999999999999999999975

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=5.7e-32  Score=238.94  Aligned_cols=192  Identities=19%  Similarity=0.266  Sum_probs=149.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+++.+|||||||+||+|.+++......  +... ....+..++.++.|+|..++.|.
T Consensus       160 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~ivHr  237 (377)
T 3cbl_A          160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLESKCCIHR  237 (377)
T ss_dssp             THHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCcCCc
Confidence            57999999999999999999999999999999999999999998764321  1111 12223345678888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+..+.+++.||+.......      .+...+|+.|+|||++.+..++.++||||+||++|||++ |..||.
T Consensus       238 Dlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~  317 (377)
T 3cbl_A          238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP  317 (377)
T ss_dssp             CCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                   233446788888875432211      122345778999999988889999999999999999998 999999


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +.+..+....+... ..+.|...+..+.++|.+||..||.+|||+.++++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          318 NLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            88877766665543 34567778999999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=1.5e-32  Score=240.31  Aligned_cols=200  Identities=21%  Similarity=0.343  Sum_probs=146.4

Q ss_pred             hhHHHHHhcCCCCC------ccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRN------VVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~Hpn------IV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+.++++++|+|      |+.++++++..+.+||||||| +|++.+.+...... .+..... ..+..+..++.++|.
T Consensus        64 ~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~lH~  141 (355)
T 2eu9_A           64 RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQ-PYPLPHVRHMAYQLCHALRFLHE  141 (355)
T ss_dssp             HHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            47999999998777      999999999999999999999 66777776654211 1122222 223345678888887


Q ss_pred             hCCcee--------ec------------------CCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccch
Q psy6191          75 YGFGYQ--------LN------------------DDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVD  127 (305)
Q Consensus        75 ~~~~~~--------~~------------------~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~D  127 (305)
                      .++.|.        +.                  +....+++.||+...... ...+.+||+.|+|||++.+..++.++|
T Consensus       142 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  221 (355)
T 2eu9_A          142 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCD  221 (355)
T ss_dssp             TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHH
T ss_pred             CCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccc
Confidence            775432        21                  223456777776543322 234568999999999999888999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCC-----------------------------------------
Q psy6191         128 VWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA-----------------------------------------  166 (305)
Q Consensus       128 iwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~-----------------------------------------  166 (305)
                      |||+||++|||++|..||.+.+..+....+......+|.                                         
T Consensus       222 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (355)
T 2eu9_A          222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML  301 (355)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCS
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccc
Confidence            999999999999999999988766654443322111111                                         


Q ss_pred             ---CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccccC
Q psy6191         167 ---TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYC  203 (305)
Q Consensus       167 ---~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~~  203 (305)
                         ..+..+.+||.+||..||.+|||+.|+++||||+...
T Consensus       302 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             ccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence               1134678999999999999999999999999998643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=1.2e-31  Score=225.55  Aligned_cols=193  Identities=16%  Similarity=0.248  Sum_probs=151.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+||||+++|+|.+++......  ..... ...+..+..++.+.|..++.|.
T Consensus        51 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~  128 (267)
T 3t9t_A           51 IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHR  128 (267)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCccc--CCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            47999999999999999999999999999999999999999998764321  11111 1223345677888888776442


Q ss_pred             -------ecCCCCCeeEcchhHHHHh-----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML-----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.|++.....     .......||+.|+|||++.+..++.++||||+||++|+|++ |..||..
T Consensus       129 dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (267)
T 3t9t_A          129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  208 (267)
T ss_dssp             SCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence                   2233456777887654432     12234568889999999998889999999999999999999 8999999


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+... ....|...+..+.+++.+||..||.+|||+.+++++
T Consensus       209 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          209 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8888877777654 334566788999999999999999999999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=7e-32  Score=238.76  Aligned_cols=195  Identities=18%  Similarity=0.290  Sum_probs=154.1

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-------------CCCCcCc-hhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-------------EMSDPAA-QPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-------------~~~~~~~-~~~~~~~   66 (305)
                      .+|+++++++ +|||||++++++.+++.+|+|||||++|+|.+++.......             .+..... ..+..++
T Consensus       122 ~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  201 (382)
T 3tt0_A          122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA  201 (382)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHH
Confidence            4799999999 99999999999999999999999999999999998754211             1111111 2233456


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.++|..++.+.       +.+....+++.||+......      ......||+.|+|||++.+..++.++||||+||
T Consensus       202 ~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~  281 (382)
T 3tt0_A          202 RGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV  281 (382)
T ss_dssp             HHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHH
Confidence            78888888776442       23344678888887544322      123456889999999999889999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++|+|++ |..||.+.+..+....+... ....|...+.++.++|.+||..||.+|||+.+++++
T Consensus       282 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          282 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999 99999998888877776654 445677889999999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=7.1e-32  Score=227.18  Aligned_cols=193  Identities=19%  Similarity=0.225  Sum_probs=150.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+|||||++|+|.+++......  +..... ..+..+..++.+.|..++.|.
T Consensus        51 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~  128 (268)
T 3sxs_A           51 FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESHQFIHR  128 (268)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            47999999999999999999999999999999999999999998765321  122222 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.......     .....||+.|+|||++.+..++.++||||+||++|+|++ |..||..
T Consensus       129 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (268)
T 3sxs_A          129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL  208 (268)
T ss_dssp             SCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence                   233445677778764432211     123456778999999998889999999999999999999 9999998


Q ss_pred             CCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+.... ...|...+..+.+++.+||..||.+|||+.+++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          209 YTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            88877776665543 34456678999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=3.4e-32  Score=234.23  Aligned_cols=195  Identities=13%  Similarity=0.204  Sum_probs=150.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC---------------------CCCcC-c
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE---------------------MSDPA-A   59 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~---------------------~~~~~-~   59 (305)
                      .+|++++++++|||||++++++.+++.+|+|||||+||+|.+++........                     +.... .
T Consensus        74 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (314)
T 2ivs_A           74 LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLI  153 (314)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHH
T ss_pred             HHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHH
Confidence            4799999999999999999999999999999999999999999986543110                     11111 1


Q ss_pred             hhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccc
Q psy6191          60 QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEV  126 (305)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~  126 (305)
                      ..+..+..++.++|..++.|.       +.+....+++.||+......      ......||+.|+|||++.+..++.++
T Consensus       154 ~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  233 (314)
T 2ivs_A          154 SFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS  233 (314)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHH
T ss_pred             HHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchh
Confidence            222345677888888775433       22234567777876543221      12344678999999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         127 DVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       127 DiwSlGvilye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||||+||++|+|++ |..||.+.+..+....+... ....|...+..+.++|.+||..||.+|||+.+++++
T Consensus       234 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999 99999988877776666544 345667889999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=7.5e-32  Score=228.70  Aligned_cols=192  Identities=20%  Similarity=0.302  Sum_probs=142.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++. ++..|+|||||++|+|.+++......  ...... ..+..+..++.+.|..++.|.
T Consensus        64 ~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~  140 (281)
T 1mp8_A           64 LQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESKRFVHR  140 (281)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTT--SCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            47999999999999999999984 56789999999999999998754311  121111 222345678888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+..+.+++.||+.......     .....||+.|+|||++.+..++.++||||+||++|||++ |.+||.+
T Consensus       141 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~  220 (281)
T 1mp8_A          141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  220 (281)
T ss_dssp             CCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence                   222345677888875543322     223457889999999998889999999999999999996 9999998


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+... ....|...+..+.++|.+||..||.+|||+.+++++
T Consensus       221 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          221 VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8777776666554 345677899999999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=7.2e-32  Score=227.46  Aligned_cols=191  Identities=18%  Similarity=0.304  Sum_probs=141.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhC---C
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYG---F   77 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~   77 (305)
                      .+|+++++.++|||||++++++.+++..|+|||||+||+|.+++... .+   ..... .....+..++.+.|..+   +
T Consensus        54 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~---~~~~~~~i~~~l~~~l~~lH~~~~~~i  129 (271)
T 3dtc_A           54 RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RI---PPDILVNWAVQIARGMNYLHDEAIVPI  129 (271)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS-CC---CHHHHHHHHHHHHHHHHHHHHSSSSCC
T ss_pred             HHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC-CC---CHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence            47999999999999999999999999999999999999999987532 11   22222 22334567788888776   3


Q ss_pred             ce--------eecC-------CCCCeeEcchhHHHHhcC--CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh
Q psy6191          78 GY--------QLND-------DSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        78 ~~--------~~~~-------~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~  140 (305)
                      .|        .+..       ....+++.||+.......  .....||+.|+|||++.+..++.++||||+||++|+|++
T Consensus       130 ~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~  209 (271)
T 3dtc_A          130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT  209 (271)
T ss_dssp             CCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH
T ss_pred             eecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence            22        2222       134577788765443222  234679999999999998889999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         141 GKPPFETSTLKETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       141 g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |+.||.+.+.......+...  ....|...+..+.++|.+||..||.+|||+.|++++
T Consensus       210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          210 GEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            99999988877665555433  345567789999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=1.2e-31  Score=242.18  Aligned_cols=193  Identities=22%  Similarity=0.322  Sum_probs=148.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC-eEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK-FVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~-~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++|++++|||||++++++.+++ .+|||||||++|+|.+++....... +... .......+..++.|+|..++.|
T Consensus       234 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~ivH  312 (450)
T 1k9a_A          234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNFVH  312 (450)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTT-CCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            47999999999999999999987655 7999999999999999998653310 1111 1223344567888888777543


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~  150 (305)
                      .       +.+....+++.||+...... ...+..+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.
T Consensus       313 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~  392 (450)
T 1k9a_A          313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  392 (450)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred             CCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            2       23344667888886443221 1223468899999999998899999999999999999998 9999998777


Q ss_pred             HHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         151 KETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       151 ~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+....+... ....|...+..+.++|.+||..||.+|||+.++++
T Consensus       393 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          393 KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6666666543 45567788999999999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=1.9e-32  Score=238.33  Aligned_cols=195  Identities=22%  Similarity=0.394  Sum_probs=120.9

Q ss_pred             HHHhcCCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           6 AIHRSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         6 ~il~~l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      ..++.++|||||++++++++    +..+|+|||||+||+|.+++...... .+..... ..+..+..++.++|..|+.|.
T Consensus        74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~ivH~  152 (336)
T 3fhr_A           74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-AFTEREAAEIMRDIGTAIQFLHSHNIAHR  152 (336)
T ss_dssp             HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CC-CCBHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            44677899999999999986    56699999999999999999764321 1122222 223345678888887775332


Q ss_pred             --------ecC--CCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LND--DSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~~--~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +..  ....+++.||+......  ...+.+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.
T Consensus       153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             CCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                    222  12347778876443221  224568999999999998888999999999999999999999999776


Q ss_pred             CHHHH----HHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         149 TLKET----YSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       149 ~~~~~----~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +....    ...+......+|    ..++..+.++|.+||..||.+|||+.|+++||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          233 TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             ------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            54332    122222222222    467899999999999999999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=1e-31  Score=228.56  Aligned_cols=193  Identities=20%  Similarity=0.326  Sum_probs=150.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||+||+|.+++...... ....... ..+..+..++.+.|..++.|.
T Consensus        57 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  135 (288)
T 3kfa_A           57 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFIHR  135 (288)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTT-TSCHHHHHHHHHHHHHHHHHHHHHTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccC-CccHhHHHHHHHHHHHHHHHHHHCCccCC
Confidence            47999999999999999999999999999999999999999999764321 1122222 222345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+........     ....||+.|+|||++.+..++.++||||+||++|+|++ |.+||.+
T Consensus       136 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~  215 (288)
T 3kfa_A          136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  215 (288)
T ss_dssp             CCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                   2233355777787765443221     23457889999999998889999999999999999999 9999998


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.......+... ....|...+..+.+++.+||..||.+|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          216 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            8777666655443 34566788999999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=235.32  Aligned_cols=195  Identities=24%  Similarity=0.375  Sum_probs=144.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCe------EEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKF------VYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~------~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+.++++++|||||++++++.+.+.      +|+||||+. |+|.+++...     +..... ..+..+..++.++|.
T Consensus        71 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~i~~qi~~al~~LH~  144 (353)
T 3coi_A           71 YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLK-----FSEEKIQYLVYQMLKGLKYIHS  144 (353)
T ss_dssp             HHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTSC-----CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHH
Confidence            479999999999999999999988754      499999998 5777665321     122222 223345678888888


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhc-CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .|+.|.       +.+....+++.||+...... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||
T Consensus       145 ~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  224 (353)
T 3coi_A          145 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF  224 (353)
T ss_dssp             TTCCCSSCCGGGEEECTTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCcccCCCCHHHEeECCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            776443       23344567888886543322 2235689999999999876 67899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccc-------------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         146 ETSTLKETYSRIKKVE-------------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .+.+..+....+....                               ...+...+..+.++|.+||..||.+|||+.+++
T Consensus       225 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  304 (353)
T 3coi_A          225 KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL  304 (353)
T ss_dssp             BSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            9887666554442210                               112345788999999999999999999999999


Q ss_pred             cCcccccc
Q psy6191         195 HFEFFNDY  202 (305)
Q Consensus       195 ~~~~~~~~  202 (305)
                      +||||+..
T Consensus       305 ~hp~f~~~  312 (353)
T 3coi_A          305 THPFFEPF  312 (353)
T ss_dssp             TSGGGTTT
T ss_pred             cCcchhhc
Confidence            99999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=1.7e-31  Score=235.46  Aligned_cols=192  Identities=15%  Similarity=0.212  Sum_probs=143.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+|||||||++|+|.+++......  ..... ...+..+..++.++|..++.|.
T Consensus        94 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~  171 (373)
T 2qol_A           94 LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDMGYVHR  171 (373)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTC--SCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCC--CCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence            47999999999999999999999999999999999999999998754211  11111 2223345678888988776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+........       ....||+.|+|||++.+..++.++||||+||++|||++ |+.||
T Consensus       172 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~  251 (373)
T 2qol_A          172 DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY  251 (373)
T ss_dssp             CCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTT
T ss_pred             CCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCC
Confidence                   3344567888888765443221       12245788999999998889999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+..+....+... ..+.+...+..+.+++.+||..||.+||++.++++
T Consensus       252 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             TTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            988887777666544 33445678889999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=1.9e-31  Score=230.93  Aligned_cols=192  Identities=17%  Similarity=0.227  Sum_probs=148.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||+++++++ ++..|+|||||++|+|.+++.....  .+.... ......+..++.|+|..++.|.
T Consensus        63 ~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  139 (325)
T 3kex_A           63 TDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEHGMVHR  139 (325)
T ss_dssp             CHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence            47999999999999999999986 4669999999999999999875321  112222 2233445788899998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+..+.+++.||+........      ....||+.|+|||++.+..++.++||||+||++|+|++ |..||.
T Consensus       140 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  219 (325)
T 3kex_A          140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA  219 (325)
T ss_dssp             CCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence                   2334466788888766543221      34568889999999998889999999999999999999 999999


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +.+..+....+... ....|...+.++.+++.+||..||.+|||+.+++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          220 GLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            88777776666554 345566788889999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=9.2e-32  Score=230.12  Aligned_cols=195  Identities=21%  Similarity=0.346  Sum_probs=139.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-------------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-------------SKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSK   67 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-------------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~   67 (305)
                      .+|+.++++++|||||++++++.+             ++.+|+|||||+||+|.+++......  .... ....+..+..
T Consensus        50 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~  127 (303)
T 1zy4_A           50 LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--QQRDEYWRLFRQILE  127 (303)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGG--GCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccc--cchHHHHHHHHHHHH
Confidence            479999999999999999998865             46799999999999999999753211  1111 1122334567


Q ss_pred             HHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhc------------------CCcccccCCCcccccccccC-C
Q psy6191          68 WVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------------------NKNTLCGTPNYIAPEILNKN-G  121 (305)
Q Consensus        68 ~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------------------~~~~~~Gt~~y~aPE~~~~~-~  121 (305)
                      ++.++|..++.|.       +.+..+.+++.|++......                  .....+||+.|+|||++.+. .
T Consensus       128 ~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  207 (303)
T 1zy4_A          128 ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH  207 (303)
T ss_dssp             HHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSC
T ss_pred             HHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCC
Confidence            8888888776442       23344567888875432211                  12356799999999998765 6


Q ss_pred             CCccchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         122 HSFEVDVWSIGCIMYTLLVGKPPFET-STLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       122 ~~~~~DiwSlGvilye~l~g~~Pf~~-~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++.++||||+||++|+|++   ||.. .+..+....+......+|.    ..+..+.++|.+||..||.+|||+.++++|
T Consensus       208 ~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          208 YNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            8999999999999999998   6653 2334445555554444443    455678999999999999999999999999


Q ss_pred             ccccc
Q psy6191         197 EFFND  201 (305)
Q Consensus       197 ~~~~~  201 (305)
                      |||+.
T Consensus       285 ~~~~~  289 (303)
T 1zy4_A          285 GWLPV  289 (303)
T ss_dssp             SCSCC
T ss_pred             CCcCC
Confidence            99974

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=4.3e-32  Score=233.43  Aligned_cols=190  Identities=18%  Similarity=0.262  Sum_probs=142.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++..|+|||||+||+|.+++......  ..... ......+..++.++|..++.|.
T Consensus        55 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~  132 (310)
T 3s95_A           55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSMNIIHR  132 (310)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTT--SCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            47999999999999999999999999999999999999999999763221  11111 2223345678888888775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC------------------CcccccCCCcccccccccCCCCccchHHHHHHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN------------------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIM  135 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~------------------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvil  135 (305)
                             +.+....+++.||+.......                  ..+.+||+.|+|||++.+..++.++||||+||++
T Consensus       133 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l  212 (310)
T 3s95_A          133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVL  212 (310)
T ss_dssp             CCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred             CCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHH
Confidence                   223345677888764332111                  1156899999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHH-----HHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         136 YTLLVGKPPFETSTLKET-----YSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       136 ye~l~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |||++|..||........     ....  .....|...+..+.+++.+||..||.+|||+.++++
T Consensus       213 ~el~~g~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          213 CEIIGRVNADPDYLPRTMDFGLNVRGF--LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHHHTCCSSTTTSCBCTTSSBCHHHH--HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCCCcchhhhHHHHhhhhhcc--ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999865321110     0000  112346778889999999999999999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=1.5e-31  Score=241.79  Aligned_cols=192  Identities=16%  Similarity=0.272  Sum_probs=150.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCC-cCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++. ++.+|||||||++|+|.+++....... ... ........++.++.|+|..++.|.
T Consensus       231 ~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~ivHr  308 (454)
T 1qcf_A          231 LAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNYIHR  308 (454)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHT-CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            48999999999999999999986 567999999999999999987532111 111 112223445778888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+......     ......||+.|+|||++....++.++|||||||++|||++ |+.||.+
T Consensus       309 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~  388 (454)
T 1qcf_A          309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG  388 (454)
T ss_dssp             SCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence                   33445678889987654432     1234457889999999998889999999999999999999 9999999


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ..+.|...+.++.++|.+||..||.+|||++++++
T Consensus       389 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          389 MSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            8887777666543 34556778999999999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=3.7e-32  Score=241.41  Aligned_cols=198  Identities=19%  Similarity=0.278  Sum_probs=137.7

Q ss_pred             hhHHHHHhcCC--------CCCccceeEEEE----cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHH
Q psy6191           2 SQEIAIHRSLK--------HRNVVGFHSFFE----DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKW   68 (305)
Q Consensus         2 ~~Ei~il~~l~--------HpnIV~l~~~~~----~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~   68 (305)
                      .+|+.++++++        |||||++++++.    ++..+||||||| +|++.+.+..... ..+..... ..+..++.+
T Consensus        81 ~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~a  158 (397)
T 1wak_A           81 LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQG  158 (397)
T ss_dssp             HHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHH
Confidence            47999999985        888999999998    667899999999 5667666654321 11222222 223345778


Q ss_pred             HHHhhhh-CCcee--------ecCCC------------------------------------------------CCeeEc
Q psy6191          69 VDYSDKY-GFGYQ--------LNDDS------------------------------------------------SGVMFN   91 (305)
Q Consensus        69 ~~~~~~~-~~~~~--------~~~~~------------------------------------------------~~v~~~   91 (305)
                      +.++|.. |+.|.        +..++                                                ..+++.
T Consensus       159 L~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~  238 (397)
T 1wak_A          159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA  238 (397)
T ss_dssp             HHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEEC
T ss_pred             HHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEec
Confidence            8899886 65443        21111                                                146666


Q ss_pred             chhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhccc---
Q psy6191          92 DLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST------LKETYSRIKKVE---  161 (305)
Q Consensus        92 d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~------~~~~~~~i~~~~---  161 (305)
                      ||+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+      .......+....   
T Consensus       239 DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  318 (397)
T 1wak_A          239 DLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV  318 (397)
T ss_dssp             CGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSC
T ss_pred             cccccccccccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCC
Confidence            665443222 2245689999999999998889999999999999999999999997644      122222221100   


Q ss_pred             ---------------------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         162 ---------------------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       162 ---------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                                                             +..+...+..+.+||.+||+.||.+|||+.|+++||||++
T Consensus       319 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          319 PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                                                   0111223356789999999999999999999999999973

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=1.2e-31  Score=237.24  Aligned_cols=199  Identities=18%  Similarity=0.240  Sum_probs=142.8

Q ss_pred             hhHHHHHhcCC-CC-----CccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLK-HR-----NVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~-Hp-----nIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   74 (305)
                      .+|+.+++.++ |+     +||++++++.+++.+|||||||+ |+|.+++...... .+..... ..+..+..++.++|.
T Consensus        98 ~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~  175 (382)
T 2vx3_A           98 QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLAT  175 (382)
T ss_dssp             HHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhcc
Confidence            36888888875 55     49999999999999999999996 5999998764321 1122222 222334567777763


Q ss_pred             --hCCc--------eeec-CCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCC
Q psy6191          75 --YGFG--------YQLN-DDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        75 --~~~~--------~~~~-~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                        .++.        +++. +....+++.||+...... .....+||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus       176 ~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~  255 (382)
T 2vx3_A          176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE  255 (382)
T ss_dssp             TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence              3432        2232 223457777776554332 224568999999999999989999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhccccCCC------------------C------------------C-------------------
Q psy6191         143 PPFETSTLKETYSRIKKVEYKLP------------------A------------------T-------------------  167 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~~~~~~------------------~------------------~-------------------  167 (305)
                      +||.+.+..+....+.......|                  .                  .                   
T Consensus       256 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  335 (382)
T 2vx3_A          256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR  335 (382)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTT
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccc
Confidence            99999887776665543111000                  0                  0                   


Q ss_pred             ---------CCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         168 ---------LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       168 ---------~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                               .+..+.+||.+||+.||.+|||++|+++||||+..
T Consensus       336 ~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             cccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence                     00267899999999999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.97  E-value=1.1e-31  Score=232.56  Aligned_cols=195  Identities=19%  Similarity=0.293  Sum_probs=147.5

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-------------CCCCCcCc-hhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-------------EEMSDPAA-QPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-------------~~~~~~~~-~~~~~~~   66 (305)
                      .+|+++++++ +|||||++++++++++.+|+|||||++|+|.+++......             ..+..... ..+..+.
T Consensus        73 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  152 (327)
T 1fvr_A           73 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA  152 (327)
T ss_dssp             HHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHH
Confidence            4799999999 9999999999999999999999999999999998754310             01111111 2233456


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHh---cCCcccccCCCcccccccccCCCCccchHHHHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIML---ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvily  136 (305)
                      .++.++|..++.|.       +.+....+++.||+.....   .......||+.|+|||++.+..++.++||||+||++|
T Consensus       153 ~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  232 (327)
T 1fvr_A          153 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  232 (327)
T ss_dssp             HHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence            77888887775432       2223345666666533211   1122346788999999998888899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         137 TLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       137 e~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +|++ |..||.+.+..+....+... ....|...+..+.++|.+||..||.+|||+.+++++
T Consensus       233 ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          233 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9998 99999998888877776554 345567789999999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=1.8e-31  Score=230.67  Aligned_cols=195  Identities=13%  Similarity=0.195  Sum_probs=152.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-------CCCCCcC-chhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-------EEMSDPA-AQPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-------~~~~~~~-~~~~~~~~~~~~~~~   73 (305)
                      .+|+.++++++|||||++++++.+++..|+|||||++|+|.+++......       ....... ...+..+..++.+.|
T Consensus        76 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH  155 (322)
T 1p4o_A           76 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN  155 (322)
T ss_dssp             HHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999999999999999999999999998754321       1111111 122334567888888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~  140 (305)
                      ..|+.|.       +.+....+++.||+......      ......||+.|+|||++.+..++.++||||+||++|+|++
T Consensus       156 ~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  235 (322)
T 1p4o_A          156 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT  235 (322)
T ss_dssp             HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence            8776443       23344678888886443221      1234467899999999998889999999999999999999


Q ss_pred             -CCCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         141 -GKPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       141 -g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                       |..||.+.+..+....+.... ...+...+..+.++|.+||..||.+|||+.+++++
T Consensus       236 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          236 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             899999988877777665543 34567789999999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=4.7e-31  Score=226.90  Aligned_cols=192  Identities=18%  Similarity=0.277  Sum_probs=140.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+.++++++|||||++++++++++.+|+|||||+||+|.+++.....+.+  .........+..++.++|..++.+. 
T Consensus        82 ~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~i~~qi~~~l~~lH~~~i~H~d  159 (309)
T 2h34_A           82 QREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAP--PRAVAIVRQIGSALDAAHAAGATHRD  159 (309)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCH--HHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             HHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCcCCcCC
Confidence            4799999999999999999999999999999999999999999987544321  1112223345677888888776442 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                            +.+..+.+++.||+.......     ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus       160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (309)
T 2h34_A          160 VKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ  239 (309)
T ss_dssp             CCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred             CChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence                  233446678888865433221     235679999999999998889999999999999999999999998876


Q ss_pred             HHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCC-CHhhhhc
Q psy6191         150 LKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRP-PVAQLLH  195 (305)
Q Consensus       150 ~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~-~~~~~l~  195 (305)
                      .......+.....   ..+..++..+.++|.+||..||.+|| +++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          240 LSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            6544444433221   34567888999999999999999999 7887764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4.7e-31  Score=229.26  Aligned_cols=193  Identities=16%  Similarity=0.223  Sum_probs=148.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+.+..|||||||++|+|.+++......  +.... ...+..+..++.++|..|+.|.
T Consensus        94 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~  171 (333)
T 1mqb_A           94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLANMNYVHR  171 (333)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTC--SCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            47999999999999999999999999999999999999999998754211  12111 2223345677888888776442


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+.......       .....||+.|+|||++.+..++.++||||+||++|||++ |..||
T Consensus       172 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf  251 (333)
T 1mqb_A          172 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY  251 (333)
T ss_dssp             CCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCc
Confidence                   333456788888865443221       112356889999999998889999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         146 ETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+.+..+....+... ....+...+..+.++|.+||..||.+||++.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          252 WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            988887777776654 345566788999999999999999999999998763

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=9.6e-32  Score=245.40  Aligned_cols=193  Identities=20%  Similarity=0.327  Sum_probs=149.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||++++++.+++.+|||||||++|+|.+++...... .+..... ..+..++.++.|+|..++.|.
T Consensus       264 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHr  342 (495)
T 1opk_A          264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFIHR  342 (495)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            47999999999999999999999999999999999999999999764321 1111111 222345678889888775443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.......     .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       343 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~  422 (495)
T 1opk_A          343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  422 (495)
T ss_dssp             CCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence                   223345677777764433211     123456789999999998889999999999999999999 9999998


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ....|...+..+.++|.+||..||.+|||+.++++
T Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          423 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            8877766665443 34557788999999999999999999999999975

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=6.9e-32  Score=236.73  Aligned_cols=195  Identities=18%  Similarity=0.266  Sum_probs=145.5

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCC-eEEEEEeccCCCCHHHHHHHhcCCCC--------------------------
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSK-FVYIILELCRKRSMMELYNSACDLEE--------------------------   53 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~-~~ylVmEy~~~g~L~~~~~~~~~~~~--------------------------   53 (305)
                      .+|+++++++ +|||||++++++.+++ .+|+|||||+||+|.+++........                          
T Consensus        73 ~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (359)
T 3vhe_A           73 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRR  152 (359)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------
T ss_pred             HHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhcc
Confidence            4799999999 7999999999998755 59999999999999999976432100                          


Q ss_pred             -------------------------------------CCCcC-chhHHHHHHHHHHhhhhCCcee-------ecCCCCCe
Q psy6191          54 -------------------------------------MSDPA-AQPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGV   88 (305)
Q Consensus        54 -------------------------------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v   88 (305)
                                                           +.... ......+..++.|+|..++.|.       +.+....+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~  232 (359)
T 3vhe_A          153 LDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV  232 (359)
T ss_dssp             -------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             ccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcE
Confidence                                                 00000 1112345677888888876443       22334567


Q ss_pred             eEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHh-c
Q psy6191          89 MFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETY-SRIK-K  159 (305)
Q Consensus        89 ~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~~~~-~~i~-~  159 (305)
                      ++.||+.......      .....||+.|+|||++.+..++.++||||+||++|||++ |..||.+.+..+.. ..+. .
T Consensus       233 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  312 (359)
T 3vhe_A          233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG  312 (359)
T ss_dssp             EECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred             EEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC
Confidence            7888876543321      234578999999999998889999999999999999998 99999886644332 3332 2


Q ss_pred             cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         160 VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       160 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .....|...++++.+++.+||..||.+|||+.++++|
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            3445677889999999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=8.5e-32  Score=237.29  Aligned_cols=199  Identities=19%  Similarity=0.321  Sum_probs=139.7

Q ss_pred             hhHHHHHhcCC-----------CCCccceeEEEEcCC----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHH
Q psy6191           2 SQEIAIHRSLK-----------HRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWV   65 (305)
Q Consensus         2 ~~Ei~il~~l~-----------HpnIV~l~~~~~~~~----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~   65 (305)
                      .+|+.++++++           |||||++++++...+    .+|+||||+ +|+|.+++....... ..... ...+..+
T Consensus        63 ~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-~~~~~~~~i~~qi  140 (373)
T 1q8y_A           63 EDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLIYVKQISKQL  140 (373)
T ss_dssp             HHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSC-CCHHHHHHHHHHH
T ss_pred             hHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccC-CcHHHHHHHHHHH
Confidence            47899998886           899999999998654    899999999 899999987643211 12111 2223345


Q ss_pred             HHHHHHhhhh-CCcee--------ec-----CCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHH
Q psy6191          66 SKWVDYSDKY-GFGYQ--------LN-----DDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWS  130 (305)
Q Consensus        66 ~~~~~~~~~~-~~~~~--------~~-----~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwS  130 (305)
                      ..++.++|.. |+.|.        +.     +....+++.||+...... .....+||+.|+|||++.+..++.++||||
T Consensus       141 ~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s  220 (373)
T 1q8y_A          141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWS  220 (373)
T ss_dssp             HHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHH
T ss_pred             HHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHH
Confidence            6788888886 65433        11     111235666766443322 224568999999999999888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCH------HHHHHHHhc------------------------------------------ccc
Q psy6191         131 IGCIMYTLLVGKPPFETSTL------KETYSRIKK------------------------------------------VEY  162 (305)
Q Consensus       131 lGvilye~l~g~~Pf~~~~~------~~~~~~i~~------------------------------------------~~~  162 (305)
                      +||++|||++|+.||.+.+.      ......+..                                          ...
T Consensus       221 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
T 1q8y_A          221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY  300 (373)
T ss_dssp             HHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT
T ss_pred             HHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc
Confidence            99999999999999986541      111111111                                          111


Q ss_pred             CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         163 KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       163 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .++...+.++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       301 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          301 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             CCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             cCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence            2333445678899999999999999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=2.3e-31  Score=240.33  Aligned_cols=192  Identities=16%  Similarity=0.283  Sum_probs=145.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCC-cCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+ +.+|||||||++|+|.+++...... .+.. ........+..++.|+|..++.|.
T Consensus       227 ~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHr  304 (452)
T 1fmk_A          227 LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMNYVHR  304 (452)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            479999999999999999999876 6799999999999999998643211 0111 112233445778888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.......     .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus       305 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~  384 (452)
T 1fmk_A          305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  384 (452)
T ss_dssp             CCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence                   223345677788765433211     223457889999999988889999999999999999999 9999999


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ..+.|...+..+.++|.+||..||.+|||++++++
T Consensus       385 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          385 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             CCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8888777776544 34556788999999999999999999999999976

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.2e-31  Score=233.88  Aligned_cols=195  Identities=17%  Similarity=0.265  Sum_probs=147.7

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC--------------------CCCCcC-c
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE--------------------EMSDPA-A   59 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~--------------------~~~~~~-~   59 (305)
                      .+|+.+++++ +|||||++++++.+++.+|+|||||++|+|.+++.......                    .+.... .
T Consensus        96 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  175 (344)
T 1rjb_A           96 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL  175 (344)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHH
T ss_pred             HHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHH
Confidence            4799999999 99999999999999999999999999999999997643210                    001111 1


Q ss_pred             hhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccc
Q psy6191          60 QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEV  126 (305)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~  126 (305)
                      ..+..+..++.++|..|+.|.       +.+....+++.||+.......      .....||+.|+|||++.+..++.++
T Consensus       176 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  255 (344)
T 1rjb_A          176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS  255 (344)
T ss_dssp             HHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhH
Confidence            122345677888887775432       223345677888876543322      1245688899999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         127 DVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       127 DiwSlGvilye~l~-g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||||+||++|+|++ |..||.+.+.......+..  .....|...+.++.++|.+||..||.+|||+.+++++
T Consensus       256 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          256 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            99999999999998 9999988665444333322  2344567789999999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=4.9e-31  Score=228.59  Aligned_cols=192  Identities=17%  Similarity=0.218  Sum_probs=149.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.++. .|+||||+.+|+|.+++......  ..... ......+..++.++|..++.|.
T Consensus        65 ~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~ivH~  141 (327)
T 3poz_A           65 LDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRRLVHR  141 (327)
T ss_dssp             HHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTS--CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHhhCCeeCC
Confidence            47999999999999999999998865 88999999999999998764321  11111 2223345778889998876443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+....+++.||+........      ....||+.|+|||++.+..++.++||||+||++|||++ |+.||.
T Consensus       142 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  221 (327)
T 3poz_A          142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  221 (327)
T ss_dssp             CCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence                   2233456888898876654322      23457889999999999999999999999999999999 999999


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +.+..+....+... ....|...+..+.+++.+||+.||.+||++.+++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          222 GIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            88777766655543 345567788999999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=2.1e-31  Score=231.16  Aligned_cols=191  Identities=20%  Similarity=0.244  Sum_probs=143.3

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++++++ +||||+++++++.+++..|+||||| +|+|.+++.....  .+..... ..+..+..++.++|..++.|
T Consensus        52 ~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~iiH  128 (330)
T 2izr_A           52 HLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKNLIY  128 (330)
T ss_dssp             HHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            4799999999 9999999999999999999999999 9999999876421  1122222 22334567888999877644


Q ss_pred             e-------ecCCCCC-----eeEcchhHHHHhcC-----------CcccccCCCcccccccccCCCCccchHHHHHHHHH
Q psy6191          80 Q-------LNDDSSG-----VMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        80 ~-------~~~~~~~-----v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvily  136 (305)
                      .       +.+..+.     +++.||+.......           ....+||+.|+|||++.+..++.++|||||||++|
T Consensus       129 rDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  208 (330)
T 2izr_A          129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFM  208 (330)
T ss_dssp             CCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             cCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHH
Confidence            3       2222222     78888875543221           23678999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCC---CHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         137 TLLVGKPPFETS---TLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       137 e~l~g~~Pf~~~---~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||++|+.||.+.   +..+.+..+.......|.    ...+++.+++.+||..||.+||+++++.+
T Consensus       209 ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          209 YFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            999999999873   444555555443333221    11238999999999999999999998865

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=2.3e-31  Score=230.01  Aligned_cols=192  Identities=19%  Similarity=0.333  Sum_probs=148.8

Q ss_pred             hhHHHHHhcCC--CCCccceeEEEEcCCeEEEEEeccCC-CCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLK--HRNVVGFHSFFEDSKFVYIILELCRK-RSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~--HpnIV~l~~~~~~~~~~ylVmEy~~~-g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   77 (305)
                      .+|+.++++++  ||||+++++++.+++..|+||||+.+ ++|.+++.....+.   .... ..+..+..++.++|..++
T Consensus        94 ~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~---~~~~~~i~~qi~~~L~~LH~~~i  170 (320)
T 3a99_A           94 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ---EELARSFFWQVLEAVRHCHNCGV  170 (320)
T ss_dssp             EHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCC---HHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCC---HHHHHHHHHHHHHHHHHHHHCCc
Confidence            36999999996  59999999999999999999999987 89999988754432   2222 223345678888887775


Q ss_pred             cee--------ecCCCCCeeEcchhHHHHhcC--CcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCC
Q psy6191          78 GYQ--------LNDDSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        78 ~~~--------~~~~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      .+.        +......+++.||+.......  ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.
T Consensus       171 vH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  250 (320)
T 3a99_A          171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  250 (320)
T ss_dssp             ECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EeCCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence            332        322445677788765433222  234679999999999876654 778999999999999999999997


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ..+      .+......++..++.++.++|.+||..||.+|||++++++||||++.
T Consensus       251 ~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          251 HDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             SHH------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             Chh------hhhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence            642      22334455677899999999999999999999999999999999863

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=1.9e-31  Score=229.45  Aligned_cols=195  Identities=18%  Similarity=0.255  Sum_probs=147.3

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC---------------CCCCcC-chhHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE---------------EMSDPA-AQPVIW   64 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~---------------~~~~~~-~~~~~~   64 (305)
                      .+|+.+++++ +|||||++++++.+++..|+|||||++|+|.+++.......               ...... ...+..
T Consensus        74 ~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  153 (313)
T 1t46_A           74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ  153 (313)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHH
T ss_pred             HHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHH
Confidence            4799999999 99999999999999999999999999999999997653210               011111 122234


Q ss_pred             HHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHH
Q psy6191          65 VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSI  131 (305)
Q Consensus        65 ~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSl  131 (305)
                      +..++.++|..++.|.       +.+....+++.||+.......      .....||+.|+|||++.+..++.++||||+
T Consensus       154 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  233 (313)
T 1t46_A          154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY  233 (313)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence            5677888888776443       223345677888876543322      224567889999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         132 GCIMYTLLV-GKPPFETSTLKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       132 Gvilye~l~-g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||++|+|++ |..||.+.+..........  .....+...+..+.++|.+||..||.+|||+.+++++
T Consensus       234 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            999999999 9999987665443333322  2234456788999999999999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=4.9e-31  Score=226.57  Aligned_cols=192  Identities=19%  Similarity=0.271  Sum_probs=137.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh---hCC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK---YGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~   77 (305)
                      .+|++++++++|||||++++++.+  ..|+|||||+||+|.+++.............. .....+.+++.++|.   .++
T Consensus        49 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~i  126 (307)
T 2eva_A           49 IVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL  126 (307)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCC
T ss_pred             HHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence            479999999999999999998874  48999999999999999976543322221111 222345677888887   454


Q ss_pred             cee--------ecCCCCCeeEcchhHHHHhcC-CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          78 GYQ--------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        78 ~~~--------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .|.        +..+...+++.||+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       127 vH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             CCCCCSGGGEEEETTTTEEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             ecCCCChhHEEEeCCCCEEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            332        222322367788765433222 23457999999999999888999999999999999999999999754


Q ss_pred             C--HHHHHHHH-hccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         149 T--LKETYSRI-KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       149 ~--~~~~~~~i-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .  .......+ .......+..++..+.++|.+||..||.+|||++++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          207 GGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             CSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3  22332222 23334556678999999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.3e-31  Score=227.89  Aligned_cols=193  Identities=17%  Similarity=0.218  Sum_probs=147.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||+++++++ .+..|+|||||++|+|.+++.....  .+..... .....+..++.++|..++.+.
T Consensus        58 ~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  134 (287)
T 1u59_A           58 MREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHR  134 (287)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCCEeeC
Confidence            47999999999999999999994 5669999999999999998854321  1122112 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+......       ......||+.|+|||++.+..++.++||||+||++|+|++ |+.||
T Consensus       135 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  214 (287)
T 1u59_A          135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY  214 (287)
T ss_dssp             CCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence                   12223456677776443321       1223457899999999988889999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         146 ETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      ...+..+....+.... ...|...+..+.++|.+||..||.+||++.+++++.
T Consensus       215 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          215 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             TTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            9887777776665543 456778999999999999999999999999998763

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=3.2e-31  Score=224.43  Aligned_cols=193  Identities=21%  Similarity=0.314  Sum_probs=143.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++|||||++++++.+ ++.+|+|||||++|+|.+++...... ..... .......+..++.++|..++.|
T Consensus        62 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H  140 (278)
T 1byg_A           62 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFVH  140 (278)
T ss_dssp             HHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH-HCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccc-cCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            479999999999999999999755 45799999999999999998754321 01111 1222334567888888877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC-CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~  150 (305)
                      .       +.+..+.+++.|++....... .....||+.|+|||++.+..++.++||||+||++|+|++ |+.||...+.
T Consensus       141 ~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  220 (278)
T 1byg_A          141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  220 (278)
T ss_dssp             SCCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred             cCCCcceEEEeCCCcEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            3       233446678888865443222 234578999999999988889999999999999999998 9999998877


Q ss_pred             HHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         151 KETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       151 ~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+....+... ....+...++.+.++|.+||..||.+|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          221 KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             GGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            7776666543 34566788999999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=3.3e-31  Score=228.07  Aligned_cols=192  Identities=19%  Similarity=0.344  Sum_probs=143.8

Q ss_pred             hhHHHHHhcC----CCCCccceeEEEEcCCeEEEEEec-cCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSL----KHRNVVGFHSFFEDSKFVYIILEL-CRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l----~HpnIV~l~~~~~~~~~~ylVmEy-~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|+.+++++    +|||||++++++.+++..|+|||| +.+|+|.+++.....+   ..... ..+..+..++.+.|..
T Consensus        82 ~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~---~~~~~~~~~~qi~~~l~~lH~~  158 (312)
T 2iwi_A           82 PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPL---GEGPSRCFFGQVVAAIQHCHSR  158 (312)
T ss_dssp             CHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSC---CHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHC
Confidence            4699999998    899999999999999999999999 7999999999875443   22222 2233456778888877


Q ss_pred             CCcee--------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCC
Q psy6191          76 GFGYQ--------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        76 ~~~~~--------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~P  144 (305)
                      ++.|.        +....+.+++.||+......  .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus       159 ~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  238 (312)
T 2iwi_A          159 GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP  238 (312)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCC
Confidence            75432        22234557777776443322  2245679999999999876655 4589999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         145 FETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      |....      .+......++...+..+.++|.+||..||.+|||+.++++||||+..
T Consensus       239 f~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          239 FERDQ------EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             CCSHH------HHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             CCChH------HHhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            97532      23334556778899999999999999999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=1e-30  Score=244.84  Aligned_cols=190  Identities=18%  Similarity=0.219  Sum_probs=149.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++ +..|||||||++|+|.+++.....+   .... ...+..+..++.|+|..++.|.
T Consensus       418 ~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l---~~~~~~~i~~qi~~~L~yLH~~~iiHr  493 (635)
T 4fl3_A          418 LAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHV---KDKNIIELVHQVSMGMKYLEESNFVHR  493 (635)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTC---CHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCC---CHHHHHHHHHHHHHHHHHHHHCCEeCC
Confidence            479999999999999999999975 4589999999999999999765433   2222 2233345778889998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+....+..       .....||+.|+|||++.+..++.++||||+||++|||++ |+.||
T Consensus       494 DLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf  573 (635)
T 4fl3_A          494 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY  573 (635)
T ss_dssp             CCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                   223345678889987655422       123457889999999998899999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.+..+....+... ....|...+.++.++|.+||..||.+||++.++++
T Consensus       574 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          574 RGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            998888877777654 34567789999999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=2.7e-31  Score=231.93  Aligned_cols=189  Identities=14%  Similarity=0.122  Sum_probs=139.9

Q ss_pred             hHHHHHhcCCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCC
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGF   77 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   77 (305)
                      +|+.+++.++|||||++++++.+    +..+||||||| ||+|.+++.....+   ..... ..+..+..++.++|..++
T Consensus        97 ~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~---~~~~~~~i~~qi~~aL~~LH~~~i  172 (345)
T 2v62_A           97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTF---KKSTVLQLGIRMLDVLEYIHENEY  172 (345)
T ss_dssp             HHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBC---CHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCe
Confidence            67888999999999999999988    78999999999 99999998654432   22222 223345678888888775


Q ss_pred             cee--------ecCC-CCCeeEcchhHHHHhcC-----------CcccccCCCcccccccccCCCCccchHHHHHHHHHH
Q psy6191          78 GYQ--------LNDD-SSGVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        78 ~~~--------~~~~-~~~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  137 (305)
                      .+.        +..+ ...+++.||+....+..           ....+||+.|+|||++.+..++.++|||||||++||
T Consensus       173 vH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  252 (345)
T 2v62_A          173 VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR  252 (345)
T ss_dssp             ECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred             eCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence            432        2222 23788888875532211           135589999999999998889999999999999999


Q ss_pred             HHhCCCCCCC--CCHHHHHHHHhccccCCCC---------CCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         138 LLVGKPPFET--STLKETYSRIKKVEYKLPA---------TLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       138 ~l~g~~Pf~~--~~~~~~~~~i~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |++|+.||.+  .+..............+|.         ..+.++.++|.+||..||.+||+++++++
T Consensus       253 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          253 WLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9999999965  2332222222221122222         68889999999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=1.2e-30  Score=221.94  Aligned_cols=190  Identities=16%  Similarity=0.273  Sum_probs=139.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhC--Cc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYG--FG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~   78 (305)
                      .+|+.++++++|||||++++++.+..  |+|||||++|+|.+.+......  ..... ...+..+..++.+.|..+  +.
T Consensus        71 ~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~~~iv  146 (287)
T 4f0f_A           71 QREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQNQNPPIV  146 (287)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSC--CCHHHHHHHHHHHHHHHHHHHTSSSCCB
T ss_pred             HHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCC--ccHHHHHHHHHHHHHHHHHHHhCCCCee
Confidence            47999999999999999999997766  7999999999999887643221  11111 122334567888888877  54


Q ss_pred             ee-------ecCCCCC-----eeEcchhHHHHhc-CCcccccCCCcccccccc--cCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          79 YQ-------LNDDSSG-----VMFNDLTRMIMLA-NKNTLCGTPNYIAPEILN--KNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        79 ~~-------~~~~~~~-----v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~--~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      |.       +.+....     +++.||+...... .....+||+.|+|||++.  ...++.++||||+||++|+|++|+.
T Consensus       147 H~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  226 (287)
T 4f0f_A          147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG  226 (287)
T ss_dssp             CSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCCcceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCC
Confidence            32       1111222     6777776443222 223568999999999984  4457889999999999999999999


Q ss_pred             CCCCCCHHHH--HHHHh--ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         144 PFETSTLKET--YSRIK--KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       144 Pf~~~~~~~~--~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||...+....  ...+.  .....+|...+..+.++|.+||..||.+|||+.++++
T Consensus       227 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             TTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9987543322  23322  2334567788999999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=4.5e-31  Score=229.46  Aligned_cols=195  Identities=19%  Similarity=0.296  Sum_probs=151.0

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-------------CCCCcC-chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-------------EMSDPA-AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-------------~~~~~~-~~~~~~~~   66 (305)
                      .+|+++++++ +|||||++++++.+++.+|+|||||++|+|.+++.......             .+.... ...+..+.
T Consensus        88 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  167 (334)
T 2pvf_A           88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA  167 (334)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHH
Confidence            4799999999 89999999999999999999999999999999997653210             011111 11223456


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.++|..++.+.       +.+..+.+++.||+.......      .....||+.|+|||++.+..++.++||||+||
T Consensus       168 ~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  247 (334)
T 2pvf_A          168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV  247 (334)
T ss_dssp             HHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred             HHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHH
Confidence            77888887775432       233446678888865433221      22346788999999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++|+|++ |..||.+.+..+....+... ....|...+..+.++|.+||..||.+|||+.+++++
T Consensus       248 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          248 LMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999 99999998887777666544 345667789999999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=6.1e-31  Score=223.06  Aligned_cols=192  Identities=19%  Similarity=0.253  Sum_probs=144.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||+++++++++ ..|+||||+++|+|.+++......  ...... .....+..++.++|..|+.|.
T Consensus        61 ~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~  137 (281)
T 3cc6_A           61 MSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESINCVHR  137 (281)
T ss_dssp             HHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhcccc--CCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            4799999999999999999998764 579999999999999998764321  122112 222345678888888876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.......     .....||+.|+|||++.+..++.++||||+||++|+|++ |+.||..
T Consensus       138 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~  217 (281)
T 3cc6_A          138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW  217 (281)
T ss_dssp             CCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence                   222334577778765443221     234467889999999988889999999999999999998 9999987


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+... ....|...+..+.++|.+||..||.+|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          218 LENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             SCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            7666655555433 345567789999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=6.5e-31  Score=224.02  Aligned_cols=190  Identities=18%  Similarity=0.226  Sum_probs=145.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++ +.+..|+||||+++|+|.+++.....+   .... ...+..+..++.++|..++.|.
T Consensus        66 ~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~qi~~~l~~LH~~~i~H~  141 (291)
T 1xbb_A           66 LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV---KDKNIIELVHQVSMGMKYLEESNFVHR  141 (291)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTC---CHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCC---CHHHHHHHHHHHHHHHHHHHhCCeEcC
Confidence            4799999999999999999999 567789999999999999999765433   2222 2223345678888888775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+.......       .....||+.|+|||++.+..++.++||||+||++|+|++ |..||
T Consensus       142 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  221 (291)
T 1xbb_A          142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY  221 (291)
T ss_dssp             CCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCC
Confidence                   122234566777764432211       122357789999999988888999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.+..+....+.... ...|...+..+.++|.+||..||.+||++.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          222 RGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9988877776665543 4566788999999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=8.6e-31  Score=223.95  Aligned_cols=192  Identities=17%  Similarity=0.222  Sum_probs=145.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEE-EcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFF-EDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~-~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++|||||++++++ ++++..|+|||||++|+|.+++......  ...... .....+..++.++|..++.|
T Consensus        74 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~i~H  151 (298)
T 3f66_A           74 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYLASKKFVH  151 (298)
T ss_dssp             HHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCC--CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            4799999999999999999985 5567899999999999999998753221  111111 22234567888888877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhc--------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLA--------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKP  143 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~--------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~  143 (305)
                      .       +.+....+++.||+......        ......||+.|+|||++.+..++.++||||+||++|+|++ |.+
T Consensus       152 ~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~  231 (298)
T 3f66_A          152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP  231 (298)
T ss_dssp             SCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            3       23344678888887654321        1234568899999999998889999999999999999999 677


Q ss_pred             CCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         144 PFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||.+.+..+....+.... ...|...+..+.+++.+||..||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          232 PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             SSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            887766665555554443 3446678899999999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.9e-31  Score=233.03  Aligned_cols=193  Identities=16%  Similarity=0.201  Sum_probs=141.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE-cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE-DSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~-~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++|||||++++++. .++..|+|||||++|+|.+++......  .... .......+..++.++|..++.|
T Consensus       138 ~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH  215 (373)
T 3c1x_A          138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKKFVH  215 (373)
T ss_dssp             HHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCC--CBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccC--CCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            47999999999999999999864 466899999999999999998754321  1111 1122234577888998877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC--------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKP  143 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~  143 (305)
                      .       +.+....+++.||+.......        .....||+.|+|||++.+..++.++||||+||++|||++ |.+
T Consensus       216 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~  295 (373)
T 3c1x_A          216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP  295 (373)
T ss_dssp             SCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCC
Confidence            3       334456788899876543221        123467889999999998899999999999999999999 788


Q ss_pred             CCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         144 PFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||.+.+..+....+... ....|...+..+.+++.+||..||.+|||+.+++++
T Consensus       296 p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          296 PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             SCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99876655555555443 334566789999999999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=3.2e-30  Score=222.26  Aligned_cols=197  Identities=22%  Similarity=0.320  Sum_probs=137.1

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhh-hCCcee
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDK-YGFGYQ   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~   80 (305)
                      +|..+++.++|||||++++++.+++.+|+||||+ ++.+..+......  .+..... ..+..+..++.++|. .++.|.
T Consensus        73 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~  149 (318)
T 2dyl_A           73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEKHGVIHR  149 (318)
T ss_dssp             HHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred             HHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhhCCEEeC
Confidence            3456788899999999999999999999999999 5566555543221  1122222 223345677888886 366442


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                             +.+....+++.||+.......   ....+||+.|+|||++.     ...++.++||||+||++|+|++|+.||
T Consensus       150 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (318)
T 2dyl_A          150 DVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY  229 (318)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCC
Confidence                   233446678888865433221   23457999999999984     456888999999999999999999999


Q ss_pred             CC-CCHHHHHHHHhcccc-CCC--CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         146 ET-STLKETYSRIKKVEY-KLP--ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~-~~~~~~~~~i~~~~~-~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .. .+..+....+..... .+|  ...+.++.++|.+||..||.+||+++++++||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          230 KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             TTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            87 344455555544332 223  3578999999999999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.4e-30  Score=225.68  Aligned_cols=191  Identities=17%  Similarity=0.231  Sum_probs=145.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.++. .++||||+.+|+|.+++......  +.... ......+..++.++|..++.|.
T Consensus        65 ~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~  141 (327)
T 3lzb_A           65 LDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRRLVHR  141 (327)
T ss_dssp             HHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHhhCCCcCC
Confidence            47999999999999999999998865 88999999999999998764321  12211 2223345778889998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+....+++.||+.......      .....||+.|+|||++.+..++.++||||+||++|+|++ |.+||.
T Consensus       142 Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  221 (327)
T 3lzb_A          142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  221 (327)
T ss_dssp             CCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence                   222335677888865543321      123457889999999999999999999999999999999 999999


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +.+..+....+... ....|...+.++.++|.+||..||.+||++.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          222 GIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88877766666544 34566778999999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=2.7e-31  Score=230.65  Aligned_cols=194  Identities=18%  Similarity=0.267  Sum_probs=144.4

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC-----------CCCcC-chhHHHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-----------MSDPA-AQPVIWVSKW   68 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~-----------~~~~~-~~~~~~~~~~   68 (305)
                      .+|+.+++++ +|||||++++++.+++.+|+|||||++|+|.+++........           +.... ...+..+..+
T Consensus        97 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  176 (333)
T 2i1m_A           97 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG  176 (333)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHH
Confidence            4799999999 899999999999999999999999999999999876432110           11111 1122345677


Q ss_pred             HHHhhhhCCceee-------cCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHH
Q psy6191          69 VDYSDKYGFGYQL-------NDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIM  135 (305)
Q Consensus        69 ~~~~~~~~~~~~~-------~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvil  135 (305)
                      +.++|..++.|.-       .+....+++.||+.......      .....||+.|+|||++.+..++.++||||+||++
T Consensus       177 l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  256 (333)
T 2i1m_A          177 MAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL  256 (333)
T ss_dssp             HHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             HHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHH
Confidence            8888887754431       12234556777765443221      1245678899999999888899999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         136 YTLLV-GKPPFETSTLKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       136 ye~l~-g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |+|++ |..||.+.........+..  .....|...+..+.++|.+||..||.+|||+.++++
T Consensus       257 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            99998 9999987665444333322  233456678899999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=5e-31  Score=228.05  Aligned_cols=190  Identities=14%  Similarity=0.187  Sum_probs=132.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhh-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKY-   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-   75 (305)
                      .+|+.++++++|||||++++++.++.    .+|+|||||++|+|.+++.... +   .... ......+..++.|+|.. 
T Consensus        66 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~---~~~~~~~i~~qi~~al~~LH~~~  141 (322)
T 3soc_A           66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-V---SWNELCHIAETMARGLAYLHEDI  141 (322)
T ss_dssp             HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-B---CHHHHHHHHHHHHHHHHHHTCCE
T ss_pred             HHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC-C---CHHHHHHHHHHHHHHHHHHHhhc
Confidence            36889999999999999999998754    4799999999999999997532 1   2222 22233456778888866 


Q ss_pred             ---------CCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccC-----CCCccchH
Q psy6191          76 ---------GFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKN-----GHSFEVDV  128 (305)
Q Consensus        76 ---------~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~-----~~~~~~Di  128 (305)
                               ++.|.       +.+....+++.||+.......      ....+||+.|+|||++.+.     .++.++||
T Consensus       142 ~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  221 (322)
T 3soc_A          142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM  221 (322)
T ss_dssp             EEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH
T ss_pred             cccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchh
Confidence                     43321       223345677777765433211      2346899999999998763     45678999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCC----------------HHHHHHHHhcccc--CCCCC-----CCHHHHHHHHHHhhcCCC
Q psy6191         129 WSIGCIMYTLLVGKPPFETST----------------LKETYSRIKKVEY--KLPAT-----LKKPAATMIKKMLLLDPV  185 (305)
Q Consensus       129 wSlGvilye~l~g~~Pf~~~~----------------~~~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~l~~dp~  185 (305)
                      ||+||++|||++|+.||.+..                .......+.....  .++..     .+..+.++|.+||..||.
T Consensus       222 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  301 (322)
T 3soc_A          222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE  301 (322)
T ss_dssp             HHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChh
Confidence            999999999999999997532                1222222222111  11111     123488999999999999


Q ss_pred             CCCCHhhhhc
Q psy6191         186 QRPPVAQLLH  195 (305)
Q Consensus       186 ~R~~~~~~l~  195 (305)
                      +|||+.++++
T Consensus       302 ~Rps~~ell~  311 (322)
T 3soc_A          302 ARLSAGCVGE  311 (322)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCcCHHHHHH
Confidence            9999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=1.4e-30  Score=243.31  Aligned_cols=191  Identities=17%  Similarity=0.227  Sum_probs=145.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++ +.+|||||||++|+|.+++.....  .+..... ..+..++.++.|+|..++.|.
T Consensus       384 ~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiHr  460 (613)
T 2ozo_A          384 MREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHR  460 (613)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence            479999999999999999999987 569999999999999998854321  1122112 223345678889988776543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+....+..       .....||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus       461 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf  540 (613)
T 2ozo_A          461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY  540 (613)
T ss_dssp             CCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence                   223345677888865543221       123346789999999998899999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.+..+....+.... ...|...+.++.++|.+||..||.+||++.++++
T Consensus       541 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          541 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9988777777776543 4567789999999999999999999999999854

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=7.1e-31  Score=222.36  Aligned_cols=192  Identities=16%  Similarity=0.294  Sum_probs=146.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+ +..|+|||||++|+|.+++...... ...... ...+..+..++.+.|..|+.|.
T Consensus        56 ~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  133 (279)
T 1qpc_A           56 LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR  133 (279)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            479999999999999999999864 5689999999999999988543210 011111 2223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.......     .....||+.|+|||++.+..++.++||||+||++|+|++ |+.||.+
T Consensus       134 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  213 (279)
T 1qpc_A          134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (279)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence                   233445677788765443221     223457889999999988889999999999999999999 9999999


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ....|...+..+.+++.+||..||.+|||+.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          214 MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            8887777666544 33456678899999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=3.8e-30  Score=219.80  Aligned_cols=191  Identities=17%  Similarity=0.170  Sum_probs=143.8

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++++ +||||+++++++.++...|+||||+ +|+|.+++......  +.... ...+..+..++.++|+.++.|
T Consensus        53 ~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH  129 (298)
T 1csn_A           53 RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEKSLVY  129 (298)
T ss_dssp             HHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            4799999999 8999999999999999999999999 99999999764321  12222 222334567888888877543


Q ss_pred             e-------ecCCCC-----CeeEcchhHHHHhcC-----------CcccccCCCcccccccccCCCCccchHHHHHHHHH
Q psy6191          80 Q-------LNDDSS-----GVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        80 ~-------~~~~~~-----~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvily  136 (305)
                      .       +.+..+     .+++.||+.......           ....+||+.|+|||++.+..++.++||||+||++|
T Consensus       130 ~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  209 (298)
T 1csn_A          130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFM  209 (298)
T ss_dssp             CCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHH
Confidence            2       222112     278888865443221           24567999999999999888999999999999999


Q ss_pred             HHHhCCCCCCCC---CHHHHHHHHhcccc-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         137 TLLVGKPPFETS---TLKETYSRIKKVEY-----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       137 e~l~g~~Pf~~~---~~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||++|+.||.+.   +..+....+.....     ..+..++.++.+++.+||..||.+||+++++++
T Consensus       210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          210 YFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            999999999873   33444444433221     123468899999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.1e-30  Score=220.35  Aligned_cols=192  Identities=18%  Similarity=0.231  Sum_probs=146.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeE-EEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFV-YIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~-ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++|||||++++++.+++.. |+||||+.+|+|.+++......  ..... ......+..++.++|..|+.|
T Consensus        70 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H  147 (298)
T 3pls_A           70 LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYLAEQKFVH  147 (298)
T ss_dssp             HHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCC--CBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccC--CCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            4799999999999999999999876655 9999999999999998753221  11111 122234567888888877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh--------cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML--------ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKP  143 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~--------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~  143 (305)
                      .       +.+....+++.||+.....        .......||+.|+|||++.+..++.++||||+||++|+|++ |.+
T Consensus       148 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~  227 (298)
T 3pls_A          148 RDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP  227 (298)
T ss_dssp             SCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred             CCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCC
Confidence            3       2334457888888654322        12234578999999999998899999999999999999999 566


Q ss_pred             CCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         144 PFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||...+..+....+... ....|...+..+.+++.+||..||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          228 PYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             TTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            67666666665555443 34556678999999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=1.7e-30  Score=223.74  Aligned_cols=197  Identities=21%  Similarity=0.325  Sum_probs=143.6

Q ss_pred             hhHHHHHhcCC--CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK--HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~--HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++  |||||++++++.+++.+|+||| +.+|+|.+++.....+..  ......+..+..++.++|..++.+
T Consensus        74 ~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~--~~~~~i~~qi~~aL~~LH~~~ivH  150 (313)
T 3cek_A           74 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIHQHGIVH  150 (313)
T ss_dssp             HHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCH--HHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCH--HHHHHHHHHHHHHHHHHHHCCcee
Confidence            47999999997  5999999999999999999999 678899999986543311  111222334567888888877644


Q ss_pred             eecC------CCCCeeEcchhHHHHhc------CCcccccCCCccccccccc-----------CCCCccchHHHHHHHHH
Q psy6191          80 QLND------DSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNK-----------NGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        80 ~~~~------~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvily  136 (305)
                      .-..      +.+.+++.||+......      .....+||+.|+|||++.+           ..++.++||||+||++|
T Consensus       151 ~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~  230 (313)
T 3cek_A          151 SDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY  230 (313)
T ss_dssp             CCCCGGGEEEETTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred             cCCCcccEEEECCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence            3111      12456777775433221      1234579999999999865           46788999999999999


Q ss_pred             HHHhCCCCCCCCC-HHHHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         137 TLLVGKPPFETST-LKETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       137 e~l~g~~Pf~~~~-~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +|++|+.||.... .......+...  ...+|...+..+.++|.+||..||.+|||+.++++||||+.
T Consensus       231 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          231 YMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             HHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             HHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            9999999997653 23333333322  33456677889999999999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=9.6e-31  Score=240.90  Aligned_cols=192  Identities=16%  Similarity=0.279  Sum_probs=148.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCC-cCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+ +.+|||||||++|+|.+++...... .+.. .....+..+..++.|+|..++.|.
T Consensus       310 ~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivHr  387 (535)
T 2h8h_A          310 LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMNYVHR  387 (535)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            479999999999999999999876 6799999999999999998643211 0111 112233445678889988776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+......     ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus       388 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~  467 (535)
T 2h8h_A          388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  467 (535)
T ss_dssp             CCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred             CCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                   22334567788886543321     2234467889999999988889999999999999999999 9999999


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ....|...+..+.+||.+||..||.+|||++++++
T Consensus       468 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          468 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8888877776554 34556788999999999999999999999999976

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=6.4e-30  Score=220.08  Aligned_cols=195  Identities=16%  Similarity=0.188  Sum_probs=144.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC-----eEEEEEeccCCCCHHHHHHHhcCC---CCCCCcCc-hhHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK-----FVYIILELCRKRSMMELYNSACDL---EEMSDPAA-QPVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~ylVmEy~~~g~L~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~   72 (305)
                      .+|+.++++++|||||++++++.+.+     ..|+|||||++|+|.+++......   ..+..... ..+..+..++.++
T Consensus        84 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  163 (313)
T 3brb_A           84 LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL  163 (313)
T ss_dssp             HHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999998755     459999999999999998643211   11111111 2223456788899


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHH
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL  139 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l  139 (305)
                      |..++.|.       +.+....+++.||+......      ......||+.|+|||++.+..++.++||||+||++|+|+
T Consensus       164 H~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  243 (313)
T 3brb_A          164 SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA  243 (313)
T ss_dssp             HTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred             HhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence            88776443       23344567888886443321      122346788999999999888999999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         140 V-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       140 ~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      + |.+||.+.+..+....+... ....|...+..+.++|.+||..||.+|||+.+++++
T Consensus       244 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          244 TRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9 99999988777766665543 345667789999999999999999999999999864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=1.4e-29  Score=217.59  Aligned_cols=194  Identities=21%  Similarity=0.412  Sum_probs=139.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++|||||++++++.+++..|+||||+++|+|.+++...... ........ ..+..+..++.++|..++.+
T Consensus        80 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H  159 (310)
T 2wqm_A           80 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMH  159 (310)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeC
Confidence            47999999999999999999999999999999999999999988653211 11122212 22334567788888877644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      .       +.+..+.+++.|++.......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus       160 ~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             CCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             CCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            3       233456788888875543322    23457999999999999888999999999999999999999999764


Q ss_pred             --CHHHHHHHHhccccC-C-CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         149 --TLKETYSRIKKVEYK-L-PATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       149 --~~~~~~~~i~~~~~~-~-~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                        +.......+...... . +...+.++.++|.+||..||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          240 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             -CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              333444455444332 1 2467889999999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=1.2e-30  Score=222.87  Aligned_cols=192  Identities=19%  Similarity=0.238  Sum_probs=139.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++|||||++++++.+  ...+|+|||||++|+|.+++......  ...... .....+..++.++|..++.
T Consensus        59 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~iv  136 (295)
T 3ugc_A           59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRYI  136 (295)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGG--CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccc--cCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence            479999999999999999999865  45699999999999999998764321  121111 2233456788888887764


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhc-------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      |.       +.+....+++.||+......       ......||+.|+|||++.+..++.++||||+||++|+|++|..|
T Consensus       137 H~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~  216 (295)
T 3ugc_A          137 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK  216 (295)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCT
T ss_pred             cCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccc
Confidence            43       22233557777775443221       12234578889999999988999999999999999999999999


Q ss_pred             CCCCCHH----------------HHHHHH-hccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETSTLK----------------ETYSRI-KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~~~~----------------~~~~~i-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |......                .....+ .....+.|...+.++.++|.+||..||.+|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            8653211                111122 12344567788999999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=1.4e-30  Score=220.92  Aligned_cols=194  Identities=21%  Similarity=0.330  Sum_probs=144.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc----------------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHH
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED----------------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIW   64 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~----------------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~   64 (305)
                      .+|++++++++|||||++++++++                ...+|+|||||++|+|.+++...... ....... ..+..
T Consensus        52 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~q  130 (284)
T 2a19_B           52 EREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALELFEQ  130 (284)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGS-CCCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCC-CCCHHHHHHHHHH
Confidence            589999999999999999999865                45699999999999999999764221 1122111 22334


Q ss_pred             HHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHH
Q psy6191          65 VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCI  134 (305)
Q Consensus        65 ~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvi  134 (305)
                      +..++.++|..++.|.       +.+....+++.||+.......   ....+||+.|+|||++.+..++.++||||+||+
T Consensus       131 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  210 (284)
T 2a19_B          131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI  210 (284)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHH
Confidence            5677888887775432       122334566777764433222   234579999999999998889999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         135 MYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       135 lye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      +|+|++|..||...  ......+...  .++...+..+.++|.+||..||.+|||+.+++++.+.-
T Consensus       211 l~~l~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          211 LAELLHVCDTAFET--SKFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HHHHHSCCSSHHHH--HHHHHHHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCcchhH--HHHHHHhhcc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999988532  2233333332  34667889999999999999999999999999987654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.96  E-value=7.7e-32  Score=232.97  Aligned_cols=195  Identities=17%  Similarity=0.192  Sum_probs=138.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-CCCCcC-chhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-EMSDPA-AQPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.++++++|||||++++++.+++..|+|||||++|+|.+++....... ...... ......+..++.+.|..++.|
T Consensus        83 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH  162 (321)
T 2qkw_B           83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH  162 (321)
T ss_dssp             HHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeec
Confidence            479999999999999999999999999999999999999998875432110 111111 122334567788888877544


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      .       +.+....+++.||+.......      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       163 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~  242 (321)
T 2qkw_B          163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV  242 (321)
T ss_dssp             SCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred             CCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence            2       223345677788765432211      134569999999999988889999999999999999999999997


Q ss_pred             CCCHHHHH-------HHHhccc------cCC----CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         147 TSTLKETY-------SRIKKVE------YKL----PATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       147 ~~~~~~~~-------~~i~~~~------~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +....+..       .......      ...    +...+..+.+++.+||..||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            64322110       0111110      111    11233467899999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=9.1e-31  Score=225.49  Aligned_cols=195  Identities=18%  Similarity=0.260  Sum_probs=145.2

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCC-eEEEEEeccCCCCHHHHHHHhcCCCC-------------CCCc-CchhHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSK-FVYIILELCRKRSMMELYNSACDLEE-------------MSDP-AAQPVIWV   65 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~-~~ylVmEy~~~g~L~~~~~~~~~~~~-------------~~~~-~~~~~~~~   65 (305)
                      .+|+.+++++ +|||||++++++.+++ .+|+|||||++|+|.+++........             +... ....+..+
T Consensus        78 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi  157 (316)
T 2xir_A           78 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV  157 (316)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHH
Confidence            4799999999 7999999999988754 59999999999999999976432100             0111 11122345


Q ss_pred             HHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHH
Q psy6191          66 SKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIG  132 (305)
Q Consensus        66 ~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlG  132 (305)
                      ..++.++|..++.|.       +.+....+++.||+.......      .....||+.|+|||++.+..++.++||||+|
T Consensus       158 ~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG  237 (316)
T 2xir_A          158 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG  237 (316)
T ss_dssp             HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHH
Confidence            677888888776443       223345677788875543321      2345689999999999988899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCHHHH-HHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         133 CIMYTLLV-GKPPFETSTLKET-YSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       133 vilye~l~-g~~Pf~~~~~~~~-~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |++|+|++ |..||.+.+..+. ...+.. .....|...+..+.++|.+||..||.+|||+.++++|
T Consensus       238 ~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999998 9999987654333 333332 2345667789999999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.96  E-value=1.5e-30  Score=228.84  Aligned_cols=190  Identities=19%  Similarity=0.221  Sum_probs=137.1

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcC----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCC
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDS----KFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGF   77 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   77 (305)
                      +|+..++.++|||||++++++.+.    ...||||||| ||+|.+++......  +.... ......+..++.|+|..++
T Consensus        97 ~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~i  173 (364)
T 3op5_A           97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR--FSRKTVLQLSLRILDILEYIHEHEY  173 (364)
T ss_dssp             HHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSC--CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            466778889999999999998764    5699999999 99999999764211  12222 2223345778889887775


Q ss_pred             cee--------ec-CCCCCeeEcchhHHHHhcC-----------CcccccCCCcccccccccCCCCccchHHHHHHHHHH
Q psy6191          78 GYQ--------LN-DDSSGVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYT  137 (305)
Q Consensus        78 ~~~--------~~-~~~~~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  137 (305)
                      .|.        +. +....+++.||+....+..           ....+||+.|||||++.+..++.++|||||||++||
T Consensus       174 iHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~e  253 (364)
T 3op5_A          174 VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ  253 (364)
T ss_dssp             ECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             EEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHH
Confidence            432        22 1446678888875532211           134569999999999999889999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHhcc--c---------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         138 LLVGKPPFETSTLKETYSRIKKV--E---------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       138 ~l~g~~Pf~~~~~~~~~~~i~~~--~---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |++|+.||.+.............  .         ...+...+.++.+++..||..||.+||++.++++
T Consensus       254 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          254 WLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            99999999863322211111000  0         0012467889999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=1.7e-30  Score=221.26  Aligned_cols=191  Identities=18%  Similarity=0.244  Sum_probs=144.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++ .|+||||+++|+|.+++......  ..... ...+..+..++.+.|..++.|.
T Consensus        69 ~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~  145 (291)
T 1u46_A           69 IREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLESKRFIHR  145 (291)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGG--SCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCC--cCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            47999999999999999999998765 89999999999999998764221  12211 2223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+.......       .....||+.|+|||++.+..++.++||||+||++|+|++ |+.||
T Consensus       146 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  225 (291)
T 1u46_A          146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW  225 (291)
T ss_dssp             CCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence                   122234566777764432211       123468889999999988888999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHhccc--cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKVE--YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+.+..+....+....  ...+...+..+.++|.+||..||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          226 IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             TTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            9988888777775543  3445678899999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=1.4e-30  Score=223.52  Aligned_cols=194  Identities=16%  Similarity=0.236  Sum_probs=138.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++..|+||||+++|+|.+++.............. ..+..+..++.++|..++.|.
T Consensus        78 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  157 (307)
T 2nru_A           78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR  157 (307)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecC
Confidence            4799999999999999999999999999999999999999999875432211222111 223345677888887775432


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+....+++.||+.......      ....+||+.|+|||++.+. ++.++||||+||++|+|++|.+||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCccc
Confidence                   233445677888765433221      2345799999999998754 78899999999999999999999986


Q ss_pred             CCHHH----HHHHHhccc-----------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKE----TYSRIKKVE-----------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~----~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+...    ....+....           ...+...+..+.+++.+||..||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             TBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            54321    111111111           11122234567899999999999999999999853

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=2.9e-30  Score=219.83  Aligned_cols=191  Identities=17%  Similarity=0.314  Sum_probs=133.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||+++++. .....|+|||||+||+|.+++......  ..... ......+..++.++|..++.|.
T Consensus        68 ~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~~L~~lH~~~i~H~  144 (289)
T 3og7_A           68 KNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKSIIHR  144 (289)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            4799999999999999999954 566799999999999999988543211  11111 1223345677888888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccc---cCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILN---KNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+..+.+++.||+......      .....+||+.|+|||++.   +..++.++||||+||++|+|++|+.|
T Consensus       145 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  224 (289)
T 3og7_A          145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP  224 (289)
T ss_dssp             CCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCC
Confidence                   22334567788886543322      123467999999999986   55678899999999999999999999


Q ss_pred             CCCCCHHH-HHHHHhcccc-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETSTLKE-TYSRIKKVEY-----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~~~~~-~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |.+.+..+ ....+.....     ..+...+..+.++|.+||..||.+|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          225 YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            98755443 3333333222     123467789999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.96  E-value=2.3e-30  Score=224.30  Aligned_cols=199  Identities=21%  Similarity=0.314  Sum_probs=123.8

Q ss_pred             hHHH-HHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC--CCCCCcCc-hhHHHHHHHHHHhhhh-CC
Q psy6191           3 QEIA-IHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL--EEMSDPAA-QPVIWVSKWVDYSDKY-GF   77 (305)
Q Consensus         3 ~Ei~-il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~-~~   77 (305)
                      +|+. +++.++|||||++++++.+++..|+|||||++ +|.+++......  ........ .....+..++.+.|.. ++
T Consensus        69 ~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i  147 (327)
T 3aln_A           69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI  147 (327)
T ss_dssp             HHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCE
Confidence            3444 78889999999999999999999999999986 787777642111  11111111 2233456778888876 65


Q ss_pred             cee-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCccccccc----ccCCCCccchHHHHHHHHHHHHhCCC
Q psy6191          78 GYQ-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEIL----NKNGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        78 ~~~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~----~~~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      .+.       +.+..+.+++.||+.......   ....+||+.|+|||++    .+..++.++||||+||++|+|++|+.
T Consensus       148 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  227 (327)
T 3aln_A          148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF  227 (327)
T ss_dssp             CCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred             eECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence            432       223345677788764432211   2234799999999998    45568999999999999999999999


Q ss_pred             CCCCCCH-HHHHHHHhccc-cCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         144 PFETSTL-KETYSRIKKVE-YKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       144 Pf~~~~~-~~~~~~i~~~~-~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||.+.+. .+....+.... ..++    ...+..+.++|.+||..||.+|||+.++++||||...
T Consensus       228 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          228 PYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            9987432 22222222221 1222    3578899999999999999999999999999999764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=4.8e-30  Score=221.35  Aligned_cols=192  Identities=20%  Similarity=0.237  Sum_probs=143.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||+||+|.+++.....  ....... ..+..+..++.+.|..++.|.
T Consensus        77 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~  154 (319)
T 2y4i_B           77 KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAKGILHK  154 (319)
T ss_dssp             CTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            5799999999999999999999999999999999999999999864321  1122222 223345678889988876543


Q ss_pred             ecC------CCCCeeEcchhHHHHh---------cCCcccccCCCccccccccc---------CCCCccchHHHHHHHHH
Q psy6191          81 LND------DSSGVMFNDLTRMIML---------ANKNTLCGTPNYIAPEILNK---------NGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        81 ~~~------~~~~v~~~d~~~~~~~---------~~~~~~~Gt~~y~aPE~~~~---------~~~~~~~DiwSlGvily  136 (305)
                      -..      +++.+++.||+.....         .......||+.|+|||++.+         ..++.++||||+||++|
T Consensus       155 dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~  234 (319)
T 2y4i_B          155 DLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY  234 (319)
T ss_dssp             CCCSTTEEEC--CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred             CCChhhEEEeCCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence            211      1345667777632211         11234569999999999864         34788999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhccccCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         137 TLLVGKPPFETSTLKETYSRIKKVEYKL--PATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       137 e~l~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +|++|+.||...+.......+.......  +...+.++.++|.+||..||.+|||+.++++
T Consensus       235 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          235 ELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999988877766665443221  2357889999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=1.5e-30  Score=241.62  Aligned_cols=200  Identities=21%  Similarity=0.274  Sum_probs=141.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~   74 (305)
                      .+|++++++++|||||++++++.+      ++..|+|||||+||+|.+++........+....... +..+..++.+.|.
T Consensus        60 ~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs  139 (676)
T 3qa8_A           60 CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE  139 (676)
T ss_dssp             HHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            479999999999999999999766      778999999999999999997644322223333322 3345678889998


Q ss_pred             hCCcee--------ecCCCC--CeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhC
Q psy6191          75 YGFGYQ--------LNDDSS--GVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        75 ~~~~~~--------~~~~~~--~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g  141 (305)
                      .|+.|.        +..++.  .+++.||+.......   ....+||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus       140 ~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG  219 (676)
T 3qa8_A          140 NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG  219 (676)
T ss_dssp             TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSS
T ss_pred             CCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHC
Confidence            776443        221111  255667654433222   2356899999999999989999999999999999999999


Q ss_pred             CCCCCCCCHHHHHH---------HH-----hcccc------CCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         142 KPPFETSTLKETYS---------RI-----KKVEY------KLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~---------~i-----~~~~~------~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      ..||.+......+.         .+     .....      +.|    ..++..+.++|.+||..||.+|||+.++++||
T Consensus       220 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp  299 (676)
T 3qa8_A          220 FRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG  299 (676)
T ss_dssp             CSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCT
T ss_pred             CCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCH
Confidence            99997653322110         00     00111      111    22456789999999999999999999999999


Q ss_pred             cccc
Q psy6191         198 FFND  201 (305)
Q Consensus       198 ~~~~  201 (305)
                      ||+.
T Consensus       300 ~F~~  303 (676)
T 3qa8_A          300 CFQA  303 (676)
T ss_dssp             THHH
T ss_pred             HHHH
Confidence            9964

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.96  E-value=5.4e-30  Score=240.76  Aligned_cols=191  Identities=20%  Similarity=0.306  Sum_probs=145.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++. ++.+|+|||||++|+|.+++......  ..... ......+..++.|+|..++.|.
T Consensus       439 ~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givHr  515 (656)
T 2j0j_A          439 LQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLESKRFVHR  515 (656)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            47999999999999999999985 46799999999999999998754311  11111 1223345778889998776543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+..+.+++.||+.......     .....||+.|||||++.+..++.++||||+||++|||++ |.+||.+
T Consensus       516 Dikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  595 (656)
T 2j0j_A          516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  595 (656)
T ss_dssp             CCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence                   222335567777764432211     123467889999999998889999999999999999997 9999999


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... ....|...+..+.++|.+||..||.+|||+.++++
T Consensus       596 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          596 VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8888777776554 34567789999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=3.5e-30  Score=222.30  Aligned_cols=190  Identities=18%  Similarity=0.244  Sum_probs=141.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++|||||++++++.+  ...+|+|||||++|+|.+++.... +   ..... .....+..++.++|..++.
T Consensus        81 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~---~~~~~~~i~~~l~~~l~~LH~~~iv  156 (318)
T 3lxp_A           81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-I---GLAQLLLFAQQICEGMAYLHAQHYI  156 (318)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC-C---CHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC-C---CHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            579999999999999999999987  468999999999999999986532 1   22111 2223456778888877653


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.       +.+....+++.||+.......       .....||+.|+|||++.+..++.++||||+||++|+|++|..|
T Consensus       157 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p  236 (318)
T 3lxp_A          157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS  236 (318)
T ss_dssp             CSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             CCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCc
Confidence            32       233446688888875543322       2345688999999999988899999999999999999999999


Q ss_pred             CCCCCHH---------------HHHHHHh-ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETSTLK---------------ETYSRIK-KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~~~~---------------~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |......               .....+. ......|...+..+.++|++||..||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          237 SQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             GGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9753221               1111122 2234556778999999999999999999999999984

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=3.5e-30  Score=222.95  Aligned_cols=197  Identities=16%  Similarity=0.222  Sum_probs=138.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC-CCCcCc-hhHHHHHHHHHHhhhh---C
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE-MSDPAA-QPVIWVSKWVDYSDKY---G   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~---~   76 (305)
                      .+|++++++++|||||++++++.+++..|+|||||++|+|.+++........ +..... .....+..++.++|..   +
T Consensus        75 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~  154 (326)
T 3uim_A           75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK  154 (326)
T ss_dssp             HHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred             HHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            4799999999999999999999999999999999999999999875432211 111111 2233456778888877   6


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.|.       +.+....+++.||+.......     ....+||+.|+|||++.+..++.++||||+||++|+|++|+.|
T Consensus       155 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  234 (326)
T 3uim_A          155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA  234 (326)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCS
T ss_pred             eEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCc
Confidence            5332       223345677777765433221     1245699999999999888899999999999999999999999


Q ss_pred             CCCCC--------HHHHHHHHhcc-------ccCC----CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         145 FETST--------LKETYSRIKKV-------EYKL----PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       145 f~~~~--------~~~~~~~i~~~-------~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      |....        ...........       ....    +...+..+.+++.+||..||.+|||+.++++|-.
T Consensus       235 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          235 FDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             BCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            95211        11111110000       0011    1112356789999999999999999999998743

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=3.8e-30  Score=222.91  Aligned_cols=193  Identities=16%  Similarity=0.196  Sum_probs=142.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE--cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE--DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~--~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++|||||++++++.  +++.+|+|||||++|+|.+++......  ...... ..+..+..++.++|..++.
T Consensus        72 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~iv  149 (327)
T 3lxl_A           72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQICKGMEYLGSRRCV  149 (327)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            58999999999999999999987  567799999999999999998764321  122222 2233456778888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhc-------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.       +.+....+++.||+......       ......||+.|+|||++.+..++.++||||+||++|+|++|..|
T Consensus       150 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p  229 (327)
T 3lxl_A          150 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK  229 (327)
T ss_dssp             CSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             CCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence            32       22233557777876554322       12345688999999999988899999999999999999999999


Q ss_pred             CCCCCHH---------------HHHHHHh-ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         145 FETSTLK---------------ETYSRIK-KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       145 f~~~~~~---------------~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |......               .....+. ......+...+..+.++|.+||..||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             GGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9653321               1222222 22345567789999999999999999999999999753

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=4.6e-30  Score=224.66  Aligned_cols=190  Identities=15%  Similarity=0.181  Sum_probs=139.9

Q ss_pred             hhHHHHHhcCCCCCccc---------------eeEEEEc-CCeEEEEEeccCCCCHHHHHHHh--cCCCCCCCcC-chhH
Q psy6191           2 SQEIAIHRSLKHRNVVG---------------FHSFFED-SKFVYIILELCRKRSMMELYNSA--CDLEEMSDPA-AQPV   62 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~---------------l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~--~~~~~~~~~~-~~~~   62 (305)
                      .+|++++++++|||||+               +++++.. ++..||||||| +|+|.+++...  ..+   .... ...+
T Consensus        90 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l---~~~~~~~i~  165 (352)
T 2jii_A           90 FNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL---SERSVLQVA  165 (352)
T ss_dssp             HHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCC---CHHHHHHHH
T ss_pred             HHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCC---CHHHHHHHH
Confidence            47999999999999998               6777765 78999999999 99999999864  222   2222 2233


Q ss_pred             HHHHHHHHHhhhhCCcee-------ecCCCC--CeeEcchhHHHHhcC-----------CcccccCCCcccccccccCCC
Q psy6191          63 IWVSKWVDYSDKYGFGYQ-------LNDDSS--GVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKNGH  122 (305)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~-------~~~~~~--~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~~~  122 (305)
                      ..+..++.++|..++.+.       +.+..+  .+++.||+.......           ....+||+.|+|||++.+..+
T Consensus       166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  245 (352)
T 2jii_A          166 CRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP  245 (352)
T ss_dssp             HHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC
Confidence            445778889998876443       222233  678888875533211           134589999999999998889


Q ss_pred             CccchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHh---ccccCCC------CCCCHHHHHHHHHHhhcCCCCCCCHh
Q psy6191         123 SFEVDVWSIGCIMYTLLVGKPPFETST--LKETYSRIK---KVEYKLP------ATLKKPAATMIKKMLLLDPVQRPPVA  191 (305)
Q Consensus       123 ~~~~DiwSlGvilye~l~g~~Pf~~~~--~~~~~~~i~---~~~~~~~------~~~~~~~~~li~~~l~~dp~~R~~~~  191 (305)
                      +.++|||||||++|+|++|+.||....  .........   .....++      ..++..+.++|.+||..||.+|||++
T Consensus       246 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  325 (352)
T 2jii_A          246 SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA  325 (352)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence            999999999999999999999998753  322222221   1111111      24689999999999999999999999


Q ss_pred             hhhc
Q psy6191         192 QLLH  195 (305)
Q Consensus       192 ~~l~  195 (305)
                      ++++
T Consensus       326 ~l~~  329 (352)
T 2jii_A          326 MLRN  329 (352)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=8.6e-30  Score=219.63  Aligned_cols=195  Identities=18%  Similarity=0.352  Sum_probs=136.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE----cCCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE----DSKFVYIILELCRKRSMMELYNSACDL-EEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~----~~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|+.++++++|||||++++++.    .....|+|||||++|+|.+++...... ..+..... ..+..+..++.++|..
T Consensus        74 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  153 (317)
T 2buj_A           74 QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK  153 (317)
T ss_dssp             HHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            47999999999999999999987    345899999999999999998764221 11122222 2233456788888877


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHh-------------cCCcccccCCCcccccccccCC---CCccchHHHHH
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIML-------------ANKNTLCGTPNYIAPEILNKNG---HSFEVDVWSIG  132 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~-------------~~~~~~~Gt~~y~aPE~~~~~~---~~~~~DiwSlG  132 (305)
                      ++.|.       +.+....+++.||+.....             .......||+.|+|||++.+..   ++.++||||+|
T Consensus       154 ~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG  233 (317)
T 2buj_A          154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG  233 (317)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHH
T ss_pred             CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHH
Confidence            75432       2233456677777522111             1112346899999999987554   68899999999


Q ss_pred             HHHHHHHhCCCCCCCCCH--HHHHHHHh-ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         133 CIMYTLLVGKPPFETSTL--KETYSRIK-KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       133 vilye~l~g~~Pf~~~~~--~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |++|+|++|+.||.....  ......+. ....+.+...+..+.++|.+||..||.+|||+.+++++
T Consensus       234 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          234 CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            999999999999953110  01111121 22233445788999999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.6e-30  Score=231.10  Aligned_cols=194  Identities=20%  Similarity=0.305  Sum_probs=137.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC--eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK--FVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~--~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++|||||++++++.+.+  ..|+|||||+||+|.+++........+...... .+..+..++.++|..++.
T Consensus        55 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  134 (396)
T 4eut_A           55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV  134 (396)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            37999999999999999999998765  789999999999999998654332112222222 223456788888877754


Q ss_pred             ee--------ec---CCCCCeeEcchhHHHHhcC---CcccccCCCccccccccc--------CCCCccchHHHHHHHHH
Q psy6191          79 YQ--------LN---DDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNK--------NGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        79 ~~--------~~---~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~--------~~~~~~~DiwSlGvily  136 (305)
                      |.        +.   +....+++.||+.......   ..+.+||+.|+|||++.+        ..++.++||||+||++|
T Consensus       135 H~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~  214 (396)
T 4eut_A          135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY  214 (396)
T ss_dssp             CCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHH
T ss_pred             ECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHH
Confidence            32        11   2233467888875543322   235689999999999864        45788999999999999


Q ss_pred             HHHhCCCCCCC----CCHHHHHHHHhccccC-------------------CC------CCCCHHHHHHHHHHhhcCCCCC
Q psy6191         137 TLLVGKPPFET----STLKETYSRIKKVEYK-------------------LP------ATLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       137 e~l~g~~Pf~~----~~~~~~~~~i~~~~~~-------------------~~------~~~~~~~~~li~~~l~~dp~~R  187 (305)
                      ||++|+.||..    ....+....+....+.                   +|      ...+..+.++|.+||+.||.+|
T Consensus       215 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R  294 (396)
T 4eut_A          215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC  294 (396)
T ss_dssp             HHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTS
T ss_pred             HHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhh
Confidence            99999999964    2233444444333211                   11      1123456799999999999999


Q ss_pred             CCHhhhhc
Q psy6191         188 PPVAQLLH  195 (305)
Q Consensus       188 ~~~~~~l~  195 (305)
                      +++.++++
T Consensus       295 ~s~~e~l~  302 (396)
T 4eut_A          295 WGFDQFFA  302 (396)
T ss_dssp             CCHHHHHH
T ss_pred             ccHHHHHH
Confidence            99999865

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=1.6e-29  Score=215.77  Aligned_cols=191  Identities=16%  Similarity=0.173  Sum_probs=139.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEE-EcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFF-EDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~-~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.++|+|++..+.++ .+++..|+||||| +|+|.+++.....  .+..... .....+..++.++|..++.|
T Consensus        52 ~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH  128 (296)
T 3uzp_A           52 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIH  128 (296)
T ss_dssp             HHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            4799999999998877666554 6778899999999 9999999874322  1122222 22334567888888777543


Q ss_pred             e--------ec--CCCCCeeEcchhHHHHhcC-----------CcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          80 Q--------LN--DDSSGVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        80 ~--------~~--~~~~~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      .        +.  +....+++.||+.......           ....+||+.|+|||++.+..++.++||||+||++|+|
T Consensus       129 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l  208 (296)
T 3uzp_A          129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF  208 (296)
T ss_dssp             SCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHH
Confidence            2        21  2445677788765443221           2356899999999999998899999999999999999


Q ss_pred             HhCCCCCCCCC---HHHHHHHHhccccCC-----CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         139 LVGKPPFETST---LKETYSRIKKVEYKL-----PATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       139 l~g~~Pf~~~~---~~~~~~~i~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++|+.||.+.+   ..+.+..+.......     +...+.++.+++.+||..||.+|||+.++++
T Consensus       209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          209 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            99999998632   222333333222222     3678899999999999999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=2e-29  Score=215.75  Aligned_cols=189  Identities=18%  Similarity=0.365  Sum_probs=128.1

Q ss_pred             hhHHHHH-hcCCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIH-RSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il-~~l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|+.++ +.++|||||++++++++    +..+|||||||+||+|.+++...... .+..... .....+..++.++|..
T Consensus        58 ~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~  136 (299)
T 3m2w_A           58 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSI  136 (299)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4788888 66799999999999987    78899999999999999999864321 1122222 2233456778888865


Q ss_pred             CCceeecCCCCCeeEcchhHHHHhcCCc---ccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          76 GFGYQLNDDSSGVMFNDLTRMIMLANKN---TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        76 ~~~~~~~~~~~~v~~~d~~~~~~~~~~~---~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                      +           +.|+|+++.+++.+..   ..+--..|-..+.+.+..++.++||||+||++|+|++|..||.+.+...
T Consensus       137 ~-----------i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  205 (299)
T 3m2w_A          137 N-----------IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  205 (299)
T ss_dssp             T-----------EECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred             C-----------cccCCCCHHHEEEecCCCCCcEEEeccccccccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence            5           4445555444443321   0000001112233445668899999999999999999999998765443


Q ss_pred             HHHH----HhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         153 TYSR----IKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       153 ~~~~----i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ....    +......+|    ...+.++.++|.+||..||.+|||+.|+++||||...
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          206 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             --CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             hhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            3221    222223333    4678999999999999999999999999999999853

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=1.4e-29  Score=216.80  Aligned_cols=192  Identities=19%  Similarity=0.267  Sum_probs=140.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC--CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS--KFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~--~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++|||||++++++.++  +.+|+|||||++|+|.+++......  ...... .....+..++.++|..++.
T Consensus        71 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~  148 (302)
T 4e5w_A           71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGSRQYV  148 (302)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTT--CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcccc--CCHHHHHHHHHHHHHHHHHhhcCCcc
Confidence            4799999999999999999999887  7799999999999999998654321  122111 2233456778888877754


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhc-------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      |.       +.+..+.+++.||+......       ......||+.|+|||++.+..++.++||||+||++|+|++|..|
T Consensus       149 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  228 (302)
T 4e5w_A          149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS  228 (302)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             cCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCC
Confidence            32       22223456777776543322       12345789999999999988899999999999999999999998


Q ss_pred             CCCC--------------C-HHHHHHHHh-ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETS--------------T-LKETYSRIK-KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~--------------~-~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +...              . .......+. ......|...+..+.++|.+||..||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          229 DSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            6432              1 112222222 2234567788999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=4.5e-29  Score=212.86  Aligned_cols=191  Identities=17%  Similarity=0.185  Sum_probs=139.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEE-EcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFF-EDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~-~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+++.++|+|+|..+..+ .+++..|+||||| +|+|.+++......  ...... .....+..++.+.|..++.|
T Consensus        52 ~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivH  128 (296)
T 4hgt_A           52 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNFIH  128 (296)
T ss_dssp             HHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSC--CCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            4799999999998877666654 6788999999999 99999998753221  122222 22334567888888877543


Q ss_pred             e-------ec---CCCCCeeEcchhHHHHhcC-----------CcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          80 Q-------LN---DDSSGVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        80 ~-------~~---~~~~~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      .       +.   +....+++.||+.......           ....+||+.|+|||++.+..++.++||||+||++|+|
T Consensus       129 ~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l  208 (296)
T 4hgt_A          129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF  208 (296)
T ss_dssp             SCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHH
Confidence            2       22   3445677788765443221           2356899999999999998899999999999999999


Q ss_pred             HhCCCCCCCCCH---HHHHHHHhccccCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         139 LVGKPPFETSTL---KETYSRIKKVEYKLP-----ATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       139 l~g~~Pf~~~~~---~~~~~~i~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++|+.||.+.+.   ......+.......|     ...+.++.++|.+||..||.+|||+.++++
T Consensus       209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          209 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            999999976432   122223322222222     567899999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.96  E-value=2.4e-29  Score=215.09  Aligned_cols=189  Identities=20%  Similarity=0.340  Sum_probs=128.7

Q ss_pred             hHHHHHhc--CCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhh--
Q psy6191           3 QEIAIHRS--LKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSD--   73 (305)
Q Consensus         3 ~Ei~il~~--l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--   73 (305)
                      +|.+++..  ++|||||++++++.+    ...+|+|||||++|+|.++++.. .+   .... ...+..+..++.++|  
T Consensus        49 ~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~---~~~~~~~i~~~i~~~l~~lH~~  124 (301)
T 3q4u_A           49 RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TL---DTVSCLRIVLSIASGLAHLHIE  124 (301)
T ss_dssp             HHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC-CB---CHHHHHHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc-cc---CHHHHHHHHHHHHHHHHHHHHh
Confidence            46666665  899999999998654    35699999999999999998532 11   2211 222334567788888  


Q ss_pred             ------hhCCcee-------ecCCCCCeeEcchhHHHHhcC--------CcccccCCCcccccccccC------CCCccc
Q psy6191          74 ------KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNKN------GHSFEV  126 (305)
Q Consensus        74 ------~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~~------~~~~~~  126 (305)
                            +.++.|.       +.+....+++.||+.......        ....+||+.|+|||++.+.      .++.++
T Consensus       125 ~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  204 (301)
T 3q4u_A          125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV  204 (301)
T ss_dssp             BCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHH
T ss_pred             hhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchh
Confidence                  5554332       223345677777764432211        2234899999999999876      345689


Q ss_pred             hHHHHHHHHHHHHhC----------CCCCCCCC----HHHHHHHHhc---cccCCCC-----CCCHHHHHHHHHHhhcCC
Q psy6191         127 DVWSIGCIMYTLLVG----------KPPFETST----LKETYSRIKK---VEYKLPA-----TLKKPAATMIKKMLLLDP  184 (305)
Q Consensus       127 DiwSlGvilye~l~g----------~~Pf~~~~----~~~~~~~i~~---~~~~~~~-----~~~~~~~~li~~~l~~dp  184 (305)
                      ||||+||++|||++|          ..||....    ..........   ....+|.     ..+..+.+++.+||..||
T Consensus       205 DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  284 (301)
T 3q4u_A          205 DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP  284 (301)
T ss_dssp             HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSG
T ss_pred             hHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcCh
Confidence            999999999999999          88986532    1222222221   1222222     133568899999999999


Q ss_pred             CCCCCHhhhhc
Q psy6191         185 VQRPPVAQLLH  195 (305)
Q Consensus       185 ~~R~~~~~~l~  195 (305)
                      .+|||+.++++
T Consensus       285 ~~Rps~~~i~~  295 (301)
T 3q4u_A          285 SARLTALRIKK  295 (301)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hhCCCHHHHHH
Confidence            99999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.95  E-value=4.6e-29  Score=216.62  Aligned_cols=193  Identities=21%  Similarity=0.322  Sum_probs=121.2

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEE--------cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHH
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFE--------DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDY   71 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~--------~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   71 (305)
                      .+|+.+++++. |||||++++++.        +...+|+|||||. |+|.+++........+..... ..+..+..++.+
T Consensus        73 ~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~  151 (337)
T 3ll6_A           73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH  151 (337)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            47999999996 999999999994        4456999999996 789998865332222222222 223345678889


Q ss_pred             hhhhC--Ccee-------ecCCCCCeeEcchhHHHHhcC----------------CcccccCCCccccccc---ccCCCC
Q psy6191          72 SDKYG--FGYQ-------LNDDSSGVMFNDLTRMIMLAN----------------KNTLCGTPNYIAPEIL---NKNGHS  123 (305)
Q Consensus        72 ~~~~~--~~~~-------~~~~~~~v~~~d~~~~~~~~~----------------~~~~~Gt~~y~aPE~~---~~~~~~  123 (305)
                      +|..+  +.|.       +.+....+++.||+.......                ..+.+||+.|+|||++   .+..++
T Consensus       152 LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  231 (337)
T 3ll6_A          152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG  231 (337)
T ss_dssp             HHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSS
T ss_pred             HHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC
Confidence            98877  5443       223345677777764432211                1245799999999998   566688


Q ss_pred             ccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCc
Q psy6191         124 FEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE  197 (305)
Q Consensus       124 ~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~  197 (305)
                      .++|||||||++|+|++|+.||............  .....+...+..+.++|.+||+.||.+|||+.+++++-
T Consensus       232 ~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          232 EKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCCC--------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             hHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            9999999999999999999999876544333222  12233455677899999999999999999999999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=7.6e-29  Score=215.38  Aligned_cols=190  Identities=16%  Similarity=0.272  Sum_probs=129.7

Q ss_pred             hHHHHHhc--CCCCCccceeEEEEcC----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhh
Q psy6191           3 QEIAIHRS--LKHRNVVGFHSFFEDS----KFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKY   75 (305)
Q Consensus         3 ~Ei~il~~--l~HpnIV~l~~~~~~~----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   75 (305)
                      +|.+++..  ++|||||++++++.+.    ..+|+|||||++|+|.+++.... +   .... ......+..++.+.|..
T Consensus        78 ~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~---~~~~~~~i~~~i~~~l~~lH~~  153 (337)
T 3mdy_A           78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-L---DAKSMLKLAYSSVSGLCHLHTE  153 (337)
T ss_dssp             HHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCC-B---CHHHHHHHHHHHHHHHHHHHSC
T ss_pred             hHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccC-C---CHHHHHHHHHHHHHHHHHHHHh
Confidence            45556655  4999999999999887    78999999999999999996532 2   2211 22233456778888866


Q ss_pred             --------CCcee-------ecCCCCCeeEcchhHHHHhc--------CCcccccCCCcccccccccCCCCcc------c
Q psy6191          76 --------GFGYQ-------LNDDSSGVMFNDLTRMIMLA--------NKNTLCGTPNYIAPEILNKNGHSFE------V  126 (305)
Q Consensus        76 --------~~~~~-------~~~~~~~v~~~d~~~~~~~~--------~~~~~~Gt~~y~aPE~~~~~~~~~~------~  126 (305)
                              ++.|.       +.+....+++.||+......        ...+.+||+.|+|||++.+..++.+      +
T Consensus       154 ~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  233 (337)
T 3mdy_A          154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA  233 (337)
T ss_dssp             BCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHH
T ss_pred             hhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCcccc
Confidence                    43221       22234556677765432211        1135689999999999987766554      9


Q ss_pred             hHHHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHh--ccccCCCC-----CCCHHHHHHHHHHhhcCC
Q psy6191         127 DVWSIGCIMYTLLVG----------KPPFETST-----LKETYSRIK--KVEYKLPA-----TLKKPAATMIKKMLLLDP  184 (305)
Q Consensus       127 DiwSlGvilye~l~g----------~~Pf~~~~-----~~~~~~~i~--~~~~~~~~-----~~~~~~~~li~~~l~~dp  184 (305)
                      ||||+||++|||++|          ..||....     .......+.  .....+|.     ..+..+.++|.+||..||
T Consensus       234 DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  313 (337)
T 3mdy_A          234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP  313 (337)
T ss_dssp             HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSG
T ss_pred             chHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhCh
Confidence            999999999999999          77775421     122222221  22223332     234558899999999999


Q ss_pred             CCCCCHhhhhcC
Q psy6191         185 VQRPPVAQLLHF  196 (305)
Q Consensus       185 ~~R~~~~~~l~~  196 (305)
                      .+|||+.+++++
T Consensus       314 ~~Rps~~ell~~  325 (337)
T 3mdy_A          314 ASRLTALRVKKT  325 (337)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCCCHHHHHHH
Confidence            999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=6.1e-29  Score=215.27  Aligned_cols=192  Identities=19%  Similarity=0.243  Sum_probs=138.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC--eEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK--FVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFG   78 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~--~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   78 (305)
                      .+|++++++++|||||++++++.+.+  .+|+|||||++|+|.+++......  ..... ......+..++.++|..++.
T Consensus        90 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iv  167 (326)
T 2w1i_A           90 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRYI  167 (326)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTS--SCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            58999999999999999999987654  799999999999999999764321  12111 12233456778888877654


Q ss_pred             ee-------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          79 YQ-------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        79 ~~-------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      +.       +.+....+++.||+.......       .....||+.|+|||++.+..++.++||||+||++|+|++|..|
T Consensus       168 H~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~  247 (326)
T 2w1i_A          168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK  247 (326)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred             ccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCC
Confidence            32       122234567777765433221       1234578889999999888889999999999999999999999


Q ss_pred             CCCCCHH----------------HHHHHHh-ccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         145 FETSTLK----------------ETYSRIK-KVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       145 f~~~~~~----------------~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |......                .....+. ....+.|...+.++.++|.+||..||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             GGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8642110                1111222 2234556778999999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.95  E-value=4.4e-29  Score=216.89  Aligned_cols=195  Identities=15%  Similarity=0.170  Sum_probs=128.2

Q ss_pred             HHHHHhcCCCCCccceeEEEEc-----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhh---
Q psy6191           4 EIAIHRSLKHRNVVGFHSFFED-----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKY---   75 (305)
Q Consensus         4 Ei~il~~l~HpnIV~l~~~~~~-----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---   75 (305)
                      |+..++.++||||+++++++..     ...+|||||||++|+|.+++......   ..........+..++.|+|..   
T Consensus        57 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~i~~qi~~~L~~LH~~~~~  133 (336)
T 3g2f_A           57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD---WVSSCRLAHSVTRGLAYLHTELPR  133 (336)
T ss_dssp             HHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCBC---HHHHHHHHHHHHHHHHHHHCCBCC
T ss_pred             HHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcccc---hhHHHHHHHHHHHHHHHHHhhhcc
Confidence            4444556899999999986542     33689999999999999998654321   111122334456788888876   


Q ss_pred             ------CCcee-------ecCCCCCeeEcchhHHHHhc------------CCcccccCCCccccccccc-------CCCC
Q psy6191          76 ------GFGYQ-------LNDDSSGVMFNDLTRMIMLA------------NKNTLCGTPNYIAPEILNK-------NGHS  123 (305)
Q Consensus        76 ------~~~~~-------~~~~~~~v~~~d~~~~~~~~------------~~~~~~Gt~~y~aPE~~~~-------~~~~  123 (305)
                            ++.|.       +.+....+++.||+....+.            .....+||+.|+|||++.+       ..++
T Consensus       134 ~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  213 (336)
T 3g2f_A          134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESAL  213 (336)
T ss_dssp             GGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHH
T ss_pred             ccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccc
Confidence                  54332       22334567777776543221            1124579999999999976       3466


Q ss_pred             ccchHHHHHHHHHHHHhCCCCCCCCCH------------------HHHHHHH--hccccCCCCCC------CHHHHHHHH
Q psy6191         124 FEVDVWSIGCIMYTLLVGKPPFETSTL------------------KETYSRI--KKVEYKLPATL------KKPAATMIK  177 (305)
Q Consensus       124 ~~~DiwSlGvilye~l~g~~Pf~~~~~------------------~~~~~~i--~~~~~~~~~~~------~~~~~~li~  177 (305)
                      .++||||+||++|||++|..||.....                  ......+  ......+|...      +..+.++|.
T Consensus       214 ~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  293 (336)
T 3g2f_A          214 KQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE  293 (336)
T ss_dssp             HHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHH
Confidence            789999999999999999776643211                  1111111  11122333332      236899999


Q ss_pred             HHhhcCCCCCCCHhhhhc------Cccccc
Q psy6191         178 KMLLLDPVQRPPVAQLLH------FEFFND  201 (305)
Q Consensus       178 ~~l~~dp~~R~~~~~~l~------~~~~~~  201 (305)
                      +||..||.+|||+.|+++      ++|-++
T Consensus       294 ~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          294 DCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             HHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            999999999999999954      566654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.95  E-value=3e-28  Score=212.06  Aligned_cols=192  Identities=15%  Similarity=0.255  Sum_probs=133.3

Q ss_pred             hhHHHHHhc--CCCCCccceeEEEEcCC----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhh--
Q psy6191           2 SQEIAIHRS--LKHRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSD--   73 (305)
Q Consensus         2 ~~Ei~il~~--l~HpnIV~l~~~~~~~~----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--   73 (305)
                      .+|+++++.  ++|||||++++++.++.    .+|+|||||++|+|.+++.... +.  .......+..+..++.++|  
T Consensus        82 ~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~--~~~~~~i~~~i~~~l~~lH~~  158 (342)
T 1b6c_B           82 FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VT--VEGMIKLALSTASGLAHLHME  158 (342)
T ss_dssp             HHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCC-BC--HHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccC-cc--HHHHHHHHHHHHHHHHHHHHH
Confidence            368888877  79999999999998876    8999999999999999997531 11  1112223334567788888  


Q ss_pred             ------hhCCcee-------ecCCCCCeeEcchhHHHHhcC--------CcccccCCCcccccccccCC------CCccc
Q psy6191          74 ------KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNKNG------HSFEV  126 (305)
Q Consensus        74 ------~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~~~------~~~~~  126 (305)
                            ..++.|.       +.+....+++.||+.......        ....+||+.|+|||++.+..      ++.++
T Consensus       159 ~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  238 (342)
T 1b6c_B          159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA  238 (342)
T ss_dssp             BCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHH
T ss_pred             HhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcc
Confidence                  4443222       223345667777764432221        23457999999999987653      33689


Q ss_pred             hHHHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHhccc--cCCCCC-----CCHHHHHHHHHHhhcCC
Q psy6191         127 DVWSIGCIMYTLLVG----------KPPFETST-----LKETYSRIKKVE--YKLPAT-----LKKPAATMIKKMLLLDP  184 (305)
Q Consensus       127 DiwSlGvilye~l~g----------~~Pf~~~~-----~~~~~~~i~~~~--~~~~~~-----~~~~~~~li~~~l~~dp  184 (305)
                      ||||+||++|||++|          ..||....     .......+....  ..+|..     .+..+.+++.+||..||
T Consensus       239 Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  318 (342)
T 1b6c_B          239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG  318 (342)
T ss_dssp             HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSG
T ss_pred             cHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccCh
Confidence            999999999999999          78986542     233333333222  222221     22467899999999999


Q ss_pred             CCCCCHhhhhcC
Q psy6191         185 VQRPPVAQLLHF  196 (305)
Q Consensus       185 ~~R~~~~~~l~~  196 (305)
                      .+|||+.+++++
T Consensus       319 ~~Rps~~~i~~~  330 (342)
T 1b6c_B          319 AARLTALRIKKT  330 (342)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCCCHHHHHHH
Confidence            999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=2.2e-28  Score=215.09  Aligned_cols=190  Identities=15%  Similarity=0.134  Sum_probs=136.8

Q ss_pred             hhHHHHHhcCC---CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC--CCCCcCc-hhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLK---HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE--EMSDPAA-QPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~---HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~   75 (305)
                      .+|++++++++   |||||++++++.+++..|||||||+||+|.+++.......  .+....+ .....+..++.|+|..
T Consensus       112 ~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~  191 (365)
T 3e7e_A          112 YIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC  191 (365)
T ss_dssp             HHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            36888888887   9999999999999999999999999999999997643321  1122222 2233457788899987


Q ss_pred             CCcee-------ecCC-----------CCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHH
Q psy6191          76 GFGYQ-------LNDD-----------SSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSI  131 (305)
Q Consensus        76 ~~~~~-------~~~~-----------~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSl  131 (305)
                      ++.|.       +.+.           ...+++.||+....+.      ...+.+||+.|||||++.+..++.++||||+
T Consensus       192 ~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  271 (365)
T 3e7e_A          192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV  271 (365)
T ss_dssp             TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHH
T ss_pred             CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHH
Confidence            75432       2222           4678888887653221      1245689999999999999889999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHhccccCCC-CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         132 GCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP-ATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       132 Gvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||++|||++|+.||.......     ......++ ...+....+++.+||..+|.+|++..+.+.+
T Consensus       272 G~il~elltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          272 AATVYCMLFGTYMKVKNEGGE-----CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             HHHHHHHHHSSCCCEEEETTE-----EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhCCCccccCCCCc-----eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            999999999999996532211     00011111 1245677899999999999999765554443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.95  E-value=1.5e-28  Score=208.95  Aligned_cols=171  Identities=13%  Similarity=0.129  Sum_probs=126.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCceee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQL   81 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (305)
                      .+|+.++++++|||||++++++++++..|||||||+||+|.++++..  .  ........+..+..++.|+|..|     
T Consensus        79 ~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~--~~~~~~~i~~ql~~aL~~lH~~g-----  149 (286)
T 3uqc_A           79 LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--P--SPVGAIRAMQSLAAAADAAHRAG-----  149 (286)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--C--CHHHHHHHHHHHHHHHHHHHHTT-----
T ss_pred             HHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--C--ChHHHHHHHHHHHHHHHHHHHCC-----
Confidence            47999999999999999999999999999999999999999998542  1  11122233344567788888765     


Q ss_pred             cCCCCCeeEcchhHHHHhcCC--cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHH---H
Q psy6191          82 NDDSSGVMFNDLTRMIMLANK--NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYS---R  156 (305)
Q Consensus        82 ~~~~~~v~~~d~~~~~~~~~~--~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~---~  156 (305)
                            +.|+|++..|++.+.  ....+++.|++|       ++.++||||+||++|||++|+.||.+.+..+...   .
T Consensus       150 ------ivH~Dikp~NIll~~~g~~kl~~~~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~  216 (286)
T 3uqc_A          150 ------VALSIDHPSRVRVSIDGDVVLAYPATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER  216 (286)
T ss_dssp             ------CCCCCCSGGGEEEETTSCEEECSCCCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB
T ss_pred             ------CccCCCCcccEEEcCCCCEEEEeccccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH
Confidence                  445555555554322  234568888876       7889999999999999999999998765432110   1


Q ss_pred             Hhcccc----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         157 IKKVEY----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       157 i~~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ......    ..+..++..+.++|.+||..||.+| |+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            111111    1235688999999999999999999 9999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.95  E-value=2.9e-27  Score=214.43  Aligned_cols=191  Identities=17%  Similarity=0.191  Sum_probs=140.0

Q ss_pred             hhHHHHHhcCCC-CCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKH-RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~H-pnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++++.|+| ++|+.+..++.+.+..||||||| +|+|.+++......  +..... ..+..++.++.|+|..++.|
T Consensus        50 ~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~--l~~~~~~~i~~qi~~aL~yLH~~gIvH  126 (483)
T 3sv0_A           50 LYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLH  126 (483)
T ss_dssp             HHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            479999999987 55666677778889999999999 99999999753221  122222 22334567888998877543


Q ss_pred             e--------ec--CCCCCeeEcchhHHHHhcC-----------CcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          80 Q--------LN--DDSSGVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        80 ~--------~~--~~~~~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      .        +.  +....+++.||+.......           ....+||+.|+|||++.+..++.++|||||||++|||
T Consensus       127 rDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~el  206 (483)
T 3sv0_A          127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYF  206 (483)
T ss_dssp             CCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHH
Confidence            2        31  3445677888875543222           1256899999999999999999999999999999999


Q ss_pred             HhCCCCCCCCC---HHHHHHHHhcccc-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         139 LVGKPPFETST---LKETYSRIKKVEY-----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       139 l~g~~Pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++|+.||.+..   ..+.+..+.....     .++..++.++.++|.+||..||.+||++.++++
T Consensus       207 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          207 LRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999998743   3333333332211     223567889999999999999999999998754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.94  E-value=8.7e-29  Score=234.22  Aligned_cols=186  Identities=18%  Similarity=0.265  Sum_probs=135.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCe-----EEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKF-----VYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~-----~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   75 (305)
                      .+|+.++++++|||||++++++++.+.     .|||||||+||+|.+.+..  .+   .... ......+..++.|.|..
T Consensus       127 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l---~~~~~~~~~~qi~~aL~~lH~~  201 (681)
T 2pzi_A          127 MAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KL---PVAEAIAYLLEILPALSYLHSI  201 (681)
T ss_dssp             HHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CC---CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CC---CHHHHHHHHHHHHHHHHHHHHC
Confidence            479999999999999999999988665     7999999999999887653  11   2211 22234456788888887


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHhcCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                      |+.|.       +.+. ..+++.||+...........+||+.|||||++.+.. +.++||||+||++|+|++|.+||.+.
T Consensus       202 giiHrDlkp~NIll~~-~~~kl~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~  279 (681)
T 2pzi_A          202 GLVYNDLKPENIMLTE-EQLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR  279 (681)
T ss_dssp             TEECCCCSGGGEEECS-SCEEECCCTTCEETTCCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred             CCeecccChHHeEEeC-CcEEEEecccchhcccCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence            75443       1222 367788887665555556788999999999987654 88999999999999999999998753


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         149 TLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      .....    .  ........+..+.++|.+||..||.+||+..+.+.|+|+.
T Consensus       280 ~~~~~----~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          280 YVDGL----P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ECSSC----C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccccc----c--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            11100    0  0000012356788999999999999999998888888874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.93  E-value=1.7e-28  Score=213.39  Aligned_cols=188  Identities=14%  Similarity=0.207  Sum_probs=126.9

Q ss_pred             hhHHHHHhcCC---------CCCccc-----------------eeEEEEc-------------CCeEEEEEeccCCCCHH
Q psy6191           2 SQEIAIHRSLK---------HRNVVG-----------------FHSFFED-------------SKFVYIILELCRKRSMM   42 (305)
Q Consensus         2 ~~Ei~il~~l~---------HpnIV~-----------------l~~~~~~-------------~~~~ylVmEy~~~g~L~   42 (305)
                      .+|+.++++++         |||||+                 ++++|++             ++.+|||||||++|++.
T Consensus        71 ~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll  150 (336)
T 2vuw_A           71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDL  150 (336)
T ss_dssp             HHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEET
T ss_pred             HHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccH
Confidence            47999999886         555554                 4544444             78999999999999776


Q ss_pred             HHHHHhcCCCCCCCcCchh-HHHHHHHHHHhh-hhCCcee--------ecCCC-------------------CCeeEcch
Q psy6191          43 ELYNSACDLEEMSDPAAQP-VIWVSKWVDYSD-KYGFGYQ--------LNDDS-------------------SGVMFNDL   93 (305)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~--------~~~~~-------------------~~v~~~d~   93 (305)
                      +.+... .   ..+..+.. +.++..++.|+| ..++.|+        +...+                   ..+++.||
T Consensus       151 ~~~~~~-~---~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DF  226 (336)
T 2vuw_A          151 EQMRTK-L---SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDY  226 (336)
T ss_dssp             GGGTTT-C---CCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCC
T ss_pred             HHHHhc-C---CCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeec
Confidence            655321 1   12222222 334577888998 7876543        22221                   16778888


Q ss_pred             hHHHHhcCCcccccCCCcccccccccCCCCccchHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHh-cccc--CC----
Q psy6191          94 TRMIMLANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCI-MYTLLVGKPPFETSTL-KETYSRIK-KVEY--KL----  164 (305)
Q Consensus        94 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvi-lye~l~g~~Pf~~~~~-~~~~~~i~-~~~~--~~----  164 (305)
                      +.+.... ..+.+||+.|||||++.+.. +.++||||+|++ .+++++|..||.+... ......+. ....  ..    
T Consensus       227 G~a~~~~-~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (336)
T 2vuw_A          227 TLSRLER-DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPA  304 (336)
T ss_dssp             TTCBEEE-TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHH
T ss_pred             cccEecC-CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhh
Confidence            7654433 24568999999999998776 889999998777 7888999999954211 11222222 1111  11    


Q ss_pred             CCCCCHHHHHHHHHHhhcCCCCCCCHhhhh-cCcccc
Q psy6191         165 PATLKKPAATMIKKMLLLDPVQRPPVAQLL-HFEFFN  200 (305)
Q Consensus       165 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~l-~~~~~~  200 (305)
                      +..+++++++||++||++|     |++|++ +||||+
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            1236678999999999987     999999 999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.91  E-value=1.5e-25  Score=200.03  Aligned_cols=168  Identities=13%  Similarity=0.215  Sum_probs=119.3

Q ss_pred             eEEEEEeccCCCCHHHHHHHhcCCCC----CCCcCchhH-HHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhH
Q psy6191          28 FVYIILELCRKRSMMELYNSACDLEE----MSDPAAQPV-IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTR   95 (305)
Q Consensus        28 ~~ylVmEy~~~g~L~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~   95 (305)
                      .+|++|+++ +|+|.++++.......    +.......+ ..+..++.|+|..++.|.       +.+..+.+++.||+.
T Consensus       179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~  257 (413)
T 3dzo_A          179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH  257 (413)
T ss_dssp             SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred             ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence            467888875 5799988853211100    011111122 345678889888775432       333445688888876


Q ss_pred             HHHhc-CCcccccCCCccccccc----------ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccccCC
Q psy6191          96 MIMLA-NKNTLCGTPNYIAPEIL----------NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL  164 (305)
Q Consensus        96 ~~~~~-~~~~~~Gt~~y~aPE~~----------~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~~~~~i~~~~~~~  164 (305)
                      ..... ...+.+| +.|||||++          .+..++.++|||||||++|||++|+.||.+.+..+....+..    .
T Consensus       258 a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~----~  332 (413)
T 3dzo_A          258 LVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR----S  332 (413)
T ss_dssp             CEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS----S
T ss_pred             eeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh----h
Confidence            43322 2345688 999999998          555688899999999999999999999988765443333322    2


Q ss_pred             CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         165 PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       165 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ...++..+.++|.+||..||.+||++.++++||||+.
T Consensus       333 ~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          333 CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            2467899999999999999999999999999999975

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.88  E-value=1.5e-24  Score=200.31  Aligned_cols=138  Identities=12%  Similarity=0.094  Sum_probs=95.4

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|+++ +||||+++++++++++.+|||||||+||+|.+++.....+.+     .+.+.+++.++.|+|+.|+.|+
T Consensus       289 ~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~-----~~I~~QIl~AL~ylH~~GIIHR  363 (569)
T 4azs_A          289 HNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDR-----EKILGSLLRSLAALEKQGFWHD  363 (569)
T ss_dssp             HHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCH-----HHHHHHHHHHHHHHHHTTCEES
T ss_pred             HHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCH-----HHHHHHHHHHHHHHHHCCceec
Confidence            5799999999 799999999999999999999999999999999987655422     2345566788999998887553


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                             +.+.++.+++.||+.+...    ....+.|||+.|||||++.+. +..++|+||+|+++|++.+|..||
T Consensus       364 DIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          364 DVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             cCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence                   3344567899999854432    223467999999999999765 567899999999998876665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.62  E-value=3.9e-17  Score=150.04  Aligned_cols=135  Identities=13%  Similarity=0.033  Sum_probs=100.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCceee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQL   81 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (305)
                      .+|++++++++|||||++..++.+++..|||||||+||+|.+++..          .......+.+++.|+|..++.|.-
T Consensus       387 ~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrD  456 (540)
T 3en9_A          387 AREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHND  456 (540)
T ss_dssp             HHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTT
T ss_pred             HHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCC
Confidence            5899999999999999666666677788999999999999998754          234455567888888887754431


Q ss_pred             cCCCC-----CeeEcchhHHHHhcC-----------CcccccCCCccccccccc--CCCCccchHHHHHHHHHHHHhCCC
Q psy6191          82 NDDSS-----GVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNK--NGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        82 ~~~~~-----~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~--~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      ...++     .+++.||+.......           ..+++||+.|||||++..  ..|+..+|+||.++-..+...++.
T Consensus       457 iKp~NILl~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~  536 (540)
T 3en9_A          457 LTTSNFIFDKDLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRA  536 (540)
T ss_dssp             CCTTSEEESSSEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCS
T ss_pred             CCHHHEEECCeEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcc
Confidence            11100     677788764332211           136789999999999986  568888999999998888888777


Q ss_pred             CCC
Q psy6191         144 PFE  146 (305)
Q Consensus       144 Pf~  146 (305)
                      +|.
T Consensus       537 rY~  539 (540)
T 3en9_A          537 RYV  539 (540)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            763

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.41  E-value=2.4e-13  Score=115.49  Aligned_cols=69  Identities=35%  Similarity=0.614  Sum_probs=60.2

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .++.+.. .+.+.+++.+++.++.|++.|+.|||+++++|||+||+|||++.++.+||+|||+|+.+...
T Consensus       117 G~L~~~i-~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          117 GELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            3444443 34567999999999999999999999999999999999999999999999999999988643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.37  E-value=6.1e-13  Score=114.70  Aligned_cols=60  Identities=28%  Similarity=0.492  Sum_probs=56.2

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      +.+++.++..++.|++.|+.|||+++++|||+||+|||++.++.+||+|||+|+.+....
T Consensus       165 ~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          165 TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            469999999999999999999999999999999999999999999999999999886543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.37  E-value=6.6e-13  Score=111.09  Aligned_cols=68  Identities=41%  Similarity=0.683  Sum_probs=55.6

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+.+... +.+.+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.....
T Consensus        98 ~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           98 ELFDYIV-QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             EHHHHHH-HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            3444433 3567999999999999999999999999999999999999999999999999999876543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.35  E-value=8.2e-13  Score=112.08  Aligned_cols=68  Identities=32%  Similarity=0.478  Sum_probs=57.6

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .++.+... +.+.+++.++..++.|++.|+.|+|+++++|||+||+|||++.++.+|++|||+|+.+..
T Consensus       111 g~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          111 GDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             CEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            34444433 346799999999999999999999999999999999999999999999999999987643

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.35  E-value=7.5e-13  Score=113.73  Aligned_cols=61  Identities=34%  Similarity=0.594  Sum_probs=54.3

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-ceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF-VVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~-~~k~~dfg~a~~~~~~  300 (305)
                      +.+.+++.++..++.|++.|+.|+|+++++|||+||+|||++.++ .+||+|||+|+.+..+
T Consensus       143 ~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          143 QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            456799999999999999999999999999999999999999887 6999999999987543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.35  E-value=1.2e-12  Score=115.80  Aligned_cols=60  Identities=28%  Similarity=0.492  Sum_probs=56.2

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      +.+++.++..++.|++.||.|||++|++|||+||+|||++.++.+||+|||+|+.+....
T Consensus       242 ~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          242 TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            459999999999999999999999999999999999999999999999999999886543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.33  E-value=1.4e-12  Score=110.81  Aligned_cols=68  Identities=35%  Similarity=0.549  Sum_probs=58.8

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .++.+........+++.++..++.|++.|+.|+|+++++|||+||+|||++.++.+||+|||+|+.+.
T Consensus       116 GsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          116 SSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             CBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            44555554455679999999999999999999999999999999999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.33  E-value=1.3e-12  Score=112.75  Aligned_cols=69  Identities=32%  Similarity=0.509  Sum_probs=58.8

Q ss_pred             ccchhhccc-ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         231 KPLMERNSK-RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       231 ~~l~~r~~~-~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .++.+.... +...+++.++..++.|++.|+.|+|++|++|||+||+|||++.++.+||+|||+|+.+..
T Consensus       108 g~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             CcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            344444432 334578999999999999999999999999999999999999999999999999987754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.27  E-value=4.8e-12  Score=117.37  Aligned_cols=70  Identities=30%  Similarity=0.490  Sum_probs=60.6

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      +++..... +.+.+++.+++.|++||+.|+.|||++|++|||+||+|||++.++.+||+|||+|+.+....
T Consensus       277 GdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          277 GDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             CBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            34444433 35679999999999999999999999999999999999999999999999999999876443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.27  E-value=4.6e-12  Score=107.60  Aligned_cols=56  Identities=39%  Similarity=0.657  Sum_probs=47.0

Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       245 ~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ....+..++.|++.|+.|+|+++++|||+||+|||++.++.+||+|||+|+.+...
T Consensus       116 ~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~  171 (299)
T 4g31_A          116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  171 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC------
T ss_pred             HHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCC
Confidence            44557889999999999999999999999999999999999999999999887543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.25  E-value=6.5e-12  Score=110.81  Aligned_cols=60  Identities=38%  Similarity=0.749  Sum_probs=55.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +.+.+++.+++.++.|++.||.|||++|++|||+||+||+++.++.+|++|||+|+.+..
T Consensus       151 ~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          151 SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            456799999999999999999999999999999999999999999999999999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.25  E-value=6.5e-12  Score=105.96  Aligned_cols=59  Identities=44%  Similarity=0.679  Sum_probs=53.4

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecC-CCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSD-NFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~--~~~~~l~~~~~l~~~-~~~~k~~dfg~a~~~~  298 (305)
                      +.+.+++.++..++.|++.|+.|+|+++  ++|||+||+|||++. ++.+||+|||+|+...
T Consensus       122 ~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          122 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            4567899999999999999999999998  999999999999974 7899999999997543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.23  E-value=9.2e-12  Score=108.55  Aligned_cols=57  Identities=28%  Similarity=0.455  Sum_probs=52.7

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~-~~~k~~dfg~a~~~~~  299 (305)
                      .+++.+++.++.|++.|+.|+|++|++|||+||+|||++.+ +.+|++|||+|+.+..
T Consensus       113 ~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            48999999999999999999999999999999999999876 7999999999986643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.23  E-value=8.1e-12  Score=108.39  Aligned_cols=60  Identities=42%  Similarity=0.544  Sum_probs=55.3

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      ..+++.++..++.|++.|+.|+|+++++|||+||.|||++.++.+||+|||+|+.+..+.
T Consensus       180 ~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~  239 (353)
T 4ase_A          180 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  239 (353)
T ss_dssp             TCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred             ccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCC
Confidence            458899999999999999999999999999999999999999999999999999875443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.22  E-value=5.3e-12  Score=107.09  Aligned_cols=59  Identities=32%  Similarity=0.600  Sum_probs=54.8

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.|+.|+|+++++|||+||+|||++.++.+||+|||+|+.+...
T Consensus       123 ~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  181 (299)
T 4asz_A          123 TELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST  181 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCC
Confidence            46899999999999999999999999999999999999999999999999999876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.21  E-value=1.1e-11  Score=105.73  Aligned_cols=60  Identities=32%  Similarity=0.581  Sum_probs=55.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.+...++.|++.|+.|+|+++++|||+||.|||++.++.+||+|||+|+.+...
T Consensus       139 ~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~  198 (308)
T 4gt4_A          139 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA  198 (308)
T ss_dssp             ECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCC
Confidence            456889999999999999999999999999999999999999999999999999877543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.21  E-value=1.1e-11  Score=106.65  Aligned_cols=60  Identities=30%  Similarity=0.459  Sum_probs=49.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.|+.|+|+++++|||+||.|||++.++.+||+|||+|+.+...
T Consensus       152 ~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~  211 (329)
T 4aoj_A          152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST  211 (329)
T ss_dssp             CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCC
Confidence            356889999999999999999999999999999999999999999999999999877543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.14  E-value=4.1e-11  Score=110.69  Aligned_cols=58  Identities=17%  Similarity=0.251  Sum_probs=49.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      .+.+++.   .++.|++.||.|+|++||+|||+||+|||++.++.+||+|||+|+.+..++
T Consensus       336 ~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          336 GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            4455543   478999999999999999999999999999999999999999999876543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.12  E-value=5.4e-11  Score=101.29  Aligned_cols=58  Identities=31%  Similarity=0.351  Sum_probs=53.2

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDH--------KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~--------~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..++.++...++.|++.|+.|+|++        +++|||+||+|||++.++.+||+|||+|+....
T Consensus        95 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           95 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            4578888999999999999999987        899999999999999999999999999987654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.11  E-value=5.8e-11  Score=109.73  Aligned_cols=70  Identities=29%  Similarity=0.526  Sum_probs=60.7

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC--CceEEeecccceecCcc
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN--FVVKIGDFGLAARIEFD  300 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~--~~~k~~dfg~a~~~~~~  300 (305)
                      ..+.+....+.+.+++.++..++.|++.|+.|||+++++|||+||+||+++..  +.+||+|||+|+.+...
T Consensus       239 g~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          239 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            45555555556679999999999999999999999999999999999999854  78999999999987644

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.01  E-value=4.7e-10  Score=100.30  Aligned_cols=69  Identities=26%  Similarity=0.478  Sum_probs=59.6

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+.....+....+++..+..++.|++.|+.|+|+++++|||+||+||+++.++.+||+|||+|+.+...
T Consensus       160 ~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          160 DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             cHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            444444333566999999999999999999999999999999999999999999999999999876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=98.99  E-value=5.8e-10  Score=98.98  Aligned_cols=69  Identities=28%  Similarity=0.470  Sum_probs=59.5

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+.....+....+++..+..++.|++.|+.|+|+++++|||+||+||+++..+.+|++|||+|+.+...
T Consensus       147 ~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          147 DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             BHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            344444333456899999999999999999999999999999999999999999999999999877544

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=98.98  E-value=5.6e-10  Score=97.11  Aligned_cols=59  Identities=36%  Similarity=0.630  Sum_probs=54.7

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +...+++.++..++.|++.|+.|||+++++|||+||+||+++.++.+|++|||+|+...
T Consensus       117 ~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          117 KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            34569999999999999999999999999999999999999999999999999998643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=98.96  E-value=8.9e-10  Score=97.24  Aligned_cols=58  Identities=36%  Similarity=0.651  Sum_probs=54.2

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      +...+++.++..++.|++.|+.|||+++++|||+||+||+++.++.+||+|||+|+..
T Consensus       146 ~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          146 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            3456999999999999999999999999999999999999999999999999999863

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=98.95  E-value=8.8e-10  Score=99.28  Aligned_cols=59  Identities=36%  Similarity=0.598  Sum_probs=55.2

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.|+.|||+++++|||+||+||+++.++.+||+|||+|+.+.
T Consensus       149 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          149 TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            34568999999999999999999999999999999999999999999999999998765

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=98.94  E-value=5.8e-10  Score=96.24  Aligned_cols=57  Identities=23%  Similarity=0.314  Sum_probs=52.5

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEecCCC--------------------ceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLH-DHKIIHRDLKLGNLFLSDNF--------------------VVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h-~~~~~~~~l~~~~~l~~~~~--------------------~~k~~dfg~a~~~~  298 (305)
                      ..+++.++..++.|++.|+.|+| +++++|||+||+||+++..+                    .+||+|||+|+.+.
T Consensus       156 ~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~  233 (336)
T 2vuw_A          156 KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER  233 (336)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC
Confidence            34789999999999999999999 99999999999999999876                    89999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=98.94  E-value=1.3e-09  Score=93.53  Aligned_cols=68  Identities=29%  Similarity=0.480  Sum_probs=58.4

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +........+.+++..+..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+...
T Consensus       101 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A          101 LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             SHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             HHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            33333333456889999999999999999999999999999999999999999999999999876543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=98.93  E-value=1.1e-09  Score=97.14  Aligned_cols=59  Identities=27%  Similarity=0.515  Sum_probs=54.9

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++..+..++.|++.|+.|+|+++++|||+||+||+++..+.+|++|||+|+.+...
T Consensus       163 ~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            35899999999999999999999999999999999999999999999999999877543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=98.93  E-value=1.3e-09  Score=94.08  Aligned_cols=59  Identities=39%  Similarity=0.664  Sum_probs=54.4

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +...+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+...
T Consensus        98 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           98 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            34568999999999999999999999999999999999999999999999999998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=98.93  E-value=1.3e-09  Score=94.71  Aligned_cols=58  Identities=36%  Similarity=0.566  Sum_probs=54.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+.+++.++..++.|++.|+.|+|++|++|||+||+||+++.++.+|++|||+|+...
T Consensus       115 ~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A          115 VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            3568999999999999999999999999999999999999999999999999998643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=98.93  E-value=1.3e-09  Score=95.16  Aligned_cols=61  Identities=30%  Similarity=0.444  Sum_probs=55.7

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec--CCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~--~~~~~k~~dfg~a~~~~~~  300 (305)
                      ....+++.++..++.|++.|+.|+|+++++|+|+||+||+++  ..+.+||+|||+|+.+...
T Consensus       145 ~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          145 NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGG
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccC
Confidence            346689999999999999999999999999999999999998  8899999999999877544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=98.92  E-value=1.7e-09  Score=95.03  Aligned_cols=60  Identities=28%  Similarity=0.557  Sum_probs=55.6

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.|+.|+|++|++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       108 ~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A          108 QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            345689999999999999999999999999999999999999999999999999987653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=98.91  E-value=1.7e-09  Score=93.79  Aligned_cols=58  Identities=33%  Similarity=0.588  Sum_probs=54.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.|+.|+|++|++|||+||+||+++.++.+|++|||+|+...
T Consensus       112 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A          112 CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            4568999999999999999999999999999999999999999999999999998653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=98.91  E-value=1.4e-09  Score=95.01  Aligned_cols=58  Identities=22%  Similarity=0.360  Sum_probs=53.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-----------CCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-----------NFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~-----------~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.|+.|+|+++++|||+||+||+++.           .+.+|++|||+|+.+.
T Consensus       166 ~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~  234 (365)
T 3e7e_A          166 EKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK  234 (365)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhh
Confidence            456899999999999999999999999999999999999988           8999999999997654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=98.91  E-value=1.5e-09  Score=93.51  Aligned_cols=60  Identities=37%  Similarity=0.660  Sum_probs=55.3

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+.+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+...
T Consensus       108 ~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A          108 HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            456899999999999999999999999999999999999999999999999999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=98.91  E-value=2e-09  Score=90.92  Aligned_cols=65  Identities=26%  Similarity=0.470  Sum_probs=57.4

Q ss_pred             hhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       234 ~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ........+.+++.++..++.|++.|+.|+|++|++|+|+||+||+++.++.+|++|||+|+.+.
T Consensus        88 ~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           88 KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            33333345678999999999999999999999999999999999999999999999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=98.91  E-value=1.8e-09  Score=93.54  Aligned_cols=58  Identities=36%  Similarity=0.651  Sum_probs=54.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      +...+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+..
T Consensus       103 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A          103 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            3456899999999999999999999999999999999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=98.90  E-value=1.8e-09  Score=94.57  Aligned_cols=57  Identities=35%  Similarity=0.627  Sum_probs=53.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      ...+++.++..++.|++.|+.|+|++|++|||+||+||+++.++.+|++|||+|+..
T Consensus       133 ~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          133 ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            456899999999999999999999999999999999999999999999999999764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=98.89  E-value=1.7e-09  Score=96.63  Aligned_cols=60  Identities=37%  Similarity=0.566  Sum_probs=54.7

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+..
T Consensus       122 ~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          122 TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            345689999999999999999999999999999999999999999999999999987754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=98.89  E-value=2.3e-09  Score=94.41  Aligned_cols=57  Identities=28%  Similarity=0.582  Sum_probs=53.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++..+..++.|++.|+.|+|++|++|||+||+||+++.++.+|++|||+|+.+.
T Consensus       104 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A          104 NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            468889999999999999999999999999999999999999999999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=98.89  E-value=2.3e-09  Score=91.80  Aligned_cols=58  Identities=36%  Similarity=0.630  Sum_probs=54.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++..+..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+.
T Consensus       100 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A          100 SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            4568999999999999999999999999999999999999999999999999998764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=98.89  E-value=2.2e-09  Score=93.21  Aligned_cols=59  Identities=37%  Similarity=0.622  Sum_probs=54.9

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+.+++.++..++.|++.++.|+|++|++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            35689999999999999999999999999999999999999999999999999987653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=98.89  E-value=2.4e-09  Score=100.96  Aligned_cols=59  Identities=36%  Similarity=0.564  Sum_probs=54.8

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+.+++.++..++.|++.|+.|||+++++|||+||+||+++.++.+||+|||+|+...
T Consensus       435 ~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          435 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            34568999999999999999999999999999999999999999999999999998654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=98.88  E-value=2.6e-09  Score=91.14  Aligned_cols=65  Identities=32%  Similarity=0.623  Sum_probs=57.0

Q ss_pred             hhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       234 ~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..........+++.++..++.|++.|+.|+|++|++|+|+||+||+++.++.+|++|||+|+.+.
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A          106 KKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             HHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            33333344568999999999999999999999999999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=98.87  E-value=1.4e-09  Score=93.53  Aligned_cols=67  Identities=31%  Similarity=0.494  Sum_probs=58.1

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +..........+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       103 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A          103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             HHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            4444444456688999999999999999999999999999999999999999999999999987643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=98.87  E-value=1.9e-09  Score=92.00  Aligned_cols=67  Identities=27%  Similarity=0.457  Sum_probs=57.4

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +..........+++..+..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       143 L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          143 LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             HHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            3333333445689999999999999999999999999999999999999999999999999877653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=98.86  E-value=3.8e-09  Score=90.60  Aligned_cols=68  Identities=28%  Similarity=0.454  Sum_probs=58.4

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--CCceEEeecccceecCc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD--NFVVKIGDFGLAARIEF  299 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~--~~~~k~~dfg~a~~~~~  299 (305)
                      .+.+........+++.++..++.|++.|+.|+|++|++|+|+||+||+++.  ++.+|++|||+|+.+..
T Consensus        87 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           87 DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             BHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            344444444456899999999999999999999999999999999999987  78999999999987754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=98.86  E-value=3.1e-09  Score=93.80  Aligned_cols=60  Identities=33%  Similarity=0.500  Sum_probs=54.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~-~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++..+..++.|++.|+.|+|++|++|+|+||+||+++ .++.+|++|||+|+.+..
T Consensus       134 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          134 LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            345688999999999999999999999999999999999998 789999999999987643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=98.86  E-value=3e-09  Score=94.71  Aligned_cols=61  Identities=31%  Similarity=0.577  Sum_probs=54.2

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CceEEeecccceecCc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKIGDFGLAARIEF  299 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~-~~~k~~dfg~a~~~~~  299 (305)
                      .....+++..+..++.|++.|+.|||+++++|||+||+||+++.+ +.+||+|||+|+.+..
T Consensus       148 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            345668999999999999999999999999999999999999954 6789999999987653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=98.86  E-value=2.7e-09  Score=96.19  Aligned_cols=57  Identities=35%  Similarity=0.553  Sum_probs=50.3

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.|+.|||++|++|||+||+||+++.++.+||+|||+|+....
T Consensus       160 ~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          160 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            488899999999999999999999999999999999999999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=98.86  E-value=3.8e-09  Score=89.51  Aligned_cols=58  Identities=31%  Similarity=0.571  Sum_probs=54.1

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+++.++..++.|++.|+.|+|+++++|+|++|+||+++.++.+|++|||+|+.+...
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A          112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            5889999999999999999999999999999999999999999999999999876543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=98.85  E-value=1.9e-09  Score=95.88  Aligned_cols=58  Identities=17%  Similarity=0.171  Sum_probs=51.9

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.....++.|++.|+.|||+++++|||+||+||+++.++.+||+|||+|+...
T Consensus       205 ~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~  262 (413)
T 3dzo_A          205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  262 (413)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecC
Confidence            3446677778888999999999999999999999999999999999999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=98.85  E-value=4.2e-09  Score=89.18  Aligned_cols=58  Identities=40%  Similarity=0.798  Sum_probs=54.1

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|+|+++++|+|++|.||+++.++.+|++|||+|+.+..
T Consensus       132 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  189 (298)
T 2zv2_A          132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG  189 (298)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            4588999999999999999999999999999999999999999999999999987653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=98.85  E-value=3.6e-09  Score=91.34  Aligned_cols=59  Identities=49%  Similarity=0.767  Sum_probs=54.7

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+.+++.++..++.|++.|+.|+|++|++|+|+||+||+++.++.+|++|||+|+....
T Consensus       102 ~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B          102 KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            45689999999999999999999999999999999999999999999999999876643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=98.85  E-value=4.4e-09  Score=96.35  Aligned_cols=59  Identities=41%  Similarity=0.653  Sum_probs=55.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++..+..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+..
T Consensus       283 ~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          283 NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             SCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            44689999999999999999999999999999999999999999999999999987654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=98.84  E-value=2.5e-09  Score=91.99  Aligned_cols=68  Identities=31%  Similarity=0.471  Sum_probs=54.6

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+..........+++.++..++.|++.++.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       102 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A          102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            34444444456688999999999999999999999999999999999999999999999999987643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=98.84  E-value=4.5e-09  Score=89.44  Aligned_cols=57  Identities=35%  Similarity=0.632  Sum_probs=53.3

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.++.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       116 ~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  172 (308)
T 3g33_A          116 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY  172 (308)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCC
Confidence            388999999999999999999999999999999999999999999999999976643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=98.84  E-value=4.9e-09  Score=91.75  Aligned_cols=57  Identities=39%  Similarity=0.556  Sum_probs=53.2

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .++..++..++.|++.|+.|+|.++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       199 ~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  255 (370)
T 2psq_A          199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN  255 (370)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTC
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCc
Confidence            478888999999999999999999999999999999999999999999999987654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=98.84  E-value=5.2e-09  Score=89.92  Aligned_cols=60  Identities=30%  Similarity=0.463  Sum_probs=54.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.++.|+|.++++|+|+||+||+++.++.++++|||+|+.+..
T Consensus       144 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          144 HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            345689999999999999999999999999999999999999999999999999987654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=98.83  E-value=5.5e-09  Score=88.97  Aligned_cols=59  Identities=34%  Similarity=0.483  Sum_probs=54.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|++|+||+++.++.+|++|||+|+.+..
T Consensus       102 ~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A          102 DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            45688999999999999999999999999999999999999999999999999987643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=98.83  E-value=4.4e-09  Score=90.48  Aligned_cols=59  Identities=22%  Similarity=0.323  Sum_probs=54.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCc-----eEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV-----VKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~-----~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|+||+||+++..+.     +|++|||+|+.+..
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           99 DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            456899999999999999999999999999999999999998876     99999999987643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=98.83  E-value=5.3e-09  Score=90.74  Aligned_cols=60  Identities=35%  Similarity=0.607  Sum_probs=55.1

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .....+++.++..++.|++.|+.|+|++|++|+|+||+||+++.++.+|++|||+|+.+.
T Consensus       116 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A          116 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             CTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            334568999999999999999999999999999999999999999999999999998765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=98.83  E-value=4.7e-09  Score=90.08  Aligned_cols=58  Identities=40%  Similarity=0.685  Sum_probs=54.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.++.|||++|++|+|++|+||+++..+.+|++|||+|+.+.
T Consensus        99 ~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           99 DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            3458899999999999999999999999999999999999999999999999998654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=98.83  E-value=4.3e-09  Score=90.48  Aligned_cols=58  Identities=34%  Similarity=0.476  Sum_probs=51.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+.+++.++..++.|++.|+.|+|.+|++|+|+||.||+++.++.+|++|||+|+...
T Consensus       115 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A          115 EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            4568899999999999999999999999999999999999999999999999987654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=98.82  E-value=5.6e-09  Score=91.30  Aligned_cols=57  Identities=42%  Similarity=0.723  Sum_probs=53.8

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++.++..++.|++.|+.|+|++|++|+|+||+||+++.++.+|++|||+|+...
T Consensus       123 ~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          123 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            468899999999999999999999999999999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=98.82  E-value=5.4e-09  Score=88.21  Aligned_cols=60  Identities=27%  Similarity=0.478  Sum_probs=54.7

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~---~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|+||+||++   +..+.+|++|||+|+.+...
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           99 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            4568999999999999999999999999999999999999   78889999999999876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=98.81  E-value=6.5e-09  Score=87.84  Aligned_cols=60  Identities=20%  Similarity=0.335  Sum_probs=53.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCc-----eEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV-----VKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~-----~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|++|+||+++..+.     +|++|||+|+.+...
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A          100 GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            445899999999999999999999999999999999999987665     999999999876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=98.81  E-value=4e-09  Score=89.13  Aligned_cols=67  Identities=34%  Similarity=0.529  Sum_probs=55.1

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +..........+++.++..++.|++.++.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       100 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A          100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             HHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             HHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            3333333344588999999999999999999999999999999999999999999999999987643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=98.81  E-value=6e-09  Score=91.58  Aligned_cols=62  Identities=27%  Similarity=0.497  Sum_probs=55.5

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCceEEeecccceecCcc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~-~~~~~k~~dfg~a~~~~~~  300 (305)
                      .....+++..+..++.|++.|+.|+|++|++|+|+||+||+++ .++.+|++|||+|+.+...
T Consensus       133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  195 (383)
T 3eb0_A          133 RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS  195 (383)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence            3456689999999999999999999999999999999999997 6889999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=98.81  E-value=4.3e-09  Score=89.07  Aligned_cols=60  Identities=32%  Similarity=0.540  Sum_probs=54.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+.+++.++..++.|++.++.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       104 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A          104 SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            345689999999999999999999999999999999999999999999999999876543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=98.81  E-value=7.1e-09  Score=89.79  Aligned_cols=60  Identities=23%  Similarity=0.398  Sum_probs=54.5

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC--ceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF--VVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~--~~k~~dfg~a~~~~~~  300 (305)
                      .+.+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++  .+|++|||+|+.+...
T Consensus       145 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~  206 (345)
T 2v62_A          145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN  206 (345)
T ss_dssp             GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccc
Confidence            34789999999999999999999999999999999999998777  9999999999877543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=98.81  E-value=4.6e-09  Score=91.39  Aligned_cols=58  Identities=38%  Similarity=0.568  Sum_probs=54.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|+||.||+++.++.+|++|||+|+.+.
T Consensus       153 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          153 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            3568899999999999999999999999999999999999999999999999998764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=98.81  E-value=3.4e-09  Score=89.36  Aligned_cols=59  Identities=34%  Similarity=0.632  Sum_probs=54.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+.+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+.
T Consensus        93 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           93 CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            34568899999999999999999999999999999999999999999999999987654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=98.81  E-value=6.4e-09  Score=91.22  Aligned_cols=67  Identities=22%  Similarity=0.339  Sum_probs=57.5

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+..........++..++..++.|++.|+.|+|+++++|+|++|.||+++.++.+|++|||+|+...
T Consensus       198 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             BHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            3443333344568899999999999999999999999999999999999999999999999998654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=98.81  E-value=7e-09  Score=89.51  Aligned_cols=61  Identities=36%  Similarity=0.655  Sum_probs=55.7

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ....+++..+..++.|++.++.|+|.++++|+|+||.||+++.++.+|++|||+|+.+...
T Consensus       123 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  183 (335)
T 3dls_A          123 RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG  183 (335)
T ss_dssp             TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence            3446899999999999999999999999999999999999999999999999999877543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=98.80  E-value=4.5e-09  Score=94.35  Aligned_cols=59  Identities=39%  Similarity=0.667  Sum_probs=54.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~-~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +...+++.++..++.|++.|+.|||+ +|++|+|+||+||+++.++.+||+|||+|+...
T Consensus       241 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          241 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            34568999999999999999999998 999999999999999999999999999987643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=98.80  E-value=6.6e-09  Score=87.79  Aligned_cols=67  Identities=33%  Similarity=0.501  Sum_probs=57.4

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +..........+++.++..++.|++.++.|+|++|++|+|++|+||+++.++.+|++|||+|+.+..
T Consensus       110 L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          110 LLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             HHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            3333333455688889999999999999999999999999999999999999999999999976543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=98.80  E-value=7.7e-09  Score=88.46  Aligned_cols=57  Identities=35%  Similarity=0.684  Sum_probs=53.2

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++..+..++.|++.|+.|+|++|++|+|+||+||+++.++.+|++|||+|+.+.
T Consensus       103 ~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A          103 RGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            347888999999999999999999999999999999999999999999999998764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=98.80  E-value=4e-09  Score=92.54  Aligned_cols=53  Identities=17%  Similarity=0.139  Sum_probs=48.8

Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         246 EPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       246 ~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +.....++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+...
T Consensus       205 ~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~  257 (377)
T 3byv_A          205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  257 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence            36677799999999999999999999999999999999999999999998643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=98.80  E-value=5.6e-09  Score=92.36  Aligned_cols=58  Identities=41%  Similarity=0.598  Sum_probs=52.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~---~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|||+++++|+|+||+||+++.   ++.+||+|||+|+....
T Consensus       156 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          156 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             -CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            35899999999999999999999999999999999999987   78899999999987653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=98.80  E-value=6.3e-09  Score=95.75  Aligned_cols=58  Identities=34%  Similarity=0.559  Sum_probs=54.3

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+..
T Consensus       281 ~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            3489999999999999999999999999999999999999999999999999987754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=98.80  E-value=8.4e-09  Score=89.93  Aligned_cols=60  Identities=47%  Similarity=0.710  Sum_probs=54.3

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----ceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF----VVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~----~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.|+.|||.+|++|+|+||+||+++..+    .+|++|||+|+.+...
T Consensus       109 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~  172 (361)
T 2yab_A          109 KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG  172 (361)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC
Confidence            45689999999999999999999999999999999999998766    7999999999877543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=98.80  E-value=3.6e-09  Score=92.61  Aligned_cols=49  Identities=16%  Similarity=0.312  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         250 RFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       250 ~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+...
T Consensus       197 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~  245 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG  245 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETT
T ss_pred             HHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecC
Confidence            3556999999999999999999999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=98.80  E-value=8.5e-09  Score=87.21  Aligned_cols=67  Identities=31%  Similarity=0.436  Sum_probs=57.2

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +..........++..++..++.|++.++.|+|+++++|+|++|+||+++.++.+|++|||+|+.+..
T Consensus       114 L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          114 LRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             HHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            3333333445678889999999999999999999999999999999999999999999999986643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=98.79  E-value=8e-09  Score=90.76  Aligned_cols=58  Identities=34%  Similarity=0.576  Sum_probs=54.0

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       186 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  243 (382)
T 3tt0_A          186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH  243 (382)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSC
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCccccccc
Confidence            4588999999999999999999999999999999999999999999999999987653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=98.79  E-value=4.1e-09  Score=88.46  Aligned_cols=60  Identities=32%  Similarity=0.571  Sum_probs=47.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.++.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       109 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A          109 RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            344688999999999999999999999999999999999999999999999999987643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=98.79  E-value=5.8e-09  Score=89.32  Aligned_cols=57  Identities=32%  Similarity=0.520  Sum_probs=49.5

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.++.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       133 ~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~  189 (323)
T 3qup_A          133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS  189 (323)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccc
Confidence            588899999999999999999999999999999999999999999999999987643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=98.79  E-value=8.3e-09  Score=93.22  Aligned_cols=59  Identities=41%  Similarity=0.665  Sum_probs=55.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+.+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       110 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A          110 NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            45689999999999999999999999999999999999999999999999999987654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=98.79  E-value=6e-09  Score=88.18  Aligned_cols=58  Identities=29%  Similarity=0.347  Sum_probs=53.5

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLH--------DHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h--------~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++..+..++.|++.|+.|+|        +++++|+|+||+||+++.++.+|++|||+|+....
T Consensus       100 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  165 (301)
T 3q4u_A          100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ  165 (301)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccc
Confidence            45888999999999999999999        99999999999999999999999999999976543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=98.78  E-value=7e-09  Score=89.84  Aligned_cols=59  Identities=44%  Similarity=0.715  Sum_probs=54.4

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.|+.|+|+++++|+|++|+||+++.++.+|++|||+|+.+.
T Consensus       105 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A          105 NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            34568889999999999999999999999999999999999999999999999998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=98.78  E-value=6.8e-09  Score=90.95  Aligned_cols=67  Identities=30%  Similarity=0.442  Sum_probs=51.8

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ++.+........++..++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+.
T Consensus       177 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          177 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             BHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            3444433444567888899999999999999999999999999999999999999999999998664

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=98.78  E-value=1e-08  Score=85.31  Aligned_cols=60  Identities=27%  Similarity=0.486  Sum_probs=54.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||+|+....
T Consensus        97 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           97 HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             HGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            344689999999999999999999999999999999999999999999999999986643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=98.78  E-value=1.1e-08  Score=90.06  Aligned_cols=68  Identities=37%  Similarity=0.575  Sum_probs=56.9

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--CCceEEeecccceecCcc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD--NFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~--~~~~k~~dfg~a~~~~~~  300 (305)
                      +..........+++.++..++.|++.|+.|+|+++++|+|+||+||+++.  .+.+|++|||+|+.+...
T Consensus       135 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             HHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            43433334456899999999999999999999999999999999999974  467999999999877543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=98.78  E-value=5.9e-09  Score=88.90  Aligned_cols=60  Identities=28%  Similarity=0.432  Sum_probs=52.0

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+.+++.++..++.|++.++.|+|+++++|+|++|+||+++.++.+|++|||+|+.+..
T Consensus       109 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A          109 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            345689999999999999999999999999999999999999999999999999986643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=98.77  E-value=1e-08  Score=87.98  Aligned_cols=57  Identities=39%  Similarity=0.620  Sum_probs=51.6

Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       244 l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .....+..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+...
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            445567889999999999999999999999999999999999999999999887654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=98.77  E-value=6.6e-09  Score=90.85  Aligned_cols=57  Identities=42%  Similarity=0.713  Sum_probs=47.1

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++.++..++.|++.|+.|+|++|++|+|+||+||+++.++.+|++|||+|+...
T Consensus       127 ~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          127 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            458899999999999999999999999999999999999999999999999997654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=98.77  E-value=8.5e-09  Score=87.33  Aligned_cols=62  Identities=39%  Similarity=0.620  Sum_probs=56.1

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .....+++.++..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||+|+.+...
T Consensus       118 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          118 KNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             HHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             hccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            34456889999999999999999999999999999999999999999999999999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=98.77  E-value=1.1e-08  Score=91.59  Aligned_cols=60  Identities=38%  Similarity=0.595  Sum_probs=54.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~---~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.|+.|+|++|++|+|+||+||+++   .++.+|++|||+|+.+...
T Consensus       104 ~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A          104 REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            45689999999999999999999999999999999999998   4578999999999876543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=98.77  E-value=8.7e-09  Score=93.23  Aligned_cols=60  Identities=25%  Similarity=0.439  Sum_probs=54.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~---~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.+|.|||.++++|+|+||.||++   +..+.+||+|||+|+.+...
T Consensus        97 ~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           97 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            4568999999999999999999999999999999999999   57889999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=98.77  E-value=7.6e-09  Score=88.79  Aligned_cols=66  Identities=32%  Similarity=0.552  Sum_probs=56.3

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +..........+++.++..++.|++.|+.|+|++|++|+|++|+||+++.++.+|++|||+|+...
T Consensus        86 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           86 LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            333333344568889999999999999999999999999999999999999999999999987654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=98.76  E-value=1.3e-08  Score=87.39  Aligned_cols=59  Identities=49%  Similarity=0.752  Sum_probs=54.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----ceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF----VVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~----~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|+||+++..+    .+|++|||+|+.+..
T Consensus       108 ~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A          108 KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            45689999999999999999999999999999999999998877    799999999987753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=98.76  E-value=8.8e-09  Score=87.78  Aligned_cols=59  Identities=34%  Similarity=0.527  Sum_probs=51.5

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|++|.||+++.++.+|++|||+++.+..
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~  199 (313)
T 3brb_A          141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS  199 (313)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC-----
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            35688999999999999999999999999999999999999999999999999987643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=98.76  E-value=1.1e-08  Score=89.33  Aligned_cols=58  Identities=36%  Similarity=0.665  Sum_probs=54.1

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.++.|+|++|++|+|++|+||+++.++.+|++|||+|+....
T Consensus       123 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          123 QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            4588999999999999999999999999999999999999999999999999987653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=98.76  E-value=8.8e-09  Score=90.23  Aligned_cols=67  Identities=31%  Similarity=0.446  Sum_probs=51.5

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +..........++..++..++.|++.|+.|+|.++++|+|+||.||+++.++.+|++|||+|+.+..
T Consensus       133 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             HHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            3333333345688999999999999999999999999999999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=98.76  E-value=1.4e-08  Score=87.12  Aligned_cols=59  Identities=32%  Similarity=0.566  Sum_probs=54.5

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.|+.|+|+++++|+|++|+||+++.++.+|++|||+++.+...
T Consensus       136 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          136 VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence            35889999999999999999999999999999999999999999999999999877543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=98.76  E-value=7.5e-09  Score=89.95  Aligned_cols=58  Identities=41%  Similarity=0.545  Sum_probs=53.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.++.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       188 ~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          188 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             TCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence            3478899999999999999999999999999999999999999999999999987643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=98.76  E-value=9.4e-09  Score=89.18  Aligned_cols=60  Identities=42%  Similarity=0.702  Sum_probs=55.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       147 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          147 HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            345688999999999999999999999999999999999999999999999999976643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=98.76  E-value=1.4e-08  Score=88.95  Aligned_cols=69  Identities=39%  Similarity=0.530  Sum_probs=57.5

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe--cCCCceEEeecccceecCcc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL--SDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~--~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+..........+++.++..++.|++.|+.|+|+++++|+|+||.||++  +..+.+|++|||+|+.+...
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            3444443444568899999999999999999999999999999999999  56678999999999876543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=98.75  E-value=1.2e-08  Score=86.13  Aligned_cols=60  Identities=27%  Similarity=0.480  Sum_probs=54.3

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~---~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|++|.||+++   .++.+|++|||+|+.+...
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           99 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            45689999999999999999999999999999999999994   7889999999999876543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=98.75  E-value=1.6e-09  Score=91.20  Aligned_cols=114  Identities=12%  Similarity=0.052  Sum_probs=72.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCceee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQL   81 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (305)
                      .+|+++|++++  | +++++++.. +..|+|||||+||+|.+ +.    .    .........+..++.+.|..|+.|.-
T Consensus       152 ~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~----~~~~~i~~qi~~~l~~lH~~giiHrD  218 (282)
T 1zar_A          152 RNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR----V----ENPDEVLDMILEEVAKFYHRGIVHGD  218 (282)
T ss_dssp             HHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----C----SCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc----h----hhHHHHHHHHHHHHHHHHHCCCEeCC
Confidence            48999999998  5 677776644 55799999999999987 31    1    11223344557788888877754432


Q ss_pred             cCCCCCeeEcchhHHHHhcCCcccccCCCccccccccc----------CCCCccchHHHH
Q psy6191          82 NDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNK----------NGHSFEVDVWSI  131 (305)
Q Consensus        82 ~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~----------~~~~~~~DiwSl  131 (305)
                      .. ..+|.+.  .....+.+.+..+++..|+|||++..          ..|+..+|+|++
T Consensus       219 lk-p~NILl~--~~~vkl~DFG~a~~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          219 LS-QYNVLVS--EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             CS-TTSEEEE--TTEEEECCCTTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             CC-HHHEEEE--CCcEEEEECCCCeECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            22 2333332  22223444445567888999999854          345556666653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=98.75  E-value=1e-08  Score=87.31  Aligned_cols=58  Identities=33%  Similarity=0.546  Sum_probs=53.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|+|+++++|+|++|+||+++.++.+|++|||+|+.+..
T Consensus       145 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~  202 (314)
T 2ivs_A          145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE  202 (314)
T ss_dssp             CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTT
T ss_pred             cCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccc
Confidence            3478889999999999999999999999999999999999999999999999987643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=98.75  E-value=1.3e-08  Score=85.32  Aligned_cols=60  Identities=30%  Similarity=0.485  Sum_probs=54.8

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .....+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||+++.+.
T Consensus       112 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A          112 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             CGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            334568999999999999999999999999999999999999999999999999987654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=98.75  E-value=1.9e-08  Score=86.05  Aligned_cols=57  Identities=35%  Similarity=0.528  Sum_probs=53.0

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++.+...++.|++.++.|+|.++++|+|++|.||+++.++.+|++|||+++...
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          134 MSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT  190 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred             cccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            357888999999999999999999999999999999999999999999999998654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=98.75  E-value=1.3e-08  Score=88.48  Aligned_cols=59  Identities=39%  Similarity=0.623  Sum_probs=52.7

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCc---eEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV---VKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~---~k~~dfg~a~~~~~~  300 (305)
                      ..+++..+..++.|++.++.|+|+++++|+|+||+||+++..+.   +|++|||+|+.+...
T Consensus       125 ~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~  186 (351)
T 3c0i_A          125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES  186 (351)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCC
Confidence            45889999999999999999999999999999999999986554   999999999877543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=98.75  E-value=1.2e-08  Score=85.95  Aligned_cols=69  Identities=36%  Similarity=0.567  Sum_probs=58.7

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+.+........+++.++..++.|++.++.|+|.++++|+|++|+||+++.++.+|++|||+++.+...
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A          106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             BHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             CHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            344444444466899999999999999999999999999999999999999999999999999877543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=98.74  E-value=1.1e-08  Score=90.08  Aligned_cols=57  Identities=16%  Similarity=0.354  Sum_probs=53.0

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++.++..++.|++.|+.|||+++++|+|+||+||+++.++.+|++|||.+..+.
T Consensus       123 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          123 DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            458899999999999999999999999999999999999999999999999886553

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=98.74  E-value=9.3e-09  Score=91.07  Aligned_cols=56  Identities=34%  Similarity=0.590  Sum_probs=49.8

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----cCCCceEEeecccceecC
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL----SDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~----~~~~~~k~~dfg~a~~~~  298 (305)
                      .+++..+..++.|++.|+.|||+++++|+|+||+||++    +..+.+||+|||+|+.+.
T Consensus       124 ~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  183 (405)
T 3rgf_A          124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  183 (405)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC---
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecC
Confidence            48899999999999999999999999999999999999    667899999999998664

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=98.74  E-value=1.4e-08  Score=87.15  Aligned_cols=57  Identities=33%  Similarity=0.605  Sum_probs=52.2

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-ceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF-VVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~-~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.|+.|+|+++++|+|+||+||+++..+ .+|++|||+|+.+..
T Consensus       126 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            378889999999999999999999999999999999999666 899999999987654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=98.74  E-value=9.4e-09  Score=88.92  Aligned_cols=58  Identities=36%  Similarity=0.645  Sum_probs=52.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.|+.|+|.++++|+|+||+||+++ ++.+|++|||+|+.+.
T Consensus       101 ~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A          101 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            345688999999999999999999999999999999999997 5789999999998764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=98.74  E-value=1.3e-08  Score=88.29  Aligned_cols=59  Identities=19%  Similarity=0.398  Sum_probs=54.5

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC--ceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF--VVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~--~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.|+.|+|+++++|+|++|.||+++.++  .+|++|||+|+.+...
T Consensus       154 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCC
Confidence            5689999999999999999999999999999999999999988  8999999999876543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=98.74  E-value=1.6e-08  Score=86.46  Aligned_cols=58  Identities=31%  Similarity=0.571  Sum_probs=52.9

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----cCCCceEEeecccceecCcc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL----SDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~----~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+++.++..++.|++.|+.|+|+++++|+|+||+||++    +..+.+|++|||+|+.+...
T Consensus       108 ~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A          108 GLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            38899999999999999999999999999999999998    67778999999999877544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=98.74  E-value=1.1e-08  Score=87.80  Aligned_cols=60  Identities=37%  Similarity=0.605  Sum_probs=52.6

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---ceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF---VVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~---~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.++.|+|+++++|+|++|+||+++..+   .+|++|||+|+....
T Consensus        99 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           99 KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            345689999999999999999999999999999999999998665   899999999986543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=98.74  E-value=1.3e-08  Score=87.44  Aligned_cols=59  Identities=34%  Similarity=0.595  Sum_probs=54.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||+++.+..
T Consensus       121 ~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          121 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            45689999999999999999999999999999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=98.74  E-value=7.7e-09  Score=86.16  Aligned_cols=60  Identities=28%  Similarity=0.476  Sum_probs=54.4

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .....+++.++..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||+|+...
T Consensus        98 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           98 TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             hcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence            344568899999999999999999999999999999999999999999999999987654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=98.73  E-value=1.2e-08  Score=87.35  Aligned_cols=59  Identities=34%  Similarity=0.579  Sum_probs=54.2

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDH----------KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~----------~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.|+.|+|+.          +++|+|+||+||+++.++.+|++|||+|+.+...
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~  184 (322)
T 3soc_A          116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG  184 (322)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccc
Confidence            3488999999999999999999999          9999999999999999999999999999876543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=98.73  E-value=9.9e-09  Score=86.34  Aligned_cols=51  Identities=25%  Similarity=0.257  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         248 ETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       248 ~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ++..++.|++.++.++|++|++|+|+||.||+++ ++.++++|||+|+.+..
T Consensus       194 ~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~~~  244 (282)
T 1zar_A          194 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE  244 (282)
T ss_dssp             CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEETTS
T ss_pred             hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeECCC
Confidence            4556999999999999999999999999999999 99999999999987643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=98.73  E-value=1.7e-08  Score=86.93  Aligned_cols=61  Identities=64%  Similarity=1.197  Sum_probs=55.8

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ....+++.++..++.|++.++.|+|.++++|+|++|.||+++.++.++++|||+++.+...
T Consensus       134 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          134 RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            3456899999999999999999999999999999999999999999999999999877533

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=98.73  E-value=6e-09  Score=87.71  Aligned_cols=62  Identities=26%  Similarity=0.367  Sum_probs=50.1

Q ss_pred             ccccccCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         238 SKRRKAITEPETRFYMKQILEGVSYLHDH-KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       238 ~~~~~~l~~~~~~~~~~qi~~~l~~~h~~-~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ......+++..+..++.|++.++.|+|++ +++|+|++|+||+++..+.+|++|||+|+.+..
T Consensus       100 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A          100 IDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            33456789999999999999999999998 999999999999999999999999999876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=98.73  E-value=1.7e-08  Score=87.73  Aligned_cols=56  Identities=30%  Similarity=0.505  Sum_probs=51.6

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-------------------------CCceEEeecccceec
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-------------------------NFVVKIGDFGLAARI  297 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~-------------------------~~~~k~~dfg~a~~~  297 (305)
                      .+++.++..++.|++.|+.|+|+++++|+|+||+||+++.                         .+.+|++|||+|+..
T Consensus       133 ~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~  212 (360)
T 3llt_A          133 GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK  212 (360)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEET
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceec
Confidence            4888999999999999999999999999999999999975                         788999999999865


Q ss_pred             C
Q psy6191         298 E  298 (305)
Q Consensus       298 ~  298 (305)
                      .
T Consensus       213 ~  213 (360)
T 3llt_A          213 S  213 (360)
T ss_dssp             T
T ss_pred             C
Confidence            4

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=98.73  E-value=1.6e-08  Score=85.75  Aligned_cols=59  Identities=41%  Similarity=0.589  Sum_probs=54.1

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~---~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.|+.|+|+++++|+|++|+||+++.   ++.++++|||+|+.+...
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  173 (299)
T 3m2w_A          112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE  173 (299)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccccc
Confidence            35889999999999999999999999999999999999997   788999999999877643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=98.73  E-value=1.1e-08  Score=89.28  Aligned_cols=57  Identities=44%  Similarity=0.708  Sum_probs=50.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCc--eEEeecccceec
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGDFGLAARI  297 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~--~k~~dfg~a~~~  297 (305)
                      .+.+++.++..++.|++.|+.|||++|++|+|+||+||+++..+.  +|++|||+|+..
T Consensus       110 ~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A          110 AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            456899999999999999999999999999999999999987665  999999998744

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=98.73  E-value=1.2e-08  Score=88.92  Aligned_cols=66  Identities=35%  Similarity=0.575  Sum_probs=54.1

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +..........+++.++..++.|++.|+.|+|+++++|+|++|+||+++.++.+|++|||+|+...
T Consensus       120 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (362)
T 3pg1_A          120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT  185 (362)
T ss_dssp             HHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC-----
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccc
Confidence            344444444568999999999999999999999999999999999999999999999999987544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=98.73  E-value=1.4e-08  Score=87.70  Aligned_cols=58  Identities=33%  Similarity=0.487  Sum_probs=52.7

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|+|.+|++|+|++|.||+++.++.+|++|||+|+.+..
T Consensus       167 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~  224 (344)
T 1rjb_A          167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS  224 (344)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGG
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCccccc
Confidence            4478889999999999999999999999999999999999999999999999986643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=98.73  E-value=1.4e-08  Score=86.38  Aligned_cols=59  Identities=31%  Similarity=0.540  Sum_probs=54.7

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++..+..++.|++.|+.|+|++|++|+|++|+||+++.++.++++|||+|+.+.
T Consensus        95 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           95 YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            34568899999999999999999999999999999999999999999999999998765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=98.72  E-value=1.1e-08  Score=86.25  Aligned_cols=64  Identities=38%  Similarity=0.559  Sum_probs=50.1

Q ss_pred             hhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         235 ERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       235 ~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .........+++.++..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||+|+...
T Consensus       108 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A          108 HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             HHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence            3333344568889999999999999999999999999999999999999999999999987554

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=98.72  E-value=1.1e-08  Score=85.70  Aligned_cols=61  Identities=30%  Similarity=0.536  Sum_probs=54.2

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .....+++..+..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||+++.+..
T Consensus       105 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A          105 RNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             HHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             hccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            3345688999999999999999999999999999999999999999999999999886643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=98.72  E-value=1.9e-08  Score=87.77  Aligned_cols=59  Identities=39%  Similarity=0.669  Sum_probs=52.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC---CceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN---FVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~---~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|.++++|+|+||+||+++..   +.+|++|||+|+.+..
T Consensus       122 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          122 REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            3468899999999999999999999999999999999999864   4599999999987653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=98.72  E-value=1e-08  Score=95.65  Aligned_cols=61  Identities=28%  Similarity=0.527  Sum_probs=55.3

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .....+++.++..++.|++.|+.|||+++++|+|+||.||+++.++.+||+|||+|+.+..
T Consensus       428 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          428 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             TCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            3455689999999999999999999999999999999999999999999999999987643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=98.72  E-value=1.4e-08  Score=87.42  Aligned_cols=58  Identities=28%  Similarity=0.362  Sum_probs=53.2

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDH--------KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~--------~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|+|.+        +++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       129 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~  194 (337)
T 3mdy_A          129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS  194 (337)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence            3588999999999999999999999        999999999999999999999999999976644

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=98.72  E-value=1.6e-08  Score=86.96  Aligned_cols=57  Identities=28%  Similarity=0.435  Sum_probs=52.2

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDH---------KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~---------~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+...+..++.|++.|+.|+|+.         +++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       107 ~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~  172 (336)
T 3g2f_A          107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG  172 (336)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccc
Confidence            347778888999999999999999         999999999999999999999999999987653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=98.72  E-value=1.7e-08  Score=87.55  Aligned_cols=57  Identities=37%  Similarity=0.676  Sum_probs=53.7

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++.++..++.|++.|+.|+|++|++|+|++|.||+++.++.+|++|||+|+.+.
T Consensus       107 ~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A          107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            458899999999999999999999999999999999999999999999999998765

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=98.72  E-value=2.1e-08  Score=84.61  Aligned_cols=61  Identities=64%  Similarity=1.197  Sum_probs=55.7

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ....+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||+++.+...
T Consensus       108 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A          108 RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            3456899999999999999999999999999999999999999999999999999876533

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=98.72  E-value=1.6e-08  Score=85.06  Aligned_cols=60  Identities=30%  Similarity=0.556  Sum_probs=55.2

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.++.++|+++++|+|++|.||+++.++.++++|||+++.+..
T Consensus       103 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A          103 KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            445688999999999999999999999999999999999999999999999999987743

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=98.72  E-value=1.3e-08  Score=88.98  Aligned_cols=56  Identities=36%  Similarity=0.576  Sum_probs=49.3

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+...
T Consensus       123 ~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          123 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            47888999999999999999999999999999999999999999999999997664

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=98.72  E-value=2e-08  Score=84.10  Aligned_cols=59  Identities=42%  Similarity=0.683  Sum_probs=54.7

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++..+..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||+++.+...
T Consensus       117 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  175 (284)
T 2a19_B          117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND  175 (284)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccc
Confidence            46888899999999999999999999999999999999999999999999999877644

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=98.71  E-value=9e-09  Score=88.81  Aligned_cols=57  Identities=37%  Similarity=0.641  Sum_probs=53.4

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.+|++|||+++.+.
T Consensus       169 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  225 (343)
T 1luf_A          169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY  225 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccc
Confidence            568889999999999999999999999999999999999999999999999987654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=98.71  E-value=2.1e-08  Score=87.53  Aligned_cols=60  Identities=43%  Similarity=0.783  Sum_probs=55.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++..+..++.|++.|+.|+|++|++|+|++|.||+++.++.++++|||++..+...
T Consensus       194 ~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          194 KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            456899999999999999999999999999999999999999999999999999877543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=98.71  E-value=1.8e-08  Score=85.66  Aligned_cols=59  Identities=34%  Similarity=0.528  Sum_probs=54.4

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.+|++|||+++.+...
T Consensus       140 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  198 (313)
T 1t46_A          140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND  198 (313)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccccccccccc
Confidence            35888999999999999999999999999999999999999999999999999876543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=98.71  E-value=1.3e-08  Score=89.65  Aligned_cols=58  Identities=36%  Similarity=0.607  Sum_probs=51.3

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|||.++++|||+||+||+++ ++.+|++|||+|+.+..
T Consensus       149 ~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            44688889999999999999999999999999999999995 57899999999987643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=98.71  E-value=2e-08  Score=84.02  Aligned_cols=59  Identities=51%  Similarity=0.900  Sum_probs=54.5

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||++..+.
T Consensus       105 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A          105 RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            34568899999999999999999999999999999999999999999999999988764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=98.71  E-value=2.2e-08  Score=86.66  Aligned_cols=60  Identities=33%  Similarity=0.568  Sum_probs=52.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC----CceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN----FVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~----~~~k~~dfg~a~~~~~~  300 (305)
                      .+.+++.++..++.|++.++.|+|++|++|+|+||+||++...    +.+|++|||+|+.+...
T Consensus       110 ~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A          110 QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            4568999999999999999999999999999999999998543    35999999999876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=98.71  E-value=2.3e-08  Score=85.67  Aligned_cols=59  Identities=39%  Similarity=0.738  Sum_probs=54.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDH---KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~---~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...++...+..++.|++.++.|+|.+   +++|+|++|.||+++.++.+|++|||+|+.+..
T Consensus       125 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY  186 (326)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence            34588899999999999999999999   999999999999999999999999999987653

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=98.71  E-value=2.1e-08  Score=85.88  Aligned_cols=59  Identities=32%  Similarity=0.473  Sum_probs=54.3

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~-~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++..+..++.|++.++.|+|+++++|+|++|.||+++ ..+.+|++|||+++.+..
T Consensus       143 ~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~  202 (320)
T 3a99_A          143 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  202 (320)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence            45688999999999999999999999999999999999998 788999999999987654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=98.70  E-value=1.7e-08  Score=90.07  Aligned_cols=57  Identities=32%  Similarity=0.478  Sum_probs=52.3

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCc--eEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--VKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~--~k~~dfg~a~~~~  298 (305)
                      ..+++..+..++.|++.|+.|||+++++|+|+||+||+++..+.  +|++|||+|+...
T Consensus       195 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~  253 (429)
T 3kvw_A          195 QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH  253 (429)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence            34889999999999999999999999999999999999998876  9999999987654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=98.70  E-value=1.6e-08  Score=87.06  Aligned_cols=60  Identities=28%  Similarity=0.504  Sum_probs=51.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.++.|+|.++++|+|++|.||+++.++.+|++|||+++.+..
T Consensus       140 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          140 KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            345688999999999999999999999999999999999999999999999999987643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=98.69  E-value=2.2e-08  Score=85.93  Aligned_cols=68  Identities=35%  Similarity=0.544  Sum_probs=57.8

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +.+........+++.++..++.|++.++.++|+++++|+|++|.||+++.++.++++|||+|+.+...
T Consensus       131 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          131 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             HHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            33333333455889999999999999999999999999999999999999999999999999877543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=98.69  E-value=1.1e-08  Score=89.49  Aligned_cols=56  Identities=34%  Similarity=0.533  Sum_probs=50.4

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---ceEEeecccceec
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF---VVKIGDFGLAARI  297 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~---~~k~~dfg~a~~~  297 (305)
                      ..++..++..++.|++.|+.|||+++++|+|+||+||+++..+   .+|++|||+|+.+
T Consensus       176 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~  234 (367)
T 3l9p_A          176 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI  234 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccccc
Confidence            3578889999999999999999999999999999999998544   5999999999755

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=98.68  E-value=2.1e-08  Score=84.56  Aligned_cols=59  Identities=27%  Similarity=0.516  Sum_probs=54.5

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||+++.+..
T Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A          111 NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            44588999999999999999999999999999999999999999999999999987654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=98.68  E-value=1.8e-08  Score=86.49  Aligned_cols=59  Identities=37%  Similarity=0.504  Sum_probs=54.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~--~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+.+++.++..++.|++.++.|+|.++  ++|+|++|.||+++.++.+|++|||+++.+..
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  190 (337)
T 3ll6_A          130 RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH  190 (337)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccc
Confidence            346899999999999999999999999  99999999999999999999999999987654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=98.68  E-value=1.6e-08  Score=84.99  Aligned_cols=59  Identities=19%  Similarity=0.285  Sum_probs=52.6

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCc--------eEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV--------VKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~--------~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.|+.|+|+++++|+|+||+||+++.++.        +|++|||++....
T Consensus       106 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~  172 (289)
T 4fvq_A          106 NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL  172 (289)
T ss_dssp             TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccccccc
Confidence            3444889999999999999999999999999999999999988776        9999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=98.68  E-value=3.3e-08  Score=82.65  Aligned_cols=59  Identities=37%  Similarity=0.598  Sum_probs=53.9

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~---~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|.||++   +.++.++++|||+|..+..
T Consensus       100 ~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A          100 KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            4558899999999999999999999999999999999999   7788999999999987654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=98.68  E-value=2e-08  Score=90.38  Aligned_cols=57  Identities=39%  Similarity=0.636  Sum_probs=53.1

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..++..+...++.|++.|+.|||+++++|+|++|.||+++.++.+|++|||+|+.+.
T Consensus       279 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          279 SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            357888899999999999999999999999999999999999999999999998764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=98.68  E-value=1.9e-08  Score=86.43  Aligned_cols=60  Identities=35%  Similarity=0.594  Sum_probs=51.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++..+..++.|++.++.|+|.++++|+|++|.||+++.++.++++|||+|+.+..
T Consensus       117 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          117 FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            345688999999999999999999999999999999999999999999999999976543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=98.68  E-value=3e-08  Score=87.50  Aligned_cols=58  Identities=31%  Similarity=0.571  Sum_probs=52.8

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----cCCCceEEeecccceecCcc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL----SDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~----~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+++.++..++.|++.|+.|+|+++++|+|+||+||++    +..+.+|++|||+|+.+...
T Consensus       108 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A          108 GLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (396)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence            38899999999999999999999999999999999998    66778999999999877544

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=98.68  E-value=1.1e-08  Score=95.86  Aligned_cols=59  Identities=27%  Similarity=0.516  Sum_probs=54.5

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|||+++++|||+||+||+++.++.+||+|||+|+.+..
T Consensus       463 ~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          463 NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            45688999999999999999999999999999999999999999999999999987653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=98.68  E-value=3.1e-08  Score=83.27  Aligned_cols=68  Identities=29%  Similarity=0.446  Sum_probs=56.8

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCc-----eEEeecccceecCc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSDNFV-----VKIGDFGLAARIEF  299 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~--~~~~~l~~~~~l~~~~~~-----~k~~dfg~a~~~~~  299 (305)
                      .+..........+++..+..++.|++.++.|+|+++  ++|+|++|+||+++..+.     +|++|||+|+....
T Consensus       107 ~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~  181 (287)
T 4f0f_A          107 DLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH  181 (287)
T ss_dssp             BHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS
T ss_pred             CHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc
Confidence            343444444556889999999999999999999999  999999999999987776     99999999875543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=98.68  E-value=2.9e-08  Score=83.06  Aligned_cols=57  Identities=39%  Similarity=0.586  Sum_probs=53.5

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.++.++|+++++|+|++|.||+++.++.++++|||+++.+..
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A          105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            588899999999999999999999999999999999999999999999999987653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=98.68  E-value=2.5e-08  Score=88.73  Aligned_cols=59  Identities=41%  Similarity=0.648  Sum_probs=52.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---ceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF---VVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~---~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|+||+||+++..+   .+|++|||+|+.+..
T Consensus       233 ~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  294 (419)
T 3i6u_A          233 NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE  294 (419)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence            35688999999999999999999999999999999999997544   599999999987653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=98.68  E-value=2.9e-08  Score=83.22  Aligned_cols=59  Identities=32%  Similarity=0.567  Sum_probs=52.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-------------------CCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-------------------NFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~-------------------~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|+||+++.                   ...++++|||++..+..
T Consensus       109 ~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  186 (289)
T 1x8b_A          109 MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS  186 (289)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC
Confidence            356899999999999999999999999999999999999984                   44789999999987754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=98.67  E-value=3.5e-08  Score=84.36  Aligned_cols=57  Identities=42%  Similarity=0.701  Sum_probs=53.6

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||+|+.+..
T Consensus       130 ~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          130 SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            488999999999999999999999999999999999999999999999999987654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=98.67  E-value=2.7e-08  Score=85.09  Aligned_cols=58  Identities=33%  Similarity=0.567  Sum_probs=52.9

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..++..++..++.|++.++.|+|+++++|+|++|.||+++.++.+|++|||+++.+..
T Consensus       133 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~  190 (322)
T 1p4o_A          133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE  190 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGG
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcccccccc
Confidence            3467888999999999999999999999999999999999999999999999876543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=98.67  E-value=2.7e-08  Score=84.90  Aligned_cols=59  Identities=25%  Similarity=0.347  Sum_probs=54.4

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.++.|+|.++++|+|++|.||+++.++.++++|||+++...
T Consensus       127 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          127 KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            45668999999999999999999999999999999999999999999999999887653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=98.67  E-value=3.2e-08  Score=82.58  Aligned_cols=58  Identities=40%  Similarity=0.685  Sum_probs=53.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||++..+.
T Consensus        99 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           99 DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            3458899999999999999999999999999999999999999999999999987654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=98.67  E-value=2.2e-08  Score=87.56  Aligned_cols=56  Identities=38%  Similarity=0.721  Sum_probs=50.4

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+++.++..++.|++.|+.|+|+++++|+|++|+||+++.++.+|++|||+|+...
T Consensus       140 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          140 EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence            48899999999999999999999999999999999999999999999999987654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=98.67  E-value=2.3e-08  Score=83.73  Aligned_cols=59  Identities=32%  Similarity=0.567  Sum_probs=53.3

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.++.|+|.++++|+|++|.||+++.++.++++|||++....
T Consensus       102 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A          102 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            34568899999999999999999999999999999999999999999999999886543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=98.67  E-value=3.2e-08  Score=85.16  Aligned_cols=57  Identities=39%  Similarity=0.556  Sum_probs=53.1

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .++..++..++.|++.|+.|+|+++++|+|++|.||+++.++.+|++|||+|+.+..
T Consensus       153 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  209 (334)
T 2pvf_A          153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN  209 (334)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTT
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccc
Confidence            478889999999999999999999999999999999999999999999999987654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=98.67  E-value=2.7e-08  Score=85.39  Aligned_cols=59  Identities=42%  Similarity=0.630  Sum_probs=52.5

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~---~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.++.|+|.+|++|+|++|.||+++.   .+.+|++|||+|+.+...
T Consensus       126 ~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          126 EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            45889999999999999999999999999999999999987   789999999999876543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=98.67  E-value=3.1e-08  Score=84.78  Aligned_cols=57  Identities=35%  Similarity=0.669  Sum_probs=53.2

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.|+.|+|.+|++|+|++|.||+++.++.+|++|||+++.+..
T Consensus       116 ~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  172 (326)
T 1blx_A          116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF  172 (326)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccC
Confidence            488899999999999999999999999999999999999999999999999887653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=98.67  E-value=1.9e-08  Score=91.40  Aligned_cols=58  Identities=28%  Similarity=0.497  Sum_probs=53.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..++......++.|++.|+.|||+++++|+|++|.||+++.++.+||+|||+|+.+..
T Consensus       313 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          313 QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            4578889999999999999999999999999999999999999999999999987643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=98.66  E-value=2.5e-08  Score=83.83  Aligned_cols=60  Identities=35%  Similarity=0.580  Sum_probs=51.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~---~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++..+..++.|++.++.|+|+++++|+|++|.||+++   ..+.+|++|||+|+.+..
T Consensus       117 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            346689999999999999999999999999999999999994   457899999999976543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=98.66  E-value=3e-08  Score=86.11  Aligned_cols=61  Identities=25%  Similarity=0.453  Sum_probs=54.7

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEecC-CCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLH--DHKIIHRDLKLGNLFLSD-NFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h--~~~~~~~~l~~~~~l~~~-~~~~k~~dfg~a~~~~~~  300 (305)
                      ....+++..+..++.|++.++.|+|  .++++|+|+||+||+++. ++.+|++|||+|+.+...
T Consensus       122 ~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~  185 (360)
T 3e3p_A          122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS  185 (360)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC
Confidence            4556788899999999999999999  999999999999999996 889999999999876543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=98.66  E-value=1.5e-08  Score=87.04  Aligned_cols=58  Identities=33%  Similarity=0.588  Sum_probs=53.4

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|+|+++++|+|++|.||+++.++.+|++|||+|+.+..
T Consensus       159 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  216 (333)
T 2i1m_A          159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN  216 (333)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGG
T ss_pred             cccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECcccccccccc
Confidence            3478889999999999999999999999999999999999999999999999986643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=98.66  E-value=1.9e-08  Score=85.76  Aligned_cols=57  Identities=42%  Similarity=0.552  Sum_probs=52.8

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.++.|+|+++++|+|++|.||+++..+.+|++|||+|+.+..
T Consensus       144 ~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  200 (316)
T 2xir_A          144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK  200 (316)
T ss_dssp             CEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTT
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCcccccccc
Confidence            377889999999999999999999999999999999999999999999999987643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=98.66  E-value=2.4e-08  Score=85.13  Aligned_cols=58  Identities=33%  Similarity=0.536  Sum_probs=50.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCc---eEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV---VKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~---~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|+||+++..+.   +|++|||+++.+.
T Consensus       105 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A          105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            356889999999999999999999999999999999999987665   9999999987664

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=98.66  E-value=3e-08  Score=83.72  Aligned_cols=59  Identities=44%  Similarity=0.670  Sum_probs=53.5

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.|+.|+|+++++|+|++|.||+++.++.++++|||+++.+.
T Consensus       109 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  167 (303)
T 1zy4_A          109 ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH  167 (303)
T ss_dssp             SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTT
T ss_pred             cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcc
Confidence            34457788888999999999999999999999999999999999999999999987664

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=98.66  E-value=4.8e-08  Score=82.90  Aligned_cols=58  Identities=33%  Similarity=0.535  Sum_probs=53.5

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..++...+..++.|++.++.|+|.++++|+|++|.||+++.++.++++|||+++....
T Consensus       128 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          128 PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            4588889999999999999999999999999999999999999999999999876643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=98.66  E-value=1.7e-08  Score=86.84  Aligned_cols=59  Identities=37%  Similarity=0.676  Sum_probs=51.5

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-----CCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-----DNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~-----~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.++.|+|+++++|+|+||+||+++     ..+.+|++|||+|+.+.
T Consensus       125 ~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            344688999999999999999999999999999999999995     44569999999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=98.65  E-value=2.7e-08  Score=86.32  Aligned_cols=56  Identities=38%  Similarity=0.719  Sum_probs=51.6

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+++.++..++.|++.|+.|+|++|++|+|++|.||+++.++.+|++|||+++...
T Consensus       122 ~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            48889999999999999999999999999999999999999999999999987653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=98.65  E-value=4.3e-08  Score=82.27  Aligned_cols=58  Identities=29%  Similarity=0.557  Sum_probs=53.7

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||++....
T Consensus       108 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A          108 HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            3468899999999999999999999999999999999999999999999999987654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=98.65  E-value=3.8e-08  Score=85.15  Aligned_cols=57  Identities=26%  Similarity=0.495  Sum_probs=51.9

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe-------------------cCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-------------------SDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~-------------------~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++.++..++.|++.|+.|+|+++++|+|+||+||++                   +..+.+|++|||+|+...
T Consensus       118 ~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~  193 (355)
T 2eu9_A          118 QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH  193 (355)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccc
Confidence            458899999999999999999999999999999999999                   567889999999987654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=98.65  E-value=2.5e-08  Score=85.54  Aligned_cols=56  Identities=30%  Similarity=0.649  Sum_probs=52.5

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      ..+++.++..++.|++.++.|+|+++++|+|++|+||+++.++.+|++|||+++..
T Consensus       137 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~  192 (327)
T 1fvr_A          137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ  192 (327)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESS
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccc
Confidence            46889999999999999999999999999999999999999999999999998744

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=98.65  E-value=2.8e-08  Score=84.72  Aligned_cols=56  Identities=32%  Similarity=0.597  Sum_probs=48.3

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~--~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      .+++.++..++.|++.++.|+|+++  ++|+|+||+||+++.++.+|++|||+|+...
T Consensus       133 ~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          133 QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             HSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            4888999999999999999999999  9999999999999999999999999987543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=98.64  E-value=2.9e-08  Score=82.39  Aligned_cols=59  Identities=29%  Similarity=0.483  Sum_probs=53.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++.++..++.|++.++.++|+++++|+|++|.||+++.++.++++|||+++...
T Consensus        97 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           97 QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccc
Confidence            34568889999999999999999999999999999999999999999999999987653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=98.64  E-value=4.9e-08  Score=82.69  Aligned_cols=57  Identities=33%  Similarity=0.625  Sum_probs=53.4

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||++..+.
T Consensus       104 ~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C          104 KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            458889999999999999999999999999999999999999999999999998764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=98.64  E-value=3.1e-08  Score=85.91  Aligned_cols=59  Identities=42%  Similarity=0.655  Sum_probs=48.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~---~~~~k~~dfg~a~~~~~  299 (305)
                      .+.+++.++..++.|++.|+.|+|.++++|+|++|.||+++.   ++.+|++|||+|+.+..
T Consensus       142 ~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          142 KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            345889999999999999999999999999999999999975   78999999999886643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=98.64  E-value=3.7e-08  Score=86.61  Aligned_cols=43  Identities=37%  Similarity=0.652  Sum_probs=40.0

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDH-KIIHRDLKLGNLFLSDNF  284 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~-~~~~~~l~~~~~l~~~~~  284 (305)
                      ..+++.++..++.|++.|+.|+|++ |++|+|+||+||+++.++
T Consensus       141 ~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            4589999999999999999999998 999999999999998765

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=98.64  E-value=4.8e-08  Score=82.48  Aligned_cols=59  Identities=37%  Similarity=0.673  Sum_probs=54.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|.++++|+|++|.||+++.++.++++|||++..+..
T Consensus       118 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  176 (298)
T 1phk_A          118 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  176 (298)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence            45688999999999999999999999999999999999999999999999999987654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=98.64  E-value=3.4e-08  Score=88.71  Aligned_cols=55  Identities=27%  Similarity=0.495  Sum_probs=51.8

Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       244 l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +++.++..++.|++.|+.|+|+++++|+|++|.||+++.++.+|++|||+|+...
T Consensus       286 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            6888899999999999999999999999999999999999999999999998654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=98.64  E-value=4.3e-08  Score=83.88  Aligned_cols=59  Identities=47%  Similarity=0.721  Sum_probs=53.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----ceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF----VVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~----~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|+||+++.++    .++++|||+++.+..
T Consensus       109 ~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A          109 KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            45688999999999999999999999999999999999998877    799999999987654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=98.63  E-value=5.2e-08  Score=83.65  Aligned_cols=56  Identities=32%  Similarity=0.440  Sum_probs=51.3

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-------------------CCceEEeecccceecC
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-------------------NFVVKIGDFGLAARIE  298 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~-------------------~~~~k~~dfg~a~~~~  298 (305)
                      .+++.++..++.|++.|+.|+|+++++|+|+||+||+++.                   .+.+|++|||+|+...
T Consensus       114 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~  188 (339)
T 1z57_A          114 PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD  188 (339)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETT
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCc
Confidence            5788999999999999999999999999999999999987                   5679999999988654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=98.63  E-value=2.3e-08  Score=89.89  Aligned_cols=57  Identities=37%  Similarity=0.632  Sum_probs=51.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..++..++..++.|++.|+.|+|+++++|+|++|.||+++.++.+|++|||+|+.+.
T Consensus       275 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            458889999999999999999999999999999999999999999999999998764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=98.63  E-value=3.8e-08  Score=83.75  Aligned_cols=59  Identities=24%  Similarity=0.433  Sum_probs=54.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~-~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|.||+++ .++.++++|||+++.+..
T Consensus       133 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~  192 (312)
T 2iwi_A          133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD  192 (312)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhccc
Confidence            45689999999999999999999999999999999999998 788999999999987654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=98.63  E-value=5.8e-08  Score=82.26  Aligned_cols=58  Identities=38%  Similarity=0.669  Sum_probs=54.0

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.++.++|.++++|+|++|.||+++.++.++++|||++..+..
T Consensus       114 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            4588999999999999999999999999999999999999999999999999987654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=98.63  E-value=4.8e-08  Score=83.61  Aligned_cols=59  Identities=41%  Similarity=0.627  Sum_probs=52.7

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCc---eEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV---VKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~---~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|++|.||+++..+.   +|++|||+++.+..
T Consensus       108 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  169 (322)
T 2ycf_A          108 NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE  169 (322)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence            346889999999999999999999999999999999999987654   99999999987643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=98.63  E-value=4.6e-08  Score=88.89  Aligned_cols=60  Identities=47%  Similarity=0.751  Sum_probs=53.3

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC---CceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN---FVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~---~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.|+.|||+++++|+|+||+||+++..   +.+|++|||+|+.+...
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          130 RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            4568999999999999999999999999999999999999764   45999999999876543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=98.62  E-value=2.9e-08  Score=83.92  Aligned_cols=58  Identities=36%  Similarity=0.681  Sum_probs=53.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.|+.|+|.++++|+|++|.||+++.++.++++|||+++.+.
T Consensus       115 ~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A          115 SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             TCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            4458899999999999999999999999999999999999999999999999987654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=98.62  E-value=3.1e-08  Score=89.79  Aligned_cols=59  Identities=42%  Similarity=0.742  Sum_probs=53.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~---~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|||+++++|+|+||+||++   +..+.+|++|||+|+.+..
T Consensus       120 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          120 RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            4568999999999999999999999999999999999999   4578899999999977654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=98.62  E-value=5.9e-08  Score=81.32  Aligned_cols=60  Identities=38%  Similarity=0.651  Sum_probs=53.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCc---eEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV---VKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~---~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.   +|++|||+|......
T Consensus        99 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           99 REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            456889999999999999999999999999999999999976554   999999999766543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=98.62  E-value=4.1e-08  Score=83.65  Aligned_cols=57  Identities=44%  Similarity=0.890  Sum_probs=51.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~-~~~~~k~~dfg~a~~~~  298 (305)
                      +.+++.++..++.|++.|+.|+|+++++|+|++|+||+++ .++.+|++|||+++.+.
T Consensus       115 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~  172 (320)
T 2i6l_A          115 GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD  172 (320)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-
T ss_pred             CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccC
Confidence            4588899999999999999999999999999999999997 56799999999998654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=98.62  E-value=2.6e-08  Score=83.71  Aligned_cols=58  Identities=29%  Similarity=0.512  Sum_probs=53.5

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++..+..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||+|+....
T Consensus       106 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A          106 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            4588889999999999999999999999999999999999999999999999876653

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=98.62  E-value=3.2e-08  Score=92.96  Aligned_cols=60  Identities=32%  Similarity=0.564  Sum_probs=54.7

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....++...+..++.|++.|+.|+|+++++|+|+||+||+++.++.+|++|||+|+.+..
T Consensus       484 ~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          484 RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            344688889999999999999999999999999999999999999999999999987643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=98.61  E-value=3.8e-08  Score=81.66  Aligned_cols=52  Identities=25%  Similarity=0.351  Sum_probs=47.4

Q ss_pred             hHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         246 EPETRFYMKQILEGVSYLH-DHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       246 ~~~~~~~~~qi~~~l~~~h-~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      +.++..++.|++.++.++| .+|++|+|++|.||+++.  .++++|||+|..+..
T Consensus       169 ~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred             hHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccCCC
Confidence            5577889999999999999 999999999999999998  899999999987643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=98.61  E-value=4e-08  Score=89.10  Aligned_cols=59  Identities=39%  Similarity=0.712  Sum_probs=52.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~---~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|||+++++|+|+||+||+++   ..+.+|++|||+|+.+..
T Consensus       115 ~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          115 RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            35689999999999999999999999999999999999995   455799999999976643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=98.61  E-value=4.8e-08  Score=83.62  Aligned_cols=57  Identities=40%  Similarity=0.713  Sum_probs=51.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++..+..++.|++.++.|+|.++++|+|++|.||+++.++.++++|||++..+.
T Consensus       124 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          124 NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            468889999999999999999999999999999999999999999999999987654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=98.60  E-value=6.8e-08  Score=82.23  Aligned_cols=60  Identities=38%  Similarity=0.634  Sum_probs=55.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.++.|+|.++++|+|++|.||+++.++.++++|||++..+..
T Consensus       118 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          118 RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            345688999999999999999999999999999999999999999999999999977653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=98.60  E-value=4.8e-08  Score=81.72  Aligned_cols=55  Identities=27%  Similarity=0.495  Sum_probs=48.5

Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       244 l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +++.++..++.|++.++.++|+++++|+|++|.||+++.++.++++|||+++...
T Consensus       114 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A          114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            7888899999999999999999999999999999999999999999999987654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=98.59  E-value=4.8e-08  Score=83.08  Aligned_cols=60  Identities=30%  Similarity=0.563  Sum_probs=49.0

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||+++.+..
T Consensus       129 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          129 QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            345688999999999999999999999999999999999999999999999999876543

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=98.59  E-value=5e-08  Score=82.42  Aligned_cols=57  Identities=37%  Similarity=0.705  Sum_probs=52.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++..+..++.|++.++.|+|++|++|+|++|+||+++.++.++++|||+++.+.
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  154 (299)
T 2r3i_A           98 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  154 (299)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence            457888899999999999999999999999999999999999999999999987654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=98.59  E-value=7e-08  Score=87.95  Aligned_cols=60  Identities=43%  Similarity=0.697  Sum_probs=54.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---ceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF---VVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~---~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.|+.|||+++++|+|++|+||+++..+   .+|++|||+|+.+...
T Consensus       140 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  202 (504)
T 3q5i_A          140 RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD  202 (504)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC
Confidence            45689999999999999999999999999999999999998765   6999999999876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=98.59  E-value=4.8e-08  Score=83.14  Aligned_cols=59  Identities=24%  Similarity=0.338  Sum_probs=50.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||++.....
T Consensus       128 ~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          128 QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            45688999999999999999999999999999999999999999999999999876543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=98.59  E-value=6.3e-08  Score=83.50  Aligned_cols=58  Identities=38%  Similarity=0.600  Sum_probs=51.2

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~---~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.++.|+|.++++|+|++|.||+++.   .+.+|++|||+|+....
T Consensus       123 ~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            35899999999999999999999999999999999999976   44599999999986653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=98.59  E-value=4.7e-08  Score=81.60  Aligned_cols=59  Identities=39%  Similarity=0.618  Sum_probs=54.3

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|.||+++.++.++++|||++..+..
T Consensus       105 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A          105 HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            34688999999999999999999999999999999999999999999999999877654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=98.58  E-value=3.6e-08  Score=90.52  Aligned_cols=57  Identities=37%  Similarity=0.632  Sum_probs=53.3

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ..+++.++..++.|++.||.|||.++++|+|+++.||+++.++.+||+|||+|+.+.
T Consensus       358 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          358 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            458889999999999999999999999999999999999999999999999998664

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=98.57  E-value=5.5e-08  Score=83.81  Aligned_cols=58  Identities=31%  Similarity=0.362  Sum_probs=53.5

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLH--------DHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h--------~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.++.|+|        .++++|+|++|+||+++.++.+|++|||+|+.+..
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  199 (342)
T 1b6c_B          134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  199 (342)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccc
Confidence            35888999999999999999999        89999999999999999999999999999977654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=98.57  E-value=6.4e-08  Score=82.54  Aligned_cols=57  Identities=37%  Similarity=0.562  Sum_probs=49.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceec
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI  297 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~  297 (305)
                      ....+++.++..++.|++.|+.|+|.++++|+|++|.||+++ ++.++++|||+|+..
T Consensus       123 ~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          123 AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            344688999999999999999999999999999999999998 678999999997654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=98.57  E-value=7.9e-08  Score=80.50  Aligned_cols=59  Identities=46%  Similarity=0.741  Sum_probs=53.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----ceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF----VVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~----~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.++.|+|+++++|+|++|.||+++..+    .++++|||++..+..
T Consensus       102 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A          102 KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            45689999999999999999999999999999999999998776    799999999987643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=98.56  E-value=6e-08  Score=83.70  Aligned_cols=55  Identities=36%  Similarity=0.552  Sum_probs=49.8

Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC--ceEEeecccceecC
Q psy6191         244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF--VVKIGDFGLAARIE  298 (305)
Q Consensus       244 l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~--~~k~~dfg~a~~~~  298 (305)
                      +++..+..++.|++.++.|+|+++++|+|++|.||+++.++  .+|++|||+|+.+.
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~  221 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY  221 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGG
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeecccccccc
Confidence            46777888999999999999999999999999999998766  89999999998764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=98.55  E-value=8.2e-08  Score=83.75  Aligned_cols=58  Identities=31%  Similarity=0.478  Sum_probs=51.3

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEec------CCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDH-KIIHRDLKLGNLFLS------DNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~-~~~~~~l~~~~~l~~------~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.|+.|+|++ +++|+|+||+||+++      ..+.+|++|||+|+.+..
T Consensus       126 ~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~  190 (373)
T 1q8y_A          126 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE  190 (373)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred             cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC
Confidence            4488899999999999999999998 999999999999994      344799999999987653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=98.55  E-value=8.6e-08  Score=79.74  Aligned_cols=58  Identities=43%  Similarity=0.610  Sum_probs=48.4

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEecC--------CCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHK---IIHRDLKLGNLFLSD--------NFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~---~~~~~l~~~~~l~~~--------~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++.++..++.|++.++.|+|+++   ++|+|++|+||+++.        .+.++++|||+|+.+..
T Consensus       100 ~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  168 (271)
T 3dtc_A          100 KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR  168 (271)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccc
Confidence            46889999999999999999999999   889999999999985        67899999999876543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=98.55  E-value=8.8e-08  Score=80.61  Aligned_cols=59  Identities=44%  Similarity=0.674  Sum_probs=52.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEec-CCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLS-DNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~--~~~~~l~~~~~l~~-~~~~~k~~dfg~a~~~~  298 (305)
                      ....+++..+..++.|++.++.|+|+++  ++|+|++|.||+++ .++.++++|||+|....
T Consensus       122 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          122 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             HccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            3456889999999999999999999999  99999999999997 78899999999986543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=98.54  E-value=1.1e-07  Score=82.18  Aligned_cols=58  Identities=31%  Similarity=0.501  Sum_probs=53.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~-~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++..+..++.|++.|+.|+|+ +|++|+|++|.||+++.++.++++|||++..+.
T Consensus       145 ~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  203 (348)
T 2pml_X          145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV  203 (348)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECB
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccc
Confidence            3568899999999999999999999 999999999999999999999999999998764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=98.54  E-value=8.2e-08  Score=81.75  Aligned_cols=58  Identities=38%  Similarity=0.622  Sum_probs=50.7

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++.++..++.|++.|+.|+|+++++|+|++|.||+++. +.+|++|||+++.+..
T Consensus       121 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            456888899999999999999999999999999999999964 8899999999987643

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=98.54  E-value=5.8e-08  Score=86.68  Aligned_cols=59  Identities=32%  Similarity=0.459  Sum_probs=48.1

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-----CCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-----NFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~-----~~~~k~~dfg~a~~~~~  299 (305)
                      .....+.++..++.|++.|+.|+|+++++|||+||+||+++.     ...++++|||+|+.+..
T Consensus       112 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          112 DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            334555667789999999999999999999999999999953     23578999999987653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=98.54  E-value=6.2e-08  Score=81.97  Aligned_cols=56  Identities=38%  Similarity=0.772  Sum_probs=52.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeeccccee
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR  296 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~  296 (305)
                      ...+++.++..++.|++.++.|+|.++++|+|++|.||+++.++.++++|||++..
T Consensus       111 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A          111 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            45588999999999999999999999999999999999999999999999998753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=98.53  E-value=7.5e-08  Score=82.53  Aligned_cols=59  Identities=27%  Similarity=0.409  Sum_probs=52.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDH-KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~-~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++..+..++.|++.++.|+|.+ +++|+|++|.||+++.++.+|++|||+++.+..
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             cccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            45688889999999999999999999 999999999999999999999999999977643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=98.53  E-value=1.2e-07  Score=83.15  Aligned_cols=58  Identities=29%  Similarity=0.452  Sum_probs=51.3

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHh--CCceecCCCCCcEEec--CCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHD--HKIIHRDLKLGNLFLS--DNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~--~~~~~~~l~~~~~l~~--~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+++..+..++.|++.++.|+|.  .+++|+|+||+||+++  ..+.+|++|||+|+.+..
T Consensus       152 ~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~  213 (382)
T 2vx3_A          152 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ  213 (382)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence            458899999999999999999994  6899999999999995  467899999999987643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=98.52  E-value=1.4e-07  Score=79.43  Aligned_cols=56  Identities=46%  Similarity=0.789  Sum_probs=50.9

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCceEEeecccceecC
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-NFVVKIGDFGLAARIE  298 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~-~~~~k~~dfg~a~~~~  298 (305)
                      .+++..+..++.|++.++.|+|.++++|+|++|.||+++. ++.++++|||+++.+.
T Consensus       118 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          118 KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             TTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             CccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            3567788889999999999999999999999999999987 8899999999998764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=98.50  E-value=7.1e-08  Score=80.62  Aligned_cols=58  Identities=36%  Similarity=0.525  Sum_probs=52.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHK-----IIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~-----~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.++.|+|..+     ++|+|++|.||+++.++.+|++|||+++.+.
T Consensus       105 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~  167 (279)
T 2w5a_A          105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  167 (279)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeec
Confidence            345889999999999999999999999     9999999999999999999999999987654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=98.50  E-value=6.6e-08  Score=86.40  Aligned_cols=53  Identities=40%  Similarity=0.620  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-------------CceEEeecccceecCc
Q psy6191         247 PETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-------------FVVKIGDFGLAARIEF  299 (305)
Q Consensus       247 ~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~-------------~~~k~~dfg~a~~~~~  299 (305)
                      .++..++.|++.|+.|+|+++++|+|+||+||+++..             ..+|++|||+|+.+..
T Consensus       115 ~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~  180 (434)
T 2rio_A          115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS  180 (434)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC
T ss_pred             hhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCC
Confidence            3456799999999999999999999999999999754             4899999999987754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=98.49  E-value=1.1e-07  Score=80.93  Aligned_cols=59  Identities=29%  Similarity=0.478  Sum_probs=50.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDH-KIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~-~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++..+..++.|++.++.|+|.. +++|+|++|.||+++.++.+|++|||+++.+..
T Consensus       118 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          118 QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            45688999999999999999999995 999999999999999999999999999876543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=98.49  E-value=1.2e-07  Score=87.10  Aligned_cols=49  Identities=31%  Similarity=0.361  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         249 TRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       249 ~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...++.|++.++.|+|+++++|||+||+||+++.  .+|++|||+|+.+..
T Consensus       433 ~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          433 NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            4578999999999999999999999999999998  999999999998754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=98.49  E-value=1.5e-07  Score=88.92  Aligned_cols=56  Identities=32%  Similarity=0.534  Sum_probs=51.9

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+++.++..++.|++.++.|+|++|++|+|+||+||+++.+ .+|++|||+++.+..
T Consensus       178 ~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          178 KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence            58899999999999999999999999999999999999875 899999999987754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=98.49  E-value=1.2e-07  Score=80.38  Aligned_cols=58  Identities=40%  Similarity=0.659  Sum_probs=52.6

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL---SDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~---~~~~~~k~~dfg~a~~~~  298 (305)
                      .+.+++.++..++.|++.++.|+|.++++|+|++|.||++   +..+.++++|||+++...
T Consensus       100 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A          100 RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            4568899999999999999999999999999999999999   678899999999987543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	305
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-37
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-17
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-14
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-09
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-14
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-33
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-13
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-07
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-14
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-31
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-13
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-11
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-30
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-16
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-29
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-11
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-29
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-16
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-28
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-15
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-28
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-14
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-28
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-16
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-28
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-08
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-28
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-11
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-27
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-19
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-27
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-15
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-26
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-16
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-25
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-11
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-25
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-11
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-25
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-10
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-25
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-12
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-24
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-10
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-24
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-12
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-24
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-10
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-24
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-12
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-23
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-13
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-22
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-12
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-22
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-12
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-22
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-12
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-22
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-13
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-09
d2ogqa1	124	d.223.1.2 (A:371-494) Serine/threonine-protein kin	9e-22
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-21
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-13
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-21
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-12
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-21
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-08
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-21
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-14
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-21
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-09
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-21
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-13
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-20
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-11
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-20
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-09
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-20
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-09
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-19
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-13
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-19
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-10
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-19
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-12
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-19
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-08
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-19
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-12
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-19
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-11
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-19
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-12
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-19
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-07
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-19
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-11
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-18
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-12
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-18
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-11
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-18
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-13
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-18
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-10
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-18
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-08
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-17
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-08
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-10
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-14
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-12
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-13
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-10
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-10
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-10

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 7e-37
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 11/206 (5%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ I   L+H N++  + +F D+  VY+ILE     ++          +E     A  +
Sbjct: 55  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYI 112

Query: 63  IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANKNTLCGTPNYIA 113
             ++  + Y       ++       L   +  +   D   +     + + TLCGT +Y+ 
Sbjct: 113 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 172

Query: 114 PEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAA 173
           PE++    H  +VD+WS+G + Y  LVGKPPFE +T +ETY RI +VE+  P  + + A 
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 232

Query: 174 TMIKKMLLLDPVQRPPVAQLLHFEFF 199
            +I ++L  +P QRP + ++L   + 
Sbjct: 233 DLISRLLKHNPSQRPMLREVLEHPWI 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.7 bits (191), Expect = 3e-17
 Identities = 19/60 (31%), Positives = 30/60 (50%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           ++     E  T  Y+ ++   +SY H  ++IHRD+K  NL L     +KI DFG +    
Sbjct: 98  QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 2e-34
 Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 13/216 (6%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            EI + R  K+ N+V +   +     +++++E     S+ ++    C  E       +  
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125

Query: 63  IWV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN----TLCGTPNYIA 113
           +       S  V + D       L  D S V   D      +  +     T+ GTP ++A
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 114 PEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKK---VEYKLPATLKK 170
           PE++ +  +  +VD+WS+G +   ++ G+PP+           I      E + P  L  
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244

Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
                + + L +D  +R    +LL  +F     P S
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.0 bits (171), Expect = 2e-14
 Identities = 18/63 (28%), Positives = 35/63 (55%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
              + E +     ++ L+ + +LH +++IHRD+K  N+ L  +  VK+ DFG  A+I  +
Sbjct: 110 ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Query: 301 GQR 303
             +
Sbjct: 170 QSK 172

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (313), Expect = 3e-34
 Identities = 52/221 (23%), Positives = 87/221 (39%), Gaps = 15/221 (6%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELY--NSACDLEEMSDPAAQ 60
            EIA+   +KH N+V     +E    +Y+I++L     + +           + S    Q
Sbjct: 56  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ 115

Query: 61  --------PVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANK-NTLCGTPNY 111
                     + +       +   +     D    +    L++M    +  +T CGTP Y
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGY 175

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPA----T 167
           +APE+L +  +S  VD WSIG I Y LL G PPF      + + +I K EY+  +     
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLP 208
           +   A   I+ ++  DP +R    Q L   +          
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 53.5 bits (128), Expect = 8e-09
 Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 3/69 (4%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAA 295
             +   TE +    + Q+L+ V YLHD  I+HRDLK  NL      ++  + I DFGL+ 
Sbjct: 99  VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158

Query: 296 RIEFDGQRK 304
             +      
Sbjct: 159 MEDPGSVLS 167

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  125 bits (314), Expect = 5e-34
 Identities = 56/266 (21%), Positives = 96/266 (36%), Gaps = 30/266 (11%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMME-LYNSACDLEEMSDPAAQP 61
           +EI     L+H  +V  H  FED   + +I E      + E + +    + E  D A + 
Sbjct: 72  KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE--DEAVEY 129

Query: 62  VIWVSKWVDYSDKYGFGYQ---------LNDDSSGVMFNDLTRMIMLANKN---TLCGTP 109
           +  V K + +  +  + +              S+ +   D      L  K       GT 
Sbjct: 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 189

Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP---- 165
            + APE+       +  D+WS+G + Y LL G  PF      ET   +K  ++ +     
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249

Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSF 225
           + + +     I+K+LL DP  R  + Q L   +                AP  DS +PS 
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG-----------NAPGRDSQIPSS 298

Query: 226 NSPRRKPLMERNSKRRKAITEPETRF 251
              + +  ++           P  R 
Sbjct: 299 RYTKIRDSIKTKYDAWPEPLPPLGRI 324

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 71.3 bits (174), Expect = 1e-14
 Identities = 20/68 (29%), Positives = 40/68 (58%), Gaps = 2/68 (2%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGD 290
           L E+ +     ++E E   YM+Q+ +G+ ++H++  +H DLK  N+  +   +  +K+ D
Sbjct: 110 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 169

Query: 291 FGLAARIE 298
           FGL A ++
Sbjct: 170 FGLTAHLD 177

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 8e-33
 Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 19/217 (8%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE--MSDPAAQ 60
           +E  +   L H   V  +  F+D + +Y  L   +   +++        +E       A+
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 116

Query: 61  PVIWV----SKWVDYSDKYGFGYQLNDDSSGVMFNDL------TRMIMLANKNTLCGTPN 110
            V  +     K + + D       LN+D   +   D       +     A  N+  GT  
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           Y++PE+L +       D+W++GCI+Y L+ G PPF        + +I K+EY  P     
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235

Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFE------FFND 201
            A  +++K+L+LD  +R    ++  +       FF  
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 24/66 (36%), Positives = 39/66 (59%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           +  +  E  TRFY  +I+  + YLH   IIHRDLK  N+ L+++  ++I DFG A  +  
Sbjct: 101 KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160

Query: 300 DGQRKR 305
           + ++ R
Sbjct: 161 ESKQAR 166

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-32
 Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 17/233 (7%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE------MSD 56
           +E++I + ++H NV+  H  +E+   V +ILEL     + +       L E      +  
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 121

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSG-----VMFNDLTRMIMLANKNT-LCGTPN 110
                    S  + + D       L D +       ++   L   I   N+   + GTP 
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 181

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP----A 166
           ++APEI+N      E D+WSIG I Y LL G  PF   T +ET + +  V Y+      +
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241

Query: 167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFD 219
                A   I+++L+ DP +R  +   L   +      T    S   + P+F+
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK-DTQQALSSAWSHPQFE 293

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (112), Expect = 7e-07
 Identities = 31/75 (41%), Positives = 44/75 (58%), Gaps = 4/75 (5%)

Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFV----VKIG 289
           +      ++++TE E   ++KQIL GV YLH  +I H DLK  N+ L D  V    +KI 
Sbjct: 100 LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 159

Query: 290 DFGLAARIEFDGQRK 304
           DFGLA +I+F  + K
Sbjct: 160 DFGLAHKIDFGNEFK 174

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  120 bits (302), Expect = 3e-32
 Identities = 48/269 (17%), Positives = 92/269 (34%), Gaps = 18/269 (6%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELY---NSACDLEEMSDPAA 59
            EI+I   L H  ++  H  FED   + +ILE      + +     +      E+ +   
Sbjct: 75  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 134

Query: 60  QPVIWV----SKWVDYSDKYGFGYQLNDDSSG-VMFNDLTRMIMLANKNTL---CGTPNY 111
           Q    +       + + D            +  V   D      L     +     T  +
Sbjct: 135 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 194

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP----AT 167
            APEI+++    F  D+W+IG + Y LL G  PF      ET   +K+ +++      ++
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNS 227
           +   A   IK +L  +P +R  V   L   +              + + R++ +      
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR---IPSSRYNKIRQKIKE 311

Query: 228 PRRKPLMERNSKRRKAITEPETRFYMKQI 256
                   + +  R A      +   ++ 
Sbjct: 312 KYADWPAPQPAIGRIANFSSLRKHRPQEY 340

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 69.3 bits (169), Expect = 5e-14
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 2/73 (2%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGD 290
           L +R +     ++E E   YM+Q  EG+ ++H+H I+H D+K  N+         VKI D
Sbjct: 113 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 172

Query: 291 FGLAARIEFDGQR 303
           FGLA ++  D   
Sbjct: 173 FGLATKLNPDEIV 185

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 3e-31
 Identities = 52/260 (20%), Positives = 95/260 (36%), Gaps = 24/260 (9%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMME-LYNSACDLEEMSDPAAQP 61
           +EI+I    +HRN++  H  FE  + + +I E      + E +  SA +L E        
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE--REIVSY 107

Query: 62  VIWVSKWVDYSDKYGFGYQ--------LNDDSSGVM----FNDLTRMIMLANKNTLCGTP 109
           V  V + + +   +  G+              S  +    F    ++    N   L   P
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167

Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP---- 165
            Y APE+   +  S   D+WS+G ++Y LL G  PF   T ++    I   EY       
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227

Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSF 225
             +   A   + ++L+ +   R   ++ L   +        +    + T          +
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE-RVSTKVIRTLKHR----RYY 282

Query: 226 NSPRRKPLMERNSKRRKAIT 245
           ++  +K L    S  R +  
Sbjct: 283 HTLIKKDLNMVVSAARISCG 302

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.2 bits (161), Expect = 5e-13
 Identities = 19/74 (25%), Positives = 36/74 (48%), Gaps = 2/74 (2%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGD 290
           + ER +     + E E   Y+ Q+ E + +LH H I H D++  N+      +  +KI +
Sbjct: 88  IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIE 147

Query: 291 FGLAARIEFDGQRK 304
           FG A +++     +
Sbjct: 148 FGQARQLKPGDNFR 161

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-30
 Identities = 47/213 (22%), Positives = 86/213 (40%), Gaps = 14/213 (6%)

Query: 1   MSQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
           M ++  +  + +H  +      F+  + ++ ++E      +M    S    +     A  
Sbjct: 50  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL--SRATF 107

Query: 61  PVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIML----ANKNTLCGTP 109
               +   + +    G  Y+       L D    +   D           A  NT CGTP
Sbjct: 108 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTP 167

Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLK 169
           +YIAPEIL    ++  VD WS G ++Y +L+G+ PF     +E +  I+      P  L+
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 227

Query: 170 KPAATMIKKMLLLDPVQRPPVA-QLLHFEFFND 201
           K A  ++ K+ + +P +R  V   +     F +
Sbjct: 228 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.3 bits (148), Expect = 2e-11
 Identities = 19/65 (29%), Positives = 31/65 (47%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +           FY  +I+ G+ +LH   I++RDLKL N+ L  +  +KI DFG+     
Sbjct: 95  QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154

Query: 299 FDGQR 303
               +
Sbjct: 155 LGDAK 159

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (286), Expect = 2e-30
 Identities = 45/245 (18%), Positives = 86/245 (35%), Gaps = 17/245 (6%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+   + L+H N + +   +      ++++E C   +   L      L+E     A   
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--VEIAAVT 121

Query: 63  IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPE 115
               + + Y   +   ++       L  +   V   D     ++A  N+  GTP ++APE
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPE 181

Query: 116 IL---NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL--PATLKK 170
           ++   ++  +  +VDVWS+G     L   KPP            I + E          +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241

Query: 171 PAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAPRFDSVVPSFNSPRR 230
                +   L   P  RP    LL   F     P   P   +    R    V   ++ + 
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP---PTVIMDLIQRTKDAVRELDNLQY 298

Query: 231 KPLME 235
           + + +
Sbjct: 299 RKMKK 303

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 76.2 bits (187), Expect = 2e-16
 Identities = 25/66 (37%), Positives = 39/66 (59%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
             +     +K + E E        L+G++YLH H +IHRD+K GN+ LS+  +VK+GDFG
Sbjct: 101 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 160

Query: 293 LAARIE 298
            A+ + 
Sbjct: 161 SASIMA 166

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (278), Expect = 3e-29
 Identities = 44/218 (20%), Positives = 88/218 (40%), Gaps = 15/218 (6%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E  +   + H  ++     F+D++ +++I++      +  L   +         A    
Sbjct: 53  DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP--VAKFYA 110

Query: 63  IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKN-TLCGTPNYIAP 114
             V   ++Y       Y+       L D +  +   D      + +   TLCGTP+YIAP
Sbjct: 111 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAP 170

Query: 115 EILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAAT 174
           E+++   ++  +D WS G ++Y +L G  PF  S   +TY +I   E + P    +    
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230

Query: 175 MIKKMLLLDPVQRPP-----VAQLLHFEFFNDYCPTSL 207
           ++ +++  D  QR          + +  +F +     L
Sbjct: 231 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 60.5 bits (146), Expect = 4e-11
 Identities = 21/54 (38%), Positives = 29/54 (53%)

Query: 245 TEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
             P  +FY  ++   + YLH   II+RDLK  N+ L  N  +KI DFG A  + 
Sbjct: 102 PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 5e-29
 Identities = 48/222 (21%), Positives = 93/222 (41%), Gaps = 31/222 (13%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMME-LYNSACDLEEMSDPAA 59
            E+ + R LKH N+V ++    D  +  +YI++E C    +   +     + + + +   
Sbjct: 52  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 111

Query: 60  QPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLT-RMIMLANK---------------- 102
             V+        +      ++ +D    V+  DL    + L  K                
Sbjct: 112 LRVM-----TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166

Query: 103 -----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRI 157
                    GTP Y++PE +N+  ++ + D+WS+GC++Y L    PPF   + KE   +I
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 226

Query: 158 KKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF 198
           ++ ++ ++P         +I +ML L    RP V ++L    
Sbjct: 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.9 bits (181), Expect = 7e-16
 Identities = 24/76 (31%), Positives = 37/76 (48%), Gaps = 5/76 (6%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHD-----HKIIHRDLKLGNLFLSDNFVVK 287
           ++ + +K R+ + E      M Q+   +   H      H ++HRDLK  N+FL     VK
Sbjct: 95  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154

Query: 288 IGDFGLAARIEFDGQR 303
           +GDFGLA  +  D   
Sbjct: 155 LGDFGLARILNHDTSF 170

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  109 bits (272), Expect = 1e-28
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 23/221 (10%)

Query: 3   QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
           +E+ I R +  H N++     +E + F +++ +L +K  + +       L E      + 
Sbjct: 58  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE--KETRKI 115

Query: 62  VIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANK---NTLCGTPNY 111
           +  + + +    K    ++       L DD   +   D      L        +CGTP+Y
Sbjct: 116 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175

Query: 112 IAPEIL------NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
           +APEI+      N  G+  EVD+WS G IMYTLL G PPF           I    Y+  
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235

Query: 166 ----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                        ++ + L++ P +R    + L   FF  Y
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 72.8 bits (178), Expect = 2e-15
 Identities = 22/67 (32%), Positives = 39/67 (58%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
             +  ++E ETR  M+ +LE +  LH   I+HRDLK  N+ L D+  +K+ DFG + +++
Sbjct: 102 TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161

Query: 299 FDGQRKR 305
              + + 
Sbjct: 162 PGEKLRE 168

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 1e-28
 Identities = 35/216 (16%), Positives = 76/216 (35%), Gaps = 22/216 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDS----KFVYIILELCRKRSMMELYNSACDLEEMSDPA 58
           +E  + + L+H N+V F+  +E +    K + ++ EL    ++         ++      
Sbjct: 57  EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI--KVL 114

Query: 59  AQPVIWVSKWVDYSDKYGFGYQ----------LNDDSSGVMFND--LTRMIMLANKNTLC 106
                 + K + +                   +   +  V   D  L  +   +    + 
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 174

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKVEY--K 163
           GTP ++APE+     +   VDV++ G  M  +   + P+ E     + Y R+        
Sbjct: 175 GTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 233

Query: 164 LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF 199
                      +I+  +  +  +R  +  LL+  FF
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.1 bits (166), Expect = 6e-14
 Identities = 27/59 (45%), Positives = 36/59 (61%), Gaps = 3/59 (5%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLSD-NFVVKIGDFGLA 294
           KR K +     R + +QIL+G+ +LH     IIHRDLK  N+F++     VKIGD GLA
Sbjct: 104 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-28
 Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EI I++ L H NVV F+    +    Y+ LE C    + +       + E    A +  
Sbjct: 52  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRFF 109

Query: 63  IWVSKWVDYSDKYGFGY--------QLNDDSSG-VMFNDLTRMIMLANK----NTLCGTP 109
             +   V Y    G  +         L++  +  +    L  +    N+    N +CGT 
Sbjct: 110 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

Query: 110 NYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETST-LKETYSRIKKVEYKLP-- 165
            Y+APE+L +   H+  VDVWS G ++  +L G+ P++  +   + YS  K+ +  L   
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229

Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCP 204
             +      ++ K+L+ +P  R  +  +    ++N    
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.0 bits (184), Expect = 2e-16
 Identities = 23/67 (34%), Positives = 37/67 (55%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           +    + EP+ + +  Q++ GV YLH   I HRD+K  NL L +   +KI DFGLA    
Sbjct: 95  EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154

Query: 299 FDGQRKR 305
           ++ + + 
Sbjct: 155 YNNRERL 161

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  108 bits (271), Expect = 2e-28
 Identities = 36/214 (16%), Positives = 79/214 (36%), Gaps = 24/214 (11%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPA 58
           +E     +L H  +V  +   E         YI++E     ++ ++ ++   +      A
Sbjct: 56  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP--KRA 113

Query: 59  AQPVIWVSKWVDYSDKYGFGYQ----LNDDSSGVMFNDLTRMIMLAN----------KNT 104
            + +    + +++S + G  ++     N   S      +    +                
Sbjct: 114 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKL 164
           + GT  Y++PE    +      DV+S+GC++Y +L G+PPF   +      +  + +   
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233

Query: 165 PAT----LKKPAATMIKKMLLLDPVQRPPVAQLL 194
           P+     L      ++ K L  +P  R   A  +
Sbjct: 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 52.4 bits (125), Expect = 1e-08
 Identities = 18/65 (27%), Positives = 30/65 (46%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
                +T       +    + +++ H + IIHRD+K  N+ +S    VK+ DFG+A  I 
Sbjct: 103 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162

Query: 299 FDGQR 303
             G  
Sbjct: 163 DSGNS 167

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 8e-28
 Identities = 43/203 (21%), Positives = 82/203 (40%), Gaps = 11/203 (5%)

Query: 3   QEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E ++   L+H N+V       E+   +YI+ E   K S+++   S        D   + 
Sbjct: 49  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 108

Query: 62  VIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANK-NTLCGTPNYIA 113
            + V + ++Y +   F ++       L  + +    +D       ++  +T      + A
Sbjct: 109 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 168

Query: 114 PEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKK-VEYKLPATLKKP 171
           PE L +   S + DVWS G +++ +   G+ P+    LK+   R++K  +   P      
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228

Query: 172 AATMIKKMLLLDPVQRPPVAQLL 194
              ++K    LD   RP   QL 
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLR 251

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.2 bits (148), Expect = 1e-11
 Identities = 17/61 (27%), Positives = 29/61 (47%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           S+ R  +       +   + E + YL  +  +HRDL   N+ +S++ V K+ DFGL    
Sbjct: 94  SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153

Query: 298 E 298
            
Sbjct: 154 S 154

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-27
 Identities = 41/226 (18%), Positives = 80/226 (35%), Gaps = 22/226 (9%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            EI I  S  H N+V     F     ++I++E C   ++  +         +++   Q V
Sbjct: 58  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVV 115

Query: 63  IW-VSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIM--LANKNTLCGTPN 110
                  ++Y       ++       L      +   D  ++      +  +++  GTP 
Sbjct: 116 CKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY 175

Query: 111 YIAPEIL-----NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY--- 162
           ++APE++         + ++ DVWS+G  +  +   +PP           +I K E    
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL 235

Query: 163 KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLP 208
             P+         +KK L  +   R   +QLL   F        + 
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 281

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.5 bits (206), Expect = 3e-19
 Identities = 26/71 (36%), Positives = 44/71 (61%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           +     +  + +TE + +   KQ L+ ++YLHD+KIIHRDLK GN+  + +  +K+ DFG
Sbjct: 96  VDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFG 155

Query: 293 LAARIEFDGQR 303
           ++A+     QR
Sbjct: 156 VSAKNTRTIQR 166

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-27
 Identities = 42/220 (19%), Positives = 82/220 (37%), Gaps = 12/220 (5%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E+ +        +VGF+  F     + I +E     S+ ++   A  + E      +  
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVS 110

Query: 63  IWVSKWVDYSDKYGFGYQLNDDSSGVMFND----------LTRMIMLANKNTLCGTPNYI 112
           I V K + Y  +       +   S ++ N           ++  ++ +  N+  GT +Y+
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170

Query: 113 APEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPA 172
           +PE L    +S + D+WS+G  +  + VG+ P      KE             A      
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230

Query: 173 ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCL 212
            T  + +       RPP+A     ++  +  P  LP+   
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.2 bits (179), Expect = 2e-15
 Identities = 18/61 (29%), Positives = 36/61 (59%), Gaps = 1/61 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           K+   I E         +++G++YL + HKI+HRD+K  N+ ++    +K+ DFG++ ++
Sbjct: 96  KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

Query: 298 E 298
            
Sbjct: 156 I 156

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 1e-26
 Identities = 39/215 (18%), Positives = 81/215 (37%), Gaps = 26/215 (12%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMME-LYNSACDLEEMSDPAAQP 61
            E+ + R  +H N++ F  +   +  + I+ + C   S+   L+      E         
Sbjct: 53  NEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDI 109

Query: 62  VIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND------LTRMIMLANKNTLCGT 108
               ++ +DY       ++          +   V   D       +R         L G+
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169

Query: 109 PNYIAPEIL---NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLP 165
             ++APE++   +KN +SF+ DV++ G ++Y L+ G+ P+     ++    +    Y  P
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229

Query: 166 ATLKKP------AATMIKKMLLLDPVQRPPVAQLL 194
              K           ++ + L     +RP   Q+L
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.6 bits (183), Expect = 4e-16
 Identities = 25/62 (40%), Positives = 32/62 (51%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L              +     +Q  +G+ YLH   IIHRDLK  N+FL ++  VKIGDFG
Sbjct: 90  LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 149

Query: 293 LA 294
           LA
Sbjct: 150 LA 151

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 1e-25
 Identities = 31/215 (14%), Positives = 66/215 (30%), Gaps = 18/215 (8%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE------MSD 56
            E  + + L +  +V      E   +  +++E+     + +       +++      +  
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 115

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSS------GVMFNDLTRMIMLANKNTLCGTPN 110
            +            + D       L           G+             +        
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEY-KLPATL 168
           + APE +N    S + DVWS G +M+     G+ P+      E  + ++K E    PA  
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 235

Query: 169 KKPAATMIKKMLLLDPVQRPP---VAQLLHFEFFN 200
            +    ++      D   RP    V   L   +++
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.5 bits (146), Expect = 3e-11
 Identities = 17/61 (27%), Positives = 29/61 (47%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + + + +      + Q+  G+ YL +   +HRDL   N+ L      KI DFGL+  +  
Sbjct: 100 QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159

Query: 300 D 300
           D
Sbjct: 160 D 160

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-25
 Identities = 36/214 (16%), Positives = 74/214 (34%), Gaps = 22/214 (10%)

Query: 3   QEIAIHRSLK--HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ 60
            E+ + + +      V+    +FE      +ILE       +  + +      + +  A+
Sbjct: 56  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELAR 113

Query: 61  PVIW-VSKWVDYSDKYGFGYQ--------LNDDSSGVMFND--LTRMIMLANKNTLCGTP 109
              W V + V +    G  ++        ++ +   +   D     ++         GT 
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 173

Query: 110 NYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATL 168
            Y  PE +     H     VWS+G ++Y ++ G  PFE          I + +      +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRV 227

Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                 +I+  L L P  RP   ++ +  +  D 
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (144), Expect = 5e-11
 Identities = 19/61 (31%), Positives = 34/61 (55%), Gaps = 1/61 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS-DNFVVKIGDFGLAARI 297
             R A+ E   R +  Q+LE V + H+  ++HRD+K  N+ +  +   +K+ DFG  A +
Sbjct: 102 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161

Query: 298 E 298
           +
Sbjct: 162 K 162

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.2 bits (244), Expect = 8e-25
 Identities = 31/207 (14%), Positives = 71/207 (34%), Gaps = 15/207 (7%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E  +   L H  +V  +    +   + ++ E      + +   +   L           
Sbjct: 49  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAET-LLGMC 107

Query: 63  IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKNT-----LCGTPN 110
           + V + + Y ++    ++       L  ++  +  +D      + +              
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKK-VEYKLPATL 168
           + +PE+ + + +S + DVWS G +M+ +   GK P+E  +  E    I        P   
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227

Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLH 195
                 ++       P  RP  ++LL 
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLR 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.2 bits (140), Expect = 2e-10
 Identities = 18/61 (29%), Positives = 30/61 (49%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L +    +R              + EG++YL +  +IHRDL   N  + +N V+K+ DFG
Sbjct: 87  LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG 146

Query: 293 L 293
           +
Sbjct: 147 M 147

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.8 bits (248), Expect = 9e-25
 Identities = 51/280 (18%), Positives = 106/280 (37%), Gaps = 33/280 (11%)

Query: 3   QEIAIH-RSLKHRNVVGFHSFFEDS----KFVYIILELCRKRSMMELYNSACDLEEMSDP 57
           +E+ +H R+ +  ++V     +E+     K + I++E      +        D       
Sbjct: 53  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112

Query: 58  AAQPVIWVSKWVDYSDKYGFGYQ----------LNDDSSGVMFNDLTRMIMLANKN---T 104
           A++ +  + + + Y       ++              ++ +   D        + N   T
Sbjct: 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSRIKKV 160
            C TP Y+APE+L    +    D+WS+G IMY LL G PPF      +      +RI+  
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232

Query: 161 EYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAP 216
           +Y+ P    + + +    +I+ +L  +P QR  + + ++  +                 P
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT-------P 285

Query: 217 RFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQI 256
              S V   +  R + + E  +     +     +  +K+I
Sbjct: 286 LHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKI 325

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.6 bits (154), Expect = 3e-12
 Identities = 24/68 (35%), Positives = 32/68 (47%), Gaps = 3/68 (4%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLA 294
            +  +A TE E    MK I E + YLH   I HRD+K  NL  +    N ++K+ DFG A
Sbjct: 102 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161

Query: 295 ARIEFDGQ 302
                   
Sbjct: 162 KETTSHNS 169

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 1e-24
 Identities = 37/248 (14%), Positives = 86/248 (34%), Gaps = 42/248 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +EI + + L H N++G    F     + ++ +       + + +++  L          +
Sbjct: 49  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP--SHIKAYM 106

Query: 63  IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKNTL----CGTPNY 111
           +   + ++Y  ++   ++       L D++  +   D        + N        T  Y
Sbjct: 107 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWY 166

Query: 112 IAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY-------- 162
            APE+L     +   VD+W++GCI+  LL+  P     +  +  +RI +           
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226

Query: 163 --------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                                + +        +I+ + L +P  R    Q L  ++F++ 
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

Query: 203 CPTSLPAS 210
              +    
Sbjct: 287 PGPTPGCQ 294

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.6 bits (138), Expect = 3e-10
 Identities = 26/60 (43%), Positives = 34/60 (56%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
                +T    + YM   L+G+ YLH H I+HRDLK  NL L +N V+K+ DFGLA    
Sbjct: 92  DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 2e-24
 Identities = 35/225 (15%), Positives = 81/225 (36%), Gaps = 19/225 (8%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           QE  + + L+H  +V  ++   +   +YI+ E   K S+++                   
Sbjct: 61  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 119

Query: 63  IWVSKWVDYSDKYGFGYQLNDDSSGVMFND----------LTRMI---MLANKNTLCGTP 109
             ++  + Y ++  +    +  ++ ++  +          L R+I       +       
Sbjct: 120 AQIASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178

Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKK-VEYKLPAT 167
            + APE       + + DVWS G ++  L   G+ P+     +E   ++++      P  
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLLHF--EFFNDYCPTSLPAS 210
             +    ++ +    +P +RP    L  F  ++F    P   P  
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.7 bits (157), Expect = 1e-12
 Identities = 23/73 (31%), Positives = 36/73 (49%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L     +  K +  P+      QI  G++Y+     +HRDL+  N+ + +N V K+ DFG
Sbjct: 99  LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158

Query: 293 LAARIEFDGQRKR 305
           LA  IE +    R
Sbjct: 159 LARLIEDNEYTAR 171

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.3 bits (239), Expect = 5e-24
 Identities = 32/206 (15%), Positives = 72/206 (34%), Gaps = 13/206 (6%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSAC---DLEEMSDPAA 59
           +E  +  +L H  +V  +      + ++II E      ++            +++ +   
Sbjct: 48  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 107

Query: 60  QPV-----IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIM---LANKNTLCGTPNY 111
                   +   +++            +     V    L+R ++     +         +
Sbjct: 108 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKK-VEYKLPATLK 169
             PE+L  +  S + D+W+ G +M+ +  +GK P+E  T  ET   I + +    P    
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227

Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLH 195
           +   T++         +RP    LL 
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLS 253

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.5 bits (141), Expect = 1e-10
 Identities = 20/73 (27%), Positives = 32/73 (43%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L+    + R      +     K + E + YL   + +HRDL   N  ++D  VVK+ DFG
Sbjct: 86  LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 145

Query: 293 LAARIEFDGQRKR 305
           L+  +  D     
Sbjct: 146 LSRYVLDDEYTSS 158

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 9e-24
 Identities = 42/215 (19%), Positives = 79/215 (36%), Gaps = 18/215 (8%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E  + ++ +H  +      F+    +  ++E      +    +      E  + A    
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE--ERARFYG 111

Query: 63  IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKNT----LCGTPNY 111
             +   ++Y       Y+       + D    +   D        +        CGTP Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           +APE+L  N +   VD W +G +MY ++ G+ PF     +  +  I   E + P TL   
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231

Query: 172 AATMIKKMLLLDPVQRPP-----VAQLLHFEFFND 201
           A +++  +L  DP QR         +++   FF  
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.8 bits (157), Expect = 2e-12
 Identities = 25/65 (38%), Positives = 35/65 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            R +  TE   RFY  +I+  + YLH   +++RD+KL NL L  +  +KI DFGL     
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156

Query: 299 FDGQR 303
            DG  
Sbjct: 157 SDGAT 161

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.0 bits (233), Expect = 6e-23
 Identities = 28/207 (13%), Positives = 67/207 (32%), Gaps = 16/207 (7%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMEL---YNSACDLEEMSDPAA 59
           +E  I   L +  +V      +      +++E+     + +          +  +++   
Sbjct: 58  REAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 116

Query: 60  QPV-----IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMI-----MLANKNTLCGTP 109
           Q       +    +V           +N   + +    L++ +         ++      
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEY-KLPAT 167
            + APE +N    S   DVWS G  M+  L  G+ P++     E  + I++ +  + P  
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236

Query: 168 LKKPAATMIKKMLLLDPVQRPPVAQLL 194
                  ++    +     RP    + 
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVE 263

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.1 bits (158), Expect = 8e-13
 Identities = 20/70 (28%), Positives = 32/70 (45%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L +    +R+ I        + Q+  G+ YL +   +HRDL   N+ L +    KI DFG
Sbjct: 95  LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154

Query: 293 LAARIEFDGQ 302
           L+  +  D  
Sbjct: 155 LSKALGADDS 164

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.3 bits (231), Expect = 1e-22
 Identities = 39/222 (17%), Positives = 79/222 (35%), Gaps = 31/222 (13%)

Query: 3   QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E+ +   L  H N++      E   ++Y+ +E     ++++    +  LE   DPA   
Sbjct: 59  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET--DPAFAI 116

Query: 62  VIWVSKWVDYSDKYGFGYQL-----NDDSSGVMFNDL-TRMIML---------------- 99
               +  +       F   +            +  DL  R I++                
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 176

Query: 100 ----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETY 154
                 K        ++A E LN + ++   DVWS G +++ ++  G  P+   T  E Y
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 155 SRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
            ++ +    + P         ++++     P +RP  AQ+L 
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.7 bits (154), Expect = 3e-12
 Identities = 28/156 (17%), Positives = 49/156 (31%), Gaps = 17/156 (10%)

Query: 153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQR--------------PPVAQLLHFEF 198
            + ++ K   K        A   +K+    D  +               P +  LL    
Sbjct: 22  NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 81

Query: 199 FNDYCPTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILE 258
              Y      A            +         P     +     ++  +   +   +  
Sbjct: 82  HRGYL---YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 138

Query: 259 GVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLA 294
           G+ YL   + IHRDL   N+ + +N+V KI DFGL+
Sbjct: 139 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.5 bits (229), Expect = 1e-22
 Identities = 34/210 (16%), Positives = 65/210 (30%), Gaps = 17/210 (8%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSAC---DLEEMSDPAA 59
           +E+    SL HRN++  +          ++ EL    S+++          L  +S  A 
Sbjct: 60  REVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118

Query: 60  QPV-----IWVSKWVDYSDK-----YGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTP 109
           Q       +   +++                +     G+M            +       
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 110 NYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVEYKL--PA 166
            + APE L     S   D W  G  ++ +   G+ P+      +   +I K   +L  P 
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238

Query: 167 TLKKPAATMIKKMLLLDPVQRPPVAQLLHF 196
              +    ++ +     P  RP    L  F
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (152), Expect = 5e-12
 Identities = 25/71 (35%), Positives = 35/71 (49%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L++R  K +          Y  Q+ EG+ YL   + IHRDL   NL L+   +VKIGDFG
Sbjct: 97  LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156

Query: 293 LAARIEFDGQR 303
           L   +  +   
Sbjct: 157 LMRALPQNDDH 167

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.9 bits (225), Expect = 5e-22
 Identities = 31/217 (14%), Positives = 74/217 (34%), Gaps = 25/217 (11%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E  + + L+H+ +V  ++       +YII E     S+++   +   ++   +      
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115

Query: 63  IWVSKWVDYSDKYG----------------FGYQLNDDSSGVMFNDLTRMIMLANKNTLC 106
             +++ + + ++                     ++ D     +  D              
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR----EGAK 171

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKK-VEYKL 164
               + APE +N    + + DVWS G ++  ++  G+ P+   T  E    +++      
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231

Query: 165 PATLKKPAATMIKKMLLLDPVQRPPVAQLLHF--EFF 199
           P    +    +++      P  RP    L     +FF
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.7 bits (157), Expect = 1e-12
 Identities = 23/68 (33%), Positives = 35/68 (51%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +     +T  +      QI EG++++ +   IHRDL+  N+ +SD    KI DFGLA  I
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159

Query: 298 EFDGQRKR 305
           E +    R
Sbjct: 160 EDNEYTAR 167

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.5 bits (229), Expect = 5e-22
 Identities = 38/217 (17%), Positives = 76/217 (35%), Gaps = 20/217 (9%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
             +++  +     +V     F     +  IL+L     +    +      E         
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE--ADMRFYA 113

Query: 63  IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKNT--LCGTPNYIA 113
             +   +++       Y+       L D+   V  +DL      + K      GT  Y+A
Sbjct: 114 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMA 173

Query: 114 PEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV---EYKLPATLK 169
           PE+L K   +    D +S+GC+++ LL G  PF     K+ +   +       +LP +  
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

Query: 170 KPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND 201
               ++++ +L  D  +R         ++    FF  
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 65.9 bits (160), Expect = 7e-13
 Identities = 19/60 (31%), Positives = 35/60 (58%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            +    +E + RFY  +I+ G+ ++H+  +++RDLK  N+ L ++  V+I D GLA    
Sbjct: 99  SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (227), Expect = 7e-22
 Identities = 51/271 (18%), Positives = 94/271 (34%), Gaps = 42/271 (15%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKF------VYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + ++H NV+G    F   +        Y+++          + +     + +  
Sbjct: 66  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125

Query: 57  PAAQPVIWV----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYI 112
              Q +  +    +  + + D       +N+D    + +        +       T  Y 
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYR 185

Query: 113 APE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           APE ILN   ++  VD+WS+GCIM  ++ GK  F+ S   +    I KV    PA   + 
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 172 -------------------------------AATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
                                          A  +++KML+LD  QR    + L   +F 
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

Query: 201 DYCPTSLPASCLMTAPRFDSVVPSFNSPRRK 231
               T            FD V  + +  +R 
Sbjct: 306 SLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 336

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.8 bits (131), Expect = 3e-09
 Identities = 24/59 (40%), Positives = 40/59 (67%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
           + + + E   +F + Q+L+G+ Y+H   IIHRDLK GNL ++++  +KI DFGLA + +
Sbjct: 114 KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172

>d2ogqa1 d.223.1.2 (A:371-494) Serine/threonine-protein kinase plk C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 124

class: Alpha and beta proteins (a+b)
fold: Polo-box domain
superfamily: Polo-box domain
family: Polo-box duplicated region
domain: Serine/threonine-protein kinase plk C-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.4 bits (214), Expect = 9e-22
 Identities = 34/60 (56%), Positives = 42/60 (70%)

Query: 51  LEEMSDPAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPN 110
            EE  DPA  P+ WVSKWVDYSDKYG GYQL D+S GV+FND TR+I+  + ++L     
Sbjct: 27  QEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIER 86

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.4 bits (226), Expect = 1e-21
 Identities = 45/248 (18%), Positives = 88/248 (35%), Gaps = 48/248 (19%)

Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ I R L H N+V    FF      +D  ++ ++L+   +       + +   + +  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 57  PAAQPVIW-VSKWVDYSDKYGF--------GYQLNDDSSGVMFNDLTRMIMLANKN---T 104
              +  ++ + + + Y   +G            L+ D++ +   D      L       +
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

Query: 105 LCGTPNYIAP-EILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV--- 160
              +  Y AP  I     ++  +DVWS GC++  LL+G+P F   +  +    I KV   
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241

Query: 161 --------------EYKLPATLKKP------------AATMIKKMLLLDPVQRPPVAQLL 194
                         E+K P     P            A  +  ++L   P  R    +  
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301

Query: 195 HFEFFNDY 202
              FF++ 
Sbjct: 302 AHSFFDEL 309

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.7 bits (162), Expect = 4e-13
 Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 1/67 (1%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFL-SDNFVVKIGDF 291
           +    S+ ++ +     + YM Q+   ++Y+H   I HRD+K  NL L  D  V+K+ DF
Sbjct: 108 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 167

Query: 292 GLAARIE 298
           G A ++ 
Sbjct: 168 GSAKQLV 174

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 2e-21
 Identities = 41/206 (19%), Positives = 71/206 (34%), Gaps = 14/206 (6%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSAC---DLEEMSDPAA 59
           QE    R   H ++V       +   V+II+ELC    +           DL  +   A 
Sbjct: 57  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115

Query: 60  QPVIWV----SKWVDYSDKYGFGYQLNDD----SSGVMFNDLTRMIMLANKNTLCGTPNY 111
           Q    +    SK   + D       ++ +          +           +       +
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVEY-KLPATLK 169
           +APE +N    +   DVW  G  M+ +L+ G  PF+     +   RI+  E   +P    
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235

Query: 170 KPAATMIKKMLLLDPVQRPPVAQLLH 195
               +++ K    DP +RP   +L  
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKA 261

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.5 bits (151), Expect = 7e-12
 Identities = 21/72 (29%), Positives = 35/72 (48%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L      R+ ++       Y  Q+   ++YL   + +HRD+   N+ +S N  VK+GDFG
Sbjct: 94  LRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153

Query: 293 LAARIEFDGQRK 304
           L+  +E     K
Sbjct: 154 LSRYMEDSTYYK 165

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 3e-21
 Identities = 31/210 (14%), Positives = 59/210 (28%), Gaps = 17/210 (8%)

Query: 3   QEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E  I +   H NV+              ++L   +   +     +      + D     
Sbjct: 77  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 136

Query: 62  VIWVSKWVDYSDKYGFGYQLND--------------DSSGVMFNDLTRMIMLANKNTLCG 107
           +         + K      L                D              + NK     
Sbjct: 137 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 108 TPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKVEYKL-P 165
              ++A E L     + + DVWS G +++ L+  G PP+      +    + +    L P
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256

Query: 166 ATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                P   ++ K        RP  ++L+ 
Sbjct: 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.7 bits (123), Expect = 3e-08
 Identities = 20/62 (32%), Positives = 29/62 (46%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L           T  +   +  Q+ +G+ +L   K +HRDL   N  L + F VK+ DFG
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175

Query: 293 LA 294
           LA
Sbjct: 176 LA 177

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.8 bits (222), Expect = 3e-21
 Identities = 42/232 (18%), Positives = 79/232 (34%), Gaps = 38/232 (16%)

Query: 3   QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNS-----ACDLEEMSD 56
            E+ +   L  H N+V        S  +Y+I E C    ++    S     + D  E  +
Sbjct: 89  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQ-----------------------LNDDSSGVMFND- 92
                       + + D   F YQ                       L      V   D 
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208

Query: 93  -LTRMIMLANKNTL----CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFE 146
            L R IM  +   +         ++APE L +  ++ + DVWS G +++ +  +G  P+ 
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268

Query: 147 TSTLKETYSRIKKVEYKL--PATLKKPAATMIKKMLLLDPVQRPPVAQLLHF 196
              +   + ++ +  +K+  P    +    +++     D  +RP    L  F
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.0 bits (168), Expect = 5e-14
 Identities = 20/68 (29%), Positives = 32/68 (47%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
            +    +T  +   +  Q+ +G+ +L     +HRDL   N+ ++   VVKI DFGLA  I
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 298 EFDGQRKR 305
             D     
Sbjct: 215 MSDSNYVV 222

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 5e-21
 Identities = 45/240 (18%), Positives = 79/240 (32%), Gaps = 40/240 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCR---KRSMMELYNSACDLEEMSDPAA 59
           +EI++ + L H N+V           +Y++ E      K+ M     +   L  +     
Sbjct: 50  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 109

Query: 60  QPV----IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYI 112
           Q +       S  V + D       +N + +  + +                   T  Y 
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169

Query: 113 APEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY--------- 162
           APEIL    + S  VD+WS+GCI   ++  +  F   +  +   RI +            
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

Query: 163 --------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                               K+   L +   +++ +ML  DP +R      L   FF D 
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.0 bits (134), Expect = 1e-09
 Identities = 21/65 (32%), Positives = 37/65 (56%)

Query: 238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARI 297
           +     I  P  + Y+ Q+L+G+++ H H+++HRDLK  NL ++    +K+ DFGLA   
Sbjct: 93  ASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

Query: 298 EFDGQ 302
               +
Sbjct: 153 GVPVR 157

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 88.7 bits (219), Expect = 5e-21
 Identities = 33/211 (15%), Positives = 66/211 (31%), Gaps = 19/211 (9%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E +I     H NV+        S  V II E     S+            +       +
Sbjct: 76  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ-LVGML 134

Query: 63  IWVSKWVDYSDKYGFGYQ----------------LNDDSSGVMFNDLTRMIMLANKNTLC 106
             ++  + Y     + ++                ++D        D T      +     
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 107 GTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKK-VEYKL 164
               + APE +     +   DVWS G +M+ ++  G+ P+   T ++  + I++      
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254

Query: 165 PATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
           P         ++      D   RP   Q+++
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 67.1 bits (163), Expect = 2e-13
 Identities = 21/72 (29%), Positives = 33/72 (45%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L     +     T  +    ++ I  G+ YL D   +HRDL   N+ ++ N V K+ DFG
Sbjct: 114 LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG 173

Query: 293 LAARIEFDGQRK 304
           L+  +E D    
Sbjct: 174 LSRFLEDDTSDP 185

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 87.2 bits (215), Expect = 2e-20
 Identities = 47/238 (19%), Positives = 83/238 (34%), Gaps = 39/238 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE------MSD 56
           +EI+I + LKH N+V  +      K + ++ E   +     L      LE       +  
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFN-DLTRMIMLANKN--TLCGTPNYIA 113
                     + V + D       +N +    + +  L R   +  +       T  Y A
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168

Query: 114 PEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY---------- 162
           P++L  +  +S  +D+WS+GCI   ++ G P F   +  +   RI ++            
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228

Query: 163 -------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND 201
                                   L +    ++ KML LDP QR    Q L   +F +
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 61.1 bits (147), Expect = 2e-11
 Identities = 20/65 (30%), Positives = 35/65 (53%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
                +     + ++ Q+L G++Y HD +++HRDLK  NL ++    +KI DFGLA    
Sbjct: 92  VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151

Query: 299 FDGQR 303
              ++
Sbjct: 152 IPVRK 156

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (216), Expect = 2e-20
 Identities = 56/250 (22%), Positives = 91/250 (36%), Gaps = 31/250 (12%)

Query: 3   QEIAIHRSLKHR-NVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E  +   ++    +V  H  F+    +++IL+      +    +      E        
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIY 134

Query: 62  VIWVSKWVDYSDKYGF-------GYQLNDDSSGVMFNDLTRMIMLANKNT-----LCGTP 109
           V  +   +++  K G           L D +  V+  D           T      CGT 
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 110 NYIAPEIL--NKNGHSFEVDVWSIGCIMYTLLVGKPPF----ETSTLKETYSRIKKVEYK 163
            Y+AP+I+    +GH   VD WS+G +MY LL G  PF    E ++  E   RI K E  
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254

Query: 164 LPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFNDYCPTSLPASCLMTAPRF 218
            P  +   A  +I+++L+ DP +R         ++    FF       L A   + AP  
Sbjct: 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK-KVPAP-- 311

Query: 219 DSVVPSFNSP 228
               P     
Sbjct: 312 --FKPVIRDE 319

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.0 bits (134), Expect = 1e-09
 Identities = 22/60 (36%), Positives = 35/60 (58%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
            +R+  TE E + Y+ +I+  + +LH   II+RD+KL N+ L  N  V + DFGL+    
Sbjct: 121 SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 85.2 bits (210), Expect = 9e-20
 Identities = 28/223 (12%), Positives = 59/223 (26%), Gaps = 34/223 (15%)

Query: 3   QEIAIHRSLKHRN-VVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E   ++ L     +   + F ++     ++++L        L          +   A  
Sbjct: 49  DEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKT--VAMA 106

Query: 62  VIWVSKWVDYSDKYGFGYQ---------------------LNDDSSGVMFND--LTRMIM 98
              +   V    +    Y+                     + D      + D    + I 
Sbjct: 107 AKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166

Query: 99  LANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIK 158
              K  L GT  Y++         S   D+ ++G +    L G  P++         + +
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226

Query: 159 KVEYK--------LPATLKKPAATMIKKMLLLDPVQRPPVAQL 193
           ++  K        L A   +     +     L     P    L
Sbjct: 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 53.7 bits (128), Expect = 6e-09
 Identities = 12/71 (16%), Positives = 28/71 (39%), Gaps = 5/71 (7%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF-----VVKIGDFGL 293
              +  +        KQ+L  V  +H+  +++RD+K  N  +         ++ + DFG+
Sbjct: 93  LCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152

Query: 294 AARIEFDGQRK 304
                    ++
Sbjct: 153 VKFYRDPVTKQ 163

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 85.6 bits (211), Expect = 1e-19
 Identities = 40/210 (19%), Positives = 81/210 (38%), Gaps = 11/210 (5%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE------MSD 56
            E  I +++    +V     F+D+  +Y+++E      M           E       + 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEI 116
                    S  + Y D       ++      + +      +     TLCGTP  +APEI
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEI 209

Query: 117 LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKPAATMI 176
           +   G++  VD W++G ++Y +  G PPF      + Y +I   + + P+        ++
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 177 KKMLLLDPVQRPP-----VAQLLHFEFFND 201
           + +L +D  +R       V  + + ++F  
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 66.4 bits (161), Expect = 6e-13
 Identities = 23/57 (40%), Positives = 31/57 (54%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAAR 296
           R    +EP  RFY  QI+    YLH   +I+RDLK  NL +     +++ DFG A R
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.5 bits (208), Expect = 1e-19
 Identities = 38/224 (16%), Positives = 79/224 (35%), Gaps = 34/224 (15%)

Query: 3   QEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E+ + + + KH+N++           +Y+I+E   K ++ E            + +  P
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 124

Query: 62  VIWVSKWVDYSDKYGFGYQL-----NDDSSGVMFNDLTRMIMLANKN------------- 103
                + +   D     YQ+        S   +  DL    +L  ++             
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184

Query: 104 -----------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLK 151
                             ++APE L    ++ + DVWS G +++ +  +G  P+    ++
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244

Query: 152 ETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLL 194
           E +  +K+      P+        M++      P QRP   QL+
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.2 bits (137), Expect = 5e-10
 Identities = 22/79 (27%), Positives = 37/79 (46%)

Query: 227 SPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVV 286
            P  +     +    + ++  +      Q+  G+ YL   K IHRDL   N+ ++++ V+
Sbjct: 115 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 174

Query: 287 KIGDFGLAARIEFDGQRKR 305
           KI DFGLA  I      K+
Sbjct: 175 KIADFGLARDIHHIDYYKK 193

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.8 bits (209), Expect = 1e-19
 Identities = 30/211 (14%), Positives = 65/211 (30%), Gaps = 14/211 (6%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRK--RSMMELYNSACDLEEMSDPAAQ 60
            E  +  S+ + +V         S    I   +        +  +      + + +   Q
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119

Query: 61  PV-----IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANK----NTLCGTPNY 111
                  +   + V                  +    L +++    K            +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 112 IAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKVEY-KLPATLK 169
           +A E +    ++ + DVWS G  ++ L+  G  P++     E  S ++K E    P    
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239

Query: 170 KPAATMIKKMLLLDPVQRPPVAQLL-HFEFF 199
                ++ K  ++D   RP   +L+  F   
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (156), Expect = 2e-12
 Identities = 21/73 (28%), Positives = 37/73 (50%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L++   + +  I       +  QI +G++YL D +++HRDL   N+ +     VKI DFG
Sbjct: 97  LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 156

Query: 293 LAARIEFDGQRKR 305
           LA  +  + +   
Sbjct: 157 LAKLLGAEEKEYH 169

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 84.1 bits (207), Expect = 2e-19
 Identities = 28/230 (12%), Positives = 61/230 (26%), Gaps = 34/230 (14%)

Query: 3   QEIAIHRSLKHRN-VVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E  I++ ++    +        +  +  +++EL            +             
Sbjct: 51  IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSL--KTVLLL 108

Query: 62  VIWVSKWVDYSDKYG----------FGYQLNDDSSGVMFNDL-----------TRMIMLA 100
              +   ++Y               F   L    + V   D             + I   
Sbjct: 109 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168

Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
               L GT  Y +         S   D+ S+G ++    +G  P++         + +++
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228

Query: 161 EYK--------LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
             K        L        AT +     L    +P  + L   + F + 
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR--QLFRNL 276

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 52.1 bits (124), Expect = 2e-08
 Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 3/72 (4%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIG 289
           L +  +   +  +         Q++  + Y+H    IHRD+K  N  +       +V I 
Sbjct: 89  LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 148

Query: 290 DFGLAARIEFDG 301
           DFGLA +     
Sbjct: 149 DFGLAKKYRDAR 160

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 83.6 bits (206), Expect = 3e-19
 Identities = 38/208 (18%), Positives = 77/208 (37%), Gaps = 14/208 (6%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
           +E A+ + +KH N+V            YII E     ++++        E  +       
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 63  IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLANKNTL-----CGTPN 110
             +S  ++Y +K  F ++       L  ++  V   D     ++                
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKK-VEYKLPATL 168
           + APE L  N  S + DVW+ G +++ +   G  P+    L + Y  ++K    + P   
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 241

Query: 169 KKPAATMIKKMLLLDPVQRPPVAQLLHF 196
            +    +++     +P  RP  A++   
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQA 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 62.4 bits (151), Expect = 8e-12
 Identities = 19/67 (28%), Positives = 30/67 (44%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE 298
             R+ ++     +   QI   + YL     IHRDL   N  + +N +VK+ DFGL+  + 
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166

Query: 299 FDGQRKR 305
            D     
Sbjct: 167 GDTYTAH 173

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.8 bits (206), Expect = 3e-19
 Identities = 41/244 (16%), Positives = 88/244 (36%), Gaps = 46/244 (18%)

Query: 3   QEIAIHRSLK---HRNVVGFHSFFEDSKF-----VYIILELCRKRSMMELYNSACDLEEM 54
           +E+A+ R L+   H NVV        S+      + ++ E    + +    +   +    
Sbjct: 56  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVP 114

Query: 55  SDPAAQPVIWVSKWVDYSDKYGFGYQ------LNDDSSGVMFNDLTRMIMLANK----NT 104
           ++     +  + + +D+   +   ++      +   SSG +      +  + +      +
Sbjct: 115 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 174

Query: 105 LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY-- 162
           +  T  Y APE+L ++ ++  VD+WS+GCI   +   KP F  S+  +   +I  V    
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234

Query: 163 -------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFE 197
                                    K    + +    ++ K L  +P +R      L   
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294

Query: 198 FFND 201
           +F D
Sbjct: 295 YFQD 298

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.9 bits (144), Expect = 5e-11
 Identities = 20/70 (28%), Positives = 36/70 (51%)

Query: 225 FNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF 284
           F    +      +      +     +  M Q+L G+ +LH H+++HRDLK  N+ ++ + 
Sbjct: 94  FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 153

Query: 285 VVKIGDFGLA 294
            +K+ DFGLA
Sbjct: 154 QIKLADFGLA 163

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.1 bits (207), Expect = 4e-19
 Identities = 51/288 (17%), Positives = 93/288 (32%), Gaps = 50/288 (17%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKF-----VYIILELCRKRSMMELYNSACDLEEMSDP 57
           +EI I    +H N++G +             VY++  L        L       + +   
Sbjct: 55  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF 114

Query: 58  AAQPV-----IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKN-----TLCG 107
             Q +     I  +  +    K             +    L R+    + +         
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 108 TPNYIAPEIL-NKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEY---- 162
           T  Y APEI+ N  G++  +D+WS+GCI+  +L  +P F      +  + I  +      
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 163 ---------------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                                      +L       A  ++ KML  +P +R  V Q L 
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

Query: 196 FEFFNDYC-PTSLPASCLMTAPRFDSVVPSFNSPRRKPLMERNSKRRK 242
             +   Y  P+  P +      +FD  +      + K L+   + R +
Sbjct: 295 HPYLEQYYDPSDEPIA--EAPFKFDMELDDLPKEKLKELIFEETARFQ 340

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.3 bits (153), Expect = 5e-12
 Identities = 22/64 (34%), Positives = 36/64 (56%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + + ++     +++ QIL G+ Y+H   ++HRDLK  NL L+    +KI DFGLA   + 
Sbjct: 102 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161

Query: 300 DGQR 303
           D   
Sbjct: 162 DHDH 165

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 8e-19
 Identities = 49/260 (18%), Positives = 88/260 (33%), Gaps = 42/260 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFV-----YIILELCRKRSMMELYNSACDLEEMSDP 57
           +E+ + + +KH NV+G    F  ++ +       ++       +  +       ++    
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125

Query: 58  AAQPVIWV-----SKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTLCGTPNYI 112
               ++       S  + + D       +N+D    + +                T  Y 
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYR 185

Query: 113 APEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKKP 171
           APEI LN   ++  VD+WS+GCIM  LL G+  F  +   +    I ++     A L K 
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245

Query: 172 -------------------------------AATMIKKMLLLDPVQRPPVAQLLHFEFFN 200
                                          A  +++KML+LD  +R   AQ L   +F 
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

Query: 201 DYCPTSLPASCLMTAPRFDS 220
            Y               F+S
Sbjct: 306 QYHDPDDEPVADPYDQSFES 325

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (115), Expect = 3e-07
 Identities = 24/61 (39%), Positives = 39/61 (63%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF 299
           + + +T+   +F + QIL G+ Y+H   IIHRDLK  NL ++++  +KI DFGLA   + 
Sbjct: 114 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173

Query: 300 D 300
           +
Sbjct: 174 E 174

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 9e-19
 Identities = 31/208 (14%), Positives = 70/208 (33%), Gaps = 17/208 (8%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E  I     H N++         K + II E     ++ +          +       +
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ-LVGML 116

Query: 63  IWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFND--LTRMIMLANKNTL-----CGT 108
             ++  + Y     + ++       L + +     +D  L+R++    + T         
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 109 PNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKK-VEYKLPA 166
             + APE ++    +   DVWS G +M+ ++  G+ P+   +  E    I        P 
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 236

Query: 167 TLKKPAATMIKKMLLLDPVQRPPVAQLL 194
                   ++ +    +  +RP  A ++
Sbjct: 237 DCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (145), Expect = 3e-11
 Identities = 18/70 (25%), Positives = 35/70 (50%)

Query: 234 MERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
            +   ++    +  +    ++ I  G+ YL +   +HRDL   N+ ++ N V K+ DFGL
Sbjct: 97  DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156

Query: 294 AARIEFDGQR 303
           +  +E D + 
Sbjct: 157 SRVLEDDPEA 166

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.5 bits (203), Expect = 1e-18
 Identities = 42/227 (18%), Positives = 77/227 (33%), Gaps = 33/227 (14%)

Query: 3   QEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP 61
            E+ +   L  H N+V             +I E C    ++       D    S  +   
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 62  VIWVSKWVDYSDKYGFGYQLNDD-----SSGVMFNDL-TRMIMLANKNT----------- 104
           +      +D  D   F YQ+        S   +  DL  R I+L +              
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 105 ------------LCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLK 151
                             ++APE +    ++FE DVWS G  ++ L  +G  P+    + 
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 152 ETYSRIKKVEYKL--PATLKKPAATMIKKMLLLDPVQRPPVAQLLHF 196
             + ++ K  +++  P         ++K     DP++RP   Q++  
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.1 bits (155), Expect = 3e-12
 Identities = 21/73 (28%), Positives = 33/73 (45%)

Query: 231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGD 290
           K           A+   +   +  Q+ +G+++L     IHRDL   N+ L+   + KI D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188

Query: 291 FGLAARIEFDGQR 303
           FGLA  I+ D   
Sbjct: 189 FGLARDIKNDSNY 201

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.9 bits (201), Expect = 2e-18
 Identities = 46/260 (17%), Positives = 80/260 (30%), Gaps = 55/260 (21%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKF--------VYIILELCRKRSMMELYNSACDL--E 52
           +EI I + LKH NVV                   +Y++ + C       L N        
Sbjct: 58  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 117

Query: 53  EMSDPAAQPVIWV----SKWVDYSDKYGFGYQLNDDSSGVM-------FNDLTRMIMLAN 101
           E+       +  +       + + D       +  D    +          L +      
Sbjct: 118 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 102 KNTLCGTPNYIAPE-ILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKV 160
                 T  Y  PE +L +  +   +D+W  GCIM  +    P  + +T +   + I ++
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 161 EYKLP--------------------------------ATLKKPAATMIKKMLLLDPVQRP 188
              +                                       A  +I K+L+LDP QR 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 189 PVAQLLHFEFF-NDYCPTSL 207
                L+ +FF +D  P+ L
Sbjct: 298 DSDDALNHDFFWSDPMPSDL 317

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.8 bits (149), Expect = 1e-11
 Identities = 23/70 (32%), Positives = 37/70 (52%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFG 292
           L    S      T  E +  M+ +L G+ Y+H +KI+HRD+K  N+ ++ + V+K+ DFG
Sbjct: 103 LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162

Query: 293 LAARIEFDGQ 302
           LA        
Sbjct: 163 LARAFSLAKN 172

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 81.4 bits (200), Expect = 2e-18
 Identities = 28/231 (12%), Positives = 63/231 (27%), Gaps = 37/231 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMEL------YNSACDLEEMSD 56
           +E A+     + N+V         K + ++ E      + E       +           
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 57  PAAQPVIWVSKWVDYSDKYGFGYQL-----NDDSSGVMFNDLTRMIMLANKN-------- 103
             A+        +  +++     Q+            +  DL     L  +N        
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184

Query: 104 ----------------TLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE 146
                                  ++ PE +  N ++ E DVW+ G +++ +   G  P+ 
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244

Query: 147 TSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF 196
               +E    ++       P         +++      P  RP    +   
Sbjct: 245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 66.4 bits (161), Expect = 3e-13
 Identities = 25/84 (29%), Positives = 38/84 (45%)

Query: 222 VPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS 281
           V S +          +S     ++  E     +Q+  G++YL + K +HRDL   N  + 
Sbjct: 115 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 174

Query: 282 DNFVVKIGDFGLAARIEFDGQRKR 305
           +N VVKI DFGL+  I      K 
Sbjct: 175 ENMVVKIADFGLSRNIYSADYYKA 198

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.8 bits (198), Expect = 3e-18
 Identities = 47/242 (19%), Positives = 83/242 (34%), Gaps = 40/242 (16%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELY--NSACDLEEMSDPAAQ 60
           +EI + + LKH+N+V  H      K + ++ E C +         N   D E +     Q
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 61  PV----IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNTL---CGTPNYIA 113
            +       S+ V + D       +N +    + N                   T  Y  
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169

Query: 114 PEILNKNG-HSFEVDVWSIGCIMYTLLVGK-PPFETSTLKETYSRIKKVEY--------- 162
           P++L     +S  +D+WS GCI   L     P F  + + +   RI ++           
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229

Query: 163 --------------------KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY 202
                                +   L      +++ +L  +PVQR    + L   +F+D+
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

Query: 203 CP 204
           CP
Sbjct: 290 CP 291

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.0 bits (139), Expect = 2e-10
 Identities = 17/63 (26%), Positives = 33/63 (52%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
              +     + ++ Q+L+G+ + H   ++HRDLK  NL ++ N  +K+ +FGLA      
Sbjct: 95  NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154

Query: 301 GQR 303
            + 
Sbjct: 155 VRC 157

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.1 bits (199), Expect = 3e-18
 Identities = 26/216 (12%), Positives = 64/216 (29%), Gaps = 23/216 (10%)

Query: 3   QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV 62
            E ++ +     +VV         +   +I+EL  +  +     S       +   A P 
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 63  IWVSKWVDYSDKYGFGYQLND--------------DSSGV-------MFNDLTRMIMLAN 101
           +     +      G  Y   +                          M  D+        
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 102 KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLL-VGKPPFETSTLKETYSRIKKV 160
                    +++PE L     +   DVWS G +++ +  + + P++  + ++    + + 
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251

Query: 161 EY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
                P         +++     +P  RP   +++ 
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.4 bits (122), Expect = 3e-08
 Identities = 19/57 (33%), Positives = 34/57 (59%)

Query: 237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGL 293
           N+      +  +      +I +G++YL+ +K +HRDL   N  ++++F VKIGDFG+
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.7 bits (190), Expect = 7e-17
 Identities = 46/255 (18%), Positives = 93/255 (36%), Gaps = 55/255 (21%)

Query: 3   QEIAIHRSLKHRNVVGFHSFF------EDSKFVYIILELCRKRSMMELYNSACDLEEMSD 56
           +E+ + + + H+N++   + F      E+ + VY+++EL    ++ ++     D E MS 
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY 123

Query: 57  PAAQPV-----IWVSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLANKNT-LCGTPN 110
              Q +     +  +  +    K       +D +  ++   L R    +   T    T  
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 183

Query: 111 YIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETYSRIKKVEYKLPATLKK 170
           Y APE++   G+   VD+WS+GCIM  ++  K  F      + ++++ +          K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 171 P------------------------------------------AATMIKKMLLLDPVQRP 188
                                                      A  ++ KML++DP +R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 189 PVAQLLHFEFFNDYC 203
            V   L   + N + 
Sbjct: 304 SVDDALQHPYINVWY 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (122), Expect = 5e-08
 Identities = 20/64 (31%), Positives = 31/64 (48%)

Query: 241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD 300
           +  +      + + Q+L G+ +LH   IIHRDLK  N+ +  +  +KI DFGLA      
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 301 GQRK 304
               
Sbjct: 173 FMMT 176

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 73.7 bits (180), Expect = 1e-15
 Identities = 40/254 (15%), Positives = 87/254 (34%), Gaps = 62/254 (24%)

Query: 3   QEIAIHRSLK-HRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAA 59
           +EI I  +L+   N++      +D  S+   ++ E        +LY +      ++D   
Sbjct: 78  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDI 131

Query: 60  QPVIW-VSKWVDYSDKYGFGYQLNDDSSGVMFNDLTRMIMLAN------------KNTLC 106
           +  ++ + K +DY    G  ++ +     VM +   R + L +             N   
Sbjct: 132 RFYMYEILKALDYCHSMGIMHR-DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 190

Query: 107 GTPNYIAPEI-LNKNGHSFEVDVWSIGCIMYTLLVGKPPF-ETSTLKETYSRIKKV---- 160
            +  +  PE+ ++   + + +D+WS+GC++ +++  K PF       +   RI KV    
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250

Query: 161 ---------------------------------EYKLPATLKKPAATMIKKMLLLDPVQR 187
                                              +    +   A   + K+L  D   R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310

Query: 188 PPVAQLLHFEFFND 201
               + +   +F  
Sbjct: 311 LTAREAMEHPYFYT 324

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 57.5 bits (138), Expect = 4e-10
 Identities = 19/61 (31%), Positives = 36/61 (59%), Gaps = 1/61 (1%)

Query: 239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGN-LFLSDNFVVKIGDFGLAARI 297
           +  + +T+ + RFYM +IL+ + Y H   I+HRD+K  N +   ++  +++ D+GLA   
Sbjct: 121 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180

Query: 298 E 298
            
Sbjct: 181 H 181

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.3 bits (171), Expect = 2e-14
 Identities = 38/228 (16%), Positives = 77/228 (33%), Gaps = 35/228 (15%)

Query: 1   MSQEIAIHRSLKHRNVVGFH-SFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA 59
           MS+   +     H NVV    +  +    + +I+E C+  ++     S     E      
Sbjct: 64  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS--KRNEFVPYKV 121

Query: 60  QPVIWVSKWVDYSDKYGFGYQLND-----DSSGVMFNDLT-RMIMLANKNTL-------- 105
            P      ++       + +Q+        S   +  DL  R I+L+ KN +        
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 181

Query: 106 ---------------CGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVG-KPPFETST 149
                               ++APE +    ++ + DVWS G +++ +      P+    
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241

Query: 150 LKETYSRI--KKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH 195
           + E + R   +    + P          +      +P QRP  ++L+ 
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.1 bits (155), Expect = 2e-12
 Identities = 38/149 (25%), Positives = 57/149 (38%), Gaps = 4/149 (2%)

Query: 157 IKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTSLPASCLMTAP 216
           +K +  K  AT  +  A M +  +L+       V  LL            +   C     
Sbjct: 48  VKML--KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN- 104

Query: 217 RFDSVVPSFNSPRRKPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLG 276
              + + S  +      +      +  +T      Y  Q+ +G+ +L   K IHRDL   
Sbjct: 105 -LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163

Query: 277 NLFLSDNFVVKIGDFGLAARIEFDGQRKR 305
           N+ LS+  VVKI DFGLA  I  D    R
Sbjct: 164 NILLSEKNVVKICDFGLARDIYKDPDYVR 192

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.9 bits (165), Expect = 1e-13
 Identities = 30/244 (12%), Positives = 74/244 (30%), Gaps = 54/244 (22%)

Query: 4   EIAIHRSLKHRNVVGFHSFFEDS----KFVYIILELCRKRSMME-LYNSACDLEEMSDPA 58
           EI     L+H N++GF +           ++++ +     S+ + L      +E M   A
Sbjct: 47  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA 106

Query: 59  AQPVIWV----SKWVDYSDKYGFGYQLNDDSSGVMFN----------------DLTRMIM 98
                 +     + V    K    ++ +  S  ++                  D     +
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHR-DLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165

Query: 99  LANKNTLCGTPNYIAPEILNKNGH------SFEVDVWSIGCIMYTLLVGKPPFETSTLKE 152
               N   GT  Y+APE+L+ + +          D++++G + + +             +
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225

Query: 153 TYSRI-----------------KKVEYKLPATLKKPAAT-----MIKKMLLLDPVQRPPV 190
                                 +K+   +P   +   A      ++++    +   R   
Sbjct: 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285

Query: 191 AQLL 194
            ++ 
Sbjct: 286 LRIK 289

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.3 bits (140), Expect = 2e-10
 Identities = 19/71 (26%), Positives = 26/71 (36%), Gaps = 8/71 (11%)

Query: 240 RRKAITEPETRFYMKQILEGVSYLHDH--------KIIHRDLKLGNLFLSDNFVVKIGDF 291
            R  +T             G+++LH           I HRDLK  N+ +  N    I D 
Sbjct: 93  NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152

Query: 292 GLAARIEFDGQ 302
           GLA R +    
Sbjct: 153 GLAVRHDSATD 163

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 58.9 bits (141), Expect = 1e-10
 Identities = 24/154 (15%), Positives = 40/154 (25%), Gaps = 48/154 (31%)

Query: 101 NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKETY------ 154
           +      T  Y +PE+L         D+WS  C+++ L+ G   FE              
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244

Query: 155 ------------------------------------------SRIKKVEYKLPATLKKPA 172
                                                       +   +YK      K  
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304

Query: 173 ATMIKKMLLLDPVQRPPVAQLLHFEFFNDYCPTS 206
           +  +  ML LDP +R     L++  +  D     
Sbjct: 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 39.2 bits (90), Expect = 4e-04
 Identities = 19/69 (27%), Positives = 28/69 (40%), Gaps = 7/69 (10%)

Query: 233 LMERNSKRRKAITEPETRFYMKQILEGVSYLH-DHKIIHRDLKLGNLFLSDN------FV 285
           L        + I     +   KQ+L G+ Y+H    IIH D+K  N+ +           
Sbjct: 111 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170

Query: 286 VKIGDFGLA 294
           +KI D G A
Sbjct: 171 IKIADLGNA 179

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 55.2 bits (132), Expect = 8e-10
 Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 2/63 (3%)

Query: 233 LME-RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDF 291
           LME  ++K    +        +  ILE V+  +   I+H DL   N+ +S+  +  I DF
Sbjct: 88  LMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DF 146

Query: 292 GLA 294
             +
Sbjct: 147 PQS 149

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	305
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.96
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.29
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.27
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.25
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.24
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.23
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.22
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.22
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.22
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.2
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.2
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.19
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.19
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.18
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.17
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.16
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.16
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.16
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.15
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.15
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.15
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.15
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.14
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.14
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.14
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.13
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.13
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.11
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.11
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.11
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.1
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.1
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.1
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.09
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.08
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.08
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.08
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.06
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.05
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.04
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.04
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.02
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.02
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.01
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	98.99
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	98.99
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	98.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	98.97
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	98.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	98.94
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	98.94
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	98.93
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	98.92
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	98.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	98.89
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	98.89
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	98.86
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	98.8
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	98.74
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	98.72
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	98.51
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	98.09
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	82.9

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=318.79  Aligned_cols=197  Identities=28%  Similarity=0.562  Sum_probs=169.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++++.+|||||||+||+|.+++.....+.   +..+. .+.++..++.|+|+.++.|+
T Consensus        54 ~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~---e~~~~~i~~qi~~al~~lH~~~ivHr  130 (263)
T d2j4za1          54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALSYCHSKRVIHR  130 (263)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCC---HHHHHHHHHHHHHHHHHHHHCCeeee
Confidence            479999999999999999999999999999999999999999998765542   22222 33456788999998876553


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC--CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLK  151 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~  151 (305)
                             +.+..+.+++.||+.+.....  ....+||+.|||||++.+..|+.++||||+||++|||++|++||.+.+..
T Consensus       131 DiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~  210 (263)
T d2j4za1         131 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ  210 (263)
T ss_dssp             CCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             eeccccceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH
Confidence                   333446788888876543322  34568999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         152 ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +.+..+.+..+.+|..+++++++||.+||+.||.+|||++|+++||||+.
T Consensus       211 ~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         211 ETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999999999999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=315.95  Aligned_cols=198  Identities=22%  Similarity=0.463  Sum_probs=166.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++|++++.+|||||||+||+|.+++.....+.   +..+.. ..++..++.|+|+.++.|+
T Consensus        56 ~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~---e~~~~~~~~qi~~al~ylH~~~iiHr  132 (288)
T d1uu3a_          56 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD---ETCTRFYTAEIVSALEYLHGKGIIHR  132 (288)
T ss_dssp             HHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCC---HHHHHHHHHHHHHHHHhhccccEEcC
Confidence            489999999999999999999999999999999999999999988776553   233333 3345788999998876443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                             +.+..+.+++.||+.+..+.      ...+.+||+.|||||++.+..|+.++||||+||++|||++|++||.+
T Consensus       133 DiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence                   33345678888987654322      23457899999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhh------hcCcccccc
Q psy6191         148 STLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQL------LHFEFFNDY  202 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~------l~~~~~~~~  202 (305)
                      .+..+.+.+|.+..+.+|..+++++++||.+||+.||.+|||++|+      ++||||++.
T Consensus       213 ~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         213 GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             SSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             cCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            9999999999999999999999999999999999999999999984      779999753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-45  Score=313.12  Aligned_cols=197  Identities=29%  Similarity=0.500  Sum_probs=156.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++++.+|||||||+||+|.+++.....+   .+..+. .+.++..++.|+|+.++.|+
T Consensus        55 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l---~e~~~~~~~~qi~~al~ylH~~~iiHr  131 (307)
T d1a06a_          55 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY---TERDASRLIFQVLDAVKYLHDLGIVHR  131 (307)
T ss_dssp             CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCC---CHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCC---CHHHHHHHHHHHHHHHHhhhhceeeeE
Confidence            58999999999999999999999999999999999999999999765444   333333 33445788999998886553


Q ss_pred             --------ec--CCCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q psy6191          81 --------LN--DDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFET  147 (305)
Q Consensus        81 --------~~--~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~  147 (305)
                              +.  +..+.+++.||+.+.....   ..+.+||+.|||||++.+..|+.++||||+||++|||++|++||.+
T Consensus       132 DiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  211 (307)
T d1a06a_         132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD  211 (307)
T ss_dssp             CCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence                    21  2345688999986654322   2467899999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         148 STLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      .+..+....+....+.++    ..+++++.+||.+||++||.+|||++|+++||||+.
T Consensus       212 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         212 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            998888888887765543    468899999999999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=310.15  Aligned_cols=196  Identities=19%  Similarity=0.337  Sum_probs=160.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++|++++.+|||||||+||+|.+++... .+   .+..+..+ .++..++.|+|+.|+.|+
T Consensus        65 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~-~l---~~~~~~~i~~qi~~aL~yLH~~~iiHr  140 (293)
T d1yhwa1          65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CM---DEGQIAAVCRECLQALEFLHSNQVIHR  140 (293)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc-CC---CHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            58999999999999999999999999999999999999999987653 22   33333333 345788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.+..+.    .....+||+.|||||++.+..|+.++||||+||++|+|++|++||.+.+
T Consensus       141 DiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  220 (293)
T d1yhwa1         141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (293)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence                   33345678899987655432    2346689999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHhcc---ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         150 LKETYSRIKKV---EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ..+....+...   .+..|..++.++++||.+||+.||.+|||++|+++||||+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         221 PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            77766555432   23445678999999999999999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-45  Score=312.21  Aligned_cols=197  Identities=21%  Similarity=0.390  Sum_probs=170.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||+++++|++++.+|||||||+||+|.+++.....+   .+..++.+ ..++.++.|+|+.++.|+
T Consensus        53 ~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~---~e~~~~~~~~qil~al~ylH~~~iiHR  129 (337)
T d1o6la_          53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSALEYLHSRDVVYR  129 (337)
T ss_dssp             HHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCC---CHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCC---cHHHHHHHHHHHhhhhhhhhhcCcccc
Confidence            47999999999999999999999999999999999999999999887655   33333333 346788999998887553


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.+....    ...+.|||+.|||||++.+..|+.++||||+||++|||++|++||.+.+
T Consensus       130 DlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence                   34445678999998664332    2346799999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                      ..+++..+....+.+|..+++++++||++||++||.+|++     ++|+++||||+.
T Consensus       210 ~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         210 HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            9999999999999999999999999999999999999995     899999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=301.48  Aligned_cols=198  Identities=23%  Similarity=0.442  Sum_probs=153.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCC-CCCCCcCchh-HHHHHHHHHHhhhhC-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDL-EEMSDPAAQP-VIWVSKWVDYSDKYG-   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~-   76 (305)
                      .+|+++|++++|||||++++++.+  ++.+|||||||+||+|.+++...... ..+.+..+.. +.+++.++.|+|+.+ 
T Consensus        51 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~  130 (269)
T d2java1          51 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD  130 (269)
T ss_dssp             HHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            479999999999999999999865  56799999999999999998653211 1123322322 334567777877654 


Q ss_pred             ----Cce-------eecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhC
Q psy6191          77 ----FGY-------QLNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        77 ----~~~-------~~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g  141 (305)
                          +.|       .+.+..+.+++.||+.+..+..    ..+.+||+.|||||++.+..|+.++||||+||++|||++|
T Consensus       131 ~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg  210 (269)
T d2java1         131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL  210 (269)
T ss_dssp             ---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhC
Confidence                322       2334457789999987765432    2467899999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         142 KPPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      ++||.+.+..+....+....+ .+|..+++++.+||.+||+.||.+|||++|+++|||+
T Consensus       211 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         211 MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             SCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            999999998888888876654 4677899999999999999999999999999999995

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-44  Score=307.87  Aligned_cols=198  Identities=22%  Similarity=0.446  Sum_probs=169.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||++++++++++.+|+|||||+||+|.+++.....+.   ...+.. ..++..++.|+|+.++.|+
T Consensus        52 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~---~~~~~~~~~qi~~al~~lH~~~iiHr  128 (316)
T d1fota_          52 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLHSKDIIYR  128 (316)
T ss_dssp             HHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCC---HHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             HHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccccc---ccHHHHHHHHHHHhhhhhccCcEEcc
Confidence            479999999999999999999999999999999999999999988765542   222222 3356788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                             +.+..+.+++.||+.+.... ...+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+
T Consensus       129 DiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~  208 (316)
T d1fota_         129 DLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK  208 (316)
T ss_dssp             CCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             ccCchheeEcCCCCEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH
Confidence                   33445678888887654432 2346899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      ...++......+|..++++++++|.+||++||.+|+     |++++++||||++.
T Consensus       209 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         209 TYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            999999888899999999999999999999999996     89999999999863

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=306.80  Aligned_cols=197  Identities=24%  Similarity=0.454  Sum_probs=153.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++++.+|||||||+||+|.+++.....+   .+..+. .+.++.+++.|+|+.++.|+
T Consensus        51 ~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l---~e~~~~~i~~qi~~al~ylH~~~IiHr  127 (271)
T d1nvra_          51 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM---PEPDAQRFFHQLMAGVVYLHGIGITHR  127 (271)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBC---CHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHHHcCCccC
Confidence            58999999999999999999999999999999999999999988654433   333333 33456788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------CCcccccCCCcccccccccCCC-CccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNKNGH-SFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                             +.+..+.+++.||+.+..+.      ...+.+||+.|||||++.+..+ +.++||||+||++|||++|++||.
T Consensus       128 DiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~  207 (271)
T d1nvra_         128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD  207 (271)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             cccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence                   33344678899987654432      1246789999999999987765 678999999999999999999997


Q ss_pred             CCCHH-HHHHHHhcccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         147 TSTLK-ETYSRIKKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       147 ~~~~~-~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      ..+.. .....+.....  ..+..++.++.+||.+||+.||.+|||++|+++||||+.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         208 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             SSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             CCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            65433 22333332222  222468999999999999999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-44  Score=303.41  Aligned_cols=198  Identities=20%  Similarity=0.276  Sum_probs=159.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++++.+|||||||+||+|.+++.+....  +.+..+.. +.++..++.|+|..++.|+
T Consensus        57 ~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~--l~e~~~~~i~~qi~~gL~ylH~~~ivHr  134 (288)
T d2jfla1          57 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNKIIHR  134 (288)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHCCEEEe
Confidence            58999999999999999999999999999999999999999987654321  23333333 3456788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHh----cCCcccccCCCcccccccc-----cCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML----ANKNTLCGTPNYIAPEILN-----KNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~----~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+.++.+++.||+.+...    ....+.+||+.|||||++.     +..|+.++||||+||++|||++|++|
T Consensus       135 DiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P  214 (288)
T d2jfla1         135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP  214 (288)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence                   3334467888888753221    2234678999999999983     45688999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhcccc---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         145 FETSTLKETYSRIKKVEY---KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      |.+.+..+.+.++....+   ..|..+++++++||.+||+.||.+|||++|+++||||+.
T Consensus       215 f~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         215 HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             TTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            999888888777766543   335678999999999999999999999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-44  Score=298.58  Aligned_cols=195  Identities=17%  Similarity=0.274  Sum_probs=154.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   76 (305)
                      .+|+++|++++|||||++++++++    +..+|||||||+||+|.+++.+...+   .+..+. ...++++++.|+|..+
T Consensus        56 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~---~~~~~~~~~~qi~~gl~yLH~~~  132 (270)
T d1t4ha_          56 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM---KIKVLRSWCRQILKGLQFLHTRT  132 (270)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccc---cHHHHHHHHHHHHHHHHHHHHCC
Confidence            589999999999999999999975    45699999999999999999876544   222222 2345578888988776


Q ss_pred             --Cce--------eecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          77 --FGY--------QLNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        77 --~~~--------~~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                        +.|        ++.+..+.+++.||+.+....  ...+.+||+.|||||++.+ .|+.++||||+||++|||++|+.|
T Consensus       133 ~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~P  211 (270)
T d1t4ha_         133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP  211 (270)
T ss_dssp             SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCC
Confidence              433        343445678899998765432  2346799999999999875 589999999999999999999999


Q ss_pred             CCCC-CHHHHHHHHhcccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         145 FETS-TLKETYSRIKKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       145 f~~~-~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      |.+. +..+....+.....  .++...+++++++|.+||..||++|||++|+++||||+
T Consensus       212 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         212 YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             TTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            9764 45555666655432  34456788999999999999999999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-44  Score=303.44  Aligned_cols=198  Identities=26%  Similarity=0.463  Sum_probs=163.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++|++++.+|||||||+||+|.+++.....+   .+..+.. +..+..++.|+|..++.|+
T Consensus        61 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l---~~~~~~~~~~qi~~al~yLH~~~ivHr  137 (293)
T d1jksa_          61 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYYLHSLQIAHF  137 (293)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccccc---chhHHHHHHHHHHHHHHhhhhcceeec
Confidence            47999999999999999999999999999999999999999999876544   2333332 3345788999998776443


Q ss_pred             --------ecCCC---CCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          81 --------LNDDS---SGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        81 --------~~~~~---~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                              +...+   ..+++.|++.+....   ...+.+||+.|||||++.+..++.++||||+||++|||++|+.||.
T Consensus       138 DiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  217 (293)
T d1jksa_         138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  217 (293)
T ss_dssp             CCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence                    22221   247888887654332   2345789999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +.+..+.+..+....+.++    ...+..+++||++||..||.+|||++|+++||||++.
T Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             CSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999888888766554    4688999999999999999999999999999999854

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-44  Score=304.17  Aligned_cols=198  Identities=20%  Similarity=0.277  Sum_probs=162.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+++.+|||||||+||+|..++.....+   .+..+ ....++..++.|+|..|+.|+
T Consensus        63 ~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l---~e~~~~~i~~qi~~aL~yLH~~~iiHr  139 (309)
T d1u5ra_          63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL---QEVEIAAVTHGALQGLAYLHSHNMIHR  139 (309)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCC---CHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            47999999999999999999999999999999999999997776655444   22222 233456788999998887554


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCCcccccCCCccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANKNTLCGTPNYIAPEILNK---NGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                             +.+.++.+++.||+.+.......+.+||+.|||||++.+   +.|+.++||||+||++|||++|..||.+.+.
T Consensus       140 DiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~  219 (309)
T d1u5ra_         140 DVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (309)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             CCCcceEEECCCCCEEEeecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence                   233456788899987766666678899999999999864   3588999999999999999999999999888


Q ss_pred             HHHHHHHhccccC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         151 KETYSRIKKVEYK--LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       151 ~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+....+.....+  .+...++++++||.+||+.||.+|||++|+++||||...
T Consensus       220 ~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            8777766554332  234578999999999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-43  Score=307.01  Aligned_cols=199  Identities=24%  Similarity=0.377  Sum_probs=163.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++|+|||||+++++|++++.+|||||||+||+|.+++.....  .+.+..+..+ .+++.++.|+|+.|+.|+
T Consensus        71 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~iiHr  148 (350)
T d1koaa2          71 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHL  148 (350)
T ss_dssp             HHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeee
Confidence            5899999999999999999999999999999999999999998854321  1233333333 345788999998876443


Q ss_pred             --------ecC-CCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LND-DSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~~-~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +.. .++.+++.||+.+..+..   ..+.+||+.|||||++.+..|+.++||||+||++|||++|++||.+.
T Consensus       149 DiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  228 (350)
T d1koaa2         149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  228 (350)
T ss_dssp             CCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence                    332 245688889876544332   23578999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +..+.+..|....+.++    ..+++++++||.+||..||.+|||++|+++||||+..
T Consensus       229 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         229 NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             SHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99998888887766554    3588999999999999999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.4e-43  Score=305.43  Aligned_cols=199  Identities=23%  Similarity=0.360  Sum_probs=163.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++|+|||||+++++|++++.+|||||||+||+|.+.+.....  .+.+..+.. +..++.++.|+|+.|+.|+
T Consensus        74 ~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~iiHR  151 (352)
T d1koba_          74 KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHSIVHL  151 (352)
T ss_dssp             HHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            5799999999999999999999999999999999999999987654321  123333333 3445788999998876443


Q ss_pred             --------ecC-CCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LND-DSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~~-~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +.. ..+.+++.||+.+..+..   ..+.+||+.|||||++.+..|+.++||||+||++|||++|++||.+.
T Consensus       152 DiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  231 (352)
T d1koba_         152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE  231 (352)
T ss_dssp             CCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             ccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                    321 345688888876554332   23568999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         149 TLKETYSRIKKVEYKLP----ATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      +..+.+..+....+.+|    ..+++++.+||.+||++||.+|||++|+++||||+..
T Consensus       232 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         232 DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99998888887766554    4688999999999999999999999999999999853

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=303.32  Aligned_cols=198  Identities=22%  Similarity=0.314  Sum_probs=152.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhh-hCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDK-YGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~   79 (305)
                      .+|+.+|++++|||||+++++|++++.+|||||||+||+|.+++.+...+   .+..... ..+++.++.|+|. .++.|
T Consensus        52 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l---~~~~~~~~~~qil~aL~yLH~~~~IiH  128 (322)
T d1s9ja_          52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGLTYLREKHKIMH  128 (322)
T ss_dssp             HHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCC---CHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            48999999999999999999999999999999999999999999876554   3333333 3355788888885 57654


Q ss_pred             e-------ecCCCCCeeEcchhHHHHh--cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIML--ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL  150 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~  150 (305)
                      +       +.+..+.+++.||+.+...  ....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+.
T Consensus       129 RDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             SCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             cccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            3       3344567899999755433  334578999999999999999999999999999999999999999977543


Q ss_pred             HHHHH------------------------------------------HHhcc-ccCCCC-CCCHHHHHHHHHHhhcCCCC
Q psy6191         151 KETYS------------------------------------------RIKKV-EYKLPA-TLKKPAATMIKKMLLLDPVQ  186 (305)
Q Consensus       151 ~~~~~------------------------------------------~i~~~-~~~~~~-~~~~~~~~li~~~l~~dp~~  186 (305)
                      .+...                                          .+... .+..|. ..+.++.+||.+||+.||.+
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~  288 (322)
T d1s9ja_         209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE  288 (322)
T ss_dssp             THHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhH
Confidence            22110                                          01100 011121 35788999999999999999


Q ss_pred             CCCHhhhhcCcccccc
Q psy6191         187 RPPVAQLLHFEFFNDY  202 (305)
Q Consensus       187 R~~~~~~l~~~~~~~~  202 (305)
                      |||++|+|+||||+..
T Consensus       289 R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         289 RADLKQLMVHAFIKRS  304 (322)
T ss_dssp             SCCHHHHHTSHHHHHH
T ss_pred             CcCHHHHhhCHhhCcC
Confidence            9999999999999753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-43  Score=300.04  Aligned_cols=196  Identities=23%  Similarity=0.403  Sum_probs=165.2

Q ss_pred             hHHHHH-hcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCcee
Q psy6191           3 QEIAIH-RSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         3 ~Ei~il-~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   80 (305)
                      +|+.++ +.++|||||++++++++++.+|||||||+||+|.+++.....+.   +..+. ....++.++.|+|+.++.|+
T Consensus        51 ~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~---e~~~~~~~~qi~~al~ylH~~~iiHr  127 (320)
T d1xjda_          51 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD---LSRATFYAAEIILGLQFLHSKGIVYR  127 (320)
T ss_dssp             HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCC---HHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCC---HHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            466665 47999999999999999999999999999999999998766553   22222 23446788999998886553


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc----CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA----NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETST  149 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~  149 (305)
                             +.+..+.+++.||+.+....    .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+
T Consensus       128 Dikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence                   33445678888887654322    2345689999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHh-hhhcCccccc
Q psy6191         150 LKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVA-QLLHFEFFND  201 (305)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~-~~l~~~~~~~  201 (305)
                      ..++...+....+.+|..+++++++||++||++||.+|||+. ++++||||++
T Consensus       208 ~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         208 EEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            999999999888999999999999999999999999999996 8999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-42  Score=301.03  Aligned_cols=197  Identities=22%  Similarity=0.409  Sum_probs=169.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++++.+.+|+|||||.||+|.+.+.....+   .+..+.. +.++..++.|+|..++.|+
T Consensus        89 ~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l---~e~~~~~i~~qi~~aL~yLH~~~iiHR  165 (350)
T d1rdqe_          89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLHSLDLIYR  165 (350)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCC---CHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            47999999999999999999999999999999999999999999876554   2333333 3445788999998876443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc-CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA-NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETSTLKE  152 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~~~  152 (305)
                             +.+..+.+++.||+.+..+. ...+.+||+.|||||++.+..|+.++||||+||++|||++|++||.+.+...
T Consensus       166 DIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~  245 (350)
T d1rdqe_         166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ  245 (350)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cCCHHHcccCCCCCEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH
Confidence                   33445678889987665443 2356789999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCccccc
Q psy6191         153 TYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFND  201 (305)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~  201 (305)
                      ...+|....+.+|..+++++.++|++||++||.+|+     |++++++||||++
T Consensus       246 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence            999999888889999999999999999999999995     8999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.3e-42  Score=289.01  Aligned_cols=198  Identities=26%  Similarity=0.503  Sum_probs=162.6

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+.+|++++ |||||++++++++++.+|||||||+||||.+++...+.+   .+..+..+ .++.+++.|+|..|+.|
T Consensus        57 ~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l---~e~~~~~~~~qi~~al~~lH~~~ivH  133 (277)
T d1phka_          57 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL---SEKETRKIMRALLEVICALHKLNIVH  133 (277)
T ss_dssp             HHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSC---CHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCCcc
Confidence            47999999997 999999999999999999999999999999999876654   33333333 45678899999887644


Q ss_pred             e-------ecCCCCCeeEcchhHHHHhcC---CcccccCCCccccccccc------CCCCccchHHHHHHHHHHHHhCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNK------NGHSFEVDVWSIGCIMYTLLVGKP  143 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~------~~~~~~~DiwSlGvilye~l~g~~  143 (305)
                      .       +.+.++.+++.||+....+..   ....+||+.|+|||++.+      ..++.++||||+||++|||++|+.
T Consensus       134 rDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~  213 (277)
T d1phka_         134 RDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP  213 (277)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence            3       334456788888876544332   345789999999998852      346889999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         144 PFETSTLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||.+.+..+....+....+.++.    .+|+++++||.+||+.||.+|||++|+++||||+.+
T Consensus       214 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         214 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             SSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            99999988888888776654443    689999999999999999999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-43  Score=298.36  Aligned_cols=198  Identities=23%  Similarity=0.383  Sum_probs=163.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++|++++.+|||||||+||+|.+++.....  .+.+..+.. +..+..++.|+|+.|+.|+
T Consensus        49 ~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~iiHr  126 (321)
T d1tkia_          49 KKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHNIGHF  126 (321)
T ss_dssp             HHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCCcc
Confidence            5899999999999999999999999999999999999999999865431  123333333 3345788999998876443


Q ss_pred             --------ecC-CCCCeeEcchhHHHHhcC---CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 --------LND-DSSGVMFNDLTRMIMLAN---KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 --------~~~-~~~~v~~~d~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                              +.. +...+++.||+.......   ..+.+||+.|+|||++.+..|+.++||||+||++|+|++|.+||.+.
T Consensus       127 DlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~  206 (321)
T d1tkia_         127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             CCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence                    222 233577788875543322   23568999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         149 TLKETYSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +..+.+..|.+..+.+|.    .++.++++||++||++||.+|||++|+++||||+.
T Consensus       207 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         207 TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             CHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            999999999887776654    68999999999999999999999999999999974

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-41  Score=295.67  Aligned_cols=196  Identities=18%  Similarity=0.256  Sum_probs=158.7

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-   80 (305)
                      +|+++++.++|||||+++++|++++.+|||||||+||+|.+++.+...+   .+..+..+ ..++.++.|+|..++.|+ 
T Consensus        56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~---~e~~~~~~~~qi~~aL~ylH~~~iiHrD  132 (364)
T d1omwa3          56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEHMHNRFVVYRD  132 (364)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSC---CHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccc---cHHHHHHHHHHHHHHHHHHHHCCcccee
Confidence            3578888999999999999999999999999999999999999876554   22233333 345788999998876543 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC--CcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN--KNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVGKPPFETSTL-  150 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~--~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~g~~Pf~~~~~-  150 (305)
                            +.+..+.+++.||+.+..+..  ..+.+||+.|||||++. +..|+.++||||+||++|||++|++||.+.+. 
T Consensus       133 lKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~  212 (364)
T d1omwa3         133 LKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  212 (364)
T ss_dssp             CSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred             eccceeEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence                  334456788899886554332  34678999999999986 45689999999999999999999999986543 


Q ss_pred             --HHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhhhhcCccccc
Q psy6191         151 --KETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPP-----VAQLLHFEFFND  201 (305)
Q Consensus       151 --~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~-----~~~~l~~~~~~~  201 (305)
                        ......+....+.+|..+++++++||.+||++||.+|||     ++|+++||||++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         213 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             CHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence              344455556667778889999999999999999999999     799999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-41  Score=287.95  Aligned_cols=198  Identities=18%  Similarity=0.300  Sum_probs=156.3

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||++++++++++.+|||||||.||++..+......+   .+..+..+ .++..++.|+|+.|+.|+
T Consensus        48 ~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l---~~~~~~~~~~qil~aL~~lH~~~iiHr  124 (299)
T d1ua2a_          48 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL---TPSHIKAYMLMTLQGLEYLHQHWILHR  124 (299)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSC---CSSHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCC---CHHHHHHHHHHHHHHHHHhhccceecc
Confidence            47999999999999999999999999999999999998777665433333   33333333 346788999998887554


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+..+.+++.||+.+.....    ..+.+||+.|||||++.+ ..|+.++||||+||++|||++|.+||.+.
T Consensus       125 DiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             CCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence                   334556788999987654432    235689999999998864 56899999999999999999999999998


Q ss_pred             CHHHHHHHHhccccC----------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         149 TLKETYSRIKKVEYK----------------------------LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       149 ~~~~~~~~i~~~~~~----------------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      +..+.+.+|......                            .....++++.+||.+||+.||++|||++|+|+||||+
T Consensus       205 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             CHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence            888877666431100                            0124678899999999999999999999999999998


Q ss_pred             cc
Q psy6191         201 DY  202 (305)
Q Consensus       201 ~~  202 (305)
                      +.
T Consensus       285 ~~  286 (299)
T d1ua2a_         285 NR  286 (299)
T ss_dssp             SS
T ss_pred             CC
Confidence            63

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=293.63  Aligned_cols=199  Identities=21%  Similarity=0.412  Sum_probs=152.1

Q ss_pred             hhHHHHHhc-CCCCCccceeEEEEc----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhh
Q psy6191           2 SQEIAIHRS-LKHRNVVGFHSFFED----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~-l~HpnIV~l~~~~~~----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~   75 (305)
                      .+|+.++.+ ++|||||+++++|++    +..+|||||||+||+|.+++...+.. .+.+..+.. +..++.++.|+|+.
T Consensus        52 ~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~-~l~e~~~~~i~~qi~~al~ylH~~  130 (335)
T d2ozaa1          52 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSI  130 (335)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCC-CEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCC-CcCHHHHHHHHHHHHHHHHHHHHc
Confidence            589998754 589999999999986    56799999999999999999764321 123333333 33457889999988


Q ss_pred             CCcee--------ecC--CCCCeeEcchhHHHHhc---CCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCC
Q psy6191          76 GFGYQ--------LND--DSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        76 ~~~~~--------~~~--~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                      |+.|+        +.+  ....+++.||+.+....   ...+.+||+.|||||++.+..|+.++||||+||++|+|++|+
T Consensus       131 ~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~  210 (335)
T d2ozaa1         131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY  210 (335)
T ss_dssp             TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSS
T ss_pred             CCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCC
Confidence            76543        222  12357888887654332   234678999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHH----HHHHhccccCCCC----CCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         143 PPFETSTLKET----YSRIKKVEYKLPA----TLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       143 ~Pf~~~~~~~~----~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +||.+.+..+.    ...+....+.+|.    .+++++++||++||+.||.+|||+.|+++||||..
T Consensus       211 ~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         211 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             CSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            99987654333    3344555555553    47889999999999999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=279.48  Aligned_cols=191  Identities=19%  Similarity=0.343  Sum_probs=153.9

Q ss_pred             hhHHHHHhcCC--CCCccceeEEEEcCCeEEEEEeccCC-CCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLK--HRNVVGFHSFFEDSKFVYIILELCRK-RSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~--HpnIV~l~~~~~~~~~~ylVmEy~~~-g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   77 (305)
                      .+|+.+|++++  |||||+++++|++++.+|+|||||.+ +++.+++.....+   .+..+. .+.++.+++.|+|+.++
T Consensus        55 ~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l---~e~~~~~~~~qi~~al~~lH~~~i  131 (273)
T d1xwsa_          55 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL---QEELARSFFWQVLEAVRHCHNCGV  131 (273)
T ss_dssp             EHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSC---CHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCC---CHHHHHHHHHHHHHHHHHHHHCCC
Confidence            47999999987  89999999999999999999999986 6888888776554   233333 33456788999998776


Q ss_pred             cee--------ecCCCCCeeEcchhHHHHhc--CCcccccCCCcccccccccCC-CCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          78 GYQ--------LNDDSSGVMFNDLTRMIMLA--NKNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        78 ~~~--------~~~~~~~v~~~d~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      .|+        +..+...+++.||+.+....  ...+.+||+.|||||++.+.. ++.++||||+||++|||++|+.||.
T Consensus       132 iHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  211 (273)
T d1xwsa_         132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  211 (273)
T ss_dssp             ECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence            443        33344567888887654322  235678999999999998665 4677999999999999999999997


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccccc
Q psy6191         147 TSTLKETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFND  201 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~  201 (305)
                      +.+      .+......++..+|+++++||++||+.||.+|||++|+++||||++
T Consensus       212 ~~~------~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         212 HDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             SHH------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             Cch------HHhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            632      3455667788899999999999999999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-40  Score=276.74  Aligned_cols=195  Identities=17%  Similarity=0.222  Sum_probs=151.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee-
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ-   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (305)
                      .+|+++|++++|||||+++++++++ ..|||||||++|+|.+++.....+.+  .........++.++.|+|+.++.|+ 
T Consensus        56 ~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~--~~~~~i~~qi~~gl~ylH~~~iiHrD  132 (277)
T d1xbba_          56 LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLEESNFVHRD  132 (277)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCH--HHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCH--HHHHHHHHHHHHHHhhHHhCCcccCC
Confidence            4899999999999999999999765 57999999999999999887554421  1122333456788999998775432 


Q ss_pred             ------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 ------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 ------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                            +.+..+.+++.||+.+..+..       .....||+.|||||++.+..++.++|||||||++|||++ |++||.
T Consensus       133 lKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~  212 (277)
T d1xbba_         133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  212 (277)
T ss_dssp             CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence                  222335566777764432211       124579999999999998889999999999999999998 899999


Q ss_pred             CCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh---cCccc
Q psy6191         147 TSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL---HFEFF  199 (305)
Q Consensus       147 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l---~~~~~  199 (305)
                      +.+..+....+.+. .++.|...+.++.+||.+||..||.+|||+++++   +++|+
T Consensus       213 ~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         213 GMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            98888887777664 4567788999999999999999999999999984   56554

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-39  Score=273.68  Aligned_cols=193  Identities=17%  Similarity=0.218  Sum_probs=149.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+++.+|||||||+||+|.+++......  +.... ......++.++.|+|..++.|+
T Consensus        75 ~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~--l~~~~~~~i~~qia~gl~yLH~~~iiHr  152 (299)
T d1jpaa_          75 LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIAAGMKYLADMNYVHR  152 (299)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTC--SCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCC--CCHHHHHHHHHHHHHHHHHHhhCCCccC
Confidence            48999999999999999999999999999999999999999988754321  12222 2233456788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC---------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK---------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKP  143 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~---------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~  143 (305)
                             +.+....+++.||+.+..+...         ....||+.|||||++.++.|+.++|||||||++|||+| |++
T Consensus       153 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~  232 (299)
T d1jpaa_         153 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER  232 (299)
T ss_dssp             CCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCC
Confidence                   3344567889999865543221         12468999999999998999999999999999999998 899


Q ss_pred             CCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         144 PFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       144 Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||.+.+..+....+... ..+.|...+..+.+|+.+||..||.+|||+.|+++.
T Consensus       233 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         233 PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99998888887777654 345677889999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-39  Score=268.58  Aligned_cols=193  Identities=16%  Similarity=0.251  Sum_probs=147.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCC-cCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++.+++.+|||||||++|+|.+++......  ... ........++.++.|.|..++.|+
T Consensus        48 ~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~--~~~~~~~~i~~qia~gl~~lH~~~iiHr  125 (263)
T d1sm2a_          48 IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHR  125 (263)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCT
T ss_pred             HHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccC--CCHHHHHHHHHHHHHHHHhhhccceeec
Confidence            58999999999999999999999999999999999999999988654321  111 122334456788889888776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.......     .....||+.|||||++.+..|+.++||||+||++|||+| |.+||..
T Consensus       126 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~  205 (263)
T d1sm2a_         126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  205 (263)
T ss_dssp             TCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             ccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence                   333446788888875543322     234579999999999999999999999999999999999 6788888


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+... ....|...++++.+++.+||+.||.+|||++|++++
T Consensus       206 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         206 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            8887777777654 344567788999999999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-38  Score=268.52  Aligned_cols=199  Identities=20%  Similarity=0.311  Sum_probs=151.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++|++++.+|||||||.++.+ +++..... ..+.+..+.. ..+++.++.|+|+.++.|+
T Consensus        49 ~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~-~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~~IiHr  126 (298)
T d1gz8a_          49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK-KFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHRVLHR  126 (298)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH-HHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchh-hhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcCCEEcc
Confidence            4799999999999999999999999999999999986544 44432211 1123333333 3345788999998887543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+....+++.||+.+.....    ....+||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.
T Consensus       127 DiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             CCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence                   334456788899987765533    23458999999999876554 588999999999999999999999988


Q ss_pred             CHHHHHHHHhcccc------------------CC-----------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKVEY------------------KL-----------PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~~~------------------~~-----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +..+...++.....                  ..           ...++.++.+||++||+.||.+|||++|+++||||
T Consensus       207 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff  286 (298)
T d1gz8a_         207 SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF  286 (298)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             CHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence            87776655432100                  00           12457889999999999999999999999999999


Q ss_pred             ccc
Q psy6191         200 NDY  202 (305)
Q Consensus       200 ~~~  202 (305)
                      ++.
T Consensus       287 ~~~  289 (298)
T d1gz8a_         287 QDV  289 (298)
T ss_dssp             TTC
T ss_pred             ccC
Confidence            863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-40  Score=275.63  Aligned_cols=196  Identities=17%  Similarity=0.240  Sum_probs=153.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||+++++++++ .+|||||||+||+|.+++.....  .++... ...+..++.++.|+|+.++.|+
T Consensus        57 ~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~iiHr  133 (285)
T d1u59a_          57 MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHR  133 (285)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            4899999999999999999999764 58999999999999998753321  122222 2233456788999998775433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+.+..+..       ....+||+.|||||++.++.++.++||||+||++|||+| |++||
T Consensus       134 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf  213 (285)
T d1u59a_         134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY  213 (285)
T ss_dssp             CCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCC
Confidence                   223345677888875443221       234579999999999998899999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhh---hcCcccc
Q psy6191         146 ETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQL---LHFEFFN  200 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~---l~~~~~~  200 (305)
                      .+.+..+....+..+ .+..|..+++++.+||.+||..||++|||+.++   |+++|++
T Consensus       214 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         214 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            988877877777664 356778899999999999999999999999887   5677765

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=279.62  Aligned_cols=195  Identities=17%  Similarity=0.268  Sum_probs=150.8

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-C-------------------CCCCcCc-
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-E-------------------EMSDPAA-   59 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-~-------------------~~~~~~~-   59 (305)
                      .+|+.+|+++ +|||||++++++++++.+|||||||+||+|.+++...... .                   .+..... 
T Consensus        88 ~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  167 (325)
T d1rjba_          88 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL  167 (325)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHH
T ss_pred             HHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHH
Confidence            4799999998 8999999999999999999999999999999999764321 0                   0111111 


Q ss_pred             hhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccc
Q psy6191          60 QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEV  126 (305)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~  126 (305)
                      .....+.+++.|+|..++.|+       +.+....+++.||+.+.....      ..+.+||+.|||||++.++.|+.++
T Consensus       168 ~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~  247 (325)
T d1rjba_         168 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS  247 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcce
Confidence            122345778888887775443       233446788889876543322      1356789999999999999999999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc--ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         127 DVWSIGCIMYTLLV-GKPPFETSTLKETYSRIKKV--EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       127 DiwSlGvilye~l~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||||+||++|||++ |++||.+.+..+.+..+...  .++.|...++++++||.+||+.||.+|||++|+++|
T Consensus       248 DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             eccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999998 89999887665555444333  345677899999999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-39  Score=273.04  Aligned_cols=199  Identities=21%  Similarity=0.302  Sum_probs=148.6

Q ss_pred             hhHHHHHhcC---CCCCccceeEEEEc-----CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHh
Q psy6191           2 SQEIAIHRSL---KHRNVVGFHSFFED-----SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l---~HpnIV~l~~~~~~-----~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   72 (305)
                      .+|+.+|+.|   +|||||+++++|..     ...+|+|||||++|++........  ..+.+.... .+.++..++.|+
T Consensus        55 ~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yL  132 (305)
T d1blxa_          55 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFL  132 (305)
T ss_dssp             HHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHH
Confidence            3788888776   79999999999863     357999999999987654433221  112222222 334457889999


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHh---cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCC
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIML---ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                      |..++.|+       +.+..+.+++.||+.....   ....+.+||+.|||||++.+..|+.++||||+||++|||++|+
T Consensus       133 H~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~  212 (305)
T d1blxa_         133 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK  212 (305)
T ss_dssp             HHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             HhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCC
Confidence            98876553       2333456667776543221   2234678999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhccc---------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         143 PPFETSTLKETYSRIKKVE---------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +||.+.+..+.+..+....                           ..++..+++.+.+||.+||++||.+|||++|+++
T Consensus       213 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         213 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            9999988877766653210                           1123457889999999999999999999999999


Q ss_pred             Ccccccc
Q psy6191         196 FEFFNDY  202 (305)
Q Consensus       196 ~~~~~~~  202 (305)
                      ||||++.
T Consensus       293 Hpff~~i  299 (305)
T d1blxa_         293 HPYFQDL  299 (305)
T ss_dssp             SGGGTTC
T ss_pred             ChhhcCc
Confidence            9999863

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.7e-39  Score=270.48  Aligned_cols=196  Identities=18%  Similarity=0.290  Sum_probs=140.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   76 (305)
                      .+|+++|++++|||||++++++++++    .+|||||||+||+|.+++.....+.   +..+ ..+.++.+++.|+|+.|
T Consensus        55 ~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~---~~~~~~i~~qi~~al~~lH~~~  131 (277)
T d1o6ya_          55 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEVIADACQALNFSHQNG  131 (277)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCC---HHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCC---HHHHHHHHHHHHHHHHHHHhCC
Confidence            58999999999999999999998754    4899999999999999887765542   2222 33345578899999877


Q ss_pred             Cceeec-------CCCCCeeEcchhHHHH-------hcCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCC
Q psy6191          77 FGYQLN-------DDSSGVMFNDLTRMIM-------LANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        77 ~~~~~~-------~~~~~v~~~d~~~~~~-------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~  142 (305)
                      +.|+-.       +....+++.|++....       .....+.+||+.|||||++.+..|+.++||||+||++|||++|+
T Consensus       132 iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~  211 (277)
T d1o6ya_         132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE  211 (277)
T ss_dssp             EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCC
Confidence            544311       1223334444432111       11234568999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhccccCC----CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccc
Q psy6191         143 PPFETSTLKETYSRIKKVEYKL----PATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFN  200 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~  200 (305)
                      +||.+.+..+...++....+..    +..+++.+.++|.+||++||.+||+..+.+.|+|.+
T Consensus       212 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         212 PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999988888776665544432    346889999999999999999999544444466653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-39  Score=265.85  Aligned_cols=193  Identities=19%  Similarity=0.237  Sum_probs=156.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCC-cCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSD-PAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.++++++|||||++++++.+++.+|+|||||++|+|.+++......  ... ........+++++.|+|..++.|.
T Consensus        47 ~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~--~~~~~~~~i~~qi~~gl~~LH~~~iiH~  124 (258)
T d1k2pa_          47 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQFLHR  124 (258)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGC--CCHHHHHHHHHHHHHHHHHHHHTTBCCS
T ss_pred             HHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccC--CcHHHHHHHHHHHHHHHHHHhhcCcccc
Confidence            48999999999999999999999999999999999999999987544321  111 122333456788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.|++....+..     ....+||+.|||||++.+..++.++||||+||++|||+| |+.||.+
T Consensus       125 dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~  204 (258)
T d1k2pa_         125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER  204 (258)
T ss_dssp             CCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence                   334456788888876543221     224679999999999999999999999999999999998 8999999


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+... ....|...+.++.+||.+||+.||.+|||++++++|
T Consensus       205 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         205 FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9988888888765 345667788999999999999999999999999876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-38  Score=268.39  Aligned_cols=193  Identities=20%  Similarity=0.304  Sum_probs=150.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+++.+|||||||++|+|.+++...... .+.+... ....+++.++.|+|..++.|+
T Consensus        61 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~-~~~~~~~~~i~~qi~~gL~yLH~~~iiHr  139 (287)
T d1opja_          61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFIHR  139 (287)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcccc-chHHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            58999999999999999999999999999999999999999998754321 1222222 223456788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC-----cccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCC-CCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK-----NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKP-PFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~-----~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~-Pf~~  147 (305)
                             +.+....+++.||+.+......     ....||+.|||||++.++.|+.++||||+||++|||++|.. ||.+
T Consensus       140 DlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~  219 (287)
T d1opja_         140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  219 (287)
T ss_dssp             CCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence                   3334467788888766543222     23458999999999999999999999999999999999655 5566


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      .+..+....+... .+..|...++++.+||.+||+.||.+|||++|+++
T Consensus       220 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            6666666655443 45667789999999999999999999999999965

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-39  Score=268.88  Aligned_cols=192  Identities=18%  Similarity=0.277  Sum_probs=142.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++. ++.+|||||||+||+|.+++......  +... .......+++++.|+|..++.|+
T Consensus        52 ~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~--~~~~~~~~i~~qi~~gl~yLH~~~ivHr  128 (276)
T d1uwha_          52 KNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHR  128 (276)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHhcCCEecc
Confidence            47999999999999999999864 56789999999999999998654221  1222 22233456788999998776543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhc------CCcccccCCCccccccccc---CCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLA------NKNTLCGTPNYIAPEILNK---NGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~------~~~~~~Gt~~y~aPE~~~~---~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                             +.+....+++.||+.+....      ...+.+||+.|||||++.+   ..|+.++||||+||++|||+||+.|
T Consensus       129 DlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~P  208 (276)
T d1uwha_         129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP  208 (276)
T ss_dssp             CCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCC
Confidence                   33445678888887543221      2245789999999999864   3478999999999999999999999


Q ss_pred             CCCCCHHHHH-HHHhccc-----cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         145 FETSTLKETY-SRIKKVE-----YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       145 f~~~~~~~~~-~~i~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      |.+.+..... ..+....     ...+...++++.+++.+||..||.+|||+.|++++
T Consensus       209 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         209 YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9886554433 3333321     12355678899999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=266.66  Aligned_cols=192  Identities=21%  Similarity=0.305  Sum_probs=146.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||++++++. ++.+|||||||++|+|.+++......  +... .......++.++.|+|+.++.|+
T Consensus        56 ~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~--l~~~~~~~~~~qi~~gl~ylH~~~iiHr  132 (273)
T d1mp8a_          56 LQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESKRFVHR  132 (273)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTT--SCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCC--CCHHHHHHHHHHHHHHhhhhcccCeecc
Confidence            47999999999999999999996 46799999999999999987653321  1221 22233456788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.+..+..     ....+||+.|||||++.+..|+.++||||+||++|||++ |.+||.+
T Consensus       133 DlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~  212 (273)
T d1mp8a_         133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  212 (273)
T ss_dssp             CCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence                   223345678888876554322     235578999999999999999999999999999999998 8999999


Q ss_pred             CCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         148 STLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       148 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .+..+....+.... .++|...++++.+||.+||..||.+|||+.|++++
T Consensus       213 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         213 VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            88888887776654 56788899999999999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-39  Score=268.84  Aligned_cols=197  Identities=16%  Similarity=0.308  Sum_probs=152.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+ +.+|||||||++|+|.+++...... .+... .......+.+++.|+|..++.|+
T Consensus        56 ~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~-~l~~~~~~~i~~qi~~gl~~lH~~~ivHr  133 (272)
T d1qpca_          56 LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR  133 (272)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            589999999999999999998754 5689999999999999876433211 11211 22333455788888887775433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-----CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-----KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-----~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~  147 (305)
                             +.+....+++.||+.+..+..     .....||+.|||||++.++.++.++||||+||++|||+| |.+||..
T Consensus       134 DiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~  213 (272)
T d1qpca_         134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (272)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence                   334456788888876544322     234679999999999998889999999999999999999 5667777


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc--Ccccc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH--FEFFN  200 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~--~~~~~  200 (305)
                      .+..+....+... ....|...+.++.+|+.+||+.||++|||++++++  ++||+
T Consensus       214 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         214 MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            7777777777654 44567789999999999999999999999999987  77875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-37  Score=263.15  Aligned_cols=197  Identities=23%  Similarity=0.323  Sum_probs=152.1

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||++++++++++..|+||||+.++++..+......+   .+..+..+ ..+..++.|+|..++.|+
T Consensus        48 ~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l---~~~~~~~i~~qi~~~L~~LH~~~IvHr  124 (286)
T d1ob3a_          48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGL---ESVTAKSFLLQLLNGIAYCHDRRVLHR  124 (286)
T ss_dssp             HHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCC---CHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCc---chhhhHHHHHHHHHHHHHhccCcEEec
Confidence            48999999999999999999999999999999999988777766544333   33333333 345788899998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPFETS  148 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf~~~  148 (305)
                             +.+....+++.|++.+.....    ....+||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.
T Consensus       125 DiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             CCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence                   334456788899987766543    235579999999999865 45799999999999999999999999988


Q ss_pred             CHHHHHHHHhccc-----------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCccc
Q psy6191         149 TLKETYSRIKKVE-----------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFF  199 (305)
Q Consensus       149 ~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~  199 (305)
                      +..+...++....                             ...+..+++.+++||++||+.||++|||++|+++||||
T Consensus       205 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f  284 (286)
T d1ob3a_         205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (286)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             CHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            8777666543210                             01234567889999999999999999999999999999


Q ss_pred             cc
Q psy6191         200 ND  201 (305)
Q Consensus       200 ~~  201 (305)
                      ++
T Consensus       285 ~~  286 (286)
T d1ob3a_         285 KE  286 (286)
T ss_dssp             GC
T ss_pred             Cc
Confidence            74

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-38  Score=263.70  Aligned_cols=195  Identities=22%  Similarity=0.298  Sum_probs=147.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEE-cCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFE-DSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~-~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|++++++++|||||++++++. +++.+|||||||++|+|.+++.......--..........++.++.|.|..++.|.
T Consensus        48 ~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~  127 (262)
T d1byga_          48 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR  127 (262)
T ss_dssp             HHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceecc
Confidence            48999999999999999999885 45679999999999999999865422100011222334456788999998776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh-cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML-ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFETSTLK  151 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~~~~~~  151 (305)
                             +.+....+++.|++..... ....+.+||+.|||||++.+..++.++|||||||++|||++ |++||...+..
T Consensus       128 dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~  207 (262)
T d1byga_         128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  207 (262)
T ss_dssp             CCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred             ccchHhheecCCCCEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence                   3344556778887655432 22345689999999999998899999999999999999998 79999988888


Q ss_pred             HHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         152 ETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       152 ~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +....+.. ..+++|...++++.+||.+||..||.+|||+.+++++
T Consensus       208 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         208 DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             GHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            88777765 4567788899999999999999999999999999763

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=261.75  Aligned_cols=199  Identities=16%  Similarity=0.287  Sum_probs=150.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||++++++.+ +.+|+|||||++|+|..++.....- .+... .......++.++.|+|..++.|.
T Consensus        60 ~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~ivH~  137 (285)
T d1fmka3          60 LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMNYVHR  137 (285)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhheecc
Confidence            589999999999999999999855 5689999999999999887543211 11222 22334456788999998876443


Q ss_pred             -------ecCCCCCeeEcchhHHHHh-----cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIML-----ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVG-KPPFET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g-~~Pf~~  147 (305)
                             +.+....+++.||+.+...     ......+||+.|||||++.++.++.++||||+||++|||++| .+||.+
T Consensus       138 DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~  217 (285)
T d1fmka3         138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  217 (285)
T ss_dssp             CCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence                   2333456778888654322     122346799999999999999999999999999999999995 666677


Q ss_pred             CCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc--Ccccccc
Q psy6191         148 STLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH--FEFFNDY  202 (305)
Q Consensus       148 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~--~~~~~~~  202 (305)
                      .+..+....+... ..+.|...+.+++++|.+||+.||++|||+++++.  ++||+..
T Consensus       218 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            7777777776544 45677889999999999999999999999999987  7787653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-37  Score=266.26  Aligned_cols=201  Identities=21%  Similarity=0.364  Sum_probs=149.2

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~   74 (305)
                      .+|+++|++++|||||+++++|..      +.++|||||||++|.+..+.........+.+..++. ..+++.++.|+|.
T Consensus        61 ~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~  140 (350)
T d1q5ka_          61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS  140 (350)
T ss_dssp             CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            589999999999999999999853      346899999998775544433222222233333333 3345788999998


Q ss_pred             hCCcee--------ecCCCCCeeEcchhHHHHhc---CCcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCC
Q psy6191          75 YGFGYQ--------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGK  142 (305)
Q Consensus        75 ~~~~~~--------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~  142 (305)
                      .|+.|+        +..+...+++.||+......   ...+.+||+.|+|||++.+ ..|+.++||||+||++|||++|+
T Consensus       141 ~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~  220 (350)
T d1q5ka_         141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ  220 (350)
T ss_dssp             TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTS
T ss_pred             cCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCC
Confidence            876443        33333467788887554332   2346789999999998764 56899999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhcc-----------------ccC------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhhh
Q psy6191         143 PPFETSTLKETYSRIKKV-----------------EYK------------LPATLKKPAATMIKKMLLLDPVQRPPVAQL  193 (305)
Q Consensus       143 ~Pf~~~~~~~~~~~i~~~-----------------~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~  193 (305)
                      +||...+..+.+..+.+.                 ...            .....++++.+||.+||++||.+|||+.|+
T Consensus       221 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  300 (350)
T d1q5ka_         221 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA  300 (350)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            999988877665554321                 001            123467889999999999999999999999


Q ss_pred             hcCcccccc
Q psy6191         194 LHFEFFNDY  202 (305)
Q Consensus       194 l~~~~~~~~  202 (305)
                      ++||||++.
T Consensus       301 L~Hp~f~~~  309 (350)
T d1q5ka_         301 CAHSFFDEL  309 (350)
T ss_dssp             HTSGGGGGG
T ss_pred             hcCHhhccc
Confidence            999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-37  Score=261.34  Aligned_cols=198  Identities=26%  Similarity=0.417  Sum_probs=155.0

Q ss_pred             hhHHHHHhcCCC-CCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKH-RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~H-pnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++|++++| ||||+++++++++..+|+|||||.||+|.+.+.......   +.... .+.++..++.|+|+.++.|
T Consensus        76 ~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~---e~~~~~~~~Qi~~al~~lH~~~ivH  152 (322)
T d1vzoa_          76 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQIYVGEIVLALEHLHKLGIIY  152 (322)
T ss_dssp             CCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCC---HHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccccc---HHHHHHHHHHHHHHHHHhhcCCEEe
Confidence            479999999977 899999999999999999999999999999998776542   22222 2334577888888877654


Q ss_pred             e-------ecCCCCCeeEcchhHHHH-----hcCCcccccCCCcccccccccC--CCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          80 Q-------LNDDSSGVMFNDLTRMIM-----LANKNTLCGTPNYIAPEILNKN--GHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        80 ~-------~~~~~~~v~~~d~~~~~~-----~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      +       +.+..+.+++.||+.+..     .....+.+||+.|+|||.+.+.  .++.++||||+||+||||++|+.||
T Consensus       153 rDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF  232 (322)
T d1vzoa_         153 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF  232 (322)
T ss_dssp             CCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence            3       334456788888864432     2223467899999999998654  4688999999999999999999999


Q ss_pred             CCCCHH----HHHHHHhccccCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhhhhcCcccccc
Q psy6191         146 ETSTLK----ETYSRIKKVEYKLPATLKKPAATMIKKMLLLDPVQRP-----PVAQLLHFEFFNDY  202 (305)
Q Consensus       146 ~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----~~~~~l~~~~~~~~  202 (305)
                      .+.+..    ..........+++|...++++.+||++||++||.+||     |++|+++||||++.
T Consensus       233 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         233 TVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             SCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            775433    3333344556677888999999999999999999999     48999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-37  Score=264.54  Aligned_cols=196  Identities=23%  Similarity=0.367  Sum_probs=147.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCC------eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchh-HHHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSK------FVYIILELCRKRSMMELYNSACDLEEMSDPAAQP-VIWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~------~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~   74 (305)
                      .+|+++|++++|||||+++++|.+.+      .+||||||| +++|..+.+.. .+   .+..+.. ..+++.++.|+|+
T Consensus        65 ~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~l---~~~~~~~~~~qi~~aL~~LH~  139 (346)
T d1cm8a_          65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-KL---GEDRIQFLVYQMLKGLRYIHA  139 (346)
T ss_dssp             HHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC-CC---CHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc-cc---cHHHHHHHHHHHHHHHHHHHh
Confidence            47999999999999999999998765      579999999 66777776543 23   3333333 3345788999998


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHhcC-CcccccCCCccccccccc-CCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIMLAN-KNTLCGTPNYIAPEILNK-NGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~~~-~~~~~Gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .|+.|+       +.+....+++.||+.+..... ..+.+||+.|+|||++.+ ..++.++||||+||++|+|++|++||
T Consensus       140 ~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf  219 (346)
T d1cm8a_         140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF  219 (346)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCcccccCcchhhcccccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC
Confidence            776443       333445667777765543322 245789999999998865 45789999999999999999999999


Q ss_pred             CCCCHHHHHHHHhccc-------------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         146 ETSTLKETYSRIKKVE-------------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .+.+.......+....                               .......++.+.+||.+||+.||.+|||++|+|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL  299 (346)
T d1cm8a_         220 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL  299 (346)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            9887665544332211                               012245788999999999999999999999999


Q ss_pred             cCcccccc
Q psy6191         195 HFEFFNDY  202 (305)
Q Consensus       195 ~~~~~~~~  202 (305)
                      +||||+..
T Consensus       300 ~Hp~f~~~  307 (346)
T d1cm8a_         300 AHPYFESL  307 (346)
T ss_dssp             HSGGGTTT
T ss_pred             cChhhCcC
Confidence            99999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-36  Score=254.96  Aligned_cols=192  Identities=15%  Similarity=0.204  Sum_probs=147.8

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+++.+|+|||||.+|++.+++......  ..... ......+..++.|.|+.++.|+
T Consensus        57 ~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~i~~~i~~gl~~lH~~~iiHr  134 (283)
T d1mqba_          57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLANMNYVHR  134 (283)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTC--SCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccccc--ccHHHHHHHHHHHHHhhhhccccccccC
Confidence            47999999999999999999999999999999999999999887654321  11111 2233345778899998776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhC-CCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVG-KPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g-~~Pf  145 (305)
                             +.+....+++.||+....+..       .....||+.|||||++.++.++.++|||||||++|||++| .+||
T Consensus       135 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~  214 (283)
T d1mqba_         135 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY  214 (283)
T ss_dssp             CCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence                   334456788999976544321       1235689999999999999999999999999999999995 5666


Q ss_pred             CCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         146 ETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ...+..+....+... .++.|...+..+.++|.+||..||++|||+.|+++
T Consensus       215 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         215 WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            667777777766543 34566778899999999999999999999999976

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-37  Score=260.55  Aligned_cols=195  Identities=18%  Similarity=0.274  Sum_probs=149.6

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC-------------CCCCCcC-chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL-------------EEMSDPA-AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~-------------~~~~~~~-~~~~~~~~   66 (305)
                      .+|+++|+++ +|||||++++++.+++.+|||||||+||+|.+++......             ..+.... ......++
T Consensus        58 ~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia  137 (309)
T d1fvra_          58 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA  137 (309)
T ss_dssp             HHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHH
Confidence            4899999999 7999999999999999999999999999999998654211             1111111 12233457


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHh---cCCcccccCCCcccccccccCCCCccchHHHHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIML---ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvily  136 (305)
                      .++.|.|+.++.|+       +.+....+++.||+.....   ......+||+.|+|||.+.++.|+.++|||||||++|
T Consensus       138 ~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~  217 (309)
T d1fvra_         138 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  217 (309)
T ss_dssp             HHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             HHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence            78888888775442       2233345667777643321   1223557999999999999889999999999999999


Q ss_pred             HHHhC-CCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         137 TLLVG-KPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       137 e~l~g-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ||++| .+||.+.+..+....+... .+..|..+++++++||.+||..||++|||+.+++++
T Consensus       218 ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         218 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99996 5689888888888877653 556677899999999999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-36  Score=259.82  Aligned_cols=197  Identities=22%  Similarity=0.304  Sum_probs=144.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc--------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED--------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYS   72 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~--------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~   72 (305)
                      .+|+.+|++++|||||++++++.+        ++.+|+|||||.++++........   ...+.....+ .++..++.|+
T Consensus        57 ~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~l  133 (318)
T d3blha1          57 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYI  133 (318)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHh
Confidence            489999999999999999999865        456999999999886654432222   2222223233 3357888999


Q ss_pred             hhhCCcee-------ecCCCCCeeEcchhHHHHh--------cCCcccccCCCcccccccccC-CCCccchHHHHHHHHH
Q psy6191          73 DKYGFGYQ-------LNDDSSGVMFNDLTRMIML--------ANKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMY  136 (305)
Q Consensus        73 ~~~~~~~~-------~~~~~~~v~~~d~~~~~~~--------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvily  136 (305)
                      |+.|+.|+       +.+..+.+++.|++.....        ....+.+||+.|+|||++.+. .|+.++||||+||++|
T Consensus       134 H~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~  213 (318)
T d3blha1         134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA  213 (318)
T ss_dssp             HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             ccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceee
Confidence            98776543       2334456777787644322        123456899999999998754 6899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhccccCCCC--------------------------------CCCHHHHHHHHHHhhcCC
Q psy6191         137 TLLVGKPPFETSTLKETYSRIKKVEYKLPA--------------------------------TLKKPAATMIKKMLLLDP  184 (305)
Q Consensus       137 e~l~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------------~~~~~~~~li~~~l~~dp  184 (305)
                      ||++|++||.+.+..+....+.......+.                                ..++.+.|||.+||+.||
T Consensus       214 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP  293 (318)
T d3blha1         214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP  293 (318)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred             eHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence            999999999988877766655432211111                                125567899999999999


Q ss_pred             CCCCCHhhhhcCccccc
Q psy6191         185 VQRPPVAQLLHFEFFND  201 (305)
Q Consensus       185 ~~R~~~~~~l~~~~~~~  201 (305)
                      ++|+|++|+++||||+.
T Consensus       294 ~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         294 AQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSCCHHHHHHSGGGSS
T ss_pred             hHCcCHHHHHcChhhcc
Confidence            99999999999999984

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-36  Score=258.54  Aligned_cols=192  Identities=18%  Similarity=0.222  Sum_probs=151.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCc-CchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDP-AAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||++++++.++ ..|+|||||.+|+|.+.+......  +... .......++.++.|+|..++.|+
T Consensus        59 ~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~i~~qi~~gl~yLH~~~iiHr  135 (317)
T d1xkka_          59 LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRRLVHR  135 (317)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccC--CCHHHHHHHHHHHHHHHHHHHHcCcccC
Confidence            4899999999999999999999875 578899999999999987654322  1222 22233456788999998876543


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcCC------cccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLANK------NTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPFE  146 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~~------~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf~  146 (305)
                             +.+....+++.||+.+......      ....||+.|||||++.++.|+.++|||||||++|||+| |.+||.
T Consensus       136 DlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~  215 (317)
T d1xkka_         136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  215 (317)
T ss_dssp             CCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCC
Confidence                   2333457888999876654321      23468999999999999999999999999999999998 899999


Q ss_pred             CCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         147 TSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      +.+..+....+..+. ++.|...+.++.+++.+||..||.+|||+.|++.|
T Consensus       216 ~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         216 GIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             TSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            888777777666543 56677899999999999999999999999999886

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-36  Score=254.03  Aligned_cols=190  Identities=18%  Similarity=0.232  Sum_probs=146.6

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcC-chhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPA-AQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|++++|||||++++++.+ ..+|+|||||++|++.+.+......  +.... ......+..++.|+|..++.|+
T Consensus        59 ~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~--l~~~~~~~~~~qi~~gl~ylH~~~iiHr  135 (273)
T d1u46a_          59 IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLESKRFIHR  135 (273)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGG--SCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCC--CCHHHHHHHHHHHHHHHHHhhhCCEeee
Confidence            489999999999999999999976 4689999999999999877654321  12222 2334456788999998775433


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC-------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh-CCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN-------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV-GKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~-g~~Pf  145 (305)
                             +.+....+++.||+....+..       ....+||+.|||||++.+..++.++|||||||++|||++ |++||
T Consensus       136 Dikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf  215 (273)
T d1u46a_         136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW  215 (273)
T ss_dssp             CCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             eecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCC
Confidence                   122234567777764433211       124568889999999999999999999999999999998 89999


Q ss_pred             CCCCHHHHHHHHhcccc--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         146 ETSTLKETYSRIKKVEY--KLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       146 ~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      .+.+..+....+.....  +.|..+++++++||.+||..||.+|||+.+++
T Consensus       216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         216 IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             TTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            99999998888765543  45667899999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-35  Score=250.92  Aligned_cols=194  Identities=15%  Similarity=0.180  Sum_probs=152.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC---------------------CCCc-Cc
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE---------------------MSDP-AA   59 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~---------------------~~~~-~~   59 (305)
                      .+|+++|++++|||||++++++.+++.+|+|||||++|+|.+++........                     +... ..
T Consensus        64 ~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  143 (301)
T d1lufa_          64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL  143 (301)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHH
T ss_pred             HHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHH
Confidence            5899999999999999999999999999999999999999999875432110                     0000 11


Q ss_pred             hhHHHHHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccc
Q psy6191          60 QPVIWVSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEV  126 (305)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~  126 (305)
                      .....++.++.|.|..++.|+       +.+.+..+++.||+.+.....      .++.+||+.|||||++.+..|+.++
T Consensus       144 ~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ks  223 (301)
T d1lufa_         144 CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES  223 (301)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhh
Confidence            112234677888887776443       334456788999976554322      2356899999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHhcccc-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         127 DVWSIGCIMYTLLVGK-PPFETSTLKETYSRIKKVEY-KLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       127 DiwSlGvilye~l~g~-~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      |||||||++|||++|. +||.+.+..+....+..... ..|..+++++.+||.+||+.||.+|||+.|+++
T Consensus       224 DVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         224 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999984 78999998888888876653 457789999999999999999999999999964

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-35  Score=250.70  Aligned_cols=194  Identities=18%  Similarity=0.302  Sum_probs=151.9

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCC-------------CCCCcC-chhHHHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLE-------------EMSDPA-AQPVIWVS   66 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~-------------~~~~~~-~~~~~~~~   66 (305)
                      .+|+..+.++ +|||||++++++.+++.+|+|||||++|+|.+++.......             .+.... ......++
T Consensus        66 ~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  145 (299)
T d1fgka_          66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA  145 (299)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHH
Confidence            3688888777 89999999999999999999999999999999997653210             011111 12223457


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.|+|..++.|+       +.+..+.+++.|++.......      ....+||+.|||||++.++.|+.++|||||||
T Consensus       146 ~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gv  225 (299)
T d1fgka_         146 RGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV  225 (299)
T ss_dssp             HHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHH
Confidence            78899998876543       334445677777754332211      23467999999999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHhcc-ccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         134 IMYTLLV-GKPPFETSTLKETYSRIKKV-EYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       134 ilye~l~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ++|||++ |.+||.+.+..+....+... .+..|...++++.+||.+||+.||.+|||+.|+++
T Consensus       226 vl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            9999998 79999998888887777554 45667789999999999999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-35  Score=253.47  Aligned_cols=197  Identities=20%  Similarity=0.336  Sum_probs=145.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCe----EEEEEeccCCCCHHHHHHHhcCCCCCCCcCch-hHHHHHHHHHHhhhhC
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKF----VYIILELCRKRSMMELYNSACDLEEMSDPAAQ-PVIWVSKWVDYSDKYG   76 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~----~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   76 (305)
                      .+|+++|++|+|||||++++++..+..    .+++|||+.||+|.+++... .+   ++.... .+.+++.++.|+|..|
T Consensus        54 ~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~-~l---~~~~i~~i~~qil~al~yLH~~~  129 (345)
T d1pmea_          54 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HL---SNDHICYFLYQILRGLKYIHSAN  129 (345)
T ss_dssp             HHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC-CC---CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC-CC---CHHHHHHHHHHHHHHHHHHHHCC
Confidence            379999999999999999999976532    34445567799999998753 22   333332 3344578899999887


Q ss_pred             Ccee-------ecCCCCCeeEcchhHHHHhc-------CCcccccCCCcccccccc-cCCCCccchHHHHHHHHHHHHhC
Q psy6191          77 FGYQ-------LNDDSSGVMFNDLTRMIMLA-------NKNTLCGTPNYIAPEILN-KNGHSFEVDVWSIGCIMYTLLVG  141 (305)
Q Consensus        77 ~~~~-------~~~~~~~v~~~d~~~~~~~~-------~~~~~~Gt~~y~aPE~~~-~~~~~~~~DiwSlGvilye~l~g  141 (305)
                      +.|+       +.+..+.+++.||+.+....       .....+||+.|+|||++. +..++.++||||+||++|||++|
T Consensus       130 iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g  209 (345)
T d1pmea_         130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN  209 (345)
T ss_dssp             EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred             CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhC
Confidence            6443       33444677788876543221       134568999999999985 55689999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcccc-------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCH
Q psy6191         142 KPPFETSTLKETYSRIKKVEY-------------------------------KLPATLKKPAATMIKKMLLLDPVQRPPV  190 (305)
Q Consensus       142 ~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~  190 (305)
                      ++||.+.+.............                               ...+.+++++++||.+||+.||.+|||+
T Consensus       210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta  289 (345)
T d1pmea_         210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV  289 (345)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH
Confidence            999988776554433321000                               0123567889999999999999999999


Q ss_pred             hhhhcCcccccc
Q psy6191         191 AQLLHFEFFNDY  202 (305)
Q Consensus       191 ~~~l~~~~~~~~  202 (305)
                      +|+|+||||+..
T Consensus       290 ~e~L~hpf~~~~  301 (345)
T d1pmea_         290 EQALAHPYLEQY  301 (345)
T ss_dssp             HHHHTSGGGTTT
T ss_pred             HHHhcCHhhccC
Confidence            999999999854

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-35  Score=256.20  Aligned_cols=195  Identities=19%  Similarity=0.320  Sum_probs=136.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc------CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED------SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDK   74 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~------~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   74 (305)
                      .+|+.++++++|||||+++++|..      .+.+|+|||||.+|.+ +.+..  .   +.+..++.+ ..+..++.|.|.
T Consensus        64 ~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~~--~---~~~~~i~~~~~qil~gl~~LH~  137 (355)
T d2b1pa1          64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQM--E---LDHERMSYLLYQMLCGIKHLHS  137 (355)
T ss_dssp             HHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHTS--C---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhhhc--C---CCHHHHHHHHHHHHHHHHHhhh
Confidence            489999999999999999999963      4789999999987644 43321  1   222223333 345788999998


Q ss_pred             hCCcee-------ecCCCCCeeEcchhHHHHh---cCCcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q psy6191          75 YGFGYQ-------LNDDSSGVMFNDLTRMIML---ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPP  144 (305)
Q Consensus        75 ~~~~~~-------~~~~~~~v~~~d~~~~~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~P  144 (305)
                      .|+.|+       +.+....+++.|++.....   ......+||+.|+|||++.+..++.++||||+||++|+|++|++|
T Consensus       138 ~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~p  217 (355)
T d2b1pa1         138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL  217 (355)
T ss_dssp             TTCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCC
Confidence            886553       2233345566666432221   123456899999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhccc----------------------cCC--------------C------CCCCHHHHHHHHHHhhc
Q psy6191         145 FETSTLKETYSRIKKVE----------------------YKL--------------P------ATLKKPAATMIKKMLLL  182 (305)
Q Consensus       145 f~~~~~~~~~~~i~~~~----------------------~~~--------------~------~~~~~~~~~li~~~l~~  182 (305)
                      |.+.+......++....                      ...              +      ...++++.+||++||..
T Consensus       218 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~  297 (355)
T d2b1pa1         218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI  297 (355)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcC
Confidence            99887665544432110                      000              0      01245678999999999


Q ss_pred             CCCCCCCHhhhhcCcccccc
Q psy6191         183 DPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       183 dp~~R~~~~~~l~~~~~~~~  202 (305)
                      ||++|||++|+|+||||+..
T Consensus       298 dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         298 DPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             STTTSCCHHHHHTSTTTGGG
T ss_pred             ChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-35  Score=255.12  Aligned_cols=197  Identities=22%  Similarity=0.308  Sum_probs=146.9

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcC-----CeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHH-HHHHHHHHhhhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDS-----KFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVI-WVSKWVDYSDKY   75 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~   75 (305)
                      .+|+++|++++|||||++++++...     ...++|||||.||+|.+++... .   +.+..++.++ ++..++.|+|+.
T Consensus        65 ~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~-~---l~e~~~~~i~~qil~aL~~LH~~  140 (348)
T d2gfsa1          65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-K---LTDDHVQFLIYQILRGLKYIHSA  140 (348)
T ss_dssp             HHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC-C---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc-c---ccHHHHHHHHHHHHHHHHHHHhC
Confidence            4899999999999999999999743     3456677888999999988542 2   3333343333 457889999988


Q ss_pred             CCcee-------ecCCCCCeeEcchhHHHHh-cCCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCCC
Q psy6191          76 GFGYQ-------LNDDSSGVMFNDLTRMIML-ANKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPFE  146 (305)
Q Consensus        76 ~~~~~-------~~~~~~~v~~~d~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf~  146 (305)
                      |+.|+       +.+..+.+++.|++..... ....+.+||+.|+|||++.+. .++.++||||+||++|+|++|++||.
T Consensus       141 giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~  220 (348)
T d2gfsa1         141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  220 (348)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCcccccCCccccccccccccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence            87554       2334456667776554332 223467899999999986654 56889999999999999999999999


Q ss_pred             CCCHHHHHHHHhccccCC-------------------------------CCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         147 TSTLKETYSRIKKVEYKL-------------------------------PATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       147 ~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      +.+.......+.......                               ....++++++||++||..||.+|||++|+|+
T Consensus       221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         221 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            888776665553321111                               1246888999999999999999999999999


Q ss_pred             Ccccccc
Q psy6191         196 FEFFNDY  202 (305)
Q Consensus       196 ~~~~~~~  202 (305)
                      ||||+..
T Consensus       301 Hp~f~~~  307 (348)
T d2gfsa1         301 HAYFAQY  307 (348)
T ss_dssp             SGGGTTT
T ss_pred             CHhhCCC
Confidence            9999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=245.62  Aligned_cols=200  Identities=21%  Similarity=0.375  Sum_probs=150.0

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+.+|+.++|||||++++++.+.+..|+||||+.|+++..++......   ..... ..+.+++.++.|+|..++.|+
T Consensus        49 ~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~q~~~aL~~lH~~~IvHr  125 (292)
T d1unla_          49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCHSRNVLHR  125 (292)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCC---CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccccccc---chhHHHHHHHHHHHHHHHhhcCCEeee
Confidence            48999999999999999999999999999999999999988887655433   22222 223345678889988776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC----CcccccCCCcccccccccCC-CCccchHHHHHHHHHHHHhCCCCC-CC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN----KNTLCGTPNYIAPEILNKNG-HSFEVDVWSIGCIMYTLLVGKPPF-ET  147 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~-~~~~~DiwSlGvilye~l~g~~Pf-~~  147 (305)
                             +.+....+++.||+.+.....    .....+++.|+|||++.+.. ++.++||||+||++|||++|+.|| .+
T Consensus       126 DiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  205 (292)
T d1unla_         126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred             cccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence                   233345667777765543322    12446889999999987654 689999999999999999999885 45


Q ss_pred             CCHHHHHHHHhccc-----------------------------cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcc
Q psy6191         148 STLKETYSRIKKVE-----------------------------YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEF  198 (305)
Q Consensus       148 ~~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~  198 (305)
                      .+..+....+....                             ...+..+++.+.+||++||+.||.+|||++|+|+|||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~  285 (292)
T d1unla_         206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             CCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence            55555555442210                             1122356788999999999999999999999999999


Q ss_pred             ccccCC
Q psy6191         199 FNDYCP  204 (305)
Q Consensus       199 ~~~~~~  204 (305)
                      |+++.+
T Consensus       286 f~~~~~  291 (292)
T d1unla_         286 FSDFCP  291 (292)
T ss_dssp             GSSCSC
T ss_pred             hcCCCC
Confidence            987643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-35  Score=248.21  Aligned_cols=194  Identities=15%  Similarity=0.160  Sum_probs=145.7

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCCcee
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGFGYQ   80 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (305)
                      .+|+++|++++|||||++++++.+ ++..|+|||||++|+|.+++........ .....+....++.++.|.|..++.|.
T Consensus        76 ~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~-~~~~~~i~~qia~gL~~lH~~~iiHr  154 (311)
T d1r0pa_          76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKFLASKKFVHR  154 (311)
T ss_dssp             HHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCB-HHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccch-HHHHHHHHHHHHHhhhhhcccCcccC
Confidence            589999999999999999999765 5689999999999999998875432211 01122333456778888887776443


Q ss_pred             -------ecCCCCCeeEcchhHHHHhcC--------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          81 -------LNDDSSGVMFNDLTRMIMLAN--------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        81 -------~~~~~~~v~~~d~~~~~~~~~--------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                             +.+....+++.||+....+..        .....||+.|+|||.+....++.++|||||||++|||++|..||
T Consensus       155 DLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~  234 (311)
T d1r0pa_         155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP  234 (311)
T ss_dssp             CCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence                   334556788899876544322        12356899999999999889999999999999999999977776


Q ss_pred             CC-CCHHHHHHHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         146 ET-STLKETYSRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       146 ~~-~~~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      .. .+..+....+.. ..+..|...++++.+||.+||..||.+||++.|++++
T Consensus       235 ~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         235 YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            54 333344444433 3445677889999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-35  Score=247.77  Aligned_cols=194  Identities=13%  Similarity=0.188  Sum_probs=153.4

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCC----CC---CCCc-CchhHHHHHHHHHHhh
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDL----EE---MSDP-AAQPVIWVSKWVDYSD   73 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~----~~---~~~~-~~~~~~~~~~~~~~~~   73 (305)
                      .+|+.++++++|||||++++++..++.+|+|||||++|+|.+++......    ..   .... .......+++++.|+|
T Consensus        71 ~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH  150 (308)
T d1p4oa_          71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN  150 (308)
T ss_dssp             HHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh
Confidence            48999999999999999999999999999999999999999988653211    00   0111 1122334567888888


Q ss_pred             hhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHHHHHHHHh
Q psy6191          74 KYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTLLV  140 (305)
Q Consensus        74 ~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~l~  140 (305)
                      ..++.|+       +.+....+++.||+.+..+..      ....+||+.|||||.+.++.++.++||||+||++|||++
T Consensus       151 ~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t  230 (308)
T d1p4oa_         151 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT  230 (308)
T ss_dssp             HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHh
Confidence            7765432       344556788899875543322      234579999999999999999999999999999999999


Q ss_pred             C-CCCCCCCCHHHHHHHHhccc-cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         141 G-KPPFETSTLKETYSRIKKVE-YKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       141 g-~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      | .+||.+.+..+.+..+.+.. ...|...+..+.++|.+||+.||.+|||+.++++
T Consensus       231 ~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         231 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8 58999999888888776644 4556788999999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-34  Score=249.68  Aligned_cols=194  Identities=19%  Similarity=0.341  Sum_probs=143.5

Q ss_pred             hhHHHHHhcCC-CCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHHHHHHhhhhCC
Q psy6191           2 SQEIAIHRSLK-HRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSKWVDYSDKYGF   77 (305)
Q Consensus         2 ~~Ei~il~~l~-HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   77 (305)
                      .+|+++|++++ |||||+++++|+.  ...+|+|||||++|+|.++.+      .+.+..++.+ .+++.++.|+|..|+
T Consensus        77 ~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~gI  150 (328)
T d3bqca1          77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGI  150 (328)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhccc
Confidence            48999999995 9999999999984  467999999999999876532      1233333333 345788999998876


Q ss_pred             cee--------ecCCCCCeeEcchhHHHHhc---CCcccccCCCcccccccccC-CCCccchHHHHHHHHHHHHhCCCCC
Q psy6191          78 GYQ--------LNDDSSGVMFNDLTRMIMLA---NKNTLCGTPNYIAPEILNKN-GHSFEVDVWSIGCIMYTLLVGKPPF  145 (305)
Q Consensus        78 ~~~--------~~~~~~~v~~~d~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye~l~g~~Pf  145 (305)
                      .|+        +..++..+++.||+.+....   .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus       151 vHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf  230 (328)
T d3bqca1         151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF  230 (328)
T ss_dssp             ECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             ccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCC
Confidence            443        33333457888888665432   23467899999999997754 5799999999999999999999999


Q ss_pred             CCCCH-HHHHHHHhc-------------cc------------------------cCCCCCCCHHHHHHHHHHhhcCCCCC
Q psy6191         146 ETSTL-KETYSRIKK-------------VE------------------------YKLPATLKKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       146 ~~~~~-~~~~~~i~~-------------~~------------------------~~~~~~~~~~~~~li~~~l~~dp~~R  187 (305)
                      ..... ......+..             ..                        ......+++++.+||++||.+||.+|
T Consensus       231 ~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R  310 (328)
T d3bqca1         231 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR  310 (328)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGS
T ss_pred             CCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHC
Confidence            76432 222111110             00                        00112367889999999999999999


Q ss_pred             CCHhhhhcCccccc
Q psy6191         188 PPVAQLLHFEFFND  201 (305)
Q Consensus       188 ~~~~~~l~~~~~~~  201 (305)
                      ||++|+|+||||++
T Consensus       311 ~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         311 LTAREAMEHPYFYT  324 (328)
T ss_dssp             CCHHHHHTSGGGTT
T ss_pred             cCHHHHhcCcccCC
Confidence            99999999999985

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=246.61  Aligned_cols=194  Identities=19%  Similarity=0.248  Sum_probs=147.4

Q ss_pred             hhHHHHHhcC-CCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCC---------------CCCcCc-hhHHH
Q psy6191           2 SQEIAIHRSL-KHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEE---------------MSDPAA-QPVIW   64 (305)
Q Consensus         2 ~~Ei~il~~l-~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~---------------~~~~~~-~~~~~   64 (305)
                      .+|+.+++++ +|||||++++++++++.+|||||||++|+|.+++........               +..... ....+
T Consensus        74 ~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  153 (311)
T d1t46a_          74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ  153 (311)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHH
Confidence            4799999998 699999999999999999999999999999999876543211               111111 12234


Q ss_pred             HHHHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHH
Q psy6191          65 VSKWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSI  131 (305)
Q Consensus        65 ~~~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSl  131 (305)
                      ++.++.|+|..++.|+       +.+....+++.|++.......      ....+||+.|||||++.+..++.++|||||
T Consensus       154 i~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~  233 (311)
T d1t46a_         154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY  233 (311)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccch
Confidence            5678889988776443       223345667778775544322      134689999999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHhc--cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhc
Q psy6191         132 GCIMYTLLV-GKPPFETSTLKETYSRIKK--VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLH  195 (305)
Q Consensus       132 Gvilye~l~-g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~  195 (305)
                      ||++|||++ |.+||.+.+..+.+..+..  .....|...+..+.+||.+||..||.+|||++|+++
T Consensus       234 G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999998 6777777666555444432  334456678999999999999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-34  Score=242.32  Aligned_cols=194  Identities=18%  Similarity=0.251  Sum_probs=141.2

Q ss_pred             hHHHHHhcC-CCCCccceeEEEEc-CCeEEEEEeccCCCCHHHHHHHhcCCC-------------CCCCcCc-hhHHHHH
Q psy6191           3 QEIAIHRSL-KHRNVVGFHSFFED-SKFVYIILELCRKRSMMELYNSACDLE-------------EMSDPAA-QPVIWVS   66 (305)
Q Consensus         3 ~Ei~il~~l-~HpnIV~l~~~~~~-~~~~ylVmEy~~~g~L~~~~~~~~~~~-------------~~~~~~~-~~~~~~~   66 (305)
                      +|+.++.++ +|||||++++++.+ ++.+|+|||||++|+|.+++.......             .+..... ....+++
T Consensus        65 ~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  144 (299)
T d1ywna1          65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA  144 (299)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHH
Confidence            566666665 78999999999765 457999999999999999997653210             0111111 2223457


Q ss_pred             HHHHHhhhhCCcee-------ecCCCCCeeEcchhHHHHhcC------CcccccCCCcccccccccCCCCccchHHHHHH
Q psy6191          67 KWVDYSDKYGFGYQ-------LNDDSSGVMFNDLTRMIMLAN------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGC  133 (305)
Q Consensus        67 ~~~~~~~~~~~~~~-------~~~~~~~v~~~d~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGv  133 (305)
                      .++.|+|+.++.|+       +.+....+++.||+.+.....      ..+.+||+.|||||++.++.++.++||||+||
T Consensus       145 ~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv  224 (299)
T d1ywna1         145 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV  224 (299)
T ss_dssp             HHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHH
Confidence            88899998876543       333446788899986654322      23568999999999999999999999999999


Q ss_pred             HHHHHHhC-CCCCCCCCHHHHH-HHHhc-cccCCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcC
Q psy6191         134 IMYTLLVG-KPPFETSTLKETY-SRIKK-VEYKLPATLKKPAATMIKKMLLLDPVQRPPVAQLLHF  196 (305)
Q Consensus       134 ilye~l~g-~~Pf~~~~~~~~~-~~i~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~  196 (305)
                      ++|||++| .+||.+.+..+.+ ..+.. ..+..|...++++.++|.+||..||.+|||++|+++|
T Consensus       225 il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         225 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999986 5788776544433 33332 3456677899999999999999999999999999876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.6e-33  Score=234.93  Aligned_cols=190  Identities=14%  Similarity=0.195  Sum_probs=124.9

Q ss_pred             hHHHHHhcCCCCCccceeEEEEcCC----eEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhHHHHHHHHHHhhhhCC-
Q psy6191           3 QEIAIHRSLKHRNVVGFHSFFEDSK----FVYIILELCRKRSMMELYNSACDLEEMSDPAAQPVIWVSKWVDYSDKYGF-   77 (305)
Q Consensus         3 ~Ei~il~~l~HpnIV~l~~~~~~~~----~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-   77 (305)
                      +|+..+++++|||||++++++.+++    .+|||||||++|+|.+++++.. +.  .+...+....++.++.+.|..+. 
T Consensus        46 ~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-l~--~~~~~~~~~~ia~gl~~lH~~~~~  122 (303)
T d1vjya_          46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VT--VEGMIKLALSTASGLAHLHMEIVG  122 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-BC--HHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred             HHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC-CC--HHHHHHHHHHHHHHHHHHHHhhhh
Confidence            4555667899999999999998654    6899999999999999997642 11  11112333445677777775422 


Q ss_pred             -------ce-------eecCCCCCeeEcchhHHHHhc--------CCcccccCCCcccccccccCC------CCccchHH
Q psy6191          78 -------GY-------QLNDDSSGVMFNDLTRMIMLA--------NKNTLCGTPNYIAPEILNKNG------HSFEVDVW  129 (305)
Q Consensus        78 -------~~-------~~~~~~~~v~~~d~~~~~~~~--------~~~~~~Gt~~y~aPE~~~~~~------~~~~~Diw  129 (305)
                             .|       .+.+....+++.||+......        .....+||+.|||||++.+..      ++.++|||
T Consensus       123 ~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~  202 (303)
T d1vjya_         123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY  202 (303)
T ss_dssp             TTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred             hccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhh
Confidence                   11       122333556666665332211        123468999999999987543      56789999


Q ss_pred             HHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHhccc--cCCCCCC-----CHHHHHHHHHHhhcCCCCC
Q psy6191         130 SIGCIMYTLLVGKPPFETS---------------TLKETYSRIKKVE--YKLPATL-----KKPAATMIKKMLLLDPVQR  187 (305)
Q Consensus       130 SlGvilye~l~g~~Pf~~~---------------~~~~~~~~i~~~~--~~~~~~~-----~~~~~~li~~~l~~dp~~R  187 (305)
                      ||||++|||++|.+||...               ........+....  +.+|...     ...+.+++.+||+.||.+|
T Consensus       203 S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  282 (303)
T d1vjya_         203 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR  282 (303)
T ss_dssp             HHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGS
T ss_pred             hhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHC
Confidence            9999999999999887432               1222222222222  2222221     1247799999999999999


Q ss_pred             CCHhhhhc
Q psy6191         188 PPVAQLLH  195 (305)
Q Consensus       188 ~~~~~~l~  195 (305)
                      ||+.|+++
T Consensus       283 ps~~ei~~  290 (303)
T d1vjya_         283 LTALRIKK  290 (303)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHHH
Confidence            99999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.5e-30  Score=220.73  Aligned_cols=196  Identities=15%  Similarity=0.105  Sum_probs=135.0

Q ss_pred             hhHHHHHhcCCCCCc-cceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNV-VGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnI-V~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|++++++++|+|+ +.+++++.+++..|+|||||. |++.+.+......  ...... .....++.++.|+|+.|+.|
T Consensus        50 ~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~iiH  126 (299)
T d1ckia_          50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNFIH  126 (299)
T ss_dssp             HHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCC--CcHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            479999999987765 555666788899999999995 5666655443221  122222 22334577888999877654


Q ss_pred             eec----------CCCCCeeEcchhHHHHhcC-----------CcccccCCCcccccccccCCCCccchHHHHHHHHHHH
Q psy6191          80 QLN----------DDSSGVMFNDLTRMIMLAN-----------KNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMYTL  138 (305)
Q Consensus        80 ~~~----------~~~~~v~~~d~~~~~~~~~-----------~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvilye~  138 (305)
                      +-.          +....+++.||+.+..+..           ..+.+||+.|||||++.+..++.++||||+||++|||
T Consensus       127 rDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el  206 (299)
T d1ckia_         127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF  206 (299)
T ss_dssp             SCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHH
T ss_pred             ccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHH
Confidence            311          1233467778765443221           2356899999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHH---hccc-----cCCCCCCCHHHHHHHHHHhhcCCCCCCCHhh---hhcCcccc
Q psy6191         139 LVGKPPFETSTLKETYSRI---KKVE-----YKLPATLKKPAATMIKKMLLLDPVQRPPVAQ---LLHFEFFN  200 (305)
Q Consensus       139 l~g~~Pf~~~~~~~~~~~i---~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~---~l~~~~~~  200 (305)
                      ++|+.||...+.......+   ....     ...+..+++++.+++.+||..||.+||++++   +++++|.+
T Consensus       207 ~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            9999999875543322211   1111     1223568899999999999999999999875   46677654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.96  E-value=7.4e-30  Score=215.48  Aligned_cols=190  Identities=16%  Similarity=0.173  Sum_probs=140.9

Q ss_pred             hhHHHHHhcCCC-CCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKH-RNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~H-pnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|+++++.|+| |||++++++++++...|+||||| +|+|.+++......  ...... .....+..++.++|+.|+.|
T Consensus        48 ~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~--~~~~~~~~i~~q~~~~l~~lH~~giiH  124 (293)
T d1csna_          48 RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEKSLVY  124 (293)
T ss_dssp             HHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccc--hhhHHHHHHHHHHHHHHHHHHHCCcee
Confidence            579999999976 89999999999999999999999 68999988764432  122222 22334567788888887644


Q ss_pred             e--------ecC----CCCCeeEcchhHHHHhc-----------CCcccccCCCcccccccccCCCCccchHHHHHHHHH
Q psy6191          80 Q--------LND----DSSGVMFNDLTRMIMLA-----------NKNTLCGTPNYIAPEILNKNGHSFEVDVWSIGCIMY  136 (305)
Q Consensus        80 ~--------~~~----~~~~v~~~d~~~~~~~~-----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSlGvily  136 (305)
                      +        +..    ..+.+++.||+.+....           ...+.+||+.|||||++.+..++.++||||+||++|
T Consensus       125 rDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~  204 (293)
T d1csna_         125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFM  204 (293)
T ss_dssp             CCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             ccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHH
Confidence            3        221    13457788887554322           123568999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCC---HHHHHHHHhcccc-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhhhh
Q psy6191         137 TLLVGKPPFETST---LKETYSRIKKVEY-----KLPATLKKPAATMIKKMLLLDPVQRPPVAQLL  194 (305)
Q Consensus       137 e~l~g~~Pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l  194 (305)
                      ||++|..||.+.+   ..+....+.....     .++..+++++.+++..|+..+|.+||+.+.+.
T Consensus       205 elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         205 YFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             HHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            9999999997643   3333333322211     22356888999999999999999999877664

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=3.5e-29  Score=217.81  Aligned_cols=200  Identities=17%  Similarity=0.272  Sum_probs=129.9

Q ss_pred             hhHHHHHhcCC-----------CCCccceeEEEEc--CCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCchhH-HHHHH
Q psy6191           2 SQEIAIHRSLK-----------HRNVVGFHSFFED--SKFVYIILELCRKRSMMELYNSACDLEEMSDPAAQPV-IWVSK   67 (305)
Q Consensus         2 ~~Ei~il~~l~-----------HpnIV~l~~~~~~--~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~~~~-~~~~~   67 (305)
                      .+|+.++++++           |||||+++++++.  ....++||+++..+......................+ ..+..
T Consensus        57 ~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~  136 (362)
T d1q8ya_          57 EDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL  136 (362)
T ss_dssp             HHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHH
Confidence            47899988876           5789999998864  5678889998887765554444333322233333333 33467


Q ss_pred             HHHHhhh-hCCceeecCCCCC--------------eeEcchhHHHHh-cCCcccccCCCcccccccccCCCCccchHHHH
Q psy6191          68 WVDYSDK-YGFGYQLNDDSSG--------------VMFNDLTRMIML-ANKNTLCGTPNYIAPEILNKNGHSFEVDVWSI  131 (305)
Q Consensus        68 ~~~~~~~-~~~~~~~~~~~~~--------------v~~~d~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DiwSl  131 (305)
                      ++.++|. .|+.|+-... .+              +++.|++.+... ......+||+.|+|||++.+..|+.++||||+
T Consensus       137 al~~lh~~~~IvHrDlKp-~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  215 (362)
T d1q8ya_         137 GLDYMHRRCGIIHTDIKP-ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWST  215 (362)
T ss_dssp             HHHHHHHTTCEECSCCSG-GGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred             HHHHHhhhcCcccccCCh-hHeeeeccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccch
Confidence            7778775 5443321111 11              334444432221 12345689999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHH------HHHHHHh---c---------------------------------------cccC
Q psy6191         132 GCIMYTLLVGKPPFETSTLK------ETYSRIK---K---------------------------------------VEYK  163 (305)
Q Consensus       132 Gvilye~l~g~~Pf~~~~~~------~~~~~i~---~---------------------------------------~~~~  163 (305)
                      ||++++|++|+.||...+..      .......   .                                       ....
T Consensus       216 G~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
T d1q8ya_         216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK  295 (362)
T ss_dssp             HHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC
T ss_pred             HHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccc
Confidence            99999999999999754321      1111100   0                                       0001


Q ss_pred             CCCCCCHHHHHHHHHHhhcCCCCCCCHhhhhcCcccccc
Q psy6191         164 LPATLKKPAATMIKKMLLLDPVQRPPVAQLLHFEFFNDY  202 (305)
Q Consensus       164 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~l~~~~~~~~  202 (305)
                      .+...++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus       296 ~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         296 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             CCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             cCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence            111234568899999999999999999999999999853

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=1.7e-12  Score=106.65  Aligned_cols=61  Identities=38%  Similarity=0.686  Sum_probs=56.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +.+.+++.++..++.|++.|+.|+|++|++|||+||+||+++.++.+|++|||+|+.+..+
T Consensus        96 ~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          96 PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            3456999999999999999999999999999999999999999999999999999877543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=2.9e-12  Score=106.43  Aligned_cols=60  Identities=30%  Similarity=0.547  Sum_probs=55.9

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      ..+++.++..++.|++.|+.|+|++|++|||+||+||+++.++.+|++|||+|+.+....
T Consensus       111 ~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            468999999999999999999999999999999999999999999999999999876443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=3.8e-12  Score=107.87  Aligned_cols=62  Identities=39%  Similarity=0.643  Sum_probs=56.9

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+.+.+++.+++.++.|++.|+.|+|++|++|||+||+||+++.++.+|++|||+|+.+...
T Consensus        97 ~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          97 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             HHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             hcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            34567899999999999999999999999999999999999999999999999999877543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=3.8e-12  Score=105.56  Aligned_cols=66  Identities=36%  Similarity=0.597  Sum_probs=57.6

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +........+.+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+.
T Consensus        96 L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          96 VDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccC
Confidence            333333345569999999999999999999999999999999999999999999999999997654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.23  E-value=5.2e-12  Score=103.33  Aligned_cols=61  Identities=31%  Similarity=0.536  Sum_probs=56.2

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +.+.+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+..+
T Consensus        99 ~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          99 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            4456999999999999999999999999999999999999999999999999999877543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.22  E-value=4.5e-12  Score=104.50  Aligned_cols=69  Identities=36%  Similarity=0.515  Sum_probs=57.9

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .++..........+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+||+|||+|+.+..
T Consensus        88 g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          88 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            344444444456689999999999999999999999999999999999999999999999999977643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.22  E-value=6.5e-12  Score=107.01  Aligned_cols=61  Identities=38%  Similarity=0.625  Sum_probs=56.5

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +.+.+++.++..++.|++.|+.|||+++++|||+||+||+++.++.+||+|||+|+.+...
T Consensus       134 ~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            3457999999999999999999999999999999999999999999999999999987643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.22  E-value=8.9e-12  Score=106.19  Aligned_cols=70  Identities=36%  Similarity=0.554  Sum_probs=60.0

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec--CCCceEEeecccceecCcc
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS--DNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~--~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+.+........+++.++..++.|++.|+.|||++|++|||+||+||+++  ..+.+||+|||+|+.+..+
T Consensus       111 g~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             ChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            344444444556799999999999999999999999999999999999997  5689999999999987644

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=5.7e-12  Score=105.17  Aligned_cols=59  Identities=42%  Similarity=0.562  Sum_probs=48.6

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+||+|||+|+.....
T Consensus       129 ~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  187 (299)
T d1ywna1         129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  187 (299)
T ss_dssp             -CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhcccc
Confidence            45889999999999999999999999999999999999999999999999999876543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.20  E-value=8.6e-12  Score=104.42  Aligned_cols=61  Identities=41%  Similarity=0.682  Sum_probs=56.2

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+.+++.++..++.|++.|+.|+|++|++|||+||+||+++.++.+|++|||+|+....
T Consensus       107 ~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_         107 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            3456799999999999999999999999999999999999999999999999999987654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.19  E-value=8.4e-12  Score=103.40  Aligned_cols=62  Identities=37%  Similarity=0.673  Sum_probs=56.3

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+.+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+...
T Consensus       100 ~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_         100 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            34567999999999999999999999999999999999999999999999999999987643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.19  E-value=7.7e-12  Score=104.28  Aligned_cols=68  Identities=29%  Similarity=0.426  Sum_probs=52.4

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .+........+.+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+||+|||+|+.+..
T Consensus       113 ~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         113 SLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             cceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            33333334455689999999999999999999999999999999999999999999999999987754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.18  E-value=1.4e-11  Score=105.51  Aligned_cols=62  Identities=31%  Similarity=0.563  Sum_probs=56.8

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      +...+++.++..++.|++.|+.|+|.++++|||+||+||+++..+.+|++|||+|+.+....
T Consensus       100 ~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3         100 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             hcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            34568899999999999999999999999999999999999999999999999999876543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.17  E-value=1.7e-11  Score=100.99  Aligned_cols=61  Identities=36%  Similarity=0.654  Sum_probs=57.0

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+.+++.++..++.|++.|+.|||.++++|||+||+||+++.++.+||+|||+|+.+..+
T Consensus       103 ~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  163 (277)
T d1phka_         103 EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG  163 (277)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCC
Confidence            4567999999999999999999999999999999999999999999999999999887643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.16  E-value=2e-11  Score=102.44  Aligned_cols=63  Identities=33%  Similarity=0.559  Sum_probs=56.8

Q ss_pred             ccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       238 ~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ......+++..+..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+...
T Consensus        95 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          95 LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             HHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             ccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            344566888999999999999999999999999999999999999999999999999887543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.16  E-value=1e-11  Score=102.89  Aligned_cols=60  Identities=32%  Similarity=0.547  Sum_probs=54.9

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++..+..++.|++.|+.|+|+++++|||+||+||+++.++.+||+|||+|+.+..+
T Consensus       109 ~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_         109 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            356888899999999999999999999999999999999999999999999999876543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=1.7e-11  Score=101.44  Aligned_cols=69  Identities=30%  Similarity=0.522  Sum_probs=59.5

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ++.......+..+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+...
T Consensus        94 ~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             cHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            343333344567899999999999999999999999999999999999999999999999999887543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.15  E-value=2.5e-11  Score=103.31  Aligned_cols=70  Identities=29%  Similarity=0.526  Sum_probs=59.3

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--CCceEEeecccceecCcc
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD--NFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~--~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+.+......+.+++.++..++.|++.|+.|||++|++|||+||+||+++.  ++.+|++|||+|+.+...
T Consensus       108 g~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         108 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            3454444445567999999999999999999999999999999999999964  578999999999887643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=1.8e-11  Score=102.07  Aligned_cols=64  Identities=41%  Similarity=0.630  Sum_probs=57.5

Q ss_pred             cccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       237 ~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ....+..+++.++..++.|++.|+.|+|++|++|||+||+||+++..+.+|++|||+|+.+...
T Consensus        90 ~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          90 IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             HTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             hhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC
Confidence            3344567899999999999999999999999999999999999999999999999999876543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=1.9e-11  Score=103.13  Aligned_cols=59  Identities=34%  Similarity=0.505  Sum_probs=53.7

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.|+.|||+++++|||+||+||+++.++.+||+|||+|+.....
T Consensus       159 ~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~  217 (325)
T d1rjba_         159 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD  217 (325)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCC
Confidence            45889999999999999999999999999999999999999999999999999876544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=1.8e-11  Score=101.22  Aligned_cols=64  Identities=28%  Similarity=0.486  Sum_probs=52.4

Q ss_pred             cccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       237 ~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .......++..+...++.|++.|+.|+|+++++|||+||+||+++.++.+||+|||+|+.+...
T Consensus       100 ~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_         100 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             HHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             hhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            3334456889999999999999999999999999999999999999999999999999876543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=2.8e-11  Score=103.22  Aligned_cols=63  Identities=32%  Similarity=0.571  Sum_probs=55.9

Q ss_pred             ccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-ceEEeecccceecCcc
Q psy6191         238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF-VVKIGDFGLAARIEFD  300 (305)
Q Consensus       238 ~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~-~~k~~dfg~a~~~~~~  300 (305)
                      ......+++.+++.++.|++.|+.|||++|++|||+||+||+++.++ .+|++|||+|+.+...
T Consensus       113 ~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_         113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            34456799999999999999999999999999999999999998764 8999999999887543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=1.1e-11  Score=104.41  Aligned_cols=59  Identities=29%  Similarity=0.546  Sum_probs=54.3

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~-~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      +.+.+++..+..++.|++.|+.|+|+ ++++|||+||+||+++.++.+|++|||+|+.+.
T Consensus        97 ~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          97 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            34569999999999999999999996 699999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=2.7e-11  Score=99.51  Aligned_cols=59  Identities=37%  Similarity=0.567  Sum_probs=54.9

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.|+.|+|.++++|||+||+||+++.++.+||+|||+|+.+..+
T Consensus       104 ~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_         104 IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            35889999999999999999999999999999999999999999999999999887643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.13  E-value=9.5e-12  Score=102.10  Aligned_cols=68  Identities=34%  Similarity=0.531  Sum_probs=52.4

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHK-----IIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~-----~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+.+..+....+++.++..++.|++.|+.|+|+.+     ++|||+||+||+++.++.+|++|||+|+.+..+
T Consensus        95 ~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  167 (269)
T d2java1          95 VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD  167 (269)
T ss_dssp             HHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred             HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence            33444445567999999999999999999999865     999999999999999999999999999877543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.13  E-value=3.5e-11  Score=98.95  Aligned_cols=62  Identities=31%  Similarity=0.419  Sum_probs=55.1

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCceEEeecccceecCcc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-NFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~-~~~~k~~dfg~a~~~~~~  300 (305)
                      .+...+++.++..++.|++.|+.|+|+++++|||+||+||+++. .+.+|++|||+|+.....
T Consensus       102 ~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~  164 (273)
T d1xwsa_         102 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT  164 (273)
T ss_dssp             HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc
Confidence            34567999999999999999999999999999999999999985 579999999999876543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.11  E-value=3.1e-11  Score=99.44  Aligned_cols=62  Identities=27%  Similarity=0.532  Sum_probs=56.5

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+...+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+.+...
T Consensus        99 ~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          99 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             HHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             hhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            34456899999999999999999999999999999999999999999999999999877543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.11  E-value=2.5e-11  Score=99.22  Aligned_cols=68  Identities=28%  Similarity=0.423  Sum_probs=52.4

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +..........+++.....++.|++.|+.|+|+++++|||+||+||+++.++.+||+|||+|+.+...
T Consensus        87 L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          87 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             HHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence            33333334456788889999999999999999999999999999999999999999999999876543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.11  E-value=2.4e-11  Score=102.10  Aligned_cols=69  Identities=30%  Similarity=0.478  Sum_probs=59.7

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .+..........+++.++..++.|++.|+.|||+++++|||+||+||+++.++.+|++|||+|+.+...
T Consensus        96 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          96 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             BHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            344444445567889999999999999999999999999999999999999999999999999877543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=3.2e-11  Score=100.51  Aligned_cols=60  Identities=35%  Similarity=0.655  Sum_probs=55.2

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+|+....
T Consensus        95 ~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          95 ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC
Confidence            345689999999999999999999999999999999999999999999999999976643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=4.9e-11  Score=101.41  Aligned_cols=59  Identities=37%  Similarity=0.680  Sum_probs=54.9

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.++..++.|++.|+.|+|++|++|||+||+||+++..+.+|++|||+|+.+...
T Consensus       104 ~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_         104 QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            46899999999999999999999999999999999999999999999999999876543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=4.3e-11  Score=98.31  Aligned_cols=70  Identities=36%  Similarity=0.560  Sum_probs=60.6

Q ss_pred             cchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         232 PLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       232 ~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      .+........+.+++..+..++.|++.|+.|+|+++++|||+||.||+++.++.+|++|||+|+.+....
T Consensus        96 ~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          96 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             BHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             chhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            3444445556679999999999999999999999999999999999999999999999999999875543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.09  E-value=3e-11  Score=99.36  Aligned_cols=68  Identities=29%  Similarity=0.481  Sum_probs=51.3

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +..........+++.++..++.|++.|+.|+|+++++|||+||+||+++..+.+|++|||+|+.+...
T Consensus        94 l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          94 LRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             HHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             HHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            33333444566899999999999999999999999999999999999999999999999999877543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.08  E-value=7.9e-11  Score=99.03  Aligned_cols=70  Identities=27%  Similarity=0.432  Sum_probs=58.8

Q ss_pred             ccchhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--CCceEEeecccceecCcc
Q psy6191         231 KPLMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD--NFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       231 ~~l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~--~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+.+........+++.++..++.|++.|+.|||++|++|||+||+||+++.  ...+|++|||+|+.+..+
T Consensus        86 g~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            3455544444457999999999999999999999999999999999999985  448999999999887543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.08  E-value=5.9e-11  Score=97.27  Aligned_cols=59  Identities=44%  Similarity=0.674  Sum_probs=53.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEec-CCCceEEeecccceecC
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHK--IIHRDLKLGNLFLS-DNFVVKIGDFGLAARIE  298 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~--~~~~~l~~~~~l~~-~~~~~k~~dfg~a~~~~  298 (305)
                      +...+++.++..++.|++.|+.|+|+++  ++|||+||+||+++ .++.+|++|||+|+...
T Consensus       105 ~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_         105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            4456899999999999999999999998  99999999999996 57899999999997544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.08  E-value=3.9e-11  Score=99.30  Aligned_cols=64  Identities=31%  Similarity=0.555  Sum_probs=57.5

Q ss_pred             hcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         236 RNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       236 r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ......+.+++.++..++.|++.|++|+|+++++|||+||+||+++.++.+|++|||.|..+..
T Consensus        89 ~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          89 LLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             HHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             HHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            3344556799999999999999999999999999999999999999999999999999876643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.06  E-value=1e-10  Score=98.67  Aligned_cols=59  Identities=32%  Similarity=0.576  Sum_probs=53.1

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDN-FVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~-~~~k~~dfg~a~~~~~~  300 (305)
                      +.+++.+++.++.|++.||.|||++|++|||+||+||+++.. +.+|++|||+|+.+...
T Consensus       124 ~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            358999999999999999999999999999999999999865 56999999999877543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.05  E-value=1.1e-10  Score=98.17  Aligned_cols=61  Identities=31%  Similarity=0.578  Sum_probs=56.2

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .....+++.++..++.|++.|+.|+|+++++|||+||+||+++..+.+|++|||+|+.+..
T Consensus        95 ~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          95 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence            3456689999999999999999999999999999999999999999999999999987654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.04  E-value=1.2e-10  Score=98.53  Aligned_cols=60  Identities=40%  Similarity=0.582  Sum_probs=53.9

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCceEEeecccceecCccc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~---~~~~k~~dfg~a~~~~~~~  301 (305)
                      ..+++.++..++.|++.|+.|||++|++|||+||+||+++.   .+.+|++|||+|+.+....
T Consensus       106 ~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1         106 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC
Confidence            46899999999999999999999999999999999999985   4579999999998776543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.04  E-value=9.9e-11  Score=97.76  Aligned_cols=61  Identities=36%  Similarity=0.536  Sum_probs=48.1

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLS---DNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~---~~~~~k~~dfg~a~~~~~~  300 (305)
                      +.+.+++.++..++.|++.|+.|+|+++++|||+||+||++.   .++.+|++|||+|+.+..+
T Consensus       100 ~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_         100 EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            345799999999999999999999999999999999999995   4678999999999876543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.02  E-value=8.4e-11  Score=98.02  Aligned_cols=59  Identities=36%  Similarity=0.602  Sum_probs=54.2

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..++..++..++.|++.|+.|+|+++++|||+||+||+++.++.+||+|||+|+.+...
T Consensus       135 ~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~  193 (301)
T d1lufa_         135 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA  193 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred             CCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCC
Confidence            45788899999999999999999999999999999999999999999999999866443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.02  E-value=2.2e-10  Score=94.91  Aligned_cols=63  Identities=27%  Similarity=0.493  Sum_probs=56.9

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      ...+.+++.++..++.|++.|+.|+|.++++|||+||+||+++..+.+|++|||.|+......
T Consensus        93 ~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          93 SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            345668899999999999999999999999999999999999999999999999998776443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.01  E-value=2.3e-10  Score=97.21  Aligned_cols=59  Identities=41%  Similarity=0.686  Sum_probs=55.4

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ...+++..+..++.|++.|+.|||++|++|||+||+||+++.++.+|++|||+|+....
T Consensus       115 ~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_         115 HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence            45699999999999999999999999999999999999999999999999999987754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.00  E-value=1.1e-10  Score=96.47  Aligned_cols=58  Identities=36%  Similarity=0.615  Sum_probs=52.2

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.++..++.|++.|+.|+|.++++|+|+||+||+++.++.+||+|||+|+.+.
T Consensus       107 ~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3         107 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence            3458999999999999999999999999999999999999999999999999998664

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.00  E-value=2.8e-10  Score=92.52  Aligned_cols=68  Identities=29%  Similarity=0.442  Sum_probs=58.3

Q ss_pred             chhhcccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         233 LMERNSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       233 l~~r~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      +..........+++..+..++.|++.|+.|+|.++++|+|+||+||+++.++.+|++|||+|+.+...
T Consensus        86 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             HHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            33333444556888999999999999999999999999999999999999999999999999876543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.00  E-value=2.3e-10  Score=96.04  Aligned_cols=61  Identities=34%  Similarity=0.608  Sum_probs=55.8

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      .....+++.+++.++.|++.|+.|+|++|++|||+||+||+++.++.+|++|||+|+.+..
T Consensus       109 ~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~  169 (318)
T d3blha1         109 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL  169 (318)
T ss_dssp             CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence            3445688999999999999999999999999999999999999999999999999987653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.99  E-value=2.5e-10  Score=95.23  Aligned_cols=61  Identities=33%  Similarity=0.624  Sum_probs=55.3

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ....+++..++.++.|++.|+.|+|+++++|||+||+||+++..+.+|++|||+++.....
T Consensus       109 ~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~  169 (305)
T d1blxa_         109 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ  169 (305)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc
Confidence            4456889999999999999999999999999999999999999999999999998766543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.99  E-value=2.8e-10  Score=94.70  Aligned_cols=63  Identities=25%  Similarity=0.409  Sum_probs=54.8

Q ss_pred             ccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCceEEeecccceecCcc
Q psy6191         238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD---NFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       238 ~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~---~~~~k~~dfg~a~~~~~~  300 (305)
                      ......+++.++..++.|++.|++|+|+++++|||+||+||+++.   +..++++|||+|+.+...
T Consensus        94 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          94 NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             hhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            334556899999999999999999999999999999999999864   457999999999987643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=3.7e-10  Score=93.61  Aligned_cols=62  Identities=47%  Similarity=0.720  Sum_probs=55.2

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----ceEEeecccceecCccc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNF----VVKIGDFGLAARIEFDG  301 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~----~~k~~dfg~a~~~~~~~  301 (305)
                      ..+.+++.++..++.|++.|+.|||+++++|||+||+||+++..+    .+|++|||+|+.+....
T Consensus       106 ~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~  171 (293)
T d1jksa_         106 EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN  171 (293)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC
T ss_pred             cccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc
Confidence            345799999999999999999999999999999999999998765    59999999998876443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=3.6e-10  Score=93.97  Aligned_cols=61  Identities=33%  Similarity=0.530  Sum_probs=55.8

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCccc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFDG  301 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~~  301 (305)
                      ...+++.++..++.|++.|+.|+|+++++|||+||+||+++.++.+|++|||+++.+....
T Consensus       129 ~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~  189 (299)
T d1fgka_         129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID  189 (299)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccc
Confidence            3458899999999999999999999999999999999999999999999999998776543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.96  E-value=3.3e-10  Score=95.22  Aligned_cols=60  Identities=37%  Similarity=0.545  Sum_probs=54.9

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..+.+++..+..++.|++.|+.|+|+.+++|||+||+|++++.++.+|++|||+|+.+..
T Consensus       122 ~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         122 QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             hcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            445678899999999999999999999999999999999999999999999999987653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.94  E-value=5.8e-10  Score=93.20  Aligned_cols=64  Identities=30%  Similarity=0.445  Sum_probs=56.0

Q ss_pred             cccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         237 NSKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       237 ~~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .......++......++.|++.|+.|+|+.+++|||+||+||+++.++.+||+|||+|+.+...
T Consensus       120 ~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             HHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             hccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            3334455677788899999999999999999999999999999999999999999999877544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.94  E-value=6.5e-10  Score=92.14  Aligned_cols=60  Identities=20%  Similarity=0.345  Sum_probs=53.3

Q ss_pred             ccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-----CCceEEeecccceecCc
Q psy6191         240 RRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSD-----NFVVKIGDFGLAARIEF  299 (305)
Q Consensus       240 ~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~-----~~~~k~~dfg~a~~~~~  299 (305)
                      ....++..++..++.|++.|+.|+|++|++|||+||+||+++.     .+.++++|||+|+.+..
T Consensus        94 ~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          94 CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            3446889999999999999999999999999999999999964     56899999999987653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=98.93  E-value=5.2e-10  Score=91.97  Aligned_cols=62  Identities=27%  Similarity=0.416  Sum_probs=55.8

Q ss_pred             ccccccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         238 SKRRKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       238 ~~~~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ....+.+++.++..++.|++.|+.|+|++|++|||+||+||+++..+..+++|||.++.+..
T Consensus       102 ~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_         102 VHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             hcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence            34456799999999999999999999999999999999999999999999999999876543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.92  E-value=6.6e-10  Score=94.38  Aligned_cols=59  Identities=41%  Similarity=0.694  Sum_probs=51.0

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.+++.++.|++.|+.|||++|++|||+||+||+++.++.+|++|||+|......
T Consensus       116 ~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1         116 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence            45999999999999999999999999999999999999999999999999998766543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.90  E-value=8.3e-10  Score=92.25  Aligned_cols=60  Identities=33%  Similarity=0.522  Sum_probs=54.9

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ...+++.++..++.|++.|+.|||.++++|||+||+||+++..+.++++|||+|+.+...
T Consensus       139 ~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~  198 (311)
T d1t46a_         139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND  198 (311)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCC
Confidence            345889999999999999999999999999999999999999999999999999877643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=98.89  E-value=6.7e-10  Score=86.06  Aligned_cols=56  Identities=23%  Similarity=0.293  Sum_probs=48.7

Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         244 ITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       244 l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ++...+..++.|++.++.++|.+|++|+|+||+||+++.. .++++|||.|......
T Consensus       100 l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~  155 (191)
T d1zara2         100 VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEE  155 (191)
T ss_dssp             CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTST
T ss_pred             hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCC
Confidence            4556677899999999999999999999999999999865 4789999999887543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=9.6e-10  Score=91.73  Aligned_cols=58  Identities=33%  Similarity=0.570  Sum_probs=52.9

Q ss_pred             cCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         243 AITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       243 ~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      .++..+...++.|++.|+.|+|.++++|||+||+||+++.++.+||+|||+|+.+...
T Consensus       129 ~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~  186 (308)
T d1p4oa_         129 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  186 (308)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCC
Confidence            3577788899999999999999999999999999999999999999999999876543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.86  E-value=1e-09  Score=91.60  Aligned_cols=58  Identities=31%  Similarity=0.643  Sum_probs=54.0

Q ss_pred             cccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecC
Q psy6191         241 RKAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIE  298 (305)
Q Consensus       241 ~~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~  298 (305)
                      ...+++.+...++.|++.|+.|+|+++++|||+||.||+++.++.+|++|||+|+...
T Consensus       121 ~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~  178 (309)
T d1fvra_         121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE  178 (309)
T ss_dssp             SCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccccccc
Confidence            4568899999999999999999999999999999999999999999999999987654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.80  E-value=2.2e-09  Score=89.25  Aligned_cols=59  Identities=31%  Similarity=0.335  Sum_probs=53.1

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHD--------HKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~--------~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..++..+...++.|++.|+.|+|.        ++++|||+||+||+++.++.+||+|||+|+.+...
T Consensus        95 ~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          95 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            357888888999999999999997        59999999999999999999999999999877543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.74  E-value=5e-09  Score=85.16  Aligned_cols=58  Identities=26%  Similarity=0.454  Sum_probs=49.9

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEF  299 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~  299 (305)
                      ..++......++.|++.|+.|+|+++++|+|++|.||+++.++.+|++|||+++....
T Consensus        98 ~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          98 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence            3588999999999999999999999999999999999999999999999999987654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.72  E-value=6e-09  Score=88.58  Aligned_cols=59  Identities=34%  Similarity=0.529  Sum_probs=49.9

Q ss_pred             ccCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCceEEeecccceecCcc
Q psy6191         242 KAITEPETRFYMKQILEGVSYLHDHKIIHRDLKLGNLFLSDNFVVKIGDFGLAARIEFD  300 (305)
Q Consensus       242 ~~l~~~~~~~~~~qi~~~l~~~h~~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~~~~~~  300 (305)
                      ..+++.+++.++.|++.|+.|+|++|++|||+||+||+++.++.++++|||+++.....
T Consensus       114 ~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1         114 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            35889999999999999999999999999999999999999999999999998766543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.51  E-value=4.6e-08  Score=83.11  Aligned_cols=61  Identities=30%  Similarity=0.380  Sum_probs=52.6

Q ss_pred             cccccCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCC------ceEEeecccceecCc
Q psy6191         239 KRRKAITEPETRFYMKQILEGVSYLHD-HKIIHRDLKLGNLFLSDNF------VVKIGDFGLAARIEF  299 (305)
Q Consensus       239 ~~~~~l~~~~~~~~~~qi~~~l~~~h~-~~~~~~~l~~~~~l~~~~~------~~k~~dfg~a~~~~~  299 (305)
                      .....+++..+..++.|++.|+.|+|+ +|++|||+||+||+++..+      .++++|||.|.....
T Consensus       117 ~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~  184 (362)
T d1q8ya_         117 YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE  184 (362)
T ss_dssp             TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred             ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc
Confidence            345568889999999999999999998 8999999999999997544      489999999886654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=98.09  E-value=5.7e-07  Score=69.00  Aligned_cols=64  Identities=11%  Similarity=0.048  Sum_probs=43.5

Q ss_pred             hhHHHHHhcCCCCCccceeEEEEcCCeEEEEEeccCCCCHHHHHHHhcCCCCCCCcCc-hhHHHHHHHHHHhhhhCCce
Q psy6191           2 SQEIAIHRSLKHRNVVGFHSFFEDSKFVYIILELCRKRSMMELYNSACDLEEMSDPAA-QPVIWVSKWVDYSDKYGFGY   79 (305)
Q Consensus         2 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~ylVmEy~~~g~L~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   79 (305)
                      .+|...+.++.|+|+++.+++..    -++||||++++.+.++          ..... .....+..++.+.|..|+.|
T Consensus        62 ~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~giiH  126 (191)
T d1zara2          62 RNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRGIVH  126 (191)
T ss_dssp             HHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCCEEE
Confidence            36889999999999999887632    2799999998755331          12222 23334567788888776543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=82.90  E-value=0.22  Score=39.68  Aligned_cols=30  Identities=30%  Similarity=0.401  Sum_probs=27.0

Q ss_pred             CCceecCCCCCcEEecCCCceEEeecccce
Q psy6191         266 HKIIHRDLKLGNLFLSDNFVVKIGDFGLAA  295 (305)
Q Consensus       266 ~~~~~~~l~~~~~l~~~~~~~k~~dfg~a~  295 (305)
                      .|++|.|+.+.|++++.+....+.||+.|.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988888999998764